note_rowid,subject_id,hadm_id,note_text
0,10029649,25577737," 
Name:  ___                      Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PSYCHIATRY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
""I don't feel like I can do anything anymore.""
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ year old woman with a history of chronic 
anxiety and dysthymia who is brought to the emergency department 
by EMS due to worsening symptoms of depression, irritability, 
and expressed suicidal ideation. On initial and subsequent 
interviews, patient is unable to describe fully her current 
symptoms, nor precipitants for current symptoms. Although she 
endorses fatigue and diminished motivation, she is unable to 
cite specific stressors or precipitants for decline in mood or 
functioning. Stated, ""I feel frustrated and exhausted."" 
Explained that she currently lives with her sister and 
step-grandmother in her step-grandmother's home; described 
living arrangements as ""cramped"" (e.g. ""I don't have space to do 
what I want to do""), adding that she has ""anxiety about wanting 
to get organized."" Has been self-employed as a ___ for 
the past ___ years, working four days per week; describes work as 
""tiring"" but ""it's the only thing [she knows] how to do for 
work."" Also cited intermittent conflict with boyfriend as 
contributing to low mood. Explained, ""It feels like I'm losing 
control in these situations. One little thing, and it's like the 
last straw. In those moments I don't know what to do."" However, 
patient describes her relationship with her boyfriend as 
supportive; two have been dating for ___ year (met eachother ___ 
years ago). [Should be noted that patient's boyfriend called EMS 
and reported to Dr. ___ patient had not been eating or 
sleeping, and endorsed suicidal ideation]. Regarding thoughts of 
suicide, patient was not able to elaborate further beyond ""vague 
thoughts of death."" However, affirmed that she feels safe on 
this unit, and would be capable of approaching staff if 
thoughts/urges of self-harm intensified.
 
Past Medical History:
Past psychiatric history notable for previous diagnoses of 
depression and anxiety. No previous hospitalizations. Has 
therapist ___ ___, no consistent 
psychiatrist. Reported previous medication trials of several 
antidepressants (Prozac, Cymbalta, Celexa), none with 
significant improvement in symptoms. Of noted, patient reported 
that ""citalopram ___ years ago led to significant weight gain and 
feeling numb, not helpful. Duloxetine ___ to help with 
chronic pain, led to severe exhaustion and did not help."" Denies 
previous suicide attempts or self-injurious behavior. 
  
Past medical history:
- myofacial pain syndrome in neck
- recurrent UTIs
- asthma
- chronic pelvic pain
  
Allergies: NKDA; pollen and shellfish
 
Social History:
___
Family History:
Family psychiatric history notable for several family members 
with depression and anxiety; siblings with chronic SI, no known 
suicide attempts
 
Physical Exam:
PHYSICAL EXAMINATION: 
 VS: ___ 2252 Temp:97.7 BP:117/80 HR:74 RR:16 O2:98% 
 General: NAD, sitting up in chair.
 HEENT: PERRL, MMM.
 Neck: Supple. No adenopathy or thyromegaly.
 Lungs: CTAB; no crackles or wheezes.
 CV: RRR; no m/r/g
 Abdomen: Soft, NT, ND.
 Extremities: No clubbing, cyanosis, or edema.
 Skin: Warm and dry, no cyanosis or erythema. No rash.
  
NEUROLOGICAL EXAM:
CN: PERRL, EOMI, smile symmetric, shoulder shrug intact
Motor: strength ___ in all four ext b/l
*Deep tendon Reflexes: Patellar: 1+
Gait/Romberg: gait wnl, Romberg not assessed
  
MENTAL STATUS EXAM:
-Appearance: ___ year old woman who appears younger than stated 
age, sitting up in chair in NAD
-Behavior: Calm and cooperative with interview, makes 
appropriate eye contact, answers questions appropriately
-Mood and Affect: ""tired"", affect constricted, fatigued, 
dysphoric
-Thought process: linear, goal-directed, no loose associations, 
no tangentiality, no circumstantiality
-Thought Content: Denies SI/HI/AVH, does not appear to be 
responding to internal stimuli
-Judgment and Insight: impaired/impaired
  
COGNITIVE EXAM:
*Attention, *orientation, and executive function: has difficulty 
attending to some aspects of interview, able to state DOTWB; 
fully oriented to person, ___, and date; executive function 
not formally tested
*Memory: intact to recent events on interview
*Fund of knowledge: Accurately states last three ___ presidents.
*Speech: normal amount, volume and tone normal, rhythm normal
*Language: fluent, native ___ speaker

 
Pertinent Results:
___ 02:10PM URINE  HOURS-RANDOM
___ 02:10PM URINE  UCG-NEGATIVE
___ 02:10PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG
___ 02:10PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 02:10PM URINE  BLOOD-SM* NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 02:10PM URINE  RBC-<1 WBC-1 BACTERIA-FEW* YEAST-NONE 
EPI-1
___ 02:10PM URINE  MUCOUS-OCC*
___ 12:46PM   GLUCOSE-85 UREA N-11 CREAT-0.6 SODIUM-142 
POTASSIUM-4.3 CHLORIDE-105 TOTAL CO2-22 ANION GAP-15
___ 12:46PM   CALCIUM-9.1 PHOSPHATE-2.2* MAGNESIUM-2.3
___ 12:46PM   WBC-7.0 RBC-4.50 HGB-13.0 HCT-40.2 MCV-89 
MCH-28.9 MCHC-32.3 RDW-14.0 RDWSD-45.6
___ 12:46PM   NEUTS-74.4* LYMPHS-18.5* MONOS-5.1 EOS-0.9* 
BASOS-0.7 IM ___ AbsNeut-5.24 AbsLymp-1.30 AbsMono-0.36 
AbsEos-0.06 AbsBaso-0.05
___ 12:46PM   PLT COUNT-354
 
Brief Hospital Course:
Mr. ___ is a ___ year old woman with a history of chronic 
anxiety and dysthymia who is brought to the emergency department 
by EMS due to worsening symptoms of depression, irritability, 
and expressed suicidal ideation. 
  
  
1. LEGAL & SAFETY:  
On admission, the patient signed a conditional voluntary 
agreement (Section 10 & 11) and remained on that level 
throughout their admission. She was also placed on 15 minute 
checks status on admission and remained on that level of 
observation throughout while being unit restricted.
  
  
2. PSYCHIATRIC
#Major Depressive Disorder 
At the time of presentation, the patient had difficulty fully 
describing her current mood state, almost to the point of 
alexithymia. She did endorse recent fatigue, poor sleep, poor 
appetite, anhedonia, decreased motivation, diminished 
concentration, and passive suicidal thoughts. While she denied 
suicidal plan or intent, she did note that she had recently felt 
worried that she may lose control and do something unsafe. 
Collateral from her boyfriend, in addition to patient's 
appraisal of her own functioning, was concerning for recent 
deterioration and heightened irritability and depressed mood. On 
initial exam, she had a restricted affect and made minimal eye 
contact with interviewers. 
  
Her presentation appeared most consistent with major depressive 
disorder, but there was additionally an element of 
trauma-related symptoms contributing to her presentation. 
Patient has a history of sexual assault and also described 
arguments with boyfriend evoking memories from childhood when 
she observed her mother/stepfather arguing. 

She reported previous medication trials of fluoxetine, 
citalopram, and duloxetine which were discontinued either due to 
ineffectiveness or side effects. She was started on Wellbutrin 
XR 150mg daily and Hydroxyzine 25mg BID:PRN anxiety/insomnia. 
She reported feeling jittery, anxious, with racing heart on 
Wellbutrin XR 150mg so was transitioned to Wellbutrin SR 100mg. 
She tolerated this well with no reported side effects. Over the 
course of her admission, she engaged in treatment, including 
individual therapy as well as groups focused on coping. She 
reported improvement in her mood and energy level. She denied 
any suicidal ideation, reporting that she was no longer in a 
dark place. She had a less constricted affect and was brighter 
and more reactive. At the time of discharge, she was 
future-oriented, looking forward to getting back to work. 
  
  
3. MEDICAL
#Chronic pelvic pain: Patient reported intermittent right-sided 
pelvic pain exacerbated by urination, bowel movements, and 
intercourse. She denied heavy or irregular menstrual bleeding 
and stated that she usually does not take anything for the pain, 
as ibuprofen and Tylenol have never seemed to help. Patient has 
had discussions about endometriosis with doctors in the past but 
has never been definitively diagnosed. She reports that her 
symptoms are currently at baseline and tolerable. She declined 
offer for PRN pain medication during this admission.
  
  
4. SUBSTANCE USE: Patient reported intermittent marijuana use.  
She was provided with counseling regarding marijuana use and 
possible negative impact substance use has on her anxiety/mood. 
  
  
5. PSYCHOSOCIAL
#) GROUPS/MILIEU:  
The patient was encouraged to participate in the various groups 
and milieu therapy opportunities offered by the unit.  The 
patient often attended these groups that focused on teaching 
patients various coping skills.  She was also noted to be social 
with her peers in the milieu and pleasant with staff members. 
  
#) COLLATERAL CONTACTS & FAMILY INVOLVEMENT:
Patient provided verbal permission to contact her outpatient 
therapist ___ ___ and her 
outpatient PCP (Dr. ___ ___. Providers were 
contacted for collateral information and for discharge planning. 
Patient also gave verbal permission to contact her boyfriend  
___ who provided the primary team with 
collateral information.
  

INFORMED CONSENT: The team discussed the indications for, 
intended benefits of, and possible side effects and risks of 
starting Wellbutrin and Hydroxyzine, and risks and benefits of 
possible alternatives, including not taking the medications, 
with this patient.   We discussed the patient's right to decide 
whether to take this medication as well as the importance of the 
patient's actively participating in the treatment and discussing 
any  questions about medications with the treatment team, and I  
answered the patient's questions.  The patient appeared able to 
understand and consented to begin the medication.
  
  
RISK ASSESSMENT
On presentation, the patient was evaluated and felt to be at an 
increased risk of harm to herself and/or others based upon 
worsening functioning with passive suicidal ideation, fears of 
losing control and doing something unsafe.  Her static factors 
noted at that time include history of trauma and abuse, chronic 
mental illness, chronic pain (fibromyalgia, myofascial pain 
syndrome, chronic pelvic pain) .  The modifiable risk factors, 
which included lack of outpatient treaters, passive suicidal 
ideation, acute mood episode, and medication noncompliance 
(history of discontinuing several antidepressants due to side 
effects) were also addressed at that time.  The patient engaged 
in individual and group therapy focusing on coping skills during 
her admission; she was also started on Wellbutrin which she 
tolerated well and outpatient follow up was scheduled.  Finally, 
the patient is being discharged with many protective factors, 
including future-oriented thinking, willingness to seek help, 
and sense of responsibility to family.  Overall, based on the 
totality of our assessment at this time, the patient is not at 
an acutely elevated risk of self-harm nor danger to others. 
 
Medications on Admission:
None
 
Discharge Medications:
1.  BuPROPion (Sustained Release) 100 mg PO QAM 
RX *bupropion HCl [Wellbutrin SR] 100 mg 1 tablet by mouth daily 
Disp #*14 Tablet Refills:*0 
2.  HydrOXYzine 25 mg PO BID:PRN insomnia/anxiety 
RX *hydroxyzine HCl 25 mg 1 tablet by mouth daily PRN Disp #*14 
Tablet Refills:*0 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Major depressive disorder

 
Discharge Condition:
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Mental Status:
  -Appearance: ___ year old woman, appearing her stated age, well
groomed, wearing casual home clothing
  -Behavior: sitting up in a chair, making appropriate eye
contact with interviewers, no psychomotor agitation or
retardation
  -Attitude: calm and cooperative with the interview, easily
engaged
  -Mood and Affect: 'fine'; bright, appropriately reactive 
affect smiling several times throughout interview appropriately; 
less anxious appearing than previous
  -Speech: normal volume, rate, tone
  -Thought process: linear, no loose associations, organized
  -Thought content: denies SI and is future oriented, looking 
forward to getting back to work, did not endorse HI or AVH, does 
not appear to be responding to internal stimuli, no evidence of 
paranoia or delusions
  -Judgment and Insight: good

 
Discharge Instructions:
-Please follow up with all outpatient appointments as listed - 
take this discharge paperwork to your appointments.
-Unless a limited duration is specified in the prescription, 
please continue all medications as directed until your 
prescriber tells you to stop or change.
-Please avoid abusing alcohol and any drugs--whether 
prescription drugs or illegal drugs--as this can further worsen 
your medical and psychiatric illnesses.
-Please contact your outpatient psychiatrist or other providers 
if you have any concerns.
-Please call ___ or go to your nearest emergency room if you 
feel unsafe in any way and are unable to immediately reach your 
health care providers.
It was a pleasure to have worked with you, and we wish you the 
best of health.
 
Followup Instructions:
___
"
1,10240593,21634747," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
 
Chief Complaint: Chest pain  

 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Ms. ___ is a ___ yo f with history of paranoid schizophrenia, 
asthma and DM sent from ___ due to CP and 
SOB for 2 days and AMS, more combative. Also with left leg/thigh 
pain. She is an extremely poor historian and can only describe 
having pain in the ___ her sternum starting about 2 days 
ago with some associated chest tightness and questionable 
shortness of breath. She denies onset with exertion. Per report 
from her facility, she had cough with clear sputum as well as 
diarrhea and LLQ pain at ___. She told the ED she had a 
seizure last night but the OSH did not have reports of this.  
.  
In the ED, initial vs were: 97.5, 86, 136/79, 18, with 97% on 
RA. Patient underwent a head CT that is prelim negative. EKG 
with no apparent signs of ischemia. ___ trop negative. She was 
given 1L IVF for ?ARF. D-dimer was negative. She also reported 
thigh pain, but exam was normal. Vitals on transfer were HR 84, 
BP 111/55, RR 18, sat 97% on RA.  
.  
On the floor, she cannot thoroughly answer questions or describe 
her symptoms. She does deny any suicidal or homicidal ideation.  

.  
Review of sytems: Unable to obtain secondary to paranoid 
schizophrenia  

 
Past Medical History:
paranoid schizophrenia  
DM  
asthma  
HTN  
HL  
urinary retention  

 
Social History:
___
Family History:
unable to obtain 
 
Physical Exam:
Vitals: T: 97.4 BP: 152/91 P: 79 R: 22 O2: 98% RA  
General: Alert, oriented to month and year but not date or 
place, answering some questions but not completely, no acute 
distress  
HEENT: NC/AT, sclera anicteric, MM tachy, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: Clear to auscultation bilaterally anteriorly (patient 
""unable to move"" for posterior auscultation, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, trace BLE edema, no 
clubbing or cyanosis  

 
Pertinent Results:
___ 07:55AM BLOOD WBC-6.7 RBC-3.76* Hgb-11.6* Hct-34.9* 
MCV-93 MCH-30.9 MCHC-33.3 RDW-12.7 Plt ___
___ 12:52PM BLOOD Neuts-70.1* ___ Monos-3.6 Eos-2.6 
Baso-0.5
___ 07:55AM BLOOD Plt ___
___ 12:52PM BLOOD Plt ___
___ 07:55AM BLOOD
___ 07:55AM BLOOD Glucose-157* UreaN-22* Creat-1.2* Na-140 
K-4.7 Cl-102 HCO3-28 AnGap-15
___ 12:39PM BLOOD Glucose-160* UreaN-26* Creat-1.2* Na-136 
K-4.5 Cl-99 HCO3-26 AnGap-16
___ 12:39PM BLOOD estGFR-Using this
___ 07:55AM BLOOD CK(CPK)-159
___ 10:41PM BLOOD CK(CPK)-215*
___ 12:39PM BLOOD ALT-35 AST-36 LD(LDH)-193 CK(CPK)-282* 
AlkPhos-102 TotBili-0.1
___ 07:55AM BLOOD CK-MB-4 cTropnT-<0.01
___ 10:41PM BLOOD CK-MB-6 cTropnT-<0.01
___ 12:39PM BLOOD CK-MB-9 cTropnT-<0.01
___ 12:39PM BLOOD Calcium-9.9 Phos-2.7 Mg-1.9
___ 02:33PM BLOOD D-Dimer-394
___ 12:39PM BLOOD TSH-1.5
___ 12:39PM BLOOD HoldBLu-HOLD
___ 12:39PM BLOOD LtGrnHD-HOLD
___ 12:39PM BLOOD GreenHd-HOLD
.
CXR-IMPRESSION: No acute cardiopulmonary abnormality. Relative 
prominence of the ascending thoracic aorta. 
.
CT head-IMPRESSION: No acute intracranial process.

 
Brief Hospital Course:
Pt is a ___ y.o female with h.o paranoid schizophrenia, HTN, HL, 
DM who presents s/p CP, SOB and now with ?AMS.  
.  
# AMS: Per her psych facility, she has had increased agitation 
over the past couple of days with mental status changes. Her 
baseline is unknown given paranoid schizophrenia but she 
partially answers some questions and is oriented to month, year 
and hospital (although incorrect hospital). No overt signs of 
aggression but appears withdrawn. CXR negative for signs of 
infection or reason for cough. Pt was continued on haldol as per 
prior regimen. There was no sign of infection, Bcx, Ucx were 
negative. TSH was normal. Pt did not display aggression during 
this hospitalization. Tegretol level was ordered.
.  
# Atypical CP: Pt does have risk factors for ACS including HTN, 
HL and DM. Patient was unable to fully describe her symptoms but 
points to the ___ her chest and says it hurts. Pt has 3 
sets of cardiac enzymes that were negative. She was observed on 
telemetry and did not have any events. Her EKG did not show any 
evidence of ischemia. She was continued on statin, ACEI and her 
ASA was increased to full dose.  
.  
# Paranoid schizophrenia: She was continued on haldol as above 
and klonopin, celexa, tegretol. She was evaluated by psychiatry 
and it was decided that she will require further inpatient 
psychiatric treatment.  
.  
# DM: Pt was continued on home 70/30 15 units BID and humalog 
ISS started.   
.  
# Anemia: Patient has history of anemia (unknown baseline) and 
takes iron supplements at home.  She was continued on iron 
tablets and her HCT monitored. 
.  
# HTN: She was continued on ACE-I and HCTZ. 
.  
# HL: Continued on home simvastatin.  
.  
# Asthma: started on combivent inhaler.
.  
Prophylaxis: Subcutaneous heparin, bowel regimen, pain control 
with tylenol  
.  
Access: peripherals  
Code: Full (presumed)  
Communication: Patient  
Emergency contact: Per psych records, ___ (child) 
___ pt home number ___  
 
Medications on Admission:
tegretol 200mg BID  
klonopin 0.5mg BID  
celexa 30mg daily  
enalapril maleate 20mg daily  
HCTZ 25mg daily  
simvastatin 20mg daily  
haldol 20mg qhs  
metoformin 1g BID  
asa 81mg daily  
ferrous sulfate 325mg BID  
loratadine 10mg daily  
eucerin PRN BID  
Humulin 70/30 15 units BID  
hydrocortisone cream 1% BID  
colace 100 BID  
senna 2 tabs BID  
mylanta 30mL q4 PRN  
milk of mag 30mL qhs PRN  
ibuprofen 400mg q4 PRN  
combivent 2 puffs QID PRN  
haldol 5mg q6 PRN  
acetaminophen 650mg q4 PRN  
dextromethorphan HBr 10mL q6 PRN  

 
Discharge Medications:
1. Carbamazepine 200 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
2. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times 
a day).  
3. Citalopram 20 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  
4. Enalapril Maleate 20 mg Tablet Sig: One (1) Tablet PO once a 
day.  
5. Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO 
DAILY (Daily).  
6. Simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  
7. Haloperidol 20 mg Tablet Sig: One (1) Tablet PO at bedtime.  
8. Haloperidol 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for agitation.  
9. Metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. 
 
10. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
11. Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) 
Tablet PO twice a day.  
12. Loratadine 10 mg Tablet Sig: One (1) Tablet PO once a day.  
13. Humulin 70/30 100 unit/mL (70-30) Suspension Sig: Fifteen 
(15) units Subcutaneous twice a day.  
14. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
15. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
16. Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q6H 
(every 6 hours) as needed for pain, fever.  
17. Combivent ___ mcg/Actuation Aerosol Sig: ___  Inhalation 
four times a day as needed for shortness of breath or wheezing.
Disp:*1 inhaler* Refills:*0*

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Major:
atypical chest pain
.
Minor:
DM
HTN
HL
schizophrenia

 
Discharge Condition:
Mental Status: Confused - sometimes
Level of Consciousness: Alert and interactive
Activity Status: Ambulatory - Independent

 
Discharge Instructions:
You were admitted after reporting chest pain. You had a chest 
x-ray that was normal. In addition, your telemetry monitoring 
did not show evidence of an arrhythmia. Your blood tests did not 
show evidence of a heart attack. Your pain was relieved by 
tylenol. 
.
You will be returning to your psychiatric facility for continued 
treatment of your schizophrenia.
.
You were prescribed a combivent inhaler for your asthma.
 
Followup Instructions:
___
"
2,10240593,21249643," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
UTI
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with paranoid schizophrenia who is non-verbal and 
minimally cooperative/interactive presents from ___ 
___ for abnormal labs. Patient has a h/o psychogenic 
polydipsia and was found to have Na 128 -> 122. She was also 
incontinent of urine and stool, with report of frequent loose 
BMs. ___ also reports that she has also had 3 falls, 
reportedly in a ""controlled manner"" and was medically cleared at 
___ on ___. BP reported to be low at 77/45, 81/45 at 
___ and pt afebrile.
.  
Per her daughter, when she's at her best she can walk with a 
walker (but very unsteady). Can speak ___ and ___ but 
when she's sick she only speaks ___. When daughter last saw 
her 3 weeks ago she was speaking fine. At her worst, she is 
violent and physically abusive (kind of manic per daughter). 
.
In the ED, initial vs were: 97.2 80 113/54 18 100. Patient was 
combative and spitting, got haldol. Also given ciprofloxacin for 
? UTI and admitted.
.  
On the floor, pt is hemodynamically stable, follows simple 
commands, mostly nonverbal (did tell me to ""get the hell out"" at 
one point)
.  
Review of sytems: unable to obtain 

 
Past Medical History:
paranoid schizophrenia  
DM  
asthma  
HTN  
HL  
urinary retention 
several UTI recently ___ catheters
 
Social History:
___
Family History:
unable to obtain 
 
Physical Exam:
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: Clear to auscultation anteriorly
CV: Regular rate and rhythm, distant heart sounds
Abdomen: soft, ?tender as pt got angry at me when I touched her 
abdomen but tolerated the rest of the exam, obese, 
non-distended, bowel sounds present, no rebound tenderness or 
guarding
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Skin: per ___ pt has rash on buttocks but could not turn 
pt over by myself (pt mostly uncooperative) 
Neuro: pt blinks and squeezes my hands on command. will not 
stick out her tongue or point her toes. tracks me as I walk 
around the room with her eyes. spoke to me x3: once to say ""get 
the hell out"" when I examined her abd, and then also said ""yes"" 
when I asked if I could look at her feet and then commented that 
she was cold with the blanket off. 
 
Pertinent Results:
___ 09:55AM BLOOD WBC-12.0* RBC-3.90* Hgb-12.2 Hct-35.0* 
MCV-90 MCH-31.2 MCHC-34.7 RDW-12.8 Plt ___
___ 09:55AM BLOOD Neuts-82.9* Lymphs-11.8* Monos-3.7 
Eos-1.0 Baso-0.5
___ 08:00AM BLOOD ___ PTT-21.6* ___
___ 09:55AM BLOOD Glucose-222* UreaN-15 Creat-1.3* Na-134 
K-4.1 Cl-94* HCO3-26 AnGap-18
___ 08:00AM BLOOD Glucose-260* UreaN-10 Creat-1.0 Na-136 
K-3.7 Cl-100 HCO3-23 AnGap-17
___ 09:55AM BLOOD ALT-47* AST-41* LD(___)-209 AlkPhos-165* 
TotBili-0.3
___ 08:00AM BLOOD ALT-36 AST-24 LD(___)-190 AlkPhos-165* 
TotBili-0.3
___ 08:00AM BLOOD Albumin-3.8 Calcium-9.3 Phos-2.3* Mg-1.8
___ 09:55AM BLOOD Carbamz-6.1
___ 10:15AM BLOOD Glucose-216* Na-133* K-4.1
___ 10:30PM URINE Blood-LG Nitrite-NEG Protein-150 
Glucose-NEG Ketone-150 Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-MOD
___ 10:30PM URINE RBC->50 WBC->50 Bacteri-MOD Yeast-NONE 
___

___ Blood culture x1 pending
___ Urine cultures x2 pending

 NSR @ 82, normal axis, borderline low voltage, ? ___ mm STE in 
V1 alone 
 
Brief Hospital Course:
___ y.o female with h.o paranoid schizophrenia, HTN, HL, DM who 
presents with incontinence and abdominal pain and UTI and 
several abscesses s/p large MRSA perirectal abscess drainage in 
the OR. 
.
# R buttock abscess and several other sm buttock and thigh 
abscesses: Surgery consulted and drained large perirectal 
abscess in OR ___ and again ___. Cultures grew MRSA 
sensitive to doxycycline, bactrim, and vancomycin (as well as sm 
amt of corynebacterium). Pt initially started on doxycycline but 
this was transitioned to vancomycin after infectious disease 
consultation. She was transitioned to bactim and will complete a 
full course of this. Pt had several additional abscesses, 
including one on R thigh that was I+Ded at bedside (by surgery). 
Pt had careful wound care to buttock wound to avoid stool 
contamination and foley to avoid keeping the wound wet (pt 
frequently incontinent and retained urine often). However, 
patient did not need a foley near the end of her discharge. 
Prior to discharge patient did not have a foley and her urine 
volume was less than 200 cc. Discharged without a foley. Pt's 
pain was controlled c oxycodone plus dilaudid for dressing 
changes. However, near the end of her discharge, patient 
required minimal pain medication. 
.
# UTI: Pt found to have pan-sensitive pseudomonas. She was 
treated with ciprofloxacin for 5 doses (combination of IV and PO 
as pt sometimes refused PO meds and sometimes pulled out her 
IVs). Her last dose was IM cefepime (as pt refusing POs and had 
no IV access at the time. Repeat UA and Ucx without growth.
.
# abd pain on admission: ? ___ UTI. Pt had ab/pelvis CT on 
admission which was reassuring and abd pain improved c treatment 
of UTI. She continued to have intermittent lower abdominal pain 
when foley was out. Patient intermittently retained urine and 
foley improved her pain. Patient's foley was removed for >48 
hours prior to discharge and she was not retaining, however 
incontinent. She did not have pain. Bladder scan prior to 
discharge was less than 200 cc.
.
# Elevated INR: Pt noted to have elevated INR and low albumin 
and mildly enlarged liver on CT abd/pelvis. Hepatitis serologies 
were negative and INR improved c 3d of vitamin K. 
.
# Constipation: Pt started on miralax, colace, senna, bisacodyl. 

.
# Hypotension on admission: pt's blood pressure meds were held 
and her BP trended up. Enalapril was planned for continuation, 
however she developed a slight increase in her Cr to 1.3 (from 
1.0). She was given fluids prior to discharge as her labs 
appeared hemo-concentrated. Cr should be re-checked two days 
post-discharge in rehab and this medication should be 
re-evaluated.  HCTZ was discontinued.
.
# urinary retention: has been an occasional issue over the past 
___ months per her daughter. The etiology is unclear but 
initially felt to be ___ benztropine which was discontinued 
prior to admission. Haldol and klonopin can both cause urinary 
retention, however, neither of these meds are new to her, make 
this etiology less likely. Pt had foley placed after an episode 
of 900cc of urinary retention. It was initially planned that the 
foley would quickly be discontinued, however, it was ultimately 
continued through most of her admission ___ concern about her 
wound site getting wet as pt is incontinent. However was 
discontinued two days prior to discharge as patient consistently 
pulled it out. She did not retain urine and her dressing changes 
were more frequent (up to ___ times per day) to ensure a clean 
abscess site. Patient tolerated this well. 
  
# psychogenic polydipsia: free water restricted to 2L. Pt did 
not seem interested in drinking excessively during this 
admission.
.
# petichiae: Pt noted to have diffuse petichiae on lower 
extremities and chest. her CBC was checked and was within normal 
limits. Petichiae resolved. 
.  
# Paranoid schizophrenia: Pt was followed by our psychiatry 
department. She was continued on her meds from psych facility 
(haldol, klonopin, celexa, tegretol, zyprexa). Zyprexa and 
haldol were given IM when pt refused PO. Pt has ___ 
guardianship.  EKG showed stable QTc interval.
.  
# DM type 2, uncontrolled: On admission, pt was on sliding 
scale, she had also been discharged on 70/30 though it was 
unclear whether she had been getting 70/30 at her psych 
facility. Pt was started on lantus and humalog sliding scale 
which were titrated up aggressively given her elevated blood 
sugars. She maintainted appropriate blood sugars on regimen of 
44 units of Lantus with HISS.

# Anemia: continued iron supplementation. b12 and folate wnl. 
-Recommend outpt colonoscopy when psychosis improved (this was 
discussed with pt's daughter)

# CKD: at recent baseline, however had small increase in Cr to 
1.3. Likely pre-renal as further labs appeared hemoconcentrated. 
Gave IVFs prior to discharge. Should be rechecked in 2 days for 
further management.
.
# HL: Continued on home simvastatin.  
.
# Communication: Patient and her legal guardian ___ 
___ (pt does also have ___ per report from 
___) 
 
Medications on Admission:
Medications (per ___ list):  
klonopin 0.5 BID
tegretol 200 BID
enalapril 20 qam
simvastatin 20 qam
prilosec 20 daily
haldol 10mg TID (if does not take PO meds, gets 10mg of haldol 
IM)
zyprexa 5mg daily (5mg IM if does not take PO)
lispro sliding scale
asa 81
iron sulfate
zinc oxide to excoriated wound
trazodone 50 prn insomnia
mylanta 30 mL prn
milk of mag 30 ml prn
combivent 2 puffs 4x daily prn
haldol 5mg PO or IV prn psychosis
tylenol prn
guaifenesin prn
 
Discharge Medications:
1. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times 
a day).  
2. Carbamazepine 200 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
3. Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
4. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
5. Haloperidol 10 mg Tablet Sig: One (1) Tablet PO three times a 
day as needed for psychosis.  
6. Olanzapine 2.5 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily): If cannot tolerate PO, OK to give IM.  
7. Insulin Lispro 100 unit/mL Solution Sig: See below units 
Subcutaneous ASDIR (AS DIRECTED): Please follow sliding scale.  
8. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
9. Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) 
Tablet PO BID (2 times a day).  
10. Trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime) as needed for insomnia.  
11. Zinc Oxide     Ointment Sig: ___ cc Topical once a day: 
Please apply topically to wound.  
12. Alum-Mag Hydroxide-Simeth 200-200-20 mg/5 mL Suspension Sig: 
___ MLs PO QID (4 times a day) as needed for gerd.  
13. Ipratropium-Albuterol ___ mcg/Actuation Aerosol Sig: Two 
(2) Puff Inhalation Q6H (every 6 hours) as needed for shortness 
of breath or wheezing.  
14. Haloperidol 5 mg Tablet Sig: One (1) Tablet PO TID (3 times 
a day) as needed for psychosis: If not taking PO, OK to give IM. 
 
15. Guaifenesin 100 mg/5 mL Syrup Sig: ___ MLs PO Q6H (every 6 
hours) as needed for cough.  
16. Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q6H 
(every 6 hours) as needed for pain.  
17. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day) as needed for constipation.  
18. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1)  
Injection TID (3 times a day): Please continue to administer 
until patient ambulates.  
19. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1)  
PO DAILY (Daily) as needed for constipation.  
20. Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal 
HS (at bedtime) as needed for constipation.  
21. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
22. Menthol-Cetylpyridinium 3 mg Lozenge Sig: One (1) Lozenge 
Mucous membrane PRN (as needed) as needed for sore throat.  
23. Zofran 4 mg Tablet Sig: One (1) Tablet PO every eight (8) 
hours as needed for nausea.  
24. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO QID (4 times a day) as needed for heartburn. 
 
25. Lantus 100 unit/mL Solution Sig: ___ (44) units 
Subcutaneous at bedtime.  
26. Sulfamethoxazole-Trimethoprim 800-160 mg Tablet Sig: One (1) 
Tablet PO BID (2 times a day) for 10 doses.  
27. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every six (6) 
hours as needed for pain.  
28. Outpatient Lab Work
Please check Chem-7 in ___ as patient had mildly elevated 
Creatinine on day of discharge

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis:
Urinary tract infection
___ abscess s/p drainage in OR x 2

Secondary diagnosis:
Diabetes Mellitus type 2
Paranoid Schizophrenia

 
Discharge Condition:
Level of Consciousness: Lethargic but arousable at times, alert 
at other times
Activity Status: Out of Bed with assistance to chair or 
wheelchair.
Mental Status: Confused - always

 
Discharge Instructions:
You were admitted to ___ for a urinary tract infection. We 
treated this with an antiobiotic called ciprofloxacin. You were 
also found to have several abscesses including one large 
___ abscess which was drained in the operating room 
under anesthesia twice. You recieved antibiotics for these 
abscesses and will need to continue while you are in rehab. Your 
sugars were very high, which probably made you more likely to 
get abscesses. We increased your insulin regimen. Good control 
of sugars is very important for fighting infection, for your 
heart and nerves and almost all of the rest of your body. 
Lastly, you seemed to be having incontinence with a full bladder 
(called overflow incontinence). You had a bladder catheter 
placed which help your incontinence and also helped keep your 
wound clean, however, you continued to pull it out. We kept it 
out and you appeared to be urinating without diffuclty. Prior to 
discharge we checked the amount of urine in your bladder and it 
appeared you were not retaining very much urine (< 200 cc) You 
may need to have one in intermittently if you continue to hold 
your urine. 

You should take your medications as prescribed with the 
following important changes.
1. CONTINUE: Bactrim DS 1 tablet every 12 hours every day and 
stop on ___
2. INCREASE Lantus to 44 units at bedtime. Please use sliding 
scale for further insulin coverage
3. HOLD Enalapril as you have some mild kidney dysfunction. You 
will have your kidney function monitored and this should be 
re-started once this normalizes.
4. STOP: HCTZ
5. Continue wound care as directed
6. START: Oxycodone as needed for pain
7. Continue Olanzapine and Haldol as directed.

It is important that you keep all of your doctor's appointments

 
Followup Instructions:
___
"
3,10241958,24866228," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: UROLOGY
 
Allergies: 
codeine / latex
 
Attending: ___.
 
Chief Complaint:
Chronic infection associated with penile prosthesis pump
 
Major Surgical or Invasive Procedure:
SCOTUM EXPLORATION; WASHOUT INFECTED SCROTUM IMPLATED AREA; 
REVISION OF PENILE PROSTHESIS

 
History of Present Illness:
___ h/o G7 PCa s/p radical prostatectomy and also ADT/EBRT in 
setting of rising PSA, AUS and 3 piece IPP placed in ___ now 
with chronically infected IPP with associated draining sinuses 
s/p treatment course of Keflex with good clinical response.
 
Past Medical History:
1.  Diabetes type 2, complicated by stocking glove neuropathy
2.  Hypertension.
3.  Hyperlipidemia.
4.  Anxiety.
5.  Depression.
6.  Glaucoma.
7.  Essential tremor, status post placement of a deep brain
stimulator.
8.  Back surgery x 2.
9.  Chronic low back pain.
 
Social History:
___
Family History:
Noncontributory
 
Physical Exam:
WdWn male, NAD, AVSS
Interactive, cooperative
Abdomen soft, Nt/Nd
Hemiscrotum Incision c/d/i w/out evidence hematoma or infection
Frenular incision c/d/i
Lower extremities w/out edema or pitting and no report of calf 
pain
 
Pertinent Results:
___ 07:00AM BLOOD WBC-9.3 RBC-3.99* Hgb-11.6* Hct-36.4* 
MCV-91 MCH-29.1 MCHC-31.9* RDW-12.7 RDWSD-42.5 Plt ___
___ 07:00AM BLOOD Glucose-251* UreaN-12 Creat-0.9 Na-140 
K-3.8 Cl-104 HCO3-26 AnGap-14
 
Brief Hospital Course:
This patient was admitted to the Urology service after 
frenuloplasty, scrotal exploration with debridement and washout, 
and revision of penile prosthesis. No concerning intraoperative 
events occurred; please see dictated operative note for details. 
 Vancomycin and Gentamicin were administered for ___ 
infection prophylaxis.  The patient tolerated the procedure well 
and was recovered in the PACU before transfer to the general 
surgical floor.  The post-op course was uncomplicated.  

His foley catheter was removed on POD1 the patient voided 
without difficulty. At discharge, patient's pain was well 
controlled with oral pain medications, tolerating regular diet, 
ambulating without assistance, and voiding without difficulty. 
Incision at discharge without erythema or hematoma.  He will 
follow-up with his urologist as directed and complete at least a 
2 course of Bactrim DS.

Of note, the patients AUS was attempted to have been 
re-activated after removing the catheter.  He did, however, 
report some incontinence after catheter removal.  He opted to 
leave with his sphincter as is rather than wait for MD 
evaluation. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 40 mg PO DAILY 
2. Gabapentin 600 mg PO 6A AND 1P 
3. Gabapentin 1200 mg PO QHS 
4. ALPRAZolam 0.5 mg PO DAILY:PRN anxiety 
5. MetFORMIN (Glucophage) 1000 mg PO BID 
6. Docusate Sodium 100 mg PO DAILY 
7. Simvastatin 10 mg PO QPM 
8. bimatoprost 0.01 % ophthalmic QPM 
9. Aspirin 81 mg PO DAILY 
10. GlipiZIDE XL 20 mg PO DAILY 
11. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1. ALPRAZolam 0.5 mg PO DAILY:PRN anxiety 
2. Gabapentin 600 mg PO 6A AND 1P 
3. GlipiZIDE XL 20 mg PO DAILY 
4. Simvastatin 10 mg PO QPM 
5. Acetaminophen 650 mg PO Q6H:PRN pain / fever 
6. TraMADol 50 mg PO Q4H:PRN Pain 
RX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours 
Disp #*30 Tablet Refills:*0
7. bimatoprost 0.01 % ophthalmic QPM 
8. Docusate Sodium 100 mg PO DAILY 
9. Gabapentin 1200 mg PO QHS 
10. Lisinopril 40 mg PO DAILY 
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. Vitamin D 1000 UNIT PO DAILY 
13. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 3 Weeks 
RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by 
mouth twice a day Disp #*21 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
ERECTILE DYSFUNCTION; INFECTED PENILE PROSTHESIS

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
-Please also refer to the instructions provided to you by the 
manufacturer of this prosthesis

-ALWAYS call to inform, review and discuss any medication 
changes and your post-operative course with your primary care 
doctor.

-over the next several days you may experience some increased 
swelling of your phallus (and scrotum) resembling a semi-rigid 
phallus (semi-erect); this is ""normal"" from the prosthesis and 
related surgery/edema. This may be accompanied by discoloration 
(ecchymosis) involving the phallus and the scrotum; this too is 
normal and will gradually resolve.

-Please remove the surgical dressing over penis and/or under 
scrotum on post-operative day two: no further wound care is 
needed and you may leave the wound open to air. 

-Please keep your phallus at midline, pointed toward your 
umbilicus, taped in place with protective gauze/pads (if 
necessary) for the next ___ days. Of course you may point it 
downward for voiding.

-Use a jock-supporter/strap or jockey-type briefs or tight, 
tighty-whities to facilitate this; Subsequently you may 
transition to loose fitting briefs or boxer-briefs for 
support--they should be cotton and/or breathable.

-Do NOT use prosthesis for 6 weeks and until explicitly advised 
by your urologist

-Complete a 7 day course of antibiotics as directed 
(Ciprofloxacin/Cephalexin)

-You may shower, but do NOT bathe, swim or otherwise immerse 
your incision.

-Do NOT lift anything heavier than a phone book and no sports, 
vigorous physical activity (including sexual).

-Tylenol should be your first line pain medication, a narcotic 
pain medication has been prescribed for breakthough pain >4. 
Replace Tylenol with narcotic pain medication. Max daily Tylenol 
dose is 4gm, note that narcotic pain medication also contains 
Tylenol (acetaminophen)

-Do NOT drive or drink alcohol while taking narcotics and do NOT 
operate dangerous machinery. 
For your safety, please do NOT DRIVE FOR ONE WEEK AFTER SURGERY 
or unless otherwise advised. 

-Colace has been prescribed to avoid post-surgical constipation 
and constipation related to narcotic pain medication, 
discontinue if loose stool or diarrhea develops. Colace is a 
stool ""softener""- it is NOT a laxative

-Resume your home medications, EXCEPT HOLD NSAIDs (aspirin, and 
ibuprofen containing products such as Advil & Motrin, Excedrin) 
for ONE week or until you see your urologist in follow-up OR you 
are explicitly advised to resume sooner by your PCP, ___ 
or Cardiologist.  DO NOT RESUME medications like VIAGRA, LEVITRA 
or CIALIS.

-If you have fevers > 101.5 F, vomiting, or increased redness, 
swelling, or discharge from your incision, call your doctor or 
go to the nearest emergency room.

 
Followup Instructions:
___
"
4,10325512,26153860," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Augmentin
 
Attending: ___.
 
Chief Complaint:
Status post fall
 
Major Surgical or Invasive Procedure:
None

Echocardiogram: The left atrium is moderately dilated. There is 
mild symmetric left ventricular hypertrophy. The left 
ventricular cavity size is normal. Overall left ventricular 
systolic function is normal (LVEF 70%). There is no left 
ventricular outflow obstruction at rest or with Valsalva. Right 
ventricular chamber size and free wall motion are normal. The 
aortic valve leaflets (3) are mildly thickened but aortic 
stenosis is not present. No aortic regurgitation is seen. The 
mitral valve leaflets are mildly thickened. There is no mitral 
valve prolapse. Mild (1+) mitral regurgitation is seen. There is 
moderate pulmonary artery systolic hypertension. There is no 
pericardial effusion. 

Compared with the findings of the prior report (images 
unavailable for review) of ___, no major change is 
evident.

Head CT: Left frontal scalp hematoma. No acute intracranial 
process.

CT cervical spine: 1. No fractures. 
2. Significant multilevel degenerative disease with posterior 
osteophytosis, impinging on the thecal sac, worst at C5-C6 

 
History of Present Illness:
___ year old woman coming in from a nursing home after an 
unwitnessed fall, the details of which she does not recall. In 
the ED she denied any precipitating symptoms but did not recall 
the details. To my exam she does not remember this at all. Found 
down w LOC; has left frontal hematoma; complaining of bilateral 
shoulder R>L pain. RN report from ___ states: ""Resident was found 
lying on the floor in her room on her left side, has limited ROM 
on both shoulders, sustained hematoma on L forehead; ice 
applied, unable to tell how she fell due to her confusion, also 
c/o of excruciating pain R shoulder. VS 97.8, 56, 160/90, 14, 
96%RA."" She seemed to be in a great deal of pain initially, head 
was negative; not on anticoagulation; c-spine no acute fxs but 
multilevel osteophytes, if concern MR of spine; ED tried to 
clear her collar, but pt continued to insist she has mid-line 
pain. 
 
Past Medical History:
left hip fx w ORIF, ___  
dementia of unknown source  
depression  
anxiety  
gait disorder w hx of falls  
hypothyroidism  
htn on atenolol  
cataracts  
CAD w past poss inferior/anterior ischemia  
spinal stenosis  
urinary incontinence, resolved  
CRI stage III  
___ fx of left rib  
RBBB, LAFB as of ___  

 
Social History:
___
Family History:
Non specific heart problems in both parents and 1 brother with a 
heart issue. A sister died from unknown cause. 
 
Physical Exam:
Exam at the time of discharge: 
VS: Tc:95.3, Tmax:99, HR:81, BP: 180/106 (132/95-180-106)RR:18, 
O2:98% on RA
Gen: NAD, sleeping in bed, stating pain is well controlled
Head: ecchymosis over left eye, tracking around her left eye
Neck: cervical collar in place
CV: bradycardic rate, regular rhythm, +S1/S2, ___ systolic 
murmur
Lungs: CTA b/l
Abd: +bs, soft, nontender, nondistended
Ext: no edema

 
Pertinent Results:
Troponin T <0.01, <0.___rief Hospital Course by Problem: 

#) Status post fall: on presentation to ___ patient was 
initially evaluated in the ER, and given that she had 
experienced an unwitnessed fall, she had multiple radiographic 
studies for furhter evaluation, CT of head showed no 
intracranial bleeding, CT of her cervical spine showed no 
fractures or dislocations, x-rays of her shoulders did not show 
any evidence of fracture.  Additionally in the ER, since her 
cervical spine had been cleared radiographically, they tried to 
clear her c-spine and take the cervical collar off but she 
complained of continued neck pain.  After speaking with 
neurosurgery, they recommended leaving the collar on for 2 weeks 
and then reassessing to see if her pain had resolved to take the 
collar off.  Patient can be seen by orthopedic surgery in two 
weeks for re-evaluation of the cervical collar.  Since the fall 
was unwitnessed and the patient was unable to give a good 
history, there was concern for the cause of this fall, patient 
was monitored on telemetry and also had an echocardiogram.  The 
echocardiogram was unchanged from prior studies, and while she 
was monitored on telemetry, it was noted that with reinitiation 
of her atenolol the patient's HR dropped to 35 while she was 
sleeping and then increased to the 40's when the nurses had 
woken her up.  Per nursing it was difficult to tell whether she 
was symptomatic since she seemed slightly confused at baseline.  
Given her decreased heart rate her atenolol was stopped and to 
control the patient's blood pressure, she was started on an ACE 
Inhibitor, lisinopril 10mg daily, that can be further titrated 
as an outpatient.  

#) Hypertension: Patient had previously been treated with 
atenolol 25mg daily, however given her very decreased HR, the 
medication was discontinued.  In the short term in the hospital 
she was controlled with 20mg po hydralazine, however for long 
term control she will be started on lisinopril 10mg daily, which 
can be titrated up as an outpatient.  Since she was just started 
on lisinopril, she will need to have her electrolytes checked in 
one week.

#) Dementia: remained stable in the hospital, continued her 
outpatient dose of aricept

#) Hypothyroid: currently being managed by her PCP, continued on 
her home synthroid dose

#) Osteoporosis: patient was continued on her calcium and 
vitamin D supplementation, however we would hold her 
bisphosphonate until the cervical collar is removed so that the 
patient can sit upright and take the medication safely. 

#) CAD: repeat echocardiogram showed no decline in LV systolic 
function, will continue aspirin but atenolol has been 
discontinued as patient's heart rate cannot tolerate beta 
blockade
 
Medications on Admission:
fosamax 70 mg ___  
asa 81 daily  
atenolol 25 q evening  
calcium carb 650 mg TID before meals  
vitamin d 1000 units daily  
aricept 5 mg HS  
levothyroxine 137.5 mcg  
lidocaine patch  
oxycontin 10 mg q morning, 20 mg q evening  
seroquel 37.5 mg qhs  
senna bid  
warm prune juice qAM  
opth ointment, apply to each eyelid x7 days (6 days given) 

 
Discharge Medications:
1. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO TID (3 times a day) as needed for before 
meals.  
2. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
3. Levothyroxine 137 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Donepezil 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). 
 
5. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: 
One (1) Adhesive Patch, Medicated Topical DAILY (Daily).  
6. Quetiapine 25 mg Tablet Sig: 1.5 Tablets PO HS (at bedtime).  

7. Acetaminophen 500 mg Tablet Sig: One (1) Tablet PO Q6H (every 
6 hours) as needed for pain.  
8. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day): Hold for loose stools .  
9. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day): Hold for loose stools.  
10. Oxycodone 10 mg Tablet Sustained Release 12 hr Sig: One (1) 
Tablet Sustained Release 12 hr PO QAM (once a day (in the 
morning)).  
11. Oxycodone 20 mg Tablet Sustained Release 12 hr Sig: One (1) 
Tablet Sustained Release 12 hr PO QPM (once a day (in the 
evening)).  
12. Lisinopril 10 mg PO Daily  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
1. Status Post Mechanical Fall

 
Discharge Condition:
At the time of discharge, patient was able to ambulate with a 
walker, tolerate oral intake without difficulty, her heart had 
increased off atenolol, other vital signs were stable and she 
was medically clear for discharge. 

 
Discharge Instructions:
You were admitted to ___ after falling at the nursing home, 
when you arrived in the emergency room, multiple radiology 
studies were done, which showed that you did have any bleeding 
your head or any other broken bones.  However, since you were 
still complaining of neck pain, even though the CT scan of the 
bones in your neck was normal, they were unable to remove the 
cervical collar.  Since no one had seen you fall, we were 
concerned about caused the fall, as a result we also did an 
echocardiogram to look at the function of your heart and 
monitored the rhythm of your heart while you were in the 
hospital.  The only concerning finding during your 
hospitalization was that when we restarted your atenolol, your 
heart rate decreased into the 30's while you were sleeping, and 
only increased into the 40's when you were awake, as a result we 
stopped this medication since we were concerned that this could 
have contributed to your fall.   

Please call your doctor or return to the hospital if you have 
any other falls, experience a change in your vision, headaches, 
chest pain, palpitations or any other concerning symptoms.  
 
Followup Instructions:
___
"
5,10325512,25473583," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Penicillins / Augmentin
 
Attending: ___.
 
Chief Complaint:
s/p Fall
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ yo F with PMHx of dementia, gait d/o with history of falls,
hypertension, CAD, spinal stenosis presents from ___ 
after
an unwitnessed fall at nursing home. Patient is unable to relate
story of how she fell or whether she had loss of consciousness
following the fall. She states she currently has significant 
pain
located mostly in the right shoulder. Details of the story 
difficult
to ascertain due to baseline dementia.

While in ___ she developed V-tach - 10 beat run on 2 episodes and 
was given 150mg Amiodarone. 

 
Past Medical History:
left hip fx w ORIF, ___  
dementia of unknown source  
depression  
anxiety  
gait disorder w hx of falls  
hypothyroidism  
htn on atenolol  
cataracts  
CAD w past poss inferior/anterior ischemia  
spinal stenosis  
urinary incontinence, resolved  
CRI stage III  
___ fx of left rib  
RBBB, LAFB as of ___  

 
Social History:
___
Family History:
Non specific heart problems in both parents and 1 brother with a 
heart issue. A sister died from unknown cause. 
 
Physical Exam:
Upon presentation to ___:
T 98.2 P 74 BP 144/77 R 18 SpO2 99% 3L
GEN: elderly woman in c-collar w/ racoon eyes, NAD
HEENT: racoon eyes, 
CV: RRR
PULM: CTABL
ABD: soft, NT, ND
Ext: several ecchymoses

MS: alert, oriented to hospital, not to date or year. Unable to
related details of history. Language was fluent w/ no paraphasic
errors. 
CN: pupils 2 mm - 1.5 mm reactive, EOMI no nystagmus, facial
sensation intact b/l, smile symmetric, hearing intact b/l, 
palate
symmetric, tongue midline
Motor: increased tone b/l ___, able to grasp finger b/l in hands,
not moving R arm due to pain from shoulder dislocation, L arm
strength intact, able to lift both legs and move feet b/l
Sensory: intact to painful stimuli in all 4 extremities
Coordination: no dymetria w/ L hand on FNF, limited exam on R
hand due to dislocation
Reflexes: symmetric and ___ in ___, toes b/l flexion
Gait: not tested

 
Pertinent Results:
___ 09:38PM   GLUCOSE-118* UREA N-14 CREAT-0.6 SODIUM-138 
POTASSIUM-4.1 CHLORIDE-102 TOTAL CO2-27 ANION GAP-13
___ 09:38PM   CALCIUM-8.9 PHOSPHATE-2.7 MAGNESIUM-1.8
___ 09:38PM   WBC-8.3# RBC-4.33 HGB-13.3 HCT-40.0 MCV-92 
MCH-30.6 MCHC-33.2 RDW-13.5
___ 09:38PM   PLT COUNT-175
___ 09:38PM   ___ PTT-23.8 ___

Micro/Imaging:
___ CT head 8-9 mm parafalcine SDH without significant mass 
effect  
___ CT C-spine 
___ B hips s/p ORIF L femur, no acute dislocation/fracture  

___ Left ankle no acute dislocation/fracture  
___ Right shoulder normal anatomic alignment  

 
Brief Hospital Course:
She was admitted to the ACS service and evaluated by Orthopaedic 
Spine and Neurosurgery. Her injuries were managed non 
operatively. She underwent MRI imaging of her cervical spine for 
concern of an occult or ligamentous injury; her CT cervical 
spine however did not show any fractures. The MRI scan did not 
revela any acute injuries but was noted with multilevel cervical 
spondylosis, severe at C3-4 and C5-6. The hard cervical collar 
was removed and she is being recommended to wear a soft collar 
for comfort prn. 
 
Her neurologic status was monitored closely and it appears that 
she is back to her baseline dementia. Her aspirin was withheld 
and can be resumed ON ___. She will follow up in ___ 
clinic in 4 weeks for a repeat head CT scan.

She was treated with Ciprofloxacin 3 day course for a urinary 
tract infection.

Physical therapy was consulted and has recommended rehab after 
her acute hospital stay.

 
Medications on Admission:
Senokot 2 tabs BID, calcium carbonate 650 mg BID, seroquel 37.5 
mg QHS, aricept 10 mg QHS, oxycontin 10 mg BID, oxycodone 2.5 mg 
Q6H PRN pain, synthroid ___ mcg daily, flonase 1 spray both 
nares daily, aspirin 81 mg daily, zestril 10 mg daily, prilosec 
80 mg daily, sorbitol 30 mL daily, tylenol ___ mg daily at noon, 
fosamax 70 mg every ___, vitamin D-2 ___ units every 21 
days, milk of mag 30 mL PRN constipation, bengay PRN pain 
 
Discharge Medications:
1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
2. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
3. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO TID (3 
times a day).  
4. Calcium Carbonate 200 mg (500 mg) Tablet, Chewable Sig: One 
(1) Tablet, Chewable PO three times a day.  
5. Vitamin D 400 unit Capsule Sig: Two (2) Capsule PO once a 
day.  
6. Fosamax 70 mg Tablet Sig: One (1) Tablet PO EVERY ___ 
MORNING BEFORE BREAKFAST.  
7. Quetiapine 25 mg Tablet Sig: ___ Tablet PO QHS (once a day 
(at bedtime)).  
8. Donepezil 5 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 
 
9. Oxycodone 5 mg Tablet Sig: 0.5 Tablet PO Q6H (every 6 hours) 
as needed for pain.  
10. Levothyroxine 75 mcg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
11. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) 
Spray Nasal DAILY (Daily).  
12. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
13. Sorbitol 70 % Solution Sig: Thirty (30) ML Miscellaneous 
DAILY (Daily).  
14. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) 
ML PO Q6H (every 6 hours) as needed for constipation.  
15. Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H 
(every 12 hours) for 1 days.  
16. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
17. Oxycodone 10 mg Tablet Sustained Release 12 hr Sig: One (1) 
Tablet Sustained Release 12 hr PO Q12H (every 12 hours). 
18. RESUME BABY ASA 81 MG DAILY PO ON ___ 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
s/p Fall
Subdural hemorrhage
Multilevel cervical spondylosis, severe at C3-4 and C5-6 
Right shoulder dislocation (relocated now)
Urinary tract infection

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.
 
Discharge Instructions:
You must wea the hard cervical collar for at least ___ weeks 
until tols that it can be removed by Orthopedic Spine Surgery. 
The collar may be removed for personal hygiene.
 
Followup Instructions:
___
"
6,10325512,22496415," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Augmentin
 
Attending: ___.
 
Chief Complaint:
Status Post Mechanical Fall 
 
Major Surgical or Invasive Procedure:
none 
 
History of Present Illness:
___ year old female past medical history of dementia, 
hypothyroid, hip replacement presenting from outside hospital 
with concern for new T9/T10 fracture status post mechanical 
fall.  
.  
Patient is a poor historian at baseline and unable to provide 
additional history. Based on review of medical record, she had a 
witnessed fall that was mechanical in nature immediately prior 
to presentation at outside hospital. No head strike, no loss of 
consciousness, no seizure activity. At the outside hospital, she 
had a CT of her head, neck, torso that reveals a T9/T10 
fracture. No other acute findings were appreciated. She was 
transferred for spinal surgery evaluation.  
.  
In the ED, initial vitals 97.9 66 188/72 18 97%. Imaging from 
___ were reviewed including CT Head, neck, torso which 
revealed t9/10 fx. ___ was consulted who recommeneded TLSO. 
While in the emergency department patient spiked a fever to 102. 
Fever work up was negative for evidence of meningitis, no 
pneumonia on CT torso. UA was performed which revealed 24 WBC, 6 
RBC, NO Bacteria. Blood and urine cultures were sent and are 
pending. Blood counts and renal function at baseline. Patient 
was given acetaminophen 650mg suppository. CT of the abdomen was 
performed which revealed pneumobilia and dilated common bile 
duct. Surgery was consulted and felt that this was similar to 
prior CT examination and recommended no intervention. Patient 
did recieve flagyl, however no other antibiotics were given as 
they were felt to not be indicated. Vitals on transfer to the 
floor 98.2, 114/78, 82, 16, 97%RA.  
.  
Review of Systems: Negative despite what mentioned in HPI.  

 
Past Medical History:
left hip fx w ORIF, ___  
dementia of unknown source  
depression  
anxiety  
gait disorder w hx of falls  
hypothyroidism  
htn on atenolol  
cataracts  
CAD w past poss inferior/anterior ischemia  
spinal stenosis  
urinary incontinence, resolved  
CRI stage III  
___ fx of left rib  
RBBB, LAFB as of ___  

 
Social History:
___
Family History:
Non specific heart problems in both parents and 1 brother with a 
heart issue. A sister died from unknown cause. 
 
Physical Exam:
Physical Exam on Admission:  
Vitals: T 96.4 BP 129/49 HR 52 RR 16 100RA  
General:laying in bed sleepy but arousable, not cooperative with 
exam, not answering ?s appropriately per son this is her 
baseline  
HEENT: EOMI, left eye ptosis and meiosis, both pupils reactive, 
MMM  
Neck:supple, no LAD  
Heart: S1S2, RRR, no m,r,g appreciated  
Lungs:CTAB on ant exam  
Abdomen:NT, ND, BS+  
Extremities: WWP, no ___ edema  
Neurological:spinal TTP along entire ___, not cooperative for 
neuro exam, no focal deficits noted  

On Discharge:
GA: Lying in bed. Oriented x2 (person, place). Moving around bed 
due to back pain.
Cards: RRR S1/S2 heard. no murmurs/gallops/rubs.  
Pulm: CTAB no crackles or wheezes  
Abd: soft, NT ND, +BS. no organomegaly.  
Extremities: wwp, no edema. Back with lidocaine patch in place.  

Neuro/Psych: Awake, alert and oriented x2 as above. Moving all 
extremeties. ___ strength in ___ b/l. Limited exam due to pain. 
 
Pertinent Results:
Labs on Admission:
___ 07:35AM BLOOD WBC-7.7 RBC-4.15* Hgb-13.4 Hct-39.9 
MCV-96 MCH-32.3* MCHC-33.5 RDW-12.8 Plt ___
___ 07:35AM BLOOD Neuts-87.9* Lymphs-7.6* Monos-4.1 Eos-0.2 
Baso-0.2
___ 07:35AM BLOOD Glucose-121* UreaN-12 Creat-0.6 Na-142 
K-3.9 Cl-102 HCO3-32 AnGap-12
___ 07:35AM BLOOD ALT-15 AST-26 AlkPhos-84 TotBili-0.6
___ 06:20AM BLOOD Calcium-9.1 Phos-3.7 Mg-1.8
___ 07:52AM BLOOD Lactate-2.2*

Labs on Discharge:
___ 08:00AM BLOOD WBC-6.7 RBC-4.04* Hgb-12.8 Hct-38.4 
MCV-95 MCH-31.7 MCHC-33.3 RDW-12.9 Plt ___
___ 08:00AM BLOOD Glucose-90 UreaN-19 Creat-0.6 Na-139 
K-3.9 Cl-102 HCO3-31 AnGap-10

Micro:
Respiratory Viral Culture (Final ___: 
      No respiratory viruses isolated. 
      Culture screened for Adenovirus, Influenza A & B, 
Parainfluenza type
      1,2 & 3, and Respiratory Syncytial Virus.. 
      Detection of viruses other than those listed above will 
only be
      performed on specific request. Please call Virology at 
___
      within 1 week if additional testing is needed. 
      Reported to and read back by ___ (___) ON 
___ AT
      9:45AM. 

   Respiratory Viral Antigen Screen (Final ___: 
      Negative for Respiratory Viral Antigen. 
      Specimen screened for: Adeno, Parainfluenza 1, 2, 3, 
Influenza A, B,
      and RSV by immunofluorescence. 
      Refer to respiratory viral culture for further 
information.

Studies:
.
CT Abd - IMPRESSION: 1. Unchanged moderate intra- and 
extrahepatic biliary dilation with smooth tapering of the 
hepatic duct below the insertion of the cystic duct. Gallbladder 
distension is likely related to the ductal process rather than 
acute cholecystitis given the lack of wall thickening or 
pericholecystic fluid but clinical correlation is advised. 2. 
Possible 12-mm hypodensity in the head of the pancreas which is 
most likely focal fat deposition and is unchanged from the prior 
study. A mass cannot be entirely excluded and MRCP could be 
obtained if clinically relevant. 3. No findings to explain a 
sterile pyuria. 4. Colonic diverticulosis without evidence of 
acute diverticulitis. 5. Marked degenerative changes of the 
thoracolumbar ___ with further cortical destruction of the T9 
vertebral body. 
.
MR ___ - 1. Findings involving the T9 vertebral body, as on 
the prompting CT, likely represent a relatively acute 
osteoporotic compression fracture with very prominent fracture 
cleft. 2. While there is no significant loss of height, there is 
some retropulsion of its dorsal cortex with possible impingement 
upon the exiting right T9 nerve root. 3. Associated abnormality 
of, particularly, the right anterolateral paraspinal soft 
tissues at this level, with an overall appearance most 
suggestive of associated hemorrhage/granulation tissue, with no 
finding to specifically suggest a neoplastic process. 4. Bone 
marrow signal abnormalities involving the contiguous T10 
vertebral body, supporting underlying osteoporotic nature of 
this process, related to axial- loading injury. 5. Several 
chronic thoracolumbar vertebral wedge deformities with 
retropulsion, as detailed; in particular, there is significant 
spinal canal narrowing at the T12-L1 level, with deformity of 
the distal spinal cord but no discrete signal abnormality. 6. No 
other pathologic focus of enhancement seen to specifically 
suggest neoplastic disease. 

 
Brief Hospital Course:
___ year old female past medical history of dementia, 
hypothyroid, hip replacement presenting from outside hospital 
with concern for new T9/T10 fracture status post fall who 
developed fevers in the ED.  
.  
#. Mechanical Fall: Initially there was concern for T9/T10 
Fracture at ___. The pt was transfered to ___ for 
orthopedics ___ eval who determined that the fracture was not 
acute. They recommended a TLSO for comfort only. Due to concern 
for possible malignancy, the patient underwent MRI scan of the 
___ on ___ which showed a relatively acute osteoporotic 
compression fracture with very 
prominent fracture cleft but no evidence of neoplastic disease. 
The patient was in a significant amount of back pain initially 
and received a combination of opiates, toradol, standing tylenol 
and lidocaine patch. In discussion with the patient's nursing 
facility it was determined that this pain was not much changed 
from the patient's baseline and that at the nursing facility the 
patient receives oxycontin 30mg BID. The patient was placed on 
this regimen with good improvement in pain although continues to 
have difficulty with turns/sitting/deep breahing. The TLSO brace 
was not yet ready at time of discharge. Discharged with plan for 
further pain management per provider at ___. Of 
note, a vertebroplasty was discussed to help palliate the 
patient's pain however it was decided that the risks outwighed 
benefits in this ___ year-old woman.
.  
#. Fever: The patient develoepd a fever to 102.0 in the ED. No 
clear source was identified initially. A UA showed pyuria 
however no bacteria and was nitrite negative. A CT torso at 
___ without evidence of pulmonary infiltrate.  Pt 
arrived to floor with foley in place, per records it was placed 
at ___ prior to transfer. This foley was removed on 
admission to the floor. Blood and Urine cultures remained 
negative and a respiratory viral screen including influenza was 
negative. The patient was afebrile throughout the remainder of 
her hospital course. 
.  
#Dementia- Pt severely demented at baseline per family. In the 
hosiptial she was oriented to eprson and place. At times able to 
answer questions appropriately. Continued on home donepezil.
.  
#Hypothyroidism- Continued home levothyroxine.
.
#. Transitional Issues:
1) Pain control: Optimize pain regimen with PO medications and 
can consider vertebroplasty as outpatient if not improving.
2) Orthopedics reccomended a TLSO brace for comfort. The brace 
was not yet ready at time of discharge. Can consider ordering at 
___.
3) Was saturating ~90% on RA. Most likely due to splinting from 
pain. On 2L O2 NC on discharge. 
4) Discontinued Seroquel as patient was overly sedated in-house. 
Can re-start if alertness improved at nursing facility.
 
Medications on Admission:
Acetaminophen 675mg PO BID
Calcium Carbonate 1300mg PO BID
Duloxetine 60mg PO Daily
Divalproex Sodium Sprinkle 125mg PO BID
Donepezil 5mg PO qhs
Ergocalciferol 500,000 units q12
Fluticasone Propionate 1 puff BID
Estrogen, Topical 
Levothyroxine 150mcg PO daily
Lidocaine patch 5% daily
Lisinopril 10mg PO daily
Omeprazole40mg PO daily
Miralax 17GM PO daily
Quetiapine Fumarate 12.5mg QHS
Quetiapine Fumarate 12.5mg daily PRN anxiety
Senna
Trazodone 25mg PO QHS
Oxycontin 30mg PO BID

 
Discharge Medications:
1. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO twice a 
day.  
2. calcium carbonate 650 mg calcium (1,625 mg) Tablet Sig: Two 
(2) Tablet PO once a day.  
3. duloxetine 60 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
4. divalproex ___ mg Capsule, Sprinkle Sig: One (1) Capsule, 
Sprinkle PO twice a day.  
5. donepezil 5 mg Tablet Sig: One (1) Tablet PO At Night.  
6. ergocalciferol (vitamin D2) 50,000 unit Capsule Sig: One (1) 
Capsule PO q21 days.  
7. Flovent HFA 220 mcg/actuation Aerosol Sig: One (1)  
Inhalation twice a day.  
8. levothyroxine 125 mcg Capsule Sig: One (1) Capsule PO once a 
day.  
9. Lidoderm 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One 
(1)  Topical once a day.  
10. lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day.  
11. omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
12. Miralax 17 gram/dose Powder Sig: One (1)  PO once a day.  
13. Seroquel 25 mg Tablet Sig: One (1) Tablet PO QHS.  
14. Seroquel 25 mg Tablet Sig: One (1) Tablet PO once a day as 
needed for Anxiety, Agression.  
15. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
16. trazodone 50 mg Tablet Sig: 0.5 Tablet PO at bedtime.  
17. OxyContin 30 mg Tablet Extended Release 12 hr Sig: One (1) 
Tablet Extended Release 12 hr PO twice a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Primary: T9/10 Vertebral Compression Fractures

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
It was a pleasure taking care of you at ___!

You were admitted following a fall during which you may have 
sustained a vertebral fracture. In the hospital you were seen by 
orthopedic surgeons who did not feel a surgical intervention 
would be beneficial and carried a large amount of risk. Instead 
your pain was managed with oral pain medications and a lidocaine 
patch. You also had a fever while in the hospital although you 
never required antibiotics. Your flu screen was negative.

See below for changes in your home medication regimen:

 
                             ___ MD ___
 
Completed by: ___
"
7,10451947,20691197," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
transferred for eval of right wrist compartment syndrome 
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ yo female with a h/o ETOH dependence and 
depression who presented to ___ on ___ 
with abdominal pain and found to have acute pancreatitis. Before 
presenting to the hospital, she had multiple days of nausea and 
vomiting which were not associated with meals. She kept drinking 
and on the day of admission to the OSH, the patient started 
wretching. She went to the hospital and was treated for acute 
pancreatitis. On ___ she developed a fever to to 101 which 
prompted concern for necrotizing pancreatitis and subsequent CT 
abd. This study was c/b extravasation of 80cc IV dye into 
patient's right wrist. The wrist became acutely swollen and 
painful. Pallor became obvious though she remained 
neurovascularly intact. Patient transferred to ___ for ortho 
hand c/s.  
.  
The patient also has a history of alcohol withdrawal. She says 
that her skin has felt ""funny"" in the past and she developed 
symptoms of nervousness/shaking. She tried to quit alcohol in 
the past, but has relapsed. She has had increased drinking over 
this last year. Patient reports that she has been drinking about 
1 pint of vodka daily x ___ yr. Prior to this she drank heavily 
for at least ___ yrs. She has never had pancreatitis previously. 
Many of her family members are alcoholics. Prior to admission at 
___ she had abdominal pain and was vomitting for a few days. 
She had not eaten in at least 4 days but was drinking ETOH right 
up until her admission.  
.  
In the ED, VS: T99.6 HR 102 BP134/80 ___ on RA. In ED she was 
evaluated by ortho hand who felt she has borderline compartment 
syndrome and recommended strict elevation and volar splint which 
they placed. R hand noted to be swollen and pale up to the 
mid-forearm though radial pulse intact. She was also given 1L NS 
and 1mg IV dilaudid.  
.  
Currently, she is complaining of abdominal pain and pain from 
her right wrist. She also notes that she is feeling tremulous. 
Her last drink of ETOH was on ___. She denies any other 
constitutional symptoms other than constipation.  
.  
ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, shortness 
of breath, chest pain, diarrhea, melena, hematochezia, dysuria, 
hematuria.  

 
Past Medical History:
-Depression  
-ETOH dependence  
-Marijuana Abuse  
-Tobacco Abuse  
-s/p 2 c-sections  
-s/p internal anal sphincterotomy  

 
Social History:
___
Family History:
Alcoholism, no history of gallstones 
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
Vitals - T:99.8 BP:112/77 HR:92 RR:20 02 sat:97RA  
GENERAL: Pleasant, well appearing female in NAD  
HEENT: Normocephalic, atraumatic. No conjunctival pallor. No 
scleral icterus. PERRLA/EOMI. MMM. OP clear. Neck Supple, No LAD 
 
CARDIAC: Tachycardic, regular. Normal S1, S2. No murmurs, rubs 
or ___.  
LUNGS: decreased BS at bases, good air movement biaterally. No 
crackles, rhonchi or wheezes  
ABDOMEN: NABS. Soft,+ epigastric tenderness, no distension  
EXTREMITIES: Right Wrist: +radial pulse, able to flex fingers 
and flex/abduct thumb. +swelling of hand and forearm, +pallor of 
hand up to mid-forearm.  
PULSES: 2+ dorsalis pedis/ posterior tibial pulses.  
SKIN: No rashes/lesions, ecchymoses.  

 
Pertinent Results:
OSH Admission Labs:  
Lipase>600  
Lactic Acid 5.8  
K 2.9  
CO2 14  
AG 29  
AST 204  
ALT 35  
Alk Phos 117  
Amylase 220  
Serum ETOH: 59  
.  
MICROBIOLOGY:  
OSH Records:  
Urine Cx ___: neg  
Blood Cx ___: Pending  
.  
STUDIES:  
OSH CT Abd/Pelv ___:  
--peripancreatic fat stranding and fluid suggestive of acute 
pancreatitis  
--marked fatty infiltrate of liver  
--bilat pleural eff R>L  
--2.5 mm non-obstructing calc in r kidney  
___ records

EKG: Sinus rhythm with baseline artifact. P-R interval is at the 
lower limits of normal. Compared to the previous tracing of 
___ the rate is slower. P-R interval continues at the lower 
limits of normal. Non-specific inferior ST segment flattening is 
unchanged, as is the ST segment flattening in leads V5-V6. 
Tracing is likely within normal limits.

___
___

Admission laboratories:

___ WBC-8.5 RBC-4.07* Hgb-12.9 Hct-39.3 MCV-96 MCH-31.6 
MCHC-32.8 RDW-12.9 Plt ___
___ Neuts-75.0* Lymphs-16.2* Monos-6.3 Eos-2.0 Baso-0.6
___ ___ PTT-26.1 ___
___ 09:10PM BLOOD ALT-18 AST-76* LD(LDH)-251* AlkPhos-121* 
TotBili-3.1*

___  Glucose-67* UreaN-3* Creat-0.5 Na-131* K-4.1 Cl-96 
HCO3-20* AnGap-19

___ 09:10PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE
___ 09:10PM BLOOD HCV Ab-NEGATIVE
 
Brief Hospital Course:
Summary: This is a ___ yo female with h/o ETOH dependence who 
presented to ___ and found to have acute pancreatitis 
whose course c/b CT contrast infiltration into R wrist who was 
transferred to ___ for management of possible wrist 
compartment syndrome.
.
# Alcoholic Pancreatitis: The patient presented with severe 
epigastric pain, an inability to tolerate PO, and abnormal LFTs. 
She was found to have hyperbilirubinemia, transaminitis, 
hyponatremia and an anion gap metabolic acidosis. She was given 
IV fluids and IV morphine for pain control. Over the course of 
her stay, the patient started to tolerate a regular diet without 
nausea and vomiting. Her pain was better controlled and her LFTs 
trended to normal ranges. The patient was discharged with 16 
pills of Percocet and told to followup at her scheduled 
appointment or sooner with her primary care doctor if she 
requires more pain control. 

# ETOH Dependence/Withdrawl: The patient reportedly had been 
drinking heavily over the past year. During her stay, she 
developed increased anxiety, tremulousness, fever, and 
tachycardia. She was started on a CIWA scale and required PO 
Valium to help her. She also reports vivid nightmares. Social 
work consulted with the patient and suggested resources for her 
to explore as an outpatient. The patient has a desire to quit 
alcohol, but has too many life stressors. She was given Valium 
20 mg PO on discharge.

# Right Wrist Swelling: Orthopedics hand surgery evaluated the 
patient and thought that her swelling was possibly due to 
compartment syndrome. They recommended against surgical 
intervention and suggested keeping the arm elevated and 
controlling her pain. With elevation, the pain subsided. The 
hand always remained neurovascularly intact and had normal 
pulses/strength/sensation on discharge. Ortho hand said to 
followup PRN in their clinic.

Normocytic anemia: The patient continued to have a normocytic 
anemia. It was stable throughout her stay. If it persists, it 
will likely need to be assessed as an outpatient. On discharge 
her Hct was 34.8. 

Depression/anxiety: The patient has poor social support and 
psychiatric issues and uses alcohol to cope with her problems. 
Social work spoke with the patient and provided outpatient 
resources. She was given a three day supply of Ativan 1 mg BID: 
PRN anxiety.

Uninsured: The patient reports having no insurance and said it's 
difficult to fill prescriptions and see doctors. ___ social 
worker here linked the patient to a state-sponsored health 
insurance plan.

 
Medications on Admission:
MEDICATIONS HOME:  
none  
.  
MEDICATIONS ON TRANSFER:  
NS @ 100cc/hr  
Morphine IV 2mg Q4  
Protonix 40mg IV daily  
Nicotine Patch 14 mg daily  
Heparin SC 5000 units TID  
Ertapenem 1gm Q24 (given at 0900 on ___  
Prochloperazine 10mg IV Q4  
Zofran 4mg IC Q8  

 
Discharge Medications:
1. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO 
every ___ hours as needed for pain: This medication will make 
you drowsy. You should not drive or operate machinery on this 
medication.
Disp:*15 Tablet(s)* Refills:*0*
2. Ativan 1 mg Tablet Sig: One (1) Tablet PO BID:PRN as needed 
for anxiety.
Disp:*6 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
1. Alcoholic Pancreatitis
2. Alcohol withdrawal
3. Compartment syndrome

Secondary:
Alcohol dependence

 
Discharge Condition:
Stable. On room air. Pain controlled. 

 
Discharge Instructions:
You were transferred to the hospital after contrast leaked into 
your right arm. You were evaluated by a hand specialist who 
recommended to elevate your arm and give you adequate pain 
control. You had swelling which resolved. You have normal pulses 
and nerve function in this hand. 
.
You also had pancreatitis caused by alcohol. You should decrease 
or stop your alcohol intake. You were also given pain 
medications to help with the pain.
.
You also had alcohol withdrawal symptoms and given valium. Your 
symptoms improved during the hospitalization.
.
You should come back to the hospital if you have increased 
nausea, vomiting, fevers, chills or if your hand swelling 
increases.
 
Followup Instructions:
___
"
8,10451947,29966221," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
SSRI
 
Attending: ___.
 
Chief Complaint:
Valproic acid overdose
 
Major Surgical or Invasive Procedure:
Intubation
 
History of Present Illness:
This is a ___ year old woman w/ h/o bipolar disorder, anxiety, 
ETOH, heroin abuse transferred from OSH for valproic acid 
overdose.  
.
She was initially found unresponsive in the bathroom by her 
father.  She had vomited and was laying on the ground. She was 
not answering questions and EMS was called. An empty bottle of 
valproic acid was found.  She was taken to OSH, where her labs 
were notable for: Valproic acid ___, bicarbonate 16, ammonia was 
1359, ETOH 48, salicalyte/tylenol negative and anion gap of 21. 
She received lactulose and ativan, and was transferred to ___. 
 
.  
At ___ ED, initial VS were: HR 92, RR 17, BP 113/62, 100% RA. 
She was intubated for airway protection. Toxicology was 
consulted who recommended activated charcoal, l-carnatine. Her 
ECG was sinus tachycardia, Qtc 428. Her labs were notable for: 
ammonia 59, inr 1.3, alt/ast ___, tbili 0.2, hco 18, AG 19, 
serium tox neg for asa/etoh/tylenol/benzo/barb/tca, valproate 
150, abg 7.37/32/511, lactate 4.9. She received 20gm activated 
charcoal, loading dose of l-carnatine iv, and NS. Current vent 
settings: FiO2 100%, 450, 20, 5.  
.  
In the MICU, pt l-carnatine was continued, and Toxicology 
recommended stopping after ammonia and valproate levels 
continued to trend downward.  She had an elevated lactate that 
improved with IVF.  She was successfully extubated on ___, and 
she was placed on an ativan CIWA scale and given a bannana bag 
given her h/o Etoh abuse.  A psychiatry consult was ordered, and 
the patient was started on a 1:1.
.
On the floor, patient complaining of some throat pain that has 
been present since extubation. She also notes some mild 
epigastric discomfort. When asked to describe the pain, she 
states that it feels more like she wants to throw up than it 
does actual pain.  She denies fevers/chills, congestion.  She 
states she had not been feeling sick recently.

 
Past Medical History:
-Depression  
-ETOH dependence  
-Marijuana Abuse  
-Tobacco Abuse  
-s/p 2 c-sections  
-s/p internal anal sphincterotomy  

 
Social History:
___
Family History:
Alcoholism, no history of gallstones 
 
Physical Exam:
Adm PE:
General: intubated
HEENT: Sclera anicteric, PERRL   
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no organomegaly  
GU: no foley
.
Discharge PE:
Vitals: 98.2 95/49 55 18 98%RA
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, PERRL, oropharynx with erythema, 
few palatal hemorrhages likely related to recent intubation  
Neck: supple, mild cervical ___, some tenderness of 
submandibular area. 
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
Abdomen: soft, mild tenderness to palpation in epigastric 
region.  non-distended, bowel sounds present, no organomegaly, 
no peritoneal signs, no rebound or guarding.  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Skin: no rashes

 
Pertinent Results:
Adm labs:
___ 08:45PM   PLT COUNT-199
___ 08:45PM   NEUTS-76.9* ___ MONOS-3.7 EOS-0.2 
BASOS-0.8
___ 08:45PM   WBC-10.3# RBC-4.54# HGB-14.2# HCT-39.5 
MCV-87# MCH-31.3 MCHC-36.0*# RDW-12.9
___ 08:45PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 08:45PM   VALPROATE-150*
___ 08:45PM   CALCIUM-9.1 PHOSPHATE-3.0 MAGNESIUM-1.8
___ 08:45PM   ALT(SGPT)-9 AST(SGOT)-15 LD(LDH)-195 ALK 
PHOS-57 TOT BILI-0.2
___ 08:45PM   estGFR-Using this
___ 08:45PM   GLUCOSE-88 UREA N-10 CREAT-0.9 SODIUM-143 
POTASSIUM-4.4 CHLORIDE-106 TOTAL CO2-18* ANION GAP-23*
___ 09:09PM   ___ PTT-20.6* ___
___ 09:09PM   AMMONIA-59
___ 09:12PM URINE  RBC-1 WBC-1 BACTERIA-NONE YEAST-NONE 
EPI-1
___ 09:12PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR 
GLUCOSE-NEG KETONE-40 BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-NEG
___ 09:12PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 09:12PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG mthdone-NEG
___ 09:12PM URINE  UCG-NEGATIVE
___ 09:12PM URINE  HOURS-RANDOM
___ 09:21PM   LACTATE-4.9*
___ 09:21PM   TYPE-ART TEMP-36.8 RATES-/20 TIDAL VOL-450 O2 
FLOW-100 PO2-511* PCO2-32* PH-7.37 TOTAL CO2-19* BASE XS--5 
INTUBATED-INTUBATED VENT-CONTROLLED
.
Discharge labs:
___ 06:50AM BLOOD WBC-7.3 RBC-3.69* Hgb-11.1* Hct-32.5* 
MCV-88 MCH-30.1 MCHC-34.1 RDW-12.1 Plt ___
___ 12:39AM BLOOD ___
___ 06:50AM BLOOD Glucose-95 UreaN-5* Creat-0.6 Na-139 
K-3.5 Cl-106 HCO3-23 AnGap-14
___ 08:45PM BLOOD ALT-9 AST-15 LD(LDH)-195 AlkPhos-57 
TotBili-0.2
___ 06:50AM BLOOD Amylase-37
___ 06:50AM BLOOD Calcium-8.7 Phos-3.1 Mg-1.8
___ 06:50AM BLOOD Ammonia-33
___ 06:50AM BLOOD Valproa-30*
___ 05:20AM BLOOD Type-ART pO2-146* pCO2-31* pH-7.41 
calTCO2-20* Base XS--3
.
Studies:
Chest xray: The endotracheal tube is above the thoracic inlet, 
6.6 cm above the carina and can be advanced for more optimal 
placement. An enteric feeding tube terminates within the mid 
esophagus and should be advanced for more optimal positioning. 
The lungs are clear. There are no pleural effusions or 
pneumothorax. The cardiomediastinal and hilar contours are 
normal. Pulmonary vascularity is normal. 
  
IMPRESSION: Support lines as described with endotracheal tube 
above the 
thoracic inlet and enteric feeding tube within the mid 
esophagus, both of 
which could be advanced for more optimal positioning. 
.

 
Brief Hospital Course:
Summary: ___ yo F w/ h/o bipolar disorder, anxiety, ETOH abuse 
transferred from OSH for valproic acid overdose.
.
# Overdose, unresponsiveness: In the MICU, Valproic acid and 
ammonia levels trended down after patient received L-carnitine.  
Remainder of tox screen was negative.  Lactate, AG acidosis 
trended down after getting ivfs.  Patient was extubated on 
hospital day 2 and transferred to the floor, where her ammonia 
and valproic acid levels continued to decline.  Patient denies 
any memory of ingesting anything.
.
# Suicide Attempt / Bipolar disorder with predominant 
depression:  Initially medications were held at the 
recommendation of the consult psychiatry team.  Seroquel was 
started on hospital day 3.  The pt was kept ___ with a 
1:1 sitter.  She was transferred to a psychiatry floor when 
medically stable, for further treatment of her depression. 
.
# Etoh abuse: Pt with significant alcohol use.  CIWA protocol 
was used, pt intially scoring for withdrawal, later for anxiety 
related to her underlying psychiatry diagnosis and a headache 
felt to be tension headache.  Thiamine, folate, and MVI were 
initiated. She will continue to be monitored for withdrawal on 
the psychiatry unit.
.
# Epigastric pain:  Gerd/gastritis were possibilities.  Was 
improving with tylenol.  Amylase and lipase were normal, and she 
tolerated a full diet prior to discharge to psychiatry.  
.
# Headache: Tension headache, improved with tylenol. Initially 
treated with ibuprofen as well as tylenol, but this was stopped 
given the concern for gastritis.
.
----
Transitional issues:
.
# O/D:  Pt does not remember taking, does have history of 
suicide attempt in past.
.
# Abdominal pain: Likely related to gastritis or reflux, treated 
conservatively with tylenol. Try to avoid NSAID use given 
gastritis concern.  Started on ranitidine, consider stopping 
when symptoms have resolved.
.
# Tension Headache:  Treated with tylenol.
.
# Alcohol withdrawal:  Intially in withdrawal, later was scoring 
on CIWA for anxiety and headache, likely unrelated to alcohol 
withdrawal.
.
# Medication reconcilliation:  Unclear what regimen pt was 
currently on.  She will need titration of her psychiatric 
medications while on the psychiatry floor.  At the consult 
team's rec, pt received seroquel 150mg QHS to help with sleep.
 
Medications on Admission:
Unclear which medications patient is taking, the following have 
been noted:
Geodon  
Lithium  
Valproic acid  
Chlorpromazine  
Benztropine  
Cymbalta  
Naltrexone  
Seroquel  
Propranolol  

 
Discharge Medications:
1. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. quetiapine 50 mg Tablet Sig: Three (3) Tablet PO HS (at 
bedtime).  
3. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours) as needed for pain.  
4. folic acid 1 mg Tablet Sig: One (1) Tablet PO once a day.  
5. multivitamin     Tablet Sig: One (1) Tablet PO once a day.  
6. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO once a day. 
 
7. Valium 5 mg Tablet Sig: ___ Tablets PO every six (6) hours as 
needed for CIWA >10.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Valproic Acid overdose
Alcohol abuse and withdrawal
Bipolar disorder

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted after an overdose of valproic acid.  We gave 
you medications to lower these levels.  You required a breathing 
tube because of your sleepiness and to protect your airway 
(breathing).  
.
You were also withdrawing from alcohol, so we gave you 
medication to treat this.
.
You were transferred to a psychiatry floor to help with your 
bipolar disorder, and to help make sure to get you on the right 
medications to best help you feel better.
.
For your abdominal pain, you should START
-Ranitidine 150mg daily
-Tylenol 1g every 6 hours as needed for belly pain or headache.  
Do NOT take more than 4g daily.
-Thiamine, a multivitamin, and folic acid.  These medications 
will help supplement your nutrition.
 
Followup Instructions:
___
"
9,10451947,25266954," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PSYCHIATRY
 
Allergies: 
SSRI
 
Attending: ___
 
Chief Complaint:
s/p Depakote and Neurontin overdose
 
Major Surgical or Invasive Procedure:
None 
 
History of Present Illness:
The patient is a ___ year old Caucasian female, past history of 
BPAD, opiate dependence, current alcohol dependence, one past SA 
by OD one year ago, two past psych hospitalizations, last one 
month ago at ___ who was transferred to ___ on ___ for 
further treatment s/p OD on Depakote and Neurontin. Per OMR, Pt 
was found down by father in home, who called EMS; subsequently 
transferred to ___ for further evaluation and treatment. 
.
In the MICU, she was intubated, received activated charcoal, and 
l-carnitine. Hospital course was significant for delerium in the 
setting of elevated LFT's and hyperammonemia, which trended 
down. She was extubated on hospital day 2 and transferred to the 
floor, where her ammonia and valproic acid levels continued to 
decline.  Patient denied any memory of ingesting anything. On 
the floor, pt c/o headache, most likely tension, which was 
treated with Tylenol. Ibuprofen held as pt c/o of epigastric 
tenderness. Amylase, lipase, and LFT's WNL at time of admission 
to Deaconess 4. Pt started on ranitidine for epigastric pain. 
She was put on a ___ protocol for management of withdrawal 
symptoms. She was followed by C/L psychiatry, who recommended 
discontinuing psych meds aside from seroquel 150 mg bid.  
.
Per OMR, pt stated she decided to overdose on meds when she had 
trouble
obtaining her other psych meds including thorazine, neurontin, 
seroquel, depakote, and lithium that she had recently been 
prescribed after her discharge from ___ in ___. 
She expressed long-standing frustration of the healthcare 
system-- she has not been seeing the same provider consistently, 
and as a result her medication regimen is changed frequently. Pt 
reported becoming angry/violent when she is not on her 
medications, experiencing significant anxiety characterized by 
palpitations, a sensation of chest pressure, diaphoresis, and 
feelings of restlessness. Also endorsed depressive symptoms 
including difficulty sleeping, feelings of guilt/worthlessness, 
SI, difficulty feeling pleasure while in the setting of numerous 
psychosocial stressors including not having custody of her 
children, living with her parents, unemployment. Has been 
drinking approximately 2 pints of hard liquor per day in order 
to help with anxiety symptoms. 
.
Also reported seeing shadows but was told it is related to 
alcohol withdrawal; has history of withdrawal seizures in past, 
blackouts, and tremors. She has been
hospitalized for withdrawal in past. Her last drink was ___. 

 
Past Medical History:
Past psychiatric history:
Dx: BPAD, Panic Disorder. Opiate Dependence, in remission.
Alcohol Dependence. 
Hospitalizations: 2 total, last one month ago at ___ s/p
SI. Previously one year ago at ___, s/p OD on sleeping
pills. 
SA/SIB: one past OD on sleeping pills in ___. Denies 
other SA or SIB. 
Treaters: upon recent discharge patient was given treaters but
did not follow due to financial issues. Last had treaters 
several
months ago at ___. 

PMHx: denies

Substance use history:
Alcohol: pt has been using approx 2 pints of hard alcohol daily
for the past several months, has been using more regularly in
___ years ago since she stopped opiates and custody battle.
Endorses withdrawal seizure last year, DTs in the past. 
Drugs: snorted heroin for several months approx ___ years ago,
went to rehab and has been sober from opiates since. Denies any
other drugs since or recently. States some past cocaine but not
regularly. 

 
Social History:
___
Family History:
Father: alcoholic
 
Physical ___:
Patient was fully ambulatory at time of discharge. 
97.8 101 114/70 18 96%RA
A/B: Appears younger than stated age, obese, dressed in street
clothes, calm, cooperative with interviewer, maintains good eye
contact, no psychomotor retardation or agitation. 
S: increased in rate rate, normal volume, normal prosody
M: ""Better.""
A: brighter, appropriate, mood congruent
TC: linear, goal oriented
TP: no A/V hallucinations, no SI/HI, no evidence of delusions
C: alert and oriented x3
I: fair
J: fair

 
Pertinent Results:
___ 06:50AM   PLT COUNT-168
___ 06:50AM   WBC-7.3 RBC-3.69* HGB-11.1* HCT-32.5* MCV-88 
MCH-30.1 MCHC-34.1 RDW-12.1
___ 06:50AM   VALPROATE-30*
___ 06:50AM   AMMONIA-33
___ 06:50AM   CALCIUM-8.7 PHOSPHATE-3.1 MAGNESIUM-1.8
___ 06:50AM   LIPASE-16
___ 06:50AM   AMYLASE-37
___ 06:50AM   GLUCOSE-95 UREA N-5* CREAT-0.6 SODIUM-139 
POTASSIUM-3.5 CHLORIDE-106 TOTAL CO2-23 ANION GAP-14
 
Brief Hospital Course:
This is a ___ year old female history of bipolar disorder, ___ 
transferred from MICU/medicine s/p OD of neurontin, depakote, 
alcohol; event possibly suicide attempt in the setting of 
numerous psychosocial stressors and being unable to obtain her
prescription medications.

Axis I: GAD, History of bipolar, polysubstance abuse, r/o MDD 
Axis II: deferred
Axis III: s/p Depakote and neurontin overdose 
Axis IV: severe: unemployed, lives at home with dysfunctional
parents, lost custody of children, multiple psych issues. 
Axis V: 30

#). Anxiety: Pt reports long history of severe anxiety with 
chest pressure, racing thoughts, diaphoresis, inner feeling of 
restlessness previously treated with numerous high-dose 
medication (thorazine, seroquel, neurontin). 
- Although akathesia was certainly on the differential, pt 
described feelings of restlessness prior to initiation of 
antipsychotics. In addition, stated anxiety sxs were best 
controlled on neurontin, thorazine, seroquel.  
- Due to concerns of polypharmacy in the setting of two prior 
overdoses, we initially held the patient's Depakote, Neurontin, 
Thorazine, and continued Seroquel 150 mg bid. 
- Started mirtazapine 30 mg qhs for anxiety and depression, 
however, pt continued to c/o severe anxiety symptoms. Eventually 
added Luvox that was tapered up to 150 mg qhs as well as 
thorazine 75 mg tid and 175 mg qhs, Neurontin 600 mg tid, and 
atenolol that was tapered to 50 mg po qd with careful monitoring 
of BP and HR. 
- Pt expressed concern that she would not be able to receive 
thorazine as an outpatient, so d/c'ed thorazine and started 
perphenazine 8mg tid, 16 qhs with significant improvement in 
anxiety symptoms. 

#). Ethanol dependence/PSA: Per OMR, pt reported drinking 
approximately 2 pints of hard liquor per day. Also h/o opiate 
dependence.
- CIWA scale initially started. Vital signs remained stable 
throughout hospitalization with no complications. 
- group/milieu therapy.

#). Depression, History of bipolar disorder: difficult to assess 
validity of diagnosis at this time, as the patient's only period 
of sobriety was during her pregnancies. However, no evidence of 
mania on this admission and no clear history of mania in the 
past. 
- The patient met diagnostic criteria for MDD, but has been 
abusing alcohol to control her anxiety symptoms. To target 
depressive and anxiety symptoms, we started mirtazapine and 
Luvox. 
- Held lithium and depakote therapy, particularly considering 
the hx of recent SA per overdosing. 
 
#) s/p overdose of depakote and neurontin: clinically stable. 
LFT's normalized, last depakote level= 30's. Not 
encephalopathic. 
- Patient remained medically stable throughout this admission. 

#). Legal/Safety: Pt was admitted to ___ on CV. She was 
able to maintain her safety throughout the admission on q15 
minute checks 

#). Dispo: Patient will be discharged to ___ 
Services in ___ as noted below. 

 
Medications on Admission:
Per outpatient pharmacy
Seroquel 100 mg po qhs
Seroquel XR 600mg po qd
Chlorpromazine 100 mg po qid
Lithium 300 mg po tid
Gabapentin 600 mg po tid
Depakote 500 mg po bid
 
Discharge Medications:
1. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
Tablet(s) 
2. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).
Disp:*30 Tablet(s)* Refills:*1*
3. mirtazapine 30 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime).
Disp:*30 Tablet(s)* Refills:*1*
4. quetiapine 300 mg Tablet Sig: 0.5 Tablet PO BID (2 times a 
day) as needed for anxiety.
Disp:*15 Tablet(s)* Refills:*1*
5. gabapentin 300 mg Capsule Sig: Two (2) Capsule PO TID (3 
times a day).
Disp:*180 Capsule(s)* Refills:*1*
6. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.
Disp:*60 Tablet(s)* Refills:*0*
7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day) as needed for constipation.
Disp:*60 Capsule(s)* Refills:*0*
8. perphenazine 8 mg Tablet Sig: One (1) Tablet PO TID (3 times 
a day): take 1 tab three times daily as needed for anxiety at 2 
tabs at bedtime.
Disp:*150 Tablet(s)* Refills:*1*
9. fluvoxamine 50 mg Tablet Sig: Three (3) Tablet PO HS (at 
bedtime).
Disp:*150 Tablet(s)* Refills:*1*
10. atenolol 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*1*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Axis I: GAD, History of bipolar, polysubstance abuse, r/o MDD, 
Axis II: deferred
Axis III: s/p Depakote and neurontin overdose 
Axis IV: severe: unemployed, lives at home with dysfunctional
parents, lost custody of children, multiple psych issues. 
Axis V: 40

 
Discharge Condition:
Patient was fully ambulatory at time of discharge. 
97.8   101   114/70   18   96%RA
A/B: Appears younger than stated age, obese, dressed in street
clothes, calm, cooperative with interviewer, maintains good eye
contact, no psychomotor retardation or agitation. 
S: increased in rate rate, normal volume, normal prosody
M: 'Better.'
A: brighter, appropriate, mood congruent
TC: linear, goal oriented
TP: no A/V hallucinations, no SI/HI, no evidence of delusions
C: alert and oriented x3
I: fair
J: fair

 
Discharge Instructions:
-Please follow up with all outpatient appointments as listed - 
take this discharge paperwork to your appointments.
-Please continue all medications as directed.
-Please avoid abusing alcohol and any drugs--whether 
prescription drugs or illegal drugs--as this can further worsen 
your medical and psychiatric illnesses.
-Please contact your outpatient psychiatrist or other providers 
if you have any concerns.
-Please call ___ or go to your nearest emergency room if you 
feel unsafe in any way and are unable to immediately reach your 
health care providers.
 
*It was a pleasure to have worked with you, and we wish you the 
best of health.*
 
Followup Instructions:
___
"
10,10497294,27162706," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___
 
Chief Complaint:
clotted L UE AV fistula

 
Major Surgical or Invasive Procedure:
Attempted AV fistula thrombectomy by ___ ___
Tunneled central line placement ___

 
History of Present Illness:
___ y/o man w/ ESRD ___ PKD with non-functioning LUE 
brachicephalic AV fistula who presented for ___ guided 
angiography and thrombectomy.  Unfortunately the clot could not 
be removed, therefore tunneled line placement was placed for 
urgent hemodialysis.  The patient missed dialysis on ___.  
The procedure was completed without complications.  The patient 
states he was told that the clot was unable to be removed, but 
there is no operative report available as of yet.  He missed 
hemodialysis on ___ of this week due to non-functioning 
fistula.  Currently he has mild arm pain in area of fistula.  
Denies F/C, SOB, chest pain, abdominal pain.  He was 
hemodynamically stable upon transfer from the PACU.
.  
ROS: per HPI  

 
Past Medical History:
1.  Polycystic kidney disease.
2.  Hypertension for ___ years.
3.  History of hepatitis C.  Underwent interferon treatment in 
the past.
4.  History of nephrectomy in ___ for stones.
5.  History of bladder stretching in ___ in ___ and ___.
6.  History of parathyroidectomy.

 
Social History:
___
Family History:
mother and three sisters with DM

 
Physical Exam:
VS - 98.6 173/96 73 98% RA FSG 66
GENERAL - NAD, comfortable, appropriate
HEENT - PERRL, EOMI, sclerae anicteric, MM dry, OP clear
NECK - supple, no JVD, no carotid bruits
LUNGS - CTA bilat, no r/rh/wh, resp unlabored
HEART - RRR, no MRG, nl S1-S2
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no 
rebound/guarding
EXTREMITIES - no edema, + peripheral pulses (radials, DPs), 
cannot feel thrill over fistula site, fistula is c/d/i, HD line 
site c/d/i
SKIN - no rashes or lesions
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout

 
Pertinent Results:
Labs upon admission:
.
___ 01:08PM BLOOD WBC-3.9* RBC-3.97* Hgb-13.0* Hct-40.5 
MCV-102* MCH-32.8* MCHC-32.2 RDW-15.2 Plt ___
___ 01:08PM BLOOD Neuts-63.6 ___ Monos-3.9 Eos-2.3 
Baso-0.4
___ 01:08PM BLOOD ___ PTT-30.5 ___
___ 01:08PM BLOOD Glucose-64* UreaN-53* Creat-16.5* Na-141 
K-6.5* Cl-101 HCO3-24 AnGap-23*
___ 01:08PM BLOOD Calcium-10.0 Phos-5.5*# Mg-2.9*
___ 01:20PM BLOOD Glucose-58* K-5.9*
.
Labs upon discharge:
.
___ 07:30AM BLOOD WBC-3.7* RBC-3.49* Hgb-11.7* Hct-35.3* 
MCV-101* MCH-33.5* MCHC-33.1 RDW-15.2 Plt ___
___ 07:30AM BLOOD Glucose-113* UreaN-43* Creat-13.0*# 
Na-142 K-4.7 Cl-100 HCO3-33* AnGap-14
___ 07:30AM BLOOD Calcium-8.5 Phos-4.2 Mg-2.4
.
AV Fistulogram report: ___: pending
 
Brief Hospital Course:
___ y/o man w/ ESRD ___ PKD with non-functioning LUE 
brachicephalic AV fistula who presented for ___ guided 
angiography and thrombectomy, but unfortunately the fistula 
could not be cannulized and the thrombus was unable to be 
removed.  He therefore had a tunneled line placed for 
hemodialysis.  He received 2 sessions of hemodialysis prior to 
discharge ___ and ___.  The transplant surgery office will 
contact the patient for a follow up appointment for surgical 
thrombectomy. 
.
He was continued on his home medications for his chronic medical 
issues including end stage renal disease, depression, 
hypertension, and restless leg syndrome.  
.
He was FULL CODE for this admission.
 
Medications on Admission:
 - vit B 100mg daily
 - folate 1 tab PO daily
 - benadryl 50mg PO TID PRN
 - Hectorol 2.5mcg PO qweek
 - Epogen 4000unit/mL soln with HD
 - gabapentin 300mg PO qHS PRN
 - metoprolol 100mg PO BID
 - Ropinirole 2.5mg PO qHS
 - lisinopril 5mg daily
 - morphine 10mg BID - patient states he receives this at 
prison, however this in not documented in physician notes here 
at ___
 - amitryptyline 25mg BID
 
Discharge Medications:
1. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

3. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
4. ropinirole 1 mg Tablet Sig: 2.5 Tablets PO HS (at bedtime).  
5. lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

6. gabapentin 300 mg Capsule Sig: One (1) Capsule PO HS PRN () 
as needed for pain.  
7. sevelamer carbonate 800 mg Tablet Sig: One (1) Tablet PO TID 
W/MEALS (3 TIMES A DAY WITH MEALS).  
8. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
9. diphenhydramine HCl 25 mg Capsule Sig: Two (2) Capsule PO Q6H 
(every 6 hours) as needed for itching.  
10. Hectorol 2.5 mcg Capsule Sig: One (1) Capsule PO once a 
week.  
11. Epogen 4,000 unit/mL Solution Sig: One (1)  Injection once a 
week: with HD.  

 
Discharge Disposition:
Home with Service
 
Discharge Diagnosis:
AV fistula thrombus
End stage renal disease - due to polycystic kidney disease
Hypertension
Depression
Restless Leg syndrome

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You came to the hospital because of a clot in your AV fistula.  
The Interventional Radiologists attempted to remove the clot, 
however they were unsuccessful.  You will need to follow up with 
transplant surgery to have the clot removed.  The transplant 
surgery office will call you with a follow up appointment.  You 
had a temporarily central line placed for hemodialysis that will 
remain in place until the fistula is working again.
.
We made NO changes to your medications
.
Please follow up with your physicians.
 
Followup Instructions:
___
"
11,10497294,27733001," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Fevers
 
Major Surgical or Invasive Procedure:
Tunneled HD catheter placement by ___ 
 
History of Present Illness:
___ yo imprisoned man with ESRD ___ to PCKD, on dialysis with a 
tunneled catheter in his right arm that was implanted ~90 days 
ago, and on the transplant list presents with fevers from 
100-105 on and off for the past 2 weeks. He was admitted to 
___ on ___ where had a BP of 102/55, HR 93, and a 10% 
bandemia. He was febrile to 105, with rigors, nausea, and 
vomiting. He also complained of chills and diarrhea. He was 
started on abx. He was worked up by renal and ID, who felt that 
the most likely source of this assumed infx was his tunnelled 
cath but in the absence of a definite source it was initially 
not removed. His fever abated, his abx were d/c'd, and he was 
discharged. On ___ he went to dialysis and was found to have 
low grade temp, N/V, was sent to ___ ED and discharged. On 
___ he was found to have a fever of 105 with rigors and he was 
readmitted to ___, where he was started on vanc, then switched 
to zosyn on ___ and had his tunnelled catheter removed. He was 
then transferred to ___ for further work up and management of 
dialysis access.
 
Past Medical History:
1.  Polycystic kidney disease for ___ years.
2.  Hypertension for ___ years.
3.  History of hepatitis C.  Underwent interferon treatment in 
the past.
4.  History of nephrectomy in ___ for stones.
5.  History of bladder stretching in ___ in ___ and ___.
6.  History of parathyroidectomy.
7.  Gout
8.  History of endocarditis, thought to be peritoneal 
dialysis-associated  
9.  History of lumbar osteomyelitis, thought to be peritoneal 
dialysis-associated 
 
Social History:
___
Family History:
mother and three sisters with DM 
 
Physical Exam:
PHYSICAL EXAM ON ADMISSION:
VS - Temp 99.2 128/80 79 20 98% RA  
GENERAL - well-appearing man in NAD, comfortable, appropriate  
HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  
NECK - supple, no thyromegaly, no JVD  
LUNGS - CTA bilat, possible pleural rub auscultated on R, good 
air movement, resp unlabored, no accessory muscle use, possible 
dullness to percussion bilaterally at bases. Pain on palpation 
of midback. 
HEART - PMI non-displaced, RRR, III/VI crescendo-decrescendo 
murmur heard all throughout the precordium that radiated to the 
carotids, nl S1-S2.  
ABDOMEN - NABS, soft/ND, mild tenderness to palaption in left 
lower quadrant, no masses or HSM, no rebound/guarding  
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (DPs). Mild 
effusion palpated on left knee. Pain on palpation of left knee 
and big toe.  
SKIN - no rashes or lesions   
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout. 
.
PHYSICAL EXAM ON DISCHARGE:
VS - 97.6 Tmax 99 147/87 65 15 100% RA
GENERAL - well appearing, NAD  
HEENT - MMM, no cervical lymphadenopathy
LUNGS - CTAB
CV - RRR, III/VI crescendo-decrescendo murmur heard all 
throughout the precordium that radiated to the carotids. S4 vs 
split s1 present. 
ABDOMEN - NABS, soft, NT/ND, no rebound or guarding  
EXTREMITIES - warm well perfused, no ___ edema, positive pain to 
palpation in L knee, ankle, and big toe. 
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___
 
Pertinent Results:
___ 07:55AM BLOOD WBC-2.8* RBC-2.99* Hgb-9.5* Hct-28.0* 
MCV-94 MCH-31.9 MCHC-34.0 RDW-14.6 Plt ___
___ 07:05AM BLOOD WBC-3.2* RBC-3.03* Hgb-9.5* Hct-28.4* 
MCV-94 MCH-31.2 MCHC-33.3 RDW-14.7 Plt ___
___ 07:55AM BLOOD Neuts-38* Bands-1 ___ Monos-15* 
Eos-5* Baso-0 Atyps-5* ___ Myelos-0
___ 07:05AM BLOOD Glucose-92 UreaN-57* Creat-13.2*# Na-141 
K-4.9 Cl-101 HCO3-25 AnGap-20
.
Microbiology results from ___: Blood cx on ___ grew E. coli 
resistant to ampicillin, cefazolin, ciprofloxacin, and 
levofloxacin. Sensitive to ceftriaxone, ceftazidime, amikacin, 
gentamicin, ertapenem, imipenem, and bactrim 
 
Brief Hospital Course:
ASSESSMENT: ___ yo imprisoned man with ESRD ___ to PCKD, on 
dialysis with a tunneled catheter in his right arm that was 
implanted ~90 days ago, and on the transplant list presents with 
fevers from 100-105, rigors, N/V/D on and off for the past 2 
weeks, s/p tunnelled catheter removal on ___.
.
ACTIVE ISSUES
.
# Fevers, bacteremia: Pt presented with fevers and rigors, N/V/D 
x 2 weeks. He was initially treated with gentamicin and then 
vanc and then zosyn at ___ over this time on multiple 
admissions, as described in the HPI. Blood cultures grew gram 
negative bacilli, later speciated as E coli.  His tunneled 
catheter was thought to be the most likely source and it was 
removed on ___ at ___. He was then transferred to ___ for 
further work-up and new line placement. He was started 
empirically on zosyn and switched to ceftriaxone when speciation 
from ___ returned as E. coli sensitive to ceftriaxone and 
ceftazidime. He does have a significant history of bacteremic 
infections, including lumbar osteomyelitis and bacterial 
endocarditis (unclear which valve, ?aortic) in ___ thought to 
be related to the peritoneal dialysis he was receiving at the 
time. Recurrence of these infections was considered as a 
possibility, especially given the fact that he endorsed lower 
back pain and had a III/VI systolic murmur. But he endorsed that 
his back pain is chronic, his murmur was noted in a transplant 
note from ___, and he had no other endocarditis stigmata, so 
these were thought to be less likely. It also was considered 
whether his painful joints could be infectious, but they were 
not warm, had minimal if any effusions, and he said that these 
joints are this painful at baseline. He was afebrile throughout 
his admission and blood cultures were consistently negative. He 
was switched on the day of discharge to ceftazidime 1g IV to be 
given at dialysis for 2 weeks. He will need follow-up at the 
___ clinic to monitor for signs of recurrent infection.  No 
TTE was obtained, given extremely low suspicion for 
endocarditis, however can consider doing this in the future to 
assess the cause of his prominent systolic murmur.
.
# ESRD: Pt was dialyzed on the day of admission, ___. His 
tunneled catheter was then removed at ___ on ___ and he was 
transferred to ___. Renal was consulted and they recommended 
that ___ place a new tunneled catheter for HD access. This was 
placed on ___ and he dialyzed immediately following placement. 
He is slated to have an eventual brachiobasilic fistula created 
with Dr. ___ the transplant service, who are following him 
longitudinally. He has a follow-up appointment with them 
scheduled for ___. His dialysis is coordinated by the prison on 
a MWF schedule and he will followup with the clinic there for 
his next dialysis session on ___.  Sevelamer was continued but 
at an increased dose.
.
# Joint pains:  Patient presented with L knee, ankle, big toe, 
and low back which have been worse over the past ___ months, but 
he apparently has had them for years. He has been treated for 
gout for years (though rheum at the prison has seen him and 
doubts gout). He attributes these current pains to gout. We were 
unable to attain original documentation of how the gout was 
diagnosed from the prison but he was treated for a flare as 
recently ___ with prednisone, ___, and allopurinol. There 
also was a question for septic arthritis or lumbar osteomyelitis 
given his bacteremia and fevers and PMHx of lumbar 
osteomyelitis, however his exam was not particularly impressive 
and this chronic time course would be unusual. He was maintaned 
on renally-dosed allopurinol (w HD) and his pain was controlled 
with oxycodone 5 mg q4 prn in house (for more reliable nonrenal 
clearance). He will followup with the prison clinic regarding 
the management of chronic joint pain. He was discharged on 
MScontin.
.
CHRONIC ISSUES:
.
# Hepatitis C: He has a history of chronic hep C with prior 
interferon treatment.He is not currently being treated. He 
presented to ___ with a mild transaminitis. It was unclear if 
this was acute from sepsis or evidence of evolving cirrhosis. He 
will follow up with the prison clinic regarding his chronic hep 
C. 
.
# Hypertension: Pt has baseline hypertension controlled with a 
home regimen. He was normotensive throughout his admission. Pt 
was restarted on home regimen but renal recommended stopping 
lisinopril, so it was discontinued on discharge.   
.
# Anemia: This is secondary to chronic renal disease, remained 
stable throughout admission. 
.
TRANSITION ISSUES
.
1. Fevers/bacteremia: Ensure afebrile, continue ceftazidime 
course. Consider ECHO to assess systolic murmur. 
.
2. ESRD: MWF dialysis.
.
3. Mild transaminitis: Consider repeat LFT's to ensure return to 
baseline. 
  
 
Discharge Medications:
1. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day) as needed for constipation.  
3. doxercalciferol 2.5 mcg Capsule Sig: Two (2) Capsule PO 
3X/WEEK (___).  
4. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
5. ropinirole 1 mg Tablet Sig: 2.5 Tablets PO QPM (once a day 
(in the evening)).  
6. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO 
TID W/MEALS (3 TIMES A DAY WITH MEALS).  
7. heparin (porcine) 1,000 unit/mL Solution Sig: as dir 1,000 
unit/mL  Injection PRN (as needed) as needed for dialysis: Dwell 
to catheter volume 
.  
8. ceftazidime 1 gram Recon Soln Sig: One (1) Recon Soln 
Injection QHD (each hemodialysis): 8 more doses. LAST DAY of 
therapy,  ___.  
9. diphenhydramine HCl 25 mg Capsule Sig: Two (2) Capsule PO 
every six (6) hours as needed for itching.  
10. MS ___ 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO once a day.  
11. allopurinol ___ mg Tablet Sig: One (1) Tablet PO MWF after 
dialysis.  
12. lisinopril 5 mg Tablet Sig: One (1) Tablet PO once a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
E. Coli bacteremia
End-stage renal disease
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Mr. ___,

You were transferred to our care to establish new dialysis 
access. You had your tunneled line removed because of an 
infection. You will need antibiotics with dialysis to treat that 
infection

MEDICATION CHANGES:
1. Start ceftazidime to treat infection - given during your 
dialysis runs
2. Increase Sevalemer to 2400 mg with meals
 
Followup Instructions:
___
"
12,10497294,21852467," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Low grade fever after dialysis
 
Major Surgical or Invasive Procedure:
Transesophageal ultrasound with conscious sedation, ruled out 
endocarditis.

 
History of Present Illness:
___ incarcerated male w/ ESRD ___ PCKD on HD with recent 
admission for E. coli bacteremia believed secondary to a line 
infection, who represents with fevers and chills at dialysis. 
Admitted on ___ for a fever of 105 with rigors at dialysis. He 
was started on vanc (14 days PTA), switched to zosyn on ___ 
(13days PTA)and had his tunnelled catheter removed. He was then 
transferred from ___ to ___ for further work up and 
management of dialysis access. On admission from ___, 
patient was treated with zosyn, which was narrowed to CTX given 
E. coli from ___ cultures sensitive to CTX and ceftaz. A new 
tunnelled HD line was placed by ___ on ___. He was discharged on 
ceftaz (10 days PTA) with a two week course to be dosed at 
dialysis. There was concern for a possible underlying source of 
persistent infection given frequent bactermia. Pt w/ h/o lumbar 
osteomyelitis, endocarditis in ___ thought to be related to PD 
he was getting at the time and has a persistent murmur. TTE was 
not pursued during prior admission as surveillance cultures at 
___ were negative and there was no stigmata of endocarditis.  
.  
On day of admission, temperature to 99.8 w/ chills at dialysis. 
Given IV vancomycin and ceftazadine after dialysis and was sent 
to ED. He denied pain at the catether site, but did endorse f/c 
and weakness. Also w/ pain in b/l ankles, knee, and hip (new) 
which he attributes to his gout, but worse pain than usual. 
Denies cough, SOB, CP, N/V/D, abdominal pain, rash, or change in 
mental status.  
.  
In the ED, initial VS were: 98.4 89 109/57 18 96%. Exam was 
notable for no tenderness, edema, discharge or erythema at the 
catheter site and for b/l hip pain. Labs were notable for WBC of 
8.4 from 3.5 at time of discharge, lactate 2.4, CRP 17.7, and 
ESR 50, He received MS contin 30 mg for pain and acetaminophen 
1000 mg for a rising temperature as well as 1L IVF. Blood cx x2 
sent. CXR was obtained which was negative for acute process but 
showed an 8 mm nodule. Pelvic plain films negative for acute 
fracture or dislocation of hips. Orthopedics consulted, will 
evaluate on the floor. VS on transfer were: 100.3 84 114/63 16 
100%.  
 
Past Medical History:
1.  Polycystic kidney disease for ___ years.
2.  Hypertension for ___ years.
3.  History of hepatitis C.  Underwent interferon treatment in 
the past.
4.  History of nephrectomy in ___ for stones.
5.  History of bladder stretching in ___ in ___ and ___.
6.  History of parathyroidectomy.
7.  Gout
8.  History of endocarditis, thought to be peritoneal 
dialysis-associated  
9.  History of lumbar osteomyelitis, thought to be peritoneal 
dialysis-associated 
 
Social History:
___
Family History:
Mother and three sisters with DM 
 
Physical Exam:
Admission PE:
VS: Tc 97.5, Tm 98.4, 110/70 76 16 99%RA  
GENERAL: Well-appearing man in NAD, comfortable, appropriate, 
leg cuffs in place.  
HEENT: NC/AT, PERRL, EOMI, sclerae anicteric, MMM, OP clear.  
NECK: lower neck scar visible, no LAD
HEART: RRR, III/VI systolic murmur loudest at LUSB w/ radiation 
to carotids, nl S1-S2; no rubs/gallops  
LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored. 
 
ABDOMEN: 2cm scar near umbilicus (old peritoneal dialysis site), 
Soft/NT/ND, no masses or HSM, no rebound/guarding.  
EXTREMITIES: Left ankles slightly warm to touch but no obvious 
edema; Left great toe cool, w/o edema or erythema, active ROM 
___ pain, intact passively. ___ strength in proximal lower 
extremities, left worse than right; WWP, no c/c/e, 2+ peripheral 
pulses.  
SKIN: Right tunnelled catheter site w/ clean dressing in place; 
no visible erythema, edema, discharge or TTP. Multiple tattoos. 
No Oslers nodes, splinter hemorrhages, rashes or lesions.  Graft 
in LUE without a thrill.   
BACK: mild tenderness to palpation in L5-S2 region, centrally 
and para-spinally; no point tenderness  
NEURO: Awake, A&Ox3, ___ strength in proximal lower 
extremities, left worse than right; otherwise muscle strength 
___ throughout, sensation grossly intact throughout. 

Discharge PE:
VSS Tc 98.3, 134/72, 64, 18, 97%RA
GENERAL: resting in HD bed, A+O x3, very pleasant.
HEENT: MMM, PERRL, OP clear 
HEART: RRR, ___ systolic murmur loudest at LUSB, nl S1-S2; no 
rubs/gallops
LUNGS: CTAB, with some minor crackles at lung bases bilaterally. 
NO wheezes or rhonchi. 
ABDOMEN: 2cm scar near umbilicus, Soft/NT/ND
EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses.  
SKIN: Right tunnelled catheter site w/ clean dressing in place, 
being used for HD; no visible erythema, edema, discharge or 
tenderness to palp. Multiple tattoos. Graft in LUE without a 
thrill. b/l ring fingers and left middle finger DIP and PIP 
joints getting stuck when flexed and ""pop"" when extended.
BACK: moderate tenderness to palpation in L5-S2 region, 
centrally and para-spinally; no point tenderness  
NEURO: Awake, A&Ox3. ___ ___ strength in hips bilaterally, some 
pain with use.

 
Pertinent Results:
___ 07:30AM BLOOD WBC-3.3* RBC-3.29* Hgb-10.6* Hct-30.7* 
MCV-93 MCH-32.3* MCHC-34.6 RDW-15.4 Plt ___
___ 06:25AM BLOOD WBC-3.5* RBC-3.26* Hgb-10.4* Hct-30.8* 
MCV-94 MCH-31.9 MCHC-33.8 RDW-15.3 Plt ___
___ 05:15AM BLOOD WBC-3.9* RBC-3.06* Hgb-10.0* Hct-28.7* 
MCV-94 MCH-32.7* MCHC-34.9 RDW-16.1* Plt ___
___ 06:00AM BLOOD WBC-3.4* RBC-2.91* Hgb-9.6* Hct-27.2* 
MCV-94 MCH-33.0* MCHC-35.3* RDW-16.2* Plt ___
___ 08:20PM BLOOD WBC-3.0* RBC-2.91* Hgb-9.5* Hct-27.4* 
MCV-94 MCH-32.7* MCHC-34.7 RDW-16.2* Plt ___
___ 06:43AM BLOOD WBC-4.6 RBC-2.91* Hgb-9.6* Hct-27.6* 
MCV-95 MCH-32.9* MCHC-34.7 RDW-16.3* Plt ___
___ 06:10AM BLOOD WBC-4.2 RBC-2.79* Hgb-9.3* Hct-26.8* 
MCV-96 MCH-33.1* MCHC-34.5 RDW-16.5* Plt ___
___ 08:39PM BLOOD WBC-8.4# RBC-3.00* Hgb-9.8* Hct-29.0* 
MCV-96 MCH-32.7* MCHC-33.9 RDW-15.9* Plt ___
___ 08:39PM BLOOD ESR-50*
___ 08:39PM BLOOD ___ PTT-31.2 ___
___ 08:20PM BLOOD ___ PTT-32.8 ___
___ 07:30AM BLOOD Glucose-99 UreaN-40* Creat-12.0* Na-136 
K-4.7 Cl-90* HCO3-35* AnGap-16
___ 06:25AM BLOOD Glucose-92 UreaN-36* Creat-12.9*# Na-134 
K-5.0 Cl-91* HCO3-28 AnGap-20
___ 05:15AM BLOOD Glucose-91 UreaN-33* Creat-10.5*# Na-138 
K-4.4 Cl-94* HCO3-33* AnGap-15
___ 06:00AM BLOOD Glucose-93 UreaN-22* Creat-7.9*# Na-138 
K-4.9 Cl-95* HCO3-33* AnGap-15
___ 06:43AM BLOOD Glucose-92 UreaN-44* Creat-12.2*# Na-138 
K-5.7* Cl-97 HCO3-31 AnGap-16
___ 06:10AM BLOOD Glucose-85 UreaN-32* Creat-9.9* Na-141 
K-4.8 Cl-100 HCO3-31 AnGap-15
___ 08:39PM BLOOD Glucose-82 UreaN-26* Creat-9.0*# Na-139 
K-4.9 Cl-96 HCO3-34* AnGap-14
___ 06:25AM BLOOD Calcium-10.7* Phos-7.9* Mg-2.7*
___ 06:00AM BLOOD Calcium-9.8 Phos-7.2* Mg-2.3
___ 06:10AM BLOOD Calcium-10.2 Phos-5.9* Mg-2.5
___ 08:39PM BLOOD CRP-17.7*
___ 07:30AM BLOOD Vanco-19.2
___ 06:22AM BLOOD Vanco-17.6
___ 06:43AM BLOOD Vanco-7.9*
___ 07:49AM BLOOD Lactate-1.6
___ 08:43PM BLOOD Lactate-2.4*

___ TEE: No atrial septal defect is seen by 2D or color 
Doppler. Overall left ventricular systolic function is normal 
(LVEF>55%). There are simple atheroma in the descending thoracic 
aorta at 35 cm. There are three aortic valve leaflets. The 
aortic valve leaflets are moderately thickened. No masses or 
vegetations are seen on the aortic valve. Trace aortic 
regurgitation is seen. No mass or vegetation is seen on the 
mitral valve. Mild (1+)ecentric mitral regurgitation is seen. No 
masses or vegetations are seen on the tricuspid valve, but 
cannot be fully excluded due to suboptimal image quality. There 
is no pericardial effusion. Impression: no vegetations seen  

___ Head CT w/o contrast: No hemorrhage, large territorial 
infarction, edema, mass, or shift of normally midline structures 
is present. Periventricular hyperdensities in the bilateral 
frontal lobes may represent acute infarcts or dilated 
___ spaces. The ventricles and sulci are normal in 
size and appearance. The basal cisterns are widely patent. 
Paranasal sinuses and mastoid air cells are well aerated. 
IMPRESSION: No acute intracranial process. 

___ CT T and L spine w/o contrast: 1. Destructive disc space 
changes at the L5-S1 disc space, endplate sclerosis and anterior 
osteophyte formation suggest that these are chronic changes from 
prior osteomyelitis. Comparison with prior imaging may be 
helpful. MRI is a more sensitive test for acute osteomyelitis. 
If the patient has a contraindication, a three-phased bone scan 
may be obtained.
___ CT pelvis w/ contrast: 1. The findings are in keeping 
with changes related chronic osteomyelitis/discitis at L5-S1. 
2. Grade 1 retrolisthesis of L5 on S1. 3. Moderate degenerative 
changes at the femoroacetabular joints. 4. No CT evidence of 
acute osteomyelitis or fracture. 
___ TTE: The left atrium is elongated. There is mild 
symmetric left ventricular hypertrophy. The left ventricular 
cavity size is normal. Overall left ventricular systolic 
function is normal (LVEF>55%). Right ventricular chamber size 
and free wall motion are normal. The aortic valve leaflets are 
mildly thickened (?#). No aortic regurgitation is seen. The 
mitral valve leaflets are mildly thickened. Mild (1+) mitral 
regurgitation is seen. The tricuspid valve leaflets are mildly 
thickened. There is borderline pulmonary artery systolic 
hypertension. There is a very small pericardial effusion. There 
are no echocardiographic signs of tamponade. 
No vegetation seen (cannot definitively exclude).
___ ECG: Rate 78, Sinus rhythm. Left axis deviation. Poor R 
wave progression, probably a normal variant. Non-specific ST-T 
wave changes, particularly in leads V4-V6. No previous tracing 
available for comparison.  
___ CXR: No acute intrathoracic process with an 8-mm nodule 
in the left base for with shallow obliques or non-emergent CT is 
recommended further evaluation.  
___ Xray pelvis: No fracture, dislocation, or definite 
radiographic evidence of acute steomyelitis, although please 
note evaluation of the inferior sacrum and coccyx is not 
optimal. If clinical concern is high, please note that MRI is 
more sensitive. 

 

 
Brief Hospital Course:
Reason for Admission: low grade fever and chills at dialysis. 

___ yo M w/ h/o ESRD ___ to PCKD, on dialysis and recent 
admission for E. coli bacteremia who presented with chills and 
low grade fevers at dialysis session while on outpatient 
antibiotic (ceftazidime) regimen, now on vanc (___) and zosyn 
(___) with no growth in blood cultures to date. 
.
Active Issues:
# Low grade fevers- Patient was admitted for a temperature of 
99.8 at dialysis in the ___ week of treatment for e.coli 
bacteremia. Patient has been afebrile throughout admission and 
cultures drawn in the hospital had no growth.  Additionally 
cultures from ___ Dialysis unit from 
48hrs, 4 days and 7 days prior to admission had no growth.  
Because of this, it was felt that the patient's line could be 
left in place.  During admission, patient was treated with 
vancomycin (___) and zosyn (___). Patient had a history 
of osteomyelitis and endocarditis in ___, so these were 
evaluated with a TTE, TEE (requiring conscious sedation) and a 
CT spine which did not show evidence of current endocarditis or 
osteomyelitis. ID followed this patient throughout the admission 
and felt that given lack of fevers, negative blood blood 
cultures, and no obvious source, they felt he could go back to 
prison without antibiotics.
.  
# ESRD: Pt gets MWF dialysis, which was continued throughout the 
admission. Renal transplant service was made aware of patient's 
admission, as they are planning to create a brachiocephalic 
fistula for dialysis. Pt is on transplant list, transplant 
surgery elected to defer surgery while patient is being worked 
up for infection.  Continued home sevelamer, doxercalciferol and 
given lenient renal diet (per patient insistence) and was fluid 
restricted (1L/day). Patient will be seen by trasnplant shortly 
after discharge.
.  
# Joint pains: Pt w/ chronic pain of back, as well as L ankle 
and L great toe, which he attributes to gout. Patient remained 
on allopurinol during admission. Was not started on colchicine, 
and renal fellow recommended against this medication in ESRD 
patients. Ortho consult felt his back pain may be secondary to 
sacroiliitis. A pelvic xray did not show any fracture, 
dislocation, or acute osteo. A CT spine of his back did not show 
signs concerning for osteomyelitis either. Patient was continued 
on his home regimen of MS contin 30mg BID for chronic pain as 
well as started on NSAIDs for management of pain. Additonally 
complaining of locked DIP and PIP joints bilaterally, which was 
not actively assessed as an inpatient. Patient has outpatient 
follow up with orthopedic surgery.
.
# Hypertension: Patient's blood pressure ranged from the 
120s-140s in the hours after dialysis, to the 160s-190s in the 
day and a half leading up to the next dialysis session.  Patient 
c/o frequent HAs with elevated pressures and had an episode of 
vomitting with a BP of 177/90. During this time, pt had no 
papiledema or AMS. A CT head was negative for intracranial 
process and HA improved with hydralazine. Patient required 
several additional doses of hydralazine and lisinopril, and on 
the day prior to discharge, his standing lisinopril was 
increased from 5mg to 10mg PO daily with improved BPs 
(140s/80s). 
.  
Chronic Issues:
# Hepatitis C: Chronic hep C with prior interferon treatment. He 
is not currently being treated.  
- defer to outpatient management  
.  
# Anemia: Hct ranged from ___ throughout admission, baseline 
appears to be around 28. Secondary to chronic renal disease.  
Stable. Epo was held during admission for concern of possible 
history of parathyroid cancer. We were not able to locate 
records from his operation (only were able to determine from 
___ that it occurred in ___ in ___, 
___ prior to discharge.  After further discussion with 
nephrology, it was not felt that this distant and questionable 
history of cnacer should be a contraindication to epo so they 
were going to give instructions to resume epo in their sign-out 
to the patient's local hemodialysis center.
.  
# Lung nodule: 8 mm nodule in left base, new from prior studies. 
Will need follow up with non-emergent chest CT scan for further 
characterization as an outpatient.
.
Transitional Issues: Patient is incarcerated and gets his care 
at ___. Do not ___ any transitional issues.
 
Medications on Admission:
1. amitriptyline 25 mg PO BID  
2. docusate sodium 100 mg PO BID  
3. doxercalciferol 5 mcg PO 3X/WEEK (___).  
4. metoprolol tartrate 100 mg PO BID  
5. ropinirole 2.5 mg PO QPM  
6. sevelamer carbonate 2400 mg PO TID W/MEALS  
7. ceftazidime 1 gram Recon Soln Sig: One (1) Recon Soln  
Injection QHD (each hemodialysis): 8 more doses. LAST DAY of  
therapy, ___.  
8. diphenhydramine HCl 50 PO q6hr prn  
9. MS ___ 30 mg ER PO daily  
10. allopurinol ___ mg PO MWF after dialysis.  
11. lisinopril 5 mg PO daily 
 
Discharge Medications:
1. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
3. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
4. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO Q12H (every 12 hours).  
5. ropinirole 1 mg Tablet Sig: 2.5 Tablets PO QPM (once a day 
(in the evening)).  
6. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO 
TID W/MEALS (3 TIMES A DAY WITH MEALS).  
7. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
8. allopurinol ___ mg Tablet Sig: One (1) Tablet PO MWF after 
dialysis.  
9. doxercalciferol 0.5 mcg Capsule Sig: One (1) Capsule PO MWF.  

10. diphenhydramine HCl 50 mg Tablet Sig: One (1) Tablet PO Q6hr 
PRN as needed for allergy symptoms.  
11. ibuprofen 400 mg Tablet Sig: One (1) Tablet PO three times a 
day as needed for pain: please take with food.  

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Final Diagnosis:
Low grade fever

Secondary:
1. Polycystic kidney disease for ___ years.  
2. Hypertension for ___ years.  
3. History of hepatitis C. s/p interferon treatment.  
4. History of nephrectomy in ___ for stones.  
5. History of bladder stretching in ___ in ___ and ___.  
6. History of parathyroidectomy.  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to the hospital because you were having low 
grade fevers during your dialysis session.  You were being 
treated for a bacteria in your blood at your outpatient dialysis 
unit for the past 2 weeks, and so we were worried that the 
antibiotics you were on were not treating your infection.  While 
you were in the hospital, we gave you 2 strong antibiotics.  You 
did not have a fever in the hospital and we never found any 
bacteria growing in your blood.  The blood drawn at your 
dialysis unit also never had any bacteria growing in it. We did 
some imaging of your back and heart because we were concerned 
that you may have an infection in either of these areas, however 
there was no evidence of infection on these studies.  Because 
there is not evidence that you are still infected, we have 
stopped your antibiotics.  It is common to have low grade fevers 
while getting dialysis, so this may be a chronic event for you. 
If you remain afebrile over the next week (with a temperature 
not greater than 100.4F), you should be able to have a fistula 
or graft placed soon.  We have made an appointment with your 
transplant surgeon, Dr. ___, for next week (see 
details below), so that you will have close follow up and so the 
procedure will be done as soon as possible.

You were noted to have a lung nodule of unknown significance on 
CXR. You should follow up with your PCP and should be scheduled 
for an outpatient Chest CT to follow this.

Please continue your home medication as prescribed.  You no 
longer need to take Ceftazidime, the antibiotic you were getting 
at dialysis.

The following changes have been made to your medications:
- please INCREASE lisinopril to 10 mg daily
- please START ibuprofen 400 mg every 8 hours, if this isn't 
managing your pain, you can increase to 600 or 800 mg every 8 
hours.  Please be sure to take ibuprofen with food, do not take 
it on an empty stomach.
- please STOP taking ceftazidime.  There is no active evidence 
of infection, so you do not need any antibiotics right now.

The rest of your medications have not changed.  Please continue 
to take them as originally prescribed.
 
Followup Instructions:
___
"
13,10497294,22132227," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Fever
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old gentleman incarcerated since ___, past medical 
history of ESRD secondary to PKD and history of multiple 
hospital admissions in past month for recurrent fevers and 
rigors often HD-associated with previous positive workup for E. 
coli bacteremia likely secondary to tunneled HD line, now 
presents with non-HD associated fever to 103 with chills/shakes 
for several hours the day prior to admission. Previous 
significant history includes multiple PD-associated infections 
from ___ to ___, including peritonitis, lumbar discitis/ 
osteomyelitis/ epidural abscess and endocarditis secondary to 
enterococcus bacteremia. Otherwise patient has been in normal 
health until 1 month ago:
___: symptoms warmth and chills, 99.4F, resolved with 2 Advil
___: Repeat symptoms, 99.0F, resolved with tylenol
___: Presented to ___ with fevers, 
chills, non-bloody non-bilious vomiting, occasional pain around 
Port-A-Cath site but no redness, swelling or drainage. Treated 
with vanc, zosyn, tylenol and IVF. ID consult thought bacteremia 
secondary to to HD line. Also noted left knee and ankle was 
warm, swollen, and extremely tender to touch on exam but without 
erythema. Stopped antibiotics when cultures returned neg and 
fevers abated. Returned to prison.
.
___: 100.0F, given vanc and gentamycin possibly by prison 
physician, resolved
___: Presented to ___ with fever 102.0F. Resolved without 
intervention, and d/c to prison.
___: Presented to ___ with fever 105.0F during dialysis. 
Started on Vanc and removed HD line. Blood cultures grew E. coli 
resistant to ampicillin, cefazolin, ciprofloxacin and 
levofloxacin, otherwise sensitive.
___: Transferred from ___ to ___. Given Zosyn. Mild 
effusion palpable on left knee. Switch Vanc/zosyn to ceftazidime 
once blood culture results returned.
___: HD Line replaced by ___. Discharged on ceftazidime x10 
more days. WBC 3.2.
.
___: Neg Blood cultures from ___.
___: Neg Blood cultures from ___.
___: Neg Blood cultures from ___.
.
___ to ___: 99.8F and chills at HD. Given Vanc and zosyn 
then sent to ___ ED where T 100.3F. New onset bilateral hip 
pain. WBC 8.4 (compared to 3.2 nine days prior), CRP 17.7, ESR 
50. Neg pelvic Xray but CXR notable to 8 mm rim calcified 
nodular opacity within left lung base. CT T/L spine and pelvis 
neg for acute osteomyelitis but showed evidence of changes 
consistent with chronic osteomyelitis. TTE neg for valvular 
vegetation. Ortho consult considered sacroiliitis. ID followed 
as well. Pt given Vanc ___ and Zosyn ___. Pt 
remained afebrile through admission. Multiple serial Blood 
cultures returned neg so line was left in place and pt d/c to 
prison.
.
___: 99.0F at dialysis without chills or rigors.
___: 103.0F measured by patient with chills and rigors 
starting at 12pm and lasting for several hours. Notably not 
during dialysis; patient lying down at time with no other 
activity. Ceftaz given in ED where T 102.1F. 
 
Past Medical History:
ESRD on HD MWF through right Port-A-Cath, on dialysis since 
___, PD ___ complicated by recurrent peritonitis, failed 
LUE AV fistula ___
Polycystic kidney disease s/p right nephrectomy ___
Hypertension ___ years
Hepatitis C dx ___ s/p failed interferon treatment ___
L5-S1 discitis, osteomyelitis, epidural abscess ___ 
enterococcus bacteremia, treated with 10 days of 
ampicillin/gentamycin
Endocarditis (___)
Hyperparathyroidism, s/p subtotal parathyroidectomy ___, 
revision ___ s/p thyroid lobectomy
Gout (questionable diagnosis but on treatment)
Carotid stenosis
Restless leg syndrome
Depression
Chronic pain syndrome
Neurogenic bladder
Diverticulosis
Trigger finger
 
Social History:
___
Family History:
Mother - diagnosed with DM in her ___
Father - died of drugs and alcohol and pancreatic cancer at ___
3 of 4 or ___ healthy brother
2 children (estranged) - ___nd health ___ yo
 
Physical Exam:
Admission Exam:
VS: 100.0 126/62 77 18 99%RA  
GENERAL: Well-appearing man in NAD, comfortable, appropriate.  
HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear.  
NECK: Supple, no thyromegaly, no JVD, no carotid bruits.  
HEART: RRR, ___ systolic murmur (previously documented), nl 
S1-S2.  
LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored. 
 
ABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding, 
multiple scars  
EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses. L arm 2 old 
fistula sites.  
SKIN: No rashes or lesions. R chest tunnelled line, no 
erythema/no pain/tenderness  
LYMPH: No cervical LAD.  
NEURO: Awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout, DTRs 2+ and 
symmetric, cerebellar exam intact, steady gait.  
.
Discharge Exam:
VS: 97.6F (Tmax 98.6F), 150/72 (117-150/58-72), 58, 18, 98%/RA
GENERAL: Well-appearing man in NAD, comfortable, appropriate, 
looks younger than stated age
HEENT: NCAT, PERRLA, arcus senilis, sclerae anicteric, MMM, OP 
clear
HEART: RRR, ___ systolic murmur loudest over LLSB, nl S1-S2
LUNGS: CTAB, no r/r/w, good air movement, resp unlabored
ABDOMEN: +BS, soft/NT/ND, tympanic to percussion throughout, no 
masses or HSM, no rebound/guarding, multiple scars
BACK: extremely tender to light touch over lumbar sacral spinous 
processes and paraspinal areas
EXTREMITIES: WWP, no c/c/e, 2+ DP pulses, L arm 2 old fistula 
sites, L knee and ankle tender to light touch, able to flex 
actively
SKIN: R chest tunnelled line, no erythema, pain or tenderness
NEURO: Awake, AOx3
 
Pertinent Results:
Labs at Admission:
___ 06:45PM BLOOD WBC-9.6# RBC-3.11* Hgb-10.2* Hct-28.8* 
MCV-93 MCH-32.8* MCHC-35.3* RDW-15.7* Plt ___
___ 06:45PM BLOOD Neuts-96* Bands-0 Lymphs-2* Monos-2 Eos-0 
Baso-0
___ 06:45PM BLOOD Glucose-86 UreaN-32* Creat-11.6* Na-135 
K-4.8 Cl-98 HCO3-23 AnGap-19
___ 06:45PM BLOOD Albumin-4.1 Iron-24*
___ 07:40AM BLOOD Calcium-10.2 Phos-6.5* Mg-2.4
___ 06:45PM BLOOD ALT-15 AST-18 LD(LDH)-188 AlkPhos-83 
Amylase-90 TotBili-0.4
___ 06:45PM BLOOD calTIBC-276 Ferritn-133 TRF-212
___ 06:45PM BLOOD CRP-7.7*
___ 07:07PM BLOOD Lactate-1.2
___ 6:45 pm BLOOD CULTURE      #1. 

   Blood Culture, Routine (Preliminary): 
      ESCHERICHIA COLI.    FINAL SENSITIVITIES. 
         Piperacillin/Tazobactam sensitivity testing performed 
by ___
         ___. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--  =>32 R
CEFAZOLIN-------------  =>64 R
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------     2 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----       R
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

   Anaerobic Bottle Gram Stain (Final ___: 
      GRAM NEGATIVE ROD(S). 
.
.
.
Labs at Discharge:
___ 07:00AM BLOOD WBC-3.8* RBC-2.84* Hgb-9.3* Hct-26.9* 
MCV-95 MCH-32.6* MCHC-34.4 RDW-15.2 Plt ___
___ 07:00AM BLOOD Glucose-101* UreaN-29* Creat-11.3*# 
Na-135 K-4.8 Cl-95* HCO3-31 AnGap-14
___ 07:00AM BLOOD Calcium-10.7* Phos-6.5*# Mg-2.7*
___ 6:55 pm BLOOD CULTURE      #2. 

   Blood Culture, Routine (Pending): 

___ 7:40 am BLOOD CULTURE      #1. 

   Blood Culture, Routine (Pending): 
___ 9:35 pm BLOOD CULTURE      R. 

   Blood Culture, Routine (Pending): 

___ 6:55 am BLOOD CULTURE

   Blood Culture, Routine (Pending): 

___ 9:50 am BLOOD CULTURE

   Blood Culture, Routine (Pending): 
.
.
.
Chest X-Ray ___:
PA AND LATERAL VIEWS OF THE CHEST: Right-sided dual-lumen 
dialysis catheter tip terminates in the proximal right atrium, 
unchanged. The cardiac, mediastinal and hilar contours are 
within normal limits. The pulmonary vascularity is normal. 8-mm 
rim calcified nodular opacity within the left lung base appears 
unchanged. Lungs are clear. No pleural effusion or pneumothorax 
is seen. There are no acute osseous abnormalities. Multiple 
clips are seen in the right upper quadrant. Calcifications are 
noted in the left upper quadrant of the abdomen, compatible with 
calcifications seen within innumerable left renal cysts on CT. 
IMPRESSION: No acute cardiopulmonary abnormality, and no 
interval change from prior. 
.
MRI Lumbar spine without contrast ___:
Endplate erosion with loss of disc height at L5-S1 levels, with 
mild increased T2 signal, likely representing chronic discitis 
osteomyelitis. Additionally there is a disc bulge and bilateral 
facet arthrosis at this level causing moderate bilateral neural 
foramina narrowing and compression of the L5 nerve roots and 
abutting the S1 nerve roots. 
 
Brief Hospital Course:
___ year old incarcerated male with ESRD secondary to Polycystic 
Kidney Disease on HemoDialysis with recent E. coli bacteremia 
diagnosed by Blood culture from outside hospital on ___ 
believed secondary to HD line infection, presented this time 
with fevers, chills/rigors, found to have 1 out of 4 bottle E 
coli bacteremia. He was stable and discharged on Bactrim for 1 
week. 
.
# Fevers: Patient admitted to ___ for the third time in the 
past month with fevers and rigors. Patient last had 
blood-culture proven E. coli bacteremia in ___. The 
source of infection is most likely the tunneled right-sided HD 
line, but blood cultures during this admission only grew E. coli 
in one bottle, so contamination of the sample by multiple 
hospital admission acquired skin flora cannot be ruled out and 
bacteremia cannot be ruled in. Patient's history is also 
significant for chronic osteomyelitis of his lumbar spine, but 
no acute infection was evident on MRI. Patient was initially 
treated wtih ceftazidime in the ED, broaded to 
vancomycin/cefepime, and after the culture returned GNR, 
narrowed to cefepime only. After speciation and sensitivity 
returned, and given question of bacteremia, patient was treated 
conservatively with Bactim DS once a day at evening for a total 
of 7 days without need for a line change at this time.
.  
# ESRD: He continued to receive MWF dialysis in-house. Renal 
transplant service and Transplant surgery were aware of pt on 
previous admission and were informed of current admission. 
Patient continued his home sevelamer, doxercalciferol, renal 
caps, and renal diet in-house.  
.  
# Chronic joint pains: Patient has chronic pain of back, knees 
and ankles which he attributes to gout. Previous ortho consult 
felt his back pain may be secondary to sacroiliitis, pelvic xray 
did not show any fracture, dislocation, or acute osteomyelitis, 
and CT spine did not show signs concerning for osteomyelitis 
either. Diagnosis of gout is questionable given chronicity of 
pains, location, and pain without signs consistent with acute 
gout flares. Rheumatology at the ___ has seen the patient and 
doubts gout. Have been unable to attain original documentation 
of how the gout was diagnosed, but pt was most recently treated 
for a flare in ___ with prednisone, ___, and 
allopurinol. MRI of lumbar spine was done this admission and 
showed signs of chronic osteomyelitis and bilateral neural 
foramina narrowing and compression of the L5 nerve roots and 
abutting the S1 nerve roots, likely the source of the pain. No 
evidence of acute osteomyelitis was seen. Patient's pain was 
controlled with his home regimen of MS contin and allopurinol.
.
# Hypertension: Controlled in house with home dose of lisinopril 
and metoprolol.
.
Transitional Issues:
1. Please follow up with pending blood cultures. 
2. Replacement of HD catheter once antibiotic course is 
complete.
3. Completion of bactrim course
 
Medications on Admission:
amitriptyline 25 mg PO BID
lisinopril 10 mg PO DAILY
MS contin 30 mg PO Q12H
ropinirole 2.5 mg PO QHS
sevelamer carbonate 2400 mg PO TID
metoprolol 100 mg PO BID
allopurinol ___ mg PO MWF
doxercalciferol 55 mcg PO MWF
 
Discharge Medications:
1. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
3. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
4. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO Q12H (every 12 hours).  
5. ropinirole 1 mg Tablet Sig: 2.5 Tablets PO QPM (once a day 
(in the evening)).  
6. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO 
TID W/MEALS (3 TIMES A DAY WITH MEALS).  
7. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
8. allopurinol ___ mg Tablet Sig: One (1) Tablet PO QMWF (): MWF 
after dialysis.  
9. doxercalciferol 2.5 mcg Capsule Sig: Two (2) Capsule PO QMWF. 
 
10. diphenhydramine HCl 50 mg Tablet Sig: One (1) Tablet PO 
every six (6) hours as needed for allergy symptoms.  
11. ibuprofen 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours) as needed for pain: please take after meals.  
12. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) 
Tablet PO QPM (once a day (in the evening)) for 7 days.
Disp:*7 Tablet(s)* Refills:*0*
13. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap 
PO DAILY (Daily).
Disp:*30 Cap(s)* Refills:*2*

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Primary Diagnosis:
E.coli bacteremia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr ___,
.
It was great pleasure taking care of you as your doctor.
.
You were admitted to ___ because of fever. You initially 
received IV antibiotics, which were later switched to an oral 
antibiotic. You had an imaging of your back which was suggestive 
of chronic bone infection.
.
We made the following changes to your medication.
Please START Bactrim Double Strength 1 tab every evening for 
another 7 days.
Please START Nephrocaps 1 tablet daily
.
Please continue the rest of your medications the way you were 
taking them at home prior to this admission.
.
Please follow with your appointments as illustrated below.
 
Followup Instructions:
___
"
14,10497294,25014373," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Fever
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ yo M with ESRD on HD secondary to PKD, HTN, and chronic 
osteomyelitis, with multiple recent admissions for fevers 
following HD, presenting with fever to 101 following HD 
yesterday.  Patient was last admitted with fever on ___ 
with 1 blood culture positive for e.coli.  He hsa a tunneled HD 
catheter which was changed ___ during another episode of 
e.coli bacteremia.  Patient was most recently treated with 7 
days bactrim, but in the past has been treated with vanc/zosyn 
and ceftazadime. E.coli in past has been resistant to 
ampicillin, cefazolin, ciprofloxacin, and levofloxacin.  
.
Patient reports that other than transient fever following HD, he 
has been feeling well.  He denies cough, runny nose or shortness 
of breath.  He denies diarrhea.  He does not make urine.  He 
denies worsening low back pain at the site of his chronic 
osteomyelitis.
 
Past Medical History:
ESRD on HD MWF through right Port-A-Cath, on dialysis since 
___, PD ___ complicated by recurrent peritonitis, failed 
LUE AV fistula ___ 
Polycystic kidney disease s/p right nephrectomy ___ 
Hypertension ___ years 
Hepatitis C dx ___ s/p failed interferon treatment ___ 

L5-S1 discitis, osteomyelitis, epidural abscess ___ 
enterococcus bacteremia, treated with 10 days of 
ampicillin/gentamycin 
Endocarditis (___) 
Hyperparathyroidism, s/p subtotal parathyroidectomy ___, 
revision ___ s/p thyroid lobectomy 
Gout (questionable diagnosis but on treatment) 
Carotid stenosis 
Restless leg syndrome 
Depression 
Chronic pain syndrome 

 
Social History:
___
Family History:
Mother - diagnosed with DM in her ___
Father - died of drugs and alcohol and pancreatic cancer at ___
3 of 4 or ___ healthy brother
2 children (estranged) - ___nd health ___ yo
 
Physical Exam:
Admission Physical Exam:
T 99.0 BP 163/94 HR 76 R 18 O2Sat 100%
Gen- middle aged man in NAD
HEENT- NCAT, PERRL, EOMI, MMM, oropharynx clear
Neck- No JVD
CV- RRR, normal S1/S2, grade II/VI holosystolic murmur heard 
throughotu precordium without radiation to axilla or carotids.  
No carotid bruit.
Pulm- CTA bilaterally w/o wheezes, ronchi, rales.  Tunneled 
catheter line c/d/i, no erythema, tenderness or warmth at site
Abd- Soft, NTND +BS. No HSM appreciated.  Midline scars from 
previous PD.
GU- no foley
Ext- Right arm with old AV fistula scars, no bruits. No ___ 
edema. 2+ ___ pulses
Neuro- A+O x3, normal speech, strength ___ b/l

Discharge Physical Exam:
Afebrile T98.1 BP 136/84 (129-158/78-84) P 58 R 18 98% RA
HD line in place, tunneled under skin into right subclavian 
artery.  Clean, dry, intact, nontender without erythema or 
exudate.
CV- unchanged
Pulm- unchanged
Exam otherwise stable.
 
Pertinent Results:
WBC 2.8 Hgb 10.2 Hct 30.4 Plts 121
Na 140 K 4.8 Cl 101 CO2 28 BUN 28 Cr 9.8
Ca ___ Mag 2.3 Phos 4.2
Lactate 1.3
ESR 30  CRP 14.9

Blood culture (___) x 2- no growth
Blood culture (___) x 3- no growth
Blood culture (___) x 2- no growth
Blood culture (___) x 2- no growth
CATHETER TIP-IV      TUNNELED HD CATH HIP. 
                            **FINAL REPORT ___
   WOUND CULTURE (Final ___: 
      DUE TO MIXED BACTERIAL TYPES ( >= 3 COLONY TYPES) NO 
FURTHER WORKUP
      WILL BE PERFORMED. 
      ___ ___ (___) REQUESTED SPECIATION OF THE MIXED 
BACTERIAL
      TYPES ___. 
      VIRIDANS STREPTOCOCCI.    10 COLONIES. 
      STAPHYLOCOCCUS, COAGULASE NEGATIVE.    1 COLONY. 
      GAMMA(I.E. NON-HEMOLYTIC) STREPTOCOCCUS.    1 COLONY. 
      CORYNEBACTERIUM SPECIES (DIPHTHEROIDS).    3 COLONIES. 

CXR- Lungs are clear. 8-mm rim-calcified left base nodule is 
again 
demonstrated. Right-sided dialysis catheter is noted terminating 
in the 
proximal right atrium, as before. Right upper quadrant clips and 

calcifications corresponding to left renal cysts are again 
demonstrated.  
Cardiac size is top normal with normal cardiac silhouette. 
Slight rightward tracheal deviation is from left thyroid or 
parathyroid enlargment.  

CT Abd w/contrast (___)- 1. No evidence of intra-abdominal 
abscess. 
2. Innumerable cysts with calcifications in the left kidney 
consistent with polycystic kidney disease (status post right 
nephrectomy). The larger cysts demonstrate internal soft tissue 
density, ? hemorrhagic cysts vs. enhancing soft tissue elements 
within these cysts given lack of non-contrast examination for 
comparison. Recommend comparison with previous examinations if 
available. If not available, a followup scan should be performed 
with and without contrast. 
3. Significantly distended stomach without obvious structural 
abnormality.  Correlate for gastroparesis. 
4. Appearance of L5/S1 may be due to erosions from renal 
osteodystrophy or 
Chronic discitis/osteomyelitis at L5-S1. 

Ultrasound of prostate (___)- The prostate measures 4.1 x 
3.3 x 3.4 cm and is normal in appearance. Both seminal vesicles 
are normal as well. The estimated prostatic volume is 24 cc and 
the predicted PSA based on volume is 2.8. 
  IMPRESSION: Prostatic volume of 23.5 with a predicted PSA of 
2.8. No abscess is noted. 

WBC Tagged Scan/ Bone scan (___)- negative
 
Brief Hospital Course:
___ M with ESRD on HD, HTN, chronic osteomyelitis and multiple 
admissions for fevers presenting with fever following HD.

# Fevers - Patient has had multiple admissions for transient 
fevers, often following HD, with blood cultures occasionally 
positive for E.coli.  Fevers only began once tunnel catheter was 
placed, after AVF clotted.  ESR and CRP are at patient's 
baseline so unlikely acute on chronic osteomyelitis.  In 
addition, patient had no worsening of his low back pain.  
Radiography showed stable process as well. CXR showed no acute 
cardiopulmonary process.  Patient given vancomycin/cefepime x1 
in ER.  Overnight on HD1/2 patient spiked fevers to 103.2 and on 
HD2, tunneled catheter line was pulled and patient was started 
on vancomycin and ceftazadime with dialysis. Patient was given a 
line holiday for 2 days prior to replacement of line.  Line tip 
culture grew strep viridans, coag negative staph, non hemolytic 
strep and corynebacterium consistent with skin or oral flora. 
Blood cultures were negative to date on the day of discharge.  
Patient was afebrile following removal of HD line and did not 
have further fevers.  He completed a 7 day course of vancomycin 
and cefepime following the discontinuation of the HD line.  
Other potential sources of occult infection were investigation 
with a CT abdomen, prostate ultrasound, WBC tagged scan and bone 
scan.  All of these studies were negative for infection.  

# ESRD on HD - Patient gets dialysis ___. 
He was continued on his home sevelamer, doxercalciferol and 
nephrocaps while inpatient. He was dialyzed on ___ 
prior to removal of original tunneled HD line, and spiked a 
fever to 105.  The line was removed following dialysis and 
patient had a ""line holiday"" until ___ when a 
new tunneled cath was placed without issue.  Patient was 
dialyzed on ___ and ___ as scheduled following 
replacement of catheter.  He had no fevers during or following 
dialysis.  Patient has follow-up scheduled with surgical team 
regarding AV fistula v graft.

# Leukopenia/Thrombocytopenia - Has had WBC as low as 2.8 back 
in ___, this appears to be the first time platelets have 
dipped so low. Patient recently on bactrim which ended 1.5 weeks 
ago, and working diagnosis was residual thrombocytopenia due 
this antibiotic.  In addition, with history of HepC, may be due 
to decreased liver function.  Platelets initially trended down, 
but were increasing above admission levels at the time of 
discharge.

# Chronic pain - Has chronic joint pains which have been 
associated with gout in the past. Also with history of chronic 
osteomyelitis as above.  Pain was at baseline and well 
controlled on home regimen of amitriptyline, MS contin 30mg BID, 
ropinirole.  
  
# Hypertension: Patient was intiially continued on lisinopril 
and metoprolol at home doses.  On HD 4, blood pressures were 
elevated, likely in the setting of volume overload due to 
dietary indiscretions and no HD over the weekend.  Patient was 
given hydralazine 25mg q6h, and following dialysis with removal 
of 4.5L, pressures remained elevated.  Lisinopril was increased 
to 40mg daily as well and patient was discharged on hydralazine 
and new dose of lisinopril.   Consider titrating off of 
hydralazine as full effect of lisinopril is seen.
  
# Hepatitis C: Chronic hep C with prior interferon treatment 
dc'ed for GI bleed and ineffectiveness. He is not currently 
being treated.  
  
# Anemia: On prior admission Hct ranged from ___ throughout 
admission, baseline appears to be around 28, secondary to 
chronic renal disease and possibly iron deficiency.  Hematocrit 
remained at baseline throughout admission.

# Transitional issues:
- Please titrate down and discontinue entirely if blood 
pressures well controlled on increased dose of lisinopril.
- 8-mm rim calcified nodular opacity within the left lung base 
noted on CXR, patient will need a non-emergent CT scan to better 
evaluate  
- Patient will have follow-up with surgical team regarding AV 
fistula/graft.  This should be done as soon as possible to avoid 
further tunneled line infections.  
 
Medications on Admission:
1. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO BID (2  
times a day).  
2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
 
times a day).  
3. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
 
4. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet  
Extended Release PO Q12H (every 12 hours).  
5. ropinirole 1 mg Tablet Sig: 2.5 Tablets PO QPM (once a day  
(in the evening)).  
6. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO  
TID W/MEALS (3 TIMES A DAY WITH MEALS).  
7. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID  
(2 times a day).  
8. allopurinol ___ mg Tablet Sig: One (1) Tablet PO QMWF (): MWF 
 
after dialysis.  
9. doxercalciferol 2.5 mcg Capsule Sig: Two (2) Capsule PO QMWF. 
 
 
10. diphenhydramine HCl 50 mg Tablet Sig: One (1) Tablet PO  
every six (6) hours as needed for allergy symptoms.  
11. ibuprofen 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8  

hours) as needed for pain: please take after meals.  
13. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap 
 
PO DAILY (Daily).  
Disp:*30 Cap(s)* Refills:*2* 
 
Discharge Medications:
1. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
3. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO Q12H (every 12 hours).  
4. ropinirole 1 mg Tablet Sig: 2.5 Tablets PO QPM (once a day 
(in the evening)).  
5. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO 
TID W/MEALS (3 TIMES A DAY WITH MEALS).  
6. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
7. allopurinol ___ mg Tablet Sig: One (1) Tablet PO MWF 
(___).  
8. doxercalciferol 2.5 mcg Capsule Sig: One (1) Capsule PO 
3X/WEEK (___).  
9. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap 
PO DAILY (Daily).  
10. hydralazine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 
hours).  
11. lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis: Fever, hemodialysis line infection

Secondary Diagnosis:
1. End stage renal disease
2. Polycystic kidney disease
3. Hypertension
4. Hepatitis C

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your recent 
admission to ___.

You were admitted because of a high fever following 
hemodialysis.  You have had frequent fevers following dialysis 
in the past due to bacteria in your blood.  Blood tests were 
drawn and you were monitored in the hospital for 24 hours.  You 
did not spike any more fevers, and your blood cultures remained 
negative.  The catheter tip grew some bacteria, and so you were 
continued on antibiotics.  In addition, you had an abdominal CAT 
scan to ensure there was no infection in your abdomen.  This 
exam was negative.

Your tunneled catheter line was replaced after a ""line holiday"" 
for two days.

Medication changes:
- INCREASE lisinopril to 40mg daily
- START hydralazine 25mg four times day, this should be tapered 
down and discontinued as your blood pressure responds to the 
increased dose of lisinopril
 
Followup Instructions:
___
"
15,10497294,23719828," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
ESRD
 
Major Surgical or Invasive Procedure:
cadaveric renal transplant ___
left forearm lesion excision

 
History of Present Illness:
Mr. ___ is a ___ year old male with ESRD secondary to
Polycystic Kidney Disease, hypertension and HCV who is being
transferred from prison to ___ for renal transplantation. The
patient's HPI begins approximately ___ years ago when he started
hemodyalysis ___ failing kidneys from PKD. He has been on HD MWF
ever since. In ___, the patient claims that the people at the
___ encouraged him to enroll for a kidney. At this
time he also found out that he was HCV+. The patient claims he
does not know how he became HCV+, he thinks that it might have
been from all the dialysis. He denies ever using IV drugs.  In
___, he had a right nephrectomy for kidney stones. The patient
has had many AV grafts which he claims have now all failed. He
also notes that most of his medical admissions stem from
line/catheter related infections. Approximately 3weeks ago he 
was
admitted to the BI for a catheter related infection where he was
treated for ___ related infection with antibiotics. Since 
then
he denies any fevers, chills, shortness of breath, cough, sore
throat, nausea, vomiting, diarrhea, or headaches. He is anuric.
He said his exercise tolerance is good and that he exercises
routinely. ROS is otherwise negative. 

 
Past Medical History:
ESRD on HD MWF through right Port-A-Cath, on dialysis since 
___, PD ___ complicated by recurrent peritonitis, failed 
LUE AV fistula ___ 
Polycystic kidney disease s/p right nephrectomy ___ 
Hypertension ___ years 
Hepatitis C dx ___ s/p failed interferon treatment ___ 

L5-S1 discitis, osteomyelitis, epidural abscess ___ 
enterococcus bacteremia, treated with 10 days of 
ampicillin/gentamycin 
Endocarditis (___) 
Hyperparathyroidism, s/p subtotal parathyroidectomy ___, 
revision ___ s/p thyroid lobectomy 
Gout (questionable diagnosis but on treatment) 
Carotid stenosis 
Restless leg syndrome 
Depression 
Chronic pain syndrome 

 
Social History:
___
Family History:
Mother - diagnosed with DM in her ___
Father - died of drugs and alcohol and pancreatic cancer at ___
3 of 4 or ___ healthy brother
2 children (estranged) - ___nd health ___ yo
 
Physical Exam:
Vitals: Pain:0, BP 147/86, Hr 62, RR 16 100%RA. Wt 67.2Kg.
GEN: NAD, AAOx3. Physically fit appears younger than stated age.
Several tattoos, several scars from access sites and surgeries
over his arms and torso. 
Heart: RRR. II/VI systolic murmur. 
Lungs: CTA B/L 
Abdomen: Non-tender, soft, non-distended. 
Extremities: UE Pulses R arm ulnar pulse 2+ radial not felt. L
arm 1+ radial/ulnar pulse. No c/c/e. Heavily scarred. 
Neuro: CN ___ in tact. Fluent speach. Appropriate affect. 

Labs: 

141|100|27     /       AGap=13
4.5|33    |       9.9       \

CBC: WBC 2.2. Hgb: 10, HCT 30, PLT 146

Additional labs pending.
 
Pertinent Results:
___ 01:00PM BLOOD WBC-2.2* RBC-3.02* Hgb-10.0* Hct-30.0* 
MCV-99* MCH-33.0* MCHC-33.2 RDW-15.2 Plt ___
___ 06:15AM BLOOD WBC-1.5* RBC-2.47* Hgb-8.1* Hct-24.0* 
MCV-99* MCH-32.7* MCHC-32.9 RDW-15.4 Plt Ct-83*
___ 05:10AM BLOOD ___ PTT-40.8* ___
___ 06:15AM BLOOD Glucose-119* UreaN-43* Creat-6.7*# Na-140 
K-4.1 Cl-101 HCO3-32 AnGap-11
___ 06:15AM BLOOD Calcium-9.0 Phos-4.3 Mg-2.3
___ 06:15AM BLOOD tacroFK-6.9
___ 04:55PM BLOOD HIV Ab-NEGATIVE
___ 04:55PM BLOOD HBsAg-NEGATIVE HBsAb-POSITIVE 
HBcAb-NEGATIVE
 
Brief Hospital Course:
On ___, he underwent renal transplant from a HCV positive 
donor (recipient's HCV VL was 1,100,000 cop/ml on ___ 
right iliac fossa with neo ureterocystostomy over a ___ 
double-J stent with JP drain placed. Small amounts of urine were 
made immediately. Surgeon was Dr. ___. A peritoneal 
tear occurred during mobilization of the peritoneum during 
vascular exposure. Per report the kidney was decapsulated. A old 
stent was also removed from left forearm. Please refer to 
operative note for details. Postop, vital signs.   

Urine output was scant. IV hydration was given. Creatinine 
remained elevated. On postop day 1, potassium was elevated to 
7.0. He experienced delayed renal graft function (DGF). 
Hemodialysis was performed via the tunnelled right IJ line. 
Urine output was scant averaging 32-0cc/day. IV fluid was 
stopped and hemodialysis continued with last treatment on ___ 
for 2300ml. Weight was 75.5kg on ___.  

He was given a total of 4 doses of ATG, Cellcept and tapering 
doses of steroids per protocol until off (last dose ___. 
Prograf was started on postop day 0. Trough levels were low 
(goal 10)and dose was up titrated to 10mg bid on ___. 

Labs were notable for hct that trended down daily to 24 on 
___. Epogen was planned for dialysis days. 

He was tolerating a regular diet, ambulating independently 
(steady on feet)and RLQ incision was clean, dry and intact with 
staples. The JP drain output was high initially (720ml/day)and 
thus the drain remained in place. Output decreased to 115 ml by 
postop day 5. JP drain fluid was serosanguinous and creatinine 
of this fluid was 6.8 ruling out a urine leak (similar to 
serum). He did have a small amount of scrotal edema and was 
instructed to elevate scrotum on a towel. 

Left forearm incision was intact with staples without 
redness/drainage. 

He was discharged back to prison. 

 
Medications on Admission:
Medications - Prescription
ALLOPURINOL -  (Prescribed by Other Provider) - 100 mg Tablet - 
1
Tablet(s) by mouth once a day
AMITRIPTYLINE -  (Prescribed by Other Provider) - 25 mg Tablet -
1 Tablet(s) by mouth twice a day
B COMPLEX-VITAMIN C-FOLIC ACID [DIALYVITE] -  (Prescribed by
Other Provider) - 1 mg-100 mg Tablet - 1 Tablet(s) by mouth once
a day
DOXERCALCIFEROL [HECTOROL] -  (Prescribed by Other Provider; 
Dose
adjustment - no new Rx) - 2.5 mcg Capsule - 1 Capsule(s) by 
mouth
TIW
EPOETIN ALFA [EPOGEN] -  (Prescribed by Other Provider) - 10,000
unit/mL Solution - at HD at HD
HYDRALAZINE -  (Prescribed by Other Provider) - 25 mg Tablet - 1
Tablet(s) by mouth four times a day
LISINOPRIL -  (Prescribed by Other Provider) - 40 mg Tablet - 1
Tablet(s) by mouth once a day
METOPROLOL TARTRATE -  (Prescribed by Other Provider) - 50 mg
Tablet - 2 Tablet(s) by mouth twice a day
MORPHINE -  (Prescribed by Other Provider) - 30 mg Tablet - 1
Tablet(s) by mouth twice a day
ROPINIROLE -  (Prescribed by Other Provider) - 1 mg Tablet - ___ tabs Tablet(s) by mouth hs
SEVELAMER CARBONATE [RENVELA] -  (Prescribed by Other Provider;
Dose adjustment - no new Rx) - 800 mg Tablet - 3 Tablet(s) by
mouth four times a day
TRIAMCINOLONE ACETONIDE -  (Prescribed by Other Provider) - 0.1 
%
Cream - as di twice a day
 
Medications - OTC
DIPHENHYDRAMINE HCL -  (Prescribed by Other Provider) - 25 mg
Capsule - 2 Capsule(s) by mouth prn tid itch
DOCUSATE SODIUM -  (Prescribed by Other Provider) - 100 mg
Capsule - 1 Capsule(s) by mouth twice a day

 
Discharge Medications:
1. sulfamethoxazole-trimethoprim 400-80 mg Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
2. nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID 
(4 times a day).  
3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
4. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours) as needed for Pain.  
5. mycophenolate mofetil 500 mg Tablet Sig: Two (2) Tablet PO 
BID (2 times a day).  
6. famotidine 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
7. allopurinol ___ mg Tablet Sig: One (1) Tablet PO EVERY OTHER 
DAY (Every Other Day).  
8. tacrolimus 5 mg Capsule Sig: Two (2) Capsule PO Q12H (every 
12 hours).  
9. amitriptyline 50 mg Tablet Sig: One (1) Tablet PO HS.  
10. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap 
PO DAILY (Daily).  
11. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day): hold if sbp <110 or HR <60.  
12. zolpidem 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). 
 
13. valganciclovir 450 mg Tablet Sig: One (1) Tablet PO 2X/WEEK 
(___).  
14. ropinirole 1 mg Tablet Sig: One (1) Tablet PO QPM (once a 
day (in the evening)).  
15. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO Q12H (every 12 hours).  
16. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 
hours) as needed for pain.  
17. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO 
TID W/MEALS (3 TIMES A DAY WITH MEALS).  
18. Outpatient Lab Work
Every ___ and ___ for cbc, chem 10, UA, ast, t.bili and 
trough prograf level with results fax'd to ___ Transplant, 
___ RN ___
19. Outpatient Lab Work
Labs ___ for cbc, chem 10, ast, t.bili, ua and 
trough prograf. Process stat fax to ___ Transplant, ___ RN 
coordinator

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
esrd
L forearm AVF stent

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You will continue on dialysis until kidney function improves
-blood will be drawn for lab monitoring twice weekly
-you may shower as long as you keep the tunnelled line clean and 
dry
-empty and record abdominal JP drain output. bring record of 
drain outputs to next outpatient follow up appointment
-
 
Followup Instructions:
___
"
16,10497294,28509541," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Hyperkalemia
 
Major Surgical or Invasive Procedure:
___: Ureteral Stent removal

 
History of Present Illness:
___ PKD-ESRD HCV+ s/p cadaveric kidney transplant from high risk 
donor ___ has been off HD for ~ 2 wks now with 
hyperkalemia. Patient had routine labs today which demonstrated 
a potassium of 6.8 (per report, no labs are with the patient).  
He was sent to the ED.  EKG demonstrated peak T waves in the 
anterior leads.  He was treated medically with calcium, insulin 
and kayexelate.  Nephrology and transplant were consulted.  
Patient reports making ___ cc of urine a day.  He remained on 
HD after his transplant but reports being off HD for ~ 2 weeks 
now.  He still has a tunneled HD line.  He is otherwise 
asymptomatic.  Denies chest pain, SOB, fevers, chills, nausea,
emesis, diarrhea, constipation.  Denies burning with urination.

 
Past Medical History:
ESRD (dialysis since ___, (PD ___ complicated by 
recurrent peritonitis, failed LUE AV fistula ___ now s/p 
kidney transplant ___ 
Polycystic kidney disease s/p right nephrectomy ___ 
Hypertension ___ years 
Hepatitis C dx ___ s/p failed interferon treatment ___ 

L5-S1 discitis, osteomyelitis, epidural abscess ___ 
enterococcus bacteremia, treated with 10 days of 
ampicillin/gentamycin 
Endocarditis (___) 
Hyperparathyroidism, s/p subtotal parathyroidectomy ___, 
revision ___ s/p thyroid lobectomy 
Gout (questionable diagnosis but on treatment) 
Carotid stenosis 
Restless leg syndrome 
Depression 
Chronic pain syndrome 

 
Social History:
___
Family History:
Mother - diagnosed with DM in her ___
Father - died of drugs and alcohol and pancreatic cancer at ___
3 of 4 or ___ healthy brother
2 children (estranged) - ___nd healthy ___ yo
 
Physical Exam:
VS: afvss
Gen: NAD, AOx3
___: RRR
Pulm: no disress
Abd: S/NT/ND Incision healing well, no drainage, erythema or
fluctuance.  
___: no LLE
Chest: R chest with tunneled HD line, site clean no erythema or
fluctuance

 
Pertinent Results:
On Admission: ___
WBC-3.4*# RBC-3.21*# Hgb-10.0*# Hct-32.1*# MCV-100* MCH-31.2 
MCHC-31.2 RDW-15.7* Plt ___ PTT-34.6 ___
Glucose-105* UreaN-41* Creat-3.7*# Na-135 K-6.5* Cl-111* 
HCO3-17* AnGap-14
Calcium-11.3* Phos-1.7*# Mg-2.0
At Discharge: ___ 
WBC-3.2* RBC-3.28* Hgb-10.2* Hct-32.5* MCV-99* MCH-31.2 
MCHC-31.5 RDW-15.8* Plt ___
Glucose-112* UreaN-33* Creat-3.5* Na-141 K-5.4* Cl-108 HCO3-26 
AnGap-12
Calcium-10.6* Phos-3.5 Mg-2.2
.
Cholesterol and Triglycerides pending at discharge
 
Brief Hospital Course:
___ y/o male s/p kidney transplant on ___ with delayed graft 
function, off HD for 2 weeks who now presents through the ED 
from ___ with hyperkalemia. 
The patient underwent transplant kidney ultrasound, findings 
were normal vascular waveforms and resistive indices, no 
hydronephrosis.
He was treated medically with insulin, dextrose, bicarb, 
calcium, and also received kayexalate for the admission 
potassium. EKG done on admission showed peaked T waves.
He was placed on telemetry and transferred to the surgical 
floor.
Repeat potassium was 5.2
Nephrology was consulted who recommended discontinuing Bactrim
The following day the potassium was again 6.5. This was 
medically treated, and patient received further doses of 
Kayexalate.
On ___, the urology service came by to d/c the ureteral stent 
placed at time of kidney transplant.
Due to continued hyperkalemia, the patient will be converted to 
Sirolimus (Rapamycin) as Prograf can cause hyperkalemia. The 
patient will be discharged on both agents, follow up potassium 
tomorrow, and full labs with trough Prograf and sirolimus levels 
on ___.
Patient received pentamidine inhalation on ___

 
Medications on Admission:
Tacro 8'' (per pt), MMF 250'',  Allopurinol ___ mg',
amitriptyline 50 mg qhs, metoprolol 25 mg'', morphine SR 30 

 
Discharge Medications:
1. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed for pain.  
2. allopurinol ___ mg Tablet Sig: One (1) Tablet PO EVERY OTHER 
DAY (Every Other Day).  
3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day) as needed for constipation.  
4. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO Q12H (every 12 hours).  
5. ropinirole 1 mg Tablet Sig: One (1) Tablet PO QPM (once a day 
(in the evening)).  
6. valganciclovir 450 mg Tablet Sig: One (1) Tablet PO 2X/WEEK 
(___).  
7. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
8. mycophenolate mofetil 250 mg Capsule Sig: One (1) Capsule PO 
BID (2 times a day).  
9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO BID (2 times a day).  
10. tacrolimus 1 mg Capsule Sig: Four (4) Capsule PO twice a 
day.  
11. sodium polystyrene sulfonate 15 g/60 mL Suspension Sig: 
Thirty (30) grams PO As directed as needed for hyperkalemia.  
12. pentamidine 300 mg Recon Soln Sig: Three Hundred (300) mg 
Inhalation once a month: Monthly Inhalation. First dose ___.  
13. sirolimus 1 mg Tablet Sig: Six (6) Tablet PO DAILY (Daily): 
First dose given ___.  
14. Lasix 20 mg Tablet Sig: ___ Tablet PO once a day.  
15. Neupogen 300 mcg/0.5 mL Syringe Sig: One (1) dose Injection 
As directed as needed for neutropenia: As needed for 
neutropenia.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Hyperkalemia
s/p kidney transplant with delayed graft function

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent. 

 
Discharge Instructions:
Please call the transplant clinic at ___ for fever > 
101, chills, nausea, vomiting, diarrhea, constipation, decreased 
urine output, dysuria, hematuria, pain over kidney graft, easy 
bruising, inability to tolerate food fluids or medications, 
increased cough or sputum production
.
Patient being converted off prograf and starting Sirolimus 
(Rapamycin) as prograf can cause hyperkalemia. Additionally, 
Bactrim is being held and he will start pentamadine inhalation 
treatments for PCP ___.
Please have neupogen available as Sirolimus may cause 
pancytopenia, and he has already been neutropenic.
The patient should avoid lifting greater than 10 pounds
The dialysis catheter will remain in place, and need will be 
re-assessed at next transplant kidney appointment due to history 
of delayed graft function in the new kidney transplant.
.
Labs are recommended as follows:
___ Potassium only
___ Full labs to include chem 10, AST,  t bili, CBC, 
Trough Prograf, Trough Sirolimus (___), urinalysis.
Please fax results to Transplant clinic at ___
.
Patient may take kayexalate PRN for hyperkalemia
He should avoid potassium containing foods to include, potatoes, 
tomatoes (and sauce), orange juice, citrus, bananas, dark green 
vegetables (broccoli, kale, spinach) nuts and chocolate. Dietary 
restrictions will be reassessed once hyperkalemia is resolved.
.
Start on 10 mg lasix PO daily
.
Patient has received first Pentamadine treatment on ___, this 
should be given as inhalation once monthly and Bactrim has been 
d/c'd. This may be re-evaluated once ___ conversion is complete 
and if hyperkalemia resolves.
.
Ureteral stent has been removed from time of kidney transplant
 
Followup Instructions:
___
"
17,10497294,27372636," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___
 
Chief Complaint:
elective admission for antibody mediated tranplanted kidney 
rejection
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Mr. ___ is a ___ black man with HCV genotype 1a (no 
cirrhosis per ___ fibroscan score of 5.6), hypertention s/p 
kidney transplant for polycystic kidney disease ___ (on 
sirolimus and mycophenolate, baseline Cr 1.5-1.7) who is 
admitted from his ___ for 
treatment of antibody mediated humoral chronic kidney rejection.
.
He received a standard criteria donor kidney transplant from a 
CDC high risk donor on ___.  He had delayed graft function 
initially but subsequently has had reasonable renal allograft 
function. However patient was noted to have rising cr from 1.5 
in ___ to 1.9 in ___.  For evalaluation he underwent 
kidney biopsy ___, showing antibody mediated chronic rejection. 
Patient is on Sirolimus, Celcept as immunosupressive. He reports 
being very compliant with all his medications.
.
He denies any symptoms. He denies any fevers, chills, night 
sweats, back pain, dysuria, hematuria.  He reports keeping good 
po intake and had been drinking normally.  
 
Past Medical History:
- Hepatitis C virus, genotype 1a, viral load 700,000 
international
units per mL. No cirrohisis per ___ fibroscan score of 5.6  
He attempted.  s/p Peginterferon monotherapy ___ with no 
response. He has never experienced complications of liver 
disease including
jaundice, encephalopathy, ascites, and portal hypertensive
bleeding.
- Polycystic kidney disease status post kidney transplant in
___. Received a standard criteria donor kidney 
transplant from a CDC high risk donor on ___.  He had 
delayed graft function initially but subsequently has had 
reasonable renal allograft function.
- Hx of Recurrent peritonitis while he was on peritoneal 
dialysis
- Osteomyelitis, ___
- Epidural abscess ___.  
- Endocarditis ___.
- Hypertention
- Hyperparathyroidism status post subtotal parathyroidectomy
revision ___, thyroid lobectomy.
- Gout.
- Carotid stenosis.
- Restless legs syndrome.
- Depression.
- Chronic pain syndrome.
 
Social History:
___
Family History:
Mother - diagnosed with DM in her ___
Father - died of drugs and alcohol and pancreatic cancer at ___
3 of 4 or ___ healthy brother
2 children (estranged) - ___nd healthy ___ yo
 
Physical Exam:
Admission Physical Exam:
Vitals: 97.7  158/92  89  100%RA
GENERAL: Appears well, no acute distress, lying in bed 
comfortably  
HEENT: Sclera an-icteric. MMM 
NECK: Supple with low JVP  
CARDIAC: RRR, S1 S2 clear and of good quality without murmurs, 
rubs or gallops. No S3 or S4 appreciated.  
LUNGS: Resp were unlabored, no accessory muscle use, moving air 
well and symmetrically. CTAB, no crackles, wheezes or rhonchi.  
ABDOMEN: +Bs, soft nontender, non-distended 
EXTREMITIES: Warm and well perfused, No edema. 
.
Discharge Physical Exam:
Vitals: 98.2  139/56  96  98%RA
GENERAL: appears well, NAD  
HEENT: non-icteric. MMM, OP clear
NECK: Supple, no JVD
CARDIAC: RRR, no m/r/g
LUNGS: CTAB
ABDOMEN: +BS, soft, non-tender, non-distended
EXTREMITIES: WWP, No edema.   
NEURO: alert and oriented x3.  No focal findings. 

 
Pertinent Results:
Pertinent Labs:
___ 01:10PM BLOOD WBC-2.6* RBC-5.29 Hgb-15.6 Hct-46.6 
MCV-88 MCH-29.4 MCHC-33.5 RDW-14.1 Plt ___
___ 07:10AM BLOOD WBC-4.9# RBC-5.43 Hgb-16.3 Hct-48.1 
MCV-89 MCH-30.0 MCHC-33.9 RDW-13.9 Plt ___
___ 07:50AM BLOOD WBC-6.9 RBC-4.95 Hgb-14.5 Hct-43.6 MCV-88 
MCH-29.3 MCHC-33.3 RDW-13.8 Plt ___
___ 01:10PM BLOOD Neuts-79* Bands-0 Lymphs-11* Monos-8 
Eos-2 Baso-0 ___ Myelos-0
___ 01:10PM BLOOD ___ PTT-38.1* ___
___ 01:10PM BLOOD CD19%-20.5 CD19Abs-59 CD20%-19.6 
CD20Abs-56
___ 01:10PM BLOOD Glucose-73 UreaN-20 Creat-2.1* Na-136 
K-5.5* Cl-102 HCO3-25 AnGap-15
___ 01:10PM BLOOD ALT-34 AST-36 AlkPhos-183* TotBili-0.5
___ 01:10PM BLOOD Albumin-4.6 Calcium-9.6 Phos-2.7 Mg-1.7
___ 06:20AM BLOOD TSH-0.12*
___ 12:50PM BLOOD PTH-187*
___ 07:50AM BLOOD rapmycn-13.3
___ 06:20AM BLOOD tacroFK-5.1
___ 07:50AM BLOOD tacroFK-4.2*
.
___ 1:10 pm IMMUNOLOGY
                            **FINAL REPORT ___

   HCV VIRAL LOAD (Final ___: 
      8,854,733 IU/mL. 
.
Discharge Labs:
___ 06:00AM BLOOD WBC-6.1 RBC-4.94 Hgb-14.4 Hct-43.4 MCV-88 
MCH-29.1 MCHC-33.1 RDW-14.1 Plt ___
___ 01:00PM BLOOD ___ PTT-150* ___
___ 03:12PM BLOOD ___ PTT-135.2* ___
___ 06:10AM BLOOD ___ PTT-68.4* ___
___ 03:12PM BLOOD Thrombn-150*
___ 06:10AM BLOOD Glucose-107* UreaN-35* Creat-1.7* Na-134 
K-4.4 Cl-104 HCO3-23 AnGap-___ black man with HCV genotype 1a (no cirrhosis per 
___ fibroscan score of 5.6), hypertension, s/p kidney 
transplant for polycystic kidney disease ___ who was 
admitted from ___ for subacute renal 
failure thought to be secondary to antibody mediated humoral 
chronic kidney rejection. 
.
# Subacute Ab-mediated Allograft kidney Rejection: Patient had 
received a standard criteria donor kidney transplant from a ___ 
high risk donor on ___.  Given rising Cr he had renal 
biopsy on ___ which based on staining showed antibody 
mediated allograft chronic kidney rejection. On admission his 
sirolimus was replaced with tacrolimus and he was given three 
days of pulse steroids with IV solumederol and IVIg and was 
subsequently started on prednisone 20mg daily. His Cr was noted 
to be around 1.7 on discharge.  His Tacro level. Patient was 
started on pepsid for GI prophylaxis and continued on Bactrim SS 
for PCP ___. He will f/u with his nephrologist who will 
decide on further treatment with Rituximab. Patient needs 
biweekly tacro levels checked with results faxed to Dr. 
___ to adjust his tacrolimus dose. 
.
# Elevated PTT: One day prior to discharge patient's PTT was 
elevated >150 with elevated thrombin time suggesting presence of 
heparin as the cause.  His SC heparin was discontinued and his 
PTT down trending toward normal level.  He should have repeat 
Coag tested as outpatient to document normalization of his PTT.
.
# Flu Prophylaxis: Patient was discharged on tamiflu prophylaxis 
given flu outbreak at ___ facility.  Tamiflu 
may be discontinued when flu outbreak resolves.  
.
# Hyperkalemia: On admission he was found to have hyperkalemia 
likely secondary to subacute renal failure. Hyperkalemia 
resolved after starting patient on low potassium diet. 
.
# Hypercalcemia, hypophosphatemia, elevated PTH: likely 
tertiary. Ca and Phos were normal 
.
# Hepatitis C: No cirrhosis per ___ fibroscan score of 5.6. 
LFTs at baseline.  HCV viral load of 8.8 millions.
.
# Hypertension: Blood pressure was stable. Lisinopril was held 
in the setting of renal failure and hyperkalemia.  He should be 
restarted on lisinopril or other agent once his recover from his 
subacute kidney injury. 
. 
# Osteoporosis. His last bone densitometry on ___ showed 
osteoporosis and hence is on alendronate. He is on cinacalcet 
and vitamin D supplement. He was continued on weekly alendronate 
, vitamin D and cinacalcet
.
# Dyslipidemia:  His last LDL was 152 on ___.  Not on any 
meds.
.
# Mechanical Fall: Patient had mechanical fall with blunt trauma 
to his back on ___. Plain films of his spine were not 
remarkable for any acute traumatic findings. There was no focal 
neurologic signs on exam. His pain was treated with PRN 
acetaminophen and oxycodone in addition to his home dose of MS 
___. He was discharged on his MS ___. 
.
# Chronic Pain: Chronic shoulder pain. He was continued on his 
usual dose of MS ___.
.
Transitions of Care:
- Please have patient follow up with outpatient nephrologist. 
- Please check Bi-weekly tacro levels.
- Please recheck patient's coagulation test: PTT 
- Patient should continue tamiflu prophylaxis until resolution 
of flu outbreak your facility 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Alendronate Sodium 35 mg PO QSUN 
2. Amitriptyline 100 mg PO HS 
3. Cinacalcet 30 mg PO DAILY 
4. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
5. Lisinopril 5 mg PO DAILY 
6. Morphine SR (MS ___ 10 mg PO Q12H 
7. Mycophenolate Mofetil 500 mg PO BID 
8. Sirolimus 4 mg PO DAILY 
Daily dose to be administered at 6am 
9. Sodium Bicarbonate 1300 mg PO BID 
10. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 

 
Discharge Medications:
1. Alendronate Sodium 35 mg PO QSUN 
2. Amitriptyline 100 mg PO HS 
3. Cinacalcet 30 mg PO DAILY 
4. Morphine SR (MS ___ 10 mg PO Q12H 
5. Mycophenolate Mofetil 1000 mg PO BID 
6. Sodium Bicarbonate 1300 mg PO BID 
7. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
8. Famotidine 20 mg PO Q24H 
9. PredniSONE 20 mg PO DAILY 
10. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
11. Oseltamivir 75 mg PO Q24H 
untill instructed otherwise by the transplant team.  
12. Tacrolimus 5 mg PO Q12H 
13. Outpatient Lab Work
Please check Tacro levels every ___ and ___ and page 
results to outpatient Nephrologist, Dr. ___. 
___

 
14. Insulin SC 
      Sliding Scale

Fingerstick QACHS
Insulin SC Sliding Scale using HUM Insulin

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
1. Antibody mediated humoral chronic kidney rejection
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___, you were noted to have chronic rejection on 
your recent kidney biopsy therefore you were admitted to receive 
treatment with steriods and other immunosuppressive medcaitions. 
You kidney function remained stable.  During your stay here you 
slipped and fell in the bathroom and had some increase in your 
back pain afterwards for which you were given pain medicine. 
X-ray of your spine did not show and spinal damage from the 
fall. You will be schduled a follow up appointment with you 
nephrologist for further treatment.  
 
Followup Instructions:
___
"
18,10497294,26922382," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___
 
Chief Complaint:
Hyponatremia

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
 Mr. ___ is a ___ y/o M with PMH of APCKD s/p CDC high risk 
donor transplant on ___ who presents from ___ with 
hyponatremia. 

The patient was in his USOH and underwent routine laboratory 
testing ___ that showed a Cr elevation from a baseline 
~1.8 to 2.2. The patient was thought to be dry and was 
instructed to increase his PO ydration.  However, the patient 
states that he tries to have a daily fluid intake of 2.5 gallons 
of water/day and this has not changed recently. He returned for 
repeat lab work on ___ and had an impoved Cr to 1.8 but sodium 
of 122. On the day of admission, the patient had repeat labs and 
was found to have a sodium of 121. No MS changes but c/o leg 
cramps. Cr above baseline at 2.1. Decision made to send to ___ 
for management of hyponatremia. 

Notably, on ___, the patient started a religiuos fast.  He 
states that prior to ___, the patient ate 3 regular 
meals/day.  Starting on ___, he started a religious fast. 
He continued to take his medications and drink fluids, but was 
only eating 1 small meal/day of salad.

On arrival to ___, the patient appears well. Has no acute 
complaints. 
  
ROS: (+) as per HPI. A 12-point ROS is otherwise negative. 
  

 
Past Medical History:
- Hepatitis C virus, genotype 1a, viral load 700,000 
international
units per mL. No cirrohisis per ___ fibroscan score of 5.6  
He attempted.  s/p Peginterferon monotherapy ___ with no 
response. He has never experienced complications of liver 
disease including
jaundice, encephalopathy, ascites, and portal hypertensive
bleeding.
- Polycystic kidney disease status post kidney transplant in
___. Received a standard criteria donor kidney 
transplant from a CDC high risk donor on ___.  He had 
delayed graft function initially but subsequently has had 
reasonable renal allograft function.
- Hx of Recurrent peritonitis while he was on peritoneal 
dialysis
- Osteomyelitis, ___
- Epidural abscess ___.  
- Endocarditis ___.
- Hypertention
- Hyperparathyroidism status post subtotal parathyroidectomy
revision ___, thyroid lobectomy.
- Gout.
- Carotid stenosis.
- Restless legs syndrome.
- Depression.
- Chronic pain syndrome.
 
Social History:
___
Family History:
Mother: deceased in her ___, had T2DM
Father: deceased at age ___ from pancreatic cancer. Suffered from 
alcohol and drug abuse
Sisters: ___ sisters have T2DM
Brother: healthy

 
Physical ___:
On Admission:
VS:  t: 97.9 bp: 145/92 hr: 79 rr: 18 100% on RA
General: Appears well, in NAD
HEENT: PERRLA, EOMI, anicteric 
Neck: Supple, no JVD  
CV: RRR, S1 and S2, no m/r/g 
Lungs: CTAB
Abdomen: Soft, NT/ND
GU: No foley
Ext: No edema
Neuro: CN II-XII grossly intact, moving all extremities, alert 
and oriented x 3.

On Discharge:
Vitals: t 98.8 bp 118/62 hr 90 rr 18 100% on RA
BG 123
General: Appears well, in NAD
HEENT: anicteric 
Neck: Supple
CV: RRR, S1 and S2, no m/r/g 
Lungs: CTAB
Abdomen: Soft, NT/ND
GU: No foley
Ext: No edema
Neuro: AAOx3
 
Pertinent Results:
On Admission:
___ 05:50AM BLOOD WBC-2.4*# RBC-4.36* Hgb-14.0# Hct-40.6# 
MCV-93 MCH-32.0 MCHC-34.4 RDW-13.6 Plt ___
___ 04:05PM BLOOD Neuts-44.2* Lymphs-14.6* Monos-40.1* 
Eos-0.5 Baso-0.6
___ 05:50AM BLOOD ___ PTT-35.6 ___
___ 05:50AM BLOOD Glucose-105* UreaN-27* Creat-2.2* Na-124* 
K-5.4* Cl-93* HCO3-25 AnGap-11
___ 05:50AM BLOOD Calcium-9.7 Phos-4.3# Mg-1.3*
___ 05:50AM BLOOD Osmolal-273*
___ 05:50AM BLOOD tacroFK-7.6

On Discharge:
___ 07:31AM BLOOD WBC-4.7# RBC-4.36* Hgb-13.8* Hct-41.4 
MCV-95 MCH-31.6 MCHC-33.3 RDW-13.7 Plt ___
___ 07:31AM BLOOD Glucose-102* UreaN-24* Creat-2.1* Na-133 
K-5.4* Cl-99 HCO3-28 AnGap-11
 
Brief Hospital Course:
Mr. ___ is a ___ year-old man with PMH of APCKD s/p CDC high 
risk donor transplant on ___ who presented from ___ with 
hyponatremia. 

#. Hyponatremia - The patient presented with a sodium of 121. 
This was thought to be related to decreased PO intake recently 
as he has been on a religious fast. Also had been drinking more 
when told to increase hydration for better kidney perfusion (see 
below). Exercises vigorously daily and likely loses salt in that 
setting. The patient's sodium improved while here with simple PO 
intake encouragement. Never had MS changes. Sodium was 133 on 
day of dsicharge. 

#. Renal txpt, AOCKD - The patient's Cr has been elevated since 
___ to 2.2 from a baseline ~1.8. No clear etiology and this 
remained stable while here. He was continued on all 
immunosupressives and taro level was at goal between ___. 
Urinalysis was unremarkable as was a renal ultrasound. Further 
follow-up as an outpatient is warranted. Continued on bactrim 
PPx. 

#. Hyperkalemia - The patient's potassium was elevated in house. 
Never had ECG changes. Switched to a low-K diet and Ace-I 
stopped. Potassium was 5.4 on day of discharge. 

#. Leukopenia - The patient had a mild leukopenia in house. 
Unclear etiology and resolved on its own prior to discharge. Was 
on azithro when admitted for a possible sinus infection, however 
had no infectious symptoms in-house and this was stopped. 

#. HTN - Lisinopril was held due to ___ and hyperkalemia. The 
patient remained normotensive in-house.

#. Osteoporosis - Continued home medications. 

TRANSITIONAL ISSUES:
- Please check chemistry panel and CBC this week. Fax results to 
___ Att: Dr. ___ ___
- Patient to follow-up with Dr. ___ on ___
- Ensure patient is eating three meals daily and staying well 
hydrated. Low potassium diet.
- Monitor BP. ___ need an alternative agent added if becomes 
increasingly hypertensive. Lisinopril was stopped in-house. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Alendronate Sodium 35 mg PO QSUN 
2. Amitriptyline 100 mg PO HS 
3. Cinacalcet 30 mg PO DAILY 
4. Morphine SR (MS ___ 10 mg PO Q12H 
5. Mycophenolate Mofetil 1000 mg PO BID 
6. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
7. Lisinopril 10 mg PO DAILY 
8. PredniSONE 5 mg PO DAILY 
9. Ranitidine 150 mg PO BID 
10. Sodium Bicarbonate 1300 mg PO BID 
11. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
12. Tacrolimus 3 mg PO Q12H 
13. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1. Alendronate Sodium 35 mg PO QSUN 
2. Mycophenolate Mofetil 1000 mg PO BID 
3. Amitriptyline 100 mg PO HS 
4. Cinacalcet 30 mg PO DAILY 
5. Morphine SR (MS ___ 10 mg PO Q12H 
6. Multivitamins 1 TAB PO DAILY 
7. PredniSONE 5 mg PO DAILY 
8. Ranitidine 150 mg PO BID 
9. Sodium Bicarbonate 1300 mg PO BID 
10. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
11. Tacrolimus 3 mg PO Q12H 
12. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
13. Outpatient Lab Work
Please have labs including chemistry and CBC check this coming 
___. Results should be faxed to the ___ transplant 
center Att: Dr. ___ ___.

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Primary: Hyponatremia, Malnourishment

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a pleasure taking care of you at ___!

You were admitted due to a low sodium level. This has since 
improved with eating and drinking. We believe that the low 
sodium was related to a lower food intake during your recent 
fast.

Please continue to eat regular meals and stay hydrated. 
 
Followup Instructions:
___
"
19,10497294,26090777," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___
 
Chief Complaint:
abdominal pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ year old man with history of hepatitis C (treated), hx of 
endocarditis and vertebral osteomyelitis, hypertension, 
polycystic kidney disease, s/p SCD renal transplant in ___, 
complicated by subacute antibody-mediated rejection in ___, 
with progressive CKD of his allograft, presenting with acute 
onset
abdominal pain, ___. 

Pain began last night after eating dinner, sudden onset, 
initially periumbilical later migrating to the lower right 
quadrant and right flank. States that the pain is ""right in the 
transplanted kidney."" Pain is now constant, cramping/aching. 
Induced vomiting several times to help relieve discomfort, but 
did not help. NBNB emesis, no hematochezia/melanotic stool. Pain 
worse with movement; he has not eaten since last night before 
the pain began.  Has never had this pain before, had eaten 
earlier that night w/ no pain. No hematuria, dysuria. +bilateral 
___ swelling. Denies f/c, CP, SOB. No missed doses of medicine.  

In the ED, initial VS were: 99.2 108 132/82 100% RA. HRs 
improved to ___. sBPs variable, but mostly in 110-130s (some 
values in 160-180s). Other vitals remained stable.
 
Exam notable for:   On exam, has enlarged and tender RLQ renal 
allograft, also tender in periumbilical area. 1+ b/l pitting 
edema. Lungs clear. Tachycardic. RUE brachiocephalic fistula 
without flow. systolic murmur LUS/LLSB

Labs showed: Cr 3.1 -> 3.2. K 5.4, repeat 5.6. Mg 1.1, improved 
to 1.6 w/ IV mag. Phos 1.7. LFTs and coags unremarkable. Lactate 
normal, flu negative.  UA with blood and proteinuria.

Imaging showed:  
CT A/P W/O contrast 
Nonspecific perinephric stranding surrounding the transplant 
kidney. No perinephric abscess or hydronephrosis. Nonspecific 
stranding around the third portion of the duodenum without wall 
thickening. Mild duodenitis is possible in appropriate clinical 
setting. No additional acute process within the abdomen or
pelvis.

RENAL TRANSPLANT U/S
No hydronephrosis or perinephric fluid collection. Elevated 
resistive indices compared to prior studies. Whether there is 
true diastolic flow within the intrarenal arteries or artifacts 
with possible loss of diastolic flow is difficult to discern. 
Close follow-up with repeat ultrasound is recommended.

Consults:  renal transplant recommended CT abdomen and 
transplant surgery c/s. continue immunosuppression meds, hold 
Bactrim for hyperK. Transplant surg found no indication for 
surgery. 

Patient received: 
___ 13:14 PO Acetaminophen 1000 mg   
___ 14:01 SC Morphine Sulfate 4 mg  
___ 15:13 IV Magnesium Sulfate  
___ 16:10 IV HYDROmorphone (Dilaudid) .5 mg x2   
___ 18:54 PO/NG PredniSONE 5 mg 
___ 18:54 PO/NG Labetalol 200 mg 
___ 20:16 PO Tacrolimus 2.5 mg  
___ 20:16 PO Mycophenolate Sodium ___ 360 mg 
___ 20:37 PO/NG Amitriptyline 75 mg 
___ 22:40 PO/NG Magnesium Oxide 400 mg  
___ 00:27 PO/NG Phosphorus 500 mg
___ 00:27 PO/NG OxyCODONE (Immediate Release) 5 mg 
  
On arrival to the floor, patient reports ongoing abdominal pain 
in same location, no further n/v. Just started having loose 
stools tonight.  
 
REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as
per HPI  

 
Past Medical History:
ESRD due to polycystic kidney disease, on HD ___ to ___ s/p
SCD renal transplant ___
Hypertension
GERD
Hepatitis C, treated with interferon monotherapy then Harvoni
post-transplant
Osteomyelitis, ___ 
Epidural abscess ___.  
Endocarditis ___. 
Hypertention 
Hyperparathyroidism status post subtotal parathyroidectomy 
revision ___, thyroid lobectomy. 
Gout. 
Carotid stenosis. 
Restless legs syndrome. 
Depression. 
 

 
Social History:
___
Family History:
Father: ___
Mother: No medical conditions
Sister: CAD
Son: ___
 
Physical Exam:
ADMISSION PHYSICAL EXAM 
=====================
VS: 99.3PO 172 / 86 86 19 95 RA   
GENERAL: NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
MMM  
NECK: supple, no LAD, no JVD  
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: crackles in b/l bases, nonlabored breathing  
ABDOMEN: diffuse TTP, worse in RLQ right over transplant site, 
no
rebound, soft, nondistended. no fluid wave noted. bowel sounds
present.
EXTREMITIES: ___ b/l ___ edema, no cyanosis, warm, well perfused 

PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no
rashes   

DISCHARGE PHYSICAL EXAM 
======================
VS: 98.7 PO 171 / 89 (123-171/70-80s) 74 (60-80s) 18 97 RA 
I/O: 800/175
Wt: 156.7 -> 157.2 
GENERAL: NAD, laying in bed  
HEENT: anicteric sclera, pink conjunctiva, MMM  
NECK: supple, no elevaed JVD  
HEART: RRR, S1/S2, ___ SEM LUSB
LUNGS: nonlabored breathing on RA, CTAB
ABDOMEN: diffusely mildly TTP (R>L), no rebound tenderness, 
soft,
moderately distended, no guarding. BS+.
EXTREMITIES: no edema, no cyanosis, warm, well perfused  
PULSES: 2+ DP pulses bilaterally  
NEURO: alert, interactive, moving all 4 extremities with purpose 

 
 
Pertinent Results:
ADMISSION LABS
==============
___ 12:55PM BLOOD WBC-9.1 RBC-3.72* Hgb-10.5* Hct-34.1* 
MCV-92 MCH-28.2 MCHC-30.8* RDW-13.5 RDWSD-45.3 Plt ___
___ 12:55PM BLOOD Neuts-87.3* Lymphs-4.6* Monos-7.3 
Eos-0.4* Baso-0.0 Im ___ AbsNeut-7.95* AbsLymp-0.42* 
AbsMono-0.67 AbsEos-0.04 AbsBaso-0.00*
___ 12:55PM BLOOD ___ PTT-30.5 ___
___ 12:55PM BLOOD Glucose-91 UreaN-37* Creat-3.1* Na-138 
K-5.4* Cl-107 HCO3-19* AnGap-12
___ 12:55PM BLOOD Albumin-3.3* Calcium-9.0 Phos-1.8* 
Mg-1.1*
___ 12:55PM BLOOD ALT-8 AST-12 AlkPhos-65 TotBili-0.3
___ 12:55PM BLOOD Lipase-28
___ 01:17PM BLOOD Lactate-1.6
___ 12:00PM URINE Color-Straw Appear-Clear Sp ___
___ 12:00PM URINE Blood-TR* Nitrite-NEG Protein-300* 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
___ 12:00PM URINE RBC-1 WBC-1 Bacteri-NONE Yeast-NONE 
Epi-<1
___ 12:00PM URINE CastHy-1*
___ 12:00PM URINE Hours-RANDOM Na-102
___ 12:00PM URINE Osmolal-451
___ 04:43PM OTHER BODY FLUID FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
 
PERTINENT STUDIES
=================
___ 07:00AM BLOOD CRP-81.5*
___ 07:00AM BLOOD CMV VL-NOT DETECT
___ 06:44AM BLOOD Lactate-1.0
___ 11:36AM URINE Color-Straw Appear-Clear Sp ___
___ 11:36AM URINE Blood-NEG Nitrite-NEG Protein-100* 
Glucose-TR* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
___ 11:36AM URINE RBC-1 WBC-1 Bacteri-FEW* Yeast-NONE 
Epi-<1
___ 11:36AM URINE CastHy-1*
___ 09:10PM URINE Hours-RANDOM Creat-51 TotProt-159 
Prot/Cr-3.1*
___ 09:20PM STOOL NoroGI-NEGATIVE NoroGII-NEGATIVE
 
MICRO
=====
___ EHEC: Negative

___ OVA & PARASITES: NEGATIVE  

___ FECAL CULTURE (Final ___:    
   NO SALMONELLA OR SHIGELLA FOUND. 
   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 
   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 
   Cryptosporidium/Giardia (DFA) (Final ___: 
      NO CRYPTOSPORIDIUM OR GIARDIA SEEN. 
   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: 
      No E. coli O157:H7 found. 
___ C. difficile DNA amplification assay (Final ___:  
negative

___ Blood culture: NGTD 

___ U culture: negative

IMAGING
=======
___ RENAL TX U/S
No evidence of hydronephrosis within the right lower quadrant 
transplanted kidney.  Stable elevated resistive indices of the 
intra renal arteries.  Patent main renal artery and main renal 
vein with appropriate waveforms. 
 
___ CT A/P
1. Nonspecific perinephric stranding surrounding the transplant 
kidney.  No perinephric abscess or hydronephrosis. 
2. Nonspecific stranding around the third portion of the 
duodenum without wall thickening.  Mild duodenitis is possible 
in appropriate clinical setting. 
3. No additional acute process within the abdomen or pelvis. 

DISCHARGE LABS
===============
___ 06:40AM BLOOD WBC-4.0 RBC-3.39* Hgb-9.6* Hct-30.4* 
MCV-90 MCH-28.3 MCHC-31.6* RDW-13.3 RDWSD-44.0 Plt ___
___ 06:40AM BLOOD Glucose-96 UreaN-42* Creat-3.2* Na-141 
K-5.1 Cl-107 HCO3-22 AnGap-___ year old man with history of hepatitis C (treated), 
hypertension, polycystic kidney disease, s/p SCD renal 
transplant in ___, complicated by subacute antibody-mediated 
rejection in ___, with progressive CKD of his allograft, 
presenting with
acute onset abdominal pain and ___. 
 
ACTIVE ISSUES 
===========
# Abdominal Pain
# Diarrhea, bloody
Presented with sudden onset diffuse abdominal pain shortly after 
eating dinner. CT scan with duodenitis of unclear significance, 
and mild enlargement of the kidney with perinephric stranding. 
No evidence of obstruction, appendicitis. Ischemic colitis 
considered given bloody stools, but given chronicity of pain 
with repeated normal lactate, was thought less likely. 
Infectious diarrhea is most likely given
immunosuppression with no clear history or symptoms of 
inflammatory diarrhea and reportedly unremarkable recent 
endoscopic evaluation. Stool studies unrevealing and abdominal 
pain/diarrhea improved without intervention, likely etiology 
viral gastroenteritis. He received dilaudid and acetaminophen 
while in house, discharged without opioids. By discharge was 
tolerating regular diet.  Consider GI follow up as an outpatient
 
# ESRD s/p renal transplant:
# Hyperkalemia
He has had prior subacute antibody mediated rejection in ___, 
with DSAs to DQ7 and B18, treated with IVIG, steroids, 
rituximab, and change of immunosuppression from rapamycin to 
tacrolimus. Biopsy in ___ showed more chronic damage. He has 
had moderate proteinuria for some time now, likely due to 
transplant glomerulopathy. He did not have ___ as Cr was near 
recent baselines per transplant database. Renal transplant U/S x 
2 w/ stable elevated resistive indices compared to prior studies
but no fluid collections, hydro with no changes on close follow 
up scan. Renal biopsy was deferred. Discontinued losartan and 
Bactrim given persistent hyperkalemia and started sodium 
bicarbonate 1300mg BID, atovaquone for ppx. 
Discharge Immunosuppression
- tacrolimus 3mg Q12h
- mycophenolate myfortic 360mg PO BID
- prednisone 5mg PO daily
- atovaquone 1500 daily 
 
# HTN: presented with uncontrolled severe asymptomatic 
hypertension, improved with increased labetalol and with 
addition of nifedipine. Discharge regimen labetalol 400mg TID 
and nifedipine ER 30mg QD. Losartan was discontinued 

# Bone/mineral disease: continued home dose cinacalcet 

TRANSITIONAL ISSUES: 
====================
[] MEDICATION CHANGES 
   [ ] STOP: Bactrim, losartan 
   [ ] START: atovaquone, nifedipine, sodium bicarbonate
   [ ] CHANGED: MMF decreased, tacro increased
[] IMMUNOSUPPRESSION REGIMEN
- tacrolimus 3mg Q12h
- mycophenolate myfortic 360mg PO BID
- prednisone 5mg PO daily
- atovaquone 1500 daily 
[] Consider GI follow up as an outpatient
[] Patient should follow up with the renal transplant team 
within 1 month of discharge 
[] ___ need further uptitration of anti-HTN regimen. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amitriptyline 75 mg PO QHS 
2. Aspirin 81 mg PO DAILY 
3. Calcium Carbonate 500 mg PO BID 
4. Cinacalcet 30 mg PO DAILY 
5. Labetalol 200 mg PO BID 
6. Losartan Potassium 100 mg PO DAILY 
7. Magnesium Oxide 400 mg PO DAILY 
8. Mycophenolate Sodium ___ 360 mg PO QID 
9. PredniSONE 5 mg PO DAILY 
10. Ranitidine 150 mg PO BID 
11. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
12. Tacrolimus 2.5 mg PO Q12H 
13. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  
2.  Atovaquone Suspension 1500 mg PO DAILY  
3.  NIFEdipine (Extended Release) 30 mg PO DAILY  
4.  Sodium Bicarbonate 1300 mg PO BID  
5.  Labetalol 400 mg PO TID  
6.  Mycophenolate Sodium ___ 360 mg PO BID  
7.  Ranitidine 150 mg PO DAILY  
8.  Tacrolimus 3 mg PO Q12H  
9.  Amitriptyline 75 mg PO QHS  
10.  Aspirin 81 mg PO DAILY  
11.  Calcium Carbonate 500 mg PO BID  
12.  Cinacalcet 30 mg PO DAILY  
13.  Magnesium Oxide 400 mg PO DAILY  
14.  Multivitamins 1 TAB PO DAILY  
15.  PredniSONE 5 mg PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY
- Abdominal pain
- Diarrhea
- Viral gastroenteritis
- Hypertension

SECONDARY
- S/p kidney transplantation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to the hospital for abdominal pain and 
diarrhea. You had a thorough evaluation including a CT scan and 
stool studies. The stool studies were reassuring. The CT scan 
showed duodenitis (inflammation of your small bowel). The most 
likely cause of your pain and diarrhea was a viral infection of 
you GI system. 

During your hospitalization, you immunosuppression for your 
kidney transplant was adjusted. You were started on a new 
medication called atovaquone to prevent infection, as well as a 
blood pressure medication called nifedipine. Please stop taking 
the Bactrim and losartan. 

Please follow up with your outpatient providers as below.

Wishing you well,

Your ___ Care Team 
 
Followup Instructions:
___
"
20,10497294,29505948," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___
 
Chief Complaint:
Orthopnea, ___
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mr. ___ is a ___ w/ ESRD s/p deceased donor renal
transplant in ___ complicated by chronic allograft dysfunction
(antibody-mediated rejection ___, biopsy-confirmed chronic
transplant glomerulopathy, interstitial fibrosis & tubular
atrophy ___, HTN, GERD, HCV s/p ledipasvir-sofosbuvir, &
hyperparathyroidism s/p sub-total parathyroidectomy ___ who
presents w/ dyspnea on exertion progressing to dyspnea at rest, 
&
orthopnea for 1 week.  

Of note, the patient was recently admitted ___ w/ acute
abdominal pain in the ___ & RLQ region w/ diarrhea,
ultimately thought to be ___ non-specific viral enteritis. 
Importantly on that admission his creatinine was ~3 (baseline). 
He had persistent hyperkalemia throughout that admission
(5.5-6.0) so losartan & TMP-SMX were discontinued & he was
started on sodium bicarbonate.  He also had persistent
hypertension (SBP > 170) so his labetalol was increased &
nifedipine was initiated. 

On this admission, the patient noted increasing SOB since ___. 
He reports that the SOB progressed to SOB at rest & was worst
when lying flat.  He notes no CP, palpitations, or infectious
symptoms.  He states that he has felt like this in the past when
fluid overloaded prior to dialysis sessions. 

In the ED, 

-Initial VS:  
T97.6 HR74 BP 134/68 RR16 O2100% RA 

-Initial exam notable for: 

""PE: NAD, well-appearing, breathing normally
Lungs: dullness to percussion at bases. Mild expiratory wheezes
bilaterally.
Heart: III/VI systolic crescendo-decrescendo murmur at RUSB.
Abdomen: soft, nontender, nondistended, with surgical scars
Extremities: nonpitting edema ___ of the way up the calf
bilaterally""

-Initial labs notable for:

   \ 9.0  /
4.4 ------ 193
   / 28.8 \

137 | 105 | 48  /
---------------- 105
6.1 | 15  | 4.3 \

___

Lactate: 1.4

Troponin: < 0.01

-Initial imaging notable for:  

CXR:
There is mild cardiac enlargement which is new since prior. 
There are small bilateral pleural effusions.  There is pulmonary
vascular congestion without overt edema.  No focal 
consolidation.
No acute osseous abnormalities. 

Renal Transplant US  
1. No hydronephrosis.  
2. Mildly elevated resistive indices, although slightly 
decreased
compared to prior. Main renal artery and main renal vein are
patent with appropriate waveforms.  

-The patient was given:  
___ 00:39 IV Furosemide 80 mg  
___ 01:20 IV Insulin (Regular) for Hyperkalemia 10 units  

___ 01:20 IV Dextrose 50% 25 gm  
___ 01:20 IV Calcium Gluconate 1 gm  
___ 01:34 PO Tacrolimus 3 mg  
___ 01:34 PO Mycophenolate Sodium ___ 360 mg  
___ 01:34 PO/NG Labetalol 400 mg  
___ 02:12 PO/NG Amitriptyline 75 mg  
___ 09:52 PO/NG PredniSONE 5 mg  
___ 09:52 PO/NG Ranitidine 150 mg  
___ 11:56 IV Furosemide 80 mg  
___ 11:59 PO/NG Labetalol 400 mg  
___ 12:50 PO/NG Atovaquone Suspension 1500 mg  
___ 12:50 PO Cinacalcet 30 mg  
___ 17:05 PO Tacrolimus 3 mg  

-On the floor, the patient confirms the above history.  He 
states
he feels comfortable w/o fevers, chills, SOB, CP, palpitations,
abdominal pain, N/V/D, dysuria, myalgias. 

REVIEW OF SYSTEMS: 
==================
Pertinent positives & negatives noted in HPI. 
 
Past Medical History:
ESRD due to polycystic kidney disease, on HD ___ to ___ s/p
SCD renal transplant ___
Hypertension
GERD
Hepatitis C, treated with interferon monotherapy then Harvoni
post-transplant
Osteomyelitis, ___ 
Epidural abscess ___.  
Endocarditis ___. 
Hypertention 
Hyperparathyroidism status post subtotal parathyroidectomy 
revision ___, thyroid lobectomy. 
Gout. 
Carotid stenosis. 
Restless legs syndrome. 
Depression. 
 

 
Social History:
___
Family History:
Father: ___
Mother: No medical conditions
Sister: CAD
Son: ___
 
Physical Exam:
ADMISSION PHYSICAL
==================
T98.0 BP200/91 HR104 RR18 O295Ra 
GENERAL: WN/WD middle-aged male, NAD, A/O3. 
HEAD: NC/AT. 
NECK: JVD to mid-upper neck. 
CARDIAC: ___ holo-systolic murmur throughout, RRR, S1S2.
RESPIRATORY: Trace b/l crackles, comfortable. 
ABDOMEN: Soft, NT, +BS. 
EXTREMITIES: Warm, no edema.

DISCHARGE PHYSICAL
==================
VS: 24 HR Data (last updated ___ @ 801)
    Temp: 98.5 (Tm 99.0), BP: 158/81 (___), HR: 69
(66-70), RR: 16 (___), O2 sat: 98% (96-98), O2 delivery: Ra,
Wt: 150.1 lb/68.09 kg (150.1-151.1)   
GENERAL: WN/WD middle-aged male, NAD, AAOx3. 
HEAD: NC/AT, EOMI, PERRL, MMM.
NECK: Supple, JVP ~6cm 
CARDIAC: ___ holo-systolic murmur throughout, RRR, S1S2.
RESPIRATORY: Trace bilateral crackles at the bases only,
comfortable. 
ABDOMEN: Soft, NT, +BS. 
EXTREMITIES: Warm, no edema, no clubbing, no cyanosis, od access
in L arm - no bruit or thrill
 
Pertinent Results:
ADMISSION LABS
==============
___ 09:47PM BLOOD WBC-4.4 RBC-3.21* Hgb-9.0* Hct-28.8* 
MCV-90 MCH-28.0 MCHC-31.3* RDW-14.6 RDWSD-47.4* Plt ___
___ 09:47PM BLOOD Neuts-79.2* Lymphs-12.3* Monos-7.1 
Eos-0.7* Baso-0.2 Im ___ AbsNeut-3.47 AbsLymp-0.54* 
AbsMono-0.31 AbsEos-0.03* AbsBaso-0.01
___ 09:47PM BLOOD ___ PTT-29.0 ___
___ 09:47PM BLOOD Glucose-105* UreaN-48* Creat-4.3*# Na-137 
K-6.1* Cl-105 HCO3-15* AnGap-17
___ 09:47PM BLOOD CK-MB-2
___ 09:47PM BLOOD CK(CPK)-169
___ 09:47PM BLOOD cTropnT-0.01
___ 10:00AM BLOOD proBNP-5538*
___ 09:47PM BLOOD Calcium-8.8 Phos-3.5 Mg-1.8
___ 10:03PM BLOOD ___ pO2-35* pCO2-34* pH-7.34* 
calTCO2-19* Base XS--6 Intubat-NOT INTUBA
___ 12:48AM URINE Color-Straw Appear-Clear Sp ___
___ 12:48AM URINE Blood-NEG Nitrite-NEG Protein-100* 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
___ 12:48AM URINE RBC-0 WBC-<1 Bacteri-NONE Yeast-NONE 
Epi-0
___ 12:48AM URINE Hours-RANDOM Creat-60 Na-75 Cl-59
___ 12:48AM URINE Osmolal-301
___ 11:46AM OTHER BODY FLUID FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE

MICRO
=====
Urine Culture ___ - No Growth

TACROLIMUS LEVELS
=================
___ 05:10PM BLOOD tacroFK-4.1*
___ 04:14AM BLOOD tacroFK-4.4*
___ 04:58AM BLOOD tacroFK-4.5*
___ 04:57AM BLOOD tacroFK-4.1*

IMAGING
=======
TTE ___
The left atrial volume index is mildly increased. No atrial 
septal defect is seen by 2D or color Doppler. The estimated 
right atrial pressure is ___ mmHg. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF>55%). Tissue Doppler 
imaging suggests an increased left ventricular filling pressure 
(PCWP>18mmHg). Right ventricular chamber size and free wall 
motion are normal. The aortic valve leaflets (3) are mildly 
thickened but aortic stenosis is not present. No aortic 
regurgitation is seen. The mitral valve leaflets are mildly 
thickened. An eccentric, posteriorly directed jet of mild (1+) 
mitral regurgitation is seen. The pulmonary artery systolic 
pressure could not be determined. There is a trivial/physiologic 
pericardial effusion.

IMPRESSION: Mild symmetric left ventricular hypertrophy with 
preserved biventricular systolic function. Increased left 
ventricular filling pressure. Indeterminate pulmonary pressure. 

CXR ___: Mild cardiomegaly with small pleural effusions and 
pulmonary vascular congestion. 

RENAL TRANSPLANT US ___:
1. No hydronephrosis. 
2. Mildly elevated resistive indices, slightly decreased 
compared to prior.  Main renal artery and main renal vein are 
patent with appropriate waveforms. 

BILATERAL VEIN MAPPING UPPER EXTREMITITES ___
FINDINGS: 
 
RIGHT:
The cephalic vein is patent with measurements of 0.09 cm to 0.17 
cm.  The
basilic vein is patent with measurements of 0.26 to 0.___rtery measures 0.23 cm. The brachial artery measures 0.49 cm. 
Heavy arterial
calcifications are present.
 
LEFT:
The cephalic vein is patent with measurements of 0.13 at the 
wrist but there
is occlusion proximally. The basilic vein is patent with 
measurements of 0.36
to 0.___rtery measures 0.30 cm but is occluded 
at the wrist. 
The brachial artery measures 0.78 cm. Heavy arterial 
calcifications are
present.
 
There is phasic flow in both subclavian veins.
 
IMPRESSION: 
 
Patent right cephalic and basilic veins with diameters as above. 
 Occluded
left cephalic but patent basilic vein.  Patent right radial and 
bilateral
brachial arteries with diameters as shown above. 

DISCHARGE LABS
==============
___ 04:57AM BLOOD WBC-2.8* RBC-3.48* Hgb-9.7* Hct-30.7* 
MCV-88 MCH-27.9 MCHC-31.6* RDW-14.4 RDWSD-45.5 Plt ___
___ 04:57AM BLOOD Neuts-55.5 ___ Monos-18.2* 
Eos-2.3 Baso-0.3 Im ___ AbsNeut-1.68 AbsLymp-0.71* 
AbsMono-0.55 AbsEos-0.07 AbsBaso-0.01
___ 04:57AM BLOOD Glucose-94 UreaN-56* Creat-4.3* Na-136 
K-4.6 Cl-98 HCO3-24 AnGap-14
___ 04:57AM BLOOD Calcium-9.0 Phos-5.0* Mg-2.1
___ 04:57AM BLOOD tacroFK-4.1*

 
Brief Hospital Course:
Mr. ___ is a ___ w/ ESRD s/p deceased donor renal 
transplant in ___ complicated by chronic allograft dysfunction 
(antibody-mediated rejection ___, biopsy-confirmed chronic 
transplant glomerulopathy, interstitial fibrosis & tubular 
atrophy ___, HTN, GERD, HCV s/p ledipasvir-sofosbuvir, & 
hyperparathyroidism s/p sub-total parathyroidectomy ___ who 
presented with increasing shortness of breath. 

# Dyspnea
# ?Acute CHF Exacerbation 
The patient presented with a history of orthopnea & dyspnea w/ 
CXR findings of bilateral effusions & pulmonary vascular 
congestion consistent with fluid overload state. His weight was 
noted to be higher recently from prior discharge. No medication 
non-adherence or dietary changes although the recent addition of 
sodium bicarbonate may be contributing due to increased Na load. 
Patient's blood pressures were uncontrolled & likely further 
increased his left-sided afterload. A TTE on ___ revealed 
elevated PCWP and E/E' with preserved EF. Overall patient 
reported symptomatic improvement with diuresis and his daily 
weights continued to trend down. Although there are no concerns 
of rejection based on a bland urine sediment and an unremarkable 
renal ultrasound, the etiology of the patient's volume overload 
may have been in part also been caused by worsening renal 
function as evidenced by creatinines in the 4s compared to his 
baseline of creatinine in the 3s. Patient was diuresed with IV 
furosemide PRN and transitioned to oral diuretics. His 
electrolytes are monitored and repleted as needed. His labetalol 
was increased to 600 mg 3 times daily and he was continued on 
his nifedipine 30 mg daily.

# ___:
# ESRD w/p transplant c/b chronic rejection:
Cr 4 on presentation, up from discharge 3.2 on ___. His elevated 
creatinine may be cardiorenal in etiology given clinical context 
and possible end-organ damage in setting of hypertension but 
worsening overall renal function cannot be ruled out given lack 
of significant improvement with diuresis. His renal US had no 
evidence/concern for hydronephrosis and there was less concern 
for rejection at this time given bland urine and lack of 
characteristics findings on renal US. The patient's renal 
function was trended daily. He was continued on his 
immunosuppressive regimen of mycophenolate, tacrolimus, and 
prednisone. His tacrolimus levels were trended daily. He was 
continued on atovaquone prophylaxis. His MAPs were maintained 
above 65. He is also continued on calcium and cinacalcet. Sodium 
bicarbonate was held in the setting of his volume overloaded 
state. His blood pressure was better controlled as noted.

# HTN:
The patient was noted to have systolic blood pressure readings 
in the ___. He was previously on losartan & labetalol last 
hospitalization but losartan was held on discharge given 
persistent hyperkalemia. At that time, labetalol dosing was 
increased to 400mg TID from 200mg BID & nifedipine ER 30mg QD 
was initiated. No evidence of renal artery stenosis in 
transplant kidney as though no changes in resistive indices. The 
patient's labetalol was increased to 600 mg 3 times daily and he 
was continued on nifedipine along leading to better blood 
pressure control.

# Mild Hyperkalemia:
Patient presented with mild hyperkalemia and on review of 
records, it appeared that patient was chronically mildly 
hyperkalemic. His hyperkalemia improved with ongoing IV diuresis 
with Furosemide. 

# Normocytic anemia:
His home hemoglobin was similar to baseline values in setting of 
end-stage renal disease. His CBCs were trended daily and he did 
not require a blood transfusion during his hospitalization.

# GERD:
Continued on his prior dose of ranitidine.

# Insomnia:
Continued on his prior dose of amitriptyline. His ramelteon was 
held due to concerns of possible toxicity to the renal 
transplant.

TRANSITIONAL ISSUES
===================
[]Added new oral diuretics: PO Lasix 40 mg BID, please uptitrate 
as tolerated
[]New BP regimen as follows: Labetalol 600 mg TID and Nifedipine 
30 mg daily, please uptitrate as tolerated
[]Please check electrolytes in five days to monitor K and Mg
[]Please have patient follow-up with Dr. ___ one 
month to discuss possibility of HD in the future
[] IMMUNOSUPPRESSION REGIMEN
- tacrolimus 3mg Q12h
- mycophenolate myfortic 360mg PO BID
- prednisone 5mg PO daily
- atovaquone 1500 mg daily 
#Code: Full (presumed)
#Contact: ___ (son)
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amitriptyline 75 mg PO QHS 
2. Aspirin 81 mg PO DAILY 
3. Calcium Carbonate 500 mg PO BID 
4. Cinacalcet 30 mg PO DAILY 
5. Labetalol 400 mg PO TID 
6. Magnesium Oxide 400 mg PO DAILY 
7. Multivitamins 1 TAB PO DAILY 
8. Mycophenolate Sodium ___ 360 mg PO BID 
9. PredniSONE 5 mg PO DAILY 
10. Tacrolimus 3 mg PO Q12H 
11. Ranitidine 150 mg PO DAILY 
12. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 
13. Atovaquone Suspension 1500 mg PO DAILY 
14. NIFEdipine (Extended Release) 30 mg PO DAILY 
15. Sodium Bicarbonate 1300 mg PO BID 

 
Discharge Medications:
1.  Furosemide 40 mg PO BID  
2.  Labetalol 600 mg PO TID  
3.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  
4.  Amitriptyline 75 mg PO QHS  
5.  Aspirin 81 mg PO DAILY  
6.  Atovaquone Suspension 1500 mg PO DAILY  
7.  Calcium Carbonate 500 mg PO BID  
8.  Cinacalcet 30 mg PO DAILY  
9.  Magnesium Oxide 400 mg PO DAILY  
10.  Multivitamins 1 TAB PO DAILY  
11.  Mycophenolate Sodium ___ 360 mg PO BID  
12.  NIFEdipine (Extended Release) 30 mg PO DAILY  
13.  PredniSONE 5 mg PO DAILY  
14.  Ranitidine 150 mg PO DAILY  
15.  Sodium Bicarbonate 1300 mg PO BID  
16.  Tacrolimus 3 mg PO Q12H  

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Primary Diagnoses
=================
End-stage renal disease with prior transplant complicated by 
chronic rejection
Pulmonary edema
Dyspnea
Orthopnea
Hyperkalemia
Hypertension

Secondary Diagnoses
===================
Normocytic anemia
GERD
Insomnia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

It was a pleasure taking care of you in the hospital!

Why was I admitted to the hospital?
-You came to the hospital because you were having difficulty 
breathing when walking and when lying flat

What happened while I was admitted to the hospital?
-You were found to have fluid in your lungs and high blood 
pressure and these were likely causing your symptoms
-Your heart health was checked with an ultrasound and lab tests 
but no major abnormalities were found
-You were given medications to help to urinate out the fluid and 
her blood pressure medications were adjusted to decrease your 
blood pressure
-Your lab numbers were closely monitored and you were continued 
on your home medications
-You underwent imaging to evaluate the vasculature in your arms 
as your renal dysfunction may be progressing and therefore you 
may require dialysis in the future

What should I do after I leave the hospital?
-Please continue taking all of your medications as prescribed, 
details below
-Keep all of your appointments as scheduled 

We wish you the very best! 

Your ___ Care Team
 
Followup Instructions:
___
"
21,10497294,25310635," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Flank pain
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ male past medical history significant for ESRD 
secondary to polycystic kidney disease status post failed liver 
transplant in ___ currently on hemodialysis, hypertension, hep 
C, endocarditis, carotid stenosis presenting to the emergency 
department with left flank pain since the ___ that is constant 
with no known ameliorating or exacerbating factors and radiates 
down to the left testicle. Patient was seen and had a 2 mm 
kidney stone in the left kidney that has now resolved. Upon exam 
at ___, patient was found to have 
possible right sided pyelo-with bacteriuria on CT. Patient was 
sent here for specialty evaluation as he receives his renal 
transplant care here. Patient received ceftriaxone prior to 
arrival

In the ED:

Initial vital signs were notable for:
T98.8, HR98, BP161/90, RR20, 95% RA, Pain ___

Exam notable for:
GA: Uncomfortable
HEENT: No scleral icterus
Cardiovascular: Normal S1, S2, regular rate and rhythm, no 
murmurs/rubs/gallops, 2+ peripheral pulses bilaterally
Pulmonary: Clear to auscultation bilaterally
Abdominal: Soft, nontender, nondistended, no masses
GU: Normal testicles without signs of tenderness, edema
Extremities: No lower leg edema
Integumentary: No rashes noted

Labs were notable for:

5.1 > 9.1/28.6 < 230

133 88 36   
---------- 104
5.0 26 5.3

Ca 9.6 Mg 2.0 P 4.9

Tacro 2.0

Studies performed include:
Scrotal US:
Findings equivocal for epididymitis.

Renal US:
1. No hydronephrosis.
2. Normal intrarenal resistive indices, slightly decreased from
prior.
3. Main renal artery and main renal vein are patent with
appropriate
waveforms.

CT A/P performed at ___

Patient was given: Dilaudid, Ceftriaxone x1, Doxy

Consults: Transplant Medicine

Vitals on transfer: T97.6, BP103/60,HR75, RR18, 93%RA

Upon arrival to the floor, pt complained of pain ___ kidney 
stones and epididymitis. The pain is sharp and throbbing and 
starts in his L back, radiating to his groin and down his leg. 
He also says his hands are cramping because of the fluid 
overload visible in both his arms/legs. He received dialysis 
today and got ___ lbs of fluids off. Denies symptoms of chest 
pain, N/V/F/C. 
 
Past Medical History:
ESRD due to polycystic kidney disease, on HD ___ to ___ s/p
SCD renal transplant ___
GERD
Hepatitis C, treated with interferon monotherapy then Harvoni
post-transplant
Hypertension 
Hyperparathyroidism status post subtotal parathyroidectomy 
revision ___, thyroid lobectomy. 
Gout. 
Carotid stenosis. 
Restless legs syndrome. 
Depression. 
 
Social History:
___
Family History:
Father: ___
Mother: No medical conditions
Sister: CAD
Son: ___
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
======================
VITALS: T97.6, BP103/60,HR75, RR18, 93%RA
GENERAL: Alert and interactive. Moderately uncomfortable.
HEENT: NCAT. EOMI. Sclera anicteric and without injection. MMM.
NECK: No gross abnormalities
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No 
murmurs/rubs/gallops.
LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or 
rales. No increased work of breathing.
BACK: CVA tenderness on L.
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep 
palpation in all four quadrants. No organomegaly.
EXTREMITIES: No clubbing, cyanosis. Pitting edema 1+ ___ b/l. 
Mild edema b/l in the arms as well. Pulses DP/Radial 2+ 
bilaterally.
SKIN: Warm. Cap refill <2s. No rash.
NEUROLOGIC: Normal sensation. AOx3.

DISCHARGE PHYSICAL EXAM:
========================
VITALS: Temp: 98.5 PO BP: 142/80 HR: 70 RR: 20 O2 sat: 100% RA 
GENERAL: Alert and interactive. NAD. Lying comfortably in bed. 
HEENT: NCAT. Sclera anicteric and without injection. MMM.
NECK: Supple. 
CARDIAC: RRR with normal S1 and S2. II/VI systolic murmur heard 
throughout. No rubs or gallops. 
LUNGS: Normal respiratory effort. CTAB over anterior chest 
without wheezes, rales or rhonchi.  
ABDOMEN: Soft, non-tender, non-distended. Normoactive BS. No 
guarding or masses.  
EXTREMITIES: Warm, well perfused. No ___ edema or erythema. Mild 
TTP over left buttocks and greater trochanter. 
SKIN: Warm, dry. No rashes. 
NEUROLOGIC: Alert and interactive. CN II-XII grossly intact. 
Moves all extremities. 
 
Pertinent Results:
ADMISSION LABS:
==============
___ 11:20PM BLOOD WBC-5.1 RBC-3.22* Hgb-9.1* Hct-28.6* 
MCV-89 MCH-28.3 MCHC-31.8* RDW-16.5* RDWSD-48.5* Plt ___
___ 11:20PM BLOOD Neuts-93.3* Lymphs-4.9* Monos-1.2* 
Eos-0.0* Baso-0.0 Im ___ AbsNeut-4.72 AbsLymp-0.25* 
AbsMono-0.06* AbsEos-0.00* AbsBaso-0.00*
___ 11:20PM BLOOD Glucose-112* UreaN-29* Creat-4.5* Na-133* 
K-4.5 Cl-89* HCO3-28 AnGap-16
___ 11:20PM BLOOD ALT-<5 AST-18 CK(CPK)-300 AlkPhos-81 
TotBili-0.4
___ 11:20PM BLOOD Lipase-13
___ 11:50PM BLOOD Lactate-2.2*

PERTINENT LABS/MICRO:
====================
___ 11:20PM BLOOD Lipase-13

___ 11:20PM BLOOD cTropnT-0.08*
___ 04:20AM BLOOD CK-MB-12* cTropnT-0.27*
___ 07:04PM BLOOD CK-MB-6 cTropnT-0.29*
___ 01:00AM BLOOD CK-MB-5 cTropnT-0.36*
___ 04:35AM BLOOD CK-MB-3 cTropnT-0.42*
___ 09:34AM BLOOD CK-MB-2 cTropnT-0.45*

___ 07:50AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG
___ 07:50AM BLOOD HCV Ab-POS*
___ 07:50AM BLOOD HCV VL-NOT DETECT

___ 11:50PM BLOOD Lactate-2.2*
___ 07:31PM BLOOD Lactate-1.7

___ 12:43PM URINE Color-Yellow Appear-Hazy* Sp ___
___ 12:43PM URINE Blood-MOD* Nitrite-NEG Protein->600* 
Glucose-100* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
___ 12:43PM URINE RBC-2 WBC-7* Bacteri-FEW* Yeast-NONE 
Epi-<1 TransE-<1
___ 12:43PM URINE CastGr-3* CastHy-4*

___ 12:43PM URINE CT-NEG NG-NEG
___ Blood culture: Negative 
___ Urine culture: Negative

DISCHARGE LABS:
==============
___ 04:51AM BLOOD WBC-4.4 RBC-3.56* Hgb-9.8* Hct-32.2* 
MCV-90 MCH-27.5 MCHC-30.4* RDW-17.2* RDWSD-56.8* Plt ___
___ 04:51AM BLOOD Glucose-98 UreaN-25* Creat-4.7* Na-131* 
K-4.8 Cl-88* HCO3-27 AnGap-16

PERTINENT IMAGING:
=================
___ Scrotal Ultrasound:
Findings equivocal for bilateral epididymitis.

___ Renal Transplant Ultrasound:
1. No hydronephrosis.
2. Normal intrarenal resistive indices, slightly decreased from 
prior.
3. Main renal artery and main renal vein are patent with 
appropriate
waveforms.
4. Unchanged 4 mm right lower pole renal lesion, possibly a 
small
angiomyolipoma.

___ Left Hip Xray:
No acute fracture.  There is mild degenerative changes of the 
hip, and partial ankylosis of the SI joints and degenerative 
discopathy and facet OA at L5/S1, that could potentially 
contribute to patient's symptoms.  If there remains high 
clinical suspicion for occult injury, further evaluation with CT 
is an option.

___ Second Opinon OSH CT Abd/pelvis:
1. No hydronephrosis or nephrolithiasis of the right lower 
quadrant transplant kidney.
2. Improvement in perinephric stranding compared to prior study 
from ___.

___ CXR:
There is moderate pulmonary edema and layering bilateral pleural 
effusions. No pneumothorax.  The size of the cardiac silhouette 
is within normal limits.

___ TTE:
The left atrial volume index is mildly increased. The right 
atrium is mildly enlarged. There is no evidence for an atrial 
septal defect by 2D/color Doppler. There is mild symmetric left 
ventricular hypertrophy with a normal cavity size. There is 
normal regional and global left ventricular systolic function. 
The visually estimated left ventricular ejection fraction is 
65%. There is no resting left ventricular outflow tract 
gradient. No ventricular septal defect is seen. Tissue Doppler 
suggests an increased left ventricular filling pressure (PCWP 
greater than 18mmHg). Mildly dilated right ventricular cavity 
with normal free wall motion. The aortic sinus diameter is 
normal for gender with normal ascending aorta diameter for 
gender. The aortic arch diameter is normal. There is no evidence 
for an aortic arch coarctation. The aortic valve leaflets are 
moderately thickened. There is mild aortic valve stenosis (valve 
area 1.5-1.9 cm2). There is trace aortic regurgitation. The 
mitral valve leaflets are mildly thickened with no mitral valve 
prolapse. There is an eccentric, inferolateral directed jet of 
moderate [2+] mitral regurgitation. Due to acoustic shadowing, 
the severity of mitral regurgitation could be UNDERestimated. 
Due to the Coanda effect, the severity of mitral regurgitation 
could be UNDERestimated. The tricuspid valve leaflets appear 
structurally normal. There is mild [1+] tricuspid regurgitation. 
There is moderate pulmonary artery systolic hypertension. There 
is a trivial pericardial effusion.

IMPRESSION: Mild symmetric left ventricular hypertrophy with 
preserved biventricular systolic function. Increased left 
ventricular filling pressure. Mild aortic stenosis. Moderate 
mitral regurgitation. Mild tricuspid regurgitation. Moderate 
pulmonary hypertension.

___ MRI Left Hip w/o Contrast:
1. Mild degenerative changes of the left hip.  No findings to 
suggest 
infection or avascular necrosis. 
2. Chronic appearing tear of the anterosuperior aspect of the 
left acetabular labrum. 
3. Degenerative disc disease in the lower lumbar spine better 
evaluated on the dedicated lumbar spine MRI performed on the 
same date. 

___ MRI L Spine w/o Contrast:
1. L5-S1 loss of disc height, disc irregularity, endplate 
irregularities, and L5 loss of height are again demonstrated, 
suggesting either chronic 
spondyloarthropathy secondary to end-stage renal disease, versus 
sequela of prior discitis/osteomyelitis.  Also unchanged mild 
retrolisthesis and 
prominent epidural fat at this level.  Unchanged mild narrowing 
of the thecal sac and severe bilateral neural foraminal 
narrowing at this level. 
2. Mild spinal canal narrowing at L2-L3 and L3-L4 has progressed 
since ___. Moderate L3-L4 neural foraminal narrowing has 
slightly progressed on the right but is not significantly 
changed on the left. 
3. At L4-L5, moderate right and severe left neural foraminal 
narrowing, as 
well as mild, left greater than right subarticular zone 
narrowing, are not 
significantly changed. 
 
Brief Hospital Course:
Mr. ___ is a ___ y/o male with a history of ESRD ___ PCKD s/p 
deceased donor renal transplant (___) c/b chronic allograft 
dysfunction, now back on HD since ___, HCV s/p Harvoni, and 
HTN who presented with left flank/hip/testicular pain. 
Infectious work up was unremarkable. MRI spine was notable for 
degenerative disc disease, likely causing radicular pain. 
Chronic pain service and orthopedic surgery were consulted and 
recommended ongoing pain management. 

ACUTE ISSUES:
=============
#Left flank/hip/back pain, severe uncontrolled pain
#Neuropathic pain
The patient presented with ___ weeks of left flank pain that 
then moved into his left hip, thigh, groin and left testicle. 
Initial evaluation was notable for CVA tenderness and left 
testicular tenderness concerning for UTI/nephrolithiasis vs 
epididymitis. CT abd/pelvis showed an atrophic kidney without 
nephrolithiasis or pyelonephritis and testicular ultrasound was 
equivocal for epidimyitis. He was initially started on broad 
spectrum antibiotics, which were discontinued after urine 
culture, GC & chlamydia returned negative. Given persistent 
pain, MRI L-spine and pelvis were done, demonstrating L5-S1 
changes c/w chronic spondyloarthropathy ___ ESRD vs sequela of 
prior discitis, as well as severe left-sided L4-L5 neural 
foraminal narrowing. The L4-L5 was felt to be the etiology of 
his pain given the correlating location. Chronic pain service 
and orthopedic surgery were consulted and provided recommends 
for pain management. He was continued on oxycodone, 
amitriptyline and started on tizanidine as well as lyrica with 
improvement in his pain. He will follow up in the ___ spine 
clinic for further management. 

#ESRD ___ PCKD s/p renal transplant c/b rejection now on HD
Presented with moderate volume overload, particularly noted to 
have bilateral pleural effusions on CXR. He underwent multiple 
daily sessions of dialysis with improvement and then was 
transitioned to his normal regimen. He had significant weight 
gain between sessions and required tighter fluid restriction, 
which should be continued as an outpatient. Additionally, his 
home prednisone and tacrolimus were continued.

#Acute hypoxic respiratory failure
#Acute pulmonary edema
Patient noted to have rapidly worsening hypoxia one evening 
during his hospitalization briefly requiring a non-rebreather. 
Repeat CXR showed significant pulmonary edema with bilateral 
effusions. He was started on a nitroglycerin gtt and underwent 
urgent bedside dialysis overnight with improvement in his 
clinical status. He was rapidly weaned to room air and remained 
stable for the remainder of the hospitalization. 

#NSTEMI
Troponin 0.08 on admission and continued to rise to 0.45 in the 
setting of fluid overload and acute hypoxic respiratory failure. 
EKG showed borderline submillimeter ST depressions in I, V5-V6 
(different from baseline), which was stable/improving on serial 
EKGs. He denied having any chest pain during this time. 
Cardiology was consulted and felt the presentation was 
consistent with type II NSTEMI due to fluid overload. Follow up 
TTE did not demonstrate a wall motion abnormality. Ultimately, 
cardiology decided against stress test at this time. He was 
discharged on his home aspirin with the addition of atorvastatin 
and metoprolol. 

#Atrial fibrillation 
Noted to be in atrial fibrillation on ___, which rapidly 
resolved within hours to a day. This was a new diagnosis for the 
patient, felt to be ___ fluid shifts vs less likely cardiac 
ischemia. TSH normal. His home labetalol was switched to 
metoprolol and his heart rate and rhythm remained stable. Given 
a CHADSVASC of 1, anticoagulation was not started.  

#Access
Newly placed fistula with some ulceration. He should follow up 
with Dr. ___ in Nephrology to evaluate as an outpatient. 

CHRONIC ISSUES:
===============
#Hypertension
He was continued on his home nifedipine. He refused several 
daily doses of labetalol, stating the dose was too high. Given 
new episode of atrial fibrillation, possible cardiac disease, 
and normotensive pressures without labetalol, he was switched to 
metoprolol and remained stable on this regimen.  

#Normocytic anemia 
Hemoglobin stable from prior, felt to be ___ anemia of chronic 
disease ___ ESRD
and iron deficiency. He was continued on his on iron 
supplementation. 

#GERD
- Continued ranitidine 

#BPH
- Continued tamsulosin

TRANSITIONAL ISSUES:
====================
[ ] Follow up in ___ Spine Clinic on ___ and with your 
primary care provider ___ ___ weeks 
[ ] Monitor pain, titrate medications as necessary, consider 
down-titrating back to oxycodone 10 mg TID if pain improves and 
able 
[ ] Monitor mental status on several sedating medications - 
consider stopping tizanidine in the future once pain improves 
given unclear benefit
[ ] Blood pressure regimen changed, follow up BP and titrate as 
necessary 
[ ] Developed one episode of atrial fibrillation, if future 
episodes occur, consider further discussion regarding 
anticoagulation 
[ ] Ensure the patient is adhering to a 1.5-2L fluid restriction 

[ ] Recommend follow up Echocardiogram in ___ years

#CODE: Full (confirmed)
#CONTACT: ___ (Son) - no number on file 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild 
2. Amitriptyline 75 mg PO QHS 
3. Aspirin 81 mg PO DAILY 
4. Atovaquone Suspension 1500 mg PO DAILY 
5. Calcium Carbonate 500 mg PO BID 
6. Cinacalcet 30 mg PO DAILY 
7. Ferrous GLUCONATE 324 mg PO BID 
8. Furosemide 80 mg PO 4X/WEEK (___) 
9. Labetalol 600 mg PO TID 
10. Magnesium Oxide 800 mg PO DAILY 
11. NIFEdipine (Extended Release) 30 mg PO DAILY 
12. OxyCODONE (Immediate Release) 10 mg PO Q8H:PRN Pain - Severe 

13. PredniSONE 5 mg PO EVERY OTHER DAY 
14. Ranitidine 150 mg PO DAILY 
15. Tacrolimus 3 mg PO Q12H 
16. Tamsulosin 0.4 mg PO QHS 
17. Vitamin D ___ UNIT PO 1X/WEEK (___) 

 
Discharge Medications:
1.  Atorvastatin 80 mg PO QPM  
2.  Lidocaine 5% Patch 1 PTCH TD QAM  
3.  Metoprolol Succinate XL 50 mg PO DAILY  
4.  Pregabalin 25 mg PO BID  
5.  Tizanidine 2 mg PO BID  
6.  Acetaminophen 1000 mg PO Q8H  
7.  OxyCODONE (Immediate Release) 10 mg PO Q6H:PRN Pain - 
Moderate 
RX *oxycodone 10 mg 1 tablet(s) by mouth every six (6) hours 
Disp #*15 Tablet Refills:*0 
8.  Amitriptyline 75 mg PO QHS  
9.  Aspirin 81 mg PO DAILY  
10.  Atovaquone Suspension 1500 mg PO DAILY  
11.  Calcium Carbonate 500 mg PO BID  
12.  Cinacalcet 30 mg PO DAILY  
13.  Ferrous GLUCONATE 324 mg PO BID  
14.  Furosemide 80 mg PO 4X/WEEK (___)  
15.  Magnesium Oxide 800 mg PO DAILY  
16.  NIFEdipine (Extended Release) 30 mg PO DAILY  
17.  PredniSONE 5 mg PO EVERY OTHER DAY  
18.  Ranitidine 150 mg PO DAILY  
19.  Tacrolimus 3 mg PO Q12H  
20.  Tamsulosin 0.4 mg PO QHS  
21.  Vitamin D ___ UNIT PO 1X/WEEK (___)  

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
#Primary:
Lower extremity radicular neuropathy 
Left flank/groin pain, difficult to control

#Secondary:
ESRD s/p renal transplant c/b rejection on hemodialysis 
NSTEMI
Paroxysmal atrial fibrillation 
Acute hypoxic respiratory failure
Pulmonary edema 
Hypertension
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___, 

It was a pleasure caring for you at ___ 
___!

Why you were admitted to the hospital:
- You were having pain in your side, back, hip and groin

What happened while you were here:
- Infectious work up was unremarkable - specifically you had no 
infection in your urine or testicles 
- There was concern for a kidney stone though imaging did not 
show this so it was felt to be less likely
- MRI of your back showed narrowing and pressure on the nerves, 
which was felt to be the cause of your pain 
- Orthopedic spine surgery and the pain service were consulted 
and assisted with pain management
- Additionally, you had significant fluid overload (fluid in 
your lungs), requiring oxygen and repeat dialysis sessions 
- Lab tests showed that there was additional stress on your 
heart. You should continue taking your heart medications as 
prescribed. 

What you should do once you leave the hospital:
- Please continue taking your medications as prescribed
- Please follow up at the appointments outlined below 

Sincerely,
Your ___ Care Team 
 
Followup Instructions:
___
"
22,10497294,22569872," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
Hand and foot wounds
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Mr. ___ is as ___ incarcerated male with ESRD
secondary to PCKD s/p failed kidney transplant in ___ and on HD
___, Hepatitis C (treated), HTN, hx of osteomyelitis/
endocarditis per chart review, and carotid stenosis who is
presenting with approximately 4 months of worsening bilateral
hand and unilateral foot pain swelling and skin breakdown. 

He reports no known antecedent trauma to his hands and his feet
but has had progressive pain and discoloration of two fingers on
his right hand, one finger on his left hand, and right big toe.
He reports trying to seek help earlier but was unable to get
medical attention at his ___ facility. The pain has
progressively gotten worse to now ___ pain, limiting his
ability to ambulate and use his hands.

Regarding his ulcers, per outpatient notes, Mr. ___ has a 
long
history of manipulative and self-injurious behavior. The wound 
on
the right hand started as a small cut likely from trimming his
finger nails. Without adequate wound care or dressing changes,
this progressed into a blister and then further progressed to 
the
necrotic lesion.

He had an ultrasound of the right subclavian to rule out 
thrombus
and an echo which showed no vegetations. ANCA panel and
cryoglobulins were negative. He had a period where the hand
became edematous and erythematous, with elevated ESR and CRP and
was treated with IV vanco and ceftaz with improvement in the
wound appearance, edema and erythema. Despite this, he continued
to be non-compliant with wound care.

He was seen by Vascular Surgery at ___ and on ___ an
arteriogram was done there showing:

The right subclavian artery axillary and brachial arteries were
all widely patent.  The right ulnar artery was the primary
outflow to the hand as the radial artery occluded in the distal
forearm.  On the left the subclavian axillary and brachial
arteries were all widely patent.  There was reversal of flow
distal to the fistula, the fistula filled very quickly.  With
fistula compression the ulnar artery had improved flow and was
the primary runoff to the hand as the radial artery occluded in
the mid forearm.  Of note, there was significant sluggish flow
throughout all of his vessels concerning for a possible central
source.

Dr. ___ performed the study, had no good explanation
for the very sluggish flow in this patient whose last EF was
normal. There were no treatable lesions as above.

Dr. ___, the transplant physician who has been managing his 
left upper extremity fistula, felt that ligating the fistula 
would be recommended in this setting to optimize flow to the 
left hand and help healing as much as possible, although patient 
has declined in the past. This may be an elective option in the 
future.

In the ED, initial vitals:  
T 96.0  HR 88  BP 156/77  RR 20  O2 Sat 95% RA 

- Exam notable for:  
Con: In no acute distress
CV: 3 out of 6 holosystolic ejection murmur
MSK: Secondary digits of right hand, second digit of left hand,
first digit of right foot with ulcerations consistent with dry
gangrene, possible small amount of purulence of second digit of
right hand, swelling of feet bilaterally, all extremities cool
and tender to palpation, digits of hands are tender to palpation
and swollen however are not held in a flexed position can be
fully extended without pain

- Labs notable for:  
Chem panel: Na 133, K 5.2, Cl 92, CO2 27, BUN 31, Cr 6.3, Glc 
88,
AG 14; extended lytes are normal
CBC: WBC 6.2, Hgb 12.1 with MCV 86, Plt 180
Coags: Normal
LFTs: Normal
UA: 600 protein, 6 WBC
Lactate: 1.5

- Imaging notable for:  

XR Bilateral Hands-
Loss of soft tissue at the tip of the right long finger, 
possibly
reflecting necrotic changes, with subtle loss of bone at the
terminal phalangeal tuft concerning for focal osteomyelitis. 
Left
hand grossly unremarkable.

XR Bilateral Feet-
No evidence of osteomyelitis or soft tissue gas. Soft tissue
swelling noted bilaterally slightly more pronounced on the right
than left. 

RLE US:
No evidence of DVT in the right lower extremity.

CXR:
1. No acute intrathoracic process. 
2. Dialysis catheter appears well positioned. 

Hand surgery was consulted and felt that there was no need for
acute intervention particularly given that patient is afebrile
and does not have an elevated WBC. Recommended IV antibiotics.

- Pt given:  
PO oxycodone 5mg
Tylenol 1g
Morphine IV 4mg x 2
IV Vancomycin 1g and Ciprofloxacin 400mg 

- Vitals prior to transfer:  
HR 74  BP 176/92  RR 16  O2 Sat 95% RA 

On the floor, patient reports ___ pain in his right hand
(second and third fingers), left second finger, and right big
toe. He manages his medications by himself and does not have any
issues remembering his medications. He is very hypertensive on
arrival, as he did not get any of his BP medications on ___.
Metoprolol ER and nifedipine ER were given to him early on
arrival to the floor. He denies any headache, dizziness, visual
changes, chest pain, shortness of breath.

ROS:
Specifically denies any fevers, chills, sweats.
Has had some weight loss due to poor appetite.
Has had decreased urine output.
No visual changes, no chest pain, no shortness of breath or
cough.
No nausea, vomiting or diarrhea.
No mood changes.
Otherwise 10-point review of systems negative 
 
Past Medical History:
ESRD due to polycystic kidney disease, on HD ___ to ___ s/p
SCD renal transplant ___
GERD
Hepatitis C, treated with interferon monotherapy then Harvoni
post-transplant
Hypertension 
Hyperparathyroidism status post subtotal parathyroidectomy 
revision ___, thyroid lobectomy. 
Gout. 
Carotid stenosis. 
Restless legs syndrome. 
Depression. 
L5-S1 discitis, osteomyelitis, epidural abscess ___
enterococcus bacteremia, treated with 10 days of
ampicillin/gentamycin Endocarditis (___) 

 
Social History:
___
Family History:
Father: ___, pancreatic cancer, alcohol and drug abuse
Mother: ___, diabetes
Sister: CAD
- Most sisters (___ or ___) with DM 
Brother: healthy
Son: ___

 
Physical Exam:
ADMISSION PHYSCIAL EXAM:
========================
VITALS: T 98.1 BP 184 / 93 HR 75 RR 18 O2 Sat 96 ra 
General: Alert, oriented, no acute distress  
HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL. No
JVD.
Chest: Has HD catheter tunneled into right chest
CV: Regular rate and rhythm, normal S1 + S2, II/VI systolic
murmur heard throughout
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi  
Abdomen: Soft, non-tender, non-distended, bowel sounds present.
Prior transplant scar on right abdomen.
Ext: Warm. Fistula in left arm is in process with scar tissue
proximally and distally. Mild pitting edema up to mid shin R > 
L.
No erythema or tenderness to palpation over fistula.
 -- RUE: Necrosis of distal tips of R ___ and ___ finger with
tenderness to palpation; pain with passive ROM and active ROM.
Significant nail changes, detached from underlying skin. 2+
radial pulse. Sensation intact.
 -- LUE: Necrosis of distal tip of L ___ finger with tenderness
to palpation and again, pain with passive ROM and active ROM.
Radial artery not palpable. 
 -- RLE: Necrosis of distal R big toe, significant tenderness to
palpation; pain with passive and active ROM. Sensation intact.
Neuro: CNII-XII intact. ___ strength distal extremities but
limited by pain.  

DISCHARGE PHYSICAL EXAM:
======================
___ 0707 Temp: 98.3 PO BP: 186/94 HR: 85 RR: 17 O2 sat: 96%
O2 delivery: Ra 
General: Alert, oriented, no acute distress  
HEENT: Sclerae anicteric, MMM, oropharynx clear
Chest: Has HD catheter tunneled into right chest
CV: Regular rate and rhythm, normal S1 + S2, II/VI systolic
murmur heard throughout
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi  
Abdomen: Soft, non-tender, non-distended, bowel sounds present.
Prior transplant scar on right abdomen.
Ext: Warm. Fistula in left arm. Several fingers with dressing.
Necrosis of distal R big toe. Several other fingers seem to be
forming discoloration. 
Neuro: CNII-XII intact. ___ strength distal extremities but
limited by pain.  
 
 
Pertinent Results:
ADMISSION LABS:
===============
___ 07:30PM BLOOD WBC-6.2 RBC-4.29* Hgb-12.1* Hct-36.8* 
MCV-86 MCH-28.2 MCHC-32.9 RDW-16.6* RDWSD-51.7* Plt ___
___ 07:30PM BLOOD Neuts-78.9* Lymphs-12.5* Monos-7.7 
Eos-0.6* Baso-0.0 Im ___ AbsNeut-4.91 AbsLymp-0.78* 
AbsMono-0.48 AbsEos-0.04 AbsBaso-0.00*
___ 08:00PM BLOOD ___ PTT-33.4 ___
___ 07:30PM BLOOD Glucose-88 UreaN-31* Creat-6.3*# Na-133* 
K-5.2 Cl-92* HCO3-27 AnGap-14
___ 08:00PM BLOOD Albumin-3.5 Calcium-9.8 Phos-4.3 Mg-2.4
___ 10:16PM BLOOD TotProt-5.4*
___ 08:19PM BLOOD Lactate-1.5

PERTINENT/DISCHARGE LABS:
=========================
___ 10:16PM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG
___ 10:16PM BLOOD ANCA-NEGATIVE B
___ 08:00PM BLOOD CRP-45.5*
___ 10:16PM BLOOD C4-21
___ 10:16PM BLOOD HIV Ab-NEG
___ 10:16PM BLOOD HCV Ab-POS*
___ 10:09AM BLOOD SerVisc-1.6
___ 10:16PM BLOOD Lupus-NOTDETECTE dRVVT-S-1.11 SCT-S-1.12
___ 08:40AM BLOOD b2micro-19.4*
___ 10:16PM BLOOD PEP-NO SPECIFI IFE-NO MONOCLO
___ 10:09AM BLOOD C3-119

IMAGING:
========
XR Bilateral Hands: ___
Loss of soft tissue at the tip of the right long finger, 
possibly
reflecting necrotic changes, with subtle loss of bone at the
terminal phalangeal tuft concerning for focal osteomyelitis. 
Left
hand grossly unremarkable.

XR Bilateral Feet: ___
No evidence of osteomyelitis or soft tissue gas. Soft tissue
swelling noted bilaterally slightly more pronounced on the right
than left. 

RLE US: ___
No evidence of DVT in the right lower extremity.

CXR: ___
1. No acute intrathoracic process. 
2. Dialysis catheter appears well positioned. 

TTE ___ 
IMPRESSION: Mild symmetric left ventricular hypertrophy with 
normal cavity size and regional/global biventricular systolic 
function. Mild aortic stenosis. Moderate mitral regurgitation 
(may be UNDERestimated due to shadowing). No 2D 
echocardiographic evidence for endocarditis. If
clinically suggested, the absence of a discrete vegetation on 
echocardiography does not exclude the diagnosis of endocarditis. 
Compared with the prior TTE (images reviewed) of ___, the 
findings are similar.

MR ___ Hand ___
Limited study. Nonspecific marrow edema in the distal phalanges 
of the index, long, and ring fingers.  Although these findings 
could represent early osteomyelitis, given the patient's 
clinical presentation, the findings are more likely related to 
the patient's peripheral vascular disease. 

Lower extremity ABIs ___
Noncompressible distal vessels bilaterally with diminished toe 
pressures 
consistent with significant obstructive arterial disease. 
Doppler and pulse volume recordings consistent with tibial 
disease 
bilaterally, with significantly diminished left digit PVR. 

DISCHARGE LABS
=============
___ 04:31AM BLOOD WBC-6.4 RBC-3.83* Hgb-10.7* Hct-34.9* 
MCV-91 MCH-27.9 MCHC-30.7* RDW-17.0* RDWSD-55.5* Plt ___
___ 04:31AM BLOOD Glucose-99 UreaN-50* Creat-6.8* Na-137 
K-5.2 Cl-96 HCO3-27 AnGap-14
___ 04:31AM BLOOD Calcium-9.1 Phos-5.3* Mg-2.8*
 
Brief Hospital Course:
Mr. ___ is a ___ y/o male with a history of ESRD ___ PCKD s/p 
deceased donor renal transplant (___) c/b chronic allograft 
dysfunction, now back on HD since ___, HCV s/p Harvoni, and 
HTN who presented with bilateral digital ulcers, with imaging 
concerning for possible osteomyelitis. Broad workup sent to rule 
out vasculitic process and embolic source. Presentation 
ultimately thought secondary to peripheral vascular disease with 
associated dry gangrene of the digits.

ACUTE/ACTIVE PROBLEMS: 

# Foot/Hand ulcers
# Concern for osteomyelitis
Patient presented with worsening pain, swelling, and necrotic 
changes of the R index/middle and L index fingers in the setting 
of progressively worsening chronic hand ischemia. Duration seems 
likely ___ months, as not noted on prior admission discharged in 
___. Per outpatient notes, injury was apparently incurred and 
resulted in worsening appearance and apparent concern for 
superinfection which was treated with IV Vanc/Ceftaz at ___ 
additionally, reportedly ANCA and Cryoglobulins were sent and 
were negative. When not improved, patient was sent to ___ 
where arteriogram shows sluggish flow without evidence of a flow 
limiting lesion. This may be seen in the presence of a central 
lesion or can also be seen in advanced heart failure, however EF 
was noted to be preserved. Broad differential was considered for 
decreased perfusion and vasculopathy including peripheral 
arterial disease, embolic (hypercoagulability, infectious, 
central lesion) vasculitis(small/medium/large vessel 
involvement, cryoglobulinemia) with work up unrevealing. He also 
underwent CTA chest which did not show a central lesion in his 
aorta. He had ABIs of the lower extremities which showed 
significant vascular occlusive disease. Calciphylaxis was 
considered, dermatology was consulted but thought unlikely given 
isolated involvement of fingertips. For potential benefit of 
increased perfusion via vasodilation, nifedipine was uptitrated. 
Tacrolimus was discontinued after discussion with renal given 
limited benefit to graft and known side effect of 
vasoconstriction. Admission radiographs concerning for R digit 
osteomyelitis and as such MR was obtained which was not fully 
completed, but did not show osteomyelitis. Repeat MRI was not 
pursued as hand surgery did not think it would change 
management. Vascular surgery and hand surgery were consulted. 
Vascular surgery did not recommend intervention. Hand surgery 
felt his presentation was most likely consistent with dry 
gangrene related to his peripheral vascular disease and the 
fingers would likely self-demarcate/self-amputate. Pain was 
aggressively controlled with OxyCODONE (Immediate Release) 15 mg 
PO Q8H:PRN Pain on discharge. He was also started on gabapentin 
100 mg daily as adjuvant medication which discussed with the 
nephrology team.

#Atypical pneumonia
Found to incidentally have multifocal opacities on CTA chest per 
above. He was asymptomatic without leukocytosis, fever, cough. 
Differential diagnosis for the opacities included vasculitis 
given the above workup, however was ultimately felt to be most 
consistent with an atypical pneumonia. He received azithromycin 

#ESRD ___ PCKD s/p DDRT ___ c/b chronic allograft dysfunction 
(antibody-mediated rejection ___, biopsy-confirmed chronic 
transplant glomerulopathy, interstitial fibrosis & tubular 
atrophy ___ 
Patient maintained on HD ___ schedule for dialysis. Discharge 
weight was around
148lb on prior admission. On admission 140lbs. Discharge weight 
140.1 lbs.
- Continued home nephrocap daily, Mg oxide 800mg daily, Calcium
Carbonate 500 mg PO BID, and Cinacalcet 30 mg PO DAILY, EPO shot 
once weekly, renal diet, fluid restriction 1.5L daily. 
Tacrolimus was discontinued given limited benefit to graft and 
known side effect of vasoconstriction. 

# Immunosuppression
Continued prednisone 5mg daily. Prior to admission tacrolimus 
2.5mg BID which is vasoconstrictive, held after discussion with 
renal. Continued PCP ppx with ___ Suspension 750 mg PO 
DAILY. 

#Hypertension
Uptitrated nifedipine to 30 daily.

#Afib:
Labetolol switched to metoprolol succinate 50 daily last 
admission. Downtitrated metoprolol to 25 mg daily to decrase 
potential vasoconstriction.

CHRONIC/STABLE PROBLEMS: 
========================

#Normocytic anemia 
Hemoglobin stable from prior, felt to be ___ anemia of chronic 
disease ___ ESRD and iron deficiency. Continued ferrous 
gluconate 324mg BID.

# Left-sided L4-L5 neural foraminal narrowing
On past admission, patient presented with left flank/hip/back 
pain. MRI L-spine and pelvis were done, demonstrating L5-S1 
changes c/w chronic spondyloarthropathy ___ ESRD vs. sequela of 
prior discitis, as well as severe left-sided L4-L5 neural 
foraminal narrowing. Continued pain management: APAP 1000mg Q8h, 
amitriptyline 100mg QHS, lidocaine patch.

# GERD
Continued home ranitidine daily, simethicone for gas.

# Hyperlipidemia: 
Continued home atorvastatin 80mg daily.

# Health maintenance
Continued home Vitamin D weekly (___), aspirin 81mg daily.

GENERAL/SUPPORTIVE CARE: 
#CODE: Full confirmed
#CONTACT: ___ (Son) - No number on file
For emergency contact, patient requests ___ (mom) be called
___

TRANSITIONAL ISSUES
===================
[] Continue azithromycin 250 mg daily for treatment of atypical 
pneumonia (end date = ___
[] Recommend outpatient referral to vascular medicine for 
further evaluation of non-operative management of vascular 
disease
[] Consider repeat CT chest imaging to evaluate for resolution 
of multifocal opacities
[] Follow up with hand surgery in two weeks for further 
management of dry gangrene
[] Follow up with Dr. ___ surgery) at ___ in 
approximately 1 month
[] Gabapentin 100 mg daily started for pain control. Consider 
dosing with additional 100-200 mg post-dialysis on HD days. 
[] Discharge pain regimen: oxycodone 15 mg TID PRN pain. Please 
consider weaning off as acute pain resolved. 
[] Wound care recs:
1. Commercial wound cleanser or normal saline to cleanse wounds. 
Pat the tissue dry with dry gauze.
2. Right great toe:
- Apply betadine, may cover with DSD. Change daily.
3.Bilateral pointer finger and right second finger:
- Apply Betadine over necrotic ulcers, cover with DSD. Change 
Daily.
- Elevate right hand

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever 
2. Amitriptyline 100 mg PO QHS 
3. Aspirin 81 mg PO DAILY 
4. Atovaquone Suspension 750 mg PO DAILY 
5. Atorvastatin 80 mg PO QPM 
6. Calcium Carbonate 500 mg PO BID 
7. Cinacalcet 30 mg PO DAILY 
8. Ferrous GLUCONATE 324 mg PO BID 
9. Lidocaine 5% Patch 1 PTCH TD QPM 
10. Furosemide 80 mg PO 4X/WEEK (___) 
11. Epoetin ___ ___ unit/ml SC 1/WEEK 
12. Magnesium Oxide 800 mg PO DAILY 
13. Metoprolol Succinate XL 50 mg PO DAILY 
14. Morphine SR (MS ___ 10 mg PO DAILY 
15. NIFEdipine (Extended Release) 30 mg PO DAILY 
16. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chset pain 
17. nutri.supp,lacto-free,iron-soy 0.04 gram- 1 kcal/mL Other 
3X/WEEK 
18. PredniSONE 5 mg PO DAILY 
19. Ranitidine 150 mg PO DAILY 
20. Simethicone 80 mg PO TID:PRN bloating 
21. Tacrolimus 2.5 mg PO Q12H 
22. Vitamin D ___ UNIT PO 1X/WEEK (___) 
23. Nephro-Vite (B complex-vitamin C-folic acid) 0.8 mg oral 
DAILY 

 
Discharge Medications:
1.  Azithromycin 250 mg PO DAILY Duration: 4 Doses 
RX *azithromycin 250 mg 1 tablet(s) by mouth Daily Disp #*1 
Tablet Refills:*0 
2.  Bisacodyl 10 mg PO DAILY 
RX *bisacodyl 5 mg 2 tablet(s) by mouth Daily Disp #*30 Tablet 
Refills:*0 
3.  Gabapentin 100 mg PO DAILY 
RX *gabapentin 100 mg 1 capsule(s) by mouth Daily Disp #*30 
Capsule Refills:*0 
4.  Nephrocaps 1 CAP PO DAILY 
RX *B complex with C#20-folic acid [Nephrocaps] 1 mg 1 
capsule(s) by mouth Daily Disp #*30 Capsule Refills:*0 
5.  OxyCODONE (Immediate Release) 15 mg PO Q8H:PRN Pain - Severe 

RX *oxycodone 15 mg 1 tablet(s) by mouth Every 8 hours Disp #*21 
Tablet Refills:*0 
6.  Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth Twice daily Disp 
#*30 Tablet Refills:*0 
7.  Metoprolol Succinate XL 25 mg PO DAILY 
RX *metoprolol succinate 25 mg 1 tablet(s) by mouth Daily Disp 
#*30 Tablet Refills:*0 
8.  NIFEdipine (Extended Release) 60 mg PO DAILY 
RX *nifedipine 60 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet 
Refills:*0 
9.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever  
10.  Amitriptyline 100 mg PO QHS  
11.  Aspirin 81 mg PO DAILY  
12.  Atorvastatin 80 mg PO QPM  
13.  Atovaquone Suspension 750 mg PO DAILY  
14.  Calcium Carbonate 500 mg PO BID  
15.  Cinacalcet 30 mg PO DAILY  
16.  Epoetin ___ ___ unit/ml SC 1/WEEK  
17.  Ferrous GLUCONATE 324 mg PO BID  
18.  Furosemide 80 mg PO 4X/WEEK (___)  
19.  Lidocaine 5% Patch 1 PTCH TD QPM  
20.  Magnesium Oxide 800 mg PO DAILY  
21.  Nephro-Vite (B complex-vitamin C-folic acid) 0.8 mg oral 
DAILY  
22.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chset pain  
23.  nutri.supp,lacto-free,iron-soy 0.04 gram- 1 kcal/mL Other 
3X/WEEK  
24.  PredniSONE 5 mg PO DAILY  
25.  Ranitidine 150 mg PO DAILY  
26.  Simethicone 80 mg PO TID:PRN bloating  
27.  Vitamin D ___ UNIT PO 1X/WEEK (___)  
28. HELD- Morphine SR (MS ___ 10 mg PO DAILY  This 
medication was held. Do not restart Morphine SR (MS ___ 
until you are told to do so by your doctor.

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
PRIMARY DIAGNOSES
=================
Dry gangrene of digits
Chronic vascular insufficiency secondary to peripheral vascular 
disease

SECONDARY DIAGNOSES
===================
ESRD ___ PCKD s/p failed transplant
Hypertension
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr ___, 
 
It was a pleasure caring for you at ___ 
___.  

WHY WAS I IN THE HOSPITAL?  
- You had ulcers on your fingers that became very painful

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- You were seen by our specialists for your ulcers. Your ulcers 
developed due to poor blood flow.
- There was concern you had a bone infection of your finger. 
- Our vascular surgeons recommended no surgery. 
- Our hand surgeons recommended waiting until the tips of your 
fingers broke off on their own.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
- Please take your medications and go to your follow up 
appointments as described in this discharge summary.  
- If you experience any of the danger signs listed below, please 
call your primary care doctor or go to the emergency department 
immediately. 
- Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs. 

We wish you the best!  

Sincerely,  

Your ___ Team  

 
Followup Instructions:
___
"
23,10497294,24511922," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Iodine
 
Attending: ___.
 
Chief Complaint:
bilateral hallux gangrene
 
Major Surgical or Invasive Procedure:
bilateral hallux TMA 

 
History of Present Illness:
Mr. ___ is a ___ patient with ESRD currently on HD due to 
failed renal transplant (Last dialysis ___. He recently was 
started on Apixaban due to a fib. At ___ he underwent 
arteriogram due to upper extremity gangrene involving the tips 
of the second and third fingers of both hands.
Arteriogram showed mid forarm occlusion of the radial artery but 
good flow via the ulnar. He was evaluated by vascular medicine 
recently due to bilateral hallux gangrene. 

 
Past Medical History:
ESRD due to polycystic kidney disease, on HD ___ to ___ s/p
SCD renal transplant ___
GERD
Hepatitis C, treated with interferon monotherapy then Harvoni
post-transplant
Hypertension 
Hyperparathyroidism status post subtotal parathyroidectomy 
revision ___, thyroid lobectomy. 
Gout. 
Carotid stenosis. 
Restless legs syndrome. 
Depression. 
L5-S1 discitis, osteomyelitis, epidural abscess ___
enterococcus bacteremia, treated with 10 days of
ampicillin/gentamycin Endocarditis (___) 

 
Social History:
___
Family History:
Father: ___, pancreatic cancer, alcohol and drug abuse
Mother: ___, diabetes
Sister: CAD
- Most sisters (___ or ___) with DM 
Brother: healthy
Son: ___

 
Physical Exam:
Prior to admission

Physical Exam:
Vital Signs sheet entries for ___: 
BP: 142/80. Heart Rate: 80. O2 Saturation%: # (unable to get a
reading ). Weight: 138.2 (With Clothes; With Shoes). Height: 
68.5
(With Shoes). BMI: 20.7. Temperature: 99.1. Resp. Rate: 17. Pain
Score: 10.
GEN: A&O, NAD
HEENT: No scleral icterus
CV: RRR
PULM: No respiratory distress
ABD: Soft, nondistended, nontender
EXT:
-Bilateral ulnar, radial, & palmar arch dopplerable signals. 
Palpable ulnar pulses.
Fingertips of bilateral second and third digits have gangrene
extending to the nailbed but not proximal to the distal
interphalangeal joint.
Left upper extremity AV fistula nonpalpable.  No thrill or 
pulse.

Both femoral and popliteal pulses are palpable.  There are no
palpable pulses present at the ankles.  Trace edema is present. 
Bilateral hallux ulceration involving the nailbeds to the
proximal interphalangeal joint is noted.  This has slight odor
but is largely dry.

 97.9  PO     BP 167 / 92 R Lying    // HR  82//   RR 17  //  
FSBS 63 
GEN:  awake/ alert /appropriate affect /speech clear
lungs: CTA bilaterally 
COR: + systolic murmur (known per pt)
ACW: right sub clavicular line dressing CDI
EXT:  known bilateral upper extremity digit dry gangrene to 
multiple fingers/ pictures in OMR.  DP and ___ pulses dopplerable 
with excellent signal bilaterally.  no edema - bilateral hallux 
incisions CDI without drainage.  Sutures intact.  

 
Pertinent Results:
___ 04:41AM BLOOD WBC-3.9* RBC-3.67* Hgb-10.5* Hct-35.1* 
MCV-96 MCH-28.6 MCHC-29.9* RDW-17.8* RDWSD-61.9* Plt ___
___ 04:39AM BLOOD WBC-5.2 RBC-3.86* Hgb-10.9* Hct-36.3* 
MCV-94 MCH-28.2 MCHC-30.0* RDW-17.8* RDWSD-60.7* Plt ___
___ 04:41AM BLOOD Plt ___
___ 04:39AM BLOOD Plt ___
___ 04:41AM BLOOD Glucose-102* UreaN-27* Creat-5.5*# Na-139 
K-4.5 Cl-94* HCO3-29 AnGap-16
___ 04:39AM BLOOD Glucose-89 UreaN-52* Creat-9.1* Na-137 
K-5.1 Cl-96 HCO3-23 AnGap-18
___ 04:41AM BLOOD Calcium-8.3* Phos-4.5 Mg-2.1
___ 04:39AM BLOOD Calcium-9.3 Phos-4.7* Mg-2.5
 
Brief Hospital Course:
Pt was admitted for the proposed procedure and underwent 
bilateral hallux amputation without difficulty.  His procedure 
was completed on ___ by Dr. ___.

Postop day one he went to HD and tolerated this well.  His diet 
and activity were advanced - lab values remained stable.  He was 
cleared to ambulate essential distances only with surgical 
shoes.  

His apixaban was restarted on post op day #1 at 2.5mg po bid.  

He will maintain Bactrim SS once daily x 5 days postoperatively. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. PredniSONE 5 mg PO EVERY OTHER DAY 
2. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever 
3. Gabapentin 300 mg PO QHS 
4. Cinacalcet 30 mg PO DAILY 
5. vitamin A and D    topical DAILY 
6. Metoprolol Succinate XL 25 mg PO DAILY 
7. NIFEdipine (Extended Release) 60 mg PO DAILY 
8. Apixaban 5 mg PO BID 
9. Epoetin ___ ___ UNIT IV WITH HD 
10. Ranitidine 150 mg PO DAILY 
11. Atorvastatin 80 mg PO QPM 
12. Furosemide 80 mg PO 4X/WEEK (___) 
13. Ferrous GLUCONATE 324 mg PO DAILY 
14. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 
15. OxyCODONE (Immediate Release) 10 mg PO QAM:PRN Pain - 
Moderate 
16. OxyCODONE (Immediate Release) 10 mg PO QPM:PRN Pain - 
Moderate 
17. OxyCODONE (Immediate Release) 30 mg PO NOON 
18. sevelamer CARBONATE 800 mg PO DAILY 
19. Amitriptyline 100 mg PO QHS 
20. folic acid-vit B6-vit B12 (vit B complx-folic ac-C-biotin) 
0.8-10-115 mg-mg-mcg oral DAILY 
21. Doxercalciferol 4 mcg IV 3X/WEEK (___) 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY 
RX *aspirin [Aspirin Low Dose] 81 mg 1 tablet(s) by mouth once a 
day Disp #*30 Tablet Refills:*11 
2.  Sulfameth/Trimethoprim SS 1 TAB PO DAILY Duration: 5 Days 
RX *sulfamethoxazole-trimethoprim [Bactrim] 400 mg-80 mg 1 
tablet(s) by mouth once a day Disp #*5 Tablet Refills:*0 
3.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever  
4.  Amitriptyline 100 mg PO QHS  
5.  Apixaban 5 mg PO BID  
6.  Atorvastatin 80 mg PO QPM  
7.  Cinacalcet 30 mg PO DAILY  
8.  Doxercalciferol 4 mcg IV 3X/WEEK (___)  
9.  Epoetin ___ ___ UNIT IV WITH HD  
10.  Ferrous GLUCONATE 324 mg PO DAILY  
11.  folic acid-vit B6-vit B12 (vit B complx-folic ac-C-biotin) 
0.8-10-115 mg-mg-mcg oral DAILY  
12.  Furosemide 80 mg PO 4X/WEEK (___)  
13.  Gabapentin 300 mg PO QHS  
14.  Metoprolol Succinate XL 25 mg PO DAILY  
15.  NIFEdipine (Extended Release) 60 mg PO DAILY  
16.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain  
17.  OxyCODONE (Immediate Release) 10 mg PO QPM:PRN Pain - 
Moderate  
18.  OxyCODONE (Immediate Release) 10 mg PO QAM:PRN Pain - 
Moderate  
19.  PredniSONE 5 mg PO EVERY OTHER DAY  
20.  Ranitidine 150 mg PO DAILY  
21.  sevelamer CARBONATE 800 mg PO DAILY  
22.  vitamin A and D    topical DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___ 
 
Discharge Diagnosis:
bilateral hallux gangrene

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent - should only be 
walking essential distances only in a surgical shoe 

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___.  During your hospitalization, you had surgery to 
remove unhealthy tissue on your lower extremity.  You tolerated 
the procedure well and are now ready to be discharged from the 
hospital.   Please follow the recommendations below to ensure a 
speedy and uneventful recovery.

LOWER  EXTREMITY AMPUTATION (bilateral first hallux) 
DISCHARGE INSTRUCTIONS

ACTIVITY 

You should keep your amputation site elevated whenever 
possible.It is very important that you put WEIGHT BEAR FOR 
ESSENTIAL DISTANCES ONLY UNTIL YOU ARE SEEN IN FOLLOW UP. 

MEDICATION

Before you leave the hospital, you will be given a list of all 
the medicine you should take at home.  If a medication that you 
normally take is not on the list or a medication that you do not 
take is on the list please discuss it with the team!  

You will likely be prescribed narcotic pain medication on 
discharge which  can be very constipating.  If you take 
narcotics,  please also take a stool softener such as Colace.   
If constipation becomes a problem, your pharmacist can suggest 
an additional over the counter laxative. 

You should take Tylenol ___ every 6 hours, as needed for 
pain.  If this is not enough, take your prescription narcotic 
pain medication.  You should require less pain medication each 
day.  Do not take more than a daily total of 3000mg of Tylenol.  
Tylenol is used as an ingredient in some other over-the-counter 
and prescription medications.  Be aware of how much Tylenol you 
are taking in a day.

BATHING/SHOWERING: 
You may shower when you feel strong enough but no tub baths or 
pools until you have permission from your surgeon and the 
incision is fully healed.  DO NOT SOAK YOUR INCISION.
After your shower, gently dry the incision well.   Do not rub 
the area. 

WOUND CARE:
Please keep the wound clean and dry. It is very important that 
there is no pressure on the wound.    If there is no drainage, 
you may leave the incision open to air.  

Your staples/sutures will remain in for at least 3 weeks.  At 
your followup appointment, we will see if the incision has 
healed enough to remove the sutures. 

CALL THE OFFICE FOR: ___
Opening, bleeding or drainage or odor from your wound incision 

Redness, swelling or warmth in your wound.
Fever greater than 101 degrees, chills, or worsening 
incisional/wound pain  

NO OTHER PROVIDER, EXCEPT YOUR VASCULAR SURGEON, SHOULD 
DETERMINE IF YOUR SUTURES ARE READY TO BE REMOVED FROM YOUR 
WOUND!   
IF THERE ARE ANY QUESTIONS, THE PROVIDER SHOULD CALL THE 
VASCULAR SURGERY OFFICE AT ___ TO DISCUSS.   THE 
SUTURES WILL BE REMOVED IN THE OFFICE AT YOUR FOLLOWUP 
APPOINTMENT WHEN IT IS DETERMINED BY THE VASCULAR SURGEON THAT 
THE WOUND HAS SUFFICIENTLY HEALED.
 
Followup Instructions:
___
"
24,10608904,21646110," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
latex / Penicillins / Cipro / Iodinated Contrast Media - IV Dye
 
Attending: ___.
 
Chief Complaint:
Decreased vision
 
Major Surgical or Invasive Procedure:
Ocular Biopsy

 
History of Present Illness:
___ with history of myotonic dystrophy and cutaneous B-cell
lymphoma and PET-avid adenopathy without evidence of 
lymphomatous
nodal infiltration who is admitted for further management of
lymphomatous infiltration of his bilateral orbits. 

The patient has a history of decreased vision over the past 
three
months. He was last seen by his oncologist on ___ with plans for
6 month follow-up. He went to see his optometrist on ___ given
worsened visual acuity, and this was confirmed (OD ___, OS
___. He therefore saw an ophthalmologist, who noted proptosis
with periorbital edema, dilated temporal episcleral veins and
decreased vision. An MRI of the orbits was ordered given concern
for retro-orbital mass. This came back positive for findings
consistent with bilateral lymphomatous infiltration of his
orbits, and he was therefore sent to the ___ ED.

In the ED, initial VS were: 96.5 90 139/91 19 96% RA 
Labs were notable for:  no acute changes from prior
Imaging included:  None
Consults called:  rad/onc and neuro-onc
Recommendations:  6 mg IV dexamethasone q6h, formal consults to
follow but will likely need systemic chemo and radiation
Treatments received: 6 mg IV dex, 20 mg omeprazole, 4 mg IV
morphine
  
On arrival to the floor, patient endorses the above story as 
well
as sinus pressure that is not particularly bothersome. He thinks
his vision, especially in his right eye, is improving.  
 
Past Medical History:
- B cell lymphoma, cutaneous, as above
- chronic pain
- tobacco dependence
- pulmonary emphysema
- dysplipidemia
- ventricular premature contractions
- prehypertension
- myotonic dystrophy
- low testosterone
- chronic prostatitis
- BPH
 
Social History:
___
Family History:
- mother's sister with colon cancer
- sister with unknown type of gynecologic cancer
 
Physical Exam:
GENERAL: NAD  
HEENT:  EOMI, no pain with extraocular movements, visual fields
appear grossly intact, no oropharyngeal lesions, anicteric
sclera, some periocular edema greater on the right.
CARDIAC:  RRR
LUNG:   CTAB
ABD:  NT/ND, no organomegaly appreciated
EXT:  WWP,  no edema.
NEURO: Alert and oriented, CN except visual acuity intact,
sensation intact to light touch throughout, moves all four
extremities with purpose, strength intact
SKIN: no rash
 
Pertinent Results:
___

WBC: 7.0. RBC: 4.88. HGB: 15.8. HCT: 45.9. MCV: 94. RDW: 12.3.
Plt Count: 255. 
Na: 135. K: 4.3. Cl: 98. BUN: 20. Creat: 0.7. 
 
Brief Hospital Course:
___ with history of myotonic dystrophy and cutaneous B-cell
lymphoma with PET-avid nodes without evidence of lymphoma in
these nodes who is admitted for management of lymphomatous
infiltration of his bilateral orbits.

# Lymphomatous infiltration of orbits: Vision improved with IV
steroids.  
- dexamethasone 6 mg IV q6h, will switch to PO on discharge.
- omeprazole 20 mg daily
- artificial tears (home med)
- neuro-onc and rad-onc consulted; s/p mapping and radiation. 
- For pain, continued on PRN oxycodone and Tylenol for 
headaches.
- CT torso with pre-meds due to contrast allergy ordered for
staging.
- Ophthalmology consulted for biopsy as this is possibly a
different and more aggressive type of lymphoma than his previous
cutaneous. He was transferred to mass eye and ear ___ for biopsy
due to lack of necessary equipment being available here and
returned later in the day.
- Erythromycin ointment to eye per optho.
- Ice packs to eye that had biopsy.
- Follow up on biopsy pathology, preliminary read unclear.

# Myotonic dystrophy: Continued home meds

# Insomnia: Trazodone at home dose

# Dyslipidemia: Continued atorvastatin

# Depression: Continued venlafaxine

# Emphysema: Continued flovent, albuterol

# EMERGENCY CONTACT HCP: Patient stated that his mother was
previously his proxy but he does not wish for this to be the 
case
given her frailty. He has no other family or friends that he can
identify as HCP. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. clomiPHENE citrate 50 mg oral 3X/WEEK 
2. Atorvastatin 40 mg PO QPM 
3. Mexiletine 150 mg PO Q8H 
4. Gabapentin 300 mg PO TID 
5. Nabumetone 500 mg PO BID 
6. TraZODone 200 mg PO QHS 
7. Venlafaxine XR 150 mg PO DAILY 
8. Fluticasone Propionate 110mcg 2 PUFF IH BID 
9. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB, wheeze 
10. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
11. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 

 
Discharge Medications:
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB, wheeze 
2. Atorvastatin 40 mg PO QPM 
3. Fluticasone Propionate 110mcg 2 PUFF IH BID 
4. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
5. Gabapentin 300 mg PO TID 
6. Mexiletine 150 mg PO Q8H 
7. TraZODone 200 mg PO QHS 
8. Venlafaxine XR 150 mg PO DAILY 
9. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 
10. Acetaminophen 1000 mg PO Q8H:PRN Pain 
RX *acetaminophen 500 mg 2 tablet(s) by mouth three times a day 
Disp #*30 Tablet Refills:*0
11. Docusate Sodium 100 mg PO BID Constipation 
RX *docusate sodium [Stool Softener] 50 mg 2 capsule(s) by mouth 
twice a day Disp #*30 Capsule Refills:*0
12. Omeprazole 20 mg PO DAILY 
RX *omeprazole 20 mg 1 capsule(s) by mouth daily Disp #*7 
Capsule Refills:*0
13. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN Pain 
RX *oxycodone 5 mg 1 capsule(s) by mouth Q4 hour Disp #*12 
Capsule Refills:*0
14. Polyethylene Glycol 17 g PO BID:PRN Constipation 
RX *polyethylene glycol 3350 17 gram/dose 17gm gm by mouth twice 
a day Refills:*0
15. Senna 8.6 mg PO BID:PRN Constipation 
RX *sennosides 8.6 mg 8.6 mg by mouth twice a day Disp #*30 
Tablet Refills:*0
16. clomiPHENE citrate 50 mg oral 3X/WEEK 
17. Nabumetone 500 mg PO BID 
18. Erythromycin 0.5% Ophth Oint 0.5 in RIGHT EYE TID 
RX *erythromycin 5 mg/gram (0.5 %) 5 mg in the right eye three 
times a day Refills:*0
19. Dexamethasone 6 mg PO Q6H 
RX *dexamethasone 6 mg 1 tablet(s) by mouth four times a day 
Disp #*28 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Ocular Lymphoma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
 You presented to the hospital with decreased vision and were 
evaluated by opthamology and oncology, and started radiation for 
ocular lymphoma. You were sent home on pain medications, oral 
steroids, and a bowel regimen and will have close follow up with 
those services. 
 
Followup Instructions:
___
"
25,10614625,25891474," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
Motrin / Zantac / Penicillins
 
Attending: ___
 
___ Complaint:
Right knee pain
 
Major Surgical or Invasive Procedure:
RIGHT TOTAL KNEE ARTHROPLASTY

 
History of Present Illness:
HPI: ___ with history of chronic right knee pain

 
Past Medical History:
PMH: Chronic Back Pain, Asthma, DM, Hyperlipidemia, HTN, 
migraine, elevated BMI, OA, rosacea, OSA, Followed by 
Psychiatry, diverticulosis

PSH: History of 11 prior abdominal procedures including ovarian 
procedure, bowel perforation, Hysterectomy, Ovaryiectomy 
w/single remaining ovary
 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
Well appearing in no acute distress
Afebrile with stable vital signs
 Pain well-controlled
 Respiratory: CTAB
 Cardiovascular: RRR
 Gastrointestinal: NT/ND
 Genitourinary: Voiding independently
 Neurologic: Intact with no focal deficits
 Psychiatric: Pleasant, A&O x3
 Musculoskeletal Lower Extremity:
  *   Incision healing well with staples
  *   Scant serosanguinous drainage
  *   Thigh full but soft
  *   No calf tenderness
  *   ___ strength ___
  *   SILT DP/SP/T/S/S
  *   Toes warm
 
Pertinent Results:
___ 10:50AM BLOOD WBC-4.8 RBC-3.22* Hgb-8.4* Hct-27.0* 
MCV-84 MCH-26.0* MCHC-31.1 RDW-17.6* Plt ___
___ 07:25AM BLOOD WBC-7.6 RBC-2.89* Hgb-7.3* Hct-23.6* 
MCV-82 MCH-25.1* MCHC-30.8* RDW-17.2* Plt ___
___ 07:20AM BLOOD WBC-9.8 RBC-3.31* Hgb-8.3* Hct-26.7* 
MCV-81* MCH-25.1* MCHC-31.2 RDW-17.4* Plt ___
___ 07:10AM BLOOD WBC-6.8 RBC-3.33* Hgb-8.3* Hct-27.4* 
MCV-82 MCH-25.0* MCHC-30.3* RDW-16.6* Plt ___
___ 07:25AM BLOOD Glucose-161* UreaN-16 Creat-0.8 Na-133 
K-4.2 Cl-99 HCO3-25 AnGap-13
___ 07:20AM BLOOD Glucose-193* UreaN-13 Creat-0.8 Na-134 
K-4.2 Cl-100 HCO3-25 AnGap-13
___ 07:10AM BLOOD Glucose-241* UreaN-14 Creat-0.8 Na-134 
K-4.6 Cl-100 HCO3-26 AnGap-13
___ 07:20AM BLOOD Phos-2.1* Mg-1.7
___ 07:10AM BLOOD Calcium-8.4 Phos-2.2* Mg-1.2*
 
Brief Hospital Course:
The patient was admitted to the orthopaedic surgery service and 
was taken to the operating room for above described procedure. 
Please see separately dictated operative report for details. The 
surgery was uncomplicated and the patient tolerated the 
procedure well. Patient received perioperative IV antibiotics.

Postoperative course was remarkable for the following:
POD#2  Tm 102.9 overnight (11pm)), UA sent which was negative, 
no further fever workup pursued given pod#1 and has not been 
using IS nor ambulating much.  No pulmonary sx, no urinary sx, 
likely atelectasis and continued to monitor closely.
POD#3 was tachycardic to Tm 101.9 at 3am, tachy to 114, 95%2L 
denied sob/pleuritic chest pain, reported that uses O2 at home 
sometimes, no urinary sx, reports ear pain, no calf pain. 
Incision c/d/i with small area of ecchymosis/erythema.  
Cxr/ua/blood cultures ordered with close monitoring for any 
changes in symptoms and to determine need for further workup 
with PE CT if does not improve given fever/tachy/O2 requirement 
overnight. Also received 1u prbc for drop in hematocrit.
POD#4 Tachycardia improved s/p prbc transfusion, decreased O2 
requirement overnight, afebrile, chest x-ray shows decreased 
lung volume, ua negative. Remained afebrile and asymptomatic 
with no further O2 requirement throughout day, was mildly 
somnolent, but A&Ox3 and easily arousable.  Incision c/d/i with 
___ erythema. Otherwise pain well controlled and no 
acute symptoms 

Otherwise, pain was initially controlled with a PCA followed by 
a transition to oral pain medications on POD#1.  The patient 
received lovenox for DVT prophylaxis starting on the morning of 
POD#1.  The foley was removed on POD#2 and the patient was 
voiding independently thereafter. The surgical dressing was 
changed on POD#2 and the surgical incision was found to be clean 
and intact without erythema or abnormal drainage. The patient 
was seen daily by physical therapy. Labs were checked throughout 
the hospital course and repleted accordingly. At the time of 
discharge the patient was tolerating a regular diet and feeling 
well.  The patient was afebrile with stable vital signs.  The 
patient's hematocrit was acceptable and pain was adequately 
controlled on an oral regimen. The operative extremity was 
neurovascularly intact and the wound was benign. 

The patient's weight-bearing status is weight bearing as 
tolerated on the operative extremity.
 

Ms. ___ is discharged to home with services/rehab in 
stable condition.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN Wheezing 
2. Amitriptyline 30 mg PO HS 
3. Clonazepam 1 mg PO BID 
4. Fluoxetine 40 mg PO DAILY 
5. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
6. Fluticasone Propionate 110mcg 2 PUFF IH BID 
7. Furosemide 20 mg PO DAILY 
8. Gabapentin 800 mg PO BID 
9. GlipiZIDE XL 10 mg PO BID 
10. Hyoscyamine 0.125 mg PO QID 
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. Omeprazole 20 mg PO BID 
13. Quetiapine Fumarate 200 mg PO QHS 
14. Simvastatin 40 mg PO DAILY 
15. Januvia *NF* (sitaGLIPtin) 100 mg Oral QD 
16. Cetirizine *NF* 10 mg Oral QD 
17. Albuterol Inhaler 2 PUFF IH Q6H:PRN Wheezing 
18. Detrol LA *NF* (tolterodine) 4 mg Oral QHS 

 
Discharge Medications:
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN Wheezing 
2. Albuterol Inhaler 2 PUFF IH Q6H:PRN Wheezing 
3. Amitriptyline 30 mg PO HS 
4. Cetirizine *NF* 10 mg Oral QD 
5. Clonazepam 1 mg PO BID 
6. Fluoxetine 40 mg PO DAILY 
7. Fluticasone Propionate 110mcg 2 PUFF IH BID 
8. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
9. Furosemide 20 mg PO DAILY 
10. Gabapentin 800 mg PO BID 
11. GlipiZIDE XL 10 mg PO BID 
12. Hyoscyamine 0.125 mg PO QID 
13. Januvia *NF* (sitaGLIPtin) 100 mg Oral QD 
14. MetFORMIN (Glucophage) 1000 mg PO BID 
15. Quetiapine Fumarate 200 mg PO QHS 
16. Simvastatin 40 mg PO DAILY 
17. Acetaminophen 650 mg PO Q6H 
18. Docusate Sodium 100 mg PO BID 
19. Enoxaparin Sodium 40 mg SC UNDEFINED Duration: 4 Weeks 
RX *enoxaparin 40 mg/0.4 mL 40 u Q24H Disp #*30 Syringe 
Refills:*0
20. Omeprazole 20 mg PO BID 
21. Senna 1 TAB PO BID 
22. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN Pain 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours 
Disp #*80 Tablet Refills:*0
23. Detrol LA *NF* (tolterodine) 4 mg Oral QHS 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
RIGHT KNEE OSTEOARTHRITIS

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
1. Please return to the emergency department or notify your 
physician if you experience any of the following: severe pain 
not relieved by medication, increased swelling, decreased 
sensation, difficulty with movement, fevers greater than 101.5, 
shaking chills, increasing redness or drainage from the incision 
site, chest pain, shortness of breath or any other concerns.
2. Please follow up with your primary physician regarding this 
admission and any new medications and refills. 
3. Resume your home medications unless otherwise instructed.
4. You have been given medications for pain control. Please do 
not drive, operate heavy machinery, or drink alcohol while 
taking these medications. As your pain decreases, take fewer 
tablets and increase the time between doses. This medication can 
cause constipation, so you should drink plenty of water daily 
and take a stool softener (such as colace) as needed to prevent 
this side effect.  Call your surgeons office 3 days before you 
are out of medication so that it can be refilled.  These 
medications cannot be called into your pharmacy and must be 
picked up in the clinic or mailed to your house.  Please allow 
an extra 2 days if you would like your medication mailed to your 
home.
5. You may not drive a car until cleared to do so by your 
surgeon.
6. Please keep your wounds clean. You may shower starting five 
(5) days after surgery, but no tub baths or swimming for at 
least four (4) weeks. No dressing is needed if wound continues 
to be non-draining. Any stitches or staples that need to be 
removed will be taken out at your follow-up visit in three (3) 
weeks after your surgery.
7. Please call your surgeon's office to schedule or confirm your 
follow-up appointment in three (3) weeks.
8. Please DO NOT take any non-steroidal anti-inflammatory 
medications (NSAIDs such as celebrex, ibuprofen, advil, aleve, 
motrin, etc).
9. ANTICOAGULATION: Please continue your lovenox for four (4) 
weeks to help prevent deep vein thrombosis (blood clots).  If 
you were taking aspirin prior to your surgery, it is OK to 
continue at your previous dose while taking this medication.  
___ STOCKINGS x 6 WEEKS.
10. WOUND CARE: Please keep your incision clean and dry. It is 
okay to shower five days after surgery but no tub baths, 
swimming, or submerging your incision until after your four (4) 
week checkup. Please place a dry sterile dressing on the wound 
each day if there is drainage, otherwise leave it open to air. 
Check wound regularly for signs of infection such as redness or 
thick yellow drainage. Staples will be removed at your follow-up 
visit in three (3) weeks.
11. ___ (once at home): Home ___, dressing changes as 
instructed, and wound checks.
12. ACTIVITY: Weight bearing as tolerated on the operative 
extremity. Mobilize. CPM/ROM as tolerated. No strenuous exercise 
or heavy lifting until follow up appointment.
Physical Therapy:
ACTIVITY: Weight bearing as tolerated on the operative 
extremity. Mobilize. CPM/ROM as tolerated. No strenuous exercise 
or heavy lifting until follow up appointment.
Treatments Frequency:
WOUND CARE: Please keep your incision clean and dry. It is okay 
to shower five days after surgery but no tub baths, swimming, or 
submerging your incision until after your four (4) week checkup. 
Please place a dry sterile dressing on the wound each day if 
there is drainage, otherwise leave it open to air. Check wound 
regularly for signs of infection such as redness or thick yellow 
drainage. Staples will be removed at your follow-up visit in 
three (3) weeks.

 
Followup Instructions:
___
"
26,10614625,20238164," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins
 
Attending: ___.
 
Chief Complaint:
hyperglycemia/polyuria
 
Major Surgical or Invasive Procedure:
NONE

 
History of Present Illness:
___ y/o female with PMHx of DM2 presenting with hyperglycemia.  
Patient notes about 1 week of polydipsia and polyuria, family 
checked her FSBS which was in the 400s for them over past 
several days. Patient also reports nausea and SOB with cough, 
non-productive. She was diagnosed with bronchitis a few weeks 
ago, treatment included steroids which she completed over 1 week 
ago.  
She reports taking all her medications except Januvia, which she 
hasn't been able to fill for past few days due to insurance 
issue. Denies missing any doses of metformin or glipizide. 
Denies any fevers/chills, chest pain, abd pain, vomiting, 
dysuria, rash.  
Initial vital signs in the ED were 97.7 92 148/84 16 99% on room 
air. Her first FSBG was 439. Labs with WBC 7.8 Hbg/Hct 12.8/37.8 
Plt 96. Chemistry with Na 135 K 4.7 Cl 94 HCO3 24 BUN 41 Cr 1.3. 
Lactate was 5.4. Urinalysis was negative and no ketones. VBG 
with pH of 7.4, pCO2 of 34. Flu swab was negative. CXR was 
normal.  
She was given 10 units of regular insulin, 2L of IVFs. Repeat 
FSBG still in the 400s, repeat lactate was 4.3. She was given 
another 14units of SQ insulin, and admitted to medicine for 
further treatment.  
Vital signs on transfer were: 97.9 66 144/72 18 98% RA  
Upon arrival to the floor, she reports dry cough, mild dyspnea. 
No chest pain or palpitations. Mild nausea but no vomiting or 
diarrhea  
Review of Systems:  
(+) per HPI  
(-) fever, chills, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, chest pain, abdominal pain, 
vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, 
dysuria, hematuria.  
 
Past Medical History:
PMH: Chronic Back Pain, Asthma, DM, Hyperlipidemia, HTN, 
migraine, elevated BMI, OA, rosacea, OSA, Followed by 
Psychiatry, diverticulosis

PSH: History of 11 prior abdominal procedures including ovarian 
procedure, bowel perforation, Hysterectomy, Ovaryiectomy 
w/single remaining ovary
 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
Vitals 98.3 134/80 p76 r18 95%RA  
GENERAL: Alert and oriented. NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, good dentition  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: Bilateral wheezes with appreciable air entry  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

DISCHARGE PHYSICAL EXAM
PHYSICAL EXAM:  
Vitals 97.9 161/72 68 18 97 on RA 
GENERAL: Alert and oriented. NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, good dentition  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: minimal Bilateral wheezes with appreciable air entry  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 
 
Pertinent Results:
ADMISSION LABS
==================
___ 06:10PM   PLT COUNT-96*
___ 06:10PM   NEUTS-76.6* LYMPHS-17.2* MONOS-5.4 EOS-0.8 
BASOS-0.1
___ 06:10PM   WBC-7.8# RBC-4.50 HGB-12.8 HCT-37.8 MCV-84 
MCH-28.4 MCHC-33.7 RDW-16.8*
___ 06:10PM   GLUCOSE-499*
___ 06:10PM   ALBUMIN-4.4
___ 06:10PM   LIPASE-45
___ 06:10PM   ALT(SGPT)-59* AST(SGOT)-37 ALK PHOS-160* TOT 
BILI-0.4
___ 06:10PM   estGFR-Using this
___ 06:10PM   GLUCOSE-522* UREA N-41* CREAT-1.3* SODIUM-135 
POTASSIUM-4.7 CHLORIDE-94* TOTAL CO2-24 ANION GAP-22
___ 07:21PM URINE  RBC-1 WBC-4 BACTERIA-FEW YEAST-NONE 
EPI-5
___ 07:21PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR 
GLUCOSE-1000 KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-NEG
___ 07:21PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 07:21PM URINE  GR HOLD-HOLD
___ 07:21PM URINE  UHOLD-HOLD
___ 07:21PM URINE  HOURS-RANDOM
___ 07:21PM URINE  HOURS-RANDOM
___ 07:52PM   LACTATE-5.4*
___ 07:52PM   ___ PO2-60* PCO2-34* PH-7.40 TOTAL 
CO2-22 BASE XS--2
___ 08:30PM OTHER BODY FLUID  FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
___ 11:15PM   GLUCOSE-436* UREA N-33* CREAT-1.0 SODIUM-136 
POTASSIUM-5.1 CHLORIDE-101 TOTAL CO2-21* ANION GAP-19
___ 11:42PM   LACTATE-4.3*
___ 05:59AM   PLT COUNT-91*
___ 05:59AM   WBC-5.6 RBC-4.06* HGB-11.1* HCT-33.6* MCV-83 
MCH-27.4 MCHC-33.1 RDW-16.7*
___ 05:59AM   ALBUMIN-3.9 CALCIUM-8.5 PHOSPHATE-2.6* 
MAGNESIUM-2.0
___ 05:59AM   ALT(SGPT)-44* AST(SGOT)-33 LD(LDH)-135 ALK 
PHOS-137* TOT BILI-0.3
___ 05:59AM   GLUCOSE-209* UREA N-27* CREAT-1.0 SODIUM-137 
POTASSIUM-4.9 CHLORIDE-101 TOTAL CO2-24 ANION GAP-17
___ 09:24AM   LACTATE-2.4*
___ 01:46PM   LACTATE-3.8*
___ 06:49PM   CALCIUM-7.9* PHOSPHATE-2.4* MAGNESIUM-1.7
___ 06:49PM   GLUCOSE-311* UREA N-23* CREAT-0.9 SODIUM-136 
POTASSIUM-4.7 CHLORIDE-102 TOTAL CO2-22 ANION GAP-17
___ 07:38PM   LACTATE-3.0*

STUDIES
=============
Cardiovascular ReportECGStudy Date of ___  6:53:46 ___
 
Sinus rhythm. Left ventricular hypertrophy. Non-specific septal 
ST-T wave
changes. Compared to the previous tracing of ___ no 
diagnostic change.
 
Read ___.
 IntervalsAxes
___
___

___ CXR
IMPRESSION: 
No acute cardiopulmonary abnormality.

DISCHARGE LABS
======================
___ 07:45AM BLOOD WBC-5.3 RBC-3.98* Hgb-10.9* Hct-33.4* 
MCV-84 MCH-27.5 MCHC-32.8 RDW-16.9* Plt Ct-84*
___ 07:45AM BLOOD Plt Ct-84*
___ 07:45AM BLOOD Glucose-123* UreaN-16 Creat-0.8 Na-139 
K-4.3 Cl-105 HCO3-26 AnGap-12
___ 05:59AM BLOOD ALT-44* AST-33 LD(LDH)-135 AlkPhos-137* 
TotBili-0.3
___ 07:45AM BLOOD Calcium-9.0 Phos-3.0 Mg-2.2
___ 08:01AM BLOOD Lactate-1.8
 
Brief Hospital Course:
Ms. ___ is a ___ woman with Type 2 DM, asthma and recent 
bronchitis episode who p/w with polydypsia, polyuria, 
hyperglycemia and elevated lactate. Patient was found to have 
FSBG greater than 400 on admission. Elevated BS most likely 
triggered by recent corticosteroid use and also not having her 
Januvia for some days concurrently. Patient started on insulin 
and given many liters of IV fluid resuscitation. Patient Lactate 
downtrended to within normal values with aggressive fluid 
administration. Patient was seen by ___ who assisted with 
titrating insulin. Patient had difficulty with drawing up 
insulin and grandson (whom lives with patient) will help 
administer insulin at home. Patient will follow up with PCP and 
___ contact patient after discharge for a follow up. 

ACUTE ISSUES
=====================
# Hyperglycemia/Diabetes Mellitus Type II, uncontrolled: 
Elevated BS most likely triggered by recent corticosteroid use 
and also not having her Januvia for some days concurrently. NO 
s/sxs of acute infection; chest xray clear and urine with few 
bacteria but 5epithelial cells. No GI symptoms. BG down to 332 
on the floor. No e/o DKA. Patient Lactate downtrending after 
IVF. Patient seen by ___ while in the hospital and started on 
long and prandial insulin while in the hospital. The patient was 
discontinued on metformin/januvia due to elevated lactate. The 
patient will return home on glipizide and insulin. The patient 
and the patient's grandson were trained at administering insulin 
while in the hospital by the ___ educator and the nursing 
team. The patient will follow up with ___ and PCP.   See 
medication list for discharge dose of insulin. 

# Elevated lactate: Likely due to osmotic diuresis in setting of 
significant hyperglycemia. resolving with IVF on ___. Lactate 
trending down, but still abnormal on ___. Lactate normalized on 
___ after multiple units of isotonic fluid. We held metformin 
and januvia in setting of elevated lactate. Patient was 
responsive to fluid and will need close follow up with PCP after 
discharge. Lactate normal on discharge. 

# HTN: Patient was started on Lisinopril for her high blood 
pressure given her diabetes. Patient will follow up with her 
PCP. Held Lasix due to polyuria from hyperglycemia. Will see PCP 
prior to restarting. 

CHRONIC ISSUES
=====================

# Asthma: Stable on admission. Avoided all steroid medications. 
Continued patient on all home inhalers and nebulizers. 

# HLD: Continued statin. 

# Anxiety/Depression: Continued on home medications. 

TRANSITIONAL ISSUES
=====================
- patient started on Insulin (lantus and humalog with sliding 
scale) (see below for dosages)
- patient and grandson provided ___ with ___ and 
nursing
- patient started on Lisinopril 5mg PO daily, please check 
electrolytes as below
- stopped Lasix due to polyuria; should follow up with PCP prior 
to restarting
- stopped Metformin and Januvia due to elevated Lactate and poor 
glucose control while inpatient. 
- patient will need Chem 10 (Chem 7 plus Ca, Mag and Phos) drawn 
on ___ and faxed to Dr. ___ (FAX: 
___
- patient should also have repeat UA in her PCP to check for 
glucosiuria at first appointment. 
- patient will need follow up with ___ after discharge. If 
she has not heard by her apt on ___, she should call the 
___ for help with obtaining an appointment
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
2. albuterol sulfate 90 mcg/actuation inhalation q6h prn 
shortness of breath 
3. Cyanocobalamin Dose is Unknown  PO DAILY 
4. Fluoxetine 40 mg PO DAILY 
5. Flovent HFA (fluticasone) 220 mcg/actuation inhalation Q 6H 
prn shortness of breath 
6. Furosemide 20 mg PO DAILY 
7. Gabapentin 400 mg PO TID 
8. GlipiZIDE XL 10 mg PO BID 
9. Hyoscyamine SO4 (Time Release) 0.125 mg PO QID 
10. Combivent Respimat (ipratropium-albuterol) ___ 
mcg/actuation inhalation QID PRN Shortness of breath 
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. metroNIDAZOLE 0.75 % topical BID 
13. Montelukast 10 mg PO DAILY 
14. Mupirocin Ointment 2% 1 Appl TP BID 
15. Nystatin Oral Suspension 5 mL PO QID 
16. Omeprazole 20 mg PO BID 
17. QUEtiapine Fumarate 200 mg PO QHS 
18. Simvastatin 40 mg PO QPM 
19. sitaGLIPtin 100 mg oral DAILY 
20. Acetaminophen 1000 mg PO Q8H:PRN PAIN 
21. Cetirizine 10 mg PO DAILY 
22. Docusate Sodium 100 mg PO DAILY:PRN CONSTIPATION 
23. Ferrous Sulfate 325 mg PO BID 
24. ClonazePAM 1 mg PO BID 

 
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H:PRN PAIN 
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
3. ClonazePAM 1 mg PO BID 
4. Docusate Sodium 100 mg PO DAILY:PRN CONSTIPATION 
5. Ferrous Sulfate 325 mg PO BID 
6. Fluoxetine 40 mg PO DAILY 
7. Gabapentin 400 mg PO TID 
8. GlipiZIDE XL 10 mg PO BID 
9. Montelukast 10 mg PO DAILY 
10. Omeprazole 20 mg PO BID 
11. QUEtiapine Fumarate 200 mg PO QHS 
12. Simvastatin 40 mg PO QPM 
13. albuterol sulfate 90 mcg/actuation INHALATION Q6H PRN 
shortness of breath 
14. Cetirizine 10 mg PO DAILY 
15. Combivent Respimat (ipratropium-albuterol) ___ 
mcg/actuation inhalation QID PRN Shortness of breath 
16. Cyanocobalamin 250 mcg PO DAILY 
17. Flovent HFA (fluticasone) 220 mcg/actuation inhalation Q 6H 
prn shortness of breath 
18. Hyoscyamine SO4 (Time Release) 0.125 mg PO QID 
19. metroNIDAZOLE 0.75 % topical BID 
20. Mupirocin Ointment 2% 1 Appl TP BID 
21. Nystatin Oral Suspension 5 mL PO QID 
22. Lisinopril 5 mg PO DAILY 
RX *lisinopril 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
23. Glargine 15 Units Breakfast
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
RX *insulin glargine [Lantus Solostar] 100 unit/mL (3 mL) ___ Units before BKFT; 14 Units at night Disp #*1 
Syringe Refills:*5
RX *insulin lispro [Humalog KwikPen] 100 unit/mL 1 injection sq 
Up to 14 Units QID per sliding scale 14 Units before LNCH; Units 
QID per sliding scale 14 Units before DINR; Disp #*1 Syringe 
Refills:*5
RX *lancets ___ FastClix]  1 fingerstick four times a day 
Disp #*100 Each Refills:*3
RX *insulin syringe-needle U-100 [Advocate Syringes] 30 gauge x 
___ 1 syringe QID for insulin administration Disp #*100 
Syringe Refills:*5
24. Outpatient Lab Work
Please draw a Chem 10 on ___ and forward to ___. 
MD ___ ___. ICD 9 250.0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY: Insulin Dependent Diabetes Melitus; Elevated Lactate; 
Dehydration ___ Polydipsia
SECONDARY: HLD, HTN, Migraines, Osteoarthritis, Sleep Apnea

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

It was a pleasure to take part in your care during your stay 
here at ___. You came into the hospital after noticing 
multiple finger stick blood sugars greater than 400 at home. You 
were also noting increased urination at home during these 
episodes of high blood sugar. You were brought to the medical 
floor for rehydration and for tighter control of your blood 
sugars. You were seen by the ___ team and started on Insulin 
for better control. You were discharged on insulin and glipizide 
and will follow up with your PCP and with the ___ team. 

Thank you for allowing us to participate in your care during 
your stay in the hospital. 

Sincerely, 

Your ___ Team
 
Followup Instructions:
___
"
27,10614625,28844762," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins
 
Attending: ___.
 
Chief Complaint:
headache, backpain 
 
Major Surgical or Invasive Procedure:
None 

 
History of Present Illness:
___ F pmh migraine headaches, asthma, IDDM, HTN, HLD who with 
one week history of headache, back pain and three days of right 
flank pain. She states she has a mild headache, cough, feels 
generally weak. She also reports lower back pain. She states the 
back pain began 4 days ago when she bent over. Denies any focal 
numbness or weakness.  
 Patient states 2 weeks prior to presentation to the ED, she had 
similar symptoms of back pain and headache. She was hydrated 
with IVF and discharged home. About 1 week prior to presentation 
to the ED, headache returned and she describes it as starting 
behind the right eye and radiating through the back of her head 
with sore neck muscles, light sensitivity and nausea. Denies 
aura or vomiting.  
 Patient also developed symptoms of dysuria three days prior to 
presentation to the ED. She endorsed two episodes of hematuria, 
suprapubic pain, and right flank pain.  
 Patient endorses back pain in the cervical and lumbar regions. 
She endorses the pain has worsened over the past week, is tender 
to the touch. Denies recent falls or trauma. Patient has a 
history of multiple abdominal surgeries including 
hystercotomy/splinoorphrtomy in ___ complicated by 11 
intestinal surgeries due to perforated bowel.  
 In the ED, initial VS were temp 96.0 HR 103 BP 142/78 RR ___ 
RA  
 Exam in the ED demonstrated CV RRR, lungs CTA, mild diffuse 
abdominal pain with no rebound. Patient was treated with APAP 
1000, 650 mg, Ketorolac 15 mg 2X,clonazepam 1 mg, Montelukast 10 
mg, Fluoxetine 20 mg and 2U insulin for a blood glucose of 203.  

 Patient was given 3L NS. Labs showed an elevated creatnine to 
1.7 on admission that downtrended to 1.3 after resuscitation 
with 3 L NS. and low platlet count to 71; her platelet count has 
been down trending for the past year. UA 2X was contaminated. 
Flu was negative. Imaging showed CXR was normal, no focal 
consolidation, effusion, or pneumothorax and no free air under 
the diaphragm.  
 Transfer VS were Temp 97.8F HR 81 BP 110/63 RR 18 96% RA  
 Decision was made to admit to medicine for further management.  

 On arrival to the floor, patient reports ___ pain in head, 
neck, cervical and lumbar spine, right sided flank and upper 
quadrant pain.  
 abdominal pain, nausea, vomiting, diarrhea, constipation, 
BRBPR, melena, hematochezia, dysuria, hematuria.  

 
Past Medical History:
PMH: Chronic Back Pain, Asthma, DM, Hyperlipidemia, HTN, 
migraine, elevated BMI, OA, rosacea, OSA, Followed by 
Psychiatry, diverticulosis

PSH: History of 11 prior abdominal procedures including ovarian 
procedure, bowel perforation, Hysterectomy, Ovaryiectomy 
w/single remaining ovary
 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
============================
 VS - Temp 98.3F BP 128/67 HR 77 RR 18 99% RA Blood glucose 141  

 Weight 178 kg  
 GENERAL: NAD  
 HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, poor dentition  
 NECK: No JVD  
 CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
 LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
 ABDOMEN: RUQ and right flank TTP, +BS,no rebound/guarding  
 EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
 PULSES: 2+ DP pulses bilaterally  
 NEURO: CN II-XII intact  
 SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

DISCHARGE PHYSICAL EXAM: 
=========================
VS - Temp 98.3F BP 128/67 HR 77 RR 18 99% RA Blood glucose 141  
 Weight 178 kg  
 GENERAL: NAD  
 HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, poor dentition  
 NECK: No JVD  
 CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
 LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
 ABDOMEN: RUQ and right flank TTP, +BS,no rebound/guarding  
 EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
 PULSES: 2+ DP pulses bilaterally  
 NEURO: CN II-XII intact  
 SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

 
Pertinent Results:
ADMISSION LABS: 
===================
___ 05:43PM BLOOD WBC-4.7 RBC-4.14 Hgb-12.0 Hct-37.0 MCV-89 
MCH-29.0 MCHC-32.4 RDW-14.7 RDWSD-47.8* Plt Ct-71*
___ 05:43PM BLOOD Neuts-52.1 ___ Monos-14.0* 
Eos-0.4* Baso-0.6 Im ___ AbsNeut-2.45 AbsLymp-1.52 
AbsMono-0.66 AbsEos-0.02* AbsBaso-0.03
___ 05:43PM BLOOD Plt Ct-71*
___ 05:43PM BLOOD Glucose-164* UreaN-28* Creat-1.6* Na-135 
K-4.9 Cl-98 HCO3-24 AnGap-18

DISCHARGE LABS: 
==================
___ 07:15AM BLOOD Glucose-88 UreaN-18 Creat-1.2* Na-137 
K-4.1 Cl-103 HCO3-23 AnGap-15
___ 07:15AM BLOOD Albumin-3.5 Calcium-8.3* Phos-2.5* 
Mg-1.4*

RESULTS: 
==========
Cardiovascular Report ECG Study Date of ___  4:26:34 ___ 

Sinus rhythm. RSR' pattern in lead V1 with early precordial R 
wave transition of unclear significance but which could be 
related to variations in precordial lead positioning. Compared 
to the previous tracing of ___ the findings are similar 
overall. 

  Intervals     Axes 
Rate PR QRS QT QTc (___)    P QRS T 
95 134 91 ___   20 0 40 
 
CHEST (PA & LAT) Study Date of ___  
IMPRESSION: 
No acute intrathoracic process. 

 
Brief Hospital Course:
___ F pmh migraine headaches, asthma, IDDM, HTN, HLD who with 
one week history of headache, back pain and three days of 
dysuria, right flank pain. 
 
# Migraine headache: patient has history of migraine headaches. 
She received ketorolac 15mg X2 in ED, and sumatriptan with some 
relief. Headache was resolved at time of discharge, with no red 
flag symptoms, and to be followed by PCP. 

# Back pain: history of chronic back pain. No recent falls or 
trauma. No spinous process tenderness or alarm symptoms.  
Improved with tizanidine, APAP, lidocaine patch. 

# ___: Baseline Cr 0.8-1.0; Mild renal cortical atrophy 
bilaterally. On admission, Cr was 1.7, which improved to 1.2 
with IVF. 
  
# Steatosis: hx steatosis on RUQ. Low platelets. ALT elevated; 
AST, Tbili, Alkphos normal. To be followed by PCP. 

# Thrombocytopenia: Plts downtrending over past year. Stable at 
her baseline around 80. Followed by Heme Dr. ___, MD. ___ 
etiology is ITP vs. MDS vs. progressive chronic liver disease.  

# ASTHMA: continued on home Fluctisone  

# DIABETES MELLITUS: Last hgA1C 7.7%. On Metformin, Glipizide. 
Maintained on insulin while inpatient (Humalog plus 10 units 
lantus at bedtime) .
 
# HYPERLIPIDEMIA: Last LDL 63 in ___. Continued on home 
simivstatin 40 mg.  
 
# HYPERTENSION: remained normotensive on home meds. 

======================================
Transitional Issues: 
======================================
- Recommend repeat RUQ US or CT in outpatient setting to assess 
worsening steatosis or NASH cirrhosis 
- Chronic lower back pain; patient was continued on gabapentin + 
tizanidine
- Thrombocytopenia stable. Followed by Dr. ___. Concern for 
worsening liver disease.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Docusate Sodium (Liquid) 100 mg PO BID:PRN constipation  
2. Flovent HFA (fluticasone) 220 mcg/actuation 2 puffs BID 
3. Glargine 20 Units Bedtime
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
4. Januvia (sitaGLIPtin) 100 mg oral DAILY 
5. Acetaminophen 1000 mg PO Q8H:PRN pain  
6. QUEtiapine Fumarate 200 mg PO QHS 
7. Albuterol 0.083% Neb Soln 1 NEB IH Q6H 
8. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 
9. Cetirizine 10 mg PO DAILY 
10. ClonazePAM 1 mg PO BID 
11. DiCYCLOmine 10 mg PO BID 
12. Fluoxetine 40 mg PO DAILY 
13. fluticasone 50 mcg/actuation nasal DAILY 
14. Furosemide 20 mg PO ONCE 
15. Gabapentin 600 mg PO TID 
16. GlipiZIDE XL 10 mg PO BID 
17. Ketoconazole Shampoo 1 Appl TP ASDIR 
18. MetFORMIN (Glucophage) 1000 mg PO DAILY 
19. MetronidAZOLE Topical 1 % Gel 1 Appl TP BID 
20. Montelukast 10 mg PO DAILY 
21. Omeprazole 20 mg PO BID 
22. Simvastatin 10 mg PO QPM 
23. Tizanidine 2 mg PO TID:PRN muscle spasms  

 
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H:PRN pain  
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H 
3. Cetirizine 10 mg PO DAILY 
4. ClonazePAM 1 mg PO BID 
5. DiCYCLOmine 10 mg PO BID 
6. Docusate Sodium (Liquid) 100 mg PO BID:PRN constipation  
7. Fluoxetine 40 mg PO DAILY 
8. Gabapentin 600 mg PO TID 
9. Glargine 20 Units Bedtime
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
10. Montelukast 10 mg PO DAILY 
11. Omeprazole 20 mg PO BID 
12. Simvastatin 10 mg PO QPM 
13. Tizanidine 2 mg PO TID:PRN muscle spasms  
14. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 
15. Flovent HFA (fluticasone) 220 mcg/actuation 2 puffs BID 
16. fluticasone 50 mcg/actuation NASAL DAILY 
17. Furosemide 20 mg PO ONCE 
18. GlipiZIDE XL 10 mg PO BID 
19. Januvia (sitaGLIPtin) 100 mg oral DAILY 
20. Ketoconazole Shampoo 1 Appl TP ASDIR 
21. MetFORMIN (Glucophage) 1000 mg PO DAILY 
22. MetronidAZOLE Topical 1 % Gel 1 Appl TP BID 
23. QUEtiapine Fumarate 200 mg PO QHS 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY: 
Migraine headache 
Chronic lower back pain 
Steatosis
Thrombocytopenia

CHRONIC: 
Asthma 
IDDM 
HTN
HLD 

CHRONIC: 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You were admitted to ___ for fatigue and lower back pain. We 
were concerned you had a urinary tract infection. We tested your 
urine, you do not have a urinary tract infection. 

You were also admitted with headache and back pain. We gave you 
a medication called sumatriptan to stop your headache. It worked 
well, your headache improved. 

You were also having severe lower back pain. We treated your 
back pain with your home medication, gabapentin and tizanidine. 
Additionally we gave you a lidocaine patch to help with the 
pain. We think your lower back pain is muscular in nature. You 
should follow up with your primary care physician to discuss 
whether you need physical therapy to help with your back. 

Thank you for allowing us to participate in your care

___ care team 
 
Followup Instructions:
___
"
28,10614625,29075534," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins
 
Attending: ___.
 
Chief Complaint:
back pain
 
Major Surgical or Invasive Procedure:
renal ultrasound (normal)

 
History of Present Illness:
This is a ___ F with asthma, IDDM, HTN, HLD and chronic back pain
presenting with cough x4 days and back pain since yesterday.
Cough has been ongoing for three weeks without improvement. No
SOB or chest pain. Her back pain is related to a mechanical fall
in her bathroom 2 days ago.

No sore throat. No vomiting. No abdominal pain. 

Complaining of throbbing headache over her left forehead and 
eye.

Reports urinary frequency of unclear duration, no dysuria. 

In the ED, vitals T 98.2 BP 112/69 HR 102 RR 18 O2 100%RA
Labs notable for WBC 3.1 (baseline ~4), HGB 10.3 PLT 64, bicarb
20, lactate 4.0, UA grossly positive. 
CXR unremarkable.
Given 2L NS and ceftriaxone. 

 
Past Medical History:
PMH: Chronic Back Pain, Asthma, DM, Hyperlipidemia, HTN, 
migraine, elevated BMI, OA, rosacea, OSA, Followed by 
Psychiatry, diverticulosis

PSH: History of 11 prior abdominal procedures including ovarian 
procedure, bowel perforation, Hysterectomy, Ovaryiectomy 
w/single remaining ovary
 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
DISCHARGE PHYSICAL EXAM:  
T98.4 104/60  P78  R18  94% on RA
General:  no acute distress, brightly dyed hair, animated, 
alert, and oriented
HEENT: sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-tender, non-distended, + CVA tenderness 
bilaterally (mild)
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNs2-12 intact, motor function grossly normal  
 
Pertinent Results:
Hematology 
  COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW RDWSD 
Plt Ct 
___ 08:15    3.0* 3.41* 9.8* 30.9* 91 28.7 31.7* 14.7 
49.3* 62* 
___ 07:01    3.0* 3.39* 9.7* 30.8* 91 28.6 31.5* 14.8 
49.7* 66* 
___ 14:05    3.1* 3.55* 10.3* 32.4* 91 29.0 31.8* 15.1 
50.1* 64* 
 DIFFERENTIAL Neuts Bands Lymphs Monos Eos Baso Atyps Metas Im 
___ AbsLymp AbsMono AbsEos AbsBaso 
___ 14:05    51.7   36.7 10.1 0.6* 0.3     0.6 1.59* 
1.13* 0.31 0.02* 0.01 
  BASIC COAGULATION ___, PTT, PLT, INR) Plt Ct 
___ 08:15    62* 
___ 07:01    66* 
___ 14:05    64* 
 

Chemistry 
  RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap 
___ 08:15    ___ 135 4.5 ___ 
___ 07:01    ___ 141 4.6 ___ 
___ 14:05    169*1 23* 1.2* 139 4.9 106 20* 18 
 
Hematology 
 GENERAL URINE INFORMATION Type Color ___ 
___ ___      Yellow Hazy 1.028 
 DIPSTICK URINALYSIS Blood Nitrite Protein Glucose Ketone 
Bilirub Urobiln pH Leuks 
___ 16:04    NEG NEG 30 NEG NEG NEG 8* 6.5 LG 
 MICROSCOPIC URINE EXAMINATION RBC WBC Bacteri Yeast Epi TransE 
RenalEp 
___ 16:04    0 40* MANY NONE 3     
 URINE CASTS CastHy 
___ 16:04    1* 
 OTHER URINE FINDINGS Mucous 
___ 16:04    RARE 
 
___ 16:04    

Urine culture
                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------   <=2 S
AMPICILLIN/SULBACTAM--   <=2 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----  =>16 R
 
Brief Hospital Course:
Ms. ___ is a ___ woman with asthma, chronic 
thrombocytopenia, DM type 2, HTN, HLD and chronic back pain who 
presente with cough x4 days, dysuria, and back pain since the 
day prior to admission, found to have a positive UA concerning 
for pyelo in the setting of her back pain. She was started on 
ceftriaxone which was transitioned to PO cipro according to 
sensitivities. A renal ultrasound was done which showed no 
obstruction or stone and normal kidneys. She was toleratined PO 
intake well and pain was improved. She ambulated the hallways 
well. Her labs were also notable for stable thrombocytopenia for 
which she will continue her outpatient follow up with hematology 
which was arranged for her. Rest of hospital course/plan are 
outlined by issue below. 

#UTI/pyelonephritis: prior urine has grown pansensitive e coli 
in the past (except R to Bactrim) and grew the same this time as 
well (pansensitive except for Bactrim)
-ceftriaxone started (___) and changed to PO cipro on ___ just 
prior to discharge for a course x total 10 days for pyelo (last 
day ___, transitioned to PO cipro for good tissue penetration. 
She was instructed to hold tizanidine while taking this as it 
may interact with cytochromes and also instructed to watch her 
blood sugars closely as quinolones may exacerbate hypoglycemia. 

#Back pain: choric, exacerbated by UTI. PRN Tylenol for pain 
control

#Cough has been ongoing for three weeks without improvement. 
Relates mild URI symptoms, likely post-viral syndrome. Lung exam 
was benign and symptoms had improved. CXR was negative for 
infiltrate.  F/u with PCP if not improved. ddx post nasal drip 
vs asthma vs GERD

#Thrombocytopenia: Plts downtrending over past year. Near her 
baseline around 80 without signs of bleeding. Followed by Heme 
Dr. ___, MD who has previously suggested  etiology is ITP vs. 
MDS vs. progressive chronic liver disease. will follow up with 
heme as outpt as below.   

#Cough

#DM
-hold PO antihyperglycemics
-insulin sliding scale

#Transitional: 
-f/u with Heme Dr. ___, MD was arranged prior to discharge as 
well as PCP follow up. 
-___ day of antibiotics ___
-Patient doesn't seem to fully understand her extensive 
medication list, recommended eval for home services and med rec

spent > 30 minutes seeing patient and organizing discharge. 
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 1000 mg PO Q8H:PRN pain  
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H 
3. Cetirizine 10 mg PO DAILY 
4. ClonazePAM 1 mg PO BID 
5. DiCYCLOmine 10 mg PO BID 
6. Docusate Sodium (Liquid) 100 mg PO BID:PRN constipation  
7. Fluoxetine 40 mg PO DAILY 
8. Gabapentin 600 mg PO TID 
9. Montelukast 10 mg PO DAILY 
10. Omeprazole 20 mg PO BID 
11. Simvastatin 10 mg PO QPM 
12. Tizanidine 2 mg PO TID:PRN muscle spasms  
13. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 
14. Flovent HFA (fluticasone) 220 mcg/actuation 2 puffs BID 
15. fluticasone 50 mcg/actuation NASAL DAILY 
16. Furosemide 20 mg PO ONCE 
17. GlipiZIDE XL 10 mg PO BID 
18. Januvia (sitaGLIPtin) 100 mg oral DAILY 
19. Ketoconazole Shampoo 1 Appl TP ASDIR 
20. MetFORMIN (Glucophage) 1000 mg PO DAILY 
21. MetronidAZOLE Topical 1 % Gel 1 Appl TP BID 
22. QUEtiapine Fumarate 200 mg PO QHS 

 
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H:PRN pain  
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H 
3. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 
4. Cetirizine 10 mg PO DAILY 
5. ClonazePAM 1 mg PO BID 
6. DiCYCLOmine 10 mg PO BID 
7. Docusate Sodium (Liquid) 100 mg PO BID:PRN constipation  
8. Flovent HFA (fluticasone) 220 mcg/actuation 2 puffs BID 
9. Fluoxetine 40 mg PO DAILY 
10. fluticasone 50 mcg/actuation NASAL DAILY 
11. Gabapentin 600 mg PO TID 
12. Montelukast 10 mg PO DAILY 
13. Omeprazole 20 mg PO BID 
14. QUEtiapine Fumarate 200 mg PO QHS 
15. Simvastatin 10 mg PO QPM 
16. Furosemide 20 mg PO ONCE 
17. GlipiZIDE XL 10 mg PO BID 
18. Januvia (sitaGLIPtin) 100 mg oral DAILY 
19. Ketoconazole Shampoo 1 Appl TP ASDIR 
20. MetFORMIN (Glucophage) 1000 mg PO DAILY 
21. MetronidAZOLE Topical 1 % Gel 1 Appl TP BID 
22. Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth two 
times a day Disp #*18 Tablet Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
pyelonephritis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were diagnosed with pyelonephritis and you will be 
discharged on an antibiotic called cipro. You should take the 
cipro two times a day until the last day which will be on 
___. 

The cipro interacts with tizanidine so you should stop taking 
tizanidine while you are on cipro. 

Also, check your blood sugars every day as the cipro can also 
lower your blood sugars. If they are low, call your doctor 
immediately. 

 
Followup Instructions:
___
"
29,10614625,25554833," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins
 
Attending: ___.
 
Chief Complaint:
Asthma/Flu
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a a ___ woman with PMHx significant for DM, 
HTN, asthma, and multiple chronic pain issues including low back 
pain and migraines, who presents with a 1 day history of 
generalized body aches, headache, fever, chills, nausea, and 
vomiting. The patient states that ___ days ago she developed 
fever, cough productive of light sputum, and sore throat. Since 
then it has progressed to severe body aches. States it hurts 
when she coughs. She reports that yesterday she vomited ___ 
times non-bloody, has not vomited today. Normal bowel movements 
with the last one being yesterday. Today she complains of 
subjective feeling of abdominal distention. Additionally she has 
had a headache for the last few days. 

In the ED, initial vital signs were: T 104 P 95 BP 117/53 R 18 
O2 sat 97%. Exam was notable for diffuse mild expiratory wheeze, 
generalized body tenderness, intact neurologic exam. Labs were 
notable for lactate 1.0, WBC 2.7, H/H 9.2/28.8, BUN/Cr ___. 
Patient was held overnight for further evaluation. Patient was 
given 1L of fluids, tamiflu and her usual medications as well as 
metoclopramide.

 
Past Medical History:
PMH: Chronic Back Pain, Asthma, DM, Hyperlipidemia, HTN, 
migraine, OA, OSA, diverticulosis

PSH: History of 11 prior abdominal procedures including ovarian 
procedure, bowel perforation, Hysterectomy, Ovaryiectomy 
w/single remaining ovary
 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
ADMISSION EXAM:
Vitals-  T98.2  P72  BP104/66  RR 18 O2 Sat 100% Room Air
GENERAL: AOx3, NAD
HEENT: Normocephalic, atraumatic.  Pupils equal, round, and 
reactive bilaterally, extraocular muscles intact.  No 
conjunctival pallor or injection, sclera anicteric and without 
injection.  Oropharynx is clear.
NECK:  No cervical lymphadenopathy.
CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops.  
No JVD.
LUNGS: Diffuse expiratory wheezes bilaterally. 
ABDOMEN: Obese, Normal bowels sounds, non distended, mildly 
tender to deep palpation, worse on left.  No organomegaly 
aprreciated.
EXTREMITIES: No clubbing, cyanosis, or edema, no sign of 
atrophy/hypertrophy. Pulses DP/Radial 2+ bilaterally.
SKIN: No evidence of ulcers, rash or lesions suspicious for 
malignancy
NEUROLOGIC: CN2-12 intact.  Grossly normal strength througout.  
Normal sensation.

DISCHARGE EXAM:
Vitals-  98.1| 124-144/60-90| 60-90s| 18| 100% on RA
GENERAL: AOx3, NAD, sitting up in bed
HEENT: EOMI
NECK:  No cervical lymphadenopathy.
CARDIAC: RRR, no m/r/g
LUNGS: Few expiratory wheezes bilaterally 
ABDOMEN: Obese, non distended, no TTP
EXTREMITIES: No edema
NEUROLOGIC: Alert and oriented.  

 
Pertinent Results:
ADMISSION LABS:
___ 03:40PM BLOOD WBC-4.7# RBC-3.59* Hgb-10.2* Hct-32.0* 
MCV-89 MCH-28.4 MCHC-31.9* RDW-14.9 RDWSD-47.9* Plt Ct-78*
___ 03:40PM BLOOD Neuts-53.7 ___ Monos-10.4 
Eos-0.4* Baso-0.6 Im ___ AbsNeut-2.52# AbsLymp-1.60 
AbsMono-0.49 AbsEos-0.02* AbsBaso-0.03
___ 03:40PM BLOOD Glucose-119* UreaN-22* Creat-1.3* Na-134 
K-4.3 Cl-99 HCO3-21* AnGap-18
___ 03:45PM BLOOD Lactate-2.2*
___ 06:37AM BLOOD Lactate-1.0
___ 05:21AM BLOOD Calcium-8.3* Phos-2.2* Mg-2.5
___ 05:21AM BLOOD Glucose-213* UreaN-21* Creat-1.0 Na-140 
K-4.2 Cl-107 HCO3-24 AnGap-13
___ 05:21AM BLOOD WBC-2.3* RBC-3.29* Hgb-9.1* Hct-29.7* 
MCV-90 MCH-27.7 MCHC-30.6* RDW-14.7 RDWSD-48.9* Plt Ct-65*

DISCHARGE LABS:
___ 05:21AM BLOOD WBC-2.3* RBC-3.29* Hgb-9.1* Hct-29.7* 
MCV-90 MCH-27.7 MCHC-30.6* RDW-14.7 RDWSD-48.9* Plt Ct-65*
___ 05:21AM BLOOD Glucose-213* UreaN-21* Creat-1.0 Na-140 
K-4.2 Cl-107 HCO3-24 AnGap-13
___ 06:37AM BLOOD Lactate-1.0

IMAGING/REPORTS:

CXR ___
No focal consolidation is seen.  No pleural effusion or 
pneumothorax is seen. The cardiac and mediastinal silhouettes 
are stable. 
IMPRESSION:  
No acute cardiopulmonary process.  No focal consolidation to 
suggest 
pneumonia.

HEAD CT ___
There is no hemorrhage, acute infarction, edema, large mass, or 
mass effect.  Mild prominence of the ventricles and sulci is 
consistent with age-appropriate global involutional change.  
There is preservation of gray-white matter differentiation.  The 
basal cisterns are patent, and there is no shift of normally 
midline structures.  There is mild left maxillary sinus, 
sphenoid sinus, and ethmoid air cell mucosal thickening.  The 
frontal and right maxillary sinuses are clear.  The mastoid air 
cells are clear.  The globes and bony orbits are intact and 
unremarkable. 
IMPRESSION:  
No acute intracranial process.

ABDOMINAL XRAY ___
There are no abnormally dilated loops of large or small bowel.  
Air and stool is seen in the large bowel to the rectum. 
There is no free intraperitoneal air. 
Osseous structures are unremarkable. Surgical clips are seen in 
the right 
pelvis. Note is made of 6 lumbar type vertebral bodies. 
There are no unexplained soft tissue calcifications or 
radiopaque foreign 
bodies. 
IMPRESSION: 
Nonobstructive bowel gas pattern. 
 

 
Brief Hospital Course:
BRIEF HOSPITAL COURSE
___ woman with PMHx significant for DM, HTN, asthma, and 
multiple chronic pain issues including low back pain and 
migraines, who presented with Flu A and asthma flare.

#Asthma Flare: Patient has known asthma but baseline peak flow 
is unknown, she has never been admitted or intubated in the past 
for asthma. She uses her albuterol ___ per wk. Peak flow on 
admission was 150, on discharge 225 with ambulatory saturation 
at 97%. She was started on prednisone 40mg per day, Day 1 
___. She was given duonebs PRN Q4HPRN. Her oxygenation 
saturation remained good on room air. The patient was adamant 
about leaving on day of discharge, understood that should her 
symptoms worsen or not continue to improve she should return to 
the emergency department.

#Patient reported approximately a week of symptoms including 
fevers and body aches as well as sore throat, nausea and 
vomiting. She was found to be flu A positive in the ED. She was 
started on Tamiflu BID x 5 days. D1 ___. Last ___.

#Abdominal Pain: Patient has had EGD and colonoscopy several 
years ago which showed diverticulosis. Patient has had history 
of multiple abdominal surgeries. Current pain possibly secondary 
to repeated retching and vomiting. However she has been passing 
gas and having normal bowel movements. KUB without obstruction. 
LFTs stable to chronic mild elevation. Lipase WNL.

CHRONIC
# Thrombocytopenia: 50 on admission. Has continued to drop over 
the last year. Recent baseline appears to be ___. Followed by 
Heme Dr. ___, MD. ___ etiology is likely ITP. Held SC 
Heparin for low platelets.

# DIABETES MELLITUS: Last hgA1C 7.7%. On Metformin, Glipizide, 
and insulin. Held oral medications. Continued insulin, added 
sliding scale.

# HYPERLIPIDEMIA: Continued on home simivstatin 40 mg. 

# HYPERTENSION: Home lisinopril and furosemide held in setting 
of mild hypotension, restarted on discharge.

TRANSITIONAL ISSUES:
-Re-check Peak flow (peak flow 225 on discharge) 
-Prednisone 40 mg PO for 7 days D1 ___ last day ___ 
-Patients WBC decreased, please re-check CBC with diff to ensure 
patient isn't neutropenic. On D/C WBC was 2.4.
-Thrombocytopenia has continued to decrease platelets on D/C 56 
(known ITP).
-Tamiflu D1 ___ last day ___
# Code Status: Full Code confirmed
# Emergency Contact/HCP: Son ___ ___

 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Fluoxetine 20 mg PO BID 
2. Acetaminophen w/Codeine 1 TAB PO DAILY:PRN head ache 
3. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
4. Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath 
5. ClonazePAM 1 mg PO QID:PRN anxiety 
6. FeroSul (ferrous sulfate) 325 mg (65 mg iron) oral DAILY 
7. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
8. Flovent HFA (fluticasone) 220 mcg/actuation inhalation BID 
9. Furosemide 20 mg PO DAILY 
10. Gabapentin 600 mg PO TID 
11. GlipiZIDE XL 10 mg PO BID 
12. Glargine 20 Units Bedtime
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
13. Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H 
14. Lisinopril 5 mg PO DAILY 
15. MetFORMIN (Glucophage) 1000 mg PO BID 
16. Montelukast 10 mg PO DAILY 
17. Nortriptyline 10 mg PO QHS 
18. Omeprazole 20 mg PO BID 
19. QUEtiapine Fumarate 200 mg PO QHS 
20. Simvastatin 40 mg PO DAILY 
21. Cetirizine 10 mg PO DAILY 
22. Docusate Sodium 100 mg PO BID:PRN constipation 
23. DiCYCLOmine 10 mg PO BID 

 
Discharge Medications:
1. Cetirizine 10 mg PO DAILY 
2. ClonazePAM 1 mg PO QID:PRN anxiety 
3. DiCYCLOmine 10 mg PO BID 
4. Docusate Sodium 100 mg PO BID:PRN constipation 
5. Fluoxetine 20 mg PO BID 
6. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
7. Gabapentin 600 mg PO TID 
8. Glargine 20 Units Bedtime
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
9. Montelukast 10 mg PO DAILY 
10. Nortriptyline 10 mg PO QHS 
11. Omeprazole 20 mg PO BID 
12. QUEtiapine Fumarate 200 mg PO QHS 
13. Simvastatin 40 mg PO DAILY 
14. OSELTAMivir 30 mg PO Q12H 
Last day ___ 
RX *oseltamivir [Tamiflu] 30 mg 1 capsule(s) by mouth every 12 
hours Disp #*3 Capsule Refills:*0
15. PredniSONE 40 mg PO DAILY 
Last day ___ 
RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*8 Tablet 
Refills:*0
16. Acetaminophen w/Codeine 1 TAB PO DAILY:PRN head ache 
17. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN shortness of 
breath 
18. Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath 
19. FeroSul (ferrous sulfate) 325 mg (65 mg iron) oral DAILY 
20. Flovent HFA (fluticasone) 220 mcg/actuation inhalation BID 
21. Furosemide 20 mg PO DAILY 
22. GlipiZIDE XL 10 mg PO BID 
23. Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H 
24. Lisinopril 5 mg PO DAILY 
25. MetFORMIN (Glucophage) 1000 mg PO BID 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Flu A
Asthma Flare

Secondary:
Thrombocytopenia
DM2

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,
You were admitted to ___ on ___ for fevers, headache, and 
body aches. We found that you had the flu which caused you to 
have an asthma flare. We treated you with medications and your 
symptoms improved. You told us you had abdominal pain which was 
likely because of all your vomiting. Your x-ray did not show 
anything concerning and your labs were stable. Your symptoms 
should continue to improve after you leave. Please take all of 
your medications as prescribed and attend all of your follow up 
appointments, particularly the scheduled follow-up you mentioned 
with your primary care provider this coming ___. Take care 
and be well.
Sincerely,
Your ___ Care Team
 
Followup Instructions:
___
"
30,10614625,29597160," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Motrin / Zantac / Penicillins
 
Attending: ___.
 
Chief Complaint:
Abdominal pain, vomiting 
 
Major Surgical or Invasive Procedure:
None 

 
History of Present Illness:
This is a ___ ___ with multiple previous abdominal 
surgeries presenting with one day of abdominal pain and 
vomiting. She woke up yesterday morning with diffuse, throbbing 
abdominal pain, then had 5+ episodes of non-bloody, yellow 
emesis. Her last bowel movement was yesterday at around 5pm, and
was normal in quality and caliber. She has not passed gas for 
more than 24 hours. She feels that her stomach is more distended 
than usual. Denies fever within the last week or diarrhea. No 
recent sick contacts or travel. She explains that a few weeks 
ago she had a fever associated with a respiratory infection, 
which is improving but she is still experiencing cough, 
congestion.
 
Past Medical History:
Past Medical History:
- IDDM
- HTN
- HLD
- asthma
- migraines
- chronic back pain
- depression & anxiety, recent ED evaluation on ___ for SI

Past Surgical History:
___: L salpingo-oophorectomy complicated by sigmoid
perforation
___: Sigmoid  resection,  creation  ___ pouch,
takedown of splenic flexure and sigmoid colostomy.
___: I&D, debridement of abdominal abscess
___: Left colectomy/colostomy closure, takedown splenic
flexure, diverting ileostomy
___: Ileostomy take-down
___: Laparotomy, excision of scar and extensive
adhesiolysis.
___: Ventral hernia repair w/ vicryl mesh
___: Incisional hernia repair w/ mesh
___: Medial L knee meniscectomy
___: R knee meniscectomy
___: R total knee replacement

 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
Admission Physical Exam:

Vitals: T:97.4 BP:130/74 HR:110 RR:18 O2:96% on 2.5L NS
GEN: A&Ox3
HEENT: No scleral icterus, dry membranes moist
CV: Tachycardic, regular rhythm, no M/G/R
PULM: Rhonchi throughout
ABD: Obese, multiple prior surgical scars, no umbilicus,
moderately distended, tender in RLQ and LLQ without rebound or
guarding, no palpable masses/hernia
Ext: No ___ edema, ___ warm and well perfused

Discharge Physical Exam:
VS: T: 98.4, BP: 112/62, HR: 82, RR: 20, O2: 98% RA
General: A+Ox3, NAD
CV: RRR
PULM: rhonchi with cough, CTA b/l at bases
ABD: soft, non-distended, non-tender
Extremities: no edema, warm, well-perfused b/l
 
Pertinent Results:
___ 09:50PM   GLUCOSE-128* UREA N-15 CREAT-0.9 SODIUM-135 
POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-25 ANION GAP-12
___ 09:50PM   CALCIUM-8.8 PHOSPHATE-1.7* MAGNESIUM-2.8*
___ 05:19AM   GLUCOSE-255* UREA N-25* CREAT-1.2* SODIUM-138 
POTASSIUM-5.6* CHLORIDE-103 TOTAL CO2-25 ANION GAP-16
___ 05:19AM   CALCIUM-9.6 PHOSPHATE-2.6* MAGNESIUM-1.4*
___ 05:19AM   WBC-7.1 RBC-4.09 HGB-11.4 HCT-36.7 MCV-90 
MCH-27.9 MCHC-31.1* RDW-15.0 RDWSD-49.5*
___ 05:19AM   PLT SMR-LOW PLT COUNT-88*
___ 02:45AM   cTropnT-<0.01
___ 02:45AM URINE  COLOR-Yellow APPEAR-Hazy SP ___
___ 02:45AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 
GLUCOSE-300 KETONE-10 BILIRUBIN-NEG UROBILNGN-2* PH-5.5 LEUK-TR
___ 02:45AM URINE  RBC-0 WBC-3 BACTERIA-FEW YEAST-NONE 
EPI-9 TRANS EPI-<1
___ 02:45AM URINE  HYALINE-4*
___ 02:45AM URINE  MUCOUS-RARE
___ 09:04PM   LACTATE-1.7
___ 08:11PM   GLUCOSE-189* UREA N-24* CREAT-1.2* SODIUM-136 
POTASSIUM-4.9 CHLORIDE-102 TOTAL CO2-22 ANION GAP-17
___ 08:11PM   ALT(SGPT)-52* AST(SGOT)-46* ALK PHOS-133* TOT 
BILI-0.5
___ 08:11PM   LIPASE-32
___ 08:11PM   cTropnT-<0.01
___ 08:11PM   ALBUMIN-4.5
___ 08:11PM   WBC-6.0 RBC-4.34 HGB-12.0 HCT-38.8 MCV-89 
MCH-27.6 MCHC-30.9* RDW-14.7 RDWSD-47.8*
___ 08:11PM   NEUTS-78.9* LYMPHS-12.9* MONOS-5.8 EOS-1.3 
BASOS-0.3 IM ___ AbsNeut-4.76# AbsLymp-0.78* AbsMono-0.35 
AbsEos-0.08 AbsBaso-0.02
___ 08:11PM   PLT COUNT-101*#

Imaging: 

___: EKG:
Sinus tachycardia. Left axis deviation. ST segment depression 
and T wave 
inversion in leads V1-V2 with early precordial R wave transition 
raising the question of active posterior ischemic process, new 
as previously compared  with ___. Followup and clinical 
correlation are suggested. 

___: KUB:
Unremarkable exam.

___: CT ABD/PEL:
1. Likely complete small bowel obstruction with a transition 
point in the 
right lower quadrant adjacent to ventral hernia repair mesh.  No 
bowel wall thickening, pneumatosis, or pneumoperitoneum.  
Evaluation for bowel wall ischemia is limited without the use of 
IV contrast. 
2. Mild splenomegaly. 

___: CXR:
New enteric tube terminates within the stomach.

___: KUB:
No evidence of obstruction or perforation.

___: CXR:
  
Compared to prior chest radiographs since one ___, 
most recently ___. 
  
No free subdiaphragmatic gas.  Mild cardiomegaly.  Lungs clear.  
No pleural abnormality. 

 
Brief Hospital Course:
Ms. ___ is a ___ year-old female with a history of multiple 
previous abdominal surgeries who presented this admission with 
abdominal pain and emesis. CT abd/pelvis revealed a small bowel 
obstruction with a transition point in the right lower quadrant 
adjacent to ventral hernia repair mesh.  She was made NPO, had a 
NGT placed to low continuous wall suction and started on IVF.  
On HD1, the patient passed flatus and had minimal NGT output, so 
her NGT was removed. Her admission EKG showed new ST depressions 
in the anterior, left axis and troponins were sent which were 
negative. CXR was unremarkable. 

On HD2, the patient was advanced to a regular diet which was 
well-tolerated. The patient was ordered oxycodone for a 
migraine. The patient was later febrile to 103,  urinalysis, 
urine culture and blood culture were ordered.  There was no 
leukocytosis.  CXR was unremarkable.  

On HD3, the patient reported facial and ear pain and she was 
diagnosed with acute sinusitis.  Given her allergy to 
penicillin, she was started on Azithromycin.  The patient has a 
history of migraines and PO fioricet prn was started. A social 
work consult was placed to address her current housing and 
coping issues. 

On HD4, the patient was again febrile to 103 at night time and 
she received acetaminophen with good effect.  On HD5, the 
patient reported her facial pain had greatly improved, was 
afebrile and reported no abdominal pain.  She had a bowel 
movement and was passing flatus. 

The patient was alert and oriented throughout hospitalization; 
pain was initially managed with po oxycodone and acetaminophen.  
Oxycodone was discontinued as she reported her pain had 
improved. The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored. The patient 
remained stable from a pulmonary standpoint; vital signs were 
routinely monitored. Good pulmonary toilet, early ambulation and 
incentive spirometry were encouraged throughout hospitalization. 
The patient's intake and output were closely monitored.  The 
patient's blood counts were closely watched for signs of 
bleeding, of which there were none. The patient received 
subcutaneous heparin and ___ dyne boots were used during this 
stay and was encouraged to get up and ambulate as early as 
possible.

At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable.  The patient was tolerating a diet, 
ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge with the aid of 
___ interpreter services.  Teaching and follow-up 
instructions were discussed with understanding verbalized and 
agreement with the discharge plan. A follow-up appointment was 
scheduled with the patient's Primary Care Provider. 

 
Medications on Admission:
Medications: (per psych ED eval note on ___
1.Cetirizine 10 mg PO DAILY 
2.ClonazePAM 1 mg PO QID:PRN anxiety 
3.DiCYCLOmine 10 mg PO BID 
4.Docusate Sodium 100 mg PO BID:PRN constipation 
___ 20 mg PO BID 
___ Propionate NASAL 1 SPRY NU DAILY 
7.Gabapentin 600 mg PO TID 
8.Glargine 20 Units Bedtime
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
___ 10 mg PO DAILY 
10.Nortriptyline 10 mg PO QHS 
11.Omeprazole 20 mg PO BID 
12.QUEtiapine Fumarate 200 mg PO QHS 
13.Simvastatin 40 mg PO DAILY 
14.Acetaminophen w/Codeine 1 TAB PO DAILY:PRN head ache 
15.Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN shortness of 
breath 
16.Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath 
___ (ferrous sulfate) 325 mg (65 mg iron) oral DAILY 
___ HFA (fluticasone) 220 mcg/actuation inhalation BID 
___ 20 mg PO DAILY 
20.GlipiZIDE XL 10 mg PO BID 
21.Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H 
22.Lisinopril 5 mg PO DAILY 
___ (Glucophage) 1000 mg PO BID 

 
Discharge Medications:
1. Gabapentin 600 mg PO TID 
2. Montelukast 10 mg PO DAILY 
3. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 
4. Nortriptyline 10 mg PO QHS 
5. QUEtiapine Fumarate 200 mg PO QHS 
6. Senna 8.6 mg PO BID:PRN constipation  
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp 
#*30 Tablet Refills:*0
7. Omeprazole 20 mg PO BID 
8. Furosemide 20 mg PO DAILY 
9. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
10. FLUoxetine 40 mg PO DAILY 
11. Fluticasone Propionate 110mcg 2 PUFF IH BID 
12. ClonazePAM 1 mg PO QID:PRN anxiety  
13. Cetirizine 10 mg PO DAILY 
14. Acetaminophen 500 mg PO Q4H:PRN Fever 
15. Azithromycin 500 mg PO Q24H Duration: 3 Days 
RX *azithromycin 500 mg 1 tablet(s) by mouth Q24H Disp #*1 
Tablet Refills:*0
16. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN migraine  
RX *butalbital-acetaminophen-caff 50 mg-325 mg-40 mg ___ 
tablet(s) by mouth every eight (8) hours Disp #*10 Tablet 
Refills:*0
17. Docusate Sodium 100 mg PO BID:PRN constipation  
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*30 Capsule Refills:*0
18. Single Point Cane
Dx: Small bowel obstruction 
Px: Good
Duration: 13 (thirteen) months

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Small bowel obstruction

Secondary: 
Acute sinusitis  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You were admitted to the hospital with a small bowel 
obstruction. You were managed non-operatively and had a tube 
placed in your nose into your stomach to help decompress your 
abdomen.  Your obstruction resolved on its own and the tube was 
removed.  You are now having bowel function, tolerating a 
regular diet, and your pain is better controlled.  

You were also diagnosed with acute sinusitis, an infection of 
your sinuses which can cause facial pain and fevers.  You were 
started on an antibiotic called Azithromycin and will be 
discharged with a prescription.  

You are now medically cleared to be discharged home to continue 
your recovery.  Please note the following discharge 
instructions: 

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

Avoid driving or operating heavy machinery while taking pain 
medications.

 
Followup Instructions:
___
"
31,10614625,26074363," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins / levofloxacin
 
Attending: ___
 
Chief Complaint:
cough, fatigue, back pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ ___ F with PMHx DM, HTN, HLD, asthma, depression 
& anxiety with ED evaluation on ___ for SI (discharged to 
follow-up with Arbour), recent admission ___ for SBO 
managed conservatively (also treated for acute sinusitis; noted 
to have new anterior ST depressions with L axis compared to EKG 
1mth prior but troponins were negative), now admitted for PNA. 

She returns to the ED today with several days of malaise, cough 
and dyspnea. She also had myalgias of her back. She had some CP 
with coughing, none with exertion. 

In the ED, initial VS were: 98.6 101 113/61 18 96% Nasal 
Cannula.
   
Exam notable for: scattered wheeze, rhonchi most pronounced 
right base, there is suprapubic tenderness

Labs showed: No leukocytosis or bandemia. Hct 33. BUN/Cr ___. 
Mg 1.4. P 1.6. AP 116 (TBili 1.0). proBNP 1014. Lactate 1.7. UA 
negative for infection.
  
Imaging showed: CXR: Right lower lobe focal opacity which could 
be pneumonia in the proper clinical setting. Repeat after 
treatment suggested to document resolution.
  
EKG with NSR, nl axis, QTc 481msec, TWI V1-V3.

Received:
___ 16:38 PO Acetaminophen 1000 mg 
___ 16:38 IV Levofloxacin 750 mg 
*Suffered localized skin rash at IV site, was given Benadryl and 
switched to CTX.
___ 16:58 IH Albuterol 0.083% Neb Soln 1 NEB 
___ 16:58 IH Ipratropium Bromide Neb 1 NEB 
___ 16:59 IVF 1000 mL NS 1000 mL   
___ 17:45 IV Azithromycin 500 mg 
___ 17:45 IV DiphenhydrAMINE 50 mg 
  
Transfer VS were: 98.6 86 103/61 18 96% RA. 
  
On arrival to the floor, patient reports that she is feeling 
so-so. Last night she developed pain in her back and waist. She 
had to go to bed with this. Also reports chronic cough that has 
worsened over the last several days. Says that she was coughing 
so much that she was unable to get out of bed. Regarding her 
back pain, she has chronic back pain but says this pain was 
worse. Notes intermittent radiation to her legs. Denies 
urinary/fecal incontinence, new focal weakness, 
numbness/tingling or fevers/chills. Denies fevers, chills, n/v, 
diarrhea, constipation, chest pain, SOB, dysuria. Also reports 
some chest pain at home that she has a hard time describing. Is 
non radiating. Not associated with SOB, diaphoresis, vomiting, 
but she did have some nausea. Denies recent sick contacts. Has 
not had recent falls or trauma but says she has fallen at home 
before, but has never lost consciousness. Has felt dizzy before 
and felt dizzy earlier today. 

 
Past Medical History:
Past Medical History:
- IDDM
- HTN
- HLD
- asthma
- migraines
- chronic back pain
- depression & anxiety, recent ED evaluation on ___ for SI

Past Surgical History:
___: L salpingo-oophorectomy complicated by sigmoid
perforation
___: Sigmoid  resection,  creation  ___ pouch,
takedown of splenic flexure and sigmoid colostomy.
___: I&D, debridement of abdominal abscess
___: Left colectomy/colostomy closure, takedown splenic
flexure, diverting ileostomy
___: Ileostomy take-down
___: Laparotomy, excision of scar and extensive
adhesiolysis.
___: Ventral hernia repair w/ vicryl mesh
___: Incisional hernia repair w/ mesh
___: Medial L knee meniscectomy
___: R knee meniscectomy
___: R total knee replacement

 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
ADMISSION EXAM:
GENERAL: NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, good dentition  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: distant, RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: Diffuse rhonci heard along the R middle base 
ABDOMEN: obese, nondistended, +BS, nontender in all quadrants, 
no rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII grossly intact

DISCHARGE EXAM:
VS - 97.9 72 113/61 17 94 r/a
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, good dentition  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: distant, RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: Diffuse rhonci heard b/l, with audible wheezing
ABDOMEN: obese, nondistended, +BS, nontender in all quadrants, 
no rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally 

 
Pertinent Results:
LABS UPON ADMISSION:
___ 04:30PM BLOOD WBC-9.8 RBC-3.64* Hgb-10.2* Hct-33.0* 
MCV-91 MCH-28.0 MCHC-30.9* RDW-16.0* RDWSD-52.9* Plt Ct-74*
___ 04:30PM BLOOD Glucose-137* UreaN-28* Creat-1.4* Na-137 
K-4.0 Cl-103 HCO3-23 AnGap-15
___ 04:30PM BLOOD ALT-40 AST-33 AlkPhos-116* TotBili-1.0
___ 04:30PM BLOOD Albumin-3.9 Calcium-8.7 Phos-1.6* Mg-1.4*
___ 04:30PM BLOOD proBNP-1014*

LABS UPON DISCHARGE:
___ 12:24AM BLOOD cTropnT-<0.01
___ 06:20AM BLOOD cTropnT-<0.01

OTHER LABS:
___ 05:40AM BLOOD WBC-5.3 RBC-3.58* Hgb-10.1* Hct-32.0* 
MCV-89 MCH-28.2 MCHC-31.6* RDW-15.0 RDWSD-48.9* Plt Ct-97*
___ 05:40AM BLOOD Glucose-211* UreaN-22* Creat-1.1 Na-134 
K-5.1 Cl-100 HCO3-22 AnGap-17
___ 05:40AM BLOOD Calcium-9.2 Phos-2.4* Mg-2.4
___ 04:33PM BLOOD Lactate-1.7
___ 04:30PM BLOOD ALT-40 AST-33 AlkPhos-116* TotBili-1.0
___ 04:30PM BLOOD Lipase-20

IMAGING:
IMPRESSION:  
CXR ___  
Right lower lobe focal opacity which could be pneumonia in the 
proper clinical setting.  Repeat after treatment suggested to 
document resolution. 

TTE ___
There is mild symmetric left ventricular hypertrophy with normal 
cavity size and regional/global systolic function (LVEF>55%). 
Doppler parameters are indeterminate for left ventricular 
diastolic function. Right ventricular chamber size and free wall 
motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The aortic valve leaflets 
(3) appear structurally normal with good leaflet excursion and 
no aortic stenosis or aortic regurgitation. The mitral valve 
leaflets are structurally normal. There is no mitral valve 
prolapse. Trivial mitral regurgitation is seen. The estimated 
pulmonary artery systolic pressure is normal. There is an 
anterior space which most likely represents a prominent fat pad. 

IMPRESSION: Suboptimal image quality. Mild symmetric left 
ventricular hypertrophy with preserved regional/global systolic 
function. 

 
Brief Hospital Course:
___ yo ___ F with PMHx DM, HTN, HLD, asthma, 
depression & anxiety with ED evaluation on ___ for SI 
(discharged to follow-up with Arbour), recent admission 
___ for SBO managed conservatively (also treated for acute 
sinusitis; noted to have new anterior ST depressions with L axis 
compared to EKG 1mth prior but troponins were negative), 
admitted with fatigue, back pain and cough found to have CAP.

# RLL PNA:
CURB 65 score 1. S/p treatment with levofloxacin and 
azithromycin in ED. Developed rash with levo. CXR with RLL 
opacity. Given asthma and persistent cough with wheezing, likely 
experiencing exacberation of asthma as well. Pt was transitioned 
to cefpodoxime 400 mg BID to complete five day course (end date 
___ and prednisone 60 mg daily for five days (end date ___.

# Chest Pain:
# Anterior TWI:
Pt reported CP prior to hospitalization. Pt also endorsed DOE 
and relief with rest. Pt also with new EKG changes with anterior 
ST depression and TWI. Troponins negative x2 during 
hospitalization. Echo w/o focal wall motion abnormality and 
preserved EF.  A dobutamine pharmacologic stress test was 
ordered and it was attempted two times, but the nuclear lab 
would not perform the test given the patient's concurrent lung 
disease. We requested cardiology follow up appointment, which 
was pending upon discharge. 

# Asthma exacerbation:
Currently wheezing on exam and report of worsening DOE at home 
c/w asthma exacerbation. Pt was continued on at home meds- 
Montelukast 10 mg PO DAILY, Fluticasone Propionate 110mcg 2 PUFF 
IH BID, Ipratropium-Albuterol Neb 1 NEB NEB Q6H, cetirizine. 
Prednisone 60 mg daily was initiated.

#Chronic pain and back pain
No warning signs of back pain given chronicity, lack of fevers, 
change in weight, and new neurologic symptoms. Continued 
gabapentin at reduced renal dose

# Anemia: 
Baseline Hb ___. Fe level 13. TF sat 4%. C/w both ___ and ACD. 
Recommend IV iron therapy as an outpatient given concurrent 
infection

# Psych:
Patient continued on at home medications.

# Diabetes Mellitus:
Initiated long acting insulin at reduced dose and ISS while in 
the hospital.

**Transitional issues**
-Patient's medication list in OMR was slightly different than 
the medications that the pt reported taking. We did not change 
any of her current medications, just added the antibiotic and 
steroid.
-Patient was instructed to continue taking all of her 
medications and to complete cefpoxodime and prednisone
-New medications added:
--Cefpodoxime 400 mg PO BID, to complete 7 day course ___ to 
___
--Prednisone 60 mg daily, to complete 5 day course ___ to ___
-Please ensure cardiology follow up and pharm stress test upon 
discharge given changes in EKG and reported chest pain and DOE.
-Patient has evidence of iron deficiency anemia and IV iron 
should be considered for treatment

>30 minutes spent in coordination of care and counseling on day 
of discharge
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Gabapentin 600 mg PO TID 
2. Montelukast 10 mg PO DAILY 
3. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 
4. Senna 8.6 mg PO BID:PRN constipation  
5. Omeprazole 20 mg PO BID 
6. Furosemide 20 mg PO DAILY 
7. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
8. FLUoxetine 40 mg PO DAILY 
9. Fluticasone Propionate 110mcg 2 PUFF IH BID 
10. ClonazePAM 1 mg PO QID:PRN anxiety  
11. Cetirizine 10 mg PO DAILY 
12. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN migraine  
13. Docusate Sodium 100 mg PO BID:PRN constipation  
14. Amitriptyline 100 mg PO QHS 
15. Simvastatin 40 mg PO QPM 
16. QUEtiapine Fumarate 200 mg PO QHS 
17. Lisinopril 5 mg PO DAILY 
18. Nortriptyline 10 mg PO QHS 
19. Glargine 22 Units Breakfast
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner
20. MetFORMIN (Glucophage) 1000 mg PO BID 

 
Discharge Medications:
1. Amitriptyline 100 mg PO QHS 
2. Cetirizine 10 mg PO DAILY 
3. ClonazePAM 1 mg PO QID:PRN anxiety  
4. Docusate Sodium 100 mg PO BID:PRN constipation  
5. FLUoxetine 40 mg PO DAILY 
6. Fluticasone Propionate 110mcg 2 PUFF IH BID 
7. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
8. Furosemide 20 mg PO DAILY 
9. Gabapentin 600 mg PO TID 
10. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 
11. Lisinopril 5 mg PO DAILY 
12. Montelukast 10 mg PO DAILY 
13. Omeprazole 20 mg PO BID 
14. QUEtiapine Fumarate 200 mg PO QHS 
15. Senna 8.6 mg PO BID:PRN constipation  
16. Simvastatin 40 mg PO QPM 
17. Cefpodoxime Proxetil 400 mg PO Q12H 
RX *cefpodoxime 200 mg 2 tablet(s) by mouth twice daily Disp 
#*16 Tablet Refills:*0
18. PredniSONE 60 mg PO DAILY Duration: 5 Days 
RX *prednisone 20 mg 3 tablet(s) by mouth daily Disp #*9 Tablet 
Refills:*0
19. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN migraine  
Do not exceed 6 tablets/day 
20. Nortriptyline 10 mg PO QHS 
21. DME
Rolling walker
Dx: Asthma J45.909., Unsteady gait R26.81
Prognosis: good
Length of need: 13 months
22. Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN Cough Duration: 
5 Days 
RX *dextromethorphan-guaifenesin [Adult Cough Formula DM Max] 
200 mg-10 mg/5 mL 5 ml by mouth q 6 hours Refills:*0
23. MetFORMIN (Glucophage) 1000 mg PO BID 
24. Glargine 22 Units Breakfast
Humalog 10 Units Breakfast
Humalog 14 Units Lunch
Humalog 14 Units Dinner

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis:
Community acquired pneumonia
Chest pain
Asthma exacerbation

Secondary diagnoses:
Chronic back pain
Anemia
Diabetes Mellitus

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms ___,

Why did I come to the hospital?
-You came to the hospital because of cough and back pain

What happened while I was in the hospital?
-We treated you with antibiotics for pneumonia and steroids to 
help with your lung inflammation

What should I do when I leave the hospital?
-Continue taking your antibiotics
-We have not made other changes to your medications so you can 
continue taking your medications as prescribed
-You should follow up with your primary care physician and your 
cardiologist.

Best,
Your ___ Team
 
Followup Instructions:
___
"
32,10614625,26472823," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins / levofloxacin
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
Endoscopy on ___, biopsies pending

 
History of Present Illness:
This is a ___ year old ___ female with PMHx of DM, 
HTN, HLD, asthma, depression, anxiety and multiple abdominal 
surgeries in the past, who is admitted for abdominal pain. 
Patient reports that she has been feeling diffuse abdominal pain 
for the last 2 weeks. However, when inquiring more about it, 
patient reports that she has had the pain for the last months. 
She states that since ___ the pain has gotten worse and has 
been associated with decreased appetite and decrease in oral 
intake. Patient reports that the pain is worse in the epigastric 
and RUQ area, but ""she feels it everywhere"". She reports that 
the pain has been worse with food intake, especially when she 
has greasy foods. She had an episode of vomit this morning. She 
denies diarrhea or constipation. She reports ""dark stools"" in 
the past. She passed the last BM today. She reports chills, but 
it is not sure if she has had any fever. She denies urinary 
symptoms, chest pain, LH, dizziness, weight loss.  

 
Past Medical History:
Past Medical History:
- IDDM
- HTN
- HLD
- asthma
- migraines
- chronic back pain
- depression & anxiety, recent ED evaluation on ___ for SI

Past Surgical History:
___: L salpingo-oophorectomy complicated by sigmoid
perforation
___: Sigmoid  resection,  creation  ___ pouch,
takedown of splenic flexure and sigmoid colostomy.
___: I&D, debridement of abdominal abscess
___: Left colectomy/colostomy closure, takedown splenic
flexure, diverting ileostomy
___: Ileostomy take-down
___: Laparotomy, excision of scar and extensive
adhesiolysis.
___: Ventral hernia repair w/ vicryl mesh
___: Incisional hernia repair w/ mesh
___: Medial L knee meniscectomy
___: R knee meniscectomy
___: R total knee replacement

 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
VITALS: 98.0 BP 131 / 72 HR 71 RR 16 O2 sats 96% RA  
General: Alert, oriented, no acute distress  
Neck: Supple, no JVP distention.  
Cardiac: Regular heart sounds, no murmurs.  
Pulm: No respiratory effort, expiratory wheezing.  
Abdominal: Soft, distended, diffuse tenderness at palpation, 
more marked in the epigastric and RUQ area. No guarding.  
Extremities: Warm, well perfused, no edema. 

DISCHARGE PHYSICAL EXAM:
VITAL SIGNS:  T 98.0 BP 112 / 67 HR 74 RR 20 O2 96% RA 
GENERAL: No acute distress, tired-appearing 
HEENT: NCAT, EOMI, MMM, oropharynx clear
NECK: supple
CV: RRR, S1S2 normal, no MRG, 2+ radial pulses b/l
RESP: lungs CTAB, no increased work of breathing
GI: normoactive bowel sounds, soft, mild diffuse tenderness to
palpation, no organomegaly
EXTREMITIES: no edema, cyanosis, or clubbing
SKIN: No rashes or petechiae
NEURO: AAOx3, strength and sensation grossly normal throughout
 
Pertinent Results:
ADMISSION LABS:
===============
___ 12:40PM BLOOD WBC-6.4 RBC-4.25 Hgb-11.8 Hct-38.0 MCV-89 
MCH-27.8 MCHC-31.1* RDW-14.7 RDWSD-47.5* Plt ___
___ 12:40PM BLOOD Neuts-62.7 ___ Monos-6.6 Eos-0.3* 
Baso-0.3 Im ___ AbsNeut-3.98 AbsLymp-1.89 AbsMono-0.42 
AbsEos-0.02* AbsBaso-0.02

___ 12:40PM BLOOD Glucose-205* UreaN-29* Creat-2.3*# Na-140 
K-5.0 Cl-99 HCO3-20* AnGap-21*
___ 12:40PM BLOOD ALT-38 AST-33 AlkPhos-109* TotBili-0.4

___ 01:06PM BLOOD Lactate-4.7*
___ 06:10PM BLOOD Lactate-2.1*
___ 07:24AM BLOOD Lactate-1.6

MICROBIOLOGY:
=============
   HELICOBACTER PYLORI ANTIBODY TEST (Final ___: 
      NEGATIVE BY EIA. 

IMAGING/REPORTS:
================
Endoscopy ___: Biopsy results normal

DISCHARGE LABS:
==============

___ 07:45AM BLOOD WBC-2.4* RBC-3.52* Hgb-9.8* Hct-31.1* 
MCV-88 MCH-27.8 MCHC-31.5* RDW-14.2 RDWSD-45.5 Plt Ct-64*
___ 07:45AM BLOOD Glucose-312* UreaN-11 Creat-1.0 Na-142 
K-4.7 Cl-106 HCO3-21* AnGap-15
 
Brief Hospital Course:
PATIENT SUMMARY
___ year old woman with a PMH DM, HTN, HLD, Asthma, and multiple 
abdominal surgeries after a complicated oophorectomy, who 
presents with 2 weeks worsening epigastric pain and acute kidney 
injury. She was resuscitated with fluids with subsequent 
resolution of ___. Given persistent abdominal pain concerning 
for PUD vs gastritis, she underwent endoscopy on ___ which 
showed patchy erythema. Biopsies were taken, and she was 
discharged with close GI and PCP ___. 

ACUTE ISSUES:
===============
#Abdominal Pain, possible dyspepsia
Patient presented with 2 weeks of epigastric pain, worse with 
meals, unrelieved by PPI therapy. She has a prolonged history of 
abdominal
surgeries following an oophorectomy with subsequent sigmoid 
perforation. On admission, CT showed no evidence SBO or 
pathology at her previous anastomosis. She was empirically 
treated with IV antibiotics over concern for intraabdominal 
infection. However, she remained afebrile with no leukocytosis, 
with overall low concern for infection, so antibiotics were 
stopped upon arrival to the floor. Recal occult blood test was 
negative. Her pain is likely secondary to gastritis vs peptic 
ulcer disease. 

GI was consulted for endoscopy given her history of gastritis 
and failure of a PPI trial. Endoscopy was performed on ___ and 
showed patchy erythema. Biopsies were taken, and patient will 
follow up in GI clinic with Dr. ___ (fellow). Her home 
omeprazole 20 mg PO BID was continued. Dicyclomine was changed 
to four times a day. H. pylori antibody testing was negative.

#Acute kidney injury
Creatinine was 2.3 on admission, likely secondary to pre-renal 
zotemia, ___ to hypovolemia in the setting of poor po intake 
from continued abdominal pain. Her Creatinine was 1.0 on 
discharge. Furosemide was held on admission and at discharge. 
Lisinopril was held on admission and restarted at discharge. 

CHRONIC PROBLEMS
================
# Pancytopenia: Stable throughout admission. 

# HTN: Furosemide was held on admission and at discharge. 
Lisinopril was held on admission and restarted at discharge. 

# HLD: Home simvastatin was continued.

# Chronic back pain: Gabapentin was continued at reduced renal 
dose until resolution of ___. Tylenol and Tramadol were given 
PRN. 

# Asthma:
Home regimen was continued: Fluticasone-Salmeterol Diskus, 
Fluticasone Propionate, Cetirizine and Montelukast.

# Psych: Home regimen was continued: Fluoxetine, Clonazepam, 
Quetiapine

# Diabetes Mellitus: Lantus 20 units in the morning and HISS 
were given in the hospital. Metformin, glipizide and sitagliptin 
were held. She will resume her home regimen. 

TRANSITIONAL ISSUES:
===================
[ ] Dicyclomine was increased to ___ need to be titrated
[ ] Follow up with PCP.
[ ] Evaluation of pancytopenia (ITP vs MDS vs other etiology)
[ ] Lasix held at discharge in setting of pre-renal ___, BPs 
were stable in the 110s-120s/60s-70s while in hospital. 
Re-evaluate BPs as outpatient and consider restarting Lasix vs 
adjusting regimen. 

#CODE: Full 
#EMERGENCY CONTACT HCP: 
Name of health care proxy: ___ 
___: daughter 
Phone number: ___ 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Cetirizine 10 mg PO DAILY 
2. ClonazePAM 1 mg PO Q8H:PRN anxiety  
3. Docusate Sodium 100 mg PO BID:PRN constipation  
4. FLUoxetine 40 mg PO DAILY 
5. Furosemide 20 mg PO DAILY 
6. Gabapentin 600 mg PO TID 
7. Lisinopril 5 mg PO DAILY 
8. Omeprazole 20 mg PO BID 
9. Simvastatin 40 mg PO QPM 
10. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN migraine  
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID 
13. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
14. Glargine 22 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin
15. SITagliptin 100 mg oral DAILY 
16. QUEtiapine Fumarate 200 mg PO QHS 
17. Montelukast 10 mg PO DAILY 
18. DICYCLOMine 10 mg PO BID:PRN GI cramping 
19. GlipiZIDE 10 mg PO DAILY 
20. Venlafaxine XR 300 mg PO QAM 
21. Zolpidem Tartrate 10 mg PO QHS 

 
Discharge Medications:
1.  Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN migraine  
Do not exceed 6 tablets/day  
2.  Docusate Sodium 100 mg PO BID:PRN constipation   
3.  DICYCLOMine 10 mg PO ___ GI cramping  
4.  Glargine 22 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin 
5.  Cetirizine 10 mg PO DAILY  
6.  ClonazePAM 1 mg PO Q8H:PRN anxiety   
7.  FLUoxetine 40 mg PO DAILY  
8.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
9.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  
10.  Gabapentin 600 mg PO TID  
11.  GlipiZIDE 10 mg PO DAILY  
12.  Lisinopril 5 mg PO DAILY  
13.  MetFORMIN (Glucophage) 1000 mg PO BID  
14.  Montelukast 10 mg PO DAILY  
15.  Omeprazole 20 mg PO BID  
16.  QUEtiapine Fumarate 200 mg PO QHS  
17.  Simvastatin 40 mg PO QPM  
18.  SITagliptin 100 mg oral DAILY  
19.  Venlafaxine XR 300 mg PO QAM  
20.  Zolpidem Tartrate 10 mg PO QHS  
21. HELD- Furosemide 20 mg PO DAILY  This medication was held. 
Do not restart Furosemide until you see your primary care 
doctor.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
Abdominal Pain

SECONDARY DIAGNOSES:
Pancytopenia
Diabetes Mellitus II

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you at ___ 
___!

WHY WERE YOU ADMITTED?
-You were admitted for abdominal pain and vomiting.

WHAT HAPPENED IN THE HOSPITAL?
-You were given antibiotics until we felt certain that your pain 
was NOT due to an infection.
-You were found to be dehydrated with low blood pressure and 
acute kidney injury. You were given IV fluids and these issues 
resolved. 

WHAT SHOULD YOU DO AT HOME?
-You should continue taking all your medications as prescribed.
-You should follow up with your primary care doctor. 
-___ should follow up with your new GI doctor at the appointment 
listed below.
-You should avoid fatty foods and soda, which can make your 
stomach pain worse.

Thank you for allowing us be involved in your care, we wish you 
all the best!

Your ___ Team

 
Followup Instructions:
___
"
33,10614625,23965036," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins / levofloxacin
 
Attending: ___.
 
Chief Complaint:
Occipital scalp cellulitis and abscess
 
Major Surgical or Invasive Procedure:
I&D of occiptal scalp abscess

 
History of Present Illness:
Patient is a ___ with history of
NASH, anemia/thrombocytopenia, T2DM, multiple prior abdominal
surgeries, GERD/gastritis, dyslipidemia, HTN, asthma,
depression/anxiety, and migraines who presents with occipital
pain and swelling for the past ___.

Patient says that she began to experience mild discomfort on the
back of her head this past ___.  She didn't think much of it
as she has had self-resolved bumps on her scalp in the past.  
The
pain, however, soon intensified, reaching ___ with palpation
of an increasingly swollen/soft area on her occiput at midline. 
Patient had her husband inspect the area and he noticed a
swollen/soft raised area of skin that was slightly erythematous. 

Patient endorses throbbing discomfort at rest, worsened upon
palpation and with stretching of her scalp skin with neck
flexion.  +Feeling feverish over the past 24 hours.  Patient had
presented to an outpatient provider on ___ who told her that
she most likely had a cyst.  She was not given any antibiotics. 
Given her increasing pain not responsive to tylenol, patient
decided to present to the ___ ED for evaluation/management.    


In the ED, initial VS were: 96.9 100 107/68 16 95% RA 

Exam notable for:
Approx. 4cm diameter indurated and very tender swelling to left
occiput. Soft, boggy, and very tender swelling throughout much 
of
scalp. Mild erythema over indurated area.

Labs showed:
CBC 6.9>11.1/34.9<83 (76.7% PMNs, MCV 89)
BMP ___
HbA1C 9.4% 
VBG 7.38/37
UA notable for 30protein and few bacteria

Imaging showed:
CT Head with contrast
1. Edema and soft tissue swelling overlying the right occipital
region without focal collections identified likely representing
cellulitis.
2. No acute intracranial abnormality identified.

US Head
Limited study due to overlying hair. No drainable fluid
collection. Consider CT for further evaluation.

Consults: General surgery (no concern for EIC, no drainable 
fluid
collection)

Patient received:
___ 13:09 IVF  NS 1000 mL
___ 13:53 IV Morphine Sulfate 2 mg 
___ 17:51 IV Morphine Sulfate 2 mg 
___ 18:30 IV Ondansetron 4 mg
___ 18:31 IVF  NS 1000 mL 
___ 20:23 IV Vancomycin
___ 21:08 IVF  NS 1000 mL 
___ 23:13 PO Acetaminophen 1000 mg

Transfer VS were: 102.7 73 147/65 16 97% RA 
 
On arrival to the floor, patient recounts the history as above
using a phone interpreter.  She continues to have throbbing pain
on her scalp, markedly tender to palpation.  Review of systems 
is
otherwise notable for worsening nausea over the past four days,
associated with multiple (>5) episodes of bilious/non-bloody
emesis over the past 48hrs.  Patient has had some abdominal
distention over this time period, she mentions feeling 'gassy.' 
No BM since late ___.  PO intake has been poor,
patient has also noticed increased blood sugars.  +Flatus, 
though
not since earlier today.  Patient has a history of asthma and 
her
husband notes that she has been coughing more during the past
several days, no sputum production.  Patient denies any
subjective shortness of breath, chest pain, or palpitations. 
10-point ROS is otherwise NEGATIVE. 

Of note, patient has an unknown allergy to penicillins.  She
denies any prior respiratory reactions, mentions rash and GI
upset.  It seems that in review of ___, patient has received
cefepime/CTX/cefazolin/cefpodoxime in the past. 
 
Past Medical History:
Past Medical History:
- IDDM
- HTN
- HLD
- asthma
- migraines
- chronic back pain
- depression & anxiety, recent ED evaluation on ___ for SI

Past Surgical History:
___: L salpingo-oophorectomy complicated by sigmoid
perforation
___: Sigmoid  resection,  creation  ___ pouch,
takedown of splenic flexure and sigmoid colostomy.
___: I&D, debridement of abdominal abscess
___: Left colectomy/colostomy closure, takedown splenic
flexure, diverting ileostomy
___: Ileostomy take-down
___: Laparotomy, excision of scar and extensive
adhesiolysis.
___: Ventral hernia repair w/ vicryl mesh
___: Incisional hernia repair w/ mesh
___: Medial L knee meniscectomy
___: R knee meniscectomy
___: R total knee replacement

 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: 99.6 98/62 84 18 93 ra 
GENERAL: NAD when at rest, notable discomfort upon palpation of
the scalp
HEENT: Anicteric sclera, MMM.  ~3.5cm circular area of tender
swelling at the occipital midline, inferiorly with overlying
erythema and induration.  The area is soft to touch and markedly
tender. 
NECK: No JVP elevation.
CV: RRR, S1/S2, soft systolic murmur at the LUSB, no gallops or
rubs.
PULM: Transmitted upper airway sounds, otherwise clear to
auscultation b/l, no wheeze.
GI: Distended, normoactive BS throughout, mild diffuse 
tenderness
to palpation with rebounding/guarding, no palpable HSM. 
EXTREMITIES: No cyanosis, clubbing, or edema.
PULSES: 1+ radial pulses bilaterally.
NEURO: Alert, moving all 4 extremities with purpose, face
symmetric.

DISCHARGE PHYSICAL EXAM:
==========================
Vitals: 98.5 PO 138 / 82 77 16 91 RA 
GENERAL: NAD when at rest, notable discomfort upon palpation of
the occipital scalp  
HEENT: Anicteric sclera, MMM. Occiptal scalp with packing,
wrapped with gauze, sanguinous drainage.   
NECK: Supple, tender to palpation along R trapezius muscles and
neck. No meninigismus. 
HEART: RRR, S1/S2, soft systolic murmur at the LUSB, no gallops
or rubs.  
LUNGS: CTAB no wheezing or rales
ABDOMEN: Mildly distended, non-tender, no palpable HSM.  
EXTREMITIES: No cyanosis, clubbing, or edema.    
NEURO: Alert, moving all 4 extremities with purpose, face
symmetric.  
Skin: Skin type IV. Ther is a healing wound on occipital scalp 
without purlent drainage or surroudning erythema. 
 
Pertinent Results:
ADMISSION LABS:
===============

___ 11:55AM BLOOD WBC-6.9 RBC-3.94 Hgb-11.1* Hct-34.9 
MCV-89 MCH-28.2 MCHC-31.8* RDW-14.8 RDWSD-48.1* Plt Ct-83*
___ 11:55AM BLOOD Neuts-76.7* Lymphs-16.1* Monos-6.5 
Eos-0.1* Baso-0.3 Im ___ AbsNeut-5.30 AbsLymp-1.11* 
AbsMono-0.45 AbsEos-0.01* AbsBaso-0.02
___ 06:41AM BLOOD ___ PTT-52.0* ___
___ 11:55AM BLOOD Glucose-149* UreaN-24* Creat-1.4* Na-141 
K-4.7 Cl-102 HCO3-21* AnGap-18
___ 06:41AM BLOOD Albumin-3.5 Calcium-7.7* Phos-2.9 Mg-1.1*
___ 12:43PM BLOOD %HbA1c-9.4* eAG-223*
___ 12:46PM BLOOD ___ pO2-29* pCO2-37 pH-7.38 
calTCO2-23 Base XS--3

IMAGING:
========
CT Neck w/ contrast ___:
IMPRESSION: 
  
  
1. Partially visualized complex right suboccipital fluid without
complete rim enhancement, surrounded by soft tissue density, at
the site of prior subcutaneous edema.  This suggests a 
developing, though not fully formed abscess. 
2. Mildly enlarged, morphologically normal left lower posterior 
triangle/supraclavicular lymph nodes, contralateral from the
right suboccipital fluid collection, are most likely reactive,
but of uncertain etiology. 

CT HEAD W CONTRAST ___  
1. Scalp edema in the right occiput concerning for cellulitis. 
No
evidence of fluid collection or soft tissue gas.  
2. No acute intracranial abnormality. 

CT NECK W CONTRAST ___:
IMPRESSION: 
  
  
1. Partially visualized complex right suboccipital fluid without 
complete rim 
enhancement, surrounded by soft tissue density, at the site of 
prior 
subcutaneous edema.  This suggests a developing, though not 
fully formed 
abscess. 
2. Mildly enlarged, morphologically normal left lower posterior 
triangle/supraclavicular lymph nodes, contralateral from the 
right 
suboccipital fluid collection, are most likely reactive, but of 
uncertain 
etiology. 
  

CT HEAD W/ CONTRAST ___:
  
IMPRESSION: 
  
  
1. Noncontrast head CT demonstrates increased density at the 
site of the 
previously seen right suboccipital subcutaneous edema, also 
partially imaged on the concurrent contrast enhanced neck CT, 
demonstrating a probable  developing complex fluid collection 
without fully formed rim enhancement.  This is concerning for 
developing abscess. 
2. No evidence for acute intracranial abnormalities. 

CT CHEST/ABD/PELVIS W/ CONTRAST ___:
 
IMPRESSION:  
  
No CT evidence of acute infectious process within the chest, 
abdomen, or 
pelvis. 
  
Cirrhotic liver and splenomegaly unchanged from prior imaging. 
  
Stable postoperative change as above. 

DISCHARGE LABS:
=================

___ 07:15AM BLOOD WBC-3.4* RBC-2.88* Hgb-7.8* Hct-25.3* 
MCV-88 MCH-27.1 MCHC-30.8* RDW-14.6 RDWSD-47.0* Plt ___
___ 07:15AM BLOOD Neuts-65 Bands-4 ___ Monos-3* Eos-0 
Baso-1 ___ Metas-4* Myelos-0 NRBC-1* AbsNeut-2.35 
AbsLymp-0.78* AbsMono-0.10* AbsEos-0.00* AbsBaso-0.03
___ 07:15AM BLOOD ___ PTT-46.2* ___
___ 07:15AM BLOOD Glucose-133* UreaN-14 Creat-1.2* Na-142 
K-4.7 Cl-103 HCO3-27 AnGap-12
___ 07:15AM BLOOD ALT-14 AST-47* LD(LDH)-198 AlkPhos-200* 
TotBili-0.3
___ 07:15AM BLOOD calTIBC-278 Hapto-254* Ferritn-183* 
TRF-214
 
Brief Hospital Course:
Patient is a ___ with history of NASH, anemia/thrombocytopenia, 
T2DM, multiple prior abdominal surgeries, GERD/gastritis, 
dyslipidemia, HTN, asthma, depression/anxiety, and migraines who 
presented with occipital pain and swelling found to have 
occiptal scalp cellulitis which progressed to occipital scalp 
abscess.  

ACUTE ISSUES:  
==========================    
#FEVER:
#OCCIPTAL SCALP CELLULITIS:
#OCCIPTAL SCALP ABSCESS 
Patient presented with ___ of worsening occipital scalp
tenderness and swelling, found to have a 3-4cm area consistent 
with cellulitis. Patient was febrile to 102.7 in the ED, 
otherwise was without leukocytosis (neutrophilic predominant, no 
bands). Given signs of possible systemic toxicity (fever, 
borderline BP upon arrival to the floor), continued MRSA in 
addition to strep coverage with vancomycin which was then 
transitioned to cefazolin.  Additionally, due to persistent 
fever on antibiotics as well as neck pain, a CT neck, and torso 
were obtained which showed emerging abcess. Abscess developed 
with purulent discharge. ACS was consulted and she underwent 
I&D. A She did well and antibiotics were narrowed to cephalexin 
to complete ten day course from day of I&D, end date ___. 

#NAUSEA AND ABDOMINAL PAIN:   
Patient has a history of multiple intraabdominal surgeries, 
additional GERD/gastritis (taking meloxicam daily). No BM for 
over 24 hours upon admission. The patient complained of 
worsening abdominal distention with associated nausea/emesis. 
Etiologies considered were bowel obstruction vs. PUD vs. 
evolving gastritis vs. SBP with known history of NASH +/- 
cirrhosis. Of note, patient was admitted ___ with abdominal 
pain and nausea/vomiting, symptoms thought to be related to 
gastritis/PUD. RUQUS without e/o ascites. KUB without evidence 
of ileus or obstruction. The morning that the day team picked up 
the patient, her abdominal exam was significantly improved and 
she only had mild tenderness to palpation. There were no further 
issues with this. 

#ACUTE KIDNEY INJURY:  
Cr was previously ~1, though increased to 1.3 ___ iso ED 
presentation for N/V/D. Suspected prerenal iso GI losses and 
poor PO intake, exacerbated by ongoing ACE-I and furosemide 
administration. No signs of UTI on UA. s/p 3L IVF in ED. Held 
home lisinopril and furosemide. After further IVF and stopping 
vancomycin the patient's ___ resolved. 
  

CHRONIC ISSUES:  
==========================
#THROMBOCYTOPENIA: 
#NORMOCYTIC ANEMIA: 
Chronic, possible related to underlying liver disease (reported 
___, patient was previously referred to the ___ though 
was not evaluated). Hb and plts were stable and at baseline.
 
#HYPERTENSION: 
Borderline BPs upon presentation to the floor.  Held home 
lisinopril, furosemide, clonidine during admission. Upon 
discharge these medications were resumed. 
 
#Type II Diabetes Mellitus (HbA1C 9.4%)  
- Continued home lantus, held home standing short acting 
insulin, and used a sliding scale. Also held metformin and 
sitagliptin.

TRANSITIONAL ISSUES:
[ ] Patient has prior diagnosis of NASH and with evidence of 
cirrhosis on imaging. Please consider referral to hepatologist
[ ] Wound care: Occipital scalp wound- apply wound cleanser, 
gauze and sterile kerlix wrap around head. Daily dsg change.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Cetirizine 10 mg PO DAILY 
2. ClonazePAM 1 mg PO Q8H:PRN anxiety  
3. Docusate Sodium 100 mg PO BID:PRN constipation  
4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID 
5. Gabapentin 600 mg PO TID 
6. Montelukast 10 mg PO DAILY 
7. Simvastatin 40 mg PO QPM 
8. Venlafaxine XR 150 mg PO QAM 
9. QUEtiapine Fumarate 400 mg PO QHS 
10. Furosemide 20 mg PO DAILY 
11. GlipiZIDE 10 mg PO DAILY 
12. MetFORMIN (Glucophage) 1000 mg PO BID 
13. SITagliptin 100 mg oral DAILY 
14. Lisinopril 10 mg PO DAILY 
15. DICYCLOMine 10 mg PO QID GI cramping 
16. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 
17. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheeze 
18. Pantoprazole 40 mg PO Q24H 
19. Ondansetron ODT 4 mg PO Q8H:PRN nausea 
20. meloxicam 1000 mg oral DAILY 
21. Lidocaine 5% Ointment 1 Appl TP DAILY:PRN pain 
22. Glargine 20 Units Breakfast
Humalog 10 Units Breakfast
Humalog 13 Units Lunch
Humalog 13 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
23. Hydrocortisone Cream 1% 1 Appl TP BID 
24. Doxepin HCl 50 mg PO HS 
25. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO DAILY 
26. CloNIDine 0.1 mg PO TID 

 
Discharge Medications:
1.  Cephalexin 500 mg PO Q8H  
2.  Glargine 20 Units Breakfast
Humalog 10 Units Breakfast
Humalog 13 Units Lunch
Humalog 13 Units Dinner
Insulin SC Sliding Scale using HUM Insulin 
3.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild  
4.  Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheeze  
5.  Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO DAILY  
6.  Cetirizine 10 mg PO DAILY  
7.  ClonazePAM 1 mg PO Q8H:PRN anxiety   
8.  CloNIDine 0.1 mg PO TID  
9.  DICYCLOMine 10 mg PO QID GI cramping  
10.  Docusate Sodium 100 mg PO BID:PRN constipation   
11.  Doxepin HCl 50 mg PO HS  
12.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  
13.  Furosemide 20 mg PO DAILY  
14.  Gabapentin 600 mg PO TID  
15.  GlipiZIDE 10 mg PO DAILY  
16.  Hydrocortisone Cream 1% 1 Appl TP BID  
17.  Lidocaine 5% Ointment 1 Appl TP DAILY:PRN pain  
18.  Lisinopril 10 mg PO DAILY  
19.  MetFORMIN (Glucophage) 1000 mg PO BID  
20.  Montelukast 10 mg PO DAILY  
21.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  
22.  Pantoprazole 40 mg PO Q24H  
23.  QUEtiapine Fumarate 400 mg PO QHS  
24.  Simvastatin 40 mg PO QPM  
25.  SITagliptin 100 mg oral DAILY  
26.  Venlafaxine XR 150 mg PO QAM  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Occipital scalp cellulitis and abscess
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___:

You were admitted to the hospital because you were having pain 
and swelling on your scalp and you were having fevers. 

At the hospital you were found to have cellulitis and an abscess 
on your scalp. You had a procedure to drain the abscess. You 
were given antibiotics. 

When you leave the hospital please take all of your medications. 
Please follow up with your doctors. 

Qu es un ___? Un ___ es un rea ___ 
acumula pus (fluido infectado). Un ___ es a menudo causado 
por bacterias, hongos u otros grmenes que entran en una ___ 
abierta. Usted ___ un ___ en cualquier ___ 
___.

Cmo ___ trata un ___? 
Incisin y drenaje es un procedimiento que ___ usa para drenar el 
pus y el lquido del ___ mdico har una incisin en el 
___ para que pueda drenar. ___ pondr ___ 
y ___ cubrir con una venda.

Cundo ___ atencin inmediata? 
El rea alrededor del ___ dolorosa, caliente o 
tiene manchas ___.
Usted tiene fiebre o escalofros.
___ corazn est latiendo mas rpido de lo normal. 
___ siente desmayar o confundido.

It was a pleasure caring for you!

Sincerely, 

Your ___ Treatment Team

 
Followup Instructions:
___
"
34,10614625,29561176," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Motrin / Zantac / Penicillins / levofloxacin / amoxicillin
 
Attending: ___.
 
Chief Complaint:
CC: ___
 
Major ___ or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ woman with history of IDDMII, 
HTN, HLD, depression/anxiety presenting with dizziness and back 
pain.

The patient is interviewed with the assistance of a ___ 
telephone translator. She reports that she has been feeling 
unwell for several days prior to admission. She reports that she 
has had about 1 week of right lower back pain and dysuria. She 
tried cranberry juice and drinking more water, but this did not 
help. She also reports that her blood sugars have become very 
high, so high that they are reading over her glucometer; she has 
been taking her insulin as prescribed. She reports polyuria and 
polydipsia. She reports that in the days preceding her 
presentation she began to feel dizzy, particularly when get up 
from sitting to walk. 

She denies any fevers or chills. No nausea, vomiting, abdominal 
pain, or diarrhea. Denies chest pain, palpitations, shortness of 
breath. She reports a cough, which has been ongoing for many 
months and is worse at night. 

In the ED, vitals: 97.6 116 110/63 16 95% RA 
Exam notable for: right CVA tenderness, dry mucous membranes, 
poorly localized mild abdominal pain without peritoneal signs 
Labs notable for: Hb 10.5, plt 72, BUN/Cr ___, AG 20; lactate 
5.4->2.1
Imaging: CXR
Patient given: 2L LR, magnesium sulfate 2 gm, insulin gtt, 
insulin SC 4 units, ceftriaxone 1 gm 
On arrival to the floor, the patient reports ongoing right lower 
back pain. She reports that she feels somewhat better than when 
she came to the ED. 

ROS: Pertinent positives and negatives as noted in the HPI. All 
other systems were reviewed and are negative. 

 
Past Medical History:
Past Medical History:
- IDDM
- HTN
- HLD
- asthma
- migraines
- chronic back pain
- depression & anxiety, recent ED evaluation on ___ for SI

Past Surgical History:
___: L salpingo-oophorectomy complicated by sigmoid
perforation
___: Sigmoid  resection,  creation  ___ pouch,
takedown of splenic flexure and sigmoid colostomy.
___: I&D, debridement of abdominal abscess
___: Left colectomy/colostomy closure, takedown splenic
flexure, diverting ileostomy
___: Ileostomy take-down
___: Laparotomy, excision of scar and extensive
adhesiolysis.
___: Ventral hernia repair w/ vicryl mesh
___: Incisional hernia repair w/ mesh
___: Medial L knee meniscectomy
___: R knee meniscectomy
___: R total knee replacement

 
Social History:
___
Family History:
Family history is notable for cardiac disease of her sisters. 

 
Physical Exam:
VITALS: 97.5 168/88 78 18 100 RA 
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate; dry
mucous membranes
CV: Heart regular, no murmur
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel
sounds present.
GU: No suprapubic fullness or tenderness to palpation; right CVA
tenderness
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented, face symmetric, gaze conjugate with 
EOMI,
speech fluent, moves all limbs, sensation to light touch grossly
intact throughout
PSYCH: Very pleasant, appropriate affect

 
Pertinent Results:
Labs:
___ 10:15AM BLOOD WBC: 4.0 RBC: 3.92 Hgb: 10.5* Hct: 34.9
MCV: 89 MCH: 26.8 MCHC: 30.1* RDW: 14.1 RDWSD: 45.___* 
___ 10:15AM BLOOD Glucose: 409* UreaN: 27* Creat: 1.9* Na:
138 K: 4.3 Cl: 100 HCO3: 18* AnGap: 20* 
___ 10:15AM BLOOD Calcium: 9.3 Phos: 3.5 Mg: 1.2* 
___ 11:17AM BLOOD Lactate: 5.4* 
___ 03:26PM BLOOD Lactate: 2.1* 

U/A: Nit+, ___ large, >182 WBC
Urine cx: 
 URINE CULTURE (Final ___: 
      ESCHERICHIA COLI.    >100,000 CFU/mL.  PRESUMPTIVE 
IDENTIFICATION. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMIKACIN--------------   <=2 S
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--     4 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------  =>16 R
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------     8 I
TRIMETHOPRIM/SULFA----   <=1 S

OTHER DATA: 
# CXR (___): No acute cardiopulm process
 
Brief Hospital Course:
ASSESSMENT & PLAN: ___ h/o DM2, HTN, HLD, depression/anxiety 
presenting with dizziness and back pain, found to have suspected 
pyelonphritis, ___, and hyperglycemia.

ACUTE/ACTIVE PROBLEMS:
# Suspected pyelonephritis: 
  Ms. ___ was admitted with dysuria, R flank pain, 
positive urinalysis c/f pyelonephritis.  She was initially 
treated with IV CTX - with good symptomatic improvement.  Urine 
cx grew Ecoli - which was sensitive to cephalosporin.  She was 
placed on PO cefpodoxime (allergic to quinolones) and observed 
overnight.  She continued to do well - and was discharged for 8 
additional days to complete a 10 day course. Pain control with 
Tylenol as needed

# Acute kidney injury: Baseline Cr 1.1, admit Cr 1.9. Likely 
pre-renal azotemia in setting of hyperglycemia with osmotic 
diuresis. After hydration, Cr stabilized to 1.3.  She may 
benefit from ___ in setting of diabetes - to be explored as 
an outpt. 

# DM2 with hyperglycemia: She presented with dizziness, 
polyuria, polydipsia, and hyperglycemia in setting of infection 
as above. Elevated lactate.  Although there was an elevated 
anion gap,   U/A ket neg, betahydroxybutyrate 0.3 making DKA 
unlikely.  Metformin, glipizide were held and restarted on 
discharge.  She was continued on Lantus, Humalog with meals, 
hISS. 

# Asthma: Patient with reported history of asthma and has 
chronic
cough. No wheezing on exam. Per pharmacy records, pulmonary
medications have not been filled recently.  Stable during this 
admission. 

CHRONIC/STABLE PROBLEMS:
# Thrombocytopenia
# Anemia: Chronic, stable, thought to be related to NASH

# HTN:
- Continue clonidine

# HLD:
- Continue simvastatin

# Depression/Anxiety:
- Continue venflafaxine, quetiapine, chlorpromazine, dozepin,
clonazepam, clonidine

# GERD: 
- Continue pantoprazole

GENERAL/SUPPORTIVE CARE:
# Nutrition/Hydration: Diabetic
# Functional status: Activity as tolerated
# Bowel Function: As needed
# Lines/Tubes/Drains: PIV
# Precautions: None
# VTE prophylaxis: ___ if plt>50
# Consulting Services: None
# Contacts/HCP/Surrogate and Communication: See OMR
# Code Status/Advance Care Planning: Full presumed
# Disposition:  Home, no services. 

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 
2. Doxepin HCl 100 mg PO HS 
3. Pantoprazole 40 mg PO Q24H 
4. QUEtiapine Fumarate 400 mg PO QHS 
5. Simvastatin 80 mg PO QPM 
6. Venlafaxine XR 300 mg PO QAM 
7. MetFORMIN (Glucophage) 1000 mg PO BID 
8. GlipiZIDE 10 mg PO DAILY 
9. ClonazePAM 1 mg PO Q8H:PRN anxiety  
10. CloNIDine 0.1 mg PO TID 
11. Glargine 10 Units Bedtime
Novolog 10 Units Breakfast
Novolog 13 Units Lunch
Novolog 13 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
12. ChlorproMAZINE 200 mg PO QHS 
13. Vitamin D ___ UNIT PO 1X/WEEK (___) 
14. Ferrous Sulfate 325 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever 
RX *acetaminophen 500 mg 2 tablet(s) by mouth every eight (8) 
hours Disp #*60 Tablet Refills:*0 
2.  Cefpodoxime Proxetil 200 mg PO Q12H Duration: 8 Days 
RX *cefpodoxime 200 mg 1 tablet(s) by mouth every twelve (12) 
hours Disp #*16 Tablet Refills:*0 
3.  Glargine 10 Units Bedtime
Novolog 10 Units Breakfast
Novolog 13 Units Lunch
Novolog 13 Units Dinner
Insulin SC Sliding Scale using HUM Insulin 
4.  ChlorproMAZINE 200 mg PO QHS  
5.  ClonazePAM 1 mg PO Q8H:PRN anxiety   
6.  CloNIDine 0.1 mg PO TID  
7.  Doxepin HCl 100 mg PO HS  
8.  Ferrous Sulfate 325 mg PO DAILY  
9.  GlipiZIDE 10 mg PO DAILY  
10.  MetFORMIN (Glucophage) 1000 mg PO BID  
11.  Pantoprazole 40 mg PO Q24H  
12.  QUEtiapine Fumarate 400 mg PO QHS  
13.  Simvastatin 80 mg PO QPM  
14.  Venlafaxine XR 300 mg PO QAM  
15.  Vitamin D ___ UNIT PO 1X/WEEK (___)  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Pyelonephritis, UTI 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___,

   It was a pleasure looking after you.  As you know, you were 
admitted with dizziness and back pain.  You were found to have a 
urinary tract infection which likely involved your kidney as 
well.  This may partly account for your back pain.   You were 
treated with intravenous antibiotics and switched to oral 
antibiotics once the urine cultures identified the bacteria 
(E.coli) and confirmed its sensitivity to the antibiotic you are 
being prescribed.
   
   Please complete the antibiotics (Cefpodoxime) for an 
additional 8 days to complete a 10 day course.  Otherwise, to 
avoid future urinary tract infection, please ensure that you are 
well hydrated and that your diabetes is in good control.  This 
will prevent future urinary tract infections from happening.  

 You were also found to be dehydrated and with mild acute kidney 
injury.  After hydration, your kidney function improved.  Please 
insure good oral intake of fluids and good control of sugars 
(higher sugars can lead to loss of water). 

 You may have a component of musculoskeletal back pain too.  For 
this, we recommend following with your medical doctor and taking 
acetaminophen (Tylenol) as needed. 

There are otherwise, no changes to your medication.  We wish you 
a quick recovery!

Your ___ team. 

 
Followup Instructions:
___
"
35,11247436,26290780," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
respiratory failure, septic shock

 
Major Surgical or Invasive Procedure:
- Arterial line placement
- Central venous line placement 
- ERCP with biliary stent placement

 
History of Present Illness:
___ w chronic thrombocytopenia, thrombophilia ___ s/p lap CCY 
xfer from OSH w postop course c/b hypotension, postop 
hemorrhage, multiorgan dysfunction syndrome.  Patient w biliary 
colic taken for elective lap CCY ___ ___ - Dr. 
___.  Preop workup included RUQ US equivocal for stones and 
non-filling HIDA suspected to be related to porcelain GB.  On 
chronic coumadin for thrombophilia w hx DVT/PE.  Bridged w 
lovenox for OR.  Per op report, lap CCY uneventful w porcelain 
GB, minimal EBL.  Received 1L LR, 1 pack platelets intraop for 
preop platelets of 27k.  In PACU, patient hypotensive with hct 
37 (preop ___ -> 21 (postop), platelets 45k.  Transferred to 
ICU w pressor requirement.  Received 4 pRBC w hct 18 ___ ___ 
-> 32 ___ AM); also  transfused additional pack platelets.  
POD1 to 2, pt persistently hypotensive requiring pressors w hct 
falling from 32 -> 24 ___ AM).  Febrile to 103.1 POD1 w 
concurrent increase in WBC from 5.4 preop to 30 on ___ and 
started on zosyn ___.  Postop course also c/b worsening 
hypoxic respiratory failure requiring intubation, rising 
transaminases (normal preop, postop ___: ALT: 821, AST: 576, 
Tbili: 1.5, Amylase: 411), ___ (preop Cr 0.8 -> 1.8 ___.  No 
abdominal imaging obtained.  Transferred to ___ for 
further management.  
  
On arrival to the ___, patient's VS: T 98.6, HR 104, BP 96/43, 
RR 30, sPO2 97% on volume control 460 x 18 PEEP 12, FiO2 100%, 
Peak pressure 26, plateau pressure 24, with ABG: 7.34/___/117/16. 
Lactate went from 3.1 ->1.8.
 
Review of systems: Unable to obtain given patient is intubated. 
She is rousable and acknowledges some abdominal pain, improved 
with fentanyl bolus. 

 
Past Medical History:
- Rectal bleeding: ___ tx'd DDAVP
- Thrombocytopenia:  ___ BM biopsy with erythroid 
hyperplasia and granulocytic hypoplasia
- History of DVT/PE on coumadin
- Hypothryoidism
- Fe deficiency Anemia 
- Porcelain gallbladder now s/p cholecystectomy ___
- Hyperlipidemia
- HTN
- s/p exploratory laparoscopy ___
- s/p tubal ligation ___
- osteoarthritis
 
Social History:
___
Family History:
Father (deceased) colon ca, Mother (deceased) liver ca, one 
brother treated for colon ca. 
 
Physical Exam:
General: Sedated and intubated elderly female, generalized 
jaundice  
HEENT: Scleral Icterus, dry MM, PERRL  
Neck: supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, ___ SEM L sternal 
border, no rubs/gallops  
Lungs: Mild diffuse wheezes, No rales/rhonchi  
Abdomen: Soft, non-distended, diffuse tenderness throughout, 
decreased bowel sounds, no organomegaly, no rebound or guarding, 
laproscopic cholecystectomy sites clean/intact/no erythema, 
large irregularly shaped bruise on right side measuring 5x2 
inches.
GU: Foley
Ext: Cold extremities, 1+ pulses, no clubbing, cyanosis or edema 
 
Neuro: Lethargic, but follows commands.

DISCHARGE EXAM notable for:
GEN: Awake, alert, pleasant, NAD. 
CV: RRR. ___ SM.
PULM: Greatly diminished breath sounds at bilateral bases, poor 
air movement, poor respiratory effort (limited by pleuritic RUQ 
pain)
ABD: Soft, tender in RUQ without rebound or guarding. lap chole 
sites clean. 
EXT: warm, well perfused
 
Pertinent Results:
Admission labs:
___ 01:54PM BLOOD WBC-24.7* RBC-2.51* Hgb-7.6* Hct-22.3* 
MCV-89 MCH-30.3 MCHC-34.2 RDW-15.1 Plt Ct-49*
___ 01:54PM BLOOD Neuts-77* Bands-10* Lymphs-5* Monos-4 
Eos-0 Baso-0 ___ Metas-4* Myelos-0 NRBC-6*
___ 01:54PM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 01:54PM BLOOD ___ PTT-37.7* ___
___ 01:54PM BLOOD ___ 01:54PM BLOOD Glucose-112* UreaN-40* Creat-1.8* Na-141 
K-4.4 Cl-111* HCO3-18* AnGap-16
___ 01:54PM BLOOD Albumin-2.8* Calcium-6.8* Phos-3.6 
Mg-1.3*
___ 02:08PM BLOOD freeCa-1.03*
___ 01:54PM BLOOD ALT-774* AST-1131* AlkPhos-42 TotBili-1.5
___ 03:13PM BLOOD Type-ART Temp-36.7 Tidal V-450 PEEP-5 
FiO2-100 pO2-117* pCO2-28* pH-7.34* calTCO2-16* Base XS--8 
AADO2-570 REQ O2-94 -ASSIST/CON Intubat-INTUBATED
___ 02:08PM BLOOD Lactate-3.1*
 
Notable labs:
___ 01:22PM BLOOD cTropnT-<0.01
___ 08:56PM BLOOD cTropnT-0.02*
___ 01:27AM BLOOD cTropnT-0.01
 
Discharge labs:
___ White Blood Cells 12.7* 4.0 - 11.0 K/uL 
___ Hemoglobin 12.0 12.0 - 16.0 g/dL 
___ Hematocrit 36.0 36 - 48 % 
___ Platelet Count 38* 150 - 440 K/uL 
___ Urea Nitrogen ___ mg/dL 
___ Creatinine 0.7 0.4 - 1.1 mg/dL 
___ Creatinine 0.9
___ Sodium ___ mEq/L 
___ Potassium 4.2 3.3 - 5.1 mEq/L 
___ Chloride 98 96 - 108 mEq/L 
___ Bicarbonate 26 22 - 32 mEq/L 
___ Alanine Aminotransferase (ALT) 31 0 - 40 IU/L 
___ Asparate Aminotransferase (AST) 34 0 - 40 IU/L 
___ Alkaline Phosphatase 149* 35 - 105 IU/L 
___ Bilirubin, Total 2.2* 0 - 1.5 mg/dL 

___ INR 2.0

Micro:
___ 5:27 pm URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 
 
___ 5:27 pm URINE      HEME S# ___ ADDED ___. 

                            **FINAL REPORT ___

   Legionella Urinary Antigen  (Final ___: 
      NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. 
 
___ 10:53 pm BLOOD CULTURE      Source: Line-art line. 

   Blood Culture, Routine: Negative
 
___ 7:22 am BLOOD CULTURE      Source: Line-TLCL 2 OF 2. 

   Blood Culture, Routine: Negative.  (Pending): 
 
___ 11:31 am SPUTUM      Source: Endotracheal. 

   GRAM STAIN (Final ___: 
      ___ PMNs and <10 epithelial cells/100X field. 
      NO MICROORGANISMS SEEN. 

___  **FINAL REPORT ___
   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Illumigene DNA
      amplification assay. 
           (Reference Range-Negative). 
 
Studies: 
___ CXR
SINGLE FRONTAL VIEW OF THE CHEST 
REASON FOR EXAM:  Acute shortness of breath, followup pulmonary 
edema. 
Comparison is made with prior study, ___. 
There are persistent low lung volumes.  Mild cardiomegaly is 
stable.  
Mild-to-moderate pulmonary edema has minimally improved.  Right 
perihilar 
opacities consistent with atelectasis are unchanged.  If any, 
there are small bilateral pleural effusions. There is a large 
hiatal hernia. 

___ CXR
FINDINGS:  In comparison with study of ___, the endotracheal 
and nasogastric tubes have been removed.  The right IJ catheter 
again extends into the right atrium. Continued low lung volumes 
with stable cardiomediastinal silhouette. Bilateral multifocal 
opacifications persist, though in some areas appear less 
prominent than on the prior study.  Bilateral pleural effusions 
with bibasilar volume loss persist, with poor definition of the 
left hemidiaphragm. 

___ CXR 
FINDINGS:  Indwelling support and monitoring devices are 
unchanged in 
position, including a nasogastric tube coiled within a hiatal 
hernia and a 
right internal jugular vascular catheter with tip overlying the 
region of the body of the right atrium.  Cardiomediastinal 
contours are stable in 
appearance.  Lung volumes remain low.  Worsening multifocal 
pulmonary 
opacities, particularly within the right upper lobe and left 
lower lobe, but some improved aeration within the right lower 
lobe as compared to the priorstudy.  Small bilateral pleural 
effusions are unchanged on the left and minimally improved on 
the right. 

___ ECHO
The left atrium is elongated. No atrial septal defect is seen by 
2D or color Doppler. Left ventricular wall thicknesses are 
normal. The left ventricular cavity size is normal. Due to 
suboptimal technical quality, a focal wall motion abnormality 
cannot be fully excluded. Overall left ventricular systolic 
function is probably mildly to moderately depressed (LVEF= 40 
%). There is LV dysynchrony (bundle branch block). No masses or 
thrombi are seen in the left ventricle. There is no ventricular 
septal defect. Right ventricular chamber size is normal with 
borderline normal free wall function. The aortic valve leaflets 
(3) are mildly thickened but aortic stenosis is not present. 
Mild to moderate (___) aortic regurgitation is seen. The mitral 
valve leaflets are mildly thickened. There is no mitral valve 
prolapse. Moderate (2+) mitral regurgitation is seen. The 
tricuspid valve leaflets are mildly thickened. There is mild 
pulmonary artery systolic hypertension. There is no pericardial 
effusion.

___ CHEST (PORTABLE AP)
Indwelling support and monitoring devices are unchanged in 
position including nasogastric tube coiled within a hiatal 
hernia.  Heart is mildly enlarged, accompanied by mild pulmonary 
vascular congestion.  Multifocal pulmonary opacities are again 
demonstrated in the right mid and both lower lungs, which may 
reflect a combination of multifocal atelectasis and infectious 
consolidation.  Overall, this has slightly worsened in the 
interval.  Small pleural effusions are also noted. 
 
___ CHEST (PORTABLE AP)
Endotracheal tube continues to have its tip approximately 3 cm 
above the carina.  A right internal jugular central line has its 
tip in the right atrium  unchanged.  Nasogastric tube is seen 
within a hiatal hernia.  There is  persistent more confluent 
opacity in the right upper lobe, medial right lung  base and 
left lower lobe, all of which is concerning for multifocal 
pneumonia  or aspiration, less likely atelectasis.  Persistent 
small left effusion.   Overall stable cardiac and mediastinal 
contours.  Biliary stent remains in  place.  No pneumothorax.  
 
___ CHEST (PORTABLE AP)  
Right internal jugular central line continues to have its tip in 
the right atrium.  Endotracheal tube has its tip approximately 4 
cm above the carina.  A  nasogastric tube is seen coursing below 
the diaphragm with the tip projecting  over the stomach.  
Biliary stent in place.  Low lung volumes. There has been  no 
significant interval change in the patchy airspace consolidation 
in the  periphery of the right upper lung and perihilar region 
concerning for  pneumonia.  In addition, persistent retrocardiac 
opacity is seen with  associated small left effusion which could 
reflect a partial lower lobe  atelectasis, although pneumonia or 
aspiration is also possible.  Clinical  correlation is advised. 
Overall stable cardiac and mediastinal contours. Scattered air 
in non-distended loops of predominantly small bowel.  No  
pneumothorax. 
  
___ CHEST (PORTABLE AP)
Interval placement of orogastric tube in standard position seen 
within the fundus of the stomach.  Interval improvement in 
pulmonary edema. Persistent left lower lobe atelectasis or 
collapse and persistent pneumonia  predominantly in the axillary 
region of the right lung. 
 
___ CTA ABD & PELVIS
1.  Large amount of blood within the abdomen, greatest around 
the liver with increased density along the liver consistent with 
more recent bleed, but no evidence of active arterial 
extravasation.  
2.  Hypodensity in the periphery of the right lobe of the liver, 
possibly consistent with contusion. 
3.  Patchy ground-glass opacities within the lungs bilaterally, 
right greater than left, suggest infection versus inflammation. 
4.  Bilateral pleural effusions with adjacent atelectasis. 
 
___ ERCP
Findings: Esophagus: Limited exam of the esophagus was normal 
Stomach: Limited exam of the stomach was normal 
Duodenum: Limited exam of the duodenum was normal 
Major Papilla: Normal major papilla 
Cannulation:  Cannulation of the biliary duct was successful and 
deep with a sphincterotome using a free-hand technique. Contrast 
medium was injected resulting in partial opacification. 
Cannulation of the pancreatic duct was successful and 
superficial with a sphincterotome using a free-hand technique. 
Contrast medium was injected resulting in partial opacification. 
 
 
Fluoroscopic Interpretation of Biliary Tree: The common bile 
duct, common hepatic duct, right and left hepatic ducts were 
grossly normal. Given cholangitis, high pressure detailed 
cholangiogram was not performed.  
Procedures: A 7cm by ___ ___ biliary stent was placed 
successfully using a Oasis system stent introducer kit.  
 
Impression: (cannulation, cannulation) 
Limited cholangiogram showed a normal biliary tree. given 
cholangitis, detailed cholangiogram was not performed. A biliary 
stent was emperically placed. No pus was seen. 
(stent placement) 
Otherwise normal ercp to third part of the duodenum
 
Recommendations: Watch for complications - bleeding , 
perforation, pancreatitis. Repeat ERCP in 1 month for assessment 
of biliary tree and stent removal. Return to ICU.
 
    
___ CHEST (PORTABLE AP)
Cardiac size is top normal.  There are low lung volumes.  
Widened mediastinum  could be due to the projection.  ET tube 
tip is 5 cm above the carina.   Multifocal consolidations in the 
right lung are worrisome for aspiration  pneumonia.  There is a 
large area of atelectasis in the left lower lobe.   There are 
small bilateral pleural effusions.  There is no evident  
pneumothorax.  There are low lung volumes.  The stomach is 
distended. 
 
___ ECG 
Baseline artifact. Regular supraventricular rhythm. P wave 
difficult to assess in the limb leads. Left bundle-branch block. 
No previous tracing available for comparison. Clinical 
correlation is suggested. 
 
 
Brief Hospital Course:
SUMMARY OF ICU COURSE PER ICU TEAM:
==================================
___ w chronic thrombocytopenia, thrombophilia s/p lap CCY 
___ for porcelain ___ transferred from OSH with postop 
multiorgan dysfunction syndrome in setting of postoperative 
hemorrhage with hemoperitoneum, sepsis ___ cholangitis vs 
aspiration PNA/ HCAP. 
 
ACTIVE ISSUES in ICU: 

# Septic and hypovolemic shock: On transfer from OSH, patient 
met criteria for severe sepsis given multisystem organ 
dysfunction (elevated LFTs, poor UOP, rising creatinine, 
hypoxia). Most likely infectious sources are 
gallbladder/cholangitis given recent surgery vs. pulmonary given 
new infiltrates on CXR and multiple ground glass opacities on 
subsequent CT scan. Other possible sources are urine, peripheral 
IV lines. Currently on phenylephrine to maintain pressures. 
Patient was started on emperic vancomycin and zosyn (day 1 = 
___ to cover for possible biliary or lung sources. Blood, 
urine and sputum cultures were sent and are negative or pending 
as of ___ at 1644. Hypovolemia was also likely contributing 
to hypotension in the context of acute blood loss anemia with CT 
showing large amount of blood within the abdomen, greatest 
around the liver with increased density along the liver 
consistent with more recent bleed, but no evidence of active 
arterial extravasation.  Central line was placed as patient 
required phenylephrine. This was subsequently weaned and patient 
became hypertensive and tachycardic requiring IV nitro drip 
which was also weaned. Thereafter patient was hemodynamically 
stable for transfer to the medical floor where her pressure 
remained stable. 
 
# Respiratory Failure: Patient was intubated for airway 
protection prior to transfer to the ___. Patient was sedated 
with fentanyl and midazolam boluses. Did not complete RSBI 
evaluation on ___ given hypertension, diaphoresis, and patient 
discomfort. She was diuresed and SBT/RSBI were repeated on ___ 
and ___, and patient was successfully extubated. After 
extubation, patient endorsed visual hallucination of ants 
crawling on the wall and appeared to have a hypoactive delerium, 
which was moderately improved by time of transfer from the FICU. 
She had one further episode of wheezing prior to transfer. She 
received nebs and expectorated mucus, after which she improved. 
There was no desaturation. She was back to baseline prior to 
transfer to medical floor.  Respiratory status on floor 
complicated by acute systolic heart failure, as below.
  
# Anemia, thrombocytopenia: She has MDS by ___ with deletion 
20q and intermediate-1 risk. Baseline Hct is normal (40 on 
___ and baseline plts are ~40s.  At OSH in the PACU, patient 
was hypotensive with hct of 21 following elective 
cholecystectomy from 37 pre-op.  Transferred to ICU w pressor 
requirement.  Received 4 pRBC w hct 18 ___ ___ -> 32 ___ 
AM).  On arrival to ___ hct of 22 and she received a total of 
4 units pRBCs on ___ and hematocrit increased to 30.5. 
Likely acute blood loss anemia as patient had CT scan which 
revealed large amounts of blood within the abdomen, greatest 
around the liver with increased density along the liver 
consistent with more recent bleed. 
 
# ___: Creatine 1.8 on arrival from. Likely secondary to poor 
perfusion from sepsis as above. Her urine lytes consistent with 
pre-renal etiology with FENa of 0.41%. Patient was volume 
repleted and received multiple units of pRBCs and creatinine 
trended to baseline of 0.6-0.7.  
 
# Thrombocytopenia: Long-standing per notes. Bone marrow biopsy 
in the past was not diagnostic. Platelets have been dropping at 
OSH which may be in the setting of acute illness vs. waxing and 
waning at baseline, however given recent Lovenox (started to 
bridge several days pre-op) there was initially concern for HIT, 
though outpatient hematologist ___ felt there was 
no concern for HIT in this setting.
 
# History of DVT/PE: Spoke with outpatient hematologist 
___ (___) who confirms prothrombin gene 
mutation with multple DVT/PE and need for ongoing 
anticoagulation. She take warfarin, but this was held and she 
was on lovenox pre-operatively. She has MDS by ___ with 
deletion 20q and intermediate-1 risk. Baseline Hct is normal (40 
on ___ and baseline plts are ~40s. She is not concerned for 
HIT in this setting. Given acute blood loss anemia (above) 
warfarin and lovenox were held and she was started on heparin SC 
for DVT prophylaxis. On ___, hematology recommended holding 
all heparin products and sending HIT antibody. HIT antibody was 
pending at the time of transfer out of the FICU.--> Heparin PF4 
Antibody Test by ___ was negative.
 
 
# Hypothyroidism: Stable. Continued home levothyroxine. 
 
# ? Hypertension: Metoprolol held initially in the setting of 
hypotension as above. 
 
# Hyperlipidemia: Statin held in setting of rising LFTs, with 
concern for shock liver. AST and ALT subsequently trended down. 
 
# Communication: Sister ___ ___
# Code: Full
=====================================
SUMMARY OF COURSE WHILE ON GENERAL MEDICAL SERVICE:
___ yo woman with MDS, prothrombin gene mutation, multiple DVT, 
PE, s/p elective lap CCY at OSH on ___ for porcelain GB (path 
showed no malignancy per phone call to ___ on ___. Postop 
course c/b hypotension, hemoperitoneum, hypoxia requiring 
intubation, ARF, elevated transaminases. She was med-flighted 
from ___ to the ICU at the ___ on ___ and 
underwent an ERCP on ___ with biliary stent placement.  She 
stabilized on pressors, IVF, 4U PRBCs, empiric zosyn/vanco for 
HCAP +/- cholangitis, and ultimately was weaned from pressors, 
extubated and finished an 8-day course of abx. 
.
Hematology saw patient in the ICU given h/o MDS, 
thrombocytopenia, and thrombophilia (DVT/PE). They recommended 
restarting warfarin when plt >25K.  Her Hct remained stable in 
the low ___ x several days & she was hemodynamically stable, 
thus warfarin was restarted ___ (5 mg po x 1, then 2 mg po 
___ with increase in INR to 2.7.  INR fell to 2.0 on ___, 
coumadin restarted at 2 mg daily. INR stable at 2.0 on ___. 
.
Her course on the floor was notable for persistent hypoxemia and 
relative tachypnea.  Her volume status has been difficult 
initially with copious CDiff neg diarrhea (now improved on 
loperamide).  On ___ she developed wheezing and was given a 
neb which 'worsened' her respiratory status, she was 
hypertensive, tachycardic, diaphoretic and had rales throughout 
c/w acute on chronic systolic heart failure.  Responded well to 
nitropaste, furosemide (40 mg IV x 1 after already receiving 20 
mg po earlier) and oxygen.  Of note, TTE earlier in 
hospitalization showed an EF 40% without clear wall motion 
abnormalities.  Afterload reduction was added with captopril.  
She was diuresed with IV lasix with improvement. She appeared 
euvolemic on ___, therefore lasix was stopped.  Captopril was 
added for afterload reduction, this should be changed to 
lisinopril at rehab.  She requires ongoing careful monitoring 
for volume status and may require addition lasix at rehab.  
Recommend repeat transthoracic echocardiogram in ___ weeks to 
reassess ventricular function for improvement after recovery 
from critical illness. 
.
She continues to have RUQ abdominal pain.  GI was consulted for 
this, and feel it is likely due to her large hemoperitoneum.  
Pain control achieved with oxycodone.  Patient with significant 
atelectesis due to pleuritic pain - working on pain control, 
incentive spirometry. 

OTHER ISSUES
## Acute on chronic systolic heart failure, EF 40% - unclear 
cause of cardiomyopathy (? sepsis v other), + pulmonary vascular 
congestion, bilateral pleural effusions.  Requires repeat TTE as 
outpatient, outpt cardiology eval if persistant. 

## Resolving Multifocal PNA/Aspiration PNA +/- TRALI.  Still 
with hypoxia / ___ O2 requirement at discharge.  Encourage 
incentive spirometry.   

## Recovering from septic and hemorrhagic shock s/p 8 days 
vanc/pip/tazobactam, shock liver/ischemic insult to hepatic 
parenchyma

## s/p CCY for porcelain gallbladder

## thrombophilia - prothrombin gene mutation with DVT/PEs in 
past on chronic warfarin therapy - will require careful INR 
monitoring at rehab due to malnutrition leading to labile INRs

## myelodysplasia syndrome - should follow up with heme upon 
discharge from rehab

## mild pulmonary artery systolic hypertension - stable

## Moderate mitral regurgitation, mild-moderate aortic 
insufficiency

## hypothyroidism - stable

## Acute blood loss anemia - stable

## marked deconditioning - requires ___ / OT

## mild malnutrition - appetite poor, in part due to 
hemoperitoneum. 

TRANSITIONAL ISSUES:
## Patient requires f/u ERCP, scheduled for ___ to remove 
stent in CBD
## monitor BUN/Cr/Potassium carefully given diuresis and 
recently started ACE-i.  Captopril was added for afterload 
reduction, consider uptitration and changing to  lisinopril at 
rehab.
## monitor INR / coumadin dosing carefully given malnutrition
## She requires ongoing careful monitoring for volume status and 
may require addition lasix at rehab. 
## Patient will require workup to investigate cause of 
cardiomyopathy.  Recommend repeat transthoracic echocardiogram 
in ___ weeks to reassess ventricular function for improvement 
after recovery from critical illness. 
## restart oral iron therapy (stopped in-house due to bowel 
issues)
 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Ferrous Sulfate 65 mg PO DAILY 
2. Levothyroxine Sodium 75 mcg PO DAILY 
3. Enoxaparin Sodium 80 mg SC DAILY 
Patient was bridging to surgery with lovenox (takes warfarin at 
home)  
4. Warfarin 4 mg PO DAILY16 
5. Omeprazole 20 mg PO DAILY 
6. Pravastatin 20 mg PO HS 
7. Docusate Sodium 100 mg PO DAILY:PRN constipation 
8. Vitamin D 400 UNIT PO DAILY 
9. Metoprolol Succinate XL 50 mg PO DAILY 

 
Discharge Medications:
1. Levothyroxine Sodium 75 mcg PO DAILY 
2. Warfarin ___ mg PO DAILY16 
3. Ferrous Sulfate 65 mg PO DAILY 
4. Metoprolol Succinate XL 50 mg PO DAILY 
5. Multivitamins 1 TAB PO DAILY 
6. Tucks Hemorrhoidal Oint 1% 1 Appl PR TID PRN hemorrhoids 
7. Omeprazole 20 mg PO DAILY 
8. Pravastatin 20 mg PO HS 
9. Vitamin D 400 UNIT PO DAILY 
10. Acetaminophen 650 mg PO Q8H pain 
11. Captopril 12.5 mg PO TID 
12. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB/WHEEZE 
13. OxycoDONE (Immediate Release)  2.5 - 5 mg PO Q4H:PRN pain 
14. Senna 1 TAB PO HS Constipation 
15. Docusate Sodium 100 mg PO BID 
16. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
# septic/hemorrhagic shock
# cholecystitis/cholangitis
# health care-associated pneumonia  
# hemoperitoneum
# acute blood loss anemia
# acute systolic CHF 

Secondary diagnoses:
# pulmondary edema
# diarrhea: antibiotic-associated
# moderate malnutrition
# acute on chronic thrombocytopenia
# myelodysplastic syndrome 
# hypercoagulability/ prothrombin mutation
# multiple DVT/PE 
# hypothyroidism
# hypertension
# hyperlipidemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
please see below
 
Followup Instructions:
___
"
36,11247436,28801754," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Perihepatic/pelvic fluid collections
 
Major Surgical or Invasive Procedure:
___ - CT-guided perihepatic and pelvic fluid collection 
drainage
___ - ERCP

 
History of Present Illness:
___ y/o F with hx of prothrombin gene mutation, recurrent PE/DVT, 
thrombocytopenia, s/p laparoscopic CCY at ___ on ___ 
for porcelain GB with complicated post op course including 
medflight to ___, intubation, and multiple organ failure who 
presents today as transfer from ___ with 
complaints of suprapubic pain, elevated temp to 100.6, and CT 
findings of fluid collection in the pouch ___ as well as
in the perihepatic region.

Of note on last hospitalization was noted to become hypotensive 
post lap CCY, required pressors and ICU stay. During that time 
she was also found to have PNA, ___, and transient respiratory 
failure. She had a prolonged ICU stay and was found to have 
large fluid collection perihepatic and pelvic during that
hospitalization that was thought to be hemorrhagic. She was sent 
to rehab restarted on her coumadin with known fluid in her 
abdomen. GI was consulted before discharge for persistently 
elevated LFTS and there was concern for hepatic 
necrosis/ischemia and that her LFTs would be trended.  

Currently complains of suprapubic discomfort with urination and 
defecation.  Was constipated in rehab, given laxative and has 
had large amounts of loose stools that are dark in color, 
although patient notes that she is taking iron supplements.
 
Past Medical History:
- Rectal bleeding: ___ tx'd DDAVP
- Thrombocytopenia:  ___ BM biopsy with erythroid 
hyperplasia and granulocytic hypoplasia
- History of DVT/PE on coumadin
- Hypothryoidism
- Fe deficiency Anemia 
- Porcelain gallbladder now s/p cholecystectomy ___
- Hyperlipidemia
- HTN
- s/p exploratory laparoscopy ___
- s/p tubal ligation ___
- osteoarthritis
 
Social History:
___
Family History:
Father (deceased) colon ca, Mother (deceased) liver ca, one 
brother treated for colon ca. 
 
Physical Exam:
Physical Exam upon presentation:
VS - 97.8 80 122/50 96%RA
___ - elderly woman, tired, NAD
CARDIAC - RRR, no m/r/g
CHEST - CTAB
ABDOMEN - surgical incision sites clean with steri strips
present, soft, non-distended, tenderness to deep palpation in
suprapubic region > LUQ and RUQ
NEURO - alert, oriented

Physical Exam upon discharge:
VS: 97.8, 129/76, 73, 18, 97/RA
GEN: Resting comfortably in bed, NAD.
HEENT: Mucus membranes moist, EOMI
CARDIAC: Normal S1, S2. RRR No MRG
PULM: Lungs diminished at bases. No W/R/R 
ABDOMEN: Soft/nontender/mildly distended.
EXT: + pedal pulses. No CCE
NEURO: AAOx4, normal mentation. 
 
Pertinent Results:
___ 03:55AM   ___ PTT-25.5 ___
___ 03:55AM   PLT SMR-VERY LOW PLT COUNT-27*
___ 03:55AM   HYPOCHROM-NORMAL ANISOCYT-NORMAL 
POIKILOCY-NORMAL MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-NORMAL
___ 03:55AM   NEUTS-64 BANDS-0 LYMPHS-16* MONOS-13* EOS-5* 
BASOS-0 ATYPS-2* ___ MYELOS-0
___ 03:55AM   WBC-9.4 RBC-3.89* HGB-11.5* HCT-35.3* MCV-91 
MCH-29.6 MCHC-32.5 RDW-14.7
___ 03:55AM   ALBUMIN-3.1*
___ 03:55AM   LIPASE-33
___ 03:55AM   ALT(SGPT)-15 AST(SGOT)-28 ALK PHOS-101 TOT 
BILI-1.3
___ 03:55AM   estGFR-Using this
___ 03:55AM   GLUCOSE-131* UREA N-13 CREAT-0.6 SODIUM-133 
POTASSIUM-4.6 CHLORIDE-98 TOTAL CO2-24 ANION GAP-16
___ 03:59AM   LACTATE-1.3
___ 03:59AM   ___ COMMENTS-GREEN TOP
___ 05:34AM BLOOD WBC-7.0 RBC-3.43* Hgb-10.0* Hct-31.3* 
MCV-91 MCH-29.0 MCHC-31.8 RDW-15.1 Plt Ct-25*
___ 12:16AM BLOOD WBC-8.8 RBC-3.51* Hgb-10.1* Hct-32.0* 
MCV-91 MCH-28.8 MCHC-31.6 RDW-14.9 Plt Ct-34*
___ 02:50AM BLOOD WBC-8.3 RBC-3.61* Hgb-10.5* Hct-32.8* 
MCV-91 MCH-29.1 MCHC-32.0 RDW-14.7 Plt Ct-23*
___ 03:55AM BLOOD Neuts-64 Bands-0 Lymphs-16* Monos-13* 
Eos-5* Baso-0 Atyps-2* ___ Myelos-0
___ 05:34AM BLOOD Glucose-119* UreaN-6 Creat-0.5 Na-135 
K-3.6 Cl-104 HCO3-22 AnGap-13
___ 12:16AM BLOOD Glucose-119* UreaN-7 Creat-0.6 Na-137 
K-3.9 Cl-105 HCO3-22 AnGap-14
___ 02:50AM BLOOD Glucose-119* UreaN-9 Creat-0.6 Na-136 
K-3.7 Cl-105 HCO3-24 AnGap-11
___ 05:34AM BLOOD Calcium-7.5* Phos-2.2* Mg-1.5*
___ 12:16AM BLOOD Calcium-7.6* Phos-2.6* Mg-1.7
___ 02:50AM BLOOD Calcium-7.9* Phos-2.7 Mg-1.8
___ 03:55AM BLOOD Albumin-3.1*
___ 03:59AM BLOOD Lactate-1.3

___ GALLBLADDER SCAN 
IMPRESSION: No evidence of bile leak or biliary obstruction.  
Surgically absent gallbladder. 

___   DRAINAGE HEMATOMA/FLUID 
IMPRESSION: 
  
1.  Satisfactory placement of pigtail catheter within the pelvic 
hematoma.  If the catheter does not continue to drain, it should 
be removed. Sample sent for culture. 
2.  Aspiration of thick clotted blood from perihepatic 
collection.  This is felt to represent a clotted hematoma and, 
therefore, a catheter was not left in situ. 

 
Brief Hospital Course:
___ admitted for abdominal pain secondary to perihepatic/pelvic 
fluid collections after undergoing elective laparoscopic 
cholecystectomy at OSH on ___.  Upon admission her INR was 
2.4, and her platelets 27, so on ___ she was unable to undergo 
drainage as her anticoagulated state needed to be reversed and 
her platelets restored.  To this end, she was given vitamin K, a 
heparin drip started at 600 units/hr for a PTT goal of 50-70, 
and she was scheduled to undergo drainage on ___, which she 
did.  She tolerated the procedure well, and her regular diet was 
resumed.  On ___, she was evaluated by a nutritionist after 
she stated that she had not been eating well; they recommended 
Ensure daily with meals. Her albumin came back as 3.1. On 
___, she had a HIDA scan that showed ""no evidence of bile 
leak or biliary obstruction. Surgically absent gallbladder"". 

On ___, the patient's pelvic drain was removed due to 
minimal drainage, and the culture and gram stain of the fluid 
was negative for bacterial growth. Blood cultures were also 
negative. Antibiotics were discontinued at this time.   

On ___, the patient was transfused with one unit of 
platelets in order to undergo a previously scheduled ERCP for 
stent removal. She tolerated the procedure without any 
complications: ""The prior placed plastic stent was removed using 
a snare. Cannulation of the biliary duct was successful and deep 
with a balloon catheter using a free-hand technique.  The 
intrahepatics were normal. The common bile duct was normal in 
size. Small filling defects seen in the common bile duct. The 
cystic duct stump was visualized along with RUQ surgical clips 
from the prior cholecystectomy. Sludge was extracted 
successfully using a extraction balloon. An occlusion 
cholangiogram showed no further filling defects. There was 
excellent flow of bile and contrast.""   

After her procedure, her heparin gtt was held for 6 hours and 
she was discharged back to ___ with plan to restart 
her heparin gtt at 1700 pm (___). She was started back on 
her coumadin as well in order to obtain a therapeutic INR level. 
She was discharged on ___ with scheduled followup in the 
___.   
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Levothyroxine Sodium 75 mcg PO DAILY 
2. Warfarin ___ mg PO DAILY16 
3. Ferrous Sulfate 65 mg PO DAILY 
4. Metoprolol Succinate XL 50 mg PO DAILY 
5. Multivitamins 1 TAB PO DAILY 
6. Tucks Hemorrhoidal Oint 1% 1 Appl PR TID PRN hemorrhoids 
7. Omeprazole 20 mg PO DAILY 
8. Pravastatin 20 mg PO HS 
9. Vitamin D 400 UNIT PO DAILY 
10. Acetaminophen 650 mg PO Q8H pain 
11. Captopril 12.5 mg PO TID 
12. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB/WHEEZE 
13. OxycoDONE (Immediate Release)  2.5 - 5 mg PO Q4H:PRN pain 
14. Senna 1 TAB PO HS Constipation 
15. Docusate Sodium 100 mg PO BID 
16. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 

 
Discharge Medications:
1. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 
2. Captopril 12.5 mg PO TID 
3. Docusate Sodium 100 mg PO BID 
4. Ferrous Sulfate 65 mg PO DAILY 
5. Levothyroxine Sodium 75 mcg PO DAILY 
6. Pravastatin 20 mg PO HS 
7. Tucks Hemorrhoidal Oint 1% 1 Appl PR TID PRN hemorrhoids 
8. Vitamin D 400 UNIT PO DAILY 
9. Senna 1 TAB PO HS Constipation 
10. Omeprazole 20 mg PO DAILY 
11. Multivitamins 1 TAB PO DAILY 
12. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB/WHEEZE 
13. Heparin IV 
No Initial Bolus
Initial Infusion Rate: 600 units/hr
14. Warfarin ___ mg PO DAILY16 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Perihepatic and pelvic fluid collections
Stent removal

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the acute care surgery service for 
perihepatic/pelvic fluid collections.
 
Please call your doctor or go to the emergency department if:
*You experience new chest pain, pressure, squeezing or 
tightness.
*You develop new or worsening cough, shortness of breath, or 
wheeze.
*You are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons.  Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience an unusual discharge.
*Your pain is not improving within 12 hours or is not under 
control within 24 hours.
*Your pain worsens or changes location.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*You develop any concerning symptoms.
 
___ Discharge Instructions:
Please resume all regular home medications, unless specifically 
advised not to take a particular medication.  Please take any 
new medications as prescribed.
Please take the prescribed analgesic medications as needed.  You 
may not drive or heavy machinery while taking narcotic analgesic 
medications.  You may also take acetaminophen (Tylenol) as 
directed, but do not exceed 4000 mg in one day.
Please get plenty of rest, continue to walk several times per 
day, and drink adequate amounts of fluids.  Avoid strenuous 
physical activity and refrain from heavy lifting greater than 20 
lbs., until you follow-up with your surgeon, who will instruct 
you further regarding activity restrictions.  Please also 
follow-up with your primary care physician.
 
Followup Instructions:
___
"
37,11247436,28466068," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
cc: thrombocytopenia
 
Major ___ or Invasive Procedure:
none

 
History of Present Illness:
This is a ___ F with hx of prothrombin gene mutation, 
recurrent PE/DVT, thrombocytopenia and recent complicated 
medical course presented from rehab with thrombocytopenia found 
on routine labs. The patient had recently been discharged from 
___ on a heparin drip and labs were being checked daily. Her 
PTL count trended down slowly was found to be 9 on the day of 
transfer. The patient reports that heparin had been discontinued 
and she was maintained on warfarin. The pateint has no 
complaints at this time. States that she has some blood on the 
tissue when she blows her nose but no recent nose bleeds. No 
bleeding gums. Easy bruising, mostly related to IVs and blood 
draws. Denies blood in stool. Does have dark stool but this is 
consistent. Does report hemorrhoids. Denies chest pain, sob, 
fever, chills. Has felt weak since discharge from ___ on 
___.
Remainder of ROS was negative.

Her previous hospitalization begain after she  underwent a CCY 
at ___ on ___ for porcelain GB. Postop course was c/b 
hypotension, hemoperitoneum, hypoxia requiring intubation, ARF, 
and  elevated transaminases. She was med-flighted  from ___ 
___ to the ICU at the ___ on ___ and underwent 
an ERCP on ___ with biliary stent placement.  She stabilized 
on pressors, IVF, 4U PRBCs, empiric zosyn/vanco for HCAP +/- 
cholangitis, and ultimately was weaned from pressors, extubated 
and finished an 8-day course of abx. Her course on the medical 
floor was complicated by acute on chronic systolic heart 
failure. She was discharged to rehab and then re-presented with 
abdominal pain and low grade fevers on ___. She was admitted to 
the surgical serivce and had ___ drainiage of intrabdominal fluid 
collections. Cultures were negative and the patient was 
discharged on ___ to rehab on a heparin drip. She did undergo 
a repeat ERCP on ___ for stent removal and recieved a platelet 
transfusion at that time.
 

 
Past Medical History:
- Thrombocytopenia:  ___ BM biopsy with erythroid 
hyperplasia and granulocytic hypoplasia
- Systolic CHF- ECHO on ___- EF 40% 
- History of DVT/PE on coumadin
- Rectal bleeding: ___ tx'd DDAVP
- Prothrombin gene mutation
- Hypothryoidism
- Fe deficiency Anemia 
- Porcelain gallbladder now s/p cholecystectomy ___
- Hyperlipidemia
- HTN
- s/p exploratory laparoscopy ___
- s/p tubal ligation ___
- osteoarthritis
 
Social History:
___
Family History:
Father (deceased) colon ca, Mother (deceased) liver ca, one 
brother treated for colon ca. 
 
Physical Exam:
ADMISSION:
Laying in bed in NAD.
Vitals: T: 97 HR: 96 R: 18 BP: 134/75 O2 93% RA
HEENT: + white plaque on tongue, no petecchia, no LAD
Lungs: clear B/L on auscultation
___: RRR, S1, S2 present
Abd: Soft, NT, ND
Ext: no edema, Right UE Midline
Skin: multiple bruises in various stages of healing covering all 
4 extremites.
Neuro: AAOX3

DISCHARGE:
Vitals: T: 97 HR: 96 R: 18 BP: 134/75 O2 93% RA
GEN:
HEENT: + white plaque on tongue, no petecchia, no LAD
Lungs: clear B/L on auscultation
___: RRR, S1, S2 present
Abd: Soft, NT, ND
Ext: no edema, Right UE Midline
Skin: multiple bruises in various stages of healing covering all 
4 extremites.
Neuro: AAOX3
 
Pertinent Results:
___ 10:00PM   GLUCOSE-117* UREA N-14 CREAT-0.6 SODIUM-135 
POTASSIUM-4.3 CHLORIDE-99 TOTAL CO2-23 ANION GAP-17
___ 10:00PM   CALCIUM-8.7 PHOSPHATE-3.8# MAGNESIUM-1.9
___ 10:00PM   WBC-5.6 RBC-4.34# HGB-12.8# HCT-39.7# MCV-91 
MCH-29.5 MCHC-32.3 RDW-15.9*
___ 10:00PM   NEUTS-45* BANDS-0 ___ MONOS-6 EOS-5* 
BASOS-0 ATYPS-2* ___ MYELOS-0
___ 10:00PM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-1+ 
MACROCYT-OCCASIONAL MICROCYT-OCCASIONAL POLYCHROM-NORMAL 
TARGET-OCCASIONAL TEARDROP-OCCASIONAL
___ 10:00PM   PLT SMR-RARE PLT COUNT-18*
___ 10:00PM   ___ PTT-38.0* ___

LUE Duplex IMPRESSION:  Superficial thrombophlebitis involving 
the left basilic vein.

___ 7:36 pm CATHETER TIP-IV      Source: L mid-line. 
WOUND CULTURE (Preliminary):    No significant growth. 

___ 06:40AM BLOOD WBC-4.8 RBC-4.18* Hgb-12.1 Hct-37.1 
MCV-89 MCH-28.8 MCHC-32.5 RDW-16.2* Plt Ct-16*
 
Brief Hospital Course:
___ y/o female with history of prothrombin gene mutation, 
multiple DVT/PE on coumadin and thrombocytopenia likely due to 
MDS who presented with thrombocytopenia found on routine blood 
work and GUAIAC positive stool.

Thromboctopenia: No evidence of acute bleeding. PTL here were 18 
and 9 at ___. Coumadin held. Case discussed with primary 
hematologist who recommended there is no need to transfuse if 
patient is not bleeding and platelets are greater than 3. On the 
day of discharge platelet count was 16.

GUAIAC positive dark stool: concern for GIB in ED, but has 
hemorrhoids, hemodynamically stable. H/H above baseline and 
remained stable during admission. Sx likely hemorrhoidal in 
setting of low PTL and therapeutic INR.

DVT/PE on coumadin: will resume coumadin when PTL>25. No need to 
reverse INR

Thrombophlebitis: found at site of midline PICC. Line removed, 
tip cultured. Results pending.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Captopril 12.5 mg PO TID 
2. Docusate Sodium 100 mg PO BID 
3. Levothyroxine Sodium 75 mcg PO DAILY 
4. Pravastatin 20 mg PO HS 
5. Tucks Hemorrhoidal Oint 1% 1 Appl PR TID PRN hemorrhoids 
6. Vitamin D 400 UNIT PO DAILY 
7. Senna 1 TAB PO HS Constipation 
8. Multivitamins 1 TAB PO DAILY 
9. Warfarin ___ mg PO DAILY16 
10. Acetaminophen 650 mg PO Q8H pain 
11. Zolpidem Tartrate 5 mg PO HS:PRN insomnia 
12. Ferrous Sulfate 325 mg PO BID 
13. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY 
14. Nystatin Oral Suspension 5 mL PO QID 
15. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 

 
Discharge Medications:
1. Acetaminophen 650 mg PO Q8H pain 
2. Captopril 12.5 mg PO TID 
3. Docusate Sodium 100 mg PO BID 
4. Ferrous Sulfate 325 mg PO BID 
5. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY 
6. Levothyroxine Sodium 75 mcg PO DAILY 
7. Multivitamins 1 TAB PO DAILY 
8. Nystatin Oral Suspension 5 mL PO QID 
9. Pravastatin 20 mg PO HS 
10. Senna 1 TAB PO HS Constipation 
11. Tucks Hemorrhoidal Oint 1% 1 Appl PR TID PRN hemorrhoids 
12. Vitamin D 400 UNIT PO DAILY 
13. Zolpidem Tartrate 5 mg PO HS:PRN insomnia 
14. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Thrombocytopenia
Phlebitis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
You were admitted due to a low platelet count. On repeat testing 
your platelet count was slightly higher. On discussion with your 
hematologist it was decided that there was no need to transfuse 
platelets as you were not bleeding.
There was also concern that you might be bleeding from your 
colon however your blood counts remained stable. The trace 
amount of blood found in your stool is most likely due to 
hemorrhoids and the dark color of your stool is due to the iron 
pills you take. 
Also during your stay the site of your mid-line PICC became 
painful. It was removed and the catheter was cultured to look 
for infection. Those results remain pending at the time of 
discharge but the preliminary results are negative.
 
Followup Instructions:
___
"
38,11598228,23673505," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
gait instability
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Ms ___ is a ___ year-old R-handed woman with history
of Alzheimer's dementia who presents with a 1 day history of 
gait
instability.  History is relayed through patient and
daughter-in-law who is at the bedside.  Ms ___, 
currently
resides in a assisted living facility for Alzheimer's disease
patients.  They called the daughter-in-law this morning after
they found that Ms ___ was unable to walk.  Per report,
she continued to fall toward the right side.  They attributed
this to her early morning state, and hoped that it would improve
as the day went forward.  however, by early afternoon, not only
were the symptoms not improved but they seemed worse and
therefore she was brought in for further evaluation.  

 
Past Medical History:
-Alzheimer's Dementia - followed at ___
-Had an appendectomy years ago

 
Social History:
___
Family History:
noncontributory, but no dementia, strokes or neurologic diseases

 
Physical Exam:
Vitals: T:98.2  P:83  R: 16  BP:170/94  SaO2:99%
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx
Neck: Supple, no carotid bruits appreciated.
Pulmonary: Lungs CTA bilaterally without R/R/W
Cardiac: RRR, nl. S1S2, no M/R/G noted
Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or
organomegaly noted.
Extremities: warm and well perfused

Neurologic:
-Mental Status: alert, oriented to self, but states it is the
___.  Knows she is in a medical place but unsure
where.  Able to relate history but with moderate difficulty and
confusion. Inattentive, unable to name ___ forward or backward. 
Easily frustrated.  Language is fluent with intact repetition 
and
comprehension.  Normal prosody.  There were no paraphasic 
errors.
Pt. was able to name high frequency with some difficulty with 
low
frequency objects.  Able to read without difficulty.  Speech was
not dysarthric. Able to follow both midline and appendicular
commands. 

-Cranial Nerves:
I: Olfaction not tested.
II: PERRL 3 to 2mm and brisk.  VFF to confrontation. 
III, IV, VI: EOMI without nystagmus.  Normal saccades.
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii and SCM bilaterally.
XII: Tongue protrudes in midline.

-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally.
No adventitious movements, such as tremor, noted. No asterixis
noted.
  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___
L  5    ___   ___  5   5    5  5     5     5   5
R  5    ___   ___  5   5    5  5     5     5   5

-Sensory: No deficits to light touch, pinprick, cold sensation,
vibratory sense, proprioception throughout. No extinction to 
DSS.

-DTRs:
  Bi Tri ___ Pat Ach
L  2  2    2    2   1
R  2  2    2    2   1
Plantar response was flexor bilaterally.

-Coordination: Ataxic movements on the right upper extremity 
with
FNF.  dysdiadochokinesia noted in right lower extremity with 
HKS.
+ Rebound on the right.  Overshoot on the right.

-Gait: Good initiation. Narrow-based, persistently ataxic 
falling
to the right.  normal stride and arm swing.  

Romberg absent.

 
Pertinent Results:
___ 07:40PM BLOOD WBC-7.8 RBC-4.57 Hgb-13.8 Hct-41.5 MCV-91 
MCH-30.1 MCHC-33.1 RDW-13.7 Plt ___
___ 07:40PM BLOOD ___ PTT-20.6* ___
___ 07:40PM BLOOD Glucose-124* UreaN-15 Creat-0.9 Na-141 
K-4.3 Cl-105 HCO3-23 AnGap-17
___ 07:40PM BLOOD ALT-12 AST-20 LD(LDH)-296* AlkPhos-56 
TotBili-0.2
___ 11:10AM BLOOD Calcium-9.3 Phos-2.9 Mg-2.1 Cholest-224*
___ 11:10AM BLOOD Triglyc-194* HDL-60 CHOL/HD-3.7 
LDLcalc-125
___ 11:10AM BLOOD %HbA1c-5.5 eAG-111
TOX SCREEN NEGATIVE

URINE STUDIES
URINE Blood-SM Nitrite-POS Protein-25 Glucose-NEG Ketone-TR 
Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG
___ Bacteri-MANY Yeast-NONE ___

URINE TOX NEGATIVE

UCX: >100,000 E COLI (PAN-SENSITIVE)

EKG: Sinus rhythm with ectopic atrial rhythm. Delayed QRS 
transition in the precordial leads. Non-specific T wave changes 
in leads aVL and III. No 
previous tracing available for comparison.  

IMAGING:
NONCONTRAST HEAD CT:
There is no intracranial hemorrhage. The gray-white matter 
differentiation is preserved. There is no edema or mass effect. 
The 
ventricles are prominent in size consistent with age-related 
atrophic changes. 
Periventricular white matter hypodensities are consistent with 
small vessel ischemic disease. A focal hypodensity within the 
right basal ganglia likely represents a chronic lacune. 
Paranasal sinuses and mastoid air cells are clear. 

MRI/A HEAD AND NECK:
Area of subacute ischemia is identified involving the 
postero-lateral aspect of the left thalamus as described in 
detail above, 
visualized on the ADC, T2 and FLAIR sequences. 
  
Chronic microvascular ischemic changes with associated cortical 
volume loss as described in detail above. 
  
The area of ischemia also is involving the lateral aspect of the 
left 
thalamus. 

Limited examination with possible arteriosclerotic changes and 
narrowing of the distal branches of the MCA as described above. 
The left 
vertebral artery is patent as well as the basilar artery; 
however, the right vertebral artery is not clearly identified, 
possibly terminating in ___.  Hypoplasia of the A1 segment on 
the right is identified. 

CXR
No acute cardiopulmonary abnormality.

 
Brief Hospital Course:
Ms ___ is a ___ year-old R-handed woman with
history of Alzheimer's dementia who presents with a 1 day 
history
of gait instability.  

# L THAMALMIC STROKE:
Neurologic examination at admission was notable for ataxia on 
the right
side, overshooting on the right, rebound on the right, as well 
as
continued difficulties with ambulation with falling onto the the
right side.  Her NCHCT was negative for any acute processes
without any overt evidence of ischemia. Due to concern for 
stroke, she was admitted to neurology. MRI showed acute left 
thalamic infarct. MRA showed diffuse atherosclerosis with 
narrowing in distal MCAs but without any significant occlusive 
disease. The etiology of this small stroke is likely small 
vessel disease. The patient underwent a stroke workup including 
echocardiogram, toxic/metabolic studies, ___. 
She was started on ASA 325 mg and simvastatin. Her fasting lipid 
panel showed total cholesterol 224, HDL 60, LDL 125 and 
triglycerides 194.
She was monitored on telemetry and had no arrhythmias. 

# UTI:
Positive UA, Ucx for E coli, pansensitive, completed ___actrim for uncomplicated UTI.

# ___:
Patient was ambulating more steadily and was cleared by ___ 
for discharge home with services to her group living facility.

# CODE STATUS: Family determined she was DNR/DNI during this 
admission.
 
Medications on Admission:
-Vitamin B12 1000 qAM
-Vitamin D 800 qAM
-Donepezil 10 qHS
-Namenda 10 BID
-Venlafaxine 75 q AM, 150 q ___

 
Discharge Medications:
1. aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) 
Tablet, Delayed Release (E.C.) PO DAILY (Daily).
Disp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*2*
2. cyanocobalamin (vitamin B-12) 500 mcg Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
3. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
4. donepezil 10 mg Tablet Sig: One (1) Tablet PO once a day.  
5. memantine 10 mg Tablet Sig: One (1) Tablet PO twice a day.  
6. venlafaxine 75 mg Tablet Sig: One (1) Tablet PO QAM (once a 
day (in the morning)).  
7. venlafaxine 75 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
8. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Left thalamic stroke

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).
Neuro status: mild right upper extremity dysmetria

 
Discharge Instructions:
You were admitted for difficulty walking. You were found to have 
a small stroke in your left thalamus. This was likely caused by 
atherosclerosis (plaque buildup) on the small blood vessels that 
supply this part of the brain. You were started on full dose 
aspirin 325 mg and simvastatin, which will help prevent more 
strokes.  
 
Followup Instructions:
___
"
39,12544417,24507287," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: CARDIOTHORACIC
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Shortness of breath, fatigue

 
Major Surgical or Invasive Procedure:
1. Aortic valve replacement 25 mm Bicor Epic tissue valve.
2. Mitral valve repair with a Gore-Tex neo chordae
    implantation and a mitral valve annuloplasty with a 32
    mm physio 2 annuloplasty ring.
3. Resection of ascending aortic aneurysm.  Ascending
   aortic replacement with a 28 mm gel weave tube graft.

 
History of Present Illness:
___ year old male with history of aortic stenosis and
insufficiency. He has been followed with echocardiograms.
Recently he had increased shortness of breath and fatigue from
congestive heart failure. He was started on diuretics and over
one week had a 14 pound weight loss. Underwent an echo on ___
which showed moderately severe AS and moderate AI. He is now
referred for surgical consultation.

 
Past Medical History:
Critical Symptomatic AS, MR ___ flail anterior mitral leaflet 
and ascending Aortic Aneurysm. S/P. AVR, MVR and Asceding Aortic 
Replacement
PMH:
Osteoarthritis
Congenital hypospadias
GERD and ___ Esophagus
Anemia
Past Surgical History:
s/p Bilateral total knee replacement
s/p Left and right inguinal hernia repair
s/p Appendectomy
s/p bilateral GSV stripping

 
Social History:
___
Family History:
non-contributory
 
Physical Exam:
Pulse:  78  Resp: 16  O2 sat: 100% 
B/P  Right: 119/61   Left: 113/69
Height: 67""    Weight: 154 lb

General: NAD, appears older than stated age
Skin: Warm [x] Dry [x] Intact [x]
HEENT: NCAT [x] PERRLA [x] EOMI [x]
Neck: Supple [x] Full ROM [x] JVD []
Chest: Lungs clear bilaterally [x]
Heart: RRR [x] Irregular [] Murmur [x] Grade ___ syst. 
Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds 
+
[x]
Extremities: Warm [x], well-perfused [x] Edema [] _none_
Varicosities: None [x]  multiple skip incisions s/p vein
stripping bilaterally
Neuro: Grossly intact [x]
Pulses:
Femoral      Right: 2+  Left:2+
DP           Right: 2+  Left:2+
___           Right: 2+  Left:2+
Radial       Right: 2+  Left:2+

Carotid Bruit      Right:    Left:
+ radiation of cardiac murmur

 
Pertinent Results:
___ Intra-op TEE
Conclusions  
Pre-Bypass:
The left atrium is moderately dilated. No spontaneous echo 
contrast or thrombus is seen in the body of the left atrium or 
left atrial appendage. No atrial septal defect is seen by 2D or 
color Doppler. There is moderate symmetric left ventricular 
hypertrophy. The left ventricular cavity is severely dilated. 
Overall left ventricular systolic function is moderately 
depressed (LVEF=35-40 %). Right ventricular chamber size and 
free wall motion are normal. The aortic root is mildly dilated 
at the sinus level. The ascending aorta is mildly dilated. The 
number of aortic valve leaflets cannot be determined. The aortic 
valve leaflets are severely thickened/deformed. Significant 
aortic stenosis is present (not quantified). Moderate to severe 
(3+) aortic regurgitation is seen. The aortic regurgitation jet 
is eccentric, directed toward the anterior mitral leaflet. The 
mitral valve leaflets are moderately thickened. Torn mitral 
chordae are present. An eccentric jet of Moderate to severe (3+) 
mitral regurgitation is seen. There is no pericardial effusion. 
Dr. ___ was notified in person of the results on ___ at 
0830.

Post-Bypass:
The patient is in SR on a milrinone, epinephrine, and 
phenylepphrine infusion s/p AVR, mitral ring, and ascending 
aorta repair. 
Left ventricular function is improved in the setting of 
ionotropic support with an estimated EF 45%. The septum is 
hypokinetic with mild dyskinesis. 
There is a well seated bioprosthetic aortic valve. There are no 
perivalular leaks. The peak and mean gradients are 36/14mmHg at 
a CO of 6.5.
There is a well seated mitral annuloplasty ring.. The mitral 
regurgitation is significantly improved - now trace. Peak and 
mean gradients are ___ mmHg at a CO of 6.5.
There is an echodense structure consitant with a tube graft in 
the ascending aortic position. 
The remainder of the exam is unchanged. 
.

___ 06:05AM BLOOD WBC-9.4 RBC-3.43* Hgb-10.4* Hct-31.6* 
MCV-92 MCH-30.3 MCHC-33.0 RDW-13.7 Plt ___
___ 06:20AM BLOOD WBC-11.8* RBC-3.28* Hgb-10.0* Hct-30.2* 
MCV-92 MCH-30.7 MCHC-33.3 RDW-14.1 Plt ___
___ 06:05AM BLOOD Glucose-116* UreaN-51* Creat-1.3* Na-132* 
K-4.3 Cl-95* HCO3-30 AnGap-11
___ 06:20AM BLOOD Glucose-107* UreaN-44* Creat-1.2 Na-131* 
K-4.6 Cl-96 HCO3-25 AnGap-15
 
Brief Hospital Course:
The patient was admitted to the hospital and brought to the 
operating room on ___ where the patient underwent AVR (25mm 
tissue), MVrepair (32mm ring), and Ascending Aorta Replacement 
(28mm gelweave graft) with Dr. ___.  Overall the patient 
tolerated the procedure well and post-operatively was 
transferred to the CVICU in stable condition for recovery and 
invasive monitoring. POD 1 found the patient extubated, alert 
and oriented and breathing comfortably.  The patient was 
neurologically intact and hemodynamically stable on no inotropic 
or vasopressor support.  Beta blocker was initiated and the 
patient was gently diuresed toward the preoperative weight.  The 
patient was transferred to the telemetry floor for further 
recovery.  Chest tubes and pacing wires were discontinued 
without complication.  Free water was restricted for mild 
hyponatremia, which improved prior to discharge.  He had a brief 
episode of rapid Atrial Fibrillation, which converted to SR with 
IV lopressor and titration of Atenolol. 
The patient complained of nausea and ""wretching"".  SLP evaluated 
the patient and he passed the swallow study without difficulty.  
The patient was evaluated by the physical therapy service for 
assistance with strength and mobility.  By the time of discharge 
on POD 5 the patient was ambulating freely, the wound was 
healing and pain was controlled with oral analgesics.  The 
patient was discharged to ___ in good condition with 
appropriate follow up instructions.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Furosemide 40 mg PO DAILY 
am 
2. Furosemide 20 mg PO DAILY 
pm 
3. Potassium Chloride 20 mEq PO DAILY 
4. Lorazepam 0.5-1 mg PO HS:PRN insomnia 
5. Omeprazole 40 mg PO BID 
6. Viagra *NF* (sildenafil) 100 mg Oral prn ED 
7. Astelin *NF* (azelastine) 137 mcg NU daily 
8. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 

 
Discharge Medications:
1. Omeprazole 40 mg PO BID 
2. Docusate Sodium 100 mg PO BID 
3. Acetaminophen 650 mg PO/PR Q4H:PRN temperature >38.0 
4. Aspirin EC 81 mg PO DAILY 
5. Atenolol 25 mg PO BID 
6. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 
7. Astelin *NF* (azelastine) 137 mcg NU daily 
8. Lorazepam 0.5-1 mg PO HS:PRN insomnia 
RX *lorazepam 0.5 mg 0.5-1.0 mg by mouth hs Disp #*30 Tablet 
Refills:*0
9. Furosemide 40 mg PO DAILY 
am 
10. Potassium Chloride 20 mEq PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Critical Symptomatic AS, MR ___ flail anterior mitral leaflet 
and ascending Aortic Aneurysm. S/P. AVR, MVR and Asceding Aortic 
Replacement 
PMH: 
Osteoarthritis 
Congenital hypospadias 
GERD and ___ Esophagus 
Anemia 
Past Surgical History: 
s/p Bilateral total knee replacement 
s/p Left and right inguinal hernia repair 
s/p Appendectomy 
s/p bilateral GSV stripping 

 
Discharge Condition:
Alert and oriented x3 nonfocal 
Ambulating, deconditioned
Incisional pain managed with oral analgesics
Incisions: Sternal - healing well, no erythema or drainage 
Edema: none

 
Discharge Instructions:
Please shower daily including washing incisions gently with mild 
soap, no baths or swimming until cleared by surgeon. Look at 
your incisions daily for redness or drainage.
Please NO lotions, cream, powder, or ointments to incisions 
Each morning you should weigh yourself and then in the evening 
take your temperature, these should be written down on the chart 

No driving for approximately one month and while taking 
narcotics, will be discussed at follow up appointment with 
surgeon when you will be able to drive. 
No lifting more than 10 pounds for 10 weeks
Please call with any questions or concerns ___
**Please call cardiac surgery office with any questions or 
concerns ___. Answering service will contact on call 
person during off hours**

 
Followup Instructions:
___
"
40,12544417,24641366," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
palpitations, shortness of breath
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___  with palpitations and shortness of breath at rehab. He 
underwent an aortic valve replacement, mitral chordal repair, 
and asending aorta replacement on ___. He was found to have 
afib with RVR with hypotension and SOB at rehab. He reports he 
was feeling well at rehab with occasional transient episodes of 
light palpitations and SOB over the past 3 days that quickly 
resolved, but then on the day of admission had sudden onset 
worse palpitations and SOB, orthopnea that did not resolve all 
day. Was found to have HR 180s-200s BP 94/64, 98%RA. Denied 
chest pain. Has had leg swelling L>R since the surgery, US neg 
for DVT at rehab per report. Also noted to have stage 1 sacral 
ulcer and leukocytosis on ___ evaluation, per report CXR UA 
neg. 

Of note: Hosptialized ___ for  AVR + MV repair + 
Ascending Aorta Replacement for Mixed AR and AS, MR with flail 
anterior mitral leaflet and ascending Aortic Aneurysm.  
Operation was done here at ___ by Dr. ___ ___. Post 
operatively pnt was started on Beta blockers and was diuresed 
toward the preoperative weight. Free water was restricted for 
mild hyponatremia, which improved prior to discharge.  He had a 
brief episode of rapid Atrial Fibrillation, which converted to 
SR with IV lopressor and titration of Atenolol. He was 
discharged on POD 5, no discharge weight available.  

In the ED: 
Admission vitals: 120 ___ 100% Non-Rebreather.
EKG: AFIB/RVR to 120, LAHB + LBBB which are baseline. 
CXR: Decrease in size of moderate left and small right pleural 
effusion with bibasilar atelectasis. 
Labs remarkable for leukocytosis 14.2 with 86% Neu which is new, 
sodium 129, K = 5.2, 4.7 on recheck. mild non gap acidosis (no 
albumin with HCO3 at 20. Cr 1.2 at baseline over past month or 
2.   
FAST: pleural effusion. no cardiac effusion.
. 
Subsequently in the ED HR 120-130's, pressures in the 80___-90___, 
GIven 500 NS, no rate or rhythm control. Admitted to ___ after 
discusion with cardiac surgery. 

On review of systems, he complains of dry painful sensation in 
his throat , denies fevers, chills, myalgias, headache, N/V/D, 
constipation, abdominal pain, chest pain, dysuria, cough. 

 
Past Medical History:
Mixed AR and AS, MR ___ flail anterior mitral leaflet 
and ascending Aortic Aneurysm. S/P. AVR, Repair of mitral valve 
chordae and Ascending Aorta Replacement ___
Osteoarthritis
Congenital hypospadias
GERD and ___ Esophagus
Anemia

Past Surgical History:
s/p Bilateral total knee replacement
s/p Left and right inguinal hernia repair
s/p Appendectomy
s/p bilateral GSV stripping
 
Social History:
___
Family History:
father with ""angina"" late in life

 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
VS: T=98.1 BP=118/81 HR= 67 RR=22 O2 sat=100%2L  
GENERAL: Ill appearing male in NAD, Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI.  Conjunctiva pink, 
no pallor or cyanosis of the oral mucosa, MMM
NECK: Supple with JVP of 5 cm.  
CARDIAC: RR, normal S1, S2. No r/g. ___ systolic murmur over 
LUSB. No thrills, lifts. No S3 or S4.  
LUNGS: sternotomy incision healing well without signs of 
infection. No chest wall deformities, scoliosis or kyphosis. 
Resp were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi.  Decreased breath sounds and dullness to 
percussion half way up on Left posteriorly
ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not 
enlarged by palpation. No abdominal bruits.  
EXTREMITIES: trace edema on right, 1 + on left, no calf 
tenderness, no cords palpated. L groin ecchymosis non-tender No 
femoral bruits.   L wrist access site no ecchymosis or hematoma 
PULSES:  2+ radial and DP pulses bilat

DISCHARGE PHYSICAL EXAMINATION:  
VS: 98.2, 108/61 (sbp 90-123), HR 65 (60s), RR 18, 100%  
I/O: 1640po/319 5urine weight 72.2=>71.4kg (157 lbs)  
GENERAL: pale frail male in NAD, Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, 
MMM. OP clear  
CARDIAC: RRR, normal S1, S2. No r/g. ___ systolic murmur over 
LUSB. No thrills, lifts. No S3 or S4.  
LUNGS: sternotomy incision healing well without signs of 
infection. Resp unlabored, no accessory muscle use. No crackles. 
No wheezes or rhonchi. Decreased breath sounds at base on Left 
ABDOMEN: +BS Soft, NTND. No HSM or tenderness.  
EXTREMITIES: trace edema on left, 1 + on left L groin ecchymosis 
non-tender No femoral bruits.  
PULSES: 2+ radial and DP pulses bilat  

 
Pertinent Results:
ADMISSION LABS:
___ 04:00PM BLOOD WBC-14.2*# RBC-3.73* Hgb-11.2* Hct-34.3* 
MCV-92 MCH-29.9 MCHC-32.5 RDW-13.8 Plt ___
___ 04:00PM BLOOD Neuts-86.3* Lymphs-6.6* Monos-5.1 Eos-1.6 
Baso-0.4
___ 04:00PM BLOOD ___ PTT-30.5 ___
___ 04:00PM BLOOD Glucose-123* UreaN-28* Creat-1.2 Na-129* 
K-5.2* Cl-98 HCO3-20* AnGap-16
___ 06:47AM BLOOD Calcium-8.7 Phos-3.9 Mg-1.9
___ 04:00PM BLOOD TSH-7.2*
___ 04:14PM BLOOD Lactate-1.4 K-4.7
___ 04:30PM URINE Color-Yellow Appear-Clear Sp ___
___ 04:30PM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 04:30PM URINE RBC-0 WBC-3 Bacteri-NONE Yeast-NONE 
Epi-<1

DISCHARGE LABS:
___ 06:51AM BLOOD WBC-6.5 RBC-3.85* Hgb-11.1* Hct-34.1* 
MCV-89 MCH-28.7 MCHC-32.4 RDW-13.6 Plt ___
___ 06:51AM BLOOD ___
___ 06:51AM BLOOD Glucose-95 UreaN-20 Creat-0.8 Na-132* 
K-4.6 Cl-97 HCO3-28 AnGap-12
___ 06:51AM BLOOD Calcium-8.7 Phos-4.2 Mg-2.0

MICRO:
___ Blood Culture, Routine-NEG FINAL
___ Blood Culture, Routine-NEG FINAL 

IMAGING: 
CXR ___
FINDINGS: Two views were obtained of the chest.  Improved small 
right and 
unchanged moderate left pleural effusions are accompanied by 
basal 
atelectasis.  The lungs are otherwise clear.  Moderate 
cardiomegaly is mildly decreased from previous examination with 
intact sternotomy wires and valvuloplasty ring noted. 
IMPRESSION: Decrease in size of small right and unchanged 
moderate left  
pleural effusion with accompanying bibasilar atelectasis. 

pCXR ___
Portable AP radiograph of the chest was reviewed in comparison 
to ___.  Cardiomegaly is severe, unchanged.  Left 
retrocardiac consolidation and pleural effusion are unchanged.  
Lungs are essentially clear at the upper and mid portions.  No 
pneumothorax is demonstrated.

___ TTE 
The left atrium is moderately dilated. The right atrium is 
markedly dilated. There is mild symmetric left The left atrium 
is moderately dilated. The right atrium is markedly dilated. 
There is mild symmetric left ventricular hypertrophy with normal 
cavity size. There is moderate to severe global left ventricular 
hypokinesis (LVEF = 25 %). No masses or thrombi are seen in the 
left ventricle. Tissue Doppler imaging suggests an increased 
left ventricular filling pressure (PCWP>18mmHg). Right 
ventricular chamber size is normal. with mild global free wall 
hypokinesis. The aortic root is mildly dilated at the sinus 
level. A bioprosthetic aortic valve prosthesis is present. The 
aortic valve prosthesis appears well seated, with normal leaflet 
motion and transvalvular gradients. A mitral valve annuloplasty 
ring is present. The mitral annular ring appears well seated 
with normal gradient. An eccentric, jet of mild (1+) mitral 
regurgitation is seen. The estimated pulmonary artery systolic 
pressure is high normal. There is no pericardial effusion.

IMPRESSION: Symmetric left ventricular hypertrophy with normal 
cavity size and global hypokinesis Normal functioning aortic 
valve bioprosthesis and mitral valve repair. Dilated aortic 
sinus.

 

 
Brief Hospital Course:
___ s/p recent surgical AVR, MV repair and asending aorta 
replacement discharged on high dose furosemide now admitted with 
hypovolemia, hypotension and afib with RVR not responsive to 
metoprolol, but rate controlled with atenolol and sotalol.

# Paroxysmal Atrial fibrillation with rapid ventricular 
response: 
High dose Metoprolol 100 mg po TID was ineffective at rate 
control. So was started on atenolol 50 mg po BID and sotalol. 
His QTc stayed 440-470 on sotalol. He had brief episodes of HR 
dropping to the ___ due to concealed PACs. Atenolol was 
decreased to 25 mg po BID.

Patient started on warfarin this admission, received nutrition 
education for warfarin. INR will be followed by Dr. ___.

# Arrythmia: concealed PACs which blocked at AV node and sinus 
giving bradycardia. Dose of atenolol decreased. Pt also had 2.2 
sec run of WCT (6 beats, CL 400ms). No Sx. Will follow with Dr. 
___.

# Hyponatremia: Most likely from daily furosemide use vs 
hypovolemic hyponatremia as improved with IVF and improvement of 
hypotension, but then downtrended slightly with increased dose 
of furosemide.

# Leukocytosis: Noted to have WBC 17K at rehabilitation, which 
continued to downtrend until normal this admission without 
antibiotics. Urine cultures and chest xray as well as blood 
cultures were unrevealing. No diarrhea noted to suggest c. diff. 
Surgical incision without signs of infection.  

# CHF: He was not volume overloaded at admission. In fact, he 
was dehydrated due to increase in dose of diuretics at rehab in 
the week prior to admission. CHF and decline in LV systolic 
function was indication to replace AVR. Dry weight at discharge 
is 157 lbs. Attention to whether he needs diuretic and at what 
dose will be done as outpatient as he resolves ___ space pleural 
fluid in the post-op course. Systolic blood pressures were in 
the ___ this admission, so ACEI or spironolactone were not 
added to regimen.

# Cough: Most likely viral URI with post nasal drip causing 
cough, but also possibly from GERD, atelectasis, or URI. Given 
prolonged sx and constellation of symptoms, did not suspect 
influenza. CXR showed left post surgical pleural effusion and 
bibasilar atelectasis. Patient was afebrile throughout admission 
and leukocytosis resolved without intervention. He was treated 
with benzonatate and guaifenesin cough syrup. 

# Recent cardiac surgery: Wound appeared clean and dry, no sign 
of infection, bypass access sites with healing ecchymosis  as 
well. Cardiac surgery made aware of admission, Mr. ___ has 
outpatient follow up with them. 

# GERD: continued PPI. There was a report of guaiac positive 
brown stool from rehabilitation center when he was not on 
warfarin. CBC was stable, no bloody or melanotic stools 
observed. Stool guiac near end of admission when he was on 
warfarin was negative for occult blood.

# Elevated TSH: ___ sick euthyroid picture gien recent cardiac 
surgery. Will have outpatient follow up after recovery from 
acute illness/recent surgery

# Nutrition: iron supplement

# Anxiety: lorazepam 0.5mg PO daily prn

# Insomnia: zolpidem 5mg QHS prn

# Rehab: HE was able to walk 60+ feet on level ground and climb 
1 flight of stairs. He should continue walking and stairs 
exercise at home. 

TRANSITIONAL ISSUES:
- Started warfarin for atrial fibrillation. INR to be followed 
by Dr. ___ on discharge with coumadin dose adjusted 
to achieve INR in ___ range.
- Admitted from rehab just before planned discharge home from 
there, patient discharged from ___ with home physical therapy
- discharge weight was 71.4kg (standing)
- Full code, wife is HCP ___ ___ 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. AtroVENT *NF* (ipratropium bromide) 0.03%  NU 1 spray BID 
2. Omeprazole 40 mg PO BID 
3. Aspirin 81 mg PO DAILY 
4. Docusate Sodium 100 mg PO BID 
5. Atenolol 25 mg PO BID Duration: 1 Doses 
hold for SBP < 90 or HR < 60 
6. traZODONE 12.5 mg PO HS:PRN sleep 
7. Bisacodyl 10 mg PO DAILY:PRN constipation 
8. Guaifenesin ___ mL PO Q6H:PRN cough 
9. Senna 2 TAB PO DAILY:PRN constipation 
10. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB: Wheezing 
11. Lorazepam 0.5 mg PO QDAY:PRN anxiety 
12. Furosemide 80 mg PO DAILY 
13. Potassium Chloride 20 mEq PO DAILY Duration: 24 Hours 
ER formulation 
14. guaiFENesin AC *NF* (codeine-guaifenesin) 200mg-20mg per 
10mL Oral QHS: PRN cough 

 
Discharge Medications:
1. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB: Wheezing 
RX *albuterol  1 puff every six (6) hours Disp #*1 Inhaler 
Refills:*0
2. Aspirin 81 mg PO DAILY 
RX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0
3. Omeprazole 40 mg PO BID 
RX *omeprazole 40 mg 1 capsule(s) by mouth once a day Disp #*30 
Capsule Refills:*0
4. AtroVENT *NF* (ipratropium bromide) 0.03%  NU 1 spray BID 
5. Lorazepam 0.5 mg PO QDAY:PRN anxiety 
RX *lorazepam 0.5 mg 1 tablet(s) by mouth once a day Disp #*14 
Tablet Refills:*0
6. Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*28 Capsule Refills:*0
7. Ferrous Sulfate 325 mg PO DAILY 
RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth 
once a day Disp #*30 Tablet Refills:*0
8. Zolpidem Tartrate 5 mg PO HS:PRN insomnia 
RX *zolpidem 5 mg 1 tablet(s) by mouth at bedtime Disp #*14 
Tablet Refills:*0
9. Potassium Chloride 20 mEq PO DAILY Duration: 24 Hours 
ER formulation 
RX *potassium chloride 10 mEq 2 tablets by mouth once a day Disp 
#*60 Tablet Refills:*0
10. Benzonatate 100 mg PO TID cough 
RX *benzonatate 100 mg 1 capsule(s) by mouth three times a day 
Disp #*42 Capsule Refills:*0
11. Bisacodyl 10 mg PO DAILY:PRN constipation 
RX *bisacodyl [Laxative] 5 mg 1 tablet(s) by mouth daily Disp 
#*14 Tablet Refills:*0
12. Furosemide 60 mg PO DAILY 
RX *furosemide 20 mg 3 tablet(s) by mouth once a day Disp #*90 
Tablet Refills:*0
13. Warfarin 3 mg PO DAILY16 
This dose may change according to your INR. Please following Dr. 
___ regarding dosing after each INR blood draw. 
 
RX *warfarin 1 mg 3 tablet(s) by mouth once daily at 4pm Disp 
#*90 Tablet Refills:*0
14. Atenolol 25 mg PO BID Duration: 1 Doses 
RX *atenolol 25 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0
15. Sotalol 120 mg PO BID 
RX *sotalol 120 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary: 1) atrial fibrillation with rapid ventricular response; 
2) Hypotension; 3) Dehydration 4) Anemia due to blood loss; 5) 
s/p aortic valve replacement; 6) s/p mitral valve chordae 
repair; 7) s/p asecending aortic repair; 8) anxiety; 9) 
bradycardia; 10) hypomagnesemia; 11) abnormal EKG; 12) Left 
ventricular hypertrophy

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).
 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure caring for you during your hospitalization at 
___. You were admitted for a fast irregular heart rate (called 
atrial fibrillation) and low blood pressures. Your symptoms 
improved with medications to slow your heart rate down. To 
minimize your risk of complication(s) with this irregular rhythm 
you were started on a blood thinner called warfarin (or 
coumadin). This medicine requires regular requires frequent 
monitoring of a blood test called INR, which you will follow up 
with Dr. ___. While taking this medication it is important 
that you avoid leafy greens or other foods high in vitamin K. 
Please seen medical attention if you experience bleeding on this 
medication.

Please weigh yourself every morning, call your doctor if weight 
goes up more than 3 pounds in a day or 5 pounds in a week. Your 
weight on our scale on the day of discharge was 71.4kg (157.4 
pounds).
 
Followup Instructions:
___
"
41,12683473,23119981," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Sulfa (Sulfonamide Antibiotics)
 
Attending: ___
 
Chief Complaint:
relapse of alcohol/distended abdomen + jaundice, clotted feeding 
tube
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ year old woman with a history of 
depression and alcoholic  cirrhosis (c/b small varices) and 
relapse of alcohol use, who is presenting with alcohol relapse, 
abdominal distension, and a clogged feeding tube. 

The patient was recently admitted to ___ ___ for 
decompensated alcoholic cirrhosis and HCAP; she completed an 8 
day course of vancomycin/cefepime. She was discharged to home 
with a dobhoff and ___ services, and was also started on 
prednisone 40 mg for alcoholic hepatitis. Discharge weight was 
79.3kg.

On ___, patient's hepatologist was contacted because patient 
relapsed on alcohol for 5 days and was more jaundiced and with 
increased abdominal girth as per the ___. In addition, her NG 
tube had clogged. She was sent to the ER by her hepatologist for 
labs, ascites management (and diagnostic/therapeutic 
paracentesis), and for social work consultation given her 
depressive symptoms. She has a court date scheduled for ___ for a DUI, and can potentially can go to a rehab 
facility after this. 

Upon arrival to the floor, the patient said she currently feels 
well, and her only complaint is that her dobhoff is clogged. She 
shares that her last drink was four days ago, and she had been 
drinking for about 5 days, a bottle of hard liquor per day. She 
attributes her recent relapse to the death of her uncle. She 
also shares that on the day of her last drink, she had a 
temperature was 100.7. She has had no symptoms of withdrawal, 
but has had withdrawal seizures in the past. She denies any 
subjective confusion, trouble breathing, cough, increasing 
abdominal distension, urinary frequency or dysuria. 

 
Past Medical History:
Alcohol abuse complicated by presumed cirrhosis, neuropathy, and 
 
withdrawal seizures  
Alcoholic hepatitis  
Anemia  
Hypothyroidism  
Depression  
Hypertension  
 
 
Social History:
___
Family History:
None
 
Physical Exam:
ADMISSION PHYSICAL EXAM
VS: T98.9 BP131/84 HR103 O2 99 RA
General: alert; lying in bed; appears comfortable, NAD. 
HEENT: mildly icteric sclerae; moist mucosa; dobhoff in place, 
rigid to touch; dandruff.
CV: tachycardic, normal S1, S2, no appreciable murmurs.
Lungs:  CTA2.
Abdomen: mildly distended, soft, nontender, hepatomegaly. 
Ext: nonedematous; bilateral pedal pulses
Neuro: oriented to self, thinks at ___, knows 
year and month, can count days of week backwards, mild 
asterixis.
Skin: no jaundice, no rashes.
 

DISCHARGE PHYSICAL EXAM
VS: Tm98.9 BP130s/70s-80s HR91-108 RR18 O2 96 RA
General: alert; sitting up in bed eating breakfast; appears 
comfortable, NAD. 
HEENT: mildly icteric sclerae; moist mucosa; dobhoff in place.
CV: RRR, normal S1, S2, no appreciable murmurs.
Lungs:  CTA2.
Abdomen: mildly distended, soft, nontender, hepatomegaly. 
Ext: nonedematous; bilateral pedal pulses 1+
Neuro: AOx3, mild asterixis vs tremor 
Skin: no jaundice, no rashes.
 
 
Pertinent Results:
ADMISSION LABS
___ 12:50PM BLOOD WBC-3.6*# RBC-2.13* Hgb-8.4* Hct-24.8* 
MCV-116* MCH-39.4* MCHC-33.9 RDW-13.9 RDWSD-58.1* Plt Ct-41*
___ 12:50PM BLOOD Neuts-70 Bands-0 Lymphs-13* Monos-14* 
Eos-3 Baso-0 ___ Myelos-0 AbsNeut-2.52 AbsLymp-0.47* 
AbsMono-0.50 AbsEos-0.11 AbsBaso-0.00*
___ 12:50PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-3+ Microcy-NORMAL Polychr-NORMAL Ovalocy-1+ Tear Dr-1+ 
Acantho-OCCASIONAL
___ 12:50PM BLOOD ___ PTT-38.8* ___
___ 12:50PM BLOOD Glucose-112* UreaN-12 Creat-1.2* Na-133 
K-4.7 Cl-95* HCO3-25 AnGap-18
___ 12:50PM BLOOD ALT-31 AST-128* AlkPhos-103 TotBili-5.5*
___ 12:50PM BLOOD Albumin-3.2* Calcium-8.1* Phos-3.8 
Mg-1.4*
___ 12:50PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 01:00PM BLOOD Lactate-2.0

DISCHARGE LABS
___ 05:27AM BLOOD WBC-3.7* RBC-2.11* Hgb-8.2* Hct-24.8* 
MCV-118* MCH-38.9* MCHC-33.1 RDW-13.5 RDWSD-57.6* Plt Ct-41*
___ 05:27AM BLOOD ___ PTT-40.9* ___
___ 05:27AM BLOOD Glucose-111* UreaN-11 Creat-0.9 Na-133 
K-3.5 Cl-95* HCO3-26 AnGap-16
___ 05:27AM BLOOD Albumin-3.5 Calcium-8.8 Phos-3.2 Mg-1.7
___ 06:15AM URINE Color-Yellow Appear-Hazy Sp ___
___ 06:15AM URINE Blood-SM  Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln->12 pH-7.0 Leuks-NEG
___ 06:15AM URINE RBC-9* WBC-1 Bacteri-MOD Yeast-NONE Epi-1

DIAGNOSTICS AND IMAGING
___ RUQ US/Doppler:
IMPRESSION:  
1. No evidence of portal vein thrombosis.  Patent umbilical vein 
with reversed right portal venous flow. 
2. Spleen measuring up to 16.7 cm, increased since prior. 

___ CXR: 
IMPRESSION:    
Enteric tube in place.  No focal consolidation. 
 
Brief Hospital Course:
Ms. ___ is a ___ year old woman with a history of 
depression/anxiety and alcoholic cirrhosis (c/b small varices) 
and relapse of alcohol use, who is presenting with alcohol 
relapse and a clogged feeding tube.

She shares that she recently started drinking alcohol again 
after the death of her uncle. She lives within walking distance 
of two liquor stores and mentions that this has made refraining 
from alcohol particularly difficult, but that she is trying. She 
says she partakes in AA, has a sponsor, and knows what she has 
to do to quit. She has a court date ___ for a DUI, after 
which she claims she will be eligible for a court mandated rehab 
program. She was placed on CIWA during hospitalization, and did 
not score.

Her dobhoff was replaced, and tube feeds were restarted. 

Of note, patient had reported that 1 week ago she had a fever to 
100.7; infectious workup was done and negative. 

She had a RUQ ultrasound that showed worsening splenomegaly, and 
wbc and platelets below her baseline that were consistent with 
this.

TRANSITIONAL ISSUES: 
#F/u alcohol cessation and court mandated rehab program
#F/u treatment of depression and anxiety as prevention of 
alcohol relapse
#Full code
#Contact/HCP ___, ___ 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Jevity 1.5 Cal (lactose-reduced food with fibr) 0.06 gram-1.5 
kcal/mL NJ INFUSION 
2. Gabapentin 600 mg PO TID 
3. LeVETiracetam 500 mg PO BID 
4. Levothyroxine Sodium 25 mcg PO QAM 
5. Magnesium Oxide 400 mg PO BID 
6. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 
7. Thiamine 100 mg PO DAILY 
8. Multivitamins 1 TAB PO DAILY 
9. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
10. FoLIC Acid 1 mg PO DAILY 
11. Nadolol 20 mg PO DAILY 
12. Amitriptyline 10 mg PO QHS 
13. Furosemide 20 mg PO DAILY 

 
Discharge Medications:
1. Amitriptyline 10 mg PO QHS 
2. FoLIC Acid 1 mg PO DAILY 
3. Furosemide 20 mg PO DAILY 
4. Gabapentin 600 mg PO TID 
5. LeVETiracetam 500 mg PO BID 
6. Levothyroxine Sodium 25 mcg PO QAM 
7. Magnesium Oxide 400 mg PO BID 
8. Multivitamins 1 TAB PO DAILY 
9. Nadolol 20 mg PO DAILY 
10. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
11. Thiamine 100 mg PO DAILY 
12. Lactulose 30 mL PO TID 
Take so that you have ___ bowel movements per day 
RX *lactulose 20 gram/30 mL 30 ml by mouth three times a day 
Refills:*0
13. Jevity 1.5 Cal (lactose-reduced food with fibr) 0.06 
gram-1.5 kcal/mL NJ INFUSION 
14. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 
15. tube feeds
Tubefeeding:  Jevity 1.5 Full strength 
Goal rate:60 ml/hr
Flush w/  100 ml  water q3h

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES
Severe malnutrition
Alcohol abuse

SECONDARY DIAGNOSES
Alcohol cirrhosis
Chronic leg pain
Hypothyroidism
Anxiety disorder

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you during your 
hospitalization. You were admitted because your feeding tube was 
clogged, and because your liver doctor was very concerned about 
you drinking alcohol again. Your feeding tube was replaced, and 
tube feeds were restarted. 

We strongly encourage you to not drink alcohol again, as this 
will quickly cause your liver disease to worsen, and could lead 
to death. If you feel like you need extra support, please 
contact your primary care physician. You should strongly 
consider joining ___ rehab to help you treat alcoholism.

We wish you the best of luck in your health.

Sincerely,
Your ___ Care Team
 
Followup Instructions:
___
"
42,12683473,29744802," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Sulfa (Sulfonamide Antibiotics)
 
Attending: ___
 
Chief Complaint:
Decompensated cirrhosis  
 
Major Surgical or Invasive Procedure:
___ Bedside Debridement

 
History of Present Illness:
___ is a ___ year old woman with a PMH significant for alcohol 
abuse and alcoholic cirrhosis, who presented to ___ 
___ after falling, and sustaining a large hematoma 
requiring surgical evacuation, who is transferred to ___ for 
advanced care.  
 Prior to her admission at ___, she had been drinking much more 
heavily for 3 weeks. During those 3 weeks, she was drinking 1 
pint of vodka daily. Prior to that, she had been drinking 1 pint 
of vodka daily, ___ days per week. She does not identify any 
inciting factors.  
 She sustained a fall at home, while inebriated, and many 
ecchymoses, with a large R foot hematoma. After 3 days at home, 
her husband urged her to seek medical care; she then presented 
to ___.  
 Per review of the ___ records:  
 - She was initially hypotensive, requiring fluid resuscitation 
(which resulted in anasarca) and pressors. Once she recovered, 
pressors were weaned and home nadolol was restarted. She 
underwent a TTE that showed unchanged moderate pulmonary 
hypertension  
 - Stool was positive for occult blood; no intervention taken, 
given the risk. Transaminases trended up, then down, then back 
up (though trend not available in records).  
 - Imaging showed new, small ascites (not tapped)  
 - Given fever and elevated transaminases, alcoholic hepatitis 
was considered. ___ DF score = 45. Prednisolone therapy 
not initiated, given concern for adherence upon discharge.  
 - Initial urinalysis was grossly positive. No treatment 
documented, though repeat urinalysis 5 days later showed clean 
urine.  
 - MRCP showed no obstruction  
 - She also had ileus/small bowel obstruction on imaging, with 
diarrhea, which was attributed to pain medication. C. difficle 
PCR was negative.  
 - Hematomas remained stable; she received 12 u pRBC, DDAVP x3, 
as well as transfusions of FFP and vitamin K to lower the INR, 
which was unsuccessful (INR initially elevated to 1.6)  
 - She was noted to be febrile, without leukocytosis; attributed 
to blood product transfusion. She was given clindamycin x48 
hours.  
 - TSH was elevated to 7.3, due to noncompliance. Levothyroxine 
was restarted.  
 - She had waxing/waning periods of visual hallucinations and 
decreased competency. She did attempt to leave AMA at one point, 
so PICC line was removed.  
 
 Notable laboratories:  
 ___ -- ___ ------- ___  
 WBC ---- 7.2 -------------------- 3.8  
 Hb ----- 5.4 -------------------- 8.7  
 Plt ---- 53 -------------------- 95  
 INR ---- 1.6 -------------------- 1.6  
 Na ----- 127 -------------------- 132  
 K ------ 3.7 -------------------- 2.9  
 Cr ----- 1.9 -------------------- 1.1  
 AST/ALT 162/20 ----------------- 160/47  
 T. bili 8.5 -------------------- 14.8  
 UA --------------- [+] ---------- [-]  
 Notable imaging studies:  
 # MRCP, ___: small ascities. Splenomegaly. Portal 
hypertension. Cholelithiasis. Mild GB wall thickening. No 
significant biliary dilatation. No CBD calculi visible.  
 # RUQ ULTRASOUND, ___: cirrhosis, with recannulized 
umbilical vein and reversal of flow in the portal vein, as 
previously seen. Small ascites. Distended GB with mild GB wall 
thickening & multiple gallstones in the region of the GB neck. 
Tenderness with compression of the GB. Mild dilation of the CBD. 
 
 # TTE, ___: LVEF 65% with no FWMA. Normal RV function. 
Moderate AI, mild MR, mild PI and mild TR. PASP 60 mm Hg. 
Dilated IVC. No pericardial effusion. No echocardiographic 
evidence for cardiac etiology to hypotension.  
 # LOWER EXTREMITY CT, ___: no fracture of the left femur. 
Large hamtoma within the hamstring musculature & left gluteus 
maximus. Subcutaneous edema.  
 # CT TORSO, ___: no acute finding in the chest, abdomen or 
pelvis. 10 mm subcutaneous nodule in the right breast 
(ultrasound follow up recommended). Cirrhosis. Recanalization of 
the umbilical vein. Varices between the spleen and left renal 
vein. Distended GB containing gallstones.  
 Of note, she was admitted to ___ in ___ for alcoholic 
hepatitis, as well as ___ and ___.  
 On the floor, she is feeling comfortable and without 
complaints.  
 Review of systems:  
 (+) Per HPI  
 (-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denies cough, shortness of breath. Denies chest pain 
or tightness, palpitations. Denies nausea, vomiting, diarrhea, 
constipation or abdominal pain. No recent change in bowel or 
bladder habits. No dysuria. Denies arthralgias or myalgias.  
 
Past Medical History:
Alcohol abuse complicated by presumed cirrhosis, neuropathy, and 
 
withdrawal seizures  
Alcoholic hepatitis  
Anemia  
Hypothyroidism  
Depression  
Hypertension  
 
 
Social History:
___
Family History:
None
 
Physical Exam:
ADMISSION EXAM
==================
T 99.8, BP 125/70, HR 79, R 18, SpO2 99%/RA 68.9 kg  
 GENERAL: Alert, oriented, no acute distress  
 HEENT: Sclerae icteric, MMM, oropharynx clear, jaundiced 
palate, EOMI, PERRL  
 NECK: Supple, JVP not elevated, no LAD  
 CARDIAC: Regular rate and rhythm, normal S1 + S2, grade II 
diastolic murmur loudest at bilateral USBs, grade II 
holosystolic murmur at apex; no S3 or S4  
 LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
 ABDOMEN: soft, mild TTP over bilateral UQ, mild distension, no 
appreciable organomegaly or fluid collection (by percussion), no 
rebound or guarding, normal bowel sounds  
 EXTREMITIES: Warm, well perfused, 2+ ___ pulses bilaterally, no 
clubbing or cyanosis; hematoma (3 cm x 3 cm) on dorsal aspect of 
R foot; RLE without edema; LLE with 2+ pitting edema to the 
knee; large & tender ecchymosis along lateral aspect of LLE; 
moderate sized ecchymosis along volar aspect of RUE  
 NEURO: face symmetric, oriented to place, date (off by 2 days, 
thought was ___ maintains normal concentration and is 
appropriate, though has occasional misunderstandings; no 
asterixis  
 SKIN: jaundiced, few facial and upper chest angiomata, dilated 
abdominal wall veins  

DISCHARGE EXAM
====================
VITAL SIGNS: Tc 98.2, BP ___ , HR ___ , R 18, SpO2 96% 
RA 
GENERAL: Alert, oriented, NAD, 
HEENT: Sclerae icteric, MMM, oropharynx clear
CARDIAC: Regular rate and rhythm, normal S1 + S2, ___ 
holosystolic murmur at apex unchanged 
LUNGS: Clear to auscultation bilaterally
ABDOMEN: soft, non tender, no rebound or guarding, normal bowel 
sounds  
EXTREMITIES: Warm, well perfused, 2+ ___ pulses bilaterally
Hematoma on foot, 3x4 cm, covered with wound vac, c/d/i
LLE with 1+ pitting edema to the knee; large & tender ecchymosis 
along lateral aspect of LLE, firm to palpation behind and around 
knee, now smaller than prior indicated margins
NEURO:  oriented to place, date, and self, no asterixis  

 
Pertinent Results:
ADMISSION LABS
===================
___ 09:25PM   ___ PTT-34.3 ___
___ 09:25PM   PLT COUNT-97*#
___ 09:25PM   PLT COUNT-97*#
___ 09:25PM   HAPTOGLOB-<5*
___ 09:25PM   ALBUMIN-3.2* CALCIUM-8.5 PHOSPHATE-2.7 
MAGNESIUM-1.6
___ 09:25PM   ALT(SGPT)-57* AST(SGOT)-180* LD(LDH)-803* ALK 
PHOS-66 TOT BILI-15.6* DIR BILI-6.0* INDIR BIL-9.6
___ 09:25PM   estGFR-Using this
___ 09:25PM   GLUCOSE-109* UREA N-25* CREAT-0.7 SODIUM-130* 
POTASSIUM-3.1* CHLORIDE-95* TOTAL CO2-23 ANION GAP-15

PERTINENT LABS:
================
LFTs trend: ALT 57-> 52-> 41   AST 180->144->100->95
Total Bilirubin: 15.6-> 14-> 12.5-> 10.9 -> 8.2

DISCHARGE LABS:
===============
___ 06:04AM BLOOD WBC-6.0 RBC-2.41* Hgb-8.0* Hct-24.6* 
MCV-102* MCH-33.2* MCHC-32.5 RDW-25.6* RDWSD-90.3* Plt ___
___ 06:04AM BLOOD Glucose-116* UreaN-15 Creat-0.7 Na-137 
K-4.3 Cl-102 HCO3-23 AnGap-16
___ 06:04AM BLOOD ALT-42* AST-95* AlkPhos-86 TotBili-8.2*
___ 06:04AM BLOOD Calcium-9.2 Phos-4.5 Mg-1.3*

IMAGES/STUDIES
==================
___ Preliminary EEG reading: no epileptiform discharges, no 
seizures, mild encephalopathy seen

___ Portal CXR: In comparison with study of ___, there 
is an placement of a Dobhoff tube, the opaque tip of which 
straddles the esophagogastric junction.  The tube should be 
pushed forward about 10 cm to be in a more optimal position. No 
evidence of acute cardiopulmonary disease.

___ Portable Abdomen: There are a few small bowel loops 
measuring top-normal in size.  Gas is seen in the distal large 
bowel.  No air-fluid levels are visualized on left lateral 
decubitus view.  There is no free intraperitoneal air.Osseous 
structures are unremarkable. There are no unexplained soft 
tissue calcifications or radiopaque foreign bodies.
 
IMPRESSION: 
Nonspecific bowel gas pattern.  No definite ileus or 
obstruction.

___ Tibia/Fibula Left Xray: There is some soft tissue edema 
in the left calf.  This is most marked laterally.  There is no 
evidence of fracture.  No bone destruction.  No embedded 
radiopaque foreign body is seen. 

___ CXR:The lungs are clear.  Heart size is top normal. No 
focal consolidations are seen.  No pneumothorax, pleural 
effusions, or pulmonary edema. 

___ CT lower extremity: Soft tissue collection at the dorsal 
aspect of the foot, likely representing a hematoma. Navicular 
cuboid developmental coalition with reactive changes at the 
synostosis. 
 
Brief Hospital Course:
___ is a ___ year old woman with alcoholic cirrhosis and 
alcohol abuse who presented to an OSH with a large hematoma 
after sustaining a fall, with anemia, as well as alcoholic 
hepatitis and further decompensation of her liver cirrhosis, is 
transferred to ___ for further care.   
 
#TRAUMATIC HEMATOMAS: patient sustained a large left hematoma on 
her left thigh as well as a deeper small lesion on the right 
foot, per history due to falling while inebriated. Both areas 
were tender to palpation and warm to touch, but there was no 
evidence of increase in size. There was no evidence of deep 
venous thrombosis. Patient was initially followed by the 
Orthopedics team, and then followed by the Plastics team, who 
debrided the right foot and recommended conservative wound care 
management and discharge on a wound vac. There was surrounding 
erythema and pain over the foot lesion, and given its open 
nature, she was initially covered on vancomycin and ceftriaxone, 
especially given fevers noted on ___. Patient did well on IV 
antibiotics with which she remained afebrile with stable vital 
signs, and was transitioned to PO Cephalexin for a 10 day total 
course for presumed soft tissue infection. Patient to follow up 
with outpatient Plastics clinic. 

#SEIZURE: Patient had a reported partially witnessed episode of 
shaking of both upper and lower extremities of unclear etiology 
or trigger. She has a prior history of seizures, and has been on 
Keppra as a home medication although with no recent neurologic 
followup. Her electrolytes were stable, with no recurrence of 
the episode. She was placed on 24 hour EEG monitoring, with 
preliminary results were negative for epileptiform changes, 
showing some minor encephalopathy. Patient's mental status 
remained stable and she was discharged with no new medication 
changes.

#NAUSEA: patient reported continued nausea during the course of 
the hospitalization, infectious workup revealing, with no 
notable new medications. High dose opioids were avoided, and 
symptoms seemed to be from prolonged poor nutrition. Her 
symptoms mildly improved after placement of Doboff tube for 
nutrition. Nausea was controlled with ondansetron and compazine 
as needed. 

#LIVER CIRRHOSIS, WITH CONCERN FOR DECOMPENSATION: MELD-Na on 
admission to ___ 27, was approximately 34 during her course. 
Possible factors inciting decompensation included alcoholic 
hepatitis, infection, anemia (patient had hgb 5.4 on admission 
to OSH and required 12 units pRBCs). Clinical picture on 
admission to OSH appeared consistent with alcoholic hepatitis, 
with a ___ DF score of 45. Corticosteroids were not given, 
and given time course of presentation, further steroids were 
avoided, especially in the setting of concern for infection. 
There was no appreciable ascites on exam or ultrasound with 
prior no history of SBP. She was continued on empiric 
antibiotics as above, was continued on Pantoprazole 40 mg BID. 
Patient was seen by social work for resources for alcohol 
counseling outpatient. 

#HYPONATREMIA: likely from hypovolemia in setting of blood loss 
and also poor oral intake, improved with tube feeds. There were 
no signs of renal function impairment, any hypervolemic state 
such as pulmonary edema or ascites.

# POOR PO Intake: complicated by nausea , suboptimal energy 
currently and need for nutrition given alcohol hepatitis. 
Patient was initiated and discharged on Jevity tube feeds with 
home ___ care.

# ACUTE BLOOD LOSS ANEMIA, ON ANEMIA OF CHRONIC DISEASE: Patient 
with chronic anemia, with initial bleeding from right foot 
hematoma for which she had required transfusion of 12 u pRBC at 
outside hospial. Her iron studies were consistent with liver 
disease/chronic disease. Pantoprazole was continued given 
history of guaic positive stools. Patient does have history of 
grade I varices (last EGD ___. Given stable blood pressures 
and no signs of acute infection, home nadolol was resumed.

#COAGULOPATHY: patient was given vitamin K for her coagulopathy, 
note did have nausea/abdominal pain to IV dosing, to be avoided 
in future care.
 
#THROMBOCYTOPENIA:  Secondary to hepatic cirrhosis, stable. 

CHRONIC ISSUES  
# SEIZURES: continued on home leviteracetam.  
# HYPOTHYROISIDM: continued on home levothyroxine.  
# PERIPHERAL NEUROPATHY: likely related to EtOH abuse, continued 
on home gabapentin.  

TRANSITIONAL ISSUES:
====================
[] Please f/u labs outpatient, discharge Total bilirubin 8.2, 
ALT 42, AST 95 Stable Creatinine at 0.7, Hgb 8
[] Patient to continue tube feeds and will follow up with PCP
[] Patient set up with wound care ___ for right foot, follow up 
with plastics clinic
[] Ongoing emphasis that patient attend AA meetings
[]f/u on breast nodule: 10 mm subcutaneous nodule on imaging in 
medial right breast. Recommend outpatient ultrasound followup.
-Full Code
-CONTACT: HCP Mother ___, ___ 
 
___ on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Amitriptyline 10 mg PO QHS 
2. FoLIC Acid 1 mg PO DAILY 
3. Furosemide 20 mg PO DAILY 
4. Gabapentin 600 mg PO TID 
5. LeVETiracetam 500 mg PO QAM 
6. Levothyroxine Sodium 25 mcg PO QAM 
7. Magnesium Oxide 400 mg PO BID 
8. Multivitamins 1 TAB PO DAILY 
9. Nadolol 20 mg PO DAILY 
10. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
11. Thiamine 100 mg PO DAILY 
12. Lactulose 30 mL PO TID 
13. Jevity 1.5 Cal (lactose-reduced food with fibr) 0.06 
gram-1.5 kcal/mL NJ INFUSION 
14. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 
15. LeVETiracetam 750 mg PO QPM 
16. Lidocaine 5% Patch 1 PTCH TD QAM 
17. TraMADOL (Ultram) 50 mg PO Q6H:PRN PAIN 
18. Fluoxetine 20 mg PO DAILY 

 
Discharge Medications:
1. Amitriptyline 10 mg PO QHS 
2. Fluoxetine 20 mg PO DAILY 
3. FoLIC Acid 1 mg PO DAILY 
4. Furosemide 20 mg PO DAILY 
5. Gabapentin 600 mg PO TID 
6. Lactulose 30 mL PO TID 
7. LeVETiracetam 500 mg PO QAM 
8. LeVETiracetam 750 mg PO QPM 
9. Levothyroxine Sodium 25 mcg PO QAM 
10. Lidocaine 5% Patch 1 PTCH TD QAM 
11. Magnesium Oxide 400 mg PO BID 
12. Multivitamins 1 TAB PO DAILY 
13. Nadolol 20 mg PO DAILY 
14. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
15. Thiamine 100 mg PO DAILY 
16. TraMADOL (Ultram) 50 mg PO Q6H:PRN PAIN 
17. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 
18. Cephalexin 500 mg PO Q6H Duration: 3 Days 
RX *cephalexin 500 mg 1 capsule(s) by mouth every six (6) hours 
Disp #*25 Capsule Refills:*0
19. Tube Feeds
Tubefeeding: Jevity 1.5 Full strength; 
Rate: 50 ml/hr
Flush w/ 50 ml water q6h
20. Outpatient Lab Work
CBC, Chemistry Panel, INR, Liver function tests
To be drawn: ___
ICD 10: K 70.30
Please fax results to Dr. ___ at ___

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___ Diagnosis:
Primary Diagnosis:
-Traumatic Hematomas 
-Malnutrition
-Hyponatremia

Secondary Diagnosis:
-Alcohol Abuse
-Hypothyroidism
-Peripheral Neuropathy

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___,
  You were admitted to ___ on ___ after falling and having 
large bruising on your legs and an open drainage on your right 
foot. You were initially given blood transfusions for losing 
blood, and then treated for presumed infection over your foot 
given fevers you had in the hospital. 

The Plastics team recommended daily dressings, and did bedside 
care to take off any dead tissue from the foot. You are being 
discharged with a wound vac to help your foot heal and being set 
up with your prior ___ service to help with your care as well as 
wound care.

It is extremely important that you are able to keep up with your 
nutrition and continue your tube feeds at home. We also strongly 
recommend that you seek out resources to help you stop drinking 
alcohol.

We would also like you take the prescription for lab work to get 
your blood drawn on ___ (next ___ and the 
results will be sent to Dr. ___.

Please continue your antibiotics (Cephalexin every 6 hours) 
until ___.

We wish you the best,
Your ___ care team

  
 
Followup Instructions:
___
"
43,12683473,28389559," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Sulfa (Sulfonamide Antibiotics)
 
Attending: ___
 
Chief Complaint:
Biliary duct dilatation/transfer for ERCP
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Ms. ___ is a ___ with history of alcohol abuse complicated by 
presumed cirrhosis, neuropathy, and withdrawal seizures who 
initially presented to an outside hospital after a fall, found 
to have common bile duct dilatation, now transferred for 
evaluation by the ERCP service. She is a limited historian, but 
recalls slipping in the context of descending a staircase with 
the assistance of her cane, falling without headstrike or loss 
of consciousness 3 days ago. She attributes the fall, which was 
unwitnessed, to unsteadiness in the context of chronic alcoholic 
neuropathy, for which she requires a cane at baseline, denying 
prodromal symptoms, including lightheadedness, chest pain, 
palpitations, or involuntary movements; there was no subsequent 
confusion per her recollection. She does note that in the days 
preceding her fall she had been experiencing loose stools, up to 
5 per day and tinged with ""flecks"" of bright red blood, in 
association with nausea and occasional small-volume nonbloody, 
nonbilious emesis. Others in her household experienced a similar 
gastrointestinal illness, and her symptoms reportedly had 
resolved by the time of her arrival to the outside hospital. She 
endorses generally poor appetite, intermittent epistaxis and 
easy bruising, chronic minimal nonproductive cough, and perhaps 
recently increased abdominal distention, but denies fevers, 
chills, sweats, meningismus, URI symptoms, chest pain, shortness 
of breath, abdominal pain, urinary symptoms, or focal weakness. 
She believes that she has been thinking clearly. She last drank 
1 pint of vodka 5 days ago and denies withdrawal symptoms prior 
to admission to ___.  
She initially presented to ___ on ___, 
where she was found to be intoxicated with alcohol and treated 
supportively, including with a CIWA scale for impending 
withdrawal.  
CXR and cervical spine CT were unrevealing. After abdominal 
ultrasound and MRCP revealed common bile duct dilatation, 
presumably due to the presence of a stone, she was transferred 
to ___ for evaluation by the ERCP service. Of note, abdominal 
ultrasound was without significant ascites. Her stay was 
otherwise complicated by normocytic anemia nadiring at Hgb/Hct 
of ___, prompting administration of 2 units packed red blood 
cells on ___, with appropriate response to 10.4/30.4. She 
also received vancomycin and ceftazidime empirically for 
possible pneumonia in the setting of presumed atelectatic 
changes on CXR, and occasional abdominal pain was attributed to 
alcoholic pancreatitis (lipase of 511 at discharge) in the 
absence of fevers, hemodynamic instability, or other clinical 
signs of infection. Blood and urine cultures were not obtained.  

On arrival to the floor, she is sleepy, but easily arousable and 
denies discomfort of any kind, including abdominal pain.  

 
Past Medical History:
Alcohol abuse complicated by presumed cirrhosis, neuropathy, and 
withdrawal seizures  
Anemia  
Hypothyroidism  
Depression  
Hypertension  

 
Social History:
___
Family History:
None
 
Physical Exam:
Admission physical:

VS: 98.8, 107/65, 87, 20, 98% RA  
General: Sleeping, but easily arousable to voice  
HEENT: PERRL, EOMI, no significant scleral icterus appreciable 
in dim lighting  
Neck: Supple  
CV: RRR, no m/r/g  
Lungs: Breathing comfortably, no accessory muscle use, faint 
crackles at left base clear with cough  
Abdomen: +BS, softly distended, slightly tympanitic, nontender 
to deep palpation, no guarding/rebound, no clear shifting 
dullness/fluid wave  
GU: No CVAT  
Ext: Warm, well-perfused, no edema, no asterixis  
Neuro: Alert, oriented to person and hospital, CNs grossly 
intact, strength ___ throughout, light touch sensation grossly 
intact throughout  
Skin: No significant jaundice appreciable in dim lighting  

Discharge physical:

VS: Tm 99, Tc 98, 94/58, 75, 18, 100% R
I/O: (120/-) past 8 hr  
General: awake, no acute distress 
HEENT: PERRL, EOMI, no significant scleral icterus 
Neck: Supple  
CV: RRR, no m/r/g  
Lungs: Breathing comfortably, no accessory muscle use, CTAB
Abdomen: +BS, distended but not overly firm, no epigastric 
tenderness to palpation 
GU: No CVAT  
Ext: Warm, well-perfused, no edema, no asterixis  
Neuro: Alert, oriented x 3, conversing well, no asterixis. 
Skin: No significant jaundice 

 
Pertinent Results:
Admission labs:

___ 01:50AM BLOOD WBC-7.9 RBC-3.45* Hgb-10.9* Hct-34.1* 
MCV-99* MCH-31.5 MCHC-31.9 RDW-20.0* Plt ___
___ 01:50AM BLOOD ___ PTT-43.8* ___
___ 01:50AM BLOOD ALT-26 AST-164* AlkPhos-144* TotBili-7.3*
___ 01:50AM BLOOD Calcium-8.2* Phos-2.5* Mg-1.5*

Micro:

Imaging:

___ MRCP

IMPRESSION:  
  
1.  Detection of tiny stones within the biliary tree might be 
limited by 
motion artifact as well as a trace of ascites fluid. 
Cholelithiasis, but no 
definite choledocholithiasis.  There is no significant biliary 
ductal dilation 
seen on this examination. 
  
2.  Hepatomegaly, and mild-moderately fatty liver. Heterogeneity 
of the liver 
enhancement is non-mass-like and nonspecific. 
  
3.  Hypoenhancing nodules are seen in the subcapsular portion of 
segment 8 of the liver.  While they are not particularly 
suspicious for hepatocellular carcinoma, recommend continued 
hepatic surveillance given the chronic liver disease. 
  
4.  There appears to be a filling defect within the left gastric 
artery, which supplies a replaced left hepatic artery. In 
addition, there appears to be marked stenosis at the origin of 
the right hepatic artery, which is replaced and arising from the 
SMA. 
  
5.  Changes of marked portal hypertension, with trace pleural 
effusions and trace ascites also noted. 

Abdominal ultrasound (___):  
1. Heterogenous liver consistent with cirrhosis. No focal liver 
lesion. Subcapsular structures in the right lobe on CT ___ 
not visible.  
2. Retrograde flow in main portal vein.  
3. Varices with no significant ascites. Small amount of pelvic 
free fluid.  
4. Biliary ductal dilatation new since ___, with no 
etiology identified by ultrasound.  
5. Distended gallbladder with sludge and possible small 
gallstones. Mild gallbladder wall thickening as present on the 
last ultrasound.  
6. Spleen is 15.5cm in length and measured 13.5cm on ___.
  
___ CXR

FINDINGS:  No prior studies for comparison. 
  
Heart size is within normal limits.  There are no signs for 
overt pulmonary 
edema or pleural effusions.  Hazy opacity at the left base may 
represent 
atelectasis or early infiltrate.  Bony structures are intact.  
There are no pneumothoraces.

Micro:

Blood and urine: negative/ngtd

Discharge labs:

___ 05:15AM BLOOD WBC-5.9 RBC-2.99* Hgb-9.6* Hct-31.0* 
MCV-104* MCH-32.2* MCHC-31.1 RDW-19.6* Plt ___
___ 05:15AM BLOOD ___
___ 05:15AM BLOOD Glucose-131* UreaN-11 Creat-0.5 Na-135 
K-4.4 Cl-102 HCO3-26 AnGap-11
___ 05:15AM BLOOD ALT-38 AST-161* AlkPhos-128* TotBili-5.9*
___ 05:15AM BLOOD Calcium-8.7 Phos-3.1 Mg-2.0
 
Brief Hospital Course:
Ms. ___ is a ___ with history of alcohol abuse complicated by 
presumed cirrhosis, neuropathy, and withdrawal seizures who 
initially presented to an outside hospital after a fall, found 
to have common bile duct dilatation, now transferred for 
evaluation by the ERCP service.  

# Alcoholic hepatitis: Transaminitis on presentation to ___ 
___ is consistent with an alcoholic pattern of 
liver injury, with discriminant function of 37.9 at that time, 
suggesting that she may benefit from glucocorticoid therapy once 
infection has been excluded. As DF in the ______ and not rapidly 
improving, patient started on prednisone on ___ with plan to 
complete a 28 day course. No ascites to tap, no evidence of 
infectious process.
 
# Common bile duct dilatation: She was found to have common bile 
duct distention to 7mm at the outside hospital on abdominal 
ultrasound and MRCP, presumed secondary to presence of a stone. 
Per ERCP recs, MRCP performed on ___: no biliary dilatation 
seen, therefore ultimately did not need ERCP. Treated for 
alcoholic hepatitis per above.   
 
# Fall: Fall preceding presentation to ___ 
seems likely mechanical in the setting of known alcoholic 
neuropathy without prodromal symptoms to suggest alternative 
etiology. Patient was actively intoxicated at admission. She 
does report chronically poor oral intake and a recent diarrheal 
illness, since resolved, raising the possibility of contributory 
orthostasis. Gave IVF, encouraged po intake.  
 
# Alcohol abuse: She discloses significant alcohol consumption, 
having been sober intermittently in the past following 
detoxification stays. Last drink was 5 days ago, with 
intermittent scoring on CIWA scale at ___. She 
did not score on CIWA at ___. Continued folate, thiamine, 
multivitamin. Social work saw the patient and the patient stated 
that she was already set up with AA and outpatient services. She 
did not want an inpatient or outpatient rehab stay.    

# Alcoholic cirrhosis: She has radiographic evidence of 
cirrhosis on ___ imaging, as well as varices 
of uncertain grade. She is presently sleepy, but without signs 
of hepatic encephalopathy, outside hospital ultrasound was 
without tappable ascites, and she has had no clear signs of 
bleeding. She declines prior decompensation by hepatic 
encephalopathy, spontaneous bacterial peritonitis, or variceal 
bleed. She was set up with hepatology f/u at discharge as she 
does not have a primary hepatologist and has reported varices 
but is not on nadolol. 
 
# Normocytic anemia: Normocytic anemia nadiring at Hgb/Hct of 
___, prompting administration of 2 units packed red blood 
cells on ___, with appropriate response to 10.4/30.4. 
Anemia likely reflects alcohol toxicity and sequestration. B12 
and folate were reassuring at the outside hospital. There is low 
suspicion for hemolysis, given transfusion-responsiveness, and 
she has had no signs of active bleeding. Hct remained stable 
during hospital stay.
 
# Thrombocytopenia: Platelet count declined from 180 on 
admission to ___ to 88 by the time of 
transfer, likely reflecting IV hydration superimposed on chronic 
sequestration. There is low suspicion for DIC or HITT in the 
absence of documented heparin exposure. Platelet count remained 
stable.  
 
# Coagulopathy: INR has remained in the 2.4-2.5 range at ___ 
___, likely reflecting synthetic dysfunction 
coupled with poor nutrition. As above, there is low suspicion 
for consumptive coagulopathy. She was given po vitamin K to 
correct her INR. 
  
# Hypothyroidism: TSH was 9.89 at ___, perhaps 
reflecting sick euthyroidism, in which TSH may be elevated 
following an initial phase of suppression. Upon calling the 
patient's pharmacy, however, patient has not been filling her 
levothyroxine prescription. She was restarted on her home dose 
thyroxine. 

# History of withdrawal seizures: Continued home levetiracetam.
  
# Depression: Continued home fluoxetine, hydroxyzine, and 
quetiapine.
  
# Neuropathy: Presumed secondary to alcoholism. Continued home 
gabapentin.  

# Hypertension: Not currently on medications

# Incidentaloma: Right liver lesion noted incidentally on ___ 
___ imaging, with CT or MRI advised in follow-up, 
no duration specified. 
   
#CODE: Full (confirmed)  
#CONTACT: Mother and HCP ___: ___ 

Transitional issues:
-Patient will need labs every week: CBC, full chemistry panel, 
coags, LFT's
-She should have a TSH rechecked as an outpatient as she had 
stopped taking her levothyroxine prior to admission to the 
hospital. She should also have a f/u CT or MRI given an 
incidental R liver lesion noted at ___ no 
duration specified per radiology.
-Patient will continue a 28-total day course of prednisone for 
alcoholic hepatitis.
-Per social work, patient is already set up with AA and sobriety 
programs as an outpatient
-Patient will need to establish care with hepatology and has 
been scheduled an appointment with the ___ on ___.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. LeVETiracetam 500 mg PO BID 
2. QUEtiapine Fumarate 100 mg PO QHS 
3. Levothyroxine Sodium 75 mcg PO DAILY 
4. Gabapentin 600 mg PO TID 
5. Fluoxetine 20 mg PO DAILY 
6. HydrOXYzine 50 mg PO QHS 

 
Discharge Medications:
1. Fluoxetine 20 mg PO DAILY 
2. Gabapentin 600 mg PO TID 
3. HydrOXYzine 50 mg PO QHS 
4. LeVETiracetam 500 mg PO BID 
5. Levothyroxine Sodium 75 mcg PO DAILY 
6. QUEtiapine Fumarate 100 mg PO QHS 
RX *quetiapine [Seroquel] 100 mg 1 tablet(s) by mouth every 
evening Disp #*30 Tablet Refills:*0
7. FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
8. Multivitamins 1 TAB PO DAILY 
RX *multivitamin  1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
9. Pantoprazole 40 mg PO Q24H 

 
RX *pantoprazole [Protonix] 40 mg 1 tablet(s) by mouth daily 
Disp #*30 Tablet Refills:*0
10. Thiamine 100 mg PO DAILY 
RX *thiamine HCl 100 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
11. PredniSONE 40 mg PO DAILY Duration: 28 Days 
First day ___, last day ___ 
RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*26 Tablet 
Refills:*0
12. Outpatient Lab Work
Please obtain a CBC, CMP (full chemistry panel), coags, and 
LFT's on a weekly basis. Please fax results to the Liver Clinic: 
___

ICD-9: Cirrhosis 571

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
alcoholic hepatitis 
cirrhosis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___,

You were admitted to ___ for alcoholic hepatitis.  This is an 
inflammatory condition that affects the liver and can be fatal.  
It is caused by the toxic effects of alcohol.  Your liver is 
scarred and cirrhotic.  As such, it is essential that you quit 
drinking.  We have provided you with resources to help you quit. 
 If you cannot maintain sobriety, you will not be able to get on 
the liver transplant list in the future.  

Please see attached for a list of your medications and follow up 
appointments. 
 
Followup Instructions:
___
"
44,12683473,26071197," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Sulfa (Sulfonamide Antibiotics)
 
Attending: ___
 
Chief Complaint:
Anemia
 
Major Surgical or Invasive Procedure:
EGD
Placement of ___ tube

 
History of Present Illness:
___ with history of EtOH cirrhosis presenting with chest pain 
and right flank pain after falls. Patient fell 1 week ago while 
walking down the stairs. No head strike, headache, LOC, nausea, 
vomiting. She was evaluated at ___ and ___ to have 
large hematomas, anemia and jaundice. Of note, she reports that 
she had been sober for the last 7 months but started drinking 
for the last two weeks, last drink ___. Also reported 1 month 
of vaginal bleeding which she had not seen a doctor for, which 
she feels has tapered off and is nonexistent today. Denies 
pelvic pain, vaginal discharge. CT abdomen/pelvis showed ascites 
and enlarged gallbladder, she was transferred to ___ for ERCP 
evaluation. H/H at ___ was 6.5/19.7, lactate 3.5. She 
was also found to have a lactate of 3.5. She received 1 unit of 
prbcs/1 unit of ffp, levaquin/flagyl prior to transport for 
presumed cholangitis.

In the ED: initial vitals:  T101.5  HR 102   BP 112/68  RR 18  
98% NC 
Labs were notable for  Sodium 124, K 3.1, Creat 1.8, WBC 14.8 
H/H 6.2/18.3 plt 65, INR 2.1, Fibrinogen 179, lactate 2.2, K 
3.0.
 
Past Medical History:
Alcohol abuse complicated by presumed cirrhosis, neuropathy, and 
withdrawal seizures  
Alcoholic hepatitis 
Anemia  
Hypothyroidism  
Depression  
Hypertension  

 
Social History:
___
Family History:
None
 
Physical Exam:
=========================
ADMISSION PHYSICAL EXAM:
=========================
GENERAL: Alert, oriented, no acute distress. AOx3  
HEENT: Sclera icteric, MMM, oropharynx clear. Lice seen in hair.
NECK: supple, JVP not elevated, no LAD  
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: Distended, soft. TTP in RUQ, mildly tender in RLQ. 
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
SKIN:  Diffusely jaundice. Multiple hematomas on L thigh, r 
gluteal region, and chest. The hematoma on her chest is tight, 
painful, and has hard well-circumscribed mobile mass under it. 
NEURO:  no asterixis
=========================
DISCHARGE PHYSICAL EXAM:
=========================
VS: T 97.5 BP 115/65 HR 89 RR 18 96% RA
GEN: Alert, oriented, lying in bed in no distress.  
HEENT: Sclera icteric, improved; MMM, Dobhoff
HEART: RRR, normal S1 S2, no murmurs  
LUNGS: Bibasilar rales, no wheezing; coughing occasionally 
during exam 
ABD: Mild distention, normal BS, nontender, not tense  
EXT: Warm, 2+ pulses, no edema  
SKIN: Diffusely jaundiced. Multiple large hard nontender 
hematomas on R breast, R flank, R hip, L thigh, arms, and legs.
NEURO: Tremor but no asterixis  
 
Pertinent Results:
===================
ADMISSION LABS
===================
___ 03:00PM BLOOD WBC-14.8*# RBC-1.66*# Hgb-6.2*# 
Hct-18.3*# MCV-110* MCH-37.3*# MCHC-33.9 RDW-24.4* RDWSD-88.7* 
Plt Ct-65*
___ 03:00PM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-NORMAL 
Macrocy-1+ Microcy-1+ Polychr-1+
___ 03:00PM BLOOD ___ PTT-43.1* ___
___ 03:00PM BLOOD Plt Smr-VERY LOW Plt Ct-65*
___ 03:00PM BLOOD ___
___ 03:00PM BLOOD Glucose-121* UreaN-28* Creat-1.8*# 
Na-124* K-3.1* Cl-83* HCO3-30 AnGap-14
___ 03:00PM BLOOD ALT-41* AST-172* AlkPhos-111* 
TotBili-21.8* DirBili-16.5* IndBili-5.3
___ 03:00PM BLOOD Albumin-2.7* Calcium-7.1* Phos-1.6* 
Mg-1.1*
___ 03:16PM BLOOD D-Dimer-2598*
___ 10:18PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE IgM 
HAV-NEGATIVE
___ 02:27AM BLOOD HBcAb-NEGATIVE
___ 10:18PM BLOOD HCV Ab-NEGATIVE
___ 03:16PM BLOOD Lactate-2.2* K-3.0*
===================
PERTINENT RESULTS:
===================
IMAGING:
===================
RUQ US WITH DOPPLER (___):
1.  Evidence of portal hypertension with trace ascites, 
splenomegaly, patent
umbilical vein, reversed portal venous flow.
2.  Heterogeneous liver consistent with known history of 
cirrhosis.
3.  Gallbladder sludge without evidence of acute cholecystitis.
===
MRCP (___):
1.  Sludge in a mildly distended gallbladder but no mural 
thickening, hyperenhancement or pericholecystic free fluid to 
suggest acute cholecystitis. No choledocholithiasis.  No fluid 
collections.
2.  Cirrhosis with evidence of portal hypertension characterized 
by splenomegaly, ascites and recanalization of the paraumbilical 
vein.
3.  Hypoenhancing nodules scattered throughout the liver are 
most in keeping with regenerative nodules and appear similar to 
the previous exam. No concerning hepatic lesions.
4.  Moderate hepatic steatosis.
===
CXR (___): Heart size and mediastinum are unchanged. New 
bibasal consolidations are present, and although might represent 
pulmonary edema, multifocal infectious process is a possibility. 
No substantial pleural effusion is seen although minimal amount 
of pleural fluid is noted.
===
TTE (___): The left atrium is mildly dilated. Left 
ventricular wall thicknesses and cavity size are normal. Left 
ventricular systolic function is hyperdynamic (Quantitative 
(biplane) LVEF = 76%). The estimated cardiac index is high 
(>4.0L/min/m2). There is a mild resting left ventricular outflow 
tract obstruction. Right ventricular chamber size and free wall 
motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The aortic valve leaflets 
(3) appear structurally normal with good leaflet excursion. 
There is no valvular aortic stenosis. The increased transaortic 
velocity is likely related to high cardiac output. No aortic 
regurgitation is seen. The mitral valve appears structurally 
normal with trivial mitral regurgitation. There is no mitral 
valve prolapse. The pulmonary artery systolic pressure could not 
be determined. There is no pericardial effusion. 
=====================
MICROBIOLOGY:
=====================
Blood cultures ___: No growth.
Urine cultures ___: No growth.
===
HCV Viral Load (___): HCV-RNA NOT DETECTED.
___ 10:18PM BLOOD HCV Ab-NEGATIVE
___ 10:18PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE IgM 
HAV-NEGATIVE
___ 02:27AM BLOOD HBcAb-NEGATIVE
=== 
C. difficile DNA amplification assay (Final ___: Negative. 

======================
LABS:
======================
___ 05:09AM BLOOD %HbA1c-4.7* eAG-88*
=====================
DISCHARGE LABS:
=====================
___ 04:46AM BLOOD WBC-23.0* RBC-2.42* Hgb-8.5* Hct-26.2* 
MCV-108* MCH-35.1* MCHC-32.4 RDW-27.2* RDWSD-100.9* Plt Ct-95*
___ 04:46AM BLOOD ___ PTT-41.8* ___
___ 04:46AM BLOOD Glucose-130* UreaN-42* Creat-1.0 Na-134 
K-4.5 Cl-94* HCO3-30 AnGap-15
___ 04:46AM BLOOD ALT-44* AST-97* LD(LDH)-508* AlkPhos-168* 
TotBili-14.5*
___ 04:46AM BLOOD Albumin-2.6* Calcium-8.6 Phos-4.4 Mg-2.0
 
Brief Hospital Course:
Ms. ___ is a ___ y/o woman with a history of alcoholic 
cirrhosis who presented to OSH with chest and flank pain after a 
fall, found to have severe anemia, possible cholangitis, and 
positive blood culture. MRCP at ___ was negative for 
cholangitis. Positive blood culture thought to be contaminant. 
The patient was transfused 2 units pRBCs for her anemia. The 
patient then developed an oxygen requirement to 6L and was found 
to have bibasilar infiltrates concerning for HCAP. She completed 
an 8-day course of vancomycin/cefepime with improvement in her 
oxygen requirement; she was discharged on room air. For her 
alcoholic hepatitis and cirrhosis, she was initiated on steroids 
once her pneumonia was well-controlled. A Dobhoff was placed for 
nutritional support with tube feeds. The patient was started on 
PCP prophylaxis with dapsone. She underwent EGD with 3 cords of 
grade I varices and was initiated on nadolol.

===================
ACTIVE ISSUES:
===================

# Alcoholic hepatitis and cirrhosis: The patient has a history 
of alcoholic cirrhosis. She had been sober for 7 months, but two 
weeks prior to admission she began drinking again. No history of 
complications including hepatic encephalopathy, ascites, or 
variceal bleeding. She presented with a DF of 32 on admission, 
and was given prednisolone 40 mg x1. Prednisone was not 
initially continued due to pending infectious evaluation. 
Patient was subsequently diagnosed with HCAP (see below) and 
treated with 8 days of vancomycin/cefepime. Once her infection 
was well-controlled she was started on prednisone 40 mg on ___ 
for 28 days (taper TBD). She was noted to have improvement in 
Tbili and INR s/p steroid initiation. ___ was placed ___ 
and advanced via ___ ___ for Jevity tube feeds. She was started 
on dapsone for PCP ___ (neg for G6PD deficiency; Bactrim 
allergy). She also underwent EGD that showed 3 cords of grade I 
varices so she was initiated on nadolol. She was continued on 
folate, thiamine, and a multivitamin.

# ___: Patient presented with ___ (creatinine increased to 2.0) 
in setting of acute illness, likely initially pre-renal and 
subsequently secondary to possible overdiuresis in setting of 
hypoxia (below). Given albumin 1 mg/kg x 2 days without 
significant improvement. Subsequently diuresed due to concern 
for volume overload. Creatinine improved after diuretics were 
discontinued. Creatinine back to 1.0 at discharge (baseline).

# HCAP: Patient with worsening hypoxia to 6L and found to have 
bibasilar infiltrates on CXR. Initially thought to be component 
of volume overload secondary to albumin challenge for ___ as 
above, so patient diuresed with Lasix IV 20 mg. She completed 
8-days of vancomycin/cefepime with improvement in her 
respiratory status. Discharged on RA.

# Hyponatremia: Admitted with hyponatremia to 124 in setting of 
decompensation and infection. Resolved to 134 on discharge.

# CoNS bacteremia: Noted on 1 set of blood cultures at ___ 
___ to grow CoNS, believed to be contaminant. However, 
patient arrived to ___ febrile and tachycardic and therefore 
started on vancomycin. Patient was continued on vancomycin for 
HCAP treatment as above.

# Anemia: Patient presented from OSH with Hgb 6.2 and had 
appropriate increase in hemoglobin after 2 units pRBCs. There 
was no evidence of a GIB but she did report menorrhagia, which 
resolved.

# Thrombocytopenia: Patient with stable thrombocytopenia likely 
secondary to chronic sequestration.

# Coagulopathy: INR 2.0-2.5 likely reflecting synthetic 
dysfunction. Patient given IV and PO vitamin K without 
improvement in INR.

# Multiple hematomas s/p fall: Patient reports that she fell 
down a set of stairs in her home while working on a home 
___. Exam revealed multiple large hematomas. CT 
Abd/Pelvis w/o contrast at OSH on ___ without evidence of 
intrabdominal hematoma. Patient denied intimate partner 
violence. Hematomas improved over course of hospitalizations.

# Lice: Treated with lindane and permethrin.

===================
CHRONIC ISSUES:
===================
# Chronic leg pain: Continued gabapentin. 

# History of withdrawal seizures: Continued home levetiracetam.

# Hypothyroidism: Continued levothyroxine.

=======================
TRANSITIONAL ISSUES:
=======================
# Patient started on prednisone 40 mg daily for alcoholic 
hepatitis. She will be discharged on 28-day total course of 
prednisone (last day ___ with taper determined by hepatology 
follow-up.
# Patient started on dapsone for PCP ppx given sulfa allergy. 
G6PD test negative.
# Patient noted to have 3 cords of grade I varices, so was 
started on nadolol.
# Weight on discharge: 79.3 kg

# Code: Full 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Multivitamins 1 TAB PO DAILY 
2. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain 
3. Levothyroxine Sodium 25 mcg PO QAM 
4. Lidocaine 5% Patch 1 PTCH TD QAM 
5. Phytonadione 5 mg PO DAILY 
6. Magnesium Oxide 400 mg PO BID 
7. LeVETiracetam 500 mg PO BID 
8. Gabapentin 600 mg PO TID 
9. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
10. Prochlorperazine 5 mg PO TID:PRN nausea 
11. QUEtiapine Fumarate 50 mg PO QHS 
12. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 

 
Discharge Medications:
1. Jevity 1.5 Cal (lactose-reduced food with fibr) 0.06 gram-1.5 
kcal/mL NJ INFUSION 
Rate: 60mL/hour
Residual check: q4H Hold feeding for residual >200 mL
Flush with 30 mL water q8H 
RX *lactose-reduced food with fibr [Jevity 1.5 Cal] 0.06 
gram-1.5 kcal/mL 60 mL NJ Per hour Refills:*1
2. Gabapentin 600 mg PO TID 
3. LeVETiracetam 500 mg PO BID 
4. Levothyroxine Sodium 25 mcg PO QAM 
5. Lidocaine 5% Patch 1 PTCH TD QAM 
6. Magnesium Oxide 400 mg PO BID 
7. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain 
8. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 
9. Thiamine 100 mg PO DAILY 
RX *thiamine HCl 100 mg 1 tablet(s) daily daily Disp #*30 Tablet 
Refills:*0
10. Multivitamins 1 TAB PO DAILY 
11. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
12. FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
13. Nadolol 10 mg PO DAILY 
RX *nadolol 20 mg 0.5 (One half) tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0
14. PredniSONE 40 mg PO DAILY Duration: 28 Days 
last dose ___ 
RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*23 Tablet 
Refills:*0
15. Prochlorperazine 5 mg PO TID:PRN nausea 
16. Dapsone 100 mg PO DAILY 
RX *dapsone 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
=====================
PRIMARY DIAGNOSIS:
=====================
- Alcoholic hepatitis 
- Healthcare-Associated Pneumonia
=====================
SECONDARY DIAGNOSIS:
=====================
- Acute kidney injury
- Alcoholic cirrhosis
- Hyponatremia
- Hematomas
- Anemia
- Positive blood culture
- Lice

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___,

It was a pleasure taking care of ___ during ___ recent admission 
to ___. ___ were admitted after being 
diagnosed with alcoholic hepatitis from drinking. For this, we 
started ___ on steroid medications to help with inflammation. 
___ should continue this (last dose ___ unless otherwise 
instructed by your liver doctor ___ will have an 
appointment with her on ___ to further discuss the 
steroid course. Because ___ are on steroids, which could put ___ 
at increased risk of infection, we started ___ on a medication 
called dapsone. 

___ also had a feeding tube placed for nutrition while your 
liver recovers. Additionally, we have given ___ vitamins to 
take. Please make sure ___ weigh yourself daily and call your 
doctor if your weight goes up over 3 pounds in 3 days. It is 
VERY important that ___ are seeing your therapist and staying 
away from alcohol because ___ could get very ill if ___ relapse.

___ were also treated for a pneumonia with IV antibiotics. ___ 
received an endoscopy, which showed some enlarged veins in your 
esophagus. To prevent bleeding from these veins, we have started 
___ on a new medication called nadolol. If ___ are having 
dizziness or lightheadedness, please call your physician. 

We wish ___ the best,
Your ___ Care Team
 
Followup Instructions:
___
"
45,12747844,29966911," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
nausea, abdominal pain, vomiting, and diarrhea

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
The patient is a ___ y/o F with a PMHx significant for Hep C c/b 
hepatocellular carcinoma and hyperthyroidism who presents with 
likely infectious colitis diagnosed 4 days ago at ___ by CT scan 
now representing unable to take POs at home.

Per patient, she began having nausea, abdominal pain, vomiting 
and diarrhea about four days ago.  She went to ___ and had a CT 
scan which showed colitis and was given prescriptions for oral 
cipro/flagyl.  The next day, she was unable to tolerate POs and 
again went to the ED, was observed overnight and was discharged 
home.  Today, she has been vomiting and was unable to tolerate 
POs to take her antibiotics and pain medications.  She states 
the abdominal pain is sharp and located in the lower quadrants, 
is intermitant in nature and now feels much improved after the 
morphine in the ED.  She states she has vomited 3x today and had 
5 episodes of watery diarrhea.  No fevers, chills, chest pain, 
sob, hematemesis, hematochezia, melena, dysuria.  No recent abx 
use, no sick contacts.

In the ED, initial vitals were: 98.2 57 174/83 18 100%  
___ was called for the results of her CT scan.  Labs were 
significant for no leukocytosis and her baseline 
transaminitis/thrombocytopenia.  Lactate was wnl. She received 
IV Cipro 400mg, IV Flagyl 500mg, IV Zofran and IV morphine 5mg.
 
On the floor, initial vitals were: 
 
ROS:  
(+) Per HPI  

 
Past Medical History:
- HCV c/b hepatocellular carcinoma, Childs ___ class A
- Hyperthyroidism, for which she is on propylthiouracil x
approximately ___
- Osteoporosis
- History of brain hemangioma resected in ___ ___ at
___

 
Social History:
___
Family History:
Mother-diabetes ___ and hypertension
Sister- deceased, pancreatic cancer

 
Physical Exam:
ADMISSION PHYSICAL EXAM
========================
VS: 98.3 143/77 72 20 100% on RA
GENERAL: Alert, oriented, no acute distress  
HEENT: MMM 
NECK: supple
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
NEURO: AAOx3

DISCHARGE PHYSICAL EXAM
=========================
VS: T97.9 BP171/70-182/90 HR70 RR18 100RA
GENERAL: Alert, oriented, no acute distress  
HEENT: Moist mucous membranes
LUNGS: Clear to auscultation, no wheezes, rales, rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding
EXT: Warm, 2+ DP pulses, no clubbing, cyanosis or edema 

 
Pertinent Results:
ADMISSION LABS
===============
___ 02:00PM BLOOD WBC-4.4 RBC-4.58 Hgb-14.3 Hct-44.7 MCV-98 
MCH-31.2 MCHC-32.0 RDW-12.3 Plt ___
___ 02:00PM BLOOD Neuts-63.1 ___ Monos-4.1 Eos-1.2 
Baso-0.9
___ 02:00PM BLOOD Plt ___
___ 02:00PM BLOOD Glucose-156* UreaN-8 Creat-0.6 Na-135 
K-3.3 Cl-104 HCO3-22 AnGap-12
___ 02:00PM BLOOD ALT-104* AST-103* AlkPhos-104 TotBili-0.7
___ 02:00PM BLOOD Albumin-4.0

DISCHARGE LABS
=================
___ 07:21AM BLOOD WBC-9.9 RBC-5.04 Hgb-15.9 Hct-49.3* 
MCV-98 MCH-31.6 MCHC-32.3 RDW-12.8 Plt ___
___ 07:21AM BLOOD Neuts-68.0 ___ Monos-7.8 Eos-0.8 
Baso-0.6
___ 07:21AM BLOOD Plt ___
___ 07:21AM BLOOD ___ PTT-37.7* ___
___ 07:21AM BLOOD Glucose-99 UreaN-9 Creat-0.6 Na-133 K-3.6 
Cl-96 HCO3-23 AnGap-18
___ 07:21AM BLOOD ALT-117* AST-115* LD(LDH)-245 AlkPhos-77 
TotBili-1.1
___ 07:21AM BLOOD Albumin-3.9 Calcium-8.9 Phos-2.9 Mg-2.1
___ 08:10AM BLOOD TSH-1.2
___ 08:10AM BLOOD T4-11.8

MICROBIOLOGY
=============
___ 2:50 pm STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Illumigene DNA
      amplification assay. 
           (Reference Range-Negative). 

   FECAL CULTURE (Final ___: 
      NO SALMONELLA OR SHIGELLA FOUND. 
      NO ENTERIC GRAM NEGATIVE RODS FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Pending): 

   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: 
      NO E.COLI 0157:H7 FOUND. 

   FECAL CULTURE - R/O VIBRIO (Final ___:    NO VIBRIO 
FOUND. 

   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA 
FOUND. 

___ Blood cultures x2- pending at time of discharge

RADIOLOGY
==========
RUQ U/S ___
1. No evidence of acute intra-abdominal process. 
2. 1.9 x 1.7 x 1.5 cm segment VIII hepatic mass, better 
characterized on recent MRI examination. 

PER ED DASH
CT ABD at ___ on ___
Long segment of bowel thickening, fat stranding cecum to mid 
descending colon.

 
Brief Hospital Course:
___ y/o F with a PMHx significant for Hep C c/b hepatocellular 
carcinoma and hyperthyroidism who presents with likely 
infectious colitis diagnosed 4 days ago at ___ by CT scan now 
representing unable to take POs at home.

ACTIVE ISSUES
==============
#  Colitis
Patient was admitted with nausea/vomiting/diarrhea.  ___ report 
obtained and CT scan showed ""long segment of bowel wall 
thickening and surrounding fat stranding extending from te cecum 
to the mid descending colon representing colitis.  This may be 
secondary to infectious or inflammatory process, less likely 
ischemic in the distribuion.""  Most likely infectious in nature. 
 Patient was initially started on IV Cipro/Flagyl given concern 
for Cdiff as well as infectious colitis.  Cdiff returned 
negative and IV Flagyl was discontinued.  Patient continued to 
be treated with IVF and IV Zofran PRN.  Eventually, her symptoms 
improved and IV Cipro was changed to PO Cipro for a total ___levated blood pressures
Patient with elevated blood pressure during hospitalization with 
SBPs elevated to 170-180 asymptomatic, possibly in setting of 
acute illness.  Patient was started on amlodipine 5mg PO daily 
and will followup with her PCP to determine if she needs this 
long term and for possible further titration.
 
CHRONIC ISSUES
================
#  Hyperthyroidism: Continued home dose propylthiouracil 

#  Hepatitis C c/b hepatocellular carcinoma: Thrombocytopenia 
and transaminitis seemed at baseline.

#  Cigarette smoking: nicotine patch while hospitalized

TRANSITIONAL ISSUES
====================
-Antibiotics for infectious colitis with ciprofloxacin 500mg PO 
Q12H, last day ___
-Started amlodipine 5mg daily for elevated SBP 160-180s 
asymptomatic, further titration per PCP
 
___ on ___:
The Preadmission Medication list is accurate and complete.
1. Propylthiouracil 50 mg PO DAILY 
2. MetRONIDAZOLE (FLagyl) 500 mg PO TID 
3. Ciprofloxacin HCl 500 mg PO Q12H 
4. Ondansetron 4 mg PO Q8H:PRN n/v 
5. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain 
6. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1. Propylthiouracil 50 mg PO DAILY 
2. Vitamin D 1000 UNIT PO DAILY 
3. Ondansetron 4 mg PO Q8H:PRN n/v 
4. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain 
5. Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp 
#*8 Tablet Refills:*0
6. Amlodipine 5 mg PO DAILY 
RX *amlodipine 5 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
-Colitis, infectious
-Elevated blood pressures
-Orthostatic hypotension

SECONDARY:
-Hyperthyroidism
-Hepatitis C
-Tobacco abuse

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

It was a pleasure taking care of you at ___ 
___.  You were admitted to the hospital because of 
diarrhea, nausea and vomiting. This was due to colitis, or an 
inflammation in your colon.  You were treated with IV fluids and 
antibiotics.  Please find your medications and appointment 
below.

You had elevated blood pressures in the hospital, most likely 
from your illness and pain. We started you on a blood pressure 
medication called amlodipine, and this will need to be monitored 
by your primary care doctor.
 
Followup Instructions:
___
"
46,12747844,21021441," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Lamictal / methimazole
 
Attending: ___.
 
Chief Complaint:
___
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
The patient is a ___ y/o F with a PMHx significant for Hep C c/b 
hepatocellular carcinoma (Childs A), hyperthyroidism who was 
recently admitted here for what is thought to be infectious 
colitis now presenting with ___.  

She followed up with her PCP two days ago at which time she was 
still feeling weak but overall feeling better without any 
diarrhea/n/v.  At that time labs were checked and were notable 
for Cr of 1.38.  Two days ago she reported nausea and her PCP 
called in zofran.  Today, she followed up with her PCP 
complaining of two days of nausea with one episode of non-bloody 
emesis yesterday.  She otherwise denies any fevers, chills, 
chest pain, sob, abd pain or dysuria.   No diarrhea but does 
complain of black stools.  She notes that she feels incredibly 
weak with poor PO intake and poor urine output.  Labs checked at 
her PCP were significant for Cr of 4.1, Hct 50 and WBC 10.  She 
was subsequently sent to the ___ ED for further evaluation.  

In the ED, initial vitals were: 98.4 70 170/89 20 100%. 
Labs were significant for Cr 3.5, Hct 48 and baseline elevated 
LFTs and thrombocytopenia.  She was given IVF. 
 
 
Past Medical History:
- HCV c/b hepatocellular carcinoma, Childs ___ class A
- Hyperthyroidism, for which she is on propylthiouracil x
approximately ___
- Osteoporosis
- History of brain hemangioma resected in ___ ___ at
___
-Seizure Disorder: see note, ___: followed by Neurology ( 
Dr. ___ at ___ for continued seizure disorder.
-Colonic Adenoma x2, resected (see colonoscopy notes, ___, 
___
-Diverticulosis (See colonoscopy note, ___
-Internal hemorrhoids (See colonoscopy note, ___
-Schatzki Ring, broken via endoscopy x2, ___
-Diaphragmatic hernia (see endoscopy note, ___
-Umbillical hernia, noted ___
-Extrarenal pelvis in R Kidney (___)
- Tubal ligation, ___
-Gonorrhea ___
-PID, ___

 
Social History:
___
Family History:
Mother-diabetes ___ and hypertension
Sister- deceased, pancreatic cancer

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=========================
VS: 98.0 184/66 59 16 100% on RA
GENERAL: Alert, oriented, no acute distress  
HEENT: dry mucous membranes, ?thrush
NECK: supple
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema   
NEURO: AAOx3

DISCHARGE PHYSICAL EXAM
=========================
VS: 98.2 (97.5-98.2) 108/68(108-158/60-95) 72(54-73) 18 100% on 
RA
i/o's: BRP
GENERAL: Alert, oriented, no acute distress  
HEENT: MMM, orange-ish white plaque on doesum of tongue
NECK: supple, no LAD
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema   
NEURO: AAOx3

 
Pertinent Results:
ADMISSION LABS
================
___ 03:00PM BLOOD WBC-7.6 RBC-5.00 Hgb-16.1* Hct-48.7* 
MCV-98 MCH-32.1* MCHC-33.0 RDW-12.6 Plt ___
___ 03:00PM BLOOD Neuts-55.8 ___ Monos-9.2 Eos-1.1 
Baso-1.0
___ 03:00PM BLOOD Plt ___
___ 03:12PM BLOOD ___ PTT-29.1 ___
___ 03:00PM BLOOD Glucose-108* UreaN-37* Creat-3.5*# Na-135 
K-4.2 Cl-94* HCO3-25 AnGap-20
___ 03:00PM BLOOD Albumin-4.1
___ 03:09PM BLOOD Lactate-2.0

DISCHARGE LABS
================
___ 06:21AM BLOOD Glucose-98 UreaN-22* Creat-1.5* Na-137 
K-4.0 Cl-101 HCO3-25 AnGap-15

MICROBIOLOGY
==============
___ 03:45PM URINE Color-Yellow Appear-Clear Sp ___
___ 03:45PM URINE Blood-TR Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD
___ 03:45PM URINE RBC-5* WBC-17* Bacteri-NONE Yeast-NONE 
Epi-<1
URINE CULTURE (Final ___:    <10,000 organisms/ml.
 
Brief Hospital Course:
The patient is a ___ y/o F with a PMHx significant for Hep C c/b 
hepatocellular carcinoma (Childs A), hyperthyroidism who was 
recently admitted here for what is thought to be infectious 
colitis now presenting with ___.  

ACTIVE ISSUES
==============
# ___
Patient was recently admitted with infectious colitis and had 
normal renal function at that time.  She returned with ___ (Cr 
3.5) which was ultimately thought to be pre-renal in nature 
given her history of vomiting/poor PO intake and downtrending Cr 
with IVF.  On the day of discharge, her cr had downtrended to 
1.5.  Given that she has a history of hepatitic C, cryoglobulins 
were checked and were pending at the time of discharge, and 
subsequently returned negative. RF, checked as a marker for 
cryoglobulinemia, was WNL. Given significant improvement of Cr 
with hydration as well as resolution of nausea, vomiting, and 
diarrhea, pt was discharged with plans for Cr recheck within 5 
days of discharge. Hospital course and transitional issues 
including Cr f/u were discussed directly with covering PCP by 
telephone on the day of discharge.

# Nausea
Patient was admitted with complaint of two days of nausea with 
one episode of non-blood emesis.  Patient was given IV zofran 
and nausea/vomiting resolved over the course of her stay.  Given 
patient's report of leg weakness, her acute episode of 
hypertension, her past history of seizures and hyponatremia, as 
well as her intermittent nausea/vomiting/abdominal pain, if 
patient experiences another acute episode, testing for acute 
intermittent porphyria could be considered in outpatient 
setting.

# Black stools
Patient reported having ""black stools"" over the 24-hours prior 
to admission.  Hct upon admission was stable and HR was not 
elevated to suggest acute blood loss. She denied taking any iron 
or supplements which would turn her stool black. On discharge, 
patient reported that her stools were more formed compared to 
prior to admission, and were of normal brown color.  

# Elevated blood pressures
During prior admission, patient had elevated BPs to the 
systolics of 170s, she was asymptomatic at the time.  She was 
started on amlodipine 5mg PO daily but this was discontinued at 
her PCP appointment two days prior to admission given 
normotensive readings.  Upon admission patient's blood pressure 
was elevated to SBP 185 and she was reinitiated on amlodipine.  
On the day of discharge, patient was once again normotensive and 
amlodipine was discontinued. Markedly elevated BPs were likely 
associated with ___. She will followup with her PCP as an 
outpatient for further blood pressure monitoring.

CHRONIC ISSUES
================
#  Hyperthyroidism: Continued home dose propylthiouracil 
#  Hepatitis C c/b hepatocellular carcinoma: Thrombocytopenia 
and transaminitis at baseline.

TRANSITIONAL ISSUES
====================
- patient was admitted for ___ likely pre-renal in nature ___ 
dehydration in the setting of nausea/poor PO intake, Cr 1.5 on 
___ day of discharge
- patient was instructed to obtain labs on ___ to f/u Cr trend 
(labs will be faxed to PCP), patient has PCP followup 
appointment on ___
- amlodipine 5mg PO daily was discontinued upon discharge, 
patient to followup with PCP regarding BP control
- patient was discharged with mild ongoing diarrhea, please 
consider outpatient GI followup
- #AIP TESTING: Given patient's report of intermittant HTN, her 
past history of seizures and hyponatremia, as well as her 
intermittent nausea/vomiting/abdominal pain, acute intermittent 
porphyria testing can be considered (spot urine PBG test, urine 
ALA, PBG, and porphyrins tests)
 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Propylthiouracil 50 mg PO DAILY 
2. Vitamin D 1000 UNIT PO DAILY 
3. Alendronate Sodium 70 mg PO Frequency is Unknown 

 
Discharge Medications:
1. Propylthiouracil 50 mg PO DAILY 
2. Alendronate Sodium 70 mg PO QMON 
3. Vitamin D 1000 UNIT PO DAILY 
4. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
5. Outpatient Lab Work
Lab: Chem-7
Date: ___
ICD-9: 584.9 
Please fax to: ___ (Dr. ___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY
Acute Kidney Injury

SECONDARY:
-Hyperthyroidism
-Hepatitis C
-Tobacco abuse

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you on your visit to ___ 
___. You were admitted to ___ 
because your kidneys were not functioning properly. It was 
determined that your kidney injury was likely due to dehydration 
in the setting of your recent nausea/vomiting and inability to 
eat and drink. You were given IV fluids, and your kidney 
function improved. Please find your medications and appointment 
below.

Sincerely, 

Your ___ Physicians
 
___:
___
"
47,12747844,24809439," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Lamictal / methimazole
 
Attending: ___
 
Chief Complaint:
abdominal pain, transferred for biopsy
 
Major Surgical or Invasive Procedure:
EUS-guided biopsy on ___

 
History of Present Illness:
Ms. ___ is a ___ woman with history of HCV s/p Harvoni c/b
Childs A cirrhosis, history of prior hepatic lesion that
spontaneously resolved on serial imaging, hyperthyroidism, and
osteopenia who is being transferred from ___ after presenting
with abdominal pain, subsequently found to have a new 5-6cm
hepatic lesion as well as potential tumor thrombus.  

She presented to ___ on ___ w abdominal pain, recent
URI sx, non-bloody vomiting, and was found to have 5-6cm liver
lesion that would need management and biopsy at ___. Attempted transfer to ___ however we were on code 
help,
so she was accepted to ___ instead. 

While at ___, AFP checked and was normal. CT torso w IV con
showed heterogeneous liver mass at hilum w invasion vs 
thrombosis
into portal vein. MRI then obtained, showed heterogeneously
enhancing mass predominantly intravascular in location within 
the
main portal vein w portions of relative hypo-enhancement, which
may represent bland thrombus adjacent to enhancing components
that likely represent tumor thrombus or an intravascular
malignancy such as leiomyosarcoma or angiosarcoma, potentially
secondary involvement of portal vein. There wree also
heterogeneously enchaining portocaval lymphadenopathy concerning
for metastatic disease. She was evaluated by heme/onc and GI w
recs for tissue bx. Given location of mass, ___ unable to 
perform.
GI also unable to collect tissue via EUS. Initially, plan was to
consult surgical oncology for bx, however after discussion w Dr.
___ made to transfer her to ___ for continuity of
care. 

Currently, Ms. ___ states that she feels well overall. Denies
any abdominal pain, has not required any pain medications at 
___.
Still bothered by her low appetite. Last BM was 2 days ago (no
blood) but abdomen does not feel distended. She denies 
confusion,
hematemesis, SOB, chest pain, cough, ___ edema, falls,
lightheadedness. 

Of note, in ___ she was noted to have a solid lesion 
in
her liver that measured 1.4 cm and met OPTN 5A criteria. She was
closely monitored, and the lesion increased to 1.5cm -> 1.7cm 
and
had an associated AFP 31.4. She was referred for liver 
transplant
evaluation, however during this period the segment VI lesion was
noted to progressively decrease in size. She has had serial MRIs
and in ___ this lesion was no longer visible on imaging. She
continued to have serial MRIs q3-6mo with no visible lesion. Her
last MRI (___) and last RUQUS (___) continued to
demonstrate no lesion.  

 
Past Medical History:
- HCV c/b hepatocellular carcinoma, Childs ___ class A
- Hyperthyroidism, for which she is on propylthiouracil x
approximately ___
- Osteoporosis
- History of brain hemangioma resected in ___ ___ at
___
-Seizure Disorder: see note, ___: followed by Neurology ( 
Dr. ___ at ___ for continued seizure disorder.
-Colonic Adenoma x2, resected (see colonoscopy notes, ___, 
___
-Diverticulosis (See colonoscopy note, ___
-Internal hemorrhoids (See colonoscopy note, ___
-Schatzki Ring, broken via endoscopy x2, ___
-Diaphragmatic hernia (see endoscopy note, ___
-Umbillical hernia, noted ___
-Extrarenal pelvis in R Kidney (___)
- Tubal ligation, ___
-Gonorrhea ___
-PID, ___

 
Social History:
___
Family History:
Mother-diabetes ___ and hypertension
Sister- deceased, pancreatic cancer

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
VS: 98.3 118/73 69 18 95 RA 
GENERAL: NAD  
HEENT: anicteric sclera, MMM  
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: mild R-sided crackles in posterior mid-lung field, no
wheezes, rhonchi, breathing comfortably on RA
ABDOMEN: nondistended, TTP in RUQ/epigastric area, no
rebound/guarding, +BS
EXTREMITIES: wwp, no cyanosis or edema   
NEURO: A&Ox3, face symmetric, moving all extremities w purpose

DISCHARGE PHYSICAL EXAM
=======================
24 HR Data (last updated ___ @ 756)
    Temp: 98.1 (Tm 98.8), BP: 139/79 (116-195/77-100), HR: 65
(65-100), RR: 18, O2 sat: 97% (97-99), O2 delivery: Ra, Wt: 
122.7
lb/55.66 kg  

GEN: lying down, appears comfortable
CV: RRR
LUNGS: comfortable on room air
ABD: soft, nontender, nondistended
EXT: warm, well perfused
 
Pertinent Results:
ADMISSION LABS
==============
___ 04:39AM BLOOD WBC-5.7 RBC-4.63 Hgb-13.7 Hct-42.4 MCV-92 
MCH-29.6 MCHC-32.3 RDW-13.1 RDWSD-43.5 Plt ___
___ 04:39AM BLOOD ___ PTT-26.9 ___
___ 04:39AM BLOOD Glucose-100 UreaN-17 Creat-0.6 Na-136 
K-3.7 Cl-98 HCO3-24 AnGap-14
___ 04:39AM BLOOD ALT-18 AST-24 LD(LDH)-135 AlkPhos-88 
TotBili-0.7
___ 04:39AM BLOOD Calcium-9.5 Phos-3.6 Mg-1.9 Iron-155
___ 04:39AM BLOOD calTIBC-289 Ferritn-355* TRF-222
___ 04:39AM BLOOD CEA-3.7 AFP-6.6

DISCHARGE/PERTINENT LABS
========================
___ 05:54AM BLOOD WBC-5.7 RBC-4.49 Hgb-13.4 Hct-40.6 MCV-90 
MCH-29.8 MCHC-33.0 RDW-12.8 RDWSD-42.5 Plt ___
___ 05:54AM BLOOD ___ PTT-30.3 ___
___ 05:54AM BLOOD Glucose-85 UreaN-11 Creat-0.5 Na-135 
K-4.1 Cl-101 HCO3-20* AnGap-14
___ 05:54AM BLOOD ALT-18 AST-28 AlkPhos-70 TotBili-0.9
___ 05:54AM BLOOD Calcium-9.2 Phos-2.3* Mg-2.1
___ 09:15PM BLOOD Lipase-19
___ 09:15PM BLOOD TSH-1.5
___ 09:15PM BLOOD T4-9.2 T3-172
___ 05:50AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-POS*
___ 05:54AM BLOOD HIV Ab-NEG
___ 05:24AM BLOOD CMV VL-NOT DETECT
___ 05:24AM BLOOD HCV VL-NOT DETECT
___ 05:54AM BLOOD Metanephrines (Plasma)-PND 
 
Brief Hospital Course:
BRIEF HOSPITAL SUMMARY
=====================
Ms. ___ is a ___ woman with history of HCV s/p Harvoni c/b 
Childs A cirrhosis, history of prior hepatic lesion that 
spontaneously regressed on serial imaging, hyperthyroidism, and 
osteopenia who was transferred from ___ for continuity of care 
and biopsy. She initially presented to ___ with abdominal 
pain, nausea, and vomiting, where imaging showed a ~5cm liver 
lesion. She was then transferred to ___ where she had 
unsuccessful biopsy attempt, and therefore transferred to ___ for 
further workup and to see her regular providers. On arrival her 
symptoms had resolved. Radiology reread her images and 
recommended EUS-guided biopsy, lymphoma protocol (results 
pending). She had persistent hypertension after the biopsy that 
improved with medications. She also had tachycardia with 
exertion that improved with bolus of IVF. She was discharged 
with close follow up. 

TRANSITIONAL ISSUES
=================
[ ] We recommend the PCP follow up on the biopsy results. The 
oncology team here will also call the patient to schedule follow 
up when the biopsy results. 
[ ] Follow up on plasma metanephrine level and consider 24-hour 
urine metanephrine for further workup of possible 
pheochromocytoma if her symptoms persists
[ ] Will need EGD as follow up for cirrhosis management of 
variceal monitoring
[ ] If ___ has persistently poor appetite, consider starting 
mirtazapine QHS for appetite stimulation
[ ] Please titrate blood pressure medications as needed. 

# CONTACT: ___, Daughter, ___

MEDICATION CHANGES
==================
Increased lisinopril from 5mg daily to 20mg daily 
Started amlodipine 7.5mg daily for hypertension
Started marinol 2.5mg BID for appetite stimulation
Prescribing Zofran ODT for PRN use 

ACUTE ISSUES
===========
# Liver lesion with extension into portal vein 
At ___, CT torso showed heterogenous liver mass with invasion 
into the portal vein. An MRI showed a heterogenously enhancing 
mass predominantly intravascular in the main portal vein. ___ was 
unable to do the biopsy due to the location. GI was unable to 
collect tissue via EUS. Their plan was to consult surgical 
oncology for biopsy but after discussion with Dr. ___ was 
transferred to ___ for continuity of care. On arrival she 
reported her pain, nausea, and vomiting had resolved. CDs were 
obtained from ___ and ___ radiologists reread the films and 
recommended EUS. The ERCP fellow did a biopsy (results pending). 
___ had nausea and vomiting after the procedure that resolved 
with Zofran. 

# Hypertension
Well controlled on presentation. She reports she was recently 
diagnosed with hypertension but upon review of her atria's 
records it appears that she has been hypertensive in the clinic 
for several years and has declined antihypertensive medications. 
SBP 200s after procedure likely secondary to nausea, vomiting, 
and pain. However, hypertension persisted despite uptitration of 
medications. Workup for pheochromocytoma was initiated with 
plasma metanephrines because patient reported recent episodes of 
sweating. She was discharged on higher dose of lisinopril and 
amlodipine. 

# Tachycardia
#Orthostasis
Intermittent tachycardia after the biopsy worse with activity, 
not sustaining. Likely volume depleted in the setting of poor PO 
intake. We bolused her with fluids which improved her 
orthostasis.

# Nausea/Vomiting
Nausea and vomiting after biopsy likely secondary to MAC during 
the procedure. Resolved with zofran. 

# Anorexia
Patient reported poor appetite for several weeks, perhaps 
secondary to malignancy. We started marinol and nutrition was 
consulted who felt she met criteria for severe malnutrition. 

CHRONIC ISSUES
=============
# Cirrhosis
No evidence of decompensation. Childs A. 

# Osteoporosis
Continued home alendronate

# Hyperthyroidism
Continued home PTU 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Alendronate Sodium 70 mg PO QTUES 
2. Propylthiouracil 50 mg PO DAILY 
3. Multivitamins 1 TAB PO DAILY 
4. Aspirin 81 mg PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. Calcium Carbonate 500 mg PO QID:PRN heartburn 
7. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  amLODIPine 7.5 mg PO DAILY 
RX *amlodipine 5 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0
RX *amlodipine 2.5 mg 1 tablet(s) by mouth daily for a total of 
7.5mg Disp #*30 Tablet Refills:*0 
2.  Dronabinol 2.5 mg PO BID 
RX *dronabinol [Marinol] 2.5 mg 1 capsule(s) by mouth twice a 
day Disp #*30 Capsule Refills:*0 
3.  Ondansetron ODT 4 mg PO QID 
RX *ondansetron 4 mg 1 tablet(s) by mouth four times daily as 
needed Disp #*30 Tablet Refills:*0 
4.  Lisinopril 20 mg PO DAILY 
RX *lisinopril 20 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
5.  Alendronate Sodium 70 mg PO QTUES  
6.  Aspirin 81 mg PO DAILY  
7.  Calcium Carbonate 500 mg PO QID:PRN heartburn  
8.  Multivitamins 1 TAB PO DAILY  
9.  Propylthiouracil 50 mg PO DAILY  
10.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSES
================
LIVER LESION WITH EXTENSION INTO PORTAL VEIN
ANOREXIA
NAUSEA
VOMITING
HYPERTENSION
TACHYCARDIA
DEHYDRATION 
SEVERE MALNUTRITION 

SECONDARY DIAGNOSES
===================
CIRRHOSIS
OSTEOPOROSIS
HYPERTHYROIDISM

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was our pleasure to care for you at ___.

You were transferred to our hospital because you see many of our 
doctors ___. You first came to the hospital because of belly 
pain. A scan showed a possible mass and you were transferred for 
biopsy.

WHAT HAPPENED IN THE HOSPITAL?
- We got a copy of your CT and MRI scan from ___ 
___, which showed a mass
- Our radiologists read the CT and MRI scans and figured out how 
to biopsy the mass
- Our gastroenterology doctors ___ the ___. We do not have 
the results of this yet
- After the biopsy you felt very nauseous and threw up, which we 
treated with medications
- You had high blood pressure after your biopsy, which we 
treated with medications
- You were dehydrated so we gave you fluids through the IV  

WHAT SHOULD YOU DO WHEN YOU LEAVE?
- We scheduled an appointment with your PCP in ___ few days. This 
is an important appointment to go to because of your blood 
pressures, which are occasionally still high. We increased your 
medications, but a doctor should see you soon to look at your 
pressures.
- Our oncology doctors ___ appointment for you with 
the right kind of cancer doctor when the results of your biopsy 
are back. You can expect to hear from them within the week. 

We wish you the best!

Sincerely,
Your care team at ___ 
 
Followup Instructions:
___
"
48,12747844,21351037," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Lamictal / methimazole
 
Attending: ___.
 
Chief Complaint:
abdominal pain
 
Major Surgical or Invasive Procedure:
NONE

 
History of Present Illness:
Ms. ___ is a ___ woman with carcinoma of unknown
primary, HCV s/p Harvoni c/b Childs A cirrhosis, 
hyperthyroidism.
She now presents with fever.

She last received received FOLFOX C4D15 on ___. Due to
persistent cytopenias and disease progression, plan has been to
switch to new treatment at some point.

On ___ she called with new fever and fatigue. She also had 
nausea
without vomiting. She has non-productive cough. The evening 
prior
she had bilateral lower abdominal pain as well. She was
recommended to go to the ER for further evaluation.

In the ED, vital signs notable for:
T 100, HR 101, BP 186/109, RR16 100% RA

She received 2L LR and 4mg ondansetron.

At time of arrival, she reports abdominal pain that is different
from her usual abdominal discomfort. Her abdomen feels ""icky"" 
and
she is nauseous.
 
Past Medical History:
- HCV c/b hepatocellular carcinoma, Childs ___ class A
- Hyperthyroidism, for which she is on propylthiouracil x
approximately ___
- Osteoporosis
- History of brain hemangioma resected in ___ ___ at
___
-Seizure Disorder: see note, ___: followed by Neurology ( 
Dr. ___ at ___ for continued seizure disorder.
-Colonic Adenoma x2, resected (see colonoscopy notes, ___, 
___
-Diverticulosis (See colonoscopy note, ___
-Internal hemorrhoids (See colonoscopy note, ___
-Schatzki Ring, broken via endoscopy x2, ___
-Diaphragmatic hernia (see endoscopy note, ___
-Umbillical hernia, noted ___
-Extrarenal pelvis in R Kidney (___)
- Tubal ligation, ___
-Gonorrhea ___
-PID, ___

 
Social History:
___
Family History:
Mother-diabetes ___ and hypertension
Sister- deceased, pancreatic cancer

 
Physical Exam:
ADMISSION EXAM
==============
Vital Signs:  Reviewed in POE

General appearance: Generally well appearing, in no acute
distress. 
Head, eyes, ears, nose, and throat: Pupils round and equally
reactive to light. Oropharynx clear with moist mucous membranes.
Lymph: No palpable cervical or supraclavicular lymphadenopathy.
Cardiovascular: Regular rate and rhythm, S1, S2, no audible
murmurs.
Respiratory: Lungs clear to auscultation bilaterally.
Abdomen: Abdomen is tender most prominently in RUQ. No rebound
tenderness. Non distended.
Extremities: Warm, without edema.
Neurologic: Alert and oriented. Grossly normal strength,
coordination, and gait.
Skin: No rashes.

DISCHARGE EXAM
=================
PHYSICAL EXAMINATION:
24 HR Data (last updated ___ @ 007)
    Temp: 99.0 (Tm 99.2), BP: 160/66 (146-160/66-90), HR: 77
(77-91), RR: 18, O2 sat: 96% (96-98), O2 delivery: RA  
HEENT: PERRL, OP clear, MMM
Lymph: supple, normal range of motion
Cardiovascular: RRR, normal S1/S2, no m/r/g
Respiratory: not in respiratory distress, CTAB, no crackles,
wheezes, rhonchi
Abdomen: soft, no TTP in RUQ, ND, no fluid wave, no organomegaly
Extremities: wwp, no edema
Neurologic: A&Ox3, Grossly normal strength, coordination, and
gait.
Skin: No rashes or lesions

 
Pertinent Results:
ADMISSION LABS
==============

___ 08:35PM BLOOD WBC-8.6 RBC-4.28 Hgb-13.2 Hct-41.0 MCV-96 
MCH-30.8 MCHC-32.2 RDW-17.0* RDWSD-59.3* Plt ___
___ 11:15AM BLOOD WBC-12.4* RBC-3.98 Hgb-12.4 Hct-37.8 
MCV-95 MCH-31.2 MCHC-32.8 RDW-16.2* RDWSD-57.1* Plt Ct-98*
___ 08:35PM BLOOD Neuts-68.8 Lymphs-11.4* Monos-18.2* 
Eos-0.1* Baso-0.3 Im ___ AbsNeut-5.92 AbsLymp-0.98* 
AbsMono-1.57* AbsEos-0.01* AbsBaso-0.03
___ 11:15AM BLOOD Neuts-71.2* Lymphs-10.5* Monos-17.2* 
Eos-0.1* Baso-0.2 Im ___ AbsNeut-8.85* AbsLymp-1.31 
AbsMono-2.14* AbsEos-0.01* AbsBaso-0.03
___ 08:35PM BLOOD Glucose-147* UreaN-7 Creat-0.6 Na-132* 
K-3.7 Cl-96 HCO3-19* AnGap-17
___ 11:15AM BLOOD Glucose-142* UreaN-7 Creat-0.5 Na-131* 
K-3.4* Cl-96 HCO3-20* AnGap-15
___ 08:35PM BLOOD ALT-22 AST-44* AlkPhos-138* TotBili-1.3 
DirBili-0.3 IndBili-1.0
___ 11:15AM BLOOD ALT-16 AST-25 LD(LDH)-716* AlkPhos-111* 
TotBili-1.3
___ 08:35PM BLOOD Albumin-4.5
___ 11:15AM BLOOD Calcium-9.4 Phos-2.4* Mg-1.5*
___ 08:48PM BLOOD Lactate-1.5

DISCHARGE LABS
================

___ 04:14AM BLOOD WBC-8.1 RBC-3.22* Hgb-9.9* Hct-30.0* 
MCV-93 MCH-30.7 MCHC-33.0 RDW-15.3 RDWSD-52.9* Plt ___
___ 04:47AM BLOOD Neuts-64.1 Lymphs-18.5* Monos-15.8* 
Eos-0.3* Baso-0.4 Im ___ AbsNeut-5.72 AbsLymp-1.65 
AbsMono-1.41* AbsEos-0.03* AbsBaso-0.04
___ 04:14AM BLOOD Plt ___
___ 04:14AM BLOOD ___ PTT-37.0* ___
___ 04:14AM BLOOD Glucose-83 UreaN-10 Creat-0.5 Na-131* 
K-3.1* Cl-97 HCO3-22 AnGap-12
___ 04:47AM BLOOD Glucose-84 UreaN-8 Creat-0.5 Na-134* 
K-3.5 Cl-101 HCO3-21* AnGap-12
___ 04:14AM BLOOD ALT-9 AST-18 LD(___)-314* AlkPhos-89 
TotBili-0.6
___ 04:47AM BLOOD ALT-11 AST-16 LD(___)-374* AlkPhos-85 
TotBili-1.0
___ 04:14AM BLOOD Calcium-8.3* Phos-3.0 Mg-1.7 Iron-29*
___ 04:14AM BLOOD calTIBC-213* VitB12-1478* Ferritn-1005* 
TRF-164*

IMAGING
=========

RUQUS ___
IMPRESSION: 
  
  
1. Large, soft tissue lesion centered around the porta hepatis, 
with extension 
into the main portal vein, which does not demonstrate definite 
flow.  This is 
better assessed on the prior CT. 
2. Enlarged node adjacent to the pancreatic head, as seen on 
prior CT, 
measuring up to 3.5 cm. 
3. Moderate sludge within the gallbladder, without evidence of 
stones. 

MRCP ___
IMPRESSION: 
  
  
1. Redemonstration of a large mass centered with the porta 
hepatis which 
infiltrates and expands the main portal vein and the 
intrahepatic portal 
veins, not significantly changed compared with CT ___, 
but enlarged 
since  ___. 
2. No significant change in degree of mild to moderate 
intrahepatic biliary 
duct dilatation due to mass effect at the porta hepatis. 
3. Intrahepatic peribiliary enhancement, compatible with 
cholangitis.  No 
abscess. 
4. No evidence of cholecystitis. 

 
Brief Hospital Course:
Ms. ___ is a ___ woman with carcinoma of unknown 
primary, hepatobiliary in origin, HCV s/p Harvoni c/b Childs A 
cirrhosis, hyperthyroidism who presented with fever and RUQ pain 
c/f ascending cholangitis vs cholecystitis.

TRANSITIONAL ISSUES
===================
[] Patient on 7 day course of cefpedox/flagyl. Last day ___.
[] Discharge Hgb 9.9 on the day of discharge. Will follow-up on 
___ will cbc re-check.

ACUTE ISSUES
============
# Fever
# Leukocytosis
# Suspected cholangitis vs cholecystitis
She presented with fever, fatigue and abdominal pain. This was 
concerning for an infectious etiology, possibly cholangitis 
given her hx of ?hepatic carcinoma or cholecystitis. Fever could 
also be seen with cancer-associated thrombosis though there were 
no clear localizing signs to suggest this diagnosis. She had a 
leukocytosis to 12 which normalized by the time of discharge. 
She had a rising total bilirubin, which was thought to be iso 
intrahepatic biliary obstruction causing a possible infection. 
She was started on empiric ceftriaxone/flagyl. A RUQ US (___) 
showed a large soft-tissue ___ hepatis lesion extending 
into portal vein consistent with known malignancy. There were no 
signs of infection. An MRCP was then performed on ___ and showed 
intrahepatic peribiliary enhancement which was ""compatible with 
cholangitis"". By HD3 she was feeling better with no abdominal 
pain and she remained afebrile. She was transitioned to PO 
cefpedoxime/flagyl and discharged to finish a ___arcinoma of unknown primary
She had previously received FOLFOX C4D15 on ___. Due to 
persistent cytopenias and disease progression, the plan was to 
switch to new treatment at some point, possible lenvatinib. MRCP 
on ___ showed unchanged hepatic lesion with infiltration into 
the portal vein from prior CT on ___. She will have 
follow-up on ___ in ___ clinic. She was going to see 
Radiation Oncology on ___ but was unable to attend that 
appointment as she was hospitalized. She was seen by RadOnc 
during this hospitalization and will see them as an outpatient 
after discharge.

# Anemia
Pt was noted to have a down-trending hemoglobin to 9.9 (down 
from ___ on admission). Potentially there is an element of 
hemodilution however we have instructed the patient to have her 
labs checked on ___. Iron and B12 studies pending at the time of 
discharge. 

# Pain
She continued on her home oxycodone 5mg q4h PRN. Her abdominal 
pain improved during this admission.

# HTN
Her SBP was in the high 180s-190s upon admission in the setting 
of not being on her home anti-hypertensive and she remained 
asymptomatic. This was presumably in the setting of infection 
and pain. She continued on her lisinopril and amlodipine and her 
SBPs improved to 140s upon discharge.

# Osteoporosis
She continued on her weekly alendronate.

# Code status: Full presumed
# HCP: ___ (daughter) / p ___

This patient was prescribed, or continued on, an opioid pain 
medication at the time of discharge (please see the attached 
medication list for details). As part of our safe opioid 
prescribing process, all patients are provided with an opioid 
risks and treatment resource education sheet and encouraged to 
discuss this therapy with their outpatient providers to 
determine if opioid pain medication is still indicated.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Alendronate Sodium 70 mg PO QTUES 
2. Aspirin 81 mg PO DAILY 
3. Calcium Carbonate 500 mg PO QID:PRN heartburn 
4. Multivitamins 1 TAB PO DAILY 
5. Vitamin D 1000 UNIT PO DAILY 
6. Ondansetron ODT 8 mg PO Q8H:PRN Nausea/Vomiting - First Line 
7. Lisinopril 20 mg PO DAILY 
8. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - Second 
Line 

 
Discharge Medications:
1.  amLODIPine 5 mg PO DAILY 
RX *amlodipine 5 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
2.  Cefpodoxime Proxetil 200 mg PO/NG Q12H Duration: 5 Days 
RX *cefpodoxime 200 mg 1 tablet(s) by mouth twice a day Disp 
#*10 Tablet Refills:*0 
3.  MetroNIDAZOLE 500 mg PO TID Duration: 5 Days 
RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day 
Disp #*15 Tablet Refills:*0 
4.  Alendronate Sodium 70 mg PO QTUES  
5.  Aspirin 81 mg PO DAILY  
6.  Calcium Carbonate 500 mg PO QID:PRN heartburn  
7.  Lisinopril 20 mg PO DAILY  
8.  Multivitamins 1 TAB PO DAILY  
9.  Ondansetron ODT 8 mg PO Q8H:PRN Nausea/Vomiting - First Line 
 
10.  Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - Second 
Line  
11.  Vitamin D 1000 UNIT PO DAILY  
12.Outpatient Lab Work
Please draw CBC
D64.9 Anemia
Please send results to ___ MD 
Fax: ___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
=======================
Suspected cholangitis 

SECONDARY DIAGNOSIS
=======================
Carcinoma of unknown primary
Hypertension
Childs A cirrhosis
Chronic pain
Osteoporosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you here at ___ 
___!

WHY WAS I IN THE HOSPITAL?
===================================
- You came to the hospital because you were experiencing fevers, 
abdominal pain, nausea and fatigue.

WHAT HAPPENED IN THE HOSPITAL?
===================================
- You had tests done that showed that you may have had an 
infection of the bile ducts in the liver. 
- You were given intravenous fluids while you could not eat. 
- You were started on intravenous antibiotics that were later 
switched to oral antibiotics.

WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL?
===================================
- You will be leaving with antibiotics. Please take these 
medications as prescribed for the full duration through ___.
- You will have follow-up appointments with your primary care 
physician and oncologist. Please attend these appointments.
- You will have an appointment to have bloodwork drawn. Please 
go the lab on ___.
- If you have a return of your symptoms, please reach out to 
your healthcare provider.
- Radiation Oncology will be calling you to arrange an 
appointment for you for early next week because you missed the 
appointment on ___.

We wish you all the best!

Your ___ Care team
 
Followup Instructions:
___
"
49,12747844,22183104," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Lamictal / methimazole
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
None

attach
 
Pertinent Results:
ADMISSION LABS:
==============
___ 10:15AM   PLT COUNT-107*
___ 10:15AM   AbsNeut-1.04*
___ 10:15AM   WBC-2.0* RBC-4.62 HGB-13.8 HCT-42.8 MCV-93 
MCH-29.9 MCHC-32.2 RDW-13.7 RDWSD-46.2
___ 10:15AM   CEA-3.6 AFP-6.1
___ 10:15AM   ALBUMIN-4.1 CALCIUM-9.3 PHOSPHATE-2.6* 
MAGNESIUM-1.7
___ 10:15AM   ALT(SGPT)-21 AST(SGOT)-32 ALK PHOS-104 TOT 
BILI-0.9
___ 10:15AM   UREA N-8 CREAT-0.5 SODIUM-139 POTASSIUM-3.1* 
CHLORIDE-102
___ 03:50PM   ___ PTT-34.8 ___
___ 03:50PM   TSH-0.81
___ 03:50PM   cTropnT-<0.01

DISCHARGE LABS:
==============
___ 06:56AM BLOOD Calcium-9.8 Phos-3.4 Mg-1.7
___ 06:18AM BLOOD ALT-20 AST-35 LD(LDH)-243 AlkPhos-93 
TotBili-1.2
___ 06:56AM BLOOD Glucose-92 UreaN-7 Creat-0.5 Na-140 K-4.2 
Cl-100 HCO3-26 AnGap-14
___ 06:56AM BLOOD Neuts-43.9 ___ Monos-24.9* 
Eos-3.4 Baso-1.0 AbsNeut-0.90* AbsLymp-0.55* AbsMono-0.51 
AbsEos-0.07 AbsBaso-0.02
___ 06:56AM BLOOD WBC-2.1* RBC-4.53 Hgb-13.4 Hct-42.3 
MCV-93 MCH-29.6 MCHC-31.7* RDW-13.8 RDWSD-47.0* Plt Ct-90*

MICRO:
======
___ 4:13 pm URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 

IMAGING:
=======
___ CXR
IMPRESSION: No acute intrathoracic process.

___ NCHCT
IMPRESSION:
1. No acute intracranial process.  Specifically, no evidence of 
intracranial hemorrhage or acute large territorial infarction.
2. Status post right pterional craniotomy with expected 
postsurgical changes.  Area of encephalomalacia of the right 
frontotemporal lobe may be sequela of prior intracranial 
hemorrhage.  Correlation with history is recommended.
3. Chronic microangiopathic and involutional changes.

DISCHARGE EXAM:
===============
Vitals:  24 HR Data (last updated ___ @ 748)
    Temp: 98.0 (Tm 98.3), BP: 151/80 (124-181/70-96), HR: 62
(53-70), RR: 18 (___), O2 sat: 98% (95-98), O2 delivery: Ra    


GENERAL: Sleeping comfortably in bed, NAD
HEENT: Clear OP without lesions or thrush
EYES: PERRL, anicteric
NECK: supple, no JVD
RESP: No increased WOB, no wheezing, rhonchi or crackles
___: bradycardic, regular rhythm, no murmurs
GI: soft, TTP over RUQ and LUQ, no rebound or guarding
EXT: no edema, warm
SKIN: dry, no obvious rashes
NEURO: alert, fluent speech. no focal neurologic deficits 
ACCESS: POC, dressing C/D/I

 
Brief Hospital Course:
BRIEF HOSPITAL COURSE:
======================
___ yo F with PMH of hyperthyroidism on PTU, meningioma s/p
resection, depression, CAD, HCV cirrhosis s/p Harvoni, suspected
HCC s/p FOLFOX with progression, now recently started on
lenvatinib who presents for headache and elevated BP from clinic
c/f hypertensive urgency/emergency in setting of recent
lenvatinib initiation

TRANSITIONAL ISSUES:
====================
[] HTN meds on discharge: lisinopril 40mg QD, amlodipine 10mg QD
[] Consider dose reduction of lenvatinib (previously was 8mg qd) 
in setting of grade 3 neutropenia. 
[] ANC on day of discharge: 900

ACTIVE ISSUES:
==============
#Hypertensive emergency
Patient with initial symptoms concerning for hypertensive
encephalopathy. Patient's symptoms improved with BP lowering in
ED. Of note, patient with BP as low as 120s systolic after
clonidine administration in ED, though seems to have stabilized
slightly after additional IV medications. BP on admission SBP
180s. BP was lowered slowly as to not precipitate hypoperfusion. 
Etiology likely recent lenvatinib initiation vs noncompliance in 
the setting of encephalopathy at home. TSH was normal. BP meds 
on discharge were amlodipine 10mg qd and lisinopril 40mg qd. 
Patient will have ___ on discharge for BP monitoring. 

#Carcinoma of unknown primary, presumed HCC
#Cancer related pain
#Nausea/Vomiting
Patient with progression of disease on FOLFOX followed by ___ CI
with XRT. She was started on lenvatinib to delay progression of
disease and minimize tumor burden. Patient now seems to have
adverse reaction to lenvatinib with hypertensive emergency. 
Lenvatinib was given for 2 days and the again discontinued iso 
neutropenia. Continued home Zofran, Compazine and dronabinol for 
nausea and oxycodone 5mg TID PRN and MS contin 15mg BID for 
pain. She was seen by ___ while inpatient who recommended home 
with ___ services.

#Leukopenia
#Thrombocytopenia
#Neutropenia 
In setting of recent lenvatinib initiation. Lenvatinib was 
initially restarted but then held iso grade 3 neutropenia. CBC 
with diff was monitored daily. ___ on day of discharge was 900.

#Constipation
Continued home Colace and miralax with senna and Bisacodyl PRNs.

#Severe malnutrition
#Hypokalemia
#Hypomagnesemia
Nutrition consulted. Received multivitamin and PRN electrolyte 
repletion.

#Hyperthyroidism
Continued home PTU. TSH wnl.

#Osteoporosis
Continued home alendronate ___, vitamin D and calcium.

#CAD
#Bradycardia
S/p cath in ___. H/o bradycardia to 40-50s per past EKG review. 
ASA continued qd. 

CORE MEASURES:  
#HCP/Contact: ___, daughter, ___
#Code: Full, presumed

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 5 mg PO DAILY 
2. Alendronate Sodium 70 mg PO QTUES 
3. Lisinopril 20 mg PO DAILY 
4. Multivitamins 1 TAB PO DAILY 
5. Vitamin D 1000 UNIT PO DAILY 
6. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - Second 
Line 
7. Aspirin 81 mg PO DAILY 
8. Ondansetron ODT 8 mg PO Q8H:PRN Nausea/Vomiting - First Line 
9. Propylthiouracil 50 mg PO DAILY 
10. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third 
Line 
11. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
12. Calcium Carbonate 1000 mg PO DAILY 
13. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe 
14. Morphine SR (MS ___ 15 mg PO Q12H 
15. Lidocaine-Prilocaine 1 Appl TP ASDIR 
16. lenvatinib 8 mg/day (4 mg x 2) oral DAILY 
17. Dronabinol 2.5 mg PO TID:PRN nausea 

 
Discharge Medications:
1.  amLODIPine 10 mg PO DAILY  
2.  Lisinopril 40 mg PO DAILY  
3.  Alendronate Sodium 70 mg PO QTUES  
4.  Aspirin 81 mg PO DAILY  
5.  Calcium Carbonate 1000 mg PO DAILY  
6.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line  

7.  Dronabinol 2.5 mg PO TID:PRN nausea  
8.  Lidocaine-Prilocaine 1 Appl TP ASDIR  
9.  Morphine SR (MS ___ 15 mg PO Q12H  
10.  Multivitamins 1 TAB PO DAILY  
11.  Ondansetron ODT 8 mg PO Q8H:PRN Nausea/Vomiting - First 
Line  
12.  OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe 
 
13.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third 
Line  
14.  Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - Second 
Line  
15.  Propylthiouracil 50 mg PO DAILY  
16.  Vitamin D 1000 UNIT PO DAILY  
17. HELD- lenvatinib 8 mg/day (4 mg x 2) oral DAILY  This 
medication was held. Do not restart lenvatinib until you see Dr 
___ in clinic

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
#Hypertensive emergency
#Carcinoma of unknown primary, presumed ___
#Neutropenia
#Thrombocytopenia
#Severe malnutrition
#Osteoporosis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,
 
It was a pleasure caring for you at ___ 
___.  
 
WHY WAS I IN THE HOSPITAL?  
- You were admitted for elevated blood pressures. 
 
WHAT HAPPENED TO ME IN THE HOSPITAL?  
- Your blood pressure was elevated likely from lenvatinib.
- Your blood pressure medications were increased for better 
blood pressure control.
- The lenvatinib was restarted but then held because your 
neutrophil (a type of white blood cell) count was low. 

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
- Continue to take all your medicines and keep your 
appointments.  

We wish you the best!  
 
Sincerely,  
Your ___ Team

 
Followup Instructions:
___
"
50,12924398,26087236," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
abdominal pain
 
Major Surgical or Invasive Procedure:
EUS
 
History of Present Illness:
Ms. ___ is a ___ woman with history of HTN,
DMII, cirrhosis who initially presented to an outside hospital
with abdominal pain and was found to have gallstone 
pancreatitis,
transferred to ___ for ERCP.

The patient reports that she was in her usual state of health
until the day of presentation, when she developed acute onset of
severe epigastric and right-sided abdominal pain with radiation
to her back. This pain was associated with nausea and vomiting.
She denies any fevers or chills. 

No changes in bowels. She presented to ___, where was
found to have lipase over 12,000, TBili 2.2 and DBili 1.2, AST
64, ALT 28, alk phos 241, CT with distal CBD stones and
pancreatitis. BUN 10, no pleural effusion, no SIRS criteria met.

She was treated supportively with fluids, analgesics, and
antiemetics, and today her TBili was 1.3, AST 53, alk phos 196.
She was accepted in transfer for advanced endoscopy evaluation
and likely cholecystectomy. VS prior to transfer 98.0 77 111/90
100% RA.

On arrival to the floor, she reports that she has ongoing
right-sided back pain, ___. She denies any abdominal pain,
nausea, vomiting, fevers, chills, or any other complaints at
present.

ROS: Pertinent positives and negatives as noted in the HPI.  All
other systems were reviewed and are negative. 

 
Past Medical History:
HTN
NIDDMI
Cirrhosis (unknown etiology) c/b esophageal varices
 
Social History:
___
Family History:
Mother with hypertension and hyperlipidemia. No
known family history of gallbladder disease.

 
Physical Exam:
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4.  No JVD.
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored
GI: Abdomen soft, non-distended, nontender Bowel sounds present. 
 
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented, face symmetric, gaze conjugate with 
EOMI,
speech fluent, moves all limbs, sensation to light touch grossly
intact throughout
PSYCH: Pleasant, appropriate affect

 
Pertinent Results:
Per report from OSH
Imaging: 
CT A/P
1. Cirrhosis with portal hypertension, splenomegaly and multiple
varices as detailed.
2. ___ucts calculus and findings consistent 
with
mild pancreatitis evidence by peripancreatic inflammation. MRCP
may be helpful for further assessment, depending on clinical
factors.
3. No drainable collection or ascites.07:10AM BLOOD Calcium-9.0 
Phos-3.1 Mg-1.6

EUS: 2 grade 2 esophageal varices, mild portal gastropathy, 
normal CBD without stone. 

MRCP: Cirrhotic liver morphology with evidence of portal 
hypertension.  No lesions 
meeting optn criteria for ___. 
  
Cholelithiasis.  No choledocholithiasis. 

 
Brief Hospital Course:
SUMMARY/ASSESSMENT: Ms. ___ is a ___ woman with
history of HTN, DMII, cirrhosis who initially presented to an
outside hospital with abdominal pain and was found to have
gallstone pancreatitis, transferred to ___ for ERCP.

ACUTE/ACTIVE PROBLEMS:
# Abdominal pain, nausea, vomiting
# Presumed Acute gallstone pancreatitis
# Choledocholithiasis with biliary obstruction: Patient 
presented
with abdominal pain, found to have gallstone pancreatitis and
choledocholithiasis with biliary obstruction, now improving. 
Evaluated by ERCP team, and underwent EUS, which found no stone 
in CBD.  Therefore an ERCP was not pursued.  Tbili peaked at 
2.5, and was trended during hospital course. It decreased on a 
daily basis.  Transplant service was consulted, and they were 
not keen on doing a CCY until patient's MELD score was low 
enough. MRCP showed no choledocholithiasis, but Cholelithiasis.  
In the future, she will likely need a cholecystectomy.  
Initially needed pain control with Tylenol (max daily dose 
2grams), oxycodone as
needed, but on final three days of admission, was totally pain 
free and eating a regular diet. 

CHRONIC/STABLE PROBLEMS:
# DMII: 
- Hold metformin, hISS while hospitalized, ___ qID.  Restart 
metformin on discharge.  

# Cirrhosis: Unknown etiology. Patient denies any history of
alcohol. History of ascites at time of diagnosis but none since.
No history of HE. History of varices; last EGD ___ years ago per
patient. She needs to follow up with hepatologist.  Interested 
in following up with specialists at ___.  Can coordinate this 
with her PCP.  
- Continue nadolol, ursodiol

# Hypertension:
- losartan held initially, but restarted as there was no plan 
for further invasive procedures.
if blood pressures allow
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Losartan Potassium 50 mg PO DAILY 
2. Nadolol 20 mg PO DAILY 
3. MetFORMIN (Glucophage) 500 mg PO BID 
4. Ursodiol 500 mg PO DAILY 
5. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Losartan Potassium 50 mg PO DAILY  
2.  MetFORMIN (Glucophage) 500 mg PO BID  
3.  Nadolol 20 mg PO DAILY  
4.  Ursodiol 500 mg PO DAILY  
5.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
gallstone pancreatitis, acute
cirrhosis

 
Discharge Condition:
Good, ambulatory, tolerating diet
 
Discharge Instructions:
You were admitted for evaluation of abdominal pain presumed due 
to gallstone pancreatitis. For this, you underwent an endoscopic 
ultrasound, during which they could not find a stone.  You will 
eventually need to have your gallbladder removed, but this 
discussion can continue between you and your primary care and 
liver specialist. Please take all your medications as indicated. 

 
Followup Instructions:
___
"
51,12924398,21554385," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Cholelithiasis.
 
Major Surgical or Invasive Procedure:
___ Laparoscopic cholecystectomy.

 
History of Present Illness:
___ woman with likely
NASH cirrhosis.  She is well compensated Child's class A with
a MELD of 11.  She has known cholelithiasis and a recent
admission for gallstone pancreatitis.  She continues to
have episodes of right upper quadrant pain.  She presents
today for elective cholecystectomy.  The risks and benefits of
the operation had been discussed.  Informed consent was
obtained.

 
Past Medical History:
HTN
NIDDMI
Cirrhosis (unknown etiology) c/b esophageal varices
 
Social History:
___
Family History:
Mother with hypertension and hyperlipidemia. No
known family history of gallbladder disease.

 
Physical Exam:
Discharge 

PHYSICAL EXAMINATION:

GENERAL: [x ]NAD  [x ]A/O x 3  [ ]intubated/sedated [ ]abnormal
CARDIAC: [x ]RRR  [ ]no MRG  [ ]Nl S1S2 [ ]abnormal
LUNGS: [ ]CTA b/l  [x ]no respiratory distress  [ ]abnormal
ABDOMEN: [ ]NBS  [x ]soft  [x]Nontender  [ ]appropriately tender 

[x ]nondistended  [ ]no rebound/guarding  [ ]abnormal
WOUND: [x ]CD&I  [ ]no erythema/induration  [ ]JP [ ]abnormal
EXTREMITIES: [x ]no CCE  [x ]Pulse  [ ]abnormal

 
Pertinent Results:
___ 12:32PM BLOOD WBC-4.1 RBC-4.07 Hgb-12.5 Hct-39.1 MCV-96 
MCH-30.7 MCHC-32.0 RDW-13.8 RDWSD-49.0* Plt ___
___ 04:04AM BLOOD WBC-6.6 RBC-3.62* Hgb-11.2 Hct-34.1 
MCV-94 MCH-30.9
 MCHC-32.8 RDW-13.9 RDWSD-48.1* Plt ___

___ 04:04AM BLOOD Glucose-107* UreaN-10 Creat-0.7 Na-140 
K-3.7 Cl-107 HCO3-25 AnGap-8*

___ 12:32PM BLOOD ALT-34 AST-83* AlkPhos-209* TotBili-1.3
___ 04:04AM BLOOD ALT-31 AST-77* AlkPhos-178* TotBili-1.4

___ 12:32PM BLOOD Mg-1.3*
___ 04:04AM BLOOD Albumin-3.2* Calcium-8.8 Phos-3.0 Mg-1.___ F w/ h/o HTN, DM, and Childs A ___ cirrhosis, now s/p lap 
ccy for history of gallstone pancreatitis, biliary colic. Postop 
course uneventful. 
Tolerated a regular diet without N/V. She had minimal pain 
overnight and had ambulated twice. She voided after foley 
catheter removed. 

LFTs decreased. Incision was intact without redness/drainage. 
She was discharged to home in stable condition. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Nadolol 20 mg PO DAILY 
2. Ursodiol 500 mg PO DAILY 
3. Losartan Potassium 50 mg PO DAILY 
4. MetFORMIN (Glucophage) 500 mg PO BID 
5. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 
do not take more than 2000mg per day  
2.  Docusate Sodium 100 mg PO BID  
3.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg 1 tablet(s) by mouth every 6 hours as needed 
Disp #*5 Tablet Refills:*0 
4.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - 
Moderate 
  Reason for PRN duplicate override: Alternating agents for 
similar severity 
5.  Senna 8.6 mg PO BID:PRN Constipation - Second Line  
6.  Losartan Potassium 50 mg PO DAILY  
7.  MetFORMIN (Glucophage) 500 mg PO BID  
8.  Nadolol 20 mg PO DAILY  
9.  Ursodiol 500 mg PO DAILY  
10.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
gallstone pancreatitis
biliary colic
NASH cirrhosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call Dr. ___ office at ___ for fever 
of 101, chills, nausea, vomiting, diarrhea, constipation, 
increased abdominal pain, pain not controlled by your pain 
medication, swelling of the abdomen or ankles, yellowing of the 
skin or eyes, inability to tolerate food, fluids or medications, 
the incision sites have redness, drainage or bleeding, or any 
other concerning symptoms.

You may shower. Allow water to run over the incision. Do not 
apply lotion or powder to the incision area. Leave incision open 
to the air.

No lifting more than 10 pounds
No driving if taking narcotic pain medication

 
Followup Instructions:
___
"
52,12924398,20460136," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Admitted from clinic for ___
 
Major Surgical or Invasive Procedure:
Diagnostic paracentesis ___

 
History of Present Illness:
___ with history of suspected NASH cirrhosis decompensated by
ascites and EV, HTN, T2DM, recent episode of gallstone
pancreatitis s/p lap chole on ___, admitted with ___.

She was seen by Dr. ___ in liver clinic on ___, labs 
returned
with Cr 1.5 (b/l 0.8) so she was referred to the ED.

Of note, in ___ she was deemed by Hepatology team not to be
in need of transplant due to low MELD. She was also seen in
clinic last week for ecchymosis on R abdomen spreading to back.
She was noted to be distended, up 8 lbs, and started on Lasix 20
for 5 days, which she recently completed. She continued to have
abdominal distention.

In the ED, vitals: Today 11:59 0 97.5 82 161/80 16 100% RA 
                   Today 15:08 0 97.9 79 133/65 18 100% RA 

- Exam notable for: distended abdomen

- Labs notable for:
Cr 1.5 ___, 1.2 on ___. baseline 0.8
ALT 18, AST 78, ALP 204, Tb 1.8
CBC similar to prior
Mg 1.2; not repleted
MELD could not be calculated; INR not reported. MELD 14 based on
most recent INR
diagnostic para with 331 PMNs (corrected for RBC) 

- Imaging notable for:
RUQUS
1. Main and left portal veins are patent with slow hepatopetal
flow.
2. Cirrhotic liver with moderate to large volume ascites and
splenomegaly.

- Consults: Transplant surgery was consulted. No management
recommendations were given other than admitting to medicine.

- Patient was given: 2g ceftriaxone 

Upon arrival to the floor, she is feeling well. Her belly feels
full and she would like to take the fluid off. Otherwise she has
no fever, abdominal pain, decreased urine output or change in
urine color, black or bloody stool, shortness of breath, chest
pain or other symptoms. She has never had SBP before. 

 
Past Medical History:
HTN
NIDDMI
Cirrhosis (unknown etiology) c/b esophageal varices
 
Social History:
___
Family History:
Mother with hypertension and hyperlipidemia. No
known family history of gallbladder disease.

 
Physical Exam:
===========================
ADMISSION PHYSICAL EXAM
===========================
VS: PO 146 / 81 L Sitting 82 18 95 Ra 
GENERAL: NAD, lying in bed, surrounded by family
HEENT: anicteric sclera, pink conjunctiva, MMM
NECK: supple, no LAD, no JVD
HEART: RRR, S1/S2, holosystolic murmur loudest at LUSB
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: soft, moderately distended, nontender in all quadrants,
no rebound/guarding. lap chole scars c/d/i
EXTREMITIES: no ___ edema
NEURO: A&Ox3, moving all 4 extremities with purpose, no 
asterixis
SKIN: warm and well perfused, no rashes. bruising in R lower
abdomen around to back (improving per pt)

=============================
DISCHARGE PHYSICAL EXAM
=============================
GENERAL: NAD, well-nourished, sister at bedside, smiling and
watching video on phone
HEENT: anicteric sclera, pink conjunctiva, MMM
HEART: RRR, S1/S2, holosystolic murmur loudest at LUSB
LUNGS: clear, diminished breath sounds at the bases.
ABDOMEN: Significantly distended but non-tender to palpation.
soft
Substantial bruising at the RLQ, stable.
EXTREMITIES: no ___ edema bilaterally 

 
Pertinent Results:
=========================
ADMISSION LAB RESULTS
=========================

___ 03:11PM BLOOD WBC-6.3 RBC-3.63* Hgb-11.5 Hct-35.2 
MCV-97 MCH-31.7 MCHC-32.7 RDW-14.0 RDWSD-49.7* Plt ___
___ 03:11PM BLOOD Neuts-69.3 Lymphs-14.0* Monos-14.3* 
Eos-1.9 Baso-0.2 Im ___ AbsNeut-4.36 AbsLymp-0.88* 
AbsMono-0.90* AbsEos-0.12 AbsBaso-0.01
___ 03:11PM BLOOD ___
___ 03:11PM BLOOD UreaN-25* Creat-1.5* Na-142 K-4.7 Cl-101 
HCO3-25 AnGap-16
___ 03:11PM BLOOD ALT-16 AST-42* AlkPhos-221* TotBili-1.6*
___ 12:40PM BLOOD Albumin-3.5 Calcium-9.8 Phos-4.1 Mg-1.2*

==========================
DISCHARGE LAB RESULTS
==========================

___ 10:06AM BLOOD WBC-3.3* RBC-3.27* Hgb-10.1* Hct-31.7* 
MCV-97 MCH-30.9 MCHC-31.9* RDW-14.1 RDWSD-49.8* Plt ___
___ 10:06AM BLOOD Plt ___
___ 10:06AM BLOOD ___ PTT-36.4 ___
___ 10:06AM BLOOD Glucose-172* UreaN-9 Creat-0.8 Na-144 
K-4.1 Cl-106 HCO3-25 AnGap-13
___ 10:06AM BLOOD ALT-15 AST-45* LD(LDH)-158 AlkPhos-160* 
TotBili-1.1
___ 10:06AM BLOOD Albumin-4.5 Calcium-9.7 Phos-2.8 Mg-1.5*

================
MICRO DATA
================
__________________________________________________________
___ 7:23 pm BLOOD CULTURE      2 OF 2. 

   Blood Culture, Routine (Pending):    No growth to date. 
__________________________________________________________
___ 7:23 pm BLOOD CULTURE      1 OF 2. 

   Blood Culture, Routine (Pending):    No growth to date. 
__________________________________________________________
___ 1:04 pm FLUID RECEIVED IN BLOOD CULTURE BOTTLES
      PERITONEAL FLUID . 

   Fluid Culture in Bottles (Pending):    No growth to date. 
__________________________________________________________
___ 1:04 pm PERITONEAL FLUID      PERITONEAL FLUID . 

   GRAM STAIN (Final ___: 
      2+   ___ per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 
      This is a concentrated smear made by cytospin method, 
please refer to
      hematology for a quantitative white blood cell count, if 
applicable. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. 

==========================
IMAGING AND REPORTS
==========================

RUQ ULTRASOUND ___
IMPRESSION:
1. Main and left portal veins are patent with slow hepatopetal 
flow.
2. Cirrhotic liver with moderate to large volume ascites and 
splenomegaly.
 
Brief Hospital Course:
Ms. ___ is a ___ woman with history of suspected NASH 
cirrhosis decompensated by ascites and EV, recent episode of 
gallstone pancreatitis s/p lap chole on ___, who was admitted 
from clinic with SBP and ___.

ACUTE ISSUES:
=============
# Culture negative Spontaneous bacterial peritonitis
Patient underwent diagnostic paracentesis on ___. She was 
found to have peritoneal fluid PMNs 331 when corrected for RBCs. 
In the setting of recent abdominal surgery, worsening distention 
and ___, she was ultimately treated for SBP with IV Ceftriaxone 
2g daily ___ - ___. She additionally received IV 
Albumin on days ___. Of note, attempted repeat paracentesis ___ 
to evaluate progress in treating SBP and to potentially improve 
abdominal distention however there was no safely tappable 
pocket. Her peritoneal and blood cultures were without growth to 
date. At discharge, she was prescribed Ciprofloxacin 500mg daily 
for SBP prophylaxis. She will follow up in liver clinic at the 
end of the month.

# Acute kidney injury
Presented with Creatinine 1.5 on admission, subsequently 
downtrended to 0.8 by discharge. She received IV Albumin for SBP 
as per above. Overall was felt to likely be secondary to renal 
hypoperfusion in the setting of decompensated ascites and SBP. 
Her home Losartan and diuretics were held given ___ and albumin 
requirement. Diuretics were restarted at a higher dose. Losartan 
was held given her need for increased diuretics; can discuss 
restarting at next PCP ___.

# NASH cirrhosis
# Ascites
# Large, grade II esophageal varices
Patient presented with abdominal distention and ___. She was 
treated for SBP and was given albumin for ___. Her home 
diuretics and nadolol were initially held while treating ___. 
She had been on low-dose ___ but did not feel as though 
it was helping; her typical weight is 150 lbs, and she was 
admitted at a weight of 157 pounds. Discharge weight 158 pounds. 
She was discharged with an increased dose of lasix 40 and 
spironolactone 100. Nadolol was restarted for variceal bleeding 
prophylaxis. Her mental status has been appropriate, and she is 
not on rifaxmin/lactulose at home. Patient instructed to get 
bloodwork done on ___ for close monitoring of electrolytes 
and renal function on higher dose of diuretics - this will be 
followed up by Dr. ___. She is not currently on the 
transplant list, but Dr. ___ that this warrants further 
discussion and will follow up with her at next clinic visit in 
___.

CHRONIC ISSUES:
================
#HTN: Held home losartan for ___ as per above, should discuss 
restarting at next PCP ___.

#T2DM: Held home metformin given ___, however this was restarted 
at discharge.

#Status post gallstone pancreatitis: no signs of recurrence 
during her hospitalization.

=====================
TRANSITIONAL ISSUES:
=====================
[ ] Labs: Please obtain repeat BMP on ___ to monitor 
electrolytes and Cr given new Lasix and Spironolactone. To be 
followed up by Dr. ___.
[ ] Follow up Hepatology as scheduled on ___. Discuss 
initiating workup for transplant evaluation. Evaluate for 
improvement in volume status on new dose of diuretics.
[ ] Follow up PCP: To monitor BP, consider restarting Losartan
[ ] New Medications: Ciprofloxacin 500mg daily (SBP ppx), Lasix 
40mg daily, Spironolactone 100mg daily.
[ ] Held Medications: Losartan
[ ] Discharge weight: 158 pounds
[ ] Discharge creatinine: 0.8

# CODE: Presumed FULL
# CONTACT: emergency contact is daughter ___
___. needs to get HCP
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Losartan Potassium 50 mg PO DAILY 
2. Nadolol 20 mg PO DAILY 
3. MetFORMIN (Glucophage) 500 mg PO BID 
4. Ursodiol 500 mg PO DAILY 
5. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO DAILY 
RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth once a 
day Disp #*30 Tablet Refills:*3 
2.  Furosemide 40 mg PO DAILY 
RX *furosemide 40 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*3 
3.  Spironolactone 100 mg PO DAILY 
RX *spironolactone 100 mg 1 tablet(s) by mouth once a day Disp 
#*30 Tablet Refills:*3 
4.  MetFORMIN (Glucophage) 500 mg PO BID  
5.  Nadolol 20 mg PO DAILY  
6.  Ursodiol 500 mg PO DAILY  
7.  Vitamin D ___ UNIT PO DAILY  
8. HELD- Losartan Potassium 50 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until cleared by your 
primary care doctor
9.Outpatient Lab Work
ICD-10 Diagnosis Code ___ Nonalcoholic steatohepatitis 
Bloodwork for ___: basic metabolic panel
Fax results to: Dr. ___, ___, 
___ 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary: 
Spontaneous bacterial peritonitis

Secondary:
Acute kidney injury
NASH cirrhosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital for abnormal kidney function 
tests. Ultimately, you were found to have an infection in the 
fluid of your abdomen. We gave you antibiotics through the IV as 
well as Albumin, and your symptoms and your labs improved. 
Ultimately, you were safe to be discharged home.

WHAT TO DO ONCE HOME:
- Please take all your medications as prescribed, listed below
- Please go to all of your appointments as scheduled, listed 
below

We wish you the best,
Your ___ Care Team 
 
Followup Instructions:
___
"
53,12924398,29569386," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Nausea/Vomiting 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ woman with a history of  type 2
diabetes, hypertension, and NASH cirrhosis (complicated by
ascites, prior hx of SBP, and esophageal varices), currently on
the transplant list with recent MELD 10 (today is 17 on
admission) who presents with 4 days of nausea, vomiting.

She reports being in her USOH until ___ when she developed
nausea with several episodes of non bloody nonbilious vomiting
with subsequent decreased PO intake. She also describes onset of
intermittent ___ abdominal pain focused around her umbilicus
that is non radiating that comes on at times after an episode of
vomiting, and at times triggering an episode of nausea/vomiting.
These symptoms have been ongoing since ___ and she has been
unable to tolerate PO. She last attempted to eat yesterday
morning but vomited this back up. Her PO fluid intake has been
quite low. She denies any recent travel, sick contacts, or
changes in diet. Also denies any recent fever/chills, chest 
pain,
cough SOB, headache, lightheadedness/dizziness, hematochezia,
melena, dysuria. She has continued to take her medications daily
as prescribed. According to her daughter who presents with pt to
the ED, she has also been intermittently confused. Her daughter
spoke with her transplant nurse this morning recommend her to
come into the ED for further evaluation and management. 
 
Past Medical History:
HTN
NIDDMI
Cirrhosis (unknown etiology) c/b esophageal varices
 
Social History:
___
Family History:
Mother with hypertension and hyperlipidemia. No
known family history of gallbladder disease.

 
Physical Exam:
ADMISSION EXAM
==============
VS: T97.6, BP 119/79, HR 94, 98% on RA 
GENERAL: NAD
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
MMM
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: soft, nondistended, nontender in all quadrants, no
rebound/guarding
EXTREMITIES: WWP, no ___ edema.  
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, moving all 4 extremities with purpose
SKIN: no rashes or lesions

DISCHARGE PHYSICAL EXAM:
=======================
VS: 98.5 PO120 / 7896bpm18RR99%Ra
GENERAL: NAD
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
MMM
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: soft, nondistended, nontender in all quadrants, no
rebound/guarding
EXTREMITIES: WWP, no ___ edema.  
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, moving all 4 extremities with purpose
SKIN: no rashes or lesions
 
Pertinent Results:
ADMISSION LABS:
==============
___ 05:23PM BLOOD WBC-6.7 RBC-5.25* Hgb-16.0* Hct-46.6* 
MCV-89 MCH-30.5 MCHC-34.3 RDW-13.9 RDWSD-44.6 Plt ___
___ 06:07PM BLOOD ___ PTT-40.6* ___
___ 05:23PM BLOOD Glucose-96 UreaN-36* Creat-1.6* Na-134* 
K-4.8 Cl-93* HCO3-21* AnGap-20*
___ 05:23PM BLOOD ALT-33 AST-57* AlkPhos-235* TotBili-1.9*
___ 05:23PM BLOOD Albumin-4.8 Calcium-12.1* Phos-3.5 Mg-1.7
___ 05:33PM BLOOD Lactate-4.4*

MICRO
=====
___ 9:02 pm URINE
URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 

IMAGING:
=======
RUQ Ultrasound ___
IMPRESSION:
1. Cirrhotic liver morphology with trace perihepatic ascites.  
No
splenomegaly.
2. Patent hepatic vasculature.  Left portal vein slow flow.

DISCHARGE LABS
===============
___ 05:20AM BLOOD WBC-3.9* RBC-4.01 Hgb-12.4 Hct-36.6 
MCV-91 MCH-30.9 MCHC-33.9 RDW-13.9 RDWSD-46.5* Plt Ct-95*
___ 05:20AM BLOOD ___ PTT-45.8* ___
___ 05:20AM BLOOD Glucose-111* UreaN-20 Creat-1.0 Na-140 
K-4.0 Cl-103 HCO3-22 AnGap-15
___ 05:20AM BLOOD ALT-29 AST-58* AlkPhos-163* TotBili-2.1*
___ 05:20AM BLOOD Albumin-4.5 Calcium-10.1 Phos-3.0 Mg-2.0
 
Brief Hospital Course:
Ms. ___ is a ___ woman with a history of type 2 
diabetes, hypertension, and NASH cirrhosis (complicated by 
ascites, prior hx of SBP, and esophageal varices), currently on 
the transplant list, who presented with 4 days of nausea and 
vomiting, found to have ___. 

ACTIVE ISSUES
=============
#Gastroenteritis 
Patient presented with nausea and vomiting, thought likely viral 
gastroenteritis. Abdominal exam benign. No diarrhea. She had 
elevated lactate to 4.4 on admission likely related to 
hypoperfusion iso hypovolemia; it improved with fluids. Her 
nausea and vomiting resolved rapidly upon admission. Cultures 
were negative. She was tolerating a regular diet without issue 
by discharge. 

___ 
Admission Cr 1.6 from baseline 1.0. Likely prerenal in setting 
of poor PO intake with ongoing use of home diuretics. She 
received fluids and albumin with resolution of ___. Home Lasix, 
spironolactone, nadolol and losartan were held initially for 
___. She was restarted on Lasix, spironolactone and nadolol upon 
discharge with resolution of ___. Home losartan was held on 
discharge given recent ___ and normotension off of it. Discharge 
Cr 1.0. 

#NASH cirrhosis
NASH cirrhosis complicated by grade 2 esophageal varices (seen 
on EGD ___ and hx of ascites with SBP, on prophylactic 
ciprofloxacin. MELD 17 on admission. Active on transplant list. 
Home diuretics (lasix and spironolactone) were held initially 
iso ___ and restarted unchanged upon discharge. Home nadolol was 
held initially iso ___ and restarted upon discharge. She was 
continued on home ciprofloxacin for history of SBP. This 
admission she had trace perihepatic ascites that was not 
tappable. She did not have HE this admission. She was continued 
on home ursodiol. 

CHRONIC ISSUES
==============
#HTN: Held home losartan on discharge given recent ___. Please 
assess renal function and indication to restart losartan 
outpatient. She was normotensive off of losartan. 

#T2DM: Resumed home metformin on discharge 

TRANSITIONAL ISSUES
===================

[] Held home losartan on discharge given recent ___. Please 
assess renal function and indication to restart losartan 
outpatient. She was normotensive off of losartan. 
[] Monitor renal function
[] Please ensure that she attends her liver follow up 
appointment on ___.

# CODE: Presumed FULL
# CONTACT: Proxy name: ___ 
Relationship: daughter Phone: ___
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Ursodiol 500 mg PO DAILY 
2. Vitamin D ___ UNIT PO DAILY 
3. MetFORMIN (Glucophage) 500 mg PO BID 
4. Nadolol 20 mg PO DAILY 
5. Ciprofloxacin HCl 500 mg PO DAILY 
6. Furosemide 40 mg PO DAILY 
7. Spironolactone 100 mg PO DAILY 
8. Losartan Potassium 50 mg PO DAILY 

 
Discharge Medications:
1.  Atorvastatin 10 mg PO QPM 
RX *atorvastatin 10 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
2.  Ciprofloxacin HCl 500 mg PO DAILY  
3.  Furosemide 40 mg PO DAILY  
4.  MetFORMIN (Glucophage) 500 mg PO BID  
5.  Nadolol 20 mg PO DAILY  
6.  Spironolactone 100 mg PO DAILY  
7.  Ursodiol 500 mg PO DAILY  
8.  Vitamin D ___ UNIT PO DAILY  
9. HELD- Losartan Potassium 50 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until your doctor tells 
you to. 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS: 
Gastroenteritis 
Acute kidney injury 

SECONDARY DIAGNOSIS: 
Cirrhosis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

It was a pleasure to care for you at ___ 
___. 

WHY WERE YOU ADMITTED? 
- You had nausea and vomiting, and your kidneys were dehydrated. 


WHAT HAPPENED IN THE HOSPITAL? 
- You received fluids through the IV and your kidney function 
improved. Your nausea and vomiting resolved. 

WHAT SHOULD YOU DO AT HOME? 
- Take your medications as written. Please do NOT take losartan 
for now. 
- Go to your follow up appointments as scheduled. 
- Weigh yourself daily and call your doctor if weight increases 
by 3lbs or more. 

We wish you the best, 
Your ___ team 
 
Followup Instructions:
___
"
54,12924398,21250196," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Acute Kidney Injury
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ year-old woman with a history of NASH cirrhosis c/b ascites 
on furosemide and spironolactone, history of SBP, and esophageal 
varices, currently on transplant list, who was sent to the ED by 
Dr. ___ her electrolyte check showed ___ -- 
creatinine 1.0 -> 1.7. Other than nausea and poor PO intake in 
the last 24 hours, she has no other symptoms -- no dysuria, 
fevers, chills, diarrhea. She had a recent similar admission for 
___ in the setting of a gastroenteritis, resolved with fluids 
and albumin. She states she has had similar symptoms in the 
past, last aforementioned episode occurring ___ months ago. 

Presentation is most consistent with pre-renal state -- history 
of poor PO intake, tacky mucous membranes on exam. Overnight she 
received her diuretic, and her kidney function worsened. 
 
Past Medical History:
HTN
NIDDMI
Cirrhosis (unknown etiology) c/b esophageal varices and SBP
 
Social History:
___
Family History:
Reviewed and noncontributory.

Mother with hypertension and hyperlipidemia. No known family 
history of gallbladder disease.

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VITALS:
GENERAL: Alert and interactive. In no acute distress.
HEENT: PERRL, EOMI. Sclera anicteric and without injection. MMM.
NECK: No cervical lymphadenopathy. No JVD.
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops.
LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or
rales. No increased work of breathing.
BACK: No CVA tenderness.
ABDOMEN: Normal bowels sounds, mildly distended but nontender to
palpation
EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial 
2+
bilaterally.
SKIN: Warm. Cap refill <2s. No rashes.
NEUROLOGIC: AOx3. Moving all 4 limbs spontaneously. No asterixis
present 

DISCHARGE PHYSICAL EXAM:
===========================
PHYSICAL EXAM:
VS: 24 HR Data (last updated ___ @ 1110) 
Temp: 98.2 (Tm 98.2), BP: 94/58 (94-126/58-76), HR: 94 (90-95),
RR: 16 (___), O2 sat: 99% (95-99), O2 delivery: Ra, Wt: 145
lb/65.77 kg 
GENERAL: NAD
HEENT: AT/NC, anicteric sclera, MMM
NECK: supple, no LAD
CV: RRR, S1/S2, no murmurs, gallops, or rubs
PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
GI: abdomen soft, nondistended, nontender in all quadrants, no
rebound/guarding
EXTREMITIES: no cyanosis, clubbing, or edema
PULSES: 2+ radial pulses bilaterally
NEURO: Alert, moving all 4 extremities with purpose, face
symmetric
DERM: Warm and well perfused, no excoriations or lesions, no
rashes

 
Pertinent Results:
Admission Labs:
=======================
___ 08:00PM   GLUCOSE-160* UREA N-25* CREAT-1.2* SODIUM-137 
POTASSIUM-4.4 CHLORIDE-98 TOTAL CO2-23 ANION GAP-16
___ 08:11AM   LACTATE-1.9
___ 03:06AM   COMMENTS-GREEN TOP
___ 03:06AM   LACTATE-2.9*
___ 03:05AM   ___ PTT-39.3* ___
___ 02:00AM URINE  HOURS-RANDOM
___ 02:00AM URINE  UHOLD-HOLD
___ 02:00AM URINE  COLOR-Yellow APPEAR-Hazy* SP ___
___ 02:00AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-4* PH-5.5 
LEUK-MOD*
___ 02:00AM URINE  RBC-4* WBC-16* BACTERIA-FEW* YEAST-NONE 
EPI-17
___ 02:00AM URINE  HYALINE-34*
___ 02:00AM URINE  MUCOUS-OCC*
___ 10:45PM   GLUCOSE-128* UREA N-30* CREAT-1.7* 
SODIUM-134* POTASSIUM-5.0 CHLORIDE-93* TOTAL CO2-22 ANION 
GAP-19*
___ 10:45PM   ALT(SGPT)-37 AST(SGOT)-62* ALK PHOS-205* TOT 
BILI-1.5
___ 10:45PM   cTropnT-<0.01
___ 10:45PM   ALBUMIN-4.5
___ 10:45PM   WBC-6.3 RBC-4.88 HGB-15.1 HCT-43.9 MCV-90 
MCH-30.9 MCHC-34.4 RDW-13.8 RDWSD-45.1
___ 10:45PM   NEUTS-60.1 ___ MONOS-14.4* EOS-3.0 
BASOS-0.6 IM ___ AbsNeut-3.79 AbsLymp-1.36 AbsMono-0.91* 
AbsEos-0.19 AbsBaso-0.04
___ 10:45PM   PLT COUNT-159
___ 03:20PM   UREA N-31* CREAT-1.4* SODIUM-138 
POTASSIUM-5.6* CHLORIDE-94* TOTAL CO2-22 ANION GAP-22*
___ 03:20PM   estGFR-Using this
___ 03:20PM   ALT(SGPT)-43* AST(SGOT)-67* ALK PHOS-236* TOT 
BILI-1.9*
___ 03:20PM   ALBUMIN-4.9
___ 03:20PM   WBC-6.3 RBC-4.96 HGB-15.1 HCT-46.0* MCV-93 
MCH-30.4 MCHC-32.8 RDW-13.8 RDWSD-46.8*
___ 03:20PM   PLT COUNT-190
___ 03:20PM   ___

Discharge Labs:
============================
___ 07:13AM BLOOD WBC-4.1 RBC-4.30 Hgb-12.9 Hct-38.4 MCV-89 
MCH-30.0 MCHC-33.6 RDW-14.1 RDWSD-45.9 Plt ___
___ 07:26AM BLOOD Glucose-130* UreaN-12 Creat-1.0 Na-141 
K-4.7 Cl-103 HCO3-24 AnGap-14
___ 07:26AM BLOOD ALT-46* AST-92* AlkPhos-186* TotBili-2.6*
___ 07:26AM BLOOD Calcium-10.8* Phos-3.4 Mg-1.9

Micro:
==================
___ 2:00 am URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 

Imaging:
==================
CXR: IMPRESSION:  
No evidence of pneumonia. 

RUQ U/S:
IMPRESSION: 
1. Patent hepatic veins. 
2. Cirrhotic liver morphology without evidence of focal lesions 
or 
intra-abdominal ascites. 

 
Brief Hospital Course:
___ with NASH cirrhosis (MELD 17 on admission, 12 upon 
discharge) c/b prior ascites, esophageal varices, & SBP who came 
in with ___ (Cr 1.7 from baseline 1.0) in the setting of recent 
?gastroenteritis. ___ completely resolved with 75g 25% IV 
albumin challenge. By the time she was admitted her GI 
complaints had resolved as well, and her appetite was back to 
normal. She was monitored for 1 day, and then discharged off of 
her home diuretics, ___ and beta blocker given concern for poor 
renal perfusion I/s/o advanced liver disease. 

TRANSITIONAL ISSUES:
[] Dr. ___: f/u ___ Cr, BUN (and other MELD labs) that the 
patient will get drawn between discharge and liver f/u 
appointment
[] consider whether she needs resumption of Lasix/spironolactone 
later down the road (held for now as above given ___ and 
advanced cirrhosis)
[] stopped losartan I/s/o ___ and advanced cirrhosis (to our 
knowledge no hard cardiac indication to continue) 
[] reduced her home dose of metformin to 250mg BID I/s/o ___, to 
be uptitrated outpatient PRN 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Omeprazole 20 mg PO DAILY 
2. Losartan Potassium 50 mg PO DAILY 
3. Atorvastatin 10 mg PO QPM 
4. Furosemide 40 mg PO DAILY 
5. Spironolactone 100 mg PO DAILY 
6. TraZODone 50 mg PO QHS:PRN sleep 
7. Nadolol 20 mg PO DAILY 
8. MetFORMIN (Glucophage) 500 mg PO BID 
9. Ciprofloxacin HCl 500 mg PO DAILY 

 
Discharge Medications:
1.  MetFORMIN (Glucophage) 250 mg PO BID  
2.  Atorvastatin 10 mg PO QPM  
3.  Ciprofloxacin HCl 500 mg PO DAILY  
4.  Omeprazole 20 mg PO DAILY  
5.  TraZODone 50 mg PO QHS:PRN sleep  
6. HELD- Furosemide 40 mg PO DAILY  This medication was held. Do 
not restart Furosemide until Dr. ___ you to restart
7. HELD- Losartan Potassium 50 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until Dr. ___ 
___ you to restart
8. HELD- Nadolol 20 mg PO DAILY  This medication was held. Do 
not restart Nadolol until Dr. ___ you to restart
9. HELD- Spironolactone 100 mg PO DAILY  This medication was 
held. Do not restart Spironolactone until Dr. ___ 
you to restart
10.Outpatient Lab Work
ICD9 Code: ___ (___)
Please draw: Chem-10, ALT, AST, LDH, Tbili, ___
Please fax results to ___ (ATTN Dr. ___ 
at ___ 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Acute kidney injury
Non-alcoholic steatohepatitis cirrhosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at the ___ 
___.

Why did you come to the hospital?
You saw your outpatient liver doctor and your lab values related 
to your liver and kidneys had changed, so he sent you to the ED 
for treatment.

What did you receive in the hospital?
You were given fluids and albumin to help your liver and 
kidneys. Some of your medications were also stopped temporarily. 
Your labs improved and you felt well. 

What should you do once you leave the hospital?
- Please go to get your blood drawn (at the most convenient 
location to you) on ___ or ___. The results will be faxed 
to your liver doctor, who will call you if he wants you to 
change any medications. 
- Please take your medications as prescribed and go to your 
future appointments which are listed below.

We wish you all the best!
- Your ___ Care Team
 
Followup Instructions:
___
"
55,12924398,25177027," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
None

attach
 
Pertinent Results:
ADMISSION LABS:
===============
___ 11:56AM BLOOD WBC-3.3* RBC-4.15 Hgb-12.2 Hct-37.1 
MCV-89 MCH-29.4 MCHC-32.9 RDW-14.2 RDWSD-46.2 Plt Ct-94*
___ 11:56AM BLOOD Neuts-68.5 Lymphs-15.9* Monos-11.3 
Eos-3.4 Baso-0.6 Im ___ AbsNeut-2.25 AbsLymp-0.52* 
AbsMono-0.37 AbsEos-0.11 AbsBaso-0.02
___ 01:07PM BLOOD ___ PTT-42.0* ___
___ 11:56AM BLOOD Glucose-232* UreaN-9 Creat-0.7 Na-141 
K-4.2 Cl-105 HCO3-22 AnGap-14
___ 11:56AM BLOOD ALT-30 AST-65* AlkPhos-379* TotBili-1.7*
___ 11:56AM BLOOD Albumin-4.0
___ 01:06PM BLOOD Lactate-1.9

DISCHARGE LABS:
===============
___ 07:16AM BLOOD WBC-4.0 RBC-4.13 Hgb-12.4 Hct-37.6 MCV-91 
MCH-30.0 MCHC-33.0 RDW-14.3 RDWSD-47.3* Plt ___
___ 07:16AM BLOOD ___ PTT-42.3* ___
___ 07:16AM BLOOD Glucose-140* UreaN-14 Creat-1.0 Na-138 
K-4.1 Cl-101 HCO3-24 AnGap-13
___ 07:16AM BLOOD ALT-28 AST-54* AlkPhos-307* TotBili-1.9*

IMAGING:
========
Abdominal doppler ___:
IMPRESSION:  
Patent hepatic vasculature with slow flow through the portal 
system. 
Coarsened and nodular liver parenchyma without evidence of focal 
mass. 
Apparent 1.8 x 1.3 x 1.8 cm focal lesion is seen within the 
pancreatic body.  
Recommend MRCP for futher evaluation. 

CXR ___:
IMPRESSION:  
No acute cardiopulmonary abnormality. 

MICROBIOLOGY:
=============
Blood culture ___: No growth
Urine culture ___: No growth
 
Brief Hospital Course:
BRIEF HOSPITAL SUMMARY:
=======================
Ms ___ is a ___ year old woman with NASH cirrhosis (c/b 
varices, SBP), HTN, DM who presents with confusion and tremor 
likely due to hepatic encephalopathy. She was started on 
lactulose and rifaximin and had rapid improvement in symptoms. 
The remainder of her infectious work-up returned negative. She 
was discharged on lactulose and rixamin with ___ with her 
primary gastroenterologist and liver ___ here. 

TRANSITIONAL ISSUES:
====================
[ ] NEW/CHANGED/STOPPED MEDICATIONS
- Started lactulose 30mL PO TID titrate ___ bowel movements 
daily
- Started rifaximin 550mg PO BID
- Held home losartan 50mg PO QD given she has remained 
normotensive off of this

[ ] RUQUS with 1.8 x 1.3 x 1.8 cm focal lesion seen within the 
pancreatic body on RUQUS. Recommend MRCP for further evaluation. 


[ ] ___ blood pressure at PCP ___. If hypertensive 
can consider re-starting losartan as indicated

ACTIVE ISSUES
=============
# Hepatic encephalopathy
Presenting with confusion and tremors, suspect hepatic 
encephalopathy. No clear infectious trigger (no ascites for 
paracentesis seen on RUQUS and on cipro ppx, urinalysis, CXR, 
and blood cultures without evidence of infection). RUQUS without 
evidence of portal vein thrombosis. She did not previously have 
a history of hepatic encephalopathy, and was started on PO 
lactulose in the ED Q2H, which was downtitrated to TID given 
marked improvement in mental status. She was also started on 
rifaximin. 

# Pancreatic body mass
Apparent 1.8 x 1.3 x 1.8 cm focal lesion is seen within the 
pancreatic body on RUQUS. Recommend MRCP for further evaluation 
as an outpatient. 

# ___ cirrhosis c/b esophageal varices, SBP
Admission MELD 10. 
- Volume: continue home furosemide and spironolactone
- Infection: continue cipro for SBP ppx
- Bleeding: grade 2 EV on EGD ___ without high risk 
stigmata. Nadolol has been held since last DC, restarted this 
admission
- Encephalopathy: as above
- Nutrition: low sodium diet

# HTN - Held home losartan given she has remained normotensive 
off of this

# T2DM - Held home metformin, HISS in house

# CODE: Presumed FULL
# CONTACT: ___ 
 Relationship: daughter Phone: ___
 
___ on Admission:
The Preadmission Medication list may be inaccurate and requires 
further investigation.
1. Furosemide 40 mg PO DAILY 
2. Losartan Potassium 50 mg PO DAILY 
3. Nadolol 20 mg PO DAILY 
4. Spironolactone 100 mg PO DAILY 
5. Atorvastatin 10 mg PO QPM 
6. Omeprazole 20 mg PO DAILY 
7. TraZODone 50 mg PO QHS:PRN sleep 
8. MetFORMIN (Glucophage) 250 mg PO BID 
9. Ciprofloxacin HCl 500 mg PO DAILY 

 
Discharge Medications:
1.  Lactulose 30 mL PO TID  
2.  rifAXIMin 550 mg PO BID  
3.  Atorvastatin 10 mg PO QPM  
4.  Ciprofloxacin HCl 500 mg PO DAILY  
5.  Furosemide 40 mg PO DAILY  
6.  MetFORMIN (Glucophage) 250 mg PO BID  
7.  Nadolol 20 mg PO DAILY  
8.  Omeprazole 20 mg PO DAILY  
9.  Spironolactone 100 mg PO DAILY  
10.  TraZODone 50 mg PO QHS:PRN sleep  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
==================
Hepatic encephalopathy
Pancreatic body mass
Nonalcoholic steatohepatitis cirrhosis

SECONDARY DIAGNOSIS:
====================
Hypertension
Type 2 Diabetes Mellitus

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital because you were confused and 
had tremors.

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?
- Yo received a new medication called lactulose that helped 
improve your confusion and tremors.
- You improved and were ready to leave the hospital.

WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?
- Please call your doctor if you feel confused again
- Take all of your medications as prescribed (listed below)
- Keep your follow up appointments with your doctors
- Weigh yourself every morning, before you eat or take your 
medications. Call your doctor if your weight changes by more 
than 3 pounds
- Please stick to a low salt diet and monitor your fluid intake
- If you experience any of the danger signs listed below please 
call your primary care doctor or come to the emergency 
department immediately.

It was a pleasure participating in your care. We wish you the 
best!
- Your ___ Care Team

 
Followup Instructions:
___
"
56,13077594,22574617," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
latex / morphine / Cardene / nitroglycerin
 
Attending: ___.
 
Chief Complaint:
Urosepsis
 
Major Surgical or Invasive Procedure:
Intubation ___
Extubation ___ 
Reintubation ___
Trach/peg ___

 
History of Present Illness:
___ female PMH MI (s/p 2 stents ___, afib, DM2, 
PVD, depression, ?dementia with history of syncope vs. 
seizure-like events ___ years ago several and now 
seizure/convulsions in nursing home, with little history in 
between), anemia, with UTI undergoing treatment at nursing home 
presented to ___ with fever and altered mental 
status, also noted to be ""shaking"" at the nursing home.  

Per daughter, 9 days ago c/o dysuria. Increasingly confused over 
week from b/l of being able to converse fluidly. ___ was 
lethargic, opened eyes to command but would stare blankly, 
couldn't lift right arm all the way.  

At nursing home had a reported ""seizure"" consisting of tremors 
of arms/legs but not tonic-clonic motions (history per daughter 
who was not present). Urine culture ___ grew e. coli (resistant 
to fluoroquinolones, sensitive to CTX) developed a fever to 
102.8 and was started on CTX on ___.  

At ___, she was noted to be ill-appearing, 
diaphoretic and tachycardic. She was intubated for management of 
sepsis and protection of airway, had an IJ placed for poor 
access, and enteric tube placed, CT head/chest/abd/pelvis 
negative for acute pathology (7mm kidney stone noted), seized in 
CT given keppra. Given vanc/zosyn and IV insulin for glucose in 
300's (UA SG 1.038, glu 2+, ketones unavailable). Received 4L 
NS, 100 mg of hydrocortisone. Transferred to ___ ED because 
there were no intensive care beds there. She was hypotensive en 
route and norepi drip was titrated up.  
EKGs showed afib.  
 
In the ED, initial vitals: BP 110/57; HR 105-107 in Afib; sating 
100% on CMV 440/16/5/100%  
Norepi drip was titrated off.  
 
On transfer, vitals were: ___ RR 14 100%  

On arrival to the MICU, she presented as a stably intubated 
patient with lines in place. Exam was as below. She was 
transitioned from versed gtt to propofol gtt; blood pressure 
recovered to MAPs in ___.  

 
Past Medical History:
 afib  
 seizure disorder  
 PVD  
 Diabetes Type 2  
 Hyperlipidemia  
 Hypertension  
 DEPRESSION  
 Seizure  
 syncope  
 DEMENTIA  
 OSTEOPOROSIS  
 anemia  
 Non-ambulatory at baseline  
 Prior MI ___ s/p 2 stents)  
 Carotid stenosis 

 PSH:  
 Cholecystectomy  
 B/l hip replacement and elbow surgery  
 Toe amputation  

 
Social History:
___
Family History:
Father had afib when ___.  
 
Physical Exam:
============================
ADMISSION PHYSICAL EXAM:
============================  
Vitals: T: 99.2 BP:111/53 P:116 R:15 100%  
GENERAL: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
NECK: supple, JVP not elevated, no LAD  
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, protuberant, non-distended, bowel sounds 
present, no rebound tenderness (limited by mental status), no 
organomegaly  
EXT: Cold feet b/l, no pulses appreciated, no clubbing, cyanosis 
or edema  
SKIN: Scar left of midline. Left buttock unstageable ulcer. Mild 
thrush under b/l breasts.  
NEURO: Pupils pinpoint  

============================= 
DISCHARGE PHYSICAL EXAM:
=============================
Vitals: T: 98.4, 81, 140/51, 24, 100% wiith trach
GENERAL: Alert, tracks movements, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
NECK: trach in place, JVP not elevated, no LAD  
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: irregularly irregular, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, protuberant, non-distended, bowel sounds 
present, no rebound tenderness (limited by mental status), no 
organomegaly  
EXT: Cold feet b/l, no pulses appreciated, no clubbing, cyanosis 
or edema  
SKIN: Scar left of midline. Left buttock unstageable ulcer. Mild 
thrush under b/l breasts.  
NEURO: Pupils pinpoint
 
Pertinent Results:
===================
ADMISSION LABS
===================
___ 02:56AM BLOOD WBC-18.6* RBC-2.71* Hgb-8.5* Hct-26.4* 
MCV-97 MCH-31.4 MCHC-32.2 RDW-13.8 RDWSD-49.5* Plt ___
___ 09:10PM BLOOD WBC-19.6* RBC-3.46* Hgb-10.7* Hct-34.8 
MCV-101* MCH-30.9 MCHC-30.7* RDW-14.3 RDWSD-52.9* Plt ___
___ 02:56AM BLOOD Neuts-83.8* Lymphs-9.3* Monos-5.2 
Eos-0.6* Baso-0.2 NRBC-0.2* Im ___ AbsNeut-15.71* 
AbsLymp-1.74 AbsMono-0.97* AbsEos-0.12 AbsBaso-0.03
___ 02:56AM BLOOD ___ PTT-39.2* ___
___ 05:11PM BLOOD Glucose-347* UreaN-37* Creat-1.2* Na-143 
K-3.5 Cl-108 HCO3-26 AnGap-13
___ 09:10PM BLOOD Glucose-245* UreaN-48* Creat-1.4* Na-150* 
K-3.7 Cl-120* HCO3-20* AnGap-14
___ 05:56AM BLOOD ALT-16 AST-15 LD(LDH)-239 AlkPhos-48 
TotBili-<0.2
___ 04:50PM BLOOD CK(CPK)-46
___ 04:50PM BLOOD CK-MB-1 cTropnT-<0.01
___ 05:11PM BLOOD Calcium-7.5* Phos-3.1 Mg-2.2
___ 09:10PM BLOOD Albumin-2.8* Calcium-7.5* Phos-3.0 Mg-1.8
___ 02:56AM BLOOD %HbA1c-7.4* eAG-166*
___ 08:07AM BLOOD TSH-0.39
___ 12:29PM BLOOD Type-ART Rates-/___ Tidal V-375 PEEP-5 
FiO2-40 pO2-167* pCO2-38 pH-7.38 calTCO2-23 Base XS--1 
Intubat-INTUBATED Vent-SPONTANEOU
___ 09:28PM BLOOD Lactate-1.4

===================
PERTINENT LABS
===================
___ 02:20AM BLOOD WBC-20.2* RBC-3.18* Hgb-9.9* Hct-30.7* 
MCV-97 MCH-31.1 MCHC-32.2 RDW-13.7 RDWSD-48.9* Plt ___
___ 03:19AM BLOOD Glucose-175* UreaN-37* Creat-1.1 Na-141 
K-3.7 Cl-96 HCO3-33* AnGap-16
___ 10:11AM BLOOD LD(LDH)-280*
___ 10:11AM BLOOD calTIBC-156* Ferritn-477* TRF-120*
___ 02:56AM BLOOD %HbA1c-7.4* eAG-166*
___ 01:49PM BLOOD Type-CENTRAL VE pO2-38* pCO2-46* pH-7.45 
calTCO2-33* Base XS-6
___ 04:44PM BLOOD ___ pO2-33* pCO2-53* pH-7.49* 
calTCO2-41* Base XS-14
___ 10:20AM BLOOD ___ pO2-31* pCO2-51* pH-7.51* 
calTCO2-42* Base XS-14
___ 09:34PM BLOOD Type-ART pO2-331* pCO2-38 pH-7.33* 
calTCO2-21 Base XS--5
___ 03:50AM BLOOD Glucose-109* Lactate-2.2*
___ 01:49PM BLOOD Lactate-1.4
___ 09:28PM BLOOD Lactate-1.4

========================
DISCHARGE LABS
========================
___ 05:48AM BLOOD WBC-9.2 RBC-2.25* Hgb-7.2* Hct-23.1* 
MCV-103* MCH-32.0 MCHC-31.2* RDW-14.9 RDWSD-55.2* Plt ___
___ 12:15PM BLOOD PTT-72.3*
___ 06:02AM BLOOD ___ PTT-70.5* ___
___ 05:48AM BLOOD Glucose-101* UreaN-35* Creat-0.9 Na-144 
K-3.5 Cl-107 HCO3-25 AnGap-16
___ 05:48AM BLOOD Calcium-8.1* Phos-2.7 Mg-2.2

========================
MICROBIOLOGY
========================
___ STOOL C DIFF: Negative
___ BCX X 2 PENDING
___ UCX   URINE CULTURE (Final ___: NO GROWTH. 
___ MRSA SCREEN (Final ___: POSITIVE FOR METHICILLIN 
RESISTANT STAPH AUREUS. 
___    GRAM STAIN (Final ___: 
      ___ PMNs and >10 epithelial cells/100X field. 
      Gram stain indicates extensive contamination with upper 
respiratory
      secretions. Bacterial culture results are invalid. 
      PLEASE SUBMIT ANOTHER SPECIMEN. 
___ BCX X 2  Blood Culture, Routine (Final ___:    
NO GROWTH. 
___ UCX  URINE CULTURE (Final ___: YEAST.    
>100,000 CFU/mL. 
___ STOOL 
   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 
___   BRONCHIAL LAVAGE. 
Respiratory Viral Culture (Final ___: No respiratory 
viruses isolated. 
   GRAM STAIN (Final ___: 
   1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES. 
   NO MICROORGANISMS SEEN. 
   RESPIRATORY CULTURE (Final ___: 
      ___ CFU/mL Commensal Respiratory Flora. 
   LEGIONELLA CULTURE (Final ___:    NO LEGIONELLA 
ISOLATED. 
   Immunoflourescent test for Pneumocystis jirovecii (carinii) 
(Final
      ___:    NEGATIVE for Pneumocystis jirovecii 
(carinii). 
   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. 
   NOCARDIA CULTURE (Preliminary):    NO NOCARDIA ISOLATED. 
   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. 

___ ENDOTRACHEAL SPUTUM
                             STAPH AUREUS COAG +
                             |   
CLINDAMYCIN-----------       R
ERYTHROMYCIN----------   =>8 R
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------   =>8 R
OXACILLIN-------------   =>4 R
RIFAMPIN-------------- <=0.5 S
TETRACYCLINE----------   <=1 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------     1 S

___ BCX X 2 NGTD.
___ UCX    URINE CULTURE (Final ___: YEAST.    
>100,000 CFU/mL. 
___    Blood Culture, Routine (Final ___: NO GROWTH. 

___ UCX NGTD.
___ BCX X 2 NGTD.

===================
IMAGING
===================
CXR ___: Comparison to ___.  In the interval, 
the patient has received a tracheostomy tube. The nasogastric 
tube was removed.  The right internal jugular vein catheter is 
stable. No complications, notably no pneumothorax.  Otherwise 
unchanged appearance of the heart and the lung parenchyma. 
===
UNILAT UP EXT VEINS ___: PICC line is seen within the 
right basilic vein, which demonstrates nonocclusive thrombus. 
===
___ EEG: IMPRESSION: This is an abnormal continuous ICU 
monitoring study because of (1) occasional-frequent 
bifrontally-predominant sharp waves with a triphasic morphology, 
more prominent during arousals when they can occur in brief runs 
at up to 1 Hz, without evolution. This is consistent with 
generalized cortical Irritability that may be toxic-metabolic in 
etiology. (2) Mild generalized background slowing c/w a mild 
encephalopathy which is nonspecific in etiology and for which 
the most common causes are medication effect, toxic-metabolic 
Disturbance or infection. Note is made of an irregular 
tachycardia throughout much of the study. No pushbutton events 
or electrographic seizures are captured. Compared to the prior 
day's recording, there are no significant changes. 
===
___: CT HEAD WITHOUT CONTRAST 
1. No acute intracranial abnormality. 
2. No evidence acute intracranial hemorrhage. 
3. Paranasal sinus disease as described. 
==== 
___ EEG
IMPRESSION: This is an abnormal continuous ICU monitoring study 
because of 
(1) rare independent left and right temporal sharp waves, 
consistent with 
focal cortical irritability in these regions; (2) slowing and 
disorganization of the background indicative of a mild 
encephalopathy which is nonspecific in etiology and for which 
the most common causes are medication effect, toxic-metabolic 
disturbance or infection. Note is made of an irregular 
tachycardia throughout much of the study. No pushbutton events 
or electrographic seizures are captured. 
===
___ US NECK, SOFT TISSUE
Limited exam demonstrating increased echogenicity of the 
subcutaneous fat, 
compatible with inflammatory change and/or site of IV 
infiltration/hematoma, without evidence of a discrete fluid 
collection. 
===
ECHO ___
Sinus tachycardia. The left ventricular cavity is small. Left 
ventricular systolic function is hyperdynamic (EF>80%). Right 
ventricular chamber size is normal/small with 
normal/hyperdynamic free wall contractility. There is no aortic 
valve stenosis. The mitral valve leaflets are mildly thickened. 
Mild (1+) mitral regurgitation is seen. The left ventricular 
inflow pattern suggests impaired relaxation. 
===
ECHO ___
Sinus tachycardia. The left ventricular cavity is small. Left 
ventricular systolic function is hyperdynamic (EF>80%). Right 
ventricular chamber size is normal/small with 
normal/hyperdynamic free wall contractility. There is no aortic 
valve stenosis. The mitral valve leaflets are mildly thickened. 
Mild (1+) mitral regurgitation is seen. The left ventricular 
inflow pattern suggests impaired relaxation. 
===
___  MR HEAD W & W/O CONTRAST
1. No acute intracranial abnormality including hemorrhage, 
infarct or 
enhancing mass. 
2. No definite epileptogenic focus. 
3. Moderate global atrophy and white matter signal abnormality 
suggestive of chronic small vessel ischemic disease. 
4. Paranasal sinus disease as described. 
===
___ ORBITAL X-RAY   No radio-opaque foreign body is detected 
over the orbits. 
===
___ B/L VENOUS ULTRASOUND No evidence of deep venous thrombosis 
in the right or left lower extremity veins. 
===
___ ECHO The left atrium is normal in size. No atrial septal 
defect is seen by 2D or color Doppler. Left ventricular wall 
thickness, cavity size and regional/global systolic function are 
normal (LVEF >55%). There is no ventricular septal defect. Right 
ventricular chamber size and free wall motion are normal. The 
diameters of aorta at the sinus, ascending and arch levels are 
normal. The aortic valve leaflets (3) are mildly thickened but 
aortic stenosis is not present. No aortic regurgitation is seen. 
The mitral valve appears structurally normal with trivial mitral 
regurgitation. There is no mitral valve prolapse. The estimated 
pulmonary artery systolic pressure is normal. There is a 
trivial/physiologic pericardial effusion. There are no 
echocardiographic signs of tamponade.   
===
___ EEG - This continuous video-EEG monitoring study captured no 
pushbutton activations or electrographic seizures. There were 
occasional multifocal sharp waves, signifying the possibility of 
cortical hyperexcitability and an epileptogenic process. The 
background, which included very frequent and at times 
quasi-periodic triphasic-appearing slow waves, suggested a 
moderate diffuse encephalopathy, which implies widespread 
cerebral dysfunction but is nonspecific as to etiology. Note is 
made of a rapid and irregularly irregular cardiac rhythm. 
===
REPEATED CHEST X-RAYS FOR TUBE PLACEMENT NOTED good tube 
placement and Mild bibasilar atelectasis.
===
___ EEG: This continuous video-EEG monitoring study captured no 
pushbutton 
activations, electrographic seizures, or epileptiform 
discharges. The 
background suggested a mild-moderate diffuse encephalopathy, 
which implies 
widespread cerebral dysfunction but is nonspecific as to 
etiology. Note is 
made of a rapid and irregularly irregular cardiac rhythm. 
===
___ EKG Atrial fibrillation with rapid ventricular response. 
Diffuse ST-T wave abnormalities. No previous tracing available 
for comparison.  
 
Brief Hospital Course:
___ y/o woman with baseline dementia, DM2, and recent seizure 
activity (in context of hypoglycemia) transferred from 
___ with urosepsis and altered mental status. The 
patient was intubated in setting of altered mental status and 
failed extubation due to airway edema. Her hospital course was 
complicated by septic shock and respiratory failure now s/p 
trach/PEG, and new atrial fibrillation.

==================
ACTIVE ISSUES
==================

# Septic shock: On admission, the patient was found to be in 
septic shock, likely secondary to urinary source, with urine 
culture positive for E. coli from outside hospital. She was 
initially on ceftriaxone but was broadened to vancomycin/zosyn 
at OSH. Given that E. coli was sensitive was ceftriaxone, she 
was narrowed to this. However, she began to have persistent 
fevers so was broadened to vancomycin/cefepime. Given her 
altered mental status, cefepime was changed to ceftazidime due 
to concern for cefepime neurotoxicity. She completed a course of 
antibiotics for her urinary tract infection, but again became 
febrile on ___ and was started on vanc/zosyn given unclear 
etiology of fevers. Suspicion was for tracheitis in the setting 
of intubation. Her planned course of vanc/zosyn is 5 days (Last 
day: ___. At time of discharge, patient was afebrile with 
resolving leukocytosis (WBC 9.2) and minimal nonpurulent 
secretions. 

# Altered Mental Status: Patient with dementia at baseline. She 
had seizure-like events ___ years prior to admission. The patient 
had a seizure at the outside hospital while getting a CT scan. 
EEG done during admission showed mild-moderate diffuse 
encephalopathy, which implies widespread cerebral dysfunction 
but is nonspecific as to etiology. The patient had multiple 
repeat EEGs (___) that had 
similar findings. The patient was discharged on Keppra 500 mg 
BID and she should follow up with neurology.

# Respiratory failure: Patient with seizure at OSH while getting 
CT and was intubated for airway protection. She required 
intubation from ___ - ___. She then failed extuation due to 
airway edema on ___ and was reintubated. Patient had a trach 
placed on ___.

# Atrial fibrillation: New onset likely in the setting of septic 
shock. During this admission, patient has had heart rates 
ranging from 100 - 180. During this admission, she was trialed 
on various regimens with metoprolol, amiodarone, diltiazem, and 
digoxin. At time of discharge, patient was stable on metoprolol 
50 mg Q6H and digoxin 125mcg. Amiodarone was discontinued 
because it had little effect on her heart rates, and diltiazem 
was discontinued due to low blood pressures. She was started on 
anticoagulation with heparin gtt with bridge to warfarin, goal 
INR ___.

# Non-occlusive venous thrombosis (RUE): Patient was found to 
have a right upper extremity non-occlusive thrombus in setting 
of PICC line in place for IV antibiotics, last day ___. PICC 
should be discontinued as soon as possible. Patient on 
anticoagulation as above.

# PEG tube: Given altered mental status, a PEG tube was placed 
at the time of tracheostomy. The patient was initiated on tube 
feeds and was tolerating them well at time of discharge.

# DMII: Patient initially with uncontrolled glucose >400. 
Negative ketones on ___ was consulted and recommend 
adjustments to her insulin regimen. The patient was started on 
tube feeds as above. Patient was discharged on Lantus 40 units 
QAM and 12 unit regular insulin Q6H.

====================== 
CHRONIC ISSUES
======================
# CAD: MI in the past with 2 stents in RCA territory. Continued 
on home aspirin 81 mg daily and atorvastatin 20 mg daily.
# Depression: Continued on home duloxetine 30 mg po daily. 
Stopped bupropion 150mg bid given concern for seizures.
# Dementia: Continued on home donepezil 10mg po qhs
# Osteoporosis: Continued vitamin D, calcium, and alendoronate 
sodium 70 mg po.
# Ulcer: Unstageable ulcer of left buttock. Please continue 
wound care. 
# Breast thrush: Nystatin cream/powder. 

=======================
TRANSITIONAL ISSUES
=======================
- Patient to complete 5-day course of vancomycin/Zosyn for 
suspected tracheitis (Last day: ___.
- PICC line should be discontinued as soon as possible when no 
longer needed for intravenous antibiotics and heparin.
- Patient to continue heparin gtt while bridging to warfarin. 
Indication for anticoagulation is atrial fibrillation. Given 
warfarin 2.5 mg on ___. Goal INR ___. Please discontinue 
heparin gtt when therapeutic on warfarin. Next INR to be checked 
___. 
- Patient with new atrial fibrillation with RVR during this 
admission. Patient rate-controlled with metoprolol 50 mg Q6H and 
digoxin 0.125 mg daily. The patient should follow up with 
cardiology for this issue.
- Please convert metoprolol tartrate to succinate 200 mg daily 
beginning on ___. 
- Patient was discharged on Lantus 40 units QAM and 12 unit 
regular insulin Q6H. Please monitor blood sugars closely and 
adjust insulin regimen as appropriate.
- Patient had trach placed on ___. Needs trach sutures 
removed on ___.
- Discontinued home buproprion during this admission due to 
concerns about lowering seizure threshold.
- Patient was started on Keppra 500 mg BID for seizures. Patient 
to follow up with Neurology and discuss continued need for this 
medication.
- Communication: HCP: Daughter ___ 
___  
- Code: Full (MOLST in chart)  
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q4H:PRN pain or elevated temperature 
2. Bisacodyl 10 mg PR QHS:PRN constipation 
3. Fleet Enema ___AILY:PRN constipation 
4. Milk of Magnesia 30 mL PO DAILY:PRN constipation 
5.  Levemir long-acting 28 Units Q12H
6. BuPROPion (Sustained Release) 150 mg PO BID 
7. Alendronate Sodium 70 mg PO QTUES 
8. Fish Oil (Omega 3) 1000 mg PO DAILY 
9. DULoxetine 30 mg PO DAILY 
10. Atenolol 25 mg PO DAILY 
11. Donepezil 10 mg PO QHS 
12. Aspirin 81 mg PO DAILY 
13. Nystatin Cream 1 Appl TP BID 
14. Vitamin D ___ UNIT PO DAILY 
15. MetFORMIN (Glucophage) 500 mg PO Q5PM 
16. MetFORMIN (Glucophage) 1000 mg PO Q8AM 
17. Calcium Carbonate 1250 mg PO BID 
18. Metoclopramide 5 mg PO TID W/MEALS 
19. LORazepam 0.25 mg IV ONCE:PRN seizure 

 
Discharge Medications:
1.  Digoxin 0.125 mg PO DAILY  
2.  Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol  
3.  Glucose Gel 15 g PO PRN hypoglycemia protocol  
4.  Heparin IV per Weight-Based Dosing Protocol
Indication: Atrial Fibrillation
Start infusion with bolus of: 6200 units IVP
Start infusion with rate of: 1400 units/hr
Therapeutic/Target PTT Range: 60 - 99.9 seconds
Start: Today - ___, First Dose: 1700 hrs 
Bridge to warfarin. Goal INR ___. Stop heparin when INR 
therapeutic.  
5.  LevETIRAcetam 500 mg PO BID  
6.  Metoprolol Tartrate 50 mg PO Q6H  
7.  Piperacillin-Tazobactam 4.5 g IV Q8H 
Last day: ___  
8.  Vancomycin 1000 mg IV Q 24H 
Last day: ___.  Glargine 40 Units Breakfast<br> Regular 12 Units Q6H
Insulin SC Sliding Scale using REG Insulin 
10.  Acetaminophen 650 mg PO Q4H:PRN pain or elevated 
temperature  
11.  Alendronate Sodium 70 mg PO QTUES  
12.  Aspirin 81 mg PO DAILY  
13.  Calcium Carbonate 1250 mg PO BID  
14.  Donepezil 10 mg PO QHS  
15.  DULoxetine 30 mg PO DAILY  
16.  Nystatin Cream 1 Appl TP BID  
17.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___ 
 
Discharge Diagnosis:
Primary diagnosis
==================
- Septic shock
- Respiratory failure

Secondary diagnoses
===================
- Atrial fibrillation
- Dementia
- Hyperglycemia
- Non-occlusive venous thrombosis
- Coronary artery disease
- Depression

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Alert and tracking movements.
Activity Status: Bedbound.

 
Discharge Instructions:
Ms. ___,

You were admitted for your infection that lowered your blood 
pressure. You also needed a breathing tube and machine to help 
with your breathing, however, because your airway swelled you 
had to be transitioned to a tracheotomy, a surgical procedure 
that involved making an incision in your neck and connecting a 
tube to allow you to breathe. You also were given a feeding 
tube. You were started on medicines to control your heart rate, 
antibiotics to control your infection, and insulin for your 
diabetes.

Please continue the medications at rehabilitation and follow-up 
with your cardiologist and neurologist. 

We wish you the best of health.

Sincerely,
Your ___ Team
 
Followup Instructions:
___
"
57,13077594,23517691," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
latex / morphine / Cardene / nitroglycerin
 
Attending: ___.
 
Chief Complaint:
Bleeding around trach site
 
Major Surgical or Invasive Procedure:
___ bronchoscopy with airway cleaning: no source of bleed 
was detected from lower tract or even upper tract before stoma

 
History of Present Illness:
___ y/o woman with baseline dementia, DM2, and seizure activity 
(in context of hypoglycemia) and new Afib with recent admission 
for septic shock with trach/PEG in the setting of respiratory 
failure. Pt deemed stable at time of discharge but re-admitted 
for concerns of bleeding at the site of tracheotomy and new 
leukocytosis WBC > 18.

In the ED, initial vitals: 97.9 94 139/89 18 100% RA, WBC > 18. 
Pt seen by respiratory therapy noted that bleeding appears to be 
from OP site not from lower pulm tree, changed I.C. and added 
humidity. IP recommended CTA neck. Pt admitted to MICU for plan 
to ___. On arrival to MICU, T: 97.9, HR: 83, BP: 146/73, RR: 
18 SO2: 100%.  Patient was mildly interactive, with daughter at 
bedside. Trach site looks C/D/I with sutures in place, balloon 
deflated, slight blood tinged sputum w/ suction. Continued on 
trach mask, broad spectrum abx, foley and rectal tube. 
 
ROS: As per HPI.
 
Past Medical History:
 afib  
 seizure disorder  
 PVD  
 Diabetes Type 2  
 Hyperlipidemia  
 Hypertension  
 DEPRESSION  
 Seizure  
 syncope  
 DEMENTIA  
 OSTEOPOROSIS  
 anemia  
 Non-ambulatory at baseline  
 Prior MI ___ s/p 2 stents)  
 Carotid stenosis 

 PSH:  
 Cholecystectomy  
 B/l hip replacement and elbow surgery  
 Toe amputation  

 
Social History:
___
Family History:
Father had afib when ___.  
 
Physical Exam:
ADMISSION PHYSICAL EXAM
========================
Vitals: T: 97.9, HR: 83, BP: 146/73, RR: 18 SO2: 100%.  
GENERAL: Alert, tracks movements, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
NECK: trach in place (blood around trach), JVP not elevated, no 
LAD  
LUNGS: Scaterred rhonchi, L>R, no wheezes, rales  
CV: irregularly irregular, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: hyperactive bowel sounds. soft, non-tender, protuberant, 
non-distended, no rebound tenderness, no organomegaly, PEG site 
C/D/I 
EXT: UE cool and dry, no clubbing, cyanosis or edema  
SKIN: Scar left of midline. Left buttock unstageable ulcer. Mild 

thrush under b/l breasts.  
NEURO: PERRL

DISCHARGE PHYSICAL EXAM
========================
T: 98.2 HR: 90 BP: 146/52  RR 14 SO2: 100% on 45% trach mask
GENERAL:  NAD, follows commands, intermittently interactive, 
sitting in chair w/ foley, flexiseal and trach mask in place
HEENT:  tracheostomy site is c/d/I w/ sutures in place, no 
bloody secretion with suction, L neck hematoma (from 10 days 
prior) slightly smaller in size
PULM: upper lobes rhonchorous and diminished at the bases 
otherwise CTAB, no wheezes, rales, crackles; moderate secretions 
with strong cough
CV:  irregular rhythm, rate normal, +s1s2 no m/r/g
ABD:  BS, no tenderness to palpation
EXT: warm well perfused, no peripheral edema, no clubbing, 
cyanosis
SKIN: pressure ulcers on coccyx, ___

 
Pertinent Results:
ADMISSION LABS
====================
___ 05:48AM   WBC-9.2 RBC-2.25* HGB-7.2* HCT-23.1* MCV-103* 
MCH-32.0 MCHC-31.2* RDW-14.9 RDWSD-55.2*
___ 05:48AM   GLUCOSE-101* UREA N-35* CREAT-0.9 SODIUM-144 
POTASSIUM-3.5 CHLORIDE-107 TOTAL CO2-25 ANION GAP-16
___ 05:48AM   CALCIUM-8.1* PHOSPHATE-2.7 MAGNESIUM-2.2
___ 05:48AM   VANCO-22.4*
___ 05:14PM URINE  RBC-39* WBC->182* BACTERIA-FEW 
YEAST-NONE EPI-0
___ 05:14PM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-600 
GLUCOSE-70 KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-LG

MICROBIOLOGY
===================
___: URINE CULTURE (Final ___: NO GROWTH. 
___: BLOOD CULTURES: No growth to date.

IMAGING/STUDIES
====================
CTA neck w/wo contrast (___): IMPRESSION:
1. Status post tracheostomy placement with no evidence of 
arterial injury. 
===
chest x-ray (___):  IMPRESSION:  Cardiomediastinal 
contours are unchanged.  Bibasilar atelectasis are larger on  
the right side.  Tracheostomy tube is in standard position.  
Left PICC tip is in the upper to mid SVC.  There is no evident 
pneumothorax.  If any there is small right effusion 
===
___ Bronchoscopy with airway cleaning: no source of bleed
was detected from lower tract or even upper tract before stoma
========================
DISCHARGE LABS
========================
WBC: 6.9  HgB: 7.1  Hct: 22.6  Plt: 126
Na: 142  K: 4.0  Cl: 106  HCO3: 30 BUN: 27  Crt: 0.8  Glucose: 
162
Ca: 8.7  Mg: 2.1 P: 3.___ y/o woman with baseline dementia, DM2, and seizure activity, 
new Afib with recent admission for septic shock with trach/PEG 
in the setting of respiratory failure now with concerns of 
bleeding at the site of tracheotomy. Bronchoscopy failed to 
identify endobronchial source of bleeding, in discussion of 
risks and benefits with family anti-coagulation for atrial 
fibrillation will be held until ___ to allow proper wound 
healing.  At that time, anti-coagulation should be resumed, and 
Mrs. ___ should be ___ for possible de-cannulation.

ACTIVE ISSUES
=================
#tracheostomy complication: initial presented with bleeding from 
tracheostomy site. She remained hemodynamically stable and 
required no transfusion. Of note she has a stable hematoma on 
the left side of her neck which remained unchanged this 
admission. Bronchoscopy did not show endobronchial source for 
bleed. Bleeding resolved with holding of anticoagulation 
(heparin as a bridge to warfarin), which will continue to be 
held until ___.

#respiratory failure: status post tracheostomy tube placement 
placed ___. While in the ___ ICU she completed an eight 
day course of vancomycin and zosyn for presumed tracheitis. 

#altered mental status: baseline dementia and seizure disorder 
managed with keppra 500 mg BID. She had seizure-like events ___ 
years prior to admission. On prior admission, patient had 
multiple repeat EEGs (___) with 
no new findings, pt last discharged on Keppra 500 mg BID. Pt 
continued on keppra 500 mg bid.

# Atrial fibrillation: New onset likely in the setting of septic 

shock on previous admission. Rate controlled on metoprolol 50mg 
q6hrs and digoxin 0.125mg qday. CHADS-Vasc of 8, heparin drip 
and warfarin have been held given recurrent tracheal bleed until 
___. Family is aware of the risks and benefits of holding 
treatment to allow proper wound healing.

# Non-occlusive venous thrombosis (RUE): Patient was found to 
have a right upper extremity non-occlusive thrombus in setting 
of PICC line in place for IV antibiotics. This PICC line was 
removed ___, a new left PICC was put in place ___ with 
confirmed placement by CXR. 

# PEG tube: Given altered mental status, a PEG tube was placed 
at the time of tracheostomy. The patient was initiated on tube 
feeds last admission. Pt continued on tube feeds rectal tube in 
place given increased output with tube feeds. 

CHRONIC ISSUES
=================
#Diabetes Mellitus Type 2: Blood sugars well-controlled on 
Lantus 4 units QAM and aspart 6 units Q6H. Patient cannot 
receive Humalog as this contains Latex and she has a latex 
allergy.
#CAD: MI in the past with 2 stents in RCA territory. Continued 
on home aspirin 81 mg daily and atorvastatin 20 mg daily.
#Depression: Continued on home duloxetine 30 mg po daily. 
Stopped bupropion 150mg bid given concern for seizures.
#Dementia: Continued on home donepezil 10mg po qhs
#Osteoporosis: Continued vitamin D, calcium, and alendoronate 
sodium 70 mg po.
#Ulcer: Unstageable ulcer of left buttock. Please continue wound 
care. 
#Breast thrush: Nystatin cream/powder. 

TRANSITIONAL ISSUES
======================
#tracheostomy: follow-up with interventional pulmonology team to 
evaluate possible de-cannulation after ___. Sutures 
should be removed ___. 
#atrial fibrillation: long-term anticoagulation for atrial 
fibrillation should be resumed on ___. The current plan is 
for heparin drip to bridge to warfarin therapy with a goal INR 
of 2.0-3.0. Last routine dose of warfarin for Mrs. ___ was 
2.5mg.
#atrial fibrillation: please convert metoprolol tartrate to 
succinate 200 mg daily 
beginning on ___. 
#PICC line should be discontinued as soon as possible when no 
longer needed.
#seizure prophylaxis: Patient was started on Keppra 500 mg BID 
for seizures. Patient 
to follow up with Neurology and discuss continued need for this 
medication.
#diabetes mellitus type 2: Mrs. ___ blood sugar has been 
well-controlled on current regimen. Please continue to monitor 
her blood sugar.
#Communication: HCP: Daughter ___ 
___  
#Code: Full (MOLST in chart)
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Digoxin 0.125 mg PO DAILY 
2. Heparin IV Sliding Scale
Indication: Atrial Fibrillation
Start infusion with bolus of: 6200 units IVP
Start infusion with rate of: 1400 units/hr
Therapeutic/Target PTT Range: 60 - 99.9 seconds
Start: ___, First Dose: 2300 hrs 
3. LevETIRAcetam 500 mg PO BID 
4. Metoprolol Tartrate 50 mg PO Q6H 
5. Piperacillin-Tazobactam 4.5 g IV Q8H 
6. Vancomycin 1000 mg IV Q 24H 
7. Glargine 40 Units Breakfast<br> Regular 12 Units Q6H
Insulin SC Sliding Scale using HUM Insulin
8. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild 
9. Alendronate Sodium 70 mg PO QTUES 
10. Aspirin 81 mg PO DAILY 
11. Calcium Carbonate 1250 mg PO BID 
12. Donepezil 10 mg PO QHS 
13. DULoxetine 30 mg PO DAILY 
14. Nystatin Cream 1 Appl TP BID 
15. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol  
2.  Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol  
3.  Glucose Gel 15 g PO PRN hypoglycemia protocol  
4.  Heparin 5000 UNIT SC BID  
5.  Glargine 40 Units Breakfast<br> Aspart 6 Units Q6H 
6.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild  
7.  Alendronate Sodium 70 mg PO QTUES  
8.  Aspirin 81 mg PO DAILY  
9.  Calcium Carbonate 1250 mg PO BID  
10.  Digoxin 0.125 mg PO DAILY  
11.  Donepezil 10 mg PO QHS  
12.  DULoxetine 30 mg PO DAILY  
13.  LevETIRAcetam 500 mg PO BID  
14.  Metoprolol Tartrate 50 mg PO Q6H  
15.  Nystatin Cream 1 Appl TP BID  
16.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
- Tracheostomy complication
- Atrial fibrillation

SECONDARY DIAGNOSES:
- Diabetes Mellitus

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted with bleeding from your tracheostomy site. We 
stopped your blood thinners (heparin and warfarin) until 
___.  It will be important to restart these medications 
for your atrial fibrillation.  Additionally, you will follow-up 
with interventional pulmonology to evaluate whether the 
tracheostomy tube can be discontinued or changed then.

We wish you the best of health,
Your ___ Team
 
Followup Instructions:
___
"
58,13077594,24274249," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
latex / morphine / Cardene / nitroglycerin
 
Attending: ___
 
___ Complaint:
Acute renal failure
 
Major Surgical or Invasive Procedure:
Midline placement ___

 
History of Present Illness:
___ w/ PMHx atrial fibrillation, seizure disorder, congestive 
heart failure with reduced EF (though last ECHO in our system 
normal in ___, recent hospitalizations for urosepsis and ___, 
and dementia who presents with a complaint of altered mental 
status. Patient presents as transfer from ___ after 
transferred from her nursing home facility where she was noted 
to have steadily declining mental status described as decreased 
responsiveness, increased lethargy over the ___ hours prior to 
transfer. No reported fevers or respiratory symptoms, and the 
patient was otherwise in her USOH. There was also reports of 
approximately 45 minutes of ""intermittent twitching"" in her arms 
and legs which were interpreted as seizure activity. She was 
then brought into ___ for further evaluation.

 

At outside hospital she had a NCHCT and CXR which were 
reportedly unremarkable. She was started on empiric vanc/zosyn 
prior to transfer. She was then transferred to ___ for ICU 
admission as her labs were notable for acute renal failure with 
a creatinine of 4.68, elevated phosphorus of 7.2 elevated 
magnesium and hyperkalemia of 8.4 without associated EKG 
changes. She was given 1 g of calcium to transfer. Lactate at 
OSH was 3.5. She also had a L IJ placed at OSH prior to transfer 
and was given ___ of IVF. Patient is full code. 

 

Patient notably w/ dementia at baseline but apparently is able 
to carry on a conversation. Lives at a nursing facility.

 

ROS otherwise negative

 

In ED initial VS: 98.8 93 115/61 22 98% RA 

 

Exam notable for: 

Labs significant for: H/H 9.2/30.2, WBC 32.7 (N:82 Band:1 L:7 
M:9 E:0 ___ Metas: 1 Absneut: 27.14 Abslymp: 2.29 Absmono: 
2.94 Abseos: 0.00 Absbaso: 0.00), plt 312

Na 149, K 7.3, Bicarb 10, BUN 123, Cr 4.3

Coags wnl

Trop-T 0.05, CK 115, MB 4

Lactate 4.7

Dig: 2.3

UA: Cloudy, large leuks, mod blood, neg nitr, 100 prot, 10 ket, 
35 RBC, >182 WBCs, many bacteria, 4 epis

 

Nephrology consulted in the ED due to acute renal failure.

 

Patient was given 1g of keppra in ED due to history of seizures. 
Due to elevated K of 7.3 was given insulin, dextrose, and 
calcium gluconate. Just after being given 
insulin/dextrose/calcium gluconate, patient's eyes were seen to 
roll to the back of her head. She was noted to be asystolic on 
the monitor. Given chest compressions for ___ seconds (10 
seconds per RN note) and able to achieve ROSC.

 

EKG showing aVR elevation and diffuse lateral ST depressions 
that were seen to be worsening on serial EKG. Cardiology 
consulted.

 

On arrival to the MICU, the patient was moving all of her 
extremities spontaneously and able to verbalize being in 
discomfort.  

 
Past Medical History:
 afib  
 seizure disorder  
 PVD  
 Diabetes Type 2  
 Hyperlipidemia  
 Hypertension  
 DEPRESSION  
 Seizure  
 syncope  
 DEMENTIA  
 OSTEOPOROSIS  
 anemia  
 Non-ambulatory at baseline  
 Prior MI ___ s/p 2 stents)  
 Carotid stenosis 

 PSH:  
 Cholecystectomy  
 B/l hip replacement and elbow surgery  
 Toe amputation  

 
Social History:
___
Family History:
Father had afib when ___ yo.  
 
Physical Exam:
ADMISSION PHYSICAL EXAM
===================== 
VITALS: 
GENERAL: Uncomfortable, ill-appearing elderly F. Verbalizes 
discomfort during the majority of the exam but unable to 
localize  
HEENT: Opens eyes to voice, PEERL, mucous membranes dry 
NECK: Supple, JVP not elevated, no LAD  
LUNGS: Decreased breath sounds throughout  
CV: Tachycardic, regular rate, no m/r/g, anterior chest wall TTP 
 
ABD: Soft, diffuse TTP, BS+ 
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema    
NEURO: AAOx0, opens eyes to voice and sternal rub, moving 
extremities spontaneously 

DISCHARGE PHYSICAL EXAM
===================== 
VS: 98.1 85 ___ ra
GENERAL: Ill-appearing elderly woman. NAD
HEENT: Opens eyes to voice and painful stimuli, mucous membranes 
dry, no facial droop 
NECK: Supple, JVP not elevated 
LUNGS: Decreased breath sounds throughout  
CV: RRR, no m/r/g, anterior chest wall TTP  
ABD: Soft, diffuse TTP, BS+ 
EXT: Warm, well perfused, 2+ pulses, mottling present in 
bilateral feet 
NEURO: unable to assess orientation as not speaking, opens eyes 
to voice and sternal rub, moving extremities spontaneously  

 
Pertinent Results:
ADMISSION LABS
============= 
___ 10:13AM BLOOD WBC-32.7* RBC-2.62* Hgb-9.2* Hct-30.2* 
MCV-115* MCH-35.1* MCHC-30.5* RDW-17.2* RDWSD-73.0* Plt ___
___ 10:13AM BLOOD Neuts-82* Bands-1 Lymphs-7* Monos-9 Eos-0 
Baso-0 ___ Metas-1* Myelos-0 AbsNeut-27.14* AbsLymp-2.29 
AbsMono-2.94* AbsEos-0.00* AbsBaso-0.00*
___ 10:13AM BLOOD Hypochr-NORMAL Anisocy-1+* Poiklo-2+* 
Macrocy-3+* Microcy-NORMAL Polychr-1+* Burr-2+*
___ 10:13AM BLOOD ___ PTT-33.0 ___
___ 10:13AM BLOOD Glucose-131* UreaN-123* Creat-4.3*# 
Na-149* K-7.3* Cl-108 HCO3-10* AnGap-31*
___ 10:13AM BLOOD ALT-6 AST-15 CK(CPK)-115 AlkPhos-124* 
TotBili-0.5
___ 10:13AM BLOOD Lipase-55
___ 10:13AM BLOOD CK-MB-4
___ 10:13AM BLOOD cTropnT-0.05*
___ 10:13AM BLOOD Albumin-3.2* Calcium-9.5 Phos-7.5* 
Mg-3.7*
___ 10:13AM BLOOD Digoxin-2.3*
___ 02:19PM BLOOD ___ pO2-37* pCO2-42 pH-7.21* 
calTCO2-18* Base XS--11
___ 10:28AM BLOOD Lactate-4.7*
___ 02:19PM BLOOD O2 Sat-64
___ 07:54PM BLOOD freeCa-1.18
___ 11:21AM BLOOD LEVETIRACETAM  LEVEL   50.3   mcg/mL

DISCHARGE LABS
==============
___ 07:14AM BLOOD WBC-5.6 RBC-2.56* Hgb-8.6* Hct-25.9* 
MCV-101* MCH-33.6* MCHC-33.2 RDW-19.3* RDWSD-70.9* Plt Ct-90*
___ 03:21AM BLOOD ___ PTT-56.9* ___
___ 03:21AM BLOOD Glucose-152* UreaN-21* Creat-0.9 Na-145 
K-3.0* Cl-107 HCO3-27 AnGap-11
___ 03:21AM BLOOD Calcium-7.2* Phos-2.0* Mg-1.9

MICRO
=====
___ 11:21 am URINE  CATHETER. 
                            **FINAL REPORT ___
   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH FECAL
      CONTAMINATION.

___ 3:18 pm STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 
                            **FINAL REPORT ___
   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Cepheid nucleic 
acid
      amplification assay.. 
           (Reference Range-Negative). 

Wound culture: ***pending
Fecal culture: **** pending
Ova/Parasites: *** pending

IMAGING
=======

+ CXR (___)
Left IJ approach central venous catheter tip projects over the 
mid SVC.  There
is no pneumothorax.  The lungs are clear.  There is no 
consolidation or
effusion.  Cardiomediastinal silhouette is within normal limits. 
 Dense
atherosclerotic calcifications noted in the thoracic aorta.  
Rounded opacity
projecting over left upper quadrant may represent a PEG tube.  
Surgical clips
in the right upper quadrant.

+ PELVIS AP (___)
No acute fracture.

+ RENAL US (___)
Normal renal ultrasound.  No evidence of hydronephrosis.

+ ECHO (___)
CONCLUSIONS
The left atrium is normal in size. No atrial septal defect is 
seen by 2D or color Doppler. The estimated right atrial pressure 
is ___ mmHg. Left ventricular wall thicknesses and cavity size 
are normal. Left ventricular systolic function is hyperdynamic 
(EF>75%). There is a mild resting left ventricular outflow tract 
obstruction (22 mmHg at HR 96). Right ventricular chamber size 
and free wall motion are normal. There is abnormal septal 
motion/position. The aortic valve leaflets are mildly thickened 
(?#). No aortic regurgitation is seen. The mitral valve leaflets 
are structurally normal. There is no mitral valve prolapse. 
There is severe mitral annular calcification. The study is 
inadequate to exclude significant mitral valve stenosis though 
demonstrates flow acceleration across the mitral valve 
consistent with at least mild functional stenosis. Trivial 
mitral regurgitation is seen. [Due to acoustic shadowing, the 
severity of mitral regurgitation may be significantly 
UNDERestimated.] There is mild pulmonary artery systolic 
hypertension. There is a trivial/physiologic pericardial 
effusion. 

IMPRESSION: Normal left ventricular wall thickness, cavity size, 
and hyperdynamic regional/global systolic function. Mild left 
ventricular outflow tract obstruction. Aortic regurgitation and 
mitral stenosis likely present (not well quantified on current 
study). Mild pulmonary artery systolic hypertension.

Compared with the prior study (images reviewed) of ___, 
there is now a mild left ventricular outflow tract gradient 
during systole. 

+ CXR (___)
Compared to chest radiographs since ___ most recently ___.
Lung volumes are substantially lower.  New peribronchial 
opacification in the
left lower lobe is more likely atelectasis than pneumonia.  The 
upper lungs
are clear.  No pleural abnormality.  Heart size normal.  Left 
jugular line
ends in the mid SVC, as before.

+ G-TUBE CHECK (___)
A percutaneous gastrostomy tube is present and is adequately 
positioned with
no evidence of extravasated contrast material.

+ EEG (___)
This is an abnormal continuous EEG monitoring study because of
(1) posterior quadrant discharges (L>R), indicative of focal 
areas of cortical
irritability with increased propensity to develop electrographic 
seizures. (2)
Diffuse background slowing with periods of generalized 
suppressions are
consistent with a moderate to severe encephalopathy. This is a 
nonspecific
finding in regards to etiology but can be seen in the setting of
toxic/metabolic derangements, infection or medications. There 
are no
electrographic seizures. Compared to the previous day's 
recording, there is a
significant improvement in the background with much less 
frequent epileptiform
discharges/triphasic appearing waveforms.

 
Brief Hospital Course:
BRIEF SUMMARY STATEMENT:
=============================
___ w/ Afib, seizure disorder, systolic CHF, and dementia, who 
presented with altered mental status, had a cardiac arrest in 
the ED, and was admitted to the ICU for post-arrest management. 
Course was complicated by UTI and acute renal failure, and she 
improved with fluids and antibiotics. Code status changed to 
DNR/DNI. 

ACTIVE ISSUES:
=============================
# CARDIAC ARREST: Patient had transient episode of asystole in 
the ED after getting calcium gluconate/insulin/dextrose for 
hyperkalemia. ROSC achieved after brief (around 10 seconds) of 
chest compressions. Unclear precipitant but concerning 
elevations in aVR and depressions in lateral leads on EKG. 
Cardiac enzymes reassuringly negative. Long pause vs asystole 
potentially from calcium gluconate infusion in the setting of 
elevated dig level. Patient w/ known CAD and documented stents 
in RCA territory. EKG changes potentially demand in the setting 
of being hyperdynamic due to hypovolemia and infected. She was 
closely monitored on telemetry, and remained hemodynamically 
stable throughout rest of hospitalization. 

# URINARY TRACT INFECTION: Patient presented w/o documented 
fevers but with leukocytosis w/ neutrophilic predominance and UA 
suggestive of infection. CXR w/o acute process. LFTs wnl. No 
imaging evidence of pyelonephritis. Chronic ulcers to coccyx and 
___ as potential sources of infection.  New G-tube oozing at 
site, cultured- growing ___ albicans. IP adjusted 
bumper. Afebrile. She was thought to have a UTI, and was started 
initially on Vanc/Zosyn, and Vanc was stopped on ___. 
Vancomycin should continue for 7day course, to end on ___. 

# ___: Patient presented w/ Cr elevated to 4.3 and BUN 123 w/ 
anion gap metabolic acidosis and several electrolyte 
abnormalities including K of 7.3 prior to treatment. Initially 
oliguric.  UA c/w UTI and reportedly from daughter has been 
hospitalized from sepsis w/ urinary origin in the recent past 
resulting in some degree of chronic kidney damage. Electrolytes 
and kidney function improved with fluid resuscitation and 
pressors. Renal US without evidence of obstruction. K now 
normalized. At discharge, Cr was 0.9.
 
CHRONIC ISSUES: 
=============================
# HISTORY OF SEIZURES: Patient w/ baseline dementia but 
reportedly able to participate in conversations w/ family. About 
___ hours of noted increasing lethargy at her facility. NCHCT 
reassuringly w/o acute intracranial abnormality and non-focal 
neuro exam. She has multiple sources of potential toxic 
metabolic encephalopathy due to her presumed infection and acute 
renal failure. EEG with significant posterior predominant 
epileptiform discharges and triphasics. Improved with addition 
of phenytoin, which was discontinued prior to discharge. At 
discharge, she was stable on Keppra 1000mg POBID.

# Atrial fibrillation: Initially required levophed and was 
tachycardic to 110s on this. Rates have been in ___ off 
Levophed. Her digoxin was initially held in setting of ___, and 
was stopped. Her Metoprolol was also stopped due to soft blood 
pressures 
 
# Goals of care: Per patients daughter/HCP, patient has had 
repeated hospitalizations over the past year with more time 
spent in the hospital than outside of it. Code status changed to 
DNR/DNI on ___. Palliative care was consulted. 

TRANSITIONAL ISSUES: 
=============================
[ ] Complete 7-day course of Zosyn, to end on ___
[ ] Consider restarting metoprolol if HR persistently >120
[ ] platelets were ___ at discharge. 
[ ] Code status: changed to DNR/DNI 

MEDICATION CHANGES
HELD MEDICATIONS - please restart if needed. 
Docusate Sodium 100 mg PO BID 
Donepezil 10 mg PO QHS  
Ferrous Sulfate 325 mg PO DAILY 
Gabapentin 100 mg PO TID  
Gemfibrozil 600 mg PO BID  
Magnesium Oxide 400 mg PO DAILY  
Ranitidine 300 mg PO DAILY  
TraZODone 12.5 mg PO QHS:PRN insomnia 
metoprolol
Dixoxin  

NEW Medications/Orders Physician ___ 
___ ___ DROP BOTH EYES PRN eye dryness 
Nystatin Cream 1 Appl TP BID  
Piperacillin-Tazobactam  To end on ___  

CHANGED Medications/Orders Physician ___ 
___ SC Sliding Scale Insulin SC - LANTUS WAS STOPPED 
LevETIRAcetam 1000 mg PO Q12H  - DOSE WAS INCREASED

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Donepezil 10 mg PO QHS 
2. Gemfibrozil 600 mg PO BID 
3. Ranitidine 300 mg PO DAILY 
4. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild 
5. Docusate Sodium 100 mg PO BID 
6. Ferrous Sulfate 325 mg PO DAILY 
7. Digoxin 0.125 mg PO DAILY 
8. Magnesium Oxide 400 mg PO DAILY 
9. Vitamin D 1000 UNIT PO DAILY 
10. LevETIRAcetam 500 mg PO DAILY 
11. Metoprolol Tartrate 25 mg PO BID 
12. TraZODone 12.5 mg PO QHS:PRN insomnia 
13. Gabapentin 100 mg PO TID 
14. Glargine 10 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
15. LevETIRAcetam 250 mg PO QHS 
16. OxyCODONE (Immediate Release) 5 mg PO Q12H:PRN BREAKTHROUGH 
PAIN 

 
Discharge Medications:
1.  Artificial Tears ___ DROP BOTH EYES PRN eye dryness  
2.  Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line 
flush  
3.  Nystatin Cream 1 Appl TP BID  
4.  Piperacillin-Tazobactam 4.5 g IV Q8H 
end ___.  Sodium Chloride 0.9%  Flush ___ mL IV Q8H and PRN, line 
flush  
6.  Insulin SC 
      Sliding Scale
Insulin SC Sliding Scale using HUM Insulin 
7.  LevETIRAcetam 1000 mg PO Q12H  
8.  Acetaminophen 325 mg PO Q6H:PRN Pain - Mild  
9.  OxyCODONE (Immediate Release) 5 mg PO Q12H:PRN BREAKTHROUGH 
PAIN 
RX *oxycodone 5 mg 1 tablet(s) by mouth q12 hours prn Disp #*20 
Tablet Refills:*0 
10.  Vitamin D 1000 UNIT PO DAILY  
11. HELD- Digoxin 0.125 mg PO DAILY  This medication was held. 
Do not restart Digoxin until your doctor tells you to 
12. HELD- Docusate Sodium 100 mg PO BID  This medication was 
held. Do not restart Docusate Sodium until your doctor tells you 
to
13. HELD- Donepezil 10 mg PO QHS  This medication was held. Do 
not restart Donepezil until your doctor tells you to
14. HELD- Ferrous Sulfate 325 mg PO DAILY  This medication was 
held. Do not restart Ferrous Sulfate until your doctor tells you 
to
15. HELD- Gabapentin 100 mg PO TID  This medication was held. Do 
not restart Gabapentin until your doctor tells you to
16. HELD- Gemfibrozil 600 mg PO BID  This medication was held. 
Do not restart Gemfibrozil until your doctor tells you to
17. HELD- Magnesium Oxide 400 mg PO DAILY  This medication was 
held. Do not restart Magnesium Oxide until your doctor tells you 
to
18. HELD- Metoprolol Tartrate 25 mg PO BID  This medication was 
held. Do not restart Metoprolol Tartrate until your doctor tells 
you to 
19. HELD- Ranitidine 300 mg PO DAILY  This medication was held. 
Do not restart Ranitidine until your doctor tells you to
20. HELD- TraZODone 12.5 mg PO QHS:PRN insomnia  This medication 
was held. Do not restart TraZODone until your doctor tells you 
to

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
- Cardiac arrest

SECONDARY DIAGNOSES
- acute kidney injury
- toxic metabolic encephalopathy
- seizure disorder 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms ___,

It was a pleasure taking care of you.

Why was I admitted to the hospital?
- You were confused
- Your heart stopped beating 

What happened in the hospital?
- You received fluids and antibiotics to treat your infection
- Your mental status improved

What will happen when I leave the hospital?
- Take all of your medicines as prescribed
- Alert your doctors and ___ if you have any fevers, pain not 
controlled by your medicines, or any other symptoms concerning 
to you 

We wish you all the best in the future.

Sincerely,
Your ___ Care Team 

 
Followup Instructions:
___
"
59,13157375,24855226," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PSYCHIATRY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
 ""I fought to get out.""
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ name: ___ is a ___ F  with a PMHx
significant for self-reported OCD, PTSD, anxiety, depression,
?EtOH Use Disorder, hypothyroidism, multiple prior psychiatric
hospitalizations (most recent ___ ___ and overdose on
trazodone (took 4 tabs ___ presenting to the ED w/
hypothermia after being in the ___ at arrival of
285; psychiatry is consulted to assess for suicidality.

Ms. ___ states that today she was standing in shallow 
water
on a boat launch on the ___ performing
mindfulness activities when she was suddenly swept away by the
current.  She denies intentionally entering the water and states
she was ""scared as shit"" and ""fought to get out"".   She is not
able to recall a clear timeline of her time in the water, which 

she attributes appropriately to confusion in the setting of
hypothermia, but states she was rescued when she approached a
kayaker who summoned EMS.  Ms ___ denies adamantly that
this was a suicide attempt, denies ongoing suicidal ideation and
denies prior suicide attempts.  Ms ___ does report a
history of one prior overdose on 4 tabs of 50 mg trazodone that
occurred in ___.  She reports that this overdose was
accidental and occurred in the setting of her taking extra
medication to fall asleep in the middle of the afternoon after
her husband told her that he wanted a divorce.  She endorses
being found sleeping on her living room floor by her best friend
who called EMS giving her groggy and disoriented behavior.  She
states that she had been told that it was safe to take extra
pills when first prescribed the medication and did not believe
that the 4 tablets she had taken were a danger to herself.  She
denies looking up safe dosing before taking the medication, but
denies medication overuse/misuse since that time and reports she
continues to take Trazodone 50 mg QHS appropriately since that
time.  She states she received psychoeducation at ___ regarding
following the directions of her prescription medications and 
that
she underwent an 7 day outpatient program follow-up.  Patient
states that she ""lives for her son"" and adamantly denies that 
she
would ever attempt suicide.   

Ms ___ describes multiple ongoing psychosocial stressors
including most notably an ongoing divorce from her husband of ___
years who she describes as ""mean"" and notes he often ""puts her
down"" and notes a long-history of controlling behaviors 
including
stating that she has been cut off from her biologic family since
their marriage.  She notes he often criticized her for ""not 
doing
enough"" when she was at home taking care of her child.  He was
resentful that he was working full-time and was not coming home
to a ""prepared meal and a dressed-up wife"". Her mother-in-law is
also ""mean"" and told her to ""just get over it"" when she was
struggling with postpartum depression.  She describes her most
recent hospitalization as precipitated by an argument with her
husband when she states he was ""pestering and criticizing"" her
while she was chopping cucumbers in the kitchen.  She notes that
she became fed up with his criticisms and entered the bedroom to
carrying the knife she was chopping the cucumbers with.  She
states that her husband entered the bedroom and discovered the
knife under a pillow in bed and moved out of their shared house
with her son that day.  She does not provide a clear explanation
for why she placed the knife under the pillow, but adamantly
states she had no violent intent.  She denies any thoughts of
hurting herself or her baby. She was ""struggling so much"",
""didn't feel like [her]self"", and just ""wanted to hear that [she
is] not a loser.""  She notes that two days into her most recent
hospitalization at ___ ___ (8 days voluntary), she was
served divorce papers by her husband and that they quickly
settled a custody agreement.  She notes he had sought out legal
counsel in the weeks before though she notes satisfaction with
the current agreement notably she does not spend overnights with
her child and only sees him 4 days per week.  She later in the
interview describes her husband as ""taking his hurt out on 
[her]""
and states ""it's killing me"".  She also notes recently 
connecting
with her own biologic family after being separated and only
seeing them on major holidays over the last ___ years and the
recent suicide of a friend that she met in an intensive
outpatient program in ___.

Ms ___ endorses ongoing depression For the past few weeks,
Ms. ___ endorses ""crying all the time,"" having low energy,
feeling ""scattered"" and not having an appetite and high levels 
of
guilt surrounding her divorce and describes herself as ""falling
apart"" and ""having a lot of anxiety"". She denies SI and SA. When
asked if she has plans for the future, patient says that she
plans to get her own apartment in ___, continue her
schooling in early education, and continue her work for ___.  Her goal is to ""be okay with her new normal."" She
requests to be discharged on the basis that she feels safe 
living
at home w/ her parents ___ and ___ w/ whom she gets along
""fine"".  She enjoys spending time w/ her son and watching reruns
of ""The Office"".   Notably though she continues to note high
levels of distress as described above.

Patient denies AVH, alcohol or substance use.

___ (friend of ___ years) ___

father ___, mother (___) ___,
___ ___

Father, sister, and mother at bedside after interview.  Dr.
___ plan of care and they were in agreement. 
Father reported when told recommendation for inpatient 
psychiatry
""we know she needs this""

 
Past Medical History:
PAST PSYCHIATRIC HISTORY:
Dx: Anxiety ___ years), OCD (dx age ___, PTSD (24 - ___ year after
date rape), Depression ___ yo, post-partum depression ___
Hospitalizations: 2 prior ___ ___ (8 day voluntary),
___ (age ___
Current treaters and treatment: ___ in ___, ___
-- therapist ___ ext. ___ (meets weekly ___ 3 pm), Dr.
___: once a month at ___, reports case
manager ___ at ___ 
Medication and ECT trials: Prozac ___ years after PTSD - 
helpful),
Paxil (new med), Trazodone, Ativan, Abilify, Risperdal, Lexapro
Self-injury/Suicide attempts: Denies 
Harm to others: Denies 
Access to weapons: Denies access to weapons, including denies
access to guns, endorses kitchen knives at home
Trauma: patient reports being date-raped at age ___ resulting in
PTSD; denies TBI

PAST MEDICAL HISTORY:
hypothyroidism
depression
anxiety
PTSD

MEDICATIONS:
Pharmacy ___, ___ Pharmacy called by Dr. ___, confirmed meds as ___:
Quetiapine 25 mg PO BID PRN anxiety 
Quetiapine 50 mg PO QHS 
Vistaril 25 mg PO BID (___) 
Levothyroxine 25 mcg PO QAM (___)
Desipramine 25 mg PO QHS (___) 

___ Previous Meds Trials:
Valcyclovir (___)
Fluoxetine (___)
escitalopram (___) 

Patient reported current meds: Paxil, Ativan, Trazodone and
Hydroxyzine
Paxil ___ no record)
Ativan  ___ no record) 
Trazodone ___ tab ___

ALLERGIES: 
NKDA 

 
Social History:
SUBSTANCE ABUSE HISTORY:
drinks 3 glasses of wine a week, BAL 285 at presentation; denies
any use illicits or cigarettes.

FORENSIC HISTORY:
Arrests: DUI in ___ (patient states that she was walking
on slippery ice and was mistaken to be tipsy) 
Convictions and jail terms: denies

SOCIAL HISTORY:
___
Family History:
FAMILY PSYCHIATRIC HISTORY:
None known

 
Physical Exam:
EXAM: 
*VS:  BP:  121/81 HR: 121 temp: 97.8  resp: 20 O2 sat: 95% RA   
 
Neurological:  
 *station and gait: not assessed 
 *tone and strength: Patient moves all 4 extremities
symmetrically, full apparent strength
 cranial nerves: CN II-XII grossly normal 
 abnormal movements: no tics, tremors, evidence of EPS
 frontal release: not assessed 

Cognition: 
  Wakefulness/alertness: awake and alert
  *Attention (digit span, MOYB): able to spell ""EARTH"" backwards
with ease
  *Orientation: oriented to place (___), person, and time
(___)
  Executive function (go-no go, Luria, trails, FAS): able to
follow three-step command
  *Memory:  was able to immediately recall and recall after 5
minutes the 3 words easily. 
  *Fund of knowledge:  able to name current and previous
president easily. 
  Calculations:  able to calculate quarters in $1.25 easily.
  Abstraction: able to describe similarities between apple and
orange easily (""round"" and ""has skin"")
  Visuospatial: not assessed
  *Speech: normal tone, prosody, volume and rate. 
  *Language: fluent. no paraphasic errors. 
 
Mental Status:
 *Appearance:  NAD, age-appearing female, dressed in hospital
gown, reclined in bed w/ two boxes of tissues, mildly 
disheveled.
  Behavior: cooperative, friendly, engaged, normal eye contact.
  *Mood and Affect: mood is ""ok""; affect is not congruent w/
mood; patient is frequently tearful and dysphoric. 
  *Thought process / *associations:  linear, coherent,
goal-oriented.
  *Thought Content: preoccupied w/ the ongoing divorce w/ her
husband
  *Judgment and ___:  poor/fair

 
Pertinent Results:
___ 09:05PM   GLUCOSE-92 UREA N-9 CREAT-0.8 SODIUM-134 
POTASSIUM-4.5 CHLORIDE-98 TOTAL CO2-28 ANION GAP-13
___ 09:05PM   CALCIUM-9.5 PHOSPHATE-2.7 MAGNESIUM-1.9
___ 09:05PM   TSH-6.1*
___ 09:05PM   FREE T4-1.1
___ 09:05PM   WBC-5.3 RBC-3.77* HGB-12.3 HCT-36.6 MCV-97 
MCH-32.6* MCHC-33.6 RDW-12.6 RDWSD-45.2
___ 09:05PM   NEUTS-59.6 ___ MONOS-16.5* EOS-1.7 
BASOS-0.8 IM ___ AbsNeut-3.18# AbsLymp-1.13* AbsMono-0.88* 
AbsEos-0.09 AbsBaso-0.04
___ 09:05PM   PLT COUNT-214
___ 05:22PM   GLUCOSE-111* UREA N-7 CREAT-0.7 SODIUM-140 
POTASSIUM-4.2 CHLORIDE-103 TOTAL CO2-19* ANION GAP-22*
___ 05:22PM   estGFR-Using this
___ 05:22PM   CK(CPK)-143
___ 05:22PM   CALCIUM-8.6 PHOSPHATE-2.9 MAGNESIUM-2.0
___ 05:22PM   ASA-NEG ___ ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 05:22PM URINE  HOURS-RANDOM
___ 05:22PM URINE  UCG-NEGATIVE
___ 05:22PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG
___ 05:22PM   WBC-10.5* RBC-4.24 HGB-13.9 HCT-40.5 MCV-96 
MCH-32.8* MCHC-34.3 RDW-12.6 RDWSD-44.0
___ 05:22PM   NEUTS-87.8* LYMPHS-6.9* MONOS-4.2* EOS-0.1* 
BASOS-0.4 IM ___ AbsNeut-9.24* AbsLymp-0.72* AbsMono-0.44 
AbsEos-0.01* AbsBaso-0.04
___ 05:22PM   PLT COUNT-217
___ 05:22PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 05:22PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 
LEUK-NEG
 
Brief Hospital Course:
1. LEGAL & SAFETY:  
On admission, the patient signed a conditional voluntary 
agreement (Section 10 & 11) and remained on that level 
throughout her admission. She was also placed on 15 minute 
checks, our lowest checks status, and remained on that level of 
observation throughout her stay, while being unit-restricted.  

2. PSYCHIATRIC:
#) Major depressive disorder: 
On arrival to the unit, patient was tearful and endorsed 
""depressed"" mood with labile affect. She did state that she was 
having suicidal thoughts about the ""world being better off 
without me"" before getting into the ___ water, and that then 
the tide swept her away. Stated that she was very happy to have 
survived, but that she was struggling with guilt surrounding 
hurting her husband and child. Also expressed remorse 
surrounding the idea of losing custody of her child. She was 
accepting of care, and able to contract for safety while on the 
unit. Denied any acute suicidal ideation, intent, or plan. 
Stated that in the past the medication that had worked the best 
for her was Prozac. She was maintained on trazodone 50mg PO QHS 
for sleep.
During her stay, her home Paxil was downtitrated and Prozac was 
started and uptitrated. She was increased to Prozac 20mg PO QD. 
Additionally, she was started on Depakote for possible 
hypomania. She was increased to Depakote 500 mg QHS. She 
reported improvement in mood, as well as increased ability to 
cope with her circumstances. Patient and her family were very 
pleased and relieved to have a diagnosis of bipolar II disorder 
as they strongly believe her past problematic behavior is 
accurately explained by this condition. At the time of 
discharge, ___ was attending groups, was interactive in 
the milieu, and was able to participate in individual therapy. 

On discharge, patient reports ""better"" mood, has euthymic 
affect, and denies any suicidal thought, intent, or plan. She is 
future-oriented, with plan to attend intensive outpatient 
program and live at her parents' house before trying to go back 
to work. She will be discharged to home on Prozac 20 mg PO QD, 
trazodone 50mg PO QHs and Depakote 500 mg QHS.

3. SUBSTANCE USE DISORDERS:
#)Alcohol use disorder: 
Patient arrived to the ED with BAL 285, reported that she drank 
a pint of vodka prior to going into the ___. She was kept on a 
CIWA scale for withdrawal while on the inpatient unit, though 
she did not score. She reports a history of binge drinking, and 
states that she attended AA meetings a few times in the past, 
though not recently. She did attend AA and Smart Recovery while 
here on the unit. Was referred to both outpatient, and states 
that she plans to attend.

4. MEDICAL
#) Anion gap acidosis: Patient arrived to the ___ with an 
anion gap acidosis on serum testing, likely in setting of recent 
alcohol use. This resolved with conservative management in the 
ED. 

#) Hypothyroidism: Patient with TSH of 6.1 on admission to the 
inpatient unit. Her home Synthroid was increased to 50mcg PO QD. 
It is possible that hypothyroidism could have contributed in 
part to her mood episode.

5. PSYCHOSOCIAL
#) GROUPS/MILIEU:  
The patient was encouraged to participate in the various groups 
and milieu therapy opportunities offered by the unit.  The 
patients primary team met with her daily and various 
psychotherapeutic modalities were utilized during those times. 
She was increasingly able to engage in groups and therapy during 
her stay, as her mood and emotional lability improved. 

#) COLLATERAL CONTACTS & FAMILY INVOLVEMENT
A family meeting was held with the patient's mother, ___ 
___. The patient reported not wanting to be a part of 
this meeting, as she felt that it would agitate her further. 

#) INTERVENTIONS
- Medications: Prozac
- Psychotherapeutic Interventions: Individual, group, and milieu 
therapy.
- Coordination of aftercare: Intensive outpatient program

INFORMED CONSENT: The team discussed the indications for, 
intended benefits of, and possible side effects and risks of 
starting this medication, and risks and benefits of possible 
alternatives, including not taking the medication, with this 
patient.   We discussed the patient's right to decide whether to 
take this medication as well as the importance of the patient's 
actively participating in the treatment and discussing any  
questions about medications with the treatment team, and I  
answered the patient's questions.  The patient appeared able to 
understand and consented to begin the medication.

RISK ASSESSMENT
On presentation, the patient was evaluated and felt to be at an 
increased risk of harm to herself and/or others based upon 
attempted suicide attempt by drowning in the ___. 
Their static factors noted at that time include history of 
suicide attempts, chronic mental illness, history of substance 
abuse, Caucasian race, age, marital status.  She also had 
several modifiable risk factors addressed at that time, 
including disorganized and unpredictable behavior, hopelessness, 
agitation, recklessness, social withdrawal, limited coping 
skills, no established outpatient treatment, and active 
substance abuse. We addressed these risk factors by restarting 
her on Prozac, holding a family meeting, and connecting her with 
outpatient treaters and an intensive outpatient program. 
Finally, the patient is being discharged with many protective 
risk factors, including help-seeking nature, future-oriented 
viewpoint, sense of responsibility to family, lack of suicidal 
ideation, and family support. Overall, based on the totality of 
our assessment at this time, the patient is not at an acutely 
elevated risk of self-harm nor danger to others. Our prognosis 
of this patient is fair, given the above.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Levothyroxine Sodium 25 mcg PO QAM 
2. PARoxetine 40 mg PO QHS 
3. TraZODone 50 mg PO QHS 
4. HydrOXYzine 25 mg PO BID 

 
Discharge Medications:
1. HydrOXYzine 25 mg PO Q4H:PRN anxiety 
RX *hydroxyzine HCl 25 mg 1 tab by mouth q4hr Disp #*28 Tablet 
Refills:*0
2. Levothyroxine Sodium 50 mcg PO DAILY 
3. TraZODone 50 mg PO QHS 
RX *trazodone 50 mg 1 tablet(s) by mouth at bedtime Disp #*7 
Tablet Refills:*0
4. Divalproex (DELayed Release) 500 mg PO QHS 
RX *divalproex [Depakote] 500 mg 1 tablet(s) by mouth at bedtime 
Disp #*30 Tablet Refills:*0
5. FLUoxetine 20 mg PO DAILY 
RX *fluoxetine 20 mg 1 capsule(s) by mouth daily Disp #*30 
Capsule Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Unspecified bipolar disorder 
Alcohol use disorder

 
Discharge Condition:
Objective:
    Exam:
    *VS:  BP: 118/78 HR: 82 T 98.1 RR: 20 O2 sat: 100% RA

  Neurological:
    *Station and gait: walks with feet slightly pronated at
baseline, normal gait
    *Tone and strength: within normal limits
    *Appearance: Middle aged Caucasian woman appearing stated
age, wearing her own clothing
  Behavior: Cooperative with interview, with good eye contact.
Speaks at loud volume at fast rate. 
  *Mood and Affect: 'better,' affect is euthymic
  *Thought process: linear, goal directed. No flight of ideas
noted. Intrusive thoughts are noted. 
  *Thought Content: Denies current SI, HI, denies AVH. 
  *Judgment and Insight: fair/fair 

  Cognition:
    *Attention, *orientation, and executive function: AAOx3
    *Memory: grossly WNL
    *Fund of knowledge: appears average
    *Speech: normal rate, volume, prosody
    *Language: fluent ___

 
Discharge Instructions:
-Please follow up with all outpatient appointments as listed - 
take this discharge paperwork to your appointments.
-Please continue all medications as directed.
-Please avoid abusing alcohol and any drugs--whether 
prescription drugs or illegal drugs--as this can further worsen 
your medical and psychiatric illnesses.
-Please contact your outpatient psychiatrist or other providers 
if you have any concerns.
-Please call ___ or go to your nearest emergency room if you 
feel unsafe in any way and are unable to immediately reach your 
health care providers.

*It was a pleasure to have worked with you, and we wish you the 
best of health.*

 
Followup Instructions:
___
"
60,13158370,22356177," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROSURGERY
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Loss of conciousness, bi-temporal hemianopsia with total 
blindness to right eye
 
Major Surgical or Invasive Procedure:
Attmpted coiling of A-Comm aneurysm
Clipping of A-Comm Aneursym
Multiple cerebral angiograms 
Placement of External ventricular drain
Removal of external ventricular drain

 
History of Present Illness:
Ms. ___ is a ___ yo RH F w/ no significant PMH who was
transferred from an OSH for evaluation of a SAH found on CT. 10
days prior to presentation, she developed an abrupt onset severe
headache. She was also nauseated, vomited and had photophobia.
She waited for 3 days but her symptoms did not improve so she
went to see her PCP. She states that she was sent home and so 
she
decided to take Motrin 800mg around the clock. Her symptoms did 
not improve
therefore she went back to see her physician ___ ___. She
was given a prescription for an analgesic per her report and was
driving to the pharmacy when she had a surge of pain followed by
LOC. Her next memory is being found by EMS who took her to an
OSH. There she was found to have a SAH and transferred here for
further evaluation.

In the ED here, she was initially able to see from both eyes but
then noted loss of vision in her R eye as well as ""blurry"" 
vision
in her L eye. When these symptoms presented she was emergently
taken to CT and CTA which showed a aneurysm of the anterior
circulation with bleeding. 
 
Past Medical History:
PMH:
per OMR s/p cholecystectomy, common bile duct exploration

 
Social History:
___
Family History:
FH:
-Grandmother: DM, HTN
-Grandfather: MI

 
 

 
Physical ___:
ON ARRIVAL 

O: T: 98.9 BP: 138/79   HR: 10    R 14       O2Sats 100% RA
Gen: WD/WN, comfortable, NAD.
HEENT: Pupils: 1.5mm bilaterally  EOMI initially, then CNIII
partial palsy on L
Neck: mild nuchal rigidity
Lungs: CTA bilaterally.
Cardiac: RRR. S1/S2.
Abd: Soft, NT, BS+
Extrem: Warm and well-perfused.
Neuro:
Mental status: Awake and alert, cooperative with exam, normal
affect. Orientation: Oriented to person, place, and date.
Language: Speech fluent with good comprehension and repetition.
No dysarthria or paraphasic errors (per translator)

Cranial Nerves:
I: Not tested
___: Pupils equally round and reactive to light, to 1.5
mm bilaterally. R eye total blindness even to light
III, IV, VI: Extraocular movements intact bilaterally without
nystagmus initially, however later she had decreased R eye
adduction
V, VII: Facial strength and sensation intact and symmetric.
VIII: Hearing intact to voice.
IX, X: Palatal elevation symmetrical.
XI: Sternocleidomastoid and trapezius normal bilaterally.
XII: Tongue midline without fasciculations.

Motor: Normal bulk and tone bilaterally. No abnormal movements,
tremors. Strength full power ___ throughout. No pronator drift

Sensation: Intact to light touch

Reflexes: B T Br Pa Ac
Right     ___  2  1 
Left      ___  2  1

Toes downgoing bilaterally

ON DISCHARGE:

Awake alert and oriented x 3 
CN ___ intact except for right eye= completely blind, left 
eye with temporal hemionopsia, right pupil non reactive.  Speech 
clear, no facial asymmetry, no drift, motor full, sensation 
grossly intact.

 
 

 
Pertinent Results:
CT HEAD W/O CONTRAST  ___ 9:06 AM

CT HEAD W/O CONTRAST

Reason: Assess size of ventricles 

UNDERLYING MEDICAL CONDITION:
___ year old woman with ___ evd clamped 
REASON FOR THIS EXAMINATION:
Assess size of ventricles 
CONTRAINDICATIONS for IV CONTRAST: None.

HEAD CT

HISTORY: ___ woman with subarachnoid hemorrhage with 
ventricular drain clamped, assess for change in size of 
ventricles.

TECHNIQUE: Contiguous axial images of the head were obtained 
from the skull base to the vertex.

FINDINGS: Comparison is made to ___.

Again seen is a ventricular shunt via left frontal approach with 
tip of the catheter within the region of the right foramen of 
___. The ventricles are re-expanded bilaterally, and there has 
also been decrease in size of the right extra-axial fluid 
collection as well as improved edema of the right frontal and 
basal ganglial infarcts. Therefore, the increase in size of the 
ventricles likely is due to decreased mass effect with 
improvement in the subfalcine herniation as opposed to clamping 
of the ventricular shunt.

Again seen is a small hypodensity along the ventricular shunt 
tract involving the left frontal lobe as before.

The basal cisterns, especially the quadrigeminal plate and 
ambient cisterns are better visualized suggestive of improved 
edema.

Tiny amounts of pneumocephalus are again seen.

Coil pack is again seen within the anterior communicating artery 
aneurysm.

Post-surgical changes of the right scalp are again noted.

IMPRESSION: Since ___, decrease in size of right extra-axial 
collection and decreased edema of the right basal 
ganglia/frontal lobe infarct, with improvement in the subfalcine 
herniation and improvement in mass effect of the lateral 
ventricles.

The basal cisterns are better visualized suggestive of improved 
cerebral edema.

CHEST (PORTABLE AP)  ___ 8:48 AM

CHEST (PORTABLE AP)

Reason: eval CVL position 

UNDERLYING MEDICAL CONDITION:
___ year old woman with possible inadvertent withdrawal of CVL, 
meds appear to be collecting subcutaneously 
REASON FOR THIS EXAMINATION:
eval CVL position 
INDICATION: ___ female with possible inadvertent 
withdrawal of central venous line.

COMPARISON: ___.

SINGLE PORTABLE UPRIGHT CHEST RADIOGRAPH: The right subclavian 
catheter has been pulled back and now resides projecting over 
the right subclavian vein. There is no pneumothorax. The 
cardiomediastinal silhouette is stable and unremarkable and the 
lungs are clear.

CTA HEAD W&W/O C & RECONS  ___ 9:45 AM

CTA HEAD W&W/O C & RECONS; CT BRAIN PERFUSION

Reason: ** CTA/CTP** as per Dr. ___ 
Contrast: OPTIRAY

UNDERLYING MEDICAL CONDITION:
___ year old woman with acom SAH, s/p clipping 
REASON FOR THIS EXAMINATION:
** CTA/CTP** as per Dr. ___ 
CONTRAINDICATIONS for IV CONTRAST: None.

INDICATION: ___ status post ACom clipping.

COMPARISON: CT perfusion ___.

TECHNIQUE: Continuous axial images of the brain were obtained 
before and following administration of 100 cc IV Optiray 
contrast. Multiplanar MIP and volume-rendered CTA reformats were 
displayed. Mean transit time blood flow and blood volume were 
assessed by dynamic imaging.

FINDINGS:

NON-CONTRAST HEAD CT: ACom aneurysm clip with associated 
metallic artifact is noted. Again seen is a hypoattenuating area 
within the right temporal and inferior frontal lobe consistent 
with evolving infarct. There is also expanding and increasingly 
conspicuous hypoattenuation within the right basal caudate, 
putamen, and internal capsule consistent with new/progressive 
infarction of this region. High-density right extra-axial fluid 
collection with small locules of air is unchanged measuring 13 
mm in greatest diameter. There is slightly increased mass effect 
on the subjacent sulci and increasing transtentorial and 
subfalcine herniation with leftward midline shift of 8 mm, 
previously 7 mm. Left ventriculostomy catheter terminates within 
the left lateral ventricle at the midline and the ventricles are 
stable in size. There is worsening effacement of the suprasellar 
and ambient cisterns consistent with increasing mass effect. The 
13-mm subgaleal fluid collection overlying the right frontal 
craniotomy is stable.

CTA OF THE HEAD: The cervical portions of the carotid arteries, 
vertebral arteries, and basilar artery are patent. There is 
improved opacification in the circle of ___ and its major 
branches. Specifically, there is marked improvement of vasospasm 
involving the distal right M1 and right M2 segments of the MCA. 
There is improvement in vasospasm of the A1 segments bilaterally 
(right greater than left) though the right A1 segment still 
shows moderate vasospasm. The A2 segments bilaterally also 
demonstrate markedly improved caliber. The left MCA and its 
branches are unremarkable. The bilateral PCA arteries are also 
unremarkable.

CT PERFUSION: There is patchy perfusion abnormality with 
decreased blood volume in the bilateral temporal lobes and also 
right frontal lobe, which likely relate to vasospasm.

IMPRESSION:

1. New/progressive infarction within the right basal ganglia.

2. Increasing mass effect and transtentorial herniation with 
worsening effacement of the suprasellar and ambient cisterns.

3. Improving vasospasm within the right MCA, and bilateral A1 
and A2 segments of the ACA. There is, however, persistent 
moderate vasospasm within the A1 segments, in close proximty to 
the ACOM aneurysm clip.

Findings were discussed with the neurosurgical team at 5:00 p.m. 
on
 ___.

___ TRANSCATH THERAPY  ___ 12:15 ___

Reason: ? Vasospasm 
Contrast: OPTIRAY

UNDERLYING MEDICAL CONDITION:
___ year old woman with ACA s/p clipping POD7 
REASON FOR THIS EXAMINATION:
? Vasospasm 
TYPE OF STUDY: Left common carotid arteriogram, left internal 
carotid arteriogram, left vertebral arteriogram, right common 
carotid arteriogram, and right internal carotid arteriogram.

STAFF: Dr. ___.

FELLOW: Dr. ___.

Dr. ___ attending interventional neuroradiologist, was 
present and supervised throughout the procedure.

INDICATION: ___ female status post surgical clipping of 
an anterior communicating artery aneurysm, now post-operative 
day number seven. Rule out vasospasm.

COMPARISON: ___.

TECHNIQUE: Written informed consent was obtained from the 
patient's daughter after discussing the indications for the 
procedure, the risks of the procedure, and the alternative 
management. The discussed risks include stroke, loss of vision 
and/or speech which may be temporary or permanent, with possible 
treatment with stents and/or coils if needed. Additionally the 
indications, risks, and alternative management for possible 
intervention was explained.

The patient was brought to the interventional neuroradiology 
suite and placed on the biplane table in the supine position. 
Both groins were prepped and draped in the usual sterile 
fashion. A pre-procedure timeout was performed using two patient 
identifiers and verifying the procedure to be performed.

Access to the right common femoral artery was obtained using a 
19-gauge single-wall needle with 1% lidocaine mixed with sodium 
bicarbonate for local anesthetic. A 0.35 ___ wire was 
introduced through the needle, and the needle was removed. A 5 
___ vascular sheath was placed over the wire and connected to 
a saline infusion (mixed with heparin 500 units in 500 cc of 
saline) with a continuous drip. Through the sheath, a 4 ___ 
___ catheter was introduced and connected to a continuous 
saline infusion (mixed with heparin 1000 units in 1000 cc of 
saline). The following vessels were selectively catheterized, 
and arteriograms were performed from the following locations: 
Right common carotid artery, right internal carotid artery, left 
vertebral artery, left common carotid artery, and left internal 
carotid artery. After review of the study, the catheter and the 
sheath were withdrawn. Hemostasis was achieved using manual 
compression. The patient tolerated the procedure well without 
any immediate post-procedure complications.

FINDINGS:

RIGHT COMMON CAROTID ARTERY: The bifurcation is normal. There is 
no evidence of a vascular malformation.

RIGHT INTERNAL CAROTID ARTERY: The cervical, petrous, cavernous, 
and supraclinoid segments of the internal carotid artery are 
normal. There is a surgical clip identified in the region of the 
anterior communicating artery with no residual aneurysm 
identified. There is mild stenosis of the M1 segment of the 
middle cerebral artery and moderate stenosis of the M2 middle 
cerebral artery branches. Additionally there is moderate 
stenosis of the A1 segment of the anterior cerebral artery with 
a focus of luminal irregularity in its proximal portion. There 
is decreased parenchymal phase blood flow identified within the 
right anterior watershed vascular distribution.

At this point, the decision was made for an intervention. 5 mg 
of verapamil was gently infused selectively into the right 
internal carotid artery over 1 minute. A right internal carotid 
artery angiogram was then repeated at approximately 10 minutes 
after the infusion of verapamil which demonstrated residual 
mild-to-moderate narrowing of the right A1 segment of the 
anterior cerebral artery, and right M1 and M2 segments of the 
middle cerebral artery.

LEFT VERTEBRAL ARTERY: The left vertebral artery and the left 
posterior inferior cerebellar artery appear unremarkable. There 
is no reflux identified into the right vertebral artery. The 
basilar artery appears unremarkable.

5 mg of verapamil was gently infused selectively into the left 
vertebral artery over ___AROTID ARTERY: The bifurcation is normal. There is 
no vascular malformation.

LEFT INTERNAL CAROTID ARTERY: The cervical, petrous, cavernous, 
and supraclinoid segments of the left internal carotid artery 
are normal. There is mild narrowing of the A1 segment of the 
left anterior cerebral artery. The left middle cerebral artery 
as well as its major branches appear unremarkable. A surgical 
clip is identified in the region of the anterior communicating 
artery with no residual aneurysm seen.

5 mg of verapamil was gently infused selectively into the left 
internal carotid artery over 1 minute. A post-infusion angiogram 
the left internal carotid artery demonstrates mild narrowing of 
the A1 segment of the anterior cerebral artery.

MODERATE SEDATION: 100 mcg of intravenous Fentanyl and 4 mg of 
intravenous Versed were administered in divided doses by a 
registered nurse, who was monitoring the patient throughout the 
2 hour and 15 minute intraservice time. Please refer to the 
nursing record for further detail.

IMPRESSION:
1. Status post surgical clipping of an anterior communicating 
aneurysm with no residual aneurysm identified.

2. Moderate narrowing of the right M1 and M2 segments of the 
middle cerebral artery and right A1 anterior cerebral artery, 
and mild narrowing of the left A1 segment of the anterior 
cerebral artery consistent with vasospasm. 5 mg of verapamil was 
selectively infused into the right internal carotid, left 
vertebral, and left internal carotid arteries for a total of 15 
mg of verapamil. Post- infusion angiogram demonstrated residual 
mild-to- moderate narrowing of the right M1 and M2 segments of 
the middle cerebral artery and right A1 segment of the anterior 
cerebral artery and residual mild narrowing of the A1 segment of 
the anterior cerebral artery.

Cardiology Report ECG Study Date of ___  1:55:18 ___ 
 
  
Artifact is present. Sinus rhythm. The P-R interval is short 
without evidence 
of pre-exciation. Possible non-specific ST-T wave changes. 
Compared to the 
previous tracing ST-T wave changes are new.  
  
 
Read by: ___. 
 
  ___ Axes 
Rate PR QRS QT/QTc P QRS T 
89 112 78 338/388 58 56 51 
 
RADIOLOGY  Final Report

MR HEAD W/O CONTRAST  ___ 4:18 AM

MR HEAD W/O CONTRAST; MRA BRAIN W/O CONTRAST

Reason: SAH, please eval optic chiasm 

UNDERLYING MEDICAL CONDITION:
___ year old woman with large SAH in chiasm, loosing vision 
REASON FOR THIS EXAMINATION:
SAH, please eval optic chiasm 
CONTRAINDICATIONS for IV CONTRAST: None.

HISTORY: ___ female with subarachnoid hemorrhage, ACOM 
aneurysm, with total vision loss on the right and blurriness on 
the left.

COMPARISON: CTA head of ___.

TECHNIQUE: Multiplanar T1- and T2-weighted imaging sequences 
were obtained through the brain without administration of IV 
contrast. 3D time-of-flight MR arteriography was also performed.

MRI/MRA OF BRAIN: Again seen is subarachnoid hemorrhage along 
the right insular sulci, the basilar cisterns, and the 
suprasellar cistern. A cluster of punctate regions of increased 
FLAIR signal may represent extension of the subarachnoid 
hemorrhage into perivascular spaces. No other region of 
hemorrhage is noted. The size of the hemorrhage is unchanged 
from the CTA of one day prior. There is no region of infarction, 
no shift of midline structures, and no evidence of mass. Mild 
hydrocephalus remains.

Again seen is an aneurysm of the anterior communicating artery 
which measures up to 10 mm long with a region of increased 
signal within the aneurysm which may represent a thrombus. The 
aneurysm is superior to the optic chiasm and indents the 
anterior portion of the chiasm. The orbits and optic nerves 
otherwise appear normal. No other aneurysms are seen on the MRA. 
The paranasal sinuses and mastoid air cells are clear. No 
osseous or soft tissue abnormality is otherwise seen.

IMPRESSION:
1. Subarachnoid hemorrhage in the basal cisterns and the right 
sulci unchanged from CTA of one day prior.
2. ACOM aneurysm superior to chiasm extends inferiorly to indent 
the anterior portion of the optic chiasm. No other aneurysm 
seen.
3. Mild hydrocephalus, unchanged.

   RADIOLOGY  Final ___
___ CAROTID/CERVICAL BILAT  ___ 2:51 ___

Reason: Cerebral angiogram - eval for bleeding 
Contrast: OPTIRAY

UNDERLYING MEDICAL CONDITION:
___ year old woman s/p clipping of AComm 
REASON FOR THIS EXAMINATION:
Cerebral angiogram - eval for bleeding 
PROCEDURE: RIGHT COMMON CAROTID ARTERIOGRAM, LEFT COMMON CAROTID 
ARTERIOGRAM.

STAFF: Dr. ___ and Dr. ___. Dr. ___ 
attending physician, was present and supervising throughout the 
procedure.

INDICATION: ___ woman with subarachnoid hemorrhage, 
status post surgical clipping of the anterior communicating 
artery aneurysm.

TECHNIQUE: Written informed consent was obtained after 
discussing the indications for the procedure, there risks of the 
procedure, and alternative management. The discussed risks 
included stroke, loss of vision and speech, temporary or 
permanent, with possible treatment with stents and coils if 
needed. The patient was brought to the interventional 
neuroradiology suite and placed on the biplane table in supine 
position. Both groins were prepped and draped in the usual 
sterile fashion. A preprocedure timeout was performed using two 
patient identifiers. The patient had an indwelling sheath in the 
right common femoral artery from the pre-operative cerebral 
angiogram. Through the sheath, a 5 ___ ___ catheter 
was introduced and connected to a continuous saline infusion 
(mixed with heparin 1000 units in 1000 cc of saline.). The 
following vessels were selectively catheterized, and 
arteriograms were performed from the following locations: Right 
common carotid artery, left common carotid artery. After review 
of the films, the catheter and the sheath were withdrawn. 
Hemostasis was obtained with an Angio-Seal device. The patient 
tolerated the procedure well without immediate complications.

FINDINGS:

RIGHT COMMON CAROTID ARTERY: The visualized external carotid 
arterial branches appear unremarkable.

RIGHT INTERNAL CAROTID ARTERY: The cervical, petrous, cavernous 
and supraclinoid segments are normal. The right middle cerebral 
artery is normal. There is no residual filling of the previously 
noted aneurysm of the anterior communicating artery. There is no 
narrowing of the A1 segment of the right anterior cerebral 
artery. The remainder of the anterior cerebral artery appears 
normal.

LEFT COMMON CAROTID ARTERY: The visualized external carotid 
arterial branches appear unremarkable.

LEFT INTERNAL CAROTID ARTERY: The cervical, petrous, cavernous 
and supraclinoid segments are normal. The left middle cerebral 
artery is normal. There is no filling of the previously noted 
aneurysm of the anterior communicating artery. There is no 
narrowing of the A1 segment of the left anterior cerebral 
artery. The remainder of the anterior cerebral artery appears 
normal.

MEDICATIONS: The procedure was performed under general 
anesthesia.

IMPRESSION: No residual filling of the clipped aneurysm of the 
anterior communicating artery. No narrowing of the A1 segments 
of the right or left anterior cerebral arteries.

   RADIOLOGY  Final Report

CTA HEAD W&W/O C & RECONS  ___ 11:25 ___

CTA HEAD W&W/O C & RECONS

Reason: SAH, MS CHANGES
Contrast: OPTIRAY

UNDERLYING MEDICAL CONDITION:
___ year old woman with osh with sah, headache for 10 days 
REASON FOR THIS EXAMINATION:
eval for sah 
CONTRAINDICATIONS for IV CONTRAST: None.

HISTORY: ___ female with headache for ten days and 
transferred from outside hospital with subarachnoid hemorrhage.

COMPARISON: No prior exam is available for comparison.

TECHNIQUE: Contiguous axial images were obtained through the 
brain without contrast material. Subsequently, rapid axial 
imaging was performed through the brain during infusion of IV 
Optiray contrast material. Multiplanar maximum intensity 
projection images were then obtained. 3D volume-rendered images 
are pending.

CT HEAD WITHOUT IV CONTRAST: Regions of high density along the 
right sulci, the basal cisterns, and the suprasellar cisterns 
are consistent with subarachnoid hemorrhage on the right. There 
is extension of this hyperdense material into the sella. There 
is mild hydrocephalus. Otherwise, there is no evidence of mass, 
edema, shift of normally midline structures, or large vascular 
territory infarction. No fractures are seen. The frontal sinuses 
are not pneumatized. Otherwise, the paranasal sinuses and the 
mastoid air cells are clear.

CTA HEAD: There is an 8 x 5 mm anterior communicating artery 
aneurysm which points inferoposteriorly in the suprasellar 
region and extends into the sella. Slight attenuation of the 
right more than left middle cerebral arteries may represent 
vasospasm. No other aneurysm is seen. The carotid and vertebral 
arteries and their major branches are otherwise patent, without 
evidence of focal stenosis or vascular abnormality.

IMPRESSION:
1. Subarachnoid hemorrhage along right insular sulci, basal 
cisterns, and suprasellar cistern.
2. 8 x 5-mm ACOM aneurysm extends inferoposteriorly into the 
sella. Slight attenuation of the MCAs may represent some amount 
of vasospasm.
PLEASE NOTE: THIS IS AN INCOMPLETE LIST OF RADIOLOGICAL STUDIES 
FOR THIS ___.  THIS REPRESENTS AT MINIMUM THE ORIGINAL, LATEST 
AND LIST OF INDIVIDUAL STUDIES THAT THE ___ HAD DURING THIS 
HOSPITAL STAY.

 
Brief Hospital Course:
Pt was admitted to the neurosurgery service after presenting 
with continued  headache and right eye blindness.  

Neuro: Exam followed q 1 hour during ICU stay.  ICP monitored 
via external ventricular drain system.  CSF diversion through 
EVD for hydrocephalus ___ IVH/SAH.  Ultimately pt tolerated 
having system removed on ___ without further hydrocephalus or 
elevated ICP's. Pt had CTA and cerebral angiogram on arrival.  
Endovascular coiling of A-COMM aneurysm was attempted and 
unsuccessful.  She was brought to the operating for a formal 
open craniotomy for aneurysm clipping on Hospital day #1.  
Subsequent CTA's/CTP's and cerebral angiograms were performed 
based on pt clinical exam and ICP's.  She was started on 
nimodipine on hospital day number one.  She is due to finish her 
21 day course on ___.  She was treated for intermittent bouts 
of vasopsasm with injection therapy during angiography as well 
as triple H therapy.  Some resultant cerebral infarcts were 
noted during imaging (see final diagnosis / discharge 
worksheet).
She was started on antiepileptics (dilantin) on her day of 
arrival and was switched to keppra as it was questioned that 
Dilatin may have been a fever source for her. 
Mannitol and solumedrol doses were tapered to off without 
episode.  

CV: no issues during this hospitalization.

RESP:Pt was intubated for the intial angiogram and subsequent 
surgery - she was extubated the following day and tolerated it 
well.

ID: The pt had fever during her stay.  Cultures were sent 
periodically according to temp's including CSF from the EVD 
system.  Medications were switched to rule out source of temp. 
Her cultures were negative including a MRSA and VRE screen.  She 
did have a UTI / E.coli noted on hosp day #1 and this was 
treated.  No additional fever source was identified.   

RENAL: No issues during this hospitalization.

ENDO:
- placed on sliding scale coverage for glucose control during 
ICU stay 

PPX:
-placed on pneumoboots, SSI, H2 Blocker, 

FEN: pt originally had NGT feeds and was ultimately advanced to 
regular diet wihtout incidence.

general - she was seen by ___ and OT services.

CODE STATUS: FULL CODE / during entire hospital stay 
she was seen by ___ clinic x 2 - she was unable to 
participate in the full ophto exam - she will see them in follow 
up 

 
Medications on Admission:
MEDS:
-prn Motrin

 
Discharge Medications:
1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q4-6H () as 
needed.  
3. Levetiracetam 1,000 mg Tablet Sig: One (1) Tablet PO twice a 
day for 3 months.
Disp:*180 Tablet(s)* Refills:*0*
4. Percocet ___ mg Tablet Sig: ___ Tablets PO every four (4) 
hours.
Disp:*40 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
SAH with A-Comm Aneurysm
Right frontal CVA
Right Eye blindness / Left eye visual field cut
Right basal ganglia infarct
UTI

 
Discharge Condition:
Neurologically stable
Visual field deficit
 
Discharge Instructions:
DISCHARGE INSTRUCTIONS FOR CRANIOTOMY/HEAD INJURY

Have a family member check your incision daily for signs of 
infection
Take your pain medicine as prescribed
Exercise should be limited to walking; no lifting, straining, 
excessive bending
You may wash your hair only after sutures and/or staples have 
been removed 
You may shower before this time with assistance and use of a 
shower cap
Increase your intake of fluids and fiber as pain medicine 
(narcotics) can cause constipation
Unless directed by your doctor, do not take any 
anti-inflammatory medicines such as Motrin, aspirin, Advil, 
Ibuprofen etc. 
If you have been prescribed an anti-seizure medicine, take it 
as prescribed and follow up with laboratory blood drawing as 
ordered
- clearance to drive will be discussed at your post 
hospitalization office visit.

CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE 
FOLLOWING:

New onset of tremors or seizures
Any confusion or change in mental status 
Any numbness, tingling, weakness in your extremities
Pain or headache that is continually increasing or not 
relieved by pain medication
Any signs of infection at the wound site: redness, swelling, 
tenderness, drainage
Fever greater than or equal to 101 F

 
Followup Instructions:
___
"
61,13158370,23446112," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
CC: Stuck ERCP basket wire 

 
Major Surgical or Invasive Procedure:
ERCP
 
History of Present Illness:
CP: Dr. ___
. 
CC: Stuck ERCP basket wire 
History obtained with the assistance of the ___ interpretor 
over the telephone and her dtr ___
________________________________________________________________
HPI: 
___ y/o female with gallstones, CCY ___, HTN, DM, admitted on 
___ at ___ for biliary obstruction from CBD stone when 
she presented with n/v/diarrhea/subjective fevers and epigastric 
pain. These sx are similar to what she experienced prior to CCY 
in ___. She went to the ___ endoscopy unit today for 
ERCP and stone extraction today.  During procedure, 
sphincterotomy performed with some pus drainage noted; basket 
unfortunately
broke and is stuck.  Basket wire still in place and in patient's 
mouth.  Airway stable, pt on room air (98/RA), other VSS.  
Getting unasyn for presumed cholangitis. Needs transfer tonight 
for ERCP tomorrow AM to retrieve basket and stone.  Pt stable 
but at risk for perforation and worsening infection.  Per call 
in pt needs tele and continuous O2 sat monitoring.  Per report 
she
travelled to ___ one year ago.  
. 
ROS
PAIN SCALE: ___  epigastric pain radiating to the back 

CONSTITUTIONAL:        [] All Normal
[ +] Fever  [+ ] Chills   [ ] Sweats  [ ] Fatigue   [ ] Malaise  

[ ]Anorexia  [ ]Night sweats
[- ] _____ lbs.    weight  loss/gain     over _____ months
Eyes
        [X] All Normal
[ ] Blurred vision   [ ] Loss of vision [] Diplopia [ ]
Photophobia
ENT []
[+ ] Dry mouth  [ ] Oral ulcers [ ] Bleeding gums [ ] Sore 
throat
[] Sinus pain [ ] Epistaxis  [ ] Tinnitus
[ ] Decreased hearing    [ ] Other:
RESPIRATORY:    [X] All Normal
[ ] Shortness of breath      [ ] Dyspnea on exertion [ ] Can't
walk 2 flights     [ ] Cough [ ] Wheeze  [ ] Purulent sputum    
[
] Hemoptysis   [ ]Pleuritic pain 
[ ] Other:
CARDIAC:        [X]  All Normal
[ ] Palpitations   [ ] Edema   [ ] PND [ ] Orthopnea    [ ] 
Chest
Pain [ ] Dyspnea on exertion [ ] Other:
GI:             [+] Per HPI
GU:             [X] All Normal
[ ] Dysuria      [ ] Incontinence or retention  [ ] Frequency   
[ ] Hematuria  []Discharge []Menorrhagia  
SKIN:           [] All Normal
[ ] Rash        [ +] Pruritus
NEURO:          [] All Normal
[ ] Headache    [ ] Visual changes   [ ] Sensory change [
+]Confusion with anesthetic but none now[ ]Numbness of
extremities
[ ] Seizures   [ ] Weakness [ ] Dizziness/Lightheaded [ ]Vertigo
[ ] Headache

 
Past Medical History:
# HTN/HLD
# DM2 hgbA1C = 6.5 ___ not on any medications as outpt
# atypical CP negative stress test ___
# obesity
# SAH
# Anxiety
# memory d/o
# migraine
# optic neuropathy 

 
Social History:
___
Family History:
Her father died of an MI at age ___. Her mother is still alive 
and has DM. No one in her family has a history of gallstones. 

 
Physical Exam:
VITAL SIGNS: 
PAIN SCORE ___. VS: T = 99.7 P = 88 BP 144/77 RR 16 O2Sat on  ___97% on 2L
GENERAL:  Obese pleasant female laying in bed
Nourishment:good  
Grooming: good  
Mentation: alert, speaking in full sentences  
2. Eyes: [] WNL 
PERRL, EOMI without nystagmus, Conjunctiva: clear
3. ENT [] WNL
[X] Moist  [] Endentulous  [] Ulcers  [] Erythema  [] JVD ____ 
cm
[] Dry  [] Poor dentition  [] Thrush  [] Swelling  [] Exudate
4. Cardiovascular [X] WNL
[X] Regular  [] Tachy  [X] S1 [X] S2 [+] Systolic Ejection 
Murmur
___, Location: LUSB
[X] Edema RLE  None  [X] Edema LLE None 
2+ DPP b/l
[] Vascular access  [X] Peripheral [] Central site:
5. Respiratory [ X]WNL
[X] CTA bilaterally  [- ] Rales  [ ] Diminshed 
[X] Comfortable     [ ] Rhonchi   [ ] Dullness
6. Gastrointestinal [ ] WNL
NABS, soft +epigastric tenderness. No rebound. Mild RUQ 
tenderness. 
[] Non distended  [+] distended  [] bowel sounds Yes/No  [] 
guiac: positive/negative
7. Musculoskeletal-Extremities [X] WNL
[ ] Tone WNL  [X]Upper extremity strength ___ and symmetrical  
[]Other:
[ ] Bulk WNL    [X] Lower extremity strength ___ and symmetrica 
[] Other:
8. Neurological [] WNL
[X] Alert and Oriented x 3 [ ] Romberg: Positive/Negative  [ ] 
CN II-XII intact  [ X] Normal attention  [ ] FNF/HTS WNL [] 
Sensation WNL  [ -] Delirious/confused  [ ] Asterixis 
Present/Absent  [ ] Position sense WNL
9. Integument  [] WNL [X] Warm  [X] Dry  [] Cyanotic [] Rash:
none/diffuse/face/trunk/back/limbs  
10. Psychiatric [X] WNL [X] Appropriate [] Flat affect [-] 
Anxious [] Manic []
Intoxicated [X] Pleasant [] Depressed [] Agitated [] Psychotic  
[] Combative

 
Pertinent Results:
LABS: ___ at ___
140|103|8
3.3|25 |0.6
Ca = 8.4
Mg = 1.9
Tbili = 8.1 up from 5.7 on ___ 
with Dbili = 6.8 up from 4.7 on ___
AST = 156
ALT = 461
ALP = 378
Lipase = 130
ALP = 370
      13.2
11.6/39.1\253
68.7N/0.7B/18.4L
INR = 1.1
.
LAST ECHO:
Stress echo in ___ with no evidence of ischemia
.
___
Hpylori + ve
.
___ UA negative. 
.
# OSH ERCP (___): The major papilla was normal. The bile 
duct was deeply cannulated. Contrast was injected. I personally 
interpreted the bile duct images. Ductal flow of contrast was 
adequate. Imagequality was adequate. Contrast extended to the 
main bile duct. Contrast extended to the cystic duct. Contrast 
extended to  the hepatic ducts. A long cystic duct stump 
originated in the
lower third of the main bile duct. The lower third of the main 
bile duct contained one stone. The main bile duct was dilated. 
Biliary sphincterotomy was made with a traction (standard) 
sphincterotome using ___ electrocautery. There was no 
post-sphincterotomy bleeding. The biliary tree was swept with a 
11.5 mm balloon and basket starting at the bifurcation. Sludge 
was swept from the duct. A few stones were removed. Pus was 
coming out of the ampulla. One stone remained. The basket got 
stuck with the stone in the bile duct and the wire broke 
proximally instead of breaking around the stone. 
Post Procedure Diagnosis:
     - The major papilla appeared normal.
     - The patient has had a cholecystectomy.
     - The entire main bile duct was dilated.
     - Choledocholithiasis with a partial obstruction was found.
Partial removal was accomplished by biliary sphincterotomy; no 
stent was inserted. 
Complications: Unable to remove basket with one wire coming out 
of the mouth 
.
# OSH CT abd/pelvic (___): Mild diffuse thickening of the 
gastric  antrum, which can be seen in  the setting of gastritis. 
 2. Uterine fibroids. 

# ERCP (___): The scout film showed an impacted wire basket. The 
bile duct was deeply cannulated with the sphincterotome. 
Contrast was injected and there was brisk flow through the 
ducts. Contrast extended to the entire biliary tree. The wire 
basket was seen in the distal CBD. The left and right hepatic 
ducts and all intrahepatic branches were normal. To facilitate 
removal of the basket, a sphincteroplasty was made with a CRE 
balloon from 12 mm to 15 mm.  The biliary tree was then swept 
with a balloon above the impacted basket. The wire basket was 
removed from the patient. Stones were also extracted. A ___ x 5 
cm double pigtail stent was placed in the main duct. Excellent 
bile and contrast drainage was seen endoscopically and 
fluoroscopically

 
Brief Hospital Course:
ASSESSMENT & PLAN: ___ year old female with h/o DM, HTN, HLD, h/o 
gallstones s/p remote CCY in ___ who presents with 
n/v/abdominal pain/diarrhea/fevers found to have obstructive 
choledolithiasis and cholangitis s/p ERCP with removal of some 
stones but then the basket got stuck with the stone in the bile 
duct and the wire
broke proximally.
.
# OBSTRUCTIVE CHOLEDOLITHIASIS, CHOLANGITIS, RETAINED BASKET 
WIRE. Ms. ___ was admitted s/p ERCP (done at ___ 
Endoscopy) for cholangitis - however course was complicated by 
the retention of basket wire within the distal CBD.  She 
underwent ERCP here where sphincteroplasty was performed, basket 
wire was retrieved along with multiple CBD stones.  A CBD stent 
was placed to expedite clearance of any remaining stones/sludge. 

   She presented with leukocytosis, elevated LFTs, RUQ abd pain, 
pus from the CBD duct c/w cholangitis.  For this, she was 
treated with IV unasyn along with IV dilaudid and zofran PRN for 
pain/nausea control.  She did well after the ERCP procedure - 
and was able to tolerate a regular diet the same day.  She will 
need to complete 5 more day of ciprofloxacin and flagyl.  Due to 
loose stool and diarrhea (and recent iv antibiotics), the 
concern was for the possibility of C.diff.  Stool c.diff were 
sent - and extra doses of flagyl were prescribed in case the 
stool studies returned positive.  She should not take any 
aspirin, Plavix, NSAIDS, Coumadin for the following 5 days.  She 
will need a repeat ERCP 4 weeks for stent pull and 
re-evaluation. 

# GASTRITIS:  Ms. ___ had a positive H pylori test at OSH.  
Abd CT also revealed with diffuse thickening of the antrum 
consistent with gastritis.  A 14-day prescription of PPI, 
Clarithromycin and Amoxicilli was given for treatment of H. 
Pylori.  Since this is not urgent, she (through her daughter) 
understands that this need not be immediately treated and may be 
postponed until the cholangitis is fully treated (and prospect 
of C.diff is eliminated). 

# DIABETES MELLITUS - last Hgb A1C 6.5 not on medications at 
home.  She was placed on ISS here along with diabetic diet.

# HTN/HLD: HCTZ/toprol/lisinpril were continued.  Lipitor can be 
resumed on d/c.
# DEPRESSION:
- Continue wellbutrin
.
# FEN: [X]Oral   [ ]Tube feeds  [ ]Parenteral [X] NPO 
# DVT PROPHYLAXIS: [ X]Pharmacological  [] Mechanical  []
Ambulation
# Lines and drains: [ X]Periphera [ ]CVL _____ days(s) [ ]PICC  
____day(s) []Foley day(s)
# PRECAUTIONS: [X ] None [ ]Fall       [] Aspiration   []
MRSA/VRE/C diff/ESBL/Droplet/Neutropenic/Airbourne  [ 
]Restraints
# DISPOSITION: [X] Home    [ ] Rehab   [ ] SNF [] Hospice
 Can likely go home later today
# Code Status: FULL CODE d/w pt 
___: Dtr ___ ___- oncology RN at ___

# Transition: f/u stent removal in 4 weeks.  Complete PO abx.  
HPylori treatment therafter

 
Medications on Admission:
bismuth subsalicylate (PEPTO BISMOL) 262 MG chewable tablet 
clobetasol (TEMOVATE) 0.05 % cream 
camphor-menthol (SARNA) lotion 
hydrOXYzine (ATARAX) 25 MG tablet 
cholecalciferol (VITAMIN D) 1000 UNITS capsule 
nitroGLYCERIN (NITROSTAT) 0.4 MG sublingual tablet 
lisinopril (PRINIVIL,ZESTRIL) 5 MG tablet 
hydrochlorothiazide (HYDRODIURIL) 25 MG tablet 
atorvastatin (LIPITOR) 40 MG tablet 
metoprolol (TOPROL-XL) 25 MG 24 hr tablet 
buPROPion (WELLBUTRIN) 100 MG tablet bid 

 
Discharge Medications:
1. BuPROPion 100 mg PO BID 
2. Lisinopril 5 mg PO DAILY 
3. Metoprolol Succinate XL 25 mg PO DAILY 
4. Ciprofloxacin HCl 500 mg PO Q12H Duration: 5 Days 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve 
(12) hours Disp #*10 Tablet Refills:*0
5. Amoxicillin 1000 mg PO Q12H 
RX *amoxicillin 500 mg 2 tablet(s) by mouth every twelve (12) 
hours Disp #*56 Tablet Refills:*0
6. Atorvastatin 40 mg PO QPM 
7. Clarithromycin 500 mg PO Q12H 
RX *clarithromycin 500 mg 1 tablet(s) by mouth every twelve (12) 
hours Disp #*28 Tablet Refills:*0
8. Hydrochlorothiazide 25 mg PO DAILY 
9. Omeprazole 20 mg PO BID 
RX *omeprazole 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0
10. MetRONIDAZOLE (FLagyl) 500 mg PO TID 
RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day 
Disp #*42 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Cholangitis
Choledocholithiasis
Foreign body common bile duct
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
It was a pleasure looking after you, Ms. ___.  As you know, 
you underwent an ERCP here to retrieve the wire basket stuck in 
the common bile duct.  You tolerated the ERCP here well: the 
wire was removed along with the stones within the common bile 
duct.  A bile duct stent was also placed to ensure adequate 
passage of biliary stones.   
   Please complete 5 days of ciprofloxacin and flagyl 
(antibiotics) to treat the infection within the bile duct.  
Thereafter, you can start the other antibiotics (prilosec, 
amoxicillin, clarithromycin) to treat H.Pylori.  Since treatment 
of H.Pylori is not urgent, you may elect to delay the H.Pylori 
treatment until there is enough time to recover from the 
cholangitis and ensure that you are not infected with C.diff.  
We will contact you with the stool Cdiff results. 
   You will be contacted by our ERCP department to schedule a 
follow up ERCP to remove the stent.  
 
Followup Instructions:
___
"
62,13158370,26789912," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Chest pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with PMHx ___ ___ s/p right acom aneurysm rupture and
clipping with residual right sided blindness, DM2, HTN who
presented to the ED with chest pain in the setting of an 
abnormal
stress test. ETT/MIBI performed on ___ was notable for a small
area of decreased perfusion in the anteroseptal wall of the LV 
on
exercise stress images with relative reperfusion on rest images. 


On ___ she presented to her cardiologist's office to follow up
on her recent stress testing for chest pain.  During the visit
she reported retrosternal chest pressure with associated 
dyspnea.
She noted the chest pain while seating at rest as well as when
she exerts herself.  Her daughter called in to the appointment
and confirmed that this pain has been present when she is not
active as well as she is active for last couple of weeks. EKG in
the office showed no STE or STD when compared to previous.  She
was given 324mg of aspirin and 1 tab of nitroglycerin and was
sent to the ___ ED for further evaluation. Her pain responded
to NTG.  
 
In the ED initial vitals were:  T98.1 HR79 BP117/79 RR18 98%RA
 
EKG: sinus 81 NA NI q wave III, TWF III (qwave since ___

CHA CXR: No acute cardiopulmonary findings. 
 
Labs/studies notable for:  
WBC 10.2 H/H 13.2/39.9 Plt 235
proBNP 28 TNT <0.01 
BMP notable for Cr 0.5 
INR 1.1
 
Patient was ordered for asa & atorvastatin. 
 
Vitals on transfer: T98.0 HR76 BP142/90 RR22 98%RA

On the floor, Ms. ___ is resting comfortably.  At beginning
of interview denied chest pain or pressure, dyspnea, jaw/arm
pain, nausea, diaphoresis or palpitations.  She stated she felt
chest pressure while in doctors office today but it went away
with NTG.  She states she has had chest pressure on and off for
months, can experience it at rest and with activity.  She states
she will feel it when she goes ""walking"" but cannot tell me how
long she can walk before it occurs.  She cannot clearly tell me
if it resolves when she rests.  Of note, she states she does
experience heart burn and acid reflux often but this chest
""pressure"" is new and different.  At the end of the interview,
she reported feeling acute onset chest pressure ___ similar to
prior chest pain.  EKG at time of chest discomfort notable for
possible flutter waves then return to sinus rhythm with q wave
III and possible submm STD I, aVL.  Chest pain resolved after
given NTG on floor.  ___ ___ Temp: 97.8 PO BP: 135/80 R
Sitting HR: 72 RR: 18 O2 sat: 97% O2 delivery: Ra FSBG: 89 EKG
similar post NTG. 

 
Past Medical History:
# HTN/HLD
# DM2 hgbA1C = 6.5 ___ not on any medications as outpt
# atypical CP negative stress test ___
# obesity
# SAH
# Anxiety
# memory d/o
# migraine
# optic neuropathy 

 
Social History:
___
Family History:
Her father died of an MI at age ___. Her mother is still alive 
and has DM. No one in her family has a history of gallstones. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM
========================
VS: 24 HR Data (last updated ___ @ 428) Temp: 97.8 (Tm
97.8), BP: 104/73 (104-135/73-80), HR: 72, RR: 18, O2 sat: 97%,
O2 delivery: Ra  
GENERAL: Well developed, well nourished obese female in NAD.
Oriented x3. Mood, affect appropriate.  
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI.
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa.
No xanthelasma.  
NECK: Supple. No JVD. 
CARDIAC: PMI located in ___ intercostal space, midclavicular
line. Regular rate and rhythm. Normal S1, S2. No murmurs, rubs,
or gallops. No thrills or lifts.  
LUNGS: No chest wall deformities or tenderness. Respiration is
unlabored with no accessory muscle use. No crackles, wheezes or
rhonchi.  
ABDOMEN: Soft, non-tender, non-distended. 
EXTREMITIES: Warm, well perfused. No peripheral edema.  
SKIN: No significant skin lesions or rashes.  
PULSES: Distal pulses palpable and symmetric.  

DISCHARGE PHYSCIAL EXAM
========================
GENERAL: Well-appearing, well-nourished obese female sitting at
bedside. NAD.
HEENT: Normocephalic, atraumatic. EOMI. Sclera anicteric. No 
JVD.
CV: RRR, normal S1/S2. No murmurs, rubs, or gallops.
RESP: CTAB, no wheezes, rales, or rhonchi.
GI: Soft, nontender, nondistended. NABS. No rebound or guarding.
MSK: No ___ edema
SKIN: No lesions or rashes noted.
NEURO: Moving all 4 extremities with purpose. Awake, alert, and
answering questions appropriately.

 
Pertinent Results:
ADMISSION LABS
================
___ 07:30PM BLOOD WBC-10.2* RBC-4.36 Hgb-13.2 Hct-39.9 
MCV-92 MCH-30.3 MCHC-33.1 RDW-14.4 RDWSD-48.5* Plt ___
___ 07:30PM BLOOD Neuts-50.7 ___ Monos-6.4 Eos-3.4 
Baso-0.3 Im ___ AbsNeut-5.19 AbsLymp-3.94* AbsMono-0.65 
AbsEos-0.35 AbsBaso-0.03
___ 09:53PM BLOOD ___ PTT-30.1 ___
___ 07:30PM BLOOD Glucose-87 UreaN-10 Creat-0.5 Na-143 
K-4.1 Cl-105 HCO3-26 AnGap-12
___ 07:30PM BLOOD cTropnT-<0.01 proBNP-28
___ 04:56AM BLOOD Calcium-9.3 Phos-3.7 Mg-1.8

PERTINENT INTERVAL LABS
=========================
___ 01:17AM BLOOD cTropnT-<0.01
___ 04:56AM BLOOD CK-MB-1 cTropnT-<0.01
___ 04:56AM BLOOD TSH-2.7

DISCHARGE LABS
================
___ 05:47AM BLOOD WBC-10.8* RBC-4.59 Hgb-13.7 Hct-41.1 
MCV-90 MCH-29.8 MCHC-33.3 RDW-14.3 RDWSD-46.6* Plt ___
___ 05:47AM BLOOD Glucose-116* UreaN-13 Creat-0.6 Na-144 
K-4.5 Cl-106 HCO3-19* AnGap-19*
___ 05:47AM BLOOD Calcium-9.9 Phos-4.3 Mg-2.3

MICROBIOLOGY
==============
None

IMAGING STUDIES
=================
The left atrial volume index is normal. No atrial septal defect 
is seen by 2D or color Doppler. The estimated right atrial 
pressure is ___ mmHg. Left ventricular wall thickness, cavity 
size and regional/global systolic function are normal (LVEF 
>55%). Doppler parameters are most consistent with normal left 
ventricular diastolic function. There is no ventricular septal 
defect. Right ventricular chamber size and free wall motion are 
normal. The diameters of aorta at the sinus, ascending and arch 
levels are normal. The aortic valve leaflets (3) appear 
structurally normal with good leaflet excursion and no aortic 
stenosis or aortic regurgitation. The mitral valve appears 
structurally normal with trivial mitral regurgitation. There is 
no mitral valve prolapse. The estimated pulmonary artery 
systolic pressure is normal. There is no pericardial effusion. 

 IMPRESSION: Normal biventricular chamber size and 
regional/global systolic function. No pathologic valvular flow.  

 
Brief Hospital Course:
TRANSITIONAL ISSUES
====================
[ ] Chest pain - unclear if of cardiac etiology or otherwise. If 
this is deemed to be of cardiac origin, initiation of a 
long-acting nitrate can be considered as blood pressures allow
[ ] Positive MIBI - patient should follow up with a cardiologist 
to decide whether elective cardiac catheterization is necessary 
following a recent MIBI with a small area of decreased perfusion 
that reversed with rest
[ ] Started on Aspirin - discussed w/ ___. Pt okay to be on 
ASA. Felt it has benefit for her primary prophylaxis in CAD. 

___ year old female with DMII, HTN, HLD, history of ICH w/ 
residual R-sided blindness and a recent stress MIBI suggestive 
of a small area of decrease perfusion that reversed with rest 
presented from her PCPs office with chest pain concerning for a 
coronary etiology.

ACTIVE PROBLEMS
================
# Chest Pain
The patient presented with chest pain that she described as 
""pressure"" in her neck. Given concern for coronary artery 
disease, troponins were checked (negative x3) and EKGs were 
obtained (no acute ischemic changes). A more robust history was 
elicited, which suggested that she feels this chest pain 
intermittently (no daily but several times per week) and has not 
noted any correlation with rest or exercise. She takes her 
sublingual nitroglycerin when she is feeling pain, which helps 
sometimes but not always. She also recalls some events that were 
relieved with rest and some that lasted for several hours. Based 
on this, it remains unclear if her chest pain is coronary in 
origin. She also had an echocardiogram that was unremarkable. 
Given the negative objective work up and the very questionable 
history of her chest pain, cardiac catheterization was deferred 
at this time. Her metoprolol succinate and lisinopril were 
continued, and she was started on 81mg aspirin daily (after 
consultation with neurosurgery). Consideration was made to 
initiate nitrate therapy, however he blood pressures remained 
too soft. This can be further considered in the outpatient 
setting.

CHRONIC/STABLE PROBLEMS
========================
# DMII - held metformin while inpatient and initiated Humalog 
sliding scale

# HTN - held HCTZ in favor of lisinopril and metoprolol

# HLD - continued atorvastatin

# Anxiety - continued Wellbutrin 100mg BID
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. BuPROPion 100 mg PO BID 
2. Lisinopril 5 mg PO DAILY 
3. Metoprolol Succinate XL 25 mg PO DAILY 
4. Atorvastatin 80 mg PO QPM 
5. Hydrochlorothiazide 25 mg PO DAILY 
6. MetFORMIN XR (Glucophage XR) 1000 mg PO BID 
7. Cetirizine 10 mg PO DAILY 
8. HydrOXYzine 25 mg PO Q8H:PRN itching 
9. Vitamin D 1000 UNIT PO DAILY 
10. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Atorvastatin 80 mg PO QPM  
3.  BuPROPion 100 mg PO BID  
4.  Cetirizine 10 mg PO DAILY  
5.  HydrOXYzine 25 mg PO Q8H:PRN itching  
6.  Lisinopril 5 mg PO DAILY  
7.  MetFORMIN XR (Glucophage XR) 1000 mg PO BID 
Do Not Crush  
8.  Metoprolol Succinate XL 25 mg PO DAILY  
9.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain  
10.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis
===================
Chest Pain

Secondary Diagnoses
===================
DMII
HTN
HLD

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to ___ from ___.

WHY WAS I ADMITTED?
=======================
- You were having chest pain at your doctor's office.

WHAT HAPPENED WHILE I WAS HOSPITALIZED?
=========================================
- We made sure that your heart was not being damaged by poor 
blood flow.
- We adjusted your medications to make them the best combination 
for your heart.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
===============================================
- Take all of your medications as prescribed.
- Follow up with your doctors.
 
Followup Instructions:
___
"
63,13375185,20506930," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Left foot Plantar Ulcer
 
Major Surgical or Invasive Procedure:
1. Ultrasound-guided access to the right common femoral
    artery.
2. Selective catheterization of the left external iliac
    artery, ___ order vessel.
3. Abdominal aortogram.
4. Left lower extremity diagnostic angiogram.

5. Left groin cutdown and femoral endarterectomy.
6. Left common femoral artery angioplasty using greater
    saphenous vein patch.
7. Left femoral to peroneal bypass graft with non-reverse
    greater saphenous vein.

 
History of Present Illness:
Mr. ___ is a ___ year old male with a history of popliteal 
stent, IIDM, CKD, CAD s/p stents, preadmitted for hydration 
prior to an angiogram. He reports having this ulcer for about a 
year but has had problems with his toe amputation site since 
___. He does have diabetic neuropathy and uses an offloading 
shoe. He denies any rest pain or symptoms of claudication. His 
wife currently does his dressing changes with wet to dry gauze. 

 
Past Medical History:
Hypertension, Type 2 Diabetes, Peripheral Neuropathy, Sleep 
Apnea, Renal failure, PVD, GOUT, Coronary Artery Disease 
(CAD)GAMMOPATHY, Colonyc polyps, Diabetic Neuropathy, Anemia, 
Peptic Ulcer Disease, Restless Leg Syndrome, Osteomyelitis, 
Charcot foot, basal cell carcinoma, ischemic cardiomyopathy, 
Transient Ischemic Attack (TIA)

 
Social History:
___
Family History:
non contributory
 
Physical Exam:
Admission PE:

PE: 97.7 74 131/77 16 97%RA
General: comfortable, NAD
___: RRR, no murmurs
Pulm: no respiratory distress
Abdomen: soft, NT, ND
Ext: b/l: P/D/D/D
Right toe amputation site is generally well healed with some dry
skin over the incision. n the left, two ulcers on the plantar 
surface are
dry and full thickness, >1cm each with no erythema and the base 
is clean.

Discharge PE:

PE: 97.9 88 142/62 18 100%RA
General: comfortable, NAD
___: RRR, no murmurs
Pulm: no respiratory distress
Abdomen: soft, NT, ND
Ext: b/l: P/D/D/D
Right toe amputation site is well healed with dry skin over the 
incision. The two ulcers on the left plantar surface are dry and 
full thickness,<1cm with no erythema and the base is clean. The 
bypass incision is clean, dry, intact, with mild oozing in the 
superior portion. The femoral access site has no signs of seroma 
or hematoma.
 
Pertinent Results:
___ 06:20AM BLOOD WBC-9.2 RBC-2.48* Hgb-7.9* Hct-23.7* 
MCV-96 MCH-31.9 MCHC-33.3 RDW-15.7* RDWSD-55.6* Plt ___
___ 06:45AM BLOOD WBC-11.7* RBC-2.46* Hgb-7.6* Hct-23.4* 
MCV-95 MCH-30.9 MCHC-32.5 RDW-15.9* RDWSD-55.2* Plt ___
___ 10:40AM BLOOD WBC-11.7* RBC-2.54* Hgb-7.9* Hct-23.8* 
MCV-94 MCH-31.1 MCHC-33.2 RDW-16.3* RDWSD-56.8* Plt ___
___ 05:10AM BLOOD WBC-11.7* RBC-2.43* Hgb-7.6* Hct-22.6* 
MCV-93 MCH-31.3 MCHC-33.6 RDW-16.9* RDWSD-57.4* Plt ___
___ 04:40PM BLOOD WBC-16.5*# RBC-2.72* Hgb-8.4* Hct-25.7* 
MCV-95 MCH-30.9 MCHC-32.7 RDW-16.6* RDWSD-57.3* Plt ___
___ 06:50AM BLOOD WBC-9.6 RBC-3.42* Hgb-10.8* Hct-33.2* 
MCV-97 MCH-31.6 MCHC-32.5 RDW-14.6 RDWSD-52.8* Plt ___
___ 07:15AM BLOOD WBC-9.3 RBC-3.35* Hgb-10.9* Hct-32.7* 
MCV-98 MCH-32.5* MCHC-33.3 RDW-14.9 RDWSD-53.6* Plt ___
___ 07:10AM BLOOD WBC-9.9 RBC-3.42* Hgb-10.9* Hct-33.3* 
MCV-97 MCH-31.9 MCHC-32.7 RDW-14.8 RDWSD-53.4* Plt ___
___ 09:25PM BLOOD WBC-10.4* RBC-3.71* Hgb-11.7* Hct-37.1* 
MCV-100* MCH-31.5 MCHC-31.5* RDW-15.8* RDWSD-58.1* Plt ___
___ 06:20AM BLOOD Plt ___
___ 06:45AM BLOOD Plt ___
___ 10:40AM BLOOD Plt ___
___ 05:10AM BLOOD Plt ___
___ 05:10AM BLOOD ___ PTT-30.5 ___
___ 04:40PM BLOOD Plt ___
___ 06:50AM BLOOD Plt ___
___ 06:50AM BLOOD ___ PTT-32.3 ___
___ 07:15AM BLOOD Plt ___
___ 07:10AM BLOOD Plt ___
___ 09:25PM BLOOD Plt ___
___ 09:25PM BLOOD ___ PTT-35.4 ___
___ 06:20AM BLOOD Glucose-210* UreaN-26* Creat-1.5* Na-140 
K-4.2 Cl-103 HCO3-22 AnGap-15
___ 06:45AM BLOOD Glucose-141* UreaN-25* Creat-1.4* Na-139 
K-4.1 Cl-104 HCO3-21* AnGap-14
___ 10:40AM BLOOD Glucose-157* UreaN-22* Creat-1.5* Na-141 
K-4.0 Cl-105 HCO3-23 AnGap-13
___ 05:10AM BLOOD Glucose-236* UreaN-21* Creat-1.4* Na-139 
K-4.5 Cl-104 HCO3-19* AnGap-16
___ 04:40PM BLOOD Glucose-226* UreaN-24* Creat-1.4* Na-141 
K-4.5 Cl-109* HCO3-18* AnGap-14
___ 06:50AM BLOOD Glucose-189* UreaN-28* Creat-1.4* Na-139 
K-4.4 Cl-102 HCO3-23 AnGap-14
___ 07:15AM BLOOD Glucose-149* UreaN-26* Creat-1.5* Na-139 
K-4.6 Cl-103 HCO3-21* AnGap-15
___ 07:10AM BLOOD Glucose-114* UreaN-23* Creat-1.5* Na-138 
K-4.7 Cl-104 HCO3-21* AnGap-13
___ 09:25PM BLOOD Glucose-125* UreaN-30* Creat-1.9* Na-141 
K-5.1 Cl-106 HCO3-20* AnGap-15
___ 06:20AM BLOOD Calcium-8.5 Phos-3.5 Mg-1.9
___ 06:45AM BLOOD Calcium-8.5 Phos-3.4 Mg-1.8
___ 10:40AM BLOOD Calcium-8.5 Phos-2.6* Mg-1.9
___ 05:10AM BLOOD Calcium-8.0* Phos-3.5 Mg-2.3
___ 04:40PM BLOOD Calcium-7.6* Phos-3.9 Mg-1.5*
___ 06:50AM BLOOD Calcium-9.6 Phos-3.9 Mg-1.8
___ 07:15AM BLOOD Calcium-9.2 Phos-4.1 Mg-2.0
___ 07:10AM BLOOD Calcium-9.2 Phos-3.7 Mg-1.7
___ 09:25PM BLOOD Calcium-9.9 Phos-3.9 Mg-1.9
 
Brief Hospital Course:
Mr. ___ is a ___ year old male with a PMH of Hypertension, 
IDDM, Peripheral Neuropathy, Sleep Apnea, Renal failure, PVD, 
GOUT, Coronary Artery Disease(CAD)GAMMOPATHY, Colonic Polyps, 
Diabetic Neuropathy, Anemia, Peptic Ulcer Disease (PUD)Restless 
Leg Syndrome, Osteomyelitis, Charcot foot, basal cell carcinoma, 
ischemic cardiomyopathy, Transient Ischemic Attack (TIA). He has 
a history of left behind knee popliteal stent with recurrent, 
nonhealing, wound of L foot. He was admitted to this floor with 
a nonhealing left midfoot plantar ulcer. After clinical 
evaluation the decision was made to perform a left lower 
extremity angiography, revealing this findings:
1. Patent infrarenal abdominal aorta.
2. Patent bilateral iliac systems.
3. Patent left common femoral artery and profunda femoris.
    There is evidence of high-grade focal stenosis at the
    origin of the SFA caused by calcified plaque.  The
    remainder of the SFA is diseased, but otherwise patent.
    Distally in the SFA at the level of ___ canal,
    there is a ___ area with at least 2 areas of focal
    stenosis.
4. The left popliteal artery is occluded at the level of
    the previously placed stent behind the knee.
5. The remainder of the popliteal artery appears to fill
    retrograde via a collateral.
6. The left anterior tibial artery and peroneal arteries
    provide collateral flow to the foot; however, the
    anterior tibial artery is diseased proximally.
7. There is no true dorsalis pedis or posterior tibialis in
    the foot.

With these findings, the decision was made to reestablish 
vascularity with a left lower extremity femoral-peroneal bypass 
utilizing great saphenous vein graft from the same leg. He 
tolerated well the procedure and had an uneventful postoperative 
course, to ___ he has positive left ___ and peroneal 
signals.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 325 mg PO DAILY 
2. Cetirizine 10 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. Carbidopa-Levodopa (___) 1 TAB PO DAILY 
5. Metoprolol Succinate XL 50 mg PO DAILY 
6. NovoLIN ___ (insulin NPH and regular human) 100 unit/mL 
(70-30) subcutaneous BID 
7. Ferrous GLUCONATE 324 mg PO DAILY 
8. Cilostazol 50 mg PO DAILY 
9. Clopidogrel 75 mg PO DAILY 
10. Temazepam 30 mg PO QHS 
11. Amitriptyline 50 mg PO QHS 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H 
Take only if required 
RX *acetaminophen 500 mg 2 tablet(s) by mouth three times a day 
Disp #*60 Tablet Refills:*0 
2.  Nicotine Patch 14 mg TD DAILY smoking cessation 
Do not use if you can avoid tobacco on your own.  
3.  OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Severe 

  Reason for PRN duplicate override: Alternating agents for 
similar severity
Use only if in severe pain. 
RX *oxycodone 10 mg 1 tablet(s) by mouth four times a day Disp 
#*30 Tablet Refills:*0 
4.  Polyethylene Glycol 17 g PO DAILY:PRN constipation 
Use only if necessary  
5.  Senna 8.6 mg PO BID:PRN constipation 
Use only if necessary 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp 
#*30 Tablet Refills:*0 
6.  Tamsulosin 0.4 mg PO QHS 
RX *tamsulosin 0.4 mg 1 capsule(s) by mouth once a day Disp #*60 
Capsule Refills:*0 
7.  Amitriptyline 50 mg PO QHS 
RX *amitriptyline 50 mg 1 tablet(s) by mouth at bedtime Disp 
#*60 Tablet Refills:*0 
8.  Aspirin 325 mg PO DAILY 
RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth 
once a day Disp #*90 Tablet Refills:*0 
9.  Atorvastatin 40 mg PO QPM 
RX *atorvastatin 40 mg 1 tablet(s) by mouth at bedtime Disp #*60 
Tablet Refills:*0 
10.  Carbidopa-Levodopa (___) 1 TAB PO DAILY 
RX *carbidopa-levodopa 25 mg-100 mg 1 tablet(s) by mouth once a 
day Disp #*60 Tablet Refills:*0 
11.  Cetirizine 10 mg PO DAILY 
RX *cetirizine [24Hour Allergy] 10 mg 1 tablet(s) by mouth once 
a day Disp #*30 Tablet Refills:*0 
12.  Cilostazol 50 mg PO DAILY 
RX *cilostazol 50 mg 1 tablet(s) by mouth once a day Disp #*60 
Tablet Refills:*0 
13.  Clopidogrel 75 mg PO DAILY 
RX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*90 
Tablet Refills:*0 
14.  Ferrous GLUCONATE 324 mg PO DAILY 
RX *ferrous gluconate 324 mg (38 mg iron) 1 tablet(s) by mouth 
once a day Disp #*30 Tablet Refills:*0 
15.  Metoprolol Succinate XL 50 mg PO DAILY 
RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day 
Disp #*60 Tablet Refills:*0 
16.  NovoLIN ___ (insulin NPH and regular human) 100 unit/mL 
(70-30) subcutaneous BID 
RX *insulin NPH and regular human [Novolin 70/30] 100 unit/mL 
(70-30) 1 ml SC twice a day Disp #*60 Vial Refills:*0 
17.  Temazepam 30 mg PO QHS 
RX *temazepam 30 mg 1 capsule(s) by mouth at bedtime Disp #*30 
Capsule Refills:*0 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Peripheral Vascular Disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
WHAT TO EXPECT: 
 1. It is normal to feel tired, this will last for ___ weeks  
 You should get up out of bed every day and gradually increase 
your activity each day  
 Unless you were told not to bear any weight on operative foot: 
you may walk and you may go up and down stairs  
 Increase your activities as you can tolerate- do not do too 
much right away! 
 2. It is normal to have swelling of the leg you were operated 
on: 
 Elevate your leg above the level of your heart (use ___ 
pillows or a recliner) every ___ hours throughout the day and at 
night 
 Avoid prolonged periods of standing or sitting without your 
legs elevated 
 3. It is normal to have a decreased appetite, your appetite 
will return with time  
 You will probably lose your taste for food and lose some 
weight  
 Eat small frequent meals 
 It is important to eat nutritious food options (high fiber, 
lean meats, vegetables/fruits, low fat, low cholesterol) to 
maintain your strength and assist in wound healing 
 To avoid constipation: eat a high fiber diet and use stool 
softener while taking pain medication

MEDICATION: 
 Take aspirin as instructed  
 Follow your discharge medication instructions

 
Followup Instructions:
___
"
64,13375185,25687636," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Bactrim / Aleve
 
Attending: ___.
 
Chief Complaint:
Admission to initiate C1 da-EPOCH for ""Triple Hit"" Diffuse Large 
B Cell Lymphoma 

 
Major Surgical or Invasive Procedure:
___ - ___ R axillary lymph node biopsy 
___ - ___ Port exchange for double lumen port 

 
History of Present Illness:
HPI: Mr. ___ is a ___ year-old man with newly-diagnosed
""Triple Hit"" Diffuse Large B Cell Lymphoma (diagnosed ___
with Diffuse Large B Cell Lymphoma with rearrangements in MYC,
BCL2, and BCL6 via thoracentesis and possibly right axillary 
core
biopsy at ___, staging PET c/w Stage IV given
extranodal disease in pleura, possible LUL and small bowel, B
symptoms present), CAD, T2DM, HTN, HLD, PAD, CKD, who is being
directly admitted from ___ clinic for initiation of 
da-EPOCH
and lumbar puncture with intrathecal methotrexate.

He initially presented to ___ in ___ with
hoarseness and cough. CT chest demonstrated L infrahilar mass up
to 6.5cm in diameter as well as multiple nodules in the RLL,
irregular pleura thickening, and numerous markedly enlarged 
lymph
nodes. He subsequently underwent thoracentesis and possible R
axillary lymph node biopsy which demonstrated DLBC lymphoma with
rearrangements in MYC, BCL2, and BCL6. He was discharged home on
a prednisone taper. PET CT from ___ demonstrated extranodal
disease involvement of the pleura and possibly LUL and small
bowel. He was subsequently referred to ___ for further
management. He presented to clinic on the day of admission ___
for initial evaluation by Dr. ___. He received 1L IVF in
clinic for hypercalcemia and decision was made to admit directly
for expedited chemo.

Upon arrival to the floor, he endorses the above history. He
reports hoarseness and non-productive cough, as well as a 20
pound unintentional weight loss over the past ___ weeks. He has
no shortness of breath while sitting or lying flat, but does
become short of breath if he walks up more than 4 stairs. He
denies any fevers, chills, nightsweats, chest pain, abdominal
pain, nausea, vomiting, diarrhea.  

Review of Systems:  
(+) Per HPI.
Denies fever, chills, night sweats, headache, vision changes,
rhinorrhea, congestion, sore throat, cough, shortness of breath,
chest pain, abdominal pain, nausea, vomiting, diarrhea,
constipation, BRBPR, melena, hematochezia, dysuria, hematuria. 
 

 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
~ ___: In ___ started to have fatigue, weakness, falls,
dizziness. 
- ___: Admitted to ___ with hoarseness and
cough. CT chest shows an irregular mass-like density in the left
infrahilar region, measuring up to 6.5 cm in diameter, as well 
as
multiple nodular opacities in the right lower lobe, irregular
pleural thickening in the left hemithorax, numerous markedly
enlarged mediastinal and bilateral hilar lymph nodes with a 
large
conglomerate in the precarinal region, and multiple markedly
enlarged right axillary lymph nodes. 
- ___: Evaluated by Dr. ___ Hematology/Oncology, who
recommends biopsy. 
- ___: Undergoes thoracentesis and possible right axillary
lymph node biospy at ___. Per report this
demonstrates Diffuse Large B Cell Lymphoma with rearrangements 
in
MYC, BCL2, and BCL6, i.e. ""Triple Hit"" DLBCL. 
- ___: Discharged to home on prednisone taper. 
- ___: PET scan at ___ reveals pronounced
uptake within extensive supraclavicular, internal mammary,
mediastinal, hilar, paraesophageal, left epicardial, mesenteric,
and retroperitoneal lymph nodes consistent with malignancy.
Uptake is also seen within nodular pleural-based soft tissue in
the left hemithorax. Small left pleural effusion. Uptake within 
a
small left upper lobe nodule. Small area of uptake within the
mesentery of the pelvis, with some apparent misregistration of
PET and CT images in this region.  Uptake as a tubular 
appearance
and may correspond to small bowel.  Lymphoma involvement of 
small
bowel may be present. Atherosclerotic changes. 
- ___: Port-a-Cath placed at ___. 
- ___: Referred to ___.
- ___: Initial evaluation by Dr. ___ the ___
team at ___. Admitted for expedited evaluation and management. 


PAST MEDICAL/SURGICAL HISTORY:  
- Chronic Renal Insufficiency
- Anemia of chronic kidney disease 
- Coronary Artery Disease 
- Diabetes Mellitus Type 2 
- Hypertension
- Hyperlipidemia
- Peripheral Arterial Disease status-post left leg bypass 
surgery
- Osteomyelitis status-post amputation of left foot toes 
- Iron deficiency
- Restless leg syndrome, on Sinemet
- Obstructive Sleep Apnea 
- Squamous cell cancer of skin status-post amputation of middle
finger in ___
- Multiple basal cell skin cancers 

 
Social History:
___
Family History:
Per previous notes, sister died of ___.
Father died of heart failure at age ___. Mother died of heart and
lung issues at age ___. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
======================== 
Vitals: 24 HR Data (last updated ___ @ 1714)
    Temp: 97.5 (Tm 97.5), BP: 172/78, HR: 100, RR: 20, O2 sat:
98%, O2 delivery: Ra, Wt: 164.6 lb/74.66 kg  
Gen: Pleasant, calm, in NAD.  
HEENT: No conjunctival pallor. No icterus. MMM. OP clear.  
NECK: Supple. JVP not elevated at 90 degrees. 
CV: RRR. distant heart sounds. 
LUNGS: pauses every several words to take a breath. CTAB.
Rhonchorous breath sounds. No crackles.  
ABD: NABS. Soft, NT, ND.  
EXT: Extremities somewhat cool to touch L worse than R. Pitting
edema at L ankle. R foot with purple discoloration around MTP
extending up to toes. Non-tender, nonertythematous. 
SKIN: No rashes/lesions, petechiae/purpura ecchymoses.  
NEURO: A&Ox3. Moving all extremities with purpose
LINES: R port nonerythematous, nontender 

DISCHARGE PHYSICAL EXAM:
======================== 
PHYSICAL EXAM: 
___ 0723 Temp: 97.9 PO BP: 119/72 HR: 97 RR: 20 O2 sat: 94%
O2 delivery: RA FSBG: 242 
Gen: Pleasant, calm, in NAD. More alert and conversational
CV: RRR. distant heart sounds. 
LUNGS: wheezing and crackles bilaterally and coarse voice
significantly improved
ABD: NABS. Soft, NT, ND.  
EXT: 1+ edema. R foot with purple discoloration around MTP
extending up to toes, stable from prior.
LINES: R port nonerythematous, nontender. 
 
Pertinent Results:
ADMISSION LABS:
================
___ 12:00AM   GLUCOSE-160* UREA N-27* CREAT-2.6* SODIUM-141 
POTASSIUM-4.5 CHLORIDE-102 TOTAL CO2-25 ANION GAP-14
___ 12:00AM   ALT(SGPT)-<5 AST(SGOT)-8 LD(LDH)-406* ALK 
PHOS-104 TOT BILI-0.2
___ 12:00AM   ALBUMIN-3.2* CALCIUM-11.1* PHOSPHATE-4.1 
MAGNESIUM-1.6 URIC ACID-6.1 IRON-29*
___ 12:00AM   calTIBC-226* VIT B12-622 FOLATE-12 
FERRITIN-117 TRF-174*
___ 12:00AM   NEUTS-85.3* LYMPHS-3.7* MONOS-7.4 EOS-2.8 
BASOS-0.2 IM ___ AbsNeut-7.88* AbsLymp-0.34* AbsMono-0.68 
AbsEos-0.26 AbsBaso-0.02
___ 12:00AM   PLT COUNT-357
___ 12:00AM   ___ PTT-31.6 ___
___ 12:00AM   RET AUT-1.7 ABS RET-0.05
___ 09:45PM URINE  HOURS-RANDOM UREA N-229 CREAT-42 
SODIUM-101
___ 09:45PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 09:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30* 
GLUCOSE-100* KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 09:45PM URINE  RBC-1 WBC-2 BACTERIA-NONE YEAST-NONE 
EPI-<1 TRANS EPI-<1
___ 06:20PM   GLUCOSE-182* UREA N-30* CREAT-3.0* SODIUM-139 
POTASSIUM-4.7 CHLORIDE-101 TOTAL CO2-24 ANION GAP-14
___ 06:20PM   LD(LDH)-418*
___ 06:20PM   PHOSPHATE-4.5 URIC ACID-6.4
___ 03:21PM   HGB-8.5*
___ 03:21PM   G6PD QUAL-NORMAL
___ 03:21PM   RET AUT-1.6 ABS RET-0.05
___ 11:00AM   GLUCOSE-78 UREA N-31* CREAT-3.1* SODIUM-140 
POTASSIUM-4.6 CHLORIDE-100 TOTAL CO2-24 ANION GAP-16
___ 11:00AM   estGFR-Using this
___ 11:00AM   ALT(SGPT)-8 AST(SGOT)-17 LD(LDH)-496* ALK 
PHOS-105 TOT BILI-0.2
___ 11:00AM   ALBUMIN-3.5 CALCIUM-12.3* PHOSPHATE-4.5 
MAGNESIUM-1.8 URIC ACID-6.5
___ 11:00AM   TOT PROT-6.1*
___ 11:00AM   HBsAg-NEG HBs Ab-NEG HBc Ab-NEG
___ 11:00AM   CRP-49.6*
___ 11:00AM   b2micro-13.2* IgG-572* IgA-153 IgM-256*
___ 11:00AM   HIV Ab-NEG
___ 11:00AM   HCV Ab-NEG
___ 11:00AM   WBC-10.5* RBC-3.00* HGB-8.9* HCT-28.1* MCV-94 
MCH-29.7 MCHC-31.7* RDW-14.8 RDWSD-51.1*
___ 11:00AM   NEUTS-83.6* LYMPHS-4.7* MONOS-8.5 EOS-2.3 
BASOS-0.2 IM ___ AbsNeut-8.81* AbsLymp-0.49* AbsMono-0.89* 
AbsEos-0.24 AbsBaso-0.02
___ 11:00AM   PLT COUNT-396

DISCHARGE LABS:
=====================
___ 12:00AM BLOOD WBC-18.1* RBC-2.58* Hgb-7.6* Hct-23.8* 
MCV-92 MCH-29.5 MCHC-31.9* RDW-15.1 RDWSD-48.5* Plt ___
___ 12:00AM BLOOD Neuts-100* Lymphs-0* Monos-0* Eos-0* 
Baso-0 AbsNeut-18.10* AbsLymp-0.00* AbsMono-0.00* AbsEos-0.00* 
AbsBaso-0.00*
___ 12:00AM BLOOD Plt Smr-NORMAL Plt ___
___ 12:00AM BLOOD Glucose-269* UreaN-35* Creat-1.7* Na-138 
K-4.7 Cl-101 HCO3-23 AnGap-14
___ 12:00AM BLOOD LD(LDH)-301*
___ 12:00AM BLOOD Calcium-8.0* Phos-3.0 Mg-1.8

REPORTS:
======================

___ LENIS
IMPRESSION: 
1. Limited evaluation of the posterior tibial and peroneal 
veins.  No evidence 
of acutedeep venous thrombosis in the visualized left lower 
extremity veins. 
2. Eccentric echogenic material within the popliteal vein is 
nonspecific but 
most likely represents chronic nonocclusive thrombus. 

___ TTE
The left atrial volume index is normal. The right atrium is 
mildly enlarged. There is normal left ventricular wall thickness 
with a normal cavity size. There is normal regional and global 
left ventricular systolic function. The visually estimated left 
ventricular ejection fraction is 60-65%. Left ventricular 
cardiac index is high (>4.0 L/min/m2). There is no resting left 
ventricular outflow tract gradient. Normal right ventricular 
cavity size with normal free wall motion. The aortic sinus 
diameter is normal for gender with normal ascending aorta 
diameter for gender. The aortic valve leaflets (?#) are mildly 
thickened. There is no aortic valve stenosis. There is no aortic 
regurgitation. The mitral valve leaflets are mildly thickened 
with no mitral valve prolapse. There is trivial mitral 
regurgitation. The pulmonic valve leaflets are normal. The 
tricuspid valve leaflets appear structurally normal. There is 
physiologic tricuspid regurgitation. There is mild pulmonary 
artery systolic hypertension. There is no pericardial effusion. 
IMPRESSION: Suboptimal image quality. Normal left ventricular 
wall thickness and biventricular cavity sizes and 
regional/global systolic function. Mild pulmonary artery 
systolic hypertension. 

___ RENAL US
FINDINGS:  
There is no hydronephrosis, stones, or masses bilaterally. 
Normal cortical 
echogenicity and corticomedullary differentiation are seen 
bilaterally. 
Right kidney: 7.6 cm 
Left kidney: 9.4 cm 
The bladder is moderately well distended and normal in 
appearance. 
IMPRESSION:  
Normal renal ultrasound. 

___ CT CHEST
1. Large loculated left pleural effusion measures up to 14.6 x 
5.0 cm in 
greatest dimension. 
2. Adjacent to the loculated left pleural effusion there is 
opacification 
which may represent relaxation atelectasis, however 
infection/aspiration 
cannot be excluded. 
3. Right axillary, mediastinal and upper abdominal 
lymphadenopathy is 
consistent with known history of diffuse large B-cell lymphoma. 
4. Non-obstructing nephrolithiasis of the kidneys measuring up 
to 4 mm. 

___ RUE US
IMPRESSION:  
Nonocclusive thrombus within the 1 of the brachial veins in the 
distal portion of the upper arm, around the upper extremity 
PICC. 

___ RUQUS
IMPRESSION:  
1. Patent hepatic vasculature. 
2. Diffusely coarsened liver parenchyma, without focal lesion. 
3. Irregular and thickened wall in the minimally distended 
gallbladder with a 
small stone and probable adenomyomatosis. No distension or 
pericholecystic 
fluid to suggest active inflammation. 
4. Minimally dilated common bile duct. No intrahepatic biliary 
ductal 
dilatation. 

___ CT CHEST W/O CONTRAST
IMPRESSION:
1. Large loculated left pleural effusion measures up to 14.6 x 
5.0 cm in 
greatest dimension. 
2. Adjacent to the loculated left pleural effusion there is 
opacification 
which may represent relaxation atelectasis, however 
infection/aspiration 
cannot be excluded. 
3. Right axillary, mediastinal and upper abdominal 
lymphadenopathy is 
consistent with known history of diffuse large B-cell lymphoma. 
4. Non-obstructing nephrolithiasis of the kidneys measuring up 
to 4 mm. 
  
___ CT CHEST W/O CONTRAST
IMPRESSION: 
1. Overall improvement of pre-vascular and retroperitoneal 
lymphadenopathy in comparison with ___.  Severe 
infiltrative upper and lower 
paratracheal mediastinal adenopathy grossly unchanged in bulk,, 
but there is  less narrowing around of central bronchi.  No 
apparent mass effect on the SVC. 
2. Interlobular septal thickening has increased.  This in 
combination with 
peribronchial thickening and bilateral pleural effusions suggest 
worsening 
pulmonary edema. 
3. Multiple stable pulmonary nodules measuring up to 7 mm.  
Attention on 
follow-up is recommended, if appropriate. 

___ VIDEO OROPHARYNGEAL SWALLOW
Aspiration with thin liquids and penetration with thin and 
nectar thick 
liquids. 
  
___ CT CHEST W/O CONTRAST
IMPRESSION: 
1. Several centrilobular ground-glass opacities along the 
periphery of the 
right lung are new since the prior study.  Findings are 
nonspecific and likely represent infection or inflammation of 
lower airways, but these new opacities are not extensive. 
2. Continued mild improvement in Findings associated with 
neoplastic disease in the chest. 
3. Interlobular septal thickening, likely secondary to moderate 
pulmonary 
edema, appears stable.  Etiology may be due to lymphatic outflow 
obstruction rather than congestive heart failure, however, given 
infiltrative hilar masses. 
4. Multiple bilateral nodules measuring up to 7 mm are similar 
in size to the prior study from ___, however underlying 
malignancy cannot be excluded. These nodules can be reviewed in 
follow-up imaging. 

___ CXR
IMPRESSION:  
In comparison with the study ___, there is increased 
opacification at the right base with silhouetting of the 
hemidiaphragm, most likely reflecting pleural effusion with 
atelectatic changes.  Less prominent effusion and atelectasis 
are seen on the left.  Cardiomediastinal silhouette is stable. 
Although it is difficult to determine a specific area of 
consolidation, given the extensive changes described above it 
would be difficult to unequivocally exclude superimposed 
pneumonia, especially in the absence of a lateral view. The 
multiple nodular opacifications seen on CT are beyond the 
resolution limits of plain radiographs.  Similarly, it is 
difficult to described the septal thickening seen at CT. 

___ RUE ULTRASOUND
No evidence of deep vein thrombosis in the right upper 
extremity.

___ BILATERAL LOWER EXTREMITY VEIN ULTRASOUND
Limited evaluation of the calf veins.  No evidence of acutedeep 
venous 
thrombosis in the right or left lower extremity veins.   
Multiple wall 
calcifications within the right popliteal vein are seen.  
Notably, the 
previous echogenic focus within the left popliteal vein was not 
seen on 
today's examination. 

___ VIDEO OROPHARYNGEAL SWALLOW
Aspiration with thin and nectar thick liquids, and consistent 
penetration with thin and nectar thick liquids. Please note that 
a detailed description of dynamic swallowing as well as a 
summative assessment and recommendations are reported separately 
in a standalone note by the Speech-Language Pathologist (OMR, 
Notes, Rehabilitation Services). 

PATHOLOGY:
======================

___ LYMPH NODE BIOPSY
SPECIMEN: LYMPH NODE, RIGHT AXILLARY, CORE NEEDLE BIOPSY.
DIAGNOSIS:
HIGH GRADE B-CELL LYMPHOMA, NOS, WITH IGH/BCL2 REARRANGEMENT. 
SEE NOTE.
Note: Sections of a core lymph node biopsy show three distinct 
areas comprising roughly a third of the core biopsy each. One 
zone shows a lymphoid proliferation composed almost entirely of 
medium size and large lymphocytes with irregularly shaped 
nuclei, blastic chromatin, small amounts of cytoplasm and 
inconspicuous nucleoli. Frequent mitoses, including atypical 
mitoses and apoptotic cells are seen. The second zone shows a 
proliferation of smaller lymphocytes with round nuclei, blastic 
chromatin and inconspicuous nucleoli in a background of loose 
connective tissue. Yet a third zone shows complete coagulative 
necrosis. By immunohistochemistry, CD20 highlights B-cells 
occupying the vast majority of the viable tissue. CD3 and CD5 
highlights scattered interspersed T-cells and few dense large 
aggregates. CD10 is variably positive, it stain the lymphocytes 
in the zone containing medium and large cells, but not the one 
primarily made up of small lymphocytes. MUM is variably positive 
and BCL6 is diffusely positive. BCL2 is immunoreactive in all 
lymphocytes. CD21 highlights scattered background follicular 
dendritic cell meshwork remnants. CD23 and BCL1 are negative. By 
Ki67 (MIB1) staining, the proliferation index is variable, with 
the zone of larger cells showing 90-100% staining, and 70-80% in 
the zone dominated by small blastic lymphocytes. Immunostains 
for CMYC shows staining in an average of 20% of cells.
FISH: POSITIVE for IGH/BCL2 and GAIN of MYC. Approximately 50% 
of the interphase right
axillary lymph node cells examined in this high grade lymphoma 
FISH panel had probe signal
patterns consistent with ___ extra intact copies of MYC and the 
IGH/BCL2 gene rearrangement
characteristic of follicular lymphoma and diffuse large B-cell 
lymphoma of germinal center origin.
There was no evidence of rearrangements of the BCL6 and MYC 
genes.

___ IMMUNOPHENOTYPING
INTERPRETATION 
Nondiagnostic study. Cell marker analysis was performed, but was 
nondiagnostic in this case due to insufficient numbers of 
cells/insufficient amount of tissue for analysis. Clonality 
could not be assessed in this case due to insufficient numbers 
of B cells. If clinically indicated, we recommend a repeat 
specimen be submitted to the flow cytometry laboratory. 
Correlation with clinical, morphologic (see separate pathology 
report ___-___) and other ancillary (see separate cytogenetics 
report ___-___) findings is recommended. Flow cytometry 
immunophenotyping may not detect all abnormal populations due to 
topography, sampling or artifacts of sample preparation.

___ PLEURAL FLUID
Nonspecific T cell predominant lymphoid profile; diagnostic 
immunophenotypic features of involvement by leukemia/lymphoma 
are not seen in this specimen. Correlation with clinical, 
morphologic (see separate pathology report ___-___) and other 
ancillary (see separate cytogenetics report ___) findings 
is recommended. Flow cytometry immunophenotyping may not detect 
all abnormal populations due to topography, sampling or 
artifacts of sample preparation.

___ IMMUNOTYPING 
Nondiagnostic study. Cell marker analysis was performed, but was 
nondiagnostic in this case due to insufficient numbers of 
cells/insufficient amount of tissue for analysis. Clonality 
could not be assessed in this case due to insufficient numbers 
of B cells. If clinically indicated, we recommend a repeat 
specimen be submitted to the flow cytometry laboratory. 
Correlation with clinical and other ancillary (see separate 
cytogenetics report ___) findings is recommended. Flow 
cytometry immunophenotyping may not detect all abnormal 
populations due to topography, sampling or artifacts of sample 
preparation.

 
Brief Hospital Course:
===================
SUMMARY:
===================
Mr. ___ is a ___ year-old man with newly-diagnosed 
BCL2-rearranged Diffuse Large B Cell Lymphoma (diagnosed ___ 
via thoracentesis at ___, staging PET c/w Stage 
IV given extranodal disease in pleura, possible LUL and small 
bowel, B symptoms present), CAD, T2DM, HTN, HLD, PAD, CKD, who 
was directly admitted from ___ clinic for initiation of 
da-EPOCH and lumbar puncture with intrathecal chemotherapy. He 
began C1D1 da-EPOCH on ___. His hospital course was complicated 
by loculated L pleural effusion, for which chest tube was 
placed, RUE PICC-associated DVT on therapeutic Lovenox, E. coli 
bacteremia, VRE UTI, and left vocal cord paralysis. He received 
cycle 2 of R-CHOP with plan to continue chemotherapy as an 
outpatient. He was discharged in stable condition.

TRANSITIONAL ISSUES:
====================
[] Repeat echo within ___ months after the completion of 
anthracyclines.
[] Will follow-up outpatient w/ Dr. ___ in ___ 
clinic
[] Diffusely coarsened liver parenchyma on RUQUS, recommend 
follow up and consider repeat imaging 
[] Diagnosed with COPD during this admission and started on 
daily tiotropium and advair. Should have pulm follow-up as 
outpatient.
[] Sleep study so patient can obtain CPAP at home
[] Repeat iron studies, iron sat 12% on admission though 
subsequently received blood transfusions 
[] Consider increasing atorvastatin 20 given cardiac history
[] Repeat imaging in 6 months for multiple bilateral nodules 
measuring up to 7 mm noted on CT chest ___
[] Needs outpatient ENT referral for vocal cord injection
[] Discharged on novolog 20 units AM, 10 units ___. Will need 
close monitoring for titration of insulin as needed for blood 
sugar control. 
[] Discuss when to restart ASA81 and clopidogrel (held currently 
due to recent procedures and counts dropping, indication is CAD 
s/p PCI years ago)
[] Discuss when to restart statin 

======================
ACUTE MEDICAL ISSUES:
======================
#High Grade Diffuse Large B Cell Lymphoma w/ BCL2 Rearrangement
(C1D6 da-EPOCH):
He was diagnosed ___ with Diffuse Large B Cell Lymphoma via 
thoracentesis and possibly right axillary core biopsy at ___ 
___. It was initially reported to be triple hit, 
however it was ultimately determined that FISH had not been 
performed at ___. He underwent ___ biopsy of R axillary 
node on ___ with FISH demonstrating BCL2 translocation as well 
as extra MYC signals. Staging PET was consistent with Stage IV 
given extranodal disease in pleura, possible LUL and small bowel 
and B symptoms present. He was admitted from clinic for 
initiation of da-EPOCH and lumbar puncture with intrathecal 
methotrexate. He began C1D1 da-EPOCH on ___. He was monitored 
through his neutrophil nadir and his count recovered on day 18. 
He received acyclovir and atovaquone for infectious prophylaxis. 
He received filgrastim given anticipated neutrophil nadir that 
was stopped upon count recovery. He initially received 
allopurinol for TLS prophylaxis which was subsequently 
discontinued due to transaminitis. Given poor toleration of 
da-EPOCH, he was started on R-CHOP for cycle 2 which he received 
on ___ with plan for further chemotherapy as outpatient. He was 
started on filgrastim and allopurinol on ___, but filgrastim was 
stopped a few days later following a robust increase in WBC. He 
received a dose of filgrastim right before discharge in 
preparation of further chemotherapy. 

# Dyspnea
# Loculated pleural effusion
# COPD
# Productive cough
Patient found to have large left effusion on CT after CXR for 
PICC placement demonstrated effusion. He underwent chest tube 
placement on ___ which drained 1L fluid and was subsequently 
removed on ___. Pleural fluids studies were exudative effusion, 
cytology negative for malignant cells however FISH positive 
suggestive of disease involvement. Pleural fluid cx negative. 
Additionally, he had significant wheezing on exam though no 
documented history of COPD. He underwent PFTs ___ notable for 
FEV1/FVC ratio 69% consistent with COPD. He was started on daily 
tiotropium and scheduled duonebs. He continued to have 
productive cough with crackles and rhonchi on exam. He had CT 
chest ___ showing pulmonary congestion that improved with 
diuresis. Repeat CT chest ___ showed continued congestion and 
nonspecific opacities, and he was started on metronidazole for 
possible aspiration pneumonia and completed a coarse from 
___. He was discharged on advair and tiotropium for his 
COPD. He should follow up with his PCP for further evaluation, 
consideration of referral to a pulmonologist. 

# CAD s/p stenting:
# Hx PVD s/p left femoral-peroneal bypass:
# HTN:
Per pt, most recent stent ___ year ago. Cardiology was consulted 
for cardio-onc evaluation given plan for chemo regimen with 
anthracyclines as above. Baseline TTE was obtained which 
demonstrated normal EF. He will require repeat echo within ___ 
months after the completion of anthracyclines and outpatient 
follow-up with Dr. ___ in cardio-oncology. Additionally, his 
home metoprolol was transitioned to carvedilol for 
cardioprotective and antihypertensive effect. His home 
antiplatelet regimen (Plavix QOD) was discussed with cardiology, 
vascular medicine, and vascular surgery. Per vascular surgery 
there was no indication from their standpoint for antiplatelet 
agent. Plavix was held in setting of thrombocytopenia. There was 
plan to begin aspirin, which was initially held given multiple 
procedures (LP, port replacement). He was asymptomatic and blood 
pressure remained controlled BP 110-120/60-70 until discharge. 
His aspirin and Plavix were held at discharge given he will be 
receiving further chemotherapy, with plan to rediscuss starting 
them as outpatient.

# E. coli Bacteremia:
He spiked a fever to 101 on ___ and blood cultures were 
positive for E.coli. He was started on cefepime, narrowed to 
ceftriaxone, given sensitive to E.coli (cipro and Bactrim 
resistant). He remained hemodynamically stable and afebrile 
until discharge with ___ services and line care to complete the 
2-week ceftriaxone course until ___. 
[ ] continue IV ceftriaxone (2wk, ___

# UTI: Urine was cultured in setting of fever that grew 
vancomycin-resistant enterococcus. He was started on daptomycin 
given risk of serotonin syndrome with linezolid and home 
amitriptyline. He completed a 7-day course of daptomycin from 
___.

# Left vocal cord paralysis
# Aspiration risk: He presented with a hoarse voice; no 
respiratory symptoms aside from coughing. He was evaluated by 
ENT which found left vocal cord paralysis in the setting of 
hilar and mediastinal adenopathy and soft tissue encasing the 
trachea. A video swallow was performed and showed aspiration 
with thin and nectar thick liquids. He was kept on thick liquids 
using a straw with chin tuck. He was recommended to follow-up 
with ENT as an outpatient for vocal cord injection. Repeat video 
swallow was unchanged from prior. After goals of care discussion 
with patient and his wife, he was discharged home with an 
understanding of aspiration risk. He should follow up with ENT 
for further management. 

# Tremors: He was noted to have bilateral upper extremity 
tremors at rest and with movement. There was no evidence of 
withdrawal, hyperthyroidism, or focal neurologic deficits. It 
has been chronic for several months and continues to be 
nonfocal. Likely to be drug-induced (steroids) or functional or 
Parkinsonian. The tremors remained stable through discharge.

# Maculopapular rash:
He developed a nontender, non-pruritic, blanching maculopapular 
erythematous rash across his back and flanks. The rash was 
consistent with neutrophilic eccrine hidradenitis related to his 
chemotherapy medication. He was evaluated by Dermatology and no 
treatment was indicated given the rash was asymptomatic. His 
rash remained stable throughout his hospital stay.

# Transaminitis:
He developed transaminitis while in house. It was felt to be 
most likely secondary to chemotherapy. RUQUS w/ Doppler 
unremarkable. HBV, HCV serologies were negative on admission. 
EBV/CMV viral load and serologies were negative. His 
allopurinol, home statin, and Tylenol were held in the setting 
of transaminitis. His liver function tests returned to normal at 
discharge.

# RUE PICC-associated DVT:
He was found to have a RUE PICC associated DVT, of which the 
PICC was subsequently removed. LENIS with question of chronic 
non-occlusive thrombus within popliteal vein. This was discussed 
with vascular medicine and there was initially a plan to 
reimage, however he was subsequently started on enoxaparin for 
the RUE DVT. Repeat RUE ultrasound and LENIS several weeks later 
showed no evidence of clot. Given no indication for 
anticoagulation, his enoxaparin was discontinued.

# ___ on CKD III
Cr 3.1 on presentation. Baseline Cr unknown, most recently 2.3 
in ___. Suspect pre-renal in the setting of hypercalcemia. 
Renal US was obtained which was unremarkable. Cr subsequently 
improved to 2.1 with IVF. His medications were renally dosed. 

# Acute on chronic anemia:
Hgb 8.5 on admission, previously 10.9 on admission to ___ 
___ on ___. Ferritin in ___ was ___. Previously 
receiving Procrit for anemia of chronic kidney disease. Iron sat 
12%. B12, folate wnl. Retic index c/w hypoproliferation. He 
received intermittent transfusions during this hospitalization 
for Hb<7. There was no evidence of active bleeding. 

# Hypercalcemia: 
Ca ___ on admission. Most likely in the setting of lymphoma. 
PTH ___ was 12.8, PTHrP 12. His hypercalcemia resolved with 
IVF. 

# T2DM:
He required increased dose of his home insulin novolog regimen 
(home: 23u AM, 20u ___ given steroid administration. He required 
significant insulin (40u AM, 25u ___ while on steroids) and was 
discharged on novolog 20u AM, 10u ___. He will need close follow 
up to titrate his insulin. 

#Restless Leg Syndrome:
Continued home carbidopa/levodopa ___.

#Depression: 
Continued Amitriptyline 50.

#OSA:
Continued CPAP. 

#Allergies: 
Continued home cetirizine 10.

========
BUNDLE:
======== 
# CODE: DNR/DNI
# EMERGENCY CONTACT: 
 Next of Kin: ___ 
 ___: ___ 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amitriptyline 50 mg PO QHS 
2. Atorvastatin 20 mg PO QPM 
3. Carbidopa-Levodopa (___) 1 TAB PO DAILY 
4. Clopidogrel 75 mg PO EVERY OTHER DAY 
5. Metoprolol Succinate XL 50 mg PO DAILY 
6. Temazepam 30 mg PO QHS 
7. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever 
8. Cetirizine 10 mg PO DAILY 
9. NovoLIN ___ (insulin NPH and regular human) 100 unit/mL 
(70-30) subcutaneous BID 

 
Discharge Medications:
1.  Acyclovir 400 mg PO Q12H 
RX *acyclovir 400 mg 1 capsule(s) by mouth every twelve (12) 
hours Disp #*60 Tablet Refills:*0 
2.  Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath 
RX *albuterol sulfate 90 mcg 1 puff inhaled every six (6) hours 
Disp #*120 Inhaler Refills:*0 
3.  Allopurinol ___ mg PO DAILY 
RX *allopurinol ___ mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
4.  Atovaquone Suspension 1500 mg PO DAILY 
RX *atovaquone 750 mg/5 mL 10 ml by mouth once a day Disp #*6300 
Milliliter Milliliter Refills:*0 
5.  CefTRIAXone 2 gm IV Q 24H 
RX *ceftriaxone in dextrose,iso-os 2 gram/50 mL 2 gm IV once a 
day Disp #*4 Intravenous Bag Refills:*0 
6.  Filgrastim 300 mcg SC Q24H 
RX *filgrastim [Neupogen] 300 mcg/0.5 mL 300 mcg SC once a day 
Disp #*10 Syringe Refills:*5 
7.  Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
RX *fluticasone propion-salmeterol [Advair Diskus] 250 mcg-50 
mcg/dose 1 dose inhaled twice a day Disp #*60 Disk Refills:*0 
8.  Pantoprazole 40 mg PO Q24H 
RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
9.  Tiotropium Bromide 1 CAP IH DAILY 
RX *tiotropium bromide [Spiriva with HandiHaler] 18 mcg 1 cap IH 
once a day Disp #*30 Capsule Refills:*0 
10.  NovoLIN ___ (insulin NPH and regular human) 100 unit/mL 
(70-30) subcutaneous BID  
11.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever 
RX *acetaminophen 650 mg 1 tablet(s) by mouth every four (4) 
hours Disp #*100 Tablet Refills:*0 
12.  Amitriptyline 50 mg PO QHS 
RX *amitriptyline 50 mg 1 tablet(s) by mouth at bedtime Disp 
#*30 Tablet Refills:*0 
13.  Carbidopa-Levodopa (___) 1 TAB PO DAILY 
RX *carbidopa-levodopa 25 mg-100 mg 1 tablet(s) by mouth once a 
day Disp #*30 Tablet Refills:*0 
14.  Cetirizine 10 mg PO DAILY 
RX *cetirizine 10 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
15.  Metoprolol Succinate XL 50 mg PO DAILY 
RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day 
Disp #*30 Tablet Refills:*0 
16.  Temazepam 30 mg PO QHS 
RX *temazepam 30 mg 1 capsule(s) by mouth at bedtime Disp #*30 
Capsule Refills:*0 
17. HELD- Atorvastatin 20 mg PO QPM  This medication was held. 
Do not restart Atorvastatin until your doctor tells you to do so
18. HELD- Clopidogrel 75 mg PO EVERY OTHER DAY  This medication 
was held. Do not restart Clopidogrel until your doctor tells you 
to do so

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___:
PRIMARY DIAGNOSIS
-------------------- 
Diffuse Large B Cell Lymphoma 

SECONDARY DIAGNOSIS
-------------------- 
Vocal card paralysis
Chronic Renal Insufficiency
Coronary Artery Disease 
Diabetes Mellitus Type 2 
Hypertension
Hyperlipidemia
Obstructive Sleep Apnea 
E. coli Bacteremia
VRE Urinary Tract Infection
Acute on Chronic Anemia
Pleural Effusion
Deep Venous Thrombosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___!

WHY WAS I ADMITTED TO THE HOSPITAL?
You were admitted to the hospital to begin chemotherapy for 
treatment of your diffuse large B cell lymphoma.

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
-You started on chemotherapy for your lymphoma.
-You were seen by the heart doctors because ___ have a history 
of heart disease, and some of the chemotherapy you are receiving 
can affect the heart. You will need to follow-up with them in 
clinic once you leave the hospital. 
-You were found to have a large build-up of fluid in the lining 
surrounding the lung that was making it difficult for you to 
breath. You had a tube placed in your chest to help drain this 
fluid out. Your breathing improved and the chest tube was 
removed. 
-You were diagnosed with a lung disorder called COPD. You were 
started on inhalers for this. You should follow-up with the lung 
doctors after ___ leave the hospital for this. 
-You were found to have vocal cord paralysis and at risk of 
aspiration. You were evaluated by our Speech and Swallow team to 
optimize your nutrition and prevent aspiration.

WHAT SHOULD I DO WHEN I GO HOME?
-Please take all your medications as prescribed. 
-Please follow-up with your doctor on ___. 
-Insulin regimen at discharge: novolog 20 units in the morning, 
15 units at night. 
-Please monitor your blood glucose closely and call your doctor 
if your blood glucose is <75 or >400. 
-Please talk with your cardiologist about when to restart your 
aspirin, Plavix and atorvastatin 
-You should give yourself neupogen daily until otherwise 
instructed 

We wish you the best,
Your ___ care team
 
Followup Instructions:
___
"
65,13375185,24478091," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Bactrim / Aleve
 
Attending: ___.
 
Chief Complaint:
syncope, NSTEMI transfer from ___
 
Major Surgical or Invasive Procedure:
PCI with DES to LAD ___

Cardiac angiogram ___

 
History of Present Illness:
Mr. ___ is a ___ yo male with DLBCL s/p recent da-EPOCH and 
2
cycles of RCHOP, CAD s/p prior PCI ___ at ___, 4 BMS to
dominant RCA, 50% stenosis of ___ LAD, 50% ostial of OM1. No
LMCA disease), PAD, CKD, DM2, HTN who presented to ___ via EMS
for syncope found to have NSTEMI. 

Patient was recently discharged from the ___ service on ___ 
after
a long hospital course c/b loculated pleural effusion s/p chest
tube, PICC associated DVT, E. coli bacteremia, VRE UTI, and left
vocal cord paralysis. After discharge, he states he was feeling
fine until ___ afternoon. He recalls walking towards the
kitchen but cannot recall the events thereafter until he was in
the ambulance leaving ___ coming to ___. Per patient's wife, 
he
passed out at home at which time she called EMS. While en route
to ___, patient had large volume emesis and had another bout in
the ED at ___. At the ED at ___, patient was given Zofran and
IVF. An EKG reportedly had ST elevation and Q waves septally and
troponin was elevated to 1.46. At that time, patient was
transferred to ___ for further management.

In the ED: 
Initial VS:T 98.2 HR113 BP 119/81 RR 18 SaO2 96% RA

Exam:
General: no acute distress
HEENT: Normal oropharynx, no exudates/erythema
Cardiac: RRR , no chest tenderness
Pulmonary: Diffuse rhonchi bilaterally
Abdominal/GI: Normal bowel sounds, no tenderness or masses
Renal: No CVA tenderness
MSK: No deformities or signs of trauma, no focal deficits noted
Neuro: Sensation intact upper and lower extremities, strength 
___
upper and lower, no focal deficits noted, moving all extremities
Extremities: Right upper extremity edema

EKG:NSR, HR 116, left axis deviation, normal intervals, no
STE/STD

Labs notable for: WBC: 11.5/ Hgb 7.2 -> 6.7 / Mg 1.5 / CK 22 / 
MB
2 / Cr 1.7 ->1.6 / trop 1.39 ->1.34 / 

Studies notable for:
- CTA Chest negative for PE
- TTE notable for reduced EF 35% from 65% with possible distal
LAD terrtory regionality. 

Consults: 
Cardiology initially saw patient and thought given lack of CP,
hemodynamic instability or ischemic EKG changes, there was no
urgent indication for angiography. They recommended a TTE and
upon seeing the reduced EF with WMA, patient was taken to cath
given likely NSTEMI. 

Patient was given prior to cath lab: 
- Full dose aspirin
- Heparin gtt
- metop succinate 25mg 
- plavix
- nifedipine 
= 500cc IVF x 2

In the cath lab, did R radial approach demonstrating diffuse
disease. Patient was given additional 400cc IVF given concern 
for
CKD. 

Patient denies chest pain through out the course described 
above.
Denies dyspnea, fevers, chills, abdominal pain, leg swelling.
Endorses chronic wheeze since one of his vocal cords were
paralyzed. On arrival to the floor, patient reports that he 
feels
great but is confused. He says he was suppose to get a procedure
today but cannot recall what the procedure was. Patient states
feeling overwhelmed by being in the hospital again. 

REVIEW OF SYSTEMS:  
Positive per HPI.  
All of the other review of systems were negative.
 
Past Medical History:
1. CARDIAC RISK FACTORS  
- Diabetes  
- Hypertension  
- Dyslipidemia  
2. CARDIAC HISTORY  
PCI: 
___ at ___, 4 BMS to dominant RCA, 50% stenosis of ___ LAD,
50% ostial of OM1. No LMCA disease.
- Rhythm? Sinus  
3. OTHER PAST MEDICAL HISTORY  
- Lymphoma s/p C2 RCHOP
- Chronic Renal Insufficiency
- Anemia of chronic kidney disease 
- Coronary Artery Disease 
- Diabetes Mellitus Type 2 
- Hypertension
- Hyperlipidemia
- Peripheral Arterial Disease status-post left leg bypass 
surgery
- Osteomyelitis status-post amputation of left foot toes 
- Iron deficiency
- Restless leg syndrome, on Sinemet
- Obstructive Sleep Apnea 
- Squamous cell cancer of skin status-post amputation of middle
finger in ___
- Multiple basal cell skin cancers 

PAST ONCOLOGIC HISTORY:  
~ ___: In ___ started to have fatigue, weakness, falls,
dizziness. 
- ___: Admitted to ___ with hoarseness and
cough. CT chest shows an irregular mass-like density in the left
infrahilar region, measuring up to 6.5 cm in diameter, as well 
as
multiple nodular opacities in the right lower lobe, irregular
pleural thickening in the left hemithorax, numerous markedly
enlarged mediastinal and bilateral hilar lymph nodes with a 
large
conglomerate in the precarinal region, and multiple markedly
enlarged right axillary lymph nodes. 
- ___: Evaluated by Dr. ___ Hematology/Oncology, who
recommends biopsy. 
- ___: Undergoes thoracentesis and possible right axillary
lymph node biospy at ___. Per report this
demonstrates Diffuse Large B Cell Lymphoma with rearrangements 
in
MYC, BCL2, and BCL6, i.e. ""Triple Hit"" DLBCL. 
- ___: Discharged to home on prednisone taper. 
- ___: PET scan at ___ reveals pronounced
uptake within extensive supraclavicular, internal mammary,
mediastinal, hilar, paraesophageal, left epicardial, mesenteric,
and retroperitoneal lymph nodes consistent with malignancy.
Uptake is also seen within nodular pleural-based soft tissue in
the left hemithorax. Small left pleural effusion. Uptake within 
a
small left upper lobe nodule. Small area of uptake within the
mesentery of the pelvis, with some apparent misregistration of
PET and CT images in this region.  Uptake as a tubular 
appearance
and may correspond to small bowel.  Lymphoma involvement of 
small
bowel may be present. Atherosclerotic changes. 
- ___: Port-a-Cath placed at ___. 
- ___: Referred to ___.
- ___: Initial evaluation by Dr. ___ the ___
team at ___. Admitted for expedited evaluation and management. 

 
Social History:
___
Family History:
Per previous notes, sister died of ___.
Father died of heart failure at age ___. Mother died of heart and
lung issues at age ___. 

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=========================
VS: 24 HR Data (last updated ___ @ ___
    Temp: 97.9 (Tm 97.9), BP: 106/64 (106-115/60-70), HR: 112
(112-114), RR: 19, O2 sat: 97% (92-97)  
GENERAL: Well developed, well nourished male in NAD. Oriented 
x2.
Mood- frightful/anxious. 
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI.
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa.
No xanthelasma.  
NECK: JVP 12cm.  
CHEST: portacath in anterior R wall
CARDIAC: Tachycardic, regular rhythm, no m/r/g
LUNGS: Diffuse rhonci bilaterally, wheezing, bibasilar crackles
ABDOMEN: Soft, non-tender, non-distended. 
EXTREMITIES: 2+ pitting edema of the b/l ___ to the knees. Warm,
well perfused. 
PULSES: Distal pulses palpable and symmetric.  

DISCHARGE PHYSICAL EXAM
==========================
___ 0341 Temp: 97.8 PO BP: 102/60 HR: 98 RR: 18 O2 sat: 
100%
O2 delivery: Ra 
Gen: Alert and oriented, elderly male, sitting up in bed
comfortably, in no acute distress 
HEENT: Improved, somewhat hoarse voice with good phonation, 
moist
mucous membranes
LUNGS: Coarse breath sounds bilaterally, decreased breath sounds
at L lower base
CV: RRR, no r/g/m
ABD: Soft, nontender, nondistended 
EXT: Mild ___ edema, bruising throughout
NEURO: Alert with appropriate conversation, linear thought,
fluent speech. CN grossly intact. 
ACCESS: PORT dressing c/d/i

 
Pertinent Results:
ADMISSION LABS
=======================
___ 02:24PM   GLUCOSE-241* UREA N-27* CREAT-1.6* SODIUM-142 
POTASSIUM-4.3 CHLORIDE-106 TOTAL CO2-21* ANION GAP-15
___ 02:24PM   estGFR-Using this
___ 02:24PM   CALCIUM-8.0* PHOSPHATE-3.1 MAGNESIUM-1.6
___ 02:24PM   WBC-6.7 RBC-2.30* HGB-6.7* HCT-21.5* MCV-94 
MCH-29.1 MCHC-31.2* RDW-15.5 RDWSD-50.9*
___ 02:24PM   NEUTS-94* LYMPHS-6* MONOS-0* EOS-0* BASOS-0 
AbsNeut-6.30* AbsLymp-0.40* AbsMono-0.00* AbsEos-0.00* 
AbsBaso-0.00*
___ 02:24PM   POIKILOCY-1+* OVALOCYT-1+* TEARDROP-1+* 
ACANTHOCY-1+* RBCM-SLIDE REVI
___ 02:24PM   PLT SMR-NORMAL PLT COUNT-161
___ 02:24PM   ___ PTT-77.5* ___
___ 02:00AM   cTropnT-1.34*
___ 12:36AM URINE  HOURS-RANDOM
___ 12:36AM URINE  UHOLD-HOLD
___ 12:36AM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 12:36AM URINE  BLOOD-SM* NITRITE-NEG PROTEIN-30* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 12:36AM URINE  RBC-2 WBC-2 BACTERIA-NONE YEAST-NONE 
EPI-<1
___ 12:36AM URINE  MUCOUS-RARE*
___ 10:44PM   LACTATE-1.1
___ 10:27PM   GLUCOSE-45* UREA N-33* CREAT-1.7* SODIUM-146 
POTASSIUM-4.1 CHLORIDE-109* TOTAL CO2-23 ANION GAP-14
___ 10:27PM   ALT(SGPT)-19 AST(SGOT)-16 CK(CPK)-22* ALK 
PHOS-115 TOT BILI-0.4
___ 10:27PM   LIPASE-6
___ 10:27PM   cTropnT-1.39*
___ 10:27PM   CK-MB-2
___ 10:27PM   ALBUMIN-2.9* CALCIUM-8.2* PHOSPHATE-3.4 
MAGNESIUM-1.5*
___ 10:27PM   WBC-11.5* RBC-2.45* HGB-7.2* HCT-22.8* MCV-93 
MCH-29.4 MCHC-31.6* RDW-15.3 RDWSD-49.4*
___ 10:27PM   NEUTS-96* BANDS-1 LYMPHS-2* MONOS-1* EOS-0* 
BASOS-0 AbsNeut-11.16* AbsLymp-0.23* AbsMono-0.12* AbsEos-0.00* 
AbsBaso-0.00*
___ 10:27PM   POIKILOCY-1+* SCHISTOCY-1+* RBCM-SLIDE REVI
___ 10:27PM   PLT SMR-NORMAL PLT COUNT-180
___ 10:27PM   ___ PTT-26.5 ___
===================
DISCHARGE LABS
===================

___ 12:00AM BLOOD WBC-8.8 RBC-2.45* Hgb-7.7* Hct-24.1* 
MCV-98 MCH-31.4 MCHC-32.0 RDW-17.5* RDWSD-61.3* Plt ___
___ 12:00AM BLOOD Neuts-80* Lymphs-3* Monos-15* Eos-0* 
___ Myelos-2* AbsNeut-7.04* AbsLymp-0.26* AbsMono-1.32* 
AbsEos-0.00* AbsBaso-0.00*
___ 12:00AM BLOOD Plt Smr-NORMAL Plt ___
___ 12:00AM BLOOD ___ PTT-32.5 ___
___ 12:00AM BLOOD Glucose-357* UreaN-16 Creat-2.0* Na-142 
K-4.3 Cl-102 HCO3-27 AnGap-13
___ 12:00AM BLOOD ALT-10 AST-14 AlkPhos-126 TotBili-0.2
___ 10:15AM BLOOD CK-MB-2 cTropnT-0.03*
___ 12:00AM BLOOD Calcium-8.3* Phos-3.7 Mg-2.0 UricAcd-6.8

===================
OTHER PERTINENT LABS
==================
___ 06:49 

Report Comment: 
Source: Line-POC 
COMPLETE BLOOD COUNT 
White Blood Cells 0.3* 4.0 - 10.0 K/uL W 
Red Blood Cells 2.42* 4.6 - 6.1 m/uL W 
Hemoglobin 7.2* 13.7 - 17.5 g/dL W 
Hematocrit 21.8* 40 - 51 % W 
MCV 90 82 - 98 fL W 
MCH 29.8 26 - 32 pg W 
MCHC 33.0 32 - 37 g/dL W 
RDW 14.3 10.5 - 15.5 % W 
RDW-SD 45.6 35.1 - 46.3 fL W 
DIFFERENTIAL 
Neutrophils 19* 34 - 71 % W 
Lymphocytes 61* 19 - 53 % W 
Monocytes 15* 5 - 13 % W 
Eosinophils 0* 1 - 7 % W 
Basophils 4* 0 - 1 % W 
Blasts 1* 0 - 0 % W 
Absolute Neutrophil Count 0.06* 1.6 - 6.1 K/uL W 
Absolute Lymphocyte Count 0.18* 1.2 - 3.7 K/uL W 
Absolute Monocyte Count 0.05* 0.2 - .8 K/uL W 
Absolute Eosinophil Count 0.00* 0.04 - .54 K/uL W 
Absolute Basophil Count 0.01 0.01 - .08 K/uL W 
RED CELL MORPHOLOGY 
RBC Morphology  NORMAL N/A W 
  WITHIN NORMAL LIMITS 
BASIC COAGULATION ___, PTT, PLT, INR) 
Platelet Smear NORMAL NORMAL N/A W 
Platelet Count ___ K/uL 

===============
MICROBIOLOGY
================
___ 9:35 am BLOOD CULTURE
                            **FINAL REPORT ___
   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 1:37 pm URINE      Source: ___. 
                            **FINAL REPORT ___
   URINE CULTURE (Final ___: 
      YEAST.    10,000-100,000 CFU/mL.

___ 10:49 am Rapid Respiratory Viral Screen & Culture
      Source: Nasopharyngeal swab. 

                            **FINAL REPORT ___

   Respiratory Viral Culture (Final ___: 
      No respiratory viruses isolated. 
      Culture screened for Adenovirus, Influenza A & B, 
Parainfluenza type
      1,2 & 3, and Respiratory Syncytial Virus.. 
      Detection of viruses other than those listed above will 
only be
      performed on specific request. Please call Virology at 
___
      within 1 week if additional testing is needed. 

   Respiratory Viral Antigen Screen (Final ___: 
      Negative for Respiratory Viral Antigen. 
      Specimen screened for: Adeno, Parainfluenza 1, 2, 3, 
Influenza A, B,
      and RSV by immunofluorescence. 
 
___ 9:33 pm SPUTUM      Source: Expectorated. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      <10 PMNs and >10 epithelial cells/100X field. 
      Gram stain indicates extensive contamination with upper 
respiratory
      secretions. Bacterial culture results are invalid. 
      PLEASE SUBMIT ANOTHER SPECIMEN. 

   RESPIRATORY CULTURE (Final ___: 
      TEST CANCELLED, PATIENT CREDITED. 

   LEGIONELLA CULTURE (Final ___:    NO LEGIONELLA 
ISOLATED. 

___ 12:59 am STOOL     CONSISTENCY: SOFT      Source: 
Stool. 

                            **FINAL REPORT ___

   MICROSPORIDIA STAIN (Final ___:    NO MICROSPORIDIUM 
SEEN. 

   CYCLOSPORA STAIN (Final ___:    NO CYCLOSPORA SEEN. 

   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA 
FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   FECAL CULTURE - R/O VIBRIO (Final ___:    NO VIBRIO 
FOUND. 

   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA 
FOUND. 

   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: 
      No E. coli O157:H7 found. 

   Cryptosporidium/Giardia (DFA) (Final ___: 
      NO CRYPTOSPORIDIUM OR GIARDIA SEEN. 

___ Blood cultures x2: Pending

=================
PERTINENT IMAGING
===================
CTA CHEST ___:
1. No evidence of pulmonary embolism or acute aortic 
abnormality. 
2. Fairly diffuse ground-glass airspace opacification with a 
gravitational 
distribution as well as interlobular septal thickening is 
slightly increased 
compared to prior suggesting increasing interstitial (early 
alveolar) edema. 
3. Left pleural effusion is slightly increased in size. 
4.   Extensive mediastinal as well as right axillary adenopathy 
appears 
decreased over serial CT studies. 
5. Bilateral pulmonary nodules some of which are stable, others 
decreased in 
size.  No new or enlarging pulmonary nodules. 
6.   Endobronchial plugging, predominantly in the lower lobe 
airways, is 
likely secondary to aspiration/retained secretions. 

TTE ___
The left atrial volume index is normal. The estimated right 
atrial pressure is ___ mmHg. There is normal left
ventricular wall thickness with a normal cavity size. There is 
SEVERE regional left ventricular systolic
dysfunction with hypo/akinesis in the mid to apical 
inferolateral, inferior, true apex and apical anterior walls
(see schematic). Overall left ventricular systolic function is 
moderately depressed. The visually estimated
left ventricular ejection fraction is ___. Left ventricular 
cardiac index is normal (>2.5 L/min/m2).
There is Grade II diastolic dysfunction. Normal right 
ventricular cavity size with normal free wall motion. The
aortic sinus diameter is normal for gender with normal ascending 
aorta diameter for gender. The aortic arch
diameter is normal with a normal descending aorta diameter. The 
aortic valve leaflets (?#) are mildly
thickened. There is mild aortic valve stenosis (valve area 
1.5-1.9 cm2). There is no aortic regurgitation. The
mitral valve leaflets appear structurally normal with no mitral 
valve prolapse. There is mild [1+] mitral
regurgitation. The pulmonic valve leaflets are normal. The 
tricuspid valve leaflets appear structurally normal.
There is trivial tricuspid regurgitation. There is mild 
pulmonary artery systolic hypertension. There is a trivial
pericardial effusion.
IMPRESSION: 1) Severe regional LV systolic dysfunction wtih 
moderate reduction on global LV
function c/w prior myocardial infarction in mid to distal LAD 
territory. 2) Mild aortic stenosis. 3)
Stretched PFO versus very distal in the intreratrial septum 
located ASD with left to right shunting.
It appears that the shunt is not hemodynamically significant 
however due to its location
consideration for further work up could be made with either 
cardiac MRI or TEE.
Compared with the prior TTE ___ , LAD infarct is new. 
Left to right shunt probably present on prior
study however image quality much improved on current study.

Cardiac Angio ___
LM: The left main coronary artery is with 60-70% ostial.
LAD: The left anterior descending coronary artery is heavily 
calcified with diffuse proximal up to 80%
mid at origin large diagonal.
Circ: The circumflex coronary artery is calcified with diffuse 
disease to 50%.
RCA: The right coronary artery is heavily calcified with 
proximal 50%. Faint R-L collaterals are
present.
Complications: There were no clinically significant 
complications.

Thallium rest Viability ___
1. Severe, medium sized resting perfusion defect involving the 
LAD territory 
demonstrating low probability of recovery of function after 
revascularization of 
the apex and distal inferior wall and intermediate probability 
of the distal 
anterior wall and the mid anteroseptum.  The remaining cardiac 
segments 
demonstrate normal tracer uptake, consistent with high 
probability of recovery 
of function after revascularization. 
2. Increased left ventricular cavity size.  

PCI ___
Coronary Description
The coronary circulation is right dominant.
LM: The Left Main, arising from the left cusp, is a large 
caliber vessel. This vessel bifurcates into the
Left Anterior Descending and Left Circumflex systems. There is 
severe calcification in the ostium
extending to the proximal third of the LAD. There is a 20% 
stenosis in the ostium extending to the mid
segment.
LAD: The Left Anterior Descending artery, which arises from the 
LM, is a large caliber vessel. There is
a 95% stenosis in the proximal segment.
The Diagonal, arising from the proximal segment, is a medium 
caliber vessel.
Cx: The Circumflex artery, which arises from the LM, is a large 
caliber vessel. There is severe
calcification in the proximal segment. There is a 50% stenosis 
in the proximal segment.
The ___ Obtuse Marginal, arising from the proximal segment, is a 
medium caliber vessel.
The ___ Obtuse Marginal, arising from the mid segment, is a 
medium caliber vessel.
RCA: The Right Coronary Artery, arising from the right cusp, is 
a large caliber vessel. There is severe
calcification in the proximal and mid segments. There is a 50% 
stenosis in the proximal segment.
The Right Posterior Descending Artery, arising from the distal 
segment, is a medium caliber vessel.
The Right Posterolateral Artery, arising from the distal 
segment, is a medium caliber vessel.
 Normal left and right heart filling pressures.
 Preserved cardiac function.
 Normal pulmonary artery pressure.
 Three vessel coronary artery disease.
 IVUS of LMCA showing eccentric calcium with MLA of 9 mm2. 
Severe heavily calcified disease of proximal LAD succesfully 
treated with rotational atherectomy and 1 DES.

CXR ___:
IMPRESSION: 
There is a right chest wall Port-A-Cath with the tip terminating 
in the
superior vena cava. There is a small left pleural effusion. 
Linear opacities in the left lung base most likely represent a 
combination of subsegmental atelectasis and aspiration 
pneumonitis. There is no new consolidation or pneumothorax. The 
cardiomediastinal silhouette is within normal limits.  There is 
central pulmonary vascular congestion without overt pulmonary 
edema. Atherosclerotic calcifications of the thoracic aorta are 
noted.  There are no acute osseous abnormalities.

Video swallow ___:
IMPRESSION: 
Silent aspiration with thin and nectar thick liquids.

CXR ___:
IMPRESSION: 
There is a right-sided Port-A-Cath with distal tip at the 
cavoatrial junction. There has been worsening of the basilar 
opacities particularly on the left side since previous.  There 
is a small left-sided pleural effusion.  There are no 
pneumothoraces.

CT Chest ___:
IMPRESSION: 
Despite persistent severe central adenopathy there is no 
appreciable
compromise of vital structures.

CT Abdomen/pelvis ___:
IMPRESSION:
1. 1.1 cm retrocrural lymph node which is similar to the CT 
examination from
___ but slightly decreased in size since ___.
2. 2.2 cm soft tissue nodule immediately deep to the umbilicus 
could represent
scar or focal fibrosis, but is nonspecific.  There are no prior 
comparison
studies to assess for stability.
3. There is a 4 mm nonobstructing stone within the midpole of 
the left kidney.
4. Please refer dedicated CT chest for additional findings.

CXR ___:
IMPRESSION: 
In comparison with the study of the ___, the 
cardiomediastinal silhouette is stable.  Continued and possibly 
increasing pulmonary edema.  Opacification at the left base is 
consistent with pleural fluid and atelectatic changes. The right 
hemidiaphragmatic contour is sharply seen, though there may be 
mild blunting of the costophrenic angle. Although all of this 
appearance could be related to pulmonary edema, in the 
appropriate clinical setting it would be difficult to exclude 
superimposed aspiration/pneumonia, especially in the absence of 
a lateral view.

CXR ___:
IMPRESSION: 
Mild interval increase in volume of a left pleural effusion as 
well as
subjacent atelectasis.

___ ___:
IMPRESSION: 
No evidence of deep venous thrombosis in the left lower 
extremity veins.

CXR ___:
IMPRESSION: 
A right chest Wall Port-A-Cath tip projects over the right 
atrium, unchanged. There is a moderate left pleural effusion 
with subjacent opacities which may reflect atelectasis or 
pneumonia.  New pulmonary vascular congestion is present since 
prior. There is no pneumothorax or large right pleural effusion. 
The size of the cardiac silhouette is suboptimally evaluated 
given the abnormalities in the left hemithorax.

PET ___
IMPRESSION: 1. Relative to description of findings from PET-CT 
on ___, there has been interval decrease in FDG avidity 
of supraclavicular, right axillary, mediastinal, and hilar 
lymphadenopathy.  No FDG avid paraesophageal, epicardial, 
retroperitoneal, or internal mammary lymphadenopathy are noted. 
Size of lymph node conglomerates is overall minimally decreased 
compared to CT examinations from ___. 2. Retrocrural 
lymph node measures 1.2 x 1.2 cm with minimal FDG avidity an SUV 
max of 1.7. 3. Minimally FDG avid nodule deep to the umbilicus 
with SUV max of 2.0, nonspecific.  This finding is likely 
chronic and not related to malignancy. Attention on follow-up. 
4. 3 areas of ground-glass opacification and FDG avidity in both 
lungs are new compared to CT chest on ___.  As such, 
infection/inflammation is favored over malignancy.  Attention on 
follow-up is recommended. 5. Patulous, FDG avid 
esophagus is suggestive esophagitis. 6. Interval increase in now 
moderate left pleural effusion. 7. Unchanged 4 mm nonobstructing 
left renal stone. 

 
Brief Hospital Course:
====================
PATIENT SUMMARY:
====================
Mr. ___ is a ___ yo male with a history of DLBCL s/p recent 
da-EPOCH and 2 cycles of RCHOP, CAD s/p prior PCI, PAD, CKD, 
DM2, HTN. He was recently discharged from the ___ service on 
___ after a lengthy stay c/b pleural effusion, PICC 
associated DVT, E coli bacteremia, VRE UTI, and L vocal cord 
paralysis. On ___ had syncopal event at home and presented to 
___ where he was found to have an NSTEMI and newly reduced EF to 
35% and emergent cardiac angiogram showing 3VD. He was 
transferred to ___ on ___ for possible CABG. At ___ his HFrEF 
medications were adjusted within the limitations of his low SBPs 
and intermittent orthostatic hypotension. He was worked up with 
viability testing but C-surg evaluated him and he was determined 
not to be a candidate for CABG based on active DLBCL. The 
interventional cardiology team was consulted and on ___ he 
underwent PCI with DES to LAD without complication. His course 
was complicated by few days of neutropenia requiring neutropenic 
precautions but with ANC recovered with neupogen. Per primary 
oncologist's recommendation, patient was transferred to bone 
marrow transplant team for further chemotherapy. His cycle was 
delayed due to severe orthostatic hypotension, but he was 
eventually given rituximab ___, and started on CEP ___. He 
tolerated chemotherapy well, and was kept through his nadir. His 
course was complicated by neutropenic fever, for which he 
completed a seven day course of antibiotics.

====================
TRANSITIONAL ISSUES:
====================
[ ] DAPT: needs to stay on dual antiplatelet therapy for at 
least one year for stent placement on ___. If there is need 
to stop prior, please contact ___, MD 
cardiology attending, for recommendations 
[ ] Platelets must remain above 30 for ___ year in order to 
continue DAPT 
[ ] Consider adding ___ for GDMT iso HFrEF if BP 
improves and he no longer requires midodrine
[ ] Close follow up of blood pressures given he was 
intermittently orthostatic during his admission.
[ ] If weight increases by > 3 lb, increase torsemide to 60 mg 
daily and repeat chemistry panel the following day. If weight 
decreases by more than 3 lb, decrease to torsemide 20 mg daily. 
Please continue to trend weights/exam and titrate diuretics 
accordingly until cardiology follow up.
[ ] Decrease diuretic dose if Cr rises. Recommend at least 
weekly BMP until cardiology follow up.
[ ] Daily standing weights. 
[ ] CBC, BMP ___
[ ] Aspiration risk: was followed by speech/swallow during 
admission who noted he has risk of silent aspiration. 
 Speech and swallow recs:
 1. Patient was willing to accept risk of aspiration, so diet 
was advanced to regular with thin liquids.
 2. Meds: whole with applesauce
 3. Aspiration Precautions: 
 - 1:1 supervision during meals
 - with liquids: 
 - take a sip and hold the sip in your mouth
 - breathe in through your nose and hold your breath hard, like 
you're trying to lift something heavy
 - swallow with your breath held 
 - after every ___ sips of liquids, cough and swallow your 
saliva. 
 - Alternate bites and sips
 - Remain upright for at least ___ minutes after meals
 4. Oral care TID

- Discharge weight: 142 lb 
- Discharge creatinine: 2.0 
- Discharge diuretic: 40 mg Torsemide PO daily

# CODE: DNR/DNI
# CONTACT: ___ Phone: ___ 

====================
ACUTE ISSUES:
====================
#High Grade Diffuse Large B Cell Lymphoma w/ BCL2 Rearrangement
#Neutropenia, ANC 600 ___, now resolved
Mr. ___ was initially diagnosed on ___ via 
thoracentesis and R axillary core biopsy. He follows with Dr. 
___ and is s/p da-EPOCH with intrathecal 
methotrexate, and 2 cycles of CHOP. After admission to ___ due 
to NSTEMI (see below), patient was transferred to ___ for 
further chemotherapy, which was delayed due to severe 
orthostatic hypotension and in light of recent NSTEMI. Patient 
was given rituximab ___, and started CEP ___. Vincristine was 
not given due to likely autonomic dysfunction causing 
orthostatic hypotension and anthracyclines were avoided given 
HFrEF. Patient tolerated the chemotherapy well, and was kept 
through nadir. He was continued on his prophylactic acyclovir 
and atovaquone. Repeat PET on ___ showed substantial decrease 
in FDG uptake, suggesting good response to chemo. 

#Febrile neutropenia
While neutropenic, he developed a fever without a localizing 
source. Aspiration pneumonia was possible given high aspiration 
risk but CXR was without major changes. GI infection was 
possible given diarrhea but C.diff/stool cultures were negative, 
he was without abdominal pain, and the diarrhea had been 
improving. Soft tissue/skin infection was also possible with L 
upper thigh rash, but rash had also been improving. Cultures 
were negative. He was started on vanc/cefepime/flagyl, and 
ultimately transitioned to Levaquin. He then completed a seven 
day course of antibiotics. 

#Orthostatic Hypotension
He was having baseline SBP 90-100s, which would lower to SBP 
60-70s upon standing. The ddx for his orthostatic hypotension 
was thought to be due to poor PO intake, autonomic dysfunction 
(amitriptyline, carbidopa/levodopa, diabetes), and vincristine. 
He was started on midodrine 7.5mg TID, medications that could 
effect BPs (amitriptyline and carbidopa/levodopa) were 
discontinued, and vincristine was avoided. His AM cortisol was 
within normal limits. His SBPs improved and were in the ___ 
upon discharge. 

#NSTEMI 
#CAD 
He presented to ___ with syncope and was found to have elevated 
troponin with non-specific ST wave changes, had a TTE with new 
EF 35% so had emergent coronary angiogram demonstrating 3vdz 
(ostial left main (70%) and mid-80% tubular stenosis of the 
LAD.) It was unclear if underlying CAD had acutely worsened in 
the setting of recent cardiotoxic chemotherapy including 
doxorubicin. He was worked up with thallium viability testing 
but C-surg evaluated him and he was determined to be not a 
candidate for CABG based on active DLBCL. The interventional 
cardiology team was consulted and on ___ he underwent PCI via 
right femoral access with IVUS of LMCA showing eccentric calcium 
with MLA of 9 mm2. He had severe heavily calcified disease of 
proximal LAD successfully treated with rotational atherectomy 
and 1 DES. He was started on DAPT (minimum ___ year duration). He 
was continued on atorvastatin 80mg daily. He was not able to 
tolerate ___ in setting of low SBPs.

#Acute Decompensated HFrEF 
#ischemic cardiomyopthy
He was found to have with a newly reduced EF to 35% from prior 
65% with WMA at ___. The etiology of heart failure was likely 
ischemic given NSTEMI and cardiac angiogram showed three vessel 
disease. However he had also recently received anthracyclines as 
a part of his chemotherapy regimen which could have contributed. 
During his stay he was treated with IV Lasix for preload mgmt 
and transitioned to Lasix 20mg PO on discharge. For afterload 
reduction he was treated with Carvedilol but given intermittent 
orthostatic hypotension with reported lightheadedness, this was 
changed to metoprolol succinate on ___. He was not started on 
an ___ in setting of poor renal function and low blood 
pressures, but this could be considered as an outpatient if his 
creatinine and BP improves. He was found to be significantly 
volume overloaded, and was diuresed with 80 mg IV Lasix daily 
for four days prior to being transitioned to 40mg torsemide 
daily. 

# Left vocal cord paralysis
# Aspiration risk
During his prior admission he was noted to have a hoarse voice 
but without respiratory symptoms aside from coughing. He was 
evaluated by ENT who found left vocal cord paralysis in the 
setting of hilar and mediastinal adenopathy and soft tissue 
encasing the trachea. During the current admission he was 
followed by speech and swallow who knew him from his last 
admission. He did not present with overt s/sx concerning for 
aspiration, but he has a history of SILENT aspiration (not 
coughing when aspirating). He was judged to be at an elevated 
risk of aspiration. Speech/swallow recommended nectar thick 
liquids and ground foods with 1:1 sitting. He was seen by ENT on 
___ for vocal cord injection. SLP repeat evaluation on ___ 
showed moderate improvement, and patient was switched to thin 
liquid and regular solid diet. 

====================
CHRONIC ISSUES:
====================
# E. coli Bacteremia:
He had spiked a fever to 101 on ___ during his prior admission 
and blood cultures were positive for E.coli. He was started on 
cefepime, narrowed to ceftriaxone, given sensitive to E.coli. He 
was treated with ceftriaxone from ___. His urine cultures 
on ___ and ___ grew yeast, however he was asymptomatic and was 
not treated with antifungals per oncology recs.

#Persistent RUE swelling:
He had some swelling of his RUE at the beginning of his 
admission. He had a repeat RUE US ___ with no DVT. 

#CKD 
Unclear baseline as previously noted to be ~2, but Cr. was 1.6 
on admission thought to be ___ cardiorenal syndrome in setting 
of volume overload. His Cr was monitored daily and on discharge 
was 2.0

#T2DM: treated with fixed Lantus dose and ISS

#HX PVD s/p left femoral peroneal bypass: was continued on 
aspirin 

#Restless Leg Syndrome: Discontinued home carbidopa/levodopa due 
to possible orthostatic hypotension effect. 

#Depression: Tapered off amitriptyline due to possible 
orthostatic hypotension effect. 

#OSA: Continued home CPAP while inpatient.

#Allergies: Held home cetirizine for confusion. 

CORE MEASURES: 
#HCP/Contact: ___
 Phone: ___ 
#Code: DNR/DNI confirmed 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amitriptyline 50 mg PO QHS 
2. Carbidopa-Levodopa (___) 1 TAB PO DAILY 
3. Cetirizine 10 mg PO DAILY 
4. Temazepam 30 mg PO QHS 
5. Acyclovir 400 mg PO Q12H 
6. Atovaquone Suspension 1500 mg PO DAILY 
7. Pantoprazole 40 mg PO Q24H 
8. Tiotropium Bromide 1 CAP IH DAILY 
9. Filgrastim 300 mcg SC Q24H 
10. Allopurinol ___ mg PO DAILY 
11. CefTRIAXone 2 gm IV Q 24H 
12. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever 
13. Atorvastatin 20 mg PO QPM 
14. Metoprolol Succinate XL 50 mg PO DAILY 
15. NovoLIN ___ (insulin NPH and regular human) 100 unit/mL 
(70-30) subcutaneous BID 
16. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
17. Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Clopidogrel 75 mg PO DAILY  
3.  Famotidine 20 mg PO Q24H  
4.  Glargine 6 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin 
5.  Metoprolol Succinate XL 25 mg PO DAILY  
6.  Midodrine 7.5 mg PO TID  
7.  Torsemide 40 mg PO DAILY  
8.  Atorvastatin 80 mg PO QPM  
9.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever  
10.  Acyclovir 400 mg PO Q12H  
11.  Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath  
12.  Atovaquone Suspension 1500 mg PO DAILY  
13.  Cetirizine 10 mg PO DAILY  
14.  Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID  
15.  Tiotropium Bromide 1 CAP IH DAILY  
16. HELD- Temazepam 30 mg PO QHS  This medication was held. Do 
not restart Temazepam until told to by your doctor
17.Outpatient Lab Work
CBC, ___
ICD: 428.0
Contact Info: ___, ___ 
___ Hematology/Oncology 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
CAD with 3vessel disease
NSTEMI
Acute HFrEF exacerbation

Secondary Diagnosis:
DLBCL

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___. 

WHY WAS I ADMITTED TO THE HOSPITAL?
- You were admitted to the hospital because you passed out when 
you were at home and had a heart attack.

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
- You were given medicine to help remove the excess fluid from 
your body.
- You had an ultrasound of your heart that showed your heart is 
not pumping as well as it should.
- You had a cardiac angiogram study to assess the blood vessels 
in your heart. The test showed that you had blockages in the 
vessels in your heart.
- You were seen by the cardiac (heart) surgeons who decided you 
were not a candidate for cardiac surgery.
- You had a viability scan of your heart to assess the heart 
muscle. 
- You were seen by the interventional cardiology team who were 
able to put a stent in one of the blood vessels in your heart.
- Your oncologist Dr. ___ on your care and came 
to see you in the hospital and recommended chemotherapy. 
- You were then transferred to the bone marrow transplant 
service and started on chemotherapy. 
- You developed a fever when your cell counts were low, and we 
started you on broad-spectrum antibiotics. 
- You continued to have low blood pressures with standing, that 
improved with a medication called midodrine.  

WHAT SHOULD I DO WHEN I GO HOME?
- You should continue to take your medications as prescribed. 
- You should attend the appointments listed below. 
- Weigh yourself every morning, call your doctor if your weight 
goes up more than 3 lbs.  
- Seek medical attention if you have new or concerning symptoms 
or you develop swelling in your legs, abdominal distention, or 
shortness of breath at night.  
- Your discharge weight: ***  . You should use this as your 
baseline after you leave the hospital.  

We wish you the best!
Your ___ Care Team 

 
Followup Instructions:
___
"
66,13375185,26852109," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Bactrim / Aleve
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
___ - Thoracentesis

attach
 
Pertinent Results:
ADMISSION LABS
==============
___ 11:00AM BLOOD WBC-13.0* RBC-2.40* Hgb-8.1* Hct-25.1* 
MCV-105* MCH-33.8* MCHC-32.3 RDW-18.0* RDWSD-68.0* Plt ___
___ 11:00AM BLOOD Neuts-83.9* Lymphs-2.9* Monos-11.6 
Eos-0.2* Baso-0.3 Im ___ AbsNeut-10.89* AbsLymp-0.38* 
AbsMono-1.51* AbsEos-0.03* AbsBaso-0.04
___ 03:51AM BLOOD ___ PTT-42.7* ___
___ 11:00AM BLOOD Glucose-179* UreaN-27* Creat-1.6* Na-137 
K-4.4 Cl-100 HCO3-22 AnGap-15
___ 11:00AM BLOOD ALT-10 AST-10 LD(LDH)-158 AlkPhos-137* 
TotBili-0.3
___ 01:58PM BLOOD ___
___ 01:58PM BLOOD cTropnT-0.85*
___ 11:00AM BLOOD Albumin-3.3* Calcium-9.5 Phos-3.1 Mg-1.6 
UricAcd-7.4*
___ 05:55PM BLOOD ___ pO2-42* pCO2-34* pH-7.36 
calTCO2-20* Base XS--5 Intubat-NOT INTUBA

PERTINENT STUDIES
=================
___ 01:58PM BLOOD cTropnT-0.85*
___ 05:44PM BLOOD cTropnT-1.58*
___ 11:42PM BLOOD cTropnT-1.45*
___ 03:51AM BLOOD cTropnT-1.63*
___ 02:55PM BLOOD cTropnT-1.10*

___ 09:30AM PLEURAL TNC-394* RBC-2243* Polys-8* Lymphs-90* 
___ Macro-2*
___ 09:30AM PLEURAL TotProt-1.7 Glucose-153 Creat-1.7 
LD(LDH)-121 Albumin-1.0 Cholest-20 ___
___ 03:03PM OTHER BODY FLUID FluAPCR-NEG FluBPCR-NEG

Pleural fluid cytology ___
NEGATIVE FOR MALIGNANT CELLS.

Pleural fluid flow cytometry ___
Diagnostic immunophenotypic features of involvement by 
leukemia/lymphoma are not seen in this specimen.

MRSA Screen ___
Negative

IMAGING
=======
CT Chest without contrast ___
1. Interlobular septal thickening, ground glass opacification, 
bronchial 
cuffing, left greater than right moderate pleural effusions, 
small pericardial effusion, and engorgement of the azygos vein.  
Findings are consistent with interstitial pulmonary edema. 
2. Unchanged mediastinal, hilar, and right axillary 
lymphadenopathy. 
3. Extensive coronary artery and atherosclerotic calcification.  
Extensive 
aortic valve calcifications. 
4. Dilated, debris filled esophagus suggestive of dysmotility. 

TTE ___
The left atrium is normal in size. The estimated right atrial 
pressure is ___ mmHg. There are moderate to extensive areas of 
severe regional left ventricular systolic dysfunction with 
akinesis of the distal ___
of the left ventricle (see schematic). A left ventricular 
thrombus/mass cannot be excluded. Quantitative 3D volumetric 
left ventricular ejection fraction is 30 % (normal 54-73%). 
Global longitudinal strain is depressed (-3.6 %; normal less 
than -20%) Normal right ventricular cavity size with normal free 
wall motion. The aortic valve is not well seen. The mitral valve 
leaflets appear structurally normal with no mitral valve 
prolapse. The pulmonic valve leaflets are not well seen. The 
tricuspid valve is not well seen. The pulmonary artery systolic 
pressure could not be estimated. There is a trivial pericardial 
effusion.
IMPRESSION: Focused study. Moderate to severe regional left 
ventricular systolic dysfunction c/w Tak___'s cardiomyopathy 
or CAD in an LAD distribution. Normal right ventricular cavity 
size and systolic function.

CXR ___
Comparison to ___.  Substantial decrease in extent of 
the left 
pleural effusion after placement of a pigtail catheter in the 
left pleural 
space.  Milli metric apical left-sided pneumothorax without 
evidence of 
tension.  Stable appearance of the heart and of the right lung. 

TTE ___
EF 24%. Focused study. Mild LVH with severe LV Systolic 
dysfunction including akinetic aneurysmal apex; basal lateral 
and anterior walls contract best. Moderate mitral regurgitation. 
No LV thrombus.

DISCHARGE LABS
==============
___ 12:00AM BLOOD WBC-7.6 RBC-2.20* Hgb-7.1* Hct-22.5* 
MCV-102* MCH-32.3* MCHC-31.6* RDW-17.8* RDWSD-65.4* Plt ___
___ 12:00AM BLOOD Glucose-119* UreaN-35* Creat-1.5* Na-142 
K-4.0 Cl-107 HCO3-19* AnGap-16
___ 12:00AM BLOOD ALT-12 AST-10 LD(LDH)-231 AlkPhos-147* 
TotBili-0.3
___ 12:00AM BLOOD Albumin-3.3* Calcium-8.7 Phos-2.3* Mg-1.8

 
Brief Hospital Course:
PATIENT SUMMARY
===============
___ year old male with history of CAD and MI (s/p DES to the 
proximal LAD at ___ on ___, on aspirin/clopidogrel), new 
HFrEF (LVEF 27% on ___, complication of anthracycline), COPD 
(2L O2 baseline requirement), CKD, left vocal cord 
paralysis/aspiration, DLBCL on cycle 5 of R-CHOP, IDDM who 
presented with shortness of breath to ___ found to be 
hyperglycemic to the 500s, with type 2 NSTEMI, HFrEF 
exacerbation c/b left sided pleural effusion, and acute hypoxic 
respiratory failure. His shortness of breath resolved with 
thoracentesis and diuresis.

TRANSITIONAL ISSUES 
==================== 
[] Discharge weight: 140.1 lbs
[] Discharge creatinine: 1.5
[] Discharge oxygen requirement: Room air
[] Torsemide was decreased from 60mg QD to 20mg QD due to 
elevated creatinine and euvolemia on exam. Please continue to 
monitor daily weights, volume status and creatinine.
[] If weight increases by > 3 lb, increase torsemide to 40 mg 
daily and repeat chemistry panel the following day. If weight 
decreases by more than 3 lb, hold torsemide until weight is back 
to baseline. 
[] Midodrine was stopped as patient was not orthostatic and was 
able to ambulate without symptoms. Please continue to monitor 
orthostatics.
[] Please ensure patient follows up with Dr. ___ 
further management of his DLBCL
[] Based on overall prognosis after this cycle of chemotherapy, 
please consider pursuing ICD placement
[] Please ensure patient makes an appointment to see his PCP, 
___, MD, ___ after leaving rehab.
[] Diabetes management:
 - Target BG 140-220
 - Plan: Lantus insulin to 10 units with breakfast 
 - Monitor BG before breakfast, lunch and dinner 
 - Use correction scale of Humalog to treat BG ___ 2 unit
 201-250 4 units
 251-300 6 units
 301-350 8 units
 351-400 10 units
 >400 12 units
* If the patient is to receive prednisone 100 mg - recommend to 
increase the lantus during those FIVE days to 15 units with 
breakfast

MEDICATION CHANGES: 
- NEW: 
 - Insulin glargine
 - Allopurinol
- STOPPED:
 - Midodrine
 - ___ insulin
 - Cetirizine
 - Temazepam
- CHANGED:
 - Torsemide decreased from 60 mg QD to 20 mg QD
 - Metoprolol succinate increased from 25 mg QD to 37.5 mg QD

ACUTE ISSUES
=============
#Hypoxemic respiratory failure
Presented with subjective worsening of dyspnea with increased O2 
requirements from baseline of 2 L O2. His respiratory failure 
thought to be multifactorial secondary to COPD, acute systolic 
heart failure exacerbation, pleural effusion, and COPD. He was 
treated with 5 days of empiric antibiotics, initially broad 
spectrum, then de-escalated to CAP coverage. Infectious workup 
was negative. He was treated with prednisone (post-chemotherapy 
dosing) and nebulizer treatments. He was given IV diuresis and 
seen by IP with placement of L sided chest tube. His breathing 
improved and he was satting well on room air prior to discharge.

#NSTEMI
#CAD and recent DES of the proximal LAD on ___
Presented with troponemia in setting of recent DES. He was 
initially medically managed with heparin gtt, which was later 
discontinued in consultation with cardiology when it was felt 
his presentation was more consistent with demand ischemia. He 
was continued on atorvastatin 80 mg daily, aspirin 81 mg daily, 
clopidogrel 75 mg daily, metoprolol succinate.

#NSVT
He had multiple episodes of NSVT during his hospitalization. He 
was asymptomatic and hemodynamically stable during these 
episodes. His metoprolol succinate was increased from 25 mg to 
37.5 mg QD. The patient was amenable to ICD implantation despite 
being DNR/DNI, but further workup was deferred pending 
clarification of his cancer prognosis.

#Heart failure with reduced ejection fraction (EF 24%)
TTE on ___ with moderate to severe regional LV dysfunction, 
normal RV. He was given IV diuresis. He was given IV diuresis in 
setting of pulmonary edema, otherwise did not appear 
decompensated. He was treated with the above medications. 

#DM II
#Hyperglycemia
Patient presented with glucose in 500s on presentation to OSH 
___ to infection and prednisone that improved with insulin gtt. 
After prednisone was stopped he became hypoglycemic to the ___ 
his home regimen (Novolin 70/40 23U in AM, 20U in ___. ___ 
was consulted and he was started on Lantus 5 QAM with ISS. 
Target BG 140-220, which is age appropriate. 

# Orthostatic hypotension
Possibly related to vincristine-induced autonomic dysfunction. 
Midodrine was held on admission.
Orthostatics were negative and the patient was able to ambulate 
with ___ without symptoms. He was discharged off of midodine.

#Acute on chronic kidney injury
Creatinine peaked at 2.0 after diuresis. Diuretics were held 
after patient was transferred to ___ and creatinine decreased to 
1.6. He was restarted on decreased dose of torsemide, 20 mg QD 
(decreased from home dose of 60 mg QD). He remained euvolemic 
with a stable creatinine on this dose prior to discharge.

CHRONIC ISSUES
===============
#DLBCL s/p R-CDOP and pegfilgastrim (Cycle 5)
Followed by Dr. ___ at ___. He was continued on 
atovaquone, acyclovir 400 mg Q12 H. He was restarted on 
allopurinol given an elevated uric acid level.

#Left vocal cord paralysis/Dysphagia/Aspiration
History of aspiration on evaluation by ___. Patient accepted 
aspiration risk with regular diet. 

#Anemia
Acute on chronic. Recently received chemotherapy. He received 1 
u pRBC during his ICU course.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever 
2. Acyclovir 400 mg PO Q12H 
3. Tiotropium Bromide 1 CAP IH DAILY 
4. Aspirin 81 mg PO DAILY 
5. Clopidogrel 75 mg PO DAILY 
6. Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath 
7. Atovaquone Suspension 1500 mg PO DAILY 
8. Cetirizine 10 mg PO DAILY 
9. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
10. Famotidine 20 mg PO Q24H 
11. Torsemide 40 mg PO DAILY 
12. Midodrine 7.5 mg PO TID 
13. Metoprolol Succinate XL 25 mg PO DAILY 
14. Atorvastatin 80 mg PO QPM 
15. Temazepam 30 mg PO QHS 

 
Discharge Medications:
1.  Allopurinol ___ mg PO DAILY  
2.  Glargine 10 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin 
3.  Metoprolol Succinate XL 37.5 mg PO DAILY  
4.  Torsemide 20 mg PO DAILY  
5.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever  
6.  Acyclovir 400 mg PO Q12H  
7.  Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath  
8.  Aspirin 81 mg PO DAILY  
9.  Atorvastatin 80 mg PO QPM  
10.  Atovaquone Suspension 1500 mg PO DAILY  
11.  Clopidogrel 75 mg PO DAILY  
12.  Famotidine 20 mg PO Q24H  
13.  Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID  
14.  Tiotropium Bromide 1 CAP IH DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis:
- Congestive heart failure exacerbation

Secondary diagnoses:
- Chronic obstructive pulmonary disease
- Insulin dependent diabetes mellitus
- Diffuse large B cell lymphoma
- Chronic kidney disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,  

It was a privilege taking care of you at ___ 
___.  

WHY WAS I IN THE HOSPITAL?  
- You were admitted to the hospital because you were having 
increased shortness of breath.

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- You were initially admitted to the intensive care unit where 
you had several treatments to improve your breathing. You had 
the fluid drained from your lung with a needle (thoracentesis). 
You were given water pills to remove extra fluid from your 
lungs. You were also given inhaled medications to decrease the 
inflammation in your lungs and make it easier for you to breath. 
Your breathing improved with these treatments and you no longer 
required supplemental oxygen by the end of your hospital stay.
- You were given 5 days of antibiotics because we were 
suspicious that you might have an infection in your lungs 
(pneumonia) when you first came in. We sent several tests to 
look for an infection, however, and these all came back 
negative. Consequently, we stopped your antibiotics.
- Your water pill, torsemide, was decreased from 60 mg once a 
day to 20 mg once a day. 
- You blood pressure medication, midodrine, was stopped because 
your blood pressure was well controlled during your admission.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?   
- Please weigh yourself every day. If your weight increases by > 
3 lb, increase your torsemide to 40 mg daily. If your weight 
decreases by more than 3 lb, stop taking your torsemide until 
your weight returns to normal. 
- If you start to become lightheaded when standing up from 
sitting, or you faint, please call your doctor to discuss 
re-starting midodrine.
- Please attend you oncology appointment on ___ at 9:00 
AM at the ___ on the ___ floor
- Please attend your appointment with the diabetes doctors on 
___ at 1:00 ___ at ___ located at ___ 
___, ___. ___. 
- Please make an appointment to see your PCP, ___, 
___ after leaving rehab.

We wish you the best.

Sincerely,  
Your ___ Team 
 
Followup Instructions:
___
"
67,13375185,23687981," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Bactrim / Aleve
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
none
attach
 
Pertinent Results:
ADMISSION LABS
=============
___ 05:48AM BLOOD WBC-6.5 RBC-2.62* Hgb-8.4* Hct-26.0* 
MCV-99* MCH-32.1* MCHC-32.3 RDW-17.7* RDWSD-64.2* Plt ___
___ 05:48AM BLOOD Neuts-79.1* Lymphs-5.7* Monos-11.3 
Eos-3.1 Baso-0.3 Im ___ AbsNeut-5.11 AbsLymp-0.37* 
AbsMono-0.73 AbsEos-0.20 AbsBaso-0.02
___ 05:48AM BLOOD Glucose-212* UreaN-24* Creat-1.8* Na-142 
K-4.6 Cl-103 HCO3-23 AnGap-16
___ 05:48AM BLOOD ALT-13 AST-11 LD(LDH)-194 AlkPhos-117 
TotBili-0.4
___ 05:48AM BLOOD Calcium-8.8 Phos-3.5 Mg-1.8

PERTINENT LABS
=============
Patient was made CMO ___ after discussions with the team and 
loved ones.
___ 05:44PM BLOOD Triglyc-93
___ 07:20PM BLOOD Beta-OH-<0.2
___ 03:33AM BLOOD TSH-3.3
___ 07:20PM BLOOD TSH-4.8*
___ 05:25PM CEREBROSPINAL FLUID (CSF) TNC-1 RBC-28* 
Polys-68 ___ Monos-14 Eos-1
___ 05:25PM CEREBROSPINAL FLUID (CSF) TNC-0 RBC-475* 
Polys-56 Bands-1 ___ Monos-4 Eos-2 NRBC-24
___ 05:25PM CEREBROSPINAL FLUID (CSF) TotProt-46* 
Glucose-75

STUDIES AND IMAGING
==================
___ CXR PA LAT
Reaccumulation of laterally loculated left pleural effusion and 
probable
residual small right pleural effusion. No pneumothorax. 
Increased interstitial
markings throughout the lungs suggesting pulmonary edema though 
improved since
prior.

___ TTE
Mild symmetric left ventricular hypertrophy with global 
hypokinesis in the setting of
relative regional dysfunction ___ apex; basal 
inferolateral/anterolateral segments contract best) c/w 
multivessel coronary artery disease. Moderate mitral 
regurgitation. Indeterminate pulmonary pressure. EF 25%

___ CXR AP
Similar pulmonary vascular congestion with loculated small to 
moderate left
pleural effusion.  No definitive areas of consolidation to 
suggest pneumonia.

___ CTH W/OUT CON
1. No acute intracranial abnormality.
2. Moderate to severe periventricular deep white matter 
hypodensities which
are nonspecific, but likely represent chronic small vessel 
ischemia.

___ CT CHEST W/OUT CON
1. No acute intracranial abnormality.
2. Moderate to severe periventricular deep white matter 
hypodensities which
are nonspecific, but likely represent chronic small vessel 
ischemia.

___ MRI HEAD W/+ W/O CON
1. Motion limited exam.
2. No imaging evidence of cryptococcal CNS involvement.
3. No evidence for a mass or an acute intracranial abnormality.
4. Unchanged extensive T2/FLAIR hyperintensities in the 
supratentorial white
matter and pons, which are nonspecific but likely sequela of 
chronic small
vessel ischemic disease in this age group..
5. New paranasal sinus abnormalities compared to ___, 
including
moderate to severe opacification of the right anterior ethmoid 
air cells.

___ CXR AP
Overall improvement in vascular congestion, airspace 
opacification and
left-sided pleural effusion compared to prior.

___ FDG PET TUMOR
1. Stable in size and less metabolically active
  solid 1.3 cm left apical nodule compare to ___. 
Improvement of
multifocal bilateral pulmonary nodules with FDG avidity.  
Interval improvement
of the multifocal atelectasis.  These findings suggest improving 
infectious
process. 3. Left hilar increased FDG avidity could be reactive 
to the infectious
process. 4. Improved left small pleural effusion and resolution 
of the right
pleural effusion compared to ___ CXR AP
1. Subtle increase in opacification at the right lower lobe 
since ___,
likely representing pneumonia/aspiration that was previously 
seen on
radiograph from ___.
2. Left pleural effusion is unchanged since ___.
3. Mild pulmonary venous congestion is unchanged.

___ MRI HEAD W/O CONTRAST
1. No acute intracranial abnormality or intracranial mass is 
identified.
2. Stable nonspecific bilateral supratentorial T2/FLAIR white 
matter
hyperintensities, some of which are confluent, which may 
represent the
sequelae of chronic microangiopathy.
3. Stable mild paranasal sinus mucosal thickening.

___ RENAL US
No hydronephrosis. The bladder is moderately well distended.  
Trabeculation of the bladder wall suggests sequelae of chronic 
outlet obstruction.
 
There is a right pleural effusion.

___ CXR
Increased consolidations in the lower lungs bilaterally are 
concerning for
pneumonia.  Increased left pleural effusion.

MICROBIOLOGY
============
___ BCx
___ Sputum cx growing pseudomonas
___ Serology/blood positive cryptococcal antigen, 
quantitative
___ BCx (myco/f lytic bottle) - NGTD
___ CSF Spinal fluid negative crypto
___ CSF spinal fluid cx NGTD
___ CSF enterovirus cx negative
___ Urine Cx neg 
___ BCx NGTD
___ Urine not processed
___ BCx NGTD
___ Port insertion site drainage wound culture (stap aureus 
coag+)
___ Port insertion site drainage wound gram stain (stap 
aureus coag+)

DISCHARGE LABS
=============
Patient made CMO ___ and expired ___ at ___ 
 
Brief Hospital Course:
SUMMARY STATEMENT
==================
___ PMH of DLBCL (___) on surveillance s/p multiple tx 
regimens c/b MI s/p DES ___ w/new HFrEF (27%), vincristine 
induced autonomic dysfunc (on midodrine), COPD, OSA, CKD, HTN, 
T2DM transferring to ___ after ___ pleural fluid culture at OSH 
yielded Cryptococcus neoformans c/c/b nonconvulsive status 
epilepticus, new port site dehiscence/infection, PNA on CXR 
___, and made CMO ___ and expired ___ at ___
 
ACUTE ISSUES ADDRESSED
=======================
# Non-convulsive status epilepticus
# Altered mental status
Since ___ patient noted to have waxing, waning mental status 
iso stable vital signs, nonfocal neurological exam without gross 
deficit. Normal MRI, currently unremarkable CSF findings, but 
EEG showing non-convulsive status epilepticus. Patient loaded 
with Keppra and valproic acid s/p Ativan terminating his 
seizures. Likely due to cefepime lowering seizure threshold with 
the patient overall having a low seizure threshold in general 
___ comorbidities. The patient recovered a significant aspect of 
his mentation afterwards yet on ___ he continued to be 
obtunded most likely due to hypoactive delirium per neurology 
team. The patient was made CMO ___ after ___ discussion with 
family and expired ___ at ___.
 
#Port dehiscence
#Port insertion site purulence
On ___ the patient was noted to have purulent drainage from 
port. Afebrile with vital signs stable except tachycardia 
baseline. Dressing was uncovered and revealed purulence on the 
port site along with dehiscence of port. ___ removed port ___. 
Wound swabs were sent for culture ___. In setting of new 
worsening cough and right lower lobe pneumonia (below) was 
started on broad antibiotic coverage. The patient was made CMO 
___ after ___ discussion with family and expired ___ at 
___.
 
#Severe malnutrition in context of chronic illness
pt noted to have weight loss of >10% in 6 months (20% in ~6 
months). He has <=75% energy intake compared to estimated energy 
needs for >=1 month. In setting of status epilepticus the 
patient was started on TPN. The patient was made CMO ___ after 
___ discussion with family and expired ___ at ___.
  
# Positive cryptococcus antigen serology
# Crytococcus neoformans growth on pleural fluid ___
The patient underwent thoracentesis at ___ during 
previous admission in early ___ for which pleural cultures 
revealed Cryptococcus neoformans growth, likely representing 
chronic infection confirmed by serologic testing done at ___. 
Patient without fevers, rigors, weight loss, signs/symptoms of 
shock or neutropenia. LP results included neg gram stain, NGTD 
on fluid cx, fungal cx, or AF cx; borderline elevation in 
protein with low opening pressure (8mmHg), flow cytometry 
nondiagnostic, cytogenetics negative for IGH/BCL2. The patient 
was made CMO ___ after ___ discussion with family and expired 
___ at ___.
 
#Hypotension
#Hypoxia
#Recurrent aspiration pneumonia
Pt with recent hospitalization for COPD exacerbation requiring 
MICU stay in ___. Prior MICU hospitalization was 
multifactorial in nature secondary to COPD, acute systolic heart 
and pleural effusion. Pt was hypoxic in clinic though waveform 
was poor so unclear if was true value. CXR on admission revealed 
b/l effusions and slightly improved pulm edema. Notably, pt is 
s/p chest tube in ___. IP c/s for pleural effusion as above, 
deferring on tap as has been negative for malignancy in past. 
Patient on TPN since ___ due to asp risk and nw non-convulsive 
status epilepticus. New RLL PNA noted on CXR ___ iso worsening 
cough and pt was started on Vanc/Zosyn for likely aspiration 
once more. The patient was made CMO ___ after ___ discussion 
with family and expired ___ at ___.
 
#Pleural Effusion
CXR on admission ___ showed re-accumulation of left sided 
loculated effusion, CT chest ___ shows worsening pulmonary 
edema and increased effusion. home torsemide 20mg daily was 
restarted. The patient was made CMO ___ after ___ discussion 
with family and expired ___ at ___.
  
#Tachycardia
Pt with history of tachycardia to 110-120's. Notably, pt had 
been receiving home Torsemide daily, had been continued I/s/o 
poor PO intake. Sinus tachy on EKG with prolonged PR interval. 
Given slight ___, and collapsed IVC on bedside TTE in ED, felt 
tachycardia was most likely d/t hypovolemia. Improved after 
500cc bolus. Given that BNP was lower than baseline, and patient 
was not hypoxic, CHF exacerbation was unlikely. TTE with stable 
disease (EF 27%) from prior. Cardiology also recommended 
increasing home Toprol XL to 50mg PO daily. The patient was made 
CMO ___ after ___ discussion with family and expired ___ 
at ___.
 
#CAD 
#HFrEF 
#Ischemic Cardiomyopathy
#HLD
As above, patient not felt to be having ACS nor CHF exacerbation 
per cardiology. TTE w/ EF of 25% and global hypokinesis as 
above. Pt w/ NSTEMI on prior hospitalization thought to be due 
to demand ischemia I/s/o hypoxemic respiratory failure (___) 
with known CAD and recent DES of the proximal LAD on ___. 
As of ___ the patient is unable to take IV meds secondary to 
status epilepticus and high aspiration risk. The patient was 
switched to rectal 100 mg aspirin without a second antiplatelet 
agent iso being close to 6mo s/p ___. The patient was 
made CMO ___ after ___ discussion with family and expired 
___ at ___.
  
#DLBCL
S/p multiple lines of treatment, see prior notes for details. 
Had suspicious area in left lung apex which was being surveilled 
given his fragile clinical status. Acyclovir/atovaquone ppx was 
continued while inpatient. The patient was made CMO ___ after 
___ discussion with family and expired ___ at ___.
 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
3. Allopurinol ___ mg PO DAILY 
4. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 
5. Amitriptyline 50 mg PO QHS 
6. Fleet Enema (Mineral Oil) ___AILY:PRN constipation 
7. Glargine 10 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
8. Atorvastatin 80 mg PO QPM 
9. Fluticasone Propionate NASAL 1 SPRY NU QHS:PRN allergies 
10. Atovaquone Suspension 750 mg PO QHS 
11. Clopidogrel 75 mg PO DAILY 
12. Famotidine 20 mg PO Q24H 
13. Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath 
14. Temazepam 30 mg PO QHS 
15. Metoprolol Succinate XL 25 mg PO DAILY 
16. Tiotropium Bromide 1 CAP IH DAILY 
17. Torsemide 20 mg PO DAILY 
18. Acyclovir 400 mg PO Q12H 
19. Cetirizine 10 mg PO DAILY:PRN allergies 

 
Discharge Medications:
Patient was made CMO ___ and expired ___ at ___

 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Patient was made CMO ___ and expired ___ at 2105h

 
Discharge Condition:
Patient was made CMO ___ and expired ___ at 2105h

 
Discharge Instructions:
Patient was made CMO ___ and expired ___ at 2105h

 
Followup Instructions:
___
"
68,13520481,27106540," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Norvasc
 
Attending: ___.
 
Chief Complaint:
fatigue
 
Major Surgical or Invasive Procedure:
right knee aspiration, ___

 
History of Present Illness:
___ with dementia, ischemic cardiomyopathy EF 50%, CVA, DM, HTN, 
CKD, and newly diagnosed urothelial bladder CA admitted with 
increasing drowsiness over three weeks. According to the 
patient's son, he had been sleeping more and talking and eating 
less. His gait and behavior had been altered such that if the 
patient's son asks him to walk forward he walks backward and if 
asked to lift his tongue upward he moves it downward. His mental 
status and cognition have also been somewhat depressed. He was 
prescribed Ambien approx three weeks prior to admission for 
insomnia, however that was promptly discontinued when fatigue 
persisted. No other new medication changes. Although chronic 
urinary urgency had previously prompted the patient to ask for 
help to the bathroom, he has not been asking for assistance as 
of late. He completed a 10-day course of levofloxacin for 
pneumonia approximately one month before his admission. No 
history of fever, chills, headache, cough, chest pain, shortness 
of breath, abdominal pain, vomiting, diarrhea, dysuria, rash, 
weakness, numbness, parasthesias, or falls. The patient was 
being evaluated in neurology clinic on the day of admission 
where he was very somnolent but arousable, BP 90/50 HR 60 bpm. 
He was referred to the ED for further evaluation. In the ED, 
initial vital signs 98.5 63 146/56 18 99%RA. The patient was 
admitted to the medical service for further care.
 
Past Medical History:
urothelial bladder CA - positive cytology from ___  
CAD s/p MI  
chronic systolic CHF EF 50% by TTE ___ementia  
CKD b/l Cr ~1.3  
COPD  
HTN  
L Bell's palsy  
microcytic anemia, baseline HCT ~32%
 
Social History:
___
Family History:
Noncontributory.  
 
Physical Exam:
Admission Exam
V/S: T 97.9 HR 66 BP 159/84 RR 18 O2sat 97%RA  
GEN: Appears well, NAD  
HEENT: L eye extropion with purulent discharge, R eye scleral 
injection, L facial droop, dry MM  
NECK: supple no JVD R carotid bruit  
CV: reg rate nl S1S2 no R/M/G  
PULM: CTAB no w/r/r  
ABD: soft NTND normoactive BS guaiac negative (per ED notes).  
GU: foley draining grossly bloody urine  
EXT: warm, dry +PP no edema  
SKIN: no rash  
NEURO: somnolent but alert when aroused; oriented to person and 
""hospital"" only; with exception of peripheral VII, CN grossly 
intact; strength and sensation to light touch preserved in all 4 
ext ___  

Notable exam findings at discharge:
Mental status is arousable, oriented to person, place and 
general time, generally responding to questions appropriately 
with one or two word answers.
Lungs clear
Moderate pitting edema of the right lower extremity to mid-thigh
 
Pertinent Results:
Admission Labs:
___ 03:10PM   WBC-5.1 RBC-3.86* HGB-10.5* HCT-31.6* MCV-82 
MCH-27.3# MCHC-33.3 RDW-15.7*
___ 03:10PM   PLT COUNT-191
___ 03:10PM   NEUTS-72.9* LYMPHS-15.3* MONOS-5.5 EOS-5.7* 
BASOS-0.6
___ 03:10PM   GLUCOSE-310* UREA N-26* CREAT-1.6* SODIUM-140 
POTASSIUM-4.5 CHLORIDE-102 TOTAL CO2-28 ANION GAP-15
.
Discharge Labs:
Na 146
K 3.7
Cl 111
HCO3 30
BUN 25
Cr 1.7
Glucose 87
WBC 5.7
HCT 26.4
Plt 267
.
Admission EKG: SB 56 bpm ___ deg AV cond delay. Normal axis no 
ST-T wave abnormalities. Not significantly changed from ___.
.
Head CT (___): IMPRESSION: No evidence of acute hemorrhage 
or shift of normally midline structures to suggest large mass. 
Please note that MRI is more sensitive in detection of acute 
ischemia or mass lesions. Given the extent of dilation of the 
lateral ventricles, possibility of NPH superimposed on volume 
loss changes needs to be considered and correlated clinically. 
.
Echo (___):
The left atrium is dilated. Left ventricular wall thickness, 
cavity size and regional/global systolic function are normal 
(LVEF >55%). There is no ventricular septal defect. Right 
ventricular chamber size and free wall motion are normal. The 
aortic root is mildly dilated at the sinus level. The aortic 
valve leaflets (3) are mildly thickened but aortic stenosis is 
not present. The mitral valve leaflets are mildly thickened. 
There is no mitral valve prolapse. Trivial mitral regurgitation 
is seen. The tricuspid valve leaflets are mildly thickened. 
There is mild pulmonary artery systolic hypertension. There is 
no pericardial effusion. 
Compared with the prior study (images reviewed) of ___, 
the previously mentioned inferior and inferolateral hypokinesis 
is not seen on the current report. The other findings are 
similar.  
.
Abdominal Ultrasound (___):
FINDINGS: There is no hydronephrosis identified in either 
kidney. The bladder is only partially distended. The solid mass 
is again seen within the lumen of the bladder measuring 2.4 x 
2.7 x 3.1 cm. This appears slightly larger than the ultrasound 
of ___ when this mass measured 2.2 x 1.9 x 1.9 cm. No 
additional masses identified within the region of the pelvis, 
however, ultrasound is limited in its ability to evaluate this 
area. 
IMPRESSION: 1) No hydronephrosis. 2) Solid bladder mass 
measuring 3.1 cm 
which is slightly larger than the prior ultrasound as described 
above. 3) No additional pelvic mass identified on limited 
imaging. 
.
Right ___ ultrasound (___):
COMPARISON: Right lower extremity ultrasound from ___. 
ULTRASOUND IMAGES OF THE RIGHT LOWER EXTREMITY VEINS: The right 
common 
femoral, superficial femoral, and popliteal veins demonstrate 
normal flow, 
compressibility and augmentation. The right peroneal veins are 
patent. The 
right posterior tibial veins are not definitively identified.
IMPRESSION: Limited study as the right posterior tibial veins 
were not 
definitively identified, otherwise no evidence of deep venous 
thrombosis. 
(Please note that these findings were similar to an ultrasound 
of the RLE performed on ___ for a similar indication).
 
Brief Hospital Course:
___ male with dementia, ischemic cardiomyopathy EF 50%, DM, CKD, 
and relatively recent diagnosis of urothelial carcinoma/bladder 
mass, admitted with increasing fatigue and somnolence for three 
weeks, eventually thought most likely related to MRSA UTI.
.
#Fatigue/somnolence - A broad differential was considered, 
including possible toxic or metabolic causes. The patient's 
electrolytes were normalized and folate, B12, TSH, free T4, RPR, 
and LFTs (including ammonia) were all checked and were within 
normal limits. An initial infectious workup was negative. The 
neurology service was consulted as the patient was initially 
referred in from neurology clinic and due to concern of dilation 
of the lateral ventricles on head CT. Their impression was that 
an element of NPH was a possible contributing factor to the 
patient's presentation, but that this was unlikely to be the 
only cause. Additionally, effective evaluation of NPH would 
require the patient to be as well and stable as possible, and 
able to walk, so that he could undergo detailed testing before 
and after LP with CSF removal. An additional complication was 
that the question of NPH had been raised to the patient when he 
was more lucid, and he declined to undergo evaluation stating he 
would not want surgery for shunt placement. Outpatient neurology 
follow-up was suggested. After several days in the hospital the 
patient developed a fever, and an ongoing infectious work-up was 
continued. A urine culture eventually grew out >100,000 colonies 
of MRSA. With treatment of this infection, the patient's mental 
status improved significantly, although his overall level of 
interaction and verbal communication remained fairly low. Per 
his son, this was close to his initial baseline several weeks 
before the deterioration leading to his admission. It seems 
likely that an element of depression may also be contributing to 
the patient's overall picture; consideration was given to 
possible initiation of pharmacotherapy (such as methylphenidate 
or mirtazapine), however ultimately this was deferred, at least 
temporarily, while the patient's other medical issues reach 
resolution.
.  
#Fevers/UTI: Beginning on the patient's third hospital day, he 
began experiencing fevers. An infectious work-up, including two 
UAs, was non-revealing. He received approximately two days of 
empiric vancomycin and Zosyn out of concern for impending 
clinical deterioration. Eventually his urine culture grew MRSA, 
and this was felt to be the source of his fevers. He was at risk 
for MRSA having had urologic procedures in the last few months, 
as well as Foley catheter placement during this hospitalization. 
His catheter was removed, his antibiotic therapy narrowed to 
vancomycin alone, and his fevers resolved. Several days later, 
lower-grade temperature returned (as high as 100.8). A repeat 
infectious and non-infectious work-up was again undertaken, 
which did not reveal a cause. Drug fever was felt to be a 
possibility, and vancomycin was stopped after seven days of 
total therapy. He promptly defervesced with this and had no 
further elevated temperatures prior to discharge. 
.
#RLE and knee swelling: This was first noted several days into 
the patient's hospitalization. It began with warmth and swelling 
of the patient's right knee. An x-ray was obtained demonstrating 
the presence of previously placed orthopedic hardware and 
degenerative changes. A RLE ultrasound was negative for clot. 
The right knee was tapped on ___ to differentiate between 
gout versus possible septic arthritis; the tap was consistent 
with gout. Over the next several days, the patient developed 
ascending edema of the RLE. A repeat ultrasound was again 
obtained, to evaluate both for thrombus or a possible 
compressive pelvic mass; neither of these were identified. In 
the last two days of hospitalization, the swelling appeared to 
improve mildly. Of note, the patient had been off his diuretics 
given his renal failure. If this swelling continues to persist, 
an abdominal CT scan should be considered, however this was not 
pursued prior to discharge given the patient's rapidly changing 
renal function.
.
#Acute renal failure: The patient's baseline SCr is thought to 
be approximately 1.3-1.4. At admission, his creatinine was 
mildly elevated at 1.6. His furosemide and ___ were held. His 
creatinine subsequently improved, however several days into his 
hospitalization he was noted to have an unexplained bump in both 
his SCr (peak 2.7) and his LFTs (predominantly a transaminitis, 
peak ALT 458, peak AST 867). The etiology of both these 
processes was unclear, however they appeared to be most 
consistent with an ischemic episode of some kind (of note, no 
hypotensive episodes, even mild hypotension, were ever 
documented). Cardiac biomarkers were cycled and an echo was 
obtained, both of which were non-revealing. The patient's renal 
function and LFTs improved (SCr back to 1.5). Later on his 
hospital course, his renal failure worsened again slightly; this 
was thought to be due to poor PO intake and responded to fluid 
administration.
.
#Transient rise in LFTs: Please see section on acute renal 
failure as above. This was thought to be related to transient 
hepatorenal ischemia, although the exact etiology was not 
completely clear.
.
#Poor PO intake/electrolyte abnormalities: The patient was felt 
to have poor PO intake throughout his stay, primarily related to 
his mental status. Without IV fluid support, he would trend 
towards a pre-renal, hypernatremic picture (serum Na 146 on day 
of discharge). The patient would respond well to feeding by 
family members and the nursing staff. It is hoped that with 
rehabilitation and further improvement in his mental status, his 
ability to take POs will improve.
.
#Aspiration: The patient is felt to aspirate his sections and 
oral intake frequently. He was empirically placed on a pureed 
and thickened diet, which seemed to improve this issue somewhat. 
His did not have a formal Speech and Swallow evaluation and it 
was thought unlikely this would change the nature of his care. 
He was not thought to have frank aspiration pneumonia at any 
point in his stay.
.
#Pruritus/rash: This was a chronic issue for the patient, 
beginning many months ago. Dermatology was consulted since the 
patient was itching his skin to the extent breakdown was 
occurring. Topical therapies, including triamcinolone as needed, 
were recommended and are included in the discharge medication 
list. 
.
#Conjunctivitis/corneal abrasion: The patient had seen his 
optometrist just prior to admission and was thought to have a 
left sided conjunctivitis. In the hospital, he was empirically 
treated with erythromycin ointment and tobramycin drops. His 
right eye was also bothering him, and ophthalmology was 
eventually consulted. The patient was found to have a right eye 
corneal abrasion, probably caused when the patient was 
scratching. An eye patch and keeping the eye lid closed were 
recommended; antibiotic drops were also initiated. The patient 
is scheduled for ophthalmology follow-up at ___ tomorrow, 
___.
.
#Hematuria/urothelial cell carcinoma: The patient had been 
previously known to have a bladder mass; this was diagnosed as a 
carcinoma by urine cytology shortly before admission. At 
admission, the patient was having significant hematuria. A Foley 
catheter was placed to allow for flushing of the bladder; his 
hematuria persisted, and he eventually required continuous 
irrigation for several days. In this setting, he required a 
total of three units pRBCs transfusion (two units, followed by 
an additional unit several days later). His hematuria improved 
significantly and all catheters were able to be discontinued 
within approximately the first week of his stay. The patient has 
planned urology follow-up for resection of the mass in the 
coming weeks.
.
#anemia: This was thought to be multifactorial in etiology 
(iron-deficiency, chronic blood loss, chronic disease). The 
patient's HCT ranged in the mid-20s for most of his stay, with 
one dip as low as 21 while he was having hematuria. This 
responded to RBC transfusion.  
.  
#Ischemic cardiomyopathy: The patient was felt to by dry to 
euvolemic during most of his admission, despite the holding of 
his furosemide (and ___ due to his ARF. He also tolerated the 
administration of several liters of fluid without any evidence 
of volume overload except, possible, his RLE swelling. An echo 
was checked and was unchanged. He was continued on his home beta 
blocker and ASA.
.  
#CAD: The patient's home ASA, beta blocker and statin were 
continued.
.  
#DM: The patient's home glipizide was held. He was managed with 
fixed dose/sliding scale insulin. 
.  
#HTN: As above, the patient's home beta blocker was continued 
but his ___ was held. He was mildly hypertensive during his stay 
but not to a degree that required intervention.
.
.
#Contact: If further information concerning this complex patient 
is desired, please contact ___, MD, ___, 
pager ___.
 
Medications on Admission:
Cozaar 25 mg daily  
Aricept 5 mg daily  
Namenda dose unknown  
Lipitor 40 mg daily  
Terazosin 2 mg daily  
Furosemide 40 mg daily  
Metoprolol 12.5 mg daily  
Glipizide 10 mg daily  
Combivent 18mcg/103mcg 2 puffs QID  
Aspirin 81 mg daily  
tobradex L eye BID  
e-mycin gtt R eye BID  
 
Discharge Medications:
1. Donepezil 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). 
 
2. Terazosin 2 mg Capsule Sig: One (1) Capsule PO at bedtime.  
3. Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
5. Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 
times a day).  
6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
7. Docusate Sodium 100 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
8. Sarna Anti-Itch 0.5-0.5 % Lotion Sig: One (1) application 
Topical three times a day as needed for itching.  
9. Combivent ___ mcg/Actuation Aerosol Sig: Two (2) puffs 
Inhalation four times a day.  
10. Miralax 17 gram/dose Powder Sig: One (1) dose PO once a day 
as needed for constipation.  
11. Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical BID 
(2 times a day): Apply to groin folds.  
12. Triamcinolone Acetonide 0.1 % Ointment Sig: One (1) Appl 
Topical BID (2 times a day) as needed for skin itch.  
13. White Petrolatum-Mineral Oil     Cream Sig: One (1) Appl 
Topical BID (2 times a day) as needed for itchy skin.  
14. Insulin Aspart  Subcutaneous
15. Insulin Glargine  Subcutaneous
16. Vigamox 0.5 % Drops Sig: One (1) drop Ophthalmic four times 
a day: Right eye.  
17. Polysporin 500-10,000 unit/g Ointment Sig: One (1) drop 
Ophthalmic three times a day: Right eye.  
18. Debrox 6.5 % Drops Sig: ___ drops Otic twice a day for 3 
days: Please apply in both ears.  
19. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO TID (3 times a day).  
20. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
21. Namenda 5 mg Tablet Sig: One (1) Tablet PO once a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
urinary tract infection
drug induced fevers
acute on chronic renal failure
urothelial bladder CA 
right lower extremity swelling
right corneal abrasion

Secondary:
CAD s/p MI  
congestive heart failure
prior CVA  
diabetes
dementia  
CKD  
COPD  
HTN  
anemia 

 
Discharge Condition:
Mental status improved, ambulatory with assistance, afebrile, 
vitals stable.

 
Discharge Instructions:
You were admitted to the hospital with a decrease in your mental 
status. We believe that this was due in part to a urinary tract 
infection. We have treated you for this and you have improved. 
You will need ongoing attention to your medical problems to 
continue your recovery.

It is important that you continue to take your medications as 
directed. We made the following changes to your medications 
during this admission:
--> furosemide was stopped
--> losartan was stopped
--> antibiotic eye drops were started
--> triamcinalone was started

Contact your doctor or come to the Emergency Room should your 
symptoms return. Also seek medical attention if you develop any 
new fever, chills, trouble breathing, chest pain, nausea, 
vomiting or unusual stools.
 
Followup Instructions:
___
"
69,13689390,24224044," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Tylenol
 
Attending: ___.
 
Chief Complaint:
left sided weakness, numbness, and tingling 
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ year old man with PMH homelessness, HTN, DM, Hep C, etoh 
abuse, who presents with left sided weakness, numbness, and 
tingling. Symptoms began a few weeks ago. Begins at the left 
midclavicular line, down the torso and includes his left arm and 
leg and spares his back and face. Patient has been 
intermittently hot and cold but no objective fevers. Also having 
diaphoresis and nausea. No chest pain, palpitations, SOB, cough, 
vomiting, diarrhea, red or black stools, or dysuria. He has been 
drinking a 12-pack of beer daily, last drink was yesterday 
morning (___).  
.  
In the ED initial vitals were 97.8, 54, 170/81, 20, 96% RA. 
Neuro was consulted and felt that symptoms do not neatly fit 
into any neat single lesion. They recommended outpatient ___ 
with the neuro urgent care clinic with possible EMG/NCS. Labs 
notable for new leukopenia and thrombocytopenia, trop 0.02 -> 
<0.01, etoh level 68. CT head neg for acute process. Patient was 
initially in ED obs with plan for stress test in the AM however 
patient started to withdrawal and required multiple doses of 
diazepam so is being admitted for etoh withdrawal. Patient also 
given ASA 325, folic acid 1mg, and thiamine 100mg. Vitals prior 
to transfer were 98.0, 65, 150/88, 16, 97% on RA.  
.  
On the floor patient feels tremulous and continues to have the 
numbness/weakness over his left side. Otherwise he has no 
complaints.  

 
Past Medical History:
- DMII  
- Hypertension  
- Hepatitis C  
- Alcohol dependence  
- Tobacco abuse  
- S/p hernia repair 
 
Social History:
___
Family History:
Mother died of breast cancer, father died from  stroke (unclear 
lesion location, circumstances, etc.)  

 
Physical Exam:
Admission exam
VITALS: 98.2, 147/90, 52, 18, 99% RA  
GENERAL: Disheveled dirty-appearing man, smells of alcohol  
HEENT: NCAT, PERRL, EOMI, no icterus, MMM, no teeth  
NECK: Supple, no carotid bruits, no JVD  
LUNGS: CTAB  
HEART: RRR, normal S1 S2, no MRG  
ABDOMEN: Soft, NT, ND, NABS, no organomegaly  
EXTREMITIES: WWP, no c/c/e  
SKIN: Dirt underneath fingernails and toenails, several 3-4 cm 
annular lesions with central clearing on extremities  
NEUROLOGIC: ___, speech wnl, CN II-XII intact, strength ___ in 
UE and ___, per neuro exam he has diminished pinprick in an area 
that begins at the left mid-clavicular line and extends to the 
left axillary line. No change in pinprick over the back. It also 
includes his left arm and leg. Diminished vibration sense at the 
ankle  
and toes bilaterally.  

Discharge exam
98.3 126/58 51 18 95%ra 
GENERAL: Disheveled caucasian male, NAD 
HEENT: NCAT, PERRL, EOMI, no icterus, MMM, no teeth  
NECK: Supple, no carotid bruits, no JVD  
LUNGS: CTAB  
HEART: RRR, normal S1 S2, no MRG  
ABDOMEN: Soft, NT, ND, NABS, no organomegaly  
EXTREMITIES: WWP, no c/c/e  
SKIN: Dirt underneath fingernails and toenails, several 3-4 cm 
annular lesions with central clearing on extremities  
NEUROLOGIC: ___, speech wnl, CN II-XII intact, strength ___ in 
UE and ___, some decreased vibratory sensation in lower 
extremities

 
Pertinent Results:
Admission labs
___ 12:30PM BLOOD WBC-3.1* RBC-4.36* Hgb-11.4* Hct-35.1* 
MCV-80*# MCH-26.1* MCHC-32.5 RDW-19.4* Plt ___
___ 12:30PM BLOOD Glucose-119* UreaN-7 Creat-0.8 Na-138 
K-3.4 Cl-97 HCO3-27 AnGap-17
___ 12:30PM BLOOD Calcium-8.4 Phos-2.4*# Mg-1.6
___ 12:30PM BLOOD ASA-NEG Ethanol-68* Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NE

Cardiac labs
___ 12:30PM BLOOD cTropnT-0.02*
___ 09:20PM BLOOD cTropnT-<0.01
___ 06:00AM BLOOD cTropnT-<0.01

Discharge labs
___ 06:30AM BLOOD WBC-3.1* RBC-4.07* Hgb-10.5* Hct-33.4* 
MCV-82 MCH-25.9* MCHC-31.5 RDW-19.4* Plt ___
___ 06:30AM BLOOD Glucose-98 UreaN-14 Creat-0.9 Na-140 
K-3.7 Cl-104 HCO3-30 AnGap-10
___ 06:00AM BLOOD cTropnT-<0.01
___ 06:30AM BLOOD Calcium-8.4 Phos-3.1 Mg-1.9

Studies
Head CT: No evidence of acute process.

 
Brief Hospital Course:
Mr ___ is a ___ with h/o homelessness, HTN, t2DM, HCV, etoh 
abuse, who presents with left sided weakness, numbness, and 
tingling. Found to have mildly elevated troponin, now ruled out 
for ACS, but subsequently developed etoh withdrawal.  
.  
# Left sided weakness/numbness: Located across torso and 
includes his left arm and leg and spares his back and face, 
which does not fit into any single lesion. He does have evidence 
of a distal stocking-like sensory small fiber neuropathy which 
could be ___ alcohol or diabetes. He also has left sided foot 
drop which could be a mononeuropathy secondary to trauma or 
metabolic conditions listed above. Neurology was consulted, and 
recommend ___ in ___ clinic for possible EMG testing. An 
appointment was arranged for him. Pt advised to quit alcohol 
(see below), though declined. 
.  
# ETOH withdrawal: h/o DT's and withdrawal seizures in the past. 
Given valium per CIWA scale, w/o evidence of severe withdrawal. 
Social work was consulted, and pt offered detox, rehab, housing 
resources. Pt declined all these resources, and expressed no 
desire to quit drinking EtOH at this time. He was given 
thiamine, folate, and MVI during this admission, but refused 
Rx's upon discharge.   
.  
# Elevated troponin: No known cardiac disease. Patient denies 
any chest pain and ekg w/o ischemic changes. Ruled out for ACS 
this admission. 
.  
# Pancytopenia: Possibly related to chronic etoh abuse. However, 
was normal in ___ be toxin related. Does not appear 
to have infection. Appointment was made for pt with his PCP.    
.  
# DM: Patient does not take any medications. Used HISS in house. 
PCP ___ made   
.  
# Hep C: Has never been treated. Outpatient hepatology ___ 
arranged.   
.  
# ?Ringworm: Several 3-4 cm annular lesions with central 
clearing on extremities c/w ringworm. We started ketoconazole 
cream, but pt declined a prescription upon discharge
.
 
Medications on Admission:
none  
 
Discharge Medications:
none
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
- Neuropathy, likely related to diabetes or alcohol. Please stop 
drinking alcohol. 
- EtOH withdrawal

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr ___, 

You were admitted for numbness, and for alcohol withdrawal. You 
were evaluated by our Neurologists, who want to see you as an 
outpatient. We have made an appointment for you below. 

For your alcohol withdrawal, you were given medications. We 
offered a detox stay, but you did not want this. If you change 
your mind and want detox, please let your doctors ___. 
 
Followup Instructions:
___
"
70,13689390,24708416," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Tylenol
 
Attending: ___.
 
Chief Complaint:
right leg pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with known hepC, DM2, substance abuse and current 
homelessness presenting today with RLE pain. Per patient he 
reports breaking his right leg by stepping off the curb a couple 
weeks ago. Reportedly he was treated at ___, but denied 
casting at that time. He presents today with worsening pain, 
refractory to Tramadol.  
Of note, pt was at rehab for alcohol detox last week. Since he 
has left, he has been drinking large amounts of alcohol ___ 
pints hard alcohol daily). His last drink was this morning. Also 
has been using Xanax (quantity and time course unclear). 
Importantly, he has experienced withdrawal seizures in the past. 
 
 
In the ED, initial VS: 97.7 ___ 18 98% RA. Patient noted 
to be tremulous, smelling of alcohol and urine, also requesting 
detox. Initial labs remarkable for EtOH 120, positive benzos. 
Plan films showed no evidence of fracture. CIWA score of 17 at 
baseline. SW consult requested. Prior to transfer patient had 
received valium 40mg, thiamine 100mg, and folic acid 1mg and 1L 
NS. VS prior to transfer: 98.0 88 134/79 18 100%  
On arrival to the floor, vital signs: 98.4 173/75 106 18 97RA. 
He is complaining of right knee pain. He is agitated and 
requesting food.  
 
ROS: + nasal congestion, per HPI, denies fever, chills, night 
sweats, headache, vision changes, rhinorrhea, congestion, sore 
throat, cough, shortness of breath, chest pain, abdominal pain, 
nausea, vomiting, diarrhea, constipation, BRBPR, melena, 
hematochezia, dysuria, hematuria.  

 
Past Medical History:
 DMII  
- Hypertension  
- Hepatitis C  
- Alcohol dependence  
- Benzo abuse  
- Tobacco abuse  
- S/p hernia repair  
- posttraumatic arthritis s/p knee and femur reconstruction 
after MVC ___ years ago with patellectomy ___ years ago.  

 
Social History:
___
Family History:
Mother died of breast cancer, father died from stroke 
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
VS - 98.4 173/75 106 18 97RA  
GENERAL - disheveled, agitated, tremulous, in fetal position in 
bed.  
HEENT - NC/AT, PERRL, EOMI (no nystagmus), OP clear, dry MM  
NECK - supple,  
HEART - tachycardic, regular rhythm, no murmurs  
LUNGS - CTAB  
ABDOMEN - soft/NT/ND, no rebound/guarding  
EXTREMITIES - Scar noted on right knee. right knee with 1cm 
abrasion, suprapatellar swelling and tenderness to palpation. 
Full AROM. Strength intact. 2+ DPs  
SKIN - no rashes or lesions  
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, tremulous, gait not assessed.  

DISCHARGE PHYSICAL EXAM:  
VS - 98.5 141/81 78 16 96RA  
GENERAL - alert, oriented x3, not tremulous, NAD.  
HEENT - PERRL, EOMI (no nystagmus), MMM
HEART - RRR, no murmurs  
LUNGS - CTAB  
ABDOMEN - soft/NT/ND, no rebound/guarding  
EXTREMITIES - Scar on right knee. right knee with 1cm abrasion, 
suprapatellar swelling and tenderness to palpation. Full AROM. 
Strength intact. 2+ DPs  
SKIN - no rashes or lesions  

 
Pertinent Results:
ADMISSION LABS:
___ 11:26AM BLOOD WBC-6.5# RBC-4.59* Hgb-13.9*# Hct-41.3 
MCV-90# MCH-30.2# MCHC-33.6 RDW-14.2 Plt ___
___ 11:26AM BLOOD Neuts-57.8 ___ Monos-5.8 Eos-2.1 
Baso-0.8
___ 11:26AM BLOOD Glucose-148* UreaN-17 Creat-0.8 Na-136 
K-6.5* Cl-100 HCO3-22 AnGap-21*
___ 11:26AM BLOOD LD(LDH)-810* CK(CPK)-504*
___ 11:26AM BLOOD CK-MB-21* MB Indx-4.2
___ 11:26AM BLOOD Calcium-8.6 Phos-4.0 Mg-2.0
___ 11:26AM BLOOD ASA-NEG ___ Acetmnp-NEG 
Bnzodzp-POS Barbitr-NEG Tricycl-NEG
___ 11:31AM BLOOD Lactate-5.0* K-5.1
___ 04:39PM BLOOD Lactate-2.3*

DISCHARGE LABS:
___ 06:45AM BLOOD WBC-4.3 RBC-3.86* Hgb-11.5* Hct-34.9* 
MCV-90 MCH-29.9 MCHC-33.1 RDW-13.4 Plt ___
___ 06:45AM BLOOD Glucose-188* UreaN-14 Creat-0.8 Na-141 
K-3.7 Cl-105 HCO3-28 AnGap-12
___ 06:45AM BLOOD ALT-31 AST-29 AlkPhos-76 TotBili-0.6
___ 06:45AM BLOOD Calcium-8.5 Phos-3.0 Mg-1.9

URINE: 
___ 03:18PM URINE Color-Yellow Appear-Clear Sp ___
___ 03:18PM URINE Blood-NEG Nitrite-NEG Protein-30 
Glucose-300 Ketone-10 Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG
___ 03:18PM URINE RBC-0 WBC-<1 Bacteri-NONE Yeast-NONE 
Epi-0

PLAIN FILM XRAYS:
TWO VIEWS OF THE RIGHT FEMUR: There is no evidence of a right 
femoral neck fracture.  There is evidence of an old distal right 
femoral fracture with a medial plate and multiple interlocking 
screws.  There is a fracture of the third most superior screw.  
Otherwise, no other acute fractures are noted in the hardware. 
TWO VIEWS OF THE RIGHT TIBIA AND FIBULA: There is no evidence of 
acute fracture or dislocation.  The bones are diffusely 
demineralized.  Diffuse vascular calcifications are noted. 

 
Brief Hospital Course:
___ with known hepC, DM2, alcohol abuse and homelessness was 
admitted with right lower extremity pain and alcohol withdrawal. 
 

ACTIVE ISSUES: 
# ETOH/Benzo withdrawal: He presented with tremors, agitation, 
nausea, and endorsed heavy alcohol use and benzo use ending 
morning of ___. In the setting of prior DTs and withdrawal 
seizures he was treated with Valium per CIWA scoring.  He also 
received IVF, thiamine, MVI, and folate.  On the morning of ___, 
he was no longer exibiting signs of withdrawal and was not 
scoring on CIWA.  He was seen by social work and addiction team, 
but left against medical advice before housing could be 
arranged.  

# Post-traumatic arthritis.  He complained of suprapatellar 
right knee and leg pain on presentation that has been 
exacerbated since his recent fall from curb 2 weeks ago.  
Initially seen by ___, however it is unclear what came of 
that ED visit.  His plain films here show broken screw, but no 
fractures or joint effusion.  He was seen by ortho who 
recommended pain management and total knee arthroplasty as an 
elective procedure in the future.  They did not feel that the 
broken screw on xray needed to be repaired.  He received 
oxycodone for pain (he refused tramadol/tylenol/nsaids).  

#AMA:  Patient left AMA on ___ at 3pm.  He was no longer in 
withdrawal from alcohol.  He was agitated, yet able to verbalize 
the risks and benefits of leaving on his own will.  He denied 
SI/HI at that time.  

CHRONIC ISSUES:

# DM: His blood sugars were occasionally elevated to 200s and 
low 300s after meals. He was kept on ISS, but would frequently 
refuse injections. 

#Hep C: He has a known history of hep C that has not been 
treated.  His LFTs were within normal limits.  He has not 
followed through with outpatient hepatology follow-ups that were 
arranged.  

TRANSITIONAL:
-Patient homeless 
-As above, he left AMA on ___
 
Medications on Admission:
NONE
 
Discharge Medications:
1. FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
2. Multivitamins 1 TAB PO DAILY 
RX *multivitamin [Chewable Multi Vitamin]   1 tablet(s) by mouth 
daily Disp #*30 Tablet Refills:*0
3. Nicotine Patch 14 mg TD DAILY 
RX *nicotine [Nicoderm CQ] 14 mg/24 hour 1 patch daily Disp #*30 
Unit Refills:*0
4. Thiamine 100 mg PO DAILY 
RX *thiamine HCl 100 mg 1 tablet(s) by mouth dailyu Disp #*30 
Tablet Refills:*0
5. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain 
RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp 
#*20 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary: alcohol withdrawl,
Secondary: Hep c

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was our pleasure to care for you at ___.  You were admitted 
for alcohol withdrawl and treated with medications to treat your 
symptoms.  You were seen by the orthopedics service for your leg 
pain and they determined that there was no operation needed to 
adress it.  

We tried to find you a place at the ___ house, but 
you decided to leave before this was completed.

It is important that you do not smoke or take drugs.
 
Followup Instructions:
___
"
71,13689390,26653026," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Etoh withdrawal
 
Major Surgical or Invasive Procedure:
NONE
 
History of Present Illness:
This is a ___ year old male with a history of hypertension, 
chronic knee pain, and alcohol abuse with history of DTs who was 
found down in the snow with hypothermia, now in alcohol 
withdrawal. 

Per report, patient was found down outside by EMS, initially 
temperature around 92.2, 94.5 oral on arrival to the ED. The 
patient does not recall being found or where he was at that 
time.  He was found shivering with slurred speech and 
incontinent of urine.  ___ was 144.  On arrival to the ED, he was 
following commands and speaking in full sententences.
 
In the ED, he received a banana bag and 1 L NS. He was placed on 
a bearhugger and warmed up to T max of 99.4. Once he awoke and 
was warmed, he was agitated, tachycardic, diaphoretic, & 
tremulous, c/w EtOH withdrawal. He also expressed suicidal 
ideation; seen by psychiatry in ED who did not think he was an 
immediate danger to himself. 

On arrival to ___, belligerent, but after speaking with 
admitting resident, calmed down, apologized for his behavior and 
accepted plan for EtOH detox. 

ROS: The patient states he just feels like he was ""run over by a 
truck."" Denies any fevers, chills, weight change, nausea, 
vomiting, abdominal pain, diarrhea, constipation.  He reports 
occasional hematemesis, none recently, and occasional BRBPR, 
none recently.  never had any endoscopy.  Also complains of a 
headache now.  Denies CP, shortness of breath, orthopnea, PND, 
lower extremity oedema, cough, urinary frequency, urgency, 
dysuria, lightheadedness, gait unsteadiness, focal weakness, 
vision changes, rash or skin changes.  

 
Past Medical History:
Hypertension
Chronic knee pain from MVA in 1980s s/p multiple surgeries (? in 
___
Hepatitis C from blood transfusion in the 1980s, never treated 
(couldn't stay sober long enough), history of biopsy many years 
ago 
Alcohol abuse
Type 2 DM
Anxiety/depression
s/p umbilical hernia repair
 
Social History:
___
Family History:
Breast cancer, hepatocellular cancer in his grandmother. 

 
Physical Exam:
Vitals: 97.4  143/80  88  18 98%RA
Pain: ___ L chest/rib cage, R knee
Access: PIV
Gen: desheveled, belching
HEENT: anicteric, mmm
CV: RRR, no m
Resp: CTAB, no crackles or wheezing
Abd; soft, obese, +tenderness over R ribcage, otw nontender, +BS
Ext; no edema, no R knee swelling
Neuro: A&OX3, grossly nonfocal, mild tremors
Skin: no changes
psych: more sedated today, but easily angry/agitated when awake
gross dermatitis. No ecchymoses. 
 
Pertinent Results:
wbc 5.5
hgb 15.8-->13.3-->12.1  MCV 88
LFTs wnl ___
Chem panel unremarkable, K/phos/Mag okay
Serum tox: etoh 277, +benzo
.
.
Imaging/results: 
CXR: ___ and ___: no acute abnormality

 
Brief Hospital Course:
___ old male with longstanding ETOH dependence c/b DTs, 
tobacco abuse, narcotic abuse, Hep C, Depression/anxiety, 
chronic R knee pain, DM, homelessness brought to ___ with 
environmental hypothermia when found down in ice on ___. Was 
externally warmed up but then actively withdrawing, so t/f to 
MICU. Loaded with valium, given IVFs, bannana bag, stabilized 
overnight. Then transfered to Gen Med for social work and 
placement. Was continued on CIWA scale/valium through the night. 
Was also started on seroquel 300mg qhs (on this as outpt).  
Kicked out ___ several weeks ago for fighting, cannot 
return till ___, so now homeless. Initially was agreeable 
for inpatient detox but on HD#2, refused detox.  Stated that his 
plan was to keep drinking and pass out every day and he does not 
care if he doesnt wake up. He denied active SI or plan 
(passive). Seen by psych who felt that he understood his risks 
and was capable of making his own decisions. Signed out AMA so 
that he can ""go to liquor store and continue drinking"". Was not 
given any Rx on discharge for valium/seroquel/cymbalta/klonopin 
per psych recs since his plan was to continue drinking and he 
openly admitted that he was abusing seroquel and cymbalta and he 
still has active scripts at his pharmacy in ___. Attempts 
by psych at contacting his outpt psych were unsuccesful.   Of 
note, reported that he fell on L side so c/o a lot L chest/rib 
pain (CXR neg for fracture, no rib films done prior to him 
signing out AMA) and chronic R knee pain. Has h/o chronic 
narcotic abuse (percocet-30mg), here was getting oxycodone 15mg 
q4hrs prn. He states that he gets this off the street and 
through his MD so ___ was not given for this. He was stated on 
clonidine here for HTN but stated he would not take this on 
discharge (was previously on this and still has Rx at pharmacy). 
Refuse to comply with diabetic diet (and seroquel not helping).  
Social work tried to talk with patient about finding a homeless 
shelter but pt did not want to wait for this. Signed out AMA on 
___, got cab voucher so he can go to homeless shelter. 
.
progress note
.
Etoh withdrawal: +++longstanding ETOH abuse, History of DTs, not 
clear about seizures. Also on chronic klonipine (benzo) 
contributing to withdrawal
-Cont Valium per CIWA scale->decrease frequency as tolerated 
(also given that patient is on chronic Klonipin). monitor for 
benzo intoxication
-pt states very clearly that he intends to drink upon discharge 
(is variable about wanting detox) so will NOT given Valium on 
discharge since high risk of abuse
- cont MVI, folate, thiamine
- Psych and SW consult saw pt, he is NOT interested in inpatient 
detox, wants to sign out AMA despite multiple discussions 
emphasizing risk (weather, continued drinking)
.
.
Pain: Complaining of chronic R knee pain, also with some left 
sided rib pain, appears musculoskeletal, reproducible.  CXR done 
in ED  no obvious rib fracture and pt appears to be comfortable 
w/o any splinting and able to ambulate. Chronic narcotic user.   

- Valium as above, oxycodone 15mg (dec from 20mg) q4 prn for 
pain (patient reports getting percocet-30 from PCP and off the 
street for ___ and continue tylenol q6prn. No Rx on 
discharge 
.  
.
Hepatitis C: Reports infection during the ___ from blood 
transfusion. Denies any IVDU, no tatoos.  Has had biopsy in the 
past, no treatment.  Appears he has history of upper GI bleed 
but has never had endoscopy. LFTs wnl, coags normal, albumin 4.1 
all of which go against chronic hepatitis. 
.
.
Anemia, acute drop: HCT drop 42.9-->36.9 but has recieved IVFs 
and HCT now stable and likely his baseline. No active bleeding 
noted but he is certainly high risk

.
.
Hypertension: supposed to be on nifedipine and clonidine at 
home, not sure if taking. Also component of acute etoh 
withdrawal. 
-well controlled now with valium and clonidine 0.2mg bid. hold 
nifedipine. Pt states he will not take this meds on discharge 
though he has clonidine that he uses for w/drawal symptoms. 
.
.
Type 2 DM: On glipizide 10mg bid at home, has not been taking 
it. Sugars now in 300s since he is taking good PO. Seroquel 
making DM worse. 
- resumed glipizide while here with SSI, refused to follow 
diabetic diet
.
.
Depression/anxiety: psych following, they do not feel he is 
actively suicidal despite his occ comments about wanting to lie 
in snow and die. They feel he has capacity to leave AMA if he 
wants. 
-never recieved OSH records from OP Psych re: prior hx and  meds
-for now, on seroquel 300mg qhs (pt admits that he abuses 
seroquel as outpt). holding cymbalta and klonipin (on valium as 
above)
-spoke with psych resident, pt has refills on ALL his meds at 
pharmacy and given that he openly admits that he abuses ALL his 
meds, will no provide any additional Rx on discharge
.
.
Tobacco abuse: nicotine patch 21mg/24hr while here
.  
Left AMA 

.

 
Medications on Admission:
Glucotrol 10 mg BID
Cymbalta 60 mg BID
Nifedipine CR 30 mg
Seroquel 300 mg HS
Clonidine 0.2 mg BID
Klonipin 2 mg TID
percocet-30, 6 pills daily, prescribed, plus what patient buys 
illicitly
 
Discharge Medications:
1. Quetiapine 200 mg Tablet Sig: 1.5 Tablets PO QHS (once a day 
(at bedtime)).  
2. Clonidine 0.1 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
3. Glipizide 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
4. Multivitamin     Tablet Sig: One (1) Tablet PO once a day.  
5. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO once a day. 
 
6. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO once a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Environmental hypothermia
Etoh dependence and withdrawal
 
Discharge Condition:
At risk for further ETOH withdrawal and hypothermia
 
Discharge Instructions:
You were admitted to the intensive care unit after you were 
found down in the snow and hypothermic. While here, you 
developed alcohol withdrawal and were treated with valium. You 
were seen by psychiatry who said you were capable of making your 
own decisions since you understool all the risks associated with 
your behaviour. You decided to leave Against Medical Advice 
despite being requested to stay for inpatient detox, especially 
since it is very cold outside and you are homeless now that you 
have been kicked out ___ until ___. 
You left despite this. You were not given any prescriptions as 
your pharmacy still has Rx for you. 
 
Followup Instructions:
___
"
72,13777455,29362301," 
Name:  ___                        Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins
 
Attending: ___.
 
Chief Complaint:
cough, SOB, fever 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ yo female with history of DM type I, osteopenia, depression, 
recent L olecranon fracture fix 2 weeks ago, presents with 2 
weeks of cough, SOB, fatigue. Patient reports that she felt 
congesting shortly following her surgery 2 weeks ago at ___ 
___, which progressively turned into a cough. She's felt 
fatigued and slightly SOB this entire time, she didn't take her 
temperature at home, but felt warm at times. Tried cough 
medications which did not help.  
.  
In the ED, a CXR was performed which showed RLL pneumonia, but 
also with concerns for malignancy given atypical shape of the 
consolidation. Given her recent surgery, PE was ruled out with 
CTA, which was negative. Patient was given tylenol and 
levofloxacin 750 mg IV x1 in the ED prior to transfer. Vitals on 
transfer were: 92, 119/98, 15, 99%2L.  
.  
On the floor, patient reports feeling more comfortable. Still 
has a bit of a cough. No pleuritic chest pain, not feeling short 
of breath. No palpitations. Denies any chest pain, nausea, 
abdominal pain. Only complaint is that her sciatica pain is a 
little worse because it is hard for her to find a comfortable 
position to lie in the hospital bed with her arm in a sling.  
.  
Review of systems:  
(+) Per HPI  
(-) Denies chills, night sweats, recent weight loss or gain. 
Denies headache, sinus tenderness, rhinorrhea. Denied cough, 
shortness of breath. Denied chest pain or tightness, 
palpitations. Denied nausea, vomiting, diarrhea, constipation or 
abdominal pain. No recent change in bowel or bladder habits. No 
dysuria.  

 
Past Medical History:
DM type I c/b neuropathy  
osteopenia with multiple fractures - right 10th rib ___, 
left foot ___, olecranon fracture ___  
depression  

 
Social History:
___
Family History:
Mother's side - DM II  
Father's side - DM II, CAD  

 
Physical Exam:
Vitals: 103 128/56 92 18 98%3L  
General: AAOx3, NAD, breathing comfortably  
HEENT: Sclera anicteric, MMM, oropharynx clear, no LAD  
Neck: supple, JVP not elevated, no LAD  
Lungs: RLL dull to percussion, faint rales in RLL, no wheezes, 
grossly good air movement  
CV: RRR, S1S2, II/VI systolic ejection murmur  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
Ext: LUE - nontender, nonerythematous, in a sling. Incision 
clean/dry/intact. Warm, well perfused, 2+ pulses, no clubbing, 
cyanosis or edema  

 
Pertinent Results:
On admission:

___ 08:00PM BLOOD WBC-10.3 RBC-3.61* Hgb-11.5* Hct-34.0* 
MCV-94 MCH-31.9 MCHC-33.9 RDW-12.7 Plt ___
___ 08:00PM BLOOD Neuts-90* Bands-2 Lymphs-1* Monos-3 Eos-0 
Baso-0 ___ Metas-3* Myelos-1*
___ 08:00PM BLOOD ___ PTT-22.9 ___
___ 08:00PM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 08:00PM BLOOD Glucose-98 UreaN-21* Creat-0.6 Na-133 
K-3.6 Cl-99 HCO3-25 AnGap-13
___ 08:00PM BLOOD ALT-19 AST-24 AlkPhos-33* TotBili-0.6
___ 08:00PM BLOOD Lipase-21
___ 08:19PM BLOOD Lactate-1.4
___ 10:40PM URINE Color-Straw Appear-Clear Sp ___
___ 10:40PM URINE Blood-NEG Nitrite-NEG Protein-25 
Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG
___ 10:40PM URINE RBC-0 ___ Bacteri-FEW Yeast-NONE 
___

On discharge:

___ 05:15AM BLOOD WBC-11.3* RBC-2.91* Hgb-9.5* Hct-27.8* 
MCV-96 MCH-32.7* MCHC-34.3 RDW-12.7 Plt ___
___ 05:15AM BLOOD Glucose-205* UreaN-14 Creat-0.6 Na-130* 
K-3.8 Cl-98 HCO3-24 AnGap-12
___ 05:15AM BLOOD Calcium-8.2* Phos-1.5* Mg-1.9
Blood Culture, Routine (Pending)
URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 
COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL 
CONTAMINATION.
GRAM STAIN (Final ___ PMNs and <10 epithelial 
cells/100X field. 1+    (<1 per 1000X FIELD):   GRAM POSITIVE 
COCCI IN PAIRS. 
RESPIRATORY CULTURE (Final ___: SPARSE GROWTH Commensal 
Respiratory Flora. 
Legionella Urinary Antigen  (Final ___: NEGATIVE FOR 
LEGIONELLA SEROGROUP 1 ANTIGEN. 

ECG ___:
Normal sinus rhythm. Tracing is within normal limits. No 
previous tracing available for comparison.  

Chest (PA & LAT) ___:
UPRIGHT AP AND LATERAL VIEWS OF THE CHEST: The heart size is 
normal. The aorta is slightly unfolded. The mediastinal and 
hilar contours are otherwise unremarkable. Within the medial 
aspect of the right lung base, there is a focal rounded opacity 
identified. The left lung is clear. No pneumothorax or pleural 
effusion is present. There are no acute osseous findings. 
  
IMPRESSION: Rounded opacity projecting over the medial right 
lung base, which could represent an area of inflammation or 
infection. However, the rounded morphology may be suggestive of 
an underlying mass lesion, and further evaluation with CT is 
recommended. 

CTA Chest ___:
CTA CHEST: The pulmonary arterial vasculature is normally 
opacified to the subsegmental level, without evidence of filling 
defect to suggest pulmonary embolism. The aorta is normal in 
size and caliber without acute aortic pathology. The remaining 
great mediastinal vessels are normal.  
  
In the right lower lobe, there is a large consolidative opacity, 
measuring approximately 8.6 x 6.8 cm in maximum cross-sectional 
dimension (image 3:87).  Pulmonary arterial branches normally 
traverse through the consolidation area, compatible with the ""CT 
angiogram sign"". There are no pleural effusions or pneumothorax. 
No other pulmonary nodule or mass is noted.  
  
The heart is normal in size without pericardial effusion. The 
central tracheobronchial tree is patent. There is no 
mediastinal, hilar, or axillary lymphadenopathy. 
  
The study is not designed for subdiaphragmatic diagnosis. A 
subcentimeter hypodensity in the right hepatic lobe (image 
3:106) is too small to be fully characterized and a sub-cm 
hypodensity in the left lobe of the liver (3:100) is likely a 
cyst. The right adrenal is not visualized. The left adrenal is 
only partially imaged, but no abnormality is noted. 
  
BONE WINDOW: There are no suspicious lytic or sclerotic lesions. 

  
IMPRESSION: 
1. No pulmonary embolism or acute aortic pathology. 
2. Right lower lobe airspace consolidation, with demonstration 
of the ""CT angiogram"" sign. Differential diagnosis includes 
pneumonia, bronchioloalveolar carcinoma, and lymphoma. Recommend 
followup imaging after treatment to ensure clearance. 
 
Brief Hospital Course:
___ yo female with DM I, osteopenia, recent L olecranon fracture 
fix 2 weeks ago presenting with SOB, fever, cough, and found to 
have RLL opacity on CXR  
.  
# Fever: Pt presented with fever, cough, SOB, and pain on deep 
inspiration consistent with pneumonia.  CXR and CTA chest 
revealed RLL opacity concerning for PNA.  (In setting of recent 
surgery of olecranon fracture, CTA chest was performed to rule 
out PE.)  However, given atypical appearance of consolidation, 
malignancy could not be ruled out.  Pt was advised to have 
repeat imaging upon resolution of pneumonia and was scheduled 
for outpatient CT chest.  She was started on oral levofloxacin 
for CAP.  Gram stain of sputum revealed 1+ gram positive cocci 
in pairs; culture grew sparse commensal respiratory flora.  
Urine legionella was negative.  Despite her recent hospital 
stay, she was not started on treatment for HCAP as she appeared 
nontoxic and improved significantly over 24 hours on 
levofloxacin.  She was discharged home with instructions to 
complete a 7 day course of levofloxacin.  
.  
# Left olecranon fracture: Pt reported having been at an OSH for 
two days for surgery for her left olecranon fracture two weeks 
prior to presentation to ___.  Left arm was kept in a sling.  
She reported no pain in the arm.  Incision was clean, dry, and 
intact.  
. 
# DM type I: Pt had humalog insulin pump which was continued 
during her hospital stay.  Per protocol, she was evaluated by 
the ___ diabetes team and seen by the nutritionist.  Per 
___ recs, she was continued on her home pump settings as 
blood glucose remained grossly within target range.  She was 
continued on her home aspirin.  
.  
# Depression: No acute issues.  She was continued on her home 
citalopram  
.  
# Osteopenia: Pt had history of multiple fractures, most 
recently a fracture of her left olecranon which was repaired two 
weeks prior to admission.  She was continued on her calcium and 
vitamin D.  She was also taking alendronate once a week which 
should be continued as outpatient.   
 
Medications on Admission:
albuterol inhaler ___ puff q4-6 hr prn SOB  
citalopram 40 mg daily  
alendronate 70 mg qweek  
humalog via insulin pump  
calcium carbonate 650 mg daily  
MVI  
ASA 81 mg daily  
vitamin D 400 units daily  

 
Discharge Medications:
1. citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
3. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily) for 4 days.
Disp:*4 Tablet(s)* Refills:*0*
4. insulin pump cartridge     Cartridge Subcutaneous
5. cholecalciferol (vitamin D3) 400 unit Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
6. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
7. calcium carbonate 650 mg (1,625 mg) Tablet Sig: One (1) 
Tablet PO once a day.  
8. alendronate 70 mg Tablet Sig: One (1) Tablet PO once a week.  

9. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
___ puffs Inhalation every ___ hours as needed for shortness of 
breath or wheezing.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Pneumonia
.
Secondary:
Type 1 DM
Left olecranon fracture

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you in the hospital.  You were 
admitted with pneumonia and treated with antibiotics for this.  
You will need to continue taking the antibiotics at home for 
four more days.  You should also follow up with your primary 
care doctor to schedule a repeat chest x-ray upon resolution of 
your symptoms.  
.
The following medications were added:

1) We ADDED Levofloxacin 750mg daily for four more days
 
Followup Instructions:
___
"
73,14210659,22840032," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Percocet / Banana / latex
 
Attending: ___.
 
Chief Complaint:
New atrial fibrillation
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Patient is a ___ w/ PMHx of HTN, HLD, PVD, COPD, history of 
colon cancer, anemia who presents from outpatient cardiology 
clinic with symptosm of dizziness and feelings of being woozy 
found to have new onset atrial fibrillation.  
The patient has been having intermittent episodes of 
palpitations with diaphoresis over the past one to 2 weeks. In 
regards to the palpitations, the patient has noticed that they 
have been increasing in frequency recently. The patient notices 
accompanying dizziness and wooziness with these symptoms. She 
reports accompanying weakness. No particular activity seems to 
bring on the symptoms as they occur at rest and with activity. 
She denies CP. She SOB at baseline ___ COPD which may have been 
getting a little worse recently. She was seen at her PCP's 
office last week for these symptoms who referred her to 
cardiology where she was found to be in new onset atrial 
fibrillation. She was sent from the cardiology office for 
admission to the cardiology service.  
Of note, the patient recently was on an flight from ___ to ___. Her daughter notes that she had swelling in the 
RLE that was worse than the LLE. The patient has noticed 
increased urinary frequency but denies dysuria or hematuria. Her 
daughter noticed that her right pupil seemed to be moving back 
and forth yesterday. The patient has noticed headache at the 
back of her head. She has a cough at baseline that is productive 
of phlegm ___ COPD that has not changed.  
In the ED, initial vitals were 0 120 100/62 18 97% RA.  
Labs: CBC notable for Hgb 11.3 with nml differential, nml coags. 
UA was remarkable for Lg ___, negative nitrite, 49 WBC, few 
bacteria. Chem notable for sodium of 132, K 3.9, Cr 0.8.  
Radiology: CXR with hyperinflation with no appreciated 
cardiomegaly, pleural effusions, consolidations, or pulmonary 
edema.  
Interventions: The patient was given 10mg IV diltiazem. The 
patient was also give 25mg PO metoprolol and IV ciprofloxacin 
for treamtent of a possible UTI.  
On arrival to the floor, the patient states that she feels 
pretty good.  

 
Past Medical History:
Anemia  
Anxiety/Depression  
Cataracts  
COPD  
Hip fracture s/p repair  
Hyperlipidemia  
Hypothyroidism  
Hypertension  
s/p removal of left parotid gland  
Osteoarthritis  
Osteoporosis  
Peripheral vascular disease  
Colon cancer in ___  
Urinary incontinence  
History of left adnexal cystic lesion on pelvic MRI ___ 
unchanged from prior.  

 
Social History:
___
Family History:
Mother died of MI at age ___. Father with stroke, cancer at age 
___. Daughter w/ PE in ___ she also has a history of DVT after 
car accident in ___. 
 
Physical Exam:
ADMISSION EXAM:
VS: T 97.5 BP 103/52 HR 96 RR 20 O2 Sat 95% on RA Weight 50kg  
General: NAD, comfortable, pleasant  
HEENT: NCAT, PERRL, EOMI. MMM.  
Neck: supple, no JVD  
CV: irregularly irregular rhythm, with no appreciated m/r/g  
Lungs: Decrease breathsounds bilaterally but CTAB, no 
appreciated w/r/r  
Abdomen: soft, NT/ND, BS+, colostomy with air in bag in the LLQ. 
 
Ext: WWP, no c/c/e, 2+ distal pulses bilaterally  
Neuro: Moving all extremities. CN ___ intact bilaterally. ___ 
biceps and triceps strength. ___ plantar and dorsiflexion at the 
ankles bilaterally.  

DISCHARGE EXAM:
Physical exam:
Vitals: 97.7 94-126/48-64 62-70 20 96%RA
Weight 47.7kg ___, ? ___, 45.7kg ___
I&Os: ?/? today, 560/740+ 
Gen: Awake in NAD
HEENT: NCAT. Pupils equal and round. Dentures not in place.  
Neck: Mildly distended EJV, no appreciated JVD
CV: Regular rhythm w/ ___ systolic murmur appreciated at the 
cardiac apex most prominently and then through the precordium 
including the axilla. 
Pulm: Crackles at the bases bialterally. Nml work of breathing. 
Abd: Soft. NT. Colostomy in LLQ. Suprapubic tenderness present.
Ext: No edema. Bruising of the UE bilaterally. 
 
Pertinent Results:
ADMISSION LABS:

___ 12:05PM BLOOD WBC-5.2 RBC-4.20 Hgb-11.3* Hct-36.8 
MCV-88 MCH-27.0 MCHC-30.8* RDW-13.6 Plt ___
___ 12:05PM BLOOD Neuts-62.7 ___ Monos-5.5 Eos-2.5 
Baso-0.5
___ 12:05PM BLOOD ___ PTT-31.9 ___
___ 12:05PM BLOOD Glucose-86 UreaN-18 Creat-0.8 Na-132* 
K-3.8 Cl-99 HCO3-26 AnGap-11
___ 12:30PM URINE Color-Straw Appear-Clear Sp ___
___ 12:30PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-LG
___ 12:30PM URINE RBC-2 WBC-49* Bacteri-FEW Yeast-NONE 
Epi-1
___ 12:30PM URINE CastHy-3*

DISCHARGE LABS:
___ 07:05AM BLOOD WBC-6.3 RBC-3.74* Hgb-10.1* Hct-32.5* 
MCV-87 MCH-27.1 MCHC-31.2 RDW-13.8 Plt ___
___ 07:05AM BLOOD Glucose-94 UreaN-47* Creat-1.0 Na-139 
K-4.1 Cl-97 HCO3-33* AnGap-13
___ 07:05AM BLOOD Calcium-9.0 Phos-4.1 Mg-2.3

TTE:
The left atrium is normal in size. Left ventricular wall 
thickness, cavity size and regional/global systolic function are 
normal (LVEF >55%). Right ventricular chamber size and free wall 
motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The aortic valve leaflets 
are moderately thickened. There is no aortic valve stenosis. No 
aortic regurgitation is seen. The mitral valve leaflets are 
mildly thickened. There is no mitral valve prolapse. An 
eccentric, posteriorly-directed jet of moderate to severe (3+) 
mitral regurgitation is seen. The tricuspid valve leaflets are 
mildly thickened. Moderate [2+] tricuspid regurgitation is seen. 
There is mild pulmonary artery systolic hypertension. There is 
no pericardial effusion. 

IMPRESSION: Normal global and regional biventricular systolic 
function. Moderate to severe mitral regurgitation. Moderate 
tricuspid regurgitation. Mild pulmonary hypertension.  

INDICATIONS FOR CONSULT:  
Difficult crossmatch and/or evaluation of irregular antibody (s) 

  
CLINICAL/LAB DATA: Ms. ___ is a ___ year old female who was 
admitted 
for new onset atrial fibrillation and tachycardia. Of note. the 
patient 
had a history of anti-K and anti-E antibodies that were 
identified at 
___ in ___. A blood sample was sent for type and 
screen. 
  
Laboratory data: 
Patient ABO/Rh: Group A, Rh positive 
Antibody screen: Positive 
Antibody identity: Anti-E and Anti-K antibodies 
Patient antigen phenotype: ___ and K-antigen negative 
  
Transfusion History: 
No previous transfusions at ___ or ___. 
___ previously identified an anti-E and anti-K in 
___. 
  
DIAGNOSIS, ASSESSMENT AND RECOMMENDATIONS:  
Ms. ___ has a confirmed diagnosis of anti-E and anti-K 
antibodies, 
previously identified at ___ in ___. 
  
___ is a member of the ___ blood group system. K-antigen is 
a 
member of the ___ blood group system. Both anti-E and anti-K 
antibodies 
are clinically significant and capable of causing hemolytic 
transfusions 
reactions. 
  
Ms. ___ should receive ___ and K-antigen negative 
products for 
all red cell transfusions. Approximately 63% of ABO-compatible 
blood 
will be ___ and K-antigen negative. 

MICROBIOLOGY:
___ 4:55 pm URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      STAPH AUREUS COAG +.    >100,000 ORGANISMS/ML.. 
         Oxacillin RESISTANT Staphylococci MUST be reported as 
also
         RESISTANT to other penicillins, cephalosporins, 
carbacephems,
         carbapenems, and beta-lactamase inhibitor combinations. 


                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STAPH AUREUS COAG +
                             |   
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------   =>8 R
NITROFURANTOIN--------  <=16 S
OXACILLIN-------------   =>4 R
TETRACYCLINE----------   <=1 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------ <=0.5 S

Blood culture pending times 2 at the time of discharge.

URINE CULTURE (Final ___:    <10,000 organisms/ml.

IMAGING: 
CXR ___ 11:30pm:  COPD.  Lateral right basilar scarring 
without definite focal consolidation.  No overt pulmonary edema. 
 

CXR ___: Pulmonary edema. An underlying infectious 
infiltrate cannot be excluded.

CXR ___ 2:25AM: Worsened appearance of the lungs with 
increased bilateral infiltrates

CXR ___: There has been improvement of the pulmonary 
interstitial edema since the previous study.  There remains 
bilateral pleural effusions, right greater than left.  There is 
persistent left retrocardiac opacity.  Calcification of the 
thoracic aorta is seen.  There are no pneumothoraces.  Heart 
size is within normal limits. 

 
Brief Hospital Course:
Ms. ___ is a ___ F w/ PMHx of HTN, HLD, PVD, COPD, history 
of rectal cancer, and anemia who presented from cardiology 
clinic with symptoms of dizziness in setting of new onset atrial 
fibrillation found to have over-repletion of thyroid hormone, 
hospital course complicated by acute pulmonary edema.  

# Acute Pulmonary Edema: Early on the morning of ___, the 
patient woke up acutely short of breath and hypertensive to 
systolics of 200. A chest x-ray showed worsened pulmonary edema 
in RLL. She was treated with 40mg IV Lasix and a nitroglycerin 
drip. She required BiPAP and was transferred to the CCU where 
she was treated with 3 additional doses of 40mg IV lasix over 
the course of 2 days. She only required BiPAP for 6 hours, and 
was then weaned to nasal cannula oxygen supplementation. 
Nitroglycerin drip was weaned off and home dose amlodipine was 
restarted. Review of the TTE showed 3+ MR ___ etiology thought 
to be possible flail mitral valve leaflet) as the presumed 
cauase for the patient's acute pulmonary edema. The patient 
continued to received IV furosemide on the floor with 
improvement in oxygen requirement with the patient on RA on the 
day of discharge. The patient was transitioned to PO torsemide 
___. The patient was started on losartan for after load 
reduction as well as metoprolol. Weight on day of discharge: 
47.7kg.

# Atrial fibrillation: CHADS-2 score of 2; patient has never had 
a stroke or TIA in the past. Patient was rate controlled on 
metoprolol XL 100mg and converted to sinus rhythm on the morning 
of ___. Thyroid function testing revealed over repletion which 
may have been the etiology for new afib. Levothyroxine dose was 
decreased to 112mcg daily (from 135mcg). TFTs should be repeated 
in 6 weeks for discharge from ___ on this new dose. 
Anticoagulation was discussed with the patient's outpatient 
providers (Cardiology and Primary care physician); given the 
patient's history of falls, the decision was made to use full 
strength aspirin for anticoagulation.  Patient's metoprolol was 
decreased to 50mg metoprolol XL in light of development of acute 
pulmonary edema. 

# Pyuria: Early during admission, patient had UA suggestive of 
UTI with 49 WBC and few bacteria. Urine culture with less than 
10,000 organisms. Patient received 3 days of ciprofloxacin.  

# MRSA cystitis: Patient had Foley catheter placed during 
admission while being digressed. The patient's UA was suggestive 
of UTI but patient without white count when debris noted in the 
Foley catheter. Foley was discontinued. Urine culture showed 
MRSA, and patient complained of symptoms of dysuria. 
Sensitivities showed that MRSA was sensitive to Bactrim DS BID; 
patient was started on Bactrim ___. Blood cultures 
pending; repeat urine culture at time of discharge pending. Plan 
for 7 day course of Bactrim DS BID with day one being ___.

# PVD: ASA 325mg PO daily. The patient was started on 
pravastatin, which she should continue as an outpatient.
 
# HTN: The patient's home amlodipine was discontinued during 
this admission, while metoprolol was started and adjusted. With 
the development of acute pulmonary edema (see discussion above), 
metoprolol was decreased and ___ (losartan) was started for 
afterload reduction. ___ as opposed to ACEi was started given 
the patient's underlying cough.
 
# Hypothyroidism: TSH 0.091, FT4 2.1, consistent with 
over-repletion. Decreased levothyroxine from 135mcg daily to 
112mcg daily. Recheck TFTs in 6 weeks from discharge from acute 
hosptialization and adjust dose appropriately.
 
# Anemia: CBC stable through admission. Continued home iron 
supplementation. Patient due for B12 injection per daughter 
which she received during this admission. 

# COPD: Continued home tiotropium, Symbicort and albuterol.

# Thoracic spine area skin breakdown: Patient with Mepilex 
placed. Trending exam. Encourage ambulation. 

# CODE STATUS: FULL CODE. There had been discussion with patient 
regarding her code status. She had expressed desire to be 
DNR/DNI though patient's daughter had much difficulty accepting 
this code status. On-going discussions regarding code status 
will need to be carried out upon discharge from hospital.

TRANSITIONAL ISSUES:
-Monitor weight daily, if weight increases by 3 pounds, then 
increase dose of torsemide to 40mg PO daily. 
-Serum ___ to evaluate serum creatinine and serum lytes. 
Forward to ___ MD for review. 
-Recheck thyroid function tests in 6 weeks.
-Follow-up pending urine and blood cultures.
-Continue bactrim DS BID for total 7 day course; day ___ 
-On-going discussion regarding patient's code status. 

**Length of stay expected to be less than 30 days.**
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Alendronate Sodium 70 mg PO Frequency is Unknown 
2. Amlodipine 10 mg PO DAILY 
3. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation 
inhalation BID 
4. Cyanocobalamin 1000 mcg IM/SC QMONTH 
5. Donepezil 10 mg PO DAILY 
6. Levothyroxine Sodium 137 mcg PO DAILY 
7. Tiotropium Bromide 1 CAP IH DAILY 
8. Tolterodine 1 mg PO BID 
9. TraZODone 50 mg PO HS 
10. Detrol LA (tolterodine) 4 mg oral daily  
11. Aspirin 81 mg PO DAILY 
12. Calcium Carbonate 500 mg PO BID 
13. Vitamin D 1000 UNIT PO DAILY 
14. Docusate Sodium 100 mg PO BID 
15. Ferrous Sulfate 325 mg PO DAILY 

 
Discharge Medications:
1. Calcium Carbonate 500 mg PO BID 
2. Cyanocobalamin 1000 mcg IM/SC QMONTH 
3. Docusate Sodium 100 mg PO BID 
4. Donepezil 10 mg PO DAILY 
5. Ferrous Sulfate 325 mg PO DAILY 
6. Tiotropium Bromide 1 CAP IH DAILY 
7. Tolterodine 1 mg PO BID 
8. TraZODone 50 mg PO HS 
9. Vitamin D 1000 UNIT PO DAILY 
10. Pravastatin 40 mg PO DAILY 
11. Alendronate Sodium 70 mg PO QWEEK 
12. Detrol LA (tolterodine) 4 mg oral daily  
13. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation 
INHALATION BID 
14. Aspirin 325 mg PO DAILY 
15. Losartan Potassium 25 mg PO DAILY 
16. Torsemide 20 mg PO DAILY 
17. Metoprolol Succinate XL 50 mg PO DAILY 
18. Sulfameth/Trimethoprim DS 1 TAB PO BID 
day ___ 7 day course of antibiotics.  
19. Outpatient Lab Work
Please check chem 10 ___ and have results forwards 
to MD on premisses for ___

20. Levothyroxine Sodium 112 mcg PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
PRIMARY DIAGNOSIS:
Atrial fibrillation 
Acute pulmonary edema secondary to flail mitral valve leaflet 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
It was a pleasure caring for you during your hosptalization at 
___. 

You were hospitalized because you were found to have an 
irregular rhythm of the heart known as atrial fibrillation. We 
have started you on medications to help control your heart rate. 
We discussed starting anticoagulation with your primary care 
doctor and cardiologist and the decision was made for you to 
take full dose aspirin daily. The good news is that during your 
hospitalization your heart rate converted to normal rhythm. You 
will continue to take aspirin to reduce your stroke risk. 

During this admission, you were found to have a urinary tract 
infection. You were started on antibiotics to treat the 
infection. You will complete a 7 day course of antibiotics.  

Please see your discharge paperwork regarding medication 
changes. 

Weight on discharge: 47.7kg.

We wish you the best going forward. 
 
Followup Instructions:
___
"
74,14210659,23050243," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Percocet / Banana / latex / Macrobid
 
Attending: ___.
 
Chief Complaint:
shortness of breath, fever, and urinary frequnecy
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ woman with a history of CHF, COPD, 
MR, and atrial fibrillation (not on Coumadin) who presents with 
fever.  She has felt unwell for the last two weeks and reports 
cough with productive yellow sputum and fever to 102.  She was 
given levofloxacin which improved the fever. later the patient 
developed productive cough with yellow sputum (different from 
baseline which is clear sputum) and after presenting to her PCP 
was prescribed ___ pack.  Mrs. ___ also reports increased 
urinary frequency (going to the bathroom 3 times during the 
night) but denies dysuria.  

Yesterday the patient felt much worse compared to baseline 
suffering from shortness of breath with exertion for a couple of 
feet. She started prednisone 40 mg daily last night. Also she 
suffered from fevers (undocumented) with chills. Her doughter 
noted that her blood pressure is low. The patient endorses 
nausea but did not vomit. due to worsening of her symptoms she 
presented to her doctors office who referred her to the ED. 

The patient did not have chest pain or abdominal pain. She has 
baseline dyspnea secondary to COPD.  She has been taking 
nebulizers at home with no effect.  Patient has been taking her 
nebulizers at home with no effect. 

 
Past Medical History:
Anemia  
Anxiety/Depression  
Cataracts  
COPD  
Hip fracture s/p repair  
Hyperlipidemia  
Hypothyroidism  
Hypertension  
s/p removal of left parotid gland  
Osteoarthritis  
Osteoporosis  
Peripheral vascular disease  
Colon cancer in ___  
Urinary incontinence  
History of left adnexal cystic lesion on pelvic MRI ___ 
unchanged from prior.  

 
Social History:
___
Family History:
Mother died of MI at age ___. Father with stroke, cancer at age 
___. Daughter w/ PE in ___ she also has a history of DVT after 
car accident in ___. 
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
==========================
VS:  97.5 119/79 94 20 100% on RA
Gen: the patient is sitting comfortable in the bed with no 
distress or pain 
HEENT: uunremarkable 
CV:  normal S1 and S2 with 
Pulm:  inspiratory crackles on the left lung base. other wise 
good air entry bilaterally with no wheeze. 
Abd:  soft and non-tender, colostomy noted on the left lower 
quad with no enduration. a hernia is noted at the site of the 
colostomy with coughing.
Ext:  thin extremities with bruising. on the right leg.
Neuro:  grossly normal

DISCHARGE PHYSICAL EXAM:
=========================
VS: 97.9 F, BP 140/50s, HR ___, RR 18, 98% RA 
Gen: alert and oriented, NAD 
HEENT: NC/AT , MMM
CV:  normal S1 and S2 with no murmurs, rubs or gallops 
Pulm:  CTAB, no wheezes, rales or rhonchi
Abd:  soft, nondistended, no TTP, colostomy noted on the left 
lower quad with no enduration. 
Ext:  thin extremities, no ___ edema 
Neuro:  grossly normal
 
Pertinent Results:
ADMISSION LABS:
===============================

___ 02:15PM OTHER BODY FLUID  FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
___ 01:45PM URINE  COLOR-Yellow APPEAR-Cloudy SP ___
___ 01:45PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-100 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-LG
___ 01:45PM URINE  RBC-11* WBC->182* BACTERIA-MANY 
YEAST-NONE EPI-0 TRANS EPI-3
___ 01:45PM URINE  HYALINE-1*
___ 01:45PM URINE  WBCCLUMP-FEW MUCOUS-OCC
___ 12:47PM   LACTATE-1.1
___ 12:35PM   GLUCOSE-86 UREA N-31* CREAT-1.8* SODIUM-134 
POTASSIUM-3.4 CHLORIDE-97 TOTAL CO2-22 ANION GAP-18
___ 12:35PM   estGFR-Using this
___ 12:35PM   proBNP-1822*
___ 12:35PM   CALCIUM-9.4 PHOSPHATE-3.6 MAGNESIUM-2.0
___ 12:35PM   WBC-7.6 RBC-3.02* HGB-8.1* HCT-26.0* MCV-86 
MCH-26.8 MCHC-31.2* RDW-14.8 RDWSD-46.5*
___ 12:35PM   NEUTS-73.7* LYMPHS-15.2* MONOS-9.0 EOS-1.3 
BASOS-0.3 IM ___ AbsNeut-5.59 AbsLymp-1.15* AbsMono-0.68 
AbsEos-0.10 AbsBaso-0.02
___ 12:35PM   PLT COUNT-167
___ 12:35PM   ___ PTT-26.8 ___

PERTINENT RESULTS: 
===================
___ 07:25AM BLOOD TSH-3.2
___ 07:45AM BLOOD calTIBC-268 VitB12-332 Ferritn-61 TRF-206

IMAGING:
=================================
___ CXR: No acute cardiopulmonary process.  HYPERINFLATED 
CHEST CONSISTENT WITH COPD 

MICROBIOLOGY: 
================

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 

DISCHARGE LABS: 
===================

___ 06:30AM BLOOD WBC-10.0 RBC-3.38* Hgb-9.3*# Hct-29.5* 
MCV-87 MCH-27.5 MCHC-31.5* RDW-14.7 RDWSD-46.6* Plt ___
___ 06:30AM BLOOD Plt ___
___ 06:30AM BLOOD Glucose-79 UreaN-23* Creat-1.1 Na-134 
K-4.3 Cl-99 HCO3-27 AnGap-12
___ 06:30AM BLOOD Calcium-9.9 Phos-3.0 Mg-2.2

 
Brief Hospital Course:
This is a ___ year old pleasant lady who presents with history of 
worsening cough and shortness of breath on exersion as well as 
urinary frequency. The patient was previous prescribed 
levofloxacin and Z-pack prior to admission. However one day 
before admission her symptoms became worse prompting her to see 
her PCP who referred her to the ED. 

# UTI: Her admission labs were notable for a UA suggesting a UTI 
and an elevated Cr to 1.8. She was started on PO Cipro for a 
presumed UTI. First urine culture returned negative but pt still 
reported urinary sx so a second urine culture was sent and is 
pending at time of discharge. She completed a 5-day course of 
Cipro while in-house and her Cr improved with IV fluids. 
Discharge Cr was 1.1.   

# COPD exacerbation: pt's wheezing thought most likely to be 
COPD exacerbation. Her CXR excluded pneumonia, and her blood 
culture excluded sepsis. Since the patient recently finished a 
course of azithromycin prior to admission she was only started 
on a prednisone taper. She was discharged on a prolonged taper 
as discussed with her outpatient pulmonologist Dr. ___. 

# constipation: pt was put on bowel regimen including 
senna/Colace, lactulose, psyllium when she reported she had not 
had ostomy output for 5 days. She typically has ostomy output 
every 3 days. She will continue on senna/Colace in the 
outpatient setting. 

# urinary retention: pt was found to have persistently have high 
post-void residuals and required straight cathing. This was 
thought to be a chronic issue based on her history of UTIs and 
pyuria. She should be bladder scanned in rehab and will follow 
up with urology in the outpatient setting to discuss further 
workup. 

CHRONIC ISSUES: 

# anemia: hemoglobin trended down mildly but remained close to 
pt's baseline. Anemia is believed to be a combination of iron 
deficiency anemia and anemia of chronic disease. She received a 
unit of pRBCs for a  Hgb of 7.3, but should follow up with her 
primary care doctor about reinitiating EPO. 

# diastolic CHF: the most recent echo in ___ showed EF >55% 
and LVH with moderate to severe (3+) mitral regurgitation. The 
pt did not have s/s of CHF exacerbation in house. She was 
restarted on her torsemide at a reduced dose of 10 mg twice 
weekly. 

# anxiety: pt was discontinued from lorazepam and did not 
require treatment for anxiety

# HLD: continued home pravastatin 

# HTN: continued home metoprolol 

# hypothyroidism: continued home SYnthroid. TSH here was 3.2. 

# ostomy care: wound consult was placed for concern for sores 
around the ostomy site. The pt reports that in the past she has 
received chromalin spray that was helpful for addressing the 
sores. 

TRANSITIONAL ISSUE:
=========================
- steroid taper: prednisone 40 mg for a total of 5 days then 
transition to prednisone 20 mg for another 5 days. Pt should 
continue on 30mg/day for 3 days, 20mg/day for 3 days, then 
10mg/day for 3 days, then 5mg/day for 3 days and follow up with 
Dr. ___. 
- Torsemide dose on discharge: 10 mg. Pt should take torsemide 
twice weekly as needed. 
- urine culture: pt has urine culture from ___ pending at time 
of discharge. Please follow this up. 
- urinary retention: pt found to have persistently elevated 
post-void residuals and required straight cathing. She seems to 
have h/o chronic urinary retention. She should follow up with 
urology for question of cystoscopy. She should get bladder scans 
TID and be straight cathed for PVR >500 at rehab. 
- EPO injections: pt found to have anemia of chronic disease and 
started on iron, B12 and folate supplements. Per discussion with 
pt, she should follow up with PCP to discuss whether to continue 
EPO injections for her anemia (she hasn't received any in about 
___ years). She did receive 1 U pRBCs while inpatient. 
- medication changes: consider discontinuing donepezil as pt 
does not appear to have dementia as she has relatively high 
functional status (able to use phone, engage appropriately in 
conversation etc). Pt's lorazepam was d/c'ed as she did not 
require it in house. 
FULL CODE 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Mirtazapine 15 mg PO QHS 
2. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 
3. Tiotropium Bromide 1 CAP IH DAILY 
4. Metoprolol Succinate XL 50 mg PO DAILY 
5. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
6. Pravastatin 40 mg PO QPM 
7. Ferrous Sulfate 325 mg PO DAILY 
8. Torsemide 20 mg PO 3X/WEEK (MO,TH,SA) 
9. Budesonide Nasal Inhaler 80 mcg-4.5 mcg mcg Other BID 
10. Donepezil 10 mg PO QHS 
11. Calcium Carbonate 1000 mg PO BID 
12. Aspirin 81 mg PO DAILY 
13. Levothyroxine Sodium 112 mcg PO DAILY 
14. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY:
=========
Chronic obstructive pulmonary disease
Urinary tract infection
Acute kidney injury

SECONDARY:
===========
Atrial fibrillation
Chronic diastolic heart failure
Anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
                             ___ MD ___
 
Completed by: ___
"
75,14210659,29793943," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Percocet / Banana / latex / Macrobid / melatonin
 
Attending: ___.
 
Chief Complaint:
dyspnea, chest pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ w/CHF, COPD (Gold Stage II) on chronic azithro (no 
prednisone), valvular heart disease (3+ MR/2+TR per ___ TTE), 
and atrial fibrillation, remote h/o colorectal ca s/p ostomy, 
suprapubic catheter, presenting with malaise x 4 days, and new 
onset chest pain and dyspnea. 

The patient is interviewed with her daughter at bedside. They 
reports that her symptoms started four to five days prior to 
presenatation with general feeling of unwell, and significant 
cough. Sought assessment at ___ in ___. CXR reportedly 
without e/o of pneumonia. Given chronic azithro and negative 
radiographic findings, no escalation of antibiotics. Per NP 
note, HR noted to be 120+; dig added, no changes to patient's 
metoprolol. Symptoms persisted and worsened through the weekend. 
Patient and daughter state they were not able to go in for 
reassessment during the weekend d/t the holiday. Endorses 
increased sputum production, and characterizes the color and 
green; denies sinus pain. Endorses sick contacts at her nursing 
home. Has been using Duonebs at home QID, with some initial 
improvement of her symptoms, but then became more resistant. 
Denied objective fevers. Treated with UTI last week with unknown 
antibiotic. 

Was prompted to come into the ED because of escalating shortness 
of breath and chest discomfort. Patient denies chest discomfort 
for my interview, but per the ED, she had characterized the cp 
as bilateral chest pressure. 

In the ED, initial vitals were:   97.9 122  167/90  98% nc 
Exam notable for HR140, irregular. bibasilar crackles 
Labs showed hyponatremia 118 --> 120, K 6.9 (3.8 on recheck); Cr 
1.2 (baseline Cr 1.0-1.1); Dig: 0.7; anemia 86/18; grossly 
positive U/A 
Imaging showed  Mild cardiomegaly, mild pulmonary vascular 
congestion, no frank pulmonary edema. Small bilateral pleural 
effusions with patchy bibasilar opacities
Received IV diltizaem 15, oral diltizem 30, IV levofloxacin 750 
mg, furosemide 20 IV. 
Transfer VS were  97.8  78  130/71  17  95% RA  

Decision was made to admit to medicine for further management.  

On arrival, patient endorses the above. Breathing has improved. 
Dtr reports new per-istomal wounds since ___, but has not 
reevaled them since then. Patient endorses pain around ostomy 
site. Endorses suprapubic leakage but no pain; endorses some 
feeling of discomfort and urgency given the bulb in the 
catheter. States that were schedule to have it replaced by 
Urology this week.  Denies back pain. Denies diarrhea. Denies 
weight gain, rather states she has had 30lb weight loss for 
several months, and keeps losing weight. Dtr endorses poor oral 
intake. 

At 0200, patient complained of L mid axillary line chest 
discomfort at ~10th rib, not reproduced with palpation; pt 
denied sob, diaphoresis, nausea, although dtr state that she saw 
the patient have increased effort of breathing and wheezing. EKG 
without change from prior. 
 
Past Medical History:
Anemia  
Anxiety/Depression  
Cataracts  
COPD  
Hip fracture s/p repair  
Hyperlipidemia  
Hypothyroidism  
Hypertension  
s/p removal of left parotid gland  
Osteoarthritis  
Osteoporosis  
Peripheral vascular disease  
Colon cancer in ___  
Urinary incontinence  
History of left adnexal cystic lesion on pelvic MRI ___ 
unchanged from prior.  

 
Social History:
___
Family History:
Mother died of MI at age ___. Father with stroke, cancer at age 
___. Daughter w/ PE in ___ she also has a history of DVT after 
car accident in ___. 
 
Physical Exam:
Admission Physical Exam:
========================
Vital Signs:  97.8  127/75   72  24  96%RA
General: chronically ill appearing elderly female, no acute 
distress. cachetic   
HEENT: NCAT, +conjunctival pallor; JVP at clavicle at upright 
(exaggerated JVP increase with inspiration likely ___ to known 
valvular regurg)  
CV: Irregular rate and rhythm, normocardic, ___ systolic murmur 
Lungs: dry inspiratory and expiratory crackles throughout; pops 
in RML; sparse wheezing; 
Abdomen: LLQ ostomy; ostomy appears pink and healthy; stool 
brown and formed. Upon removing ostomy bag, 2 2cm dark mass 
appearing lesions at 5o clock positions, tender to palpation 
with associated purulence. Shallow ulcerations noted at 3 o 
clock and 8 o clock positions, no drainage. Ostomy otherwise not 
tender when palpated. NABS, soft; ?small mass with deep 
palpation of LLQ. Reducible peristomal hernia. 
GU: No foley  
Ext: warm, no edema   
Neuro: cranial nerves grossly intact; adentulous

Discharge Physical Exam:
======================== 
Vital signs: 97.3 157/81 89 18 94% RA
General: thin, frail appearing, appears younger than stated age. 
 
HEENT: NCAT  
Neck: supple  
CV: Irregular rhythm, normal rate, ___ systolic murmur  
Lungs: decreased breath sounds throughout, but overall good 
aeration. 
Abdomen: Soft, nondistended. no significant tenderness. LLQ 
ostomy, suprapubic catheter both in place, appear c/d/I.  
Ext: warm and well perfused, no edema  

 
Pertinent Results:
Admission Labs:
===============
___ 05:15PM BLOOD WBC-6.9 RBC-3.42* Hgb-9.1* Hct-28.3* 
MCV-83 MCH-26.6 MCHC-32.2 RDW-14.8 RDWSD-44.3 Plt ___
___ 05:15PM BLOOD Neuts-76.0* Lymphs-13.7* Monos-6.9 
Eos-2.3 Baso-0.7 Im ___ AbsNeut-5.26 AbsLymp-0.95* 
AbsMono-0.48 AbsEos-0.16 AbsBaso-0.05
___ 05:35AM BLOOD ___ PTT-29.1 ___
___ 05:15PM BLOOD Glucose-147* UreaN-11 Creat-1.2* Na-118* 
K-6.9* Cl-86* HCO3-18* AnGap-21*
___ 05:15PM BLOOD CK(CPK)-106
___ 05:15PM BLOOD CK-MB-3 ___
___ 05:15PM BLOOD cTropnT-<0.01
___ 11:44PM BLOOD CK-MB-3 cTropnT-<0.01
___ 01:06AM BLOOD CK-MB-3 cTropnT-<0.01
___ 05:35AM BLOOD CK-MB-4 cTropnT-<0.01
___ 05:15PM BLOOD Calcium-8.4 Phos-4.2 Mg-1.7
___ 05:15PM BLOOD Digoxin-0.7*
___ 05:35AM BLOOD TSH-0.32
___ 05:35AM BLOOD Cortsol-23.7*

Imaging:
========
___ CXR:
Mild cardiomegaly, as seen previously, with mild pulmonary 
vascular 
congestion, but no frank pulmonary edema.  Small bilateral 
pleural effusions with patchy bibasilar opacities, potentially 
atelectasis, but infection or aspiration is not excluded in the 
correct clinical setting.

___ CT Head:
1. No acute intracranial abnormalities. 
2. Global parenchymal volume loss and sequela of chronic small 
vessel ischemic disease.

___ TTE:
The left atrium is moderately dilated. Diastolic function could 
not be assessed. Right ventricular chamber size and free wall 
motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The number of aortic valve 
leaflets cannot be determined. There is no aortic valve 
stenosis. Trace aortic regurgitation is seen. The mitral valve 
leaflets are mildly thickened. There is no mitral valve 
prolapse. Moderate (2+) mitral regurgitation is seen. Due to the 
eccentric nature of the regurgitant jet, its severity may be 
significantly underestimated (Coanda effect). Moderate to severe 
[3+] tricuspid regurgitation is seen. There is mild pulmonary 
artery systolic hypertension. [In the setting of at least 
moderate to severe tricuspid regurgitation, the estimated 
pulmonary artery systolic pressure may be underestimated due to 
a very high right atrial pressure.] There is no pericardial 
effusion. 

IMPRESSION: 
1) Normal biventricular regional/global systolic function.
2) At least moderate mitral regurgitation (difficult to assess 
due to Coanda effect) due to possibly partial anterior mitral 
valve leaflet flail.
3) Moderate to severe tricuspid regurgitation with normal RV 
size/function in setting of at least mild elevation of RV 
afterload.

___ CXR:
Small left pleural effusion has increased.  Increased left 
basilar opacity, may represent atelectasis or developing 
pneumonia.

___ KUB:
IMPRESSION: 
1. No abnormally dilated loops of small or large bowel to 
suggest obstruction. 
2. Enteric tube terminates in stable position in the expected 
position of the stomach body. 

___ CXR:
IMPRESSION:    
COMPARED TO CHEST RADIOGRAPHS SINCE ___, MOST RECENTLY 
___. 
  
LUNGS ARE CLEAR ON ___.  ON ___ BIBASILAR 
OPACIFICATION HAD DEVELOPED ALONG WITH AN INCREASE IN SMALL 
BILATERAL PLEURAL EFFUSIONS. CONSOLIDATIONS IMPROVED ON ___, BUT SUBSEQUENTLY FIRST CONSOLIDATION IN THE LEFT LOWER LOBE 
AND NOW IN THE RIGHT LOWER LOBE HAD DEVELOPED, PROBABLY 
PNEUMONIA.  THERE IS NO PULMONARY EDEMA.  PLEURAL EFFUSIONS 
REMAIN SMALL. 
  
OF NOTE THE STOMACH IS MODERATELY TO SEVERELY DISTENDED WITH AIR 
AND FLUID 
RAISING QUESTION OF GASTRIC OUTLET OBSTRUCTION PREDISPOSING TO 
REFLUX AND 
ASPIRATION. 
 
  
Discharge Labs:
=============== 
___ 04:50AM BLOOD WBC-11.2* RBC-3.57* Hgb-9.4* Hct-30.9* 
MCV-87 MCH-26.3 MCHC-30.4* RDW-15.0 RDWSD-46.9* Plt ___
___ 04:52AM BLOOD Neuts-88.8* Lymphs-5.1* Monos-5.1 
Eos-0.0* Baso-0.2 Im ___ AbsNeut-10.98*# AbsLymp-0.63* 
AbsMono-0.63 AbsEos-0.00* AbsBaso-0.02
___ 04:50AM BLOOD Plt ___
___ 05:50AM BLOOD ___
___ 04:50AM BLOOD Glucose-99 UreaN-32* Creat-0.9 Na-144 
K-3.7 Cl-109* HCO3-24 AnGap-15
___ 05:18AM BLOOD ALT-19 AST-12 AlkPhos-56 TotBili-0.4
___ 04:50AM BLOOD Calcium-9.2 Phos-3.0 Mg-2.___ with PMH CHF, COPD (Gold Stage II) on chronic azithromycin, 
valvular heart disease (3+ MR/2+TR per ___ TTE), and atrial 
fibrillation, remote h/o colorectal cancer s/p ostomy, and 
suprapubic catheter, who presented with malaise x 4 days, 
hyponatremia, and new onset cough and dyspnea, thought to be 
secondary to pulmonary edema as well as pneumonia. Hospital 
course complicated by epigastric pain/ileus thought to be 
secondary to initiation of diltiazem, which improved, and new 
pneumonia noted on CXR prior to discharge.

# Dyspnea:
# Acute on chronic diastolic CHF: presented with worsening 
dyspnea. Also endorsed orthopnea, and BNP > 11,000 (previously 
1800 one year ago). CXR with mild opacities, possible 
atelectasis vs. aspiration vs. infection as well as pulmonary 
vascular congestion. TTE did not reveal any new systolic 
dysfunction. Overall her dyspnea was thought to be secondary to 
mild fluid overload, aspiration, and possibly URI/mild 
pneumonia. She was initially treated broadly with vanc and 
levofloxacin 750 mg PO Q48H. Vancomycin was discontinued given 
negative MRSA swab and she completed a 5 day course of 
levofloxacin finishing on ___. She was diuresed with IV Lasix 
boluses 20mg BID until she developed an increase in her 
creatinine. Home torsemide was re-intiated at same dose as 
prior, and patient appeared euvolemic at time of discharge. 2 
days prior to discharge, new area of likely pneumonia seen on 
CXR. Patient without fever, and good O2 sat on RA. Started 
ceftriaxone, transitioned to cefpodoxime for total ___nding ___ (see transitional issues below).
- Discharge Cr: 0.9
- Discharge weight: 39.3 kg (bed weight, may not be accurate)

# Fever: 100.7 on ___. CXR revealed likely atelectasis but 
could not rule out infection. Blood cultures were sent and were 
no growth at time of discharge. She had a grossly positive UA, 
expected given suprapubic catheter. Urine culture with no growth 
and no GU symptoms at time of discharge.

# Epigastric pain / Illeus: Patient developed significant 
abdominal pain and distension requiring NG tube placement 4 days 
prior to discharge, with improvement in symptoms after 
suctioning. Thought to be secondary to initiation of diltiazem, 
and diltiazem was d/c'ed and metoprolol reinitiated (see below). 
Epigastric pain improved and patient was drinking adequately, 
and drinking small amounts prior to discharge.

# Atrial fibrillation: RVR on arrival, improved with diltiazem 
IV and then PO diltiazem. The timing of diltiazem initiation 
coincided with GI symptoms (per above) and so this was stopped, 
and metoprolol was restarted at a higher dose with good effect, 
and HR was in the ___ to low 100s. She had recently been started 
on digoxin at urgent care. This was initially stopped but then 
restarted due to difficulty controlling rates during 
hospitalization.

# Hyponatremia: presented with serum Na of 118. Urine Na was 116 
prior to Lasix, likely SIADH. Patient reports recently 
increasing her free water intake which may explain acute onset. 
Na normalized with free water restriction.
 
# Chest pain: troponins negative x 4, poor historian. EKG was 
without ischemic changes. Likely musculoskeletal/epigastric 
pain.

# COPD: Gold stage II on chronic azithromycin. No wheezing on 
exam without evidence of active COPD exacerbation. Continued 
home tiotropium bromide 1 cap daily, ipratroprium-albuterol neb 
Q6H, and albuterol nebs prn. Home symbicort was non formulary 
and she was treated with inhaled fluticasone. 

# Ostomy: patient with peristomal raised lesions. Seen by 
colorectal surgery who recommended dermatology consult to rule 
out malignancy. They felt that this was not urgent andcould be 
done as outpatient. ___ require treatment with steroids

Transitional Issues:
====================
- INCREASED metoprolol succinate to 100mg in setting of afib w 
RVR. Initially changed to diltiazem but d/c'ed diltiazem due to 
abd symptoms (see above) 
- STARTED digoxin 0.25mg
- Patient noted to aspirate on speech and swallow evaluation. 
Should take only thickened liquids
- Please check video swallow once patient fully stable as 
outpatient, per recommendation of speech and swallow
- Discharged on 1.5L fluid restriction - hyponatremic on 
admission with Na of 118. Urine lytes consistent with SIADH. 
- CONTINUE home dose of torsemide 
- Please coordinate non-urgent dermatology evaluation for 
periostomal ulcers, may need steroid treatment
- RECHECK TSH as an outpatient. Borderline low on admission at 
0.32, consider decreasing dose of levothyroxine as outpatient 
given RVR on presentation (although more likely secondary to 
volume overload)
- STARTED cefpodoxime day for 5 days (first day ___, last day 
___
- HELD azithromycin (chronic UTI suppression) given on 
cefpodoxime and given its interaction with donepezil. Consider 
restarting. Please check EKG prior for QTc monitoring
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Pyridoxine 250 mg PO DAILY 
2. Multivitamins 1 TAB PO DAILY 
3. Vitamin D ___ UNIT PO DAILY 
4. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 
5. Calcium Carbonate 1000 mg PO BID 
6. Omeprazole 20 mg PO BID 
7. Aspirin 81 mg PO DAILY 
8. Donepezil 10 mg PO QHS 
9. Levothyroxine Sodium 137.5 mcg PO DAILY 
10. Senna 8.6 mg PO DAILY 
11. Metoprolol Succinate XL 50 mg PO DAILY 
12. Mirtazapine 15 mg PO QHS 
13. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
14. Azithromycin 250 mg PO Q24H 
15. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
16. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 
17. Tiotropium Bromide 1 CAP IH DAILY 
18. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation 
inhalation DAILY 
19. Clarinex (desloratadine) 5 mg oral DAILY 
20. Pravastatin 40 mg PO QPM 
21. FoLIC Acid 1 mg PO DAILY 
22. Cyanocobalamin 1000 mcg IM/SC MONTHLY 
23. Torsemide 10 mg PO 3X/WEEK (___) 

 
Discharge Medications:
1.  Cefpodoxime Proxetil 400 mg PO Q24H Duration: 5 Doses  
2.  Digoxin 0.25 mg PO DAILY  
3.  Lidocaine 5% Patch 1 PTCH TD QAM  
4.  Metoprolol Succinate XL 100 mg PO DAILY  
5.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  
6.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB  
7.  Aspirin 81 mg PO DAILY  
8.  Calcium Carbonate 1000 mg PO BID  
9.  Clarinex (desloratadine) 5 mg oral DAILY  
10.  Cyanocobalamin 1000 mcg IM/SC MONTHLY  
11.  Donepezil 10 mg PO QHS  
12.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
13.  FoLIC Acid 1 mg PO DAILY  
14.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H  
15.  Levothyroxine Sodium 137.5 mcg PO DAILY  
16.  Mirtazapine 15 mg PO QHS  
17.  Multivitamins 1 TAB PO DAILY  
18.  Omeprazole 20 mg PO BID  
19.  Pravastatin 40 mg PO QPM  
20.  Pyridoxine 250 mg PO DAILY  
21.  Senna 8.6 mg PO DAILY  
22.  Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation 
inhalation DAILY  
23.  Tiotropium Bromide 1 CAP IH DAILY  
24.  Torsemide 10 mg PO 3X/WEEK (___)  
25.  Vitamin D ___ UNIT PO DAILY  
26. HELD- Azithromycin 250 mg PO Q24H  This medication was held. 
Do not restart Azithromycin until consider other antibiotics 
given interaction with Donepezil

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Primary:
Acute on chronic diastolic congestive heart failure
Aspiration pneumonia
Syndrome of inappriate antidiuretic hormone
Atrial fibrillation with rapid ventricular rate

Secondary:
chronic obstructive pulmonary disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking part in your care while you were in the 
hospital. You were admitted because you were feeling short of 
breath. You were found to have a low sodium level, but this 
rapidly improved. You were given IV medication to remove fluid 
from around the lungs. You were also given antibiotics for a 
mild pneumonia. During the hospitalization, your heart rates 
increased, requiring adjustment of your medications as listed 
below. Your metoprolol dose was increased, and a drug, digoxin, 
was started. You also were noted to have abdominal pain and 
distension, and a nasogastric tube was placed to decompress your 
stomach, and improved your discomfort. At that time, a 
medication, diltiazem was stopped, as it was thought to be 
contributing to your stomach discomfort.

You likely developed a new mild pneumonia, and were treated 
first with and IV antibiotic, and one to take by mouth at the 
rehab. Your breathing was good without the need for additional 
oxygen at the time of your discharge from the hospital. Your 
abdominal discomfort improved as well.

WHAT YOU SHOULD DO AFTER LEAVING THE HOSPITAL:
1. Do not drink more than 1.5 liters of fluid a day
2. Drink only thickened liquids

Again, it has been a pleasure taking part in your care, and we 
wish you the best.

- Your ___ care team
 
Followup Instructions:
___
"
76,14210659,21859060," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Percocet / Banana / latex / Macrobid / melatonin
 
Attending: ___.
 
Chief Complaint:
Altered mental status 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ h/o COPD, CHF, colon cancer s/p colectomy w/ ostomy, urinary 
incontinence w/ Suprapubic catheter p/w 4h AMS at rehab after 
recent admission for PNA. Further collateral is not able to be 
obtained at this time as patient is confused/grandson not 
present at admission.  
 
 In the ED, initial vitals were: 103.3 92 175/47 26 92% RA  
 - Exam notable for: difficulty following commands and 
responsive to verbal stimuli but altered, decr b/l breath sounds 
 
 - Labs notable for: Lactate 3.4 -> 1.3, WBC 17.3, H/H 7.6/___.3, 
Flu positive, trop neg x1 
pH 7.44 
pCO2 35 
pO2 62 
HCO3 25 
BaseXS 0 

 - Imaging: CXR with interval decrease in basilar opacities.  
 - Cefepime, vancomycin, Tamiflu, acetaminophen and 1L IVF was 
given.  
 
Upon arrival to the floor, patient is A&Ox2 (name, year, knows 
she's in hospital but doesn't know which or why) and answers 
questions appropriately. She reports her breathing is ""fair"" and 
endorses mild RLQ pain. Unable to give a more detailed history. 

 REVIEW OF SYSTEMS:  
 (+) Per HPI  
 (-) 10 point ROS reviewed and negative unless stated above in 
HPI
 
Past Medical History:
Anemia  
 Anxiety/Depression  
 Cataracts  
 COPD  
 Hip fracture s/p repair  
 Hyperlipidemia  
 Hypothyroidism  
 Hypertension  
 s/p removal of left parotid gland  
 Osteoarthritis  
 Osteoporosis  
 Peripheral vascular disease  
 Colon cancer in ___  
 Urinary incontinence  
 History of left adnexal cystic lesion on pelvic MRI ___  
 unchanged from prior.  
 
Social History:
___
Family History:
 Mother died of MI at age ___. Father with stroke, cancer at age  

 ___. Daughter w/ PE in ___ she also has a history of DVT after 
 
 car accident in ___.  
 
Physical Exam:
Exam on admission:
=====================
VITAL SIGNS -  98.0  73  136/54  26  97% 2L
GENERAL -  NAD, very frail elderly lady
HEENT -  NCAT, PERRL, EOMI
NECK -  supple
CARDIAC -  RRR, nl s1s2
LUNGS -  distant breath sounds, but no w/c/r appreciated
ABDOMEN -  soft, mild RLQ tenderness, ostomy bag and Suprapubic 
catheter in place and secured
EXTREMITIES -  wwp, no edema
NEUROLOGIC -  A&Ox2, CN2-12 intact, motor grossly normal
LABS: reviewed. See below.  
.
Exam on discharge:
=====================
Vitals:  97.5  80  144/66  21  94% 2L
General: A&Ox3, NAD
HEENT: sclera anicteric, MMM  
Neck: supple
Lungs: distant breath sounds, no wheezes or crackles
CV: irregular rate and rhythm, normal S1 + S2, diastolic murmur
ABDOMEN -  soft, mild RLQ tenderness, ostomy bag and Suprapubic 
catheter in place and secured
EXTREMITIES -  wwp, no edema
NEUROLOGIC -  CN2-12 grossly intact, motor grossly normal
 
Pertinent Results:
Labs on admission:
====================
___ 12:55PM BLOOD WBC-17.3*# RBC-4.13 Hgb-11.3 Hct-36.1 
MCV-87 MCH-27.4 MCHC-31.3* RDW-20.2* RDWSD-61.8* Plt ___
___ 12:55PM BLOOD Neuts-89.5* Lymphs-6.3* Monos-3.4* 
Eos-0.0* Baso-0.2 Im ___ AbsNeut-15.44* AbsLymp-1.09* 
AbsMono-0.58 AbsEos-0.00* AbsBaso-0.04
___ 12:55PM BLOOD ___ PTT-25.7 ___
___ 12:55PM BLOOD Plt ___
___ 02:13PM BLOOD Glucose-131* UreaN-26* Creat-0.9 Na-144 
K-3.3 Cl-107 HCO3-22 AnGap-18
___ 02:13PM BLOOD ALT-15 AST-23 CK(CPK)-20* AlkPhos-57 
TotBili-0.6
___ 12:55PM BLOOD cTropnT-0.03*
___ 02:13PM BLOOD CK-MB-<1
___ 05:15AM BLOOD ___
___ 02:13PM BLOOD Albumin-3.4* Calcium-8.6 Phos-3.7 Mg-1.8
___ 05:15AM BLOOD Vit___-___*
___ 05:15AM BLOOD Digoxin-2.4*
___ 05:26AM BLOOD ___ pO2-62* pCO2-35 pH-7.44 
calTCO2-25 Base XS-0
___ 01:22PM BLOOD Hgb-13.0 calcHCT-39
.
Imaging:
====================
___ CXR:
IMPRESSION:  
Previously seen basilar opacities have significantly decreased 
in the 
interval, with possible mild residua remaining at the right lung 
base. 
.
___ CXR:
IMPRESSION:  
The lungs are hyperinflated.  There is an increase in 
heterogeneous 
consolidation at the right lung base concerning for developing 
pneumonia.  No pleural effusion or pneumothorax.  The left lung 
is clear.  Heart size and mediastinal contours are normal. 
.
Microbiology:
====================
BCx negative x 2
.
URINE CULTURE (Final ___: 
YEAST.    >100,000 CFU/mL. 
.
Labs on discharge:
====================
___ 07:46AM BLOOD WBC-7.7 RBC-2.63* Hgb-7.1* Hct-24.0* 
MCV-91 MCH-27.0 MCHC-29.6* RDW-17.5* RDWSD-55.7* Plt ___
___ 07:46AM BLOOD Plt ___
___ 07:46AM BLOOD Glucose-98 UreaN-23* Creat-0.9 Na-144 
K-3.4 Cl-107 HCO3-26 AnGap-14
___ 07:46AM BLOOD Calcium-8.9 Phos-3.8 Mg-1.___ h/o COPD, CHF, afib, MR/TR, remote colon cancer s/p 
colectomy w/ ostomy, and suprapubic catheter p/w AMS, found to 
be influenza A positive, with hospital course complicated by 
worsening dyspnea with new pneumonia seen on CXR. Initially 
treated with vanc/ceftazidime, transitioned to levoquin for 7 
day course (last day ___. Also s/p 5 days of Tamiflu. She 
intermittently required supplemental oxygen (2L nasal cannula). 
She continued azithromycin for COPH prophylaxis. Her digoxin 
stopped as she was supratherapeutic on it, and noted dizziness 
which may be a side effect. She had a mild hypokalemia and 
hypernatremia that were managed with repletion and IV fluids, 
respectively. An incidental finding of asymptomatic funguria was 
noted on urine culture (>100k yeast), and patient without any 
dysuria or other localizing signs of infection.

Transitional issues:
#STARTED levofloxacin 500mg Q48 for 7 day course treatment for 
pneumonia, last day ___ (two doses ___ and ___
#Please re-check electrolytes at next outpatient appointment, 
check Na and K
#STOPPED digoxin
#DECREASED mirtazapine from 15mg to 7.5mg due to fatigue, 
considering stopping this medication as outpatient
#Consider stopping statin
#STOPPED tramadol
#Repeat chest x-ray in 6 weeks to assess for resolution of 
pneumonia
#GOAL O2: >88% on RA. Supplemental O2 not required for O2 sat. 
above 88%.
#Code status: DNR / Ok to intubate
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
3. Aspirin 81 mg PO DAILY 
4. Calcium Carbonate 1000 mg PO BID 
5. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 
6. Mirtazapine 15 mg PO QHS 
7. Multivitamins 1 TAB PO DAILY 
8. Omeprazole 20 mg PO BID 
9. Pravastatin 40 mg PO QPM 
10. Senna 8.6 mg PO DAILY 
11. Tiotropium Bromide 1 CAP IH DAILY 
12. Clarinex (desloratadine) 5 mg oral DAILY 
13. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
14. FoLIC Acid 1 mg PO DAILY 
15. Pyridoxine 250 mg PO DAILY 
16. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation 
inhalation DAILY 
17. Vitamin D ___ UNIT PO DAILY 
18. Cyanocobalamin 1000 mcg IM/SC MONTHLY 
19. Levothyroxine Sodium 137.5 mcg PO DAILY 
20. Torsemide 10 mg PO 3X/WEEK (___) 
21. Metoprolol Succinate XL 100 mg PO DAILY 
22. Digoxin 0.25 mg PO DAILY 
23. Lidocaine 5% Patch 1 PTCH TD QAM 
24. Donepezil 10 mg PO QHS 
25. Azithromycin 250 mg PO Q24H 
26. Cefpodoxime Proxetil 400 mg PO Q24H 

 
Discharge Medications:
1.  Artificial Tears ___ DROP BOTH EYES PRN Dry eyes  
2.  Levofloxacin 500 mg PO Q48H Duration: 2 Doses 
To be taken on ___ and ___.  Mirtazapine 7.5 mg PO QHS  
4.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  
5.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB  
6.  Aspirin 81 mg PO DAILY  
7.  Azithromycin 250 mg PO Q24H  
8.  Calcium Carbonate 1000 mg PO BID  
9.  Clarinex (desloratadine) 5 mg oral DAILY  
10.  Cyanocobalamin 1000 mcg IM/SC MONTHLY  
11.  Donepezil 10 mg PO QHS  
12.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
13.  FoLIC Acid 1 mg PO DAILY  
14.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H  
15.  Levothyroxine Sodium 137.5 mcg PO DAILY  
16.  Lidocaine 5% Patch 1 PTCH TD QAM  
17.  Metoprolol Succinate XL 100 mg PO DAILY  
18.  Multivitamins 1 TAB PO DAILY  
19.  Omeprazole 20 mg PO BID  
20.  Pravastatin 40 mg PO QPM  
21.  Pyridoxine 250 mg PO DAILY  
22.  Senna 8.6 mg PO DAILY  
23.  Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation 
inhalation DAILY  
24.  Tiotropium Bromide 1 CAP IH DAILY  
25.  Torsemide 10 mg PO 3X/WEEK (___)  
26.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Primary:
Influenza A
Pneumonia
Altered mental status

Secondary:
COPD
congestive heart failure

 
Discharge Condition:
Confused sometimes, generally clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure treating you for flu and pneumonia. When you 
arrived at ___, you tested positive for the flu which was 
causing a fever as well as some confusion and tiredness. Your 
initial chest x-ray showed improvement of your prior pneumonia. 
While being treated for the flu and dehydration with Tamiflu and 
IV fluids, you developed a new pneumonia that was seen on a 
second chest x-ray and required antibiotics and fluids. Due to 
decreased oral intake of food and beverage, you developed 
elevated levels of sodium in your blood, which improved after 
you were given IV fluids.

Please weigh yourself every morning, and call your doctor if 
your weight goes up more than 3 lbs. Please continue to take all 
your regular medications, and follow up at any appointments that 
are scheduled. 

Again, it has been a pleasure taking part in your care, and we 
wish you the best.
- Your ___ care team
 
Followup Instructions:
___
"
77,14349210,25085009," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
right sided sensory changes
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Mr. ___ is a ___ right-handed man with history
notable for apical variant hypertrophic cardiomyopathy, HTN c/b
CKD, pituitary microadenoma c/b hyperprolactinemia, and
hypothyroidism presenting with a transient episode of 
right-sided
sensory disturbance and lightheadedness.

Mr. ___ reports being in his usual state of health this
morning as he was driving to work; on turning the corner just
after pulling out from his house, around 07:20, he noted acute
onset of lightheadedness (without vertigo or disequilibrium) as
well as right-sided sensory disturbance. He reports having
previously had similar episodes of lightheadedness for which he
was evaluated by Cardiology, who noted minimal atrial and
ventricular ectopy on cardiac monitoring, and advised Mr. 
___
that he would likely need further cardiac monitoring if his
symptoms recurred to evaluate for an occult arrhythmia. However,
he denies a similar prior history of sensory disturbance, which
he describes today as initial ""tingling"" paresthesiae of the
entire left arm and much of the left leg (sparing the ankles and
feet) replaced by mild numbness when rubbing his arm with his
left hand for the next ___ minutes. He denies associated
headache, neck pain, photo- or phonophobia, nausea, vomiting, or
a radicular or radiating pattern to his sensory symptoms, and 
has
not had recurrent symptoms since initial onset. He discussed
these symptoms with his son, who is an internal medicine
resident, who recommended presentation to the ED for further
evaluation.

On review of systems, aside from the above, Mr. ___ denies
recent headache, vertigo, speech disturbance, vision change,
diplopia, hearing change, dysarthria, dysphagia, focal weakness,
paresthesiae, bowel or bladder incontinence, gait disturbance,
nausea, vomiting, chest discomfort, palpitations, abdominal 
pain,
changes in bowel or bladder habits, myalgias, arthralgias, or 
new
rash.

 
Past Medical History:
Apical variant hypertrophic cardiomyopathy
HTN c/b CKD
Pituitary microadenoma c/b hyperprolactinemia
Hypothyroidism
___
Eczematous dermatitis
Erectile dysfunction
 
Social History:
___
Family History:
Denies family history of neurological disorders, thrombotic
complications, or early miscarriages.
 
Physical Exam:
ADMISSION EXAM
PHYSICAL EXAMINATION
Vitals: T: 98.0  HR: 73  BP: 140/86  RR: 18  SpO2: 96% RA
General: NAD
HEENT: NCAT, no oropharyngeal lesions, neck supple
___: Warm, well-perfused
Pulmonary: No tachypnea or increased WOB
Abdomen: Soft, ND
Extremities: Warm, no edema

Neurologic Examination:
- Mental status: Awake, alert, oriented x 3. Able to relate
history without difficulty. Attentive, able to name ___ backward
without difficulty. Speech is fluent with intact comprehension
and naming of both high- and low-frequency objects. No
dysarthria. No apparent hemineglect. Able to follow both midline
and appendicular commands.

- Cranial Nerves: PERRL (4 to 3 mm ___. VF full to number
counting. EOMI, no nystagmus. V1-V3 without deficits to light
touch or PP bilaterally. No facial movement asymmetry. Hearing
intact to finger rub bilaterally. Palate elevation symmetric.
Trapezius strength ___ bilaterally. Tongue midline with good
excursions.

- Motor: No pronator drift.
  [Delt][Bic][Tri][ECR][FEx][IO][IP][Quad][Ham][TA][Gas]
L   5     5    5    5    ___    5     5   5    5  
R   5     5    5    5    ___    5     5   5    5  
 
- Reflexes: 
   [Bic] [Tri] [___] [Quad] [Gastroc]
 L  2+    2+     2+      2+       1+
 R  3+    3+     3+      2+       1+  
 Plantar response mute bilaterally. 

- Sensory: No deficits to light touch, pinprick, or cold
bilaterally. No extinction to DSS. Mild sway with Romberg.

- Coordination: No dysmetria with FNF or HKS testing 
bilaterally.

- Gait: Narrow-based and steady.
============================================
DISCHARGE EXAM

PHYSICAL EXAMINATION
24 HR Data (last updated ___ @ 840)
    Temp: 98.4 (Tm 98.4), BP: 131/90 (122-146/68-90), HR: 64
(60-72), RR: 16 (___), O2 sat: 98% (97-99), O2 delivery: RA  

General: NAD
HEENT: NCAT, no oropharyngeal lesions, neck supple
___: Warm, well-perfused
Pulmonary: No tachypnea or increased WOB
Abdomen: Soft, ND
Extremities: Warm, no edema

Neurologic Examination:
- Mental status: Awake, alert, oriented x 3. Attentive. Speech 
is
fluent with intact comprehension and naming of both high- and
low-frequency objects. No dysarthria. No apparent hemineglect.
Able to follow both midline and appendicular commands.

- Cranial Nerves: PERRL (4 to 3 mm ___. VF full to number
counting. EOMI, ___ beats of nystagmus on left gaze. V1-V3
without deficits to light touch or PP bilaterally. No facial
movement asymmetry. Hearing intact to finger rub bilaterally.
Palate elevation symmetric. Trapezius strength ___ bilaterally.
Tongue midline with good excursions.

- Motor: Very mild right pronation, no orbiting. 
  [Delt][Bic][Tri][ECR][FEx][IO][IP][Quad][Ham][TA][Gas]
L   5     5    5    5    ___    5     5   5    5  
R   5     5    5    5    ___    5     5   5    5  
 
- Reflexes: 3+ throughout with + cross abductors. Toes down b/l.

- Sensory: No deficits to light touch, pinprick bilaterally. No
extinction to DSS. 

- Coordination: No dysmetria with FNF or HKS testing 
bilaterally.

 
Pertinent Results:
___ 06:30AM BLOOD WBC-5.9 RBC-4.97 Hgb-13.5* Hct-42.3 
MCV-85 MCH-27.2 MCHC-31.9* RDW-15.8* RDWSD-48.5* Plt ___
___ 06:30AM BLOOD Plt ___
___ 06:30AM BLOOD Glucose-83 UreaN-22* Creat-1.5* Na-142 
K-5.0 Cl-105 HCO3-25 AnGap-12
___ 10:17AM BLOOD ALT-37 AST-25 AlkPhos-66 TotBili-1.1
___ 10:17AM BLOOD Lipase-30
___ 10:17AM BLOOD cTropnT-<0.01
___ 06:30AM BLOOD Calcium-9.5 Phos-3.7 Mg-2.0 Cholest-113
___ 11:45AM BLOOD %HbA1c-5.1 eAG-100
___ 06:30AM BLOOD Triglyc-83 HDL-50 CHOL/HD-2.3 LDLcalc-46
___ 10:17AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Tricycl-NEG
 
Brief Hospital Course:
PATIENT SUMMARY:
================
Mr. ___ is a ___ right-handed man with history 
notable for apical variant hypertrophic cardiomyopathy, HTN c/b 
CKD, pituitary microadenoma c/b hyperprolactinemia, and 
hypothyroidism presenting with a transient episode of 
right-sided sensory disturbance and lightheadedness.

NCHCT negative for acute stroke. MR with very small punctate 
subacute infarct in the left centrum semiovale. A stroke in this 
area explains his right sided sensory changes. Exam is normal. 
Etiology is likely small vessel disease
vs cardioembolic. 

Before MR imaging was finalized, seizure was on the differential 
for his transient symptoms, thus EEG was performed. Final read 
pending at time of discharge.

Risk factor labs notable for A1c 5.1%, TSH 3.9, LDL 46. Given 
LDL < 70, no indication to increase statin dose at the present 
time.

He was started on Aspirin 81 mg daily.

Given cardiac history and possible cardioembolic etiology, TTE 
was obtained. This showed apical hypertrophic cardiomyopathy 
without left ventricular or atrial mass (cardiac MRI would be 
more sensitive for focal apical thrombus, TEE for left atrial 
appendage thrombus). Mild mitral regurgitation. 

Ziopatch was placed for extended cardiac monitoring to assess 
for occult atrial fibrillation.

TRANSITIONAL ISSUES:
====================
- Continue aspirin 81mg for stroke prevention

- Ziopatch in place. Follow up read. 

AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic 
Attack  
=
=
=
=
=
=
=
================================================================
1. Dysphagia screening before any PO intake? (x) Yes, confirmed 
done - () Not confirmed () No. If no, reason why:  
2. DVT Prophylaxis administered? (x) Yes - () No. If no, why not 
(I.e. bleeding risk, hemorrhage, etc.)  
3. Antithrombotic therapy administered by end of hospital day 2? 
(x) Yes - () No. If not, why not? (I.e. bleeding risk, 
hemorrhage, etc.)
4. LDL documented? (x) Yes (LDL = 46) - () No  
5. Intensive statin therapy administered? (simvastatin 80mg, 
simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, 
rosuvastatin 20mg or 40mg, for LDL > 70) () Yes - (x) No [if LDL 
>70, reason not given:  
 [ ] Statin medication allergy  
 [ ] Other reasons documented by physician/advanced practice 
nurse/physician ___ (physician/APN/PA) or pharmacist  
 [x ] LDL-c less than 70 mg/dL  
6. Smoking cessation counseling given? () Yes - (x) No [reason 
(x) non-smoker - () unable to participate]  
7. Stroke education (personal modifiable risk factors, how to 
activate EMS for stroke, stroke warning signs and symptoms, 
prescribed medications, need for followup) given in written 
form? (x) Yes - () No  
8. Assessment for rehabilitation or rehab services considered? 
() Yes - (x) No - at baseline. If no, why not? (I.e. patient at 
baseline functional status)
9. Discharged on statin therapy? (x) Yes - () No [if LDL >70, 
reason not given:  
 [ ] Statin medication allergy  
 [ ] Other reasons documented by physician/advanced practice 
nurse/physician ___ (physician/APN/PA) or pharmacist  
 [ ] LDL-c less than 70 mg/dL  
10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) 
Antiplatelet - () Anticoagulation] - () No  
11. Discharged on oral anticoagulation for patients with atrial 
fibrillation/flutter? () Yes - (x) No - If no, why not (I.e. 
bleeding risk, etc.) (x) N/A  

 
Medications on Admission:
1. Acetaminophen prn
2. Levothyroxine Sodium 112 mcg PO DAILY 
3. Lisinopril 5 mg PO DAILY 
4. sildenafil 100 mg oral DAILY:PRN 
5. Vitamin D ___ UNIT PO DAILY 
6. Atorvastatin 10 mg PO QPM 
7. cabergoline .25 mg oral DAILY 
8. Senna 8.6 mg PO BID:PRN Constipation - First Line 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY 
RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth 
daily Disp #*30 Tablet Refills:*3 
2.  Atorvastatin 10 mg PO QPM  
3.  cabergoline .25 mg oral DAILY  
4.  Levothyroxine Sodium 112 mcg PO DAILY  
5.  Lisinopril 5 mg PO DAILY  
6.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
7.  sildenafil 100 mg oral DAILY:PRN  
8.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Small left centrum semiovale infarct

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr ___,  

 You were hospitalized due to symptoms of right sided sensory 
changes resulting from a TRANSIENT ISCHEMIC ATTACK, a condition 
where a blood vessel providing oxygen and nutrients to the brain 
is blocked by a clot. The brain is the part of your body that 
controls and directs all the other parts of your body, so damage 
to the brain from being deprived of its blood supply can result 
in a variety of symptoms.  

 Stroke can have many different causes, so we assessed you for 
medical conditions that might raise your risk of having stroke. 
In order to prevent future strokes, we plan to modify those risk 
factors. Your risk factors are:  
 - High blood pressure  
 - High cholesterol

 We are changing your medications as follows:  
 - Please start Aspirin 81mg daily to help prevent future 
strokes 

 Please take your other medications as prescribed.  
 Please follow up with Neurology and your primary care physician 
as listed below.  
 
 If you experience any of the symptoms below, please seek 
emergency medical attention by calling Emergency Medical 
Services (dialing 911). In particular, since stroke can recur, 
please pay attention to the sudden onset and persistence of 
these symptoms:  
 - Sudden partial or complete loss of vision  
 - Sudden loss of the ability to speak words from your mouth  
 - Sudden loss of the ability to understand others speaking to 
you  
 - Sudden weakness of one side of the body  
 - Sudden drooping of one side of the face  
 - Sudden loss of sensation of one side of the body  
 
Sincerely,  
Your ___ Neurology Team  

 
Followup Instructions:
___
"
78,14432757,29450420," 
Name:  ___                       Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___
 
Chief Complaint:
___ yo G2P1 at 26w2d transferred to OB Triage from the ED.
She initially presented to ___ after having
worsening pruritus for ___ days. 
 
Major Surgical or Invasive Procedure:
Liver biopsy

 
History of Present Illness:
HPI: Pt is a ___ G2P1 at 26w2d who is admitted to the 
___
service with elevated LFTs. She reports a two-day history of
diffuse pruritus and jaundice. Pruritus was so severe that she
was unable to sleep. She found no relief from Benadryl, Tylenol
___, oatmeal baths, or topical hydrocortisone cream. She could 
not
find a rash, and when she had her mother search her skin, her
mother first noticed scleral icterus. She denies any history of
liver disease, or any abdominal pain, nausea, vomiting, fevers,
chills, or myalgias. She denies any change in color of her
stools, hematochezia, or melena, but does note that her urine is
now the color of ___. She has never had symptoms like this
before, although she does give a history of mildly elevated 
LFTs,
maybe ___ years ago, which on recheck were reportedly normal last
year.

She has a history of poly-substance abuse, including IV drug 
use,
although she acknowledges only a single use of IV heroin. She
does acknowledge other heroin use, intranasally, twice
previously. She denies any history of intranasal cocaine use. 
She
has previously abused narcotic pain medications, but has been on
methadone for the last six months since she has known about her
pregnancy, and has not used any drugs including tobacco, EtOH,
and narcotics. She denies any tattoos or piercinges (apart from
her earlobes bilaterally), and no history of blood transfusions.
She has not been sexually active recently as her husband has 
been
away from home, travelling to ___ for business. She denies any
herbs, supplements, or OTC medications apart from Tylenol ___ and
Benadryl. Regarding the Tylenol ___, she states that she took two
tablets two days ago without any relief, and took two tablets
yesterday prior to coming to the ED. She does note using an
oatmeal-based bath for her pruritus that she purchased from a
nutritional supplement store. She also acknowledges having eaten
out a number of times during her pregnancy, especially in recent
weeks during the ___. These include sushi ___ roll,
denies any uncooked fish), cold cuts (including ___, ham, and
___ cheese), fruit salad from an outdoor fair, and others. She
also does acknowledge prior hypertension during this pregnancy,
about one month ago, when she was advised to ""keep an eye on 
it"",
so she has been checking herself at ___. She notes that her 
worst
BPs have been as high as 190/90.

She did have some vomiting and diarrhea this morning, which she
attributes to withdrawing from her methadone as she did not
receive this morning's dose at the usual time of her home
schedule, and since receiving it these symptoms have resolved.

She was reportedly seen first at an OSH ED prior to transfer to 
our ED
given her elevated LFTs, but these records were reportedly ""lost
on the way"" and are unavailable for review currently.

 
Past Medical History:
PAST MEDICAL HISTORY:
- Poly-substance abuse (tobacco, narcotic pain medications)
- Anxiety
- Upper extremity DVT
- s/p C-section
- denies H/O abn pap's/STI's
 
Social History:
___
Family History:
FAMILY HISTORY: Pt acknowledges that her uncle/grandfather
suffered from liver disease of unknown type. Denies any other
liver or GI disease in the family.

 
Physical Exam:
At the time of admission:
PHYSICAL EXAM:
VS: Temp 97.4F, BP 114/70, HR 88, R 18, SaO2 100% RA
General: WA young woman in NAD, comfortable, appropriate, 
itching
diffusely
HEENT: NC/AT, PERRL/EOMI, + scleral icterus, MMM
Neck: supple, no LAD or thyromegaly
Lungs: CTA bilat, no r/rh/wh
Heart: RRR, nl S1-S2, no MRG
Abdomen: +BS, soft/NT, gravid, no HSM
Extrem: WWP, trace BLE edema
Skin: + mild jaundice, no stigmata of chronic liver disease
Neuro: no confusion or asterixis, normal gait

# of Fetuses: 1
Cardiac activity?: Y
FHR: 123 BPM
Presentation:Cephalic 
Placenta:    Posterior no previa
AFI: 13.2 cm    
EFW: 1038 g
Percentile: 58.5 % by ___

___

 
Pertinent Results:
******PENDING LABS AT DISCHARGE************

___ 11:55PM BLOOD BILE ACIDS-PND
___ 09:45AM BLOOD SOLUBLE LIVER ANTIGEN (SLA) 
ANTIBODIES-PND
___ 06:20AM BLOOD HEPATITIS C VIRAL RNA, GENOTYPE-PND

___ 04:05PM   HIV Ab-NEGATIVE
___ 10:11AM URINE  opiates-NEG cocaine-NEG amphetmn-NEG
___ 09:45AM   ALT(SGPT)-661* AST(SGOT)-1003* LD(LDH)-227 
CK(CPK)-20* ALK PHOS-116* TOT BILI-8.6* DIR BILI-6.9* INDIR 
BIL-1.7
___ 09:45AM   TSH-0.64
___ 09:45AM   HBsAg-NEGATIVE HBc Ab-NEGATIVE IgM 
HBc-NEGATIVE
___ 09:45AM   AMA-NEGATIVE Smooth-NEGATIVE ANCA-NEGATIVE B
___ 09:45AM   ___
___ 09:45AM   WBC-9.5 RBC-4.21 HGB-10.5* HCT-33.0* MCV-78* 
MCH-24.8* MCHC-31.7 RDW-16.0*
___ 09:45AM   PLT COUNT-236
___ 09:45AM   ___ PTT-33.1 ___
___ 09:45AM   ___
___ 09:42AM   ASA-NEG ETHANOL-NEG bnzodzpn-NEG barbitrt-NEG 
tricyclic-NEG
___ 03:00AM URINE  COLOR-AMB APPEAR-Hazy SP ___
___ 03:00AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-LG UROBILNGN-2* PH-6.0 LEUK-NEG
___ 03:00AM URINE  RBC-7* WBC-27* BACTERIA-FEW YEAST-NONE 
EPI-5
___ 03:00AM URINE  GRANULAR-6* HYALINE-13*
___ 03:00AM URINE  MUCOUS-RARE

___ 11:55PM   HCV Ab-POSITIVE*
___ 11:55PM   HBs Ab-NEGATIVE IgM HAV-NEGATIVE

___ 06:20AM BLOOD WBC-8.5 RBC-3.78* Hgb-9.7* Hct-29.7* 
MCV-79* MCH-25.6* MCHC-32.6 RDW-16.8* Plt ___
___ 09:45AM BLOOD WBC-9.5 RBC-4.21 Hgb-10.5* Hct-33.0* 
MCV-78* MCH-24.8* MCHC-31.7 RDW-16.0* Plt ___
___ 11:55PM BLOOD WBC-12.1* RBC-4.37 Hgb-10.9* Hct-33.7* 
MCV-77* MCH-24.9* MCHC-32.3 RDW-16.6* Plt ___
___ 11:55PM BLOOD Neuts-67.8 ___ Monos-5.3 Eos-1.7 
Baso-0.4

___ 11:55PM BLOOD ___ PTT-34.7 ___
___ 09:45AM BLOOD ___ PTT-33.1 ___
___ 06:30AM BLOOD ___ PTT-32.2 ___
___ 06:05AM BLOOD ___ PTT-33.6 ___
___ 06:20AM BLOOD ___

___ 11:55PM BLOOD Glucose-102* UreaN-5* Creat-0.4 Na-136 
K-3.2* Cl-103 HCO3-24 AnGap-12
___ 11:55PM BLOOD ALT-683* AST-1178* AlkPhos-124* 
TotBili-8.5* DirBili-6.7* IndBili-1.8
___ 09:45AM BLOOD ALT-661* AST-1003* LD(LDH)-227 
CK(CPK)-20* AlkPhos-116* TotBili-8.6* DirBili-6.9* IndBili-1.7
___ 06:30AM BLOOD ALT-472* AST-584* LD(LDH)-182 
AlkPhos-106* TotBili-7.5* DirBili-6.1* IndBili-1.4
___ 06:20AM BLOOD ALT-330* AST-260* LD(LDH)-144 
TotBili-5.9* DirBili-4.6* IndBili-1.3
___ 06:05AM BLOOD ALT-212* AST-113* TotBili-4.6* 
DirBili-3.4* IndBili-1.2
___ 06:30AM BLOOD Albumin-2.9*
___ 06:05AM BLOOD Albumin-3.0*
___ 09:45AM BLOOD TSH-0.64

___ BPP

Indication: Abnormal LFT's, Methadone for prior substance use
# of Fetuses: 1
Cardiac activity?: Y
FHR: 130BPM
Presentation: []Cephalic []Breech [x]Other: Transverse
Placenta:     []Anterior [x]Posterior []Fundal
Previa?:      []Y  [x]N
AFI: DVP  7.3cm    [x]Normal []Oligo. []Poly.

BPP: Active Fetus

Impression:
1. Reassuring fetal testing. 

___ LIVER US
1. Normal liver echogenicity. No biliary duct dilatation. 
2. Limited Doppler due to breathing motion; however, normal flow 
is seen in main, left, and right portal vein, and main hepatic 
artery. Wall-to- wall flow in the hepatic veins. 
3. Unremarkable gallbladder with no evidence of cholelithiasis 
or 
cholecystitis. 

___ Liver, needle core biopsy:

1.  Marked portal and moderate periportal and lobular mixed 
inflammation with lobular disarray and numerous apoptotic 
hepatocytes.
2.  Moderate intrahepatic and canalicular cholestasis.
3.  No significant steatosis or ballooning degeneration are 
seen.
4.  Trichrome stain shows minimally increased portal fibrosis.
5.  Iron stain shows no stainable iron.
6.  Reticulin stain does not demonstrate significant hepatic 
parenchymal necrosis or collapse.
7.  Immunohistochemical stains for cytomegalovirus and herpes 
simplex viruses are pending and will be reported in an addendum.

Note: The features are compatible with a moderately active 
hepatitis with mixed inflammation, lobular disarray, feathery 
degeneration of hepatocytes, and moderate cholestasis.  The 
differential diagnosis includes an acute hepatitis of viral or 
drug-induced etiology.  Given the patient's negative autoimmune 
serologies and lack of prominent lobular plasmacytic component, 
an acute presentation of autoimmune hepatitis is less likely. 

ADDENDUM: 
Immunostains for cytomegalovirus and herpes simplex viruses I 
and II are negative with satisfactory controls.
Addendum added by: ___. ___
Date: ___

  

 
Brief Hospital Course:
The patient was admitted to the antepartum service from ___ 
to ___ for transaminitis, jaundice, pruritus with 
coagulopathy. A hepatology consultation was obtained. A liver 
ultrasound with dopplers showed no evidence of fibrosis or other 
abnormalities. The hepatology team was significantly impressed 
by the extent of liver injury and requested a biopsy of the 
liver. Pathology was consistent with acute hepatitis. 
Viral antibody studies were sent and these were signficant for a 
positive hepatitis C antibody. Her viral load was 54,700 copies. 
Patient was counseled about this new diagnosis and questions 
were answered. 
.
Her transamnitis began to resolves spontaneously and her INR 
normalized. Her only complaint of pruritis was managed with 
pepcid, atarax and actigall.
.
Fetal testing was reassuring. EFW ___ was 1038g, 58.5 percentile 
(___).
Patient had labs pending at discharge including bile salts, HEP 
C viral RNA genotype and soluble liver antibodies. 
.
___ need follow-up with Hepatology after discharge. She 
opted to see a specialist closer to her rather than following up 
with the ___ here. She will need assistance with the 
referral. She will need monthly LFTs and viral load every 3 
months. She will also need to discuss treatment options after 
postpartum.  She is aware that this will have to be set-up by 
her primary physicians.  Please help her coordinate this. 

 
Medications on Admission:
CURRENT MEDICATIONS:
- Methadone 145 mg PO/NG DAILY
- Mirtazapine 30 mg PO/NG DAILY
- Nephrocaps 1 CAP PO DAILY
- Docusate Sodium 100 mg PO BID:PRN Constipation
- Oxazepam ___ mg PO HS:PRN insomnia
- Calcium Carbonate 500 mg PO QID:PRN Dyspepsia
- Milk of Magnesia ___ ml PO Q6H:PRN Constipation

 
Discharge Medications:
1. Mirtazapine 30 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. B Complex-Vitamin C-Folic Acid 1 mg Capsule Sig: One (1) Cap 
PO DAILY (Daily).  
3. Methadone 10 mg/mL Concentrate Sig: One Hundred ___ 
(145) mg PO DAILY (Daily).  
4. Hydroxyzine HCl 25 mg Tablet Sig: One (1) Tablet PO Q6H 
(every 6 hours) as needed for pruritis.
Disp:*20 Tablet(s)* Refills:*0*
5. Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 
hours).
Disp:*60 Tablet(s)* Refills:*0*
6. Ursodiol 300 mg Capsule Sig: One (1) Capsule PO BID (2 times 
a day).
Disp:*60 Capsule(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Hepatitis C
Abnormal liver enzymes

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
- It is important that you follow-up with your obstetrician as 
soon as possible to ensure you get the care you need.
- Please continue to take the atarax and pepcid as need and the 
actigall until your doctor tells you to stop. 
 
Followup Instructions:
___
"
79,14432757,25646002," 
Name:  ___                       Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
___ Complaint:
Shortness of breath
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ year old G2P1 @ 36 weeks 1 day with a PMH
significant for polysubstance abuse currently on methadone and
Hepatitis C who presents from ___ after being
evaluated for shortness of breath of two days duration. Patient
was initially seen and evaluated by her PCP on ___ and
prescribed inhalers with little relief. On ___, her
shortness of breath worsened and she was seen by her OB today in
the office who sent her to ___ for further
evaluation and rule out pre-eclampsia.

In the ED, the patient received Solu-Medrol 125 mg IV x 1, an
albuterol nebulizer and Ceftriaxone 1g IV x 1. The patient was
afebrile and her WBC was 9. Troponin and BNP were negative. The
patient had a CTA which per report was negative. A CXR was
significant for a mild hazy opacity throughout the lungs which
was most pronounced at the lung bases and perihilar region. This
was concerning for interstitial infiltrates. Her Echo was normal
with an EF of 65%. there were no wall motion abnormalities.
Borderline right atrial enlargement and a suspected patent
foramen ovale.

Ms. ___ was transferred to ___ given concern for 
pre-eclampsia
given her otherwise normal evaluation with continued shortness 
of
breath and elevated blood pressures. Patient reports that
symptoms much improved since steroids. Denies any headaches,
visual changes or RUQ pain.
 
Past Medical History:
PNC:
1. ___: ___
2. Prenatal records not available
3. Hospitalization at ___ ___ for jaundice and elevated
LFT's-> Hepatitis

OBHx: G2P1
- C/S x 1 after failed IOL at 42 weeks, 10# with gHTN

GynHx: denies h/o abnormal Paps, STIs

MedHx: 
1. Hepatitis C
2. substance abuse (narcotics/pain medications)
3. anxiety
4. ? Hypertension

SurgHx: C/S x 1
 
Social History:
___
Family History:
Pt acknowledges that her uncle/grandfather suffered from liver 
disease of unknown type. Denies any other liver or GI disease in 
the family.

 
Physical Exam:
Vitals - T:  BP:145/88  HR:  RR:
General: NAD, appears comfortable, occasionally audible wheeze
CV: RRR
Lungs: Decreased breath sounds bilaterally at bases with 
wheezing
bilaterally Right>Left
Abdomen: soft, gravid, no TTP
Extremities: trace edema, no calf TTP
SVE: Deferred

FHT: 110/mod var/+ accel/no decels
Toco: no ctx

TAUS: vtx, BPP ___, AFI 13.7, posterior placenta, Abd
circumference c/w GA of 34w4d
 
Brief Hospital Course:
Ms. ___ was admitted to the antepartum service for care of her 
respiratory illness.  She was seen by pulmonary in consultation. 
 Requested labs included legionella, full respiratory viral 
panel, sputum and blood cultures.  Cultures were sterile on 
discharge.  Many results had returned negative although some 
were still pending at the time of discharge.  These will be 
followed up by the primary OB.  The patient was treated with 
azithromycin and oral steroids with significant improvement.  
She was discharged home on ___ in stable condition.
 
Medications on Admission:
Remeron 30mg daily, methadone 150mg daily
 
Discharge Medications:
1. Azithromycin 250 mg Tablet Sig: Two (2) Tablet PO Q24H (every 
24 hours) for 5 days.
Disp:*10 Tablet(s)* Refills:*0*
2. Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily) 
for 5 days.
Disp:*10 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
single intrauterine pregnancy- undelivered
viral pneumonia vs reactive airway disease
gestational hypertension\nHepatitis C
substance abuse

 
Discharge Condition:
good

 
Discharge Instructions:
call primary ob for increased difficulty with respiration, 
temperature >100.4, dizziness, vaginal bleeding, loss of fluid 
from the vagina, uterine contractions, 
 
Followup Instructions:
___
"
80,14761697,24595621," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Dyspnea.
 
Major Surgical or Invasive Procedure:
EGD and colonoscopy

 
History of Present Illness:
This is a ___ yo man with CAD p/w dyspnea for ___ weeks, noted to 
have hct drop from 37 (___) to 27 (___) so was referred to 
the ED for further evaluation. He has been pale for 2 weeks, 
more fatigued, has had belching, and ___ edema. He notes the 
dyspnea both at rest and with exertion, but it does not 
interfere with his usual activities or with conversation. No 
cough, cp, wheezing. He denies abdominal pain, nausea, vomiting, 
orthopnea, pnd, fevers, chills, jaundice, bleeding from gums, 
hematuria, melena, brbpr, dysuria, rash, tingling, numbness. He 
notes egd approx. ___ years ago (? normal) and ___ a few months 
ago (? nl). He notes back pain recently for which he took aleve 
for about 4 days, last was 1 week ago.

In the ED: VS: 98.2 71 140/80 16 100% on RA. He was given 
albuterol. He was guaiac positive.

ROS: 10 point review of systems negative except as noted above.
 
Past Medical History:
CAD, s/p MI in ___
hyperlipidemia
depression/anxiety
gastritis with erosions
OA
obesity
hiatal hernia
colonic adenoma: 3 polyps removed colonoscopy ___, 3 polyps 
from rectum ___ prep, rec repeat colonoscopy in ___ 
yr ie ___
basal cell carcinoma of skin
vitamin d deficiency
CKD: baseline crt 1.4
diverticulosis
 
Social History:
___
Family History:
Father with dm, mother with ___.
 
Physical Exam:
VS: T 98.4 HR 104 BP 124/70 RR 20 Sat 96% RA
Gen: Well appearing elderly man in NAD
Eye: extra-occular movements intact, pupils equal round, 
reactive to light, sclera anicteric, not injected, no exudates
ENT: mucus membranes moist, no ulcerations or exudates
Neck: no thyromegally, JVD: flat
Cardiovascular: regular rate and rhythm, normal s1, s2, no 
murmurs, rubs or gallops
Respiratory: Clear to auscultation bilaterally, no wheezes, 
rales or rhonchi
Abd: Soft, non tender, non distended, no heptosplenomegally, 
bowel sounds present
Extremities: Trace edema bilaterally mid calf, no cyanosis, 
clubbing, joint swelling
Neurological: Alert and oriented x3, CN II-XII intact, normal 
attention, sensation normal, speech fluent, DTR's 2+ patellar, 
achilles, biceps, triceps, brachioradialis bilaterally, babinski 
down-going bilaterally
Integument: Warm, moist, no rash or ulceration  
Psychiatric: appropriate, pleasant, not anxious
Hematologic: no cervical or supraclavicular LAD
 
Pertinent Results:
Admit labs:
CBC: WBC-8.4 RBC-2.90* HGB-8.1* HCT-25.2* MCV-87 MCH-27.9 
MCHC-32.1 RDW-14.3 PLT COUNT-323; diff: NEUTS-70.7* LYMPHS-19.9 
MONOS-8.5 EOS-0.2 BASOS-0.6
BMP: GLUCOSE-93 UREA N-16 CREAT-1.4* SODIUM-140 POTASSIUM-4.1 
CHLORIDE-107 TOTAL CO2-21
CK(CPK)-178

ECG: NSR (68), left axis, ___ deg av block (338)-OLD, otherwise 
nl intervals, diffuse low voltage, TWF V2, otherwise no st-t 
changes.

CXR pa/lat ___: final: 1. No acute cardiopulmonary abnormality. 

2. Moderate-sized hiatal hernia. 

Colonoscopy Report  
 
   
diverticuli appendix anal area 
Date: ___ Endoscopist(s): ___, 
M.D.
 
Patient: ___
 Ref. Phys.: ___, MD 
    Assisting Nurse(s)/
Other Personnel: ___, RN 
Birth Date: ___ ___ years) Instrument: ___ 
___) 
ID#: ___   
Medications: Fentanyl 25 micrograms 
midazolam 0.5 mg iv 
 
Indications: Iron deficiency anemia
 
  
Procedure: The procedure, indications, preparation and potential 
complications were explained to the patient, who indicated his 
understanding and signed the corresponding consent forms. The 
efficiency of a colonoscopy in detecting lesions was discussed 
with the patient and it was pointed out that a small percentage 
of polyps and other lesions can be missed with the test. A 
physical exam was performed. The patient was administered 
moderate sedation. The physical exam was performed prior to 
administering anesthesia. Supplemental oxygen was used. The 
patient was placed in the left lateral decubitus position.The 
digital exam was abnormal. Enlarged prostate. The colonoscope 
was introduced through the rectum and advanced under direct 
visualization until the cecum and ileum were reached. The 
appendiceal orifice and ileo-cecal valve were identified. 
Careful visualization of the colon was performed as the 
colonoscope was withdrawn. The colonoscope was retroflexed 
within the rectum. The procedure was not difficult. The quality 
of the preparation was good. The patient tolerated the procedure 
well. There were no complications. 
Findings:  
 Excavated Lesions A few diverticula were seen in the distal 
ascending colon. Multiple diverticula were seen in the sigmoid 
colon and distal descending colon.  
 Other normal terminal ileum  
Impression: Diverticulosis of the distal ascending colon
Diverticulosis of the sigmoid colon and distal descending colon
Normal terminal ileum
Otherwise normal colonoscopy to cecum and ileum 
Recommendations: If any questions call ___ MD at 
___. Procedures and appointments can be scheduled by 
calling ___ or by email ___ 

_________________________________
___, M.D.  

Entoroscopy Report  
 
   
vocal cords GE junction  
   
 erosions ___ part duodenum antrum 
  
erosions antrum hiatal hernia 
Date: ___ Endoscopist(s): ___, 
M.D.
 
Patient: ___
 Ref.Phys.: ___, MD 
    Assisting Nurse(s)/
Other Personnel: ___, RN 
Birth Date: ___ ___ years) Instrument: ___ 
___) 
ID#: ___ ASA Class: P2 
Medications: Midazolam 3mg 
Fentanyl 75 micrograms 
Cetacaine 
 
Indications: Iron Deficiency Anemia
 
Procedure: The procedure, indications, preparation and potential 
complications were explained to the patient, who indicated his 
understanding and signed the corresponding consent forms. A 
physical exam was performed. The patient was administered 
moderate sedation. A physical exam was performed prior to 
administering anesthesia. Supplemental oxygen was used. The 
patient was placed in the left lateral decubitus position and an 
endoscope was introduced through the mouth and advanced under 
direct visualization until the third part of the duodenum was 
reached. Careful visualization of the upper GI tract was 
performed. The vocal cords were visualized. The Z-line was noted 
at 35 centimeters.The diaphragmatic hiatus was noted at 40 
centimeters.The procedure was not difficult. The patient 
tolerated the procedure well. There were no complications. 
Findings: Esophagus:  
 Lumen: A sliding large size hiatal hernia was seen, displacing 
the Z-line to 35 cm from the incisors, with hiatal narrowing at 
40 cm from the incisors.  
Stomach:  
 Mucosa: Localized discontinuous erosions of the mucosa was 
noted in the pre-pyloric region and antrum. These findings are 
compatible with NSAID or ASA use. Cold forceps biopsies were 
performed for histology at the stomach antrum.  
Duodenum:  
 Mucosa: Erythema and erosions of the mucosa were noted in the 
third part of the duodenum and fourth part of the duodenum 
compatible with duodenitis related to NSAIDS or ASPIRIN.  
Other
findings: scope was passed to mid-jejunum.  
Other
procedures: Cold forceps biopsies were performed for histology 
at the second part of the duodenum and third part of the 
duodenum to rule out sprue.  
 
Impression: Large hiatal hernia
Erosions in the pre-pyloric region and antrum compatible with 
NSAID or ASA use (biopsy)
Erythema and erosions in the third part of the duodenum and 
fourth part of the duodenum compatible with duodenitis
(biopsy)
Scope was passed to mid-jejunum.
Otherwise normal EGD to third part of the duodenum 
Recommendations: Patient likely has NSAID or Aspirin related 
damage. Consider stopping NSAIDS and adding misoprostol 200 mcg 
BID if aspirin needs to be continued. If questions please call 
or ___ at ___ or ___. 

 
Brief Hospital Course:
___ yo man with acute blood loss anemia, probable gib, and 
dyspnea.

1. Anemia, likley chronic blood loss with iron deficiency, with 
dyspnea due to same:  EGD and ___ reports as above.  Pt. 
transfused blood and iron.  HCT recovered to ___ and 
sob/dyspnea resolved.  No further bleeding seen.  ASA held until 
pt. sees primary md and outpatient GI md to re-address.  Follow 
up with pcp and gi arranged within ___ as below.

4. CKD: At baseline and remained stable.

5. CAD: continued acei, bb, statin; asa held as above

6. Hyperlipidemia: continued statin.

7. Depression/anxiety: continued klonopin.

On the day of discharge pt. was informed that he would be going 
home, so he dressed and left the hospital before I could review 
instructions and f/u plan as below with him.  I called him and 
discussed the instructions with him over the phone and he 
verbalized understanding.  The hospital is arranging a courier 
to bring him all the d/c paperwork, prescription for PPI, and 
d/c summary now - he will wait for courier to come within two 
hours of time I completed this summary.
 
Medications on Admission:
aspirin 81mg daily
lipitor 20mg daily
atenolol 25mg daily
lisinopril 5mg daily
klonipin 0.5mg qhs prn
 
Discharge Medications:
1. Atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  
2. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

3. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO TID (3 times 
a day) as needed for anxiety.  
5. Prilosec OTC 20 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO once a day.
Disp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Duodenal errosions and likely chronic occult GI bleeding and 
iron deficiency anemia.

 
Discharge Condition:
Mental Status:Clear and coherent
Level of Consciousness:Alert and interactive
Activity Status:Ambulatory - Independent

 
Discharge Instructions:
Do not take any NSAIDs: ibuprofen, alleve, advil, nuprin, etc.

Do not take your aspirin until you discuss its use again with 
your primary doctor.
 
Followup Instructions:
___
"
81,15090960,21152186," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PSYCHIATRY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
 haven't had my meds and I'm suicidal..I feel
hopeless and nothing...I thought about killing myself by
overdosing.""

 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Ms. ___ is a ___ widowed,
homeless ___ female with a history of alcohol
abuse/dependence, substance induced mood do with multiple
psychiatric admissions and detoxes.She was ""found passed out 
near
the T station and BIBA."" Pt yelling and combative upon arrival
and requesting the BEST team. Actively endorsing SI and yells,
""Just let me die"". FSGS 87 and BAL 339. 
When she arrived in the ED she was intoxicated, agitated and
aggressive towards staff and was screaming "" I want to kill
myself I want to see the Best Team."" The patient received a
chemical restraint of Haldol 5mg and calmed and became more
cooperative.  
The patient was re-evaluated when she was clinically sober and
reports that she stopped her medications and does not remember
when or why. She was last hospitalized this past ___ @ 
___
from this ED and was discharged to the ___ in
___ but reports that when she arrived there  it was late
and there was no available bed and she returned to ___.
She reports that she is not sleeping , eating and is quite
hopeless,is hearing voices telling her to ""just do it"", is
depressed and suicidal and is requesting admission to a dual
diagnosis unit.
She reports that she has been more depressed since her mother
died in ___ reports that she last drank yesterday Brandy
and Vodka and last smoked crack last week. 

 
Past Medical History:
PAST PSYCHIATRIC HISTORY: per Drs. ___ notes
dated ___, confirmed and updated with patient
- no current psychiatrist was last treated over a year ago
  by ___ @ ___
- Prior diagnoses: PTSD, depression, anxiety
- Hospitalizations: last @ ___, ___ prior
admissions; ___ in ___ for alcohol intoxication
with a BAL of 400; ___ in ___ also
inpatient at ___
- Medication and ECT trials: Zyprexa, Prozac, Ativan
- Suicide attempts: several via overdose
- Self-injurious behavior: denies
- Harm to others: denies
- Access to weapons: denies
 
PAST MEDICAL HISTORY: per Dr. ___ note dated ___,
confirmed and updated with patient
* Primary care physician: ___
- ___
- Asthma
- Chronic pain in extremities
- H/O abdominal trauma
- Denies history of head trauma or seizures
 

 
Social History:
___
Family History:
 Suicide completion by older brother, alcoholic who drove car
into a pond in ___ ___ years ago
- Negative for mood or personality disorders.
- Negative for substance use or dependence
 
Physical Exam:
EXAM:

VS: T 97.7  P ___  BP 110/58  RR 18  SpO2 98% (RA)
 
Neurological:  
 station and gait:steady and within normal limits 
 cranial nerves: not tested
 abnormal movements: no tremor or abnormal posturing
 frontal release: not assessed
 
Cognition: 
 Wakefulness/alertness: drowsy but alert
 Attention: correctly lists MOYF and MOYB
 Orientation: ___ ___ did not know the exact date
or the day of the week"" US.Pres.""Obama""
 Executive function (go/no go, Luria, trails, FAS): not assessed
 Memory: ___ registry, ___ recall after 5 minutes
 Fund of knowledge: able to name ___ play by ___ and knew
it was ___ Day
 Calculations: $2.24 = 8 quarters then self corrected to 9
 Abstraction: apple/orange ""fruit""
 Visuospatial: not assessed
 Speech: fluent ___, normal rate, tone, volume, and prosody
 Language: no paraphasic errors, appropriate to conversation
 
Mental Status:
 ___ yo ___ female dressed in hospital gown,
with poor grooming and hygiene, eyes closed for most of the
interview, edentulous 
 Behavior: calm, cooperative, engaged,and pleasant
 Mood: ""depressed""
 Affect: dysphoric
 Thought Process: linear, coherent, goal-oriented, no loose
associations, reports that she has racing thoughts
 Thought Content: active SI with thoughts to overdose on her 
medications denies HI,reports that she is experiencing AH,
voices, telling her
 
 Impulse Control: impaired
 Judgment: poor
 Insight: impaired
 

 
Pertinent Results:
___ 11:30AM URINE  HOURS-RANDOM
___ 11:30AM URINE  COLOR-Yellow APPEAR-Hazy SP ___
___ 11:30AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-SM 
___ 11:30AM URINE  RBC-2 WBC-11* BACTERIA-NONE YEAST-NONE 
EPI-17 TRANS EPI-1
___ 11:30AM URINE  MUCOUS-MANY
___ 06:10AM   NEUTS-23.1* LYMPHS-70.1* MONOS-3.7 EOS-1.4 
BASOS-1.7
___ 06:10AM   HYPOCHROM-1+ ANISOCYT-2+ POIKILOCY-2+ 
MACROCYT-2+ MICROCYT-OCCASIONAL POLYCHROM-NORMAL 
OVALOCYT-OCCASIONAL TARGET-2+ ENVELOP-1+
___ 06:10AM   PLT SMR-LOW PLT COUNT-138*
 
Brief Hospital Course:
1.Legal: ___
2.Medical: 
 # Etoh withdrawal: 
Patient was started on a CIWA protocol, and was scoring ___ 
for anxiety, nausea, headaches, and tremors. She required 
between 60-90mg of valium on the first three two days of 
hospitalization. She had some evidence of disorientation and 
agitation requiring redirection during admission, but no 
chemical or physical restraints. By HD 3, she was able to be 
successfully tapered off of CIWA protocol. \

# electrolyte abnormalities: She had significant hypokalemia and 
hypomagnesemia upon admission requiring 2gm of IV mag, 1200mg of 
po magnesium as well as 80mg of po K. She had significant nausea 
and vomiting that had been present for approximately one month 
prior to admission with worsening during periods of excessive 
drinking. After completion of detox her symptoms resolved. 

 

3.Psychiatric

Extensive time was spent discussing the patients diagnosis and 
psychopharmacology issues.

Outpatient Psychiatric Medications were discontinued due to 
noncompliance. 

Celexa 20mg was started to treat depression and anxiety. 
Seroquel 50mg  was started to treat insomnia and anxiety with 
uptitration to 100mg at bedtime. Hydroxyzine was used on an prn 
basis to address severe anxiety. B/R/AE/SE including but not 
limited to gastrointestinal distress, weight gain were 
discussed. These medications were well-tolerated.  

Collateral Information: (e.g. spoke with 
brother/mother/sister/spouse)

___ Abuse: No acute or chronic issues

-Medical and Psychiatric complications of substance abuse and 
addiction were discussed at length. The patient was started on 
naltexone 50mg qhs to address alcohol dependence and cravings. 
-Outpatient f/u for substance abuse was scheduled as below
-Pt was counseled to participate in AA/NA on a daily basis upon 
discharge
-Pt was encouraged to call AA/NA and treaters if they relapse on 
substances
-Pt was counseled to stop smoking and abuse nicotine products

5.Social/Milieu:

Pt  was encouraged to participate in units 
groups/milieu/therapy opportunities.  
Usage of coping skills and mindfulness/relaxation methods were 
encouraged.
Therapy addressed family/social/work/housing issues.  

6.Risk Assessment: (a sample paragraph listed below)

Will note that while patient represents a chronic risk of 
impulsive and potentially dangerous behaviors (e.g. self-injury 
or assault) given multiple risk factors (including dx with a 
major mental illness, substance abuse, prior hx of these 
behaviors) that patient is currently in good behavioral control, 
sober, and future oriented (w/ plan to engage in outpatient 
substance abuse treatment, be sober for her mother), and 
connected with outpt treatment (sp. medication compliant and 
connected w outpt treaters) and therefore not at any significant 
elevated acute risk at this time to warrant inpatient 
hospitalization.

7.Disposition: 

___ program

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Paroxetine 30 mg PO DAILY 
2. CloniDINE 0.1 mg PO TID 
3. TraZODone 50 mg PO HS 
4. OLANZapine 20 mg PO HS 
5. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1. Multivitamins 1 TAB PO DAILY 
2. Atenolol 25 mg PO BID 
3. Citalopram 20 mg PO DAILY 
4. FoLIC Acid 1 mg PO DAILY 
5. HydrOXYzine 25 mg PO Q6H:PRN anxiety/nausea 
6. naltrexone 50 mg oral qhs 
7. QUEtiapine Fumarate 100 mg PO HS 
8. Omeprazole 20 mg PO BID 
9. Thiamine 100 mg PO DAILY 
10. QUEtiapine Fumarate 25 mg PO BID:PRN anxiety 
11. CloniDINE 0.1 mg PO TID 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Alcohol dependence
PTSD
Depression NOS

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
During your admission at ___, you were diagnosed with alcohol 
dependence, depression and PTSD and treated included medication 
with naltrexone, celexa and seroquel.
Please follow up with all outpatient appointments as listed.
Please continue all medications as directed.
Please avoid abusing alcohol and any drugs--whether prescription 
drugs or illegal drugs--as this can further worsen your medical 
and psychiatric illnesses.
Please contact your outpatient psychiatrist or other providers 
if you have any concerns.
Please call ___ or go to your nearest emergency room if you feel 
unsafe in any way and are unable to immediately reach your 
health care providers.
It was a pleasure to have worked with you and we wish you the 
best of health.
If you need to talk to a ___ Staff Member regarding issues of 
your hospitalization, please call ___

 
Followup Instructions:
___
"
82,15106894,21484826," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins
 
Attending: ___
 
Chief Complaint:
Tylenol OD
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ F with h/o bipolar disorder with a prior suicide attempt 
with APAP admitted with tylenol OD. Patient was recently in 
___ for two weeks (___) for 
depressive episode. There they changed around a couple of her 
psychiatric medications. She has had several recent stressors in 
the last few months including a separation from her husband, 
moving to a new house, isolation from friends/family ___ the 
move, and a neighbor who is by her report sexually harrassing 
her. Last night at about 8:30pm she had had enough and decided 
to kill herself. She went to the pharmacy and bought a bottle of 
tylenol ___ tabs of 500mg) and took almost all of it. She also 
took 26 2mg tablets of klonipin. She had nausea and abdominal 
pain and vomited (some blood) all night. On the morning of 
admission she called her sister and was taken by EMS to ___ 
___.
She presented to ___ 15 hours after ingestion with apap level 
57. started on Nac at that time 10,500mg and then 3500 mg given 
IV. She was also given activated charcoal and zofran.
.
VS on presentation to the ED: 98.1 64 128/85 18 97. At ___ ED 
she received 50mg/kg NAC for 4 hours and then started receiving 
100mg/kg of NAC for 16 hours.
.
VS prior to transfer: HR 73 BP 139/68 RR 21 Sat 100% on RA
.
On arrival to the floor patient had no complaints of abdominal 
pain, nausea, vomiting. Did have diarrhea after receiving the 
activated charcoal. Also was hungry.
 
Past Medical History:
Bipolar disease - Dr. ___ her psych meds
Suidide attempts (30 since age ___ per OSH records) Per patient 
only once prior and that time was with APAP as well
Inpatient psych admission at ___ in ___ for 
depression
TAH
CCY
L knee replacement
Restless leg syndrome
 
Social History:
___
Family History:
No liver disease in family. two brothers and father ___ 
suicide -> all in month of ___. Mother burned to death at age 
___.
 
Physical Exam:
VITALS: 98.4 151/91 HR 61 RR 18 98%RA
GEN: Middle-aged F in NAD
HEENT: Nc/AT anicteric sclera. MMM
NECK: No JVD
LUNGS: CTAB
HEART: RRR no m/r/g
ABD: Soft. NT/ND no HSM. Negative ___ sign
EXTREM: Warm. No edema
NEURO: A+OX3 no asterixis. Pupils equal, round, reactive to 
light
 
Pertinent Results:
___ 04:55PM BLOOD WBC-15.1* RBC-4.84 Hgb-14.3 Hct-43.7 
MCV-90 MCH-29.5 MCHC-32.6 RDW-13.5 Plt ___
___ 04:45AM BLOOD WBC-10.0 RBC-4.18* Hgb-12.4 Hct-37.6 
MCV-90 MCH-29.6 MCHC-33.0 RDW-13.0 Plt ___
___ 06:40AM BLOOD WBC-9.1 RBC-4.12* Hgb-12.0 Hct-37.8 
MCV-92 MCH-29.1 MCHC-31.6 RDW-13.1 Plt ___
___ 04:55PM BLOOD Neuts-76.8* ___ Monos-2.8 Eos-1.4 
Baso-0.4
___ 04:55PM BLOOD ___ PTT-28.1 ___
___ 05:20AM BLOOD ___ PTT-32.1 ___
___ 11:55PM BLOOD ___ PTT-26.0 ___
___ 06:40AM BLOOD ___ PTT-25.8 ___
___ 04:55PM BLOOD Glucose-109* UreaN-16 Creat-0.9 Na-144 
K-3.3 Cl-109* HCO3-20* AnGap-18
___ 05:20AM BLOOD Glucose-121* UreaN-9 Creat-0.7 Na-140 
K-3.4 Cl-109* HCO3-20* AnGap-14
___ 06:40AM BLOOD Glucose-108* UreaN-7 Creat-0.6 Na-142 
K-4.6 Cl-108 HCO3-30 AnGap-9
___ 04:55PM BLOOD ALT-347* AST-549* AlkPhos-68 TotBili-0.6
___ 05:20AM BLOOD ALT-684* AST-2035* AlkPhos-63 TotBili-0.4
___ 12:33PM BLOOD ALT-2939* AST-3412* AlkPhos-66 
TotBili-0.4
___ 04:45AM BLOOD ALT-___* AST-2729* AlkPhos-64 
TotBili-0.4
___ 11:55PM BLOOD ALT-1520* AST-578* AlkPhos-71 TotBili-0.3
___ 06:40AM BLOOD ALT-712* AST-325* AlkPhos-66 TotBili-0.3
___ 04:55PM BLOOD Lipase-76*
___ 04:55PM BLOOD Calcium-9.6 Phos-2.5* Mg-2.2
___ 04:45AM BLOOD Albumin-3.9 Calcium-8.8 Phos-1.9* Mg-1.9
___ 06:40AM BLOOD Albumin-3.7 Calcium-9.5 Phos-2.5* Mg-2.1
___ 04:45AM BLOOD TSH-0.27
___ 04:55PM BLOOD HBsAg-NEGATIVE HBsAb-POSITIVE IgM 
HBc-NEGATIVE IgM HAV-NEGATIVE
___ 04:55PM BLOOD HCG-<5
___ 04:55PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-17.0 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 04:55PM BLOOD HCV Ab-NEGATIVE
___ 11:01PM BLOOD Type-ART pO2-79* pCO2-32* pH-7.42 
calTCO2-21 Base XS--2 Intubat-NOT INTUBA
___ 11:01PM BLOOD Lactate-1.4
___ 08:09PM URINE Color-Straw Appear-Clear Sp ___
___ 08:09PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG

Time Taken Not Noted     Log-In Date/Time: ___ 9:10 pm
      Blood (CMV AB)

                            **FINAL REPORT ___

   CMV IgG ANTIBODY (Final ___: 
      POSITIVE FOR CMV IgG ANTIBODY BY EIA. 
      111 AU/ML. 
      Reference Range:  Negative < 4 AU/ml, Positive >= 6 AU/ml. 


   CMV IgM ANTIBODY (Final ___: 
      NEGATIVE FOR CMV IgM ANTIBODY BY EIA. 
      INTERPRETATION:  INFECTION AT UNDETERMINED TIME. 
      A positive IgG result generally indicates past exposure. 
      Infection with CMV once contracted remains latent and may 
reactivate
      when immunity is compromised. 
      If current infection is suspected, submit follow-up serum 
in ___
      weeks. 
      Greatly elevated serum protein with IgG levels ___ mg/dl 
may cause 
      interference with CMV IgM results. 

Time Taken Not Noted     Log-In Date/Time: ___ 9:10 pm
      Blood (EBV)

                            **FINAL REPORT ___

   ___ VIRUS VCA-IgG AB (Final ___:    POSITIVE 
BY EIA. 

   ___ VIRUS EBNA IgG AB (Final ___:    POSITIVE 
BY EIA. 

   ___ VIRUS VCA-IgM AB (Final ___: 
      NEGATIVE <1:10 BY IFA. 
      INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION. 
      In most populations, 90% of adults have been infected at 
sometime
      with EBV and will have measurable VCA IgG and EBNA 
antibodies.
      Antibodies to EBNA develop ___ weeks after primary 
infection and
      remain present for life. Presence of VCA IgM antibodies 
indicates
      recent primary infection. 

___ 9:33 am STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
           (Reference Range-Negative). 

___ 3:30 pm BLOOD CULTURE

   Blood Culture, Routine (Pending): 

___ 8:09 pm URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    <10,000 organisms/ml. 

 
Brief Hospital Course:
#. Tylenol OD: Patient admitted for ingestion of a large amount 
of tylenol tablets and 26 2mg Klonopin pills. She was at risk 
for fulminant hepatic failure because she fell above 
___ line on admission to ___. She was 
appropriately given NAC and transfered to ___. On admission to 
___ her LFT's were still rising and NAC treatment was 
continued by protocol. Her LFT's peaked at AST: 2939, ALT: 3412 
on ___ and continued to trend down to 497/108 on discharge. 
.  
#. Anion gap metabolic acidosis: Pt had a mild gap metabolic 
acidosis (Gap 15) that was likely secondary to her ingestion 
with a component of vomiting. Salicylates were negative, ETOH 
was negative. Her acidosis resolved on HD 2 with hydration and 
treatment of tylenol OD w/ NAC. All subsequent labs were in the 
normal range.
.  
#.Bipolar disorder: Pt w/ depressive symptoms during her 
hospital stay, voiced that she had no desire to live on ___ and 
was counseled on different forms of help that we could provide 
to help w/ her life stressors.  Her psych meds were held in the 
setting of her acute liver failure but can now be started as her 
liver function normailizes. No manic symptoms during 
hospitalization.  Remained with 1:1 sitter throughout.
.  
#. RLS: Pt w/ history of restless leg syndrome discussed with 
pharmacy risk/benefit of stopping sinemet abruptly and felt that 
low risk of worsening liver failure and high risk of abrupt 
cessation of medication so her medication was continued. No 
episodes of restless legs reported by patient.
.
#Herniated disk: Pt w/ chronic back pain because of herniated 
disk. Started on oxycodone 5mg q6h:prn.

 
Medications on Admission:
Cymbalta 60mg QAM
Provigil 200mg BID
Sinemet 50/200 QHS for RLS
Klonipin 2mg QHS PRN
Percocet PRN back pain
 
Discharge Medications:
1. Carbidopa-Levodopa 50-200 mg Tablet Sustained Release Sig: 
One (1) Tablet PO HS (at bedtime).  
2. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
3. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Nicotine 7 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr 
Transdermal DAILY (Daily).  
5. Docusate Sodium  Oral
6. Clonazepam 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for anxiety.  
7. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 
hours) as needed for pain.  

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Primary diagnosis:
Tylenol OD
Anion Gap Metabolic acidosis

Secondary diagnosis:
Bipolar dissorder
Restless leg syndrome

 
Discharge Condition:
Good

 
Discharge Instructions:
You were admitted to the hospital because you took about half a 
bottle of tylenol and 26 klonopin pills in an attempt to end 
your life.  You were taken first to ___ where they 
started treatment for tylenol overdose and then transfered to 
___ for further treatment and management.  We continued 
treatment for tylenol overdose and monitored your liver for any 
further damage.  Your liver was transiently damaged but it has 
now recovered and we expect its function to normalize in the 
next few days.  You were also found to have a disturbance of the 
electrolytes in your blood caused by you ingestion but this 
resolved with hydration and treatment of you tylenol overdose. 
If you ever feel like you want to end your life because there is 
nothing to live for please contact you psychiatrist or go the 
nearest emergency room so you can receive some help.
 
Followup Instructions:
___
"
83,15106894,26561733," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PSYCHIATRY
 
Allergies: 
Penicillins
 
Attending: ___
 
Chief Complaint:
___ y/o woman wi unclear psychiatric hx, reportedly bipolar d/o 
although not on medications for this, who is transferred to 
___ ___ ___ s/p intentional tylenol 
ingestion, who says, ""I'm glad I'm alive.""

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
This is a ___ y/o separated woman living alone in ___ on 
___. On ___, pt took unclear amount (told me ___ 
bottle but told others entire bottle) of Tylenol ___ mg (>250 
tabs) as well as approximately twenty 2mg  tablets of Klonopin 
at 8:30 at night then went to sleep. Woke up nauseated, vomiting 
blood, called sister who called ___, sent to ___ 
where tylenol = 7 then, thought to be about 15 hours post 
ingestion. Got activated charcoal, started on NAC 15 hrs after 
ingestion, when arrived here VSS; here restarted on ___ again. 
After she finished 16 hr protocol, now starting NAC again as 
LFTs still going up. 

At ___, pt reported she took OD of medications 
""trying to kill herself"". Notes also state pt ""admits to 
suicidal ideation"". She also told EMS en route to ___ that she 
wanted to sign out AMA. Yesterday on floor pt was very sleepy 
and somewhat confused but today she has been alert and is now 
eating.

Patient currently acknowledges this was a suicide attempt. She 
states she is alone, with a few friends but ""no one will help 
me."" Stressors include doing poorly since discharge from 
___ ___ pt was given several referrals but never 
saw anyone. She is currently under legal pressure of eviction 
notice with court date later this month ___. She states this is 
because landlord has been making moves on her which she 
rejected, and that he now wants her out. Unclear why she doesn't 
move. She states no acute financial difficulties - is on 
Medicare for disability and pays rent from that money. She is a 
poor historian but acknowledging depression for last few months. 
Good appetite, no problems with concentration. She acknowledges 
chronic poor sleep and also feeling tired all day long. SHe is 
hopeless that anything will ever get better. She feels no one 
helps her or takes care of her. She denies excessive guilt but 
reports +anhedonia. She was started on provigil in ___ 
during inpatient psychiatric hospitalization and it does help 
her with being more awake in am. Says she gets manicky"" but no 
clear hx of decreased need for sleep, racing thoughts, goal 
directed activity etc. She denies sx of panic or dissociation, 
hypervigilance, but describes self as very anxious, irritable, 
and having a lot of body pain and discomfort. Has never had AH, 
VH, or paranoia. She is apparently quite impulsive; she had not 
planned the suicide attempt until just before, but then went out 
and bought tylenol also taking klonopin to help  her sleep. She 
also describes dropping in on clinics without appointments, and 
a variety of other impulsive decisions.

 
Past Medical History:
Chronic back pain
s/p CCY and TAH
s/p TKR
Restless leg syndrome

PPH:
- Dx: ? bipolar d/o - pt cannot describe clear sx of mania. She
states she has never been hospitalized for mania but that she 
was
d'x'd by Dr. ___. 
- Treaters: Referred to ___ at ___.
Also referred to Family ___ in ___. Never followed up
at either, blames them for not seeing her when she was late; on
one occasion it appears she attempted to drop in and was sent
instead to an emergency room from where she was discharged.
- Hospitalizations: Discharged from ___ ___.
Cannot recall last one prior to that, possibly ___.
___ in ___ was helpful. 
- Meds: Has never been on lithium or depakote. 
- Suicide attempts: Reports 30 in past, cannot give all details
- Harm to others: denies
- Access to weapons: denies

 
Social History:
Pt has two brothers, both of whom are deceased, and one 
stepsister with whom she is still close. She grew up in 
___ and went to ___. She dropped out in ___ 
grade while she was living with her boyfriend's family. She 
states her mother was not supportive so she had to find another 
place to live. Patient reports trauma hx as raped by boyfriend's 
brother. She eventually got GED and then did some college, 
studying ___ literature. She was married and is separated. 
She had one child but gave child up for adoption. Pt worked for 
a long time in ___ as ___. She is still close 
to her stepsister who also lives in ___; pt moved there to 
be near her then got job working for ___. More 
recently she has worked as a ___ (last worked ___.
SUBSTANCE USE:
Tobacco: < pack/week
EtOH: Pt denies ever drinking daily or on regular basis. Has 
occasional beer ""when I'm upset."" No AA, detoxes, withdrawal sx, 
___.
MJ: Uses every few days, one or two joints, then can go for 
several weeks without using.
COcaine: tried, never used regularly
IVDU: Denies ever trying

 
Family History:
Pt says father committed suicide by drug overdose and two 
brothers completed suicides, one by jumping off building, one by 
overdose. Mother died in her ___ pt states ""she burned to 
death"" but on further discussion what she means is that mother 
had acute, severe drug reaction to ?tegretol with toxic 
epidermal
necrolysis.

 
Physical Exam:
VS: 100.7  ___  ___  18  98%RA
MSE upon admission: Neatly groomed woman lying on bed in NAD, 
eating. No tremor. No diaphoresis. No abnormal movements. No 
asterixis. AMbulatory w/ nl gait/ station. Speech clear without 
pressure. Mood ""terrible"". Affect: fair range. TP: 
perseverative, tangential without loose associations. TC: Denies 
HI, AH, VH. Not suicidal at this moment in the hospital, glad to 
be alive, but feels hopeless that things will ever change. 
Cognitive: alert, oriented to her full name, full date, full 
location except floor. Attention intact: ___ moyb. 
Calculations intact: 7 q in 1.75. Memory: reg ___, recall ___ at 
5'. Fund of knowledge good, ___ as play by ___, 
current events intact. Language; fluent, naming,
repetition, comprehension all intact. Visuospatial: Able to draw 
clock with good planning and correctly set hands to 2:10.
 
Pertinent Results:
___ 08:15AM BLOOD WBC-9.1 RBC-4.06* Hgb-12.2 Hct-37.5 
MCV-93 MCH-30.0 MCHC-32.4 RDW-13.8 Plt ___
___ 09:13AM BLOOD ___ PTT-19.3* ___
___ 04:35PM BLOOD Glucose-115* UreaN-10 Creat-0.7 Na-142 
K-4.7 Cl-106 HCO3-23 AnGap-18
___ 06:40AM BLOOD ALT-1397* AST-325* AlkPhos-66 TotBili-0.3
___ 04:35PM BLOOD ALT-1454* AST-106* AlkPhos-87 TotBili-0.2
___ 08:30AM BLOOD ALT-449* AST-34 TotBili-0.2
___ 09:13AM BLOOD ALT-273* AST-27 AlkPhos-88 TotBili-0.2
___ 04:35PM BLOOD Calcium-9.9 Phos-5.3* Mg-2.0
___ 04:35PM BLOOD TSH-1.7
___ 04:35PM BLOOD HCG-<___.) Psychiatric:
- The patient was transferred from the medicine service after 
her suicide attempt by overdose on tylenol & clonazepam. She 
signed in on a CV and was placed on 15 minute checks.
- Her outpatient cymbalta and provigil were initially held and 
the patient was started on buproprion. She continued to be 
anxious and depressed, with difficulty sleeping despite her 3mg 
of clonazepam at night. The bupropion was discontinued and the 
patient was started on a low dose of lithium at night for mood 
stabilization. This improved her sleep and she tolerated it 
well.
- The patient began to complain of re-emergence of her 
fibromyalgia pain, which had been controlled with cymbalta, so a 
low dose of cymbalta was restarted.
- At the time of discharge the patient reported improved mood, 
positive future orientation and denied suicidal ideation. 

2.) Psychosocial:
- The patient was generally under good behavioral control other 
than a few episodes of crying and yelling in response to feeling 
stressed or non-supported. She became very close with a few male 
patients and had limits set regarding personal boundary rules.
- She attended selected groups, including DBT and coping skills, 
and was visible in the milieu.
- Application for D___ services was submitted during her 
admission.
- The patient's landlord was notified that the patient was in 
the hospital and would not be able to attend the eviction court 
hearing. She was given information on housing options with 
""Homeless, Not Helpless.""

3.) Medical:
- The patient's liver function tests trended down during her 
hospital stay.
- Her PCP ___ was contacted for collateral and 
confirmation of her medications.
- Oxycodone was continued for her chronic back pain and Sinemet 
continued for restless leg syndrome.
- Application for ___ was filed.

4.) Dispo:
- The patient was discharged home to the ___ with an 
appointment to see Dr. ___ following day and instructions 
on seeing a therapist and psychiatrist at the ___, 
which sees patient's without insurance. Her DMH and ___ 
status were pending at the time of discharge. She was also able 
to get the majority of her medications (with the exceptions of 
cympbalta and sinemet) from the ___ care pharmacy before she 
left the hospital.
 
Medications on Admission:
klonopin 2 mg po qday
duloxetine 60 mg qday
provigil 200 bid for daytime sleepiness
percocet for chronic back pain
Sinemet for restless leg syndrome
 
Discharge Medications:
1. Carbidopa-Levodopa 50-200 mg Tablet Sustained Release Sig: 
One (1) Tablet PO HS (at bedtime).
Disp:*30 Tablet(s)* Refills:*0*
2. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 
hours) as needed for pain.
Disp:*20 Tablet(s)* Refills:*0*
3. Clonazepam 1 mg Tablet Sig: Three (3) Tablet PO QHS (once a 
day (at bedtime)).
Disp:*21 Tablet(s)* Refills:*0*
4. Lithium Carbonate 300 mg Capsule Sig: One (1) Capsule PO QHS 
(once a day (at bedtime)).
Disp:*30 Capsule(s)* Refills:*0*
5. Duloxetine 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*0*
6. Modafinil 200 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Axis I: 
mood disorder not otherwise specified
history of bipolar disorder
polysubstance abuse (alcohol, marijuana, benzodiazepines, 
opiates)
Axis II: cluster B traits
Axis III: chronic back pain, fibromyalgia
Axis IV: severe psychosocial stressors: housing, financial, 
relationship, poor support system
Axis V: GAF upon discharge: ___
 
Discharge Condition:
MSE: Patient slightly disheveled in white robe, just out of bed. 
Pleasant and cooperative with good eye contact. No abnormal 
movements. Speech is normal in volume, rate and prosody. Mood is 
 ""better, good.""  Affect is brighter, improved range. Thought 
process is linear and thought content is without current 
SI/HI/AVH. Insight and judgment are fair.
 
Discharge Instructions:
Please take all medications as prescribed and follow up with the 
appointments listed below.
 
Followup Instructions:
___
"
84,15109929,26321582," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: UROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Erectile dysfunction
 
Major Surgical or Invasive Procedure:
Insertion penile prosthesis - ___ - Dr. ___

 
___ of Present Illness:
___ h/o radical prostatectomy ___ with post-prostatectomy ED 
unresponsive to other measures who elected for definitive 
treatment with implantable penile device. 

 
Past Medical History:
PAST MEDICAL HISTORY/PSH:  
Essential thrombocytosis. 
Exercise-induced asthma 
Radiation therapy for acne in his youth resulting in 
hypothyroidism.
Hydrocele repair by Dr. ___ in early ___.  
Cholecystectomy.
Inguinal hernia repair.

 
Social History:
___
Family History:
His father had prostate cancer and lived well
into his ___.

 
Physical Exam:
___, NAD, AVSS

Interactive, cooperative

Abdomen soft, Nt/Nd

Hemiscrotum Incision c/d/i w/out evidence hematoma or infection

Ecchymosis at penile shaft/scrotum noted but without induration

Lower extremities w/out edema or pitting and no report of calf 
pain

 
Pertinent Results:
___ 10:11AM   GLUCOSE-113* UREA N-17 CREAT-0.8 SODIUM-141 
POTASSIUM-4.4 CHLORIDE-107 TOTAL CO2-28 ANION GAP-10
___ 10:11AM   estGFR-Using this
___ 10:11AM   WBC-4.3 RBC-2.65* HGB-11.0* HCT-32.6* 
MCV-123* MCH-41.5* MCHC-33.8 RDW-15.8*
___ 10:11AM   PLT COUNT-233
 
Brief Hospital Course:
The patient was admitted to the Urology service for placement of 
penile prosthesis. No concerning intraoperative events occurred; 
please see dictated operative note for details. The patient 
received vancomycin and gentamicin for pre-operative infection 
prophylaxis and post-operatively for prophylaxis. Post-op course 
was uncomplicated. His foley catheter was removed immediately 
postoperatively and the patient voided without difficulty.  
Hemovac drain was removed on POD 1.  At discharge, patient's 
pain was well controlled with oral pain medications, tolerating 
regular diet, ambulating without assistance, and voiding without 
difficulty. Incision at discharge without erythema or hematoma. 
Specific instructions about prosthesis care given, and also 
included in this discharge summary. Antibiotic scripts for DC 
were given.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY *AST Approval Required*
2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing or dyspnea 
3. Citalopram 40 mg PO DAILY 
4. Hydroxyurea 1000 mg PO DAILY 
5. FoLIC Acid ___ mcg PO DAILY 

 
Discharge Medications:
1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing or dyspnea 
2. Citalopram 40 mg PO DAILY 
3. FoLIC Acid ___ mcg PO DAILY 
4. Hydroxyurea 1000 mg PO DAILY 
5. Acetaminophen 650 mg PO Q4H:PRN pain or fever 
6. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
RX *oxycodone 5 mg ___ capsule(s) by mouth Q4 hrs Disp #*50 
Capsule Refills:*0
7. Aspirin 81 mg PO DAILY 
8. Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*30 Capsule Refills:*0
9. Amoxicillin-Clavulanic Acid ___ mg PO Q12H 
RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tab by mouth q12 
hrs Disp #*14 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Erectile Dysfunction

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
-Please also refer to the instructions provided to you by the 
manufacturer

-Do NOT pull down on implanted bulbs in scrotum.

-ALWAYS call to inform, review and discuss any medication 
changes and your post-operative

course with your primary care doctor.

-___ keep your phallus at midline, pointed toward your 
umbilicus, taped in place with

protective gauze if necessary for the next week. Of course you 
may point it downward for

voiding.

-over the next several days you may experience some increased 
swelling of your phallus and

scrotum resembling a semi-rigid phalus (semi-erect); this is 
normal.  This may be accompanied

by discoloration (ecchymosis) involving the phallus and the 
scrotum; this too is normal and will

gradually resolve.

-Please remove the surgical dressing over penis and/or under 
scrotum on post-operative day two:

no further wound care is needed and you may leave the wound open 
to air. Wear comfortable,

loose fitting briefs or boxer-briefs for support--they should be 
cotton and/or breathable

-Do NOT use prosthesis for 6 weeks and until explicitly advised 
by your urologist

-Complete a 7 day course of antibiotics as directed

-You may shower, but do NOT bathe, swim or otherwise immerse 
your incision.

-Do not lift anything heavier than a phone book and no sports, 
vigorous physical activity (including sexual).

-Tylenol should be your first line pain medication, a narcotic 
pain medication has been

prescribed for breakthough pain >4.  Replace Tylenol with 
narcotic pain medication.  Max daily

Tylenol dose is 4gm, note that narcotic pain medication also 
contains Tylenol (acetaminophen)

-Do not drive or drink alcohol while taking narcotics and do not 
operate dangerous machinery

-Colace has been prescribed to avoid post surgical constipation 
and constipation related

to narcotic pain medication, discontinue if loose stool or 
diarrhea develops.  Colace is a stool ""softener""- it is NOT a 
laxative

-Resume all of your home medications, except hold NSAID 
(aspirin,  and ibuprofen containing

products such as advil & motrin) for ONE week or until you see 
your urologist in follow-up OR

you are explicitly advised to resume sooner by your PCP, 
___ or Cardiologist

-If you have fevers > 101.5 F, vomiting, or increased redness, 
swelling, or discharge from your

incision, call your doctor or go to the nearest emergency room.
 
Followup Instructions:
___
"
85,15109929,26004790," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: UROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Penoscrotal infection/Infected penile prosthesis

 
Major Surgical or Invasive Procedure:
Procedure ___:  Removal AND replacement of Ambicor penile
prosthesis, scrotal exploration and antibiotic irrigation.

Procedure ___:  Removal of penile prosthesis, Ambicor

 
History of Present Illness:
Mr. ___ presents for removal of infected penile prosthesis 
and replacement of new penile prosthesis. 
 
Past Medical History:
PAST MEDICAL HISTORY/PSH:  
Essential thrombocytosis. 
Exercise-induced asthma 
Radiation therapy for acne in his youth resulting in 
hypothyroidism.
Hydrocele repair by Dr. ___ in early ___.  
Cholecystectomy.
Inguinal hernia repair.

 
Social History:
___
Family History:
His father had prostate cancer and lived well into his ___.

 
Physical Exam:
WDWN male, nad, avss
abdomen soft, appropiately ttp at suprapubic area
phallus and scrotum markedly swollen but no evidence of hematoma 
or spreading infection. Incision line is clean, dry, intact at 
hemiscrotum
foley has been removed, drain has been removed
lower extremities w/out edema, pitting, pain
right arm with PICC
 
Pertinent Results:
___ 09:20AM BLOOD WBC-6.7 RBC-2.52* Hgb-9.9* Hct-27.3* 
MCV-108* MCH-39.4* MCHC-36.3* RDW-20.0* Plt ___
___ 09:25AM BLOOD WBC-7.3 RBC-2.47* Hgb-9.2* Hct-27.2* 
MCV-110* MCH-37.1* MCHC-33.7 RDW-20.8* Plt ___
___ 08:05AM BLOOD WBC-5.9 RBC-2.23*# Hgb-8.4* Hct-24.3* 
MCV-109*# MCH-37.5* MCHC-34.5 RDW-20.9* Plt ___
___ 10:00AM BLOOD WBC-5.8 RBC-1.73* Hgb-6.9* Hct-20.2* 
MCV-117* MCH-40.2* MCHC-34.5 RDW-15.1 Plt ___
___ 08:30AM BLOOD WBC-5.9 RBC-1.84* Hgb-7.3* Hct-21.6* 
MCV-118* MCH-40.0* MCHC-33.9 RDW-15.2 Plt ___
___ 07:15AM BLOOD WBC-5.8 RBC-2.01* Hgb-8.4* Hct-23.5* 
MCV-117* MCH-42.1* MCHC-35.8* RDW-15.2 Plt ___
___ 07:20AM BLOOD WBC-4.6 RBC-2.12* Hgb-8.5* Hct-25.1* 
MCV-118* MCH-40.0* MCHC-33.8 RDW-15.5 Plt ___
___ 11:47AM BLOOD WBC-5.5 RBC-2.29* Hgb-9.4* Hct-27.1* 
MCV-118* MCH-41.1* MCHC-34.8 RDW-15.5 Plt ___
___ 10:00AM BLOOD Neuts-86* Bands-0 Lymphs-6* Monos-5 Eos-3 
Baso-0 ___ Myelos-0
___ 07:20AM BLOOD Neuts-76.6* Lymphs-15.1* Monos-6.6 
Eos-1.5 Baso-0.3
___ 11:47AM BLOOD Neuts-83.6* Lymphs-9.4* Monos-5.1 Eos-1.4 
Baso-0.4
___ 10:00AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-NORMAL 
Macrocy-3+ Microcy-NORMAL Polychr-NORMAL
___ 10:00AM BLOOD Hb A-93.7 Hb S-0 Hb C-0 Hb A2-3.0 Hb 
F-0.3
___ 10:00AM BLOOD ___
___ 10:00AM BLOOD Ret Aut-4.1*
___ 09:20AM BLOOD Glucose-106* UreaN-11 Creat-0.8 Na-139 
K-4.6 Cl-102 HCO3-27 AnGap-15
___ 09:25AM BLOOD Glucose-118* UreaN-12 Creat-0.8 Na-139 
K-4.7 Cl-103 HCO3-27 AnGap-14
___ 07:20AM BLOOD Glucose-106* UreaN-12 Creat-0.7 Na-140 
K-4.5 Cl-104 HCO3-32 AnGap-9
___ 11:47AM BLOOD Glucose-136* UreaN-18 Creat-0.7 Na-137 
K-4.6 Cl-99 HCO3-29 AnGap-14
___ 10:00AM BLOOD ALT-26 AST-25 AlkPhos-75 TotBili-0.8
___ 09:20AM BLOOD TotProt-5.6* Calcium-8.8 Mg-2.3
___ 09:25AM BLOOD Calcium-8.4 Phos-2.8 Mg-2.3
___ 10:00AM BLOOD Albumin-3.1* Iron-39*
___ 09:25AM BLOOD VitB12-803
___ 10:00AM BLOOD calTIBC-160* Ferritn-414* TRF-123*
___ 10:00AM BLOOD TSH-2.3
___ 10:00AM BLOOD AFP-<1.0
___ 11:56AM BLOOD Lactate-1.7

___ FOREIGN BODY NOT PROCESSED   INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
INPATIENT 
___ URINE URINE CULTURE-FINAL INPATIENT 
___ SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL 
{PSEUDOMONAS AERUGINOSA}; ANAEROBIC CULTURE-FINAL INPATIENT 
___ SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL 
{MIXED BACTERIAL FLORA, PSEUDOMONAS AERUGINOSA}; ANAEROBIC 
CULTURE-FINAL {MIXED BACTERIAL FLORA} INPATIENT 
___ URINE URINE CULTURE-FINAL EMERGENCY WARD 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
EMERGENCY WARD 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
EMERGENCY WARD 

 
Brief Hospital Course:
Mr. ___ presented to the emergency department with penile 
pain and swelling associated with his penile prosthesis 
(initially placed ___. He was admitted to Dr. ___ 
___ service and prepped for surgery with intravenous 
antibiotics. On hospital day two he underwent removal and 
replacement of his penile prosthesis on ___ secondary to 
infection now known to be pseudomonas. He tolerated the 
procedure well, was continued on intravenous antibiotics. On 
POD1 his pain persisted and given the pseudomonas infection, 
consult with the infectious disease team and hematology was 
obtained. Mr. ___ opted for removal of the replacement 
prosthesis, especially after consultation with the infectious 
disease service. Hematology weighed in and his hydroxyurea was 
held and he received two units of packed red blood cells. On 
___, he was taken back to the operating room theatre for 
explant of the prosthesis.  He tolerated this procedure well and 
was recovered in the PACU before transfer to the general 
surgical floor. Please see the respective dictated operative 
notes for full details. His post-operative course was 
unremarkable although he did require interventional radiology 
manipulation of his bedside placed PICC line. The PICC was 
determined functional and he was given continued on intravenous 
CEFEPIME at discharge with a course plan of about ___ weeks time 
with mandated follow up with outpatient infectious disease and 
hematology. 

On POD1 after his second procedure, his Foley catheter was 
removed and he was incontinent of urine. His wounds were clean 
and dry at discharge but his phallus and scrotum remained 
markedly edematous. He was discharged home POD2 after his second 
procedure with ___ Home infusion services and explicit 
instructions for follow up. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB, wheezing 
2. Citalopram 40 mg PO DAILY 
3. Hydroxyurea 1000 mg PO SUN, TUES, THURS, SAT 
4. Aspirin 81 mg PO DAILY 
5. Hydroxyurea 1500 mg PO ___, WEDNESDSAY, ___ 

 
Discharge Medications:
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB, wheezing 
2. Citalopram 40 mg PO DAILY 
3. Acetaminophen 1000 mg PO Q6H:PRN pain, fever 
4. OxycoDONE (Immediate Release)  ___ mg PO Q3H:PRN pain 
RX *oxycodone 5 mg ___ tablet(s) by mouth Q4hrs Disp #*40 Tablet 
Refills:*0
5. Amoxicillin-Clavulanic Acid ___ mg PO Q12H 
6. Sodium Chloride 0.9%  Flush 10 mL IV DAILY and PRN, line 
flush 
RX *sodium chloride 0.9 % [Normal Saline Flush] 0.9 % 10 mL IV 
Daily & PRN PICC LINE USE Disp #*60 Syringe Refills:*0
7. Senna 8.6 mg PO BID:PRN constipation 
8. Sarna Lotion 1 Appl TP QID:PRN pruritis 
9. Polyethylene Glycol 17 g PO DAILY:PRN Severe constipation 
10. Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg ONE capsule(s) by mouth 
twice a day Disp #*60 Capsule Refills:*0
11. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line 
flush 
RX *heparin lock flush (porcine) [heparin lock flush] 10 unit/mL 
2 mL IV DAILY & PRN, line flush Disp #*5 Vial Refills:*0
12. Hydroxyurea 1000 mg PO SUN, TUES, THURS, SAT 
DO NOT RESUME without explicit instructions from Dr. ___. 
13. Hydroxyurea 1500 mg PO ___, ___, ___ 
DO NOT RESUME with explicit instructions from Dr. ___. 
14. CefePIME 2 g IV Q12H 
RX *cefepime [Maxipime] 2 gram 2 GM IV Q12hrs Disp #*42 Vial 
Refills:*0
15. Outpatient Lab Work
Follow up with ID as directed. It is VERY IMPORTANT that you 
return to ___ clinic or ED if fevers return, 
swelling/pain/erythema worsens or if you develop purulent (pus) 
drainage. 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Penoscrotal infection/Infected penile prosthesis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
DO NOT RIDE BIKES OF ANY SORT FOR AT LEAST 6 MONTHS OR UNTIL 
CLEARED BY FOLLOWUP BY ___ ___!

TAKE YOUR ANTIBIOTICS AS DIRECTED!!! DO NOT MISS DOSES.
-Follow up with ID and HEMATOLOGY as directed and scheduled. 

-It is VERY IMPORTANT that you return to ___ clinic or ED 
if fevers return, swelling/pain/erythema worsens or if you 
develop purulent (pus) drainage. 

-ALWAYS call to inform, review and discuss any medication 
changes and your post-operative course with your primary care 
doctor.

-___ keep your phallus/scrotum elevated to facilitate edema 
resolution. 

-Note that as the swelling/edema of your phallus and scrotum 
resolves, the skin may start to ""flake"" off and/or peel; this is 
a normal ""healing"" process. 

-Shower once to twice per day to keep genitals clean, dry. Avoid 
wound contamination with urine.

-Wear comfortable, loose fitting briefs or boxer-briefs for 
support--they should be cotton and/or breathable

-You may shower, but do NOT bathe, swim or otherwise immerse 
your incision.

-Do not lift anything heavier than a phone book and avoid 
sports, vigorous physical activity (including sexual) and do not 
drive. Avoid stools/hard chairs and bicycles.

-Tylenol should be your first line pain medication, a narcotic 
pain medication has been prescribed for breakthough pain >4.  
Replace Tylenol with narcotic pain medication.  Max daily 
Tylenol dose is 4gm, note that narcotic pain medication also 
contains Tylenol (acetaminophen)

-Do not drive or drink alcohol while taking narcotics and do not 
operate dangerous machinery

-Colace has been prescribed to avoid post surgical constipation 
and constipation related to narcotic pain medication, 
discontinue if loose stool or diarrhea develops.  Colace is a 
stool ""softener""- it is NOT a laxative. Senokot is a gentle 
laxative that may be used to facilitate smooth bowel movements.

-Resume all of your home medications, except as noted.

-If you have fevers > 101.5 F, vomiting, or increased redness, 
swelling, or discharge from your incision, call your doctor or 
go to the nearest emergency room.
 
Followup Instructions:
___
"
86,15109929,29212764," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: UROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
PENOSCROTAL INFECTION, URINARY INCONTINENCE, 
THROMBOCYTOPENIA/ANEMIA
 
Major Surgical or Invasive Procedure:
Surgeon:  ___, MD
PREOPERATIVE DIAGNOSIS:  Scrotal abscess.
POSTOPERATIVE DIAGNOSIS:  Scrotal and perirectal fluid 
collections.
PROCEDURE:  Incision and drainage of scrotal and perirectal 
abscess.

Surgeon: ___, MD 
PREOPERATIVE DIAGNOSIS:  Infected penile prosthesis with 
subcutaneous emphysema and possible left ischiorectal abscess.
POSTOPERATIVE DIAGNOSIS:  Infected penile prosthesis with
subcutaneous emphysema and possible left ischiorectal abscess.
PROCEDURE PERFORMED:  Incision and drainage of possible left
ischiorectal abscess.

 
History of Present Illness:
___ male w/ implantable penile prosthesis now s/p explant, 
re-implant and subsequent explant most recently on ___ 
(currently, there is no device in place, just residual swelling 
being managed with outpt antibiotics) w/ concern for ___ 
abcess on CT scan. 
 
Past Medical History:
Insertion Penile prosthesis, ___
Removal and replacment of infected penile prosthesis ___
Explant of replacement prosthesis ___

JAK2 positive Essential Thrombocythemia, followed by Dr ___ at ___
Essential thrombocytosis. 
Exercise-induced asthma 
Radiation therapy for acne in his youth resulting in 
hypothyroidism.
Hydrocele repair by Dr. ___ in early ___.  
Cholecystectomy.
Inguinal hernia repair.

 
Social History:
___
Family History:
His father had prostate cancer and lived well into his ___.

 
Physical Exam:
WDWN male, nad, avss
abdoment soft, nt/nd
extremities w/out edema, pitting, pain
PICC at right arm
hemiscrotum with surgical incison open with wick packing ___ 
iodoform gauze); wound edges clean and without evidence of 
infection
left ischial-buttock wound is clean, dry, intact and without 
evidence of infection. Packed with ___ iodoform gauze.
scrotum and phallus edematous but markedly improved compared to 
prior admission.
 
Pertinent Results:
___ 07:00AM BLOOD WBC-11.5* RBC-2.45* Hgb-8.8* Hct-26.8* 
MCV-109* MCH-35.8* MCHC-32.8 RDW-18.1* Plt ___
___ 05:23AM BLOOD WBC-9.4 RBC-2.34* Hgb-8.6* Hct-25.8* 
MCV-110* MCH-36.8* MCHC-33.4 RDW-18.6* Plt ___
___ 05:30PM BLOOD WBC-11.0# RBC-2.63* Hgb-9.5* Hct-28.5* 
MCV-108* MCH-36.1* MCHC-33.3 RDW-19.2* Plt ___
___ 05:30PM BLOOD Neuts-85.8* Lymphs-7.5* Monos-5.3 Eos-1.1 
Baso-0.3
___ 05:30PM BLOOD Hypochr-OCCASIONAL Anisocy-2+ 
Poiklo-NORMAL Macrocy-2+ Microcy-OCCASIONAL Polychr-OCCASIONAL
___ 07:00AM BLOOD Plt ___
___ 05:23AM BLOOD Plt ___
___ 05:30PM BLOOD Plt ___
___ 07:00AM BLOOD Glucose-94 UreaN-12 Creat-0.7 Na-138 
K-4.3 Cl-101 HCO3-29 AnGap-12
___ 05:23AM BLOOD Glucose-89 UreaN-14 Creat-0.7 Na-142 
K-4.2 Cl-105 HCO3-30 AnGap-11
___ 05:30PM BLOOD Glucose-120* UreaN-18 Creat-0.9 Na-140 
K-4.1 Cl-102 HCO3-30 AnGap-12
___ 07:00AM BLOOD Calcium-8.7 Phos-2.4* Mg-2.1
___ 05:23AM BLOOD Calcium-8.0* Mg-2.2
___ 05:45PM BLOOD Lactate-1.1
___ 06:42PM URINE Color-Yellow Appear-Hazy Sp ___
___ 06:42PM URINE Blood-NEG Nitrite-NEG Protein-30 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-8.5* Leuks-NEG
___ 06:42PM URINE RBC-6* WBC-3 Bacteri-FEW Yeast-NONE 
Epi-<1
___ 06:42PM URINE AmorphX-OCC
___ 06:42PM URINE Mucous-RARE

___ 11:19 pm SWAB      FLUID FROM SCROTAL ABSCESS SWAB. 
                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN. 

   FLUID CULTURE (Final ___:    NO GROWTH. 
   ANAEROBIC CULTURE (Final ___:    NO GROWTH. 

___ 6:42 pm URINE  **FINAL REPORT ___
   URINE CULTURE (Final ___:    NO GROWTH. 

___ 5:30 pm BLOOD CULTURE     **FINAL REPORT ___
   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 5:20 pm BLOOD CULTURE    **FINAL REPORT ___
   Blood Culture, Routine (Final ___:    NO GROWTH. 

 
Brief Hospital Course:
Mr. ___ is a ___ male with implantable penile prosthesis 
(___) now status post explant and re-implant (___) and 
subsequent explant (___) who presented to the emergency 
department for further evaluation after treatment with ten days 
of intravenous antibiotics. On review of his history, he 
remarked on vague pelvic/sacral pain in recent weeks which he 
attributed to his long bike ride before his whole ordeal with 
the prosthesis explant began. Additionally, he noted in recent 
days some rectal pain and pressure that had significantly 
worsened.  He reported some significant constipation. He denied 
nausea, vomiting, fevers, chills, flank pain. CT scan was 
performed after arriving to the ED and this was concerning for 
left perianal abcess. Surgery/Colorectal service and infectious 
disease notified and involved in management. Mr. ___ was thus 
taken urgently to the operating room for exploration and 
incision and drainage of the surgical site and the perianal 
site. Dr. ___ incision and drainage of scrotal and 
perirectal abscess while Dr. ___ incision and 
drainage of possible left
ischiorectal abscess.  Please see respective operative notes for 
full details. Mr. ___ tolerated the procedure well and 
arrived the PACU with both incision areas packed with 
wicks/gauze and with foley catheter in place. He was continued 
on empiric vancomycin and meropenem and hydrated with 
intravenous fluids and pain control was with intravenous and 
oral medications. 

The remainder of his hospital course was unremarkable. He was 
followed by consult services and he was eventually converted 
back to intravenous cefepime and metronidazole therapy was 
initiated. Once he could tolerate daily dressing/wick changes 
with oral pain medications, he was discharged home with home 
infusion services and ___ for wound care. Explicit instructions 
were provided. His Foley catheter was removed prior to discharge 
and given his incontinence, condom catheter was placed to reduce 
risk of wound contamination with urine. He was discharged in 
stable condition, tolerating dressing changes with oral 
antibiotics and with a three week course of intravenous CEFEPIME 
with PO METRONIDAZOLE. He was given explicit instructions for 
follow up with hematology, infectious disease and urology. All 
of his questions were answered. 

 
Medications on Admission:
Aspirin 81 mg PO DAILY  This medication was stopped. Please 
discuss with Dr. ___ when to restart but hold for at least 
one week after surgery. 

Acetaminophen 1000 mg PO Q6H:PRN pain, fever
Amoxicillin-Clavulanic Acid ___ mg PO Q12H  This is a new 
medication to treat your infection 
CefePIME 2 g IV Q12H RX *cefepime [Maxipime]  2 gram  2 GM IV  
Q12hrs Disp #*42  Vial Refills:*0 This is a new medication to 
treat your infection.  
Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace]  100 mg  ONE capsule(s) by mouth  
twice a day Disp #*60  Capsule Refills:*0 This is a new 
medication  
Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush 
RX *heparin lock flush (porcine) [heparin lock flush]  10 
unit/mL  2 mL IV  DAILY & PRN, line flush Disp #*5  Vial 
Refills:*0 This is a new medication to treat your PICC line 
OxycoDONE (Immediate Release) ___ mg PO Q3H:PRN pain 
RX *oxycodone  5 mg  ___ tablet(s) by mouth  Q4hrs Disp #*40  
Tablet Refills:*0 This is a new medication to treat your  
Sarna Lotion 1 Appl TP QID:PRN pruritis  This is a new 
medication  
Senna 8.6 mg PO BID:PRN constipation  This is a new medication 
to treat your constipation 
Sodium Chloride 0.9% Flush 10 mL IV DAILY and PRN, line flush 
RX *sodium chloride 0.9 % [Normal Saline Flush]  0.9 %  10 mL IV 
 Daily & PRN PICC LINE USE Disp #*60  Syringe Refills:*0 This is 
a new medication to treat your IV line 
CHANGED Medications/Orders Physician ___ 
___ 1000 mg PO SUN, TUES, THURS, SAT DO NOT RESUME 
without explicit instructions from Dr. ___.  You were taking 
this medication at home but it has been HELD per hematology. 
Hydroxyurea 1500 mg PO ___, ___, ___ DO NOT RESUME 
with explicit instructions from Dr. ___.  You were taking 
this medication at home but it has been HELD per hematology.  
UNCHANGED Medications/Orders Physician ___ 
___ ___ PUFF IH Q4H:PRN SOB, wheezing  You were 
taking this medication at home and you should continue it at the 
same dose (how much) and frequency (how often).  
Citalopram 40 mg PO DAILY  You were taking this medication at 
home and you should continue it at the same dose (how much) and 
frequency (how often).  
Polyethylene Glycol 17 g PO DAILY:PRN Severe constipation  You 
were taking this medication at home and you should continue it 
at the same dose (how much) and frequency (how often) 
 
Discharge Medications:
1. Acetaminophen 1000 mg PO Q6H:PRN fever, pain 
2. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB 
3. Citalopram 40 mg PO DAILY 
4. Docusate Sodium 100 mg PO BID 
5. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush 

6. Senna 8.6 mg PO DAILY 
7. Sodium Chloride 0.9%  Flush 10 mL IV DAILY and PRN, line 
flush 
for PICC line flushing 
8. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
RX *oxycodone 5 mg ___ tablet(s) by mouth Q4hrs Disp #*40 Tablet 
Refills:*0
9. CefePIME 2 g IV Q12H 
RX *cefepime [Maxipime] 2 gram 2 grams IV Q12hrs Disp #*42 Vial 
Refills:*0
10. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H 
RX *metronidazole 500 mg ONE tablet(s) by mouth Q8hrs Disp #*63 
Tablet Refills:*0
11. Outpatient Lab Work
ALL LAB RESULTS SHOULD BE SENT TO:
ATTN: ___ CLINIC - FAX: ___

CEFEPIME, METRONIDAZOLE: CBC with differential, BUN, Cr, AST, 
ALT, TB, ALK PHOS

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Scrotal and perirectal fluid collections, penoscrotal infection

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
TAKE YOUR ANTIBIOTICS AS DIRECTED!!! DO NOT MISS DOSES.
-Follow up with ID and HEMATOLOGY as directed and scheduled. 

-Take the pain pills as directed about 30minutes before you 
anticipate the ___ dressing/wick changes. 

-You may shower before the dressing changes so that the ""soiled"" 
wicks/dressings can be removed and replaced.

-It is VERY IMPORTANT that you return to ___ clinic or ED 
if fevers return, swelling/pain/erythema worsens or if you 
develop purulent (pus) drainage. 

-ALWAYS call to inform, review and discuss any medication 
changes and your post-operative course with your primary care 
doctor.

-___ keep your phallus/scrotum elevated to facilitate edema 
resolution. 

-Note that as the swelling/edema of your phallus and scrotum 
resolves, the skin may start to ""flake"" off and/or peel; this is 
a normal ""healing"" process. 

-Shower once to twice per day to keep genitals clean, dry. Avoid 
wound contamination with urine.

-Wear comfortable, loose fitting briefs or boxer-briefs for 
support--they should be cotton and/or breathable

-You may shower, but do NOT bathe, swim or otherwise immerse 
your incision.

-Do not lift anything heavier than a phone book and avoid 
sports, vigorous physical activity (including sexual) and do not 
drive. Avoid stools/hard chairs and bicycles.

-DO NOT RIDE BIKES OF ANY SORT FOR AT LEAST 6 MONTHS OR UNTIL 
CLEARED BY FOLLOWUP BY ___ ___!

-Tylenol should be your first line pain medication, a narcotic 
pain medication has been prescribed for breakthough pain >4. 
Replace Tylenol with narcotic pain medication. Max daily Tylenol 
dose is 4gm, note that narcotic pain medication also contains 
Tylenol (acetaminophen)

-Do not drive or drink alcohol while taking narcotics and do not 
operate dangerous machinery

-Colace has been prescribed to avoid post surgical constipation 
and constipation related to narcotic pain medication, 
discontinue if loose stool or diarrhea develops. Colace is a 
stool ""softener""- it is NOT a laxative. Senokot is a gentle 
laxative that may be used to facilitate smooth bowel movements.

-Resume all of your home medications, except as noted.

-If you have fevers > 101.5 F, vomiting, or increased redness, 
swelling, or discharge from your incision, call your doctor or 
go to the nearest emergency room.
 
Followup Instructions:
___
"
87,15109929,22911335," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Groin pain
 
Major Surgical or Invasive Procedure:
___ placement ___

 
History of Present Illness:
Mr. ___ is a ___ gentleman with a history of JAK2 
positive essential thrombocythemia and prostate cancer s/p 
radical prostatectomy in ___ c/b erectile dysfunction. He 
underwent penile prosthesis in ___ and has had a complicated 
course with multiple prosthesis infections. He presents with 
worsening R groin/perineal pain and leukocytosis.  

Patient's penile implant was originally placed in ___ for 
erectile dysfunction. In ___, patient developed 
infection that did not improve with PO Augmentin. He was 
admitted on ___ with worsening penile and scrotal swelling 
concerning for infected device, and he underwent wash-out and 
replacement of prosthesis on ___. Surgical culture grew 
pseudomonas. He remained febrile post op and his pre-op 
antibiotic regimen was changed from vancomycin-gentamycin to 
vancomycin and cefepime. He subsquently had the prosthesis fully 
removed on ___ and defervesced. His antibiotic regimen was 
narrowed to cefepime. PICC line was placed, and he was 
discharged with plans for ___ week course IV Cefepime. 
 
On ___, patient represented to the ED with ___ days groin and 
testicular pain. CT showed gas formation in peineal area. He was 
taken emergently to the OR on ___ for exploration of perineum 
with no evidence of active infection intraoperatively. He was 
initially covered with vancomycin and meropenem, then was 
transitioned back to cefepime with addition of metronidazole for 
anaerobic coverage on ___. Planned for ___ week course.  

On ___, patient was transitioned to PO cipro/flagyl. PICC 
was pulled. Antibiotics were stopped on ___ in the setting of 
possible antibiotic-associated diarrhea and improvement in exam. 
Diarrhea resolved.  

Over the past week, patient has had worsening R groin and 
perineal pain. He has needed to take oxycodone at night due to 
pain after weaning himself off one week prior. Pain worse 
movement, making walking difficult. Minimal increase in scrotal 
erythema. 2x packing areas changed daily, no issues with that. 
Endorses increased fatigue, denies fevers/chills, N/V/D. Saw PMD 
earlier this week, had CBC which showed WBC 20k. Of note, pt 
recently decreased hyydroxyurea for polycythemia.  

In the ED initial vitals were: 4 98.7 66 113/74 18 100% RA. Labs 
were significant for WBC 19 (86N, 0 band, 8L), H/H 13.9/39.1, 
plt 767. Cr 0.7. UA 23 WBC (chronic condom cath). CT Pel showed 
subcutaneous stranding and skin thickening in perineum and 
inferior medial gluteal regions and scrotum. Small collection of 
sub-q gas in L medal gluteal region substantially decreased from 
previous exam, may reflect packing material. No fluid 
collections.  
Urology was consulted, who did not feel there was an operative 
issue. Advised gen surg consult (they were involved in prior 
debridement), IV antibiotics, ID consult. General surgery agreed 
there was no indication for further I &D. Patient was given 
oxycodone, docusate, metronidazole, cefepime. Vitals prior to 
transfer were: 2 98.3 57 127/69 16 99% RA.  

On the floor, patient reports ongoing perineal pain R > L and 
posterior scrotal pain.
 
Past Medical History:
Insertion Penile prosthesis, ___
Removal and replacment of infected penile prosthesis ___
Explant of replacement prosthesis ___

JAK2 positive Essential Thrombocythemia, followed by Dr ___ at ___
Essential thrombocytosis. 
Exercise-induced asthma 
Radiation therapy for acne in his youth resulting in 
hypothyroidism.
Hydrocele repair by Dr. ___ in early ___.  
Cholecystectomy.
Inguinal hernia repair.

 
Social History:
___
Family History:
His father had prostate cancer and lived well into his ___.

 
Physical Exam:
ADMISSION EXAM:
97.8 133/78 61 18 98RA UOP 900 o/n
GENERAL: Well-appearing, NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
GU: Tender inguinal LAD bilaterally. Packing in place, no 
significant erythema surrounding wounds, no drainage, R perineal 
region and upper thigh TTP with very mild erythema but no 
collections, fluctuance, drainage. Posterior scrotum TTP L < R 
without palpable testicular masses, condom cath in place  
Rectal: Thrombosed external hemorrhoid at 6 o'clock  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose. Prior ___ site in RUE has 0.5 cm 
nodule with mild erythema at insertion site but appears to be 
healing well, no tenderness, phlebitis.  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

DISCHARGE EXAM:
97.5 97.9 135/75 77 18 98RA
GENERAL: Well-appearing, NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
GU: Packing in place, no significant erythema surrounding 
wounds, no drainage, R perineal region and upper thigh TTP with 
very mild erythema but no collections, fluctuance, drainage. 
Posterior scrotum TTP L < R without palpable testicular masses, 
condom cath in place  
Rectal: Thrombosed external hemorrhoid at 6 o'clock  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose. Prior ___ site in RUE has 0.5 cm 
nodule with mild erythema at insertion site but appears to be 
healing well, no tenderness, phlebitis.  
Negative ipsilateral/contralateral straight leg raise
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

 
Pertinent Results:
LABORATORY DATA:

___ 05:30PM BLOOD WBC-19.0*# RBC-4.00*# Hgb-13.9*# 
Hct-39.1*# MCV-98# MCH-34.6* MCHC-35.7* RDW-15.2 Plt ___
___ 06:02AM BLOOD WBC-14.6* RBC-3.94* Hgb-12.9* Hct-38.0* 
MCV-97 MCH-32.8* MCHC-34.0 RDW-15.9* Plt ___
___ 05:30PM BLOOD Neuts-86* Bands-0 Lymphs-8* Monos-4 Eos-2 
Baso-0 ___ Myelos-0
___ 05:30PM BLOOD Glucose-120* UreaN-18 Creat-0.7 Na-135 
K-4.7 Cl-98 HCO3-27 AnGap-15
___ 06:02AM BLOOD Glucose-94 UreaN-13 Creat-0.6 Na-138 
K-4.8 Cl-101 HCO3-28 AnGap-14
___ 06:15AM BLOOD Calcium-9.2 Phos-3.6 Mg-2.1
___ 06:27AM BLOOD CRP-50.4*
___ 06:02AM BLOOD Vanco-12.3
___ 05:40PM BLOOD Lactate-1.2

___ 06:27
SED RATE
Test Name                   In Range   Out of Range        
Reference Range
---------                   --------   ------------        
--------------Sed Rate by Modified
  ___                               23  H           < or 
= 20 mm/h
 

IMAGING:  
___  
CT Abd/Pel w Contrast  
1. Subcutaneous stranding and skin thickening involving the 
perineum and inferior medial gluteal regions as well as scrotum. 
Small collection of subcutaneous gas in the left medial gluteal 
region is substantially decreased from the previous exam, and 
may reflect packing material. No fluid collections.  
2. Bilateral hydroceles are improved.  
3. Reactive right inguinal lymphadenopathy.  

___
MRI pelvis w and wo contrast:
1. Edema and enhancement throughout the right adductor 
musculature and right aspect of the pelvic floor/perineum, may 
reflect a nonspecific myositis and may be 
infectious/inflammatory in nature although recent trauma could 
result in a similar imaging appearance; clinical correlation is 
recommended. Although adjacent edema within the right inferior 
pubic ramus potentially could be due to osteomyelitis, the 
absence of associated cortical erosion argues against this.  The 
changes are asymmetric and likely somewhat remote from a 
radiation field. 
2. Moderate subcutaneous edema along the right inguinal region, 
extending along the anteroinferior aspect of the pelvis, 
nonspecific in nature. Clinical correlation with evidence of 
cellulitis is recommended. 
3. Unchanged right inguinal lymphadenopathy, presumably 
reactive. 

___ 
L spine pelvis w and wo contrast:
1. No evidence of osteomyelitis or epidural abscess within the 
lumbar spine. 
2. Multilevel multifactorial degenerative changes throughout the 
lumbar spine, as described above. 

___
CT pelvis w/o contrast:
1. Indistinctness of the inferomedial cortex along the anterior 
aspect of the right inferior pubic ramus, corresponding to the 
area of marrow edema on the recent pelvis MRI, indeterminate in 
nature.  The possibly of osteomyelitis cannot be conclusively 
excluded.  No fracture line identified. 
2. Circumferential bladder wall thickening may be related to 
bladder's decompressed state; clinical correlation is 
recommended to exclude cystitis. 
3. Right inguinal lymphadenopathy, similar to the prior MRI from 
___. 

___
CXR line placement:
New left-sided PICC line ends in the low SVC. 

 
Brief Hospital Course:
Mr. ___ is a ___ gentleman with a history of prostate 
cancer JAK2 positive essential thrombocythemia and prostate 
cancer s/p radical prostatectomy in ___ c/b erectile 
dysfunction. He underwent penile prosthesis in ___ and has had 
a complicated course with multiple prosthesis infections. He 
presents with worsening R groin/perineal pain and leukocytosis 
in the setting of recent antibiotic cessation.

# Osteomyelitis / groin soft tissue infection:
He had perineal pain and leukocytosis concerning for recurrent 
infection in the setting of multiple previous infections after 
radical prostatectomy and penile implant. No abscess or fluid 
collection seen on CT. He was evaluated by urology and general 
surgery who determined no acute surgical intervention was 
needed. He was followed by wound care for management of his 
surgical dressings. MRI and CT showed concern for osteomyeltis 
of the pubic ramus vs small fracture. A bone biopsy was 
considered but deferred given the technical difficulty of the 
procedure and risk for complications. He had PICC placement with 
plan for vancomycin/cefepime/Flagyl for a total 6 week course 
for presumptive osteomyelitis.

CHRONIC ISSUES:
# Essential Thrombocytosis: 
His platelet count was near baseline. There was suspicion for 
additional marrow dysplasia given increase in all 3 hematogenous 
cell lines during admission. He was titrated back to his 
previous home dose of 1000 mg hydroxyurea alternating with 
1500mg daily per ___ hematology recommendations.

# Thrombosed External Hemorrhoid:
Previously on steroid creams. He was given Hydrocortisone 
(Rectal) BID during admission.

# Depression: Continued citalopram  

# Constipation: Received Senna / Colace as needed.

TRANSITION ISSUES:
- His hydroxyurea for essential thrombocytosis was restored to 
daily alternating doses of 1gm / 1.5 gm.
- He will need to complete a 6 week course of 
vancomycin/cefepime/flagyl for presumptive osteomyelitis (last 
day of therapy ___.

## Additional Transitional Issues per Previous Urology Notes:
- Pelvic floor ___ to address incontinence  
- When scrotal incision closed, d/c condom cath  
- Consider re-implant of prosthesis after 6 months and urinary 
issues resolved
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Citalopram 40 mg PO DAILY 
2. Senna 8.6 mg PO DAILY 
3. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
4. Aspirin 81 mg PO DAILY 
5. Hydroxyurea 500 mg PO DAILY 
6. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1. Aspirin 81 mg PO DAILY 
2. Citalopram 40 mg PO DAILY 
3. Hydroxyurea 0 mg PO DAILY 
Take 1000mg alternating with 1500mg every other day 
RX *hydroxyurea 500 mg as directed capsule(s) by mouth Once a 
day Disp #*45 Capsule Refills:*0
4. Multivitamins 1 TAB PO DAILY 
5. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
6. Senna 8.6 mg PO DAILY 
7. CefePIME 2 g IV Q12H 
RX *cefepime [Maxipime] 2 gram 2 grams IV Every 12 hours Disp 
#*81 Vial Refills:*0
8. Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth Twice 
a day Disp #*60 Capsule Refills:*0
9. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H 
RX *metronidazole 500 mg 1 tablet(s) by mouth Every 8 hours Disp 
#*123 Tablet Refills:*0
10. Outpatient Lab Work
Please check weekly starting ___: CBC with differential, BUN, 
Cr, ESR, CRP, Vancomycin trough (730.00)
ALL LAB RESULTS SHOULD BE SENT TO:
ATTN: ___ CLINIC - FAX: ___
11. Vancomycin 1250 mg IV Q 12H 
RX *vancomycin 500 mg 2.5 vials IV Every 12 hours Disp #*205 
Vial Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
Likely osteomyelitis

SECONDARY DIAGNOSIS:
Essential thrombocytosis
Thrombosed external hemorrhoid

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure being part of your care at ___. You were 
admitted to the hospital due to groin pain. You were found to 
have elevated white blood cell count concerning for an 
infection, given your history of multiple groin infections after 
your surgery. You had scans (MRI and CT) of the affected area 
which were concerning for possible infection of the bone and 
soft tissues. You were treated with antibiotics with some 
subsequent improvement in your pain.

After discharge, please continue to take your IV antibiotics as 
instructed.
 
Followup Instructions:
___
"
88,15109929,20058401," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
R Hip Pain, Groin Pain  

 
Major Surgical or Invasive Procedure:
___ CT guided biopsy of pubic ramus by ___

 
History of Present Illness:
___ h/o prostate cancer and recent antibiotic prolonged 
antibiotic course for pubic ramus osteomyelitis presenting with 
progressive right groin pain. Pt has h/o prostatectomy c/b 
erectile dysfunction for which he underwent penile prosthesis 
implant and subsequent removal due to pseudomonal infection 
pubic ramus osteomyelitis. Pt completed an 8 week course of 
vanc/cefepime/metronidazole, finishing ___. Since completion 
of antibiotics, pt has noted progressive right groin pain which 
worsened acutely over the last few days. He also notes left 
groin pain for the last week. Pain is exacerbated by ambulation 
and movement of the hip joint. He has been unable to walk due to 
pain since shoveling snow yesterday afternoon. He denies any 
recent trauma, fevers, chills or nightsweats. No dysuria, 
urinary frequency or skin redness or drainage. Patient initially 
presented to ___ but was transferred to ___ for continuity of 
care.  
Vitals in the ED: 98.1 66 121/65 16 96% RA  
Exam was notable for tenderness in groin but normal scrotal skin 
exam, +external hemorrhoids on rectal exam wiht guaiac negative 
stool. Labs notable for: HGB 8.5, MCV 111, normal UA, CHEM 7, 
CBC  
Patient given: morphine sulfate 2mg IV x2, 1g acetaminophen, 
oxycodone 5mg x1. Vitals prior to transfer: 98.1 72 129/68 17 
99% RA.  
On the floor, pt reports ___ right groin discomfort while 
laying still in bed.  
Review of Systems:  
(+) per HPI  
(-) shortness of breath, chest pain, abdominal pain, nausea, 
vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, 
dysuria, hematuria.  
 
Past Medical History:
-Insertion Penile prosthesis, ___  
-Removal and replacment of infected penile prosthesis ___  

-Explant of replacement prosthesis ___  
-JAK2 positive Essential Thrombocythemia, followed by Dr ___  
-___ at ___ has taken hydrea for ~ ___ years, briefly 
discontinued in the fall due to anemia and resumed ___ on 
1500mg daily  
-Exercise-induced asthma  
-Radiation therapy for acne in his youth resulting in  
hypothyroidism.  
-Hydrocele repair by Dr. ___ in early ___.  
-Cholecystectomy.  
-Inguinal hernia repair.  
 
Social History:
___
Family History:
His father had prostate cancer and lived well into his ___.

 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
Vitals - T:99 119/63 HR 69 RR 16 99% RA  
GENERAL: WDWB male sitting up in bed, NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
dry MM  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, +pain with external 
rotation, abduction and flexion of R hip  
GU: no penile or scrotal erythema, no groin or hip erythma, 
effusion or tenderness to palpation  
PULSES: 2+ DP pulses bilaterally  
NEURO: awake and alert  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

DISCHARGE PHYSICAL EXAM:
Vitals - T 97.9 BP 115/59 HR 60 RR 18 97% RA  
GENERAL: sitting up in bed comfortably, NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
dry MM  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, +pain with external 
rotation, abduction and flexion of R hip  
GU: no penile or scrotal erythema, no groin or hip erythma, 
effusion or tenderness to palpation  
PULSES: 2+ DP pulses bilaterally  
NEURO: awake and alert  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  
 
Pertinent Results:
ADMISSION PHYSICAL EXAM:
___ 10:30PM BLOOD WBC-4.1# RBC-2.16*# Hgb-8.5*# Hct-24.0*# 
MCV-111*# MCH-39.3*# MCHC-35.5* RDW-20.3* Plt ___
___ 10:30PM BLOOD Neuts-68.2 ___ Monos-7.9 Eos-0.6 
Baso-0.3
___ 10:30PM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-1+ 
Macrocy-2+ Microcy-1+ Polychr-OCCASIONAL Ovalocy-1+ 
Schisto-OCCASIONAL Tear Dr-1+
___ 12:26AM BLOOD ___ PTT-27.8 ___
___ 10:30PM BLOOD Glucose-119* UreaN-19 Creat-0.7 Na-138 
K-4.1 Cl-103 HCO3-25 AnGap-14
___ 10:30PM BLOOD LD(LDH)-211 TotBili-1.0
___ 07:10AM BLOOD Calcium-9.1 Phos-3.4 Mg-2.0

PERTINENT RESULTS:
___ 06:10AM BLOOD Iron-35*
___ 06:10AM BLOOD calTIBC-196* VitB12-478 Folate-19.4 
Ferritn-439* TRF-151*
___ 07:10AM BLOOD CRP-81.7*
___ 10:30PM BLOOD Hapto-132
___ 05:19AM BLOOD Vanco-11.8
___ 10:38PM BLOOD Lactate-1.1
___ 07:10AM BLOOD SED RATE-Test   96  H       

DISCHARGE LABS:
___ 05:18AM BLOOD WBC-4.9 RBC-2.09* Hgb-8.0* Hct-23.5* 
MCV-113* MCH-38.4* MCHC-34.2 RDW-19.6* Plt ___
___ 06:15AM BLOOD Glucose-92 UreaN-14 Creat-0.7 Na-139 
K-5.1 Cl-103 HCO3-28 AnGap-13
___ 06:55AM BLOOD Calcium-8.7 Phos-3.3 Mg-2.2

MICRO:
___ 10:50PM URINE Color-Yellow Appear-Clear Sp ___
___ 10:50PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-NEG
___ BLOOD CULTURE: NEGATIVE

___ 9:00 am TISSUE      PUBIC BONE. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      2+   ___ per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 

   TISSUE (Final ___: 
      Reported to and read back by  ___ ___ 
___ 2:20AM. 
      PSEUDOMONAS AERUGINOSA. 
         Isolated from broth media only, INDICATING VERY LOW 
NUMBERS OF
         ORGANISMS. 
         SENSITIVITIES PERFORMED ON CULTURE # ___ ___. 


   ANAEROBIC CULTURE (Final ___:    NO ANAEROBES ISOLATED. 


___ 9:00 am JOINT FLUID      PUBIC SYMPHYSIS JOINT FLUID. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      3+  ___ per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 
      SMEAR REVIEWED; RESULTS CONFIRMED. 

   FLUID CULTURE (Final ___: 
      Reported to and read back by ___ ___ 
___ 2:20PM. 
      PSEUDOMONAS AERUGINOSA.    MODERATE GROWTH. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             PSEUDOMONAS AERUGINOSA
                             |   
CEFEPIME--------------     2 S
CEFTAZIDIME-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------     2 S
MEROPENEM-------------     1 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S

___ 9:00 am BONE MARROW      BONE MARROW. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___:    NO MICROORGANISMS SEEN. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

IMAGING:  
___ MRI Prostate:  
There is persistent edema and enhancement throughout the 
inferomedial right pubic ramus and surrounding adductor 
musculature, which is slightly improved from ___. The 
absence of cortical destruction limits the conclusion of 
osteomyelitis, however, this cannot be excluded. No abscess.  

___ CT Abd & Pelvis With Contrast: 
1. No retroperitoneal hematoma. 
2. Increased sclerosis of the inferior right pubic ramus 
reflects the underlying chronic inflammatory process. No 
definite evidence for acute osteomyelitis. For additional 
details, please see the recent prostate MRI. 
3. Unchanged, mild splenomegaly. 
 
 
Brief Hospital Course:
___ with h/o prostate cancer, penile prosthesis c/b infection 
and pubic ramus osteomyelitis s/p prolonged antibiotic course 
presenting with progressive right hip pain since discontinuation 
of antibiotics.  

# Osteomyelitis / groin soft tissue infection: Pt with worsening 
pain and rising inflammatory markers (CRP 11.6 to 81 in last 10 
days) since discontinuing vanc/cefepime/metronidazole, 
suggesting antibiotic failure. No abscess on imaging. Ortho 
initially consulted but would defer open biopsy but do not see 
any need for debridement based on scans and defered to ___. S/P 
CT guided ___ biopsy of pubic ramus bone and surrounding tissue 
on ___. Culture growing pseudomonas sensitive to cefepime. Per 
ID recs will start vancomycin, cefepime, flagyl for at least 6 
weeks and they will decide final course as outpatient. Will 
likely narrow treatment once culture final. An appointment was 
made for the pt to see urologist to monitor site of surgical 
prosthesis removal and assess for any nidus of recurrent 
infection.
 
# Anemia: Hct drop 29.3-> 24 since outpatient labs drawn ___. 
Anemia with macrocytosis may represent side effect of 
hydroxyurea. No evidence of bleeding on prelim read of CT 
abd/pelvis, stool guaiac neg. Schistocytes on automated smear 
concerning for hemolysis. However, hapto, LDH, and Tbili 
negative for hemolysis. Retic index 1.9%. H/H was elevated in 
___ but currently similar to ___ and prior H/H. ___ 
heme/onc followed the patient and we were in touch with 
outpatient ___ hematologist. Held hydrea given anemia due to 
infection. Will consider restarting as outpatient. Will have 
weekly labs sent to ___ clinic which will be entered in OMR and 
hematologist will follow them up.  s/p transfusion ___ for HCT 
21 and given patient will be discharged with H/H unlikely to 
improve for quite some time due to sepsis and recent hydrea

# Depression: continued home citalopram

# Code: confirmed full  
# Emergency Contact:  
Name of health care proxy: ___ (significant other, HCP) 
 
Phone number: ___ /Cell phone: ___  
___ (son, alternate HCP) ___

**TRANSITIONAL ISSUES**
- Discharged on vancomycin 1G q12h IV, cefepime 2G q12h IV,
metronidazole 500mg q8h PO until ___ or to be determined by 
ID outpatient
- Labs: needs WEEKLY: CBC with differential, BUN, Cr, Vancomycin 
trough, ESR/CRP
ALL LAB RESULTS SHOULD BE SENT TO:
ATTN: ___ CLINIC - FAX: ___
- You should touch base with Dr. ___ day after your lab 
draw. Please call him if you do not hear from his office
- Hydrea being held for anemia in the setting of infection. 
Received 1upRBC on ___
- Will follow up with urologist this week to have site of 
prosthesis removal evaluated to rule out persistent source of 
infection
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Citalopram 40 mg PO DAILY 
3. Hydroxyurea 1500 mg PO DAILY 
4. Multivitamins 1 TAB PO DAILY 
5. Docusate Sodium 100 mg PO BID 
6. Acidophilus (L.acidoph & ___ 
acidophilus) 175 mg oral daily 
7. FoLIC Acid ___ mcg PO DAILY 
8. lutein 10 mg oral daily 
9. Vitamin A 20,000 UNIT PO DAILY 
10. Zinc Sulfate 220 mg PO DAILY 
11. Calcium 600 (calcium carbonate) 600 mg (1,500 mg) oral daily 

12. Magnesium Oxide 400 mg PO DAILY 
13. Ascorbic Acid ___ mg PO DAILY 

 
Discharge Medications:
1. CefePIME 2 g IV Q12H 
RX *cefepime [Maxipime] 2 gram 2 grams IV twice a day Disp #*56 
Vial Refills:*0
2. Vancomycin 1000 mg IV Q 12H 
RX *vancomycin 1 gram 1 gram IV twice a day Disp #*56 Vial 
Refills:*0
3. Aspirin 81 mg PO DAILY 
4. Citalopram 40 mg PO DAILY 
5. Docusate Sodium 100 mg PO BID 
6. Multivitamins 1 TAB PO DAILY 
7. Acetaminophen 650 mg PO Q6H pain 
8. Lactulose 30 mL PO DAILY:PRN constipation 
RX *lactulose 10 gram/15 mL ___ ml by mouth daily prn 
constipation Refills:*0
9. Lidocaine 5% Patch 1 PTCH TD QAM:PRN pain 
RX *lidocaine 5 % (700 mg/patch) apply one patch to area of pain 
daily as needed for pain Disp #*14 Patch Refills:*0
10. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H 
RX *metronidazole 500 mg 1 tablet(s) by mouth Q8hr Disp #*42 
Tablet Refills:*0
11. Polyethylene Glycol 17 g PO DAILY 
while taking tramadol, hold for loose stool 
RX *polyethylene glycol 3350 17 gram 1 powder(s) by mouth daily 
Disp #*14 Packet Refills:*0
12. Senna 8.6 mg PO BID 
hold for loose stool 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp 
#*28 Tablet Refills:*0
13. Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line 
flush 
RX *sodium chloride 0.9 % [Normal Saline Flush] 0.9 % ___ ml 
IV daily and prn Disp #*14 Syringe Refills:*0
14. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain 
RX *tramadol 50 mg 1 tablet(s) by mouth Q4hr prn: pain Disp #*84 
Tablet Refills:*0
15. Acidophilus (L.acidoph & 
___ acidophilus) 175 mg oral 
daily 
16. Ascorbic Acid ___ mg PO DAILY 
17. Calcium 600 (calcium carbonate) 600 mg (1,500 mg) oral daily 

18. FoLIC Acid ___ mcg PO DAILY 
19. lutein 10 mg oral daily 
20. Magnesium Oxide 400 mg PO DAILY 
21. Vitamin A 20,000 UNIT PO DAILY 
22. Zinc Sulfate 220 mg PO DAILY 
23. Outpatient Lab Work
ICD-9 730 osteomyelitis
WEEKLY: CBC with differential, BUN, Cr, Vancomycin trough, 
ESR/CRP
ALL LAB RESULTS SHOULD BE SENT TO:
ATTN: ___ CLINIC - FAX: ___

24. Outpatient Physical Therapy
Rolling walker.  
Diagnosis: Instablility of gait, prognosis good, length of need 
13 months.

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Osteomyelitis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure to take care of you at ___. You were 
admitted with groin and thigh pain concerning for recurrence of 
an infection in your bone called osteomyelitis. You were seen by 
the infectious disease team who recommended a biopsy of the 
infected area. Interventional radiology performed a biopsy of 
the pubic ramus bone. The preliminary culture of the bone and 
surrounding area grew pseudomonas, which is the same bacteria as 
your last culture. You were started on 3 antibiotics and your 
course will be determined by your infectious disease providers 
as an outpatient. We made a follow up with urology this week to 
examine your prior surgery site in order to evaluate for a 
persistent source of this infection. You are being sent home 
with tramadol for your pain. While taking tramadol you should 
take colace, senna, and miralax every day to prevent 
constipation and lactulose as needed if you do become 
constipated. You can skip these medications on days that you 
have loose stool.

We wish you the best!

Sincerely,
Your ___ medical team 
 
Followup Instructions:
___
"
89,15109929,25060624," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Ventral hernia
 
Major Surgical or Invasive Procedure:
___: Incarcerated hernia repair with mesh component 
separation and Rives-Stoppa repair

 
History of Present Illness:
___ is a very pleasant gentleman with symptomatic 
supraumbilical ventral hernia with diastasis. Consent was 
reviewed and signed for open repair with component separation.

 
Past Medical History:
thrombocytopenia, goiter, diverticulosis, prostate cancer, 
macular degeneration

PSHx: inguinal hernia repair L, R hydrocele removal, open R 
ankle repair

 
Social History:
___
Family History:
His father had prostate cancer and lived well into his ___.

 
Physical Exam:
Admission Physical Exam 
=======================
Post-op Check 
PE:
___ 1541 Temp: 98.3 PO BP: 130/52 L Lying HR: 68 RR: 16 O2
sat: 91% O2 delivery: RA 
GEN: NAD, A&Ox3 
CV: Regular rate
PULM: Breathing comfortably on RA
ABD: soft, non-tender, non-distended, surgical dressings intact
without strikethrough bleeding, drain functioning appropriately.
EXTR:  WWP 

Discharge Physical Exam 
=======================
___ 0728 Temp: 97.9 PO BP: 145/84 HR: 62 RR: 16 O2 sat: 99%
O2 delivery: Ra 
Physical exam:
Gen: NAD, AxOx3
Card: RRR, no m/r/g
Pulm: CTAB, no respiratory distress
Abd: Soft, non-tender, non-distended, normal bs.  
Wounds: Incision site c/d/I with no clinical signs of infection,
abdominal binder in place, JP drain with serosang
output
Ext: No edema, warm well-perfused
 
Pertinent Results:
___ 06:35AM BLOOD WBC-8.7 RBC-2.84* Hgb-11.3* Hct-33.5* 
MCV-118* MCH-39.8* MCHC-33.7 RDW-15.9* RDWSD-66.9* Plt ___ 
Glucose-87 UreaN-13 Creat-0.8 Na-143 K-4.9 Cl-101 HCO3-28 
AnGap-14 Calcium-8.9 Phos-3.1 Mg-2.3
 
Brief Hospital Course:
Mr. ___ presented pre-operatively with a symptomatic 
supraumbilical ventral hernia with diastasis. Consent was 
reviewed and signed for open repair with component
separation.  The patient underwent a ventral herniorraphy with 
mesh and component separation. There were no adverse events in 
the operating room; please see the operative note for details.  
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 
Neuro: The patient was alert and oriented throughout 
hospitalization; patient was transitioned to oral pain 
medications once tolerating a diet. 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: Diet was advanced sequentially to a Regular diet, 
which was well tolerated. Patient's intake and output were 
closely monitored.   Patient was voiding autonomously prior to 
discharge.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.
At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable.  The patient was tolerating a diet, 
ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 
2. Hydroxyurea 1000 mg PO DAILY 
3. Multivitamins 1 TAB PO DAILY 
4. lutein 6 mg oral DAILY 
5. Calcium Citrate + D (calcium citrate-vitamin D3) 000 mg oral 
ASDIR 
6. magnesium 400 mg oral DAILY 
7. zinc 50 mg oral DAILY 
8. Aspirin 81 mg PO DAILY 
9. albuterol sulfate 90 mcg/actuation inhalation ASDIR 
10. Citalopram 40 mg PO DAILY 
11. vitamin A 8,000 unit oral DAILY 
12. FoLIC Acid 0.4 mg PO DAILY 
13. Vitamin B Complex 1 CAP PO DAILY 
14. Ascorbic Acid ___ mg PO DAILY 

 
Discharge Medications:
1.  Cephalexin 500 mg PO Q12H JP drain, prophylaxis 
RX *cephalexin 500 mg 1 tablet(s) by mouth twice a day Disp #*14 
Tablet Refills:*0 
2.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*6 Capsule Refills:*0 
3.  Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp 
#*6 Tablet Refills:*0 
4.  TraMADol 50 mg PO Q4H:PRN Pain - Moderate 
  Reason for PRN duplicate override: Alternating agents for 
similar severity
RX *tramadol 50 mg 1 tablet(s) by mouth Q4-6H Disp #*18 Tablet 
Refills:*0 
5.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  
6.  albuterol sulfate 90 mcg/actuation inhalation ASDIR  
7.  Ascorbic Acid ___ mg PO DAILY  
8.  Aspirin 81 mg PO DAILY  
9.  Calcium Citrate + D (calcium citrate-vitamin D3) 000 mg oral 
ASDIR  
10.  Citalopram 40 mg PO DAILY  
11.  FoLIC Acid 0.4 mg PO DAILY  
12.  Hydroxyurea 1000 mg PO DAILY  
13.  lutein 6 mg oral DAILY  
14.  magnesium 400 mg oral DAILY  
15.  Multivitamins 1 TAB PO DAILY  
16.  vitamin A 8,000 unit oral DAILY  
17.  Vitamin B Complex 1 CAP PO DAILY  
18.  zinc 50 mg oral DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Incarcerated ventral hernia with severe diastasis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

You have undergone repair of your abdominal wall hernia, 
recovered in the hospital and are now preparing for discharge to 
home with the following instructions:

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

Avoid driving or operating heavy machinery while taking pain 
medications.

Incision Care:
*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap 
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up 
appointment.
*If you have steri-strips, they will fall off on their own. 
Please remove any remaining strips ___ days after surgery.

JP Drain Care:
*Please look at the site every day for signs of infection 
(increased redness or pain, swelling, odor, yellow or bloody 
discharge, warm to touch, fever).
*Maintain suction of the bulb.
*Note color, consistency, and amount of fluid in the drain. Call 
the doctor, ___, or ___ nurse if the amount 
increases significantly or changes in character.
*Be sure to empty the drain frequently. Record the output, if 
instructed to do so.
*You may shower; wash the area gently with warm, soapy water.
*Keep the insertion site clean and dry otherwise.
*Avoid swimming, baths, hot tubs; do not submerge yourself in 
water.

 
Followup Instructions:
___
"
90,15203294,21783644," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Abdominal pain, nausea, vomiting
 
Major Surgical or Invasive Procedure:
None.

 
History of Present Illness:
___ yo M with PMH of CAD s/p 4V CABG and asthma and admission in 
___ at ___ for colitis who presents with epigastric pain, 
nausea, and vomiting.  
Patient reports 4 weeks of epigastric pain worsened by PO 
intake. Patient has been taking omeprazole 40 mg BID with 
limited relief. Nausea and vomiting after PO intake for the last 
several days and patient reports feeling orthostatic from his GI 
losses and decreased PO intake. Because of these symptoms, he 
presented to ED today.  
Of note during his ___ hospitalization, he had EGD and ___ 
that only showed gastritis. Though he is not aware of any 
previous H. Pylori testing and he has not taken triple therapy 
before.  
Pt has RUE pain that is burning. Has had it since his suicide 
attempt in ___ when he laid on that arm for hours when he was 
done. Has had mild contractions in his fingers since then. He 
wants to try to get off the Vicodin as he does cause him 
constipation. He says he has asked about Gabapentin in the past 
but has never tried it.  

In the ED, initial vital signs were 97.2, 68, 139/99, 18, 97% 
RA. Labs were remarkable for WBC 11.2. EKG with new T wave 
inversion isolated in V2. Trop <0.01. CXR and CT abdomen without 
any acute findings. Patient was given GI cocktail, Zofran, 
morphine, and 2 L IVF without improvement in his symptoms. He 
was given albuterol and ipratropium nebs for wheezing. Because 
of lack of improvement and inability to tolerate PO intake, 
patient was admitted to Medicine for further management.  

 
Past Medical History:
BENIGN POSITIONAL VERTIGO  
CORONARY ARTERY DISEASE s/p CABGx4 ___  
DEPRESSION  
GRAVES' DISEASE  
HYPERLIPIDEMIA  
HYPERTENSION  
MYOCARDIAL INFARCTION  
injury to right brachial plexus in ___, with residual 
paralysis of right upper limb  
Osteoarthritis  
Asthma  
Cluster headaches  
Prior Etoh usage  
S/P RIGHT HIP ARTHROPLASTY  
ASTHMA   
GLAUCOMA  
PROSTHESIS SHOULDER AND HIP  
PSORIASIS  
SHOULDER IMPINGEMENT SYNDROME RIGHT  
THYROTOXICOSIS-AF  

 
Social History:
___
Family History:
Premature cardiac disease in father, mother, and brother  
Father: PUD  

 
Physical Exam:
ON ADMISSION
Vitals: 98.0 120/66 59 18 93%RA  
General: alert and awake, in no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: Supple, JVP not elevated, no LAD  
Lungs: CTAB, no wheezes/rales/rhonchi  
CV: RRR, normal S1/S2, no MRG  
Abdomen: soft, non-distended, moderate tenderness to palpation 
isolated in the RUQ, no rebound or guarding. no 
hepatosplenomegaly  
GU: No Foley  
Ext: Warm, well-perfused, no cyanosis/clubbing/edema, 2+ DP 
pulses. Right upper arm with mild contraction of ___ digits. 
 
Neuro: AAOx3, CN II-XII grossly intact, gait normal  

ON DISCHARGE
Vitals- Tc 97.5, Tm 98.3, (92-135)/(50-73), 45-59, ___, 93-94% 
RA  
General- Alert, oriented, no acute distress  
HEENT- Sclerae anicteric, MMM, oropharynx clear  
Neck- supple, JVP not elevated
Lungs- Diffuse expiratory wheezes bilaterally, no rales or 
rhonchi
CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen- soft, non-distended, normoactive bowel sounds present, 
tender to palpation over LUQ, no rebound tenderness or guarding, 
no organomegaly or masses   
Ext- warm, well perfused, no clubbing, cyanosis, or edema 
Neuro- EOMI, tongue midline, face symmetric, motor function 
grossly normal  

 
Pertinent Results:
On Admission:
___ 03:30PM BLOOD WBC-11.2*# RBC-4.89 Hgb-15.6 Hct-45.2 
MCV-92# MCH-31.9 MCHC-34.5 RDW-11.8 RDWSD-39.7 Plt ___
___ 03:30PM BLOOD Neuts-72.7* ___ Monos-6.6 
Eos-0.3* Baso-0.3 Im ___ AbsNeut-8.19* AbsLymp-2.21 
AbsMono-0.74 AbsEos-0.03* AbsBaso-0.03
___ 03:30PM BLOOD ___ PTT-27.6 ___
___ 03:30PM BLOOD Glucose-96 UreaN-18 Creat-0.9 Na-140 
K-4.2 Cl-102 HCO3-27 AnGap-15
___ 03:30PM BLOOD ALT-22 AST-21 CK(CPK)-96 AlkPhos-68 
TotBili-0.7
___ 03:30PM BLOOD Lipase-32
___ 03:30PM BLOOD CK-MB-3
___ 03:30PM BLOOD Albumin-4.7 Calcium-9.9 Phos-2.1* Mg-1.8
___ 03:30PM BLOOD TSH-2.7
___ 03:49PM BLOOD Lactate-1.0

On Discharge:
___ 06:41AM BLOOD WBC-7.7 RBC-4.14* Hgb-13.3* Hct-39.9* 
MCV-96 MCH-32.1* MCHC-33.3 RDW-12.0 RDWSD-41.8 Plt ___
___ 06:41AM BLOOD Plt ___
___ 06:41AM BLOOD Glucose-65* UreaN-13 Creat-0.9 Na-141 
K-4.4 Cl-105 HCO3-25 AnGap-15
___ 06:41AM BLOOD Calcium-8.7 Phos-3.0 Mg-1.9

Pertinent Labs:
___ 6:41 am SEROLOGY/BLOOD      CHEM # ___ ___. 

   HELICOBACTER PYLORI ANTIBODY TEST (Final ___: 
      NEGATIVE BY EIA. 
           (Reference Range-Negative). 

Imaging/Studies:
___ CT A/P with Contrast
1. No evidence of colitis, pancreatitis, our other acute 
intra-abdominal 
process. 
2. Chronic findings, including one liver and multiple renal 
hypodensities, too small for further characterization. 
 
Brief Hospital Course:
___ is a ___ year old M with PMH of CAD s/p 4V CABG 
and asthma and recent admission for colitis who presented with 4 
weeks of epigastric pain, nausea, and vomiting.

Active Issues: 

# Abdominal Pain
Patient has past admission to ___ in ___ for similar symptoms, 
and workup was unrevealing. Given his history of colitis, 
gastritis and PUD were suspected. Infectious etiologies such as 
gastroenteritis were deemed less likely as he had been 
symptomatic for 4 weeks and had no risk factors such as travel, 
camping, or new foods. His lipase and LFTs were normal, so 
pancreatitis, hepatitis, or biliary pathology were thought to be 
unlikely. In addition, his abdominal CT was unrevealing. 
Finally, 2 serial troponins were <.01, and there was isolated T 
wave inversion in V2, so cardiac etiology not likely. He had no 
electrolyte abnormalities or weight loss, so he had been able to 
maintain adequate nutritional intake as an outpatient. He 
reported no known history of peptic ulcers, and H. pylori IgG 
was negative. He received Maalox, diphenhydramine, and lidocaine 
as well as Tylenol PRN pain, which helped alleviate his 
symptoms. He was continued on omperazole 40mg BID and placed on 
a full liquid diet, which he was able to advance slowly, with 
LUQ pain after eating but no vomiting.

# Chronic right upper extremity pain
This pain was thought to be neurogenic as patient laid on that 
arm for hours during his ___ suicide attempt. He had been 
asking his PCP to take him off of narcotics and agreed to 
transition to gabapentin. His hydrocodone-acetaminophen was 
discontinued and he was started on gabapentin 100mg TID, to be 
uptitrated as an outpatient.  

Chronic Issues:

# Coronary Artery Disease
s/p 4v CABG in ___. His EKG was unconcerning and there was no 
rise is serial troponin levels x 2. He continued on ASA 81mg 
daily and metoprolol 100mg BID. He had said upon admission that 
he was worried about taking ASA because he thought it might harm 
his stomach, but was reassured that he should stay on this 
medication.  

# Asthma
He had wheezing in the ED, but resolved after nebs--his wheezing 
was present once he arrived on the floor, for which he received 
albuterol nebs.  

# Depression/Anxiety
History of suicide attempt in ___. No SI. He was continued on 
sertraline, trazodone, and clonazepam BID PRN. He reported being 
in a depressed mood.  

Transitional Issues:

# Follow up on H Pylori serology (lab result pending at 
discharge). 
# Consider food allergy testing, although he did not report 
symptoms with one specific food.
# Consider GI referral as an outpatient, as he has had similar 
symptoms in the past, including an admission in ___, 
without clear cause. 
# Patient wanted to stop Vicodin. He was started instead on 
low-dose gabapentin for right arm pain. Please ___ 
response as an outpatient, consider uptitration. 
# Unclear why patient not on aspirin with history of coronary 
artery disease. Consider starting if indicated.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath 
2. ClonazePAM 2 mg PO BID:PRN anxiety 
3. HYDROcodone-acetaminophen ___ mg oral QID:PRN pain 
4. Metoprolol Tartrate 100 mg PO BID 
5. Omeprazole 40 mg PO BID 
6. Sertraline 200 mg PO DAILY 
7. TraZODone 200 mg PO QHS 

 
Discharge Medications:
1. ClonazePAM 2 mg PO BID:PRN anxiety 
2. Metoprolol Tartrate 100 mg PO BID 
3. Omeprazole 40 mg PO BID 
4. Sertraline 200 mg PO DAILY 
5. TraZODone 200 mg PO QHS 
6. Gabapentin 100 mg PO TID 
RX *gabapentin 100 mg 1 capsule(s) by mouth three times per day 
Disp #*90 Capsule Refills:*0
7. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath 
8. Lidocaine Viscous 2% 15 mL PO QID:PRN abdominal pain 
RX *lidocaine HCl 2 % 15 mL by mouth four times per day 
Refills:*1
9. Aluminum-Magnesium Hydrox.-Simethicone 15 mL PO QID:PRN 
abdominal pain 
RX *alum-mag hydroxide-simeth [Maalox Advanced] 200 mg-200 mg-20 
mg/5 mL 15 ML by mouth four times per day Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary
Abdominal pain, nausea, vomiting

Secondary
Asthma
CAD s/p CABG

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___.

You were admitted for abdominal pain, nausea and vomiting. You 
received medications to help with these symptoms. Meanwhile, 
your blood tests and vital signs (like blood pressure) showed 
that you have been receiving adequate amounts of fluids and 
nutrition through the foods and liquids you drink. You had a CT 
scan which showed no cause for your symptoms. In addition, we 
were reassured that you were able to eat lunch without any 
problems. Therefore, it is safe for you to return home and you 
can complete other tests or procedures as an outpatient.  

It is likely that your pain is from inflammation in the stomach, 
called gastritis. This can be treated with medications you are 
on (omeprazole). Your symptoms could also be from ulcers in the 
stomach. We tested you for an bacteria called H. pylori which 
can cause ulcers, but the blood tests will not be back until the 
end of the week. We and your primary doctor can ___ on 
this. This can be treated (if you have it) with a short course 
of antibiotics. 

We recommend continuing on the Maalox and liquid lidocaine if 
needed to control your symptoms. Please follow up with your 
primary care doctor after discharge. 

We wish you a safe and healthy return home.

Sincerely,
Your ___ Team
 
Followup Instructions:
___
"
91,15203294,29363588," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: ORTHOPAEDICS
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Deformity/contracture right hand
 
Major Surgical or Invasive Procedure:
contracture  release at elbow and hand

 
History of Present Illness:
___ yo ___ with hx of trauma to right upper limb more than ___ year 
ago. ncs/emg pos for radial and ulnar nerve irreversible damage
 
Past Medical History:
Osteoarthritis both hips. Left total hip arthroplasty, ___.
History of steroid use
Asthma
Cluster headaches
s/p CABGx4
Prior Etoh usage  
psych
 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
claw hand of ulnar palsy with superimposed weakness of extension
 
Brief Hospital Course:
operated upon on ___ discharged ___ there were no intra 
operative or ___ hospital complications
 
Medications on Admission:
l
i
p
i
t
o
r,famotidine,neurontin,methadone,metoprolol,sertraline,androgel,
 
Discharge Medications:
same
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
paralysis/contracture right upper limb

 
Discharge Condition:
stable physically and mentally

 
Discharge Instructions:
keep hand clean  dry  elevated.  begin ROM in dressing
 
                             ___ MD ___
 
Completed by: ___
"
92,15203294,27696974," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: ORTHOPAEDICS
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
paralysis right hand
 
Major Surgical or Invasive Procedure:
intrinsic tendon transfer

 
History of Present Illness:
___ yo ___ with a hx of injury to right brachial plexus in 
___, with residual paralysis of right upper limb
 
Past Medical History:
Osteoarthritis both hips. Left total hip arthroplasty, ___.
History of steroid use
Asthma
Cluster headaches
s/p CABGx4
Prior Etoh usage  
psych
 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
clawing of right hand
 
Pertinent Results:
none
 
Brief Hospital Course:
admitted after uncomplicated surgery. discharged following day 
without incident.
 
Medications on Admission:
neurontin,metoprolol,lipitor,zoloftpepcid, methadone
 
Discharge Medications:
same
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
paralysis right hand

 
Discharge Condition:
stable both mentally and physically, ambulatory

 
Discharge Instructions:
keep right hand clean dry elevated
 
Followup Instructions:
___
"
93,15203294,27798452," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Abdominal Pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Mr. ___ is a ___ h/o HTN, HLD, CAD s/p CABGx4  
presenting with generalized abdominal pain x 3 weeks.
Pain initially epigastric. CT at ___ showed ""colitis vs. 
inflammation"" about 1 wk ago, on cipro/flagyl since ___ but 
no improvement. Noted dark stools; has been taking peptobismol 
and rolaids. Pain worse after eating, leading to ___  wt loss 
over last ___ weeks. Last ___ ___, wnl. EGD ___ with peptic 
ulcers. Taking ibuprofen lately for hip/shoulder OA, off PPI and 
H2 blocker for years.  Presented to ED for worsened pain and 
inability to tolerate PO. 

In the ED intial vitals were: 8 98.1 60 125/68 18 96%. Labs 
unrevealing, CT abd/pevlis no evidence of colitis. Given 2L NS, 
zofran, morphine, donnatol, maalox. Admitted for inability to 
tolerate PO and symptom control. On arrival to floor pain 
decreased from 9 to ___. 

 
Past Medical History:
BENIGN POSITIONAL VERTIGO  
CORONARY ARTERY DISEASE s/p CABGx4 ___  
DEPRESSION  
GRAVES' DISEASE  
HYPERLIPIDEMIA  
HYPERTENSION  
MYOCARDIAL INFARCTION  
injury to right brachial plexus in ___, with residual 
paralysis of right upper limb  
Osteoarthritis both hips. Left total hip arthroplasty, ___.  
History of steroid use  
Asthma  
Cluster headaches  
Prior Etoh usage  
*S/P RIGHT HIP ARTHROPLASTY  
ASTHMA  
E-ANTIGEN NEG BLOOD REQUIRED  
GLAUCOMA  
PROSTHESIS SHOULDER AND HIP  
PSORIASIS  
SHOULDER IMPINGEMENT SYNDROME RIGHT  
THYROTOXICOSIS-AF  
VASECTOMY  
H/O CLUSTER HEADACHES  
H/O GERD  
H/O TOBACCO USE

 
Social History:
___
Family History:
F/H PREMATURE CARDIAC DISEASE in father, mother, and brother  
Father: PUD  

 
Physical Exam:
Admission:
Vitals: 98.1 HR: 60 BP: 125/68 Resp: 18 O(2)Sat: 96 Normal
General- WD WN male, comfortable, in no acute distress  
HEENT-NCAT PERRL EOMI sclera anicteric, MMM, OP clear  
Neck- supple, no LAD, no JVD  
Lungs- normal respiratory effort CTAB no w/r/r  
CV- RRR S1, S2, no murmurs  
Abdomen- soft TTP in epigastrium, ND +BS no rebound or guarding  

GU- no foley  
Ext- WWP, no c/c/e, right hand 4 & ___ digit contraction  
Neuro- CN II-XII grossly intact, BUE and BLE ___ strength, 
sensation grossly intact  

Exam on discharge essentially unchanged
 
Pertinent Results:
Admission Labs:

___ 11:54PM BLOOD WBC-6.0 RBC-4.33* Hgb-13.8* Hct-41.9 
MCV-97 MCH-31.8 MCHC-32.8 RDW-12.7 Plt ___
___ 11:54PM BLOOD Glucose-74 UreaN-10 Creat-0.9 Na-138 
K-3.8 Cl-104 HCO3-27 AnGap-11
___ 11:54PM BLOOD ALT-28 AST-33 AlkPhos-55 TotBili-0.3
___ 11:54PM BLOOD Albumin-4.0
___ 06:00AM BLOOD Calcium-8.8 Phos-3.0 Mg-2.0
___ 11:53PM BLOOD Lactate-0.8

Discharge Labs:
___ 05:37AM BLOOD WBC-4.7 RBC-4.37* Hgb-14.1 Hct-43.1 
MCV-99* MCH-32.3* MCHC-32.7 RDW-12.4 Plt ___
___ 05:37AM BLOOD Glucose-118* UreaN-7 Creat-0.9 Na-141 
K-4.0 Cl-107 HCO3-29 AnGap-9
___ 06:00AM BLOOD tTG-IgA-6

Reports:
CT Abd Pelvis ___
IMPRESSION: 
1.  No evidence of ischemic colitis.  Intra-abdominal aorta and 
its branches demonstrate moderate calcified atherosclerotic 
disease; however, its major branches appear patent and there are 
no aneurysmal changes. 
2.  Hepatic hypodensities, most likely cysts or hamartomas.   
3.  Renal hypodensities, too small to characterize, likely 
cysts. 
4.  Left lung base opacities, may be infectious or inflammatory 
in nature. 

 
Brief Hospital Course:
Mr. ___ is a ___ yo m with PMH of CAD w/ MI and PUD 
presenting with post prandial epigastric abdominal pain x3 
weeks, diarrhea, NSAID use which is concerning for PUD vs. 
gastritis. 

Active Issues:

# Epigastric Abdominal Pain: Pt with normal labs, LFTs, lipase, 
and reassuring CT scan. He had prior scan 1 week ago at OSH 
which was concerning for colitis and he received 6 days of 
cipro/flagyl. Now reporting coffee ground colored stools, not 
currently taking pepto-bismol. No evidence of colitis, 
pancreaitis, or diverticulitis. Given NSAID use, prior PUD, 
post-prandial pain, and epigastric location peptic ulcer disease 
is most likely etiology, but could also represent NSAID 
gastritis. Patient felt maalox made him feel worse. Stopped 
cipro/flagyl on admission since no evidence of colitis; diarrhea 
improved. tTG negative. Treated here with IV PPI initially, 
transitioned back to home PO. Added sucralfate. Tolerated normal 
diet.  he did not provide sample for h. pylori serology.

#Diarrhea. Patient reports frequent watery stools. Was on 
cipro/flagyl recently; may be ___ antibiotics. Diarrhea stopped 
on admission. Ddx also includes celiac disease or infectious 
process. C. diff negative, Ttg negative. Only one small BM this 
admission, soft. 

# Depression/Anxiety:  Paitent with history of suicide attempt 
___ with alcohol and pills. Currently mood is down, but denies 
suicidal ideation.  Saw SW, put in the RIDE application, also 
will assist with food.  Continued home meds. 

Chronic Issues:

# CAD s/p CABG x4:Pt with CAD and CABG in ___. Off aspirin 
since prior PUD in ___.  Continued metoprolol tartrate 100 mg 
tablet by mouth twice a day, atorvastatin 80 mg daily  

# Asthma: Stable, continued Albuterol sulfate HFA  

# Code: Full Code confirmed  
 
# Emergency Contact: ___ (ex-wife) ___, 
___ (brother) ___  

Transitional Issues:

#h/o PUD, possible recurence: 

- EGD/Colonoscopy as outpatient (GI f/u is scheduled)  
- avoid NSAIDs  
- smoking cessation

#Social Issues: Patient put in the RIDE application with social 
work here, will need to make sure this is approved to make 
followup appointments. SW also helping with meals on wheels type 
of program. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing 
2. Clobetasol Propionate 0.05% Ointment 1 Appl TP DAILY 
3. ClonazePAM 2 mg PO BID:PRN anxiety 
4. Metoprolol Tartrate 100 mg PO BID 
5. Sertraline 200 mg PO DAILY 
6. TraZODone 200 mg PO HS:PRN insomnia 
7. Atorvastatin 80 mg PO DAILY 
8. Ibuprofen 600 mg PO Q8H:PRN pain 
9. Pantoprazole 40 mg PO Q24H 

 
Discharge Medications:
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing 
2. Atorvastatin 80 mg PO DAILY 
3. ClonazePAM 2 mg PO BID:PRN anxiety 
4. Metoprolol Tartrate 100 mg PO BID 
5. Sertraline 200 mg PO DAILY 
6. TraZODone 200 mg PO HS:PRN insomnia 
7. Sucralfate 1 gm PO QID 
RX *sucralfate [Carafate] 1 gram 1 tablet(s) by mouth twice a 
day Disp #*28 Tablet Refills:*0
8. Clobetasol Propionate 0.05% Ointment 1 Appl TP DAILY 
9. Omeprazole 40 mg PO DAILY 
RX *omeprazole 40 mg 1 capsule,delayed ___ by 
mouth daily Disp #*14 Capsule Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Abdominal Pain
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
You were admitted to the hospital with abdominal pain.  You had 
a CT scan and many blood tests which did not show a cause for 
your pain. It is still possible that you have peptic ulcer 
disease. One test for a bacteria that can cause this (H. Pylori) 
is pending; if positive you will need to take antibiotics.  In 
addition, you will see a gastroenterologist to consider an 
endoscopy.  If you have difficulty scheduling the RIDE, please 
contact Dr. ___ office to assist with this. 

Since you have a history of peptic ulcer disease and your 
symptoms are concerning for a recurrence you will be prescribed 
omeprazole (prilosec) 40mg once daily and sucralfate twice 
daily. Take these medications until you followup in your primary 
care doctor's office; he may ask you to continue until you see 
the gastroenterologist. If your h. pylori test is positive, your 
primary care doctor ___ likely treat you with antibiotics. 
 
Followup Instructions:
___
"
94,15229355,26039419," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Shortness of breath
 
Major Surgical or Invasive Procedure:
EGD

 
History of Present Illness:
This is a ___ woman with PMH of ___ disease, 
blindness, hypertension, history of bronchitis and reactive 
airway disease who presents today with several weeks of 
recurrent episodes of shortness of breath, anxiety, and gasping 
for air.
She was in her usual state of health until several weeks ago, 
when she began to have 2 or more episodes per day that her son 
describes as ""choking"" and she states that she feels like she 
has trouble breathing. When queried about whether there is 
coughing, the son states that the patient was at ___ 
___, and has been evaluated for aspiration; she is on a 
precautionary diet for this already. These episodes are not 
characterized by coughing. Rather, the patient becomes acutely 
short of breath unrelated to any obvious aggravating factor; he 
provides nebs and Maalox and tries to calm her down, and she 
seems to slowly improve over one hour. Of note, the son does 
have videos that show the patient's symptoms. She feels like she 
is in distress, with shortness of breath. She is also had mild 
nausea during the last week and on day of presentation which 
patient states is new. She presented to ___ yesterday 
for this problem; she had an unremarkable EKG by report. Per 
___, the son, they are seeing an outpatient GI specialist as 
well, and she had a CT scan done which showed patency of the 
esophagus and no obstruction that could be causing these 
episodes. H. Pylori negative. There is an outpatient endoscopy 
pending by Dr. ___ at ___ to further evaluate the 
problem that has not yet occurred. However, her son describes 
being concerned about her breathing, and worrying that he does 
not know what to do for her and wanted to rule out cardiac 
causes as well.
To note, she was taking prednisone 10 mg daily at home per her 
son's report.
In the ED, initial VS were:
97.5 84 136/70 22 100% RA
Exam notable for:
elderly, chronically ill, NAD
cor pulm abd unremarkable
resting tremor
moves 4 to cmd
EKG: normal sinus rhythm, rate, normal axis, no ischemic changes
Labs showed:
WBC 9.1
Hgb 10.8
Plt 161
Chem 7 WNL
Trop x 2 negative
lactate 1.2->2.4->1.6
MB 3
ProBNP 27
UA: contaminated

Imaging showed:
CXR:
Lung volume is low. No consolidation, pneumothorax, or pleural 
effusion is identified. Mildly enlarged cardiomediastinal 
silhouette is unchanged. Left humeral deformity is unchanged and 
is likely sequela of old fracture.

IMPRESSION:
No radiographic evidence of pneumonia.
Patient received:
___ 05:38 PO/NG Carbidopa-Levodopa (___) 1.5 TAB
___ 05:38 PO/NG PredniSONE 10 mg
___ 06:45 IVF NS ___ Started by Other Person 
250
___ 08:53 PO/NG Carbidopa-Levodopa (___) 1.5 TAB
___ 08:53 PO/NG Levothyroxine Sodium 25 mcg
___ 08:53 PO Pantoprazole 40 mg
___ 09:02 IH Fluticasone Propionate 110mcg 2 PUFF
___ 10:48 IH Ipratropium Bromide Neb 1 NEB
___ 12:13 PO/NG Carbidopa-Levodopa (___) 1.5 TAB
___ 14:23 IV CefTRIAXone 1 gm
___ 15:53 IVF NS ___
___ 15:56 PO/NG Carbidopa-Levodopa (___) 1.5 TAB
___ 17:13 IH Ipratropium Bromide Neb 1 NEB
___ 19:43 PO/NG Carbidopa-Levodopa (___) 1.5 TAB
___ 19:43 PO/NG Docusate Sodium 100 mg
___ 19:43 PO/NG Atorvastatin 20 mg
___ 19:43 IH Fluticasone Propionate 110mcg 2 PUFF
___ 20:48 PO Pantoprazole 40 mg
___ 20:48 PO/NG Aluminum-Magnesium Hydrox.-Simethicone 30 
mL
___ 20:48 PO/NG LORazepam .25 mg

Transfer VS were:
89 148/83 16 100%2L NC
On arrival to the floor, patient reports she feels improved and 
calm. She was somnolent but arousable and son reported she had 
been like this after the ED gave her lorazepam.

 
Past Medical History:
___ Disease
HTN
Bronchitis 
Bilateral blindness
 
Social History:
___
Family History:
Reviewed and none pertinent to this hospitalization
 
Physical Exam:
==========================
Admission Physical Exam
==========================
VS: 98.6 Axillary 114 / 75 70 20 99 2L
GENERAL: somnolent but arousable and appearing as if she is 
breathing very comfortably.
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM
NECK: supple, no LAD, no JVD
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles
ABDOMEN: nondistended, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly
EXTREMITIES: no cyanosis, clubbing, or edema
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, some rigidity noted in upper extremities, with 
right hand more contracted than left.
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes

========================
Discharge Physical Exam
========================
VITALS: T97.8  BP 99/54 HR 89 RR 18 SpO2 95 ra 
GENERAL: Awake and able to answer questions. Breathing
comfortably.
HEENT: AT/NC, EOMI, anicteric sclera
NECK: supple, no LAD, no JVD
HEART: RRR, S1/S2, II/VI systolic ejection murmur at RUSB. No
gallops, or rubs
LUNGS: Decreased breath sounds and poor air movement at the
bases. no wheezes, rales, rhonchi.
ABDOMEN: nondistended, nontender in all quadrants, no
rebound/guarding, no hepatosplenomegaly
EXTREMITIES: no cyanosis, clubbing, or edema
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, some rigidity noted in upper extremities, with
right hand more contracted than left.
SKIN: warm and well perfused, no excoriations or lesions, no
rashes 

 
Pertinent Results:
===============
Admission Labs
===============
___ 02:55AM ___ WBC-9.1 RBC-3.47* Hgb-10.8* Hct-32.7* 
MCV-94 MCH-31.1 MCHC-33.0 RDW-14.6 RDWSD-50.4* Plt ___
___ 02:55AM ___ Neuts-63.5 ___ Monos-9.3 Eos-0.8* 
Baso-0.3 Im ___ AbsNeut-5.79 AbsLymp-2.34 AbsMono-0.85* 
AbsEos-0.07 AbsBaso-0.03
___ 02:55AM ___ Glucose-85 UreaN-19 Creat-0.6 Na-140 
K-4.2 Cl-99 HCO3-28 AnGap-13
___ 04:25AM ___ cTropnT-<0.01
___ 11:20AM ___ CK-MB-3 proBNP-278
___ 11:20AM ___ cTropnT-<0.01
___ 04:48AM ___ Lactate-1.2

=====================
Imaging/Procedures
=====================
___ CXR
FINDINGS:  
Patient's chin obscures visualization of the lung apices.  There 
is no 
visualized consolidation, effusion, or edema.  The 
cardiomediastinal 
silhouette is stable.  Tortuosity of the thoracic aorta is again 
noted.  
Chronic deformity of the proximal left humerus suggests remote 
prior fracture. 
Old healed anterior right rib fractures are also noted.  No 
acute osseous 
abnormalities. 
  
IMPRESSION:   
No acute cardiopulmonary process. 

___ CXR
FINDINGS:  
Lung volume is low.  No consolidation, pneumothorax, or pleural 
effusion is identified.  Mildly enlarged cardiomediastinal 
silhouette is unchanged.  Left humeral deformity is unchanged 
and is likely sequela of old fracture. 
  
IMPRESSION:    
No radiographic evidence of pneumonia. 

___ Video Oropharyngeal swallow study
FINDINGS:  
The study was limited due to the patient's body habitus and 
inability to relax shoulders.  Barium passes freely through the 
oropharynx without evident aspiration.  There was significant 
esophageal retention, which did not resolve with further 
swallowing attempts. 
  
IMPRESSION:  
Significant esophageal retention of barium.  This is likely 
related to severe esophageal dysmotility, if further evaluation 
is desired, a full esophogram can be performed. 
  
___ EGD
Findings:
 
Esophagus:  

 Lumen: A medium size hiatal hernia was seen.  

 Other presbyesophagus throughout the esophagus   

Stomach:  

Mucosa: Diffuse atrophic appearing mucosa of the mucosa with no 
bleeding was noted in the stomach. These findings are compatible 
with likely atrophic gastritis.  

Duodenum: Normal duodenum. 

Impression: 
- Presbyesophagus throughout the esophagus
- Atrophic appearing mucosa in the stomach compatible with 
likely atrophic gastritis 
- Medium hiatal hernia
- Otherwise normal EGD to third part of the duodenum 

==================
Discharge Labs
==================
___ 06:50AM ___ WBC-9.9 RBC-3.76* Hgb-11.7 Hct-35.0 
MCV-93 MCH-31.1 MCHC-33.4 RDW-14.7 RDWSD-50.4* Plt ___
___ 06:50AM ___ Plt ___
___ 06:50AM ___ ___ PTT-47.0* ___
___ 06:50AM ___ Glucose-88 UreaN-24* Creat-1.1 Na-138 
K-4.2 Cl-97 HCO3-26 AnGap-15
 
Brief Hospital Course:
=========
Summary
=========
___ year old female with history of ___ disease, 
bilateral blindness, hypertension, history of bronchitis and 
reactive airway disease brought to the ED by her son with 
several weeks of recurrent episodes of shortness of breath, 
anxiety, and gasping for air. Patient was evaluated with video 
swallow study which showed esophageal dysmotility and esophageal 
retention of barium. Follow-up EGD was done which showed 
presbyesophagus. Patient was monitored with baseline diet of 
ground solids with thin liquids with medications whole with 
pureed solids. She tolerated the diet well and was discharged 
home

========================================
Acute medical/surgical issues addressed
========================================
# Esophageal dysmotility and esophageal retention of barium on
video swallow:
Patient presented with periordic episodes of shortness of breath 
and anxiety. Suspected that symptoms likely caused by esophageal 
reflux causing her to aspirate which exacerbates her reactive 
airway disease. Certainly ___ puts patient at risk for 
swallowing issues at baseline. Outpatient CT scan did not show 
any obvious esophageal obstruction. No current concern for 
infection given no leukocytosis, evidence on CXR of PNA, and pt 
has no fevers, productive cough. Breathing remained stable on 
room air and O2 sats >90%. Both GERD and reactive airway disease 
treatment were optimized at home and this continued here. Video 
swallow ___ revealed significant esophageal retention of 
barium concerning for severe esophageal dysmotility. GI 
consulted and recommended EGD ___ to evaluate for esophageal 
ring or other structural issue that could be causing retention. 
EGD revealed presbyesophagus and atrophic gastritis. Patient was 
advised to adhere to astrict aspiration precautions at home 
including eating more frequent, smaller meals, taking small 
bites and sips, sitting upright for all meals and medication 
administration and remain sitting upright for 1 hour after 
meals. Please eat only if awake, alert, and attentive.

# Reactive Airway Disease
Patient presented with episodes of SOB and anxiety that may 
represent asthma exacerbations from suspected aspirations. 
Breathing remained stable on room air and O2 sats >90%. 
Optimized reactive airway disease treatment is optimized at home 
with fluticasone IH BID, ipratropium bromide neb q6hs, 
levalbuterol neb q6hours, Perforomist IH BID, and prednisone 
10mg PO daily. While admitted patient was treated with duonebs 
q6hrs, advair BID, and prednisone 10mg daily. At discharge, 
patient was restarted on her home medications.

# Uncomplicated bacterial UTI: Patient asymptomatic but with 
floridly positive UA and urine culture growing E. coli. Patient 
was not oriented this AM but also received Ativan in the ED last 
night. Completed Bactrim DS BID (D1: ___. 

# Hypertension: not taking metoprolol as outpatient. Will need 
to verify medication list with son. ___ pressure well 
controlled overnight and SBP 150s now. Not on Metoprolol as was 
stopped at ___ due to hypotension.

# HLD: continued atorvastatin 20 daily

# GERD: continued pantoprazole 40 mg BID. Patient was discharged 
on pantoprazole 40mg PO BID and Maalox 10mL q6hrs PRN

# ___ disease: continued home Carbidopa-Levodopa 1.5 tab 
QID and 1mg at 7pm. Also continued Carbidopa 25mg QAM per son's 
home med list.

===================
Medication Changes
===================
- None

====================
Transitional Issues
====================
[ ] Continue baseline diet of ground solids with thin liquids 
with medications whole with pureed solids
[ ] Patient is currently taking oral prednisone 10mg daily. 
Appears this was started for possible asthma exacerbation but 
was no end date was given. Will discharge on prednisone 10mg 
daily but recommend tapering as outpatient.
[ ] Please ensure patient doing well with aspiration of cautions 
at home in setting of presbyesophagus.
[ ] If patient is not able to tolerate current diet, diet can be 
downgraded to puree solids. If patient is still having problems 
with aspiration, would have discussion with patient and family 
about PEG placement.
[ ] Patient is prescribed carbidopa 25mg BID, however, patient's 
son states her neurologist told him to give only once in the 
morning. Would clarify this with patient's neurologist

#CODE: Full (presumed)
#CONTACT: ___ ___, ___ ___.
Home phone ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Vitamin D 1000 UNIT PO DAILY 
2. Multivitamins 1 TAB PO DAILY 
3. Pantoprazole 40 mg PO Q12H 
4. Fluticasone Propionate 110mcg 2 PUFF IH BID 
5. Levalbuterol Neb 0.63 mg NEB Q6H 
6. Ipratropium Bromide Neb 1 NEB IH Q6H 
7. OxyCODONE (Immediate Release) 2.5 mg PO BID:PRN Pain - 
Moderate 
8. melatonin 3 mg oral QHS 
9. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 
10. Levothyroxine Sodium 25 mcg PO DAILY 
11. Senna 8.6 mg PO BID 
12. Docusate Sodium 100 mg PO BID 
13. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
14. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
indigestion 
15. Atorvastatin 20 mg PO QPM 
16. Carbidopa-Levodopa (___) 1.5 TAB PO QID 
17. PredniSONE 10 mg PO DAILY 
18. carbidopa 25 mg oral BID 
19. Carbidopa-Levodopa (___) 0.5 TAB PO 4PM ONCE DAILY 
20. carbidopa 25 mg oral QAM 

 
Discharge Medications:
1.  Carbidopa-Levodopa (___) 1 TAB PO QPM AT ___  
2.  Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
indigestion  
3.  Atorvastatin 20 mg PO QPM  
4.  Carbidopa-Levodopa (___) 1.5 TAB PO QID  
5.  carbidopa 25 mg oral QAM  
6.  Docusate Sodium 100 mg PO BID  
7.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
8.  Ipratropium Bromide Neb 1 NEB IH Q6H  
9.  Levalbuterol Neb 0.63 mg NEB Q6H  
10.  Levothyroxine Sodium 25 mcg PO DAILY  
11.  melatonin 3 mg oral QHS  
12.  Multivitamins 1 TAB PO DAILY  
13.  OxyCODONE (Immediate Release) 2.5 mg PO BID:PRN Pain - 
Moderate  
14.  Pantoprazole 40 mg PO Q12H  
15.  Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation 
BID  
16.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  
17.  PredniSONE 10 mg PO DAILY  
18.  Senna 8.6 mg PO BID  
19.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
==================
Primary Diagnosis
==================
Esophageal dysmotility and esophageal reflux secondary to 
presbyesophagus

===================
Secondary Diagnosis
===================
Reactive Airway Disease
Uncomplicated Bacterial UTI

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear ___,

___ was a pleasure taking care of you at ___ 
___.

Why was I in the hospital?
  - You were having episodes of shortness of breath at home and 
were brought in to be evaluated for potential causes of these 
episodes

What was done while I was in the hospital?
  - Your gastroesophageal reflux disease medications were 
reviewed and were felt to be optimized already
  - Your reactive airway disease/asthma medications were 
reviewed and we felt you were on an optimum regimen at home 
already.
  - You had a video swallow study which showed you had trouble 
swallowing foods. We did a follow-up EGD done which showed that 
you have a condition called presbyesophagus, a common condition 
seen in elderly individuals that predisposes you to having 
trouble swallowing and gastroesophageal reflux. 

What should I do when I go home?
  - It is very important that you take your medications as 
prescribed. We will provide you with a list of medications at 
discharge that you should continue to take
  - To prevent choking and aspiration of food, which is likely 
the cause of your episodes of shortness of breath and discomfort 
at home, we recommend:
       - Please eat more frequent, smaller meals and take small 
bites and sips. 
       - Please remember to sit upright for all meals and 
medication administration and remain sitting upright for 1 hour 
after
meals. 
       - Also, please eat only if awake, alert, and attentive
  - Please go to your scheduled appointment with your primary 
doctor.

Best wishes, 
  Your ___ team

 
Followup Instructions:
___
"
95,15229355,29333027," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Dysuria
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ year old female w/ Parkinsons, esophageal dysmotility, 
reactive airway disease requiring lev-albuterol referred from 
her PCP as her UTI is resistant to PO options.  
 
Per ED records: Patient has persistent burning with urination 
after finishing cipro yesterday. Patient also lethargic. PCP 
noted urine cx not sensitive to cipro. Right-rib cage pain is 
old, possibly ___ strap around her chest when she works with pt. 
Patient has no history of any significant head trauma. The 
family characterizes her lethargy as limited activity and she is 
not talking as quickly or as fluid as she normally talks. 
Patient does have baseline confusion.  
 
EXAM:  
 abd soft, ntnd  
 In the ED, initial VS were:  
 97.6 78 97/61 20 96% RA 125  
 Exam notable for: abd soft, ntnd  
 Labs showed: Hgb 11  
 Imaging showed: CXR pending  
 Consults: None  
 Patient received: Levalbuterol Neb .63 mg  
 ___ 01:23 IH Ipratropium Bromide Neb 1 NEB  
 ___ 01:38 IV CefTRIAXone (1 g ordered)  
 
Transfer VS were: 98.0 63 139/68 20 100% neb  
 
On arrival to the floor, patient is alert but disoriented. She 
denies F/C, N/V, chest pain, SOB, abd pain, 
constipation/diarrhea. She endorses DOE and dysuria.  
 
Son is at bedside and provides collateral. States she is usually 
very alert.  

 
Past Medical History:
___ Disease  
 HTN  
 Bronchitis  
 Bilateral blindness  
 Reactive airway disease  
 Hypothyroidism  
 HLD  

 
Social History:
___
Family History:
Reviewed and none pertinent to this hospitalization
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
==========================  
VS: 98.0 PO 140 / 64 64 18 98 Ra  
GENERAL: NAD, alert but sleepy. Soft-spoken.  
HEENT: AT/NC, blind. Tongue midline  
NECK: supple  
HEART: RRR, + murmur  
LUNGS: Crackles at bases, poor inspiratory effort.  
ABDOMEN: nondistended, nontender in all quadrants, no 
rebound/guarding  
EXTREMITIES: no edema  
NEURO: A&Ox1(name. States she's in ""heaven"" but can ___ 
hospital on prompting. States it's ___), moving all 4 
extremities. Follows commands  

DISCHARGE PHYSICAL EXAM:
=========================
Vs:
24 HR Data (last updated ___ @ 741) Temp: 98.1 (Tm 98.7),
BP: 102/48 (manual BP) (96-164/48 (manual BP)-83), HR: 68
(68-84), RR: 18 (___), O2 sat: 91% (___), O2 delivery: RA,
Wt: 118.2 lb/53.62 kg  

GENERAL: NAD, alert but sleepy. Soft-spoken. 
HEENT: AT/NC, blind. Tongue midline
NECK: supple 
HEART: RRR, + murmur
LUNGS: Crackles at bases, poor inspiratory effort. 
ABDOMEN: nondistended, nontender in all quadrants, no
rebound/guarding 
EXTREMITIES: no edema
NEURO: A&O to self and son. Answers yes/no questions
appropriately. Moving all 4 extremities. Notable for R hand pill
rolling tremor. Follows commands

 
Pertinent Results:
ADMISSION LABS:
================
___ 01:25AM BLOOD WBC-8.9 RBC-3.77* Hgb-11.0* Hct-34.7 
MCV-92 MCH-29.2 MCHC-31.7* RDW-15.5 RDWSD-52.4* Plt ___
___ 01:25AM BLOOD Neuts-67.3 ___ Monos-9.2 Eos-1.7 
Baso-0.3 Im ___ AbsNeut-6.01 AbsLymp-1.86 AbsMono-0.82* 
AbsEos-0.15 AbsBaso-0.03
___ 01:25AM BLOOD Glucose-90 UreaN-21* Creat-0.7 Na-138 
K-4.8 Cl-99 HCO3-28 AnGap-11
___ 01:45AM BLOOD Lactate-1.8

MICRO DATA:
============
___ UA:  
 MORGANELLA MORGANII  
 | KLEBSIELLA PNEUMONIAE  
 | |  
 AMPICILLIN/SULBACTAM-- 4 S  
 CEFAZOLIN------------- <=4 S  
 CEFEPIME-------------- <=1 S <=1 S  
 CEFTAZIDIME----------- <=1 S <=1 S  
 CEFTRIAXONE----------- <=1 S <=1 S  
 CIPROFLOXACIN--------- =>4 R <=0.25 S  
 GENTAMICIN------------ <=1 S <=1 S  
 MEROPENEM-------------<=0.25 S <=0.25 S  
 NITROFURANTOIN-------- 32 S  
 PIPERACILLIN/TAZO----- <=4 S <=4 S  
 TOBRAMYCIN------------ 8 I <=1 S  
 TRIMETHOPRIM/SULFA---- =>16 R <=1 S  

IMAGING:
=========
CXR ___:
No acute intrathoracic process.

DISCHARGE LABS:
=================
___ 06:10AM BLOOD WBC-7.9 RBC-3.75* Hgb-10.9* Hct-34.5 
MCV-92 MCH-29.1 MCHC-31.6* RDW-15.2 RDWSD-51.6* Plt ___
___ 06:10AM BLOOD Plt ___
___ 06:10AM BLOOD Glucose-81 UreaN-22* Creat-0.7 Na-142 
K-3.9 Cl-101 HCO3-27 AnGap-14
 
Brief Hospital Course:
========
SUMMARY
========
___ year old female w/ Parkinsons, esophageal dysmotility, 
reactive airway disease requiring lev-albuterol referred from 
her PCP as her UTI felt by history UTIs resistant to PO options 
initiated IV ceftriaxone transitioned to PO cefpodoxime 
following sensitivities of Klebsiella (panSN) and Morganella 
(resistant) w/course c/b lethargy and confusion from toxic 
metabolic encephalopathy, resolved and at baseline at time of 
d/c.

ACUTE ISSUES:
===============
#Uncomplicated UTI: Patient failed 3 days of cipro as outpatient 
and urine culture returned with pansensitive klebsiella and 
morganella resistant to cipro and Bactrim. Admitted for IV Abx 
per PCP ___. Patient is at risk for urinary 
retention given ___ disease but with normal PVR today. 
Treated for total of 5 day course given patient is at higher 
than normal risk of recurrence given comorbidities. Will 
discharge on Cefpedoxime 100mg q12hr for 2 days to complete ___.

#Deconditioning: Patient with reported significant weakness and 
already has home ___. Son reports increased burden with moving 
her over the last several days leading up to admission. ___ 
evaluated and recommended home with max services.

#Encephalopathy secondary to UTI: Noted by patient's sons to 
have lethargy at home and increasing confusion. Per sons, she is 
normally alert and oriented to self, her sons, and to place at 
baseline but does not know date or time. Was A&O to self only on 
admission exam but improved with treatment of infection. At 
discharge, patient able to state she is in the hospital in 
___ and that the day of ___ Day. This is consistent with 
her baseline. We will continue to hold home alprazolam, 
trazodone, and oxycodone given high risk for delirium with these 
medications. Plan to follow-up with PCP to discuss resuming 
these medications.

# Sacral ulcer
Noted on admission and continued wound care with balmex 
placement daily. Patient to go home with ___ services for wound 
care and follow-up with PCP for management.

#Malnutrition risk: Patient on pureed/nectar thick with ensure 
enlive 2xday and high calorie boost 1x/day. Should continue this 
on discharge.

CHRONIC ISSUES:
===============
# Esophageal dysmotility: Previously found to have esophageal 
retention of barium on video swallow and esophageal reflux 
causing her to aspirate which exacerbates her reactive airway 
disease. Prior EGD revealed presbyesophagus and atrophic 
gastritis. Has hiatal hernia, not surgical candidate. Followed 
by GI as outpatient. Family is holding home hyoscyamine. 
Symptoms are stable here on aspiration precautions with pureed 
diet and nectar thickened liquids. Consider repeat swallowing 
evaluation as outpatient to ensure patient on optimal diet 
consistency. Will discharge on home Nexium.

# Reactive Airway Disease: Hx of SOB and anxiety that may 
concerning for asthma exacerbations from suspected aspirations. 
Reactive airway disease treatment is optimized at home with 
fluticasone IH BID, ipratropium bromide neb q6hs, levalbuterol 
neb q6hours, Perforomist IH BID, and prednisone 10mg PO daily. 
Family spaces out her breathing treatments at home. Continued 
home medications at discharge

# ___ Disease
continued home Carbidopa-Levodopa and non-formulary Carbidopa
(HCP brought)

===================
TRANSITIONAL ISSUES
===================
[] UTI, Uncomplicated: will complete 5d course w/2d cefpodoxime 
___ (d1: ___
[] Encephalopathy: Improved to baseline with treatment of 
infection. We will continue to hold home alprazolam, trazodone, 
and oxycodone given high risk for delirium with these 
medications. Plan to follow-up with PCP to discuss resuming 
these medications.
[] Esophageal Dysmotility: Consider repeat swallowing evaluation 
as outpatient to ensure patient on optimal diet consistency. 
[] Deconditioning: ___ evaluated and recommended home with max 
services. Will resume home ___ at discharge.

#CODE: Full (confirmed)
#CONTACT: ___ (son/hcp) ___ ___ ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. PredniSONE 10 mg PO DAILY 
2. Ipratropium Bromide Neb 1 NEB IH Q6H 
3. ALPRAZolam 0.25 mg PO BID 
4. Carbidopa-Levodopa (___) 1.5 TAB PO QID 
5. Carbidopa-Levodopa (___) 1 TAB PO QPM 
6. carbidopa 25 mg oral QAM 
7. Fluticasone Propionate 110mcg 2 PUFF IH BID 
8. formoterol fumarate 20 mcg/2 mL inhalation DAILY 
9. Levalbuterol Neb 0.63 mg NEB Q6H 
10. Levothyroxine Sodium 25 mcg PO DAILY 
11. Nexium 40 mg Other DAILY 
12. OxyCODONE (Immediate Release) 2.5-5 mg PO Q8H:PRN Pain - 
Moderate 
13. TraZODone 25 mg PO QHS:PRN insomnia 
14. melatonin 3 mg oral QHS 
15. Multivitamins 1 TAB PO DAILY 
16. Vitamin D 1000 UNIT PO DAILY 
17. latanoprost 0.005 % ophthalmic (eye) QHS 
18. Polyethylene Glycol 17 g PO DAILY 

 
Discharge Medications:
1.  Cefpodoxime Proxetil 100 mg PO/NG Q12H Duration: 2 Days 
RX *cefpodoxime 100 mg 1 tablet(s) by mouth twice a day Disp #*4 
Tablet Refills:*0 
2.  Multivitamins W/minerals 1 TAB PO DAILY 
RX *multivitamin,tx-minerals  1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0 
3.  Carbidopa-Levodopa (___) 1.5 TAB PO QID  
4.  Carbidopa-Levodopa (___) 1 TAB PO QPM  
5.  carbidopa 25 mg oral QAM  
6.  Esomeprazole 40 mg Other DAILY  
7.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
8.  formoterol fumarate 20 mcg/2 mL inhalation DAILY  
9.  Ipratropium Bromide Neb 1 NEB IH Q6H  
10.  latanoprost 0.005 % ophthalmic (eye) QHS  
11.  Levalbuterol Neb 0.63 mg NEB Q6H  
12.  Levothyroxine Sodium 25 mcg PO DAILY  
13.  melatonin 3 mg oral QHS  
14.  Multivitamins 1 TAB PO DAILY  
15.  Polyethylene Glycol 17 g PO DAILY  
16.  PredniSONE 10 mg PO DAILY  
17.  Vitamin D 1000 UNIT PO DAILY  
18. HELD- ALPRAZolam 0.25 mg PO BID  This medication was held. 
Do not restart ALPRAZolam until you follow-up with you PCP
19. HELD- OxyCODONE (Immediate Release) 2.5-5 mg PO Q8H:PRN Pain 
- Moderate  This medication was held. Do not restart OxyCODONE 
(Immediate Release) until you follow-up with PCP
20. HELD- TraZODone 25 mg PO QHS:PRN insomnia  This medication 
was held. Do not restart TraZODone until you follow-up with your 
PCP

 
___:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
================== 
PRIMARY DIAGNOSIS 
================== 
Uncomplicated UTI 
Toxic Metabolic Encephalopathy 
 
=================== 
SECONDARY DIAGNOSIS 
=================== 
___ disease 
esophageal dysmotility 
reactive airway disease  

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
======================
DISCHARGE INSTRUCTIONS
======================

Dear ___,

___ was a pleasure caring for you at ___.

WHY WAS I IN THE HOSPITAL?
- You were admitted to the hospital because you had an infection 
in your urine that required IV antibiotics.

WHAT HAPPENED TO ME IN THE HOSPITAL?
- You were treated with antibiotics through your IV to treat 
your infection.
- We held some of your pain medications and anxiety medications 
because you are confused when you came in and these medications 
can make you more confused.
- We continued your other home medications and inhalers.
-You were seen by the physical therapy team who recommended he 
should continue physical therapy at home.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
- Continue to take all your medicines and keep your 
appointments.
- We will discharge you with antibiotic pills called 
Cefpodoxime.  Please continue to take these for the next 2 days. 
 Your last name antibiotics will be ___.
- We will be holding her anxiety medication called alprazolam 
and pain medications called oxycodone and tramadol at discharge. 
 Please continue to hold these medications until you follow-up 
with your primary care physician.
-Please continue your home diet of pured solids and nectar 
pre-thickened liquids.  Please discuss with your primary care 
physician about getting ___ repeat swallowing evaluation to 
confirm that this is the best diet for you.

We wish you the best!

Sincerely,
Your ___ Team

 
Followup Instructions:
___
"
96,15229355,24053200," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
hypoxia
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Pt is a ___ y.o female with h.o ___ disease,
esophageal dysmotility, reactive airway disease requiring
levoalbuterol who presented with SOB. According to her son, pt
has had increasing cough and congestion over the past few days
and woke up this am where she was sating in the high 80's until
she was able to sit upright and then O2 sats improved to the low
90's. He reports baseline sats in the high 90's. Pt's son 
reports
her cough sounds worse and she's having difficulty coughing up
phlegm. Pt reports increased SOB. Pt's son reports that pt 
having
more difficulty getting up into the commode due to SOB but 
denies
fever, CP, nausea, vomiting, abdominal pain, change in bowel or
bladder habits. 

Of note, pt recently admitted ___ for UTI/encephalopathy 
tx
with cefpodoxime. 

In the ED, pt noted to have b/l crackles. She reportedly has 
been
to the ED twice in the last 2 days due to increasing SOB and
cough. 
In the ED, she was given carbidopa-levodopa, nebs, 125mg IV
solumedrol. 
Last set of  vitals T 97.6 BP 9545 HR 64RR 25 sat 97% on 2L

Currently, pt reports cough with phlegm and minor SOB. Denies 
CP,
palpitations, abdominal pain, n/v/d/c, dysuria, CP, 
palpitations.

10pt ROS reviewed and otherwise negative.
 
Past Medical History:
___ Disease  
 HTN  
 Bronchitis  
 Bilateral blindness  
 Reactive airway disease  
 Hypothyroidism  
 HLD  

 
Social History:
___
Family History:
Reviewed and none pertinent to this hospitalization
 
Physical Exam:
gen-frail, appearing nad, cooperative
vitals-reviewed in VSS flowsheet
97.9
PO 126 / 71 68 22 96 2lnc  
heent-ncat eomi anicteric MMM 
respiratory-bl ae minimal expiratory wheezing
cardiovascular-s1s2 rr no m/r/g
abdomen-+bs, soft, NT, ND, no guarding or rebound
ext-no cce 2+pulses
neuro-AAox1.5, moves all extremities, resting tremor
psych-calm, cooperative 
skin- no apparent rashes
 
Pertinent Results:
___ 05:52AM BLOOD WBC-10.4* RBC-3.84* Hgb-11.3 Hct-35.6 
MCV-93 MCH-29.4 MCHC-31.7* RDW-15.5 RDWSD-52.0* Plt ___
___ 11:47AM BLOOD Neuts-71.3* Lymphs-18.6* Monos-8.9 
Eos-0.5* Baso-0.2 Im ___ AbsNeut-8.32* AbsLymp-2.17 
AbsMono-1.04* AbsEos-0.06 AbsBaso-0.02
___ 11:47AM BLOOD ___ PTT-26.1 ___
___ 05:52AM BLOOD Glucose-107* UreaN-25* Creat-0.6 Na-139 
K-4.0 Cl-99 HCO3-28 AnGap-12
___ 11:47AM BLOOD cTropnT-<0.01
___ 05:52AM BLOOD Phos-3.2 Mg-2.4

CXR:  
IMPRESSION:  
No convincing signs of pneumonia. 

EKg:overall similar to prior

 
Brief Hospital Course:
___ with PMH ___ disease, esophageal dysmotility, 
reactive airway disease, recent admission for UTI who presented 
to the ED with cough and hypoxemia, overall stable without 
convincing signs for bacterial infection.

Acute hypoxic respiratory failure - due to
Likely viral URI and reactive airway disease 
Possible viral pneumonia 
Overall stable with supportive care.  No 02 requirement. She 
likekly had a viral URI given negative CXR and re-assuring 
infectious evaluation.  She may also have a contributing from 
her chronic aspiration.  She was placed on Prednisone 60mg daily 
with supportive care.  She remained stable.  She was cleared for 
home post ___ evaluation.
- Prednisone taper 60mg x5 days, then decrease by 10mg every 2 
days until she returns back to her baseline 10mg daily

___ disease:
- continued home meds

Esophageal dysmotility:
Previously found to have esophageal retention of barium on video 
swallow and esophageal reflux causing her to aspirate, 
triggering reactive airway disease. Prior EGD revealed 
presbyesophagus and atrophic gastritis. Has hiatal hernia, not 
surgical candidate.  She had past video swallows and she remains 
an aspiration risk, and had an episode here prior to discharge 
which appeared to be reflux and responded to Mylanta.  Her usual 
diet was maintained of ground solids and thin liquids.

Chronic Sacral ulcer:
- known on last admission. Wound care. Healing, without 
exposed/raw tissue, per nursing.  

Recent encephalopathy:
- oriented to self at baseline. 
- minimized any sedating medications. 

Hypothyroidism-levothyroxine

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Sucralfate 1 gm PO TID 
2. Fluticasone Propionate 110mcg 2 PUFF IH BID 
3. Multivitamins W/minerals 1 TAB PO DAILY 
4. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 
5. ALPRAZolam 0.25 mg PO BID:PRN anxiety 
6. Atorvastatin 20 mg PO QPM 
7. Carbidopa-Levodopa (___) 1 TAB PO 5X/DAY 
8. Hyoscyamine 0.125 mg SL TID:PRN abd pain 
9. Ipratropium Bromide Neb 1 NEB IH Q6H 
10. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob 
11. Levothyroxine Sodium 25 mcg PO DAILY 
12. melatonin 3 mg oral QHS 
13. TraZODone 25 mg PO QHS:PRN insomnia 
14. Nexium 40 mg Other DAILY 
15. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
16. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Mild 
17. PredniSONE 20 mg PO DAILY 
18. carbidopa 25 mg oral DAILY 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Viral URI
Hypoxia
Reactive airways
Esophageal dysmotility

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Patient was admitted with shortness of breath and low oxygen 
levels, likely caused by a viral infection and reaction in the 
lung.  We recommend a taper of steroids and to continue her 
usual medications.  We recommend follow up with her PCP ___ 1 
week, and to follow up with her pulmonologist as scheduled

Taper prednisone as follows:
Prednisone 60mg x2 more days, then 50mg x2 days, then 40mgx2 
days, then 30mgx2 days, then 20mg x2 days, then resume 10mg 
daily
 
Followup Instructions:
___
"
97,15229355,29074135," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Encephalopathy
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ woman with history of ___ 
disease, esophageal dysmotility, reactive airway disease 
presenting from home via EMS with inability to ambulate.

History is taken primarily from the patient's son, ___, who is 
at the bedside. He reports that the patient had been in her 
usual state of health until this morning. She gets her 
___ medications at 0700, and then 1000, 1300, 1600, 
___. Her son reports that he gave her the morning dose as 
usual. Then around ___ he tried to get her out of bed, but 
noted that she seemed too weak to stand and had to support her. 
He is not sure whether she seemed more stiff than usual. He then 
gave her the 1000 dose of carbidopa/levodopa, thinking that this 
may be related to her ___ (the patient's Neurologist has 
been uptitrating her dose recently). The patient was able to 
stand after getting her 1000 dose of medication, but she still 
seemed more weak than usual, so he called the ambulance.

Upon EMS arrival she was also found to be hypoxic. She has not 
been expressing any shortness of breath prior to EMS arrival. 
Her son reports that due to her esophageal dysmotility she 
someone has choking/aspiration episodes, but he states that she 
has not had any on the day of presentation. No cough. No fevers, 
chills, nausea, vomiting, diarrhea, dysuria, or increased 
urinary frequency. Her son reports that she has not been eating 
or drinking much today. 

Of note, the patient was recently admitted from ___ with 
hypoxia that was thought to be due to viral upper respiratory 
infection triggering reactive airway disease.

In the ED, vitals: 98.5 88 95/58 24 94% 2L NC 

Exam: The patient is alert and oriented 2. She is in no acute 
respiratory distress. She is tremulous. Eye exam limited due to 
patient's blindness. Heart with regular rate and rhythm. Lungs 
clear to auscultation bilaterally. Abdomen soft nontender 
nondistended. 5 out of 5 strength in upper and lower 
extremities. Left upper extremity with increased tone, at 
baseline per patient's son. No peripheral edema.

Labs notable for: WBC 8.4 H/H 11.0/33.5, plt 155; BMP wnl; 
urinalysis grossly positive with +bacteria, WBC 14, lg leuks, 
pos nitrites.

Imaging:
- CXR: No acute cardiopulmonary abnormality. 

Patient given:
___ 15:09 IH Albuterol 0.083% Neb Soln 1 NEB 
___ 15:09 IH Ipratropium Bromide Neb 1 NEB  
___ 20:08 IH Albuterol 0.083% Neb Soln 1 NEB 
___ 20:08 IH Ipratropium Bromide Neb 1 NEB 
___ 20:08 IV CefTRIAXone  
___ 20:12 IV CefTRIAXone 1 gm L
___ 21:55 PO/NG Carbidopa-Levodopa (___) 1.5 TAB 
___ 21:55 PO/NG ALPRAZolam .25 mg 

On interview, the patient states that she is tired. She denies 
shortness of breath or dysuria. She otherwise falls asleep 
during the interview and history is primarily taken from her son 
as above.

ROS: Unable to obtain due to patient's mental status.

 
Past Medical History:
___ Disease  
HTN 
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Bronchitis 
Hypothyroidism  

 
Social History:
___
Family History:
Reviewed and found to be not relevant to this illness/reason for 
hospitalization.

 
Physical Exam:
EXAM on Admission
VITALS: 97.8 86/50 81 22 94-95% on room air
GENERAL: Sleeping but arousable, in no acute distress
EYES: Anicteric, eye exam limited due to patient blindness
ENT: Dry mucous membranes, oral thrush
CV: RRR
RESP: Lungs clear to auscultation with good air movement 
bilaterally without wheezing. Breathing is non-labored.
GI: Abdomen soft, non-distended, non-tender to palpation.Bowel 
sounds present. 
GU: No suprapubic fullness or tenderness to palpation
MSK: Moves all extremities, bilateral contractures in upper 
extremities
SKIN: No rashes or ulcerations noted
NEURO: Sleeping but arousable to voice, right nasolabial fold 
flattening, gaze conjugate with EOMI, speech fluent, moves all 
limbs, strength intact in bilateral upper and lower extremities, 
sensation to light touch grossly intact throughout

Exam on Discharge
VITALS: ___ 0726 Temp: 98.4 PO BP: 152/82 HR: 61 RR: 22 O2 
sat: 100% O2 delivery: RA  
GENERAL: As above, awake and alert, in no acute distress
EYES: Anicteric, eye exam limited due to patient blindness
ENT: Dry mucous membranes, oral thrush
CV: RRR
RESP: Lungs clear to auscultation with good air movement 
bilaterally without wheezing. Breathing is non-labored.
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel 
sounds present. 
GU: No suprapubic fullness or tenderness to palpation
MSK: Moves all extremities, bilateral contractures in upper 
extremities
SKIN: Thin fragile skin but no rashes or ulcerations noted
NEURO: Interactive, gravitational facial droop, gaze conjugate 
with EOMI, speech fluent, moves all limbs, strength intact in 
bilateral upper and lower extremities, sensation to light touch 
grossly intact throughout
 
Pertinent Results:
Labs this admission

___ 03:00PM BLOOD WBC-8.4 RBC-3.61* Hgb-11.0* Hct-33.5* 
MCV-93 MCH-30.5 MCHC-32.8 RDW-16.2* RDWSD-54.7* Plt ___
___ 07:15AM BLOOD WBC-8.8 RBC-3.16* Hgb-9.5* Hct-29.7* 
MCV-94 MCH-30.1 MCHC-32.0 RDW-16.1* RDWSD-55.5* Plt ___
___ 03:00PM BLOOD Glucose-119* UreaN-19 Creat-0.7 Na-143 
K-4.5 Cl-101 HCO3-27 AnGap-15
___ 07:15AM BLOOD Glucose-83 UreaN-18 Creat-0.6 Na-144 
K-3.7 Cl-103 HCO3-28 AnGap-13
___ 07:15AM BLOOD Calcium-8.5 Phos-2.7 Mg-2.5
___ 05:50PM URINE Blood-NEG Nitrite-POS* Protein-TR* 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-LG*
___ 05:50PM URINE RBC-2 WBC-14* Bacteri-MANY* Yeast-NONE 
Epi-3 TransE-<1

Microbiology this admission

Blood culture - NGTD
Urine culture - ESCHERICHIA COLI. >100,000 CFU/mL. AMPICILLIN 
susceptible.

Radiology this admission

CXR: I have reviewed the CXR personally and my read is: No focal 
consolidation suggestive of pneumonia or pulmonary edema.

HEAD CT: No acute abnormality.
 
Brief Hospital Course:
Brief summary: 

This is a ___ with ___ disease, esophageal dysmotility, 
reactive airway disease presenting from home via EMS with 
inability to ambulate. In the ED she was hypotensive, 
transiently mildly hypoxic, and clearly weak and 
encephalopathic. She was found to have a UTI and also thought to 
be hypovolemic. She improved very impressively with fluid 
resuscitation and antibiotic therapy, to near-baseline (though 
very poor functional status at this baseline). Her antibiotics 
were transitioned to a narrowed spectrum oral regimen prior to 
discharge.

Detailed summary:

# Urinary tract infection: Patient presenting with inability to 
ambulate, found to have positive urinalysis on admission. 
Patient denied symptoms, and was afebrile and without 
leukocytosis, but given her encephalopathy and difficulty 
ambulating, treatment was initiated with ceftriaxone. She 
improved with therapy. Urine culture with >100K E coli, 
pansusceptible. Narrowed to amoxicillin at discharge.
- Complete course of amoxicillin 500mg PO TID x5 more days

# Acute toxic metabolic encephalopathy: Patient sleepy but 
arousable on initial interview, with subsequent course notable 
for waxing/waning alertness. She improved with treatment of UTI 
and dehydration/hypovolemia.

# Inability to ambulate: Patient presenting with inability to 
ambulate, likely due to hypovolemia and UTI. Patient was noted 
to have right nasolabial flattening on exam, son is not sure if 
this was new; neurological exam otherwise seems to be at 
baseline and strength intact in upper and lower extremities and 
head CT was performed for this reason and was negative - likely 
gravitational based on serial exams. She was continued on her 
usual ___ disease medications. Her physical functioning 
improved to near-baseline (which is poor) after treatment of 
UTI/dehydration. She was seen by ___ who recommended discharge 
back to home with 24 hour care.

# Hypotension
# Hypovolemia/dehydration: Patient noted on arrival to be 
hypotensive to the systolic ___, not clearly symptomatic. 
Patient appeared dry on exam, and per report from son has not 
had much to eat or drink day of admission. BPs improved with 
IVF. Of note, patient also on prednisone 10 mg per day at home, 
completed steroid taper from last admission.

# Acute hypoxic respiratory failure: Patient found to be 
hypoxic, requiring 1L oxygen via NC in the ED. Patient was able 
to be weaned to room air upon arrival. CXR clear without 
evidence of pneumonia, pulmonary edema, or aspiration. On exam, 
patient has no wheezing to suggest acute exacerbation of her 
reactive airway disease. ___ have been aspiration event.  
Followed by Dr. ___. Home medications were continued.

# Thrush: Mild. Resolved with some nystatin. 
- Rinse mouth after inhaled steroids

# Esophageal dysmotility: Continued aspiration precautions with 
pureed solids and thickened liquids. She was seen by SLP who 
felt she was doing fairly well and could likely tolerate thin 
liquids (no straws).

# Anemia: Chronic, stable
# ___ disease: Continued carbidopa/levodopa
# Glaucoma: Continued eye gtts
# Hypothyroidism: Continued levothyroxine
# Hypertension: Controlled without medications
# Hyperlipidemia: Continued atorvastatin
# Anxiety: Continued alprazolam as needed
# Insomnia: Continued trazodone; substitute ramelteon for 
melatonin

>30 minutes spent coordinating discharge home with services
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
2. Atorvastatin 20 mg PO QPM 
3. carbidopa 25 mg oral QAM 
4. Fluticasone Propionate 110mcg 2 PUFF IH BID 
5. Hyoscyamine 0.125 mg SL TID:PRN abd pain 
6. Ipratropium Bromide Neb 1 NEB IH Q6H 
7. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob 
8. Levothyroxine Sodium 25 mcg PO DAILY 
9. Multivitamins W/minerals 1 TAB PO DAILY 
10. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 

11. TraZODone 12.5 mg PO QHS:PRN insomnia 
12. ALPRAZolam 0.25 mg PO TID:PRN anxiety 
13. melatonin 3 mg oral QHS 
14. Nexium 40 mg Other DAILY 
15. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Mild 
16. Carbidopa-Levodopa (___) 2 TAB PO BID 
17. Carbidopa-Levodopa (___) 1.5 TAB PO BID 
18. Carbidopa-Levodopa (___) 1 TAB PO ___ 
19. PredniSONE 10 mg PO DAILY 
20. Mylanta 10 mL oral QID:PRN 
21. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 

 
Discharge Medications:
1.  Amoxicillin 500 mg PO Q8H Duration: 5 Days 
RX *amoxicillin 500 mg 1 tablet(s) by mouth three times daily 
Disp #*15 Tablet Refills:*0 
2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
3.  ALPRAZolam 0.25 mg PO TID:PRN anxiety  
4.  Atorvastatin 20 mg PO QPM  
5.  Carbidopa-Levodopa (___) 2 TAB PO BID  
6.  Carbidopa-Levodopa (___) 1.5 TAB PO BID  
7.  Carbidopa-Levodopa (___) 1 TAB PO ___  
8.  carbidopa 25 mg oral QAM  
9.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
10.  Hyoscyamine 0.125 mg SL TID:PRN abd pain  
11.  Ipratropium Bromide Neb 1 NEB IH Q6H  
12.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS  
13.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob  
14.  Levothyroxine Sodium 25 mcg PO DAILY  
15.  melatonin 3 mg oral QHS  
16.  Multivitamins W/minerals 1 TAB PO DAILY  
17.  Mylanta 10 mL oral QID:PRN heartburn  
18.  Nexium 40 mg Other DAILY  
19.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Mild  
20.  Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation 
BID  
21.  PredniSONE 10 mg PO DAILY  
22.  TraZODone 12.5 mg PO QHS:PRN insomnia  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Urinary tract infection
Hypovolemia/dehydration
___ disease
 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.
 
Discharge Instructions:
You were admitted with weakness and difficulty moving. You were 
found to have a urinary tract infection and dehydration. You 
were treated with antibiotics and you improved.
 
Followup Instructions:
___
"
98,15229355,21234882," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Tachypnea
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with hx of ___ disease, dementia, esophageal 
motility, reactive airway disease presenting with tachypnea x2 
days. 

History is obtained from sons, ___ and ___, at bedside. ___ 
reports that pt began reporting abdominal pains 3 days prior to 
presentation, on ___ (?). She was brought to urgent care, and 
was found to have constipation by xray. She was prescribed 
miralax with prune juice and dulcolax. ___ administered these 
medications at home with passage of flatus only, without BMs. 
She was brought to the ED on ___, with persistent 
constipation, and was discharged home on ___ in the early am 
after CT abd/pelvis revealed persistent constipation. She was 
sent home with addition of lactulose, enema, and instructions to 
f/u with her PCP ___ ___. 

Since discharge from the ED on ___ in early am, her abdominal 
distension increased, and ___ noted progressive tachypnea. He 
called the ___ NP, who initially advised increased bowel 
regimen, but subsequently referred her to the ED for further 
evaluation of RR 30. 

Since introduction of escalating regimen, she had been passing 
flatus. ___ denies reports of N/V, F/C, melena, BRBPR. Pt 
reported sharp intermittent pain at LLQ and RLQ. 

___ reports that she has occasional throat clearing, without 
overt coughing. She is maintained on nectar thickened liquids 
for the most part (occasional thin liquids such as water mixed 
with apple juice) and pureed foods (has to ""flow like 
applesauce""). He has not noticed more frequent choking on food, 
but has noted a little more ""crackling"" after eating, which she 
is often able to clear. He has not noticed any increase in ___ 
edema, and she has no reported history of VTE. She takes Boost 
x1 per day, and Ensure x2, although sometimes more Boost if she 
is able. She has not reported F/C, chest pain, or increased 
shortness of breath. 

At baseline, her son ___ stays with her through the day. Son 
___ helps at either end of the day and overnight. Three all 
live together. Pt's husband died on ___. With respect to 
mobility, she is able to get up and pivot to the commode with 
___ person assist. She always stands with shoes for purposes of 
stability, and moves with assistance of a walker. 

In the ___ ED:
VS 97.6, 82, 120/60, 94% RA--->
97.8, 77, 94/55, 28, 98% 2L NC
Exam notable for - none documented
Labs notable for WBC 11.6, Hb 10.3, plt 153
BUN 22, Cr 0.8
UA negative for infection
CT abd/pelvis without acute process

Received:
Nebs
Bisacodyl
IVF
Home medications

Pt had 3 large BMs in the ED, per family and RN notes.

On arrival to the floor, ___ confirms above history. Pt denies 
pain but appears agitation and uncomfortable.

ROS: Pt denies chest pain, SOB, reports abdominal pain, but is 
unable to provide more details or complete 10 pt ROS ___ 
dementia
 
Past Medical History:
___ Disease  
HTN 
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Bronchitis 
Hypothyroidism  

 
Social History:
___
Family History:
Reviewed and found to be not relevant to this illness/reason for 
hospitalization.

 
Physical Exam:
EXAM ON ADMISSION
VS: ___ 1854 Temp: 98.5 PO BP: 137/53 HR: 76 RR: 18 O2 sat: 
93% O2 delivery: RA - RR 28 measured by me, while pt is agitated 
and moving in bed
GEN: elderly, frail-appearing female lying in bed, appears 
agitated, requesting repeatedly to get out of bed
HEENT: Pupils symmetric, difficult to assess response to light 
and accommodation ___ patient moving her head, anicteric, 
conjunctiva pink, oropharynx with white plaques over tongue and 
posterior oropharynx, dry mucus membranes
LYMPH: no anterior/posterior cervical, supraclavicular 
adenopathy
CARDIOVASCULAR: Regular rate and rhythm without murmurs, rubs, 
or gallops, exam limited by frequent phonation
LUNGS: bibasilar coarse crackles, no wheeze, good air movement
GI: soft, nontender, without rebounding or guarding, 
nondistended with normal active bowel sounds, no hepatomegaly 
appreciated
EXTREMITIES: no clubbing, cyanosis, or edema
GU: no foley
SKIN: no rashes, petechia, lesions, or echymoses; warm to
palpation
NEURO: alert and oriented to person (""Rose""), place (""hospital"" 
- unable to name ___, year (""___""), unable to provide any 
additional details. Cranial nerves II-XII grossly intact, moves 
all extremities spontaneously, unable to assess sensation ___ 
dementia and agitation. Coarse tremor in bilateral UEs.
PSYCH: agitated, repeatedly requesting to get out of bed, 
requesting ___ (apparently an EMT she has met on multiple 
occasions), unable to articulate reason for agitation

EXAM ON DISCHARGE
Temp: 97.7 PO BP: 139/97 HR: 57 RR: 18 O2 sat: 100% O2 delivery: 
RA 
Appears her usual baseline
Breathing is unlabored, RR probably around 20, clear lungs 
bilaterally though diminished at bases, no wheezes or rhonchi
She is taking medications in applesauce slowly with assistance 
of RN without any coughing after the medications
Abdomen is benign, NT, ND, BS+
Extremities are WWP without edema
 
Pertinent Results:
ADMISSION

___ 01:43AM BLOOD WBC-11.6* RBC-3.44* Hgb-10.3* Hct-32.8* 
MCV-95 MCH-29.9 MCHC-31.4* RDW-15.7* RDWSD-54.9* Plt ___
___ 01:43AM BLOOD Glucose-142* UreaN-22* Creat-0.8 Na-138 
K-4.8 Cl-98 HCO3-24 AnGap-16
___ 01:43AM BLOOD ALT-9 AST-47* AlkPhos-48 TotBili-0.8
___ 01:43AM BLOOD Lipase-20
___ 01:43AM BLOOD Albumin-3.8 Calcium-9.2 Phos-3.7 Mg-2.5

DISCHARGE

___ 07:31AM BLOOD WBC-9.3 RBC-3.32* Hgb-10.0* Hct-31.6* 
MCV-95 MCH-30.1 MCHC-31.6* RDW-15.1 RDWSD-53.0* Plt ___
___ 07:31AM BLOOD Glucose-100 UreaN-14 Creat-0.5 Na-142 
K-4.0 Cl-104 HCO3-22 AnGap-16
___ 07:52AM BLOOD Calcium-8.9 Phos-2.7 Mg-2.3

IMAGING STUDIES

CXR: No acute process

CT A/P: 
1. No acute process within the abdomen or pelvis to explain the 
patient's symptoms on slightly motion limited exam. 
2. Redundant sigmoid colon again noted without evidence of 
obstruction. 
3. Chronic compression deformities of T11, L1, and L2 vertebrae. 


 
Brief Hospital Course:
BRIEF SUMMARY: 

___ with advanced ___ disease, dementia, esophageal 
motility, reactive airway disease presenting with tachypnea in 
the setting of severe constipation. It was thought that she was 
tachypneic due to (1) alteration of respiratory mechanics in the 
setting of abdominal distension from constipation along with (2) 
some aspiration occurring in the setting of her chronic 
oropharyngeal and esophageal dysphagia worsened by the 
aforementioned tachypnea and missing her ___ 
medications. Tachypnea slowly resolved as her constipation 
resolved and she was kept NPO. She was evaluated by SLP during 
this resolution phase and was cleared for her usual diet. She 
appeared to return to her usual baseline and so was discharged 
to home with her usual services and her sons' excellent 
attentive care.

DETAILED SUMMARY:

# Tachypnea
# Mild intermittent hypoxia
# Acute hypoxic respiratory failure
# Esophageal dysmotility: Likely aspiration in setting of 
advanced reactive airways disease and underlying restrictive 
lung mechanics due to advanced kyphosis. This was all likely 
worsened/precipitated by progressive constipation, for which she 
is unable to compensate due to her kyphosis -- leads to 
tachypnea and then tachypnea leads to aspiration which then 
precipitates a viscious cycle of more tachypnea and aspiration. 
Missing her medications also likely contributing. SLP evaluated 
her ___ and felt she was unsafe for any PO, but she appeared to 
do better ___ so diet was advanced and she tolerated this well. 
She appeared to return to her baseline by today ___ and so was 
discharged home.
- Note: A G tube can be considered for her, if in the future she 
really cannot meet her nutritional goals and can't take meds, 
but when we involved her in the discussion she said she did not 
want one. She improved so this was not explored further, but it 
may present a potential barrier to pursuing tube placement in 
the future. 

# Constipation: Severe on presentation but now moving her 
bowels. We adjusted her bowel medications to maintain 1BM per 
day. Counselled son on the following regimen:
- Standing senna now BID, Miralax now daily
- PRN Bisacodyl given HS if no BM that day

# Acute toxic metabolic encephalopathy
# Dementia: Baseline cognitive status per ___ is ""pretty high 
functioning,"" but apparently always thinks that it is ___ 
(with air conditioning always on at home), and is not oriented 
to events. Agitation on admission likely driven by recent 
constipation followed by repeated visits to the ED overnight. At 
home pt is maintained on low dose alprazolam which typically 
provides benefit for her anxiety and agitation. She improved by 
the AM after admission and appeared to be at her baseline for 
the remainder of her hospital stay.

# Advanced ___ disease: Slowly progressive per its usual 
course. Now quite advanced. Most of her above issues are the 
result of this condition. Her home medications were continued 
according to her precise home schedule and she did well. 
Neurology was not consulted this admission given her 
improvement. 

# Anemia: Chronic, stable
# Glaucoma: Continued home eye gtts
# Hypothyroidism: Continued levothyroxine
# Hyperlipidemia: Continued atorvastatin
# Anxiety: Continued alprazolam as needed
# Insomnia: Continued low dose home trazodone; substitute 
ramelteon for melatonin

>30 minutes spent coordinating discharge home
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
2. ALPRAZolam 0.25 mg PO TID:PRN anxiety 
3. Atorvastatin 20 mg PO QPM 
4. carbidopa 25 mg oral QAM 
5. Carbidopa-Levodopa (___) 2 TAB PO BID 
6. Carbidopa-Levodopa (___) 1.5 TAB PO BID 
7. Carbidopa-Levodopa (___) 1 TAB PO ___ 
8. Fluticasone Propionate 110mcg 2 PUFF IH BID 
9. Hyoscyamine 0.125 mg SL TID:PRN abd pain 
10. Ipratropium Bromide Neb 1 NEB IH Q6H 
11. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 
12. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob 
13. Levothyroxine Sodium 25 mcg PO DAILY 
14. Multivitamins W/minerals 1 TAB PO DAILY 
15. Mylanta 10 mL oral QID:PRN heartburn 
16. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 

17. PredniSONE 10 mg PO DAILY 
18. TraZODone 12.5 mg PO QHS:PRN insomnia 
19. melatonin 3 mg oral QHS 
20. Nexium 40 mg Other DAILY 
21. Senna 17.2 mg PO QHS 
22. Docusate Sodium 200 mg PO QHS 
23. Polyethylene Glycol 17 g PO DAILY 

 
Discharge Medications:
1.  Bisacodyl 10 mg PO DAILY:PRN Constipation 
RX *bisacodyl [Laxative (bisacodyl)] 5 mg 1 tablet(s) PR daily 
Disp #*30 Tablet Refills:*0 
2.  Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
RX *chlorhexidine gluconate [Peridex] 0.12 % Rinse mouth as part 
of oral care twice a day Refills:*3 
3.  Senna 17.2 mg PO BID  
4.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
5.  ALPRAZolam 0.25 mg PO TID:PRN anxiety  
6.  Atorvastatin 20 mg PO QPM  
7.  Carbidopa-Levodopa (___) 2 TAB PO BID  
8.  Carbidopa-Levodopa (___) 1.5 TAB PO BID  
9.  Carbidopa-Levodopa (___) 1 TAB PO ___  
10.  carbidopa 25 mg oral QAM  
11.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
12.  Hyoscyamine 0.125 mg SL TID:PRN abd pain  
13.  Ipratropium Bromide Neb 1 NEB IH Q6H  
14.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS  
15.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob  
16.  Levothyroxine Sodium 25 mcg PO DAILY  
17.  melatonin 3 mg oral QHS  
18.  Multivitamins W/minerals 1 TAB PO DAILY  
19.  Mylanta 10 mL oral QID:PRN heartburn  
20.  Nexium 40 mg Other DAILY  
21.  Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation 
BID  
22.  Polyethylene Glycol 17 g PO DAILY  
23.  PredniSONE 10 mg PO DAILY  
24.  TraZODone 12.5 mg PO QHS:PRN insomnia  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Tachypnea related to kyphosis and abdominal distension along 
with some dysphagia and aspiration
Constipation
___ disease

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
You were admitted with fast breathing and low oxygen levels 
while constipated. It was thought that you might have been 
aspirating some of your food/drink. You were treated with bowel 
medications and your home medications and you improved. You were 
seen by SLP here and you were cleared for a diet.
 
Followup Instructions:
___
"
99,15229355,27594813," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Altered mental status, hypoxia
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with hx of ___ disease, dementia, esophageal 
motility and reactive airway disease who initially presented to 
___ with altered mental status and hypoxia.  
The patient was recently discharged from ___ after presenting 
with tachypnea, constipation and possibly aspiration (see 
below). She was initially doing well at home but on the morning 
of admission, her son noted that she was more lethargic and was 
having trouble clearing her throat. He checked her pulse ox and 
her oxygen sat was 80%. Of note, son reported she had taken a 
Xanax prior to this episode for anxiety. He called EMS and gave 
her a nebulizer.  EMS came and placed the patient on a 
non-rebreather in the field. Son reports that patient's dyspnea 
improved by time she reached the ED.

At ___, her initial oxygen saturation was 85% but was 
weaned down to 4L in ED. Labs there significant for a wbc 11, UA 
w/ ___ WBC, 1+ bact, 1+ nitrite; cloudy. Her trop was 0.02.  
She was transferred to ___ for further evaluation of elevated 
troponin.  

The patient was unable to answer questions at the time of 
interview but son notes that she had not had any fevers, chills, 
complaints of dysuria or frequency. Son denies obvious 
aspiration event.  Patient is on honey thick liquids at home.  
Denies vomiting.  Upon arrival to ___, she is on room air.

Previous hospital admission at ___ notes were reviewed and are
summarized as follows: Admit ___ with 2 days
tachypnea and 3 days abdominal pain for which she had been to 
urgent care prior.
Constipation and mild distention noted. Thought to have 
aspirated
prior to admission. Per son noted pt requiring apple-sauce
consistency liquids and often with 'crackling' sound after
eating, usually clears with coughing. Of note, on ___, UCx
growing pan-sensi Enterococcus (not speciated)

She was admitted to Medicine.

 
Past Medical History:
___ Disease  
HTN 
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Bronchitis 
Hypothyroidism  

 
Social History:
___
Family History:
Reviewed and found to be not relevant to this illness/reason for 
hospitalization.

 
Physical Exam:
ADMISSION EXAM:

VITALS: Afebrile and vital signs stable (see eFlowsheet)
GENERAL: Alert and in no apparent distress; oriented to person,
place
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4.  jugular flat
RESP: difficult auscultation given poor patient participation;
clear in bases; no wheeze; kyphosis noted
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.  No HSM
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented to person/place, face symmetric, gaze
conjugate with EOMI, moves all limbs, sensation to light touch
grossly intact throughout
PSYCH: unable to answer any but basic questions

DISCHARGE EXAM:
VITALS: Afebrile and vital signs stable (see eFlowsheet)
GENERAL: Alert and in no apparent distress; answering questions
this morning
EYES: Anicteric, pupils equally round
ENT: Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4.  jugular flat
RESP: easy work of breathing, clear in bases; kyphosis noted
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.  No HSM
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Sleepy, AOx2, moving all extremities
 
Pertinent Results:
ADMISSION LABS:
___ 06:17PM   cTropnT-<0.01
___ 01:20PM URINE  COLOR-Yellow APPEAR-Cloudy* SP 
___
___ 01:20PM URINE  BLOOD-NEG NITRITE-POS* PROTEIN-TR* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 
LEUK-NEG
___ 01:20PM URINE  RBC-<1 WBC-<1 BACTERIA-FEW* YEAST-NONE 
EPI-0
___ 01:20PM URINE  AMORPH-MANY*
___ 12:47PM   LACTATE-1.3
___ 12:30PM   GLUCOSE-109* UREA N-28* CREAT-0.7 SODIUM-141 
POTASSIUM-4.3 CHLORIDE-100 TOTAL CO2-28 ANION GAP-13
___ 12:30PM   ALT(SGPT)-<5 AST(SGOT)-21 ALK PHOS-55 TOT 
BILI-1.1
___ 12:30PM   cTropnT-0.02*
___ 12:30PM   ALBUMIN-4.2
___ 12:30PM   WBC-11.5* RBC-3.62* HGB-10.9* HCT-34.2 MCV-95 
MCH-30.1 MCHC-31.9* RDW-15.3 RDWSD-52.7*
___ 12:30PM   NEUTS-87.0* LYMPHS-7.1* MONOS-4.0* EOS-0.8* 
BASOS-0.3 IM ___ AbsNeut-10.04* AbsLymp-0.82* AbsMono-0.46 
AbsEos-0.09 AbsBaso-0.04

PERTINENT LABS:
Blood cultures no growth
Urine culture > 100,000 CFU Klebsiella, pan sensitive

DISCHARGE LABS:
___ 07:25AM BLOOD WBC-7.5 RBC-3.06* Hgb-9.2* Hct-29.9* 
MCV-98 MCH-30.1 MCHC-30.8* RDW-15.1 RDWSD-54.9* Plt ___
___ 07:25AM BLOOD Neuts-68.5 Lymphs-18.8* Monos-8.2 Eos-3.4 
Baso-0.4 Im ___ AbsNeut-5.11 AbsLymp-1.40 AbsMono-0.61 
AbsEos-0.25 AbsBaso-0.03
___ 07:25AM BLOOD Glucose-86 UreaN-21* Creat-0.5 Na-140 
K-3.6 Cl-103 HCO3-24 AnGap-13
 
Brief Hospital Course:
# Hypoxia requiring supplemental oxygen: 
The etiology of the patient's hypoxia at home is unclear.  Her 
oxygen saturations improved quickly when she reached ___ 
ED and she was on room air when she arrived at ___.  Chest XR 
did now show a pneumonia.  I suspect she was having trouble 
clearing her throat due to lethargy (side-effect from prior 
Xanax use) and had a transient airway obstruction or mucus plug 
as the source of her hypoxia.  While she was in the hospital she 
was continued on her home duonebs, flovent and prednisone.  Her 
son ___ plans to only give her half of a Xanax for anxiety in 
the future.

# Toxic Metabolic Encephalopathy: 
Her altered mental status at the time of admission was likely 
from a combination of medication side-effect (Xanax) as well as 
urinary tract infection.  UA was positive and urine culture grew 
> 100,000 CFU pan sensitive Klebsiella.  She completed a course 
of antibiotics while hospitalized.  Sedating medications were 
used sparingly and son ___ try melatonin for sleep rather 
than a benzodiazepine.  Trazodone was held.  

# Troponinemia:
- Initial troponin at ___ was 0.02.  She was 
transferred to ___ for further evaluation.  Her troponins 
trended 0.02 --> 0.02 --> <0.01.  Her EKG was unchanged from her 
baseline and she did not show any signs of ACS.

# Constipation: Continue senna, Miralax, bisacodyl

CHRONIC/STABLE PROBLEMS:
# Anemia: Chronic, stable
# Glaucoma: Continued home eye gtts
# Hypothyroidism: Continued levothyroxine
# Hyperlipidemia: Continued atorvastatin
# Anxiety: Continued alprazolam sparingly as needed
# Insomnia: Substitute melatonin for trazodone at discharge
# GERD: Nexium

Appeal of Discharge: Patient's son ___ appealed his mother's 
discharge.  He had a few concerns as follows.  He wanted his 
mother to complete the course of antibiotics in the hospital.  I 
explained that this was not necessary since we had culture data 
to ensure good response to PO medications.  He wanted his mother 
to have a feeding tube placed.  While this can be considered, 
___ had recently passed a swallow evaluation and had done well 
with her medications and honey thick diet in the hospital.  She 
showed no signs of aspiration.  When I initially discussed a 
feeding tube with ___, she said she did not want one.  I 
advised ___ to discuss this topic further with his PCP and 
___.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
2. ALPRAZolam 0.25 mg PO TID:PRN anxiety 
3. Atorvastatin 20 mg PO QPM 
4. carbidopa 25 mg oral QAM 
5. Carbidopa-Levodopa (___) 2 TAB PO BID 
6. Carbidopa-Levodopa (___) 1.5 TAB PO BID 
7. Carbidopa-Levodopa (___) 1 TAB PO ___ 
8. Fluticasone Propionate 110mcg 2 PUFF IH BID 
9. Hyoscyamine 0.125 mg SL TID:PRN abd pain 
10. Ipratropium Bromide Neb 1 NEB IH Q6H 
11. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 
12. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob 
13. Levothyroxine Sodium 25 mcg PO DAILY 
14. Multivitamins W/minerals 1 TAB PO DAILY 
15. Mylanta 10 mL oral QID:PRN heartburn 
16. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 

17. Polyethylene Glycol 17 g PO DAILY 
18. PredniSONE 10 mg PO DAILY 
19. Senna 17.2 mg PO BID:PRN Constipation - First Line 
20. TraZODone 12.5 mg PO QHS:PRN insomnia 
21. Bisacodyl 10 mg PO DAILY:PRN Constipation 
22. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
23. melatonin 3 mg oral QHS 
24. Nexium 40 mg Other DAILY 
25. Carbidopa-Levodopa (___) 2 TAB PO Q24 

 
Discharge Medications:
1.  Carbidopa-Levodopa (___) 2 TAB PO Q24H  
2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
3.  ALPRAZolam 0.25 mg PO TID:PRN anxiety  
4.  Atorvastatin 20 mg PO QPM  
5.  Bisacodyl 10 mg PO DAILY:PRN Constipation  
6.  Carbidopa-Levodopa (___) 2 TAB PO BID  
7.  Carbidopa-Levodopa (___) 2 TAB PO Q24 
4:00 ___  
8.  Carbidopa-Levodopa (___) 1.5 TAB PO BID  
9.  Carbidopa-Levodopa (___) 1 TAB PO ___  
10.  carbidopa 25 mg oral QAM  
11.  Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID  
12.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
13.  Hyoscyamine 0.125 mg SL TID:PRN abd pain  
14.  Ipratropium Bromide Neb 1 NEB IH Q6H  
15.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS  
16.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob  
17.  Levothyroxine Sodium 25 mcg PO DAILY  
18.  melatonin 3 mg oral QHS  
19.  Multivitamins W/minerals 1 TAB PO DAILY  
20.  Mylanta 10 mL oral QID:PRN heartburn  
21.  Nexium 40 mg Other DAILY  
22.  Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation 
BID  
23.  Polyethylene Glycol 17 g PO DAILY  
24.  PredniSONE 10 mg PO DAILY  
25.  Senna 17.2 mg PO BID:PRN Constipation - First Line  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Urinary Tract Infection

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Bedbound.

 
Discharge Instructions:
You were admitted with altered mental status and decreased 
oxygen levels.  You were likely altered (confused, not acting 
yourself) since you had a urinary tract infection and you had 
taken a sedating medication, Xanax, the night before.  You were 
given an antibiotic to treat your pneumonia. 

You also had low oxygen levels at home.  Since you were confused 
and sleepy, you likely had trouble clearing your mucus 
secretions.  This brief mucus blockage was the likely cause of 
your low oxygen level at home.  You did not show any signs of 
pneumonia and your oxygen levels quickly returned to normal.

At home, please ensure you give yourself adequate time to eat 
your meals.  Please decrease use of sedating medications like 
Xanax or take half a pill of Xanax.  You will follow-up with 
your primary care doctor and ___ as below.
 
Followup Instructions:
___
"
100,15229355,24758395," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
RLQ/hip pain
 
Major Surgical or Invasive Procedure:
PEG placement - ___

 
History of Present Illness:
___ with ___ disease, esophageal dysmotility, dementia 
who presents with hip pain versus abdominal pain. She is 
accompanied by her son, who assists with a history. He states 
that today she began complaining of pain in her right side with 
ambulation. 

On reevaluation in the ED, patient coughing and having some mild 
difficulty breathing. She received nebulizer treatment with some 
improvement, however she is noted to have a new oxygen 
requirement, with O2 sat in the high ___ on room air. Patient 
noted to be fatigued, weak, with difficulty swallowing ensure 
given by family, concern for aspiration, very weak cough. She 
was started on empiric treatment for aspiration PNA. Reportedly 
was too weak to work with ___ in the ED, and was admitted to 
medicine for weakness and hypoxia.

 
Past Medical History:
___ Disease  
HTN 
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Bronchitis 
Hypothyroidism   
 
Social History:
___
Family History:
Reviewed and none pertinent to this hospitalization
 
Physical Exam:
ADMISSION EXAM
==============
VITALS: T 98.2, BP 135/53, HR 93, RR 24, ___ 
General: alert, restless. Trying to get out of bed.
HEENT: Sclerae anicteric, MMM, oropharynx clear.
CV: RRR, S1+S2, no M/R/G 
Lungs: faint scattered ronchi throughout, faint crackles at 
bases 
Abdomen: non-distended, soft, non-tender. No rebound or 
guarding.
Ext: WWP, no edema. 
Skin: Warm, dry, no rashes or notable lesions.  
Neuro: Resting tremor in all 4 extremities. Restless and 
constantly moving around in bed. Alert, oriented to self and 
hospital. Perseverating on getting water.

DSICHARGE EXAM
==============
VITALS: ___ 0752 Temp: 99.9 BP: 105/64 R
Lying HR: 88 RR: 20 O2 sat: 94% O2 delivery: RA 
General: alert, lying propped up in in bed. NAD.
HEENT: Sclerae anicteric, MMM, oropharynx clear.
CV: RRR, S1+S2, no M/R/G 
Lungs: faint scattered ronchi throughout
Abdomen: non-distended, soft, non-tender. Has PEG in LUQ, no
surrounding erythema or drainage/bleeding. Non-tender.
Back: no TTP over right side/flank
Ext: WWP, no edema. 
Skin: Warm, dry, no rashes or notable lesions.  
Neuro: Resting tremor in all 4 extremities. Lying propped up in
bed, slouched to right side. Alert, oriented to self and
hospital. 
 
Pertinent Results:
ADMISSION LABS
==============
___ 09:06PM   WBC-12.3* RBC-3.94 HGB-11.8 HCT-37.9 MCV-96 
MCH-29.9 MCHC-31.1* RDW-14.6 RDWSD-51.8*
___ 09:06PM   NEUTS-79.1* LYMPHS-11.3* MONOS-8.1 EOS-0.5* 
BASOS-0.2 IM ___ AbsNeut-9.71* AbsLymp-1.39 AbsMono-1.00* 
AbsEos-0.06 AbsBaso-0.03
___ 09:30PM   GLUCOSE-107* UREA N-18 CREAT-0.6 SODIUM-146 
POTASSIUM-4.2 CHLORIDE-109* TOTAL CO2-26 ANION GAP-11
___ 09:30PM   CALCIUM-8.8 PHOSPHATE-3.2 MAGNESIUM-2.2
___ 09:06PM   GLUCOSE-98 UREA N-24* CREAT-0.7 SODIUM-149* 
POTASSIUM-4.4 CHLORIDE-105 TOTAL CO2-29 ANION GAP-15
___ 09:06PM   ALT(SGPT)-<5 AST(SGOT)-23 ALK PHOS-74 TOT 
BILI-1.2
___ 09:06PM   LIPASE-14
___ 09:06PM   ALBUMIN-4.2 CALCIUM-9.8 PHOSPHATE-3.3 
MAGNESIUM-2.3

MICRO
=====
None

DISCHARGE LABS
==============
___ 06:30AM BLOOD WBC-10.5* RBC-3.18* Hgb-9.5* Hct-30.4* 
MCV-96 MCH-29.9 MCHC-31.3* RDW-15.0 RDWSD-51.8* Plt ___
___ 06:30AM BLOOD Glucose-131* UreaN-16 Creat-0.4 Na-138 
K-4.3 Cl-103 HCO3-27 AnGap-8*
___ 06:30AM BLOOD Calcium-8.7 Phos-2.2* Mg-2.2

IMAGING/STUDIES
================

CT ABD/PELVIS ___
1. No acute abnormality within the abdomen or pelvis. 
2. Sigmoid diverticulosis, without evidence of acute 
diverticulitis. 
3. Stable compression deformities of the T11, L1, and L2 
vertebral bodies. 

CXR ___
Left basilar atelectasis.  No definite acute cardiopulmonary 
abnormality.

G-TUBE PLACEMENT ___
A 65 cm, 5 ___ glide catheter was negotiated through the 
Nares down to the stomach using a 0.035 glidewire.  Position in 
the stomach was confirmed with injection of air.  The tube was 
then secured and used for insufflation.  A scout image of the 
abdomen was obtained. The stomach was insufflated through the 
indwelling nasogastric tube. Under fluoroscopic guidance, 2 T 
fastener buttons were sequentially deployed elevating the 
stomach to the anterior abdominal wall. Intra-gastric position 
was confirmed with aspiration of air and injection of contrast. 
A 19 gauge needle was introduced under fluoroscopic guidance and 
position confirmed using an injection of dilute contrast. A 
Amplatz wire was introduced into the  stomach. A small skin 
incision was made along the needle and the needle was removed. 
After sequential dilation using 12, 14 in 16 ___ dilators, a 
18 ___  peel-away sheath was placed.  A 14 ___ MIC 
gastrostomy catheter was advanced over the wire into position. 
The catheter was secured by instilling dilute contrast into the 
balloon.  Contrast injection confirmed intragastric  position.  
The catheter was then flushed, capped and secured. Sterile 
dressings were applied. The patient tolerated the procedure well 
and there were no immediate 
complications. 

 
Brief Hospital Course:
___ with ___ disease, esophageal dysmotility, dementia 
who presented with hip pain versus abdominal pain, developed 
acute hypoxia while in the ED from aspiration. Admitted to the 
hospital for hypoxia.

#GOALS OF CARE:
#CHRONIC ASPIRATION
#UNINTENTIONAL WEIGHT LOSS
   The patient has oropharyngeal dysphagia due to her advanced 
___ disease and esophageal dysphagia due to her 
esophageal dysmotility. She had been taking a honey-thick diet 
at home (mostly Boost), but had been losing weight despite the 
heroic efforts of her son to encourage oral feedings, and also 
had a clinically overt aspiration event in the ED despite 
texture modification of her diet. She was seen by speech and 
swallow, who felt that even if we thicken food enough to help 
with the oropharyngeal phase of swallow, there is little we can 
do about the esophageal issue; she was recommended for strict 
NPO. 
    Given that the dysphagia is related to issues other than her 
dementia (which is not end-stage), we felt she would be a 
candidate for a feeding tube, if within the goals of care. It 
was difficult to directly understand the patient's own goals - 
there is prior documentation that the patient would refuse a 
feeding tube, and she was able to say in AM on ___ (in front 
of myself, attending MD, RN, and son) that she would not want a 
feeding tube. Since then, she said ""I'm thinking about it"" when 
asked about wanting a feeding tube. It was very difficult to 
interpret patient's wishes in this setting, and as such, we had 
to rely on the patient's son and HCP ___, who is her 
___ caregiver at home. We discussed with him that feeding tubes 
do not eliminate the risk of aspiration, but that it would 
probably be safer than oral feedings and would at least help to 
deliver nutrition more reliably and successfully. After some 
vacillation, he ultimately decided he was strongly in favor of a 
feeding tube.
    As such, interventional radiology was consulted and a PEG 
was successfully placed on ___. Tube feeds initiated on 
___ - pt tolerated well prior to discharge. She will receive 
cycled tube feeds 16 hours per day. She is also continued on her 
home BID PPI (to reduce the acidity of gastric contents should 
she micro-aspirate) and on BID chlorhexidine mouthwash.

#ACUTE HYPOXEMIC RESPIRATORY FAILURE:
#REACTIVE AIRWAY DISEASE:
#CHRONIC ASPIRATION RISK:
    Hypoxia resolved over time - ultimately it was attributed to 
aspiration pneumonitis. She is followed by Dr ___ 
pulmonology - she does not have a formal pulmonary diagnosis, as 
she is unable to cooperate for PFTs, but seems to have some mild 
pulmonary fibrosis and some kind of reactive airway disease. No 
symptoms this admission suggestive of exacerbation of reactive 
airway disease. She was continued on all of her home 
inhalers/nebulizers. 

#RIGHT SIDE PAIN:
   Pt had originally presented with pain in R side while 
ambulating - though per prior ___ records, pt is largely 
wheelchair bound and requires a lift at home for transfers, so 
unclear how much she is ambulating. She has no pain on arrival 
to the floor and no pain is elicited on exam. Had CT abd without 
any findings to explain possible RLQ pain. Has had intermittent 
constipation; ensured robust bowel regimen. Clinically felt to 
be consistent with muscle spasms in the setting of PD - treated 
with ibuprofen and acetaminophen.

#HYPERNATREMIA:
   Na 149 on admission, suspect it is due to limited free water 
intake (in the setting of needing nectar-thickened liquids). 
Resolved once started on tube feeds with free water flushes.

#PARKINSONS DISEASE:
   Has progressive ___ disease with associated 
esophageal dysmotility. Continued home carbidopa-levodopa. 
Continued home Hyoscyamine 0.125 mg SL TID:PRN esophageal spasm

#DEMENTIA:
Probably moderate in severity, but hard to assess given her 
difficulty communicating in the setting her advanced PD. Mental 
status at baseline, per son.

#HLD:
Continued home atorvastatin 20mg daily.

#HYPOTHYROIDISM:
Continued home Levothyroxine 25 mcg PO/NG DAILY.

TRANSITIONAL ISSUES:
==================
[] Started on home tube feeds (supplied via ___. Some meds 
have been changed to liquid or crushable formulations.
[] Please note that her son is very involved in her care and 
provides her with excellent (essentially LTAC-level) elder care 
at home. However, his high standards for care quality and his 
granular involvement in details of care can at times interfere 
with care delivery. For any subsequent admissions, please refer 
to ""Team Meeting"" note from ___ for details on agreements 
that have been reached with ___ about boundaries on his intimate 
involvement with his mother's inpatient care. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
2. ALPRAZolam 0.25 mg PO TID:PRN anxiety 
3. Atorvastatin 20 mg PO QPM 
4. carbidopa 25 mg oral BID 
5. Carbidopa-Levodopa (___) 1.5 TAB PO Q24H 
6. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
7. Fluticasone Propionate 110mcg 2 PUFF IH BID 
8. Ipratropium Bromide Neb 1 NEB IH Q6H 
9. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob 
10. Levothyroxine Sodium 25 mcg PO DAILY 
11. melatonin 3 mg oral QHS 
12. Multivitamins W/minerals 1 TAB PO DAILY 
13. Mylanta 10 mL oral QID:PRN heartburn 
14. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 

15. Polyethylene Glycol 17 g PO DAILY 
16. PredniSONE 10 mg PO DAILY 
17. Bisacodyl 10 mg PO DAILY:PRN Constipation 
18. Senna 17.2 mg PO QHS 
19. Carbidopa-Levodopa (___) 2 TAB PO Q24H 
20. Carbidopa-Levodopa (___) 2 TAB PO Q24H 
21. Carbidopa-Levodopa (___) 1.5 TAB PO Q24H 
22. Carbidopa-Levodopa (___) 1 TAB PO Q24H 
23. Carbidopa-Levodopa (___) 1 TAB PO Q24H 
24. Esomeprazole 20 mg Other BID 
25. Hyoscyamine 0.125 mg SL TID:PRN esophageal spasm 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 975 mg PO Q8H 
RX *acetaminophen 500 mg/15 mL 30 mL by mouth every eight (8) 
hours Disp #*3 Liter Refills:*0 
2.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
RX *lansoprazole 30 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0 
3.  Lidocaine 5% Patch 1 PTCH TD QPM Pain 
RX *lidocaine [Lidoderm] 5 % 1 patch daily Disp #*30 Patch 
Refills:*0 
4.  Milk of Magnesia 30 mL PO Q8H 
Hold for loose stool 
RX *magnesium hydroxide [Milk of Magnesia] 400 mg/5 mL 30 mL by 
mouth every eight (8) hours Refills:*0 
5.  Multi Vitamin (multivit-minerals-ferrous fum) 9 mg iron/15 
mL oral DAILY 
Any liquid multivitamin is OK. Give the amount suggested by the 
manufacturer. 
RX *multivit-minerals-ferrous fum [Complete 
Multivitamin-Mineral] 9 mg iron/15 mL 30 mL by mouth daily Disp 
#*1 Bottle Refills:*0 
6.  senna 17.6 mg/10 mL oral QHS 
Hold for loose stools 
RX *sennosides [senna] 8.8 mg/5 mL 10 mL by mouth at bedtime 
Refills:*0 
7.  Multivitamins W/minerals 15 mL PO DAILY  
8.  Atorvastatin 20 mg PO QPM  
9.  Carbidopa-Levodopa (___) 1.5 TAB PO Q24H  
10.  Carbidopa-Levodopa (___) 2 TAB PO Q24H  
11.  Carbidopa-Levodopa (___) 2 TAB PO Q24H  
12.  Carbidopa-Levodopa (___) 1.5 TAB PO Q24H  
13.  Carbidopa-Levodopa (___) 1 TAB PO Q24H  
14.  Carbidopa-Levodopa (___) 1 TAB PO Q24H  
15.  carbidopa 25 mg oral BID  
16.  Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID  
17.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
18.  Hyoscyamine 0.125 mg SL TID:PRN esophageal spasm  
19.  Ipratropium Bromide Neb 1 NEB IH Q6H  
20.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob  
21.  Levothyroxine Sodium 25 mcg PO DAILY  
22.  melatonin 3 mg oral QHS  
23.  Mylanta 10 mL oral QID:PRN heartburn  
24.  Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation 
BID  
25.  Polyethylene Glycol 17 g PO DAILY  
26.  PredniSONE 10 mg PO DAILY  
27.Portable suction device
Please supply portable suction device, connector tubing, 
Yankauer suction tip, and cannisters.
Dx: ___ disease, esophageal dysmotility
___: 13 months

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES: 
Acute hypoxic respiratory failure due to aspiration 
___ disease 
Esophageal dysmotility 
 
SECONDARY DIAGNOSES: 
Muscle spasms 
 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
WHY WERE YOU ADMITTED TO THE HOSPITAL?
- Your oxygen level was low and you were requiring extra oxygen.

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?
- You had multiple episodes of aspiration while you were here; 
ultimately, it was decided that you would have a feeding tube 
placed. You had a G-tube placed and started to receive nutrition 
that way.
- You were seen by our nutritionists and speech/language 
pathologists - it was determined that, due to your risk of 
aspiration, it was not safe for you to eat or drink anything by 
mouth. You should get all of your nutrition and medicines 
through your feeding tube. 
- You were given fluid through an IV.
- Your oxygen level improved and was stable without extra 
oxygen.
- We gave you Tylenol and ibuprofen for the pain in your right 
side.

WHAT WILL HAPPEN WHEN YOU LEAVE THE HOSPITAL?
- Continue to take all of your medicines as prescribed.
- Continue your nutrition through your feeding tube. We 
recommend that, if you truly want to minimize your risk of 
aspiration, you do not eat or drink anything by mouth. 
- That said... many people sometimes decide to do unsafe things 
that make them happy. If you feel it is important for quality of 
life to accept the risk of taking a few sips of honey-thick 
liquid once in a while, that is not totally unreasonable. People 
want to stay healthy, but they want to be happy too! 
- Please keep all of your appointments, as scheduled.
 
Followup Instructions:
___
"
101,15229355,22438691," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Lethargy
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Patient is a ___ year old female, history of ___ disease,
lung disease, esophageal dysmotility s/p feeding tube, dementia,
who presents with concern for fever and lethargy. Patient's son
reports that she has been more lethargic over the last day,
reports that she felt subjectively cool at home to touch. Took
temperature at home, registered 99 F, which he reports is very
unusual for her. Patient received multiple doses of Tylenol
today, which son is concerned may be masking underlying fever. 
No
sputum production or hemoptysis. Denies abdominal pain. Notes
possible foul-smelling urine. Denies notable change in bowel
movements. Denies mental status change. Denies chest pain,
shortness of breath, nausea, vomiting, change in bowel or 
bladder
function, change in vision or hearing, bruising, adenopathy, new
rash or lesion.

ED Course notable for:

Initial Vitals in the ED:
T 99.8, HR 80, BP 124/84, RR 16, Sat 95% RA
 
Exam notable for:
Gen: Tremulous, No Acute Distress
HEENT: NC/AT. EOMI. 
Neck: No swelling. Trachea is midline. No JVD
Cor: RRR. No m/r/g. 
Pulm: Minimal air movement, no clear rhonchi or wheezes.
Abd: Feeding tube in mid abdomen. No surrounding erythema or
discharge. Soft, nontender, nondistended.
Ext: No edema, cyanosis, or clubbing. 
Skin: No rashes. No skin breakdown
Neuro: Patient interactive. Tremulous. Gross sensorimotor 
intact.

Psych: Normal mentation. 
Heme: No petechia. No ecchymosis.

Relevant labs/imaging:
CXR:
IMPRESSION:  
Asymmetric edema, right upper lobe, or atypical pneumonia. 

CBC: WBC 9.7 Hgb 10.5 Hct 34.5 Plt 173
Na 143 K 4.9 Cl 100 CO2 25 BUN 19 Cr 0.5 Gluc 117
Lactate 1.9
Flu A/B negative
proBNP 371
Trop-T <0.01
UA - Lg Leuk, Trace Blood, Positive Nitr, 2 RBC, > 182 ___

Consults:
None

Patient Received:
IV CefTRIAXone 1 gm   
PO/NG Levothyroxine Sodium 25 mcg 
PO/NG Carbidopa-Levodopa (___) 2 TAB  
oral carbidopa *NF* 25 mg  
PO/NG PredniSONE 10 mg  
IH Ipratropium-Albuterol Neb  
PO/NG Carbidopa-Levodopa (___) 1.5 TAB 
PO/NG Carbidopa-Levodopa (___) 1.5 TAB 
PO/NG Lansoprazole Oral Disintegrating Tab 30 mg  
NEB Levalbuterol Neb .63 mg 

Vitals on Transfer: 

Upon arrival to the floor history obtained via patient and son.
Patient is able to answer simple questions but advanced
parkinsons limits her ability to speak. She endorses no pain at
present, no difficulty breathing. Denies dysuria at home though
son states her urine did have strong ammonia odor to it. She
confirmed that she was feeling more tired and ""out of it"" at 
home
than normal for her though as of this morning she has been
feeling much better. Per her son she seems to be back at her
mental status baseline. 

REVIEW OF SYSTEMS: Complete ROS obtained and is otherwise
negative.
 
Past Medical History:
___ Disease  
HTN 
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Bronchitis 
Hypothyroidism 
Recurrent Aspiration s/p PEG placement 
 
Social History:
___
Family History:
Reviewed and none pertinent to this hospitalization
 
Physical Exam:
ADMISSION PHYSICAL EXAM: 
GENERAL: Alert and interactive. In no acute distress. 
HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without 
injection.
MMM. 
NECK: No cervical lymphadenopathy. No JVD. 
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops. 
LUNGS: Poor air movement otherwise lungs clear bilaterally
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep
palpation in all four quadrants. Has PEG in LUQ, no surrounding
erythema or drainage/bleeding.
EXTREMITIES: No clubbing, cyanosis, or edema. 
SKIN: Warm. No rashes or lesions 
NEUROLOGIC: Resting tremor in all 4 extremities. Lying propped 
up
in bed, slouched to right side. Alert, oriented to self and
hospital.  

DISCHARGE PHYSICAL EXAM: 
24 HR Data (last updated ___ @ 1121)
    Temp: 98.8 (Tm 98.8), BP: 149/70 (106-149/58-71), HR: 95
(81-98), RR: 18 (___), O2 sat: 95% (92-95), O2 delivery: Ra  
GENERAL: Alert and interactive, NAD. Speech is difficult to
understand
HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without 
injection.
MMM. 
NECK: No cervical lymphadenopathy. No JVD. 
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops. 
LUNGS: Poor air movement otherwise lungs clear bilaterally
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep
palpation in all four quadrants. Has PEG in LUQ, no surrounding
erythema or drainage/bleeding.
EXTREMITIES: No clubbing, cyanosis, or edema. 
SKIN: Warm. No rashes or lesions 
NEUROLOGIC: Resting tremor in all 4 extremities. Lying in bed.
Alert, oriented to self, hospital. Says year is ___.
 
Pertinent Results:
ADMISSION/DISCHARGE LABS:
___ 03:37AM BLOOD WBC-9.7 RBC-3.46* Hgb-10.5* Hct-34.5 
MCV-100* MCH-30.3 MCHC-30.4* RDW-15.9* RDWSD-57.6* Plt ___
___ 06:27AM BLOOD WBC-6.7 RBC-3.31* Hgb-9.9* Hct-32.8* 
MCV-99* MCH-29.9 MCHC-30.2* RDW-15.9* RDWSD-57.7* Plt ___
___ 03:37AM BLOOD Neuts-70.6 Lymphs-18.2* Monos-7.9 Eos-2.3 
Baso-0.4 Im ___ AbsNeut-6.83* AbsLymp-1.76 AbsMono-0.76 
AbsEos-0.22 AbsBaso-0.04
___ 03:37AM BLOOD Glucose-117* UreaN-19 Creat-0.5 Na-137 
K-6.3* Cl-100 HCO3-25 AnGap-12
___ 06:27AM BLOOD Glucose-119* UreaN-21* Creat-0.5 Na-142 
K-4.3 Cl-103 HCO3-26 AnGap-13
___ 03:37AM BLOOD ALT-7 AST-69* AlkPhos-73 TotBili-0.5
___ 03:37AM BLOOD cTropnT-<0.01 proBNP-371
___ 03:37AM BLOOD Albumin-3.8 Calcium-9.3 Phos-3.8 Mg-2.3
___ 06:27AM BLOOD Calcium-9.2 Phos-3.3 Mg-2.4
___ 03:56AM BLOOD Lactate-1.9 K-4.9

___ 3:37 am URINE     Site: NOT SPECIFIED

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      PROTEUS MIRABILIS.    >100,000 CFU/mL.  PRESUMPTIVE 
IDENTIFICATION. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             PROTEUS MIRABILIS
                             |   
AMPICILLIN------------   <=2 S
AMPICILLIN/SULBACTAM--   <=2 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

BLOOD CULTURE ___ x2, NGTD

PORTABLE ABDOMENStudy Date of ___ 6:20 ___
IMPRESSION:  
There is a percutaneous gastrostomy tube projecting over the 
left upper
quadrant of the abdomen.  Evaluation for intraluminal location 
is limited by
the absence of enteric contrast.  There are no abnormally 
dilated loops of
large or small bowel.  There is redemonstration of the redundant 
loops of
sigmoid colon.  There is no free intraperitoneal air, although 
evaluation is
limited by supine technique. There are no unexplained soft 
tissue
calcifications or radiopaque foreign bodies.

CHEST (PA & LAT)Study Date of ___ 4:15 AM
IMPRESSION: 
Asymmetric edema, right upper lobe, or atypical pneumonia.
 
Brief Hospital Course:
___ with ___ disease, esophageal dysmotility, dementia, 
eactive airway disease/fibrotic lung disease who presented with 
lethargy at home, found to have likely UTI and possible 
pneumonia. She was treated with cefpodoxime and azithromycin and 
mental status improved to baseline. She was discharged home to 
complete a total of 5 days of antibiotics for UTI and possible 
CAP.

ACUTE ISSUES:
#UTI: UA with leuks and nitrites, culture grew pan-senstivie 
proteus.

#?CAP: Azithromycin added to cefpodoxime to cover for possible 
CAP. Continued home prednisone, fluticasone, and perforomist.

#Lethargy: Improved with antibiotics. Returned to baseline 
mental status at discharge.

#CODE: Full Code (presumed)
#CONTACT: ___ (Son/HCP) ___
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 20 mg PO QPM 
2. carbidopa 25 mg oral BID 
3. Carbidopa-Levodopa (___) 1.5 TAB PO Q24H 
4. Carbidopa-Levodopa (___) 2 TAB PO Q24H 
5. Carbidopa-Levodopa (___) 2 TAB PO Q24H 
6. Carbidopa-Levodopa (___) 1.5 TAB PO Q24H 
7. Carbidopa-Levodopa (___) 1 TAB PO Q24H 
8. Carbidopa-Levodopa (___) 1 TAB PO Q24H 
9. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
10. Fluticasone Propionate 110mcg 2 PUFF IH BID 
11. Hyoscyamine 0.125 mg SL TID:PRN esophageal spasm 
12. Ipratropium Bromide Neb 1 NEB IH Q6H 
13. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob 
14. Levothyroxine Sodium 25 mcg PO DAILY 
15. Mylanta 10 mL oral QID:PRN heartburn 
16. Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation BID 

17. Polyethylene Glycol 17 g PO DAILY 
18. PredniSONE 10 mg PO DAILY 
19. melatonin 3 mg oral QHS 
20. Acetaminophen (Liquid) 975 mg PO Q8H 
21. Multi Vitamin (multivit-minerals-ferrous fum) 9 mg iron/15 
mL oral DAILY 
22. Multivitamins W/minerals 15 mL PO DAILY 
23. Milk of Magnesia 30 mL PO Q8H 
24. Lidocaine 5% Patch 1 PTCH TD QPM Pain 
25. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
26. Ibuprofen Suspension 600 mg PO Q8H:PRN Pain - Mild 

 
Discharge Medications:
1.  Azithromycin 250 mg PO DAILY Duration: 3 Doses 
RX *azithromycin 250 mg 1 tablet(s) G-tube Daily Disp #*3 Tablet 
Refills:*0 
2.  Cefpodoxime Proxetil 400 mg PO Q12H Duration: 7 Doses 
RX *cefpodoxime 200 mg 2 tablet(s) G-tube twice a day Disp #*14 
Tablet Refills:*0 
3.  Acetaminophen (Liquid) 975 mg PO Q8H  
4.  Atorvastatin 20 mg PO QPM  
5.  Carbidopa-Levodopa (___) 2 TAB PO Q24H  
6.  Carbidopa-Levodopa (___) 2 TAB PO Q24H  
7.  Carbidopa-Levodopa (___) 1.5 TAB PO Q24H  
8.  Carbidopa-Levodopa (___) 1 TAB PO Q24H  
9.  Carbidopa-Levodopa (___) 1 TAB PO Q24H  
10.  Carbidopa-Levodopa (___) 1.5 TAB PO Q24H  
11.  carbidopa 25 mg oral BID  
12.  Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID  
13.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
14.  Hyoscyamine 0.125 mg SL TID:PRN esophageal spasm  
15.  Ibuprofen Suspension 600 mg PO Q8H:PRN Pain - Mild  
16.  Ipratropium Bromide Neb 1 NEB IH Q6H  
17.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
18.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob  
19.  Levothyroxine Sodium 25 mcg PO DAILY  
20.  Lidocaine 5% Patch 1 PTCH TD QPM Pain  
21.  melatonin 3 mg oral QHS  
22.  Milk of Magnesia 30 mL PO Q8H  
23.  Multi Vitamin (multivit-minerals-ferrous fum) 9 mg iron/15 
mL oral DAILY  
24.  Multivitamins W/minerals 15 mL PO DAILY  
25.  Mylanta 10 mL oral QID:PRN heartburn  
26.  Perforomist (formoterol fumarate) 20 mcg/2 mL inhalation 
BID  
27.  Polyethylene Glycol 17 g PO DAILY  
28.  PredniSONE 10 mg PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnoses: UTI, community acquired pneumonia

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,  
 
It was a pleasure taking part in your care here at ___!  

Why was I admitted to the hospital?  
- You were admitted for pneumonia and a urinary tract infection
 
What was done for me while I was in the hospital?  
- You were given antibiotics and you improved

What should I do when I leave the hospital?  
- You should continue taking the antibiotics for 2 more days 

Sincerely,  
Your ___ Care Team  

 
Followup Instructions:
___
"
102,15229355,29216705," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
cough
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___, history of ___ disease, advanced dementia,
esophageal dysmotility and past aspirations w/ PEG for feeding,
presenting from home with sons concerned for cough and lethargy.

History as available is provided by son. Pt unable to provide Hx
given advanced dementia.

Re cough: no hypoxia at home, as son checks regularly. Some 
cough
without production. C/f PNA on son's part. He also felt she was
lower energy and less interactive. No fevers registered. No
obvious aspiration event. In the past he has suctioned what
appeared to be TF from her throat, but none of that this time.

Re dysphagia: on TF per PEG, placed in ___ after lengthy
discussion. No issues with this, as above; no obvious
regurgitation, emesis, aspiration.

Re dementia: Pt is described at baseline by son as being able to
interact some, endorsing when she is in pain. He feels she is 
off
her baseline at present, a little lower energy and sluggish,
thoug on encounter on floor arrival, he thinks she is tired, as
it is 2:00a

Review of past OMR notes summarized as follows: 
Pall care consult on ___ was placed re placement of PEG tube; 
in
this note pt was sitting up and alert but answering questions
without obvious understanding of what was being asked. 

Numerous other admissions and ED visits. Most recent DC summary
was from ___ for CAP and UTI. Treated with cefpodoxime and
azithro.

In ED:
VS: afeb, HR 102 --> 93, 154/98, 97% on RA then on 2L but high
___
Labs: wbc 8, hb 10.8, chem unremarkable; Flu A, B neg
Imaging: read as no acute process though right apex obscured
Received: ___, carbi-levodopa x2, Xanax x1

ROS: Unable to assess ___ advanced dementia
 
Past Medical History:
___ Disease  
HTN 
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Bronchitis 
Hypothyroidism 
Recurrent Aspiration s/p PEG placement 
 
Social History:
___
Family History:
Reviewed and none pertinent to this hospitalization
 
Physical Exam:
Admission exam:
===============
VITALS: Afebrile and vital signs significant for within normal
limits; normotensive, no tachy; on RA
GENERAL: Sleeping and rouses to gentle stimulus but only mouths
responses without being able to fully articulate. Frail
appearing, with hunched over posture in bed.
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4.  No JVD. No ___ edema
RESP: Lungs without clear rales in bases though no participation
in exam, which limits effectiveness.  Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.  PEG site is clean and intact
GU: No suprapubic fullness or tenderness to palpation
SKIN: No rashes or ulcerations noted
NEURO: Cannot assess beyond that in 'general' section d/t pt 
lack
of participation
PSYCH: cannot assess d/t advanced dementia
.
.
Discharge exam:
==============
GENERAL: elderly woman with severe kyphoscoliosis laying in bed 
in NAD
EYES: anicteric, EOMI
ENT: MMM
CV: RR, no m/r/g appreciated, no JVD appreciated today
RESP: bilateral crackles to mid-lungs, no wheezing appreciated, 
normal WOB today with no accessory muscle use
GI: soft, not tender to palpation
SKIN: no jaundice
MSK: severe kyphoscoliosis
NEURO: awake, alert, oriented to person and place, responsive to 
questions with appropriate responses, moderately stuttering 
speech; vision is impaired (chronically); moderate presbycusis
PSYCH: calm, cooperative, pleasant
 
Pertinent Results:
Admission labs:
================

___ 05:30PM BLOOD WBC-8.7 RBC-3.47* Hgb-10.8* Hct-34.0 
MCV-98 MCH-31.1 MCHC-31.8* RDW-15.6* RDWSD-55.6* Plt ___
___ 05:30PM BLOOD Neuts-80.8* Lymphs-11.0* Monos-7.7 
Eos-0.1* Baso-0.1 Im ___ AbsNeut-7.02* AbsLymp-0.96* 
AbsMono-0.67 AbsEos-0.01* AbsBaso-0.01
___ 05:30PM BLOOD Glucose-120* UreaN-20 Creat-0.5 Na-139 
K-4.7 Cl-100 HCO3-26 AnGap-13

Micro:
=======
-___ BCx: cancelled
-___ BCx: cancelled
-___ UCx: no growth (final)
-___ Flu A&B PCR: negative
-___ Flu A&B PCR: negative

Imaging:
========
-___ CXR (PA & lateral)
  ""FINDINGS: Patient is kyphotic in position.  Patient's chin
overlies the lung apices, partially obscuring the view.  There
are small bilateral pleural effusions.  No definite focal
consolidation is seen.  There is no evidence pneumothorax. 
Cardiac and mediastinal silhouettes are grossly stable.  Chronic
bilateral rib deformities are again re-demonstrated.  Bones are
diffusely osteopenic and there is a chronic appearing deformity
at the left shoulder.  Previously seen compression deformities 
of
the spine were better assessed on prior studies. 
   IMPRESSION:  Patient's chin overlies the lung apices,
partially obscuring the view.  Small bilateral pleural effusions
are seen.  No definite focal consolidation. 

-___ CXR (portable):
IMPRESSION: Study is limited as the patient's head obscures the
lung apex on the left. There are very low lung volumes.  There 
is
extensive osteopenia and several old rib fractures bilateral. 
There is coarsening of the bronchovascular markings bilaterally
without overt pulmonary edema or focal consolidation.  No
definite pneumothoraces are identified.  Overall findings are
unchanged.
 
Brief Hospital Course:
Presented with reported productive cough, dyspnea, and lethargy. 
Disconcertingly, but consistently, her son, ___ would 
often say that she had a symptom, but when the patient was asked 
how she was feeling or asked specifically about that symptom, 
she would often say she was not feeling that way.

She did have a productive cough, however she did not demonstrate 
dyspnea or lethargy during her hospital course. Her CXR was not 
consistent with PNA. She had no other findings to suggest a 
bacterial infection. It was thought this represented a possible 
exacerbation of her chronic ""reactive airway disease"" which, 
itself, does not seem to have a clear underlying etiology, 
though perhaps may be due to chronic aspiration. She was treated 
with her usual home medications and she did well. No additional 
steroids were given and no antibiotics were given.

Leading up to the time of discharge, the patient's son made 
numerous requests of additional testing in an apparent attempt 
to delay and/or prevent discharge. He made all of these requests 
under the auspices of ""advocating for my mother,"" but many of 
the requests were made repeatedly, and aggressively towards the 
nursing staff, despite clear counseling by the patient's 
physicians that the tests were not necessary and would not be 
performed/repeated. His requests also did not align with the 
patient's clinical condition. On the day prior to discharge and 
the day of discharge, the patient herself noted that she felt 
quite good, was not having shortness of breath, and overall felt 
better than prior to admission. She was not noted to have any 
periods of significant dyspnea that did not respond to her usual 
home nebulizer treatments, and she was not noted to be lethargic 
during her time in the hospital.

We counseled her son that ongoing long-term prednisone use may 
not be advisable in her case.  Specifically, prednisone 
increases her risk of skin injuries (she has some already), 
slowed wound healing, osteoporosis with more fragility fractures 
(she has several already), anxiety (which has been increasingly 
problematic per family), and stomach ulcers (particularly when 
combined with Advil she takes for pain).  We advised that they 
discuss this further with Dr. ___ primary pulmonologist.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 20 mg PO QPM 
2. Fluticasone Propionate 110mcg 2 PUFF IH BID 
3. Hyoscyamine 0.125 mg SL TID:PRN oral secretions 
4. Ipratropium Bromide Neb 1 NEB IH Q6H 
5. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
6. Levalbuterol Neb 0.63 mg NEB Q6H:PRN dyspnea 
7. Levothyroxine Sodium 25 mcg PO DAILY 
8. Lidocaine 5% Patch 1 PTCH TD QPM 
9. melatonin 3 mg oral QHS:PRN 
10. Milk of Magnesia 30 mL PO Q8H:PRN Constipation - First Line 
11. PredniSONE 10 mg PO DAILY 
12. Carbidopa-Levodopa CR (___) 1 TAB PO ASDIR 
13. carbidopa 25 mg oral BID 
14. formoterol fumarate 20 mcg/2 mL inhalation BID 
15. Ibuprofen 200 mg PO QID:PRN Pain - Moderate 
16. Acetaminophen 500 mg PO QID:PRN pain 
17. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line 

 
Discharge Medications:
1.  Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line  
2.  Acetaminophen 500 mg PO QID:PRN pain  
3.  Atorvastatin 20 mg PO QPM  
4.  Carbidopa-Levodopa CR (___) 1 TAB PO ASDIR  
5.  carbidopa 25 mg oral BID  
6.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
7.  formoterol fumarate 20 mcg/2 mL inhalation BID 
at ___ and 2100  
8.  Hyoscyamine 0.125 mg SL TID:PRN oral secretions  
9.  Ibuprofen 200 mg PO QID:PRN Pain - Moderate  
10.  Ipratropium Bromide Neb 1 NEB IH Q6H  
11.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
12.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN dyspnea  
13.  Levothyroxine Sodium 25 mcg PO DAILY  
14.  Lidocaine 5% Patch 1 PTCH TD QPM  
15.  melatonin 3 mg oral QHS:PRN  
16.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line  
17.  PredniSONE 10 mg PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
# Cough
# Chronic steroid use
 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.
 
Discharge Instructions:
Dear ___,

___ were admitted to the hospital for monitoring after ___ 
presented to the emergency department with lethargy and 
productive cough.  ___ had a chest X-ray done which did not show 
evidence of a new pneumonia. Your labs were checked and were not 
concerning.  ___ were treated with your usual home medications, 
including your usual home nebulizer treatments, and ___ 
improved. On the day of discharge ___ were feeling well, with no 
shortness of breath, and said ___ wanted to go home.

It was a pleasure caring for ___ while ___ were here, and we 
wish ___ the best.

Sincerely,
The ___ Medicine Team.
 
Followup Instructions:
___
"
103,15229355,26552617," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
increase residuals per son
increased secretions
 
Major Surgical or Invasive Procedure:
None.

 
History of Present Illness:
___ with ___ disease, advanced dementia, esophageal
dysmotility w/ chronic aspirations s/p PEG for feeding, reactive
airway disease on chronic glucocorticoids, presenting with
increased PEG-tube residuals, found to have pneumonia and rib
fractures. 

Of note, the patient was recently admitted from ___ -
___ for cough, dyspnea, and lethargy. Patient was noted to
have productive cough during admission, but no dyspnea or
lethargy. She had a CXR that was not c/w PNA. It was thought 
that
her presentation may be c/w exacerbation of ""reactive airway
disease,"" and the patient was continued on her home medications.
She did not receive ABx or steroids. Hospital stay was notable
for tension between medical staff and family. Patient's son was
noted to repeatedly ask/demand additional medical testing and
sometimes act aggressively towards nursing staff. 

Patient's son reports increased TF residuals (~300 cc at home).
He also note increased secretions as of late. Otherwise, he
states that his mother seems to be at her baseline. Denies 
recent
trauma. 

ED Vitals: Afebrile, HR 80-102, BP 95-150/73-113, >93% RA
(briefly on 4L NC)

ED exam:
Oriented to baseline, G-tube site intact and nonerythematous.
Nontender to palpation. Lung sounds are quiet and difficult to
appreciate. She does seem to have more noisy breathing.

Labs:
WBC 11.2, Hgb 11.3, plts 259
BUN 23, Cr 0.5]
UA unremarkable 
Flu A/B PCR negative 

Studies:
CT Chest w/o (___): 
1. Multiple areas of atelectasis in the right lower and left
lower lobes with a patchy opacity in the lingula, could 
represent
pneumonia or aspiration. Right lower lobe mucous plugging. 
2. Trace right pleural effusion 
3. Acute to subacute fracture in the posterolateral aspect of 
the
seventh 
 right rib. Multiple additional subacute/chronic rib fractures
bilaterally 

Given multiple rib fractures, trauma was consulted in the ED and
they did not recommend and surgical intervention. 

She was given (in addition to home meds):
- IV acetaminophen 1000 mg 
- IV ceftriaxone 1 gm 
- IV azithromycin 500 mg 
- IV NS @ 100 cc/hr 
- duonebs 

 
Past Medical History:
___ Disease  
HTN
HLD   
Esophageal dysmotility
Bilateral blindness  
Reactive airway disease 
Hypothyroidism 
Recurrent Aspiration s/p PEG placement 
 
Social History:
___
Family History:
Reviewed and not pertinent to the current admission.

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VITALS: 24 HR Data (last updated ___ @ 1817)
    Temp: 97.8 (Tm 97.8), BP: 91/63, HR: 95, RR: 24, O2 sat: 
93%,
O2 delivery: Ra
GENERAL: Extremely kyphotic and Parkinonian. Fatigued. 
HEENT: Sclera anicteric and without injection. MMM.
NECK: No JVD.
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops.
LUNGS: Poor air movement. Clear to auscultation bilaterally.
BACK: Extreme kyphosis. Point tenderness on the right mid back. 
ABDOMEN:non distended, non-tender to deep palpation in all four
quadrants. PEG in epigastrium, C/D/I 
EXTREMITIES: No clubbing, cyanosis, or edema.
SKIN: Warm. No rash.
NEUROLOGIC: Patient not participating much, as she is tired.
Answers yes/no questions or 1 word sentences. Increased tone 
with
cogwheeling throuhgout. ___ Hz tremor R > L arm and jaw.
Bradykinetic. 

DISCHARGE EXAM
===============
24 HR Data (last updated ___ @ 657)
    Temp: 97.8 (Tm 98.7), BP: 171/72 (136-171/72-94), HR: 84
(84-108), RR: 18, O2 sat: 95% (85%-97), O2 delivery: 0.5 L NC
(0.5L-1L)  
GENERAL: Extremely kyphotic. 
CARDIAC: RRR, nml s1 s2, no mrg. 
LUNGS: clear to auscultation. Upper airway sounds. 
BACK: Extreme kyphosis. 
ABDOMEN: Soft, nd, nt. PEG in epigastrium, C/D/I 
EXTREMITIES: Warm, no ___. 
SKIN: Warm. No rash.
NEUROLOGIC: Answers yes/no questions. Bradykinesia alternating
with dyskinesia throughout day. Cogwheel rigidity. Jaw and b/l 
UE
tremors.

 
Pertinent Results:
ADMISSION LABS:
===============
___ 09:37PM BLOOD WBC-11.2* RBC-3.71* Hgb-11.3 Hct-36.9 
MCV-100* MCH-30.5 MCHC-30.6* RDW-15.6* RDWSD-56.8* Plt ___
___ 09:37PM BLOOD Neuts-80.1* Lymphs-12.1* Monos-6.9 
Eos-0.0* Baso-0.1 Im ___ AbsNeut-8.93* AbsLymp-1.35 
AbsMono-0.77 AbsEos-0.00* AbsBaso-0.01
___ 09:37PM BLOOD Glucose-120* UreaN-23* Creat-0.5 Na-139 
K-4.8 Cl-100 HCO3-26 AnGap-13

DISCHARGE LABS:
=============== 
___ 07:30AM BLOOD WBC-8.6 RBC-3.42* Hgb-10.5* Hct-34.7 
MCV-102* MCH-30.7 MCHC-30.3* RDW-15.3 RDWSD-57.2* Plt ___
___ 07:30AM BLOOD Glucose-108* UreaN-16 Creat-0.5 Na-142 
K-4.6 Cl-102 HCO3-31 AnGap-9*
___ 07:30AM BLOOD Calcium-9.3 Phos-2.6* Mg-2.5

MICROBIOLOGY:
=============
___ BCX: NGTD
___ 12:00 am URINE

   URINE CULTURE (Preliminary): 
      ENTEROCOCCUS SP..    >100,000 CFU/mL. 

___ 9:35 am SPUTUM      Source: Expectorated. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      <10 PMNs and >10 epithelial cells/100X field. 
      Gram stain indicates extensive contamination with upper 
respiratory
      secretions. Bacterial culture results are invalid. 
      PLEASE SUBMIT ANOTHER SPECIMEN. 

   RESPIRATORY CULTURE (Final ___: 
      TEST CANCELLED, PATIENT CREDITED. 

REPORTS:
========
___ CT CHEST W/O CONTRAST: 
1. Multiple areas of atelectasis in the right lower and left 
lower lobes with  a patchy opacity in the lingula, could 
represent pneumonia or aspiration.  Right lower lobe mucous 
plugging. 
2. Trace right pleural effusion 
3. Acute to subacute fracture in the posterolateral aspect of 
the seventh 
right rib.  Multiple additional subacute/chronic rib fractures 
bilaterally. 

___ CXR:
Within limitations of severe chest wall deformity, likely right 
upper lobe 
atelectasis/early infiltrates in the appropriate clinical 
setting.  The lower  lobes on both sides in the left upper lobe 
are clear. 

 
Brief Hospital Course:
___ with ___ disease, esophageal dysmotility w/ chronic 
aspirations s/p PEG for feeding, reactive airway disease on 
chronic glucocorticoids, presenting with increased PEG-tube 
residuals, found to have suspected pneumonia and rib fractures 
on CT chest. Patient received treatment for pneumonia and had 
persistent
episodes of hypoxemia due to aspiration from esophageal 
dysmotility, extreme kyphosis and atelectasis, dyskinesias from 
___ disease and underlying lung disease from COPD and
bronchiectasis. The patient was planned for discharge with 
appropriate ___ services and home O2 services, but patient son 
appealed the discharge. The case was reviewed by medicare who 
agreed with the medical team. 

ACUTE ISSUES:
=============
#Community acquired pneumonia
Patient has chronic cough with multiple recent admissions for 
increased cough and lethargy (per son's report, but some 
discrepancy w/ clinician observation, per prior notes). Has been 
afebrile, but has a mild lekocytosis, soft BPs, and a lingular 
consolidation on CT. Therefore, treated for CAP. That being 
said, CT changes and low-grade leukocytosis may simply represent 
pneumonitis from chronic aspiration +/- atelectasis. Treated 
with IV ceftriaxone/azithromycin for a total 5 day course 
(___). Persistent O2 requirement discussed below. 

#COPD
#Bronchiectasis 
#Acute hypoxemic respiratory failure 
Patient has been on 10 mg prednisone for some time now. Son 
called her pulmonologist due to perceived increase in WOB and 
respiratory distress and he recommended increasing prednisone to 
40 mg daily (she received 2 doses of 40 mg). On exam, patient 
was mildly tachypneic but without wheezing. Did not start 
prednisone burst, as pt has had well-documented 
prednisone-related side effects, and her respiratory status 
appears stable. She was continued on her home fluticasone, 
ipratropium, levalbuterol, and fomoterol breathing treatments, 
and prednisone 10mg qd. She was given guaifenasin q6h prn. Her 
fluctuations in respiratory function and persistent O2 
requirement despite treatment for CAP and COPD is likely due to 
chronic aspiration from esophageal dysmotility, extreme kyphosis 
and atelectasis, dyskinesias from ___ disease and 
underlying lung disease from COPD and bronchiectasis. The 
patient was discharged with home oxygen. She will have follow up 
with her pulmonologist to determine taper for prednisone. 

#Acute, subacute, and chronic rib fractures
Likely related to osteoporosis (w/ progressive demineralization 
from chronic prednisone use) and chronic cough. Evaluated by 
trauma, who do not recommend any surgical intervention. 

#Esophageal dysmotility
#Tube feed residuals 
Patient had one episode of 300 cc TF residual without any sign 
of clinical obstruction. Informed son that residuals do not need 
be checked regularly. Tube feeds were transitioned to the AM 
hours for 17 hours/day given family concern for aspirations from 
tube feeds. 

CHRONIC ISSUES:
===============
___ Disease 
Continued home carbidopa-levodopa

DISCHARGE APPEAL
================
  Repeated discussions with ___ (Son-HCP) were held 
regarding the poor prognosis for ___.  She is prone to 
aspirations, recurrent hypoxia with repeated mucous plugging.  
Given her Parksinson's, esophageal dysmotility, kyphosis and 
deconditioning, little can be done to prevent these aspirations 
from recurring.  She already has a PEG tube in place.  Despite 
efforts to impart the fact that providing ongoing care may 
actually be counterproductive, he did not appear willing to 
listen and insisted that everything should be done.  
   He appealed the discharge to Medicare - and the decision was 
made in agreement with our assessment.  She was discharged home 
with added oxygen, suctioning equipment and followup.  

TRANSITIONAL ISSUES
===================

[] Pulmonology: will work on tapering prednisone.
[] Neurology: continue to optimize sinemet. After receiving 
sinemet, patient is having significant dyskinesias exacerbating 
oxygen desaturations. 
[] Patient has a suction machine to help clear her secretions. 
The patient will need to have a renewed script to resupply the 
machine versus obtain a new machine. 
[] Patient was discharged with home oxygen. Continue to reassess 
need for oxygen. 
[] Continue to discuss with family that checking tube feed 
residuals are not necessary and have not been proven to show any 
benefit. 
[] Continue to reinforce the patient's progressive decline from 
underlying chronic medical diseases. 

#CODE: Full (per previous hospitalizations) 
#CONTACT: 
- Name of health care ___
- Relationship:Son
- Phone ___
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 500 mg PO QID:PRN pain 
2. Atorvastatin 20 mg PO QPM 
3. Carbidopa-Levodopa CR (___) 1 TAB PO ASDIR 
4. Fluticasone Propionate 110mcg 2 PUFF IH BID 
5. formoterol fumarate 20 mcg/2 mL inhalation BID 
6. Hyoscyamine 0.125 mg SL TID:PRN oral secretions 
7. Ibuprofen 200 mg PO QID:PRN Pain - Moderate 
8. Ipratropium Bromide Neb 1 NEB IH Q6H 
9. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
10. Levalbuterol Neb 0.63 mg NEB Q6H:PRN dyspnea 
11. Levothyroxine Sodium 25 mcg PO DAILY 
12. Lidocaine 5% Patch 1 PTCH TD QPM 
13. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line 
14. PredniSONE 10 mg PO DAILY 
15. carbidopa 25 mg oral BID 
16. melatonin 3 mg oral QHS:PRN 
17. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line 

 
Discharge Medications:
1.  Multivitamins W/minerals 1 TAB PO DAILY 
RX *multivitamin,tx-minerals [Vitamins and Minerals]  1 
tablet(s) by mouth daily Disp #*90 Tablet Refills:*0 
2.  Acetaminophen 1000 mg PO Q8H  
3.  Carbidopa-Levodopa (___) 2 TAB PO Q0700  
4.  Carbidopa-Levodopa (___) 1.5 TAB PO Q 1000  
5.  Carbidopa-Levodopa (___) 1.5 TAB PO Q1300  
6.  Carbidopa-Levodopa (___) 2 TAB PO Q1600  
7.  Carbidopa-Levodopa (___) 1 TAB PO Q1900  
8.  Carbidopa-Levodopa (___) 1 TAB PO AT MIDNIGHT  
9.  Atorvastatin 20 mg PO QPM  
10.  carbidopa 25 mg oral BID  
11.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
12.  formoterol fumarate 20 mcg/2 mL inhalation BID  
13.  Hyoscyamine 0.125 mg SL TID:PRN oral secretions  
14.  Ibuprofen 200 mg PO QID:PRN Pain - Moderate  
15.  Ipratropium Bromide Neb 1 NEB IH Q6H  
16.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
17.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN dyspnea  
18.  Levothyroxine Sodium 25 mcg PO DAILY  
19.  Lidocaine 5% Patch 1 PTCH TD QPM  
20.  melatonin 3 mg oral QHS:PRN  
21.  Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line  
22.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line  
23.  PredniSONE 10 mg PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
==================
Community acquired pneumonia

Secondary Diagnoses:
====================
Parkinsons Disease
Chronic obstructive pulmonary disease 
Bronchiectasis 
Acute/subacute rib fractures
Esophageal dysmotility
Malnutrition

 
Discharge Condition:
Mental Status: Confused - always. (dementia and Parkinsons) 
Level of Consciousness: Lethargic but arousable. 
Activity Status: Bedbound.

 
Discharge Instructions:
====================== 
DISCHARGE INSTRUCTIONS 
====================== 
Dear Ms. ___, 

It was a privilege caring for you at ___. 

WHY WAS I IN THE HOSPITAL? 
- You came to the hospital because your son was concerned about 
increased residuals from your tube feeds.

WHAT HAPPENED TO ME IN THE HOSPITAL? 
- We gave you IV antibiotics for potential pneumonia (lung 
infection). 
- We monitored your tube feeds residuals which were normal.
 
WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? 
- Please follow up with your pulmonologist, neurologist and 
primary care doctor. 
- Continue to take all your medicines and keep your 
appointments. 

We wish you the best! 

Sincerely, 
Your ___ Team 
 
Followup Instructions:
___
"
104,15229355,21233372," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Respiratory distress
 
Major Surgical or Invasive Procedure:
Intubation ___
PICC placement ___
Tracheostomy ___
 
History of Present Illness:
Ms. ___ is ___ female with past medical history of
___ disease, advanced dementia, esophageal dysmotility 
w/
chronic aspirations s/p PEG for feeding, reactive airway disease
on chronic glucocorticoids p/w increased work of breathing and
increased cough with sputum/secretions. 

Patient was recently admitted from ___ for pneumonia, and
was treated with IV ceftriaxone and azithro for a 5 day course
from ___. She was felt to have fluctuations in
respiratory function and persistent O2 requirement in the 
setting
of CAP and COPD. She was discharged on home oxygen. 

She re-presented to ED on ___ b/c ___ and son were 
concerned
about worsening respiratory status. Patient has been tachypneic
and shows signs of increased work of breathing. She is also been
producing copious amounts of yellow-green sputum. Has also had a
fever, T-max 100.1. She is currently on 2L of oxygen. Was
discharged on this oxygen level after last hospitalization.
  
In the ED, initially hypercapnic in ED on non-rebreather. 
Thought
not to be an appropriate candidate for positive pressure
ventilation. Noted to have jugular venous distension, concerned
for component of volume overload.  

 Initial Vitals: 100.1F, HR 80, BP 130/80, RR 22, 100% 2L NC  

 Exam in ED significant for: Shallow breathing and kyphotic
posture. 

 Labs:  
 141 | 96 | 39  
 --------------< 120  
 5.0 | 33 | 0.6  

      11.6  
 14.0>----<232  
      37.8  
 
 Lactate: 1.9  
 FluA, FluB PCR: negative  
 ___ VBG: ___  
 2242 VBG: 7.50/34/196  

Imaging:  
CXR: Limited study due to patient rotation. Given this, findings
concerning for multifocal pneumonia with patchy opacities over
the right lung and left base opacity. Underlying pulmonary edema
not excluded.  

Consults: None 
 
 Interventions:  
 Duoneb x1  
 500cc LR  
 CTZ 1g  
 Azithro 500mg  

 VS Prior to Transfer: 98 95 167/101 18 100% RA 

In the ICU, patient lying in bed. Appears uncomfortable at 
times.
Answers yes to back pain. Notes breathing improved from prior.
Denies chest pain. 

 
Past Medical History:
 ___ Disease  
 HTN  
 HLD  
 Esophageal dysmotility  
 Bilateral blindness  
 Reactive airway disease  
 COPD, bronchiectasis  
 Hypothyroidism  
 Recurrent Aspiration s/p PEG placement  
 
Social History:
___
Family History:
Sons with heart disease

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
=======================
VS: 98.1 140/103 26 93% 4L NC 
GEN: Lying in bed, intermittent tremor. Oriented to self,
difficult to hear. 
HEENT: PERRLA. EOMI. Moist mucous membranes. 
CV: RRR. No murmurs, rubs, or gallops. 
LUNGS: Diffuse rhonchi with decreased breath sounds at bases.
Few crackles at bases. Diffuse wheezing. 
GI: Soft, non-tender, non-distended. 
EXT: WWP. Pulses 2+. No edema. 
NEURO: CNII-XII intact. Cogwheel rigidity bilaterally.  

DISCHARGE PHYSICAL EXAM:
=======================
GEN: Chronically ill appear woman laying in bed, alert, follows
some commands, non-verbal 
HEENT: PERRL. Moist mucous membranes. 
NECK: Kyphosis present, trach C/D/I
CV: RRR. No rubs or gallops. Grade ___ systolic murmur heard
throughout precordium.
LUNGS: CTAB. No w/r/r 
GI: Soft, non-tender, non-distended. normoactive BS. PEG C/D/I. 
EXT: WWP. Pulses 2+. 1+ ___
NEURO: L eyelip drooping. Able to move upper extremities on
command. Unable to assess orientation. 
 
Pertinent Results:
ADMISSION LABS:
================
___ 05:55PM BLOOD WBC-14.0* RBC-3.77* Hgb-11.6 Hct-37.8 
MCV-100* MCH-30.8 MCHC-30.7* RDW-15.7* RDWSD-58.4* Plt ___
___ 04:13AM BLOOD ___ PTT-27.4 ___
___ 05:55PM BLOOD Glucose-120* UreaN-39* Creat-0.6 Na-141 
K-5.0 Cl-96 HCO3-33* AnGap-12
___ 01:34AM BLOOD ALT-<5 AST-21 AlkPhos-106* TotBili-0.4
___ 03:38AM BLOOD Calcium-9.4 Phos-2.6* Mg-2.7*
___ 07:15PM BLOOD ___ pO2-23* pCO2-72* pH-7.30* 
calTCO2-37* Base XS-4

DISCHARGE LABS:
================
___ 04:26AM BLOOD WBC-6.9 RBC-2.38* Hgb-7.5* Hct-25.0* 
MCV-105* MCH-31.5 MCHC-30.0* RDW-17.0* RDWSD-65.1* Plt ___
___ 03:30AM BLOOD ___ PTT-27.3 ___
___ 04:26AM BLOOD Glucose-133* UreaN-13 Creat-0.4 Na-142 
K-4.1 Cl-98 HCO3-27 AnGap-17
___ 04:26AM BLOOD Calcium-8.8 Phos-2.4* Mg-2.0

MICRO:
=======
___ 6:56 pm SPUTUM      Source: Induced. 
RESPIRATORY CULTURE (Final ___: 
STAPH AUREUS COAG +.    SPARSE GROWTH.  
YEAST.    MODERATE GROWTH. 
PSEUDOMONAS AERUGINOSA.    MODERATE GROWTH. 
                              SENSITIVITIES: MIC expressed in 
MCG/ML
________________________________________________________
                             STAPH AUREUS COAG +
                             |          PSEUDOMONAS AERUGINOSA
                             |          |   
CEFEPIME--------------              <=1 S
CEFTAZIDIME-----------                4 S
CIPROFLOXACIN---------           <=0.25 S
CLINDAMYCIN-----------   =>8 R
ERYTHROMYCIN----------   =>8 R
GENTAMICIN------------ <=0.5 S      <=1 S
LEVOFLOXACIN----------   =>8 R
MEROPENEM-------------           <=0.25 S
OXACILLIN-------------   =>4 R
PIPERACILLIN/TAZO-----              <=4 S
RIFAMPIN-------------- <=0.5 S
TETRACYCLINE----------   <=1 S
TOBRAMYCIN------------              <=1 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------ <=0.5 S

___ 3:12 pm SPUTUM      Source: Endotracheal. 
RESPIRATORY CULTURE (Final ___: 
      PSEUDOMONAS AERUGINOSA.    RARE GROWTH. 
      SENSITIVITIES: MIC expressed in MCG/ML
________________________________________________
                             PSEUDOMONAS AERUGINOSA
                             |   
CEFEPIME--------------  =>64 R
CEFTAZIDIME-----------  =>64 R
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----       R
TOBRAMYCIN------------   <=1 S

C. difficile PCR (Final ___: NEGATIVE. 

___ 5:55 pm BLOOD CULTURE: STAPHYLOCOCCUS, COAGULASE 
NEGATIVE. 
Isolated from only one set in the previous five days. 

MRSA SCREEN (Final ___: 
      POSITIVE FOR METHICILLIN RESISTANT STAPH AUREUS. 

STUDIES:
=========
CXR ___: IMPRESSION:  Tip right PICC line overlying the mid 
SVC. 

KUB ___: Non-obstructive bowel gas pattern with no 
significant stool burden.

CXR ___: IMPRESSION: Limited study due to patient rotation.  
Given this, findings concerning for multifocal pneumonia with 
patchy opacities over the right lung and left base opacity.  
Underlying pulmonary edema not excluded. 
 
Brief Hospital Course:
SUMMARY:
========
Ms. ___ is ___ female with past medical history of 
___ disease, advanced dementia, esophageal dysmotility 
w/ chronic aspirations s/p PEG for feeding, reactive airway 
disease on chronic glucocorticoids who presented with increased 
work of breathing and increased cough with sputum/secretions, 
found to have acute hypoxic/hypercarbic respiratory failure, 
MRSA and pseudomonas pneumonia, frequent bradycardia, and 
hypotension. 

ACUTE ISSUES 
=============== 
# Acute hypoxemic hypercarbic respiratory failure 
Initially presenting with hypoxia. Her respiratory failure 
worsened and was started on HFNC and eventually was intubated on 
___ after goals of care discussions with the family. She was 
given aggressive pulmonary toilet. Attempts to wean the 
ventilator were not successful, so she ultimately underwent 
tracheostomy placement and bronchoscopy on ___. Patient 
continued to have intermittent low minute ventilation so 
required switching from pressure support to volume control. She 
will need ongoing ventilator weaning after discharge. 

# Sepsis secondary to HAP
# MRSA pneumonia
# Pseudomonas PNA
CXR demonstrated findings concerning for multifocal pneumonia. 
Her sputum grew MRSA and Pseudomonas. For her MRSA pneumonia, 
she was given 10 days of vancomycin. For her Pseudomonas 
infection, she was initially treated with cefepime, but 
ultimately transitioned to IV ciprofloxacin for an additional 7 
days after her Pseudomonas developed intermediate sensitivities 
to cefepime. Last day of ciprofloxacin is ___. 

# Hypotension
Requiring pressors after being intubated. Likely ___ sedatives 
and sepsis. Given norepi for goal MAP >65. She did 
intermittently have brief hypotensive episodes throughout 
hospitalization that were fluid responsive. There may have been 
a component of difficulty measuring BPs given frequent 
movements. 

# Reactive airway disease/COPD
# Chronic aspiration
Patient has been on long-standing prednisone. Concern for 
chronic aspiration in the setting of esophageal dysmotility with 
kyphosis and dyskinesias from ___. Given high dose 
prednisone (50 mg) for 5 days followed by taper in addition to 
aggressive nebulizer regimen. She will be maintained on her home 
prednisone dose of 10 mg PO daily afterwards. 

# Recurrent episodes of bradycardia 
Before intubation, patient would intermittently have bradycardic 
episodes including a 10-second pause on telemetry in the setting 
of hypoxia and discomfort. Electrophysiology was consulted who 
did not feel that this regard prior to pacemaker placement. 
These episodes did not recur after intubation. Likely related to 
vagal episodes. 

# Coag negative staph in blood cultures 
Grown in one set of cultures, thought to be ___ contamination. 

# Diarrhea
C. diff negative. Likely ___ tube feeds. 

# Skin excoriations in groin
Foley placed for skin breakdown on external genitalia ___ 
urinary incontinence. 

# Hypernatremia
Likely ___ poor PO intake. Resolved with increased free water 
flushes. 

# Anemia
# Thrombocytopenia
Likely secondary to sepsis and antibiotics. Improved with 
treatment of infections. 

CHRONIC PROBLEMS:
=================
# Subacute and chronic rib fractures
Found on prior admission and thought to be due to chronic cough 
and osteoporosis. Continued Tylenol, ibuprofen and lidocaine 
patches. 

# ___ Disease
# Advanced dementia
Continued home carbidopa-levodopa and carbidopa. 

# Esophageal dysmotility
Continued tube feeds through PEG

# HLD
Continued home atorvastatin daily 

# GERD
Continued home lansoprazole 30 mg PO BID 

# Hypothyroidism
Continued home levothyroxine 25 mcg daily 

TRANSITIONAL ISSUES:
====================
[] Continue IV ciprofloxacin to end on ___
[] Please attempt to wean ventilator support 
[] Continue goals of care discussions if unable to be weaned 
from ventilator 
[] Please remove foley and attempt voiding trial
[] Pseudomonas developed resistance to cefepime, ceftazadime, 
and piperacillin-tazobactam. Please avoid use of these 
antibiotics in the future if concern for pneumonia
[] Prednisone taper
___: 20 mg x2 days
___: 10 mg PO daily indefinitely

ADVANCED CARE PLANNING:
=======================
#CODE: Full, confirmed 
#CONTACT: 
- Name of health care proxy: ___
- Relationship: Son
- Phone number: ___
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 1000 mg PO Q8H 
2. Atorvastatin 20 mg PO QPM 
3. carbidopa 25 mg oral BID 
4. Carbidopa-Levodopa (___) 2 TAB PO Q0700 
5. Carbidopa-Levodopa (___) 1.5 TAB PO Q 1000 
6. Carbidopa-Levodopa (___) 1.5 TAB PO Q1300 
7. Carbidopa-Levodopa (___) 2 TAB PO Q1600 
8. Carbidopa-Levodopa (___) 1 TAB PO Q1900 
9. Carbidopa-Levodopa (___) 1 TAB PO AT MIDNIGHT 
10. Fluticasone Propionate 110mcg 2 PUFF IH BID 
11. Hyoscyamine 0.125 mg SL TID:PRN oral secretions 
12. Ipratropium Bromide Neb 1 NEB IH Q6H 
13. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
14. Levalbuterol Neb 0.63 mg NEB Q6H:PRN dyspnea 
15. Levothyroxine Sodium 25 mcg PO DAILY 
16. Lidocaine 5% Patch 1 PTCH TD QPM 
17. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line 
18. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line 
19. PredniSONE 10 mg PO DAILY 
20. formoterol fumarate 20 mcg/2 mL inhalation BID 
21. Multivitamins W/minerals 1 TAB PO DAILY 
22. Ibuprofen 200 mg PO QID:PRN Pain - Moderate 
23. melatonin 3 mg oral QHS:PRN 
24. formoterol fumarate 20 mcg/2 mL inhalation BID 

 
Discharge Medications:
1.  Artificial Tears ___ DROP BOTH EYES PRN dry eyes  
2.  Ciprofloxacin 400 mg IV Q12H Duration: 5 Doses 
First dose ___ of ___  
3.  PredniSONE 20 mg PO DAILY Duration: 1 Dose 
Start on ___ 
This is dose # 1 of 1 tapered doses 
4.  PredniSONE 10 mg PO DAILY 
Start: After last tapered dose completes 
This is the maintenance dose to follow the last tapered dose 
5.  Acetaminophen 1000 mg PO Q8H  
6.  Atorvastatin 20 mg PO QPM  
7.  Carbidopa-Levodopa (___) 2 TAB PO Q0700  
8.  Carbidopa-Levodopa (___) 1.5 TAB PO Q 1000  
9.  Carbidopa-Levodopa (___) 1.5 TAB PO Q1300  
10.  Carbidopa-Levodopa (___) 2 TAB PO Q1600  
11.  Carbidopa-Levodopa (___) 1 TAB PO Q1900  
12.  Carbidopa-Levodopa (___) 1 TAB PO AT MIDNIGHT  
13.  carbidopa 25 mg oral BID  
14.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
15.  formoterol fumarate 20 mcg/2 mL inhalation BID  
16.  formoterol fumarate 20 mcg/2 mL inhalation BID  
17.  Ibuprofen 200 mg PO QID:PRN Pain - Moderate  
18.  Ipratropium Bromide Neb 1 NEB IH Q6H  
19.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
20.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN dyspnea  
21.  Levothyroxine Sodium 25 mcg PO DAILY  
22.  Lidocaine 5% Patch 1 PTCH TD QPM  
23.  melatonin 3 mg oral QHS:PRN  
24.  Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line  
25.  Multivitamins W/minerals 1 TAB PO DAILY  
26.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES
Acute hypoxemic hypercarbic respiratory failure 
Sepsis secondary to HAP
MRSA pneumonia
Pseudomonas pneumonia

SECONDARY DIAGNOSES
Hypotension
Reactive airway disease
Chronic aspiration
Bradycardic episodes
Diarrhea
Skin excoriations
Hypernatremia
Anemia
Thrombocytopenia 

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
Dear Ms. ___,  

It was a pleasure taking care of you at the ___ 
___!  

Why was I admitted to the hospital?  
=================================
- You were admitted because you were having difficulty breathing 
and were found to have a pneumonia.

What happened while I was in the hospital?  
====================================
- You had testing done to figure out what kind of pneumonia you 
had.  This showed you had 2 infections call MRSA and 
Pseudomonas.
 You were given IV antibiotics to treat these infections.
 You were given higher dose prednisone to help with 
inflammation in your lungs. 
 We placed you on a breathing machine called a ventilator to 
help you breath. Because you could not breathe without this 
machine, a tracheostomy (breathing tube in the neck) was placed, 
which will help you to breathe with the support of the 
ventilator, but be more comfortable. 

What should I do after leaving the hospital?  
============================================
- Please take your medications as listed in discharge summary 
and follow up at the listed appointments. 

Thank you for allowing us to be involved in your care, we wish 
you all the best!  

Sincerely,

Your ___ Healthcare Team  
 
Followup Instructions:
___
"
105,15229355,20397401," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
fever
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ is a ___ year old woman with history of advanced
___, advanced dementia, bilateral blindness, reactive
airway disease on chronic prednisone, HTN, HLD, COPD,
hypothyroidism, and recent admission for MRSA and pseudomonas
PNA, which resulted in trach/peg, now with vent dependence, who
now presents from her rehab (___) with fevers despite 
multiple
courses of antibiotics.

Since her last discharge for MRSA and pseudomonas (with 
inducible
resistance to cefepime and ceftaz) PNA, she has been on
antibiotics for resistant organisms for all but ~5 days. She has
been followed by ID while at ___, and while there, was
on vanc/cipro -> bactrim/meropenem (for stenotrophomonas and
pseudomonas) -> vancomycin/ceftaz-avibactam. She was scheduled 
to
continue Vancomycin and ceftaz/avibactam until ___ but
continued to spike fevers as high as ___, so she was sent to
___ for further evaluation per the son's request. Patient is
non-verbal and unable to provide meaningful history or ROS. She
is confirmed full code.

Of note, according to a progress note from ___ on ___
the son has been verbally abusive and yelling at staff 
requesting
that ""full investigation of all patient's current medical
problems and maximal support."" 

In the ED, 

Initial Vitals: T 99.7, HR 96, BP 176/86, RR 20 on vent.

Exam: Chronically ill appearing, frail, appears uncomfortable.
Trach midline, no surrounding erythema or drainage. Diminished
breath sounds, no wheezing or crackles. R>L upper extremity
edema.

Labs were remarkable for:
- Hgb 7.3 (recent baseline 7.5-8.5, did recently require 2u PRBC
while at ___
- WBC 12.2 (84% PMN)
- Pro-BNP 1170
- Vanc 28.5 (though collected before a true trough)
- Bland UA
- Lactate 1.1

Imaging:  
- NCHCT: extremely limited by motion, but no acute intracranial
process
- CXR: mild pulmonary edema with perihilar hazy opacities and
trace R pleural effusion, patchy opacities in lung bases could
reflect atelectasis, though early infection in the left lung 
base
is not excluded. Left PICC tip terminates in the left mid
subclavian vein
- CT Chest: small bilateral pleural effusions (R>L) on wet read
- CT A/P: no acute pathology on wet read
- RUE ___: Nonocclusive thrombi are present in the right
brachial and basilic veins. Occlusive thrombus in the right
cephalic vein. However, the right internal jugular, axillary, 
and
brachial veins appear patent, showing normal color flow and
spectral doppler. The right basilic vein is narrowed but patent.

The ED team reached out to ID, who recommended continuing
antibiotics without escalation pending culture data and imaging.

She received:
- IV LR @ 75cc/hr
- PO Alprazolam 0.5mg
- Omeprazole 40mg PO
- Pravastatin 80mg PO
- Carbidopa-Levodopa
- Hyoscyamine 0.125mg
- Olanzapine 2.5mg

VS Prior to Transfer: T 98.9, HR 87, BP 132/85, spO2 97% on 
vent.

Upon arrival to the floor, the patient was nonverbal and not 
able
to participate in interview. Her son at bedside confirmed the
above story, and beyond the fevers and apparent discomfort 
denied
any other acute changes of his mother. ___, he reports that
at his rehab facility, his mother was ""speaking with a passy 
muir
valve"".

ROS: Positives as per HPI; otherwise negative.  
====
 
Past Medical History:
Per OMR:
 ___ Disease  
 HTN  
 HLD  
 Esophageal dysmotility  
 Bilateral blindness  
 Reactive airway disease  
 COPD, bronchiectasis  
 Hypothyroidism  
 Recurrent Aspiration s/p PEG placement 
 
Social History:
___
Family History:
Per OMR
Sons with heart disease

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
=======================
VS: Reviewed in Metavision
GEN: Frail elderly woman lying in bed, not interactive, not
tracking eye movements. Appears uncomfortable.
HEENT: Sclera anicteric. PERRL. MMM.
NECK:  Kyphosis present. Trach C/D/I.
CV:  RRR. Mildly tachycardia. ___ systolic murmur heard
throughout precordium.
RESP: Few scattered rhonchi, otherwise with good air exchange, 
no
wheezes or rales.
GI:  Soft, nondistended. No hepatosplenomegaly.
EXT: WWP. Visible superficial veins. No ___ edema. + RUE pitting
edema.
SKIN: No visible ecchymoses or other rashes.
NEURO: Non verbal, not responsive to verbal commands. Groans to
sternal rub

DISCHARGE PHYSICAL EXAM:
========================
VS: BP 103/79, HR 85, spO2 100% on vent
GEN: Frail elderly woman lying in bed, not interactive, not
tracking eye movements. Appears comfortable.
HEENT: Sclera anicteric. PERRL. MMM.
NECK:  Kyphosis present. Trach C/D/I.
CV:  RRR. Mildly tachycardia. ___ systolic murmur.
RESP: Few scattered rhonchi, otherwise with good air exchange, 
no
wheezes or rales.
GI:  Soft, nondistended. No hepatosplenomegaly.
EXT: WWP. Visible superficial veins. No ___ edema. + RUE pitting
edema. Erythema around LUE PICC site.
SKIN: No visible ecchymoses or other rashes other than above.
NEURO: Non verbal, not responsive to verbal commands. 
 
Pertinent Results:
ADMISSION LABS:
===============
___ 04:14PM BLOOD WBC-12.2* RBC-2.41* Hgb-7.3* Hct-23.6* 
MCV-98 MCH-30.3 MCHC-30.9* RDW-14.3 RDWSD-51.5* Plt ___
___ 05:20AM BLOOD ___ PTT-28.2 ___
___ 04:14PM BLOOD Glucose-115* UreaN-13 Creat-0.3* Na-136 
K-4.6 Cl-98 HCO3-28 AnGap-10
___ 04:14PM BLOOD ALT-<5 AST-25 AlkPhos-201* TotBili-0.6
___ 04:14PM BLOOD proBNP-1170*
___ 04:14PM BLOOD Albumin-3.6 Calcium-8.9 Phos-3.4 Mg-2.3
___ 05:20AM BLOOD calTIBC-187* Hapto-205* Ferritn-833* 
TRF-144*
___ 04:32PM BLOOD Lactate-1.1

DISCHARGE LABS:
===============
___ 03:41AM BLOOD WBC-6.8 RBC-2.53* Hgb-7.5* Hct-24.7* 
MCV-98 MCH-29.6 MCHC-30.4* RDW-15.6* RDWSD-55.4* Plt ___
___ 03:41AM BLOOD Glucose-104* UreaN-12 Creat-0.3* Na-141 
K-4.0 Cl-103 HCO3-28 AnGap-10
___ 03:41AM BLOOD ALT-13 AST-13 AlkPhos-176*
___ 03:41AM BLOOD Calcium-8.4 Phos-3.3 Mg-2.2

MICROBIOLOGY:
=============
   GRAM STAIN (Final ___: 
      ___ PMNs and <10 epithelial cells/100X field. 
      1+    (<1 per 1000X FIELD):   BUDDING YEAST WITH 
PSEUDOHYPHAE. 

   URINE CULTURE (Final ___:    < 10,000 CFU/mL. 

   ___ Blood Culture, Routine (Pending):    No growth to 
date. 

RADIOLOGY:
==========
+CT CHEST W/CONTRAST ___
Limited study due to motion artifact.  Within this limitation, 
-Small bilateral pleural effusions, greater on the right. 
-Otherwise, no acute findings in the torso. 

+CXR: ___ 
1. Findings suggestive of mild pulmonary edema with perihilar 
hazy opacities 
and trace right pleural effusion. 
2. Patchy opacities in lung bases could reflect atelectasis, 
though early 
infection in the left lung base is not excluded. 
3. Left PICC tip terminates in the left mid subclavian vein. 

+CT HEAD ___
IMPRESSION:  
Extremely limited study due to motion artifact despite repeat 
acquisitions.  
Within this limitation, no visualized acute intracranial 
process, no 
significant mass effect. 

+UNILAT UP EXT VEINS RUE ___
IMPRESSION:    
Nonocclusive thrombi involving the right brachial and basilic 
veins. 
Occlusive thrombus in the right cephalic vein. 

+UNILAT UP EXT VEINS LUE ___  
Acute, partially occlusive deep venous thrombus about the PICC 
within the 
axillary (deep) and proximal basilic veins. 
 
Brief Hospital Course:
___ year old woman with history of advanced ___, 
bilateral blindness, reactive airway disease on chronic 
prednisone, HTN, HLD, COPD, hypothyroidism, and recent admission 
for MRSA and pseudomonas PNA, which resulted in trach/peg, now 
with vent dependence, who now presents from her rehab (___) 
with persistent fevers and leukocytosis despite broad spectrum 
ABX for PNA, found to have bilateral UE DVT. Fevers likely 
non-infectious, so antibiotics discontinued. Patient stable and 
discharged back to ___. 

ACUTE ISSUES 
=============== 
# Fevers
Patient presents from ___ with persistent fevers and 
mild leukocytosis despite broad spectrum coverage for her 
resistant PNAs. ID was consulted and felt that her culture data 
likely reflects colonization, given her non-inflammatory sputum 
studies, stable vent settings, and stable secretions. The most 
likely etiology of her fevers is non infectious such as drug 
fever or ___ DVT. Notably, she was found to
have RUE DVT of brachial, basilic, and cephalic veins of the 
RUE. She was also found to have LUE DVT of axillary veins (with 
PICC still in place). It is possible this could be contributing 
to her fevers. Less likely new or persistent bacterial 
infection, though viral infection could be considered. Flu neg. 

# Bilateral UE Catheter Associated DVT:
Patient presented with RUE edema, found to have RUE thrombi of 
the brachial (non-occlusive), cephalic (occlusive), and basilic 
(non-occlusive) veins. This occurred in the setting of RUE PICC 
placed in the R basilic vein last admission (subsequently 
removed). She was also found to have partially occlusive LUE 
thrombi within the axillary (deep) and proximal basilic veins, 
with PICC still in place due to necessity of frequent lab draws. 
After extensive conversation with the patient's son (HCP) re: 
risks and benefits of anticoagulation, it was ultimately decided 
to anticoagulate with warfarin, with lovneox bridge. She will 
need repeat ultrasounds to assess for clot resolution on 
anticoagulation, minimum planned duration 3 months. Will also 
need to monitor for e/o active bleeding.

# L UE Erythema
The patient was found to have L upper arm erythema in the 
setting of L UE DVT, with some excoriations of the skin. Given 
improvement with topical emollients and without antibiotics, 
this was thought to be excoriation in the setting of her chronic 
steroid use, and less likely an overlying cellulitis. This 
should continue to be monitored at ___.

# Chronic Hypoxic respiratory failure: 
The patient is trached and vent dependent in the setting of 
advanced dementia. Her Trach cuff pressures were within normal 
limits(28). She was continued on her outpatient ventilator 
settings of CMV overnight and PSV during day. Trach sputum 
cultures grew pseudomonas, but given low PMNs and scant sputum 
production with stable vent settings, suspect colonization as 
opposed to active infection.

# Normocytic Anemia
The patient has a recent baseline Hgb of 7.5-8.5, and has 
required 2u PRBC while at
___. Did have guaiac + stools there, though no evidence of 
overt bleeding. Could represent a slow GIB vs marrow suppression 
in the setting of recent infections. s/p 1UPRBC with robust 
response supporting that acute bleed is less likely. Iron 
studies suggest anemia of chronic inflammation.

CHRONIC ISSUES 
=============== 
# Esophageal dysmotility: s/p PEG: The patient was continued on 
nutrition's final tube feed recs from her last admission

# ___: Continued home carbidopa/levodopa regimen

# HLD: Continued home statin

# Chronic pain: Continued APAP. Home NSAIDs were held in the 
setting of anemia. 

# Reactive airway disease, copd: Continued home prednisone 10mg 
daily and home inhalers

TRANSITIONAL ISSUES:
====================
[]will need ___ weekly INR checks and CBCs to monitor blood 
counts on anticoagulation for catheter associated DVT of 
bilateral UE
--- Discharge Hgb 7.5

[]started warfarin for bilateral UE catheter associated DVT, 
planning to bridge with lovenox. Continue to assess risks and 
benefits of anticoagulation at ___.

[]L UE PICC was left in given anticipated need for serial lab 
draws with challenging venous access

[]Repeat bilateral UE U/S in 1 month (___) to evaluate RUE 
DVT and LUE DVT to determine needed duration of anticoagulation. 
Anticipated duration of anticoagulation is 3 months, but will 
potentially need longer given PICC left in place.

[]Avoid BP cuffs in UE iso DVT. The patient's son requests that 
all BPs be taken in the left leg just below the knee.

[]f/u blood cultures ___: No growth to date at time of 
discharge

[]holding home NSAIDS in the setting of anemia

[]for pain control, the patient's son prefers 1.25mg oxycodone 
PRN for pain. The patient did respond well to small (0.125mg) IV 
dilaudid boluses. Could consider supplementing with IV dilaudid 
PRN for pain control.

#Code Status: FC 
#Contact:
___ 
___: Son 
Phone number: ___ 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg NG Q6H 
2. Carbidopa-Levodopa (___) 2 TAB NG Q0700 
3. Carbidopa-Levodopa (___) 1.5 TAB NG Q 1000 
4. Carbidopa-Levodopa (___) 1.5 TAB NG Q1300 
5. Carbidopa-Levodopa (___) 2 TAB NG Q1600 
6. Ipratropium Bromide Neb 1 NEB IH Q6H 
7. Levalbuterol Neb 0.63 mg NEB Q6H 
8. Levothyroxine Sodium 25 mcg NG DAILY 
9. Lidocaine 5% Patch 1 PTCH TD QPM 
10. Artificial Tears 1 DROP BOTH EYES BID 
11. melatonin 3 mg oral QHS 
12. PredniSONE 10 mg NG DAILY 
This is the maintenance dose to follow the last tapered dose
13. formoterol fumarate 20 mcg/2 mL inhalation BID 
14. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
15. Pravastatin 80 mg PO QPM 
16. omeprazole magnesium 20 Mg oral BID 
17. Clotrimazole Cream 1 Appl TP BID 
18. Saccharomyces boulardii 250 mg oral BID 
19. Multivitamins W/minerals 1 TAB NG DAILY 
20. Milk of Magnesia 30 mL PO DAILY 
21. Polyethylene Glycol 17 g PO DAILY 
22. OxyCODONE (Immediate Release) 1.25 mg PO Q6H:PRN Pain - 
Moderate 

 
Discharge Medications:
1.  Enoxaparin Sodium 50 mg SC Q12H  
2.  ___  MD to order daily dose PO DAILY16  
3.  Acetaminophen 650 mg NG Q6H  
4.  Artificial Tears 1 DROP BOTH EYES BID  
5.  Carbidopa-Levodopa (___) 2 TAB NG Q0700  
6.  Carbidopa-Levodopa (___) 1.5 TAB PO Q 1000  
7.  Carbidopa-Levodopa (___) 1.5 TAB PO Q1300  
8.  Carbidopa-Levodopa (___) 2 TAB PO Q1600  
9.  Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID  
10.  Clotrimazole Cream 1 Appl TP BID  
11.  formoterol fumarate 20 mcg/2 mL inhalation BID  
12.  Ipratropium Bromide Neb 1 NEB IH Q6H  
13.  Levalbuterol Neb 0.63 mg NEB Q6H  
14.  Levothyroxine Sodium 25 mcg PO DAILY  
15.  Lidocaine 5% Patch 1 PTCH TD QPM  
16.  melatonin 3 mg oral QHS  
17.  Milk of Magnesia 30 mL PO DAILY  
18.  Multivitamins W/minerals 1 TAB NG DAILY  
19.  omeprazole magnesium 20 Mg oral BID  
20.  OxyCODONE (Immediate Release) 1.25 mg PO Q6H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg 0.25 tablet(s) by mouth every six (6) hours 
Disp #*14 Tablet Refills:*0 
21.  Polyethylene Glycol 17 g PO DAILY  
22.  Pravastatin 80 mg PO QPM  
23.  PredniSONE 10 mg NG DAILY 
Start: After last tapered dose completes 
This is the maintenance dose to follow the last tapered dose 
24.  Saccharomyces boulardii 250 mg oral BID  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES:
==================
1. Fevers of Unknown Origin
2. RUE Catheter Associated DVT

SECONDARY DIAGNOSES:
===================
1. Chronic Hypoxic respiratory failure
2. Esophageal dysmotility
3. Normocytic Anemia
4. Chronic pain

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
Dear Ms. ___,

It was a privilege taking care of you at ___ 
___.  

WHY WAS I ADMITTED TO THE HOSPITAL?
===================================
- You were admitted to the hospital because you were found to 
have fevers at your rehab. 

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
==========================================
- There was a concern that you had pneumonia and you were 
continued on antibiotics. However your symptoms appeared to be 
unlikely from an infection and your antibiotics were stopped. 
- You had an ultrasound of your arm which showed blood clots. It 
is possible that these blood clots were causing your fevers. We 
discussed the risks and benefits of starting a blood thinner 
with your family, and we ultimately chose to start a blood 
thinner.
- You had low blood counts and needed a blood transfusion. Your 
blood counts improved.   

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
============================================  
- Please continue to take all your medications and follow up 
with your doctors at your ___ appointments.  
- Your blood counts will need to be monitored closely in the 
setting of your new blood thinner. You will also need a repeat 
ultrasound of your arms in the future to look for interval 
change in the clots.

We wish you all the best!

Sincerely,  
Your ___ Care Team  
 
Followup Instructions:
___
"
106,15229355,25039720," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
intermittent tachypnea
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
================================  
MICU ADMISSION NOTE  
Date of ICU Admission:  ___
Reason for ICU Admission:  ventilator dependent 
================================  

HISTORY OF PRESENT ILLNESS:  
===========================  
___ with h/o advanced ___, dementia, blindness, HTN, 
HLD,
COPD, hypothyroidism, who is now ___ dependent after
pseudomonas pneumonia presents to the ED with c/o respiratory
distress. She was discharged from rehab yesterday. ___ reports
that she had been doing well at ___. About ___ weeks ago she
had a pneumonia that was treated w/ antibiotics he is unsure 
what
kind. He notes increased upper airway sounds especially when she
is on a trach mask. He had requested a CXR at ___ but they did
not do one. He says she had no oral temperatures there. He says
she has been doing well and continues to communicate when there
they create a leak in her trach. Additionally she raises her
right hand with issues. Lately she has been raising her right
hand with concerns when he asks her. Lately it has been with 
pain
in her back. 

She came home to her son yesterday. He noted that she has had
intermittent episodes of having respiratory rates of ___ and
then it will go up to 30 for a few seconds and back down. He is
concerned this is new for her and he talked to a respiratory
therapist who he has on call who recommended she get evaluated. 

While at OSH she had episodes of tachypnea. CXR was c/f
persistent pneumonia with lactate 2.2. She was given a dose of
Vancomycin and Cefepime and transferred to ___.

Of note the patient had persistent fevers in the past despite
broad spectrum antibiotics for pneumonia. ID has been consulted
in the past and felt that she likely has colonization. They
believe she likely had fevers due to non-infectious source or
drug fever. She had a DVT in her RUE brachial, basilica and
cephalic veins. She also had LUE DVT of the axillary. The
decision last admission, despite many risks was to
anticoagulation with warfarin with a lovenox bridge. She was to
get 3 weeks of anticoagulation as she had a PICC in place. She
remained vent dependent previously. 

In the ED she had a fever to 101.4. She had a HR of 81, RR 14.
She was on her home ventilator settings of CMV, 400/10/5/28%. 

Her exam showed bilateral rhonchi, no sores appreciated or other
abnormalities.   

Lab work up showed a VBG 7.46/45. Lactate 1.3. WBC 8.0 
Hemoglobin
9.4. Remaining lab work was pending at time of transfer. Lactate
2.2 at OSH vanc and Cefepime given at OSH. Started on NS. 

ROS: Positives as per HPI; otherwise negative.  

 
Past Medical History:
Per OMR:
 ___ Disease  
 HTN  
 HLD  
 Esophageal dysmotility  
 Bilateral blindness  
 Reactive airway disease  
 COPD, bronchiectasis  
 Hypothyroidism  
 Recurrent Aspiration s/p ___ placement 
 
Social History:
___
Family History:
Sons with heart disease per chart review
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
========================  
VS: afebrile, HR 82, BP    100% on vent
GEN: elderly woman, non-verbaly, trach and ___, no acute 
distress
HEENT: normocephalic, atraumatic, PERRLA
CV:  normal S1, S2, rRR no m/r/g
RESP: clear to auscultation, no wheezes or crackles noted
GI:  Soft, non-tender, ___ tube c/d/i
MSK:  warm, well perfused w/ contractors on left side
SKIN:  no breakdown noted
NEURO:  follows simple commands such as sticking out tongue
PSYCH:  unable to assess 

DISCHARGE PHYSICAL EXAM:
=========================
VS: HR 83 BP 111/62 O2SAT 100% ON 35% FiO2 trach mask
GENERAL: NAD, a bit delirious
CV RRR
Breathing well on trach mask 
No lower extremity edema
Skin dry, no erythema, no lesions 

 
Pertinent Results:
ADMISSION LABS:
===============

___ 08:09AM BLOOD WBC-8.0 RBC-3.24* Hgb-9.4* Hct-31.0* 
MCV-96 MCH-29.0 MCHC-30.3* RDW-14.7 RDWSD-51.7* Plt ___
___ 08:09AM BLOOD Neuts-66.5 ___ Monos-8.9 Eos-3.1 
Baso-0.5 Im ___ AbsNeut-5.30 AbsLymp-1.63 AbsMono-0.71 
AbsEos-0.25 AbsBaso-0.04
___ 01:32PM BLOOD ___ PTT-35.0 ___
___ 08:09AM BLOOD Glucose-100 UreaN-19 Creat-0.5 Na-136 
K-4.6 Cl-95* HCO3-28 AnGap-13
___ 08:09AM BLOOD ALT-13 AST-22 AlkPhos-97 TotBili-0.5
___ 08:09AM BLOOD Albumin-3.6 Calcium-9.5 Phos-4.0 Mg-1.9
___ 08:22AM BLOOD ___ pO2-59* pCO2-45 pH-7.46* 
calTCO2-33* Base XS-6 Comment-GREEN TOP 

DISCHARGE LABS:
===============
___ 04:05AM BLOOD WBC-6.1 RBC-3.05* Hgb-8.8* Hct-28.9* 
MCV-95 MCH-28.9 MCHC-30.4* RDW-14.6 RDWSD-50.8* Plt ___
___ 04:05AM BLOOD ___ PTT-34.4 ___
___ 04:05AM BLOOD Glucose-97 UreaN-17 Creat-0.5 Na-137 
K-4.4 Cl-97 HCO3-29 AnGap-11
___ 04:47AM BLOOD ___ ___ Tidal V-400 PEEP-5 
FiO2-35 pO2-49* pCO2-43 pH-7.47* calTCO2-32* Base XS-6 
As/Ctrl-ASSIST/CON Intubat-INTUBATED

IMAGING:
========
___ CXR
  
Comparison to ___.  No relevant change is noted.  The 
patient is 
strongly rotated.  The tracheostomy tube is in stable correct 
position.  
Healed right rib fractures with adjacent pleural thickening.  
The size of the cardiac silhouette remains slightly enlarged, 
there is a small hiatal hernia.  No pleural effusions.  No 
pulmonary edema.  No current evidence of pneumonia.

___ LENIS, upper extremity
 
IMPRESSION:  
  
No evidence of deep vein thrombosis in the bilateral upper 
extremity veins. 
  
___ CXR
IMPRESSION:  
  
Lungs continue to be low volume with multiple healed bilateral 
rib fractures.  Tracheostomy tube remains in place.  
Cardiomediastinal silhouette is stable.  Small bilateral 
effusions left greater than right are unchanged.  No 
pneumothorax. 

 
  

 
Brief Hospital Course:
PATIENT SUMMARY
===================
Ms ___ is a ___ year old woman with history of advanced 
___, bilateral blindness, reactive airway disease on 
chronic prednisone, HTN, HLD, COPD, hypothyroidism, and recent 
admission for MRSA and pseudomonas PNA which resulted in 
___, now with vent dependence (___), who now 
presents from her home w/ tachypnea (intermittent) found on last 
admission to have bl UE DVT (transitioned to warfarin). She has 
no leukocytosis on admission and no further fevers over one in 
ED. Staph coag negative at ___ and ___ culture, likely both 
contaminants.

ACUTE ISSUES 
=============== 
# Fever (noted x 1)
Most likely still colonized as noted before. Contaminated sputum 
here, CXR w/o PNA. No leukocytosis and maintains baseline 
tachypnea per prior providers. She finished her last course of 
antibiotics ___ weeks ago at ___. White count stable, no 
tachycardia. Afebrile other than 1 ED rectal temperature. One 
blood culuture at OSH and one blood culture at ___ with staph 
epi (one at OSH, one ___, but stable, thus thought to both be 
contaminants). 

#Chronic hypoxemic respiratory failure
#Trach dependent
Gas on admission reassuring. Continued home settings on trach, 
weaned as tolerated. She transitioned to trach mask, and 
intermittently used the ventilator if she appeared to be in 
respiratory distress. However this was weaned throughout her 
stay, and she was stably maintained on trach mask before 
discharge, with oxygen saturations 98-100% on 35% FiO2 and no 
respiratory distress. She did not need mechanical ventilation 
for 36 hours prior to discharge. 

# Bilateral UE Catheter Associated DVT:
Diagnosed previous admission ___ - ___. Repeat 
ultrasound here showed no evdience of DVT in upper extremity 
veins in setting of Warfarin since discharge in ___. Plan to 
continue anticoag until end of ___ with warfarin goal INR ___, 
with consideration of transitioning to enoxaparin ___omplete for lifelong anticoagulation, as she has a 
propensity to develop venothromboemboli. 

# Normocytic anemia
The patient has a recent baseline Hgb of 7.5-8.5m/dL. Iron 
studies from her last admission suggest anemia of chronic 
inflammation. She requires intermittent transfusions. 

# Severe protein-calorie malnutrition
She was continued on tube feeds per recommendation of the 
Nutrition service. 

CHRONIC ISSUES 
=============== 
# Esophageal dysmotility: s/p ___: The patient was continued on 
the Nutrition service's final tube feed recs from her last 
admission

# ___: Continued home carbidopa/levodopa regimen 
(adjusted while at ___)

# HLD: Continued home statin

# Chronic pain: We transitioned standing acetaminophen to PRN as 
she did not appear in pain, and nodded no when asked if she was 
in any pain. Home NSAIDs were held in the setting of anemia. She 
should continue on as-needed pain control with acetaminophen or 
very low dose oxycodone. 

# Reactive airway disease, copd: Taper prednisone as below in 
transitional issues

TRANSITIONAL ISSUES:
====================
[] if patient to go home in future, continue trach/vent teaching 
w/ son
[] continue on going discussions w/ family regarding prognosis 
and goals of care
[] Please discuss with family long-term anticoagulation given 
propensity for venous thromboembolism. 
[] Patient does well on trach mask, only needs ventilator if o2 
sat decreases or she appears in respiratory distress. 
[] prednisone taper as follows: 5 mg PO daily until ___, 2.5 mg 
starting ___ through ___, then stop prednisone. 
Re-evaluate need if symptoms worsen off of prednisone. 

Code: Full, confirmed w/ Son (___), Proxy ___

This patient was prescribed, or continued on, an opioid pain 
medication at the time of discharge (please see the attached 
medication list for details). As part of our safe opioid 
prescribing process, all patients are provided with an opioid 
risks and treatment resource education sheet and encouraged to 
discuss this therapy with their outpatient providers to 
determine if opioid pain medication is still indicated.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 650 mg NG Q6H 
2. Artificial Tears 1 DROP BOTH EYES BID 
3. Carbidopa-Levodopa (___) 2 TAB NG Q0700 
4. Carbidopa-Levodopa (___) 1.5 TAB PO Q 1000 
5. Carbidopa-Levodopa (___) 1.5 TAB PO Q1300 
6. Carbidopa-Levodopa (___) 1.5 TAB PO Q1600 
7. Ipratropium Bromide Neb 1 NEB IH Q6H 
8. Levalbuterol Neb 0.63 mg NEB Q6H 
9. Lidocaine 5% Patch 1 PTCH TD QPM 
10. Milk of Magnesia 30 mL PO DAILY 
11. Multivitamins W/minerals 1 TAB NG DAILY 
12. OxyCODONE (Immediate Release) 1.25 mg PO Q6H:PRN Pain - 
Moderate 
13. Polyethylene Glycol 17 g PO DAILY 
14. PredniSONE 10 mg NG DAILY 
Start: After last tapered dose completes 
This is the maintenance dose to follow the last tapered dose
15. Levothyroxine Sodium 25 mcg PO DAILY 
16. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID 
17. Clotrimazole Cream 1 Appl TP BID 
18. formoterol fumarate 20 mcg/2 mL inhalation BID 
19. melatonin 3 mg oral QHS 
20. omeprazole magnesium 20 Mg oral BID 
21. Pravastatin 80 mg PO QPM 
22. Saccharomyces boulardii 250 mg oral BID 
23. ___  MD to order daily dose PO DAILY16 
24. Enoxaparin Sodium 50 mg SC Q12H 

 
Discharge Medications:
1.  formoterol fumarate 20 mcg/2 mL inhalation BID  
2.  formoterol fumarate 20 mcg/2 mL inhalation BID  
3.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
4.  Acetaminophen 500 mg NG Q6H:PRN Pain - Mild/Fever  
5.  Artificial Tears ___ DROP BOTH EYES BID  
6.  Carbidopa-Levodopa (___) 1.5 TAB PO TID 
___, 1300, 1600  
7.  Pravastatin 20 mg PO QPM  
8.  PredniSONE 5 mg PO DAILY Duration: 7 Days  
9.  PredniSONE 2.5 mg PO DAILY Duration: 7 Days  
10.  Carbidopa-Levodopa (___) 2 TAB NG Q0700  
11.  Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID  
12.  Clotrimazole Cream 1 Appl TP BID  
13.  Ipratropium Bromide Neb 1 NEB IH Q6H  
14.  Levalbuterol Neb 0.63 mg NEB Q6H  
15.  Levothyroxine Sodium 25 mcg PO DAILY  
16.  Lidocaine 5% Patch 1 PTCH TD QPM  
17.  melatonin 3 mg oral QHS  
18.  Milk of Magnesia 30 mL PO DAILY  
19.  Multivitamins W/minerals 1 TAB NG DAILY  
20.  OxyCODONE (Immediate Release) 1.25 mg PO Q6H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg 0.25 tablet(s) by mouth Q6H PRN Disp #*10 
Tablet Refills:*0 
21.  Polyethylene Glycol 17 g PO DAILY  
22.  Saccharomyces boulardii 250 mg oral BID  
23.  ___  MD to order daily dose PO DAILY16  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
FINAL DIAGNOSIS
=================
Acute on chronic respiratory failure, tracheostomy dependent

SECONDARY DIAGNOSES
=====================
___ disease
Bilateral catheter-associated deep vein thrombosis
Anemia of chronic disease
Severe protein-calorie malnutrition

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
Dear Ms ___,

It was a pleasure taking care of you at the ___ 
___.

Why did you come to the hospital?
- You came to the hospital because there was concern at home 
with your breathing. 

What happened while you were in the hospital?
- You had a fever in the emergency department, but then no other 
fevers or signs of infection
- The respiratory therapist sometimes put you back on the 
ventilator through your tracheostomy at night if you were having 
trouble breathing. Most of the time you did very well on the 
tracheostomy mask. 
- You were continued on medications to prevent clots from 
forming in your veins. 

What should you do once you leave the hospital?
- Make sure to take your medications as prescribed. 

We wish you all the best!
- Your ___ Care Team

 
Followup Instructions:
___
"
107,15229355,27741908," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Right leg pain after stationary bike accident
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ female with advanced ___,
chronic respiratory failure s/p tracheostomy (nocturnally 
ventilated), chronic aspiration with PEG, dementia, HTN, 
hyperlipidemia who presenting for pain in her right ankle and 
foot after a mechanical injury.

Report offered by her son, ___. Patient was on an automated 
exercise bike with help of son and a hoyer lift, her strap from 
her chair sling got caught in machine and her foot ended up 
getting pulled and hyperextended at the ankle joint. She as had 
pain and swelling since.  In the ED she was diagnosed with a 
distal fibula fracture (and ?tibial fracture).

Patient is trached in ___ secondary to failure to extubate
after being intubated for pneumonia, patient had failure to
manage secretions. In the ED, patient able to minimally
communicate, but did deny chest pain, abdominal pain, trouble
breathing. Per son patient has been making appropriate urine and
stool, normal nutritional intake.

Additional history limited due to patient's chronic condition. 
 
Past Medical History:
Per OMR:
 ___ Disease  
 HTN  
 HLD  
 Esophageal dysmotility  
 Bilateral blindness  
 Reactive airway disease  
 COPD, bronchiectasis  
 Hypothyroidism  
 Recurrent Aspiration s/p PEG placement 
 
Social History:
___
Family History:
Sons with heart disease per chart review
 
Physical Exam:
ADMISSION PHYSICAL EXAM 
=========================
Gen: Comfortable, No Acute Distress
HEENT: NC/AT. EOMI. 
Neck: No swelling. Trachea is midline.
Cor: RRR. No m/r/g. 
Pulm: CTAB, Nonlabored respirations. 
Abd: Soft, nontender, nondistended.
Ext: Tenderness to palpation of the right ankle and right dorsum
of the foot, purple discoloration and diffuse edema. Good
capillary refill. Neurovascularly intact, 4 out of 5 strength
with weakness likely secondary to pain.
Skin: No rashes. No skin breakdown
Neuro: AAOx3. Gross sensorimotor intact. 
Psych: Normal mentation. 
Heme: No petechiae. No ecchymosis.

DISCHARGE PHYSICAL EXAM 
HEENT: NC/AT. EOMI. 
Neck: No swelling. Trachea is midline. Trach mask 
Cor: RRR. No m/r/g. 
Pulm: CTAB, Nonlabored respirations. 
Abd: Soft, nontender, nondistended.
Ext:Right foot cast, CSM intact 
Skin: No rashes. No skin breakdown
Neuro: AAOx3. Gross sensorimotor intact. 
Psych: Normal mentation. 
Heme: No petechiae. No ecchymosis.

 
Pertinent Results:
COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW RDWSD Plt 
Ct 
___ 03:10AM    8.1 2.59* 7.7* 26.2* 101* 29.7 29.4* 14.7 
53.7* 158 Import Result 

 
___ 05:55PM    6.5 2.38* 7.1* 23.8* 100* 29.8 29.8* 14.6 
53.5* 148* Import Result 

 
___ 02:46AM    5.6 2.34* 7.1* 23.7* 101* 30.3 30.0* 15.2 
55.8* 173 Import Result 

 
___ 02:49AM    12.5* 2.62* 7.9* 25.8* 99* 30.2 30.6* 
14.9 53.7* 145* Import Result 

 
___ 06:37PM    11.8* 2.85* 8.6* 27.9* 98 30.2 30.8* 14.7 
53.3* 150 Import Result 

 
___ 10:39AM    7.9 2.52* 7.6* 24.7* 98 30.2 30.8* 14.8 
53.1* 113* Import Result 

 
___ 03:50AM    8.1 2.57* 7.7* 25.0* 97 30.0 30.8* 14.9 
53.1* 110* Import Result 

 
___ 03:37AM    10.4* 2.77* 8.3* 27.1* 98 30.0 30.6* 15.0 
54.0* 122* Import Result 

 
___ 08:00AM    14.0* 3.02* 9.0* 29.2* 97 29.8 30.8* 14.9 
53.1* 147* Import Result 

 
___ 08:20PM    17.1* 3.59* 10.9* 34.3 96 30.4 31.8* 14.7 
51.0* 186 Import Result  

___ 08:20PM BLOOD Neuts-86.0* Lymphs-10.2* Monos-2.7* 
Eos-0.4* Baso-0.2 Im ___ AbsNeut-14.72* AbsLymp-1.74 
AbsMono-0.47 AbsEos-0.06 AbsBaso-0.04

BASIC COAGULATION ___, PTT, PLT, INR) ___ PTT Plt Ct ___ 
___ 03:10AM        158   Import Result 

 
___ 03:10AM    13.1* 35.3   1.2* Import Result 

 
___ 05:55PM        148*   Import Result 

 
___ 02:46AM        173   Import Result 

 
___ 02:46AM    13.4* 27.3   1.2* Import Result 

 
___ 02:49AM        145*   Import Result 

 
___ 02:49AM    14.0* 35.4   1.3* Import Result 

 
___ 06:37PM        150   Import Result 

 
___ 10:39AM        113*   Import Result 

 
___ 03:50AM        110*   Import Result 

 
___ 03:37AM        122*   Import Result 

 
___ 03:37AM    15.4* 31.9   1.4* Import Result 

 
___ 08:00AM        147*   Import Result 

 
___ 08:20PM        186   Import Result 
 

Chemistry 
 RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap 
___ 03:10AM    113* 17 0.3* 140 4.4 97 35* 8* Import 
Result 

 
___ 02:46AM    125* 15 0.4 139 4.1 96 30 13 Import 
Result 

 
___ 02:49AM    135* 16 0.3* 141 4.5 100 29 12 Import 
Result 

 
___ 03:50AM    115* 14 0.4 139 4.4 98 31 10 Import 
Result 

 
___ 03:37AM    123* 15 0.4 134* 4.0 96 28 10 Import 
Result 

 
___ 08:00AM    108* 17 0.4 136 4.6 98 27 11 Import 
Result 

 
___ 08:20PM    95 17 0.4 130* 4.0 91* 28 11 Import 
Result 

 
 ESTIMATED GFR (MDRD CALCULATION) estGFR 
___ 08:20PM    Using this Import Result 

 
 ENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase 
TotBili DirBili 
___ 03:37AM    9 22     67   0.8   Import Result 

 
 CHEMISTRY TotProt Albumin Globuln Calcium Phos Mg UricAcd Iron 
___ 03:10AM          9.1 3.4 2.3     Import Result 

 
___ 02:46AM          9.0 2.4* 2.1     Import Result 

 
___ 02:49AM          9.2 2.9 2.2     Import Result 

 
___ 06:37PM                  18* Import Result 

 
___ 03:50AM          9.1 2.6* 2.1     Import Result 

 
___ 03:37AM      3.7   9.3 2.8 2.0     Import Result 

 
___ 08:00AM          9.1 3.4 1.9     Import Result 

 
 HEMATOLOGIC calTIBC VitB12 Folate Ferritn TRF 
___ 06:37PM    263 868 >20 292* 202 Import Result 

 
 LAB USE ONLY LtGrnHD GreenHd HoldBLu 
___ 08:20PM        HOLD Import Result 

 
___ 08:20PM    HOLD     Import Result 

 
___ 08:20PM      HOLD   Import Result 

 
 LAB USE ONLY 
___ 03:10AM    Import Result 

 
___ 02:46AM    Import Result 

 
___ 02:49AM    Import Result 

 
___ 06:37PM    Import Result 

 
___ 03:50AM    Import Result 

 
___ 03:37AM    Import Result 

 
___ 08:00AM    Import Result 

 
___:20PM    Import Result 

 
 

Blood Gas 
 BLOOD GASES Type Temp Rates Tidal V PEEP FiO2 O2 Flow pO2 
Comment 
___ 03:34AM    ___               GREEN TOP Import Result 


 
 WHOLE BLOOD, MISCELLANEOUS CHEMISTRY Lactate 
___ 03:34AM    1.8 Import Result  
 

 
Brief Hospital Course:
Ms. ___ is a ___ female with advanced ___, 
chronic respiratory failure s/p trach, chronic aspiration with 
PEG, dementia, hypertension, hyperlipidemia who is presenting 
with distal fibula (?tibial as well) fracture and found to have 
concerns for UTI in the ED. She was admitted to the ICU given 
chronic respiratory failure and brief hypotension in the ED 
which responded to IVF.

#Comminuted distal fibula fracture
Presenting with distal fibula fracture after having trauma on
stationary bike. She was initially placed in a right lower 
extremity splint, which was subsequently casted by the 
orthopedics service. She received her home acetaminophen dose 
and oxycodone as needed for pain control. She has follow-up 
scheduled with orthopedics. 

#Hypotension, improved
Patient was briefly hypotensive in the ED with SBPs in the ___, 
Improved with 1L NS. Lactate within normal limits. Etiology 
likely either hypovolemia vs. sepsis. Given hyponatremia, 
possibly related to hypovolemia, especially given rapid 
improvement after small amount of IVF. Some concerns for UTI as 
noted below. 

#UTI
Patient found to have pyuria on UA in setting of leukocytosis. 
No other clear source of infection. She was given a 7 day course 
of ceftriaxone as treatment for urinary tract infection which 
was then transitioned to Keflex. 

#Chronic respiratory failure 
Respiratory status appears at baseline, patient has a 
tracheostomy. CXR without evidence of consolidation. Home 
settings on trach were continued with trach mask during the day 
and ventilator at night, and her home medications were 
continued. 

___: Her home carbidopa/levodopa regimen was continued. 
She had some episodes of agitation overnight and her outpatient 
neurologist Dr. ___ was consulted, who recommended an 
additional 1.5 tabs of Sinamet as needed at 3 am for agitation. 
This was noted to improve her agitation overnight. 

#Bradycardia: While in the ICU, the patient had intermittent 
episodes of sinus bradycardia overnight in the setting of being 
off the ventilator and while episodes of agitation. EKG showed 
no evidence of bundle branch block or heart block. This was 
thought to be secondary to the vasovagal episodes given timing 
with episodes of agitation as well as being off the ventilator. 
She did not have any hypotension during these episodes and 
continued to be monitored throughout her stay.  Her son, ___, 
expressed interest in a cardiology evaluation for which we 
provided him the contact information to schedule an outpatient 
appointment as her bradycardia resolved with improvement in 
agitation and pain control. 

 
Medications on Admission:
1. formoterol fumarate 20 mcg/2 mL inhalation BID 
2. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
3. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever 
4. Carbidopa-Levodopa (___) 1.5 TAB PO DAILY 
5. Carbidopa-Levodopa (___) 2 TAB PO DAILY: 0700 
6. Clotrimazole Cream 1 Appl TP BID 
7. Ipratropium Bromide Neb 1 NEB IH Q6H 
8. Levalbuterol Neb 0.63 mg NEB Q6H 
9. Levothyroxine Sodium 25 mcg PO DAILY 
10. melatonin 3 mg oral QHS 
11. Multivitamins W/minerals 1 TAB PO DAILY 
12. OxyCODONE (Immediate Release) 2.5 mg PO Q6H:PRN Pain - 
Moderate 
13. Polyethylene Glycol 17 g PO DAILY 
14. Atorvastatin 20 mg PO QPM 
15. PredniSONE 10 mg PO DAILY 
16. Carbidopa-Levodopa (___) 2 TAB PO DAILY 
17. Carbidopa-Levodopa (___) 2 TAB PO DAILY 1600 
18. Carbidopa-Levodopa (___) 1 TAB PO DAILY 
19. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 

 
Discharge Medications:
1.  Cephalexin 500 mg PO BID Duration: 2 Days 
Take 2 pills a day for the next two days (4 pills total)  
RX *cephalexin 500 mg 1 capsule(s) by mouth twice a day Disp #*4 
Capsule Refills:*0 
2.  Carbidopa-Levodopa (___) 2 TAB PO TID ___, 1300, 1600  
3.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever  
4.  Atorvastatin 20 mg PO QPM  
5.  Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line  
6.  Carbidopa-Levodopa (___) 1.5 TAB PO DAILY  
7.  Carbidopa-Levodopa (___) 1 TAB PO DAILY  
8.  Clotrimazole Cream 1 Appl TP BID  
9.  formoterol fumarate 20 mcg/2 mL inhalation BID  
10.  Ipratropium Bromide Neb 1 NEB IH Q6H  
11.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
12.  Levalbuterol Neb 0.63 mg NEB Q6H  
13.  Levothyroxine Sodium 25 mcg PO DAILY  
14.  melatonin 3 mg oral QHS  
15.  Multivitamins W/minerals 1 TAB PO DAILY  
16.  OxyCODONE (Immediate Release) 2.5 mg PO Q6H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg 0.5 (One half) tablet(s) by mouth q8hrs Disp 
#*10 Capsule Refills:*0 
17.  Polyethylene Glycol 17 g PO DAILY  
18.  PredniSONE 10 mg PO DAILY 
Prednisone was started on ___ for a thirty day course.   

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Right fibular fracture 

 
Discharge Condition:
Activity Status: Out of Bed with assistance to chair or 
wheelchair.
Level of Consciousness: Lethargic but arousable.
Mental Status: Confused - always.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure to care for you at the ___ 
___.  

Why did I come to the hospital?  
You came to the hospital after you had an accident on a 
stationary bike while at home. 
  
What happened while I was in the hospital?  
You were found to have broken one of the bones in your right 
leg. This was put in a cast by the orthopedics doctors at the 
hospital. 

We did an analysis of your urine which was concerning for a 
urinary tract infection. You received antibiotics while in the 
hospital, and will have 2 more days of antibiotics to take while 
at home. 

You had a few episodes of slower heart rate while you were in 
the intensive care unit. You were monitored while in the unit 
and did not have any changes in your hemodynamic status such as 
low blood pressure. We did a scan of your heart (EKG) which did 
not show signs of a concerning heart rhythm. You should follow 
up with the cardiology clinic upon discharge. 
  
What should I do once I leave the hospital?  
 - Take your medications as prescribed and follow up with your 
doctor appointments, including orthopedics and cardiology 
- You will receive physical therapy and speech evaluation while 
at home 

We wish you the best!  
Your ___ Care Team  
 
Followup Instructions:
___
"
108,15229355,29618054," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin / morphine
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
None
attach
 
Pertinent Results:
ADMISSION
=========
___ 06:06AM   ___ PO2-56* PCO2-51* PH-7.39 TOTAL 
CO2-32* BASE XS-4
___ 06:06AM   LACTATE-1.5
___ 05:59AM URINE  HOURS-RANDOM
___ 05:59AM URINE  UHOLD-HOLD
___ 05:59AM URINE  COLOR-Yellow APPEAR-HAZY* SP ___
___ 05:59AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.5 
LEUK-NEG
___ 05:59AM URINE  RBC-0 WBC-0 BACTERIA-NONE YEAST-NONE 
EPI-1
___ 05:09AM   GLUCOSE-95 UREA N-15 CREAT-0.5 SODIUM-140 
POTASSIUM-4.4 CHLORIDE-100 TOTAL CO2-27 ANION GAP-13
___ 05:09AM   CALCIUM-9.6 PHOSPHATE-3.4 MAGNESIUM-2.2
___ 05:09AM   WBC-9.7 RBC-3.47* HGB-10.4* HCT-34.3 MCV-99* 
MCH-30.0 MCHC-30.3* RDW-14.3 RDWSD-52.1*
___ 05:09AM   PLT COUNT-167
___ 05:09AM   ___ PTT-32.6 ___
___ 10:17PM   GLUCOSE-81 UREA N-18 CREAT-0.4 SODIUM-135 
POTASSIUM-4.2 CHLORIDE-94* TOTAL CO2-27 ANION GAP-14
___ 10:17PM   estGFR-Using this
___ 10:17PM   ALT(SGPT)-<5 AST(SGOT)-17 LD(LDH)-201 ALK 
PHOS-72 TOT BILI-0.6
___ 10:17PM   WBC-8.9 RBC-3.48* HGB-10.5* HCT-33.7* MCV-97 
MCH-30.2 MCHC-31.2* RDW-14.4 RDWSD-51.3*
___ 10:17PM   NEUTS-65.9 ___ MONOS-8.5 EOS-0.9* 
BASOS-0.6 IM ___ AbsNeut-5.89 AbsLymp-2.12 AbsMono-0.76 
AbsEos-0.08 AbsBaso-0.05
___ 10:17PM   PLT COUNT-176

IMAGING
=======
AP portable upright view of the chest.  The patient's chin 
obscures the 
superior mediastinum in the setting of hyper kyphotic thoracic 
deformity.  
Tracheostomy tube is subtly conspicuous.  Multiple chronic 
bilateral rib 
deformities are again seen.  The imaged portions of the lungs 
are relatively clear.  No large effusion is seen.  No 
pneumothorax allowing for limitations. Cardiomegaly is 
unchanged.  Limited evaluation of the mediastinum.  Bony 
structures appear grossly intact. 
  
IMPRESSION:  
Markedly limited exam.  No gross signs for pneumonia.  Thoracic 
hyper kyphosis resultant suboptimal assessment of the lung 
apices and superior mediastinum.

DISCHARGE LABS
================
___ 05:09AM BLOOD WBC-9.7 RBC-3.47* Hgb-10.4* Hct-34.3 
MCV-99* MCH-30.0 MCHC-30.3* RDW-14.3 RDWSD-52.1* Plt ___
___ 05:09AM BLOOD Glucose-95 UreaN-15 Creat-0.5 Na-140 
K-4.4 Cl-100 HCO3-27 AnGap-13
___ 06:06AM BLOOD ___ pO2-56* pCO2-51* pH-7.39 
calTCO2-32* Base XS-4

MICROBIOLOGY
==============
___ 10:17 pm BLOOD CULTURE

   Blood Culture, Routine (Pending):    No growth to date. 

 
Brief Hospital Course:
SUMMARY
=======
Ms. ___ is a ___ year old woman with chronic respiratory 
failure s/p tracheostomy ___ (nocturnally ventilated), chronic 
aspiration s/p PEG, dementia, advanced ___, HTN, 
hyperlipidemia, recent admission for a right fibula fracture, 
and other issues who presented on ___ with apparent 
lethargy (reported by her son, as the patient is variably 
interactive) in the setting of a reported right lower lobe 
pneumonia apparently noted on outpatient imaging on the day 
prior to presentation. On repeat imaging on presentation to 
___, there were no definite signs of pneumonia and there were 
no clinical indications of acute systemic inflammation or 
infection. She remained on her home ventilator settings at night 
and trach mask during the day. Although very broad spectrum 
antibiotics were provided on presentation in the ED, given the 
absence of infection on chest imaging and the lack of clinical 
symptoms of an acute infection, all antibiotics were stopped 
upon ICU admission, and she was monitored off of antibiotics for 
24 hours without any signs of clinical instability. She was 
subsequently discharged home without antibiotics.

ACUTE ISSUES 
============
# Concern for right upper lobe pneumonia (without radiographic 
or clinical evidence of right upper lobe pneumonia) 
# Chronic respiratory failure 
Ms. ___ has a tracheostomy tube in place in the setting of 
chronic respiratory failure, and requires ventilator support at 
night. During the day, she uses a humidifier with 3L of 
supplemental oxygen. Per history provided by her son (who is her 
primary caregiver at home), Ms. ___ has had increased 
secretions over the last week and an out-patient chest x-ray on 
___ was concerning for potential right upper lobe pneumonia. 
However, on presentation to ___, there was no compelling 
radiographic or clinical evidence of pneumonia. Blood cultures 
and a MRSA screen were negative. She specifically had minimal 
secretions on tracheal suctioning, no leukocytosis on her 
complete blood counts, no fever, no hypotension, no tachycardia, 
and no radiographic evidence of pneumonia (although her lung 
apices were not well visualized on chest x-ray to 
kyphoscoliosis). Ms. ___ was continued on her home 
ipratropium and levalbuterol nebuliizer treatemetns, and 
fomoterol(home med). Her ventilator settings should remain at RR 
___, PEEP 5, TV 300 (reduced from 400cc at home, given her 
height and predicted tidal volume), and FiO2 30%

# History of UTIs
In the ED, the patient did not urinate but on the floor she has 
been incontinent of urine. She has a history of UTIs, and during 
a recent prior hospitalizations, on ___ she grew Klebsiella 
and was appropriately treated. She had another UTI while at home 
prior to this hospitalization which was treated empirically with 
cephalexin and then switched to Bactrim. Urinalysis here ___ 
was without evidence of acute cystitis, and while there was 
initial concern for urinary retention she began to void 
spontaneously prior to discharge, and did not have any more 
issues with retention while inpatient.

# ___ disease 
# Dementia
During her last admission, Ms. ___ had some episodes of 
agitation overnight and her outpatient neurologist Dr. ___ 
___ was consulted. At that time, he recommended an additional 
1.5 tabs of Sinamet as needed at 3AM for agitation. During that 
prior hospitalization, this medication change was noted to 
improve her agitation overnight. Her son says that she 
communicates with him, is normally oriented to person and place, 
and can speak with Passy-Muir valve. We continued Sinamet at her 
home doses this admission.

CHRONIC ISSUES 
==============
#B/l UE catheter associated DVT
She had bilateral upper extremity DVTs diagnosed in ___, 
with repeat US in ___ showing no evidence of DVT. Now that she 
has been treated for more than six months, she remains on 
enoxaparin prophylaxis, which we continued during this 
hospitalization (and on discharge). 

#Hypothyroidism: We continued her home levothyroxine. 

#Esophageal dysmotility: s/p PEG: We continued the Nutrition 
service's final tube feed recommendations from her last 
admission. 

TRANSITIONAL ISSUES
===================
[] Follow up on respiratory secretions and respiratory status 
off of antibiotics
[] Continue to monitor for signs of urinary retention, consider 
outpatient urodynamic studies if persistently retaining.
[] Ventilator settings at discharge: RR 13, TV 300, PEEP 5, FiO2 
30%

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever 
2. Atorvastatin 20 mg PO QPM 
3. Carbidopa-Levodopa (___) 2 TAB PO TID ___, 1000, 1600 
4. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
5. Ipratropium Bromide Neb 1 NEB IH Q6H 
6. OxyCODONE (Immediate Release) 2.5 mg PO Q6H:PRN Pain - 
Moderate 
7. Multivitamins W/minerals 1 TAB PO DAILY 
8. Levothyroxine Sodium 25 mcg PO DAILY 
9. melatonin 3 mg oral QHS 
10. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 
11. Carbidopa-Levodopa (___) 1.5 TAB PO DAILY at ___ 
12. Carbidopa-Levodopa (___) 1 TAB PO DAILY at 0000 
13. Levalbuterol Neb 0.63 mg NEB Q6H 
14. Polyethylene Glycol 17 g PO DAILY 
15. PredniSONE 10 mg PO DAILY 
16. Clotrimazole Cream 1 Appl TP BID 
17. formoterol fumarate 20 mcg/2 mL inhalation BID 
18. Enoxaparin Sodium 30 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time 
19. Nystatin Cream 1 Appl TP BID 
20. Carbidopa-Levodopa (___) 2.5 TAB PO DAILY at 1300 

 
Discharge Medications:
1.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever  
2.  Atorvastatin 20 mg PO QPM  
3.  Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line  
4.  Carbidopa-Levodopa (___) 2 TAB PO TID ___, 1000, 1600  
5.  Carbidopa-Levodopa (___) 1.5 TAB PO DAILY at ___  
6.  Carbidopa-Levodopa (___) 1 TAB PO DAILY at 0000  
7.  Carbidopa-Levodopa (___) 2.5 TAB PO DAILY at 1300  
8.  Clotrimazole Cream 1 Appl TP BID  
9.  Enoxaparin Sodium 30 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time  
10.  formoterol fumarate 20 mcg/2 mL inhalation BID  
11.  Ipratropium Bromide Neb 1 NEB IH Q6H  
12.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
13.  Levalbuterol Neb 0.63 mg NEB Q6H  
14.  Levothyroxine Sodium 25 mcg PO DAILY  
15.  melatonin 3 mg oral QHS  
16.  Multivitamins W/minerals 1 TAB PO DAILY  
17.  Nystatin Cream 1 Appl TP BID  
18.  OxyCODONE (Immediate Release) 2.5 mg PO Q6H:PRN Pain - 
Moderate  
19.  Polyethylene Glycol 17 g PO DAILY  
20.  PredniSONE 10 mg PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary 
======= 
Acute on Chronic Hypoxic Respiratory Failure s/p Tracheostomy 
 
Secondary 
========= 
___ Disease 
Dementia 
Esophageal Dysmotility 
Hypertension 
Hyperlipidemia 

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
Dear Ms. ___,
  
It was a privilege caring for you at ___.  

WHY WAS I IN THE HOSPITAL?  
- You were having more secretions and there was concern for a 
pneumonia on your home chest X-Ray.

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- We repeated a Chest X-Ray which did not show any signs of 
pneumonia.
- You were given 1 dose of antibiotics in the ED but due to our 
low concern for pneumonia based on your breathing and chest 
X-Ray, we decided to stop antibiotics and watch you closely in 
the ICU and we did not see any more signs of pneumonia.
- You returned to your baseline and were discharged home.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
-Please continue to take all of your medications and follow-up 
with your appointments as listed below.

We wish you the best!  

Sincerely,  
Your ___ Team   
 
Followup Instructions:
___
"
109,15229355,27105431," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin / morphine
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
None

attach
 
Pertinent Results:
ADMISSION LABS
================
___ 02:17AM BLOOD WBC-8.5 RBC-3.45* Hgb-10.6* Hct-33.3* 
MCV-97 MCH-30.7 MCHC-31.8* RDW-14.0 RDWSD-49.3* Plt ___
___ 02:17AM BLOOD Neuts-63.9 ___ Monos-8.9 Eos-1.5 
Baso-0.4 Im ___ AbsNeut-5.46 AbsLymp-2.12 AbsMono-0.76 
AbsEos-0.13 AbsBaso-0.03
___ 02:17AM BLOOD Glucose-78 UreaN-14 Creat-0.4 Na-137 
K-4.5 Cl-97 HCO3-29 AnGap-11
___ 02:17AM BLOOD ALT-<5 AST-33 AlkPhos-58 TotBili-0.6
___ 02:17AM BLOOD Lipase-17
___ 02:17AM BLOOD cTropnT-0.01
___ 02:17AM BLOOD Albumin-4.1 Calcium-9.5 Phos-3.5 Mg-2.5
___ 09:13AM BLOOD ___ pO2-49* pCO2-50* pH-7.41 
calTCO2-33* Base XS-5
___ 09:13AM BLOOD Lactate-1.8

MICRO
=====
___ 4:12 am URINE

   URINE CULTURE (Preliminary): 
      GRAM NEGATIVE ROD(S).    >100,000 CFU/mL. 

___ 7:34 pm SPUTUM      Source: Endotracheal. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      >25 PMNs and >10 epithelial cells/100X field. 
      Gram stain indicates extensive contamination with upper 
respiratory
      secretions. Bacterial culture results are invalid. 
      PLEASE SUBMIT ANOTHER SPECIMEN. 

   RESPIRATORY CULTURE (Final ___: 
      TEST CANCELLED, PATIENT CREDITED. 

IMAGING
========
___ CXR
Evaluation is limited due to low lung volumes and patient 
positioning with chin overlying the lung apices. Within these 
limitations: 
Tracheostomy is again seen. No large pleural effusion or obvious 
pneumothorax. The cardiomediastinal silhouette is enlarged and 
stable. Aortic arch atherosclerotic calcifications are again 
seen.  Obscuration of the left hemidiaphragm may be secondary to 
atelectasis, a developing infiltrate cannot be excluded. 
The apparent opacity in the right lower lung base is not 
visualized on repeat images and is likely due to overlying soft 
tissue, possibly the patient's arm. Deformities of the bilateral 
ribs, may be related to old fractures. 

DISCHARGE LABS
==============
___ 04:35AM BLOOD WBC-6.3 RBC-2.94* Hgb-8.7* Hct-28.1* 
MCV-96 MCH-29.6 MCHC-31.0* RDW-14.0 RDWSD-49.0* Plt ___
___ 04:35AM BLOOD Glucose-93 UreaN-11 Creat-0.4 Na-137 
K-3.9 Cl-99 HCO3-26 AnGap-12
___ 04:35AM BLOOD ALT-<5 AST-25
___ 04:35AM BLOOD Calcium-8.7 Phos-2.9 Mg-2.___RIEF ICU COURSE
===================
___ year old woman with chronic respiratory failure s/p PEG/trach 
___ (nocturnally ventilated), chronic aspiration with PEG, 
dementia, advanced ___, HTN, HLD, and recent admission 
for a right fibula fracture, who presents with hypotension and 
diarrhea in the setting of C diff infection and UTI. Her 
hypotension was likely hypovolemic and rapidly improved with IV 
fluid resuscitation. She was treated with high-dose PO 
vancomycin and IV flagyl as well as IV ceftriaxone for her GNR 
UTI. Upon discharge, the patient was clinically improved with 
baseline blood pressures and decreased stool output.

TRANSITIONAL ISSUES: 
====================
[] Patient to complete PO vancomycin on ___ for total course 
of 14 days. Please ensure diarrhea has resolved following 
completion of this
[] Patient initiated on treatment for UTI and will be discharged 
with bactrim for 1 day for total 3 day course. Please ensure 
completion and resolution of UTI following this
[] Would recommend prophylactic PO vancomycin with future 
antibiotic courses to prevent recurrent C. diff

ACUTE ISSUES 
======================= 
# Diarrhea
# C difficile Infection
Patient presented with diarrhea over the past week unresponsive 
to PO vanc in the setting of known C diff infection. Although 
the number of daily stools has slowed down, the volume of the 
stools have been large. Given that she has had multiple c diff 
infections, she may be resistant to vancomycin. Stool cultures 
were sent. She was started on high dose PO vancomycin and IV 
flagyl. She was given IV fluids as below for GI losses. Her 
stool output decreased, her hypotension resolves, and she 
overall clinically was stable.

# Hypotension
Patient has blood pressures as low as ___ systolic in ED. BP was 
very responsive to fluid with no need for pressors. This was 
likely due to hypovolemia in the setting of fluid loss from 
diarrhea. Possibly, a compenent of SIRS response with C diff 
infection and UTI. No evidence of end organ damage based on 
initial labs. Blood pressures on discharge back to baseline.

# UTI
Patient with urine culture growing >100K GNR bacteria. The team 
was unable to assess symptoms given her mental status. 
Therefore, given concern for sepsis, she was treated with IV 
ceftriaxone.

# Chronic respiratory failure 
Patient has a tracheostomy and requires ventilator support at 
night. Patient has a history of frequent aspirations, with CXR 
appearing similar to baseline. She was continued on home 
ventilator settings. she was continued on home ipratropium, 
levalbuterol, and Perforomist. 

CHRONIC ISSUES 
======================= 
# ___
# Dementia
Followed by her outpatient neurologist Dr. ___. 
Patient continued on home Sinamet.

#B/l UE catheter associated DVT
Diagnosed in ___, with repeat US in ___ showing no 
evidence of DVT. Now that she has been treated for more than six 
months, enoxaparin is for DVT ppx. She was continued on 
enoxaparin 30 mg daily.

#Hypothyroidism: 
Patient continued on levothyroxine.

#Esophageal dysmotility s/p PEG 
Patient continued on tube feeds.

#CODE STATUS: full code 
#CONTACT: ___, ___ ___. ___, 
___ ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever 
2. Atorvastatin 20 mg PO QPM 
3. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 
4. Carbidopa-Levodopa (___) 2 TAB PO QID ___, 1000, 1300, 
1600 
5. Carbidopa-Levodopa (___) 1.5 TAB PO DAILY at ___ 
6. Carbidopa-Levodopa (___) 1 TAB PO DAILY at 0000 
7. Clotrimazole Cream 1 Appl TP BID 
8. Ipratropium Bromide Neb 1 NEB IH Q6H 
9. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 
10. Levalbuterol Neb 0.63 mg NEB Q6H 
11. Levothyroxine Sodium 25 mcg PO DAILY 
12. Multivitamins W/minerals 1 TAB PO DAILY 
13. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line 
14. PredniSONE 10 mg PO DAILY 
15. Nystatin Cream 1 Appl TP BID 
16. Enoxaparin (Prophylaxis) 30 mg SC DAILY 
17. melatonin 3 mg oral QHS 
18. formoterol fumarate 20 mcg/2 mL inhalation BID 
19. Vancomycin Oral Liquid ___ mg PO Q6H 

 
Discharge Medications:
1.  Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 1 Day 
___ 
RX *sulfamethoxazole-trimethoprim [Bactrim DS] 800 mg-160 mg 1 
tablet(s) by mouth twice a day Disp #*3 Tablet Refills:*0 
2.  Vancomycin Oral Liquid ___ mg PO QID Duration: 3 Days 
RX *vancomycin 50 mg/mL 1 capsule(s) by mouth four times a day 
Refills:*0 
3.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever  
4.  Atorvastatin 20 mg PO QPM  
5.  Carbidopa-Levodopa (___) 2 TAB PO QID ___, 1000, 1300, 
1600  
6.  Carbidopa-Levodopa (___) 1.5 TAB PO DAILY at ___  
7.  Carbidopa-Levodopa (___) 1 TAB PO DAILY at 0000  
8.  Clotrimazole Cream 1 Appl TP BID  
9.  Enoxaparin (Prophylaxis) 30 mg SC DAILY  
10.  formoterol fumarate 20 mcg/2 mL inhalation BID  
11.  Ipratropium Bromide Neb 1 NEB IH Q6H  
12.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  
13.  Levalbuterol Neb 0.63 mg NEB Q6H  
14.  Levothyroxine Sodium 25 mcg PO DAILY  
15.  melatonin 3 mg oral QHS  
16.  Multivitamins W/minerals 1 TAB PO DAILY  
17.  Nystatin Cream 1 Appl TP BID  
18.  PredniSONE 10 mg PO DAILY  
19. HELD- Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line  
This medication was held. Do not restart Bisacodyl until 
diarrhea resolves
20. HELD- Polyethylene Glycol 17 g PO DAILY:PRN Constipation - 
First Line  This medication was held. Do not restart 
Polyethylene Glycol until diarrhea resolves

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES
=================
C difficile infection
Urinary Tract Infection
Hypovolemia

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at the ___ 
___!  

WHY WAS I IN THE HOSPITAL?  
==========================  
- You were having diarrhea and your blood pressure was low. 

WHAT HAPPENED IN THE HOSPITAL?  
==============================  
- You were given antibiotics for an infection causing your 
diarrhea, called C difficile. 
- You were given antibiotics for a urinary tract infection
- You were given fluids intravenously to increase your blood 
pressure and you improved.

WHAT SHOULD I DO WHEN I GO HOME?  
================================  
- Please continue to take all of your medications as directed
- Please follow up with all the appointments scheduled with your 
doctor

___ you for allowing us to be involved in your care, we wish 
you all the best!  

Your ___ Team  
 
Followup Instructions:
___
"
110,15229355,21413617," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
 L hip pain 
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ presents to ER for eval of L hip pain s/p mechanical fall 
while using walker this afternoon. Witnessed by son. Negative 
plain films at PCP so sent to ER for eval of persistent hip 
pain. CT shows intertrochanteric fx. She has been ambulating 
since with discomfort. uses walker and wheelchair at baseline. 
Poor mobility ___ age and ___ disease.
 
Past Medical History:
___ Disease, HTN 
 
Social History:
___
Family History:
not significant
 
Physical Exam:
General: nad, aox3  
Vitals: af, vss  
Left lower extremity:  
- Skin intact  
- No deformity, erythema, edema, induration or ecchymosis  
- Soft, non-tender thigh and leg  
- Pain with AROM/PROM of R hip, worse with abduction. Also pain 
with logroll.  
- ___ fire  
- SILT SPN/DPN/TN/saphenous/sural distributions  
- 1+ ___ pulses, foot warm and well-perfused  

 
Pertinent Results:
IMAGING:  
CT L hip with intertrochanteric fx  

 
Brief Hospital Course:
Hospitalization Summary 

The patient presented to the emergency department and was 
evaluated by the orthopedic surgery team. The patient was found 
to have L hip with intertrochanteric fx  and was admitted to the 
orthopedic surgery service. The patient did not need surgical 
intervention at this point. The patient was initially given IV 
fluids and IV pain medications, and progressed to a regular diet 
and oral medications after deciding to continue with non 
surgical management. The patient's home medications were 
continued throughout this hospitalization. The patient worked 
with ___ who determined that discharge to rehab facility was 
appropriate. The ___ hospital course was otherwise 
unremarkable.

At the time of discharge the patient's pain was well controlled 
with oral medications, incisions were clean/dry/intact, and the 
patient was voiding/moving bowels spontaneously. The patient is 
WBAT with troch precautions in the LL extremity, and will be 
discharged on Lovenox for DVT prophylaxis. The patient will 
follow up with Dr. ___ routine. A thorough discussion was 
had with the patient regarding the diagnosis and expected 
post-discharge course including reasons to call the office or 
return to the hospital, and all questions were answered. The 
patient was also given written instructions concerning 
precautionary instructions and the appropriate follow-up care. 
The patient expressed readiness for discharge.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 20 mg PO QPM 
2. Carbidopa-Levodopa (___) 1 TAB PO TID 
3. Metoprolol Succinate XL 12.5 mg PO DAILY 
4. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Atorvastatin 20 mg PO QPM 
2. Carbidopa-Levodopa (___) 1 TAB PO TID 
3. Metoprolol Succinate XL 12.5 mg PO DAILY 
4. Omeprazole 40 mg PO DAILY 
5. OxycoDONE (Immediate Release)  2.5 mg PO Q4H:PRN pain 
6. Acetaminophen 650 mg PO TID 
RX *acetaminophen [Arthritis Pain Reliever] 650 mg 1 tablet(s) 
by mouth every six (6) hours Disp #*30 Tablet Refills:*0
7. Enoxaparin Sodium 40 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time 
RX *enoxaparin 40 mg/0.4 mL 40 mg sc once a day Disp #*30 
Syringe Refills:*0
8. Lodosyn (carbidopa) 25 mg oral BID 
9. Polyethylene Glycol 17 g PO DAILY 
RX *polyethylene glycol 3350 [SmoothLax] 17 gram 1 powder(s) by 
mouth once a day Disp #*30 Packet Refills:*0
10. Multivitamins W/minerals 1 TAB PO DAILY 
RX *multivitamin,tx-minerals  1 tablet(s) by mouth once a day 
Disp #*30 Tablet Refills:*0

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
L greater troch fx

 
Discharge Condition:
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).
Level of Consciousness: Alert and interactive.
Mental Status: Clear and coherent.

 
Discharge Instructions:
INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:

- You were in the hospital for orthopedic surgery. It is normal 
to feel tired or ""washed out"" , and this feeling should improve 
over the first few days to week. 
- Resume your regular activities as tolerated, but please follow 
your weight bearing precautions strictly at all times.

ACTIVITY AND WEIGHT BEARING:
- WBAT with walker

MEDICATIONS:
- Please take all medications as prescribed by your physicians 
at discharge.
- Continue all home medications unless specifically instructed 
to stop by your surgeon.
- Do not drink alcohol, drive a motor vehicle, or operate 
machinery while taking narcotic pain relievers.
- Narcotic pain relievers can cause constipation, so you should 
drink eight 8oz glasses of water daily and take a stool softener 
(colace) to prevent this side effect.

ANTICOAGULATION:
- Please take Lovenox 40mg daily for 4 weeks

WOUND CARE:
- you have no surgical wound and You may shower, baths or ___.

Physical Therapy:
WBAT, ROM as tolerated, Troch precautions, Limit Abduction
Treatments Frequency:
___
 
Followup Instructions:
___
"
111,15229355,24824127," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Cough and shortness of breath
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ yo woman w/ PMHx of ___ disease, 
bilateral blindness, HTN, bronchitis who was admitted from ___ 
ED for unresolved cough and shortness of breath after 3 days of 
outpatient antibiotic treatment. 

Of note, patient is currently living with her son, her primary 
care giver. At baseline, patient was not very active physically 
due to her poor vision and only ambulates minimally with walker. 
In the past few days, patient has developed increased cough, 
productive of scant white sputum and SOB.  She was seen at OSH, 
where she was diagnosed with ""pneumonia"" and was started with 
doxycycline PO treatment.  She took doxycycline for 3 days but 
her symptoms did not resolve.  She has felt weaker since the 
start of her current episode. 

In the ED, patient was noted to be afebrile and stable.  She had 
an CXR which was unremarkable. Labs did not show any 
leukocytosis. Patient was given one dose of IV ceftriaxone and 
clindamycin before she was admitted to medicine service for 
observation. 

Review of Systems: ROS negative except as above. 
 
Past Medical History:
___ Disease
HTN
Bronchitis 
Bilateral blindness
 
Social History:
___
Family History:
not significant
 
Physical Exam:
Admission:
GEN: NAD, AAOx3. 
HEENT: NC, AT, bilateral blindness at baseline, MMM. 
Neck: No JVD, no carotid bruit, no thyromegaly. 
CV: RRR, nl S1/S2, no m/r/g. 
Lungs: coarse breath sounds bilaterally, scattered wheezes. 
Abdomen: NT, ND, BS active. 
Ext: No ___, pulses 2+. 

Discharge:
VS: AVSS
Gen: NAD, resting comfortably in bed
HEENT: bilateral blindness, MMM
CV: RRR nl s1s2 no m/r/g
Resp: CTAB no w/r/r
Abd: Soft, NT, ND +BS
Ext: no c/c/e
Neuro: CN II-XII intact, ___ strength throughout
Psych: normal affect
Skin: warm, dry.  Upper chest and neck rash resolved.
 
Pertinent Results:
___ 07:40PM   WBC-9.8 RBC-4.12 HGB-12.3 HCT-37.2 MCV-90 
MCH-29.9 MCHC-33.1 RDW-13.2 RDWSD-43.2
___ 07:40PM   GLUCOSE-124* UREA N-15 CREAT-0.7 SODIUM-136 
POTASSIUM-4.5 CHLORIDE-100 TOTAL CO2-24 ANION GAP-17
___ 06:18PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG

CXR ___: No acute cardiopulmonary process.

 
Brief Hospital Course:
Ms. ___ is an ___ yo woman w/ PMHx of ___ disease 
who was admitted for unresolved SOB and cough despite antibiotic 
treatment for presumed pneumonia. 

# Bronchitis / ?Pneumonia.  Recently diagnosed with pneumonia 
and completed antibiotic course of doxycycline. Per son had some 
intermittent cough and shortness of breath but CXR here showing 
no evidence of pneumonia.  Currently she denies cough or SOB, 
has normal oxygen saturation and clear lungs on examination.  
Low suspicion for current bacterial process. She had occasional 
cough and wheezing after eating.  She was evaluated by speech 
and swallow who thought she did overall well and did not think 
VSS indicated at this time.
- Atrovent nebs q6h standing for 2 weeks
- Fluticasone inhaler for reactive airways
- Albuterol nebs PRN

# Rash: developed pruritic rash after receiving Levaquin, no 
prior history of allergies per patient or son. ___ improved 
after Benadryl and currently resolved.
- Added Levaquin as an allergy

# ___ disease
- Continue home meds. 

# Difficulty ambulating: Having worsening difficulty ambulating. 
 ___ recommending rehab, patient and family only interested in 
___ rehab where she has been before. ___ declined 
patient, so family decided to take her home with services.

Code: Full code here

Billing: >30 minutes spent coordinating discharge to home

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 20 mg PO QPM 
2. Carbidopa-Levodopa (___) 1.5 TAB PO TID 
3. Metoprolol Succinate XL 12.5 mg PO DAILY 
4. Omeprazole 40 mg PO DAILY 
5. Lodosyn (carbidopa) 25 mg oral DAILY 
6. Polyethylene Glycol 17 g PO DAILY 
7. Multivitamins W/minerals 1 TAB PO DAILY 
8. Rasagiline 0.5 mg PO DAILY 
9. melatonin 3 mg oral QHS 

 
Discharge Medications:
1. Atorvastatin 20 mg PO QPM 
2. Carbidopa-Levodopa (___) 1.5 TAB PO TID 
3. Lodosyn (carbidopa) 25 mg oral DAILY 
4. melatonin 3 mg oral QHS 
5. Metoprolol Succinate XL 12.5 mg PO DAILY 
6. Multivitamins W/minerals 1 TAB PO DAILY 
7. Omeprazole 40 mg PO DAILY 
8. Polyethylene Glycol 17 g PO DAILY 
9. Rasagiline 0.5 mg PO DAILY 
10. Ipratropium Bromide Neb 1 NEB IH Q6H 
RX *ipratropium bromide 0.2 mg/mL  (0.02 %) 1 neb INH every 6 
hours for 2 weeks and then as needed Disp #*90 Vial Refills:*0
11. Fluticasone Propionate 110mcg 2 PUFF IH BID 
RX *fluticasone [Flovent HFA] 110 mcg/actuation 2 puff INH twice 
daily Disp #*3 Inhaler Refills:*0
12. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing, 
dyspnea, cough 
RX *albuterol sulfate 2.5 mg/3 mL (0.083 %) 1 neb inh every 4 
hours as needed Disp #*90 Vial Refills:*0
13. Spacer
Diagnosis: Bronchitis, reactive airways disease
Please use with fluticasone inhaler

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Bronchitis vs airway reactivity after infection
___ disease
 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
You were admitted for occasional wheezing and cough. There was 
concern for pneumonia but your chest X-ray did not show 
pneumonia and your symptoms quickly improved with nebulizers. 
Antibiotics were stopped and you tolerated this just fine. 
Overall, your presentation is most consistent with a post 
infectious bronchitis or asthma like syndrome.

You were evaluated by speech and language pathology who felt you 
would benefit from a ground diet with thin liquids to minimize 
your risks of accidentally inhaling some of your food when you 
eat (which can predispose to pneumonia and coughing fits).

You were deconditioned and had difficulty moving around and 
physical therapy recommended going to a rehab facility. You did 
not qualify for acute level rehab and so you and your family 
elected to go home with maximal services in order to work on 
getting stronger at home.
 
Followup Instructions:
___
"
112,15229355,26861248," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Fall
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old woman with a history of ___ disease, 
bilateral blindness, HTN, and bronchitis, discharged from ___ 
on ___ after a treatment for airway reactivity, presenting 
after a fall and head strike without LOC at home. 

The patient was sleeping in a recliner at home where she lives 
with her son. She was sleeping in her recliner and suddenly 
startled and noted by her son to have a jerking motion, and 
found to be sliding out of her chair. She eventually lowered 
onto her right knee, and struck her right forehead on the wood 
floor, son unable to cath her. The patient denies any LOC, 
headache, and per her son the patient was at her baseline mental 
status with normal behavior. She was noted to be ambulatory 
after this fall and headstrike, and used her walker to go to 
EMS. Her son notes that she had an episode of emesis in the 
ambulance.

She was recently admitted from ___ with unresolved cough 
and SOB despite outpatient treatment with doxycycline after 
being diagnosed with pneumonia at an OSH. She was treated for 
bronchitis vs. airway reactivity after infection with atrovent, 
fluticasone and albuterol. There was no evidence of pneumonia on 
CXR, and there was low suspicion for bacterial process. She was 
noted to have difficulty ambulating during the admission, and ___ 
recommended rehab, but the patient and family were only 
interested in ___ rehab where she had been before, but the 
patient was declined and went home with services. 

In the ED, initial vitals were: T 96.8 HR 85 BP 138/81 RR 16 96 
RA. ED exam notable for bibasilar crackles, stable pelvis and 
___ strength in UE and LUE. Labs were notable for H/H 11.2/33.7, 
PTT 72.5, INR 1.1, Na 130, cl 95 Cr 0.7. 

The patient underwent extensive imaging in the ED. CT C spine 
was negative for acute fracture or hemorrhage. CT Head was 
negative for acute intracranial pathology. Pelvis XR, B/L Knee 
XR, L ankle XR negative for fracture. Initial CXR negative for 
acute intrathoracic pathology. 

While in the ED, the patient began to have labored respiration 
requiring O2 by NC. Per son had similar jerking movements with 
startling. Concern for aspiration as labored respriations 
occurred after patient eating meds with applesauce. Repeat CXR 
was stable. She was treated with NS and nebulizers. Her 
pressures were in the low ___ while sleeping, but after 
nebulizer treatment and sitting up her pressures were in the 
100s/70s. VBG 7.41/43/49/28, and lactate 1.8

Overall the patient received 500 ml NS, ipatroprium bromide neb 
x3, albuterol neb x2, fluticasone IH x 2,  1 g acetaminophen x2, 
carbidopa levodopa (___) 1.5 tabs, carbidopa 25 mg and 
rasagiline. 

She was admitted given her frailty, respiratory distress and 
intermittent hypoxia in the ED. Vitals on transfer were 98.7 HR 
89 BP 113/89 BP 113/99 RR 19 95 RA.

On the floor, the patient denies any shortness of breath, chest 
pain, abdominal pain, head pain, headache. Breathing is overall 
comfortable. Does endorse being tired. She has no other acute 
concerns as this time. 
 
Review of systems:  
(+) Per HPI  

 
Past Medical History:
___ Disease
HTN
Bronchitis 
Bilateral blindness
 
Social History:
___
Family History:
non contributory
 
Physical Exam:
===========================
PHYSICAL EXAM ON ADMISSION
===========================
Vital Signs:  98.1 103/56 HR 82 RR 18 97 RA
General: Alert, oriented, no acute distress, elderly woman 
sitting n chair  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated,
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Mildly decreased breath sounds at left base but no 
wheezes, rales, rhonchi, no increased work of breathing 
Abdomen: Soft, ___, bowel sounds present, 
no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, no edema, TEDS on
Skin: erythematous patches over right and left upper inner arums 
and underarms, as well as scattered over chest, per patient 
pruritis, appear in distribution of previous stickers
Neuro: ___ grossly intact, moving all extremities with 
purpose, bilateral hand tremors at rest, increased upper 
extremity rigidity with passive ROM

===========================
PHYSICAL EXAM ON DISCHARGE
===========================
Vital Signs:  T 97.9 BP 106/55 HR 83 R 20 SpO2 95 ra 
General: Alert, oriented, no acute distress, resting comfortably
HEENT: Sclera anicteric,  resolving ecchymosis over forehead, 
MMM, EOMI, JVP not elevated,
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Mildly decreased breath sounds at left lung base, 
otherwise clear to auscultation without wheezes appreciated 
Abdomen: Soft, ___, bowel sounds present, 
no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, no edema
Neuro: alert and oriented, moving all extremities with purpose, 
bilateral hand tremors
 
Pertinent Results:
====================
LABS ON ADMISSION
====================
___ 10:20PM BLOOD ___ 
___ Plt ___
___ 10:20PM BLOOD ___ 
___ Im ___ 
___
___ 10:20PM BLOOD ___ ___
___ 10:20PM BLOOD ___ 
___
___ 06:15PM BLOOD ___ ___
___ 06:15PM BLOOD ___ 
___
___ 06:15PM BLOOD ___
___ 06:15PM BLOOD ___
___ 06:15PM BLOOD ___
___ 05:19AM BLOOD ___ 
___ Base ___
___ 05:19AM BLOOD ___

====================
INTERVAL LABS
====================
___ 12:49PM URINE ___
___ 12:49PM URINE ___
___ 07:40AM BLOOD ___ 
___
___ 07:40AM BLOOD ___

====================
LABS ON DISCHARGE
====================
___ 07:31AM BLOOD ___ 
___ Plt ___
___ 07:31AM BLOOD ___ 
___
___ 07:31AM BLOOD ___

====================
MICROBIOLOGY
====================
None this admission

====================
IMAGING/STUDIES
====================
ECGStudy Date of ___  11:41:42 AM 
Clinical indication for EKG: R00.0 - Tachycardia 

Sinus tachycardia. First degree ___ block. Early precordial R 
wave
progression. Low voltage iin the precordial leads. Compared to 
the previoustracing of ___ tachcyardia is now present. Low 
voltage in the precordialleads is now present.

CT C Spine WO Contrast ___
1. No acute fracture identified. 
2. Severe cervical spondylosis with mild anterolisthesis of C2 
on C3 and C7 on 
T1.  Mild to moderate central canal narrowing without ___ 
stenosis. 
3. Anterior compression deformity of the T3 vertebral body is 
unchanged. 

CT Head ___
No acute intracranial abnormality. 

ANKLE (AP, MORTISE & LAT) LEFT  ___ 
No fracture.  Marked generalized demineralization.
 
PELVIS (AP ONLY)  ___
No fracture identified.  Marked generalized demineralization

KNEE (AP, LAT AND OBLIQUE) BILATERAL  ___  
No fracture.  Prominent osteoporosis 

CHEST (SINGLE VIEW)  ___
No acute intrathoracic abnormality.  Consider dedicated spine 
imaging if there is clinical concern for thoracic spinal 
fracture.
 
CHEST (PORTABLE AP) ___
Overall stable examination of the chest.

VIDEO OROPHARYNGEAL SWALLOW  ___spiration.

CHEST (PA & LAT) ___
The aorta is markedly unfolded and tortuous.  Heart remains 
upper limits of normal in size.  There is bilateral interstitial 
prominence which is not significantly changed since ___ and likely reflects underlying interstitial lung disease 
rather than interstitial edema.  The patient's mandible obscures 
the apices.  No pleural effusions or pneumothorax.  No focal 
airspace consolidation to suggest pneumonia.

 
Brief Hospital Course:
Ms. ___ is an ___ year old woman with a history of 
___ disease, bilateral blindness, HTN, presenting after 
a fall and head strike without LOC at home, admitted with 
respiratory distress and hypoxia in the ED with rapid 
resolution. 

# Mechanical Fall:
Patient discharged on the same day as re presentation to the ED. 
On previous admission, patient noted by ___ to be at high fall 
risk and recommended acute rehab however son declined as pt not 
accepted to first choice rehab. Patient admitted after fall from 
chair, most likely mechanical in etiology, as he patient was 
startled and slipped to the ground and in the setting of her 
weakness and ___ was unable to stop he fall. There was 
no loss of consciousness to suggest syncope as the etiology.  
Overall picture not consistent with seizure activity, as there 
was no post ictal period, also no elevation in lactate noted on 
labs, and the patient ambulated after the event with the use of 
a walker. Imaging including CT C spine, CT Head, CXR, Pelvis XR, 
bilateral knee XR and L ankle XR without fracture or acute 
pathology. There were no focal neuro signs on exam. ___ was 
consulted who recommended disposition to rehab. She was 
discharged to ___.

# Respiratory distress/Aspiration
While in the ED the patient developed respiratory 
distress/labored respirations requiring NC. The etiology was 
concerning for aspiration as she had been eating her medications 
with applesauce prior to the event. A repeat CXR in the ED was 
negative for aspiration, but may have been premature to 
visualize any changes. The differential also included airway 
reactivity, given the recent admission for reactive airways. She 
was quickly weaned to room air with nebulizer treatments. Given 
the concern for mild respiratory distress a third CXR was done 
on the floor, again without any signs of infiltrate or acute 
pathology. There was evidence of mild volume overload and pt 
received 10mg IV lasix. On the previous admission the patient 
was evaluated by SLP who recommended a diet of ground solids and 
thin liquids. SLP was re consulted this admission, and the 
patient underwent a video swallow due to concerns for bedside 
aspiration, which revealed penetration and trace aspiration, and 
the patient was initiated on a diet of ground solids and nectar 
thickened liquids. She was also seen by nutrition who 
recommended supplementation with ensure plus TID. She was 
continued on atrovent and albuterol nebulizer treatmens, and 
fluticasone inhaler. Of note, albuterol was used cautiously as 
caused pt to become tachycardiac.

# Hyponatremia - RESOLVED
Patient with new mild hyponatremia to 130, with concomitant 
hypochloremia. Likely secondary to hypovolemia given improvement 
with IVF. 
 
# Coagulopathy Elevated PTT - RESOLVED
Patient with newly elevated PTT on admission. On recent 
admission patient appears to have been on heparin 5000 U TID, 
though patient is of normal BMI, likely the etioloy of the 
elevated PTT. No concomitant elevation in INR, no 
thrombocytopenia to suggest DIC. No history of elevated PTT in 
the past to suggest the presence of an acquired or intrinsic 
inhibitor. Resolved with holding subC heparin. The patient was 
restarted on subC heparin for VTE prophylaxis with BID dosing 
without elevation in PTT

CHRONIC ISSUES
===============
# ___ disease: Stable. The patient was continued on home 
rasagiline, ___ and carbidopa dosing.

# Hypertension: Stable. The patient continued home metoprolol 
succinate 12.5 mg daily.

# Hyperlipidemia: Stable. The patient continued home 
atorvastatin.

=====================
TRANSITIONAL ISSUES
=====================
- Ensure follow up with PCP
- SLP recommendations: PO diet of nectar thick liquids, ground 
solids, meds whole with applesauce
- Aspiration precautions: fully upright for all POs, single cup 
sips, 1:1 assist for all POS, TID oral care
- Sarna and Hydrocortisone 2.5% cream for skin pruritis 
- Recommend home ___ for medication administration after 
discharge from ___

FULL CODE
CONTACT: ___ (Son, HCP)  ___
 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 20 mg PO QPM 
2. ___ 1.5 TAB PO TID 
3. Lodosyn (carbidopa) 25 mg oral DAILY 
4. melatonin 3 mg oral QHS 
5. Metoprolol Succinate XL 12.5 mg PO DAILY 
6. Multivitamins W/minerals 1 TAB PO DAILY 
7. Omeprazole 40 mg PO DAILY 
8. Polyethylene Glycol 17 g PO DAILY:PRN Constipation 
9. Rasagiline 0.5 mg PO DAILY 
10. Ipratropium Bromide Neb 1 NEB IH Q6H 
11. Fluticasone Propionate 110mcg 2 PUFF IH BID 
12. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing, 
dyspnea, cough 

 
Discharge Medications:
1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing, dyspnea, 
cough 
2. Atorvastatin 20 mg PO QPM 
3. ___ 1.5 TAB PO TID 
4. Fluticasone Propionate 110mcg 2 PUFF IH BID 
5. Ipratropium Bromide Neb 1 NEB IH Q6H 
6. Lodosyn (carbidopa) 25 mg oral DAILY 
7. Metoprolol Succinate XL 12.5 mg PO DAILY 
8. Multivitamins W/minerals 1 TAB PO DAILY 
9. Omeprazole 40 mg PO DAILY 
10. Polyethylene Glycol 17 g PO DAILY:PRN Constipation 
11. Rasagiline 0.5 mg PO DAILY 
12. Sarna Lotion 1 Appl TP QID:PRN puritis 
RX ___ [Sarna ___ 0.5 %-0.5 % Apply thin 
film to affected skin As needed Disp #*222 Milliliter Milliliter 
Refills:*0
13. melatonin 3 mg oral QHS 
14. Hydrocortisone Cream 2.5% 1 Appl TP TID PRN ITCH 
RX *hydrocortisone 2.5 % Apply thin film to the affected area up 
to three times daily Disp #*30 Gram Gram Refills:*0
15. Guaifenesin ER 600 mg PO Q12H cough 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Primary diagnosis: 
=================== 
Aspiration 
Mechanical Fall 
___ disease 
Airway reactivity 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___, 

It was a pleasure caring for you during your stay at ___. You 
were admitted to the hospital after a fall at home. Imaging of 
your head, neck, chest, pelvis, knees and ankle did not reveal 
any signs of fracture or bleeding. In the ED you had some 
shortness of breath and were admitted to the hospital. Your 
breathing improved rapidly with breathing treatments, and you 
were feeling much better by discharge. You had chest x rays 
which did not show any infection or fluid in your lungs. 

You had a video swallow study done, and the speech and language 
pathology experts recommended that you continue on a diet of 
ground foods and nectar thickened liquids to help prevent 
inhaling food when you eat (which can predispose you to 
infection)

You were evaluated by physical therapy and there were signs that 
you were deconditioned and had difficulty moving. They 
recommended that you go to a rehab facility.

Your updated medication list is included in your discharge 
paperwork. You will need to follow up with your primary care 
doctor within 1 week of discharge.

We Wish You The Best!
- Your ___ Care Team
 
Followup Instructions:
___
"
113,15229355,28844805," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Levaquin
 
Attending: ___.
 
Chief Complaint:
Cough, Shortness of breath

 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ pmh ___ disease, bilateral blindness, HTN, h/o of 
bronchitis and RAD brought to the ER by her son  the ___ because
of refractory wheezing  in ___ observation for cough and 
wheezing.
Has seen urgent care on ___ where she started prednisone with
taper and recently tapered down to 20mg daily that resulted in
exacerbation in her wheezing, cough, phlegm per her son that is
at bedside and provides the majority of the history. She has 
been
seen in Pulmonary clinic at ___ in ___ for an
abbreviated visit where she was continued on fluticasone,
duonebs, and considered PFTS but patient was unable to 
cooperate.
She was thought to have breathing difficulties also from her
kyphosis. She denies fevers or chills, abd pain, n/v/d, dysuria. 


In the ___ she was given nebulizer treatments and admitted as she
had ""failed"" observation in the ___ in the eyes of her son and ___
physician and been to urgent care several times over the last
several months for similar complaints. On arrival to the floor
she was apparently doing much better with less wheezing per the
son. He feels this all was tripped off when she lowered her of
Prednisone dose from 40-->20mg daily. 

 
Past Medical History:
___ Disease
HTN
Bronchitis 
Bilateral blindness
 
Social History:
___
Family History:
non contributory and reviewed.
 
Physical Exam:
Admission Exam:
General: Lying in bed no acute distress, winter hat on, legally
blind and not making eye contact. Alert and oriented able to
answer questions. 
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated,
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Mildly decreased breath sounds at left base with 
scattered
wheezing throughout posterior lung fields. 
Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, no edema, 
Skin: no edema, no erythema
Neuro: CNII-XII grossly intact, moving all extremities with 
purpose, bilateral hand tremors at rest, increased upper 
extremity rigidity with passive ROM

Discharge Exam:
VS: 98.1PO ___ 20 96% on RA 
General: Lying in bed no acute distress, legally blind and not 
making eye contact. Alert and oriented able to answer questions. 

HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Mildly decreased breath sounds at left base with 
scattered
rhonchi throughout posterior lung fields. 
Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, no edema, 
Skin: no edema, no erythema
Neuro: CNII-XII grossly intact, moving all extremities with 
purpose, bilateral hand tremors at rest, increased upper 
extremity rigidity with passive ROM
 
Pertinent Results:
ADMISSION LABS
--------------
___ 10:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 09:20PM   LACTATE-2.6*
___ 09:00PM   GLUCOSE-147* UREA N-19 CREAT-0.6 SODIUM-132* 
POTASSIUM-4.5 CHLORIDE-93* TOTAL CO2-24 ANION GAP-20
___ 09:00PM   WBC-16.4* RBC-3.74* HGB-11.3 HCT-34.5 MCV-92 
MCH-30.2 MCHC-32.8 RDW-13.4 RDWSD-45.3

IMAGING
-------
CXR ___ : No interval change

DISCHARGE LABS
--------------
___ 07:05AM BLOOD WBC-14.0* RBC-3.39* Hgb-10.2* Hct-31.9* 
MCV-94 MCH-30.1 MCHC-32.0 RDW-13.6 RDWSD-46.5* Plt ___
___ 07:05AM BLOOD Neuts-68.7 ___ Monos-7.7 Eos-0.7* 
Baso-0.1 Im ___ AbsNeut-9.57* AbsLymp-3.10 AbsMono-1.07* 
AbsEos-0.10 AbsBaso-0.02
___ 07:05AM BLOOD Glucose-113* UreaN-18 Creat-0.5 Na-134 
K-4.1 Cl-95* HCO3-28 AnGap-15
___ 07:05AM BLOOD Calcium-9.1 Phos-2.8 Mg-2.___ year old female with history of ___ disease, 
bilateral blindness, hypertension, history of  bronchitis and 
RAD brought to the ER by her son due to refractory wheezing and 
cough, likely chronic exacerbation of reactive airway disease 
and perhaps bronchiectasis. Patient did have CTA of chest in 
___ that had limited examination of lung parenchyma due 
to motion. She would likely benefit from outpatient pulmonary 
follow-up and treatment of lung inflammation with prednisone, 
nebulizers, and Azithromycin.  There was low suspicion for 
clinical pneumonia given no fevers and clear CXR. Flu swab was 
negative. .

# Reactive airway disease exacerbation
# Bronchitis:  patient was much improved on arrival to floor. 
She will likely benefit from Pulmonary consult to consider 
chronic treatment for bronchiectasis.  She was resumed on 
Prednisone 40 mg daily for 5 days, then was ordered for a taper 
given that she has been on high-dose prednisone for over a week. 
 She was placed on doxycyline 5 day course.  Nebulizers were 
continued.  She was given a prescription for inhaled 
fluticasone.  She may benefit from a long-acting beta 2 agonist 
as an outpatient.  She was off oxygen upon arrival to the floor, 
and had normal saturation on ambulation.  She was instructed to 
follow up with her PCP ___ ___ days of discharge, where her 
improvement can be monitored and taper modified if there is a 
need for this.

# Weight loss: patient has lost eight pounds over the last year. 
 This should be followed up as an outpatient.  She was 
instructed to use Ensure supplementation at home.

# Hypertension: continued Metoprolol 12.5
# GERD: continued Omeprazole 40 mg Daily
# ___ disease: continued Carbidopa-Levodopa

TRANSITIONS OF CARE
-------------------
# Follow-up: She was instructed to follow up with her PCP ___ 
___ days of discharge, where her improvement can be monitored 
and taper modified if there is a need for this.  She was resumed 
on Prednisone 40 mg daily for 5 days, then was ordered for a 
taper given that she has been on high-dose prednisone for over a 
week.  Weight loss should be followed up as an outpatient.  She 
was instructed to use Ensure supplementation at home.

# Code Status: Full Code

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing, dyspnea, 
cough 
2. Atorvastatin 20 mg PO QPM 
3. Carbidopa-Levodopa (___) 1.5 TAB PO QID 
4. Fluticasone Propionate 110mcg 2 PUFF IH BID 
5. Ipratropium Bromide Neb 1 NEB IH Q6H 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Multivitamins W/minerals 1 TAB PO DAILY 
8. Omeprazole 40 mg PO DAILY 
9. Polyethylene Glycol 17 g PO DAILY:PRN Constipation 
10. Influenza Vaccine Quadrivalent 0.5 mL IM NOW X1 
Start: ___, First Dose: Next Routine Administration Time 
11. Levothyroxine Sodium 25 mcg PO DAILY 
12. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
13. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
indigestion 
14. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Prior to 
ambulation 
15. Vitamin D ___ UNIT PO DAILY 
16. Furosemide 20 mg PO DAILY 
17. PredniSONE 20 mg PO DAILY 

 
Discharge Medications:
1.  Doxycycline Hyclate 100 mg PO Q12H 
RX *doxycycline hyclate 100 mg 1 tablet(s) by mouth every twelve 
(12) hours Disp #*8 Tablet Refills:*0 
2.  GuaiFENesin ___ mL PO Q6H:PRN cough 
RX *guaifenesin 100 mg/5 mL ___ mL by mouth every six (6) hours 
Refills:*0 
3.  PredniSONE 40 mg PO DAILY Duration: 3 Doses 
Start: Today - ___, First Dose: 0800 
Take 8 pills of ones you have for 3 days; then 6 for 2 days; 
then 4 for 2 days; then 2 for 2 days 
This is dose # 1 of 4 tapered doses
Tapered dose - DOWN  
4.  PredniSONE 30 mg PO DAILY Duration: 2 Doses 
Take 8 pills of ones you have for 3 days; then 6 for 2 days; 
then 4 for 2 days; then 2 for 2 days 
This is dose # 2 of 4 tapered doses
Tapered dose - DOWN  
5.  PredniSONE 20 mg PO DAILY Duration: 2 Doses 
Take 8 pills of ones you have for 3 days; then 6 for 2 days; 
then 4 for 2 days; then 2 for 2 days 
This is dose # 3 of 4 tapered doses
Tapered dose - DOWN  
6.  PredniSONE 10 mg PO DAILY Duration: 2 Doses 
Take 8 pills of ones you have for 3 days; then 6 for 2 days; 
then 4 for 2 days; then 2 for 2 days 
This is dose # 4 of 4 tapered doses
Tapered dose - DOWN  
7.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
8.  Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing, 
dyspnea, cough  
9.  Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
indigestion  
10.  Atorvastatin 20 mg PO QPM  
11.  Carbidopa-Levodopa (___) 1.5 TAB PO QID  
12.  Fluticasone Propionate 110mcg 2 PUFF IH BID 
RX *fluticasone [Flovent HFA] 110 mcg/actuation 2 puffs IH twice 
a day Disp #*1 Inhaler Refills:*0 
13.  Furosemide 20 mg PO DAILY  
14.  Ipratropium Bromide Neb 1 NEB IH Q6H  
15.  Levothyroxine Sodium 25 mcg PO DAILY  
16.  Metoprolol Succinate XL 12.5 mg PO DAILY  
17.  Multivitamins W/minerals 1 TAB PO DAILY  
18.  Omeprazole 40 mg PO DAILY  
19.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Prior to 
ambulation  
20.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation  
21.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___ 
 
Discharge Diagnosis:
Bronchitis/Reactive airway disease
Weight loss

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you during your recent admission at 
___.  You presented with wheezing, and it was thought likely 
that you have bronchitis.  You were continued on high-dose 
steroids, nebulizers and an antibiotic called doxycycline.  You 
improved shortly after admission.

Please discuss the 8-pound weight loss you have experienced over 
the last year with your primary care doctor.  We recommend that 
you take three Ensure supplements per day to help increase your 
calorie intake.

It is important that you take all medications as prescribed and 
follow up with any appointments listed below.

Good luck!
 
Followup Instructions:
___
"
114,16174060,20871287," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: PSYCHIATRY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
""I'm good."" 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
For further details of the history and presentation, please see 
OMR, including Dr. ___ initial consultation note 
dated ___, Dr. ___ initial consultation note dated ___ admission note dated ___. 
.
Briefly, this is a ___ year old single Caucasian man with 
reported history of depression s/p one psychiatric 
hospitalization in ___ ___ for 
depression and suicidal ideation, history of intermittent 
cannabis use, who presented to ___ via EMS after his roommates 
were concerned for several hours of bizarre behaviors. ED course 
was notable for agitation with patient requiring mechanical and 
chemical restraints. 
. 
Upon initial interview, patient was noted to be tangential and 
grandiose, intrusive at times, requiring frequent redirection. 
Reported that he had been working on multiple academic projects 
for several weeks, questioning the existence of magic and the 
nature of reality, with decreased need for sleep and increased 
irritability. 
. 
Per collateral obtained from his parents, who are in ___: 
they last saw patient about a week ago during a family gathering 
and at that time he appeared at his baseline. 
. 
On interview with Dr. ___, patient was notably 
disorganized, making several comments about a woman he knows, 
calling her an ""earth god"" and stating he needs to leave in 
order to be able to see her. Reported that ___ needs more 
magic"" and that ""This reality is my reality and no one can say 
my reality."" Patient became agitated when informed that he would 
be
placed on a ___ and required physical and chemical 
restraints. 
. 
Patient seen with ___, ___ and Dr. ___, 
___-2 neuro resident. Mr. ___ was significantly more 
organized and noted to be calm and cooperative on examination. 
Patient tended to minimize his presentation, stating that he 
came to the hospital because ""all of my stressors came to a head 
and I lost it on ___ Patient went on to report that he had 
had a stressful few months due to ""combined factors,"" stating 
that he is currently a grad student at ___ and that he was part 
of an organization to form a ___ school ___. Noted that he 
had been feeling pressure to ""get everything done,"" and that he 
had also recently applied for a scholarship at a ___ 
and
was trying to coordinate this with his department. in addition, 
patient reported recent travel, stating he had recently been 
visiting his cousin in ___ and shortly after went to 
go visit his grandmother for her ___ birthday. Following his 
return from his visit from his grandmother, he sated he had to 
immediately talk with his ___. Patient reported that in the 
setting of all these pressures, he started screaming into a 
___ jar, which he reports his roommate had handed him. 
. 
On my exam, patient denied current depressive symptoms but 
stated he had been hospitalized at ___ in ___ of 
this year for suicidal ideation and depression following a break 
up. Stated that he was referred to a PHP following his 
discharge, which he found useful. Of note, denies he attempted 
suicide, stating he only had a plan. Denied SI/HI, AVH on my 
examination.
Reported he sleeps about ___ hours a night and finds routine 
helpful, although has been struggling somewhat to maintain a 
consistent schedule while at school. Denied racing thoughts, 
decreased need for sleep, increased impulsivity. Admitted to 
intermittent cannabis use with last use about ___ weeks ago. 
Denied current anxiety. Declined medications at this time, 
stating he is feeing well, and was amenable to being discharged 
later this week. Reported he has been attending therapy 
regularly and gave us permission to contact his outpatient 
therapist. 

 
Past Medical History:
Past Psychiatric History: 
- Diagnoses: unclear if formal diagnoses, history of depression
in the past 
- SA/SIB: denies/denies, although per OMR, patient with suicide
attempt via attempting to jump off bridge in ___
- Hospitalizations: ___ ___ 
- Psychiatrist: none 
- Therapist: ___ in ___, ___ 
- Medication Trials: denies 

Past Medical History: 
- Reports 2 remote concussions while biking and another while
skiing
 
Social History:
___
Family History:
Family History: 
Per collateral with father, the patient has a paternal uncle, 
currently deceased, who struggled with bipolar disorder. When 
asked, patient vaguely states that he had an uncle who ""lives in 
a trailer park and might have had something,"" but declines to 
elaborate further. 
-Substance Use Disorders: None the patient is aware of 
-Suicide Attempts/Completed Suicides: None the patient is aware 
of 

 
Physical Exam:
T 97.9, HR 78, BP 145/93 , RR 18, SpO2 97% on RA
EXAM:
General:
-HEENT: Normocephalic, atraumatic.  Moist mucous membranes,
oropharynx clear, supple neck.  No scleral icterus.
-Cardiovascular: Regular rate and rhythm, S1/S2 heard, no
murmurs/rubs/gallops. Distal pulses ___ throughout.
-Pulmonary: No increased work of breathing.  Lungs clear to
auscultation bilaterally.  No wheezes/rhonchi/rales.
-Abdominal: Non-distended, bowel sounds normoactive.  No
tenderness to palpation in all quadrants.  No guarding, no
rebound tenderness.
-Extremities: Warm and well-perfused.  No edema of the limbs.
-Skin: No rashes or lesions noted.

Neurological:
-Cranial Nerves:
---I: Olfaction not tested.
---II: PERRL 3 to 2mm, both directly and consentually; brisk
bilaterally.  VFF to confrontation.
---III, IV, VI: EOMI without nystagmus
---V: Facial sensation intact to light touch in all 
distributions
---VII: No facial droop, facial musculature symmetric and ___
strength in upper and lower distributions, bilaterally
---VIII: Hearing intact to finger rub bilaterally
---IX, X: Palate elevates symmetrically
---XI: ___ strength in trapezii and SCM bilaterally
---XII: Tongue protrudes in midline
-Motor: Normal bulk and tone bilaterally. No abnormal movements,
no tremor. Strength ___ throughout.
-Sensory: No deficits to fine touch throughout
-DTRs: 2 and symmetrical throughout
Coordination: Normal on finger to nose test, no intention tremor
noted
-Gait: Good initiation.  Narrow-based, normal stride and arm
swing.  Able to walk in tandem without difficulty.  Romberg
absent.

Cognition: 
-Wakefulness/alertness: Awake and alert
-Attention: MOYb with 0 errors
-Orientation: Oriented to person, time, place, situation
-Executive function (go-no go, Luria, trails, FAS): Not tested
-Memory: ___ registration, ___ recall after 5 ___
grossly intact
-Fund of knowledge: Consistent with education; intact to last 3
presidents, identifies ___ as ""the ___
investigating ___ for his conduct with ___ 
-Calculations: 7 quarters = ""$1.75""
-Abstraction: Interprets ""the grass is always greener on the
other side"" as ""Sometimes when you're looking at something from
someone else's shoes, you might think they have it better.""
-Visuospatial: Not assessed
-Language: Native ___ speaker, no paraphasic errors,
appropriate to conversation

Mental Status:
-Appearance: Young man with long brown hair, wearing plaid shirt
and sweat pants, well-built
-Behavior: Sitting up in chair, appropriate eye contact,
fidgeting with pen throughout interview
-Attitude: Mostly cooperative and friendly but becomes slightly
less so when asked about past psychiatric symptoms
-Mood: ""Okay""
-Affect: Mood-congruent, full range, appropriate to situation
-Speech: Normal rate, volume, and tone
-Thought process: Linear, coherent, goal-oriented
-Thought Content:
---Safety: Denies SI/HI
---Delusions: No evidence of paranoia, etc. 
---Obsessions/Compulsions: No evidence based on current 
encounter
---Hallucinations: Denies AVH, not appearing to be attending to
internal stimuli
-Insight: Limited
-Judgment: Poor

 
Pertinent Results:
___ 06:55AM URINE  HOURS-RANDOM
___ 06:55AM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG
___ 06:55AM URINE  COLOR-Yellow APPEAR-Hazy* SP ___
___ 06:55AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 06:55AM URINE  RBC-4* WBC-0 BACTERIA-FEW* YEAST-NONE 
EPI-<1
___ 06:55AM URINE  HYALINE-12*
___ 06:55AM URINE  AMORPH-OCC*
___ 06:55AM URINE  MUCOUS-MANY*
___ 04:55AM   GLUCOSE-98 UREA N-7 CREAT-0.7 SODIUM-143 
POTASSIUM-4.0 CHLORIDE-106 TOTAL CO2-26 ANION GAP-11
___ 04:55AM   estGFR-Using this
___ 04:55AM   ALT(SGPT)-20 AST(SGOT)-23 ALK PHOS-44 TOT 
BILI-1.6*
___ 04:55AM   ALBUMIN-4.5 MAGNESIUM-2.3
___ 04:55AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
tricyclic-NEG
___ 04:55AM   WBC-8.9 RBC-4.77 HGB-14.6 HCT-42.2 MCV-89 
MCH-30.6 MCHC-34.6 RDW-12.0 RDWSD-38.7
___ 04:55AM   NEUTS-75.2* LYMPHS-14.1* MONOS-8.6 EOS-0.9* 
BASOS-0.7 IM ___ AbsNeut-6.67* AbsLymp-1.25 AbsMono-0.76 
AbsEos-0.08 AbsBaso-0.06
___ 04:55AM   PLT COUNT-223
 
Brief Hospital Course:
This is a ___ year old single Caucasian man with reported history 
of depression s/p one psychiatric hospitalization in ___ ___ for depression and suicidal ideation, 
history of intermittent cannabis use, who presented to ___ via 
EMS after his roommates were concerned for several hours of 
bizarre behaviors. ED course was notable for agitation with 
patient requiring mechanical and chemical restraints. 
. 
Initial presentation was concerning for severe psychosis with 
apparent acute onset (per collateral was seen by his parents 
about a week prior to presentation and appeared to be at his 
baseline) with ED course notable for grandiosity, irritability,
disorganized and tangential thought process, as well as 
agitation requiring numerous physical and chemical restraints. 
Interview on my examination was significantly more reassuring, 
with patient notably calm, cooperative with thought process that 
is linear, goal and future oriented. Of note, he denies AVH and 
he does not appear to be responding to internal stimuli. 
. 
In terms of etiology, presentation seems most consistent with 
substance induced psychosis, although the patient denies recent 
illicit substance use and his tox screen was negative on 
admission. Differential also includes brief psychotic disorder, 
bipolar disorder (although no clear history of mania in the 
past-- remains on the differential given young age with ?family 
history of bipolar). Has reportedly been depressed in the past, 
but denies depressive symptoms on examination and does not 
appear dysthymic or dysphoric on examination.  
. 
#. Legal/Safety: patient admitted to Deaconess ___ on a ___, upon admission, he declined to sign a CV, stating he wished 
to be discharged home. Patient maintained his safety throughout 
his hospitalization on 15 minute checks and did not require 
physical or chemical restraints. Given his good behavioral 
control with resolution of psychotic symptoms with consistent 
denial of SI/HI, he did not meet 7&8b criteria and was 
discharged upon expiration of his ___. 
.
#. Psychosis: as noted above
- Patient declined initiation of psychotropic medications during 
his hospitalization. He was offered prn Ativan, which he did not 
require. 
- Mr. ___ maintained excellent behavioral control in the 
milieu and was compliant in attending groups, where he 
participated appropriately 
- Of note, during his hospitalization, his psychosis cleared 
rapidly with thought process that became linear, logical, goal 
and future oriented. He was calm, cooperative on examination 
with full range of affect, consistently denying AVH with no 
evidence that he was responding to internal stimuli. 
- Patient was counseled to avoid using illicit drugs, including 
cannabis, as this may increase his risk for a recurrent episode 
of psychosis. The patient understood this risk and stated he 
would abstain. 
- Patient declined referral to a PHP and will follow up with 
outpatient treaters as noted in the discharge worksheet. 
.
#. Medical: no acute issues during this admission

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. This patient is not taking any preadmission medications

 
Discharge Medications:
Patient declined medications during this admission 
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Brief Psychotic Disorder

 
Discharge Condition:
A/B: Appears stated age, dressed casually with good hygiene and 
grooming, calm, cooperative and pleasant with interviewer, good 
eye contact, no psychomotor agitation or retardation noted 
S: normal rate, volume, prosody, goal directed
M: 'good' 
A: euthymic, mood congruent, appropriate
TC: denies SI/HI, AVH
TP: linear, logical, goal and future oriented
C: awake, alert and oriented x3 
I/J: fair/fair 

 
Discharge Instructions:
-Please follow up with all outpatient appointments as listed - 
take this discharge paperwork to your appointments.
-Unless a limited duration is specified in the prescription, 
please continue all medications as directed until your 
prescriber tells you to stop or change.
-Please avoid abusing alcohol and any drugs--whether 
prescription drugs or illegal drugs--as this can further worsen 
your medical and psychiatric illnesses.
-Please contact your outpatient psychiatrist or other providers 
if you have any concerns.
-Please call ___ or go to your nearest emergency room if you 
feel unsafe in any way and are unable to immediately reach your 
health care providers.
It was a pleasure to have worked with you, and we wish you the 
best of health.
 
Followup Instructions:
___
"
115,16362820,23978863," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: CARDIOTHORACIC
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
asymptomatic mediastinal mass
 
Major Surgical or Invasive Procedure:
___
Left video assisted thoracoscopic surgery, robotic assisted 
thymectomy

 
History of Present Illness:
Ms ___ is a ___ with a h/o hyperparathyroidism treated
successfully with 3-gland parathyroidectomy ___ who was
incidentally found on 4D CT neck to have an anterior mediastinal
mass. 
 MRI mediastinum ___ showed a solitary well-defined 5 cm
soft tissue mass located left anterior mediastinum at the level
of the main pulmonary artery containing multiple internal cystic
foci with no macroscopic fat. There is loss of fat plane between
the inferior aspect of the mass and the anterior pericardium
focally - at the level of the right ventricle, without evidence
of pericardial/ventricular wall invasion.
Her blood pressure and blood glucose are well-controlled. 
She reports good functional status, with no angina or dyspnea on
exertion. She presents for surgical resection.

 
Past Medical History:
AFib on rivaroxaban
CVA ___ (no residual deficits)
HLD
HTN
DM2
History of hyperparathyroidism, s/p parathyroidectomy ___
chronic back pain
Anterior mediastinal mass

 
Social History:
___
Family History:
Pancreas and liver cancer.
Mother: colon cancer
Father: CHF

 
Physical ___:
BP: 122/74. Heart Rate: 87. O2 Saturation%: 99. Weight: 191 
(With
Clothes; With Shoes). Height: 67. BMI: 29.9.
GENERAL        
[x] WN/WD  [x] NAD  [x] AAO  [ ] abnormal findings:

HEENT          
[x] NC/AT   [x] EOMI   [x] PERRL/A   [x] Anicteric
[x] OP/NP mucosa normal     [x] Tongue midline
[x] Palate symmetric  [x] Neck supple/NT/without mass
[x] Trachea midline [x] Thyroid nl size/contour
[ ] Abnormal findings:

RESPIRATORY    
[x] CTA/P     [x] Excursion normal     [x] No fremitus
[x] No egophony    [x] No spine/CVAT
[ ] Abnormal findings:

CARDIOVASCULAR 
[x] RRR    [x] No m/r/g    [x] No JVD   [x] PMI nl  [x] No edema
[x] Peripheral pulses nl    [x] No abd/carotid bruit
[ ] Abnormal findings:

GI             
[x] Soft    [x] NT   [x] ND  [x] No mass/HSM   [x] No hernia
[ ] Abnormal findings:

GU             [x] Deferred  
[ ] Nl genitalia    [ ] Nl pelvic/testicular exam    [ ] Nl DRE
[ ] Abnormal findings:

NEURO          
[x] Strength intact/symmetric    [x] Sensation intact/ symmetric
[x] Reflexes nl     [x] No facial asymmetry [x] Cognition intact
[x] Cranial nerves intact   [ ] Abnormal findings:

MS     

        
[x] No clubbing   [x] No cyanosis   [x] No edema   [x] Gait nl
[x] No tenderness  [x] Tone/align/ROM nl   [x] Palpation nl
[x] Nails nl   [ ] Abnormal findings:

LYMPH NODES   
[x] Cervical nl      [x] Supraclavicular nl     [x] Axillary nl
[x] Inguinal nl   [ ] Abnormal findings:

SKIN           
[x] No rashes/lesions/ulcers
[x] No induration/nodules/tightening     [ ] Abnormal findings:

PSYCHIATRIC    
[x] Nl judgment/insight    [x] Nl memory   [x] Nl mood/affect
[ ] Abnormal findings:

 
Pertinent Results:
___ 04:40PM   GLUCOSE-115* UREA N-17 CREAT-1.0 SODIUM-143 
POTASSIUM-4.9 CHLORIDE-106 TOTAL CO2-25 ANION GAP-17
___ 04:40PM   CALCIUM-8.4 PHOSPHATE-4.8* MAGNESIUM-2.1

___ CXR :
Heart size is enlarged.  Mediastinum is stable.  The left chest 
tube is in 
place.  Subcutaneous air within the left chest wall is noted.  
There is mild vascular congestion and minimal mediastinal 
widening related to recent surgery 
  

 
Brief Hospital Course:
Ms. ___ was admitted to the hospital and taken to the 
Operating Room where she underwent a robotic assisted 
thymectomy.  She tolerated the procedure well and returned to 
the PACU in stable condition.  She maintained stable 
hemodynamics and her pain was controlled with IV dilaudid.  Her 
___ drain pit out minimal serosanguinous fluid and had no air 
leak.

Following transfer to the Surgical floor she developed some 
nausea, possibly from Oxycodone and Tramadol was started for 
incisional pain which was effective in conjunction with Tylenol. 
Her nausea resolved. Her ___ drain was removed on ___ and 
her post pull chest xray revealed no pneumothorax.
Her port sites were dry and she was using her incentive 
spirometry with much encouragement.  Attempts were made to wean 
her oxygen and her room air saturations were 90-92%.

Her blood pressure was in good control with the resumption of 
her pre op medications and she will resume her xarelto tomorrow. 
 After an uneventful recovery she was discharged to home on 
___ and will follow up in the Thoracic Clinic in 2 weeks.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. irbesartan 300 mg oral QHS 
2. Labetalol 300 mg PO TID 
3. NIFEdipine CR 60 mg PO QHS 
4. Rivaroxaban 20 mg PO DAILY 
5. Simvastatin 80 mg PO QPM 
6. liraglutide 1.2 mg subcutaneous DAILY 
7. 70/30 25 Units Breakfast
70/30 35 Units Dinner
8. Torsemide 20 mg PO DAILY 
9. Isosorbide Mononitrate (Extended Release) 60 mg PO QHS 
10. Aspirin 81 mg PO DAILY 
11. Vitamin E 400 UNIT PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 650 mg PO Q6H 
RX *acetaminophen 325 mg 2 tablet(s) by mouth four times a day 
Disp #*100 Tablet Refills:*0 
2.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*60 Capsule Refills:*2 
3.  Milk of Magnesia 30 mL PO HS:PRN constipation  
4.  TraMADol 50 mg PO Q4H:PRN Pain - Moderate 
RX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours 
Disp #*60 Tablet Refills:*0 
5.  70/30 25 Units Breakfast
70/30 35 Units Dinner 
6.  Aspirin 81 mg PO DAILY  
7.  Calcitriol 0.25 mcg PO DAILY  
8.  irbesartan 300 mg oral QHS  
9.  Isosorbide Mononitrate (Extended Release) 60 mg PO QHS  
10.  Labetalol 300 mg PO TID  
11.  liraglutide 1.2 mg subcutaneous DAILY  
12.  NIFEdipine CR 60 mg PO QHS  
13.  Rivaroxaban 20 mg PO DAILY 
start ___  
14.  Simvastatin 80 mg PO QPM  
15.  Torsemide 20 mg PO DAILY  
16.  Vitamin E 400 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Anterior mediastinal mass

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
* You were admitted to the hospital for surgery to remove your 
thymus gland and you've recovered well. You are now ready for 
discharge.

* Continue to use your incentive spirometer 10 times an hour 
while awake.

* Check your incisions daily and report any increased redness or 
drainage.   Cover the area with a gauze pad if it is draining.

* Your chest tube dressing may be removed in 48 hours.  If it 
starts to drain, cover it with a clean dry dressing and change 
it  as needed to keep site clean and dry.

 * You may need pain medication once you are home but you can 
wean it over the next week as the discomfort resolves.  Make 
sure that you have regular bowel movements while on narcotic 
pain medications as they are constipating which can cause more 
problems.  Use a stool softener or gentle laxative to stay 
regular.

* No driving while taking narcotic pain medication.

* Take Tylenol  ___ mg every 6 hours in between your narcotic.  

* Continue to stay well hydrated and eat well to heal your 
incisions

* Shower daily. Wash incision with mild soap & water, rinse, pat 
dry
 * No tub bathing, swimming or hot tubs until incision healed
 * No lotions or creams to incision site

* Walk ___ times a day and gradually increase your activity as 
you can tolerate.

Call Dr. ___ ___ if you experience:
 -Fevers > 101 or chills
 -Increased shortness of breath, chest pain or any other 
symptoms that concern you.

 

 

 
 
Followup Instructions:
___
"
116,16362820,22793054," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
dyspnea/hypertension 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ y/o HTN, DMII, Stroke, pAfib, who 
developed worsening dyspnea, orthopnea over the past week. Many 
of her colleagues have had URIs. On ___ she had chest 
tightness (elephant sitting on her chest) associated with 
dyspnea and on ___ became acutely worse. She called ___ and 
EMS placed the patient initially on BIPAP, gave her 
nitroglycerin with improvement in her blood pressure. After 
arrival to ___, she continued to require BIPAP and received IV 
Lasix. She ultimately received 180mg IV Lasix and diuresed 
2200+CC in the ER. Cardiology saw her in the ED, and she was 
weaned off the BIPAP and stable on room air prior to transfer to 
the floor. In the ED she denied any fever, chills, but did have 
+cough. No abdominal pain/dysuria/leg swelling.

In the ED, initial vitals were:
___ RA
- Labs notable for:
Hgb 13.2, WBC 8.4
Cr 1.0
D dimer 515, trop < 0.01
- Imaging was notable for:
___: CXR
Lung volumes are slightly low with bibasilar atelectasis. There 
is no pulmonary edema, pleural effusion, or pneumothorax. 
Cardiomediastinal. Silhouette is stable.

IMPRESSION:
Slightly low lung volumes with bibasilar atelectasis.
- Cardiology saw patient in ED

- Patient was given:
___ 23:20 IV Furosemide 80 mg
___ 23:59 IV DRIP Nitroglycerin
___ 01:48 IV Furosemide 100 mg
___ 07:39 PO Isosorbide Mononitrate (Extended Release) 60 
mg ___ 07:39 PO NIFEdipine CR 60 mg
___ 10:03 SC Insulin 25 UNIT ___ 12:00 IV DRIP 
Nitroglycerin
___ 20:33 PO/NG Labetalol 300 mg ___ 20:36 PO/NG 
Aspirin 81 mg
- Vitals prior to transfer:
107 137/87 16 95% RA
Upon arrival to the floor, patient reports feeling significantly 
improved. She confirms the ED history including no fever, 
chills, nausea, vomiting, abdominal pain, current chest pain, 
changes in bowel habits. She notes her orthopnea is dramatically 
improved although she still feels slightly short of breath and 
notes that her abdomen is distended more than usual. She notes 
prior to feeling unwell she had a number of friends develop 
URIs, and her symptoms were initially similar until her 
respiratory decompensation. REVIEW OF SYSTEMS:
(+) Per HPI
 
Past Medical History:
1. CARDIAC RISK FACTORS
- Diabetes
- Hypertension
- Dyslipidemia
2. CARDIAC HISTORY
- AFib on rivaroxaban
3. OTHER MEDICAL HISTORY
-CVA ___ (no residual deficits)
-History of hyperparathyroidism, s/p parathyroidectomy ___
-Chronic back pain
-Anterior ___ mass s/p resection in ___
 
Social History:
___
Family History:
Mother - liver, colon cancer  
Father - HTN, DM , CHF 
Children - no medical issues, good health  

 
Physical Exam:
===============================
 ADMISSION PHYSICAL EXAM:
===============================
Vital Signs: 143 / 99 93 18 97 RA
General: Alert, oriented, no acute distress
HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL
Neck: Supple. JVP of 14cm.
CV: Regular rate and rhythm. Normal S1+S2, no murmurs, rubs, 
gallops. 
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi 
Abdomen: Distended, normoactive BS, nontender.
GU: No foley Ext: Warm, well perfused, trace edema
Neuro: gait deferred, FROM x 4
 
===============================
 DISCHARGE PHYSICAL EXAM:
===============================
VS: 97.9PO BP: 139/90 (139-153/81-100) L Lying HR: 76 18 98 RA 
Weight: 86 kg <- 84.4 kg <- 84.6kg (admit wt: 85.73) 
I/O: 8h ___ (not recorded) ; 24h 491/800 
GENERAL: WDWN in NAD. Oriented x3. Mood, affect appropriate. 
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink. No xanthelasma. 
NECK: Supple with JVP of 8 cm with hepatojugular reflux 
sustained 
CARDIAC: irregular, normal S1, S2. No m/r/g. 
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi. 
ABDOMEN: Soft, NTND. 
EXTREMITIES: No c/c/e. 
GU: no foley 
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
 
Pertinent Results:
===============================
 ADMISSION LABS:
===============================
___ 10:59PM BLOOD WBC-8.4 RBC-4.86# Hgb-13.2# Hct-43.1# 
MCV-89 MCH-27.2 MCHC-30.6* RDW-13.8 RDWSD-44.5 Plt ___
___ 10:59PM BLOOD Neuts-67.6 ___ Monos-6.2 Eos-3.0 
Baso-0.7 Im ___ AbsNeut-5.70# AbsLymp-1.85 AbsMono-0.52 
AbsEos-0.25 AbsBaso-0.06
___ 06:40AM BLOOD ___ PTT-30.0 ___
___ 10:59PM BLOOD Glucose-193* UreaN-12 Creat-1.0 Na-143 
K-4.2 Cl-101 HCO3-29 AnGap-17
___ 10:59PM BLOOD cTropnT-<0.01
___ 06:45AM BLOOD CK-MB-2 cTropnT-<0.01
___ 10:59PM BLOOD D-Dimer-515*
 
===============================
 KEY INTERVAL LABS:
===============================
___ ALDOSTERONE:   12 ng/dL
___ PLASMA RENIN ACTIVITY:   0.25 ng/mL/h
 
===============================
 MICROBIOLOGY:
===============================
___ 2:17 am URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      ESCHERICHIA COLI.    >100,000 CFU/mL.  PRESUMPTIVE 
IDENTIFICATION. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 
      KLEBSIELLA PNEUMONIAE.    >100,000 CFU/mL. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |          KLEBSIELLA PNEUMONIAE
                             |          |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--    16 I      <=2 S
CEFAZOLIN-------------   <=4 S      <=4 S
CEFEPIME--------------   <=1 S      <=1 S
CEFTAZIDIME-----------   <=1 S      <=1 S
CEFTRIAXONE-----------   <=1 S      <=1 S
CIPROFLOXACIN---------<=0.25 S   <=0.25 S
GENTAMICIN------------   <=1 S      <=1 S
MEROPENEM-------------<=0.25 S   <=0.25 S
NITROFURANTOIN--------    32 S       64 I
PIPERACILLIN/TAZO-----   <=4 S      <=4 S
TOBRAMYCIN------------   <=1 S      <=1 S
TRIMETHOPRIM/SULFA----  =>16 R      <=1 S 

===============================
 IMAGING:
===============================
___ CXR: 
Slightlylowlungvolumeswithbibasilaratelectasis. 
___ TTE: The left atrium is mildly dilated. No atrial 
septal defect is seen by 2D or color Doppler. There is moderate 
symmetric left ventricular hypertrophy. The left ventricular 
cavity size is normal. Overall left ventricular systolic 
function is moderately depressed (LVEF= 35-40%) with global 
hypokinesis and regional inferior near akinesis. No masses or 
thrombi are seen in the left ventricle. There is no ventricular 
septal defect. Right ventricular chamber size is normal with 
mild global free wall hypokinesis. The diameters of aorta at the 
sinus, ascending and arch levels are normal. The aortic valve 
leaflets (3) are mildly thickened but aortic stenosis is not 
present. No aortic regurgitation is seen. The mitral valve 
leaflets are mildly thickened. Moderate (2+) mitral 
regurgitation is seen. The tricuspid valve leaflets are mildly 
thickened. There is moderate pulmonary artery systolic 
hypertension. There is no pericardial effusion.  

===============================
 DISCHARGE LABS:
===============================

___ 06:45AM BLOOD CK-MB-2 cTropnT-<0.01
___ 10:59PM BLOOD cTropnT-<0.01
___ 06:45AM BLOOD CK(CPK)-206*
___ 06:40AM BLOOD %HbA1c-6.3* eAG-134*
 
Brief Hospital Course:
___ y/o HTN, DMII, Stroke, pAfib, who developed worsening 
dyspnea, orthopnea over the past week, presenting with acute 
dyspnea and hypertension suggestive of CHF exacerbation w/flash 
pulmonary edema, now improving s/p diuresis and with blood 
pressure control and UTI tx. 

# CORONARIES: Nonobstructive CAD (___), pmibi ___ (41% EF)
# PUMP: EF to 45-50% (___)
# RHYTHM: AFib on rivarox 

==============================
 ACTIVE ISSUES:
===============================
# acute exacerbation of chronic diastolic heart failure
#CHF exacerbation (preserved EF acute on chronic, based on ___ 
TTE): Patient w/evidence of CHF exacerbation which may have been 
triggered by uncontrolled hypertension vs infection (URI vs UTI) 
vs hypoglycemia; prior evaluation of secondary hypertension 
including negative for pheo. CXR w/o PNA just treating cough 
with Benzonatate. Trop negative x1 without ioschemic changes, no 
palpitations or indication of uncontrolled afib. PRELOAD: held 
initially then restarted at 40qday goal. Please recheck 
electrolytes in 1 week given diuretic changes. AFTERLOAD: 
Irbesartan NOT on formulary, started on Losartan 100mg daily, 
consider transition as outpatient. Neurohormonal blockade: 
switched beta blocker to carvedilol, spironolactone.
 
# Urinary Tract Infection: Likely cause of exacerbation on 
CefTRIAXone 1 gm IV Q24H day ___ = ___, discharged on 4 days of 
cefpodoxime for UTI, cultures were pending on discharge. 
 
#Acute Kidney Injury: suspect hypovolemia rather than 
cardiorenal given downtrending with holding of diuretic, stable 
at discharge. Creatinine 1.1 at discharge

# Atrial Fibrillation (CHADS-VASC of 7):
Patient was unclear in the ED if she is on her rivaroxaban, 
however with a CHADS-VASC of 7, her yearly stroke risk is 11.2%. 
The medication is documented in her ___ record. On further 
discussion with her she notes that in the distant past she was 
on pradaxa and this was switched to rivaroxaban which she is 
taking. 
- anticoagulation: Rivaroxaban 20mg QHS
- rate control: Switched home labetalol to coreg 50mg BID

# Hypertension
Patient presented with hypertensive urgency, now improved. 
Continuing home medications, but fractionated. Has hx of 
___ elevation (44.3), however ___ level was low. Renal 
US negative for renal stenosis. ___ ratio (drawn before 
starting spironolactone) is pending on discharge. Started on 
Coreg 50mg BID. Irbesartan 300mg qHS on hold due to not on 
formulary, will place on Losartan. (Could also consider 
telmisartan as outpatient if covered by insurance). Held home 
calcium channel blocker as above, increased amlodipine to 10mg 
daily on ___. Continued home nitrate (Isosorbide Mononitrate 
(Extended Release) 60 mg PO QHS) as well given stable BPs. 
Started spironolactone ___ after drawing ___ labs. 
Recommend calibrating home BP cuff to office 

# Coronary Artery Disease:
Stable. No evidence of acute ischemia, no chest pain, troponin 
is negative. Continued ASA 81mg. Switched Simvastatin 80mg PO 
QPM to atorva 40 given interaction with amlodipine. Trops 
negative x2. Consider stress test as outpatient given new 
regional wall motion abnormality on echo. 

# Diabetes Mellitus Type II: Concern for hypoglycemia. A1c of 
6.3%. Decreased home 70/30 due to hypoglycemia fasting, held 
home liraglutide. Diabetic/heart healthy diet. 

# Hyperlipidemia:
Stable. Continued simvastatin 

=============================
 TRANSITIONAL ISSUES:
=============================
- Please follow up angiotensin renin ratio (ordered prior to 
starting spironolactone)
- Switched nifedipine to amlodipine. Switched simvastatin to 
atorvastatin given interaction with amlodipine. 
- Started spironolactone
- Increased torsemide to 40qday
- Switched beta blocker to carvedilol 
- Please recheck electrolytes in 1 week given diuretic changes
- Decreased home insulin and held home liraglutide given 
inpatient lows on home insulin regimen. Please titrate diabetic 
medications. 
- Recommend stress mibi as outpatient given new regional wall 
motion abnormality on echo
- Recommend re-addressing goals of care. Patient is full code 
for now but would like to think about it. 
- Recommend calibration of home BP cuff with office 
measurements.
- Discharged on 4 days of cefpodoxime for UTI. Please follow up 
culture. 

Proxy name: ___
Relationship: daughter Phone: ___
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. liraglutide 1.2 mg subcutaneous DAILY 
3. Vitamin E 400 UNIT PO DAILY 
4. irbesartan 300 mg oral QHS 
5. Isosorbide Mononitrate (Extended Release) 60 mg PO QHS 
6. Labetalol 300 mg PO TID 
7. NIFEdipine CR 60 mg PO QHS 
8. Simvastatin 80 mg PO QPM 
9. Torsemide 20 mg PO DAILY 
10. 70/30 25 Units Breakfast
70/30 35 Units Bedtime
11. Rivaroxaban 20 mg PO DAILY 
12. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  amLODIPine 10 mg PO DAILY 
RX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Atorvastatin 40 mg PO QPM 
RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0 
3.  Carvedilol 50 mg PO BID 
RX *carvedilol 25 mg 2 tablet(s) by mouth twice a day Disp #*120 
Tablet Refills:*0 
4.  Cefpodoxime Proxetil 200 mg PO Q12H Duration: 4 Days 
RX *cefpodoxime 200 mg 1 tablet(s) by mouth every twelve (12) 
hours Disp #*8 Tablet Refills:*0 
5.  Spironolactone 25 mg PO DAILY 
RX *spironolactone 25 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0 
6.  70/30 18 Units Breakfast
70/30 26 Units Bedtime 
7.  Torsemide 40 mg PO DAILY 
RX *torsemide 20 mg 2 tablet(s) by mouth daily Disp #*60 Tablet 
Refills:*0 
8.  Aspirin 81 mg PO DAILY  
9.  irbesartan 300 mg oral QHS  
10.  Isosorbide Mononitrate (Extended Release) 60 mg PO QHS  
11.  Rivaroxaban 20 mg PO DAILY  
12.  Vitamin D ___ UNIT PO DAILY  
13.  Vitamin E 400 UNIT PO DAILY  
14. HELD- liraglutide 1.2 mg subcutaneous DAILY  This medication 
was held. Do not restart liraglutide until outpatient diabetes 
follow-up

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
acute exacerbation of chronic diastolic heart failure
Hypertension

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

It was a pleasure taking care of you at the ___ 
___!  

Why was I admitted to the hospital?  
-You were admitted because you had trouble breathing.   

What happened while I was in the hospital?  
- You had fluid removed with diuretics, that helped your 
breathing. Your high blood pressure was treated. We also treated 
your UTI. 
- We did an echocardiogram (ultrasound of your heart) which 
showed a decrease in the ejection fraction (which measures your 
heart's pumping function). 

What should I do after leaving the hospital?  
-  Please take your medications as listed in discharge summary 
and follow up at the listed appointments. 
- Please decrease your insulin to 18 in the morning and 26 at 
night and do not take your liraglutide until you see your 
primary care doctor. 
- It is VERY IMPORTANT that you call your primary doctor and 
cardiologist to make follow-up appointments. 
- Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.

Thank you for allowing us to be involved in your care, we wish 
you all the best!  

 Your ___ Healthcare Team  

 
Followup Instructions:
___
"
117,16362820,25985703," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
dizziness/vertigo 
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
The pt is a ___ year-old right-handed woman with HTN,
hypertensive heart disease, AF on Xarelto 20 mg daily, DM,
stroke, with recent admission for CHF and UTI, found to have
primary hyperaldosteronism (discharged ___ who presents 
with
acute onset dizziness/vertigo. 

Awoke at 4AM feeling okay. Went to BR, then on way back to bed
acute onset vertigo (horizontal room spinning, unclear which
direction), sat down. Took a drink of water and became 
nauseated,
had several episodes of NBNB emesis. Lay down and vertigo
resolved. Daughters called ___. In ambulance sitting up, again
with vertigo, asked EMS to have her lie down which they did,
vertigo improved somewhat but did not resolve. Persisted 
somewhat
improved into waiting room for ER and triage, then resolved.
Sitting semi-reclined patient denies ongoing vertigo but thinks
if she sits up will have it again. Reports that she is unsure if
lasted more than two minutes each time as she was unable to
tolerate sitting up long enough to see if it would resolve. 

Denies loss of vision, vision changes, blacking out, LOC,
headaches, numbness, weakness, difficulty thinking or speaking,
confusion. Denies congestion but reports having the ""flu""/URI 
two
weeks ago, then developing the shortness of breath/CHF
exacerbation and UTI (reports no urinary or abdominal symptoms
with the UTI). 

Had multiple medication changes during her recent admission,
outlined below, notably with changes in antihypertensives and
addition of spironolactone and increase of torsemide (currently
on extensive antihypertensive regimen including isosorbide,
carvedilol, spironolactone, irbesartan, amlodipine, torsemide)
after felt that she had primary hyperaldosteronism (renin and
aldosterone still pending).  

She has permanent AF on Xarelto. She has not been off
anticoagulation since ___ when she had her thymectomy
and denies missed doses of medication. 

In ED for ED physicians per report NIHSS 0, HINTS testing no
corrective saccade, no skew.  

 
Past Medical History:
Permanent AF on rivaroxaban
HTN
HLD
DM II
Cath ___ non-obstructive CAD
HFrEF, though EF 35-40% on ___ echo
primary hyperaldosteronism - diagnosed ___
thymic mass s/p thymectomy ___
hyperparathyroidism s/p three gland parathyroidectomy ___

 
Social History:
___
Family History:
Pancreas and liver cancer.
Mother: colon cancer
Father: CHF

 
Physical ___:
Admission Physical Exam:
Vitals: 97.4   79  151/111 (137/89-164/102)  22  99% RA
General: awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx
Neck: supple, no nuchal rigidity
Pulmonary: breathing comfortably on room air; few crackles at
bases, few faint scattered wheezes, good air movement 
throughout,
no increased WOB except during exertion with ___
Cardiac: irregularly irregular; palpable pulses
Abdomen: soft, NT/ND
Extremities: warm, well perfused
Skin: scattered skin tags; no other rashes or lesions noted

Neurologic:

-Mental Status: Alert, oriented x 3. Able to relate history
without difficulty. Attentive, initially some difficulty with 
___
backward given 4 person audience but with family not paying
attention able to name ___ backward without difficulty. Language
is fluent with intact repetition and comprehension. Normal
prosody. There were no paraphasic errors. Pt was able to name
both high and low frequency objects. Speech was not dysarthric.
Able to follow both midline and appendicular commands. There was
no evidence of apraxia or neglect.

-Cranial Nerves:
II, III, IV, VI:  PERRL 2mm and minimally reactive bilaterally.
EOM full with slight breakdown of smooth pursuit with ___ beats
of end gaze horizontal nystagmus bilaterally (eventually
extinguishes). With head impulse testing there seems to reliably
be a corrective saccade when head is moved to the right, though
patient has variable cooperation/ability to maintain focus on
examiner's nose. No skew. ___ bilaterally without
nystagmus. VFF to confrontation. Fundoscopic exam difficult 
given
small pupils but no obvious evidence of papilledema appreciated. 

V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii and SCM bilaterally.
XII: Tongue protrudes in midline.

-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally.
No adventitious movements, such as tremor, noted. No asterixis
noted.
  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___
L  5    ___   ___  5   5    5  5     5     5   5
R  5    ___   ___  5   5    5  5     5     5   5

-Sensory: No deficits to light touch, cold sensation throughout.
No extinction to DSS.

-DTRs:
  Bi Tri ___ Pat Ach
L  2  2    2    2   1
R  2  2    2    2   1
Plantar response was flexor bilaterally.

-Coordination: No intention tremor noted. No dysmetria on FNF
bilaterally.

-Gait: Deferred given positional intolerance 

Discharge Physical Exam
MS ___, attentive, fluent CN several beats of end gaze nystagmus 
which extinguishes, no droop, motor ___ throughout. Ambulates 
with goob balance other than some missteps with tandem
 
Pertinent Results:
___ 05:00PM BLOOD WBC-7.1 RBC-4.17 Hgb-11.4 Hct-36.4 MCV-87 
MCH-27.3 MCHC-31.3* RDW-13.7 RDWSD-43.1 Plt ___
___ 07:00AM BLOOD WBC-7.4 RBC-4.47 Hgb-12.3 Hct-39.0 MCV-87 
MCH-27.5 MCHC-31.5* RDW-13.8 RDWSD-43.7 Plt ___
___ 07:00AM BLOOD Neuts-67.5 ___ Monos-6.4 Eos-3.4 
Baso-0.7 Im ___ AbsNeut-4.96 AbsLymp-1.58 AbsMono-0.47 
AbsEos-0.25 AbsBaso-0.05
___ 05:00PM BLOOD ___ PTT-36.9* ___
___ 07:00AM BLOOD ___ PTT-39.1* ___
___ 05:00PM BLOOD Glucose-113* UreaN-20 Creat-0.9 Na-142 
K-3.9 Cl-104 HCO3-29 AnGap-13
___ 07:00AM BLOOD Glucose-142* UreaN-26* Creat-1.2* Na-144 
K-4.1 Cl-104 HCO3-28 AnGap-16
___ 05:00PM BLOOD ALT-20 AST-15 LD(LDH)-243 CK(CPK)-284* 
AlkPhos-85 TotBili-0.3
___ 07:00AM BLOOD ALT-25 AST-22 AlkPhos-95 TotBili-0.3
___ 07:00AM BLOOD proBNP-718*
___ 05:00PM BLOOD TotProt-6.5 Albumin-4.2 Globuln-2.3 
Cholest-115
___ 05:00PM BLOOD %HbA1c-6.4* eAG-137*
___ 05:00PM BLOOD Triglyc-110 HDL-32 CHOL/HD-3.6 LDLcalc-61
___ 05:00PM BLOOD TSH-0.44
___ 05:00PM BLOOD CRP-3.1
___ 07:00AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 07:10AM BLOOD ___ pO2-48* pCO2-48* pH-7.40 
calTCO2-31* Base XS-3

MRI
1. No acute infarction. 
2. Small chronic infarction in the right cerebellar hemisphere. 
3. Extensive supratentorial white matter signal abnormalities 
are nonspecific, but likely sequela of chronic small vessel 
ischemic disease, given the patient's age and cardiovascular 
risk factors. 

 
Brief Hospital Course:
___ yo F with HTN, HLD, DM, CAD, AF on Xarelto, recent admission 
for CHF and UTI and recently discovered primary 
hyperaldosteronism, recent URI presenting with several episodes 
of positional vertigo. Because of her risk factors, a MRI was 
performed which was negative for any evidence of stroke. She was 
back to baseline by the morning. She was diagnosed with benign 
paroxysmal positional vertigo and discharged with a prescription 
for vestibular ___ in case her symptoms returned.  
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY 
2. Atorvastatin 40 mg PO QPM 
3. Carvedilol 50 mg PO BID 
4. Cefpodoxime Proxetil 200 mg PO Q12H 
5. Spironolactone 25 mg PO DAILY 
6. Torsemide 40 mg PO BID 
7. Aspirin 81 mg PO DAILY 
8. irbesartan 300 mg oral QHS 
9. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
10. Rivaroxaban 20 mg PO DAILY 

 
Discharge Medications:
1.  Carbamide Peroxide 6.5% ___ DROP BOTH EARS BID Cerumen 
impaction Duration: 4 Days 
___ DROP BOTH EARS BID Cerumen impaction Duration: 4 Days  
RX *carbamide peroxide 6.5 % ___ drops BOTH EARS twice daily 
Refills:*1 
2.  amLODIPine 10 mg PO DAILY  
3.  Aspirin 81 mg PO DAILY  
4.  Atorvastatin 40 mg PO QPM  
5.  Carvedilol 50 mg PO BID  
6.  Cefpodoxime Proxetil 200 mg PO Q12H  
7.  irbesartan 300 mg oral QHS  
8.  Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY  
9.  Rivaroxaban 20 mg PO DAILY  
10.  Spironolactone 25 mg PO DAILY  
11.  Torsemide 40 mg PO BID  
12.Outpatient Physical Therapy
Vestibular Physical Therapy 
Dx: Benign paroxysmal positional vertigo (BPPV
Evaluate and Treat 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
BPPV Benign paroxysmal positional vertigo (BPPV)

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms ___, 

You were admitted with symptoms of vertigo that occurred when 
you sat up or changed position. These are consistent with a 
condition known as benign paroxysmal positional vertigo. We 
ordered an MRI to be sure there was no evidence of stroke. It 
did not show anything concerning. We gave you a prescription for 
""vestibular ___ to provide exercises to help with the vertigo if 
it occurs again. We have also provided you with a medication to 
treat the ear wax in your ears. You should use this for the next 
four days or until symptoms resolve.  
As for your CHF, please continue to weigh yourself every 
morning, call MD if weight goes up more than 3 lbs.

It was a pleasure taking care of you. 

___ Neurology 
 
Followup Instructions:
___
"
118,16362820,20608194," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
dysuria, fever
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ h/o DMII, HFrEF (35-40%), atrial fibrillation, who presents 
with 4 days of dysuria. Also reports right lower quadrant pain, 
urinary urgency. She saw her PCP, who documented a fever of 
101.3, with positive urinalysis. The patient was referred with 
concern for pyelonephritis. She denies chest pain, shortness of 
breath, diarrhea, leg swelling, cough, skin rashes, confusion. 

Exam: Right CVA tenderness, mild right-sided abdominal 
tenderness

In ED initial VS:  98.9 ___ 19 100% RA. In ED, temp rose 
to a high of 105, down to 99.5 at time of transfer. HRs 
increased to a max of 130 before sustaining in 110s. Downtrended 
to ___ at time of transfer. RR and sats remained stable.  

Labs significant for:  WBC 11.7, lactate 1.9 to 2.8, Cr 1.0, UA 
w/ many RBC, WBC, and bacteria. 

Patient was given: IV CTX, IVF 1L NS, ASA 81, labetalol 300mg, 
IV ketorolac 15mg, carvedilol 50mg, rivaroxaban 20mg, 
atorvastatin 40mg, amlodipine 10mg, irbesartan 300mg, and SC 
insulin. Started on LR 100/hr. 

Imaging notable for:  CXR w mild-to-moderate cardiomegaly with 
mild pulmonary vascular congestion. Left basilar streaky 
opacity, likely atelectasis. 

On arrival to the MICU, pt falling asleep during exam, but would 
awaken upon command and provide appropriate answers. Confirmed 
above history. Asymptomatic upon arrival.

REVIEW OF SYSTEMS: as per HPI, otherwise negative
 
Past Medical History:
AF on rivaroxaban, HTN, HLD, DM II
CAD no interventions
HFrEF, though EF 35-40% on ___ echo
primary hyperaldosteronism - diagnosed ___
thymic mass s/p thymectomy ___
hyperparathyroidism s/p three gland parathyroidectomy ___

 
Social History:
___
Family History:
Pancreas and liver cancer.
Mother: colon cancer
Father: CHF  

 
Physical ___:
DISCHARGE EXAM:
 VS: ___ 1130 Temp: 97.6 PO BP: 144/79 L Sitting HR: 76 RR:
18 O2 sat: 99% O2 delivery: Ra FSBG: 233 
 GENERAL: NAD  
 HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, good dentition  
 NECK: nontender supple neck, no LAD, no JVD  
 HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
 LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
 ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
 EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
 PULSES: 2+ DP pulses bilaterally  
 NEURO: CN II-XII intact  
 SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 
 
Pertinent Results:
ADMISSION LABS
===============
___ 12:14PM BLOOD WBC-11.7*# RBC-5.15 Hgb-13.9 Hct-43.7 
MCV-85 MCH-27.0 MCHC-31.8* RDW-13.2 RDWSD-41.0 Plt ___
___ 12:14PM BLOOD Neuts-83.1* Lymphs-8.4* Monos-7.6 
Eos-0.3* Baso-0.3 Im ___ AbsNeut-9.73*# AbsLymp-0.98* 
AbsMono-0.89* AbsEos-0.03* AbsBaso-0.03
___:14PM BLOOD Glucose-155* UreaN-12 Creat-1.0 Na-144 
K-3.6 Cl-99 HCO3-29 AnGap-16
___ 12:14PM BLOOD ALT-16 AST-15 AlkPhos-118* TotBili-0.5
___ 03:06AM BLOOD Calcium-8.5 Phos-3.3 Mg-2.1
___ 12:14PM BLOOD Albumin-4.4
___ 03:23AM BLOOD ___ pO2-42* pCO2-46* pH-7.41 
calTCO2-30 Base XS-3
___ 12:25PM BLOOD Lactate-1.9

MICROBIOLOGY
=============
___ 12:14pm URINE CULTURE: ESCHERICHIA COLI. >100,000 
CFU/mL.   SENSITIVITIES: MIC expressed in MCG/ML                 
            |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--    16 I
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------    32 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----  =>16 R

IMAGING
=======
CXR (___): Mild-to-moderate cardiomegaly with mild pulmonary 
vascular congestion.  Left basilar streaky opacity, likely 
atelectasis. 

RENAL US (___): No hydronephrosis or evidence of abscess.  
Multiple simple bilateral renal cysts.  9 mm posterior bladder 
wall urothelial lesion.  Cystoscopy is recommended to 
characterize further. 
 
DISCHARGE LABS
==============
___ 06:10AM BLOOD WBC-9.2 RBC-4.47 Hgb-11.9 Hct-39.0 MCV-87 
MCH-26.6 MCHC-30.5* RDW-13.6 RDWSD-43.3 Plt ___
___ 06:10AM BLOOD ___ PTT-37.6* ___
___ 06:35AM BLOOD Glucose-133* UreaN-9 Creat-0.8 Na-148* 
K-4.2 Cl-107 HCO3-28 AnGap-13
___ 12:14PM BLOOD ALT-16 AST-15 AlkPhos-118* TotBili-0.5
___ 06:35AM BLOOD Calcium-9.1 Phos-2.9 Mg-2.___ h/o DMII, HFrEF (35-40%), atrial fibrillation who presents 
with urinary symptoms and high grade fever c/f pyelonephritis.

# Pyelonephritis with sepsis: Patient presented with several 
days of urinary sx's, UA w/ many WBCs, bacteria, and RBCs, CVA 
tenderness on exam, and febrile all consistent with 
pyelonephritis. No other localizing symptoms to suggest other 
source for infection. She has had ___ UTIs in past, grown 
ampicillin-sensitive enterococcus, klebsiella, and E.coli, but 
nothing that was multi-drug resistant. Renal ultrasound obtained 
was negative for hydronephrosis or abscess. She received a dose 
of IV Ceftriaxone in the ED then started on vancomycin and 
cefepime for empiric coverage in the ICU.  She was transitioned 
to PO Ciprofloxacin as Urine culture grew Pan-sensitive E coli 
with plans to complete a 10 day course through ___.

# Atrial Fibrillation: EKGs all demonstrated sinus rhythm, 
however she has a hx of AF and her heart rates were as high as 
130 in the ED. Her heart rates improved with IVF. Home Coreg and 
rivaroxaban continued.

# Hypertension, Mild hypernatremia, Hypokalemia, primary 
hyperaldosteronism: Patient was started on spironolactone for 
hyperaldosteronism that was recently discontinued in ___ for 
hyperkalemia.  Since that time her blood pressure and 
electrolytes were controlled on torsemide, carvediolol, 
amlodipine, and irbesartan. On admission her some of her 
antihypertensives including torsemide were held as a precaution 
in the setting of infection/sepsis.  These were resumed with 
recovery of blood pressure.  Sodium was noted to be 148 two days 
in a row after sepsis physiology had resolved despite good PO 
intake. The patient described polyuria and polydipsia but 
appeared euvolemic on exam and felt that hypernatremia was most 
likely due to hyperaldosteronism. She was restarted on low dose 
spironolactone with plan for close outpatient monitoring for 
development of hyperkalemia. 

# DMII: Home 70/30 regimen was continued and Victoza resumed at 
discharge. 

TRANSITIONAL ISSUES
===================
[] Renal US showed 9 mm posterior bladder wall urothelial 
lesion. Please refer to urology for cystoscopy to characterize 
further.
[] Please repeat chem7 within this week to be followed by and 
likely repeated when she sees PCP. Na 148 on discharge with Cr 
0.8.
[] Please evaluate volume status and increase Torsemide as 
needed at next clinic visit.
[] Antibiotic Course: Ciprofloxacin 500 mg q12h x 10 day course 
(last day ___.
[] Consider referral to endocrinology for management of probable 
hyperaldosteronism

>30 minutes spent on discharge planning 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY 
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. Carvedilol 50 mg PO BID 
5. Victoza 2-Pak (liraglutide) 0.6 mg/0.1 mL (18 mg/3 mL) 
subcutaneous QAM 
6. 70/30 31 Units Breakfast 70/30 41 Units Bedtime
7. irbesartan 300 mg oral QHS 
8. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
9. Rivaroxaban 20 mg PO DAILY 
10. Torsemide 40 mg PO BID 
 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 
mg 1 tablet(s) by mouth every twelve (12) hours Disp #*10 Tablet 
Refills:*0 
2.  Spironolactone 12.5 mg PO DAILY RX *spironolactone 25 mg 0.5 
(One half) tablet(s) by mouth daily Disp #*15 Tablet Refills:*0 
3.  70/30 31 Units Breakfast 70/30 41 Units Dinner 
4.  Torsemide 40 mg PO DAILY  
5.  amLODIPine 10 mg PO DAILY  
6.  Aspirin 81 mg PO DAILY  
7.  Atorvastatin 40 mg PO QPM  
8.  Carvedilol 50 mg PO BID  
9.  irbesartan 300 mg oral QHS  
10.  Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY  
11.  Rivaroxaban 20 mg PO DAILY  
12.  Victoza 2-Pak (liraglutide) 0.6 mg/0.1 mL (18 mg/3 mL) 
subcutaneous QAM  
13.Outpatient Lab Work I50.32 Basic metabolic panel
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
Pyelonephritis
Hypernatremia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It has been a pleasure taking care of you at ___.

Why was I here?
- You were admitted due to a UTI which infected your kidney 
(pyelonephritis).

What was done for me here?
- You were monitored closely in the ICU.
- You were given IV fluids and IV antibiotics.
- You had an ultrasound which showed normal kidneys.

What should I do when I go home?
- You should take 40 mg Torsemide once daily, 12.5 mg 
spironolactone daily.
- You should continue to take all of your medications as 
prescribed.
- You should weigh yourself every morning, call MD if weight 
goes up more than 3 lbs.
- You need to see the urologist to discuss the lesion seen in 
your bladder.
- You need to see your PCP to discuss treatment for your high 
sodium.

Sincerely,
Your ___ Team
 
Followup Instructions:
___
"
119,16362820,25607296," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
vertigo
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
REASON FOR CONSULTATION:
Vertigo with concern for posterior circulation stroke
 
HISTORY OF PRESENT ILLNESS:
Patient is a ___ year old right handed woman with past medical
history of stroke more than ___ years ago without residual
weakness, atrial fibrillation on rivaroxaban and aspirin,
hypertension, hyperlipidemia, and insulin dependent diabetes 
whom
presents because of persistent vertigo. 

Patient reports that she was at her baseline throughout
yesterday, but awoke from a nap in the afternoon with sensation
that room was spinning around her.  Patient endorses that 
vertigo
was present with laying still and that she could initially not
tolerate sitting up or standing because of symptoms.  Patient
decided to stay in bed for the remainder of the afternoon and
evening and went to sleep.  

Patient awoke this morning and continued to have vertigo. 
Patient walked to the restroom and was having difficulty
maintaining balance with need for use of wall and furniture for
support.  Patient denied veering to one direction or another.
Patient felt that the vertigo was of equal intensity with laying
and standing.  

Patient came to the hospital with encouragement of daughter
because of persistence of symptoms.  

In ED, patient endorsed that she was continuing to have vertigo
when laying bed and that it was not altered by standing.  
Patient
denied that there was any positional element. Patient does 
report
that over the last few hours the vertigo has become more 
episodic
with short periods of feeling normal.  

Patient had NCHCT in ED which revealed chronic infarct of the
right cerebellar hemisphere.  Patient, pertinently, presented
___ with vertigo, but remarks that the symptoms then were of
much shorter duration and had a positional component.  Patient
had MRI brain during this admission which revealed the right
cerebellar infarct that was seen on today's imaging. 

Patient reports good fluid intake.  Denies symptoms of 
infection.
Denies chest pain and shortness of breath.  Patient denies
hearing loss or tinnitus.  

 
Past Medical History:
AF on rivaroxaban, HTN, HLD, DM II
CAD no interventions
HFrEF, though EF 35-40% on ___ echo
primary hyperaldosteronism - diagnosed ___
thymic mass s/p thymectomy ___
hyperparathyroidism s/p three gland parathyroidectomy ___

 
Social History:
___
Family History:
Pancreas and liver cancer.
Mother: colon cancer
Father: CHF  

 
Physical ___:
Neurologic:
Mental Status: 
Alert, oriented x 3. Able to relate history without difficulty.
Attentive, able to name months of the year backward without
difficulty. Language is fluent with intact repetition and
comprehension. Normal prosody. There were no paraphasic errors.
Able to name both high and low frequency objects.  Able to read
without difficulty. No dysarthria. Able to follow both midline
and appendicular commands. Able to register 3 objects and recall
___ at 5 minutes. There was no evidence of apraxia or neglect.

Cranial Nerves:
No visual field cut.  Physiologic anisoroia with right pupil
slightly than left by less than 1 mm.  EOMI. Pursuit is smooth.
Saccades are normal and without intrusions .  No nystagus on
fixation or end gaze. ___ is negative.  Head impulse 
test
is with corrective saccade. Cover uncover is without skew.  She
can use visual fixation to suppress the vestibular ocular 
reflex.
Facial sensation is symmetric.  Facial musculature is symmetric. 

Hearing is intact.  Palate elevates symmetrically. Uvula 
midline.
SCM ___. Tongue protrudes to midline with forceful lateral
excursions.    

Motor: 
Normal bulk and tone throughout. No pronator drift. No
adventitious movements, such as tremor or asterixis noted.
  [___]
L    5    5    5    5    5    5   5    5    5   5    5    5
R    5    5    5    5    5    5   5    5    5   5    5    5

Sensory: 
No deficits to light touch, pinprick, temperature,  vibration, 
or
proprioception throughout. No extinction to DSS. Romberg absent. 


Reflexes:
  [Bic] [Tri] [___] [Pat] [Ach]
L   2     2      2      2     1
R   2     2      2      2     1 
Plantar response was flexor bilaterally.

Coordination: 
No hypo or hypermetria.  No rebound of outstretched arms.  No
dysmetria with finger nose finger or heal to shin.  Accurate 
with
hitting crease of thumb with index finger.  Fluid alternating
movements.  No retropulsion with standing.  

Gait: 
Good initiation. Narrow-based, normal stride and arm swing. able 
to tandem
 

 
Pertinent Results:
___ 01:57PM BLOOD WBC-6.4 RBC-4.36 Hgb-12.0 Hct-37.3 MCV-86 
MCH-27.5 MCHC-32.2 RDW-12.8 RDWSD-39.2 Plt ___
___ 01:57PM BLOOD Neuts-64.4 ___ Monos-9.9 Eos-1.9 
Baso-0.5 Im ___ AbsNeut-4.10 AbsLymp-1.43 AbsMono-0.63 
AbsEos-0.12 AbsBaso-0.03
___ 01:57PM BLOOD ___ PTT-35.3 ___
___ 01:57PM BLOOD Glucose-430* UreaN-20 Creat-1.1 Na-136 
K-4.5 Cl-92* HCO3-27 AnGap-17
___ 01:57PM BLOOD ALT-26 AST-17 AlkPhos-122* TotBili-0.2
___ 08:16AM BLOOD CK-MB-2 cTropnT-<0.01
___ 08:16AM BLOOD TotProt-7.1 Albumin-4.2 Globuln-2.9 
Cholest-PND
___ 08:16AM BLOOD %HbA1c-12.7* eAG-318*
___ 08:16AM BLOOD Triglyc-PND HDL-PND
___ 08:16AM BLOOD TSH-PND
___ 08:16AM BLOOD CRP-4.4
___ 08:16AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Barbitr-NEG Tricycl-NEG
___ 02:23PM URINE Color-Straw Appear-Clear Sp ___
___ 02:23PM URINE Blood-TR* Nitrite-NEG Protein-NEG 
Glucose-1000* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 
Leuks-NEG
___ 02:23PM URINE RBC-0 WBC-<1 Bacteri-FEW* Yeast-NONE 
Epi-<1

CTA
1. Unenhanced head CT demonstrates no intracranial hemorrhage, 
mass, edema or evidence of acute large territory infarct. 
2. Vessels of the circle of ___ and their major branches are 
patent without stenosis, occlusion or aneurysm formation. 
3. The carotid arteries are patent from their origin with 
minimal plaque at the right greater than left carotid 
bifurcation that does not cause stenosis. The internal carotid 
arteries are patent bilaterally without stenosis by NASCET 
criteria. 
4. The vertebral arteries are patent from their origin 
bilaterally without 
evidence for stenosis, dissection or occlusion. 
5. 4 mm right upper lobe nodule (03:15). 
6. Multinodular thyroid gland, with the largest nodule on the 
right measuring 12 mm. 
7. Final report pending 3D reformats. 

 
Brief Hospital Course:
___ woman with multiple vascular risk factors, including 
prior stroke, atrial fibrillation on River Oxilan and aspirin, 
hypertension, hyperlipidemia, insulin-dependent diabetes 
mellitus, who initially presented with persistent vertigo.  She 
reported a positional vertigo that did not dissipate initially 
on rest.  ED evaluation was notable for hyperglycemia to 430.  
She reported some recent changes with her diabetes medications, 
followed usually by her primary care.  There were no neighboring 
signs or symptoms, or additional review of system features 
suggestive of a peripheral vestibulopathy, such as neuronitis, 
or Mnire's disease,.  Her exam was not suggestive of central 
vertigo, though given her risk factors, she was admitted for 
stroke workup.  Her CTA was unremarkable.  MRI did not reveal 
any stroke, but did show an evolution of white matter disease in 
the periventricular areas.  Therefore, the most likely etiology 
of her symptoms was felt to be hyperglycemia causing 
vertigo-like symptoms, versus benign paroxysmal positional 
vertigo.  Her vertigo-like symptoms dissipated overnight into 
the next morning after admission.  Her blood sugars were better 
controlled while admitted, though her A1c was 12.7 reflecting 
likely poorly controlled diabetes as an outpatient. She 
indicated a desire to follow-up with her primary care provider, 
but as well as the ___ further 
management.  She was advised to stay hydrated to avoid the 
effect of glucose related diuresis.

Transitional issues
[ ] Close PCP follow up, referral to ___ for diabetes 
management

AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic 
Attack  
1. Dysphagia screening before any PO intake? (x) Yes, confirmed 
done - () Not confirmed () No. If no, reason why:  
2. DVT Prophylaxis administered? (x) Yes - () No. If no, why not 
(I.e. bleeding risk, hemorrhage, etc.)  
3. Antithrombotic therapy administered by end of hospital day 2? 
(x) Yes - () No. If not, why not? (I.e. bleeding risk, 
hemorrhage, etc.)
4. LDL documented? () Yes (LDL = ) - (x) No  (no acute ischemic 
stroke)
5. Intensive statin therapy administered? (simvastatin 80mg, 
simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, 
rosuvastatin 20mg or 40mg, for LDL > 70) (x) Yes - () No [if LDL 
>70, reason not given:  
 [ ] Statin medication allergy  
 [ ] Other reasons documented by physician/advanced practice 
nurse/physician ___ (physician/APN/PA) or pharmacist  
 [ ] LDL-c less than 70 mg/dL  
6. Smoking cessation counseling given? () Yes - () No [reason 
(x) non-smoker - () unable to participate]  
7. Stroke education (personal modifiable risk factors, how to 
activate EMS for stroke, stroke warning signs and symptoms, 
prescribed medications, need for followup) given (verbally or 
written)? (x) Yes - () No  
8. Assessment for rehabilitation or rehab services considered? 
() Yes - (x) No. If no, why not? Able to ambulate without 
assistance (I.e. patient at baseline functional status)
9. Discharged on statin therapy? (x) Yes - () No [if LDL >70, 
reason not given:  
 [ ] Statin medication allergy  
 [ ] Other reasons documented by physician/advanced practice 
nurse/physician ___ (physician/APN/PA) or pharmacist  
 [ ] LDL-c less than 70 mg/dL  
10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) 
Antiplatelet - (x) Anticoagulation] - () No  
11. Discharged on oral anticoagulation for patients with atrial 
fibrillation/flutter? (x) Yes - () No - If no, why not (I.e. 
bleeding risk, etc.) () N/A  
 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY 
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. Carvedilol 25 mg PO DAILY 
5. 70/30 25 Units Breakfast
70/30 35 Units Dinner
6. irbesartan 300 mg oral DAILY 
7. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
8. Rivaroxaban 20 mg PO DAILY 
9. Torsemide 40 mg PO DAILY 
10. Vitamin D 1000 UNIT PO DAILY 
11. Vitamin E 400 UNIT PO DAILY 

 
Discharge Medications:
1.  70/30 25 Units Breakfast
70/30 35 Units Dinner 
2.  amLODIPine 10 mg PO DAILY  
3.  Aspirin 81 mg PO DAILY  
4.  Atorvastatin 40 mg PO QPM  
5.  Carvedilol 25 mg PO DAILY  
6.  irbesartan 300 mg oral DAILY  
7.  Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY  
8.  Rivaroxaban 20 mg PO DAILY  
9.  Torsemide 40 mg PO DAILY  
10.  Vitamin D 1000 UNIT PO DAILY  
11.  Vitamin E 400 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Vertigo in the setting of hyperglycemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

Your admitted to the hospital for vertigo, or a room spinning 
sensation.  Sometimes, vertigo is caused by stroke in part of 
the brain, so you are admitted for close monitoring and further 
workup.  Thankfully, your MRI did not show any strokes.  You 
felt better the next day in terms of vertigo, and you were able 
to walk around the hospital without any issues.  The most likely 
explanation for your symptoms therefore is something called 
benign paroxysmal positional vertigo, which can occur when the 
inner ear has problems with debris that builds up over time.  
The other possibility is your elevated blood sugars, which can 
certainly cause dizziness that may mimic vertigo.  In addition, 
the sugar in your blood can act as a diuretic medicine, removing 
more fluid than you are able to make up for by drinking.  This 
may lead to additional lightheadedness and feelings of dizziness 
which may have contributed to her symptoms.  If this happens 
again, you may be referred either to a neurologist or ___ 
rehab to help you with the symptoms, during which they may 
perform certain maneuvers to clear the debris from your year.  
Please contact your primary care provider if the symptoms recur. 
 However, if the symptoms persist, or are accompanied by changes 
in vision, including double vision, or weakness or sensation 
changes, please report to the nearest emergency department as 
they may reflect stroke.  Otherwise, please continue all of your 
medications as directed and do not miss doses.

It was a pleasure taking care of you.

___ neurology

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
"
120,16362820,25345675," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Dyspnea
 
Major Surgical or Invasive Procedure:
TEE/DC Cardioversion ___

 
History of Present Illness:
Ms ___ is a ___ female with a history of NICM (EF
40% in ___, permanent AF on xarelto, CKD stage IIIb, h/o 
stroke
___ no residual deficits, DMII, HTN, who presents with 4 days 
of
dyspnea, found to have elevated BNP and pulmonary congestion on
CXR, admitted for concern for heart failure exacerbation.

She was last hospitalized for heart failure exacerbation in ___
and was subsequently followed in a clinic visit by Dr. ___. 
She
reports feeling very well for the last ___ years without any
shortness of breath or leg swelling until this week.

She reports shortness of breath for the last 4 days that acutely
worsened at 5 AM this morning. She denies any fever, chest pain,
palpitations, vomiting, abdominal pain, leg pain or swelling,
dysuria or hematuria. She has been taking her medications as
prescribed without issues. She did go out to restaurants a few
times this week and may have been eating saltier foods than
usual. No infectious symptoms or other recent stressors. No
recent travel or immobilization. She reports her weight at home
is usually 192 lb though she has not checked it recently. She
reports also that she had some low blood sugars in the ___ this
week.

EMS was called and found her to be in respiratory distress,
tachypneic with VR 130s. She received 4 nitro sprays with EMS
prior to arrival and was started on bipap en route. In the ED,
she was tachycardic to 140s in AF with normal blood pressure and
received IV diltiazem and torsemide 40 mg with improvement of VR
to 100s and was subsequently taken off bipap with good O2
saturation on room air. She was admitted to the cardiology
service.

In the ED:  
Initial VS: ___  
Exam: arrived on bipap, mild faint wheezes, no acute respiratory
distress 
EKG: AF with VR ___hanges
Labs notable for: proBNP: ___, Trop-T: <0.01, Na 149, K 3.8, Cr
1.3, lactate 1.7   
Studies notable for:  CXR IMPRESSION: Cardiomegaly with central
pulmonary vascular congestion, without focal consolidation or
edema. 
Consults: respiratory therapy
Patient was given: IV Diltiazem 15 mg, Diltiazem 30 mg po,
rivaroxaban 20 mg, torsemide 40 mg 
Vitals on transfer: 97.8 109 120/73 22 94% RA 

On arrival to the cardiology service she endorses history above
and reports no chest pain or dyspnea.

REVIEW OF SYSTEMS:  
Positive per HPI.  
Cardiac review of systems is notable for absence of chest pain,
ankle edema, palpitations, syncope, or presyncope.  
On further review of systems, denies fevers or chills. Denies 
any
deep venous thrombosis, pulmonary embolism, bleeding at the time
of surgery, myalgias, joint pains, cough, hemoptysis, black
stools or red stools. Denies exertional buttock or calf pain. 
All
of the other review of systems were negative. 
 
Past Medical History:
AF on rivaroxaban, HTN, HLD, DM II
CAD no interventions
HFrEF, though EF 35-40% on ___ echo
primary hyperaldosteronism - diagnosed ___
thymic mass s/p thymectomy ___
hyperparathyroidism s/p three gland parathyroidectomy ___

 
Social History:
___
Family History:
Pancreas and liver cancer.
Mother: colon cancer
Father: CHF  

 
Physical ___:
Admission Physical Exam:

VS: 97.5 140 / 96 115 18 99 RA  
GENERAL: Well developed, well nourished in NAD. Oriented x3.
Mood, affect appropriate.  
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI.
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa.
No xanthelasma.  
NECK: JVP to mid neck at 45 degrees. 
CARDIAC: PMI located in ___ intercostal space, midclavicular
line. irregularly irregular, tachycardic. No murmurs, rubs, or
gallops. no thrills or lifts.  
LUNGS: No chest wall deformities or tenderness. Respiration is
unlabored with no accessory muscle use. No crackles, wheezes or
rhonchi.  
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No
splenomegaly.  
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or
peripheral edema.  
SKIN: No significant skin lesions or rashes.  
PULSES: Distal pulses palpable and symmetric.  

Discharge Physical Exam:
___ 0507 Temp: 97.7 PO BP: 122/84 R Sitting HR: 95 RR: 17 
O2
sat: 97% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: ___ 
GENERAL: Well appearing in no apparent distress. Awake and 
alert.
HEENT: Anicteric sclerae, no cervical lymphadenopathy. No
conjunctival injection or pallor. Neck supple. EOMI.
CARDIAC: JVP 12 cm. Irregularly irregular. No m/r/g.
LUNGS: scattered bibasilar crackles. No rales or wheezes.
Breathing without accessory muscles of respiration.
ABDOMEN: Soft, non-tender and non-distended.
EXTREMITIES: Warm, well perfused.
SKIN: No significant skin lesions or rashes.  
PULSES: Distal pulses palpable and symmetric.
 
Pertinent Results:
___ 06:45AM BLOOD WBC-6.3 RBC-4.46 Hgb-12.2 Hct-40.5 MCV-91 
MCH-27.4 MCHC-30.1* RDW-14.7 RDWSD-48.5* Plt ___
___ 07:06AM BLOOD Neuts-69.4 ___ Monos-6.7 Eos-1.9 
Baso-0.4 Im ___ AbsNeut-4.85 AbsLymp-1.48 AbsMono-0.47 
AbsEos-0.13 AbsBaso-0.03
___ 06:45AM BLOOD Plt ___
___ 06:45AM BLOOD Glucose-110* UreaN-21* Creat-1.0 Na-145 
K-4.1 Cl-102 HCO3-29 AnGap-14
___ 06:45AM BLOOD ALT-68* AST-18 AlkPhos-106* TotBili-0.4
___ 10:16AM BLOOD CK-MB-1 cTropnT-<0.01
___ 07:13AM BLOOD CK-MB-2 cTropnT-<0.01
___ 07:06AM BLOOD ___ 06:45AM BLOOD Calcium-9.3 Phos-4.0 Mg-2.6
___ 06:12AM BLOOD calTIBC-278 Ferritn-57 TRF-214
___ 07:40AM BLOOD PEP-PND FreeKap-22.3* ___ Fr 
K/L-1.7*
___ 06:12AM BLOOD TSH-0.43
___ 07:12AM BLOOD ___ pO2-37* pCO2-43 pH-7.44 
calTCO2-30 Base XS-4 Intubat-NOT INTUBA
___ 07:12AM BLOOD Lactate-1.7

PERTINENT STUDIES
===================
TTE ___

CONCLUSION:
The left atrial volume index is moderately increased. The right 
atrium is moderately enlarged. There is no,evidence for an 
atrial septal defect by 2D/color Doppler. The estimated right 
atrial pressure is ___ mmHg.
There is moderate symmetric left ventricular hypertrophy with a 
normal cavity size. There is moderate global left ventricular 
hypokinesis and relative preservation of apical function. There 
is beat-to-beat variability in the left ventricular 
contractility due to the irregular rhythm. Quantitative 3D 
volumetric left ventricular ejection fraction is 36 % (normal 
54-73%). There is no resting left ventricular outflow tract 
gradient. No ventricular septal defect is seen. Tissue Doppler 
suggests an increased left ventricular filling pressure (PCWP 
greater than 18 mmHg). There is Grade III diastolic dysfunction. 
Normal right ventricular cavity size with low normal free wall 
motion. The aortic sinus diameter is normal for gender with 
normal ascending aorta diameter for gender. The aortic arch 
diameter is normal. There is no evidence for an aortic arch 
coarctation. The aortic valve leaflets (3) appear structurally 
normal. There is no aortic valve stenosis. There is no aortic 
regurgitation.
The mitral valve leaflets are mildly thickened with no mitral 
valve prolapse. The transmitral E-wave deceleration time is 
short (less than 140ms) c/w restrictive filling. There is 
moderate [2+] mitral regurgitation. The pulmonic valve leaflets 
are not well seen. The tricuspid valve leaflets appear 
structurally normal. There is moderate [2+] tricuspid 
regurgitation. There is mild pulmonary artery systolic 
hypertension. There is a trivial pericardial effusion.
IMPRESSION: Moderate symmetric left ventricular hypertrophy with 
normal cavity size and moderate global systolic dysfunction c/w 
a nonischemic process in the setting of beat to beat variability 
in systolic function. Increased PCWP. Grade III/IV diastolic 
dysfunction. Restrictive
filling pattern. Normal right ventricular cavity size and 
low-normal systolic function. Moderate mitral regurgitation. 
Moderate tricuspid regurgitation. Mild pulmonary artery systolic 
hypertension.
Compared with the prior TTE ___, the findings are 
similar.

TEE CARDIOVERSION ___
CONCLUSION:
There is no spontaneous echo contrast or thrombus in the body of 
the left atrium/left atrial appendage. The left atrial appendage 
ejection velocity is mildly depressed. No spontaneous echo 
contrast or thrombus is seen
in the body of the right atrium/right atrial appendage. The 
right atrial appendage ejection velocity is normal. There is no 
evidence for an atrial septal defect by 2D/color Doppler. 
Overall left ventricular systolic function is moderately 
depressed. There are no aortic arch atheroma with no atheroma in 
the descending aorta to 30 cm from the incisors. The aortic 
valve leaflets (3) appear structurally normal. No masses or 
vegetations are seen on the aortic valve. No abscess is seen. 
There is no aortic regurgitation. The mitral valve leaflets are 
mildly thickened with no mitral valve prolapse. No masses or 
vegetations are seen on the mitral valve. No abscess is seen. 
There is a central jet of moderate [2+] mitral regurgitation. 
The tricuspid valve leaflets appear structurally normal. No 
mass/vegetation are seen on the tricuspid valve. No abscess is 
seen. There is mild [1+] tricuspid regurgitation. The estimated 
pulmonary artery systolic pressure is borderline elevated.
IMPRESSION: No intracardiac thrombus seen. Moderate left 
ventricular systolic dysfunction. Moderate mitral regurgitation.
 
Brief Hospital Course:
SUMMARY STATEMENT:
====================
___ female with a history of NICM (EF 40% in ___,
AF on xarelto, CKD stage IIIb, h/o stroke ___ no
residual deficits, DMII, HTN, who presents with 4 days of
dyspnea, found to have elevated BNP and pulmonary congestion on
CXR, admitted for heart failure exacerbation with new afib 
likely a contributing factor, improved with diuresis and 
successfully TEE cardioversion into sinus rhythm on ___.

TRANSITIONAL ISSUES:
====================
[] Restart amlodipine on follow up per outpatient provider. 
Blood pressure as inpatient was managed with Carvedilol which 
may not be sufficient as monotherapy
[] Restarted torsemide 40 PO on discharge, assess for fluid 
status on follow-up
[] Repeat echo if continues to be in sinus rhythm. If she 
continues to have low EF, consider guideline directed medical 
therapy.
[] Follow up is being scheduled with her cardiologist within 2 
weeks
[] Consider discontinuation of aspirin depending on whether she 
has a indication for it
[] Insulin regimen reduced to 30u in AM and 20u in ___ of 70-30 
(in addition to liraglutide) due to relative hypoglycemia while 
inpatient, please titrate per outpatient provider
[] Switched from rivaroxaban to apixaban due to chronic kidney 
disease.

ACTIVE ISSUES:
==============
# Acute on Chronic HFrEF:
# NICM: 
Presentation is c/w subacute onset of HF exacerbation thought 
___
afib and dietary changes in the last week, with wt gain, 
elevated
BNP and JVP. She likely also had a flash pulmonary edema which
caused the acute worsening the morning of presentation, which
quickly resolved with bipap. She diuresed well with IV Lasix and 
on discharge resumed torsemide 40 daily. It is thought her 
atrial fibrillation was actually new which triggered her HF 
exacerbation. She had an echo showing newly reduced EF of 36%, 
but it is thought this may be secondary to tachycardiac mediated 
cardiomyopathy.

#?New AF with rapid rates on arrival: 
The patient has a chad2vasc of 7. Despite chart diagnosis of 
pAF, no objective evidence in Atris or Partners charts of atrial 
fibrillation (she had some EKGs with NSR and frequent PACs), so 
we treated this is new atrial fibrillation. Nonetheless came in 
on rivaroxaban which she had taken for several years and was 
switched to apixaban in the setting of CKD. She does have a 
remote history of taking Pradaxa as far back as ___. Seems she 
switched to rivaroxaban ___. It is thought her new Afib 
contributed to her heart failure. She underwent successful TEE 
cardioversion (no ___ clot) with 360 J shock on ___ 
(unsuccessful 200J shock). She was discharged on carvedilol 50 
mg twice daily and rivaroxaban was switched to apixaban due to 
concern for kidney function.

#Transaminitis
Likely ___ hepatic congestion iso CHF exacerbation, downtrended 
with diuresis.

# T2DM on insulin: she reported some low blood sugars to ___ at
home, on liraglutide and 70/30 at home 36U AM 44U ___. Decreased 
to 30 AM 20 in ___ due to low sugars here.

# CKD stage IIIb: Cr 1.3 on admission, baseline is 1.0, may be
cardiorenal, improved on discharge.

# History of CVA
# Non-obstructive CAD in ___, negative pMIBI in ___: 
- continued ASA
- continued BB as above 
- continued statin

CONTACT: Name of health care proxy: ___ 
Relationship: daughter 
Phone number: ___ 
CODE STATUS: Full
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
2. irbesartan 300 mg oral DAILY 
3. amLODIPine 10 mg PO DAILY 
4. Vitamin E 400 UNIT PO DAILY 
5. Vitamin D 1000 UNIT PO DAILY 
6. Aspirin 81 mg PO DAILY 
7. Atorvastatin 40 mg PO QPM 
8. Carvedilol 50 mg PO BID 
9. Rivaroxaban 20 mg PO DAILY 
10. Torsemide 40 mg PO DAILY 
11. liraglutide 0.6 mg/0.1 mL (18 mg/3 mL) subcutaneous DAILY 
12. Tresiba FlexTouch U-200 (insulin degludec) 50 units 
subcutaneous DAILY 
13. 70/30 36 Units Breakfast
70/30 44 Units Dinner

 
Discharge Medications:
1.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever  
2.  Apixaban 5 mg PO BID 
RX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth twice a day 
Disp #*60 Tablet Refills:*0 
3.  70/30 30 Units Breakfast
70/30 20 Units Dinner
Insulin SC Sliding Scale using HUM Insulin 
4.  Aspirin 81 mg PO DAILY  
5.  Atorvastatin 40 mg PO QPM  
6.  Carvedilol 50 mg PO BID  
7.  irbesartan 300 mg oral DAILY  
8.  Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY  
9.  liraglutide 0.6 mg/0.1 mL (18 mg/3 mL) subcutaneous DAILY  
10.  Torsemide 40 mg PO DAILY  
11.  Vitamin D 1000 UNIT PO DAILY  
12.  Vitamin E 400 UNIT PO DAILY  
13. HELD- amLODIPine 10 mg PO DAILY  This medication was held. 
Do not restart amLODIPine until Follow up

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSES:
[] Atrial Fibrillation
[] Heart failure exacerbation

SECONDARY DIAGNOSIS
[] Transaminitis
[] T2DM
[] CKD stage IIIb

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___ 
___.

WHY WAS I ADMITTED TO THE HOSPITAL?
- You were admitted to the hospital because of shortness of 
breath and an irregular heartbeat.

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
- In the hospital, we performed some lab tests to determine the 
reason for your shortness of breath. We also performed 
measurements of the electrical activity of your heart, which 
showed that it was beating in an irregular rhythm. We gave you a 
pill that would reduce the amount of water your body held onto 
as well as medications to decrease the resistance against which 
your heart pumped. These medications also decrease your 
heartrate. We also performed some imaging to look at your heart. 
Because your heartbeat was so fast and irregular, it wasn't 
pumping blood efficiently. The medications helped with this, but 
you required an electrical shock to convert your heart back into 
regular rhythm. We are glad you are feeling better after these 
procedures.

WHAT SHOULD I DO WHEN I GO HOME?
- Please take all of your medications exactly as prescribed and 
attend all of your follow-up appointments listed below.
- It is particularly important that you do NOT miss ___ dose of 
your apixaban.

We wish you the best!
Your ___ Care Team 
 
Followup Instructions:
___
"
121,16384274,26243695," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfonamides
 
Attending: ___.
 
Chief Complaint:
Diarrhea.
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
This is a ___ yo man with h/o CVA and MR who ___ nausea, vomiting 
and diarrhea for 18 hours. He denies ill contacts, but works at 
___ and volunteers at a nursing home so could have come 
into contact with something at either. Also lives in group home 
but denies other residents ill. He notes last episode of 
diarrhea in ED prior to transfer, feels well currently. Denies 
melena or brbpr. He denies feeling dizzy or lightheaded. He has 
no appetite but feels he could keep pills down if needed. He 
denies fevers, chills, ha, visual changes, sob, chest pain, 
palpitations, dysuria, rash, tingling, numbness, weakness, 
myalgias.

In the ED: VS: T 97.4 HR 80 BP 115/50 RR 16 Sat 100% on RA. 
While in the ED had BP reading of 87/74 (prior was 107/47) which 
was 101/56 14 minutes later without significant intervention 
(asymptomatic, got total of 3L NS, HR 92->81). He was given 4mg 
iv and hydrocortizone 100mg iv.

ROS: 10 point review of systems negative except as noted above.
 
Past Medical History:
1) 21-hydroxylase deficiency.   
2) CVA at 6mos of age w/ resultant mental retardation.  
3) h/o diverticulitis since age ___.
4) h/o Guillain ___ syndrome in ___.  
 
Social History:
___
Family History:
Father has AAA.
 
Physical Exam:
VS: T 97.8 HR 84 BP 100/64 RR 18 Sat 96% RA
Gen: Well appearing man in NAD
Eye: extra-occular movements intact, pupils equal round, 
reactive to light, sclera anicteric, not injected, no exudates
ENT: mucus membranes moist, no ulcerations or exudates
Neck: no thyromegally, JVD: flat
Cardiovascular: regular rate and rhythm, normal s1, s2, no 
murmurs, rubs or gallops
Respiratory: Clear to auscultation bilaterally, no wheezes, 
rales or rhonchi
Abd: Soft, non tender, non distended, no heptosplenomegally, 
bowel sounds present
Extremities: No cyanosis, clubbing, edema, joint swelling
Neurological: Alert and oriented x3, CN II-XII intact, normal 
attention, sensation normal, speech fluent
Integument: Warm, moist, no rash or ulceration  
Psychiatric: appropriate, pleasant, not anxious
Hematologic: no cervical or supraclavicular LAD
 
Pertinent Results:
Admit labs:
CBC: WBC-6.7 HGB-15.0 HCT-44.2 PLT COUNT-348; diff: NEUTS-70.2* 
___ MONOS-6.1 EOS-2.3 BASOS-0.2
BMP: GLUCOSE-92 UREA N-16 CREAT-1.1 SODIUM-134 POTASSIUM-5.8 
(hemolyzed) repeat->3.9 CHLORIDE-101 TOTAL CO2-___ yo man with diarrhea, transient hypotension.
.
1. Diarrhea: Likely acute viral gastroenteritis based on 
symptoms and duration, however he does have risk of exposure 
given his volunteer work.  He was asymptomatic here and 
tolerated diet well.  He was discharged with supportive care.
.
2. Hypotension: Suspect spurious result given markedly narrow 
pulse pressure.  He had no further abnormal blood pressure 
readings while in house.
.
3. 21-hydroxylase deficiency: Stress dose steroids given 
initially in addition to Florinef.  He was transitioned back to 
his home regimen at discharge
.
Full code.

 
Medications on Admission:
Per ___, pt unable to verify, no answer at group home, 
logicianweb down:
florinef 0.1mg daily
dexamethasone 0.5mg daily
ativan 1mg prn procedure (gets 2 tabs at a time)
 
Discharge Medications:
1. Fludrocortisone 0.1 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. Dexamethasone 0.5 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Compazine 5 mg Tablet Sig: ___ Tablets PO every six (6) hours 
as needed for nausea.
Disp:*12 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Gastroenteritis
21 hydroxylase deficiency

 
Discharge Condition:
Mental Status:Clear and coherent
Level of Consciousness:Alert and interactive
Activity Status:Ambulatory - Independent

 
Discharge Instructions:
You were admitted with a gastroenteritis.  With supportive care 
and fluids your symptoms improved.  Please continue your home 
medications as you were taking them before.  Please follow up 
with your PCP as soon as possible
 
Followup Instructions:
___
"
122,16384274,21020209," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
Nausea, vomiting
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Patient is a ___ yo man with PMHx sig. for 21-hydroxylase 
deficiency and h/o CVA with resultant mental retardation in a 
group home who presents with 4 hours of nausea, vomiting, and 
diarrhea.  He denies any abdominal pain.  Currently he states 
his nausea and vomiting has resolved and he has an appetite.  In 
addition his diarrhea has slowed and is only mild.  he has no 
melena or BRBPR.  He denies any CP, shortness of breath, sick 
contacts, fevers/chills. Rest of ROS is negative.

In the ED, initial VS were: 99 64 141/89 16 98%. Exam was 
notable for LLQ tenderness. Labs were notable for lipase 83. CT 
abdomen showed ""1. Moderate colonic diverticulosis without acute 
diverticulitis. 2. Liquid stool throughout the colon and rectum, 
compatible with diarrhea. 3. No SBO. No free air or fluid.
4. Small-to-moderate hiatal hernia. 5. Otherwise, no acute 
intra-abdominal process.""  The patient received zofran, 
hydrocort 100 mg, and 2L NS. Vitals prior to transfer to the 
floor were:  115/66, 95, 18, 99RA.  
 
Past Medical History:
1) 21-hydroxylase deficiency.   
2) CVA at ___ of age w/ resultant mental retardation.  
3) h/o diverticulitis since age ___.
4) h/o Guillain ___ syndrome in ___.  
 
Social History:
___
Family History:
(from previous discharge summary ___ Father has AAA.
 
Physical Exam:
VS: afebrile, VSS
GEN: NAD, AOX3
HEENT: MMM, op clear, JVP 8cm
CARD: RRR, no m/r/g
PULM: CTAB 
ABD: soft, NT, ND, no masses or organomegaly
EXT: wwp, no c/c/e
NEURO: grossly normal, AOx3, interactive, ambulatory with normal 
gait
 
Pertinent Results:
___ 12:45AM BLOOD WBC-11.0# RBC-4.81 Hgb-15.3 Hct-43.2 
MCV-90 MCH-31.9 MCHC-35.5* RDW-12.8 Plt ___
___ 12:45AM BLOOD Neuts-80.2* Lymphs-15.1* Monos-3.4 
Eos-1.1 Baso-0.3
___ 12:45AM BLOOD ___ PTT-24.6 ___
___ 12:45AM BLOOD Glucose-123* UreaN-26* Creat-0.9 Na-141 
K-3.4 Cl-104 HCO3-25 AnGap-15
___ 06:32AM BLOOD Glucose-97 UreaN-18 Creat-0.8 Na-138 
K-3.7 Cl-107 HCO3-22 AnGap-13
___ 12:45AM BLOOD Lipase-83*
___ 12:48AM BLOOD Glucose-118* Lactate-2.2* Na-142 K-3.4* 
Cl-105 calHCO3-24

___: 
IMPRESSION: 
1. Fluid in the colon and rectum with mucosal hyperenhancement 
are compatible 
with history of diarrhea and may correlate with mild 
colitis/proctitis. 
2. Diverticulosis without diverticulitis. 
3. Moderate-sized hiatal hernia, increased in size from 
___. 
4. Mildly enlarged prostate with bladder wall thickening may 
represent 
urinary outflow obstruction 

 
Brief Hospital Course:
Mr. ___ was admitted to the ___ Medical service and did 
very well.  He had only 1 loose stool after arriving to the 
floor (after having had several in the ED).  He was supported 
with IVF and stress dose steroids as well as potassium 
repletion.  CT scan showed colitis as well as incidentally noted 
prostatic enlargement.  
.
Stool cultures were without growth.
.
On the of discharge, he was ambulating without difficulty, 
reported he felt fine, had no further loose stool x > 24 hours 
and wished to return home.
.
His case was discussed with the on-call Endocrinologist who 
agreed that 36 hours of IV steroids was likely sufficient for a 
stress dose and that he could be discharged on 1 mg po 
dexamethasone x 1 week and then resume his regular dose of 0.5 
mg po dexamethasone daily.  He should continue his Florinef.
.
He reports he drinks 1 can tomato juice daily and this was 
encouraged for potassium repletion and he was also prescribed 40 
mEq po potassium for ___.
.
Dr. ___ reviewed the case with the patient and 
his mother who reported that she would see to it that the 
medication changes were put into effect, that he would follow up 
with Dr. ___ that he would discuss his maintenance 
dexamethasone dose with Dr. ___ it seems fairly 
high) as well as the incidentally noted prostatic enlargement.
.
At the time of discharge, Mr. ___ was fully ambulatory and 
symptom free.
.

 
Medications on Admission:
dexamethasone 0.5mg po daily
fludrocortisone 0.1mg po daily
 
Discharge Medications:
1. potassium chloride 10 mEq Tablet Extended Release Sig: Four 
(4) Tablet Extended Release PO DAILY (Daily) for 1 doses.
Disp:*4 Tablet Extended Release(s)* Refills:*0*
2. dexamethasone 0.5 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily) for 7 days: Take this ___ through ___.
Disp:*14 Tablet(s)* Refills:*0*
3. fludrocortisone 0.1 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).
Disp:*30 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
1) Viral gastroenteritis 
2) Adrenal insufficiency 
3) h/o CVA at a young age with resultant developemental delay 
4) incidentally noted : ""Mildly enlarged prostate with bladder 
wall thickening may represent urinary outflow obstruction."" 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with diarrhea that resolved 
very quickly.  You seem to have recovered very nicely.  You have 
received 36 hours of stress dose steroids.  You will be 
discharged on a taper of dexamethasone as recommended by 
Endocrinology.
.
WE have changed your Dexamethasone dosing for the next 2 weeks:
--Take Dexamethasone 1 mg by mouth daily for 1 week ___ through 
___
--Then, go back to your normal schedule - Dexamethasone 0.5 mg
every day
.
***Please continue to take Florinef every day***
 
Followup Instructions:
___
"
123,16384274,24302794," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
Planned colonoscopy 
 
Major Surgical or Invasive Procedure:
Colonoscopy
Polypectomy

 
Past Medical History:
1) 21-hydroxylase deficiency.   
2) CVA at ___ of age w/ resultant mental retardation.  
3) h/o diverticulitis since age ___.
4) h/o Guillain ___ syndrome in ___.  
 
Social History:
___
Family History:
(from previous discharge summary ___ Father has AAA.
 
Physical Exam:
Admission Exam: 
VITALS: ___ 1226 Temp: 98.1 PO BP: 127/84 HR: 100 RR: 18 O2 
sat: 97% O2 delivery: RA 
GENERAL: Alert and in no apparent distress, sitting on bed, 
appears comfortable, conversant
EYES: Anicteric
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate. Moist 
mucus membranes.
CV: Heart regular, no murmur, no S3, no S4.  No JVD.
RESP: Lungs clear to auscultation with good air movement 
bilaterally.  Breathing is non-labored on room air.
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel 
sounds present.
GU: No suprapubic fullness or tenderness to palpation, no Foley
MSK: Moves all extremities, no edema
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented to person and place, not to 
___, then looked up the date), face symmetric, speech 
fluent
PSYCH: pleasant, appropriate affect

Discharge Exam: 
GENERAL: Alert and in no apparent distress, appears comfortable, 
conversant
EYES: Anicteric
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate. Moist 
mucus membranes.
CV: Heart regular, no murmur, no S3, no S4.  No JVD.
RESP: Lungs clear to auscultation with good air movement 
bilaterally. Breathing is non-labored on room air.
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel 
sounds present.
GU: No suprapubic fullness or tenderness to palpation, no Foley
MSK: Moves all extremities, no edema
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented to person and place, face symmetric, 
speech fluent
PSYCH: pleasant, appropriate affect
 
Pertinent Results:
___ 03:08PM   GLUCOSE-103* UREA N-17 CREAT-1.1 SODIUM-138 
POTASSIUM-4.0 CHLORIDE-101 TOTAL CO2-25 ANION GAP-12
___ 03:08PM   estGFR-Using this
___ 03:08PM   WBC-8.2 RBC-5.16 HGB-15.9 HCT-46.4 MCV-90 
MCH-30.8 MCHC-34.3 RDW-12.0 RDWSD-39.7
___ 03:08PM   PLT COUNT-358
 
Brief Hospital Course:
Mr. ___ is a ___ male with intellectual disability, 
diverticulosis, history of adrenal hyperplasia, history of 
___ syndrome, who presented
from his group home for inpatient preparation for screening 
colonoscopy.  He has no complaints currently and has not had 
changes in his bowel habits prior to admission.

# Need for screening colonoscopy: Last colonoscopy was in ___ 
and unremarkable except for diverticulosis of descending colon. 
Denies concerning symptoms such as changes in bowel habits or 
weight loss. He does not recall any family history.
- Clear liquids, NPO @ midnight before colonoscopy then back to 
regular diet after. He completed Moviprep and underwent 
uneventful colonoscopy on ___ notable for moderate 
diverticulosis and sigmoid polyp without signs of bleeding 
status post polypectomy. The polyp appeared benign in appearance 
but final biopsy results will be sent to referring provider for 
___. 

CHRONIC/STABLE PROBLEMS:
# Congenital adrenal hyperplasia: Salt-wasting type.  Managed by 
his PCP.
- Continued home Fludrocortisone 0.1mg daily in AM and 
Dexamethasone 0.5mg daily in AM

# History of TURP: Asymptomatic.
- Continued home Finasteride 5mg QHS and Tamsulosin 0.4mg QHS

# Intellectual disability: He works at ___ and lives in 
assisted living group home.  Brother is HCP and mother is 
secondary HCP.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Dexamethasone 0.5 mg PO DAILY 
2. Fludrocortisone Acetate 0.1 mg PO DAILY 
3. Vitamin D ___ UNIT PO DAILY 
4. Finasteride 5 mg PO QHS 
5. Tamsulosin 0.4 mg PO QHS 

 
Discharge Medications:
1.  Dexamethasone 0.5 mg PO DAILY  
2.  Finasteride 5 mg PO QHS  
3.  Fludrocortisone Acetate 0.1 mg PO DAILY  
4.  Tamsulosin 0.4 mg PO QHS  
5.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Polyp in the sigmoid colon
Moderate Diverticulosis of the descending colon and sigmoid 
colon 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,
 
 It was a pleasure taking part in your care here at ___! 

 Why was I admitted to the hospital? 
 - You were admitted to the hospital for a planned routine 
colonoscopy. 

 What was done for me while I was in the hospital? 
 - You received bowel prep for your colonoscopy which was done 
today. They found a polyp in your colon which appeared benign, 
but the biopsy results will take a couple of weeks to result. 
Please follow up with your PCP to discuss results of the biopsy. 
We also noted diverticulosis in your colon but no signs of 
bleeding or infection requiring any specific treatment. 

 What should I do when I leave the hospital? 
 - Make sure you don't operate any heavy machinery for the next 
___ hours and stay away from heavy lifting or strenuous exercise 
for at least the next day. 
 - Please avoid NSAIDs like Alleve or Naprosyn or other 
medicines that increase your risk of bleeding for the next week. 

 - Please follow up with your Primary Care Doctor to discuss the 
final results of your biopsy. 
 - Please call your doctor or present to the Emergency 
Department if you develop any signs of bleeding from below or if 
you develop dark tarry stool.  

Sincerely, 
Your ___ Care Team 
It was a pleasure to participate in your care.
 
Followup Instructions:
___
"
124,16384274,26299143," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: ORTHOPAEDICS
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
Right knee pain
 
Major Surgical or Invasive Procedure:
Right quadriceps tendon repair

 
History of Present Illness:
___ male history of developmental delay, ___
syndrome who presents with R knee pain s/p mechanical fall.
Patient was on his way to work at ___ when he tripped
and fell down a few stairs. Positive head strike, negative loss
of consciousness.  Unable to ambulate afterwards due to the 
pain.
Denies numbness or tingling.  Denies diplopia or dizziness or
pain in other extremities.
 
Past Medical History:
1) 21-hydroxylase deficiency.   
2) CVA at 6mos of age w/ resultant mental retardation.  
3) h/o diverticulitis since age ___.
4) h/o Guillain ___ syndrome in ___.  
 
Social History:
___
Family History:
(from previous discharge summary ___ Father has AAA.
 
Physical Exam:
General: Well-appearing, NAD
Resp: Normal WOB, symmetric chest rise
CV: Extremities WWP
MSK:
In knee immobilizer
SILT ___ distributions
Fires ___
Toes WWP
 
Brief Hospital Course:
The patient presented to the emergency department and was 
evaluated by the orthopedic surgery team. The patient was found 
to have a right quadriceps tendon rupture and was admitted to 
the orthopedic surgery service. The patient was taken to the 
operating room on ___ for a right quadriceps tendon repair, 
which the patient tolerated well. For full details of the 
procedure please see the separately dictated operative report. 
The patient was taken from the OR to the PACU in stable 
condition and after satisfactory recovery from anesthesia was 
transferred to the floor. The patient was initially given IV 
fluids and IV pain medications, and progressed to a regular diet 
and oral medications by POD#1. The patient was given 
___ antibiotics and anticoagulation per routine. The 
patient's home medications were continued throughout this 
hospitalization. The patient worked with ___ who determined that 
discharge to home was appropriate.  On postoperative day 1, the 
patient reported a decreased appetite, had soft systolic blood 
pressures and required a 1 L fluid bolus.  Additionally, the 
patient's potassium and magnesium were repleted during his 
admission.  The patient became acutely ill on ___ and was 
taken to the operating room for irrigation and debridement of 
the right knee.  Afterwards, the patient was transferred to the 
surgical ICU, where broad-spectrum antibiotics were continued. 
On ___ the patient was deemed to be stable enough for 
transfer back to the floor.  At the time of discharge, 
infectious disease recommended 4 weeks of IV antibiotics.  Mr. 
___ had a PICC line placed prior to discharge to rehab.

The ___ hospital course was otherwise unremarkable.

At the time of discharge the patient's pain was well controlled 
with oral medications, incisions were clean/dry/intact, and the 
patient was voiding/moving bowels spontaneously. The patient is 
weightbearing as tolerated with ___ brace locked in 
extension in the right lower extremity, and will be discharged 
on aspirin 325 mg daily for 4 weeks for DVT prophylaxis. The 
patient will follow up with Dr. ___ routine. A 
thorough discussion was had with the patient regarding the 
diagnosis and expected post-discharge course including reasons 
to call the office or return to the hospital, and all questions 
were answered. The patient was also given written instructions 
concerning precautionary instructions and the appropriate 
follow-up care. The patient expressed readiness for discharge.

Please see below for ID OPAT note with final recommendations:

Note Date: ___  Time: 1659
Note Type: Final/Sign Off
Note Title: OPAT Intake Note - Order Recommendations and 
Transition of Care Summary
Electronically signed by ___, MD on ___ at 5:07 pm  
Affiliation: ___
NEEDS COSIGN
 
=====================================================
ID OPAT Program Intake Note - Order Recommendations 
and Transition of Care Summary
=====================================================

OPAT Diagnosis: post-op septic R knee joint 

OPAT Antimicrobial Regimen and Projected Duration:
Agent & Dose: Vancomycin 1000 mg IV Q 12H (trough goal ___ 
and
CefTRIAXone 2 gm IV Q 24H 
Start Date: ___
Projected End Date: ___ yo man w/ developmental delay, adrenal hyperplasia (on
dexamethasone, fludrocortisone) who presented w/ R knee pain on
___ after slipping on ice and found to have R quad tendon
rupture s/p quad tendon repair (___) with course c/b sepsis c/f
post op infection s/p R knee washout and debridement (___) w/ 
no
growth from OR cultures. 

No growth final from the aerobic tissue cultures, however given
significant amount of polys and purulence noted during washout,
would recommend continuing vancomycin/ceftriaxone for a total 4
week course to cover the most likely organisms responsible,
especially since he's responded to this regimen inpatient. Pt
will be discharged to rehab per primary team. 

Essential Dates for OPAT therapy:
___-  Right quadriceps avulsion repair through patellar
tunnels
___- Debridement surgical wound and right knee joint space

Plan for Transition to Oral Therapy: No

LAB MONITORING RECOMMENDATIONS: NOTE: For lab work to be drawn
after discharge, a specific standing order for Outpatient Lab
Work is required to be placed in the Discharge Worksheet -
Post-Discharge Orders. Please place an order for Outpatient Labs
based on the MEDICATION SPECIFIC GUIDELINE listed below:

ALL LAB RESULTS SHOULD BE SENT TO:
ATTN: ___ CLINIC - FAX: ___

VANCOMYCIN: WEEKLY: CBC with differential, BUN, Cr, Vancomycin
trough
CEFTRIAXONE: WEEKLY: CBC with differential, BUN, Cr, AST, ALT,
Total Bili, ALK PHOS

ADDITIONAL ORDERS:
*PLEASE OBTAIN WEEKLY CRP for patients with bone/joint 
infections
and endocarditis or endovascular infections

FOLLOW UP APPOINTMENTS:
The ___ will schedule follow up and contact the patient or
discharge facility. All questions regarding outpatient 
parenteral
antibiotics after discharge should be directed to the ___ R.N.s at ___ or to the on-call ID fellow when
the clinic is closed. 

All questions regarding outpatient parenteral antibiotics after
discharge should be directed to the ___ R.N.s at
___ or to the on-call ID fellow when the clinic is
closed. 

PLEASE NOTIFY THE ID SERVICE OF ANY QUESTIONS REGARDING THESE
RECOMMENDATIONS OR WITH ANY MEDICATION CHANGES THAT OCCUR AFTER
THE DATE/TIME OF THIS OPAT INTAKE NOTE.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Dexamethasone 0.5 mg PO DAILY 
2. Fludrocortisone Acetate 0.1 mg PO DAILY 
3. Tamsulosin 0.4 mg PO QHS 
4. Finasteride 5 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 650 mg PO 5  TIMES DAILY WHILE AWAKE  
2.  Docusate Sodium 100 mg PO BID  
3.  OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain 
RX *oxycodone 5 mg ___ capsule(s) by mouth every 4 hours Disp 
#*15 Capsule Refills:*0 
4.  Senna 8.6 mg PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Right quadriceps tendon rupture

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:

- You were in the hospital for orthopedic surgery. It is normal 
to feel tired or ""washed out"" after surgery, and this feeling 
should improve over the first few days to week. 
- Resume your regular activities as tolerated, but please follow 
your weight bearing precautions strictly at all times.

ACTIVITY AND WEIGHT BEARING:
-Weightbearing as tolerated right lower extremity, in ___ 
locked in extension

MEDICATIONS:
  1)  Take Tylenol ___ every 6 hours around the clock. This is 
an over the counter medication.
  2)  Add oxycodone as needed for increased pain. Aim to wean 
off this medication in 1 week or sooner.  This is an example on 
how to wean down:
Take 1 tablet every 3 hours as needed x 1 day,
then 1 tablet every 4 hours as needed x 1 day,
then 1 tablet every 6 hours as needed x 1 day,
then 1 tablet every 8 hours as needed x 2 days, 
then 1 tablet every 12 hours as needed x 1 day,
then 1 tablet every before bedtime as needed x 1 day.  
Then continue with Tylenol for pain.
  3)  Do not stop the Tylenol until you are off of the narcotic 
medication.
  4)  Per state regulations, we are limited in the amount of 
narcotics we can prescribe. If you require more, you must 
contact the office to set up an appointment because we cannot 
refill this type of pain medication over the phone. 
  5)  Narcotic pain relievers can cause constipation, so you 
should drink eight 8oz glasses of water daily and continue 
following the bowel regimen as stated on your medication 
prescription list. These meds (senna, colace, miralax) are over 
the counter and may be obtained at any pharmacy.
  6)  Do not drink alcohol, drive a motor vehicle, or operate 
machinery while taking narcotic pain relievers.
  7)  Please take all medications as prescribed by your 
physicians at discharge.
  8)  Continue all home medications unless specifically 
instructed to stop by your surgeon.
      
ANTICOAGULATION:
- Please take aspirin 325 mg daily for 4 weeks

WOUND CARE:
- You may shower. No baths or swimming for at least 4 weeks.
- Any stitches or staples that need to be removed will be taken 
out at your 2-week follow up appointment.
- Incision may be left open to air unless actively draining. If 
draining, you may apply a gauze dressing secured with paper 
tape.
- Splint must be left on until follow up appointment unless 
otherwise instructed.
- Do NOT get splint wet.

DANGER SIGNS:
Please call your PCP or surgeon's office and/or return to the 
emergency department if you experience any of the following:
- Increasing pain that is not controlled with pain medications
- Increasing redness, swelling, drainage, or other concerning 
changes in your incision
- Persistent or increasing numbness, tingling, or loss of 
sensation
- Fever ___ 101.4
- Shaking chills
- Chest pain
- Shortness of breath
- Nausea or vomiting with an inability to keep food, liquid, 
medications down
- Any other medical concerns

THIS PATIENT IS EXPECTED TO REQUIRE ___ DAYS OF REHAB

Physical Therapy:
Activity:   Activity:  Out of bed w/ assist
 Right lower extremity:  Full weight bearing
 Left lower extremity:  Full weight bearing
Knee immobilizer or ___: At all times, locked in extension
Encourage turning, deep breathing and coughing qhour when awake.

Treatments Frequency:
Any staples or superficial sutures you have are to remain in 
place for at least 2 weeks postoperatively.  Incision may be 
left open to air unless actively draining.  If draining, you may 
apply a gauze dressing secured with paper tape.  You may shower 
and allow water to run over the wound, but please refrain from 
bathing for at least 4 weeks postoperatively.
 
Followup Instructions:
___
"
125,16384274,28346329," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
fever, abd pain, influenza like illness 
 
Major Surgical or Invasive Procedure:
None this admission
Relevant: R knee washout and debridement (___) 
 
History of Present Illness:
___ yo man w/ developmental delay, adrenal hyperplasia (on  
 dexamethasone, fludrocortisone), recent traumatic R quad tendon
rupture s/p quad tendon repair on ___ ___/b sepsis 
s/p
debridement of R knee on ___ w/ no growth from OR cultures, on
4-week course of IV vancomycin/ceftriaxone ending ___, 
currently
on PO vancomycin for presumed C. diff. He presented to the ED
today with fevers, abdominal pain, and influenza-like illness.  

 Pt reports that he woke up yesterday with nausea, fever/chills,
cough profuse watery diarrhea, and diffuse abdominal pain. Noted
to be dry heaving in the ED with multiple episodes of emesis,
nonbloody and nondiscolored. Denies chest pain or dyspnea. Most
bothersome symptom in the ED was suprapubic abdominal pain. 
 
Regarding his C. diff history, C. diff PCR was positive but 
toxin
negative on ___. However, per OPAT notes he was started on 
PO
vancomycin 125mg QID for presumptive treatment of C. diff given
copious diarrhea with abdominal cramping. Plan was to continue 
PO
vanc through ___ (5 days after completing IV antibiotics).  

 - In the ED, initial vitals were: T 101, HR 110, BP 106/54, RR
18, O2 sat 97% on RA  

 - Exam was notable for: abd soft and non-distended but 
diffusely
tender to palpation, no CVA tenderness, well healing surgical
incision on R knee without erythema, induration, fluctuance, or
purulence, no rashes.  

 - Labs were notable for: WBC 6.4 with 68% PMNs, Hgb 10.2, AST
56, ALT 62, lipase 107, K 2.9 -> 3.2 after 160mEq potassium
chloride repletion, bicarb 19, lactate 1.5. Clean UA, flu swab
negative.  

 - Studies were notable for:  
 -- CXR showing appropriate positioning of L PICC in lower SVC  
 -- CT abd/pelvis with new mild bilateral perinephric stranding
(nonspecific), 2mm nonobstructing R renal stone  
 -- R knee XR with possible small knee effusion  
 - The patient was given: Zofran 4mg x2, 2.6L NS, potassium
chloride 40mEq PO x2, potassium chloride 40mEq IV x2, zosyn 4.5g
x2, dexamethasone 0.5mg, fludrocortisone 0.1mg, PO vancomycin
125mg, IV vancomycin 1250mg  

 - Ortho was consulted: no concern for wound infection at this
time, recommend outpatient Ortho follow up.  

 He is being admitted to Medicine for further workup of his 
fever
and diarrhea.  

 On arrival to the floor the patient says he is tired and cold
(his room is cold as well). He wants to sleep. He says he 
started
feeling unwell yesterday. He says it has been sometime since has
last threw up or had nausea. He denies current fevers, chills,
headaches. He denies sick contacts. He denies current abdominal
pain, nausea, vomiting, pain with urination, or changes in
urinary frequency. He notes lots of non-black, non-bloody
diarrhea.  
 
Past Medical History:
1) 21-hydroxylase deficiency.   
2) CVA at ___ of age w/ resultant mental retardation.  
3) h/o diverticulitis since age ___.
4) h/o Guillain ___ syndrome in ___.  
 
Social History:
___
Family History:
(from previous discharge summary ___ Father has AAA.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
========================  
VITALS: 24 HR Data (last updated ___ @ 2346)
Temp: 98.6 (Tm 98.6), BP: 100/65, HR: 74, O2 sat: 97%, O2 
delivery: Ra  
GENERAL: Alert and interactive. In no acute distress.  
HEENT: PERRL, EOMI. Sclera anicteric and without injection. MMM
NECK: No cervical lymphadenopathy. No JVD.  
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No 
murmurs/rubs/gallops.  
LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or
rales. No increased work of breathing.  
BACK: No CVA tenderness.  
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep
palpation in all four quadrants. No organomegaly.  
EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial
2+ bilaterally. RT knee w/ healing surgical scars. Mild erythema
and warmth on RT knee.  
SKIN: Warm. Cap refill <2s. No rashes.  
NEUROLOGIC: AOx3. CN2-12 intact. Moving all 4 limbs
spontaneously. ___ strength throughout. Normal sensation.

DISCHARGE PHYSICAL EXAM
========================
24 HR Data (last updated ___ @ 553)
    Temp: 98.4 (Tm 98.8), BP: 120/82 (102-120/66-82), HR: 77
(77-99), RR: 20 (___), O2 sat: 97%, O2 delivery: Ra, Wt: 114.4
lb/51.89 kg   
GEN: Well appearing, in no acute distress
HEENT: Conjunctiva clear, PERRL, MMM
NECK: No JVD.
LUNGS: CTAB
HEART: RRR, nl S1, S2. No m/r/g.
ABD: NT/ND, normal bowel sounds. 
EXTREMITIES: No edema. Right knee with erythema around previous
incision site, dry eschar, mildly warm to touch, nontender. 
SKIN: No rashes.
NEURO: AOx3. 
 
Pertinent Results:
ADMISSION LABS
===============
___ 02:50AM BLOOD WBC-6.5 RBC-3.63* Hgb-10.8* Hct-32.4* 
MCV-89 MCH-29.8 MCHC-33.3 RDW-13.7 RDWSD-45.1 Plt ___
___ 02:50AM BLOOD Neuts-73.0* Lymphs-11.3* Monos-7.4 
Eos-7.2* Baso-0.6 Im ___ AbsNeut-4.77 AbsLymp-0.74* 
AbsMono-0.48 AbsEos-0.47 AbsBaso-0.04
___ 04:00AM BLOOD Glucose-95 UreaN-9 Creat-1.1 Na-138 
K-2.9* Cl-106 HCO3-19* AnGap-13
___ 04:00AM BLOOD ALT-62* AST-56* AlkPhos-59 TotBili-0.2
___ 04:00AM BLOOD Lipase-107*
___ 04:00AM BLOOD Albumin-3.1*
___ 04:45PM BLOOD Glucose-113* Lactate-1.2 Creat-1.1 Na-143 
K-3.2* Cl-111* calHCO3-21

DISCHARGE LABS
==============
___ 06:35AM BLOOD WBC-11.2* RBC-3.25* Hgb-9.5* Hct-29.8* 
MCV-92 MCH-29.2 MCHC-31.9* RDW-14.0 RDWSD-46.7* Plt ___
___ 06:35AM BLOOD Glucose-95 UreaN-9 Creat-1.2 Na-149* 
K-3.6 Cl-109* HCO3-23 AnGap-17
___ 06:35AM BLOOD Calcium-8.9 Phos-4.4 Mg-2.1

INTERVAL LABS/MICROBIOLOGY/REPORTS
================================
___ 06:08AM BLOOD Calcium-8.5 Phos-3.0 Mg-1.6 Iron-25*
___ 06:08AM BLOOD calTIBC-242* Ferritn-332 TRF-186*
___ 06:08AM BLOOD CRP-95.8*
___ 04:00AM OTHER BODY FLUID FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
___ 06:08AM STOOL NoroGI-NEGATIVE NoroGII-NEGATIVE

___ 6:08 am STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   C. difficile PCR (Final ___: 
      NEGATIVE. 
           (Reference Range-Negative). 
      The C. difficile PCR is highly sensitive for toxigenic 
strains of C.
      difficile and detects both C. difficile infection (CDI) 
and
      asymptomatic carriage. 
      A negative C. diff PCR test indicates a low likelihood of 
CDI or
      carriage. 

___ 6:08 am STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   FECAL CULTURE (Final ___: 
      NO ENTERIC GRAM NEGATIVE RODS FOUND. 
      NO SALMONELLA OR SHIGELLA FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Final ___: 
      TEST CANCELLED, PATIENT CREDITED. 
      QUANTITY NOT SUFFICIENT. 
      Reported to and read back by ___ RN 10:43 
___. 

CT ABD & PELVIS WITH CONTRASTStudy Date of ___
1. New mild bilateral perinephric stranding is nonspecific.  
Correlate with urinalysis for infection.
2. 3 mm nonobstructing right renal stone.
3. Stable moderate hiatal hernia.

KNEE (AP, LAT & OBLIQUE) RIGHTStudy Date of ___ 
1. Small knee effusion and mild soft tissue edema about the knee 
which may relate to postsurgical changes and/or infection.
2. Densities in the suprapatellar region could represent sequela 
of quadriceps tendon repair.  Suggestion of patella baja.

 
Brief Hospital Course:
___ yo man w/ developmental delay, adrenal hyperplasia (on 
dexamethasone, fludrocortisone), traumatic R quad tendon rupture 
s/p quad tendon repair on ___ ___/b sepsis s/p 
debridement of R knee on ___ w/ no growth from OR cultures, s/p 
4wks IV vancomycin/ceftriaxone ending ___. At time of discharge 
patient was feeling well, without any fevers but with some 
ongoing intermittent loose stools. Stool studies were negative 
for bacterial infection and C diff was negative, but patient was 
treated with PO vancomycin prophylaxis given history of presumed 
C diff (PCR+, toxin negative). 

TRANSITIONAL ISSUES
===================
[] Please repeat BMP in 1 week and ensure resolution of mild 
hypokalemia and hypernatremia. He should also have repeat CRP 
(Admission CRP 95) to ensure knee is recovering after septic 
joint and course of abx
[] Stop vancomycin 125mg PO BID on ___ 
[] Patient should have follow up with PCP in the next 7 days to 
reevaluate knee after cessation of antibiotics and diarrhea

ACUTE ISSUES ADDRESSED
=======================
# Fever 
# Abdominal pain 
# Presumed C. diff colitis 
Patient presented with fever and abdominal pain. He was recently 
started on PO vanc for presumed C. diff colitis. He continued to 
have diarrhea but remained afebrile, without leukocytosis, and 
with improving abdominal pain. Stool tests sent were remarkable 
for negative C. diff PCR, negative bacterial stool cultures. 
Decreased PO vancomycin to prophylactic dosing of 125mg BID. At 
time of discharge fever and abdominal pain had resolved, but 
patient did have ongoing loose bowel movements ___ daily 
without clear etiology. Suspect antibiotic associated/non 
infectious given that he was clinically well appearing 
otherwise. 

# R knee septic arthritis 
Patient had a R quad tendon rupture s/p quad tendon repair with 
course c/b sepsis c/f post op infection s/p R knee washout and 
debridement on ___. No growth from the OR cultures, but was 
started on a 4 week course of vanc/ceftriaxone (scheduled to end 
___ due to significant amount of polys and purulence noted 
during washout. Per OMR review, his knee was without erythema or 
purulence at his OPAT visit on ___. On exam on day of 
admission, patient's knee is very warm, erythematous, and tender 
to light touch, and CRP remains elevated at 95.8, which is 
concerning for a possible septic joint. ID was consulted and 
recommended joint aspiration initially, though with improvement 
in knee exam, aspiration and I&D were deferred. Continued IV 
vancomycin and ceftriaxone until ___. Patient was discharged 
off of antibiotics with plan for outpatient monitoring. 

# Hypokalemia 
# Non-anion gap metabolic acidosis 
# Hypovolemia ___ to Diarrhea 
Likely ___ GI losses, improved with IVF resuscitation and 
potassium repletion. 

# Acute on chronic normocytic anemia 
His current Hgb level is 9.5, slightly down from yesterday. 
Likely in the context of infection. Iron studies showed iron 
deficiency. Can start outpatient iron supplementation.

CHRONIC/STABLE ISSUES: 
====================== 
# Congenital adrenal hyperplasia 
Salt-wasting type, managed by his PCP. Continued home 
fludrocortisone 0.1mg QAM and dexamethasone 0.5mg QAM 

# History of TURP 
Asymptomatic. Continued home Finasteride 5mg QHS and Tamsulosin 
0.4mg QHS. 

# Intellectual disability 
He works at ___ and lives in assisted living group 
home. Brother is HCP and mother is secondary HCP. 

# CODE: Full (presumed) 
# CONTACT: 
HCP: ___, brother 
Phone number: ___ 

Will require less than 30 days of rehab 

>30 min spent on discharge planning including face to face time. 


 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Dexamethasone 0.5 mg PO DAILY 
2. Finasteride 5 mg PO DAILY 
3. Fludrocortisone Acetate 0.1 mg PO DAILY 
4. Tamsulosin 0.4 mg PO QHS 
5. CefTRIAXone 2 gm IV Q 24H 
6. Vancomycin 1250 mg IV Q 12H 
7. Vancomycin Oral Liquid ___ mg PO QID 

 
Discharge Medications:
1.  Vancomycin Oral Liquid ___ mg PO BID  
2.  Dexamethasone 0.5 mg PO DAILY  
3.  Finasteride 5 mg PO DAILY  
4.  Fludrocortisone Acetate 0.1 mg PO DAILY  
5.  Tamsulosin 0.4 mg PO QHS  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
=================
R knee septic arthritis 
C difficile infection 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of ___ at the ___ 
___.

Why did ___ come to the hospital?
- ___ came to the hospital because ___ were having a fever and 
diarrhea. 

What did ___ receive in the hospital?
- ___ received IV fluids and antibiotics to treat the infection 
in your knee.

- ___ also received a medication to treat a diarrheal illness 
called C Diff that we thought ___ might have. 

What should ___ do once ___ leave the hospital?
- Please take all of your medications as prescribed and attend 
all of your follow up appointments as scheduled.

We wish ___ all the best!
- Your ___ Care Team
 
Followup Instructions:
___
"
126,16540773,24305531," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Tylenol / Endocet / shellfish derived / hazzelnut
 
Attending: ___.
 
Chief Complaint:
Neck pain, weakness 
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
HPI: History obtained with assistance from ___ interpreter. 

Ms. ___ is a ___ yo woman with PMH of HTN/HLD presenting with
left neck pain and generalized weakness. 

She was recently discharged from ___ after an admission for a
viral illness which causes nausea and vomiting but has had
persistent weakness and anorexia. She denies fevers/chills,
n/v/d/abd pain, urinary sx, cp/SOB/cough, but says she has had
minimal appetite for weeks and has been constipated for a few
days. She notes that she does not feel at all confused at this
time but did have some confusion after her last admission. She
states that sometimes when walking she feels generally weak with
some dizziness and a feeling of numbness in her legs. 

Her primary complaint today is anterior left neck pain x3 days
which is sometimes associated with weakness in her left arm. 
She says that the neck pain started about one week ago and is in
able to point to a precipitating factor like exercise, lifting
heavy things, etc. She denies headaches, vision changes, or 
other
associated sx. She reports that she came into the hospital
instead of going to her PCP for this because she thought it was
severe enough to go to the hospital and because her family was
worried about her, especially since she has lost weight over the
last month. She thinks she lost weight because of the impact her
recent viral illness had on PO intake. 

Per report, the patient has been persistently failing at home
leading to repeated hospital admissions despite having a ___.  

In ED, initial vitals 98.2 101 149/79 16 100% RA. Received GI
cocktail, 1L NS, 600mg ibuprofen. CXR showed mild bronchial wall
thickening possibly reflected reactive airway disease with no
focal consolidation. EKG NSR rate 98 with LBBB and LVH. Bcx and
Ucx obtained. WBC 12.2, Hgb 10.3 Lactate 1.2, Chem 7/LFTs
unremarkable, trop negative x1. Guaiac negative on exam. 

Vitals on transfer: 98.2 92 136/81 16 98% RA 

ROS: As per HPI, all systems reviewed and otherwise negative. 
 
Past Medical History:
-HTN
-Arthritis
-Gait abnormality/hx of falls

PSH: C-section x1, bilateral TKR ___ years ago, R shoulder
surgery, cataracts
 
Social History:
___
Family History:
Father died of ___, mother died at ___ of
unknown causes. Brother had tetanus as a child. Grandmother had
unknown cancer. Brother had ulcer. 
 
Physical Exam:
Admission Physical Exam:
VS: 98.3 94 150/64 18 98%RA 
General: Well appearing woman sitting up in bed in NAD
Eyes: PERLL, EOMI, sclera anicteric
ENT: MMM, oropharynx clear without exudate or lesions. 
Neck: Tender to palpation near angle of mandible on the left. No
bruit or thrill. Nontender over cervical spine without notable
step offs. Negative Spurling's test bilaterally. Nontender over
trapezius. Slightly limited neck rotation to left due to
discomfort but full neck flexion/extension/rotation otherwise. 
Lymph: No supraclavicular or cervical lymphadenopathy
Respiratory: CTAB without crackles, wheeze, rhonchi. 
Cardiovascular: RRR, normal S1 and S2, +S4, no murmurs, rubs or
gallops
Gastrointestinal: Soft, nontender, nondistended, +BS, no masses
or HSM
Extremities: Warm and well perfused, no peripheral edema 
Skin: warm, no rashes/no jaundice/no skin ulcerations noted
Neurological: Alert and oriented x3, CN2-12 intact, ___ strength
in UE and ___ bilaterally. 

Discharge Physical Exam:
Physical Exam:
VS: 98.2 93 165/85 16 98%RA 
General: Well appearing woman sitting up in bed in NAD
Eyes: PERLL, EOMI, sclera anicteric
ENT: MMM, oropharynx clear without exudate or lesions. 
Neck: Nontender to palpation
Respiratory: CTAB without crackles, wheeze, rhonchi. 
Cardiovascular: RRR, normal S1 and S2, +S4, no murmurs, rubs or
gallops
Gastrointestinal: Soft, nontender, nondistended, +BS, no masses
or HSM
Extremities: Warm and well perfused, no peripheral edema 
Skin: warm, no rashes/no jaundice/no skin ulcerations noted
Neurological: Alert and oriented x3, motor and sensory exam 
grossly intact 
 
Pertinent Results:
ADMISSION LABS:

___ 01:00AM OTHER BODY FLUID  FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
___ 11:15PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 11:15PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 09:20PM   LACTATE-1.2
___ 08:23PM   GLUCOSE-118* UREA N-15 CREAT-0.9 SODIUM-138 
POTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-26 ANION GAP-16
___ 08:23PM   ALT(SGPT)-6 AST(SGOT)-12 ALK PHOS-80 TOT 
BILI-0.3
___ 08:23PM   LIPASE-32
___ 08:23PM   cTropnT-<0.01
___ 08:23PM   ALBUMIN-3.4*
___ 08:23PM   WBC-12.2* RBC-3.76* HGB-10.3* HCT-32.5* 
MCV-86 MCH-27.4 MCHC-31.7* RDW-15.4 RDWSD-49.1*
___ 08:23PM   NEUTS-65.8 ___ MONOS-8.9 EOS-1.1 
BASOS-0.2 IM ___ AbsNeut-8.03* AbsLymp-2.88 AbsMono-1.08* 
AbsEos-0.13 AbsBaso-0.03
___ 08:23PM   ___ PTT-32.2 ___

DISCHARGE LABS:

___ 01:05PM BLOOD WBC-9.5 RBC-3.65* Hgb-9.9* Hct-32.1* 
MCV-88 MCH-27.1 MCHC-30.8* RDW-15.6* RDWSD-50.0* Plt ___
___ 05:53AM BLOOD Glucose-100 UreaN-13 Creat-1.0 Na-139 
K-4.6 Cl-105 HCO3-28 AnGap-11
___ 05:53AM BLOOD Calcium-9.0 Phos-3.7 Mg-1.7

MICRO:
___ Ucx negative
___ Bcx pending

IMAGING:
___ CXR
IMPRESSION: 
 
Mild bronchial wall thickening may reflect reactive airways 
disease.  No focal
consolidation identified.

___ C-spine XR
IMPRESSION:
 
 
1. Severe degenerative changes of the cervical spine with 
degenerative disc
disease at C5-6 to C7-T1 levels.
2. 1.2 cm well-defined focus of calcification overlying the soft 
tissues and
projecting to the right of the midline at C4 level is of unknown 
etiology. 
Further evaluation by a CT of the neck may be performed only as 
clinically
relevant.

___ C-spine CT without con
IMPRESSION:
 
 
1. Right humeral implant streak artifact limits examination.
2. Bilateral carotid artery atherosclerosis, right greater than 
left, as
described.  Question if right carotid bifurcation dense 
calcification
corresponds to area of calcific density on recent cervical spine 
x-ray.
3. Multilevel cervical spine degenerative changes as described, 
including
moderate severe loss of disc height from C5-T1.  If clinically 
indicated,
consider cervical spine MRI for further evaluation.
4.  Within the limits of this noncontrast study, there is no 
definite evidence
of cervical mass.
 
Brief Hospital Course:
___ yo woman with PMH of HTN/HLD presenting with left neck pain 
and generalized weakness.      

#Neck pain: One week of neck pain without clear etiology as no
clear precipitating factors. Patient had recent viral illness 
but
denies f/c, n/v, headache, vision changes, other neurologic
changes which would be concerning for meningitis so no need for
LP. Pain is focal on left side of neck without
notable exam findings. Pt reports intermittent arm weakness but
neurological exam completely intact, Spurling test negative, no
point tenderness over spine or signs of spinal injury. No bruit
or thrill no raise concern for vascular abnormality, no mass or
lymphadenopathy to raise concern for infection. XR and CT of 
C-spine show severe cervical DJD as well as calcification of 
carotids R>L. Pain improved with ibuprofen and home tramadol on 
which she was discharged, may benefit from longstanding tx with 
COX-2 inhibitor as allergic to APAP. 

#Weakness/anorexia/gait abnormality: Exam relatively 
unremarkable, patient mentating well, but appears to
be failing at home based on multiple recent admissions. Poor PO
intake appears to be slow recovery from recent viral illness, 
but
could be part of overall subacute decline. Continued on home 
mirtazapine. Evaluated by nutrition who felt that patient has 
good diet but would benefit from Ensure supplementation. 
Evaluated by ___ who cleared patient for home without additional 
services. In conversation with patient, daughter, and social 
work, team able to get collateral information that patient has 
numerous services at home through elder services and daughter is 
considering applying for assisted living but has been anxious 
about mother's ability to function at home. Overall, patient is 
largely healthy, cognitive intact, and safe to ambulate on her 
own. Will benefit from maximal services available from elder 
services but is largely functioning well with good supports. 

#HTN: EKG with LBBB and LVH, exam notable for S4 making some end
organ damage from longstanding hypertension likely. Chem 7 wnl. 
Stable on home losartan. 
 Will follow up with PCP regarding HTN management, consideration 
of TTE, and ophthalmology f/u given evidence of end organ 
damage. 

#GERD: Stable on home omeprazole

#Anemia: Hgb 10.3->9.4 with unclear baseline. Likely ___ 
dilution as all cell lines down. Patient on home iron 
supplementation and aware of anemia. Will need ongoing 
outpatient monitoring, discharged with home iron 
supplementation. 

Transitional issues:
-Found to have extensive DJD of the cervical spine. Would 
consider outpatient discussion of longterm medications such as 
COX-2 inhibitors. 
-Extensive calcification of the right carotid bifurcation with 
less significant left carotid calcification seen on CT C-spine. 
Follow up with PCP. 
-Patient and family interested in referral to geriatrics for 
ongoing primary care. 
-Patient would benefit from maximal resources from elder 
services including access to nutritional supplementation 
-Given LVH on EKG and S4 on exam, may benefit from outpatient 
TTE for evaluation of structural heart disease. Additionally 
would benefit from ophthalmology eval as outpatient given 
evidence of end organ damage from HTN. 
#Code Status: DNR, ok to intubate (confirmed)
#Contact: ___ daughter ___ ___, son ___ ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Calcitrate (calcium citrate) 200 mg (950 mg) oral BID 
2. Ferrous GLUCONATE 324 mg PO DAILY 
3. Losartan Potassium 50 mg PO DAILY 
4. Magnesium Oxide 250 mg PO DAILY 
5. Mirtazapine 15 mg PO QHS 
6. Omeprazole 20 mg PO DAILY 
7. TraMADol 50 mg PO TID:PRN Pain - Moderate 
8. Ascorbic Acid ___ mg PO DAILY 
9. Vitamin D ___ UNIT PO EVERY 2 WEEKS (___) 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0 
2.  Ibuprofen 600 mg PO Q8H:PRN Pain - Mild 
RX *ibuprofen 600 mg 1 tablet(s) by mouth every eight (8) hours 
Disp #*32 Tablet Refills:*0 
3.  Ascorbic Acid ___ mg PO DAILY  
4.  Calcitrate (calcium citrate) 200 mg (950 mg) oral BID  
5.  Ferrous GLUCONATE 324 mg PO DAILY  
6.  Losartan Potassium 50 mg PO DAILY  
7.  Magnesium Oxide 250 mg PO DAILY  
8.  Mirtazapine 15 mg PO QHS  
9.  Omeprazole 20 mg PO DAILY  
10.  TraMADol 50 mg PO TID:PRN Pain - Moderate  
11.  Vitamin D ___ UNIT PO EVERY 2 WEEKS (___)  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary: Neck pain

Secondary: Weakness, anorexia, gait abnormality 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___, 

You were admitted to ___ for weakness and neck pain. You were 
found to have significant arthritis of the neck which is the 
likely source of your pain. Your pain improved rapidly with 
anti-inflammatory medication. You were evaluated by nutrition, 
physical therapy, and social work to ensure that you are safe at 
home. You should follow up with your primary doctor and elder 
services to ensure that you are receiving all available 
services. 

It was a pleasure caring for you,

Your ___ Care Team  
 
Followup Instructions:
___
"
127,16540773,28989974," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
Tylenol / Endocet / shellfish derived / hazzelnut / cherry 
flavor / Indocin / mango / strawberry / oxycodone / soy / 
clonazepam / Penicillins / tramadol / nuts
 
Attending: ___
 
___ Complaint:
right knee pain
 
Major Surgical or Invasive Procedure:
___: right revision total knee arthroplasty by ___. 
___, MD

 
History of Present Illness:
___ presenting for revision of right total knee arthroplasty 
that has undergone aseptic loosening and was complicated by a 
tibial plateau fracture.
 
Past Medical History:
-HTN
-Arthritis
-Gait abnormality/hx of falls

PSH: C-section x1, bilateral TKR ___ years ago, R shoulder
surgery, cataracts
 
Social History:
___
Family History:
Father died of ___, mother died at ___ of unknown causes. 
Brother had tetanus as a child. Grandmother had unknown cancer. 
Brother had ulcer. 
 
Physical Exam:
Well appearing in no acute distress  
Afebrile with stable vital signs  
Pain well-controlled  
Respiratory: CTAB  
Cardiovascular: RRR  
Gastrointestinal: NT/ND  
Genitourinary: Voiding independently  
Neurologic: Intact with no focal deficits  
Psychiatric: Pleasant, A&O x3  
Musculoskeletal Lower Extremity:  
* Incision healing well with staples  
* Scant serosanguinous drainage  
* Thigh full but soft  
* No calf tenderness  
* ___ strength  
* SILT, NVI distally  
* Toes warm
 
Pertinent Results:
___ 05:36AM BLOOD WBC-8.4 RBC-2.86* Hgb-8.8* Hct-25.9* 
MCV-91 MCH-30.8 MCHC-34.0 RDW-14.8 RDWSD-49.2* Plt ___
___ 10:21PM BLOOD WBC-10.5* RBC-3.28*# Hgb-9.9*# Hct-29.4*# 
MCV-90 MCH-30.2 MCHC-33.7 RDW-14.6 RDWSD-47.7* Plt ___
___ 06:40AM BLOOD WBC-9.0 RBC-2.42* Hgb-7.4* Hct-22.3* 
MCV-92 MCH-30.6 MCHC-33.2 RDW-15.1 RDWSD-51.0* Plt ___
___ 06:40AM BLOOD WBC-11.7* RBC-2.56* Hgb-7.8* Hct-23.5* 
MCV-92 MCH-30.5 MCHC-33.2 RDW-15.0 RDWSD-50.6* Plt ___
___ 05:00PM BLOOD WBC-13.0* RBC-2.83* Hgb-8.5* Hct-25.8* 
MCV-91 MCH-30.0 MCHC-32.9 RDW-15.1 RDWSD-50.9* Plt ___
___ 07:00AM BLOOD WBC-12.7* RBC-2.66* Hgb-8.2* Hct-24.2* 
MCV-91 MCH-30.8 MCHC-33.9 RDW-15.2 RDWSD-50.5* Plt ___
___ 09:25PM BLOOD WBC-12.8* RBC-2.80* Hgb-8.5* Hct-25.5* 
MCV-91 MCH-30.4 MCHC-33.3 RDW-14.9 RDWSD-50.0* Plt ___
___ 06:40AM BLOOD WBC-12.6* RBC-3.13* Hgb-9.5* Hct-28.8* 
MCV-92 MCH-30.4 MCHC-33.0 RDW-14.9 RDWSD-49.9* Plt ___
___ 05:36AM BLOOD Plt ___
___ 10:21PM BLOOD Plt ___
___ 06:40AM BLOOD Plt ___
___ 06:40AM BLOOD Plt ___
___ 05:00PM BLOOD Plt ___
___ 07:00AM BLOOD Plt ___
___ 09:25PM BLOOD Plt ___
___ 06:40AM BLOOD Plt ___
___ 05:36AM BLOOD Creat-1.3*
___ 10:21PM BLOOD Creat-1.3*
___ 06:40AM BLOOD Creat-1.7*
___ 06:40AM BLOOD UreaN-31* Creat-1.2*
___ 07:00AM BLOOD Creat-1.4*
___ 06:40AM BLOOD Glucose-118* UreaN-41* Creat-1.3* Na-139 
K-4.9 Cl-99 HCO3-26 AnGap-14
___ 06:40AM BLOOD Calcium-8.5 Phos-4.2 Mg-1.8
 
Brief Hospital Course:
The patient was admitted to the orthopedic surgery service and 
was taken to the operating room for above described procedure. 
Please see separately dictated operative report for details. 
Patient received perioperative IV antibiotics.

Postoperative course was remarkable for the following:
On POD #1, patient was given 500ml IV fluid bolus for 
hypotension, which she responded to appropriately. Patient was 
noted to have some post-op delirium and dilaudid was decreased 
in dosage from ___ to 0.5-2mg every 4 hours as needed. 
Oxycodone and tramadol was avoided due to reported allergy. 
Morphine was avoided due to slightly elevated creatinine of 1.4. 
Overnight, patient was noted to have increased delirium with 
temp of 100.2 and urinalysis, repeat CBC was completed. UA was 
negative, hematocrit was 25.5 and WBC 12.8.

On POD #2, hematocrit was 24.2. and WBC 12.7. Patient was 
triggered for change in mental status in the afternoon and Tmax 
of 102.0. Patient was noted to have increased delirium with new 
oxygen requirement (88-90% on room air) and slightly tachycardic 
with HR in the low 100s. A fever work-up was completed, 
including urinalysis/cultures, blood cultures and chest x-ray. 
UA was borderline, showing moderate leukocytes, WBC 12, negative 
nitrates/epi. Chest X-ray showed pacification of the right and 
left lungs, with slight blurring of the pulmonary vessels 
represent atelectasis, however cannot exclude pneumonia. Patient 
was not given Tylenol due to reported allergy and was not given 
any other alternative PO anti-pyretic medication due to 
confusion at the time/inability to swallow pills. Cool pack/ice 
was given to the patient and fever resolved on its own. Patient 
remained afebrile overnight. Gabapentin was discontinued and no 
further narcotic medications were given. The Medicine team was 
consulted for co-management of care due to complex past medical 
history and recommended empiric treatment with Levaquin if cough 
develops or consideration of further testing to rule out PE if 
patient remained tachycardic or hypoxic.

On POD #3, hematocrit was 23.5, WBC 11.7 (downtrending) and 
creatinine improved to 1.2. Patient was alert and oriented to 
self, DOB, place. Patient reported right calf pain to palpation 
and a lower extremity ultrasound was obtained, which results 
were negative for DVT.

On POD #4, hematocrit was 22.3 and patient was transfused 1 unit 
packed red blood counts, which she tolerated well. 
Post-transfusion hematocrit was 29.4.

On POD #5, her hematocrit was stable at 25.9 and her creatinine 
was 1.3.  She was discharged to rehab with repeat lab follow-up 
(hematocrit and creatinine) within 2 days of discharge.  Her 
Lasix and Losartan continue to be held until creatinine 
stabilizes.  

Urine cultures showed mixed bacterial flora consistent with skin 
contamination, no treatment indicated. Blood cultures were 
pending at the time of discharge and patient will be contacted 
if further treatment is indicated.

Otherwise, the patient received Aspirin 325 mg twice daily for 
DVT prophylaxis starting on the morning of POD#1.  The surgical 
dressing will remain on until ___. The patient was seen daily 
by physical therapy. Labs were checked throughout the hospital 
course and repleted accordingly. At the time of discharge the 
patient was tolerating a regular diet and feeling well.  The 
patient was afebrile with stable vital signs.  The patient's 
hematocrit was acceptable and pain was adequately controlled on 
an oral regimen. The operative extremity was neurovascularly 
intact and the dressing was intact. 

The patient's weight-bearing status is weight bearing as 
tolerated on the operative extremity. 
 
Ms. ___ is discharged to rehab in stable condition.

 
Medications on Admission:
1. EPINEPHrine (EpiPEN) 0.3 mg IM ONCE MR1 
2. Vitamin D ___ UNIT PO TWICE PER MONTH 
3. Furosemide 50 mg PO DAILY 
4. Losartan Potassium 50 mg PO DAILY 
5. Metoprolol Succinate XL 25 mg PO DAILY 
6. Mirtazapine 15 mg PO QHS 
7. Omeprazole 20 mg PO DAILY 
8. Ascorbic Acid ___ mg PO DAILY 
9. Aspirin 81 mg PO DAILY 
10. Calcitrate (calcium citrate) 200 mg (950 mg) oral Q24H 
11. Cetirizine 10 mg PO DAILY 

 
Discharge Medications:
1.  Codeine Sulfate 15 mg PO Q6H:PRN moderate pain 
2.  Docusate Sodium 100 mg PO DAILY 
3.  Senna 8.6 mg PO BID 
4.  Aspirin 325 mg PO BID 
Resume ASA 81 after 4 week course of ASA 325.  Continue 
Omeprazole while on Aspirin 325 (x 4 weeks). 
5.  Ascorbic Acid ___ mg PO DAILY  
6.  Calcitrate (calcium citrate) 200 mg (950 mg) oral Q24H  
7.  Cetirizine 10 mg PO DAILY  
8.  EPINEPHrine (EpiPEN) 0.3 mg IM ONCE MR1  
9.  Metoprolol Succinate XL 25 mg PO DAILY  
10.  Mirtazapine 15 mg PO QHS  
11.  Omeprazole 20 mg PO DAILY 
Continue Omeprazole daily while on ASA 325 mg twice daily (x 4 
weeks).  
12.  Vitamin D ___ UNIT PO TWICE PER MONTH  
13. HELD- Furosemide 50 mg PO DAILY  This medication was held. 
Do not restart Furosemide until creatinine has stabilized.
14. HELD- Losartan Potassium 50 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until creatinine has 
stabilized.

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
right knee aseptic loosening

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
1. Please return to the emergency department or notify your 
physician if you experience any of the following: severe pain 
not relieved by medication, increased swelling, decreased 
sensation, difficulty with movement, fevers greater than 101.5, 
shaking chills, increasing redness or drainage from the incision 
site, chest pain, shortness of breath or any other concerns.
 
2. Please follow up with your primary physician regarding this 
admission and any new medications and refills. 
 
3. Resume your home medications unless otherwise instructed.
 
4. You have been given medications for pain control. Please do 
not drive, operate heavy machinery, or drink alcohol while 
taking these medications. As your pain decreases, take fewer 
tablets and increase the time between doses. This medication can 
cause constipation, so you should drink plenty of water daily 
and take a stool softener (such as Colace) as needed to prevent 
this side effect.  Call your surgeons office 3 days before you 
are out of medication so that it can be refilled.  These 
medications cannot be called into your pharmacy and must be 
picked up in the clinic or mailed to your house.  Please allow 
an extra 2 days if you would like your medication mailed to your 
home.
 
5. You may not drive a car until cleared to do so by your 
surgeon.
 
6. Please call your surgeon's office to schedule or confirm your 
follow-up appointment in three (3) weeks.
 
7. SWELLING: Ice the operative joint 20 minutes at a time, 
especially after activity or physical therapy. Do not place ice 
directly on the skin. You may wrap the knee with an ace bandage 
for added compression. Please DO NOT take any non-steroidal 
anti-inflammatory medications (NSAIDs such as Celebrex, 
ibuprofen, Advil, Aleve, Motrin, naproxen etc) until cleared by 
your physician.
 
8. ANTICOAGULATION: Please continue your Aspirin 325 mg twice 
daily with food for four (4) weeks to help prevent deep vein 
thrombosis (blood clots).  Continue Omeprazole home dose daily 
while on Aspirin to prevent GI upset.  If you were taking 
Aspirin prior to your surgery, take it at 325 mg twice daily 
until the end of the 4 weeks, then you can go back to your 
normal dosing.
 
9. WOUND CARE: Please remove Aquacel dressing on ___. It is 
okay to shower after surgery after 5 days but no tub baths, 
swimming, or submerging your incision until after your four (4) 
week checkup. Please place a dry sterile dressing on the wound 
after aqaucel is removed each day if there is drainage, 
otherwise leave it open to air. Check wound regularly for signs 
of infection such as redness or thick yellow drainage.  Staples 
will be removed by your doctor at follow-up appointment 
approximately 3 weeks after surgery.
 
10. ___ (once at home): Home ___, dressing changes as 
instructed, and wound checks.
 
11. ACTIVITY: Weight bearing as tolerated on the operative 
extremity. Mobilize with assistive devices (___) if 
needed.  Range of motion at the knee as tolerated. No strenuous 
exercise or heavy lifting until follow up appointment.
Physical Therapy:
WBAT RLE
No range of motion restrictions
Wean assistive device as able
Mobilize frequently

Treatments Frequency:
remove aquacel ___
apply dry sterile dressing daily if needed after aquacel 
dressing is removed
wound checks daily after aquacel removed
staple removal and replace with steri-strips (at follow up 
visit)
 
Followup Instructions:
___
"
128,16540773,28402284," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Tylenol / Endocet / shellfish derived / hazzelnut / cherry 
flavor / Indocin / mango / strawberry / oxycodone / soy / 
clonazepam / Penicillins / tramadol / nuts
 
Attending: ___.
 
Chief Complaint:
Cough, shortness of breath 
 
Major Surgical or Invasive Procedure:
None 
 
History of Present Illness:
___ female past history of hypertension, anemia, heart
failure reduced ejection fraction now recovered to 51%, CAD, 
left
bundle branch block ___ CRT-P,  direct admitted from home to the
heart failure service for management of acute decompensated 
HFpEF

The patient was seen in the emergency department on ___
after having approximately 1 month of progressively worsening
shortness of breath  Which had became substantially worse than
prior 4 days.  At that encounter the patient had no lower
extremity edema, denied any chest pain, fever/chills.  She was
seen in the emergency room by EP and was found that her
dysfunction was normal with minor program changes.  She was
diuresed with IV Lasix and treated with nebulizers. 
Echocardiogram emergency room showed that her ejection fraction
improved to 51%.  She was able to be discharged shortly
thereafter.

Patient was seen in heart failure clinic on ___ in
follow-up, which point she continued to improve since medically. 

She was given additional Lasix 20 milligrams p.o. as needed to 
be
taken in addition to her standing 40 daily for shortness of
breath.

On ___, patient's daughter called heart failure clinic
reporting a new dry cough with increased bilateral lower
semi-edema.  She was unsure if her mom has been compliant with
her home medications.  Currently clinic on ___ by the heart
failure nurse practitioner team, at that visit she complained of
cough, shortness of breath, leg swelling.  Chest x-ray showed
pulmonary edema without evidence of pneumonia.  She was diuresed
with Lasix 60 mg IV.  Sent home, however her daughter called the
clinic ___ and reported that her mother was not feeling any
better.  At that point she was admitted for IV diuresis.

Regarding her history of heart failure, patient has an EF of 25%
___.  Was felt that her heart failure was due to a
markedly distinctness mechanical activation sequence, resulting
in increased left ventricular filling pressures.  ___ CRT-P
implanted on ___ without complications.  He has
subsequently recovered she was discharged on Lasix 40 mg p.o.
daily, losartan 25 mg

On arrival to the floor, the patient reports that her primary
symptom is coughing and wheezing in the morning. Her daughter is
at bedside and reports that she is concerned about the patients
ability to manage her own medications. No fevers or chills. They
had given the patient lasix 80 mg po daily as well in addition 
to
the 60 IV she received in the CDAC. 

Denies fevers/chills/n/v/cp/shortness of breath/abdominal
pain/dysuria/myalgia/arthralgia. 

 
Past Medical History:
-HTN
-Arthritis
-Gait abnormality/hx of falls

PSH: C-section x1, bilateral TKR ___ years ago, R shoulder
surgery, cataracts
 
Social History:
___
Family History:
Father died of ___, mother died at ___ of unknown causes. 
Brother had tetanus as a child. Grandmother had unknown cancer. 
Brother had ulcer. 
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
VS: ___ 1622 Temp: 98.5 PO BP: 108/55 HR: 83 RR: 18 O2 sat:
100% O2 delivery: RA 
GENERAL: NAD, A&Ox3
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI.
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa.
No xanthelasma.  
NECK: Supple. JVP of 15 cm
CARDIAC: PMI located in ___ intercostal space, midclavicular
line. regular rate and rhythm. Normal S1, S2. ___ RUSB murmur 
LUNGS: No chest wall deformities or tenderness. Respiration is
unlabored with no accessory muscle use. No crackles, wheezes or
rhonchi.  
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No
splenomegaly.  
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis. trace 
to
1 + pitting edema bilaterally to mid shin, trace pitting edema 
on
the hips. 
SKIN: No significant skin lesions or rashes.  
PULSES: Distal pulses palpable and symmetric.  

DISCHARGE PHYSICAL EXAMINATION:
VS: ___ 0404 Temp: 98.3 PO BP: 117/70 L Lying HR: 76 RR: 18
O2 sat: 93% O2 delivery: RA 
___ Total Intake: 720ml PO Amt: 720ml 
___ Total Output: 750ml Urine Amt: 750ml 
I/O: reviewed
GENERAL: NAD, A&Ox3
HEENT: No icterus or injection. No nasal discharge or sinus
tenderness. MMM.
CV: JVP 8cm, no AJR. RRR, no m/r/g.
RESP: CTAB, wheezing resolved. 
ABDOMEN: Soft, NDNT, no HSM.
EXTREMITIES: Warm, trace pitting edema bilaterally.
SKIN: No lesions or rashes.  
NEURO: Alert, oriented x3, intact attention, poor short term
memory. CN intact. Moves all extremities. No ataxia.

 
Pertinent Results:
ADMISSION LABS: 
===============
___ 05:00PM   GLUCOSE-102* UREA N-43* CREAT-1.4* SODIUM-141 
POTASSIUM-4.1 CHLORIDE-101 TOTAL CO2-26 ANION GAP-14
___ 05:00PM   ALT(SGPT)-9 AST(SGOT)-17 LD(LDH)-417* ALK 
PHOS-90 TOT BILI-0.2
___ 05:00PM   CALCIUM-9.2 PHOSPHATE-3.5 MAGNESIUM-2.1 
IRON-65
___ 05:00PM   calTIBC-329 FERRITIN-65 TRF-253
___ 05:00PM   WBC-9.2 RBC-3.76* HGB-11.2 HCT-34.7 MCV-92 
MCH-29.8 MCHC-32.3 RDW-13.8 RDWSD-46.8*
___ 05:00PM   PLT COUNT-227
___ 05:00PM   ___ PTT-32.5 ___
___ 10:45AM   UREA N-44* CREAT-1.3* SODIUM-141 
POTASSIUM-4.1 CHLORIDE-102 TOTAL CO2-25 ANION GAP-14
___ 10:45AM   estGFR-Using this
___ 10:45AM   proBNP-441
___ 10:45AM   WBC-8.7 RBC-4.06 HGB-12.2 HCT-37.6 MCV-93 
MCH-30.0 MCHC-32.4 RDW-13.8 RDWSD-47.3*
___ 10:45AM   NEUTS-53.8 ___ MONOS-7.8 EOS-7.0 
BASOS-0.5 IM ___ AbsNeut-4.66 AbsLymp-2.66 AbsMono-0.68 
AbsEos-0.61* AbsBaso-0.04
___ 10:45AM   PLT COUNT-244

Pertinent Studies: 
==================
2D-ECHOCARDIOGRAM: ___ IMPRESSION: Mild symmetric left 
ventricular hypertrophy with mild regional systolic dysfunction. 
Moderate mitral regurgitation with normal valve morphology. 
Borderline elevated pulmonary artery systolic pressure.

CXR ___
Final Report 
EXAMINATION:  CHEST (PA AND LAT) 
  
INDICATION:  ___ year old woman with cough and wheezing// ?PNA    
  ?PNA 
  
IMPRESSION:  
  
Comparison to ___.  Lung volumes have slightly decreased. 
 Mild 
cardiomegaly.  No evidence of pneumonia, no pulmonary edema.  No 
pleural 
effusions.  Stable correctly positioned pacemaker leads. 

Discharge Labs: 
===============
___ 07:35AM BLOOD WBC-7.0 RBC-3.78* Hgb-11.2 Hct-34.8 
MCV-92 MCH-29.6 MCHC-32.2 RDW-13.9 RDWSD-47.6* Plt ___
___ 07:35AM BLOOD Plt ___
___ 07:35AM BLOOD Glucose-94 UreaN-35* Creat-1.3* Na-142 
K-4.3 Cl-100 HCO3-25 AnGap-17
___ 07:35AM BLOOD Calcium-9.7 Phos-4.4 Mg-1.___ yo F with a history of heart failure with reduced ejection 
fraction (now recovered), admitted for edema, coughing, and 
increased dyspnea

Transitional Issues: 
====================
[]Discharge BUN/Creatinine: 35/1.3
[]Discharge Weight: 63.4 kg 
[]Discharge Diuretic: Torsemide 60 mg 

New Medications: Torsemide, fluticasone, albuterol 
Stopped Medications: Furosemide 
Changed Medications: None 

Code Status: Full (presumed) 
Contact: ___ (daughter) ___

Transitional Issues: 
====================
For PCP: 
[]Consider pulmonology referral for PFTs 
[]Consider adding ___ to regimen 
[]Ensure patients daughter has appropriate support at home

For Cardiology: 
[]Titrate Torsemide as needed 
[]Chem10 in one week 

Active Issues: 
==============
#Acute on chronic Heart Failure with recovered Ejection fraction 

Patient was seen in the CDAC on the day prior to admission and 
received IV diuresis with Lasix and was sent home on increased 
dosages of p.o. Lasix.  She continued to develop lower extremity 
edema and increasing dyspnea on exertion.  She was admitted for 
continued IV diuresis.  She was able to transition to a new 
outpatient regimen of torsemide 60 mg p.o. daily and was 
continued on her home losartan, amlodipine, and metoprolol.

#Reactive airway disease
#Wheezing
Patient was found to be wheezing on examination and complaining 
of significant cough.  Initially felt to be due to cardiac 
wheezing, however the patient was given fluticasone, duo nebs, 
and as needed albuterol and and her lung sounds improved 
dramatically.  She symptomatically improved.  She will be 
discharged on fluticasone and albuterol inhaler, she should be 
formally evaluated in the outpatient setting with PFTs for 
underlying lung disease.

#Chronic kidney disease
#Acute kidney injury
The patient's baseline creatinine is 0.9, she was admitted with 
a creatinine of 1.4. This improved with diuretics. The most 
likely cause was the patient's heart failure. Her discharge 
creatinine was 1.3

___ disease
The patient will be moving in with her daughter who will be 
managing her medications. The patient was frequently missing 
medications at home and will be important that her daughter 
helps her to manage her chronic disease.

Chronic issues:
#Hypertension
Patient was continued on home losartan, amlodipine, and 
metoprolol

#GERD
Patient was given Tums for heartburn 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Furosemide 40 mg PO DAILY 
3. Losartan Potassium 75 mg PO DAILY 
4. Metoprolol Succinate XL 25 mg PO DAILY 
5. EPINEPHrine (EpiPEN) 0.3 mg IM DAILY:PRN anaphylaxis 
6. amLODIPine 10 mg PO DAILY 
7. Cetirizine 10 mg PO DAILY 
8. fluticasone propionate 50 mcg/actuation nasal DAILY 
9. Meclizine 25 mg PO Q12H:PRN vertigo 

 
Discharge Medications:
1.  Albuterol Inhaler ___ PUFF IH Q4H:PRN wheezing, shortness of 
breath 
RX *albuterol sulfate 90 mcg 1 puff inhaled q4hrs PRN Disp #*1 
Inhaler Refills:*3 
2.  Fluticasone Propionate 110mcg 2 PUFF IH BID 
RX *fluticasone propionate [Flovent HFA] 110 mcg/actuation 2 
puffs IH twice a day Disp #*1 Inhaler Refills:*3 
3.  Torsemide 60 mg PO DAILY 
RX *torsemide 20 mg 3 tablet(s) by mouth once a day Disp #*270 
Tablet Refills:*3 
4.  amLODIPine 10 mg PO DAILY  
5.  Aspirin 81 mg PO DAILY  
6.  Cetirizine 10 mg PO DAILY  
7.  EPINEPHrine (EpiPEN) 0.3 mg IM DAILY:PRN anaphylaxis  
8.  fluticasone propionate 50 mcg/actuation nasal DAILY  
9.  Losartan Potassium 75 mg PO DAILY  
10.  Meclizine 25 mg PO Q12H:PRN vertigo  
11.  Metoprolol Succinate XL 25 mg PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis: 
================== 
Acute HFpEF Exacerbation  
 
Secondary Diagnosis: 
==================== 
1) Reactive Airway Disease  
2) Chronic Kidney Disease  
3) ___ Disease  
4) Hypertension  
5) GERD  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
==========================
DISCHARGE INSTRUCTIONS
==========================
Dear ___

___ were admitted to the hospital because ___ are coughing a 
lot. Please see below for more information on your 
hospitalization. It was a pleasure participating in your care!  
 
We wish ___ the best!
-Your ___ Healthcare Team  

What happened while ___ were in the hospital?  
-We gave ___ medications to help ___ pee out extra fluid.
We gave ___ medications to help improve your breathing.

What should ___ do after leaving the hospital?  
-Please take your medications as listed below and follow up at 
the listed appointments. 
-Your weight at discharge is 139.7 lbs. Please weigh yourself 
today at home and use this as your new baseline. 
-Please do not take NSAIDs (Advil, Motrin, Aleve) as these can 
cause heart failure
-Please weigh yourself every day in the morning. Call your 
doctor if your weight goes up or down by more than 3 lbs in a 
day or more than 5lbs in a week 

 
Followup Instructions:
___
"
129,16868992,25346107," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROSURGERY
 
Allergies: 
Ritalin / Sulfa (Sulfonamide Antibiotics) / promethazine / 
Macrolide Antibiotics / ibuprofen / Erythrocin / Decadron / 
azithromycin / cephalexin / erythromycin base / Nubain / 
Phenergan / mushrooms
 
Attending: ___.
 
Chief Complaint:
Cerebral aneurysm 
 
Major Surgical or Invasive Procedure:
___: Right Craniotomy for clipping of right PCOMM aneurysm 
 
History of Present Illness:
___ female presented to clinic for evaluation of a right 
posterior communicating artery aneurysm that was seen on MRA 
imaging.  She has undergone multiple MRI imaging in the past for 
chronic headaches; however, she had never
undergone a vascular imaging.  She does have a family history of 
aneurysms as her father died of a cerebral aneurysm in ___ at 
the age of ___.  That MRA showed a 4-mm right posterior 
communicating artery aneurysm.  She underwent CTA imaging, which 
confirmed the diagnosis. She has chronic headaches.  No new
nausea or emesis, at least no new nausea that is new.  She has 
no numbness, weakness in her arms or legs as well.  She has had 
a 70-pound weight loss over the last six or seven months, which 
is currently being worked up. Patient underwent diagnostic 
angiogram which confirmed a PCOMM aneurysm. 

 
Past Medical History:
IBS
Anxiety
ADD
chronic headache
 
Social History:
___
Family History:
Father, deceased, aneurysm rupture
Mother ischemic stroke with hemorrhagic conversion
 
Physical Exam:
ON ADMISSION:
=============

Gen: WD/WN, comfortable, NAD.
HEENT: PERRL, EOMs full without nystagmus
Neck: Supple.
Lungs: CTA bilaterally.
Cardiac: RRR. S1/S2.
Abd: Soft, NT, BS+
Extrem: Warm and well-perfused.
Neuro:
Mental status: Awake and alert, cooperative with exam, flat
affect.
Orientation: Oriented to person, place, and date.
Recall: ___ objects at 5 minutes.
Language: Speech fluent with good comprehension and repetition.
Naming intact. No dysarthria or paraphasic errors.

Cranial Nerves:
I: Not tested
II: Pupils equally round and reactive to light, 4 to 2
mm bilaterally. Visual fields are full to confrontation.
III, IV, VI: Extraocular movements intact bilaterally without
nystagmus.
V, VII: Facial strength and sensation intact and symmetric.
VIII: Hearing intact to voice.
IX, X: Palatal elevation symmetrical.
XI: Sternocleidomastoid and trapezius normal bilaterally.
XII: Tongue midline without fasciculations.

Motor: Normal bulk and tone bilaterally. No abnormal movements,
tremors. Strength full power ___ throughout. No pronator drift

Sensation: Intact to light touch.

=
=
=
================================================================

ON DISCHARGE:
============

Opens eyes: [x]spontaneous [ ]to voice [ ]to noxious

Orientation: [x]Person [x]Place [x]Time

Follows commands: [ ]Simple [x]Complex [ ]None

Pupils:  ___ bilat

EOM: [x]Full [ ]Restricted

Face Symmetric: [x]Yes [ ]No   Tongue Midline: [x]Yes [ ]No

Pronator Drift: [ ]Yes [x]No   Speech Fluent: [x]Yes [ ]No

Comprehension intact: [x]Yes [ ]No

Motor:
Deltoid BicepTricepGrip
Right5        5      5        5
Left5        5      5        5

IPQuadHamATEHLGast
Right5        5      5       5        5       5
Left5        5      5       5        5       5

[x]Sensation intact to light touch

Wound:
[x]OTA 
[x]Clean, dry, intact

 
Pertinent Results:
Please see OMR for pertinent imaging and lab results. 
 
Brief Hospital Course:
___ presented to ___ for admission prior to surgery 
and pre-surgical hydration on ___. Later that day she was 
taken to the OR for Right craniotomy for clipping of PCOMM 
aneurysm. Patient tolerated the procedure well. Please see 
formal op report in OMR for further intra operative details. She 
was successfully extubated and transferred to PACU for post op 
management.

#PCOMM aneurysm
The patient is now s/p right crani PCOMM aneurysm clipping 
performed ___. She was transferred from the PACU to the ___ 
for Q2h neuro checks and ongoing care and surveillance. She 
remained neurologically intact throughout her time in the ___ 
and was made floor status on POD#2. On POD#3, patient received 
IV decadron x1 for right periorbital edema.

#Pain Control
On POD1, the patient continued to have headaches that were 
controlled with PO and IV management. Acute pain management was 
consulted. After evaluating the patient, they recommended 
switching her Oxycodone PO prn to Dilaudid ___ Q4hrs prn 
severe pain. She remained on APAP prn, Fioricet prn, 
Cyclobenzaprine prn, Gabapentin and Tizanadine. Her IV pain 
medications were discontinued on POD#2.

#Asymptomatic hypotension
Overnight on POD#3, patient experienced a brief episode of 
asymptomatic hypotension likely secondary to the combination of 
medications she recieved. Medication management was discussed 
with the patient prior to discharge and she voiced 
understanding. Her lisinopril dose was decreased from 20mg to 
5mg. Patient should follow up with her PCP regarding this 
medication dose change.
 
Medications on Admission:
ALPRAZOLAM [XANAX] - Xanax 2 mg tablet. 1 tablet(s) by mouth
three times daily -  (Prescribed by Other Provider)
BUTALBITAL-ACETAMINOPHEN-CAFF [FIORICET] - Fioricet 50 mg-300
mg-40 mg capsule. 1 capsule(s) by mouth every 6 hours as needed 
-
(Prescribed by Other Provider)
COLESTIPOL [COLESTID] - Colestid 1 gram tablet. 1 tablet(s) by
mouth at bedtime as needed -  (Prescribed by Other Provider)
DENOSUMAB [PROLIA] - Prolia 60 mg/mL subcutaneous syringe. 1 SC
every 6 months -  (Prescribed by Other Provider)
DEXTROAMPHETAMINE-AMPHETAMINE [ADDERALL] - Adderall 30 mg 
tablet.
1 tablet(s) by mouth twice daily -  (Prescribed by Other
Provider)
DICYCLOMINE - dicyclomine 10 mg capsule. 1 capsule(s) by mouth
four times daily as needed -  (Prescribed by Other Provider)
DIPHENOXYLATE-ATROPINE [LOMOTIL] - Lomotil 2.5 mg-0.025 mg
tablet. 1 tablet(s) by mouth four times daily as needed for
diarrhea -  (Prescribed by Other Provider)
GABAPENTIN - gabapentin 300 mg capsule. 4 capsule(s) by mouth
three times daily -  (Prescribed by Other Provider)
LISINOPRIL - lisinopril 20 mg tablet. 1 tablet(s) by mouth daily
-  (Prescribed by Other Provider)
MELOXICAM - meloxicam 15 mg tablet. 1 tablet(s) by mouth daily - 

(Prescribed by Other Provider)
NORTRIPTYLINE - nortriptyline  . 20 mg tab takes 2 at bedtime - 
(Prescribed by Other Provider)
ONDANSETRON HCL [ZOFRAN] - Zofran 4 mg tablet. 1 tablet(s) by
mouth every 8 hours as needed for nausea -  (Prescribed by Other
Provider)
TIZANIDINE [ZANAFLEX] - Zanaflex 4 mg capsule. 1 capsule(s) by
mouth hs -  (Prescribed by Other Provider)
TRAZODONE - trazodone 100 mg tablet. 2 tablet(s) by mouth 
bedtime
patient takes 100mg -  (Prescribed by Other Provider)
 
Medications - OTC
ACETAMINOPHEN - acetaminophen 500 mg tablet. 2 tablet(s) by 
mouth
four times daily -  (Prescribed by Other Provider)
CALCIUM CARBONATE [CALCIUM 500] - Calcium 500 500 mg calcium
(1,250 mg) tablet. 1 tablet(s) by mouth daily -  (Prescribed by
Other Provider)
CALCIUM CARBONATE [TUMS] - Tums 200 mg calcium (500 mg) chewable
tablet. 1 tablet(s) by mouth as needed -  (Prescribed by Other
Provider)
CHOLECALCIFEROL (VITAMIN D3) [VITAMIN D3] - Vitamin D3 2,000 
unit
capsule. 1 capsule(s) by mouth daily -  (Prescribed by Other
Provider)
CYANOCOBALAMIN (VITAMIN B-12) [VITAMIN B-12] - Vitamin B-12 500
mcg tablet. 1 tablet(s) by mouth  -  (Prescribed by Other
Provider)

 
Discharge Medications:
1.  Bisacodyl 10 mg PO/PR DAILY:PRN constipation 
RX *bisacodyl 5 mg 2 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*3 
2.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*60 Capsule Refills:*3 
3.  HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Severe 
RX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every 
four (4) hours Disp #*25 Tablet Refills:*0 
4.  Lisinopril 5 mg PO DAILY 
Please follow up with your PCP regarding dose change. 
RX *lisinopril 5 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*3 
5.  Nicotine Patch 14 mg/day TD DAILY 
RX *nicotine [Nicoderm CQ] 14 mg/24 hour Please apply one patch 
daily. once a day Disp #*21 Patch Refills:*0 
6.  Senna 17.2 mg PO QHS 
RX *sennosides [Senna Lax] 8.6 mg 2 tablet(s) by mouth at 
bedtime Disp #*60 Tablet Refills:*3 
7.  Acetaminophen-Caff-Butalbital ___ TAB PO Q6H:PRN Headache 
  Reason for PRN duplicate override: Alternating agents for 
similar severity 
8.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever  
9.  ALPRAZolam 1 mg PO TID:PRN Anxiety   
10.  Gabapentin 1200 mg PO TID  
11.  Nortriptyline 25 mg PO QHS  
12.  Tizanidine 4 mg PO QHS  
13.  TraZODone 100 mg PO QHS  

 
Discharge Disposition:
Home With Service
 
Facility:
___ 
 
Discharge Diagnosis:
PCOMM Aneurysm 
Post-operative pain

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Call your neurosurgeons office and speak to the Nurse 
Practitioner if you experience:

- Any neurological issues, such as change in vision, speech or 
movement

- Swelling, drainage, or redness of your incision

- Any problems with medications, such as nausea vomiting or 
lethargy

- Fever greater than 101.5 degrees Fahrenheit

- Headaches not relieved with prescribed medications

Activity:
- Start to resume all activities as you tolerate  but start 
slowly and increase at your own pace.

- Do not operate any motorized vehicle for at least 10 days 
after your surgery  your Nurse Practitioner can give you more 
detail at the time of your suture removal.  

Incision Care:

- Keep your wound clean and dry.

- Do not use shampoo until your sutures are removed. 

- When you are allowed to shampoo your hair, let the shampoo run 
off the incision line.  Gently pad the incision with a towel to 
dry.

- Do not rub, scrub, scratch, or pick at any scabs on the 
incision line.

- You need your sutures removed 7 to 10 days after surgery

Post-Operative Experiences: Physical

- Jaw pain on the same side as your surgery; this goes away 
after about a month

- You may experience constipation.  Constipation can be 
prevented by:

o Drinking plenty of fluids
oIncreasing fiber in your diet by eating vegetables, prunes, 
fiber rich breads and cereals, or fiber supplements
oExercising
oUsing over-the-counter bowel stimulants or laxatives as needed, 
stopping usage if you experience loose bowel movements or 
diarrhea

- Fatigue which will slowly resolve over time

- Numbness or tingling in the area of the incision; this can 
take weeks or months to fully resolve

- Muffled hearing in the ear near the incision area

- Low back pain or shooting pain down the leg which can resolve 
with increased activity

Post-Operative Experiences: Emotional

- You may experience depression.  Symptoms of depression can 
include

o Feeling down or sad
o Irritability, frustration, and confusion
o Distractibility
o Lower Self-Esteem/Relationship Challenges
o Insomnia
o Loneliness

- If you experience these symptoms, you can contact your Primary 
Care Provider who can make a referral to a Psychologist or 
Psychiatrist

- You can also seek out a local Brain Aneurysm Support Group in 
your area through the Brain Aneurysm Foundation

o More information can be found at ___

 
Followup Instructions:
___
"
130,17044560,23186529," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: PSYCHIATRY
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___
 
Chief Complaint:
""I lost control.  I pushed someone who was in control.""

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
This patient is a ___ year old man with unknown past psychiatric
history who apparently became agitated at a widespread panic
concert and was observed to be kicking and spitting, requiring 7
officers to subdue him.  He was brought to the ED by ambulance
and was highly agitated on presentation, chanting loudly in
gibberish which he called ""speaking in tongues.""  The patient 
was
given Zyprexa 10mg and became more sedate, but was still unable
to cooperate with an interview and responded to questions with
gibberish.  

On re-evaluation the following morning, the patient was able to
speak coherently at times giving his father's name and phone
number, but repeatedly reverted back to gibberish, at which 
point
he would gesticulate and make facial expressions as if he were
trying to communicate something important.  He exhibited 
paranoia
asking for a glass of water and then refusing it three times
because it had been spit in.  He was evasive and guarded and
repeatedly suggested that the interviewers would burn in hell 
and
stated that he spoke to god daily and that he knew how to speak
in tongues.  He was easily distractible asking if we thought it
interesting that the sheets had the word ___ printed on
them.  He became quickly frustrated with the questioning and
demanded that we leave the room and threatened that we would all
be in trouble once he got out of the hospital.

Obtained collateral information from pt's father ___
___ cell, ___ office, ___ home).
According to the father, last ___ pt was behaving 
bizzarely, walking
naked around the house, staying in bathroom for several hours,
punching walls, singing, reading Bible, writing, talking about
suicide. Pt's father describes some ideas of reference, eg pt
reading a newspaper and relating it to himself, grandiosity - pt 

thinking he's direct descendant ___ ___. Father
states that pt is preoccupied with scars on his face s/p acne as
a teenager and often feels that people are looking at him. He is
not really able to describe concrete manic episodes, rather he
states that pt usually keeps to himself, sleeps during the day,
plays drums at 3 am in the attic.      

Additional collateral info was obtained per ___
(___), ___ at ___, who
visited pt at the hospital. Ms. ___ stated that she knows very
little about the patient. According to her, he is taking 2
classes at ___ - Creative Writing and 
Music.
Pt's creative writing professor remarked that pt has been in
class only twice, that he was ""strange, sarcastic, detached, had
written a bizarre writing excercise"". 

Medical records obtained from pt's ___ hospitalization
indicate that he was started on Lithium 300 mg 2 po AM and 3 po
___, as well as Lunesta 3 mg po qhs, and Valium 5 mg bid prn.

 
Past Medical History:
According to the father pt has been diagnosed with bipolar
disorder in ___ after being hospitalized for bizzare
behavior at ___ in ___, ___. At that
time pt was started on Lithium, which he has been taking
sporadically. He was followed by a psychiatrist Dr. ___
___ ___. Pt has suffered from depression
since age ___, been on mul. He has been hospitalized multiple
times. He has hx of SA, first at age ___ for OD on ""some pills""
and also another time he put rope around his neck.

Per father, no ___ PMH, no allergies
 
Social History:
___
Family History:
none
 
Physical Exam:
On admission:
MENTAL STATUS EXAM (USE FULL, DESCRIPTIVE SENTENCES WHERE
APPLICABLE)
     APPEARANCE & FACIAL EXPRESSION:  Patient is a dishevelled
young man with short brown hair and facial scruff.  he has a
small abrasion on his L shoulder and some light bruising around
his jaw line.  He avoids eye contact and has a blank expression
on his face.
     POSTURE:  No bizarre posturing or waxy flexibility.
     BEHAVIOR (NOTE ANY ABNORMAL MOVEMENTS):  Patient initially
chanting loudly in gibberish when first brought into ED.
     ATTITUDE (E.G., COOPERATIVE, PROVOCATIVE):  Patient
uncooperative with interviewer, demanding that interviewer 
""leave
now"" and ""stop asking questions.""
     SPEECH (E.G., PRESSURED, SLOWED, DYSARTHRIC, APHASIC, 
ETC.):
Speech pressured at times, sing song in quality, 
incomprehensible
as it sounds like a different language that he calls ""speaking 
in
tongues.""
     MOOD:  Patient declines to say.
     AFFECT (NOTE RANGE, REACTIVITY, APPROPRIATENESS, ETC.): 
Restricted, dysphoric.
     THOUGHT FORM (E.G., LOOSENED ASSOCIATIONS, TANGENTIALITY,
     CIRCUMSTANTIALITY, FLIGHT OF IDEAS, ETC.):  Thought process
is disorganized, tangential as he answers questions with
irrelevant responses and is easily distracted.  
     THOUGHT CONTENT (E.G., PREOCCUPATIONS, OBSESSIONS,          

DELUSIONS, ETC.):  Patient is hyperreligious, paranoid,
grandiose.
     ABNORMAL PERCEPTIONS (E.G., HALLUCINATIONS):  Patient
declines to answer.  However, states that he speaks to god 
daily.
     NEUROVEGETATIVE SYMPTOMS (E.G., DISTURBANCES OF SLEEP,      

APPETITE, ENERGY, LIBIDO):  unknown
     SUICIDALITY/HOMICIDALITY (INCLUDE IDEATION, INTENT, PLAN): 
unknown
     INSIGHT AND JUDGMENT:  Poor insight and judgment.
     COGNITIVE ASSESSMENT:  Patient alert but unable to 
cooperate
with cognitive exam.  Does not answer questions appropriately.
          

Physical exam: notable for superficial abrasions on left knee 
and shoulder

On Discharge: Pt. is a young male with intact grooming. Behavior 
is calm, but irritable at times, cooperative with exam. speech 
is RRR. Mood is ""fine."" Affect irritable. TP-linear. TC- no 
overt evidence of delusions, no abnormal perceptions. No S/H 
TIP. I/J-fair.
 
Pertinent Results:
___ 01:30PM URINE  ___ BACTERIA-FEW YEAST-NONE 
EPI-0 RENAL ___ 01:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-TR
___ 01:30PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 01:30PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG mthdone-NEG
___ 01:30PM URINE  HOURS-RANDOM
___ 06:45AM BLOOD Glucose-87 UreaN-14 Creat-0.9 Na-142 
K-4.2 Cl-106 HCO3-29 AnGap-11
___ 06:45AM BLOOD Calcium-9.7 Phos-3.9 Mg-1.8
___ 05:07PM URINE PHENCYCLIDINE-neg.

RAPID PLASMA REAGIN TEST (Final ___: 
      NONREACTIVE. 
      Reference Range: Non-Reactive. 

  
 
Brief Hospital Course:
Pt. medically cleared and admitted to ___ inpatient 
psychiatry service after spending 2 days in ED for agitated 
behavior requiring multiple chemical restraints. Patient 
evaluated upon arrival to unit and placed on 15 min checks. Pt. 
refused to sign a CV.

Psych: Pt. initial presentation consisted of psychotic symptoms, 
namely grandiose and paranoid delusions, of being ___ the 
___, being able to speak in tongues, thinking people had 
spit in his water. ___ also beleived that he could read the 
mind of the the young girl he pushed and believed that she was 
making fun of his breasts and acne scars. He consistently denied 
any auditory hallucinations. ___ thought disorder and 
disorganization of speech were quite striking during his initial 
presentation and early part of his hospitalization, 
characterized by extreme looseness of associations, bordering on 
pressured and angry derailed tirades. ___ also presented with 
noticeably flat affect despite his angry and irritable behavior 
early on in his admission. He initially refused to take any 
medication and denied anything was wrong. An affadavit for court 
commitment was filed prior to expiration of ___ and ___ 
was committed to unit for 45 days, and required to take 
medication. ___ was started on Geodon 40 mg BID, which was 
quickly titrated up to 60 mg BID and eventually 80 mg BID after 
5 days. He also received Ativan 1 mg q6 PRN anxiety and poor 
sleep which he used regularly. He tolerated the medications with 
minimal side effects, though some ? stiffness was noted and 
patient was given Cogentin as well with each dose of Geodon. In 
the second week of medication, ___ developed an episode of 
orthostatic hypotension and his dose was decreased to 60 mg BID 
for 1 week. His orthostatis resolved with increased PO intake, 
and ___ was able to be titrated back up to 80 mg BID, Cogentin 
was also d/c'd. It was felt Geodon would be an appropriate 
antipsychotic for ___ given its neutral metabolic profile, 
ability for IM dosing if needed, lower risk for EPS, and little 
risk of prolaction elevation (given concern over breasts). ___ 
responded very slowly over the first 2 weeks of medication, 
showing improvement in his thought disorder and speech 
organization. The most striking feature of ___ hospital 
course, though, were his marked negative sxs which seemed to 
worsen during his stay: flat affect, alogia, withdrawal, apathy, 
and demoralization. It was thought that ___ likely was 
suffering from post-psychotic depression. Through discussions 
about his presentation and literature review, it was thought 
___ might benefit from initiation of Mirtazapine to help with 
negative sxs. He was started on 15 mg HS. Unfortunately, ___ 
did not tolerate the medication well, and developed intolerable 
sedation. The medication was thus discontinued on ___.  The 
patient was continued on the Geodon 60mg PO BID which he 
tolerated and was also continued on Cogentin 1mg PO BID PRN and 
Ativan 1mg PO TID PRN. The patient was discharged with 
prescriptions for the above medications and with a plan to 
follow up with his psychiatrist in two weeks.

As far as Mr. ___ diagnosis. He is ___ yo male admitted with 
bizarre and agitated behavior, exhibiting grandiose and paranoid 
delusions, and severe thought disorder. Patient has a ___ year 
history dating back to age ___ of depressive sxs and obsessive 
traits, 1 pior SA, and suffered the loss of his mother to CA at 
age ___. Last ___ patient had ___ psychotic episode, initially 
thought to be manic as well, but from discussions with outpt. 
psychiatrist and viewing d/c summary, there is little evidence 
of a manic episode. Based on current presentation and past 
history, it appears that Mr. ___ is suffering from the early 
beginnings of Schizophrenia, likely paranoid type, with 
pronounced negative symptoms and subsequent post-psychotic 
depression.

In the future, if patient does not show adequate remission of 
symptoms with geodon, it may be reasonable to try Risperdone, 
given the availability of a long-acting injectable form. Also, a 
re-trial of Mirtazapine may also be a consideration in the 
future if ___ negative/cognitive sxs continue to be an issue, 
though a lower starting dose would be recommended with slow 
upward titration.

Medical: ___ initially complained is some hand pain and 
tingling in his right hand secondary to injury from concert. 
Physical exam of this region was benign. No imaging was felt to 
be necessary. Patient was managed with PRN Ibuprofen with good 
effect. One episode of orthostasis as noted above on unit, 
responded well to decrease in Geodon dose and increased PO 
intake. The patient did not experience any other medical issues 
during his hospitalization. His vitals were monitored daily and 
apart from the orthostatic episode remained stable. He will f/u 
with his PCP upon discharge.

Social: SW evaluation done on admission. SW in contact with 
family throughout stay. Conference call made with ___ and 
psychiatry resident during initial part of stay to discuss 
diagnosis, treatment, and likely dispo planning. Also, ___ 
court-ordered to contact ___ to bring school materials. 
Contact made and ___ of school came to bring ___ belongings 
and materials, thought ___ made the decision to not continue 
with school given his current hospitalization. Letter was 
submitted on his behalf in attempt to obtain refund of tuition. 
The associate ___ of ___ ___ 
(___) was contacted and will be receiving the letters. 
A family meeting was held with pt. and father, and treatment 
team on ___ to facilitate d/c planning. 

Legal: ___
Checks: 15 minutes throughout stay. No acute behavioral issues 
on unit. No suicidal ideation or behaviors noted during stay.

Dispo: The patient was found to be appropriate for discharge on 
the ___ day of hospitalization. His father ___ was 
present during his discharge, and the plan is for the patient to 
return to ___ with his father. He will follow up with his 
psychiatrist and PCP as scheduled.
 
Medications on Admission:
Lithium 600 am, 900 HS
 
Discharge Medications:
1. Lorazepam 1 mg Tablet ___: One (1) Tablet PO three times a 
day as needed for anxiety/agitation.
Disp:*20 Tablet(s)* Refills:*0*
2. Multivitamin     Tablet ___: One (1) Tablet PO DAILY (Daily). 
 
3. Tretinoin 0.1 % Cream ___: One (1) Appl Topical QHS (once a 
day (at bedtime)).  
4. Ziprasidone HCl 60 mg Capsule ___: One (1) Capsule PO BID (2 
times a day).
Disp:*30 Capsule(s)* Refills:*0*
5. Benztropine 1 mg Tablet ___: One (1) Tablet PO BID (2 times a 
day) as needed for EPS.
Disp:*26 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Axis I: Schizophrenia, paranoid type, with prominent negative 
symptoms
Axis II: deferred
Axis III: no active medical issues

 
Discharge Condition:
Medically and psychiatrically stable for discharge home without 
thoughts of self-harm.

 
Discharge Instructions:
Please call your psychiatrist or go to nearest emergency room if 
you feel suicidal, homicidal, or your symptoms worsen.

Please take your medication as prescribed.

Please follow-up with your outpatient providers as scheduled.
 
Followup Instructions:
___
"
131,17184755,23975412," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: UROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
BPH
 
Major Surgical or Invasive Procedure:
TURP

 
History of Present Illness:
Today I saw Mr. ___ for further evaluation of lower 
urinary tract symptoms, especially urgency. 
He is a ___ white male with a history of prostate
enlargement and lower urinary tract symptoms who complains
primarily of urgency and urge incontinence.  He also has a slow
stream.  He comes in to discuss options for management. 
Currently, he voids five to six times a day with nocturia x 3,
has urgency most of the time, has a reduced stream most of the
time.  Denies any leakage, does not normally wear pads.  He does
say that very rarely he will leak out a few drops prior to 
making
it to the bathroom.  He has been maintained on alfuzosin for his
BPH-related symptoms. Urodynamics showed ___ obstruction by 
___ criteria with normal bladder capacity and complacence. 
Given all the above, the decision was made to proceed with a 
TURP.

 
Past Medical History:
Onychomycosis, Hyperlipidemia, BPH, Sinus node dysfunction
 
Social History:
___
Family History:
No GU cancers
 
Physical Exam:
Afebrile, VS wnl
NAD, Ox3
Breathing comfortably RA
Abd soft, NT, ND
Voiding clear light pink urine with voided volumes > PVR
 
Brief Hospital Course:
Patient was admitted to urology after undergoing transurethral 
resection of the prostate. There were no intra-operative 
complications. Post-op course was also uncomplicated. Patient 
was placed on overnight continuous bladder irrigation which was 
light pink and discontinued on morning of POD1.  The foley was 
removed and patient voided without difficulty.   At discharge 
patient's pain well controlled with PO pain medications, 
tolerating regular diet, ambulating without assistance, and 
voiding.
 
Medications on Admission:
1. alfuzosin 10 mg Oral qday 
2. Lovastatin 10 mg Oral qday
 
Discharge Medications:
1. alfuzosin 10 mg Oral qday 
2. Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily 
Disp #*30 Capsule Refills:*0
3. Lovastatin 10 mg Oral qday 
4. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q4H:PRN 
breakthrough pain only(score>4) 
RX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth 
every 4 to 6 hours Disp #*30 Tablet Refills:*0
5. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 3 Days 
RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by 
mouth twice daily Disp #*6 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
BPH

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
-Do not lift anything heavier than a phone book (10 pounds) or 
drive until you are seen by your Urologist in follow-up

-You may continue to periodically see small amounts of blood in 
your urine--this is normal and will gradually improve

-Resume all of your pre-admission medications, except HOLD 
aspirin until you see your urologist in followup AND your foley 
has been removed (if not already done)

-Continue taking PROSCAR (Finasteride) AND/OR your other 
prostate shrinking medications until you are otherwise advised 
.

-You MAY be discharged home with a medication called PYRIDIUM 
that will help with the ""burning"" pain you may experience when 
voiding. This medication may turn your urine
bright orange.

-Colace has been prescribed to avoid post surgical constipation 
and constipation related to narcotic pain medication. 
Discontinue if loose stool or diarrhea develops. Colace is a 
stool softener, NOT a laxative, and available over the counter.  
The generic name is DOCUSATE SODIUM.  It is recommended that you 
use this medication.

-Do not eat constipating foods for ___ weeks, drink plenty of 
fluids to keep hydrated

-No vigorous physical activity or sports for 4 weeks and while 
Foley catheter is in place. 

-Tylenol should be your first line pain medication, a narcotic 
pain medication has been prescribed for breakthrough pain >4. 
Replace Tylenol with narcotic pain medication.

-Max daily Tylenol (acetaminophen) dose is 4 grams from ALL 
sources, note that narcotic pain medication also contains 
Tylenol

-Do not drive or drink alcohol while taking narcotics and do not 
operate dangerous machinery. Also, if the Foley catheter and Leg 
Bag are in place--Do NOT drive (you may be a passenger).

IF YOU ARE DISCHARGED HOME WITH A FOLEY CATHETER:

-Please refer to the provided nursing instructions and handout 
on Foley catheter care, waste elimination and leg bag usage.

-Your Foley should be secured to the catheter secure on your 
thigh at ALL times until your follow up with the surgeon.

-Follow up in 1 week for wound check and Foley removal. DO NOT 
have anyone else other than your Surgeon remove your Foley for 
any reason.

-Wear Large Foley bag for majority of time, leg bag is only for 
short-term when leaving house.

-Start prescribed antibiotic on discharge.
 
Followup Instructions:
___
"
132,17456970,27010697," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Penicillins / Topamax / Influenza Virus Vaccines / latex / 
nickel
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ has class III morbid obesity with 
weight of 259.6 pounds as of ___ with her initial screen 
weight of 255.7 pounds on ___, height of 63 inches and BMI 
of 46.0.  Her previous weight loss efforts have included Weight 
Watchers, over-the-counter dietary supplement ___ and
physician-supervised weight management with Dr. ___ 
___ at ___ treated with 
prescription weight loss medication phentermine.  She stated 
that her lowest adult weight was 191 pounds at the age of ___ and 
her highest weight is her current weight of 259.6 pounds.  She 
stated that she has been struggling with weight since the age of 
___ and cites as factors contributing to her excess weight 
genetics, large portions, too many carbohydrates and saturated 
fats and lack of exercise (physical limitation secondary to foot 
pain in boot).  She is on a vegetarian diet.  She denied history 
of eating disorders - no anorexia, bulimia, diuretic or laxative
abuse and she denied binge eating.  She does not have a clinical 
diagnosis of depression except for reactive and situational 
around her weight, has anxiety and she is not being followed by 
a therapist currently, has not been hospitalized for mental 
health issues and she is on psychotropic medications (lorazepam, 
diazepam, doxepin).

 
Past Medical History:
1)  gastroesophageal reflux
2)  hyperlipidemia
3)  history of migraine headaches
4)  vertigo
5)  history of skin cancer in remission since ___
6)  iron deficiency with saturation of 13%
7)  history of bronchitis 
8)  atypical nevi
9)  home sleep study ___ did not demonstrate obstructive 
    sleep apnea
10) h/o vitamin D deficiency

She was hospitalized at ___ in ___
___ for one night secondary to reaction to Topamax.

Her only surgical procedure is for removal of a skin mole in
___.

 
Social History:
___
Family History:
Her family history is noted for both parents living father age 
___ with heart disease, diabetes, hyperlipidemia, asthma, history 
of melanoma and obesity; mother age ___ with epilepsy and 
arthritis; paternal grandfather with type 2 diabetes and 
melanoma; paternal grandmother with type 2 diabetes and 
melanoma; paternal uncle with history of colon CA.

 
Pertinent Results:
___ 05:46AM BLOOD Hct-37.7
___ 02:04PM BLOOD Hct-40.8
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia.  
 The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA and 
transitioned to liquid oral pain medication once tolerating a 
diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Diazepam 5 mg PO Q8H:PRN vertigo 
2. LORazepam 1 mg PO Q4H:PRN AS DIR 
3. Verapamil SR 240 mg PO Q24H 
4. Ranitidine 75 mg PO DAILY 
5. Multivitamins 1 TAB PO DAILY 
6. melatonin 5 mg oral QHS 
7. eletriptan HBr 40 mg oral ASDIR 
8. Doxepin HCl 50 mg PO HS 
9. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every four (4) 
hours Disp #*300 Milliliter Refills:*0 
2.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
3.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every six (6) hours 
Refills:*0 
4.  Ranitidine 150 mg PO BID 
RX *ranitidine HCl 150 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0 
5.  Doxepin HCl 50 mg PO HS  
6.  eletriptan HBr 40 mg oral ASDIR  
7.  Multivitamins 1 TAB PO DAILY  
8.  Verapamil SR 240 mg PO Q24H 
Open capsule sprinkle contents onto 1 tablespoonful of 
applesauce, swallow whole.  
9.  Vitamin D ___ UNIT PO DAILY  
10. HELD- Diazepam 5 mg PO Q8H:PRN vertigo  This medication was 
held. Do not restart Diazepam until you are no longer requiring 
oxycodone.
11. HELD- LORazepam 1 mg PO Q4H:PRN AS DIR  This medication was 
held. Do not restart LORazepam until you are no longer taking 
oxycodone.
12. HELD- melatonin 5 mg oral QHS  This medication was held. Do 
not restart melatonin until you are no longer taking oxycodone.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You have undergone a laparoscopic sleeve gastrectomy, recovered 
in the hospital and are now preparing for discharge with the 
following instructions:

Please call your surgeon or return to the Emergency Department 
if you develop a fever greater than ___ F, shaking chills, chest 
pain, difficulty breathing, pain with breathing, cough, a rapid 
heartbeat, dizziness, severe abdominal pain, pain unrelieved by 
your pain medication, a change in the nature or severity of your 
pain, severe nausea, vomiting, abdominal bloating, severe 
diarrhea, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness, swelling from your 
incisions, or any other symptoms which are concerning to you.
Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___
"
133,17456970,22292408," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Penicillins / Topamax / Influenza Virus Vaccines / latex / 
nickel
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
___: laparoscopic cholecystectomy

 
History of Present Illness:
___ s/p lap sleeve gastrectomy ___ presenting with nausea, 
vomiting, abdominal pain. Patient was in her usual state of 
health until today, when at 2am she had nausea and vomiting, 
which continued x 4 before she presented to the ED. First 
episode was pink and the subsequent episodes were dark gray. 
This was accompanied by RUQ and midepigastric abdominal pain, 
which was worsened by the nausea. She has not had any more 
episodes of emesis since arrival in the ED. Had a normal BM 
yesterday at 10pm, no diarrhea, did not pass gas today but did 
yesterday. She had hard boiled eggs and side salad for dinner 
yesterday. No
fevers at home. No history of gallstone disease or biliary 
colic. No issues with sleeve since the surgery. Lost about 80 
lbs post-op. Has never had an EGD. Takes omeprazole for GERD, 
which controls her disease well.

WBC 11.2, LFTs wnl, CT showed no abnormalities, no signs of 
acute cholecystitis.

 
Past Medical History:
1)  gastroesophageal reflux
2)  hyperlipidemia
3)  history of migraine headaches
4)  vertigo
5)  history of skin cancer in remission since ___
6)  iron deficiency with saturation of 13%
7)  history of bronchitis 
8)  atypical nevi
9)  home sleep study ___ did not demonstrate obstructive 
    sleep apnea
10) h/o vitamin D deficiency

She was hospitalized at ___ in ___
___ for one night secondary to reaction to Topamax.

Her only surgical procedures are removal of a skin mole in
___ and a laparoscopic sleeve gastrectomy in ___

 
Social History:
___
Family History:
Her family history is noted for both parents living father age 
___ with heart disease, diabetes, hyperlipidemia, asthma, history 
of melanoma and obesity; mother age ___ with epilepsy and 
arthritis; paternal grandfather with type 2 diabetes and 
melanoma; paternal grandmother with type 2 diabetes and 
melanoma; paternal uncle with history of colon CA.

 
Physical Exam:
T 98.3 BP 119/81 P 63 RR ___ Ra  
GENERAL: no acute distress
CARDIAC: regular rate and rhythm, no murmurs appreciated
RESP: clear to auscultation, bilaterally
ABD: soft, appropriate ___ tenderness without 
rebound tenderness or guarding, abdominal lap sites with 
steri-strips, CDI
EXT: no lower extremity edema, bilaterally
 
Pertinent Results:
LABS:
___ 07:24AM BLOOD WBC-11.2* RBC-4.60 Hgb-14.0 Hct-42.6 
MCV-92 MCH-30.4 MCHC-33.2 RDW-12.3 RDWSD-40.8 Plt ___ 
Neuts-90.6* Lymphs-4.9* Monos-3.5* Eos-0.4* Baso-0.2 Im ___ 
AbsNeut-10.15* AbsLymp-0.55* AbsMono-0.39 AbsEos-0.04 
AbsBaso-0.02 ___ 10:14AM BLOOD Lactate-0.6

___ 05:25AM BLOOD ___ PTT-26.2 ___
Glucose-69* UreaN-5* Creat-0.5 Na-140 K-4.2 Cl-104 HCO3-24 
AnGap-12
ALT-8 AST-12 AlkPhos-65 TotBili-0.5

IMAGING:
CT ABD & PELVIS WITH CONTRAST: 
IMPRESSION: 
1. Status post sleeve gastrectomy without evidence of 
complication. 
2. No acute findings to account for reported symptoms. 
3. Trace left pleural effusion with minimal left basal 
atelectasis. 
  
LIVER OR GALLBLADDER US (SINGLE ORGAN):
Cholelithiasis without evidence of cholecystitis.

 
Brief Hospital Course:
Ms. ___ is a ___ s/p laparoscopic sleeve gastrectomy ___ 
who presented with abrupt onset nausea and vomiting.  An 
abdominal/pelvic CT scan was not revealing for acute 
intra-abdominal pathology, but a right upper quadrant ultrasound 
was significant for cholelithiasis.  Given her degree of pain 
and slight leukocytosis with left shift, the patient underwent a 
laparoscopic cholecystectomy on ___.  There were no adverse 
events in the operative; please see operative note for details, 
however, gallbladder edema was noted suggestive of early acute 
cholecystitis.

Post-operatively, the patient remained afebrile, hemodynamically 
stable and well controlled pain.  She tolerated a diet, 
ambulated and voided, therefore she was discharged to home and 
will follow-up in clinic with Dr. ___.  
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diazepam 5 mg PO Q8H:PRN vertigo 
2. LORazepam 1 mg PO Q6H:PRN migraines 
3. Verapamil SR 240 mg PO Q24H 
4. levonorgestrel-ethinyl estrad 0.1-20 mg-mcg oral DAILY 
5. ferrous sulfate 134 mg (27 mg iron) oral DAILY 
6. Multivitamins 2 TAB PO DAILY 
7. melatonin 5 mg oral QHS 
8. Omeprazole 20 mg PO DAILY 
9. eletriptan 40 mg oral ASDIR 
10. Doxepin HCl 10 mg PO HS 
11. cyanocobalamin (vitamin B-12) 500 mcg oral DAILY 
12. Vitamin D ___ UNIT PO DAILY 
13. Citalopram 20 mg PO DAILY 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*30 Capsule Refills:*0 
2.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours 
Disp #*10 Tablet Refills:*0 
3.  Citalopram 20 mg PO DAILY  
4.  cyanocobalamin (vitamin B-12) 500 mcg oral DAILY  
5.  Doxepin HCl 10 mg PO HS  
6.  eletriptan 40 mg oral ASDIR  
7.  ferrous sulfate 134 mg (27 mg iron) oral DAILY  
8.  melatonin 5 mg oral QHS  
9.  Multivitamins 2 TAB PO DAILY  
10.  Omeprazole 20 mg PO DAILY  
11.  Verapamil SR 240 mg PO Q24H  
12.  Vitamin D ___ UNIT PO DAILY  
13. HELD- Diazepam 5 mg PO Q8H:PRN vertigo  This medication was 
held. Do not restart Diazepam until you are no longer taking 
oxycodone.
14. HELD- levonorgestrel-ethinyl estrad 0.1-20 mg-mcg oral DAILY 
 This medication was held. Do not restart levonorgestrel-ethinyl 
estrad until two weeks after surgery.
15. HELD- LORazepam 1 mg PO Q6H:PRN migraines  This medication 
was held. Do not restart LORazepam until you are no longer 
taking oxycodone.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Acute cholecystis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You have undergone removal of your gallbladder, recovered in the 
hospital and are now preparing for discharge to home with the 
following instructions:

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

Avoid driving or operating heavy machinery while taking pain 
medications.

Incision Care:
*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap 
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up 
appointment.
*If you have steri-strips, they will fall off on their own. 
Please remove any remaining strips ___ days after surgery.

 
Followup Instructions:
___
"
134,17691205,26267152," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
lethargy, melena, hematemesis
 
Major Surgical or Invasive Procedure:
Transfusion 2u pRBC
 
History of Present Illness:
___ yo F with h/o atrial fibrillation on coumadin, s/p MVR, HTN, 
PUD, and diverticulosis who presents with lethargy, melena, 
blood oozing from her mouth and ? hematemesis. Per pt, has had 
epigastric pain for several days and vomited up ""small"" amount 
of dark colored blood for past 3 days. She later denies this and 
states that she only vomited up dark blood on one occasion on 
the day PTA. Per daughter, noted dried, dark blood around pt's 
lips on ___. Denies hematochezia, BRBPR but does report one 
episode of melena the night PTA. Per husband, he noted that pt 
was much more fatigued and tired yesterday and was unable to 
climb up a flight of stairs. He also noted ""dark colored spots"" 
over her legs and arms and dark blood oozing from her mouth 
after removing her dental plates. No coughing or vomiting up of 
blood per husband. This morning, she was found to be very hard 
to arouse from bed and again noticed dark, dried blood around 
her mouth and clothes. Upon EMS arrival, ___ reportedly wnl, BP 
60/palp. She was given IVFs during transport to ___.  
.  
In the ___, initial BP 80/palp per ___ RN. Given 500 cc bolus and 
BPs improved to 103/56. She continued to be fluid resuscitated 
with a total of 4L NS. NGL lavage performed with return of dark, 
coffee-grounds. Labs significant for Hct 29.8 (baseline mid 
30's), INR 21.2, venous lactate 10.7, Cr 3.6 (baseline 1.4 - 
1.9), troponin 0.02, CK 81. The pt was given 2 units pRBC, 2 
units FFP, panoprazole 40 mg IV X 1, and vit K 10 mg IV X 1. 
Given elevated venous lactate, a CTA abd/pelvis was performed 
that showed no signs of mesenteric ischemia, bibasilar lung 
opacities, non-specific bilateral perinephric stranding possibly 
related to renal failure, and ascites, pericholecystic fluid, 
and RV enlargement suggestive of R sided heart failure. She was 
seen by GI consult and admitted to the MICU for further care.
 
Past Medical History:
Type II diabetes mellitus  
Hypertension  
s/p mechanical mitral valve replacement ___  
Atrial fibrillation on coumadin  
Hypothyroidism  
Hyperlipidema  
Depression  
Peptic ulcer disease - dx'd by EGD in ___, H.pylori + in 
___  
Diverticulosis on colonoscopy in ___  
L vitreous hemorrhage - followed by Dr. ___ for 
vitrectomy on ___  
R retinal detachment
 
Social History:
___
Family History:
sister with breast ca. another sister with ca of unknown 
etiology. No h/o GI disease, IBD.
 
Physical Exam:
T 98.0 BP 103/65 HR 112 RR 20 O2 sat 98% on 50% shovel mask  
Gen - NAD, speaking in full sentences without SOB  
HEENT - NCAT, L eye with grossly appreciated conjunctival 
hemorrhage, R eye slighly injected, no scleral icterus, dried 
dark blood over lips, tongue, no active oozing of blood noted 
from oral cavity, JVP approximately 10 cm above sternal notch 
but difficult to fully appreciate  
CV - irregularly irregular, tachycardic, mechanical click, no 
m/r/g appreciated  
Lungs - limited by anterior exam, slight expiratory wheezing at 
bases b/l, no rales or rhonchi  
Abd - Soft, obese, non-tender to palpation throughout, no 
palpable masses or HSM, guaiac positive, grossly red colored 
stool in ___  
Ext - trace pitting ___ edema b/l, warm, cap refill < 2 sec  
Neuro - AAO X 3 (although not entirely sure which hospital she 
is in but knows she is in a hospital in ___, moves all 4 
extremities purposefully
 
Pertinent Results:
___ 09:00AM BLOOD WBC-11.4* RBC-3.03* Hgb-8.3* Hct-27.2* 
MCV-90 MCH-27.3 MCHC-30.4* RDW-15.5 Plt ___
___ 04:35AM BLOOD WBC-8.2 RBC-3.15* Hgb-9.3* Hct-27.2* 
MCV-86 MCH-29.4 MCHC-34.0 RDW-16.1* Plt ___
___ 07:30AM BLOOD WBC-7.1 RBC-3.72* Hgb-10.5* Hct-32.7* 
MCV-88 MCH-28.2 MCHC-32.1 RDW-17.6* Plt ___
___ 07:00AM BLOOD WBC-6.8 RBC-3.64* Hgb-10.4* Hct-32.8* 
MCV-90 MCH-28.5 MCHC-31.6 RDW-17.5* Plt ___
___ 09:17AM BLOOD Neuts-84.0* Bands-0 Lymphs-11.0* 
Monos-4.5 Eos-0.2 Baso-0.3
.
___ 09:17AM BLOOD ___ PTT-79.6* ___
___ 02:47PM BLOOD ___ PTT-32.9 ___
___ 12:18AM BLOOD ___ PTT-150* ___
___ 06:25AM BLOOD ___ PTT-36.8* ___
___ 06:35AM BLOOD ___ PTT-56.7* ___
___ 09:19PM BLOOD ___ PTT-74.6* ___
.
___ 09:05AM BLOOD Glucose-112* UreaN-47* Creat-3.8*# Na-142 
K-5.7* Cl-103 HCO3-12* AnGap-33*
___ 05:40PM BLOOD Glucose-211* UreaN-34* Creat-1.5* Na-140 
K-3.2* Cl-98 HCO3-31 AnGap-14
___ 07:25AM BLOOD Glucose-112* UreaN-24* Creat-1.7* Na-143 
K-3.8 Cl-101 HCO3-32 AnGap-14
___ 07:00AM BLOOD Glucose-110* UreaN-29* Creat-1.5* Na-142 
K-3.9 Cl-103 HCO3-30 AnGap-13
___ 09:05AM BLOOD Albumin-3.4 Calcium-8.1* Phos-7.7*# 
Mg-2.4
___ 06:40AM BLOOD Calcium-9.1 Phos-2.6* Mg-1.9
___ 07:28PM BLOOD Mg-2.0
___ 07:00AM BLOOD Calcium-8.9 Phos-4.0 Mg-2.1
.
___ 09:05AM BLOOD ALT-16 AST-38 CK(CPK)-81 AlkPhos-46 
Amylase-195* TotBili-1.1
.
___ 09:05AM BLOOD CK-MB-NotDone cTropnT-0.02*
___ 06:57PM BLOOD CK-MB-4 cTropnT-0.04*
___ 04:26AM BLOOD CK-MB-5 cTropnT-0.01
.
___ 09:17AM BLOOD TSH-0.67
___ 04:26AM BLOOD T3-52* Free T4-1.2
___ 09:05AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 09:02AM BLOOD Glucose-111* Lactate-10.7* Na-140 K-5.3 
Cl-105 calHCO3-17*
.
___ 09:45AM URINE Blood-TR Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
___ 02:08PM URINE Blood-MOD Nitrite-NEG Protein-30 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-7.5 Leuks-SM 
___ 09:45AM URINE ___ Bacteri-OCC Yeast-NONE 
___ 02:08PM URINE RBC-182* WBC-8* Bacteri-NONE Yeast-NONE 
Epi-<1
.
UCx neg
C diff neg
.
___ CXR
SINGLE PORTABLE VIEW OF THE CHEST: There has been previous 
sternotomy, with 
midline sternal wires and prosthetic mitral valve again 
identified. Marked 
cardiomegaly is again noted with bilateral peripheral 
interstitial opacities. 
Findings may be related to chronic interstitial lung disease 
though 
superimposed mild congestion is also probable. There is no 
pleural effusion. 
The bony thorax is unremarkable. 
  
IMPRESSION: 
  
1. Cardiomegaly with probable mild congestion. 
.
___ CT abd/pelvis
IMPRESSION: 
1. No evidence of mesenteric ischemia. 
2. New bilateral perinephric stranding, a nonspecific finding. 
This may be 
related to medical renal disease. 
3. Reticulonodular opacities at the lung bases likely reflect 
edema 
superimposed on chronic interstitial lung disease. 
4. Cardiomegaly with right heart failure. 
5. Small volume ascites.  
.
___ CT head
IMPRESSION: 
  
1. No evidence of infarction or hemorrhage, allowing for the 
presence of 
intravenous contrast from the preceding abdominal/pelvic CT. 
.
___ CT head
IMPRESSION: No evidence of acute hemorrhage or acute large 
vascular territory 
infarcts. Prominence of the ventricles slightly out of 
proportion to 
prominence of the sulci is unchanged compared to ___. 
Periventricular 
hypodensities may represent chronic small vessel ischemic 
disease, 
transependymal migration of CSF, or a combination of the two; 
comparison with 
earlier prior imaging, if available, may be helpful in assessing 
change over 
time. 
.
___ CXR
The heart is enlarged. Mitral valve replacement is present. The 
interstitial 
failure present on the prior chest ___ appears 
less marked but 
this could be due to technical differences and I suspect that 
some 
interstitial failure is still present. Atelectasis is again 
present. 
  
IMPRESSION: Persistent cardiomegaly, interstitial failure 
possibly better. 

 
Brief Hospital Course:
Hospital course was as follows: 

In the ___, initial BP 80/palp per ___ RN. Given 500 cc bolus and 
BPs improved to 103/56. She continued to be fluid resuscitated 
with a total of 4L NS. NGL lavage performed with return of dark, 
coffee-grounds. Labs significant for Hct 29.8 (baseline mid 
30___s), INR 21.2, venous lactate 10.7, Cr 3.6 (baseline 1.4 - 
1.9), troponin 0.02, CK 81. The patient was given 2 units pRBC, 
2 units FFP, panoprazole 40 mg IV X 1, and vit K 10 mg IV X 1. 
Given elevated venous lactate, a CTA abd/pelvis was performed 
that showed no signs of mesenteric ischemia, bibasilar lung 
opacities, non-specific bilateral perinephric stranding possibly 
related to renal failure, and ascites, pericholecystic fluid, 
and RV enlargement suggestive of R sided heart failure. She was 
seen by GI consult and admitted to the MICU for further care.  
.
In the MICU, GI performed EGD and noted esophagitis/gastritis 
and to have large clot in stomach but no active bleeding. 
Hematocrit nadir was 27, transfused 2 units w/ appropriate 
increase. Reversed anticoagulation w/ vitamin K, now on heparin 
gtt as INR<2 w/o new bleeding. Also patient noted to have a 
history of interstitial lung disease (f/b Dr. ___ and 
does not have home O2 but currently w/ O2 requirement s/p IVF 
resuscitation on arrival given hypovolemic hypotension in 
setting of bleed. Her O2 requirement has been lessening w/ 
diuresis. The morning of transfer, the patient was noticed to be 
slightly confused and does have a h/o sundowing. A head CT was 
negative for bleed and then found +U/A so started ciprofloxacin 
which was changed to ceftriaxone for concerns of deleriogenesis. 

.
Please see the following problem list for the pt's course once 
called out to the medical floor:
.
*) Increasing O2 requirement: Likely ___ volume overload from 
diastolic heart failure in combination with known interstitial 
lung disease. s/p echo ___ with EF 60-70%. Pt received IV lasix 
to a goal of -1.5L for approx 5 days and was transitioned to PO 
lasix when no longer exhibited signs of fluid overload. She 
continued to have a fluctuating O2 requirement and NC was 
titrated to >93%. On discharge, patient was satting well on 2L 
off of lasix.
.
*) Upper GI bleed: In setting of supratherapeutic INR. s/p 2u 
pRBC. Resolved and Hct stable s/p transfusion and Vit K. EGD 
with esophagitis, gastritis, clot but no acute bleeding. 
Continued BID protonix. Daily hcts were stable and increased 
throughout stay.  
.  
*) Anti-Coagulation/MVR - Patient on IV heparin with goal 50-70 
for anticogagulation for MVR. Initially on coumadin 2mg QD, 
which was eventually increased to her home regimen of 10mg 
___ and 15mg ___. On discharge, INR was 3.1 and heparin gtt 
discontinued. Patient to have close follow up with ___ 
Clinic.
.
*) Confusion/dementia: Pt with occasional severe agitation. Last 
episode ___ AM (pulled out IVs, refusing PO meds and O2NC). 
Likely secondary to underlying dementia/sundowning. Pt received 
zyprexa and haldol prn. Per daughter, this is her baseline.
.  
*) Acute on chronic renal failure: Prerenal, baseline Cr 
1.4-1.6. Followed Cr daily. On discharge, creatinine was 1.5.
.  
*) Cardiac - EF 60-70%. Continued metoprolol and transitioned to 
XL. Lisinopril was decreased as BPs were low normal. Continued 
statin.
.
*) UTI: Pt received cipro x 3d. Cx negative.
.  
*) s/p MVR - Mechanical valve. Heparin as above.  
.  
*) Hypothryoidism - Continued synthroid at home doses. TSH 0.68, 
free T4 normal.  
.  
*) DM II - Continue ISS while in house, but pt with little 
requirement. D/C'd on HD#12. Restarted metformin 1 day prior to 
discharge.
 
Medications on Admission:
Coumadin 2.5 mg take as directed  
Lasix 40 mg daily  
Lisinopril 20 mg daily  
Toprol 100 mg daily  
Metformin 1000 mg daily  
Flonase 1 spray daily  
Levothyroxine 112 mcg daily  
Simvastatin 20 mg qhs  

 
Discharge Medications:
1. Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).
Disp:*60 Tablet(s)* Refills:*2*
2. Levothyroxine 112 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).
Disp:*30 Tablet(s)* Refills:*2*
3. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) 
Spray Nasal DAILY (Daily).
Disp:*1 INH* Refills:*2*
4. Metformin 1,000 mg Tab,Sust Rel Osmotic Push 24hr Sig: One 
(1) Tab,Sust Rel Osmotic Push 24hr PO once a day.
Disp:*30 Tab,Sust Rel Osmotic Push 24hr(s)* Refills:*2*
5. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO once a day.
Disp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*
6. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).
Disp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*2*
7. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*2*
8. Warfarin 5 mg Tablet Sig: Two (2) Tablet PO Once Daily at 4 
___: Titrate to INR 2.5-3.5.
Disp:*60 Tablet(s)* Refills:*2*
9. Furosemide 40 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*
10. Outpatient Lab Work
Standing INR to be faxed to Dr. ___ at ___ 
Goal INR 2.5-3.5

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
-Upper GI bleed
-Interstitial lung disease
-Acute on chronic diastlic heart failure
-Mechanical mitral valve
Secondary:
-Type II diabetes mellitus
-Hypertension
-s/p mechanical mitral valve replacement ___
-Atrial fibrillation on coumadin
-Hypothyroidism
-Hyperlipidema
-Depression
-Peptic ulcer disease - dx'd by EGD in ___, H.pylori + in 
___
-Diverticulosis on colonoscopy in ___
-L vitreous hemorrhage - followed by Dr. ___ for 
vitrectomy on ___
-R retinal detachment
 
Discharge Condition:
Stable. Unstable on ambulation with walker.  We are recommending 
rehabilitation but the patient has refused and is deemed 
competent to do so.

 
Discharge Instructions:
You were admitted to the hospital for an upper gastrointestinal 
bleed because your coumadin made your blood too thin. Studies 
demonstrated no further bleeding and after receiving fluids and 
a blood transfusion, your hematocrit was stable throughout your 
hospital admission.
.
While in the ICU, you required more oxygen than at baseline and 
continued to have an increased requirement on the floor. You 
received medication to help excrete fluid that collected in your 
lungs. 
.
You were restarted on your coumadin and stayed in the hospital 
until your labs showed that your blood was thin enough for your 
mechanical heart valve. 
 
Followup Instructions:
___
"
135,17691205,22535005," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Near syncope.
 
Major Surgical or Invasive Procedure:
None.

 
History of Present Illness:
___ with DM2, CHF s/p MVR in ___, presenting with an episode of 
near syncope on ___, had a similar episode about a week 
and a half ago. The patient reports that she was at Stop and 
Shop pushing the shopping cart when she felt that her head 
became heavy, her legs became weak and was assisted to the 
ground by her husband. She reports that she felt better with 
recumbency.  Pt states she feels like she is going ""down down, 
down...like i am fading away."" She was diaphoretic and 
nauseated, but denies chest pain or shortness of breath. She 
states that she was conscious throughout the entire episode and 
remembers the EMTs working on her. She denies  Declined 
transport to hospital but family convinced her to get worked up 
today and she was brought to the ED by her niece. Last echo in 
___ showed LVEF 60-70%, marked RA dilation, mild symmetric LVH, 
RVH, moderate to severe TR.

She denies confusion following the event, incontinence of bowels 
or bladder, history of seizures or a seizure disorder, fever, 
chills, headaches, changes in vision, loss of consciousness or 
head trauma. She states that she does have a non-productive 
cough which is new for her. Denies vertigo, dizziness, 
lightheadedness.

ED Course: 
- Initial Vitals/Trigger: 97.7 58 113/90 18 96% 
- EKG: SR @ 60, NA, NI, no STE

On transfer to the floor: Vitals: 98,53,138/77, 16, 99 on 2LNC 

ROS:
(+) Per HPI

 
Past Medical History:
Type II diabetes mellitus  
Hypertension  
s/p mechanical mitral valve replacement ___  
Atrial fibrillation on coumadin  
Hypothyroidism  
Hyperlipidema  
Depression  
Peptic ulcer disease - dx'd by EGD in ___, H.pylori + in 
___  
Diverticulosis on colonoscopy in ___  
L vitreous hemorrhage - followed by Dr. ___ for 
vitrectomy on ___  
R retinal detachment
 
Social History:
___
Family History:
Sister with breast ca. Another sister with ca of unknown 
etiology. No h/o GI disease, IBD.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:

VS: Pulse: 58, RR: 16, BP: 127/69 92% RA
GENERAL: Older ___ woman lying in bed in NAD.
HEENT: L pupil round and reactive to light. R pupil not 
visualized due to scarring of eye. MMM. no LAD. no JVD. neck 
supple.
HEART: RRR S1/S2 heard. no murmurs/gallops/rubs.
LUNGS: CTAB. Decreased breath sounds on R throughout.
ABDOMEN: soft, nontender, nondistended. no guarding or rebound, 
no HSM.   
EXT: wwp, no edema. DPs, PTs 2+. 
SKIN: dry, no rash
NEURO/PSYCH: CNs II-XII intact to testing. ___ strength in upper 
and lower extremities bilaterally. 
Labs:  see above/below.

DISCHARGE PHYSICAL EXAM:

VS: Pulse: 58, RR: 16, BP: 127/69 92% RA
GENERAL: Older ___ woman lying in bed in NAD.
HEENT: L pupil round and reactive to light. R pupil not 
visualized due to scarring of eye. MMM. no LAD. no JVD. neck 
supple.
HEART: RRR S1/S2 heard. no murmurs/gallops/rubs.
LUNGS: CTAB. Decreased breath sounds on R throughout.
ABDOMEN: soft, nontender, nondistended. no guarding or rebound, 
no HSM.   
EXT: wwp, no edema. DPs, PTs 2+. 
SKIN: dry, no rash
NEURO/PSYCH: CNs II-XII intact to testing. ___ strength in upper 
and lower extremities bilaterally. 
Labs:  see above/below.

 
Pertinent Results:
___ 01:00PM BLOOD WBC-3.3* RBC-4.07* Hgb-11.2* Hct-34.8* 
MCV-86 MCH-27.5 MCHC-32.1 RDW-13.8 Plt ___
___ 07:40AM BLOOD ___ PTT-35.5 ___
___ 05:54PM BLOOD ___ PTT-42.3* ___
___ 07:40AM BLOOD Glucose-85 UreaN-34* Creat-1.8* Na-141 
K-4.1 Cl-102 HCO3-28 AnGap-15
___ 01:00PM BLOOD Glucose-84 UreaN-32* Creat-1.9* Na-139 
K-4.4 Cl-101 HCO3-28 AnGap-14
___ 03:35PM BLOOD cTropnT-<0.01
___ 07:40AM BLOOD Calcium-8.9 Phos-4.0 Mg-2.0

CXR ___: Status post valvular replacement and CABG.  Moderate 
cardiomegaly with slightly enlarged central pulmonary arteries.  
The lung parenchyma is normal.  No evidence of pulmonary edema.  
No pneumonia, no fibrosis, no pleural effusions.  Normal 
mediastinal contours. 

 
Brief Hospital Course:
___ with afib on coumadin, diastolic CHF, s/p MVR in ___ who 
presents with a presyncopal episode.

ACTIVE ISSUES:
# Syncope/Pre-syncope: The patient presented with pre-syncope 
likely either vasovagal or orthostatic in origin based on 
history. EKG was unchanged from previous and troponins were 
negative. The patient was admitted and placed on telemetry. She 
was noted to be bradycardic into the ___ and her Toprol XL 
was held with improvment in her heart rate to the ___. It 
was thought that the pre-syncope could be a combination of 
diabetic dysautonomia and orthostasis secondary to excessive 
beta blockade. The patient did not have any further pre-syncopal 
episodes while in the hospital, nor was she orthostatic based on 
vital signs. She was discharged to follow up with her PCP as an 
outpatient for further managment of her medications.

# Diabetes mellitus: Pt's HbA1C was 6.6 in ___. Because of 
her elevated creatinine, the patient's metformin was 
discontinued and she was started on an insulin sliding scale 
while in the hospital. She should follow up as an outpatient for 
further management of her diabetes.

INACTIVE ISSUES:

# Chronic Kidney Disease: Pt's Cr is 1.9 which is around her 
baseline.

# Anemia: Pt's Hct is 34.8 which is around her baseline of 
___.

# Hypothyroidism: Free T4 is normal, TSH is on the lower limit 
of normal. ___ need to adjust synthroid as an outpatient.

TRANSITIONAL ISSUES:
- Patient will likely need a repeat echocardiogram to evaluate 
valvular heart disease. Last echocardiogram was in ___ and 
showed no signs of aortic stenosis.
- Will need outpatient followup of diabetes management as 
metformin is contraindicated in the setting of an elevated 
creatinine.
- ___ need ECHO and HOLTER as outpatient

 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from Patient.
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE Q8H 
2. Citalopram 10 mg PO QHS 
3. Furosemide 40 mg PO DAILY 
4. Levothyroxine Sodium 112 mcg PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. MetFORMIN (Glucophage) 1000 mg PO DAILY 
7. Metoprolol Succinate XL 50 mg PO DAILY 
8. Omeprazole 20 mg PO DAILY 
9. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE QHS 
10. Simvastatin 40 mg PO DAILY 
11. travoprost *NF* 0.004 % OD qhs 
12. Warfarin 7.5 mg PO 4X/WEEK (___) 
13. Warfarin 2.5 mg PO 3X/WEEK (___) 

 
Discharge Medications:
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE Q8H 
2. Levothyroxine Sodium 112 mcg PO DAILY 
3. Lisinopril 5 mg PO DAILY 
4. Omeprazole 20 mg PO DAILY 
5. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE QHS 
6. Simvastatin 40 mg PO DAILY 
7. Citalopram 10 mg PO QHS 
8. Furosemide 40 mg PO DAILY 
9. travoprost *NF* 0.004 % OD qhs 
10. Warfarin 7.5 mg PO 5X/WEEK (___) 
PLEASE TAKE 7.5 Mg each evening on ___ through ___.  
11. Warfarin 5 mg PO 2X/WEEK (___) 
Take 5mg EACH EVENING on ___ and ___. 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Pre-Syncope
Mitral valve replacement in the past

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Lethargic but arousable.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you during your hospitalization 
at ___. You were admitted on ___ with an episode of 
pre-syncope or near fainting. Your vital signs were monitored 
and your medications were adjusted. Your coumadin was managed 
while in the hospital to keep your blood thinned to protect your 
mitral valve. You were discharged to follow up with your primary 
care doctor to further investigate the cause of your fainting. 
Please consider getting a holter monitor and/or echocardiogram 
from your cardiologist to better evaluate your presyncope. We 
also are holding your beta-blocker given your heart rate was a 
little low. Please consider restarting this if your cardiologist 
is okay with this. 
Someone will come from ___ tomorrow to check your INR and send 
this value to ___. Please continue to wear 
your home oxygen as recommended.  We also stopped your Metformin 
given your Kidney function. Please discuss this with your 
Primary care doctor.
 
Followup Instructions:
___
"
136,17691205,21147916," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Elevated Inr, Tachycardia, Hypoxia 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is an ___ year old woman with a history of DMII, 
afib, anticoagulated for MVR in ___ who was referred to the 
ED for an INR of >9. Ms. ___ notes poor PO intake over the 
last month since moving into assisted living. Furthermore, she 
notes more of a subacute decline in appetite since her husband 
died in ___. 

In the ED, initial vital signs were 98.4 130 104/63 16 88% 5L 
Nasal Cannula. Initially she was tachycardic to the 130s which 
resolved spontaneously. She was observed overnight after being 
given 2.5mg PO vitamin K and was noted to be hypotensive to as 
low as systolics of 70. CT abd/pelvis did not reveal any active 
bleeding. She was asyptomatic during these episodes. On transfer 
to the floor VS were 98.3 68 95/49 18 98% RA 

On the floor, T 98.2 112/66 61 16 98% on 3.5L. She has no 
complaints and is not in any pain. She denies any dark stools. 
No n/v, no abd pain. 

Review of Systems:  
(+)  
(-) fever, chills, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, cough, shortness of breath, 
chest pain, abdominal pain, nausea, vomiting, diarrhea, 
constipation, BRBPR, melena, hematochezia, dysuria, hematuria.  
 
Past Medical History:
Type II diabetes mellitus  
Hypertension  
s/p mechanical mitral valve replacement ___  
Atrial fibrillation on coumadin  
Hypothyroidism  
Hyperlipidema  
Depression  
Peptic ulcer disease - dx'd by EGD in ___, H.pylori + in 
___  
Diverticulosis on colonoscopy in ___  
L vitreous hemorrhage - followed by Dr. ___ for 
vitrectomy on ___  
R retinal detachment
CKD
Interstitial Lung Disease
h/o CHF - most recent echo ___ w/EF >65%
 
Social History:
___
Family History:
Sister with breast ca. Another sister with ca of unknown 
etiology. No h/o GI disease, IBD.
 
Physical Exam:
Admission exam:
Vitals-  98.32 112/66 61 16 98% 3.5L
General: alert and oriented, no acute distress
HEENT: Right eye closed, s/p surgery, left eye appropriate light 
reflex, left eye EOMI, oropharynx clear without lesions  
Neck: supple, no cervical or supraclavicular lymphadenopathy
CV: r/r/r, no m/r/g
Lungs: CTA bilaterally
Abdomen: soft, nontender, nondistended, normoactive bowel sounds
GU: no foley
Ext: no clubbing, cyanosis or edema, 2+ DP pulses bilaterally, 
ecchymoses noted in bilaterally antecubital fossa
Neuro: CN II-XII intact, ___ strength upper and lower 
extremities bilaterally, 2+ brachioradialis and biceps reflexes, 
no pronator drift, normal finger-nose
 
Discharge exam:
Vitals: 98.4 49 117/58 (107-128/50-90) 18 100%
General: alert and oriented, no acute distress
HEENT: Right eye closed, s/p surgery, left eye EOMI, oropharynx 
clear without lesions  
Neck: supple, 
CV: r/r/r, soft II/VI murmur best heard at left sternal border
Lungs: CTA bilaterally
Abdomen: soft, nontender, nondistended, normoactive bowel sounds
GU: foley in place
Ext: no clubbing, cyanosis or edema, 2+ DP pulses bilaterally, 
Neuro: able to move all extremities, alert, conversant
 
Pertinent Results:
Admission:
___ 04:25PM BLOOD WBC-4.0 RBC-4.19* Hgb-11.8* Hct-36.6 
MCV-88 MCH-28.2 MCHC-32.3 RDW-14.1 Plt ___
___ 04:25PM BLOOD Neuts-56.2 ___ Monos-8.9 Eos-2.7 
Baso-1.8
___ 04:25PM BLOOD ___ PTT-81.4* ___
___ 04:25PM BLOOD Glucose-111* UreaN-48* Creat-2.2* Na-139 
K-4.4 Cl-99 HCO3-22 AnGap-22*

Discharge:
___ 06:25AM BLOOD WBC-3.7* RBC-3.66* Hgb-9.9* Hct-32.6* 
MCV-89 MCH-27.1 MCHC-30.4* RDW-13.8 Plt ___
___ 06:25AM BLOOD ___ PTT-46.2* ___
___ 06:25AM BLOOD Glucose-100 UreaN-30* Creat-1.9* Na-143 
K-4.2 Cl-107 HCO3-27 AnGap-13

Imaging:

CXR ___:
FINDINGS:  Frontal and lateral views of the chest were obtained. 
 The patient is status post median sternotomy and cardiac valve 
replacement.  Mediastinal contours are stable.  There is 
againmild prominence of the main pulmonary artery.  The cardiac 
silhouette is top normal.  There is mild diffuse increase in 
interstitial markings bilaterally, which may be due to mild 
interstitial edema.  No large pleural effusion is seen.  There 
is no pneumothorax.
 
IMPRESSION:  Mild interstitial edema.

CT abd/pelvis ___:
IMPRESSION:
1.  No evidence of abdominal or retroperitoneal fluid collection
2.  Interstitial thickening and bibasilar atelectasis. 
3.  The infrarenal aorta prior to the bifurcation is ectacic 
measuring up to 2.3 cm.
4.  Fibroid uterus. 

 
Brief Hospital Course:
Impression: Ms. ___ is an ___ yo woman with a hx of DMII, s/p 
MVR with baseline CKD who presents with elevated INR and ___.

**ACUTE ISSUES**
# Coagulopathy with Supratherapeutic INR: INR reported to be 9.2 
from outside laboratory and patient referred to ED, where INR 
was found to be 12.5. This is most likely due to combination of 
poor PO intake and inappropriate medication use. Patient found 
to be hypotensive in ED to SBP in the ___ and CT abd/pelvis was 
done to r/o bleeding. Patient given 5mg vitamin K and INR was 
allowed to drift down to 4.9, at which point warfarin was 
restarted at 2.5mg. INR continued to drift down to 3.5 and her 
dose was increased to 5mg at discharge in order to remain 
therapeutic. She will need an INR check on ___.

# Weakness and anorexia: Patient describes emotional decline 
since her husband died in ___ and she has lost 10 lbs since 
___. Although she reports good social support from family 
and friends, she lives alone and cooks for herself. 
Rehabilitation was discussed, per ___ notes, but patient 
declined this option.

# Hematuria: noted on exam on HD2 while Foley was in place. UA 
was not consistent with UTI; Hct remained stable and hematuria 
resolved with observation. 

# Acute on chronic kidney disease: Likely due to poor PO intake. 
Patient's baseline creatinine likely ~1.8-2.0 and on admission 
was 2.6. Resolved with IVF and was 1.9 at discharge. Lisinopril 
and Lasix were held in this setting. 

**CHRONIC ISSUES**
# h/o diastolic heart failure: Most recent echo in ___ 
showed normal EF > 65% with normal LV thickness and cavity size. 
BNP was not markedly elevated. 

# Interstitial lung disease: Pt has been reluctant to consider 
intervention for tissue diagnosis, oxygen was continued at ___.

# T2DM: most recent A1c was 6.3% on ___ and is diet 
controlled without the use of any oral medications. 

# h/o afib: Appears to not be an issue since valve replacement 
and is not on any rate control medication.

# hypertension: Lisinopril and Lasix were held as above, blood 
pressure was well-controlled during hospitalization at SBP of 
100 - 120.

# hypothyroidism: continued home levothyroxine.

# HLD: continued home simvastatin

# GERD: continued home omeprazole

**TRANSITIONAL ISSUES**
- Patient requires continued support at home for appropriate 
warfarin use
- INR check on ___, discharged on 5mg warfarin daily
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE Q8H 
2. Levothyroxine Sodium 88 mcg PO DAILY 
3. Lisinopril 5 mg PO DAILY 
4. Omeprazole 20 mg PO DAILY 
5. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE QHS 
6. Simvastatin 40 mg PO DAILY 
7. Furosemide 40 mg PO DAILY 
8. travoprost 0.004 % OD qhs 
9. Warfarin 7.5 mg PO 5X/WEEK (___) 

 
Discharge Medications:
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE Q8H 
2. Levothyroxine Sodium 88 mcg PO DAILY 
3. Omeprazole 20 mg PO DAILY 
4. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE QHS 
5. Simvastatin 40 mg PO DAILY 
6. travoprost 0.004 % OD qhs 
7. Outpatient Lab Work
Please have your INR checked on ___ and fax results to Dr. 
___ 
Phone: ___ 
Fax: ___ 

8. Warfarin 5 mg PO DAILY 
RX *warfarin 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Elevated INR
Poor nutritional intake

Secondary:
Hypotension
Chronic kidney disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you at ___ ___ 
___. You were admitted because your coumadin level 
was dangerously high. We held your warfarin and your INR came 
down. We then restarted your warfarin. Please take warfarin as 
described below and have your INR checked. Your primary care 
doctor ___ need to adjust it depending on your blood levels. 

Medication changes:
- Warfarin 5mg DAILY until adjusted by primary care doctor.
 
Followup Instructions:
___
"
137,17691205,23522170," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
unsafe home
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ presents due to poor conditions at home. Pt lives alone and 
has a caregiver. Per ___ pt with change in mental status and has 
reportedly been refusing medications for three days, refusing to 
eat or drink and is combative. 
On arrival to ED patient denies any somatic complaints and is 
alert and oriented x2. She denies recent falls and has no signs 
of trauma. Given discrepancy between patient and caregiver 
concerns and question of patient safety at home case management 
and Social work were consulted. 
Pt then reported physical and emotional abuse from her care 
giver to ___ who filed report w/ elder protective services 
against caregiver for physical abuse.
CM in touch with family attempting to facilitate a d/c plan. Pt 
would like to return to her home. This does not appear to be an 
option at this time due to inability to care for herself. Pt 
feels as though she has enough support but acknowledges that she 
lives alone. 

On arrival to floor pt has no somatic complaints. Her family is 
with her at the bedside and she tearfully reports that her 
caregiver is the reason that she's in the hospital. She however 
cannot expound on the details of why ""She messed me up. I wasn't 
sick. And I'm not sick now, but she messed me up. She's why I'm 
here."" She reports the woman said things which ""I cannot repeat. 
I am ___ woman."" She also reports that her caregiver 
stole her clothing.

ROS: +as above, otherwise reviewed and negative

 
Past Medical History:
Type II diabetes mellitus  
Hypertension  
s/p mechanical mitral valve replacement ___  
Atrial fibrillation on coumadin  
Hypothyroidism  
Hyperlipidema  
Depression  
Peptic ulcer disease - dx'd by EGD in ___, H.pylori + in 
___  
Diverticulosis on colonoscopy in ___  
L vitreous hemorrhage - followed by Dr. ___ for 
vitrectomy on ___  
R retinal detachment
CKD
Interstitial Lung Disease
h/o CHF - most recent echo ___ w/EF >65%
 
Social History:
___
Family History:
Sister with breast ca. Another sister with ca of unknown 
etiology. No h/o GI disease, IBD.
 
Physical Exam:
Vitals: T:97.3 BP:132/75 P:84 R:18 O2:95%ra  
PAIN: 0
General: nad
Lungs: clear
CV: irreg irreg no m/r/g
Abdomen: bowel sounds present, soft, nt/nd
Ext: no e/c/c
Skin: no rash
Neuro: alert, follows commands

 
Pertinent Results:
___ 01:00PM   GLUCOSE-109* UREA N-30* CREAT-2.0* SODIUM-145 
POTASSIUM-4.1 CHLORIDE-104 TOTAL CO2-27 ANION GAP-18
___ 01:00PM   WBC-3.8* RBC-4.44 HGB-12.5# HCT-40.3 MCV-91 
MCH-28.1 MCHC-31.0 RDW-13.2
___ 01:00PM   NEUTS-61.7 ___ MONOS-5.3 EOS-2.9 
BASOS-1.4
___ 01:00PM   PLT COUNT-173
___ 01:00PM   ___ PTT-40.9* ___
___ 01:00PM URINE  COLOR-Yellow APPEAR-Hazy SP ___
___ 01:00PM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-TR 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 
LEUK-LG
___ 01:00PM URINE  RBC-1 WBC-28* BACTERIA-NONE YEAST-NONE 
EPI-3
___ 01:00PM URINE  HYALINE-3*

HEAD CT Preliminary IMPRESSION: No intracranial hemorrhage or 
acute territorial infarction 

 
Brief Hospital Course:
ASSESSMENT AND PLAN:  ___ yo presents with unsafe home situation 
and concern for elder abuse.

Elder Abuse: Social work and casemanagement as well as nursing 
and primary attending held a family meeting regarding the claims 
of abuse at her prior living situation. The family is looking 
into exactly what happened. No signs of physical injury here. No 
acute medical issues. She was established with placement at 
___ as respite until a permanent situation can be 
determined. 

Chronic Medical Conditions: all stable, cont home meds
-Type II diabetes mellitus - diet controlled 
-Atrial fibrillation - on 5mg coumadin  
-Hypothyroidism - on synthroid 
-Hyperlipidema - on simvastatin 
-Depression/grieving, not currently being treated
-Peptic ulcer disease - omeprazole
-CKD - creatinine stable
-Interstitial Lung Disease - on advair

FULL CODE
CONTACT: Granddaughter ___  ___

 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE TID 
2. Levothyroxine Sodium 88 mcg PO DAILY 
3. Omeprazole 20 mg PO DAILY 
4. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE QHS 
5. Simvastatin 40 mg PO DAILY 
6. travoprost 0.004 % OD qhs 
7. Warfarin 5 mg PO DAILY 
8. Furosemide 20 mg PO DAILY 
9. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
10. ClonazePAM 0.5 mg PO DAILY 
11. Lisinopril 5 mg PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Elder Abuse
Diet controlled type II diabetes mellitus  
Atrial fibrillation on coumadin  
Hypothyroidism  
Hyperlipidema  
Depression  
Peptic ulcer disease 
CKD
Interstitial Lung Disease
Chronic Diastolic CHF

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___, 

It was a pleasure taking part in your care. You were admitted to 
___ out of concern that you had been abused at your prior 
home. You had no active medical issues during your amission. You 
were maintained, on all of your home medications. 
 
Followup Instructions:
___
"
138,17842866,27530090," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
weakness and recent fall
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ F w/ h/o HTN, lower extremity edema and afib on coumadin 
was brought in by family for concern of lethargy and found to be 
hyponatremic to 106. Pt had an unwitnessed fall on ___ 
but denies head strike or LOC. She briefly c/o posterior right 
shoulder which resolved shortly afterwards. Family noticed that 
pt had increasing fatigue and mild intermittent confusion over 
the past week. Her son said that on ___ they were able to 
complete a 2 block walk, longer than her usual walks, and did 
not experience SOB but felt fatigued afterwards. Pt has not had 
fever, chills, cough, shortness of breath, dysuria, abdominal 
pain or bowel changes. However, family noted decreased appetite, 
po intake and urine output during this time. Pt lives alone and 
according to her son is normally quite functional and 
independently prepares her own food, reliably takes her 
medications and walks stably with a cane. Pt had complained of 
increased lower extremity edema during this time and in an 
effort to decrease edema pt reportedly decreased her fluid 
intake. When son stayed with his mother over the weekend and 
noticed decreased uop, the family recommended that she drink 
free water. Per family report she continued to take her 
prescibed doses of her medications, including ___ meds 
HCTZ, diovan and felodipine. Pt has had chronic lower extremity 
edema worsening over the past month and was evaluated by PCP ___ 
___ and ___. On both visits pt was found to have 3+ pitting 
edema in lower extremities with clear lungs and ___ 
JVP, not clinically determined to by volume overloaded. On ___ 
pt was found to be hyponatremic to 128 (baseline Na ___ over 
past year). PCP recommended compression stockings which she has 
not been compliant with, and discontinuation of felodipine 
however pt was hesitant to do so since she felt the CCB was 
improving her bp. Also of note, on ___, pt's weight was 131.5lbs 
(59 kilos) and had elevated INR of 4.7 (previously within ___ 
INR goal, on ___ INR 2.4).

Last echo (stress) ___: normal LVEF >55%, no wall motion 
abnormalities, no evidence of inducible ischemia, poor 
functional exercise capacity. Mild to moderate mitral 
regurgitation at rest. Moderate tricuspid regurgitation. Mild 
pulmonary hypertension.

In the ED, initial VS were: 97.9 HR: 60 BP: 143/68 Resp: 22 
SaO2Sat: 100. Labs notable for Na 106, K 2.9, Cl 73, Ca 7.9, 
Phos 1.3, Mg 1.8.
CXR showed bilateral pleural effusions, pulmonary edema and 
possible right lower lobe atelectasis. Pt was started on empiric 
antibiotic coverage with ceftriaxone and azithromycin. Pt was 
started on NS at 100cc/hr.
 
On arrival to the MICU, patient's VS were 97.8, hr 64, bp 
147/78, rr 19, Sa02 93% on RA. Repeat labs after pt received 
~150cc NS showed Na 106, K 3.1. Pt was continued on NS at 
100cc/hr and electrolyes repleted with Mg sulfate, K phos and Ca 
gluconate. After ~500cc NS repeat Na was still 106. After ~666cc 
NS repeat Na was 107 and Ca 8.2, Phos 2.8, Mg 2.5. Renal was 
consulted regarding starting hypertonic 3%NS. 
 
Review of systems:  
(+) Per HPI. Pt reported poor sleep over ___ and ___ 
nights for unclear reason and increased Tenderness near iv site 
on right forarm that began in ED. Pt has chronic constipation 
and has home bowel regimen.
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denies shortness of breath, cough, or wheezing. 
Denies chest pain, chest pressure, palpitations. Denies 
abdominal pain, diarrhea, dark or bloody stools. Denies dysuria, 
frequency, or urgency. Denies arthralgias or myalgias. Denies 
rashes or skin changes.  

 
Past Medical History:
hypertension
hyperlipidemia
atrial fibrillation
glaucoma
cataracts
h/o DCIS, treated with lumpectomy and arimidex tx
old pulmonary nodule
thryoid nodule
s/p left insular cortex stroke and TIAs (___)
 
Social History:
___
Family History:
There is family history of strokes (mother and father)
 
Physical Exam:
Vitals: 97.8, hr 64, bp 147/78, rr 19, Sa02 93% on RA.   
Weight 64.7 kilo (59 kilos at ___'s office on ___
General: sleepy, drifting in and out of sleep during 
interview/exam, oriented, no acute distress, primarily ___ 
speaking, hard of hearing, son as well as daughter in law over 
phone translated  
HEENT: Sclera anicteric, moderately dry mucous membranes, 
oropharynx clear, EOMI, PERRL.  
Neck: supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: diffuse crackles bilaterally, more course in bases  
Abdomen: soft, ___, bowel sounds present, 
no organomegaly, no rebound or guarding  
GU: foley draining clear yellow urine 
Ext: Warm, well perfused, 2+ pulses, 2+ lower extremity edema up 
to mid shins bilaterally. No clubbing or cyanosis. 
Neuro: A+Ox3 although slow to respond, ___ intact, ___ 
strength upper/lower extremities, grossly normal sensation, 2+ 
reflexes bilaterally, gait deferred.  
 

 
Pertinent Results:
___ 12:40PM   ___ ___
___ 12:40PM   PLT ___ PLT ___
___ 12:40PM   ___ 
___ 
___
___ 12:40PM   ___ 
___
___ 12:40PM   ___ 
___
___ 12:40PM   ___
___ 12:40PM   ___ MB ___
___ 12:40PM   cTropnT-<0.01
___ 12:40PM   ___
___ 12:40PM   ALT(SGPT)-36 AST(SGOT)-40 CK(CPK)-167 ALK 
___ TOT ___
___ 12:40PM   ___ this
___ 12:40PM   ___ UREA ___ 
___ TOTAL ___ ANION ___
___ 12:50PM URINE  ___ WBC-<1 ___ 
___
___ 12:50PM URINE  ___ 
___ 
___
___ 12:50PM URINE  ___ SP ___
___ 12:50PM URINE  ___
___ 12:50PM URINE  ___
___ 12:50PM URINE  ___ UREA ___ 
___
___ 12:51PM   ___
___ 04:40PM   ___
___ 04:40PM   ___
___ 04:40PM   ___

On the day of discharge (___), the patient's labs were:
Na 137, K 4.1, Cl 101, HCO3 26, BUN 19, Cr 0.6
INR pending
 
Brief Hospital Course:
___ F w/ week of increasing fatigue, confusion and poor po 
intake found to be hyponatremic to 106 with altered mental 
status.
.
Severe symptomatic hyponatremia of unclear etiology, resolving
- admitted to the ICU for hypertonic saline and furosemide
- Nephrology consulted
- ultimately thought to have been multifactorial, possibly 
diuretic related vs. SIADH
- volume status difficult to assess given the issues noted below
- fluid restriction 800mL/day
- stable Na for several days prior to discharge
- felodipine and HCTZ were stopped and should not be restarted
.
Pulmonary edema and lower extremity edema on admission
- found on CXR, and BNP was elevated
- attributed to her history of diastolic CHF (followed by Dr. 
___
- repeat TTE this admission showed: EF>55%, right atrial 
lengthening and moderate TR, MR, pulmonary hypertension. EKG in 
ED did not show evidence of strain or ischemia. First set ___ 
and CKMB within normal limits. Repeat BNP was similar to prior, 
mildy elevated. Improvement in respiratory satus and decreased 
O2 requirement with iv lasix suggested some volume over load
- her lower extremity edema was ultimately attributed to her 
calcium channel blocker, so felodipine was held
.
HTN, diastolic CHF
- ___ management guided by Nephrology with PCP
- atorvastatin and carvedilol were continued (latter at max 
dose)
- stopped CCB given confusion about volume status (was it 
causing leg swelling?)
- stopped HCTZ given likely contribution to hyponatremia
- restarted valsartan prior to discharge and titrated up to max 
dose -- she may require addition of other agents if she remains 
hypertensive as an outpatient
- hydralazine and clonidine could be considered (avoid more 
___, avoid diuretics, avoid CCBs)
.
Afib on warfarin (CHADS2 3 for CHF, HTN, age)
- carvedilol as above
- held warfarin intermittently given elevated INR -- 
___ will be following ___
.
Thrombocytopenia of unclear etiology with monocytosis
- abdominal ultrasound this admission showed no 
hepatosplenomegaly
- fibrinogen normal
- normal platelets the day prior to discharge, but still with 
abnormal diff, no sig change
- after d/w PCP plan is for outpt Hematology appointment (in 
___, see f/u section) with recheck of CBC in the interim
.
Other
- continued on her home artificial tears and timolol
.
Recent fall
- ___ consult recommend SNF

Day of discharge:
Interval history: There were no events the night prior to 
discharge, including no confusion (had been an issue in the 
ICU).  She felt ok, had no questions and understood the plan to 
d/c to SNF.  Her family was involved in explaining this to her 
in ___.  All of their questions were answered.

Discharge day exam:
Vitals: afebrile, BP 150/82, HR 76, RR 16, sat 98% on RA
Gen: elderly woman seated next to bed eating, alert, 
cooperative, very hard of hearing esp on L
HEENT: MMM
Chest: equal chest rise, no WOB, no cough, CTAB anteriorly
Heart: RRR, no m/r/g
Abd: soft, NTND
Extr: WWP, no sig pitting edema
Skin: no obvious rashes
Neuro: no obvious focal deficits, able to get to and from the 
bathroom
Psych: normal affect

Discharge day labs noted above
 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from Family/Caregiver.
1. Atorvastatin 10 mg PO HS 
2. Carvedilol 25 mg PO Q 8H atrial fibrillation 
hold for sbp<100 and hr<60. 
3. Felodipine 2.5 mg PO DAILY 
4. Hydrochlorothiazide 25 mg PO DAILY 
5. Valsartan 160 mg PO BID 
6. Warfarin 0.5 mg PO 2X/WEEK (___) 
___ and ___ 
7. Warfarin 1 mg PO 5X/WEEK (___) 
8. Docusate Sodium 100 mg PO BID:PRN constipation 
9. Magnesium Oxide 400 mg PO ONCE Duration: 1 Doses 
10. Artificial Tears ___ DROP BOTH EYES PRN prn 
11. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 

 
Discharge Medications:
1. Artificial Tears ___ DROP BOTH EYES PRN prn 
2. Atorvastatin 10 mg PO HS 
3. Carvedilol 25 mg PO Q 8H atrial fibrillation 
hold for sbp<100 and hr<60. 
4. Warfarin 2.5 mg PO 2X/WEEK (___) 
5. Warfarin 5 mg PO 5X/WEEK (___) 
6. Docusate Sodium 100 mg PO BID:PRN constipation 
7. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 
8. Valsartan 160 mg PO BID 

 
Discharge Disposition:
Home with Service
 
Facility:
___
 
Discharge Diagnosis:
Severe multifactorial hyponatremia
Atrial fibrillation on warfarin
Hypertension
Diastolic congestive heart failure
Chronic thrombocytopenia with monocytosis
Severe hearing loss

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
You were admitted with a very low sodium concentration 
(hyponatremia) in your body.  This was likely due to a 
combination of factors, and you were treated for these.  To 
prevent this from happening again, you need to make sure to not 
drink too much fluid and likely you need to avoid certain 
medications in the future.
 
Followup Instructions:
___
"
139,17887687,24438766," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Sulfa (Sulfonamide Antibiotics) / Tizanidine
 
Attending: ___
 
Chief Complaint:
Abdominal Pain, nausea, vomitting
 
Major Surgical or Invasive Procedure:
___  Laparoscopic appendectomy, washout of abdominal 
abscesses

___:  ___ drain placed in to abdominal fluid collection

___:  ___ drainage for post. abdominal wall collection

 
History of Present Illness:
Mrs. ___ presents to the ED with 48 hours of acute
abdominal pain, nausea, emesis, leukocytosis to ___ and
clinical and radiological findings consistent with acute
perforated appendicits. She is being seeing in consultation by
___ for furtehr management.

Her past medical history is pertinent for hypertension,
hypothyroidism, endometriosis, migraines and recent laparoscopic
left ovarian cystectomy and cystoscopy. 

She was in her usual state of health until 2 days ago when she
started feeling nauseated in AM. Her symptoms progressively
worsened since with complains of diffuse abdominal pain, emesis,
anorexia, and fever to 103. Her last BM was 2 days ago but still
passing flatus. She endorses dysuria.  
 
Past Medical History:
Past Medical History: As above. Endometriosis, hypothyroidism

Past Surgical History:
- ___: hysteroscopy, polypectomy, myomectomy, dilation 
and
curettage, insertion of Mirena IUD, laparoscopic left ovarian
cystectomy and cystoscopy
 
Social History:
___
Family History:
non-contributory
 
Physical Exam:
Physical Exam: upon admission:  ___
Vitals:
GEN: A&O, NAD
HEENT: No scleral icterus, mucus membranes moist
CV: RRR, No M/G/R
PULM: Clear to auscultation b/l, No W/R/R
ABD: Soft, nondistended, nontender, no rebound or guarding,
normoactive bowel sounds, no palpable masses
DRE: normal tone, no gross or occult blood
Ext: No ___ edema, ___ warm and well perfused

Discharge Physical Exam:
VS: 98.8, 151/97, 73, 17, 95 Ra 
Gen: A&O x3, ambulatory, NAD
CV: HRR
Pulm: LS ctab
Abd: Lap sites CDI. Prior JP drain sute CDI. Soft, NT/ND.
Ext: WWP no edema. left lower extremity erythematous crateriform 
nodule with surrounding erythema 

 
Pertinent Results:
___ 06:45AM BLOOD WBC-10.5* RBC-3.28* Hgb-9.4* Hct-30.1* 
MCV-92 MCH-28.7 MCHC-31.2* RDW-13.9 RDWSD-46.5* Plt ___
___ 06:45AM BLOOD WBC-10.3* RBC-3.17* Hgb-9.0* Hct-28.9* 
MCV-91 MCH-28.4 MCHC-31.1* RDW-13.8 RDWSD-45.3 Plt ___
___ 01:35PM BLOOD WBC-28.0* RBC-4.11 Hgb-12.1 Hct-36.3 
MCV-88 MCH-29.4 MCHC-33.3 RDW-12.6 RDWSD-40.7 Plt ___
___ 01:35PM BLOOD Neuts-84.3* Lymphs-6.5* Monos-7.7 
Eos-0.2* Baso-0.3 Im ___ AbsNeut-23.62* AbsLymp-1.81 
AbsMono-2.16* AbsEos-0.06 AbsBaso-0.08
___ 06:45AM BLOOD Plt ___
___ 06:45AM BLOOD Plt ___
___:04AM BLOOD ___ PTT-29.1 ___
___ 06:45AM BLOOD Glucose-101* UreaN-8 Creat-0.8 Na-139 
K-5.1 Cl-99 HCO3-28 AnGap-12
___ 06:45AM BLOOD Glucose-101* UreaN-9 Creat-0.7 Na-136 
K-5.1 Cl-96 HCO3-30 AnGap-10
___ 01:35PM BLOOD Glucose-108* UreaN-17 Creat-1.1 Na-139 
K-3.2* Cl-97 HCO3-26 AnGap-16
___ 06:00AM BLOOD ALT-16 AST-19 AlkPhos-108* TotBili-0.6
___ 01:35PM BLOOD ALT-17 AST-19 AlkPhos-88 TotBili-0.8
___ 01:35PM BLOOD Lipase-19
___ 06:45AM BLOOD Calcium-9.2 Phos-4.1 Mg-2.2
___ 04:21AM BLOOD Lactate-0.9

___: bil lower ext:

No evidence of deep venous thrombosis in the right or left lower 
extremity 
veins. 

___:  CT scan abd. and pelvis:

 
1. Dilated proximal small bowel loops could represent early 
partial small 
bowel obstruction versus ileus. 
2. Postsurgical changes in the right lower quadrant with 
moderate free fluid within the abdomen.  There is mild uniform 
enhancement of the peritoneum in the lower abdomen and pelvis. 
3. No organized drainable fluid collection seen in the pelvis. 

___:  ___ drainage:

Successful US-guided placement of ___ pigtail catheter into 
the right 
lower quadrant collection.  1000 cc of mildly cloudy 
sero-sanguineous fluid was drained.  Sample was sent for 
microbiology evaluation. 

___:  ct scan abd. and pelvis:

1. Interval placement of a right anterolateral approach 
percutaneous pigtail drain terminating in the right lower 
quadrant, with reduction in volume of previously seen fluid in 
the area of the drain. 
2. Interval evolution of a multi-lobulated fluid collection 
spanning the right hemi-pelvis.  The largest component posterior 
to the uterus measures up to 8.7 cm and is amenable for 
percutaneous drainage.  The two other main components to the 
collection appear to communicate. 
3. Rectal contrast reaches the cecum, without evidence of leak. 
4. Mild distention of small-bowel loops, likely related to 
ileus. 

___:  ___ drainage:

Successful CT-guided placement of an ___ pigtail catheter 
into the 
above-described posterior pelvic collection.  Samples were sent 
for 
microbiology evaluation. 
  

  

 
Brief Hospital Course:
___ year old female admitted to the hospital with  abdominal 
pain, nausea, and elevated white blood cell count.  Upon 
admission, the patient was made NPO, given intravenous fluids, 
and underwent imaging which showed perforated appendicitis. She 
was started on a course of antibiotics ceftriaxone and flagyl 
and underwent serial abdominal examinations. 

The patient was taken to the operating room on HD # 3 where she 
underwent a laparoscopic appendectomy.  Intra-operative findings 
were notable for acute perforated appendicitis with phlegmon and 
an abscess.  There was a 100 cc blood loss.  The patient was 
extubated after the procedure and monitored in the recovery 
room.  

During the post-operative course, she was febrile with an 
elevated white blood cell count. Her surgical pain was 
controlled with intravenous analgesia. Because of the 
temperature spikes, the patient underwent a cat scan of the 
abdomen on POD #5 and she was reported to have a right lower 
quadrant collection.  She was taken to interventional radiology 
where a drain was placed. Her abdominal pain persisted and she 
underwent another cat scan of the abdomen which showed an 
additional fluid collection posterior to the uterus.  She 
returned to ___ on POD #11 where another drain was placed.  Over 
the next ___ hours her white blood cell count began to normalize. 
 She continued on her course of ceftriaxone and flagyl.  

The patient was discharged home on POD #14.  Her antibiotics 
were discontinued and her white blood cell count was stable at 
11. She was transitioned to oral analgesia and was voiding 
without difficulty.  She had return of bowel function.  Her 
vital signs were stable and she was afebrile.  Discharge 
instructions were reviewed and questions answered.  A follow-up 
appointment was made in the Acute care clinic.

+++++++++++++++++++++++++++++++++++++++++

Of note, during the patient's hospitalization, she noted a left 
leg lesion.  The Dermatology service was consulted and advised 
removal of the lesion.  An appointment was made for follow-up by 
the Dermatology service.   They will call the patient with the 
time and place of the appointment.            
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze 
2. azelastine 137 mcg (0.1 %) nasal DAILY 
3. Chlorthalidone 25 mg PO DAILY 
4. Citalopram 20 mg PO QHS 
5. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
6. Levothyroxine Sodium 100 mcg PO 3X/WEEK (___) 
7. Levothyroxine Sodium 50 mcg PO 4X/WEEK (___) 
8. Lisinopril 30 mg PO DAILY 
9. Ranitidine 150 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H  
2.  Docusate Sodium 100 mg PO BID  
3.  HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN Pain - Moderate  
4.  Ibuprofen 400-600 mg PO Q8H:PRN Pain - Mild 
please take with food  
5.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second 
Line  
6.  Sarna Lotion 1 Appl TP BID:PRN rash  
7.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
8.  Albuterol Inhaler ___ PUFF IH BID  
9.  azelastine 137 mcg (0.1 %) nasal DAILY  
10.  Chlorthalidone 25 mg PO DAILY  
11.  Citalopram 20 mg PO QHS  
12.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
13.  Levothyroxine Sodium 100 mcg PO 3X/WEEK (___)  
14.  Levothyroxine Sodium 50 mcg PO 4X/WEEK (___)  
15.  Lisinopril 30 mg PO DAILY  
16.  Ranitidine 150 mg PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Perforated Appendicitis

abdominal abscesses 

secondary:

lesion left lower ext.

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital with abdominal pain and found 
to have a perforation in your appendix. You were given IV 
antibiotics but continued to have pain and signs and symptoms of 
infection. You were taken to the operating room to have your 
appendix removed laparoscopically, and the infection washout out 
of your abdomen. After surgery, you continued to an elevation in 
your white blood cell count.  On imaging, you were reported to 
have fluid collections in your abdomen for which drains were 
placed.  Since then, your white blood cell count and your pain 
has decreased.  You continue on antibiotics.  Your are preparing 
for discharge home with ___ services for drain care assistance 
with the following instructions:

Please follow up at the appointment in clinic listed below. We 
also generally recommend that patients follow up with their 
primary care provider after having surgery. We have scheduled an 
appointment for you listed below.
ACTIVITY:
 
Do not drive until you have stopped taking pain medicine and 
feel you could respond in an emergency.
You may climb stairs. 
You may go outside, but avoid traveling long distances until you 
see your surgeon at your next visit.
Don't lift more than ___ lbs for ___ weeks. (This is about the 
weight of a briefcase or a bag of groceries.) This applies to 
lifting children, but they may sit on your lap.
You may start some light exercise when you feel comfortable.
You will need to stay out of bathtubs or swimming pools for a 
time while your incision is healing. Ask your doctor when you 
can resume tub baths or swimming.
 
HOW YOU MAY FEEL: 
You may feel weak or ""washed out"" a couple weeks. You might want 
to nap often. Simple tasks may exhaust you.
You may have a sore throat because of a tube that was in your 
throat during surgery.
You could have a poor appetite for a couple days. Food may seem 
unappealing.
All of these feelings and reactions are normal and should go 
away in a short time.  If they do not, tell your surgeon.
 
YOUR INCISION:
Tomorrow you may shower and remove the gauzes over your 
incisions. Under these dressings you have small plastic bandages 
called steristrips. Do not remove steri-strips for 2 weeks. 
(These are the thin paper strips that might be on your 
incision.) But if they fall off before that that's okay.
Your incisions may be slightly red around the stitches. This is 
normal.
You may gently wash away dried material around your incision.
Avoid direct sun exposure to the incision area.
Do not use any ointments on the incision unless you were told 
otherwise.
You may see a small amount of clear or light red fluid staining 
your dressing or clothes. If the staining is severe, please call 
your surgeon.
You may shower. As noted above, ask your doctor when you may 
resume tub baths or swimming.
 
YOUR BOWELS:
Constipation is a common side effect of narcotic pain 
medicaitons. If needed, you may take a stool softener (such as 
Colace, one capsule) or gentle laxative (such as milk of 
magnesia, 1 tbs) twice a day. You can get both of these 
medicines without a prescription.
If you go 48 hours without a bowel movement, or have pain moving 
the bowels, call your surgeon. 
 
PAIN MANAGEMENT:
It is normal to feel some discomfort/pain following abdominal 
surgery. This pain is often described as ""soreness"". 
Your pain should get better day by day. If you find the pain is 
getting worse instead of better, please contact your surgeon.
You will receive a prescription for pain medicine to take by 
mouth. It is important to take this medicine as directed. Do not 
take it more frequently than prescribed. Do not take more 
medicine at one time than prescribed. Do not drink alcohol or 
drive while taking narcotic pain medication.
Your pain medicine will work better if you take it before your 
pain gets too severe.
Talk with your surgeon about how long you will need to take 
prescription pain medicine. Please don't take any other pain 
medicine, including non-prescription pain medicine, unless your 
surgeon has said its okay.
If you are experiencing no pain, it is okay to skip a dose of 
pain medicine.
Remember to use your ""cough pillow"" for splinting when you cough 
or when you are doing your deep breathing exercises.
If you experience any of the following, please contact your 
surgeon:
- sharp pain or any severe pain that lasts several hours
- pain that is getting worse over time
- pain accompanied by fever of more than 101
- a drastic change in nature or quality of your pain
 
MEDICATIONS:
Take all the medicines you were on before the operation just as 
you did before, unless you have been told differently.
If you have any questions about what medicine to take or not to 
take, please call your surgeon.
 
DANGER SIGNS:
Please call your surgeon if you develop:
- worsening abdominal pain
- sharp or severe pain that lasts several hours
- temperature of 101 degrees or higher
- severe diarrhea
- vomiting
- redness around the incision that is spreading
- increased swelling around the incision
- excessive bruising around the incision
- cloudy fluid coming from the wound
- bright red blood or foul smelling discharge coming from the 
wound
- an increase in drainage from the wound

You will also need to follow-up with Dermatology to have 
excision of lesion left lower leg.
 
 
 
 
  
  
  
 
.
.
.
. 

You are now doing better, tolerating a regular diet and ready to 
be discharged home to continue your recovery.

Please note the following discharge instructions:

 
Followup Instructions:
___
"
140,17887687,21453763," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Sulfa (Sulfonamide Antibiotics) / Tizanidine
 
Attending: ___
 
Chief Complaint:
Abdominal pain 
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ recent appendectomy for perforated appendicitis ___ c/b 
multi-loculated fluid collections requiring ___ drainage x2 
discharged ___ who re-presents to the ED with ___ days of 
abdominal pain. Of significance, patient initially presented to 
the ED with perforated appendicitis, and was initially managed
with IV antibiotics. However, she had worsening abdominal pain, 
and was taken to the OR for laparoscopic appendectomy. Her 
post-operative course was complicated by multi-lobulated fluid 
collections requiring ___ drainage on ___ and ___. She was 
eventually discharged on ___. She saw Dr. ___ on follow-up 
on ___ when her ___ drains were discontinued.  Patient states 
that about ___ days ago, she started to experience abdominal 
pain. She describes the location of the pain as epigastric and 
in the LUQ. She complains of nausea, but denies emesis. She also 
denies fever/chills. She is tolerating regular
diets as well as having regular BMs.

 
Past Medical History:
PMH: HTN, hypothyroidism, endometriosis, migraine, 
endometriosis.

PSH: laparoscopic appendectomy ___ (___), 
hysteroscopy/polypectomy/myomectomy/D&C, insertion of mirena IUD
laparoscopic left ovarian cystectomy and cystoscopy 

 
Social History:
___
Family History:
Patient is from ___ originally.  She lives in ___ 
with her husband, ___.  She is a ___ grade ___ in ___.  
The patient reports that her father passed away in ___ from ___ 
body dementia.
 
Physical Exam:
Admission Physical Exam:

VS: 98.6/98.6, 86, 113/76, 18, 100%RA
General: AAOX3
HEENT: WNL
Cardiac: Normal S1, S2
Respiratory: RA, equal breath sounds
Abdomen: Soft, tender LUQ, no rebound or guarding.
Skin: No lesions

Discharge Physical Exam:
VS: T: 98.5 PO BP: 135/85 L Sitting HR: 70 RR: 18 O2: 97% Ra 
GEN: A+Ox3, NAD
CV: Regular rate
PULM: No respiratory distress, breathing comfortably on room air
ABD: soft, non-tender, non-distended
EXT: no edema
 
Pertinent Results:
IMAGING:

___: CT Abdomen/Pelvis:
1. New mesenteric stranding in left mid upper abdomen without 
clear 
abnormality of the adjacent bowel.  No drainable collection.  No 
bowel 
obstruction. 
2. No evidence of abdominopelvic drainable fluid collections or 
discrete 
abscess.  Resolution of prior pericecal fluid collection and 
pelvic free 
fluid. 

___: CT Abdomen/Pelvis:
1. Persistent mild inflammatory wall thickening of the cecum and 
surrounding soft tissues in the right lower quadrant with wall 
thickening of the sigmoid colon which closely abuts the surgical 
bed.  No drainable fluid collections.  Orally ingested contrast 
is seen traversing through nondilated small bowel loops into the 
cecum without a leak. 
2. Interval resolution of previously noted stranding of left 
upper quadrant mesentery. 

LABS:

___ 05:06PM URINE  UCG-NEGATIVE
___ 04:30PM URINE  COLOR-Straw APPEAR-Hazy* SP ___
___ 04:30PM URINE  BLOOD-TR* NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 04:30PM URINE  RBC-<1 WBC-2 BACTERIA-NONE YEAST-NONE 
EPI-6
___ 04:30PM URINE  MUCOUS-OCC*
___ 03:00PM   GLUCOSE-93 UREA N-13 CREAT-0.7 SODIUM-140 
POTASSIUM-3.9 CHLORIDE-98 TOTAL CO2-28 ANION GAP-14
___ 03:00PM   ALT(SGPT)-20 AST(SGOT)-19 ALK PHOS-80 TOT 
BILI-0.2
___ 03:00PM   ALBUMIN-4.8
___ 03:00PM   WBC-10.7* RBC-3.72* HGB-10.8* HCT-32.8* 
MCV-88 MCH-29.0 MCHC-32.9 RDW-12.7 RDWSD-40.8
___ 03:00PM   NEUTS-64.5 ___ MONOS-7.2 EOS-2.3 
BASOS-0.5 IM ___ AbsNeut-6.88* AbsLymp-2.69 AbsMono-0.77 
AbsEos-0.25 AbsBaso-0.05
___ 03:00PM   PLT COUNT-281
 
Brief Hospital Course:
Ms. ___ is a ___ with history of recent appendectomy for 
perforated appendicitis on ___ complicated by 
multi-loculated fluid collections requiring ___ drainage x2 
discharged ___, who re-presented to the ___ ED this 
admission with ___ days of abdominal pain.  CT scan demonstrated 
new mesenteric stranding in the left mid upper abdomen without 
clear abnormality of the adjacent bowel, no drainable 
collection, bowel obstruction, or drainable fluid collections.  
She was admitted to the Acute Care Surgery service for serial 
abdominal exams and she was made NPO with IV fluid. 

On HD2, her abdominal pain improved, but she remained tender to 
palpation in the LUQ.  She passed flatus.  She had a repeat CT 
abdomen/pelvis which demonstrated  persistent mild inflammatory 
wall thickening of the cecum and surrounding soft tissues in the 
right lower quadrant.  A c.diff toxin was sent which came back 
positive.  PO vancomycin was initiated.  The patient's abdominal 
pain improved.  Her diet was advanced to a regular diet which 
she tolerated.

At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable.  The patient was tolerating a diet, 
ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan. 

 
Medications on Admission:
albuterol sulfate ___ puffs', azelastine 137mcg nasal spray,
chlorthialidone 25mg', citalopram 20mg', fluticasone 50mcg,
levothyroxine 50mg' TT, levothyroxine 100mg MWF, lisinopril
30mg', ranitidine 150mg'. 

 
Discharge Medications:
1.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  
2.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
3.  Vancomycin Oral Liquid ___ mg PO QID 
RX *vancomycin [Firvanq] 25 mg/mL 5 mL(s) by mouth every six (6) 
hours Disp #*260 Milliliter Refills:*0 
4.  Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath  
5.  Chlorthalidone 25 mg PO DAILY  
6.  Citalopram 20 mg PO DAILY  
7.  Levothyroxine Sodium 50 mcg PO 4X/WEEK (___)  
8.  Levothyroxine Sodium 100 mcg PO 3X/WEEK (___)  
9.  Lisinopril 30 mg PO DAILY  
10.  Ranitidine 150 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Colonic inflammation due to clostridium difficile 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital with abdominal pain and had 
abdominal/pelvic CT scans showing mild inflammation of your 
colon.  You tested positive for clostridium difficile, a 
bacteria in the colon, which can lead to bowel inflammation and 
diarrhea.  You were started on a medication, called Vancomycin, 
to treat this bacterial infection.  You are now tolerating a 
regular diet and are ready to be discharged from the hospital.

Please note the following discharge instructions:

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.
Avoid driving or operating heavy machinery while taking pain 
medications.
 
 
Followup Instructions:
___
"
141,17887687,28988539," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Sulfa (Sulfonamide Antibiotics) / Tizanidine
 
Attending: ___.
 
Chief Complaint:
diarrhea, abdominal pain
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
HISTORY OF PRESENT ILLNESS:  
___ hx endometriosis, IBS, HTN, perforated appendicitis 
currently
being treated for her first cdiff recurrence w/vancomycin taper
presenting with nausea, diarrhea, and abdominal pain that 
started
on 5 days prior while patient vacationing in ___. States
prior to this patient's cdiff symptoms of n/v/d were improving,
and no longer had diarrhea but then had exacerbation of fever,
nausea, diarrhea, aches/pains. Pt states feels like previous
cdiff episode.

She traveled to ___ last week, felt great for several days. 
Then about 4 days ago she again had some abdominal discomfort,
some slightly loose stools. She arrived home on ___. Then
yesterday had a fever of 102.7 felt chilled and sweats. She also
has some diarrhea.  No blood in the stool.  She had some period
of times times where she did not have a stool than will have
several times in an hour.  

While in ___, she stayed in a ___.  The only time
she left the resort was to go to the restaurant called
___.  Did not eat or drink any food or water or ice
from anywhere outside of the ___ or ___.  Traveled
with her husband, he is not experiencing any infectious or other
symptoms.

On ROS, she denies headache, neck pain, rhinorrhea, sore throat,
chest pain, palpitations, shortness of breath, cough, dysuria,
lightheadedness, lower extremity edema. 

Regarding her recent hospitalizations, she initially was 
admitted
___ with a perforated, gangrenous appendix w removal
c/b peritonitis and abscesses requiring drains. Then she was
readmitted ___ with abdominal pain, mild diarrhea
found to have C. difficile. 

She presented to PCP ___ ___ with acute abdominal pain and
slight diarrhea, no temp and was found to be C. difficile
positive again. It was decided to treat her with pulse 
vancomycin
therapy and taper. She was doing well on that; had taken to 4
times a day for couple weeks and was on the beginning the week 
of
2 times a day. 

In the ED, initial vitals: T 99.0 HR 97 BP 132/80 RR 18 95% RA  

 - Exam notable for:  
General: Well appearing, no acute distress
Cardiac: Tachycardia
Pulmonary: Clear to auscultation bilaterally, no 
crackles/wheezes
Abdominal/GI: Normal bowel sounds, diffuse discomfort to
palpation w/notable tenderness LLQ.
Renal: No CVA tenderness
Rectal: Deferred

 - Labs notable for:  
    - CBC w WBC 12.3 (PMNs 83%), hgb/hct/platelets wnl
    - CHEM w K 3.4, otherwise wnl 
    - LFTs all wnl including lipase 
    - UA w trace blood, otherwise unremarkable. UCG negative. 
    - Lactate 1.6 --> 1.0 
    - Flu negative
    - Extensive stool studies sent 
    - BCx, UCx sent 

 - Imaging notable for:  
CTABP PRELIM READ 1. Mild, circumferential wall thickening of 
the
descending and sigmoid colons, with mild mucosal hyperemia and
trace adjacent fat stranding, which could reflect colitis. 2.
Small volume pelvic free fluid.

 - Pt given: 
2L of LR 
acetaminophen 1000 mg x2
potassium cl 40 mEq PO
Zofran 4mg IV
vanco oral 125mg (at 2034)
citalopram 20mg  

 - Vitals prior to transfer: Tmax 101.8, Tc 99.2 HR 76 BP 103/60
RR 16 99% RA  

Upon arrival to the floor, the patient gives the history above.

REVIEW OF SYSTEMS: Per HPI, otherwise negative
 
Past Medical History:
PMH: HTN, hypothyroidism, endometriosis, migraine, 
endometriosis.

PSH: laparoscopic appendectomy ___ (___), 
hysteroscopy/polypectomy/myomectomy/D&C, insertion of mirena IUD
laparoscopic left ovarian cystectomy and cystoscopy 

 -tobacco: denies 
 -EtOH: social  
 -occupation: ___
 -living situation: Lives w husband. 
 
Social History:
___
Family History:
The patient reports that her father passed away in ___ from ___ 
body dementia.
 
Physical Exam:
ADMISSION PHYSICAL EXAM
VITALS: Reviewed in POE
GENERAL: well developed, well nourished in NAD, appears tired
HEENT: sclera anicteric, MMM
CARDIAC: regular rate and rhythm, no murmurs, rubs, or gallops
LUNGS: CTABL, no wheezes, rales, or rhonchi, normal WOB on room
air
ABDOMEN: soft, diffusely TTP w guarding, +hyperactive bowel
sounds, no rebound
GU: No foley
EXTREMITIES: warm, well perfused, no cyanosis or edema
SKIN: warm, dry, no rashes or notable lesions
NEURO: AOx3, face symmetric, moving all extremities 

DISCHARGE PHYSICAL EXAM:
PHYSICAL EXAM
VITALS: 24 HR Data (last updated ___ @ 804)
    Temp: 98.4 (Tm 98.9), BP: 112/75 (91-115/57-75), HR: 68
(68-71), RR: 20 (___), O2 sat: 96% (95-96), O2 delivery: Ra,
Wt: 200 lb/90.72 kg  
GENERAL: well developed, well nourished in NAD
HEENT: sclera anicteric, MMM
CARDIAC: regular rate and rhythm, no murmurs, rubs, or gallops
LUNGS: CTABL, no wheezes, rales, or rhonchi, normal WOB on room
air
ABDOMEN: soft, diffusely TTP worse in LLQ, +hyperactive bowel
sounds, no rebound
GU: No foley
EXTREMITIES: warm, well perfused, no cyanosis or edema
SKIN: warm, dry, no rashes or notable lesions
NEURO: AOx3, face symmetric, moving all extremities 
 
Pertinent Results:
ADMISSION LABS:
===============

___ 03:20PM BLOOD WBC-14.3* RBC-4.22 Hgb-12.1 Hct-37.2 
MCV-88 MCH-28.7 MCHC-32.5 RDW-13.0 RDWSD-41.3 Plt ___
___ 03:20PM BLOOD Neuts-84.7* Lymphs-9.9* Monos-4.6* 
Eos-0.1* Baso-0.2 Im ___ AbsNeut-12.09* AbsLymp-1.41 
AbsMono-0.66 AbsEos-0.01* AbsBaso-0.03
___ 09:26AM BLOOD ___ PTT-27.0 ___
___ 03:20PM BLOOD Glucose-104* UreaN-13 Creat-0.9 Na-138 
K-3.4* Cl-98 HCO3-26 AnGap-14
___ 03:20PM BLOOD ALT-24 AST-22 AlkPhos-85 TotBili-0.6
___ 03:20PM BLOOD Albumin-4.9 Calcium-9.7 Phos-4.0 Mg-2.0

DISCHARGE LABS:
==============

___ 09:26AM BLOOD WBC-7.2 RBC-3.87* Hgb-11.0* Hct-35.0 
MCV-90 MCH-28.4 MCHC-31.4* RDW-12.9 RDWSD-42.1 Plt ___
___ 09:26AM BLOOD Glucose-136* UreaN-10 Creat-0.7 Na-142 
K-3.9 Cl-101 HCO3-29 AnGap-12
___ 09:26AM BLOOD Calcium-9.3 Phos-3.2 Mg-2.2

MICRO:
================

___ 4:30 pm STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   C. difficile PCR (Final ___: 
      NEGATIVE. 
           (Reference Range-Negative). 
      The C. difficile PCR is highly sensitive for toxigenic 
strains of C.
      difficile and detects both C. difficile infection (CDI) 
and
      asymptomatic carriage. 
      A negative C. diff PCR test indicates a low likelihood of 
CDI or
      carriage. 

Norovirus genotype I and II negative

Flu A and Flu B PCR negative

RELEVANT IMAGING:
================
___ CT abdomen and pelvis w/ contrast
  
IMPRESSION: 
  
1. Mild, circumferential wall thickening of the descending and 
sigmoid colons, with mild mucosal hyperemia and trace adjacent 
fat stranding, which could reflect colitis. 
2. Small volume pelvic free fluid. 

 
Brief Hospital Course:
ASSESSMENT AND PLAN 
___ is a ___ female with hx endometriosis, 
IBS, HTN, recent perforated appendicitis currently being treated 
for her first cdiff recurrence w/vancomycin taper presenting 
with nausea, diarrhea, and abdominal pain that started on 5 days 
prior while patient vacationing in ___. States prior to this 
patient's cdiff symptoms of n/v/d were improving, and no longer 
had diarrhea but then had exacerbation of fever, nausea, 
diarrhea, aches/pains.

# Fevers, leukocytosis:
# Diarrhea:
# Recent first recurrence of cdiff on vanc taper:
Patient developed diarrhea while on vacation in ___. She has 
been febrile and has persistent sigmoid colitis on imaging. 
Cdiff PCR negative, which is a highly sensitive test, and 
suggestive that current presentation is NOT due to c diff, thus 
will continue her on her current taper as previously planned. 
Likely infectious travelers diarrhea. Noro negative. Further 
stool studies including bacterial and viral cultures pending on 
discharge. Will have close PCP follow up. 

CHRONIC ISSUES
# HTN - hold home meds given diarrhea and normotensive, will 
hold until she sees her outpatient PCP 
# ___ - cont home levothyroxine
# Depression - cont home citalopram
# GERD - cont home ranitidine

TRANSITIONAL ISSUES:
====================
[] restart home antihypertensives if hypertensive in clinic 
(normotensive during admission) 
[] ___ stool study results
[] continue vancomycin taper as scheduled (started ___ 
___ mg orally four times daily for 10, then 
___ mg orally twice daily for 7 days, then 
___ mg orally once daily for 7 days, then 
___ mg orally every 2 days for 2 weeks

Code: Full
Name of health care proxy: ___ 
Relationship: husband 
Phone number: ___ 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Citalopram 20 mg PO DAILY 
2. Chlorthalidone 25 mg PO DAILY 
3. Levothyroxine Sodium 50 mcg PO 4X/WEEK (___) 
4. Levothyroxine Sodium 100 mcg PO 3X/WEEK (___) 
5. Lisinopril 30 mg PO DAILY 
6. Senna 8.6 mg PO BID:PRN Constipation - First Line 
7. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath 
8. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 
9. Ranitidine 150 mg PO DAILY 
10. Vancomycin Oral Liquid ___ mg PO BID 
11. Cetirizine 10 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever  
2.  Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath  
3.  Cetirizine 10 mg PO DAILY  
4.  Citalopram 20 mg PO DAILY  
5.  Levothyroxine Sodium 50 mcg PO 4X/WEEK (___)  
6.  Levothyroxine Sodium 100 mcg PO 3X/WEEK (___)  
7.  Ranitidine 150 mg PO DAILY  
8.  Vancomycin Oral Liquid ___ mg PO BID  
9. HELD- Chlorthalidone 25 mg PO DAILY  This medication was 
held. Do not restart Chlorthalidone until directed by your PCP
10. HELD- Lisinopril 30 mg PO DAILY  This medication was held. 
Do not restart Lisinopril until directed by your PCP
11. HELD- Senna 8.6 mg PO BID:PRN Constipation - First Line  
This medication was held. Do not restart Senna until no longer 
having diarrhea

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
==================
Gastritis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital because you had had abdominal 
pain and diarrhea. 

We suspect that this is travelers diarrhea from your trip to 
___. You should recover on your own. Continue taking your 
medications such as your vancomycin as you have been already. 
You do not need further medications.

If you are unable to take in food by mouth or if the pain in 
your abdomen gets worse please return to the doctor/emergency 
room.

It was a pleasure taking care of you!
Your ___ care team 
 
Followup Instructions:
___
"
142,17887687,24915988," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Sulfa (Sulfonamide Antibiotics) / Tizanidine
 
Attending: ___.
 
Chief Complaint:
Wound infection s/p laparoscopic cholecystectomy 
 
Major Surgical or Invasive Procedure:
None 

 
History of Present Illness:
Mrs. ___ is a ___ female who is now 10 days status
post lap cholecystectomy which was uneventful.
She called our office complaining of erythema around the
umbilical port site scar and abdominal pain that are not getting
better ever since surgery.
I saw her in the office and referred her to the emergency
department for further work-up.
She reports for the last 2 days she has redness around her
umbilical incision associated with night seats no f/c.  She also
reports having abdominal bloating but no nausea and vomiting. 
she
reports having 3 bowel movement since her surgery.  Reports 
still
having pain that is not resulting require her to take dilaudid
over Tylenol and Motrin.
Of note the patient had presented with perforated appendicitis a
year ago and after 3 days of nonoperative management she failed
and had to have laparoscopic appendectomy after which she spent
17 days in the hospital with C. difficile colitis.
She recently undergone fecal transplantation which she reported
in the success.
The cholecystectomy she had 10 days ago therefore did not 
include
perioperative antibiotics in order not to change her gut flora
again.
Today on physical examination she appeared to have erythema and
tenderness around her umbilical scar and fullness in the
abdominal wall underneath as the patient reported night sweats
and really not recovering well from surgery decision was made to
send her to the ED for a CT scan and lab workup.

 
Past Medical History:
PAST HISTORY: 
1.  IBS.
2.  RLQ pain attacks, onset ___.  CAT scan negative/endo
3.  SIBO in ___.  Rifaximin helped.
4.  SIBO, ___, on ___ helped. 
5.  Lactose/fructose intolerance, ___.
6.  Thyroiditis.
7.  Colon polyps, SSA ___, f/u ___
8.  Endometriosis -- mirena ___.
9.  Cervical radiculopathy.
10.  Anemia.
11.  Asthma, seasonal allergies, and migraines.
12.  Eczema.
13.  Perforated appendix/abscess ___, ___
14.  C. diff ___ relapse ___, vanco taper-colitis
16.  Gerd/dysphagia onset ___ EOE; plan motility/impedence
17.  12 cm endometrioma removed ___.  Gallstones
19.  Shellfish allergy-lip swelling ___.  GE severe due to raw oysters ___.  Relapse cdiff colitis, ___- STOOL Transplant ___

PRIOR SURGICAL PROCEDURES:
1.  Colonoscopy ___ with SSA adenoma, f/u ___
2.  Mirena removed ___, reinserted ___.
3.  Laparoscopy=12cm endometrioma removed; ___
4.  Perforated appendix ___.  Endoscopy in ___, negative esophagus, sto/sb
6.  Colonoscopy ___ neg colon random/TI bx 
7.  Colonoscopy ___, stool transplant for relapsing C. diff.
8. Laparoscopic cholecystectomy

 
Social History:
___
Family History:
The patient reports that her father passed away in ___ from ___ 
body dementia.
 
Physical Exam:
VS: 98.0, 68, 128/86, 18, 96% RA
GEN: Pleasant with NAD
HEENT: NC/AT, PERRL, EOMI, no JVD, no scleral icterus 
CV: RRR
PULM: CTAB
ABD: Soft, obese. Umbilical incision with minimal blanching 
erythema around and minimal serous discharge, and covered with 
4x4 gauze. 
EXTR: Warm
 
Pertinent Results:
RECENT LABS:

___ 01:22PM BLOOD WBC-13.9* RBC-4.18 Hgb-12.5 Hct-37.2 
MCV-89 MCH-29.9 MCHC-33.6 RDW-12.0 RDWSD-38.9 Plt ___
___ 05:09AM BLOOD WBC-11.4* RBC-4.06 Hgb-11.9 Hct-36.6 
MCV-90 MCH-29.3 MCHC-32.5 RDW-11.9 RDWSD-39.3 Plt ___
___ 05:09AM BLOOD Glucose-87 UreaN-16 Creat-0.7 Na-139 
K-4.0 Cl-101 HCO3-26 AnGap-12
___ 01:22PM BLOOD ALT-26 AST-20 AlkPhos-85 TotBili-0.2
___ 05:09AM BLOOD Calcium-9.1 Phos-4.0 Mg-2.4

RADIOLOGY:
___ ABD CT:
IMPRESSION: 
1. Inflammatory, phlegmonous changes within the umbilicus with 
minimal 
extension deep to the anterior abdominal wall.  No definite 
drainable fluid collection identified. 
2. Status post cholecystectomy with minimal stranding and trace 
fluid within the cholecystectomy bed, likely postoperative. 
3. Small amount of nonhemorrhagic free fluid in the right lower 
quadrant, 
nonspecific but may be postoperative. 

 
Brief Hospital Course:
The patient s/p laparoscopic cholecystectomy ___ days ago was 
admitted at the ___ Surgery with post operative wound 
infection. On admission patient was afebrile with WBC 13.9. 
Abdominal CT revealed iflammatory, phlegmonous changes within 
the umbilicus with minimal extension deep to the anterior 
abdominal wall, no definite drainable fluid  collection was 
identified. Infectious Disease team was consulted knowing 
patient's complicated history. ID recommended IV Vancomycin. 
Patient was started on antibiotics. On HD 1, patient's wound 
erythema subsided, she remained afebrile, and her WBC stared to 
downward. ID recommended transition patient to oral Linezolid 
and add PO Vancomycin for C. diff prophylactic. Patient was 
discharged home on 5 days course of antibiotics in stable 
condition. 

 
Medications on Admission:
ALBUTEROL SULFATE [PROAIR HFA] - ProAir HFA 90 mcg/actuation 
aerosol inhaler. ___ puffs(s) IH 30 minutes prior to exercise as 
needed
CHLORTHALIDONE - chlorthalidone 25 mg tablet. 0.5 (One half) 
tablet(s) by mouth once a day Resume ___
CITALOPRAM - citalopram 20 mg tablet. 1 tablet(s) by mouth at 
bedtime
FLUOCINONIDE-EMOLLIENT [FLUOCINONIDE-E] - Fluocinonide-E 0.05 % 
topical cream. apply to affected area twice a day as needed
FLUTICASONE PROPIONATE - fluticasone propionate 50 mcg/actuation 
nasal spray,suspension. 2 sprays intranasal once a day as needed 
-  (Prescribed by Other Provider)
HYDROMORPHONE - hydromorphone 2 mg tablet. 0.5 (One half) 
tablet(s) by mouth every six (6) hours as needed for severe pain 
do NOT drive while taking dilaudid.
HYOSCYAMINE SULFATE - hyoscyamine 0.125 mg sublingual tablet. 1 
tablet(s) sublingually q 6 hours  sl prn
LEVONORGESTREL [MIRENA] - Mirena 20 mcg/24 hours ___ yrs) 52 mg 
intrauterine device.   -  (Prescribed by Other Provider)
LEVOTHYROXINE - levothyroxine 88 mcg tablet. 1 tablet by mouth 
once a day take separate from calcium and simethicone
LISINOPRIL - lisinopril 30 mg tablet. 1 tablet(s) by mouth once 
a day replaces previous prescription Resume ___
RANITIDINE HCL - ranitidine 300 mg tablet. 1 tablet(s) by mouth 
before bed -  (Prescribed by Other Provider)
SCOPOLAMINE BASE [TRANSDERM-SCOP] - Transderm-Scop 1.5 mg 
transdermal patch (1 mg over 3 days). Apply one patch behind ear 
as directed as needed Apply 4 hours prior to activity.  Replace 
after 72 hours.
 
Medications - OTC
CETIRIZINE - cetirizine 10 mg tablet. 1 tablet(s) by mouth once 
a day as needed for allergy symptoms -  (OTC)
CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 50 
mcg (2,000 unit) capsule. 1 capsule(s) by mouth once a day 
Resume on ___ -  (OTC; not consistently)
MULTIVITAMIN - Dosage uncertain -  (OTC)
MV-MN-VITC-ASBNA-GLU-LYS-HC124 [AIRBORNE (ASCORBATE SODIUM)] - 
Dosage uncertain -  (OTC) (Not Taking as Prescribed)

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever 
do not exceed more then 3000 mg/day  
2.  Linezolid ___ mg PO BID Duration: 5 Days  
3.  ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation 
BID:PRN SOB  
4.  vancomycin 125 mg oral BID Duration: 5 Days  
5.  Cetirizine 10 mg PO DAILY:PRN congestion  
6.  Chlorthalidone 12.5 mg PO DAILY  
7.  Citalopram 20 mg PO DAILY  
8.  Famotidine 40 mg PO DAILY  
9.  Fluocinonide 0.05% Cream 1 Appl TP BID  
10.  Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN sob, 
congestion  
11.  HYDROmorphone (Dilaudid) 1 mg PO Q6H:PRN Pain - Moderate  
12.  Hyoscyamine 0.125 mg SL Q6H:PRN GI/GU pain  
13.  Levothyroxine Sodium 88 mcg PO DAILY  
14.  Lisinopril 30 mg PO DAILY  
15.  Multivitamins 1 TAB PO DAILY  
16.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Wound infection 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___ were admitted to the surgery service at ___ for evaluation 
and treatment of the wound infection. ___ were started on IV 
antibiotics and your WBC started to downward. ___ were 
transitioned to oral antibiotics prior to discharge per ID 
doctors. ___ are now safe to return home to complete your 
recovery with the following instructions:
.
Please call Dr. ___ office at ___ if ___ have 
any questions or concerns. Call if ___ have fever, drainage from 
incision, or redness get worse. During off hours, call Operator 
at ___ and ask to ___ team. 
.
Wound Care:
*Please call your doctor or nurse practitioner if ___ have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
___ may shower, and wash surgical incisions with a mild soap 
and warm water.  Gently pat the area dry.
*Apply dry gauze dressing daily and prn. 
 
Followup Instructions:
___
"
143,18444359,22572836," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
chest pain
 
Major Surgical or Invasive Procedure:
Cardiac catheterization
 
History of Present Illness:
The patient is a ___ year old male with a past medical history 
only significant for HLD who presented with chest pain.  The 
patient states that 2 weeks ago he experienced exertional, 
substernal chest pressure on exertion (occurred while playing 
basketball) which subsequently resolved after a few minutes. 
Within the past few days, he has noticed episodes of burning 
chest pain which he thought was due to GERD.  The episodes have 
been occuring both with activity and at rest and last a few 
minutes in duration.  He had been taking TUMs.  The night prior 
to admission he awoke 4 times in the middle of the night with 
the burning chest pain- each episode lasted about ___ minutes. 
 On the day of presentation he experienced the worst episode of 
substernal chest pressure and burning, which he rated at a ___ 
in severity.  He denied any dyspnea during these episodes.  He 
subsequently called EMS, was given 4 baby aspirin in the 
ambulence, and was brought to the ___ ED. 
 
In the ED, initial EKG was significant for ST elevations in 
V1-V4 and the patient was taken for cardiac catheterization.  
In the cardiac cath lab, the patient received 600mg Plavix as 
well as 5400 heparin bolus.  Following placement of the wire, he 
was noted to have a reperfusion rhythm, AIVR. Cardiac cath was 
significant for complete occlusion of the proximal LAD and a 
drug eluting stent was placed.  
 
On arrival to the floor, vitals:
Temp 98.9 HR 91 BP 137/87 RR 17 98% on 2L nasal cannula
The patient denies any chest pain or burning. 
 
Past Medical History:
1. CARDIAC RISK FACTORS: No DM, No HTN, +HLD 
2. CARDIAC HISTORY:  No previous cardiac history
3. OTHER PAST MEDICAL HISTORY:  
Allergy induced asthma
Depression
Elbow surgery a few months ago
 
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or 
sudden cardiac death; otherwise non-contributory.  
Does have a family history of HLD
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
VS: Temp 98.9 HR 91 BP 137/87 RR 17 98% on 2L nasal cannula 
General:  no acute distress
HEENT:  NCAT
Neck:  no JVD noted
CV:  normal S1/S2, RRR, no murmurs
Lungs:  clear to ascultation anteriorly
Abdomen:  +BS, soft, nontender, nondistended
GU:  no foley in place
Ext:  warm, well perfused, no edema
Neuro:  AAOx3  
Pulses:  +DP pulses

DISCHARGE PHYSICAL EXAM:
VSS afebrile
General: NAD
HEENT: EOMI, PERRL
Neck: No JVD
CV: RRR, no murmurs
Lung: CTAB
ABd: BS+, soft, NTTP
Pulses: 2+ DP
Ext: WWP, no c/c/e, R arm radial access site c/d/i, unremarkable 
on exam.
 
Pertinent Results:
ADMISSION EXAM:
___ 10:40PM BLOOD WBC-10.6 RBC-4.67 Hgb-14.2 Hct-40.3 
MCV-86 MCH-30.4 MCHC-35.3* RDW-12.7 Plt ___
___ 10:40PM BLOOD ___ PTT-150* ___
___ 10:40PM BLOOD Glucose-163* UreaN-22* Creat-1.2 Na-138 
K-3.3 Cl-98 HCO3-26 AnGap-17
___ 10:40PM BLOOD CK(CPK)-113
___ 05:12AM BLOOD ALT-95* AST-431* LD(LDH)-778* 
CK(CPK)-2979* AlkPhos-49 TotBili-0.5
___ 10:40PM BLOOD Lipase-12
___ 05:12AM BLOOD Albumin-4.6 Calcium-9.7 Phos-4.7* Mg-2.0 
Cholest-220*
___ 05:12AM BLOOD Triglyc-404* HDL-31 CHOL/HD-7.1 
LDLmeas-139*
___ 05:12AM BLOOD %HbA1c-5.4 eAG-108

PERTINENT LABS:
___ 10:40PM BLOOD CK-MB-3 cTropnT-<0.01
___ 05:12AM BLOOD CK-MB-113* MB Indx-3.8 cTropnT-7.40*
___ 12:01PM BLOOD CK-MB-71* MB Indx-3.4 cTropnT-5.27*

EKG on arrival to ED: 
NSR @ 80bpm, normal axis, ST elevations in V1-V4

EKG on arrival to CCU: 
NSR @ 80bpm, normal axis, normal intervals, ST elevations in 
V1-V4, Q waves noted in V2-V3
 
CARDIAC CATH (___):  
1. Anterolateral STEMI with complete occlusion of the proximal 
   LAD
2. Successful PTCA and stenting of the LAD as above
3. Successful removal of the R radial sheath and placement of 
   Terumo band. 
4. Post MI care per CCU team. Would switch to Prasugrel in AM 
   given very proximal LAD stent and disease burden.
 
MICROBIOLOGY
___ Blood culture x 2: NTD
___ Urine culture: BETA STREPTOCOCCUS GROUP B.    10,000-100,000 
ORGANISMS/M
___ 07:58AM URINE Color-Yellow Appear-Clear Sp ___
___ 07:58AM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-5.5 Leuks-NEG
___ 07:58AM URINE RBC-1 WBC-3 Bacteri-NONE Yeast-NONE Epi-0

DISCHARGE LABS:
___ 07:42AM BLOOD WBC-10.3 RBC-4.93 Hgb-15.0 Hct-42.5 
MCV-86 MCH-30.5 MCHC-35.4* RDW-13.1 Plt ___
___ 07:42AM BLOOD Glucose-114* UreaN-21* Creat-1.1 Na-139 
K-4.5 Cl-99 HCO3-27 AnGap-18
___ 06:10AM BLOOD Calcium-9.2 Phos-4.2 Mg-2.___ year old male with a past medical history only significant 
for HLD who presented with chest pain found to have STEMI. now 
s/p cardiac cath with LAD drug eluting stent placement

# STEMI:  Patient had no significant cardiac history, presented 
with burning chest pain, worsening over the past couple weeks, 
and found to have STEMI in V1-4, elevated cardiac biomarkers and 
taken to cath via R radial access with complete LAD occlusion, 
with DES placed. His cardiac biomarkers peaked at CK 2979, CKMB 
113, and troponin 7.4.  His post-cardiac echocardiogram was 
notable for regional left ventricular systolic dysfunction with 
LVEF ___. He was found to have elevated ___ 404 and LDL 139.  
He was started on ASA 325, prasugrel, atorva 80, started on 
metop and lisinopril.  He had resolution of CP and SOB and was 
HDS at discharge.

# Fever:  He had an episode of T 101.1 on ___ without localizing 
symptoms, and negative CXR, UA and urine and blood cultures were 
NTD at discharge.  He had no leukocytosis, and he defervesced 
without intervention without recurrent fevers and had been 
afebrile for over 24 hours on day of discharge. Post discharge, 
his ucx returned positive for GBS, and he was treated with 3-day 
course of Bactrim. 
 
#  Depression: 
- continued home prozac
 
#  Asthma: 
- continued home ___, held mometasone as not on 
formulary but given fluticasone nasal spray

TRANSITIONAL ISSUES:
-Pt had DES placed, started on plavix and ASA
-Blood cultures x 2 pending at discharge
-Post discharge, ucx positive for GBS, treated with 3-day course 
of Bactrim. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Asmanex Twisthaler (mometasone) 220 mcg (120 doses) 
Inhalation daily 
2. Montelukast Sodium 10 mg PO DAILY 
3. ZyrTEC (cetirizine) 10 mg Oral daily 
4. Fluoxetine 20 mg PO DAILY 
5. Multivitamins 1 TAB PO DAILY 
6. Fish Oil (Omega 3) 4000 mg PO DAILY 
7. Cinnamon (cinnamon bark) 1000 mg Oral daily 

 
Discharge Medications:
1. Outpatient Lab Work
check Chem-7 on ___ with results to Dr. ___ at 
Phone: ___ 
Fax: ___ 
ICD 9: 428
2. Fluoxetine 20 mg PO DAILY 
3. Montelukast Sodium 10 mg PO DAILY 
4. ZyrTEC (cetirizine) 10 mg Oral daily 
5. Aspirin EC 325 mg PO DAILY 
RX *aspirin 325 mg 1 tablet,delayed release (___) by mouth 
daily Disp #*30 Tablet Refills:*0
6. Atorvastatin 80 mg PO DAILY 
RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
7. Lisinopril 5 mg PO DAILY 
RX *lisinopril 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
8. Metoprolol Succinate XL 25 mg PO DAILY 
RX *metoprolol succinate 25 mg 1 tablet extended release 24 
hr(s) by mouth daily Disp #*30 Tablet Refills:*0
9. Nitroglycerin SL 0.3 mg SL PRN pain 
Take up to 2 tabs 5 min apart, call ___ if you still have chest 
pain after 2 tabs 
RX *nitroglycerin 0.4 mg 1 tab sublingually when you have chest 
pain Disp #*30 Tablet Refills:*0
10. Prasugrel 10 mg PO DAILY 
RX *prasugrel [Effient] 10 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0
11. Asmanex Twisthaler (mometasone) 220 mcg (120 doses) 
Inhalation daily 
12. Multivitamins 1 TAB PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
ST elevation myocardial infarction
Hyperlipidemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a pleasure taking care of you at ___. 
You were admitted with chest pain and was found to be having a 
heart attack. A cardiac catheterization showed that you had a 
blockage in your left anterior descending artery that was opened 
with a drug eluting stent. It is extremely important that you 
take aspirin and prasugrel every day without fail to prevent the 
stent from clotting off and causing another heart attack. Do not 
stop taking aspirin or prasugrel or miss any doses unless Dr. 
___ it is OK to do ___. You still have a 60% blockage 
in a diagonal artery that branches off the left anterior artery. 
This blockage is not dangerous now and you are on the right 
medicines to prevent it from getting worse. Dr. ___ will 
monitor this as an outpatient. 
You had a fever in the hospital that was probably because of the 
heart attack, all tests were negative at the time of discharge. 
 
Followup Instructions:
___
"
144,18510965,22482990," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
clonidine / hydrochlorothiazide / lisinopril / NSAIDS 
(Non-Steroidal Anti-Inflammatory Drug) / aspirin / Sulfa 
(Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
shortness of breath
 
Major Surgical or Invasive Procedure:
TEE/cardioversion
 
History of Present Illness:
Ms. ___ is a ___ yo with PMH significant for HTN, 
presenting with a week long history of shortness of breath and 
dyspnea on exertion.  On presentation, she denied any chest 
pain, back pain, N/V, abdominal pain, HA, dizziness or 
peripheral edema. She has baseline DOE over the past few years 
and has been limiting her activity because of this.  She had 
been stable over the last few months but a few days ago noted 
increasing DOE.  She is having trouble walking any distance at 
all.  She has been using more of her Albuterol inhaler because 
of this.  She denies any new cough, URI symptoms or 
palpitations.  Other than feeling breathless, she has no other 
symptoms.
 
In the ED, initial vitals were  T 97.2 P ___ BP 123/65 RR 22 
SaO2 93% on RA. While in the ED, around 12:30pm the patient was 
tachycardic to 160.  Her EKG showed atrial fibrillation with 
RVR.  Her blood pressure at that time was stable with SBP of 
102/80 and O2 sats in high ___.  Patient was given 15mg IV 
Diltiazem with improvement in tachycardia to 90.  Her heart rate 
then increased back to about ~150 as the drug washed out.  She 
was given diltiazem 30mg PO.  She was offered outpatient 
management but chose admission.  

On review of systems, she denies any prior history of stroke, 
TIA, deep venous thrombosis, pulmonary embolism, hemoptysis, 
black stools or red stools. She denies recent fevers, chills or 
rigors. She has a chronic non-productive cough. She denies 
N/V/D, dysuria. All of the other review of systems were 
negative.  
 
Cardiac review of systems is notable for SOB and DOE as above, 
as well as paroxysmal nocturnal dyspnea and orthopnea. She 
denies chest pain, ankle edema, palpitations, syncope or 
presyncope.  

 
Past Medical History:
1. CARDIAC RISK FACTORS:+ Hypertension, + Hyperlipidemia, - 
Diabetes 
2. CARDIAC HISTORY:  No past cardiac history  
3. OTHER PAST MEDICAL HISTORY:  
OSA on CPAP (with variable compliance)
Asthma 
GERD
Uterine Cancer, s/p TAH BSO and radiation ___, last recorded 
pap ___
Obesity
Lichen Sclerosus et Atrophicus
Insomnia
Intestinal Angiodysplasia
 
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or 
sudden cardiac death; otherwise non-contributory.  

 
Physical Exam:
VS: T=98.2 BP=130/90 HR=120-130 RR=20 O2 sat=94%RA  
General: obese woman, mildly tachypneic whie lying at ~30 
degrees in bed
HEENT: MMM, OP clear   
Neck: No JVD appreciated  
CV: irregularly irregular, tachycardic, nl s1/s2, no murmur 
appreciated 
Lungs: bibasilar crackles
Abdomen: obese, soft, NT/ND
GU: no foley
Ext: warm, significant adipose tissue, no obvious pitting edema 
appreciated  
Neuro: AAOx3, no focal deficit
Skin: no rashes noted 
 
Pertinent Results:
___ 12:45PM BLOOD WBC-15.8* RBC-5.15 Hgb-14.8 Hct-45.9 
MCV-89 MCH-28.8 MCHC-32.3 RDW-14.6 Plt ___
___ 12:45PM BLOOD Neuts-70.4* ___ Monos-5.4 Eos-0.2 
Baso-0.6
___ 01:53PM BLOOD ___ PTT-30.8 ___
___ 05:30AM BLOOD ___ PTT-70.6* ___
___ 12:45PM BLOOD Glucose-116* UreaN-19 Creat-1.0 Na-137 
K-4.9 Cl-100 HCO3-22 AnGap-20
___ 12:45PM BLOOD cTropnT-<0.01
___ 12:45PM BLOOD Calcium-9.6 Phos-3.8 Mg-2.1
___ 12:45PM BLOOD TSH-4.0

___ CHEST X-RAY
FINDINGS:  This examination is underpenetrated, accentuating 
density of the parenchyma. Heart size is mildly enlarged.  Low 
lung volumes accentuate heart size and pulmonary vasculature 
howevere there is no overt fluid overload. Lungs are clear.  
There is no large pleural effusion or pneumothorax. 
  
IMPRESSION:  No cardiopulmonary abnormality on this 
underpenetrated study. 

___ TRANSTHORACIC ECHOCARDIOGRAM
The left atrium is mildly dilated. Left ventricular wall 
thickness, cavity size, and global systolic function are normal 
(LVEF>55%). Due to suboptimal technical quality, a focal wall 
motion abnormality cannot be fully excluded. Right ventricular 
chamber size and free wall motion are normal. The aortic valve 
leaflets (?#) appear structurally normal with good leaflet 
excursion. There is no aortic valve stenosis. No aortic 
regurgitation is seen. The mitral valve appears structurally 
normal with trivial mitral regurgitation. The pulmonary artery 
systolic pressure could not be determined. There is an anterior 
space which most likely represents a prominent fat pad. 

IMPRESSION: Suboptimal image quality. Normal biventricular 
cavity sizes with preserved global biventricular systolic 
function. No valvular pathology or pathologic flow identified.

___ TRANSESOPHAGEAL ECHOCARDIOGRAM
No spontaneous echo contrast or thrombus is seen in the body of 
the left atrium/left atrial appendage or the body of the right 
atrium/right atrial appendage. No atrial septal defect is seen 
by 2D or color Doppler. Overall left ventricular systolic 
function is normal (LVEF>55%). Right ventricular chamber size 
and free wall motion are normal. There are simple atheroma in 
the descending thoracic aorta. The aortic valve leaflets (3) are 
mildly thickened. There are filamentous strands on the aortic 
leaflets consistent with Lambl's excresences (normal variant). 
No aortic regurgitation is seen. The mitral valve leaflets are 
structurally normal. Mild (1+) mitral regurgitation is seen. 
There is no pericardial effusion. 

IMPRESSION: No intracardiac thrombus. Mild ___ regurgitation. 

  
 
Brief Hospital Course:
___ yo female presenting with dyspnea on exertion found with new 
onset symptomatic Afib with RVR and signs of volume overload.

# New onset Afib w/RVR: Pt presenting with shortness of breath 
and dyspnea on exertion which has acutely worsened over the week 
prior to admission. Pt thought to be in Afib for >48 hours upon 
presentation, outside of the window for cardioversion without 
TEE. Pt describes months of episodic dyspnea on exertion, 
self-treated as asthma with albuterol inhaler, but were perhaps 
possibly ___ paroxysms of Afib. Rate was not controlled on max 
dose diltiazem 15 mg/hr and metoprolol 400mg daily. She was 
bridged with heparin to a therapeutic INR on warfarin and 
underwent TEE/cardioversion with successful converstion to sinus 
rhythm. However, after cardioversion, pt developed >4.5 sec 
sinus pauses and bradycardia to ___. For this reason, she was 
not discharged on a beta blocker. She was set up to have an 
event monitor, with a plan to start low dose metoprolol 
succinate if she no longer has sinus pauses. INR was 3.6 on day 
of discharge; pt was prescribed warfarin 1mg, with instructions 
to hold the warfarin until INR check at ___ 
___ clinic on the day after discharge. 

# sinus pauses: occurred overnight after cardioversion, >4.5 
sec, asymptomatic. Unclear if these pauses occurred while 
patient was lying supine; she was not wearing CPAP at the time. 
Differential includes OSA vs. excessive nodal blockade vs. sick 
sinus syndrome. Pt has a history of non-compliance with CPAP and 
was counseled on the importance of CPAP for preventing sinus 
pauses and ectopy that could re-initiate her atrial 
fibrillation. Betablockade was held as above. Pt observed for 24 
hours while compliant with CPAP and did not have significant 
sinus pauses. She was arranged to have event monitor for ___ 
weeks, and to follow up with Dr. ___ in one month to monitor 
for further sinus pauses while off the beta blocker.

# orthopnea: CXR with vascular congestion. Pt likely with flash 
pulmonary edema ___ tachyarrythmia. Echo showed preserved 
systolic function, suboptimal images, could not comment on PA 
pressure. Given hives to HCTZ, a sulfa-moeity, initially avoided 
lasix in favor of ethacrynic acid, however net even with this 
agent. Ultimately diuresed with lasix IV without skin reaction, 
and orthopnea resolved. Pt still with baseline dyspnea on 
exertion. 

# Leukocytosis: Pt afebrile without focal infection signs. 
Leukocytosis persisted for 3 days; UA positive however culture 
grew mixed flora suggesting fecal contaminant. Leukocytosis 
resolved after removal of foley and 3 day course of ceftriaxone. 


# HTN: Home atenolol and amlodipine held while titrating nodal 
agents. Pt discharged on home dose of amlodipine but held beta 
blockade as above.

# OSA: Patient intermittently uses CPAP at home. Encouraged use 
and educated on importance of CPAP. Pt observed to be compliant 
towards the end of the admission.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 50 mg PO DAILY 
2. Amlodipine 10 mg PO DAILY 
3. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
4. Fluocinonide 0.05% Ointment 1 Appl TP TID:PRN rash 
5. clotrimazole-betamethasone ___ % topical BID 
6. Albuterol Inhaler ___ PUFF IH Q4H:PRN wheeze, shortness of 
breath 
7. Omeprazole 20 mg PO BID 
8. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID 
9. Betamethasone Valerate 0.1% Ointment 1 Appl TP EVERY OTHER 
DAY OR LESS itchy areas 

 
Discharge Medications:
1. Betamethasone Valerate 0.1% Ointment 1 Appl TP EVERY OTHER 
DAY OR LESS itchy areas 
2. Fluocinonide 0.05% Ointment 1 Appl TP TID:PRN rash 
3. Omeprazole 20 mg PO BID 
4. Furosemide 20 mg PO DAILY 
RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
5. Albuterol Inhaler ___ PUFF IH Q4H:PRN wheeze, shortness of 
breath 
6. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
7. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID 
8. clotrimazole-betamethasone ___ % topical BID 
9. Amlodipine 10 mg PO DAILY 
10. Warfarin 1 mg PO DAILY16 
Take as directed by ___ clinic. 
RX *warfarin [Coumadin] 1 mg 1 tablet(s) by mouth as directed 
Disp #*30 Tablet Refills:*0
11. Outpatient Lab Work
Atrial Fibrillation 427.31 
Dr. ___ ___ 
Please check INR on ___.
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Atrial Fibrillation with RVR, s/p TEE/cardioversion

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a pleasure to take care of you during your stay at ___. 
You came in with shortness of breath and were found to have an 
abnormal fast heart rhythm called atrial fibrillation. We were 
unable to slow down your heart rate with medicines, so we 
scheduled you for an echocardiogram (ultrasound of the heart) 
which showed no clot, and then shocked the heart. This 
successfully converted your heart back to normal rhythm. 

You had a little extra fluid on your body from your heart not 
pumping efficiently while it was in Afib. We diuresed you with 
lasix and will be sending you home a small dose of lasix 20mg to 
take daily at home.

After the conversion, you had some very long pauses of your 
heart beat. Because of this we want you to wear a heart rhythm 
monitor for ___ weeks at home, to make sure you are not having 
more pauses, and also monitor if you go back into Afib. ___ 
___ will be in touch with you about this heart monitor, 
which you will receive at home in the mail within 3 business 
days.

We discussed the importance of wearing your CPAP to prevent 
converting back to Afib, and also to prevent the pauses we 
observed. Talk to your PCP about getting reconnected to a sleep 
center to keep your CPAP machine maintained and make sure you 
have the best-fitting mask.

When people are in atrial fibrillation, they are at risk of 
developing clots in the heart, which can break off and cause a 
stroke. To prevent this risk, you will need to take a blood 
thinner called warfarin, in case you go back into atrial 
fibrillation.  You will have to get your INR (a measure of how 
thin your blood is) checked regularly with the ___ 
clinic at ___ to make sure you are on the right 
dose of warfarin. You should get your INR checked tomorrow, 
___.
 
Followup Instructions:
___
"
145,18607084,26324835," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
events concerning for seizure
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old right handed man with MS complicated by PML
while on Tysabri followed by ___ presenting with report of
possible seizures on Keppra 1250 mg BID. Patient reports 
episodes
in question started about one month ago, for the last week
occurring daily. Patient is followed by outpatient neurologist
Dr. ___ (cell ___. History is obtained from
patient, patient's girlfriend of ___ years in person (though
currently separated), and Dr. ___ phone. 

Patient and girlfriend report that patient diagnosed with MS in
___ in the setting of left eye decreased vision and right sided
weakness. Patient maintained on Tysabri for years until 
developed
PML in ___, per current primary neurologist Dr. ___ was followed by ___. Patient was referred to Dr. ___
he developed PML. Per report had a right frontal lesion, had
initially slight cognitive deficits then became overtly frontal,
then improved somewhat. 

Patient reports that previously his MS was largely characterized
by fatigue but that during this period he was diffusely quite
weak, very ill, hospitalized for four months. Around this time
patient reports that he had about 4 episodes of staring, being
unresponsive for ___ minutes spread out over time (months in
between). At some point over this time patient was started on
Keppra 1000 mg BID, and he was maintained on this dose until
about a month ago. 

About a month ago patient began experiencing different episodes.
He reports that these seem to start on the inside of his right
thigh with stiffening and cramping, then stiffening and low
amplitude shaking of bilateral lower extremities, shoulders, and
possibly arms, as well. Patient reports that when this happens 
he
will grab on to the railing of his bed. Sometimes patient 
reports
he has preserved awareness during and tries to keep track of the
clock (he thinks at times that he maintains awareness throughout
the entire episode but does, of note, have baseline short-term
memory difficulties). Other times patient will lose awareness 
and
come to holding onto the bed rail. The episodes typically last
___ minutes and are followed by patient being confused, tired,
sore, out of it for about 10 minutes or so, resting and getting
his bearings. Per report patient's son has witnessed several of
these episodes and has been unable to get father to respond
during. Patient reports son will try to put pressure on his
extremities to stop them from shaking and that this possibly
helps. 

Patient and girlfriend report that when these new episodes
started patient went to an OSH ED (possibly ___,
also possibly ___ at least at one point) in the
setting of an episode of unresponsiveness, not knowing where he
was or who he was (unclear if this was following one of the
shaking spells). At that time Keppra was increased to 1250 mg 
BID
and then about two weeks later to 1500 mg BID. Per patient the
episodes seemed better on 1500 mg BID, had seemed to quiet down,
so Keppra was weaned to 1250 mg BID. Per patient neurologist Dr.
___ on the phone, these episodes seemed to be better controlled
on Keppra 1500 mg BID but patient had cognitive slowing so was
decreased back to 1250 mg BID. Patient denies side effects on
Keppra 1500 mg BID and does not recall having had cognitive
slowing. 

Over the past week, patient reports he is now having these
shaking spells about daily, some days more than once. 

Per Dr. ___ had considered starting Lamictal given patient
per report with preserved awareness (at least when episodes
start) and also with known per report right frontal lesion
thought ___ PML (suggesting possibly focal seizures). However,
given increasing frequency of episodes, was concerned about
starting a medication requiring slow uptitration. As such,
referred patient to ___ ED for possible medication adjustment
and evaluation (including possible EEG) in the setting of these
frequent and prolonged spells. 

Patient reports that he has never had an EEG. Reports that his
last MRI was two weeks ago. 

Reports baseline difficulties thinking and speaking 
(particularly
with short term memory often repeating himself and with reading 
-
reports that this takes significant effort and is slow); patient
and girlfriend estimate that this has been about stable since 
his
PML.

Also reports baseline slightly decreased vision in the left eye,
left facial weakness, left greater than right extremity weakness
(reports that was initially weak on the right around the time of
MS diagnosis but then became more weak on the left with PML,
especially weak in the left hand), baseline muscle spasms and
cramping, spasticity throughout but particularly in his right
lower extremity. 

At baseline patient walks short distances with a walker, uses a
manual chair for longer distances. Typically does ___ (previously
twice per week then spaced to weekly). Has not had ___ in over 5
weeks given he gets this through ___ and ___ 
is
currently on ___ break. Reports increasing tightness, muscle
cramping, spasms in the setting of not getting his ___. Also
normally tries to walk outside if possible, is not possible in
the ___. Son does stretch patient night but still has noticed
recent worsening of spasms and tightness. 

Episodes per report typically consist of whole body shaking, at
times with preserved awareness, lasting ___ minutes. Also with
staring spells, per report he is conscious during but reports he
is unable to respond. 

Patient is current maintained on Copaxone (M, W, F - unknown
dose) as well as maraviroc for ___, likely to wean off 
maraviroc
in the near future.  

Reports right shoulder radiating to the elbow and then back
across his chest while sitting or lying certain ways for about
the past two weeks. 

No recent illnesses. Denies recent vision changes, diplopia,
vertigo, dizziness, tinnitus, hearing difficulty, new weakness,
new numbness apart from the intermittent right
arm/chest/shoulder. Denies recent changes in cognition. 

Denies recent fevers, cough, congestion, shortness of breath,
chest pain, palpitations, abdominal pain, constipation, 
diarrhea,
rashes. Endorses baseline thirst, dry mouth, and significant
diaphoresis to the point that he drinks 72 ounces of water 
before
bed nightly and wears a condom catheter overnight. Sleeps about
___ hours each night. Needs to take nighttime medications to 
have
muscle spasms and discomfort under control to be able to sleep. 

Endorses low mood, feeling like he is not adding anything.  
 
Past Medical History:
MS
PML
___ seizures
Right hip replacement
 
Social History:
___
Family History:
Son ___ is healthy.
 
Physical Exam:
ADMISSION / DISCHARGE EXAM

GEN - non-able bodied gentleman lying in bed uncomfortable and 
frustrated and later tearful, with occasional muscle spasms and 
tremulousness associated but in between non-toxic appearing
HEENT - NC/AT, MMM; poor dentition
NECK - full ROM, no meningismus
CV - RRR no MRG
RESP - normal WOB
ABD - soft, NT, ND
EXTR - atraumatic, WWP; feet somewhat edematous (non-pitting) 
with mild ankle contractures

NEUROLOGICAL EXAMINATION:
MS - Awake, alert, oriented to hospital, month, year but not 
date. Able to relate history without difficulty. Somewhat 
verbose/chatty and garrulous, at times a bit tangential. 
Attention to examiner easily attained but may again become a bit 
tangential; able to recall days of week backwards, initially 
skips ___ but then with single prompt able to self-correct. 
Naming intact to low frequency objects (pen, thumb, fingernail). 
Recalls a fairly coherent history, though again at times 
tangential. During examination patient gets tearful when his 
deficits are revealed via the exam (when has difficulty with 
strength testing, for example) and then expresses low mood and 
some hopelessness when discussing his healthcare proxy and code 
status.  Structure of speech demonstrates fluency with full 
sentences, and normal prosody. No paraphasic errors. Intact 
repetition and comprehension. No evidence of apraxia or neglect.

CN - Pupil on the left larger at baseline (4.5 vs 3mm) but 
constricts well to light bilaterally without obvious evidence of 
APD. VF full to number counting. [III, IV, VI] EOMI, no 
nystagmus. [V] V1-V3 without deficits to light touch 
bilaterally. [VII] Left lower facial droop at rest and with 
slower and incomplete activation of left lower face. [VIII] 
Hearing intact to finger rub on right, not on left (patient 
reports at times as cerumen). [IX, X] Palate elevation 
symmetric. No dysarthria. [XI] SCM/Trapezius strength ___ on 
right, trapezius 4- on left. [XII] Tongue midline.

MOTOR - Spasticity throughout, more notably in right lower 
extremity and with mild ankle contractures bilaterally. Right 
IP, quad, hamstring strength limited somewhat by patient 
beginning to have muscle spasms as testing. 
=[Delt] [Bic] [Tri] [ECR]  [IP] [Quad] [Ham] [TA] [Gas] 
  [C5]  [C5]  [C7]  [C6]   [L2]  [L3]  [L5]  [L4] [S1]  
L  4-     4-     5    3      4    5      5     5    3+     
R  5      5     5     5      3    5      3     5    5     

SENSORY - No deficits to light touch or temperature of forearms 
or shins bilaterally; deferred more extensive sensory testing as 
patient tearful at this point in the examination. 

REFLEXES - pec jerks, crossed adductors and spreading 
bilaterally. No ankle clonus though somewhat limited testing 
given mild ankle contractures*. 
=[Bic]  [___] [Quad] [Gastroc]
L 3+      3+      3+      1*        
R 3+      3+      3+      1*        
Toes upgoing bilaterally.

COORD - Deferred given patient tearful.

GAIT - Deferred; patient with known difficulty ambulating and 
tearful.

 
Pertinent Results:
==========
LABORATORY
==========
Admission labs:
     13.1     MCV 90 
6.6 >---< 287 
     37.9  
Urine Benzos Pos ** Patient known to be on Valium 
Urine Barbs, Opiates, Cocaine, Amphet, Mthdne, Oxycodone 
Negative
U/A benign

___ 07:11AM BLOOD ___ PTT-28.8 ___
___ 07:11AM BLOOD Glucose-85 UreaN-16 Creat-0.7 Na-138 
K-4.0 Cl-103 HCO3-23 AnGap-16
___ 07:10AM BLOOD ALT-29 AST-29 CK(CPK)-426* AlkPhos-103 
TotBili-0.4
___ 07:11AM BLOOD Calcium-9.1 Phos-3.8 Mg-2.0
___ 07:10AM BLOOD VitB___-___
___ 07:10AM BLOOD TSH-1.8

=================
OTHER DIAGNOSTICS
=================
EEG - ___
This is continuous EEG recording captures one pushbutton 
activation for right shoulder shrugging, and variable right arm, 
torso and head tremors which last for one minute and has no 
electrographic correlate; consistent with a psychogenic 
non-epileptic event (PNES). Otherwise the background activity is 
normal and a well-organized 9 Hz posterior dominant rhythm is 
seen. There are no seizures or epileptiform discharges. 

EEG - ___
This is continuous EEG recording that captured two pushbutton 
activations where there was no electrographic correlate. The 
background 
activity is normal. No focal, lateralized or epileptiform 
discharges were 
seen. 

EEG - ___
This is a normal continuous ICU monitoring study. There are no 
pushbutton activations. There are no electrographic seizures or 
epileptiform discharges. 
 
Brief Hospital Course:
Mr. ___ is a ___ M w PMHx MS ___ PML / ___ (R 
frontal lesion) and suspected seizures (staring spells, on 
keppra) who is admitted for characterization for a new spell 
type (severe painful R thigh spasm followed by whole body 
spasms, no LOC during event per patient but sleepy/confused/weak 
after, occurring multiple times per day). 
He was hooked up to cvEEG and multiple stereotypical ""spasm"" 
spells were captured. There was no electrographic correlate. On 
video, spells appear more consistent with PNES than pain 
reactions or muscle spasms. 
His home LEV was then discontinued in an attempt to capture his 
other spell semiology (""staring""). Despite this, no spells were 
captured over several days. Keppra was re-started at discharge 
given staring spells were not captured and patient is at risk 
for seizures.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Mirtazapine 30 mg PO QHS 
2. Diazepam 10 mg PO QHS 
3. Maraviroc 300 mg PO BID 
4. Baclofen 10 mg PO 1 IN AM, 2 IN ___ 
5. LevETIRAcetam 1250 mg PO BID 
6. Gabapentin 300 mg PO QHS 
7. Tizanidine 18 mg PO TID 
8. Copaxone (glatiramer) 40 mL subcutaneous ___ 
9. Vitamin D ___ UNIT PO DAILY 
10. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1.  Nicotine Patch 21 mg TD DAILY  
2.  Baclofen 10 mg PO 1 IN AM, 2 IN ___  
3.  Copaxone (glatiramer) 40 mL subcutaneous ___  
4.  Diazepam 10 mg PO QHS 
RX *diazepam 10 mg 1 PO by mouth at bedtime Disp #*7 Tablet 
Refills:*0 
5.  Gabapentin 300 mg PO QHS  
6.  LevETIRAcetam 1250 mg PO BID  
7.  Maraviroc 300 mg PO BID  
8.  Mirtazapine 30 mg PO QHS  
9.  Multivitamins 1 TAB PO DAILY  
10.  Tizanidine 18 mg PO TID  
11.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Myoclonic jerks

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You presented with episodes of full body stiffening and shaking. 
You had brain wave (EEG) monitoring to evaluate whether these 
episodes were seizures - this test showed that these events were 
NOT seizures. 

We will continue you on Keppra at time of discharge given you 
also have staring spell episodes which may represent seizures.

Please continue to follow-up with your outpatient neurologist 
Dr. ___.

We wish you all the best!
 
Followup Instructions:
___
"
146,18732942,29545611," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
R hip pain
 
Major Surgical or Invasive Procedure:
R hip hemi arthroplasty

 
History of Present Illness:
Ms. ___ is a pleasant ___
female who has had right hip pain for the past several months. 
She was last seen by Dr. ___ in ___.  This was worked 
up
including x-rays, which were reportedly normal and then she
subsequently had an MRI of her lumbar spine, which also showed 
no
significant abnormalities other than some mild stenosis.  She
then was overseas in ___ and came back to see Dr. ___ this week and continue to have pain in her right hip.  She
reports having an x-ray in ___ in ___ that showed a
femoral neck fracture.  Dr. ___ x-rays today, 
which
confirmed displaced femoral neck fracture of the right hip.  She
is now here to see me for management.
 
Past Medical History:
1.  Diabetes mellitus type 2.
2.  Hypertension.
3.  No history of malignancy.
 
Social History:
___
Family History:
n/c
 
Physical Exam:
 On examination today, a pleasant female.  She is alert
and oriented and answering questions appropriately through her
daughter who is interpreting today.  She is seated in a
wheelchair and could not fully ambulate.
MUSCULOSKELETAL:  On examination of her right hip, she has pain
with log rolling and any internal or external rotation at the
hip.  Distally, she is neurovascularly intact.  Her knee is
nontender.

 
Pertinent Results:
___ 12:50PM BLOOD Calcium-8.9 Phos-2.9 Mg-1.6
___ 12:50PM BLOOD Glucose-134* UreaN-21* Creat-1.5* Na-142 
K-3.9 Cl-110* HCO3-22 AnGap-14
___ 06:15AM BLOOD Glucose-143* UreaN-24* Creat-1.6* Na-138 
K-4.5 Cl-106 HCO3-24 AnGap-13
___ 06:20AM BLOOD Glucose-174* UreaN-30* Creat-2.1* Na-136 
K-4.4 Cl-106 HCO3-22 AnGap-12
___ 12:50PM BLOOD Plt ___
___ 06:15AM BLOOD Plt ___
___ 06:20AM BLOOD Plt ___
___ 12:50PM BLOOD WBC-7.3 RBC-2.91* Hgb-9.1* Hct-27.4* 
MCV-94 MCH-31.2 MCHC-33.0 RDW-13.1 Plt ___
___ 06:15AM BLOOD WBC-8.4 RBC-2.42* Hgb-7.4* Hct-23.0* 
MCV-95 MCH-30.5 MCHC-32.1 RDW-12.8 Plt ___
___ 08:20PM BLOOD Hct-29.8*#
___ 06:20AM BLOOD WBC-11.4* RBC-3.16*# Hgb-9.5*# Hct-29.5* 
MCV-93 MCH-30.0 MCHC-32.1 RDW-14.5 Plt ___
 
Brief Hospital Course:
The patient presented to the hospital and was evaluated by the 
orthopedic surgery team. The patient was found to have R hip 
fracture and was admitted to the orthopedic surgery service.  
The patient was taken to the operating room on ___ for R hip 
hemiarthroplasty which the patient tolerated well (for full 
details please see the separately dictated operative report). 
The patient was taken from the OR to the PACU in stable 
condition and after recovery from anesthesia was transferred to 
the floor.  The patient was initially given IV fluids and IV 
pain medications, and progressed to a regular diet and oral 
medications by POD#1. The patient was given perioperative 
antibiotics and anticoagulation per routine.  The patients home 
medications were continued throughout this hospitalization.  The 
patient worked with ___ who determined that discharge to rehab 
was appropriate. The ___ hospital course was otherwise 
unremarkable.

At the time of discharge the patient was afebrile with stable 
vital signs that were within normal limits, pain was well 
controlled with oral medications, incisions were 
clean/dry/intact, and the patient was voiding/moving bowels 
spontaneously. The patient is WBAT in the RLE extremity, and 
will be discharged on LVX for DVT prophylaxis.  The patient will 
follow up in two weeks per routine. A thorough discussion was 
had with the patient regarding the diagnosis and expected 
post-discharge course, and all questions were answered prior to 
discharge.
 
Medications on Admission:
Fluticasone Propionate NASAL 1 SPRY NU DAILY 
GlipiZIDE XL 5 mg PO DAILY 
Hydrochlorothiazide 25 mg PO DAILY 
Lisinopril 20 mg PO DAILY 
Omeprazole 20 mg PO DAILY 
Pioglitazone 30 mg PO DAILY 
Simvastatin 20 mg PO DAILY 
Vitamin D 50,000 UNIT PO 1X/WEEK (TH) 
 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H 
2. Docusate Sodium 100 mg PO BID 
3. Enoxaparin Sodium 30 mg SC Q24H Duration: 14 Days 
4. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
5. GlipiZIDE XL 5 mg PO DAILY 
6. Hydrochlorothiazide 25 mg PO DAILY 
7. Lisinopril 20 mg PO DAILY 
8. Omeprazole 20 mg PO DAILY 
9. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN Pain 
10. Pioglitazone 30 mg PO DAILY 
11. Simvastatin 20 mg PO DAILY 
12. Vitamin D 50,000 UNIT PO 1X/WEEK (TH) 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
R hip fracture

 
Discharge Condition:
stable

 
Discharge Instructions:
MEDICATIONS:
- Please take all medications as prescribed by your physicians 
at discharge.
- Continue all home medications unless specifically instructed 
to stop by your surgeon.
- Do not drink alcohol, drive a motor vehicle, or operate 
machinery while taking narcotic pain relievers.
- Narcotic pain relievers can cause constipation, so you should 
drink eight 8oz glasses of water daily and take a stool softener 
(colace) to prevent this side effect.

ANTICOAGULATION:
- Please take lovenox 40mg daily for 2 weeks

WOUND CARE:
- You can get the wound wet/take a shower starting 3 days after 
your surgery.  You may wash gently with soap and water, and pat 
the incision dry after showering.  
- No baths or swimming for at least 4 weeks.
- Any stitches or staples that need to be removed will be taken 
out at your 2-week follow up appointment.
- No dressing is needed if wound continues to be non-draining.

ACTIVITY AND WEIGHT BEARING:
- WBAT
Physical Therapy:
WBAT
Treatments Frequency:
Please have staples removed on first postoperative vist and 
change dressings daily
 
Followup Instructions:
___
"
147,18732942,22462674," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
SOB  
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ w/ PMH CHF, DM, HTN, HLD, CKD and anemia presents from PCP 
___/ concern for pulmonary edema. Pt states she has had dyspnea on 
exertion, which has been worsening in past 2 weeks. She also 
notes orthopnea and bilateral lower extremity edema. She has had 
a mildly productive cough. She does not believe that she has 
gained weight although she does not weight herself daily. Her 
granddaugther states the pt often adds salt to food because she 
finds regular food bland.  
She denies chest pain, fevers, nausea/vomiting, diarrhea, or 
abdominal pain.  
Pt was recently discharged several days ago from ___ per her 
granddaughter with anemia and shortness of breath. She received 
3u prbc for an initial hct 16 and on discharge hct 28. 
Colonoscopy and EGD negative. Stress normal. She was started on 
20 mg PO lasix but stopped due to concern for worsening Cr. 
Currently not on diuretics. Of note, the pt is Mandrin speaking 
only and the interview is conducted with the aid of her 
granddaughter.  
In the ED initial vitals were: 98.3 73 160/54 18 99%  
- Labs were significant for Cr 2.1, BNP 4077, h/h 9.___.9  
- ___ was given nothing  
Vitals prior to transfer were: 98.0 71 166/65 18 99% RA  
On the floor, pt is resting comfortably. She is eating ___ 
food she has brought from home.  
Review of Systems:  
(+) per HPI  
(-) fever, chills, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, chest pain, abdominal pain, 
nausea, vomiting, diarrhea, constipation, BRBPR, melena, 
hematochezia, dysuria, hematuria.  
 
Past Medical History:
Diabetes mellitus type 2.  
Hypertension.  
CKD (recent baseline 1.9-2.3)  
hypercholesterolemia  
iron deficiency anemia  
moderate mitral regurgitation  
peripheral neuropathy.  
CAD with remote history of MI
Hyperlipidemia

PAST SURGICAL HISTORY
R total hip replacement ___
s/p hysterectomy

 
Social History:
___
Family History:
 No kidney disease or heart disease
 
Physical Exam:
PHYSICAL EXAM ON ADMISSION
===========================
Vitals - 98.4, 180/72 -> on recheck 164/62, 79, 97% on RA  
GENERAL: NAD, ___ speaking elderly woman  
HEENT: AT/NC, anicteric sclera, pink conjunctiva, MMM,  
NECK: JVP difficult to assess due to R EJ  
CARDIAC: RRR, II/VI holosystolic murmur  
LUNG: crackles at bases bilaterally  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding  
EXTREMITIES: 1+ pitting edema to shins bilterally  
PULSES: 2+ DP pulses bilaterally  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 

PHYSICAL EXAM ON DISCHARGE
===========================
Vitals:  98.6 (Tm 99.0)  152/59 (119-179)/(38-52)  73 (57-73)  
18  97%RA
Tele: NSR ~65
Last 24 hours I/O: 1010/50 //1550
Last 8 hours I/O:  -- // 400
Weight on admission: 62.6 kgs
___: 61.9 kg
___: 68.1 kg
GENERAL: NAD, ___ speaking elderly woman, seen with nasal 
cannula. 
HEENT:  MMM,  
NECK: no EJ, JVD still unable to appreciate.  
CARDIAC: RRR, II/VI holosystolic murmur  
LUNG: CTAB 
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding  
EXTREMITIES: no edema
PULSES: 2+ DP pulses bilaterally  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes
 
Pertinent Results:
LABS ON ADMISSION
-------------------
___ 05:45PM BLOOD WBC-5.6 RBC-3.43* Hgb-9.3* Hct-29.7* 
MCV-87# MCH-27.1 MCHC-31.3 RDW-18.4* Plt ___
___ 05:45PM BLOOD Neuts-75.7* Lymphs-16.7* Monos-4.7 
Eos-2.9 Baso-0
___ 05:45PM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-OCCASIONAL 
Macrocy-NORMAL Microcy-1+ Polychr-NORMAL Ovalocy-OCCASIONAL
___ 05:45PM BLOOD ___ PTT-28.5 ___
___ 05:45PM BLOOD Plt ___
___ 05:45PM BLOOD Glucose-303* UreaN-35* Creat-2.1* Na-140 
K-4.3 Cl-105 HCO3-24 AnGap-15
___ 06:15AM BLOOD ALT-12 AST-18 AlkPhos-80 TotBili-0.4
___ 05:45PM BLOOD CK(CPK)-146
___ 05:45PM BLOOD CK-MB-3 proBNP-4077*
___ 05:45PM BLOOD Calcium-8.9 Phos-2.9 Mg-2.2

PERTINENT RESULTS
------------------
___:
___
5.5>4.9/16.3<262 MCV 76
127/4.5/101/___/2.26
Iron 17, TIBC 385 Ferritin 13

LABS ON DISCHARGE
------------------
___ 06:20AM BLOOD WBC-6.1 RBC-3.55* Hgb-9.5* Hct-30.8* 
MCV-87 MCH-26.8* MCHC-30.8* RDW-19.4* Plt ___
___ 06:20AM BLOOD Plt ___
___ 06:20AM BLOOD Glucose-137* UreaN-38* Creat-2.3* Na-141 
K-4.3 Cl-103 HCO3-27 AnGap-15
___ 06:20AM BLOOD Calcium-9.2 Phos-4.1 Mg-2.5

OTHER FLUID ANALYSIS
none

MICROBIOLOGY
---------------
none

IMAGING
-------
___ Imaging CHEST (PA & LAT) 
FINDINGS:  
  
Mild to moderate enlargement of the heart is present. Aortic 
knob 
calcifications are visualized. Mediastinal contour is 
unremarkable. There is mild pulmonary vascular congestion along 
with small bilateral pleural 
effusions.  Mild streaky bibasilar opacities likely reflect 
atelectasis. No pneumothorax is identified. No acute osseous 
abnormality is detected. Remote left rib fractures are 
identified. 
  
IMPRESSION:  
  
Mild pulmonary vascular congestion and small bilateral pleural 
effusions. 
  

EKGS
-----
___ Cardiovascular ECG 
Sinus rhythm. Probable old infero-posterolateral myocardial 
infarction. 
Compared to the previous tracing of ___ decreased lateral T 
wave 
abnormality. 
  
 
Read by: ___. 
 
  Intervals Axes 
Rate PR QRS QT/QTc P QRS T 
74 156 88 ___ ___ w/ PMH CHF, DM, HTN, HLD, CKD and anemia presents with 
recent hospitalization from ___, concerning for 
severe anemia (Hct 16), acute on chronic kidney injury, and CHF 
exacerbation, now presenting from PCP ___/ concern for SOB

BRIEF HOSPITAL COURSE 
=====================
ACTIVE ISSUES
-------------- 
#ACUTE ON CHRONIC DIASTOLIC CONGESTIVE HEART FAILURE: ___ 
presents clinically volume overloaded, unclear trigger, although 
___ does have much dietary indiscretion per report and also 
s/p colloid resuscitation at OSH. Unclear NSAID use from hip 
pain. Anemia at this time most likely not contributing as 
___ has been repleted w 3 UPRBCs at ___, currently 
H/H stable. Diuretics discontinued only on day of admission, per 
___ granddaughter. ACS ruled out with downtrending mild 
troponinemia, flat CK-MB and EKGS without acute or new changes. 
___ diuresed with improvement in shortness of breath. TTE 
not repeated this admission due to recent TTE (___) at OSH. 
Admission weight: 62.6 kgs. Discharge weight:61.4 kg. 

# ANEMIA: Unclear source. Severely iron deficient per OSH labs. 
EGD from OSH significant for chronic gastritis, + H.pylori. 
Colonoscopy normal at OSH. ___ is to continue iron 
repletion. She was started on triple therapy for H. pylori. She 
is to follow up with Dr. ___ 
___ for further management. 

# H. PYLORI: EGD from OSH significant for chronic gastritis, + 
H.pylori. She is to continue triple therapy for fourteen day 
course. Day 1: ___, End Date ___. ___ home dose 
simvastatin was changed to pravastatin due to contraindication 
between simvastatin and pravastatin. 

# CHRONIC KIDNEY DISEASE: ___ with Cr of 2.6 upon admission 
to ___. Appears to have resolved as our Cr on file (since 
___ ~2.0. Possibly due to severe anemia as described 
aboove. ___ home dose lisinopril (recently discontinued at 
___ d/t ___ restarted this admission as Cr returned to 
baseline 2.0. Cr on discharge 2.3, most likely ___ to 
overdiuresis. Please continue to monitor Cr as outpatient. 

# HYPERTENSION: ___ with high systolics, peak 190s when 
controlled solely with metoprolol, hydralazine and Imdur. 
Lisinopril restarted with improvement of blood pressures. 

# DIABETES MELLITUS TYPE II, NOT ON INSULIN: ___ oral 
medications held on admission. ___ maintained on insulin 
sliding scale while inpatient, restarted oral medications upon 
discharg with exception of pioglitazone as thiazolidinediones 
can worsen heart failure.

# HYPERLIPIDEMIA: ___ home dose statin (simvastatin) 
changed to pravastatin due to contraindication betwee 
simvastatin and clarithromycin. 

# h/o CORONARY ARTERY DISEASE: ___ currently on aspirin, 
statin, beta blocker. ACE restarted this admission. 

TRANSITIONAL ISSUES
===================
[] GASTRO/PCP: ___ to finish 14 day course of triple therapy 
for H. pylori (Start day ___, End Date ___
[] PCP: ___ simvastatin changed to pravastatin due to 
contraindication between simvastatin and clarithromycin. Please 
monitor for rhabdomylosis.
[] Cardio: Consider d/c Imdur/hydral as outpatient
[] PCP: ___ with restart of lisinopril 
[] PCP: ___ held as ___ with heart failure. Please 
monitor blood sugars.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 25 mg PO DAILY 
2. HydrALAzine 10 mg PO Q8H 
3. Pioglitazone 45 mg PO DAILY 
4. GlipiZIDE 5 mg PO DAILY 
5. Januvia (sitaGLIPtin) 25 mg oral daily 
6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
7. Simvastatin 20 mg PO QPM 
8. Polyethylene Glycol 17 g PO DAILY 

 
Discharge Medications:
1. HydrALAzine 20 mg PO Q8H 
RX *hydralazine 25 mg 1 tablet(s) by mouth three times a day 
Disp #*60 Tablet Refills:*0
2. Polyethylene Glycol 17 g PO DAILY 
3. Aspirin 81 mg PO DAILY 
RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*60 Tablet 
Refills:*0
4. Ferrous Sulfate 325 mg PO DAILY 
RX *ferrous sulfate [Feosol] 325 mg (65 mg iron) 1 tablet(s) by 
mouth daily Disp #*60 Tablet Refills:*0
5. Lisinopril 20 mg PO DAILY 
RX *lisinopril 20 mg 1 tablet(s) by mouth daily Disp #*60 Tablet 
Refills:*0
6. GlipiZIDE 5 mg PO DAILY 
7. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
8. Januvia (sitaGLIPtin) 25 mg oral daily 
9. Metoprolol Succinate XL 25 mg PO DAILY 
10. Amoxicillin 1000 mg PO Q12H Duration: 14 Days 
RX *amoxicillin 500 mg 2 capsule(s) by mouth twice a day Disp 
#*52 Capsule Refills:*0
11. Clarithromycin 500 mg PO Q12H Duration: 14 Days 
RX *clarithromycin [Biaxin] 500 mg 1 tablet(s) by mouth twice a 
day Disp #*26 Tablet Refills:*0
12. Pantoprazole 40 mg PO Q12H Duration: 14 Days 
RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp 
#*26 Tablet Refills:*0
13. Pravastatin 20 mg PO QPM 
RX *pravastatin [Pravachol] 20 mg 1 tablet(s) by mouth daily 
Disp #*60 Tablet Refills:*0
14. Furosemide 40 mg PO DAILY 
RX *furosemide 40 mg 1 tablet(s) by mouth daily Disp #*60 Tablet 
Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
------------------
ACUTE ON CHRONIC DIASTOLIC CONGESTIVE HEART FAILURE
H. PYLORI INFECTION

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

You were admitted for shortness of breath, most likely due fluid 
retention. This is most likely due to the blood received at your 
last hospitalization and your kidney injury. We were able to 
increase your water pills to give you more relief.  

Please weigh yourself everday. Let your doctor know if you gain 
more than 3 lbs. Your weight on discharge was 61.4 kg (135.4 kg)

In addition, your blood pressure was a little bit high. At your 
last hospitalization at ___, they had discontinued 
lisinopril because you had some additional kidney injury (which 
was mostly likely due to low blood counts). Here, it appears 
that your kidney function has returned to your baseline 
(creatinine 2.0), so we feel comfortable restarting your 
lisinopril.

During your hospitalization, we received records from ___ 
that indicate that you have a H. pylori infection in your 
stomach. We started you on ""triple therapy"" which you should 
continue to take for a 14 day course.

Please continue to take your medications as prescribed.

It was a pleasure taking care of you at ___. We wish you well

Sincerely
Your Team at ___
 
Followup Instructions:
___
"
148,18732942,23374850," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
abdominal pain, weakness, n/v

 
Major Surgical or Invasive Procedure:
___ EGD (upper endoscopy)
___ Colonoscopy
___ PRBC transfusion x 1 unit
___ PRBC transfusion x 2 units
EGD ___
COLONOSCOPY ___
 
History of Present Illness:
___ PMH CAD, DM, CKD presenting with 3 days of abdominal pain, 
fatigue. No association with food noted because has had poor 
appetite. Striking her abdomen helps somewhat, has not tried any 
medications including nsaids. Has been holding her home 
anti-hypertensives and aspirin during this time. Remained taking 
her home insulin. Yesterday she tried a ___ herbal 
medication but vomited it up, NBNB. No nausea since. Has been 
moving bowels up to 4 times a day but bm's have been small, 
dark. Feels constipated. No dysuria or blood in urine reported.

In the ED, initial vitals: 97 63 122/32 14 100% RA 

Labs notable for: hgb 4.5, cr 3.3, bun 147, trop t 0.05, heme 
positive black stool.

Imaging: CT abdomen with no signs of bleeding. 

Consults called: GI- found heme positive dark flecks of stool in 
vault. No need for urgent scope. 

Recommendations: CT abdomen performed, PPI bolus and drip 
initiated, transfused 2 units pRBC.

On arrival to the ___,  patient recounts above history with 
daughter translating. She expresses concern about where she will 
be able to urinate while lying in bed. States abdominal pain is 
currently ___.
 
Past Medical History:
PAST MEDICAL HISTORY
Diabetes mellitus type 2.  
Hypertension.  
CKD (recent 2.3-3.5 earlier in year)
hypercholesterolemia  
iron deficiency anemia  
moderate mitral regurgitation  
peripheral neuropathy 
CAD with remote history of MI
Hyperlipidemia

PAST SURGICAL HISTORY
R total hip replacement ___
s/p hysterectomy

 
Social History:
___
Family History:
No kidney disease or heart disease

 
Physical Exam:
Admission Physical Exam:
GENERAL: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
NECK: supple, JVP not elevated, no LAD  
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, ___ systolic murmur 
best heard over apex
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding, no organomegaly  
GU: positive suprapubic tenderness
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
NEURO:  cn ___ intact, moving all extremities

Discharge Physical Exam:

 
Pertinent Results:
Admission Labs:

___ 11:20AM BLOOD WBC-8.6# RBC-1.46*# Hgb-4.5*# Hct-13.6*# 
MCV-93 MCH-30.8 MCHC-33.1 RDW-18.6* Plt ___
___ 11:20AM BLOOD Neuts-78* Bands-0 Lymphs-17* Monos-3 
Eos-2 Baso-0 ___ Myelos-0
___ 11:20AM BLOOD Hypochr-1+ Anisocy-2+ Poiklo-NORMAL 
Macrocy-2+ Microcy-NORMAL Polychr-OCCASIONAL Stipple-OCCASIONAL
___ 11:20AM BLOOD ___ PTT-24.3* ___
___ 06:11PM BLOOD Ret Aut-3.4*
___ 11:20AM BLOOD Glucose-302* UreaN-147* Creat-3.3* Na-138 
K-4.7 Cl-106 HCO3-20* AnGap-17
___ 11:20AM BLOOD ALT-9 AST-18 LD(LDH)-275* AlkPhos-44 
TotBili-0.2 DirBili-0.1 IndBili-0.1
___ 06:11PM BLOOD Calcium-8.1* Phos-3.0 Mg-2.2 Iron-144
___ 11:34AM BLOOD Lactate-1.7

___ 05:03PM URINE Color-Straw Appear-Clear Sp ___
___ 05:03PM URINE Blood-TR Nitrite-NEG Protein-30 
Glucose-70 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-TR
___ 05:03PM URINE RBC-<1 WBC-2 Bacteri-NONE Yeast-NONE 
Epi-1

Pertinent Labs:

___ 06:11PM BLOOD TSH-1.4
___ 11:20AM BLOOD Hapto-76
___ 06:11PM BLOOD calTIBC-328 VitB12-500 Ferritn-83 TRF-252
___ 11:20AM BLOOD cTropnT-0.05*
___ 06:11PM BLOOD CK-MB-2 cTropnT-0.04*
___ 05:16AM BLOOD CK-MB-2 cTropnT-0.06*
___ 06:11PM BLOOD CK(CPK)-73
___ 05:16AM BLOOD CK(CPK)-50
___ 06:11PM BLOOD Ret Aut-3.4*

Discharge Labs:

Imaging/Reports:

-CT Abdomen and Pelvis wo/con:

LOWER CHEST: Relative low density of the blood pool, suggests 
anemia.  The 
lung bases are clear.  There is no pleural effusion. 
  
ABDOMEN: 
  
HEPATOBILIARY: The liver demonstrates homogenous attenuation 
throughout.  
There is no evidence of focal lesions.  There is no evidence of 
intrahepatic 
or extrahepatic biliary dilatation.  There is cholelithiasis 
without evidence 
of acute cholecystis. 
PANCREAS: The pancreas has normal attenuation throughout, 
without evidence of 
focal lesions or pancreatic ductal dilatation. There is no 
peripancreatic 
stranding. 
SPLEEN: The spleen shows normal size and attenuation throughout, 
without 
evidence of focal lesions. 
ADRENALS: The right and left adrenal glands are normal in size 
and shape. 
URINARY: The kidneys are mildly atrophic.  Sub cm hypodensity in 
the right and 
left upper poles, are too small to characterize but likely 
represent simple 
cysts.  No concerning renal lesions are seen.  There is no 
hydronephrosis.  
The ureters are normal in caliber along their course the 
bladder. 
GASTROINTESTINAL: Small bowel loops demonstrate normal caliber 
and wall 
thickness throughout. Colon and rectum are within normal limits. 
The appendix 
is not visualized but there are no secondary signs of 
appendicitis within the 
right lower quadrant. There is no evidence of mesenteric 
lymphadenopathy. 
RETROPERITONEUM: There is no evidence of retroperitoneal 
lymphadenopathy. 
VASCULAR: There is no abdominal aortic aneurysm. There is heavy 
calcium burden 
in the abdominal aorta and great abdominal arteries. 
  
PELVIS:  Views of the lower pelvis are limited by the urinary 
bladder is 
distended. There is no evidence of pelvic or inguinal 
lymphadenopathy. There 
is no free fluid in the pelvis. 
  
BONES AND SOFT TISSUES:  The abdominal wall is unremarkable.  A 
partially 
imaged right hip prosthesis is present.  A compression deformity 
of the T12 
vertebral body with seen on lumbar spine MRI from ___.  There 
are no 
concerning lytic or sclerotic bony lesions. 
  
IMPRESSION: 
  
  
1. 
2. Relative low density of the blood pool, consistent with 
anemia. 
3. Distended bladder, correlate with ability to voluntarily 
urinate. 
4. T12 compression deformity not significantly changed from 
___. 
5. Cholelithiasis. 
  

Micro: none

COLONOSCOPY: Impression: Normal mucosa in the colon
Diverticulosis of the right colon
Grade 1 internal hemorrhoids
Otherwise normal colonoscopy to cecum 
Recommendations: No evidence of recent or active bleeding on 
this examination. 
Due to suboptimal bowel preparation, this examination is not 
adequate for screening.
 
Additional notes: The procedure was performed by the fellow and 
the attending. The attending was present for the entire 
procedure and collaborated wtih the fellow on the findings of 
this report. The patient's reconciled home medication list is 
appended to this report. FINAL DIAGNOSES are listed in the 
impression section above. Estimated blood loss = zero. No 
specimens were taken for pathology 

ENDOSCOPY: Impression: Normal mucosa in the esophagus
The mucosa appeared pale and atrophied. In the fundus, the 
mucosa appeared somewhat patchy which could be consistent with 
atrophic gastritis. (biopsy)
Mucosa appeared normal but there were some dark areas of 
pigmentation likely related to iron supplementation. (biopsy)
Otherwise normal EGD to third part of the duodenum 
Recommendations: Follow up biopsy results. 
Proceed with colonoscopy. 
Additional notes: The procedure was performed by the attending 
and the GI fellow. The attending was personally present during 
the entire procedure and collaborated with the Fellow on the 
findings of this report. The patient's home medication list is 
appended to this report. FINAL DIAGNOSES are listed in the 
impression section above. Estimated blood loss = zero. Specimens 
were taken for pathology as listed above. 

 
Brief Hospital Course:
Patient arrived to floor, vital signs stable, s/p 2 units pRBC 
with appropriate crit bump. Etiology of bleed thought to be 
occult bleed via GI tract. Hemolysis labs negative. Iron labs 
grossly normal. Transfused another unit pRBC on the morning of 
___ for slow downtrend. EKG abnormalities improved with 
transfusion and troponin remained flat with no symptoms. 
Abdominal pain resolved with straight cath x 1 for urinary 
retention with normal urination since. Home lasix held for ___ 
which improved somewhat with volume resuscitation but may be at 
new baseline based on recent values.

Called out to floor for further work-up with plan for repeat 
___.

HMED FICU ACCEPT NOTE:
Date and time as above

CC: ___ Pain 
HPI: 
Ms. ___ is an ___ year old with CAD, a remote history of MI, 
DMII, CKD, who presented with three days of nausea abdominal 
pain and fatigue. She has not had any new medications, she has 
not taken nsaids, and was holding her home aspirin and HTN meds 
due to the pain. She took a ___ supplement to see if it 
would help and this caused emesis. During all of this she felt 
constipated and was having about 4 very small BMs per day which 
were dark but solid, no urinary symptoms. She had a Hgb of 4.5 
on admission, and a creatinine of 3.3 (baseline ~2.5), BUN 147. 
Trop was 0.05, with lateral ST depressions on EKG, with flat 
trops, elevated creatinine and improved with transfusion.  CTA/P 
showed no signs of bleeding. GI evaled in the ED, and she had 
flecks of black blood in the vault, no urgent EGD ___ 
needed. She was given 2 units of PRBCs with appropriate bump, 
BID pantoprazole. 

Hemolysis labs were negative. Over her day in the FICU, her HCT 
drifted to 21, and she was give another unit with bump to 25. 
On arrival to the FICU she was noted to have urinary retention 
and  abd pain resolved with one straight cath. She has voided 
normally since. 

EGD ___ planned for ___. On low residue today, clears 
tomorrow, moviprep at 11am, 4pm, NPO tomorrow night.

PAST MEDICAL HISTORY:  
Diabetes mellitus type 2.  
Hypertension.  
CKD (recent 2.3-3.5 earlier in year)  
hypercholesterolemia  
iron deficiency anemia  
moderate mitral regurgitation  
peripheral neuropathy  
CAD with remote history of MI  
Hyperlipidemia  

PAST SURGICAL HISTORY  
R total hip replacement ___  
s/p hysterectomy 

MEDS:
iron 325 daily  
imdur 60 mg daily  
glipizide 5 mg daily  
lantus 10 units daily  
januvia 25 mg daily  
miralax 1 capsule daily  
pravastatin 20 mg daily  
furosemide 40 mg daily  
metop succinate 25 mg daily  
hydral 25 mg TID (last filled ___  

ALLERGIES: sulfa  
 
SOCIAL HISTORY: ___
FAMILY HISTORY:  
No kidney disease or heart disease  

PE: 
VS: BP 116/38, HR 58, RR 14 Sats 98% on RA
Gen: NAD
HEENT: anicteric, MMM
CV: normal rate, regular rhythm, no murmurs
Pulm: CTAB, no wheezes
GI: Soft, NT, ND, NABS
Skin: no rashes
Neuro: facial symmetry, moving all extremities
Labs: See below, reviewed creatinine 2.9, HCT 25

Imaging: 
CT A/P
IMPRESSION: 
1. 
2. Relative low density of the blood pool, consistent with 
anemia. 
3. Distended bladder, correlate with ability to voluntarily 
urinate. 
4. T12 compression deformity not significantly changed from 
___. 
5. Cholelithiasis. 

A/P:
Ms. ___ is an ___ year old with CAD, a remote history of MI, 
DMII, CKD, who presented with three days of nausea abdominal 
pain and fatigue found to have a GI bleed. 

# Acute blood loss anemia, GI bleeding: s/p 3U PRBC transfusion. 
No evidence of further clinical bleeding during hosptialization, 
thus likely slow GI bleed.  Underwent ___ wihtout obvious 
source. Will need capsul study ordered by PCP.  Discussed w/ GI 
restarting baby ASA (CAD) and they are okay with this. Will get 
BI wk CBC with ___ faxed to PCP. I alerted PCP office and 
reviewed with family/patient via interpreter

# CAD / chronic dCHF:
- hold lasix
- continue imdur
- continue metoprolol
- continue ASA

# DMII:
- Insulin SS

# HTN: continue anti-hypertensives

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Ferrous Sulfate 325 mg PO DAILY 
2. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
3. GlipiZIDE 5 mg PO DAILY 
4. Glargine 10 Units Bedtime
5. Januvia (sitaGLIPtin) 25 mg oral DAILY 
6. Polyethylene Glycol 17 g PO DAILY 
7. Pravastatin 20 mg PO QPM 
8. Metoprolol Succinate XL 25 mg PO DAILY 
9. Furosemide 40 mg PO DAILY 
10. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1. Glargine 10 Units Bedtime
2. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
3. Metoprolol Succinate XL 25 mg PO DAILY 
4. Pravastatin 20 mg PO QPM 
5. Ferrous Sulfate 325 mg PO DAILY 
6. Furosemide 40 mg PO DAILY 
7. GlipiZIDE 5 mg PO DAILY 
8. Januvia (sitaGLIPtin) 25 mg oral DAILY 
9. Polyethylene Glycol 17 g PO DAILY 
10. Aspirin 81 mg PO DAILY 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Anemia
Acute on Chronic Renal Failure
CAD
HTN
DM2

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
You were admitted with profound anemia, with suspicion it is due 
to a slow GI blood loss.  You were transfused 3U blood and your 
count remained stable. You had an upper endoscopy and 
colonoscopy without identification of source. You will need a 
capsule endoscopy study to be set up by your PCP (I informed 
your PCP ___.  You tolerated food after the scope procedure. 
 You should have twice/week blood test, and I have referred you 
to ___.  Finally, I recommend you discuss with your PCP ___ 
referral to a nephrologist in light of your chronic kidney 
disease

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
"
149,18732942,20530999," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___
 
Chief Complaint:
hypertension
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with HTN, DMII, CKD, CAD w/ remote hx of MI (unclear when 
this was) who presents with ___ days of uncontrolled and slowly 
increasing BPs at home (per patient the SBP was 190s this 
morning), despite no changes in medications. On morning of ___ 
she was at a scheduled appointment to receive erythropoietin 
injection, and was noted to have SBPs over 200, with associated 
dizziness and chest pain. She denied dyspnea, fever, or cough. 
She was referred to the ___ ED. 

ED COURSE
In the ED intial vitals were:  97.5 66 227/63 20 95% on RA
EKG:  sinus rhythm, RAD, RBBB, inferolateral STD, prolonged QTC 
of 518
Labs/studies notable for: 
- troponin 0.02
- Cr 3.1, K 4.1, Na 135, glucose 400
- Mg 1.4
- LFT wnl except AP 130 
- WBC 6.7, H/H 9.7/30.3, platelets 158
Patient was given:  SL NTG 0.4 mg x 1, started NTG gtt, Mag 2g, 
insulin 8 units, ASA 324

Vitals on transfer:  98.2 59 171/55 14 97% RA 

On arrival to the floor the patient is feeling much better, and 
now feels back to normal. She was interviewed with the 
assistance of a ___ interpreter via telephone and then also 
with the assistance of the patient's grad-daughter via video 
chat.

The patient takes her BP at home daily. For the past week she 
has noticed increasing systolic numbers, with this morning being 
the highest in the 190s. Today she also felt dizzy and unwell. 
Some chest pressure vs palpitations also. No dyspnea, headaches, 
vision changes, PND, orthopnea, leg swelling.

She lives with her son and grand-daughter. She is independent in 
ADLs, uses a cane to ambulate. She takes her own medications, 
but cannot name them for me (she tells me ""blood pressure 
medicine, stomach medicine, insulin""). She tells me she does not 
have difficulty remembering to take her medications, and has not 
made any recent changes.

 
Past Medical History:
1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes
2. CARDIAC HISTORY:  
- CABG:  None
- PERCUTANEOUS CORONARY INTERVENTIONS:  None
- PACING/ICD:  None
3. OTHER PAST MEDICAL HISTORY:  
Diabetes mellitus type 2. 
Hypertension. 
CKD (recent 2.3-3.5 earlier in year)
hypercholesterolemia 
iron deficiency anemia 
moderate mitral regurgitation 
peripheral neuropathy 
CAD with remote history of MI

PAST SURGICAL/INVASIVE HISTORY
___ EGD (upper endoscopy)
___ Colonoscopy
___ PRBC transfusion x 1 unit
___ PRBC transfusion x 2 units
EGD ___
COLONOSCOPY ___
 
Social History:
___
Family History:
No kidney disease or heart disease

 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
VS: 97.9  189/59  65  18  94% on room air 
GENERAL: Alert. Oriented x3. No distress.
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthelasma.  

NECK: Supple with JVP of 6 cm.  
CARDIAC: Regular rhythm. Systolic murmur best at the apex.
LUNGS: Resp are unlabored, no accessory muscle use. Few 
bibasilar crackles. No wheezes or rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: No edema.
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  

DISCHARGE PHYSICAL EXAMINATION
VS: 97.4 afeb 118-160/40-62 57-61 18 98/RA 
Wt: 56.3kg 
GENERAL: Alert. Oriented x3. No distress.
HEENT: NCAT. PERRL, EOMI.   
NECK: Supple with JVP of 8-9 cm.  
CARDIAC: Regular rhythm. ___ Systolic murmur best at the apex.
LUNGS: Resp are unlabored, no accessory muscle use. Few 
bibasilar crackles. No wheezes or rhonchi.  
ABDOMEN: Soft, non-distended. Mildly tender in the LLQ
EXTREMITIES: No edema.  
 
 
Pertinent Results:
==============
ADMISSION LABS
==============
___ 10:20AM BLOOD WBC-6.7 RBC-3.27* Hgb-9.7* Hct-30.3* 
MCV-93 MCH-29.7 MCHC-32.0 RDW-12.5 RDWSD-42.6 Plt ___
___ 10:20AM BLOOD Neuts-77.6* Lymphs-13.7* Monos-5.5 
Eos-2.3 Baso-0.3 Im ___ AbsNeut-5.37 AbsLymp-0.95* 
AbsMono-0.38 AbsEos-0.16 AbsBaso-0.02
___ 12:45PM BLOOD Glucose-400* UreaN-58* Creat-3.1* Na-135 
K-4.3 Cl-98 HCO3-24 AnGap-17
___ 12:45PM BLOOD ALT-8 AST-13 CK(CPK)-55 AlkPhos-130* 
TotBili-0.3
___ 12:45PM BLOOD Albumin-3.7 Calcium-8.6 Phos-3.0 Mg-1.4*

==============
PERTINENT LABS
==============
___ 12:45PM BLOOD CK-MB-2
___ 12:45PM BLOOD cTropnT-0.02*
___ 07:20PM BLOOD CK-MB-2 cTropnT-0.02*
___ 06:40AM BLOOD CK-MB-2 cTropnT-0.03*

=======
IMAGING
=======
___ CXR 
Moderate cardiomegaly with minimal pulmonary vascular 
congestion.

==============
DISCHARGE LABS
==============
___ 06:10AM BLOOD WBC-8.9# RBC-3.11* Hgb-9.3* Hct-29.4* 
MCV-95 MCH-29.9 MCHC-31.6* RDW-12.5 RDWSD-42.8 Plt ___
___ 06:10AM BLOOD Glucose-154* UreaN-60* Creat-3.6* Na-138 
K-4.1 Cl-99 HCO3-26 AnGap-17
___ 06:10AM BLOOD CK-MB-2 cTropnT-0.02*
___ 06:10AM BLOOD Calcium-8.3* Phos-4.4 Mg-1.___ y/o ___ speaking only female with HTN, DMII, CKD, CAD 
(w/ remote hx of MI) who presented with hypertensive emergency. 

# CORONARIES:  no prior cath
# PUMP:  EF > 65% in ___, 2+ MR 
# RHYTHM: sinus 

# HTN EMERGENCY: Patient presented with SBPs 220s to ED, with 
associated dizziness and chest pain and troponin elevation of 
0.02. EKG with ST-depressions in II, V3-V6, similar to prior, 
troponins peaked at 0.03.  The trigger for her uncontrolled 
blood pressure is unclear at this time. She manages her own 
medication, raising some concern for medication compliance, 
although she does fill her medications regularly. She has also 
has advanced CKD, which is likely playing a role. She was 
initially on a nitro gtt, able to be weaned back to home regimen 
of metoprolol XL 25, doxazosin 1 mg BID, hydralazine 100 mg TID, 
imdur 60 qD. BPs labile with BPs to 180s-190s on this regimen, 
so metoprolol was discontinued and carvedilol 12.5 BID 
initiated, later uptitrated to 25 mg BID. She was discharged on 
carvedilol 25mg BID.  

# CHRONIC DIASTOLIC HEART FAILURE: EF > 55% in ___ with 2+ MR. 
___ euvolemic on exam. CXR without acute process. Continued 
on home furosemide 40 daily. Discharge Dry Weight 56kg. 

# CAD: hx of MI per OMR, although patient/family denies. 
Continued on home pravastatin, metoprolol XL 25, and ASA 81 
daily .

# CKD: baseline Cr 2.7 - 3.5, at baseline on admission. Patient 
is followed closely by her outpatient nephrologist. Dialysis was 
discussed in the recent past, which the patient was not 
interested in. Cr remained relatively stable throughout 
admission, discharged with cr 3.6.  

# DM II: insulin dependent. Blood sugar on admission of 400, no 
anion gap, normalized to 150s upon arrival to the floor. 
Continued on home glargine 10 U qPM, held home glipizide, 
Januvia. 

# NORMOCYTIC ANEMIA: iron deficiency anemia, EPO dependent. H/H 
stable from baseline Hgb ~ 9. Last colonoscopy in ___ normal 
except diverticulosis, internal hemorrhoids. Continued on home 
ferrous sulfate 

TRANSITIONAL ISSUES:
- Please continue to review medications and encourage adherence
- Metoprolol changed to carvedilol 25mg BID for additional blood 
pressure control
- Will need to have outpatient Cardiology follow up with repeat 
___ as outpatient given moderate 2+ MR on ___ from ___
- QTc ranged 485-518 during admission. Would recommend avoiding 
all QT prolonging medications

# CONTACT: ___ (grand-daughter) ___ ___ 
(daughter) ___
# CODE: FULL (confirmed with assistance of translator)
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Glargine 10 Units Bedtime
2. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
3. Metoprolol Succinate XL 25 mg PO DAILY 
4. Pravastatin 20 mg PO QPM 
5. Ferrous Sulfate 325 mg PO DAILY 
6. Furosemide 40 mg PO DAILY 
7. GlipiZIDE 5 mg PO DAILY 
8. Januvia (sitaGLIPtin) 25 mg oral DAILY 
9. Polyethylene Glycol 17 g PO DAILY 
10. Aspirin 81 mg PO DAILY 
11. Doxazosin 1 mg PO BID 
12. HydrALAZINE 100 mg PO TID 
13. Sodium Bicarbonate 650 mg PO BID 
14. Pantoprazole 40 mg PO Q24H 

 
Discharge Medications:
1. Doxazosin 1 mg PO BID 
2. Ferrous Sulfate 325 mg PO DAILY 
3. Furosemide 40 mg PO DAILY 
4. HydrALAZINE 100 mg PO TID 
5. Glargine 10 Units Bedtime
6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
7. Pantoprazole 40 mg PO Q24H 
8. Polyethylene Glycol 17 g PO DAILY 
9. Pravastatin 20 mg PO QPM 
10. Sodium Bicarbonate 650 mg PO BID 
11. Aspirin 81 mg PO DAILY 
12. GlipiZIDE 5 mg PO DAILY 
13. Januvia (sitaGLIPtin) 25 mg oral DAILY 
14. Calcitriol 0.25 mcg PO 3X/WEEK (___) 
15. Carvedilol 25 mg PO BID 
RX *carvedilol 25 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnoses:
- hypertensive urgency

Secondary diagnoses:
- chronic diastolic heart failure
- coronary artery disease
- chronic kidney disease stage V
- type 2 diabetes

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was our pleasure participating in your care here at ___. 
You were admitted with high blood pressure and chest pain. You 
were put on an IV blood pressure medication and then put back on 
your home medications with improvement in blood pressure.

It is very important that you take all of your medications as 
prescribed and have close follow up.

We wish you the best,
Your ___ Medicine Team
 
Followup Instructions:
___
"
150,18732942,26211065," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___
 
Chief Complaint:
Shortness of breath, dizziness, cough
 
Major Surgical or Invasive Procedure:
Right knee arthrocentesis (___)
Right knee intra-articular steroid injection (___)

 
History of Present Illness:
Ms. ___ is an ___ y/o woman with a PMH of CKDV, chronic anemia 
(EPO-dependent), CAD, HFpEF, HTN, T2DM, who presented to the ED 
with shortness of breath, chest discomfort, and dizziness. The 
symptoms have lasted two weeks and have gradually worsened. They 
are worse with exertion. Her daughter states that she has felt 
subjective fevers over the past week with malaise and cough that 
have not improved.
 
In the ED, initial vitals were: T 98.9F BP 182/57 mmHg P 65 RR 
18 O2 99% RA
Labs showed:
CHEMISTRIES:
133  97  68  
------------< 148
5.3  21  4.1  
Ca: 7.6 Mg: 1.8 P: 5.1
CK: 96  MB: 2  Trop-T: 0.03  

CBC:
      7.9   
7.6 >-----< 177  
     24.0  

DIFF: N:75.0 L:15.4 M:7.4 E:1.6 Bas:0.1 ___: 0.5 Absneut: 
5.69 Abslymp: 1.17 Absmono: 0.56 Abseos: 0.12 Absbaso: 0.01 

UA: 600 protein, 100 glucose, neg leuks, neg nitrites, neg 
bacteria

Imaging showed retrocardiac opacity concerning for pneumonia.
Received DuoNeb, ceftriaxone 1g, azithromycin 500 mg, carvedilol 
25 mg. 

Decision was made to admit to medicine for further management.  

On arrival to the floor, patient reports felling generally well. 
She denies any shortness of breath, chest pain, abdominal pain, 
diarrhea. She reports being hungry and feeling slightly dizzy 
when she first got to the room.

Review of systems:  
(+) Per HPI  
 
Past Medical History:
1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes
2. CARDIAC HISTORY:  
- CABG:  None
- PERCUTANEOUS CORONARY INTERVENTIONS:  None
- PACING/ICD:  None
3. OTHER PAST MEDICAL HISTORY:  
Diabetes mellitus type 2. 
Hypertension. 
CKD (recent 2.3-3.5 earlier in year)
hypercholesterolemia 
iron deficiency anemia 
moderate mitral regurgitation 
peripheral neuropathy 
CAD with remote history of MI

PAST SURGICAL/INVASIVE HISTORY
___ EGD (upper endoscopy)
___ Colonoscopy
___ PRBC transfusion x 1 unit
___ PRBC transfusion x 2 units
EGD ___
COLONOSCOPY ___
 
Social History:
___
Family History:
No kidney disease or heart disease

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
Vital Signs: 98.2, 192/88, 62, 18, 97% RA
General: Alert, oriented, no acute distress  
HEENT: Sclerae anicteric, MMM, oropharynx clear
Neck: Supple, JVP 10  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Diffuse ___  
___: Soft, non-tender, non-distended, bowel sounds present, 
no organomegaly, no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, 1+ pulses, 1+ ___ to the mid shins  
Neuro: CNII-XII intact, ___ strength upper/lower extremities, 
grossly normal sensation. 

DISCHARGE PHYSICAL EXAM:
========================
Vital Signs: Afeb, 120-150s/50-60s, 50-60s, 18, 96% RA
I/Os: Even
General: Alert, oriented, no acute distress  
HEENT: Sclerae anicteric, MMM, oropharynx clear
Neck: Supple, JVP 8
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Diffuse ronchi, poor air movement
Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no organomegaly, no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, 1+ pulses, trace ankle edema. Swollen 
right knee, no erythema. Pain with passive/active ROM 
Neuro: CNII-XII intact, ___ strength upper/lower extremities, 
grossly normal sensation.
 
Pertinent Results:
ADMISSION LABS:
===============
___ 12:55AM   ___ PTT-27.3 ___
___ 12:55AM   PLT COUNT-177
___ 12:55AM   NEUTS-75.0* LYMPHS-15.4* MONOS-7.4 EOS-1.6 
BASOS-0.1 IM ___ AbsNeut-5.69 AbsLymp-1.17* AbsMono-0.56 
AbsEos-0.12 AbsBaso-0.01
___ 12:55AM   WBC-7.6 RBC-2.56* HGB-7.9* HCT-24.0* MCV-94 
MCH-30.9 MCHC-32.9 RDW-12.8 RDWSD-43.8
___ 12:55AM   ALBUMIN-3.0* CALCIUM-7.6* PHOSPHATE-5.1* 
MAGNESIUM-1.8
___ 12:55AM   CK-MB-2 cTropnT-0.03*
___ 12:55AM   CK(CPK)-96
___ 12:55AM   estGFR-Using this
___ 12:55AM   GLUCOSE-148* UREA N-68* CREAT-4.1* SODIUM-133 
POTASSIUM-5.3* CHLORIDE-97 TOTAL CO2-21* ANION GAP-20
___ 12:58AM   URINE  RBC-3* WBC-1 BACTERIA-NONE YEAST-NONE 
EPI-1
___ 12:58AM   URINE  BLOOD-NEG NITRITE-NEG PROTEIN-600 
GLUCOSE-100 KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 12:58AM   URINE  COLOR-Straw APPEAR-Clear SP ___
___ 12:58AM   URINE  UHOLD-HOLD
___ 12:58AM   URINE  HOURS-RANDOM
___ 02:15AM   OTHER BODY FLUID  FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
___ 02:00PM   URINE  HOURS-RANDOM UREA N-214 CREAT-32
___ 03:30PM   CALCIUM-7.6* PHOSPHATE-4.6* MAGNESIUM-1.7
___ 03:30PM   CK-MB-3 cTropnT-0.04*
___ 03:30PM   GLUCOSE-58* UREA N-66* CREAT-3.9* SODIUM-136 
POTASSIUM-4.3 CHLORIDE-100 TOTAL CO2-22 ANION GAP-18
___ 07:50PM   PLT COUNT-145*
___ 07:50PM   WBC-6.9 RBC-2.49* HGB-7.4* HCT-24.1* MCV-97 
MCH-29.7 MCHC-30.7* RDW-12.4 RDWSD-43.6

DISCHARGE/PERTINENT LABS:
=========================
___ 06:50AM BLOOD WBC-6.3 RBC-3.57* Hgb-10.7* Hct-32.4* 
MCV-91 MCH-30.0 MCHC-33.0 RDW-12.2 RDWSD-40.8 Plt ___
___ 06:50AM BLOOD ___ PTT-27.3 ___
___ 06:50AM BLOOD Glucose-106* UreaN-73* Creat-4.3* Na-136 
K-3.9 Cl-97 HCO3-21* AnGap-22*
___ 03:10PM BLOOD ___
___ 06:50AM BLOOD Calcium-7.5* Phos-6.6* Mg-2.0
___ 09:10PM BLOOD IgG-643* IgA-137 IgM-97 IFE-NO MONOCLO

MICROBIOLOGY:
=============
___ FLUIDGRAM STAIN-FINAL NEGATIVE; FLUID 
CULTURE-PRELIMINARY  NEGATIVE
___ CULTUREBlood Culture, Routine-FINAL 
NEGATIVE
___ CULTUREBlood Culture, Routine-FINAL 
NEGATIVE
___ STAIN-FINAL; RESPIRATORY 
CULTURE-FINALOROPHARYNGEAL FLORA
___ CULTURE-FINAL {PRESUMPTIVE 
STREPTOCOCCUS BOVIS}

IMAGING:
========
___ KNEE W/O CONTRAST RI
1. Large knee joint effusion with associated synovitis.  No 
specific features for gout, however this could be further 
evaluated with arthrocentesis which I understand has been 
performed.
2. Degenerative changes as detailed above.  Tiny area of signal 
abnormality
along the posterior horn of the medial meniscus equivocal for 
small tear.  No large tear or ligamentous injury.
3. Cortical tunneling in the distal femur reflecting 
demineralization without aggressive infiltrative process 
identified.  This accounts for the
radiographic appearance.
   
___ (2 VIEWS) RIGHT
Moderate right knee joint effusion or synovitis.
There is mild degenerative arthritis of the right knee.
Diffuse small lucencies throughout visualized bones, with 
periarticular
spurring, consider disuse osteopenia, reflex sympathetic 
dystrophy or marrow infiltrative/neoplastic process if 
clinically appropriate.
   
___
The left atrial volume index is severely increased. No atrial 
septal defect is seen by 2D or color Doppler. The estimated 
right atrial pressure is ___ mmHg. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF>55%). Doppler parameters 
are most consistent with Grade II (moderate) left ventricular 
diastolic dysfunction. Right ventricular chamber size and free 
wall motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The aortic valve leaflets 
(3) appear structurally normal with good leaflet excursion and 
no aortic stenosis. Mild (1+) aortic regurgitation is seen. The 
mitral valve leaflets are mildly thickened. There is no mitral 
valve prolapse. Mild (1+) mitral regurgitation is seen. [Due to 
acoustic shadowing, the severity of mitral regurgitation may be 
significantly UNDERestimated.] There is moderate pulmonary 
artery systolic hypertension. There is no pericardial effusion. 
There is an anterior space which most likely represents a 
prominent fat pad. 
   
___ (PORTABLE AP)
No significant interval change since the prior radiograph.
   
___ (PORTABLE AP)
Persistent moderate cardiomegaly and lung hyperinflation.  No 
focal consolidation concerning for pneumonia.
  
___ U.S.
No hydronephrosis.  Atrophic kidneys demonstrating cortical 
thinning
consistent with chronic parenchymal disease.  Simple bilateral 
renal cysts are incidentally noted.
  
___ (PA & LAT)
1.  Persistent moderate cardiomegaly and lung hyperinflation.  
No focal
consolidation concerning for pneumonia.
 
2.  The extent of pulmonary vascular congestion could be 
chronic, as it is
unchanged.
 
Brief Hospital Course:
Ms. ___ is an ___ y/o woman with a past medical history of 
chronic kidney injury (stage V), chronic anemia (EPO-dependent), 
CAD, HFpEF, HTN, and T2DM, who presented with shortness of 
breath, chest discomfort, and dizziness with blood pressures 
>200/90. 

# HFpEF exacerbation | Hypertensive Urgency | Volume Overload:
Initial concern for pneumonia, given possible retrocardiac 
opacity on plain film; however, final read of CXR negative for 
new infiltrate. Influenza negative. Cough with subjective fevers 
at home without leukocytosis. Exam and work-up suggestive of 
volume overload in the setting of diastolic HF and end-stage 
renal disease. TTE showed severe diastolic dysfunction, but no 
significant change from prior. She had minimal troponinemia 
without ischemic EKG changes attributed by cardiology to demand 
and poor renal clearance. Patient was initially started on IV 
hydralazine and nitroglycerin drip and continued on her home 
blood pressure medications (isosorbide 
mononitrate/carvedilol/doxazosin) for blood pressure lowering 
and aggressive diuresis with IV furosemide (80-120mg). She 
diuresed well, with improvement in her shortness of breath and 
lower extremity edema. Renal was consulted and recommended slow 
blood pressure lowering with permissive hypertension and target 
SBP 160s in the first few days with avoidance of DBP lowering 
below the ___. She was subsequently weaned off the nitroglycerin 
drip and the hydralazine and started on amlodipine 5mg daily, 
with improved blood pressure control. Dizziness, which was not 
accompanied by focal neurologic deficits, resolved with improved 
antihypertensive control. At discharge, her blood pressure was 
120-150s/50-60s. She also was started on torsemide 20mg PO daily 
for maintenance diuresis.

# Right Knee Gout: 
Patient developed right knee swelling on ___ in the setting of 
aggressive diuresis. The knee joint was aspirated and sent for 
gram stain, culture, cell counts, and crystal analysis. Crystal 
analysis was consistent with negatively birefringent MSU 
crystals. After a negative gram stain and 36h with negative 
cultures, the knee joint was injected with 40mg of 
methylprednisolone, given limited treatment options otherwise 
(NSAIDs, colchicine suboptimal due to ESRD, systemic prednisone 
suboptimal due to hypertension and fluid overload). Knee X-ray 
showed enlarged joint space and diffuse small lucencies 
throughout visualized bones, with periarticular spurring. MRI 
was obtained and showed changes consistent with osteopenia with 
no concern for malignancy.

# Acute-on-chronic normocytic anemia:
Likely in the setting of ESRD. No evidence of hemolytic anemia. 
Guaiac negative x3. Received 2U of pRBCs for nadir Hgb of 6.6 
for Hgb threshold of 9 per nephrology, with appropriate 
improvement in Hgb. Continued ferrous sulfate 325 mg daily.

# Thrombocytopenia: Platelet count nadired in the 130s, likely 
due to physiologic stress and brief antibiotic treatment on 
admission, normalized prior to discharge without dedicated 
intervention.

# Acute-on-chronic kidney injury (stage V):
Mild elevation of BUN/Cr compared to baseline. At baseline, she 
has declined HD in the past. Most likely cardiorenal in 
etiology, given severe diastolic dysfunction and fluid overload 
on exam in the setting of severe hypertension. FeUrea consistent 
with intrinsic renal disease, which is expected given her stage 
V chronic kidney injury. Nephrology consulted, and patient did 
not need urgent dialysis. Cr remained 4.3 at discharge, likely 
her new baseline in the setting of diuresis.

# Strep bovis bacteriuria: She was found to have asymptomatic 
Strep bovis bacteriuria without pyuria. Antibiotic treatment was 
deferred due to absence of symptoms and lack of clear true UTI. 

CHRONIC ISSUES
# CAD
- continued aspirin 81 mg daily
- continued pravastatin 20 mg qPM
- continued isosorbide mononitrate 60 mg daily

# T2DM
- Humalog insulin sliding scale and glargine 10 units qhs
- held glipizide and sitagliptin

# GERD
- continued pantoprazole 40 mg q24h

TRANSITIONAL ISSUES:
====================
# Patient was started on amlodipine 5mg PO daily and home 
Isosorbide Mononitrate (Extended Release) was increased from 60 
mg to 90 mg daily, with good BP response. Target diastolic BPs 
given CAD and ESRD is >50.
# Patient was started on torsemide 20mg PO daily. ___ require 
uptitration when patient back to regular PO intake at home. 
Please monitor volume status and adjust dose of diuretics as 
needed.
# Simple bilateral renal cysts were incidentally noted on renal 
ultrasound.
# Patient diagnosed with first episode of gout, may require 
urate lowering agent if she develops another episode.
# F/U SPEP/UPEP which was still pending at time of discharge.
# Suggest further evaluation of chronic anemia; note that 
colonoscopy in ___ was inadequate for screening, and she could 
benefit from another colonoscopy if amenable, especially in 
light of Strep bovis bacteriuria, potentially fecal contaminant, 
but clinical significance of which is uncertain.
# Patient was noted to have an elevated protein to creatinine 
ratio of 8.2, please follow up on this issue and consider 
further management per primary nephrologist.
# She does not carry a diagnosis of COPD, but was found to have 
hyperinflation on CXR; could benefit from PFTs as an outpatient.
# New creatinine baseline 4.3.
# Dry weight: 55.3 Kg
# She was given lab script at discharge for reevaluation of CBC 
and chemistries/renal function.

# CODE: Full Code
# CONTACT:
- Name of health care proxy: ___ 
- Relationship: daughter 
- Phone number: ___ 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Pravastatin 20 mg PO QPM 
2. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
3. GlipiZIDE 5 mg PO DAILY 
4. Furosemide 40 mg PO DAILY 
5. Carvedilol 25 mg PO BID 
6. Pantoprazole 40 mg PO Q24H 
7. Aspirin 81 mg PO DAILY 
8. Polyethylene Glycol 17 g PO DAILY 
9. Doxazosin 4 mg PO BID 
10. Sodium Bicarbonate 650 mg PO BID 
11. Glargine 10 Units Bedtime
12. Januvia (SITagliptin) 25 mg oral DAILY 
13. Ferrous Sulfate 325 mg PO DAILY 

 
Discharge Medications:
1.  amLODIPine 5 mg PO DAILY 
RX *amlodipine 5 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet 
Refills:*2 
2.  Torsemide 20 mg PO DAILY 
RX *torsemide 20 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet 
Refills:*2 
3.  Glargine 10 Units Bedtime 
4.  Isosorbide Mononitrate (Extended Release) 90 mg PO DAILY  
5.  Aspirin 81 mg PO DAILY  
6.  Carvedilol 25 mg PO BID  
7.  Doxazosin 4 mg PO BID  
8.  Ferrous Sulfate 325 mg PO DAILY  
9.  GlipiZIDE 5 mg PO DAILY  
10.  Januvia (SITagliptin) 25 mg oral DAILY  
11.  Pantoprazole 40 mg PO Q24H  
12.  Polyethylene Glycol 17 g PO DAILY  
13.  Pravastatin 20 mg PO QPM  
14.  Sodium Bicarbonate 650 mg PO BID  
15.Outpatient Lab Work
N18.6

___
Please check CBC, CHEM10.
Fax results to ___, MD at ___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSES:
==================
Acute on Chronic Distolic Heart Failure
End-Stage Renal Disease
Right Knee Gout

SECONDARY DIAGNOSES:
====================
Anemia of Renal Disease
Type II Diabetes

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you. You were admitted to the 
___ because you were short of 
breath and your blood pressure was very elevated. This was 
thought to be related to a large amount of fluid that your body 
had accumulated because of your heart failure and your kidney 
problems. We gave you the same medication in your water pills at 
home, but in intravenous form, which helped improve your 
breathing and lower your blood pressure. We also made changes to 
your home blood pressure medication regimen to ensure that your 
blood pressure remains under control.

While you were in the hospital, you developed right knee pain 
and swelling. We took a small sample of the fluid in your knee 
and analyzed it and found out that you had condition known as 
gout. Gout is due to crystals accumulating in your joints. You 
were treated with a steroid injection in the knee with good 
results. 

Wishing you a speedy recovery,
Your ___ Care Team
 
Followup Instructions:
___
"
151,19456875,29648449," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Enalapril / Codeine / Bacitracin
 
Attending: ___
 
Chief Complaint:
Left hip pain
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ y/o female with a PMH of HTN, hyperlipidemia, and breast 
cancer who presented to the ED s/p mechanical fall to kitchen 
tile. Pt reports that she fell ___ evening on her left hip. 
She has had worsening hip pain after the fall. She slipped in 
the kitchen while wearing slippers. No LOC or presyncope 
symptoms. Landed on her left hip and banged her right elbow. 
Felt fine after the fall. Ran errands with husband on ___. 
___ AM woke up with severe pain in her left hip and could 
not walk. She came to ED for evaluation. No F/C. No N/V/D or 
abdominal pain. No cough or URI symptoms. No CP or SOB. No 
urinary or bowel complaints. Pt is a good historian and has felt 
quite good of late. No history of any fractures.  
.  
ED COURSE: Vitals upon presentation T 98.6, HR 66, BP 146/40, RR 
24, 94%RA. Initial films did not reveal a hip fracture. She was 
going to be discharged home when her pain worsened and she could 
not ambulate. She was given percocet, toradol, and valium for 
pain relief. She was admitted for observation and was noted to 
have an O2 sat of 82% on RA on a routine vital sign check. No 
CP, SOB, or respiratory distress. Improved to 92% with 2L NC. 
She then had a CTA to r/o PE which was negative but did reveal 
evidence of pulmonary disease, likely COPD, which her family 
verified. She was also given levofloxacin for a UTI. She was 
admitted to the medical floor for inability to ambulate and 
finding of hypoxia.  

 
Past Medical History:
Hypertension  
Hypercholesterolemia  
Breast cancer, s/p right mastectomy  
Retinal detachment  
Glaucoma  
Colonic polyps  
H Pylor gastritis (___)  
Anemia  
T2DM  
Cataract s/p surgery  
Former tobacco abuse, quit ___  
Lumbar spinal stenosis  
PVD on left  
RBBB  
Osteoporosis  
Basal cell carcinomas s/p removal  
Mitral regurgitation  
Colonic polyps  
h/o UGIB ___ to ulcer and gastritis, H.pylori positive, full 
treatment course completed  
NSTEMI in the setting of anemia and increased demand ___.  
Negative p-MIBI.  
E.coli urosepsis ___  
h/o multiple UTIs  

 
Social History:
___
Family History:
mother had colon cancer at ___
 
Physical Exam:
T: 98.3 BP: 154/60 P: 72 RR: 20 O2 sats: 97% 3L NC  
Gen: NAD, resting comfortably.  
HEENT: NC/AT, PERRLA, EOMI. MMM. OP clear.  
Neck: No masses  
CV: RRR, S1 and S2 with Grade II/VII systolic ejection murmur. 
No r/g.  
Pulm: Mild crackles at right base.  
Abd: NABS, soft, NTND, no guarding/rigidity/rebound.  
Back: no CVA tenderness.  
Ext: no CCE, 1+ symmetric pedal pulses.  
MSK: TTP lateral left thigh and hip, no ecchymosis. Good ROM of 
left hip joint with minimal pain. Straight leg raise negative 
B/L. Evidence of right elbow ecchymosis. Good ROM in right elbow 
joint.  
Neuro: A/O x 3.  
CN: Grossly intact  
Sensation: Intact  
Strength: ___ B/L  
Reflexes: Normal and symmetric  
 
Pertinent Results:
CXR: COPD and cardiomegaly with ? pulmonary hypertension. No  
acute pulmonary process detected.  
.  
Imaging:  
CT Pelvis: No fracture or malalignment.  Prominent degenerative 
changes at 
L4/5 and L5/S1. 
.
X-ray L hip: No acute fractures or dislocations are seen.  There 
is spurring of the superolateral aspects of both acetabuli, 
consistent with early degenerative changes.  Joint spaces are 
preserved.  Vascular calcifications are seen. There are 
extensive degenerative changes of the lower lumbar spine and of 
the left sacroiliac joint. 
.  
CTA:
1.  No pulmonary embolus. 
2.  Lingular nodule measuring 6 mm, slightly larger than that on 
___.  A six-month followup CT chest is recommended.  Other 
innumerable 
punctate nodules, largely unchange; many of these are calcified. 
  
3.  Mild dilatation of the ascending aorta, measuring 3.9 cm.  
The aorta has diffuse atherosclerotic plaques and 
calcifications. 
4.  Few borderline enlarged bilateral hilar lymph nodes. 
5.  Diffuse emphysema. 
6.  Small hiatal hernia. 
.  
Micro: U/A positive, urine cx (after antibiotics started - mixed 
macterial flora).
.
Labs on admission:

GLUCOSE-257* UREA N-30* CREAT-1.1 SODIUM-136 POTASSIUM-4.2 
CHLORIDE-98 TOTAL CO2-26 ANION GAP-16 CALCIUM-9.6 PHOSPHATE-3.1 
MAGNESIUM-2.2
.
U/A: BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-TR KETONE-NEG 
BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-MOD
.
___ WBC-10.3 RBC-3.88* HGB-11.0* HCT-34.2* MCV-88 MCH-28.4 
MCHC-32.3 RDW-14.5 NEUTS-80.1* BANDS-0 LYMPHS-11.7* MONOS-4.8 
EOS-3.2 BASOS-0.2
HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-NORMAL 
MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL
 
Brief Hospital Course:
A/P: ___ y/o female with a PMH of HTN, hyperlipidemia, and breast 
cancer who presented to the ED s/p mechanical fall and was found 
to be hypoxic.   
.  
# s/p mechanical fall: In the emergency department the patient 
had a plain film done of her left hip as well as CT scan of the 
pelvis which showed no evidence of fracture. She did have some 
initial improvement in her hip pain with addition of Percocet 
and tramadol as needed, however still had some unsteadiness on 
her feet due to pain. The physical therapy team evaluated her 
and felt that she would be safest to go to a rehabilitation 
facility to rebuild her strength before going home. She 
continued to improve with each physical therapy session.
.
# Hypoxia: The patient was noted to have an O2 sat of <85% on RA 
on the ED and was started on 4L O2 NC. This was then weaned to 
2L. On room air she repeatedly had O2 sats between 85-88% and 
<88% upon ambulation on room air. Upon review of the records 
this appears to be a common occurrence upon hospitalization that 
she has been hypoxic and requiring oxygen. She however, has been 
completely asymptomatic related to this. She had a CTA which 
showed no evidence of PE, but did show evidence of diffuse 
emphysema which was in accordance with what was seen on prior 
CTA a year ago. As a result she was scheduled for follow-up in 
___ clinic with Dr. ___ at the end of ___. She 
remained asymptomatic throughout her hospital stay.
.  
# UTI: Pt was asymptomatic, however had a urinalysis revealing 
many WBCs in her urine upon arrival to the emergency department. 
She was initially treated with levofloxacin and then switched to 
ciprofloxacin for a total of a three day course. She would 
benefit from repeat U/A and culture after discharge given a 
history of frequent UTIs in the past and episode of urosepsis on 
past admission requiring ICU care.
.  
# Acute renal failure: Pt with a rise in creatinine from 1.0 to 
1.3 on day of discharge. Her HCTZ was held and she was 
encouraged to drink plenty of liquids. This level should be 
checked upon discharge and she may need IV hydration if unable 
to take enough po for likely prerenal etiology.
.
# HTN: She had good blood pressure control with SBPs in 
120s-140. She was continued on home amlodipine, metoprolol and 
valsartan. 
.  
# Type II DM: She was continued on her home dose of glipizide 
and monitored with Humalog sliding scale infrequently as needed. 
 

 
Medications on Admission:
Aspirin 81 mg PO daily  
DIOVAN 160 mg PO daily  
Desipramine 50 mg PO daily  
HYDROCHLOROTHIAZIDE 25 mg PO daily  
Iron 325 mg PO daily  
LIPITOR 80 mg PO daily  
LORAZEPAM 0.5 mg--1 tablet(s) daily; prn  
GLiPIZIDE 5 mg PO daily  
MULTIVITAMIN  
NEURONTIN 300 mg PO TID  
PROTONIX 40 mg PO daily  
TOPROL XL 100 mg PO daily  
Timoptic, Xalatan eye drops  
Fish Oil 2 capsules PO daily  
Norvasc 5 mg PO daily  
Fosamax 70 mg PO ___  
Calcium  
Vitamin D  

 
Discharge Medications:
1. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
2. Valsartan 160 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
3. Desipramine 50 mg Tablet Sig: One (1) Tablet PO once a day.  
5. Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
6. Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
7. Glipizide 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  
8. Hexavitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).  
9. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).  
10. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
11. Timolol Maleate 0.25 % Drops Sig: One (1) Drop Ophthalmic 
DAILY (Daily).  
12. Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS 
(at bedtime).  
13. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
14. Alendronate 70 mg Tablet Sig: One (1) Tablet PO QSUN (every 
___.  
15. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO TID (3 times a day).  
16. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
17. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
18. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) 
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed.  
19. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) 
injection Injection TID (3 times a day): if pt not ambulating .  

20. Oxycodone-Acetaminophen ___ mg Tablet Sig: One (1) Tablet 
PO Q4H (every 4 hours) as needed for Pain.  
21. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) 
ML PO Q6H (every 6 hours) as needed.  
22. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
23. Aluminum-Magnesium Hydroxide 225-200 mg/5 mL Suspension Sig: 
___ MLs PO QID (4 times a day) as needed for heartburn.  
24. Tramadol 50 mg Tablet Sig: 0.5 Tablet PO Q6H (every 6 hours) 
as needed for hip pain.  
25. Toprol XL 100 mg Tablet Sustained Release 24 hr Sig: One (1) 
Tablet Sustained Release 24 hr PO once a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
1.) Mechanical fall and left hip contusion
2.) Hypoxia
3.) Urinary tract infection
Secondary:
4.) Hypertension

 
Discharge Condition:
afebrile, displaying normal heart rate and blood pressure, 
requiring 2L O2 to maintain resting sats >90% and ambulatory O2 
sats >87%, ambulating with assistance of a cane, and tolerating 
po.

 
Discharge Instructions:
You were admitted to the hospital after a fall for left hip pain 
and unsteadiness on your feet. You had a CT scan of your hip 
which showed no evidence of break or fracture and you most 
likely suffered a bad bruise. You were treated with Percocet to 
help with your pain and you were evaluated by the physical 
therapy team who felt that you would benefit from a short stay 
in a rehabilitation facility.
.
Also, while you were in the hospital you were found to have a 
low oxygen saturation in your blood. You had a CT scan of your 
chest which showed no blood clot in your lungs or lung mass, but 
did show evidence of emphysema. You have been scheduled to see a 
pulmonologist (lung specialist) for further evaluation and might 
be recommended to use home oxygen or take a medication to help 
protect your lungs.
.
If you experience worsening leg pain, fall, swelling, feel 
unsteady on your feet, difficulty breathing, chest pain, leg 
pain or swelling, upon discharge seek immediate medical 
attention.
 
Followup Instructions:
___
"
152,19456875,27658235," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Codeine / Bacitracin
 
Attending: ___.
 
Chief Complaint:
Syncope.
 
Major Surgical or Invasive Procedure:
EP diagnostic cath.
 
History of Present Illness:
Ms. ___ is a very nice ___ YO woman with history of 
hypertension, hypercholesterolemia, diabetes mellitus, MR, 
NSTEMI who comes for a syncopal episode. She has history of 
multiple syncopal episodes (___) in the last 2 months. Last 
___, 5 days ago, she had a syncopal episode without any 
prodrome. After ___ seconds of feeling ""blood rushing out of 
her"" she fell without recalling the fall. She does not remember 
hitting herself and awoke without any periof of confusion. She 
woke up in the floor, face down without any pain in the hands or 
wrists. She denies any visual changes, olfatory abnormalities, 
chest pain, palpitations, shortness of breath before the falling 
to the floor. She hit her thoracic spine and had back pain 
afterwards. The pain was getting so severe that she went to ___ 
___ ER. On admission she had sinus bradicardia up to low 
___ with right bundle branch bloock on telemetry with ___ second 
pauses. She has been pain free without edema, PND, orthopnea, 
mallaise, fatigue. 
 
Past Medical History:
Hypertension  
Hypercholesterolemia  
Breast cancer, s/p right mastectomy  
Retinal detachment  
Glaucoma  
Colonic polyps  
H Pylor gastritis (___)  
Anemia  
DM2: last A1C 8.4 on ___ 
Cataract s/p surgery  
Former tobacco abuse, quit ___ after 50 pack-year  
Lumbar spinal stenosis
PVD on left
h/o RBBB
Osteoporosis  
Basal cell carcinomas s/p removal  
Mitral regurgitation  
Colonic polyps  
h/o UGIB ___ to ulcer and gastritis, H.pylori positive, full 
treatment course completed  
NSTEMI in the setting of anemia and increased demand ___.  
Negative p-MIBI.  
E.coli urosepsis ___  
h/o multiple UTIs
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death. Mother had colon cancer at ___ and died ___ of 
___ etiology. Father died ""in his sleep"" at age ___. No 
siblings.
 
Physical Exam:
VITAL SIGNS -  Temp 98.5 F, HR 86 X', BP 151/67 mmHg, RR 20 X', 
SpO2 96% on RA.
<br>
Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

Neck: Supple with JVP of 7 cm.  
CV: PMI located in ___ intercostal space, midclavicular line. 
RR, decreased S1, increased S2. No r/g. No thrills, lifts. No S3 
or S4. SEM ___ in RUSB that improves with handgrip and does not 
radiate to neck. SEM ___ in apex, bar distribution with 
radiation to the axila and worsens with handgrip.
Chest: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi.  
Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by 
palpation. No abdominial bruits.  
Ext: No c/c/e. No femoral bruits.  
Skin: No stasis dermatitis, ulcers, scars, or xanthomas. Patient 
with atopic dermatitis lesions in the chest.
<b> 
<i>Pulses:</i>
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ ___ 1+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ ___ 1+  
 
Pertinent Results:
On Admission:
___ 09:30PM   WBC-8.3 RBC-4.22 HGB-12.3 HCT-34.4* MCV-81* 
MCH-29.1 MCHC-35.7* RDW-13.9
___ 09:30PM   NEUTS-76.0* LYMPHS-15.5* MONOS-4.5 EOS-3.5 
BASOS-0.5
___ 09:30PM   PLT COUNT-182
___ 09:30PM   GLUCOSE-189* UREA N-17 CREAT-0.9 SODIUM-135 
POTASSIUM-3.8 CHLORIDE-98 TOTAL CO2-28 ANION GAP-13
___ 09:30PM   ALT(SGPT)-24 AST(SGOT)-16 LD(LDH)-222 ALK 
PHOS-85 TOT BILI-0.6
___ 09:30PM   ALBUMIN-4.0 CALCIUM-9.3 PHOSPHATE-2.3* 
MAGNESIUM-2.0
___ 09:30PM   ___ PTT-25.8 ___ yo W with PMH of CAD, Type II DM, HTN, hyperlipidemia 
presents with syncope and eval for PPM.

<br>
#. Syncope: Patient with syncope that suggest vaso-vagal or 
bradyarrhythmia by the way it presented. Clinical presentation 
not suggestive of VF/VT. Patient has EKG showing bradycardia 
with normal PR and initially had ___ second pauses on telemetry 
at ___. Patient was on beta-blocker and calcium 
___ blocker that could have influenced her heart rate. No 
sign of tachycardia to suggest SSS or brady-tachyarrhytmnia 
either. Patient had her dose of beta-blocker reduced to 
metoprolol 25 mg Daily and she was monitored on telemetry 
throughout her stay.  Heart rates off of metoprolol entirely had 
been in the 90's without any pauses, and on 25mg daily of 
metoprolol her heart rates were in the ___ without any pauses.  
Given her apparent marked sensititivity to beta blocker therapy 
and lack of any abnormalities on extended telemetry, further 
syncope evaluation with EP study was not performed.  Her HCTZ 
and valsartan were left in the same dosage (a brief increase in 
these medications had resulted in relative hypotension). She did 
not have abnormalities on telemetry and did not have any other 
syncopal episode.  If she develops recurrent syncope or near 
syncope, she should undergo electrophysiology study.

<br>  
#. CAD:  Patient with multiple risk factors such as uncontrolled 
diabetes not on target, hypertension, dyslipidemia and with 
known history of NSTEMI in ___. She ruled out by cardiac 
enzymes and EKG for ACS. Her cardiac regimen was continued. She 
is not on aspirin for history of severe GI bleed that required 
multiple transfusions and nose bleed. Currently on bblocker, 
lipitor and ___. 

<br>  
#. Pump: Appears euvolemic on exam. Last ECHO in ___ w/o 
evidence of dysfunction.

<br>  
#. Rhythm: Evidence of sinus bradycardia, possibly symptomatic 
and felt to be due to high doses of metoprolol. Reduced dose to 
25mg daily with appropriate rate control and no further episodes 
of syncope. tolerated ambulation with ___.
<br>  
#. Acute renal failure: Patient with increased creatinine up to 
1.8 in the setting of progressively increasing valsartan in the 
setting of hypertension up to 160s. Patient suddently became 
hypotensive at a dose fo 320 mg QD. She was hydrated and the 
valsartan dose was decreased to her home dose with low-dose 
betablocker. Her BP was stable and her creatinine improved to 
baseline, 1.3.

<br>
#. Valvular heart disease - mild aortic regurgitation and mild
mitral regurgitation on echocardiography.

<br>
#. Cholesterol - excellent LDL on current regimen (18 on 
___ and HDL of 32. Continue on Fish Oil for elevated 
triglycerides.

<br>
#. Aortic ulcer - excellent LDL profile thought HDL is low and
triglycerides remain increased despite fish oil.  She will
continue ont the same regimen for now.

<br>
#. Hypertension: Reduced dose of hydrochlorothiazide to 12.5 
three times a week and metoprolol from 100 to 25mg daily. Blood 
pressure within good range.

<br>
#. Type II DM: Treated with sliding scale insulin while inhouse. 
Can return to usual regimen on discharge home.

<br>  
#.  Fall: Patient with no signs of fracture at ___. 
Pain treated with tylenol and improved upon discharge.

<br>  
#. Code:  Full code

<br>  
#. Dispo:  To rehab.
 
Medications on Admission:
Aspirin 81 mg PO daily
Fish oil 1000 mg QD
Toprol XL 100 mg QD
Protonix 40 mg PO QD
Glipizide ER5 mg PO QD
Gabapentin 300 mg PO QHS
Lipitor 80 mg PO QD
Vitamin D 1000 mg PO QD
Iron 27 mcg?
Diovan 320 mg PO QD
Nifedipine ER 30 mg QD
HCTZ 12.5 mg PO QD
Fosamax (___) Q ___
Timolol OO UI BID
Desipramine HCL 50 mg QD
 
Discharge Medications:
1. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
2. Omega-3 Fatty Acids     Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
3. Valsartan 160 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
4. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
Disp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*
5. Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO 
MWF (___).  
6. Alendronate 70 mg Tablet Sig: One (1) Tablet PO QSUN (every 
___.  
7. Glipizide 5 mg Tab,Sust Rel Osmotic Push 24hr Sig: One (1) 
Tab,Sust Rel Osmotic Push 24hr PO DAILY (Daily).  
8. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
9. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q24H (every 
24 hours).  
10. Nystatin-Triamcinolone 100,000-0.1 unit/g-% Cream Sig: One 
(1) Appl Topical BID (2 times a day).
Disp:*1 Tube* Refills:*2*
11. Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
12. Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
13. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Three (3) 
Tablet PO DAILY (Daily).  
14. Timolol Maleate 0.25 % Drops Sig: One (1) Drop Ophthalmic 
BID (2 times a day).  
15. Desipramine 25 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis
Syncope in the setting of bradycardia
Pre-renal renal failure
.
Secondary Diagnosis
Hypertension  
Hypercholesterolemia  
Anemia  
DM2: last A1C 8.4 on ___ 
Lumbar spinal stenosis
PVD on left
h/o RBBB
Mitral regurgitation  
NSTEMI in the setting of anemia and increased demand ___.  

 
Discharge Condition:
Stable, walking, BP stable and HR stable.

 
Discharge Instructions:
You were seen at the ___ for back pain and passing out 
(syncope). It seems that you passed out due to low heart rate 
(bradycardia) in the setting of high-doses of a metoprolol 
(Toprol). We stopped the medication and observed your heart rate 
and you did fine. Your blood pressure was up and we had to 
change your medications (See attached sheet). After discussion 
with our team and  Dr. ___, we decided to try very 
low dose of the metoprolol and you seem to have tolerated it. We 
do not think it is necessary to put a pacemaker at this point. 
However, if you pass out again you must come to the ___ ER 
immediately.
.
You had x-rays of your spine done at ___ that did not 
show any fracture, but showed degenerative changes. Your pain 
improved with pain medications and was better off them upon 
discharge. You will need to follow up with your primary care, 
Dr. ___ that. If you are still having pain 1 week 
from now, please call his office.
.
While we were increasing your BP medications one of them caused 
your kidney function to go down. We gave you fluids and 
decreased your medication dose and you improved. You will need 
to have your kidney function checked within a week.
 
Followup Instructions:
___
"
153,19456875,20828896," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Codeine / Bacitracin / Atenolol / Percocet / Enalapril
 
Attending: ___.
 
Chief Complaint:
AMS, HTN, AOCRF  

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ F with history of CKD, dementia, HTN, DMII, presenting from 
clinic with worsening HTN, AMS, and AOCRF. Daughter reports that 
her mental status suddenly worsened 5 days ago. She can no 
longer dress herself, can on longer be left alone at night. She 
awakens confused and can't make it to the restroom on her own. 
These are new changes for her. She usually lives alone with help 
during the day. Patient is a poor historian, denies any 
problems, denies fevers, chills, dysuria, abd pain, bowel 
changes, SOB, chest pain, headache, visual changes. Daughter 
reports that patient has help during the day that assist in 
medication administration and so has not missed any doses of 
meds. She was seen at clinic today and found to have BP of 
202/70. Noted to have a nonfocal neuro exam.  
.  
In the ED, initial vitals were: 97.9, 75, 210/58, 12, 97%RA. She 
was noted to be AAOx0. She was given hydralazine 20 mg IV and 
zyprexa 5 mg IV x1. Patient was found to have 12 white cells on 
UA, was given a dose of macrobid ___ mg. Patient's CXR was 
without any evidence of pneumonia or CHF.  
.  
Currently, patient feels restless, is very confused. Son is in 
the room with her who tells me that her baseline mental status 
is about AAOx2, usually oriented to person and place. Sundowns 
at night time. Doesn't complete sentences all the time. She's 
had no recent falls, no new bruises. No dysuria, no urinary 
frequency. Reported to have been eating and drinking well, 
although decreased appetite as of lately  
.  
ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, shortness 
of breath, chest pain, abdominal pain, nausea, vomiting, 
diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, 
hematuria.  
 
Past Medical History:
Hypertension  
Hypercholesterolemia  
Breast cancer, s/p right mastectomy  
Retinal detachment  
Glaucoma  
Colonic polyps  
H Pylor gastritis (___)  
Anemia  
DM2  
Cataract s/p surgery  
Former tobacco abuse, quit ___ after 50 pack-year  
Lumbar spinal stenosis  
PVD on left  
h/o RBBB  
Osteoporosis  
Basal cell carcinomas s/p removal  
Mitral regurgitation  
Colonic polyps  
h/o UGIB ___ to ulcer and gastritis, H.pylori positive, full  
treatment course completed  
NSTEMI in the setting of anemia and increased demand ___.  
Negative p-MIBI.  
E.coli urosepsis ___  
h/o multiple UTIs  

 
Social History:
___
Family History:
There is no family history of premature coronary artery disease  

or sudden death. Mother had colon cancer at ___ and died ___ of  
___ etiology. Father died ""in his sleep"" at age ___. No  
siblings.  

 
Physical Exam:
Admission exam:

VS - 98.1, 74, 145/73, 74, 20, 97%RA  
GENERAL - frail, NAD, AAOx0  
HEENT - blind in left eye, MMM, OP clear, no LAD  
NECK - supple, no JVD  
LUNGS - CTA b/l, no w/r/r  
HEART - S1S2, RRR, II/VI crescendo systolic murmur  
ABDOMEN - NABS, soft/NT/ND, no HSM, no rebound/guarding  
EXTREMITIES - venous stasis ulcers bilaterally, no e/c/c, 2+ 
peripheral pulses  
NEURO - awake, A&Ox0, CNs II-XII grossly intact, muscle strength 
4+/5 throughout, sensation grossly intact throughout. Nonfocal 
neuro exam.
 
Pertinent Results:
Admission labs:

___ 12:53PM BLOOD WBC-4.8 RBC-3.92* Hgb-10.9* Hct-33.0* 
MCV-84 MCH-
27.8 MCHC-32.9 RDW-14.9 Plt ___
___ 12:53PM BLOOD Neuts-58.5 ___ Monos-6.1 Eos-5.9* 
Baso-1.0
___ 12:53PM BLOOD Glucose-237* UreaN-22* Creat-1.5*# Na-141 
K-3.4 Cl-104 HCO3-26 AnGap-14
___ 04:50AM BLOOD Calcium-9.5 Phos-3.1 Mg-1.9
___ 05:25AM BLOOD VitB12-265 Folate-17.4
___ 05:25AM BLOOD TSH-3.3
___ 05:10AM BLOOD HBsAg-NEGATIVE
___ 05:10AM BLOOD HCV Ab-NEGATIVE

CT head:

Final Report 
INDICATION: Altered mental status. Evaluate for intracranial 
hemorrhage or 
stroke. 
  
TECHNIQUE: Contiguous axial images were obtained through the 
brain. No 
contrast was administered. 
  
COMPARISONS: None. 
  
FINDINGS: There is no evidence of hemorrhage, edema, masses, 
mass effect or 
infarction. The ventricles and sulci are prominent in size and 
configuration, 
consistent with age-related atrophy. There are periventricular 
white matter 
hypodensities consistent with chronic small-vessel ischemic 
disease. No 
fractures are identified. There is a small area of soft-tissue 
swelling in the 
right frontal region. The visualized portions of the paranasal 
sinuses, 
mastoid air cells, and middle ear canals are clear. 
  
IMPRESSION: No acute intracranial abnormality. 

STUDY: Three views of the right ankle ___. 
  
COMPARISON: None. 
  
INDICATION: Right ankle pain, question fracture. 
  
FINDINGS: Soft tissue swelling about the medial malleolus. No 
definite ankle 
effusion. Mild osteopenia. No dislocation. The mortise and 
syndesmosis are 
intact. Well-corticated ossific fragment is seen inferior to the 
medial 
malleolus, from prior avulsion fracture. Probable posttraumatic 
deformity of 
the distal fibula. No acute fracture identified. No dislocation. 
No 
significant degenerative changes. Small plantar spur. Posterior 
calcaneal 
enthesopathy. 
  
IMPRESSION: No acute fracture. 

Chest x-ray:
Final Report 
INDICATION: ___ woman with confusion. Assess for 
pneumonia or CHF. 
  
COMPARISON: Chest CT ___ and multiple prior chest 
radiographs, 
most recent of ___. 
  
FRONTAL AND LATERAL VIEWS OF THE CHEST: There is severe 
emphysema. Multiple 
small calcified granulomas are again seen scattered throughout 
the lungs 
bilaterally. No findings are present to suggest pneumonia. There 
is no pleural 
effusion or pneumothorax. The aorta is tortuous, stable. The 
heart size is 
normal.  
  
IMPRESSION: No evidence of pneumonia or CHF. Severe emphysema. 

 
Brief Hospital Course:
___ F with history of CKD, dementia, HTN, DMII, presenting from 
clinic with worsening hypertension, altered mental status and 
acute renal failure.

# Delirium - the patient was found to be delirious on admission. 
 Initial workup, including blood work, cultures and head CT scan 
was negative.  A paronychia of her right large toe was found 
which was drained; pain from the paronychia may have contributed 
to her initial delirium. Geriatrics was consulted, and the 
patient received supportive measures such as better pain 
control, a bowel regimen and attempts to preserve her sleep wake 
cycle.  She was agitated at times, and responded poorly to 
olanzapine but did improve with daily seroquel 6.25 at night, 
which was later increased to 12.5 to help improve her sleep/wake 
cycle.  A urinalysis was later re-checked which did demonstrate 
a urinary tract infection and she was treated with IV 
ceftriaxone for 3 days. Finally, her delirium might have been 
worsened by constipation, which was treated with disimpaction.

# Urinatry tract infection - treated as above.

# Hypertension - the patient had a blood pressure elevated with 
systolic pressures in the 200s at clinic prior to admission.  
She was continued on valsartan and amlodipine, and hydralazine 
10mg bid was added to her regimen, resulting in good blood 
pressure control.

# Diabetes - the patient was not on any oral anti-hyperglycemics 
on admission as her PCP had discontinued these 3 weeks prior.  
She was started on a humalog sliding scale and lantus.

#Acute renal failure - This resolved quickly with IV fluids. 

#Code status: The patient was confirmed to be DNR/DNI with the 
family.

#Transition of care issues: Geriatrics recommended discontinuing 
the rosuvastatin and omeprazole if they are not needed.  This 
should be discussed with the patient's primary care provider.
 
Medications on Admission:
gabapentin 300 mg qhs prn pain  
omeprazole 20 mg daily  
rosuvastatin 40 mg daily  
valsartan 320 mg daily  
aspirin 81 mg daily  
cholecalciferol 1,000 unit daily  
ferrous sulfate - dosage uncertain  
multivitamin 1 tablet daily  
omega-3 fatty acids-vitamin E 1,000 mg daily  
Lumigan - 1 drop to right eye qhs  

 
Discharge Medications:
1. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
2. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
3. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
4. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
5. latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at 
bedtime).  
6. rosuvastatin 5 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
7. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

8. hydralazine 10 mg Tablet Sig: One (1) Tablet PO BID (2 times 
a day).  
9. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
10. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
11. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H 
(every 6 hours).  
12. insulin glargine 100 unit/mL Cartridge Sig: Seven (7) units 
Subcutaneous at bedtime.  
13. insulin lispro 100 unit/mL Solution Sig: Sliding Scale 
Subcutaneous three times a day: BS 150-200 2 units, 201-250 3 
units, 251-300 4 units, 301-350 5 units, 351-400 6 units.  
14. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) 
packet PO DAILY (Daily) as needed for constipation.  
15. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as 
needed for insomnia.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Urinary tract infection
Delirium

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear ___,

___ were admitted to the hospital because ___ were confused and 
had a urinary tract infection.  We treated your urinary tract 
infection and ___ improved.  ___ also had an infection of your 
toe which we drained.  Your blood pressure was also elevated, 
and for this we changed your medications slightly.

Finally, your blood sugar was out of control when ___ came in.  
___ were started on insulin to help control your blood sugar.

The following medications were started:
Insulin Glargine 7U at night
hydralazine 10mg twice daily
trazodone 25mg qhs prn insomnia
 
Followup Instructions:
___
"
154,19940147,25746576," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Hydralazine / Cefepime
 
Attending: ___
 
Chief Complaint:
fatigue
 
Major Surgical or Invasive Procedure:
___ placement

 
History of Present Illness:
___ with history of CML diagnosed in ___, treated with 
""medicines"" who presents for transplant evaluation.  She has 
been doing well until the past week when she developed extreme 
fatigue.  She feels as if she has no energy and that her heart 
pounds when she walks around.  She denies any fever, cough, pain 
with urination, rashes.  She does have some abdominal pain, 
mostly on the left side and had one episode of diarrhea 
yesterday.  She has not had any recent antibiotic use.  She also 
admits to sweating at night over the past week. 
.  
Review of Systems:  
(+) Per HPI  
(-) Denies Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denies chest pain or tightness, Denies cough, 
shortness of breath, or wheezes. Denies nausea, vomiting, 
constipation  No recent change in bowel or bladder habits. No 
dysuria. Denies arthralgias or myalgias. Denies rashes or skin 
breakdown. No numbness/tingling in extremities. No feelings of 
depression or anxiety. All other review of systems negative.
 
Past Medical History:
ONCOLOGIC HISTORY:

- ___: Asymptomatic abnormal CBC noted by PCP during routine

visit

- ___: Bone marrow biopsy showed myeloproliferative

disorder, likely chronic myelogenous leukemia. Per patient

report, began taking interferon three times weekly shortly

after diagnosis.

- ___: Started ___ 400 mg daily. At some point

thereafter, her dose was increased to 600 mg daily

- ___: ___ increased to 400 mg twice daily with

hydroxyurea and allopurinol

- ___: Seen at ___, found to be

in late chronic phase CML. Stem cell transplant was

recommended, but she did not wish to pursue this course.

- ___: ___ held due to worsening anemia and

thrombocytosis. Started on Nilotinib

- ___: Nilotinib held due to QTC prolongation, started on

Dasatinib

Other Past Medical History:
CABG in ___, no history of chf per patient
htn
hlp 

 
Social History:
___
Family History:
nc
 
Physical Exam:
V 101.3, 100/60, 87, 97% on ra
gen: awake, alert, diaphoretic
HEENT:  no lad, no thyromegaly, ncat
CV:  rrr, s1, s2, ___ sem at base, ___ holosystolic murmur at 
___, increasing with inspiration
PULM:  cta b/l
ABD:  soft, non tender non distended, no rebound or guarding
LIMBS:  no c/c/e
SKIN:  no rashes

 
Pertinent Results:
___ 02:30PM BLOOD WBC-23.7* RBC-2.08* Hgb-6.1* Hct-17.6* 
MCV-85 MCH-29.4 MCHC-34.7 RDW-15.0 Plt ___
___ 02:30PM BLOOD Neuts-41* Bands-3 Lymphs-10* Monos-0 
Eos-3 Baso-0 ___ Metas-10* Myelos-15* Promyel-4* Other-14*
___ 02:30PM BLOOD Hypochr-NORMAL Anisocy-1+ 
Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-2+ Polychr-NORMAL 
Ovalocy-1+
___ 07:45AM BLOOD ___ PTT-27.9 ___
___ 03:13AM BLOOD ___ 12:00AM BLOOD ___ ___
___ 02:30PM BLOOD UreaN-14 Creat-0.8 Na-139 K-4.0 Cl-102 
HCO3-25 AnGap-16
___ 02:30PM BLOOD ALT-7 AST-9 CK(CPK)-35 AlkPhos-63 
TotBili-0.8
___ 02:30PM BLOOD CK-MB-1 cTropnT-0.04*
___ 07:45AM BLOOD CK-MB-1 cTropnT-0.02*
___ 02:30PM BLOOD TotProt-6.4 Albumin-4.1 Globuln-2.3 
Calcium-8.8 Phos-3.0 Mg-1.8
___ 02:30PM BLOOD TSH-3.2
___ 07:45AM BLOOD Hapto-255*
___ 02:30PM BLOOD BCR/ABL MINOR AND MAJOR BREAKPOINT 
ANALYSIS BY PCR-Test      
___ 07:00PM BLOOD B-GLUCAN-Test      
___ 07:00PM BLOOD ASPERGILLUS GALACTOMANNAN ANTIGEN-Test    
  
___ 02:50PM URINE Color-Yellow Appear-Hazy Sp ___
___ 02:50PM URINE Blood-NEG Nitrite-NEG Protein-30 
Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-4* pH-5.5 Leuks-TR
___ 02:50PM URINE RBC-2 WBC-6* Bacteri-FEW Yeast-NONE Epi-1 
TransE-<1
___ 02:50PM URINE CastHy-1*
___ 02:50PM URINE Mucous-OCC

Bone Marrow:
___:
MARKEDLY HYPERCELLULAR MYELOID DOMINANT BONE MARROW WHICH, IN 
CONJUNCTION WITH PERIPHERAL BLOOD BASOPHILIA, IS CONSISTENT WITH 
CHRONIC MYELOID LEUKEMIA IN ACCELERATED PHASE. 

___:
Severely hypocellular bone marrow, with ___ blasts, see note.

Note: The marrow is severely hypocellular with rare 
hematopoietic elements that are left shifted. Rare focal 
atypical myeloid blasts and left shifted myeloid elements are 
present.  Immunohistochemistry for CD34 and CD117 reveal about 
___ of marrow cells as precursor blasts. Since residual CML 
cannot be frequently distinguished from normal hematopoiesis, 
correlation with cytogenetics (OCA: other chromosomal 
abnormalities), BCR-ABL transcript levels and BAMA (bcr-abl 
mutation analysis) is recommended.

Imaging:
CXR ___:
FINDINGS: Normal lung volumes. Moderate cardiomegaly. No 
evidence of
pulmonary edema. Status post CABG, correct alignment of the 
wires. Mild
tortuosity of the thoracic aorta. No evidence of pneumonia, no 
pleural
effusions.

___:
CT Abdomen/Pelvis:
1. No evidence of pneumonia within the chest.
2. Massive splenomegaly measuring up to 25.2 cm in craniocaudad 
___.
3. Multiple scattered mediastinal and retroperitoneal lymph 
nodes, all of
which do not meet size criteria for pathologic enlargement.
4. Extensive atherosclerotic calcification involving the 
thoracoabdominal
aorta and its major branches, and the coronary arteries

TTE 
___:
 The left atrium is mildly dilated. Left ventricular wall 
thickness, cavity size and regional/global systolic function are 
normal (LVEF >55%). Doppler parameters are indeterminate for 
left ventricular diastolic function. There is no ventricular 
septal defect. The aortic valve leaflets (3) are mildly 
thickened but aortic stenosis is not present. No aortic 
regurgitation is seen. The mitral valve leaflets are mildly 
thickened. There is no mitral valve prolapse. Trivial mitral 
regurgitation is seen. The tricuspid valve leaflets are mildly 
thickened. There is moderate pulmonary artery systolic 
hypertension. There is no pericardial effusion.

IMPRESSION: Normal regional and global lef ventricular systolic 
function. The right ventricle is not well seen. There is 
moderate pulmonary artery systolic hypertension. No pathologic 
valvular abnormality seen.  

___:
CT Abdomen/Pelvis:
1. Massive splenomegaly, unchanged.
2. Small left pleural effusion.
3. Small amount of free intraperitoneal fluid, without organized 
fluid
collection. Moderate amount of fluid in cul-de-sac.

CT HEAD
___:
1. No evidence of intracranial hemorrhage, specifically no 
evidence of
subdural hematoma.
2. Chronic small vessel disease.

TTE:
___:
The left atrium is mildly dilated. The estimated right atrial 
pressure is ___ mmHg. Left ventricular wall thickness, cavity 
size and regional/global systolic function are normal (LVEF 
>55%). The estimated cardiac index is normal (>=2.5L/min/m2). 
Tissue Doppler imaging suggests a normal left ventricular 
filling pressure (PCWP<12mmHg). Right ventricular chamber size 
and free wall motion are normal. The diameters of aorta at the 
sinus, ascending and arch levels are normal. The aortic valve 
leaflets (3) appear structurally normal with good leaflet 
excursion and no aortic regurgitation. The mitral valve leaflets 
are structurally normal. There is no mitral valve prolapse. Mild 
(1+) mitral regurgitation is seen. The pulmonary artery systolic 
pressure could not be determined. There is no pericardial 
effusion.

IMPRESSION: Normal biventricular cavity sizes with preserved 
global and regional biventricular systolic function. Mild mitral 
regurgitation with normal valve morphology.
Compared with the prior study (images reviewed) of ___, the 
findings are similar (PA systolic pressure could not be 
estimated on the current study). 

CT CHEST:
___:
1. New 6-mm nodule in the posterior segment of the right upper 
lobe.
Recommend a 6-month followup CT.
2. No pleural effusion, focal consolidation concerning for 
infection or
pneumothorax.
3. Splenomegaly improved.
 
Brief Hospital Course:
___ with history of CML with new fatigue who was found to have 
severe anemia and elevated WBC on cbc done today in workup for 
possible transplant.  Patient became febrile after admission to 
the hospital.

# Accelerated phase CML: Patient was anemic on admission and 
transfused.  It was decided that patient should undergo 
myeloablative induction for possible allogeneic stem cell 
transplant.  Patient started induction chemotherapy on ___ 
with cytarabine and idarubicin (7+3) according to protocol.  Her 
dasatinib was held.  Her ANC nadir was ___. Her course was 
complicated by fevers for which she was started on vancomycin 
and cefepime and her PICC line was removed.  Blood cultures, 
urine cultures and stool cultures remained negative. She 
developed a diffuse rash, and dermatology was consulted.  It was 
felt that this may have been a drug rash related to cefepime, 
vancomycin or hydralazine and she was treated with topical 
steroids.  Hydralazine and cefepime were stopped and aztreonam 
was started.  She spiked a temperature of 101 on ___ and 
aztreonam was changed to meropenem.  She defervesced and 
remained afebile for the remainder of her hospitalization.  
Cultures remained negative.  Her ___ recovered to 1829 on 
___.  A pre transplant work up was completed as an inpatient, 
including infectious disease consultation and dental 
consultation.

# History of CAD: Patient was continued on her home dose of 
statin.  She was ruled out for myocardial infarction with serial 
cardiac biomarkers.  Her metoprolol was uptitrated during this 
admission due to hypertension and she was discharged on 100 mg 
PO tid. 

# HTN: Patient was initially started on her home dose of 
metoprolol.  She had several episodes of elevated blood pressure 
and her metoprolol was uptitrated to 100mg PO tid.  She was 
started on hydralazine, but it was later stopped ___ drug rash.  
She was started on valsartan 80mg PO daily, with improved 
control of her blood pressure.

# Pancytopenia: After treatment with 7+3, patient was 
periodically transfused with PRBCs to maintain her hematocrit 
above 25 and platelets to maintain her platelets above 10.  
 
# FEN: Neutropenic diet, Mg, K and Phos were repleted by 
protocol. 

# Code: FULL  

 
Medications on Admission:
sprycel 50 mg 1 tab twice daily
ferrous sulfate 1 tab daily
metoprolol 200 mg 1 tab daily
lipitor 20 mg 1 tab daily
hydrocod/ap 7.5/500 1 tab prn q ___ hours
allopurinol ___ mg 1 tab daily

 
Discharge Medications:
1. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*0*
2. Valsartan 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*0*
3. Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO TID 
(3 times a day).
Disp:*180 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Accelerated Phase Chronic Myeloid Leukemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for treatment of recurrent leukemia.  You were 
treated with a chemotherapy regimen known as ""7+3"" which 
consists of cytarabine and daunorubicin.  Your course was 
complicated by fevers, and you were treated with antibiotics.  
You also developed a rash, which may have been caused by one or 
more of the antibiotics.  Your blood counts recovered, your 
fevers resolved and all antibiotics were stopped.

Please note the following changes in your medications:
- Please START Valsartan (Diovan) 80mg by mouth daily
- Please START Metoprolol tartrate 100mg by mouth, three times 
daily.
- Please START Omeprazole 40mg by mouth daily
- Please STOP taking sprycell
 
Followup Instructions:
___
"
155,19940147,28990773," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
Elective Admission for Allogeneic Stem Cell Transplant
 
Major Surgical or Invasive Procedure:
Allogeneic Stem Cell Transplant
 
History of Present Illness:
 ___ with history of CML diagnosed in ___, presents for 
transplant following induction with 7+3 at at last admission. Pt 
was recently discharged from this hospital after undergoing 
transplant eval for treatment of her CML with transformation to 
accelerated CML vs AML. Bone marrow bx at that time showed 
hypercellular bone marrow with ___ blasts, peripheral smear 
also showed persistent blasts, therefore pt was started on 
cytarabine/idarubicin. Induction course was complicated by 
fevers requiring tx with vanc/cefepime (changed to aztreonam 
given rash); pt also with PICC placement causing 
swelling/tenderness, however no evidence of DVT on US. Was also 
treated for rash, htn and required transfusions during the 
course of her inducton therapy.
.
On arrival to the floor, pt states that she is overall feeling 
well. Pts sister is donor and is in town from ___. She 
denies any new issues since last discharge. Central lines placed 
prior to arrival on the floor without complication. 
 
Past Medical History:
ONCOLOGIC HISTORY:
- ___: Asymptomatic abnormal CBC noted by PCP during routine
visit
- ___: Bone marrow biopsy showed myeloproliferative
disorder, likely chronic myelogenous leukemia. Per patient
report, began taking interferon three times weekly shortly
after diagnosis.
- ___: Started Gleevec 400 mg daily. At some point
thereafter, her dose was increased to 600 mg daily
- ___: Gleevec increased to 400 mg twice daily with
hydroxyurea and allopurinol
- ___: Seen at ___, found to be
in late chronic phase CML. Stem cell transplant was
recommended, but she did not wish to pursue this course.
- ___: Gleevec held due to worsening anemia and
thrombocytosis. Started on Nilotinib
- ___: Nilotinib held due to QTC prolongation, started on
Dasatinib
- ___: First seen at ___. Bone marrow biopsy showed
accelerated phase CML. began induction chemo with 7+3.
- ___: Admission for MRD SCT

Other Past Medical History:
- atherosclerotic coronary vascular disease
- status post CABG in ___
- hypertension
- hyperlipidemia
- Right ankle surgery in ___
- Total abdominal hysterectomy in ___
- Appendectomy at age ___
- GERD 
 
Social History:
___
Family History:
Sister is donor, brother with prostate cancer 
 
Physical Exam:
Vitals: T:97.6 BP:152/94 P:92 R:18 O2:99% RA
General: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, JVP not elevated, no LAD
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly
GU: no foley
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema
Neuro: CNs ___ intact, no focal weakness or loss of sensation 
 
Pertinent Results:
Admission Labs:
___
CBC: WBC-13.3*# RBC-3.78* Hgb-11.2* Hct-31.2* MCV-83 MCH-29.6 
MCHC-35.9* RDW-14.2 Plt ___

Diff: Neuts-68 Bands-9* Lymphs-3* Monos-2 Eos-3 Baso-0 Atyps-4* 
Metas-8* Myelos-1* Promyel-1* Other-1*

Coags: ___ PTT-25.8 ___

Chemistries: Glucose-118* UreaN-13 Creat-0.8 Na-142 K-4.0 Cl-104 
HCO3-28 AnGap-14 Albumin-4.4 Calcium-9.5 Phos-4.9* Mg-1.8

LFTs ALT-26 AST-17 LD(LDH)-439* AlkPhos-98 TotBili-0.7
 
ECG:
Sinus rhythm. Non-specific ST-T wave changes. Compared to the 
previous tracingof ___ there is no change.
 
 Intervals        Axes
___
___
Discharge Labs:

___ 12:00AM BLOOD Calcium-9.0 Phos-4.5 Mg-1.7 UricAcd-7.1*
___ 12:00AM BLOOD ALT-42* AST-30 LD(LDH)-327* AlkPhos-66 
TotBili-0.7
___ 12:00AM BLOOD Glucose-101* UreaN-25* Creat-0.7 Na-136 
K-3.9 Cl-102 HCO3-24 AnGap-14
___ 12:00AM BLOOD ___ ___
___ 12:00AM BLOOD Plt Smr-LOW Plt Ct-94*
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ 
Macrocy-1+ Microcy-1+ Polychr-1+ Spheroc-2+ Ovalocy-1+ 
Schisto-1+ Stipple-OCCASIONAL
___ 12:00AM BLOOD WBC-8.3 RBC-3.21* Hgb-10.0* Hct-27.8* 
MCV-87 MCH-31.0 MCHC-35.9* RDW-22.4* Plt Ct-94*
 
Brief Hospital Course:
#. Accelerated Phase Chronic Myeloid Leukemia: Patient was 
treated with busulfan/cytoxan conditioning per protocol.  She 
experienced some nausea and emesis which was controlled with 
zofran.  Stem cell transplant was performed. Her course was 
complicated by neutropenic fever and she was treated with 
antibiotics. She remained culture negative. She developed 
esophagitis and was found to be negative for CMV but esophaheal 
biopsy suggested esophageal GHVD and also had evidence of skin 
GHVD. She received a tapered course of steroids and improved. 
She also developed intense headaches while she was 
thrombocytopenic. Head CT showed no acute intracranial 
hemorrhage or mass effect, with a few vague dense areas noted in 
the brainstem/posterior fossa, likely being artifactual. Her 
headaches resolved. She was discharged to the oncology 
apartments and will follow closely with the ___ and 
her primary oncologist.
.
#. Hypertension.  On admission, patients metoprolol was 
continued but her valsartan was held out of concern for renal 
toxicity with chemotherapy.  Her blood pressure trended up 
during her conditioning and her metoprolol dose was increased. 
Subsequently nifedipine was also added and she was discharged on 
nifedpine and metoprolol with good blood pressure control. She 
had serial EKGs performed given her cardiac history, and her 
cardiac status should continue to be monitored as an outpatient. 


.

 
Medications on Admission:
METOPROLOL TARTRATE - (discharge med) - 50 mg Tablet - 2
Tablet(s) by mouth three times a day
OMEPRAZOLE - (discharge med) - 20 mg Capsule, Delayed
Release(E.C.) - 1 Capsule(s) by mouth DAILY (Daily)
VALSARTAN [DIOVAN] - (discharge med) - 80 mg Tablet - 1
Tablet(s) by mouth DAILY (Daily) 
 
Discharge Medications:
1. Lorazepam 0.5 mg Tablet Sig: ___ Tablets PO once a day: 
please do not drink alcohol or perform activities that require 
fast reaction time. ___ cause sedation. .
Disp:*30 Tablet(s)* Refills:*2*
2. Acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours).
Disp:*90 Tablet(s)* Refills:*2*
3. Fluconazole 200 mg Tablet Sig: One (1) Tablet PO BID (2 times 
a day).
Disp:*60 Tablet(s)* Refills:*2*
4. Ursodiol 300 mg Capsule Sig: One (1) Capsule PO BID (2 times 
a day).
Disp:*60 Capsule(s)* Refills:*2*
5. Budesonide 3 mg Capsule, Sust. Release 24 hr Sig: One (1) 
Capsule, Sust. Release 24 hr PO TID (3 times a day).
Disp:*90 Capsule, Sust. Release 24 hr(s)* Refills:*0*
6. Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).
Disp:*120 Tablet(s)* Refills:*2*
7. Nifedipine 90 mg Tablet Sustained Release Sig: One (1) Tablet 
Sustained Release PO DAILY (Daily).
Disp:*30 Tablet Sustained Release(s)* Refills:*2*
8. Neoral 25 mg Capsule Sig: Five (5) Capsule PO every morning .
Disp:*150 Capsule(s)* Refills:*2*
9. Neoral 25 mg Capsule Sig: Four (4) Capsule PO at bedtime.
Disp:*120 Capsule(s)* Refills:*2*
10. ZOFRAN ODT 8 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, 
Rapid Dissolve PO every eight (8) hours.
Disp:*30 Tablet, Rapid Dissolve(s)* Refills:*2*
11. Bactrim DS 800-160 mg Tablet Sig: One (1) Tablet PO 3X/WEEK: 
on MWF.
Disp:*12 Tablet(s)* Refills:*2*
12. Prilosec 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) 
Capsule, Delayed Release(E.C.) PO once a day.  
13. Multivitamin     Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*6*
14. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*6*
15. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as 
needed for constipation.  
16. Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as 
needed for constipation.  

 
Discharge Disposition:
Home with Service
 
Discharge Diagnosis:
Accelerated Phased Chronic Myeloid Leukemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for allogeneic stem cell transplant.  You were 
first treated with chemotherapy (busulfan and cytoxan).  You 
experienced nausea and vomiting which was controlled with 
medications.  You had episodes of high blood pressure and your 
blood pressure medicines were increased.  You developed 
esophagitis and you had a biopsies of the esophagus which 
showed:
Your esophagitis improved as your cell count improved. 
.
 The following changes were made to your medications: 
We stopped valsartan.
.
We decreased metoprolol.
.
We added nifedpine, cyclosporine, acyclovir, fluconazole, 
bactrim, zofran, budesonide and ursodiol.
 
Followup Instructions:
___
"
156,19940147,22122103," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
diarrhea 
 
Major Surgical or Invasive Procedure:
Colonoscopy on ___
 
History of Present Illness:
Ms. ___ is a ___ year old woman with CML, s/p allogeneic 
stem cell transplant with Busulfan/Cytoxan. Her sister was her 
donor. her transplant was complicated by mucositis with biopsy 
of the esophagus suggesting upper GI GVHD which was treated with 
steroids. She is day +___.  
.  
She arrived at outpatient ___ clinic today feeling unwell. She 
reports  
vomiting yesterday morning after taking her medications, but 
otherwise having a good and active day. She had 3 soft but 
formed bowel movements that day, when her usual pattern is to 
have 2. She denies blood or grease in her BM. She awoke in the 
middle of the night with increasing ""gassy"" stomach cramping, 
which was worse again when she got up for the day. She was able 
to brush her teeth, take her pills and eat, and denies any 
vomiting today, but her stomach continued to be painful. She 
also notes feeling more nauseated after brushing her teeth. She 
reports her diet to be decreased PO intake, since ___. She 
Usually has some granola bars or cereals, but has a hard time 
eating meats, fish, chicken, milk/dairy, and does not drink 
ensure supplements. Her niece ___ whom is close to the pt. 
has been trying to encourage better intake.  
Walking over to the clinic she became diaphoretic, short of 
breath, tachycardic, and felt very weak. She improved quickly 
when sitting down and after receiving fluids, but her stomach 
cramps continued. It was decided to admit her for better 
management of suspected GVH of the gut. She denies sick contacts 
or recent travel. Also denies large volume diarrhea, 
constipation, fever, chills, night sweats, cough, chest pain, 
dizziness, swelling, dysuria, neuropathy, bleeding, bruising, 
confusion, depression. The remainder of review of systems is 
essentially negative.  

 
Past Medical History:
ONCOLOGIC HISTORY:
- ___: Asymptomatic abnormal CBC noted by PCP during routine
visit
- ___: Bone marrow biopsy showed myeloproliferative
disorder, likely chronic myelogenous leukemia. Per patient
report, began taking interferon three times weekly shortly
after diagnosis.
- ___: Started Gleevec 400 mg daily. At some point
thereafter, her dose was increased to 600 mg daily
- ___: Gleevec increased to 400 mg twice daily with
hydroxyurea and allopurinol
- ___: Seen at ___, found to be
in late chronic phase CML. Stem cell transplant was
recommended, but she did not wish to pursue this course.
- ___: Gleevec held due to worsening anemia and
thrombocytosis. Started on Nilotinib
- ___: Nilotinib held due to QTC prolongation, started on
Dasatinib
- ___: First seen at ___. Bone marrow biopsy showed
accelerated phase CML. began induction chemo with 7+3.
- ___: Admission for MRD SCT

Other Past Medical History:
- atherosclerotic coronary vascular disease
- status post CABG in ___
- hypertension
- hyperlipidemia
- Right ankle surgery in ___
- Total abdominal hysterectomy in ___
- Appendectomy at age ___
- GERD 
 
Social History:
___
Family History:
Sister is donor, brother with prostate cancer 
 
Physical Exam:
Vitals: 96.9, 126/82, 92, 18, 100% RA  
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVP not elevated. Mild b/l cervical adenopathy  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-distended, bowel sounds present, epigastric 
tenderness to palpation, no rebound tenderness or guarding, no 
organomegaly  
GU: no foley  
Skin: mild erythematous rash on upper chest/ erythema under 
breasts b/l. Tatoo RLQ/ Linear scar left forearm.  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNs ___ intact, no focal weakness or loss of sensation  
.  

 
Pertinent Results:
___ 10:00AM BLOOD WBC-12.7*# RBC-3.64* Hgb-11.8* Hct-34.2* 
MCV-94 MCH-32.4* MCHC-34.5 RDW-20.7* Plt ___
___ 10:00AM BLOOD Neuts-74* Bands-1 Lymphs-7* Monos-14* 
Eos-1 Baso-0 Atyps-1* Metas-1* Myelos-1*
___ 10:00AM BLOOD Hypochr-NORMAL Anisocy-3+ Poiklo-2+ 
Macrocy-2+ Microcy-2+ Polychr-2+ Ovalocy-2+ Tear Dr-OCCASIONAL
___ 10:00AM BLOOD UreaN-22* Creat-1.1 Na-139 K-2.8* Cl-101 
HCO3-22 AnGap-19
___ 10:00AM BLOOD ALT-31 AST-26 LD(LDH)-344* AlkPhos-60 
TotBili-0.5
___ 10:00AM BLOOD Albumin-4.1 Calcium-9.4 Phos-4.2 Mg-1.4*
___ 12:00AM BLOOD Triglyc-576* HDL-33 CHOL/HD-7.8 
LDLmeas-145*
 
Brief Hospital Course:
#N/V/D: the pt p/w reported having several loose stools and 
sporadic vomiting throughout the past week prior to 
presentation. She also reported decreased po intake since 
___ with accompanying nausea/vomiting. Additionally, pt had 
hx suggestive of upper GI GVHD. She was started empirically on 
methylprednisolone 30 mg IV BID, in addition to her Budensonide 
3 mg PO TID, and cyclosporine 125 mg IV q12 for possible GVH 
colitis. Zofran and omeprazole were ordered for her 
nausea/vomiting.  Stools were sent for o&p, bact cultures, viral 
cultures, and clostridium difficile toxin.  Due to her 
continuing diarrhea, CT abdomen done on HD3 which showed 
uncomplicated ileocolitis with continuous involvement of distal 
ileum up to proximal transverse colon just beyond the hepatic 
flexure, suggestive of graft versus host disease or 
infectious/inflammatory etiologies.  The pt. was placed NPO on 
HD3 for colonoscopy, but given her poor PO intake while in the 
hospital, was evaluated and started on TPN by HD4.   While on 
the high dose steroids, the pt's diarrhea did not improve much, 
and she wast started on empiric abx therapy with metronidazole  
500 mg IV qday and levofloxacin 750 mg IV qday (as she was 
allergic to cefepime/possibly penicillins) on HD4.  Stool 
studies all came back negative for infectious etiologies of her 
diarrhea.  Bx results from her colonoscopy were negative for CMV 
but positive for severe graft versus host colitis throughout the 
colon.  Her antibiotics were discontinued, and she was started 
on mycophenolate mofetil 1000 mg po BID and her cyclosporine was 
increased from 175 mg po BID to ___ qAM/qHS.  Her 
diarrhea began to improve, TPN was dc'd on HD 9, and she was 
discharged home on HD12 on CSA, MMF, and IV methylprednisolone 
for control of her GVH colitis.  
.  
#Hx of CML s/p alloSCT: she was continued on immunosuppressive 
therapy per above.  Additionally, she was continued on ppx 
therapy with changes in her home fluconazole to PO voriconazole 
___ concern of hepatic interaction, continuation of her 
Acyclovir 400 mg q12hr, Sulfameth/Trimethoprim DS 1 TAB PO MWF, 
and ursodiol 300 mg BID.  No further issues were encountered 
during her hospital stay.  She was discharghed home on 
acyclovir, and voriconazole.  SMX/TMP was held due to 
administration of pentamidine while in house.  Will f/u with her 
hematologist/oncologist as an outpatient for adjustment of her 
medications.
.  
#Hx of HTN: pt. had a hx of intractable htn while on 
cyclophosphamide.  Blood pressures were elevated in the 130-160 
SBP range while in house.  She was continued on her home 
nefidipine CR 90mg qday, and metoprolol tartrate 50 mg PO BID 
and discharged home on these medications. 
.
# Hx of hypomagnesemia:  secondary to CSA use.  Put on sliding 
scale magnesium repletion while in house.   Discharged on 
Magnesium oxide-Magnesium AA chelate 133 mg po TID. 
 
Medications on Admission:
Acyclovir 400 mg Tablet PO q8 hours  
Budesonide 3 mg Capsule PO TID  
Cyclosporine Modified [Neoral] 25 mg Capsule  
1 Capsule(s) by mouth twice a day dose is 175mg bid  
Fluconazole 200 mg Tablet PO BID  
Folic Acid 1 mg Tablet PO daily  
Lorazepam 0.5 mg Tablet ___ tabs PO daily  
Metoprolol Tartrate 100mg PO BID  
Nifedipine Extended Release 90mg PO daily  
Omeprazole 40 mg Capsule PO daily  
Ondansetron [ZOFRAN ODT] 8 mg Tablet PO q8H PRN nausea  
Prednisone 40 mg Tablet  
Sulfamethoxazole-Trimethoprim [Bactrim DS] 800 mg-160 mg Tablet 
3X/WEEK on ___  
Ursodiol 300 mg Capsule PO BID  
Docusate Sodium [Colace] 100 mg PO BID  
Magnesium Oxide-Mg AA Chelate [Mg-Plus-Protein] 133 mg Tablet PO 
TID  
Multivitamin 1 tab daily  
Senna 8.6 mg Tablet PO BID  

 
Discharge Medications:
1. Budesonide 3 mg Capsule, Sust. Release 24 hr Sig: One (1) 
Capsule, Sust. Release 24 hr PO TID (3 times a day).
Disp:*90 Capsule, Sust. Release 24 hr(s)* Refills:*2*
2. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).
Disp:*60 Tablet(s)* Refills:*2*
3. Methylprednisolone Sodium Succ 500 mg Recon Soln Sig: 40  mg  
Intravenous qAM.
Disp:*qs qs* Refills:*1*
4. Methylprednisolone Sodium Succ 500 mg Recon Soln Sig: Twenty 
(20) mg Intravenous qHS.
Disp:*qs qs* Refills:*2*
5. Nifedipine 90 mg Tablet Sustained Release Sig: One (1) Tablet 
Sustained Release PO DAILY (Daily): Hold for BP <100.  
6. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
7. Ursodiol 300 mg Capsule Sig: One (1) Capsule PO BID (2 times 
a day).  
8. Voriconazole 200 mg Tablet Sig: One (1) Tablet PO Q12H (every 
12 hours).
Disp:*60 Tablet(s)* Refills:*2*
9. Simethicone 80 mg Tablet, Chewable Sig: ___ Tablet, Chewables 
PO QID (4 times a day) as needed for gas.  
10. Mycophenolate Mofetil 500 mg Tablet Sig: Two (2) Tablet PO 
BID (2 times a day).
Disp:*120 Tablet(s)* Refills:*2*
11. Cyclosporine Modified 25 mg Capsule Sig: Three (3) Capsule 
PO Q12H (every 12 hours): Take with one 100 mg tablet to make 
dose 175mg every 12 hours.
Disp:*180 Capsules* Refills:*2*
12. Cyclosporine Modified 100 mg Capsule Sig: One (1) Capsule PO 
twice a day: Take with three 25mg tablets to make dose 175mg 
every 12 hours.
Disp:*60 Capsule(s)* Refills:*2*
13. Acyclovir 400 mg Tablet Sig: One (1) Tablet PO three times a 
day.  
14. Heparin Flush (10 units/ml) 2 mL IV PRN line flush 
Tunneled Access Line (e.g. ___), heparin dependent: Flush 
with 10 mL Normal saline followed by Heparin as above daily and 
PRN per lumen. 
15. Magnesium Oxide-Mg AA Chelate 133 mg Tablet Sig: One (1) 
Tablet PO three times a day. Tablet(s) 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Chronic Lymphocytic Leukemia status post allogenic stem cell 
transplant
Graft Versus Host Colitis
.
Secondary:
Hypertension
Hyperlipidemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent

 
Discharge Instructions:
You were admitted to the hospital due to nausea, vomiting, and 
diarrhea for several days duration.  You had a CT scan of you 
abdomen which showed inflammation.  You were given medications 
for a possible infection in your colon for several days, as well 
as medications for possible Graft Versus Host Disease of the 
colon.  You were evaluated by colon specialists 
(gastroenterologists) who performed a procedure to look at the 
inside of you colon and take biopsies (colonoscopy).  It was 
determined that your diarrhea was NOT from an infection, but due 
to Graft-Versus-Host-Disease (a complication that can happen in 
people with allogenic stem cell transplants).  You were placed 
on large doses of immunosuppressants (Methylprednisolone, 
Cyclosporin, Mycophenolate Mofetil, and Budenoside) to stop your 
immune system from attacking your colon.  Your diarrhea began to 
improve, you were placed on a full low bacteria diet, and 
discharged from the hospital.
.
Some of your medications have been changed:
Prednisone 20 mg <------- STOP TAKING THIS MEDICATION
Fluconazole 200 mg <----- STOP TAKING THIS MEDICATION
Bactrim DS 1 Tab <------- STOP TAKING THIS MEDICATION FOR NOW
Metoprolol Tartrate 100 mg 2x a day <----*** If this medication 
can be cut in half, take ___ a pill 2x a day.  If it cannot, DO 
NOT TAKE THIS MEDICATION****** 
.
You have been started on some new medications:
Methylprednisolone (a steroid): 40 mg IV every morning/ 20 mg 
every night
Mycophenolate Moefteil (an immune suppresant) 100 mg PO 2x a day 

Voriconazole 200 mg every 12 hours
Metoprolol Tartrate 50 mg 2x a day ****** IGNORE IF YOU ARE 
TAKING ABOVE METOPROLOL ___ tablets) *****
.
It has been a pleasure taking care of you ___!

 
Followup Instructions:
___
"
157,19940147,21938932," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
Nausea, vomiting and diarrhea
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old woman with CML, s/p allogeneic stem cell transplant 
(___) D 161 with post transplant period complicated by upper 
and lower GI GVH (biopsy ___, s/p treatment with 
steroids, currently on cyclosporine 25 in am,50 in pm and 
atovaquone, who presents with persistent nausea, vomiting, and 
diarrhea. Also notes to have possible worsening ecchymosis on 
forerms. She is admitted from clinic for steroid treatment and 
monitoring. Hct in clinic was 20.8 and she was transfused 2 
units blood. She was admitted from clinic for steroids and 
monitoring and to complete transfusions.
Presents with a 5 day hx of nausea, vomiting and 3 days of loose 
stools. Pthad been feeling unwell since ___. this 
started with abdominal pains in the central abdomen which were 
intermittent cramping pains lasting a few minutes and then 
returning. There was no radiation and at that point there was 
mild nausea and following breakfast vomited x1 non-bilious and 
no blood. The pain was associated with eating and drinking and 
had no relieving factors but worse when drinking water. The 
pains have been intermittent since and have been at worst a 
___. On ___ the pains and nausea persisted and 
vomited x1 in the same pattern after eating cereal.
___ vomited x1 with dinner and started having loose stools. 
She has opened bowels 2x per day -stool was not watery but a lot 
softer and there was no blood - she normally opens her bowels 
once per day. Appetite has not been good since her transplant 
and this was mildly worse over the past week. She notes 
abdominal pain today and is worse on mobilising. She has only 
had one bowel movement today. She has been able to drink 
sufficient fluids. At clinic, her ecchymoses on her arms were 
felt to be worse although the patient herself has not noticed a 
significant difference.
.
Review of Systems:
(+) Per HPI but notes continuing ""sniffles"" with some nasal 
congestion. Notes tingling in finger and in feet which has been 
present since her transplant.
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea. Denies 
chest pain or tightness, palpitations. Denies cough, worse 
shortness of breath, or wheezes. Denies constipation. No recent 
change in bladder habits. No dysuria or hematuria. Denies 
arthralgias or myalgias. Denies rashes or skin breakdown. No 
numbness. No feelings of depression or anxiety. All other review 
of systems negative.
 
Past Medical History:
Past Oncologic History:
- ___: Asymptomatic abnormal CBC noted by PCP during routine
visit
- ___: Bone marrow biopsy showed myeloproliferative
disorder, likely chronic myelogenous leukemia. Per patient
report, began taking interferon three times weekly shortly
after diagnosis.
- ___: Started ___ 400 mg daily. At some point
thereafter, her dose was increased to 600 mg daily
- ___: ___ increased to 400 mg twice daily with
hydroxyurea and allopurinol
- ___: Seen at ___, found to be
in late chronic phase CML. Stem cell transplant was
recommended, but she did not wish to pursue this course.
- ___: Gleevec held due to worsening anemia and
thrombocytosis. Started on Nilotinib
- ___: Nilotinib held due to QTC prolongation, started on
Dasatinib
- ___: First seen at ___. Bone marrow biopsy showed
accelerated phase CML. began induction chemo with 7+3.
- ___: Admission for MRD SCT
- ___: Discharged on day +32. Transplant complicated by
mucositis with biopsy of the esophagus suggesting upper GI
GVHD which was treated with steroids.
- ___: Admission for GVH of the gut, verified by biopsy
on ___
- ___: Discharge on methylprednisolone and cyclosporine
.
Other Past Medical History:
- CML diagnosed in ___ - had a siblinng allo SCT in ___
- atherosclerotic coronary vascular disease - no angina
- status post CABG in ___
- hypertension
- hyperlipidemia
- DVT in L leg ___ years ago - was seemingly treated for this and 
occurred after hitting her foot?
P Surgical Hx
- Right ankle surgery in ___
- Total abdominal hysterectomy in ___
- Appendectomy at age ___
No problems with GA
 
Social History:
___
Family History:
- father - died of MI, nil other health problems
- mother - had heart problems, DM
Four siblings
- 2 bothers had CABG
- 1 brother prostate cancer
- Her sister ___ is her donor and is well
 
Physical Exam:
VS: T 97.8 BP 122/78 HR 118 RR18 sO2 99% RA weight 133lb
GENERAL: Fatigued, pleasant, conversant, well groomed, in no 
acute distress
HEENT: EOMI, PERRL 3+/3+ sclera anicteric, oropharynx moist and 
without lesions, tongue coated with no thrush
NECK: Without masses, thyromegaly
LYMPH: No cervical, supraclavicular, axillary, inguinal 
lymphadenopathy
RS: Respirations unlabored. Clear to auscultation bilaterally
___: Regular rate and rhythm, normal S1 and S2, no murmurs, 
rubs, or gallops no carotid bruits. JVP mildly depressed at 2cm 
above sternal angle.
GIS: Soft, non-tender, non-distended. Normal bowel sounds. No 
hepatosplenomegaly
EXT: No clubbing, cyanosis, brittle nails with 1+ pitting edema 
to mid-shins bilaterally
SKIN: ecchymosis on forearms bilaterally - pt states not new.
CNS:
Alert and oriented x3
Some wasting of proximal musculature secondary to general disuse 
followinng transplant - having ___.
Tone normal UL and LL
Reflexes normal in UL and lower limb save absent AJs 
bilaterally. Plantar reflexes are flexor bilaterally.
Power difficult to assess as some give way weakness but somme 
mild 4+/5 weakness in shoulder abduction, 4+/5 in elbow 
extension on R, bilateral ___ worse on R finger extension, ___ 
bilateral hip flexion, 4+/5 knee extension on R and otherwise 
normal power. Mild generalised weakness.
Decreased temp sensation to knee on R and mid shin on L, normal 
vibration sensation and light touch otherwise.
CN II- XII normal save intorsion of left eye in primary 
position. Fields generally normal but poor participation.
 
Pertinent Results:
___ 01:25PM BLOOD WBC-4.7 RBC-2.14* Hgb-7.1* Hct-20.2* 
MCV-94 MCH-33.0* MCHC-35.0 RDW-23.0* Plt ___
___ 06:00AM BLOOD WBC-2.2*# RBC-2.36* Hgb-7.3* Hct-20.5* 
MCV-87# MCH-30.9 MCHC-35.5* RDW-23.2* Plt Ct-60*
___ 09:20AM BLOOD WBC-2.2* RBC-2.46* Hgb-7.6* Hct-21.6* 
MCV-88 MCH-30.8 MCHC-35.0 RDW-23.4* Plt Ct-64*
___ 08:45PM BLOOD Hct-26.1*
___ 07:45AM BLOOD WBC-1.9* RBC-2.97* Hgb-9.2* Hct-26.3* 
MCV-89 MCH-30.9 MCHC-34.9 RDW-21.0* Plt Ct-59*
___ 06:30AM BLOOD WBC-2.5* RBC-3.29* Hgb-9.9* Hct-29.1* 
MCV-89 MCH-30.3 MCHC-34.1 RDW-19.9* Plt Ct-61*
___ 01:25PM BLOOD Neuts-61 Bands-6* Lymphs-16* Monos-13* 
Eos-0 Baso-0 ___ Metas-3* Myelos-1* NRBC-4*
___ 06:00AM BLOOD Neuts-67 Bands-6* ___ Monos-4 Eos-1 
Baso-0 ___ Metas-2* Myelos-1*
___ 09:20AM BLOOD Neuts-68 Bands-0 Lymphs-15* Monos-9 Eos-0 
Baso-0 Atyps-1* Metas-1* Myelos-6* NRBC-2*
___ 07:45AM BLOOD Neuts-55 Bands-8* ___ Monos-5 Eos-0 
Baso-0 ___ Metas-6* Myelos-7* NRBC-2*
___ 06:30AM BLOOD Neuts-64 Bands-1 Lymphs-12* Monos-5 Eos-0 
Baso-0 ___ Metas-16* Myelos-1* Other-1*
___ 01:25PM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-2+ Tear Dr-1+ 
Ellipto-OCCASIONAL
___ 06:00AM BLOOD Hypochr-2+ Anisocy-3+ Poiklo-2+ 
Macrocy-2+ Microcy-1+ Polychr-1+ Ovalocy-1+ Schisto-OCCASIONAL 
Tear Dr-1+
___ 09:20AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-OCCASIONAL Microcy-OCCASIONAL Polychr-OCCASIONAL 
Ovalocy-OCCASIONAL Tear Dr-OCCASIONAL
___ 07:45AM BLOOD Hypochr-NORMAL Anisocy-3+ Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-2+
___ 06:30AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-2+ 
Macrocy-1+ Microcy-2+ Polychr-1+ Target-OCCASIONAL Stipple-1+ 
Tear Dr-1+ Fragmen-OCCASIONAL
___ 06:30AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-2+ 
Macrocy-1+ Microcy-2+ Polychr-1+ Target-OCCASIONAL Stipple-1+ 
Tear Dr-1+ Fragmen-OCCASIONAL
___ 06:00AM BLOOD ___ PTT-24.7 ___
___ 07:45AM BLOOD ___ PTT-21.5* ___
___ 06:30AM BLOOD ___ PTT-21.5* ___
___ 07:45AM BLOOD Ret Aut-5.1*
___ 01:25PM BLOOD ___ ___
___ 06:00AM BLOOD ___
___ 01:25PM BLOOD UreaN-17 Creat-0.7 Na-138 K-4.0 Cl-105 
HCO3-24 AnGap-13
___ 06:00AM BLOOD Glucose-133* UreaN-11 Creat-0.5 Na-142 
K-4.0 Cl-110* HCO3-22 AnGap-14
___ 07:45AM BLOOD Glucose-101* UreaN-18 Creat-0.5 Na-140 
K-3.6 Cl-110* HCO3-22 AnGap-12
___ 06:30AM BLOOD Glucose-146* UreaN-23* Creat-0.6 Na-142 
K-4.1 Cl-108 HCO3-23 AnGap-15
___ 01:25PM BLOOD ALT-63* AST-46* LD(___)-358* AlkPhos-87 
TotBili-0.7
___ 06:00AM BLOOD ALT-65* AST-40 LD(___)-301* AlkPhos-74 
TotBili-0.7
___ 07:45AM BLOOD ALT-89* AST-54* LD(LDH)-334* AlkPhos-82 
TotBili-0.6
___ 06:30AM BLOOD ALT-145* AST-76* LD(LDH)-366* AlkPhos-105 
TotBili-0.6
___ 01:25PM BLOOD Albumin-4.0 Calcium-9.1 Phos-3.6 Mg-1.6
___ 06:00AM BLOOD Albumin-3.4* Calcium-8.3* Phos-4.3 
Mg-1.5*
___ 07:45AM BLOOD Albumin-3.3* Calcium-8.9 Phos-4.2 Mg-1.6
___ 06:30AM BLOOD Albumin-3.7 Calcium-8.9 Phos-4.0 Mg-1.5*
___ 07:45AM BLOOD Hapto-117
___ 06:00AM BLOOD Cyclspr-LESS THAN 
___ 06:30AM BLOOD Cyclspr-44*
___ 09:45AM BLOOD Cyclspr-LESS THAN 
.
.
Urine
.
___ 03:13AM URINE RBC-0 WBC-3 Bacteri-FEW Yeast-NONE Epi-<1
___ 03:13AM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-MOD
___ 03:13AM URINE Color-Straw Appear-Clear Sp ___
.
.
Cardiology ReportECGStudy Date of ___  7:20:40 ___
 
Sinus rhythm. Poor R wave progression may be a normal variant. 
Otherwise,
normal tracing. Compared to the previous tracing of ___ no 
significant
change.
.
.
Microbiology
.
___ 1:25 pm Immunology (CMV)

   CMV Viral Load (Pending): 
.

___ 3:13 am URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      ENTEROBACTER AEROGENES.    >100,000 ORGANISMS/ML.. 
         This organism may develop resistance to third 
generation
         cephalosporins during prolonged therapy. Therefore, 
isolates that
         are initially susceptible may become resistant within 
three to
         four days after initiation of therapy.  For serious 
infections,
         repeat culture and sensitivity testing may therefore be 
warranted
         if third generation cephalosporins were used. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ENTEROBACTER AEROGENES
                             |   
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------   128 R
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S
.
BC ___ x2 pending - no growth to date
.
___ 9:57 am STOOL     CONSISTENCY: SOFT
      Source: Stool OVA AND PARASITES 1 OF 3. 

                            **FINAL REPORT ___

   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA 
FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 
 
Brief Hospital Course:
___ with CML, s/p allogeneic SCT D 163 (on discharge) with 
post-transplant period complicated by upper and lower GI GVH 
(biopsy ___, s/p treatment with steroids, currently on 
cyclosporin 50 in am, 25 in pm and atovaquone, who presents with 
persistent nausea, vomitting, and diarrhea. Anemic on 
presentation and transfused 2 units of RCC and following a 
seemingly inadequate response on lab tests received a further 2 
units. Started on IV methylprednisolone for ? GVHD and converted 
to an oral steroid taper. Cyclosporin level increased due to low 
level. Deranged LFTs noted and will be repeated in community. 
Found to have an enterobacter UTI and commenced on a 3 days 
course of oral levofloxacin.
.
#Nausea, vomiting and diarrhea: Presented with 5 days of 
symptoms which were improving on admission. For concerns of GVHD 
(see previous history) she was started on IV methylprednisolone 
30mg bid and this was converted to an oral prednisone taper 
following resolution of symptoms by the day after admission. PRN 
ondansetron for nausea. She was found to have moderate LeukE on 
UA although there were only 3WBCs on urine microscopy. She was 
commenced on a 3-day course of oral levofloxacin for her UTI 
(note sensitive to ciprofloxacin on sensitivity testing). Stool 
cultures were negative.
.
#Anemia: She was noted to have a Hb/Hct of 7.1/20.2 in clinic 
and was transfused 2 units RCC. Post transfusion HCt was only 
20.5 (cause unclear) and she received a further 2 units RCC with 
post transfusion labs Hb 9.9 HCt 29.1. Retic count was suitably 
elevated for degree of anemia and other hemolysis screen was 
negative.
.
# CML #/p stem cell transplant: continue acyclovir 400 mg Tablet 
q8 and atovaquone [Mepron] 750 mg/5 mL Suspension 10 ml by mouth 
daily. Will follow with Dr ___ on ___.
.
# Possible GVHD: Her symptoms were thought to perhaps represent 
mild GVHD although the presence of a UTI may be the cause. She 
was started on a IV methylprednisolone and converted to an oral 
steroid taper. Her cyclosporin dose was increased to 50mg am 
75mg pm following a low cyclosporin level of <30. Continued 
budesonide.
.
#Elevated LFTs: She was noted to have deranged LFTs on admission 
which were not present on previous laboratory testing. There was 
evidence of a transaminitis and increased during admission. She 
will have her blood repeated on ___ with results faxed to Dr 
___.
.
# Likely peripheral neuropathy: Tingling in hands and feet, 
absent AJs and decreased temp sensation to mid shins 
bilaterally. Likely secondary to chemo.
.
#HTN: continued metoprolol tartrate 50 mg Tablet bid and 
nifedipine [Nifediac CC] 90 mg Tablet Sustained Release DAILY
 
Medications on Admission:
-acyclovir 400 mg Tablet q8
-atovaquone [Mepron] 750 mg/5 mL Suspension 10 ml by mouth daily
-budesonide [Entocort EC] 3 mg Capsule, Sust. Release 24 hr TID
-cyclosporine modified [Neoral] 25 mg Capsule; 1 capsule in the 
morning and 2 capsules at night
-lorazepam 0.5 mg Tablet, ___ Tablet(s) by mouth once a day
-metoprolol tartrate 50 mg Tablet bid
-nifedipine [Nifediac CC] 90 mg Tablet Sustained Release DAILY
-omeprazole 20 mg Capsule, 2 Capsule(s) by mouth DAILY (Daily)
-docusate sodium [Colace] 100 mg Capsule bid prn
-magnesium oxide-Mg AA chelate [Mg-Plus-Protein] 133 mg Tablet, 
2 Tablet(s) by mouth twice a day
-senna 8.6 mg Tablet, 1 Tablet(s) by mouth twice a day as needed 
for constipation
- Multivitamin 1 tab daily
 
Discharge Medications:
1. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours).  
2. budesonide 3 mg Capsule, Sust. Release 24 hr Sig: One (1) 
Capsule, Sust. Release 24 hr PO TID (3 times a day).  
3. lorazepam 0.5 mg Tablet Sig: ___ Tablets PO DAILY (Daily).  
4. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
5. nifedipine 30 mg Tablet Sustained Release Sig: Three (3) 
Tablet Sustained Release PO DAILY (Daily).  
6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day) as needed for constipation.  
8. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
9. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
10. magnesium oxide 140 mg Capsule Sig: Two (2) Capsule PO BID 
(2 times a day).  
11. atovaquone 750 mg/5 mL Suspension Sig: Two (2)  PO DAILY 
(Daily).  
12. cyclosporine modified 25 mg Capsule Sig: Two (2) Capsule PO 
QAM (once a day (in the morning)).  
13. cyclosporine modified 25 mg Capsule Sig: Three (3) Capsule 
PO QPM (once a day (in the evening)).  
14. prednisone 20 mg Tablet Sig: Two (2) Tablet PO bid () for 1 
days.
Disp:*2 Tablet(s)* Refills:*0*
15. prednisone 10 mg Tablet Sig: Three (3) Tablet PO bid () for 
1 days.
Disp:*6 Tablet(s)* Refills:*0*
16. prednisone 10 mg Tablet Sig: Two (2) Tablet PO bid () for 1 
days.
Disp:*4 Tablet(s)* Refills:*0*
17. prednisone 10 mg Tablet Sig: One (1) Tablet PO bid () for 1 
days.
Disp:*2 Tablet(s)* Refills:*0*
18. levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H 
(every 24 hours) for 3 days.
Disp:*3 Tablet(s)* Refills:*0*
19. Outpatient Lab Work
CBC, LFTs (Bili, Alk Phos, AST, ALT, Albumin) ___, PTT, INR and 
Chem7 to be taken on ___.
Please faxe F.A.O Dr ___ ___ 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
UTI
Anemia requiring transfusion
Deranged LFTs ? cause - will need repeated
Nausea, vomiting and diarrhea ? GVHD
.
Secondary diagnoses:
CML post siblinng allo SCT in ___ complicated by gut GVHD
atherosclerotic coronary vascular disease
s/p CABG in ___
hypertension
hyperlipidemia
s/p DVT in L leg 
s/p Right ankle surgery
s/p Total abdominal hysterectomy
s/p Appendectomy

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted following 5 days of nausea, vomiting and 
softer stools. Your blood tests showed anemia and you received 2 
units of blood. For some reason, your repeat blood count was not 
quite high enough and the day after admission you received a 
further 2 units of blood. Your symptoms quickly resolved and 
your post-transfusion blood count was good. It was initially 
felt that  although mild, your symptoms have have been due to 
GVHD and you were started on IV steroids and this was changed to 
oral prednisone which we are tapering down. You were found to 
have a low cyclosporin level and your cyclosporin was increased. 
Your urine had some bacteria in it which may have been the cause 
of your symptoms ___ will be treated with 3 days of 
antibiotics (levofloxacin) for this. You were found to have 
mildly abnormal liver function tests and you should have these 
repeated on ___ and the result should be faxed to Dr ___. 
You have an appointment to see Mr ___ NP on ___ who will 
review you and an appointment to see Dr ___ on ___. we 
will call you tonight regarding whether you need to take a 
different dose of your cyclosporin following today's level. 

Changes to medications:
We increased your cyclosporin to 50mg in the morning and 75mg at 
night
Started oral prednisone which we are tapering down you should 
take 40mg this pm, 30mg twice daily on ___, 20mg twice daily 
on ___ and 10mg twice daily on ___ after which you will stop. 

Instructions:
If you have further symptoms or spike a fever please contact 
your primary oncologist, or, if out of hours, the BMT Fellow on 
call.
You should have your blood tests repeated on ___ locally and 
faxed to Dr ___ on ___.
 
Followup Instructions:
___
"
158,19940147,22634597," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
Elevated LFTs
 
Major Surgical or Invasive Procedure:
Left brachial PICC inserted ___
Right 3 lumen CVC inserted ___
central line placement
bone marrow biopsy

 
History of Present Illness:
___ year old woman with CML, s/p allogeneic stem cell transplant 
(___), with post transplant period complicated by upper 
and lower GI GVH (biopsy ___, s/p treatment with 
steroids, cyclosporine, and atovaquone. She was recently 
admitted with nausea, vomiting, and diarrhea from ___ to 
___. She responded to steroid and discharged with deemed 
diagnosis of ""GVHD"". Opon discharged, her LFTS was noticed to be 
trending up. Today, on routine follow up, her LFTs continued to 
trend up, and she will be admitted for suspicion of GVHD and 
further management. 
 
Past Medical History:
Past Oncologic History:
- ___: Asymptomatic abnormal CBC noted by PCP during routine
visit
- ___: Bone marrow biopsy showed myeloproliferative
disorder, likely chronic myelogenous leukemia. Per patient
report, began taking interferon three times weekly shortly
after diagnosis.
- ___: Started Gleevec 400 mg daily. At some point
thereafter, her dose was increased to 600 mg daily
- ___: Gleevec increased to 400 mg twice daily with
hydroxyurea and allopurinol
- ___: Seen at ___, found to be
in late chronic phase CML. Stem cell transplant was
recommended, but she did not wish to pursue this course.
- ___: Gleevec held due to worsening anemia and
thrombocytosis. Started on Nilotinib
- ___: Nilotinib held due to QTC prolongation, started on
Dasatinib
- ___: First seen at ___. Bone marrow biopsy showed
accelerated phase CML. began induction chemo with 7+3.
- ___: Admission for MRD SCT
- ___: Discharged on day +32. Transplant complicated by
mucositis with biopsy of the esophagus suggesting upper GI
GVHD which was treated with steroids.
- ___: Admission for GVH of the gut, verified by biopsy
on ___
- ___: Discharge on methylprednisolone and cyclosporine
.
Other Past Medical History:
- CML diagnosed in ___ - had a siblinng allo SCT in ___
- atherosclerotic coronary vascular disease - no angina
- status post CABG in ___
- hypertension
- hyperlipidemia
- DVT in L leg ___ years ago - was seemingly treated for this and 
occurred after hitting her foot?
P Surgical Hx
- Right ankle surgery in ___
- Total abdominal hysterectomy in ___
- Appendectomy at age ___
No problems with GA
 
Social History:
___
Family History:
- father - died of MI, nil other health problems
- mother - had heart problems, DM
Four siblings
- 2 bothers had CABG
- 1 brother prostate cancer
- Her sister ___ is her donor and is well
 
Physical Exam:
VS: T 97.8 BP 116/65 HR 108 RR18 sO2 98% RA 
GENERAL: Pleasant, conversant, well groomed, in no 
acute distress. 
HEENT: EOMI, PERRL, sclera anicteric, oropharynx moist and 
without lesions, tongue coated with no thrush. 
NECK: Without masses, thyromegaly
LYMPH: No cervical, supraclavicular, axillary, inguinal 
lymphadenopathy
RS: Respirations unlabored. Clear to auscultation bilaterally
___: Regular rate and rhythm, normal S1 and S2, no murmurs, 
rubs, or gallops no carotid bruits. JVP mildly depressed at 2cm 
above sternal angle.
GI: Soft, non-tender, non-distended. Normal bowel sounds. No 
hepatosplenomegaly
EXT: No clubbing, cyanosis, brittle nails with 1+ pitting edema 
to mid-shins bilaterally
SKIN: ecchymosis on forearms bilaterally.
NEURO: Alert and oriented x3. Wasting of proximal musculature. 
CN II- XII grossly normal, nonfocal.
.
GEN: [x]NAD []Cachectic  
SKIN: [x]WNL--> has ecchymoses, looking lighter, lesion healing 
well, line looks good  
HEENT: [x]Anicteric [x]MMM [x]OP Clear [x]No LAD  
CV: [x]RRR [x]NML S1 S2 [x]no g/m/r [x]no JVD  
RESP: [x]CTAB [x]no wheezes/rhonchi/rales  
ABD: [x]S/NT/ND [x]+BS [x]No HSM  
EXT: [x]No CCE [x] +2 DP B/L  
NEURO: [x]A&Ox3 [x]CN2-12 intact [x] motor [x] sensory [x]coord 
[x]language normal  

 
Pertinent Results:
___ 12:00AM BLOOD WBC-2.5* RBC-2.79* Hgb-9.5* Hct-26.4* 
MCV-95 MCH-34.1* MCHC-36.0* RDW-22.6* Plt Ct-58*
___ 05:14PM BLOOD WBC-3.9* RBC-3.04*# Hgb-9.8*# Hct-28.0*# 
MCV-92 MCH-32.1* MCHC-34.8 RDW-21.1* Plt Ct-58*
___ 12:00AM BLOOD WBC-2.7* RBC-2.24* Hgb-7.5* Hct-21.0* 
MCV-94 MCH-33.3* MCHC-35.5* RDW-22.9* Plt Ct-53*
___ 12:00AM BLOOD WBC-4.3 RBC-2.59* Hgb-8.5* Hct-24.1* 
MCV-93 MCH-32.9* MCHC-35.4* RDW-22.6* Plt Ct-56*
___ 12:00AM BLOOD WBC-6.3 RBC-2.75* Hgb-8.8* Hct-25.6* 
MCV-93 MCH-31.9 MCHC-34.2 RDW-21.2* Plt Ct-60*
___ 08:14PM BLOOD WBC-7.2 RBC-2.68* Hgb-8.8* Hct-25.1* 
MCV-94 MCH-32.7* MCHC-35.0 RDW-21.6* Plt Ct-54*
___ 12:00AM BLOOD WBC-12.2* RBC-3.04* Hgb-9.6* Hct-28.2* 
MCV-93 MCH-31.8 MCHC-34.3 RDW-20.4* Plt Ct-65*
___ 12:00AM BLOOD WBC-9.1 RBC-2.93* Hgb-9.6* Hct-28.1* 
MCV-96 MCH-32.6* MCHC-34.0 RDW-21.1* Plt Ct-66*
___ 12:00AM BLOOD WBC-8.8 RBC-2.79* Hgb-9.2* Hct-25.7* 
MCV-92 MCH-32.9* MCHC-35.7* RDW-20.8* Plt Ct-60*
___ 12:00AM BLOOD WBC-8.2 RBC-3.06* Hgb-9.8* Hct-28.5* 
MCV-93 MCH-31.9 MCHC-34.3 RDW-20.8* Plt Ct-67*
___ 06:50AM BLOOD WBC-7.0 RBC-3.02* Hgb-9.6* Hct-27.8* 
MCV-92 MCH-31.9 MCHC-34.6 RDW-20.6* Plt Ct-61*
___ 12:00AM BLOOD WBC-10.7# RBC-3.55* Hgb-11.3* Hct-32.6* 
MCV-92 MCH-31.7 MCHC-34.5 RDW-19.8* Plt ___
___ 09:30AM BLOOD WBC-5.1# RBC-3.27* Hgb-10.6* Hct-29.3* 
MCV-90 MCH-32.4* MCHC-36.1* RDW-19.9* Plt Ct-72*
___ 12:14AM BLOOD WBC-2.9* RBC-3.05* Hgb-9.8* Hct-27.9* 
MCV-92 MCH-32.3* MCHC-35.3* RDW-19.9* Plt Ct-75*
___ 12:05AM BLOOD WBC-3.1* RBC-3.56* Hgb-11.4* Hct-32.3* 
MCV-91 MCH-31.9 MCHC-35.2* RDW-19.7* Plt ___
___ 05:50AM BLOOD WBC-4.6# RBC-4.10* Hgb-12.5 Hct-35.6* 
MCV-87 MCH-30.4 MCHC-35.1* RDW-18.7* Plt ___
___ 05:45AM BLOOD WBC-2.8* RBC-3.66* Hgb-11.5* Hct-32.7* 
MCV-89 MCH-31.5 MCHC-35.3* RDW-19.9* Plt Ct-88*
___ 06:00AM BLOOD WBC-2.2* RBC-3.50* Hgb-11.2* Hct-31.5* 
MCV-90 MCH-31.9 MCHC-35.4* RDW-20.4* Plt Ct-71*
___ 09:05AM BLOOD WBC-2.4* RBC-3.62* Hgb-11.0* Hct-32.2* 
MCV-89 MCH-30.5 MCHC-34.3 RDW-19.7* Plt Ct-65*
___ 06:00AM BLOOD WBC-3.6*# RBC-3.43* Hgb-11.1* Hct-30.9* 
MCV-90 MCH-32.2* MCHC-35.8* RDW-20.8* Plt Ct-70*
___ 03:00PM BLOOD WBC-8.2# RBC-4.36# Hgb-13.1# Hct-38.6# 
MCV-88 MCH-30.0 MCHC-34.0 RDW-20.1* Plt ___
___ 12:00AM BLOOD Neuts-69 Bands-8* Lymphs-13* Monos-2 
Eos-0 Baso-0 Atyps-2* Metas-3* Myelos-3* NRBC-6*
___ 12:00AM BLOOD Neuts-80* Bands-3 Lymphs-6* Monos-6 Eos-0 
Baso-0 ___ Metas-2* Myelos-3* NRBC-1*
___ 12:00AM BLOOD Neuts-83* Bands-4 Lymphs-3* Monos-7 Eos-0 
Baso-0 Atyps-1* Metas-1* Myelos-1* NRBC-2*
___ 12:00AM BLOOD Neuts-93* Bands-2 Lymphs-2* Monos-1* 
Eos-0 Baso-0 ___ Metas-1* Myelos-1*
___ 08:14PM BLOOD Neuts-88* Bands-4 Lymphs-3* Monos-4 Eos-0 
Baso-0 ___ Metas-1* Myelos-0
___ 12:00AM BLOOD Neuts-85* Bands-3 Lymphs-5* Monos-1* 
Eos-0 Baso-0 ___ Metas-3* Myelos-2* Promyel-1*
___ 12:00AM BLOOD Neuts-78* Bands-13* Lymphs-4* Monos-1* 
Eos-0 Baso-0 ___ Metas-4* Myelos-0 NRBC-1*
___ 12:00AM BLOOD Neuts-90* Bands-2 Lymphs-1* Monos-2 Eos-0 
Baso-0 Atyps-1* Metas-3* Myelos-1* Promyel-0
___ 12:00AM BLOOD Neuts-72* Bands-8* Lymphs-7* Monos-3 
Eos-0 Baso-0 ___ Metas-8* Myelos-2*
___ 06:50AM BLOOD Neuts-59 Bands-11* Lymphs-10* Monos-2 
Eos-0 Baso-0 Atyps-1* Metas-13* Myelos-4*
___ 12:00AM BLOOD Neuts-71* Bands-0 Lymphs-9* Monos-4 Eos-0 
Baso-0 ___ Metas-8* Myelos-8* NRBC-4*
___ 12:14AM BLOOD Neuts-73* Bands-1 Lymphs-9* Monos-7 Eos-1 
Baso-0 Atyps-1* Metas-5* Myelos-3* NRBC-1*
___ 05:50AM BLOOD Neuts-61 Bands-9* Lymphs-5* Monos-15* 
Eos-0 Baso-0 Atyps-3* Metas-3* Myelos-3* Promyel-1* NRBC-2*
___ 05:45AM BLOOD Neuts-58 Bands-12* Lymphs-9* Monos-12* 
Eos-0 Baso-0 Atyps-1* Metas-2* Myelos-3* Promyel-3*
___ 06:00AM BLOOD Neuts-59 Bands-7* Lymphs-13* Monos-17* 
Eos-0 Baso-0 Atyps-3* ___ Myelos-1*
___ 09:05AM BLOOD Neuts-74* Bands-1 Lymphs-17* Monos-7 
Eos-0 Baso-0 ___ Myelos-1*
___ 03:00PM BLOOD Neuts-61 Bands-4 Lymphs-9* Monos-14* 
Eos-1 Baso-0 Atyps-1* Metas-3* Myelos-7* NRBC-1*
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ 
Macrocy-3+ Microcy-1+ Polychr-1+ Spheroc-2+ Ovalocy-1+ 
Schisto-1+ Stipple-OCCASIONAL Tear Dr-1+
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ 
Macrocy-2+ Microcy-1+ Polychr-1+ Spheroc-1+ Ovalocy-1+ 
Schisto-1+ Stipple-OCCASIONAL Tear Dr-1+
___ 08:14PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-NORMAL Polychr-OCCASIONAL Tear Dr-1+
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-NORMAL 
Macrocy-2+ Microcy-NORMAL Polychr-1+
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-NORMAL 
Macrocy-3+ Microcy-NORMAL Polychr-1+
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-NORMAL 
Macrocy-2+ Microcy-1+ Polychr-OCCASIONAL Spheroc-OCCASIONAL 
Schisto-OCCASIONAL
___ 06:50AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ 
Macrocy-1+ Microcy-OCCASIONAL Polychr-1+ Ovalocy-1+ Target-1+
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL 
Macrocy-1+ Microcy-NORMAL Polychr-NORMAL
___ 12:14AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ 
Macrocy-1+ Microcy-1+ Polychr-1+ Spheroc-1+ Ovalocy-1+ 
Schisto-OCCASIONAL Tear Dr-1+
___ 05:45AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-1+ Polychr-NORMAL Tear ___
___ 06:00AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-1+ Polychr-NORMAL Tear ___
___ 09:05AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-1+ 
Macrocy-NORMAL Microcy-1+ Polychr-NORMAL Ovalocy-1+ 
Stipple-OCCASIONAL Tear Dr-1+
___ 03:00PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-1+ Polychr-OCCASIONAL Ovalocy-OCCASIONAL 
Schisto-OCCASIONAL Tear ___
___ 12:00AM BLOOD ___ PTT-23.4 ___
___ 12:00AM BLOOD ___ PTT-24.6 ___
___ 12:00AM BLOOD ___ PTT-24.3 ___
___ 12:00AM BLOOD ___ PTT-23.6 ___
___ 08:14PM BLOOD ___ PTT-24.6 ___
___ 12:00AM BLOOD ___ PTT-24.2 ___
___ 12:00AM BLOOD ___ PTT-24.2 ___
___ 12:00AM BLOOD ___ PTT-24.8 ___
___ 12:00AM BLOOD ___ PTT-30.9 ___
___ 06:50AM BLOOD ___ PTT-23.1 ___
___ 12:00AM BLOOD ___ PTT-30.6 ___
___ 12:14AM BLOOD ___ PTT-27.5 ___
___ 10:40AM BLOOD ___ PTT-28.6 ___
___ 05:50AM BLOOD ___ PTT-22.1 ___
___ 05:45AM BLOOD ___ PTT-23.0 ___
___ 06:00AM BLOOD ___ PTT-23.7 ___
___ 09:05AM BLOOD ___ PTT-23.0 ___
___ 03:00PM BLOOD ___ ___
___ 12:00AM BLOOD Glucose-156* UreaN-22* Creat-0.3* Na-133 
K-4.4 Cl-103 HCO3-23 AnGap-11
___ 12:00AM BLOOD Glucose-150* UreaN-20 Creat-0.3* Na-134 
K-3.9 Cl-105 HCO3-24 AnGap-9
___ 12:00AM BLOOD Glucose-175* UreaN-20 Creat-0.3* Na-135 
K-3.9 Cl-105 HCO3-24 AnGap-10
___ 12:00AM BLOOD Glucose-195* UreaN-20 Creat-0.3* Na-135 
K-3.9 Cl-105 HCO3-23 AnGap-11
___ 08:14PM BLOOD Glucose-190* UreaN-19 Creat-0.3* Na-134 
K-3.7 Cl-107 HCO3-22 AnGap-9
___ 12:00AM BLOOD Glucose-192* UreaN-21* Creat-0.4 Na-135 
K-3.7 Cl-107 HCO3-20* AnGap-12
___ 12:00AM BLOOD Glucose-177* UreaN-18 Creat-0.3* Na-130* 
K-3.9 Cl-103 HCO3-20* AnGap-11
___ 12:00AM BLOOD Glucose-185* UreaN-14 Creat-0.3* Na-135 
K-4.0 Cl-105 HCO3-23 AnGap-11
___ 12:00AM BLOOD Glucose-189* UreaN-13 Creat-0.3* Na-135 
K-3.5 Cl-103 HCO3-22 AnGap-14
___ 06:50AM BLOOD Glucose-127* UreaN-15 Creat-0.3* Na-132* 
K-3.9 Cl-104 HCO3-24 AnGap-8
___ 12:00AM BLOOD Glucose-171* UreaN-18 Creat-0.4 Na-133 
K-3.3 Cl-101 HCO3-23 AnGap-12
___ 12:14AM BLOOD Glucose-157* UreaN-22* Creat-0.4 Na-132* 
K-3.9 Cl-104 HCO3-21* AnGap-11
___ 12:05AM BLOOD Glucose-188* UreaN-32* Creat-0.6 Na-132* 
K-3.6 Cl-104 HCO3-19* AnGap-13
___ 05:50AM BLOOD Glucose-155* UreaN-28* Creat-0.6 Na-134 
K-3.8 Cl-104 HCO3-20* AnGap-14
___ 05:45AM BLOOD Glucose-174* UreaN-21* Creat-0.5 Na-136 
K-4.1 Cl-106 HCO3-22 AnGap-12
___:00AM BLOOD Glucose-122* UreaN-15 Creat-0.5 Na-137 
K-4.1 Cl-105 HCO3-23 AnGap-13
___ 09:05AM BLOOD Glucose-96 UreaN-21* Creat-0.5 Na-139 
K-3.7 Cl-109* HCO3-22 AnGap-12
___ 06:00AM BLOOD Glucose-103* UreaN-18 Creat-0.5 Na-139 
K-4.2 Cl-109* HCO3-22 AnGap-12
___ 03:00PM BLOOD UreaN-23* Creat-0.6 Na-139 K-3.2* Cl-105 
HCO3-21* AnGap-16
___ 12:00AM BLOOD ALT-146* AST-48* LD(___)-353* 
AlkPhos-116* TotBili-1.5
___ 12:00AM BLOOD ALT-149* AST-46* LD(___)-296* 
AlkPhos-118* TotBili-0.8
___ 12:00AM BLOOD ALT-170* AST-53* LD(LDH)-308* 
AlkPhos-133* TotBili-0.9
___ 12:00AM BLOOD ALT-162* AST-47* LD(LDH)-302* 
AlkPhos-135* TotBili-0.8
___ 08:14PM BLOOD ALT-170* AST-48* LD(LDH)-305* 
AlkPhos-133* TotBili-0.7
___ 12:00AM BLOOD ALT-199* AST-58* LD(___)-367* 
AlkPhos-145* TotBili-1.0
___ 12:00AM BLOOD ALT-198* AST-72* LD(___)-393* 
AlkPhos-133* TotBili-1.1
___ 12:00AM BLOOD ALT-169* AST-61* LD(___)-360* 
AlkPhos-121* Amylase-51 TotBili-1.1
___ 12:00AM BLOOD ALT-160* AST-58* LD(___)-395* 
AlkPhos-120* TotBili-1.4
___ 06:50AM BLOOD ALT-153* AST-46* LD(___)-373* 
AlkPhos-107* TotBili-1.2
___ 12:00AM BLOOD ALT-193* AST-62* LD(___)-506* AlkPhos-97 
TotBili-2.3*
___ 12:14AM BLOOD ALT-228* AST-61* LD(___)-544* AlkPhos-87 
TotBili-2.9*
___ 10:40AM BLOOD ALT-289* AST-82* LD(___)-538* AlkPhos-104 
TotBili-5.1* DirBili-3.8* IndBili-1.3
___ 12:05AM BLOOD ALT-342* AST-109* LD(___)-498* 
AlkPhos-121* TotBili-5.7* DirBili-4.2* IndBili-1.5
___ 05:50AM BLOOD ALT-433* AST-109* LD(___)-303* 
AlkPhos-142* TotBili-1.6*
___ 05:45AM BLOOD ALT-422* AST-133* LD(___)-314* 
AlkPhos-160* TotBili-1.9* DirBili-1.3* IndBili-0.6
___ 06:00AM BLOOD ALT-298* AST-74* LD(___)-282* 
AlkPhos-146* TotBili-1.6*
___ 09:05AM BLOOD ALT-350* AST-98* LD(___)-279* 
AlkPhos-148* TotBili-1.0
___ 06:00AM BLOOD ALT-343* AST-123* AlkPhos-132* 
TotBili-1.0
___ 03:00PM BLOOD ALT-362* AST-109* LD(LDH)-404* 
AlkPhos-142* TotBili-1.1
___ 12:00AM BLOOD Albumin-2.8* Calcium-8.3* Phos-3.7 Mg-1.8
___ 12:00AM BLOOD Albumin-2.5* Calcium-7.7* Phos-3.7 Mg-1.8
___ 12:00AM BLOOD Albumin-2.7* Calcium-7.8* Phos-3.4 Mg-1.7
___ 12:00AM BLOOD Albumin-2.7* Calcium-7.4* Phos-2.9 Mg-1.9
___ 08:14PM BLOOD Albumin-2.6* Calcium-7.5* Phos-3.0 Mg-1.7
___ 12:00AM BLOOD Albumin-2.6* Calcium-8.0* Phos-3.5 Mg-1.8
___ 12:00AM BLOOD Albumin-2.7* Calcium-7.8* Phos-3.1 Mg-1.6
___ 12:00AM BLOOD Albumin-2.7* Calcium-7.5* Phos-3.4 Mg-1.7 
Iron-130
___ 12:00AM BLOOD Albumin-2.6* Calcium-7.7* Phos-3.5 Mg-1.7
___ 06:50AM BLOOD Albumin-2.5* Calcium-8.1* Phos-3.2 
Mg-1.5*
___ 12:00AM BLOOD Albumin-2.8* Calcium-8.0* Phos-2.9 Mg-1.7
___ 12:14AM BLOOD Albumin-2.6* Calcium-7.5* Phos-2.7 Mg-1.6
___ 10:40AM BLOOD Albumin-2.8*
___ 12:05AM BLOOD Albumin-2.8* Calcium-7.8* Phos-3.5 Mg-1.6
___ 05:50AM BLOOD Albumin-3.1* Calcium-8.6 Phos-4.3 Mg-1.6 
Cholest-202*
___ 05:45AM BLOOD Albumin-3.2* Calcium-8.3* Phos-4.0 Mg-1.6
___ 06:00AM BLOOD Albumin-3.2* Calcium-8.7 Phos-4.0 Mg-1.5*
___ 09:05AM BLOOD Albumin-3.3* Calcium-8.8 Phos-3.3 Mg-1.6
___ 06:00AM BLOOD Calcium-8.4 Phos-3.2 Mg-1.6
___ 03:00PM BLOOD Albumin-3.9 Calcium-9.1 Phos-3.7 Mg-1.6
___ 12:00AM BLOOD calTIBC-134* Ferritn-6629* TRF-103*
___ 05:50AM BLOOD Triglyc-574* HDL-30 CHOL/HD-6.7 
LDLmeas-86
___ 09:42AM BLOOD Cyclspr-98*
___ 09:56AM BLOOD Cyclspr-126
___ 09:41AM BLOOD Cyclspr-126
___ 09:41AM BLOOD Cyclspr-112
___ 09:52AM BLOOD Cyclspr-153
___ 09:45AM BLOOD Cyclspr-173
___ 10:07AM BLOOD Cyclspr-189
___ 08:55AM BLOOD Cyclspr-178
___ 12:04PM BLOOD Cyclspr-201
___ 09:30AM BLOOD Cyclspr-153
___ 09:15AM BLOOD Cyclspr-133
___ 09:10AM BLOOD Cyclspr-119
___ 11:25AM BLOOD Cyclspr-66*
.
Specialist labs
.
Vitamin D ___
VITAMIN D, 25 OH, TOTAL       17  L               ___ ng/mL
VITAMIN D, 25 OH, D3          17                  ng/mL
VITAMIN D, 25 OH, D2          <4                  ng/mL
 
         ___ indicates both endogenous production and
         supplementation. 25-OHD2 is an indicator of exogenous
         sources such as diet or supplementation. Therapy is 
based on
         measurement of Total 25-OHD, with levels <20 ng/mL 
indicative
         of Vitamin D deficiency, while levels between 20 ng/mL 
and
         30 ng/mL suggest insufficiency. Optimal levels are
         > or = 30 ng/mL.
.
.Urine
.
___ 06:26AM URINE Color-Yellow Appear-Clear Sp ___
___ 06:26AM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 06:26AM URINE RBC-1 WBC-1 Bacteri-NONE Yeast-NONE Epi-0
___ 06:26AM URINE Mucous-RARE
.
.
Microbiology
.
___ 06:44PM BLOOD HAV Ab-POSITIVE IgM HAV-NEGATIVE
___ HSV Ab -ve, EBV ___ copies, rpt not analysable ___, 
HHV6 and Adeno not detected ___
.
FECAL CULTURE (Final ___: 
      NO ENTERIC GRAM NEGATIVE RODS FOUND. 
      NO SALMONELLA OR SHIGELLA FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 

   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA 
FOUND. 

   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: 
      NO E.COLI 0157:H7 FOUND. 

   Cryptosporidium/Giardia (DFA) (Final ___: 
      NO CRYPTOSPORIDIUM OR GIARDIA SEEN. 

   CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
           (Reference Range-Negative). 
.
___ CMV not detectable 
.
LIVER OR GALLBLADDER US (SINGLE ORGAN) Study Date of ___ 
8:36 AM 
FINDINGS: Normal liver parenchymal echogenicity. There is a 
well-demarcated 1.5 x 1.2 x 2.5 cm hyperechoic focus adjacent to 
the portal vein in the right lobe of liver. The appearances are 
typical of an area of focal fatty infiltration. No suspicious 
liver lesion is identified. Echogenic sludge is identified 
within the gallbladder. No biliary dilatation. The common duct 
measures 3 mm maximally. Normal appearance of the pancreatic 
head and body. The tail was poorly visualized due to overlying 
bowel gas (2.5 cm). The left, middle and right hepatic veins 
appear normal on Doppler examination. In addition normal flow 
was seen within the right, main and left portal veins. Normal 
appearance of the IVC and superior mesenteric vein. Of note, 
there is persistent splenomegaly with the spleen measuring 18 cm 
in long axis. 
IMPRESSION: 
1. No evidence of portal vein or hepatic vein thrombus.  
2 2.5 cm area of focal fatty infiltration adjacent to the 
proximal 
intrahepatic portal vein. 
3. Small gallstones 
.
MR 3D RENDERING W/POST PROCESSING ON INDEPENDENT WS Study Date 
of ___ 12:56 ___ 
IMPRESSION: 
1. Enteritis involving the third and fourth portions of duodenum 
and proximal jejunum which may be inflammatory or infectious in 
origin.  
2. Small stones in the gallbladder without evidence of 
intrahepatic or 
extrahepatic biliary dilatation. 
3. Hemosiderosis in the liver and spleen. 
4. Focal ectasia of infrarenal abdominal aorta up to 1.9 cm. 
.
US EXTREMITY NONVASCULAR LEFT Study Date of ___ 9:38 AM 
IMPRESSION:   
Subcutaneous edema corresponding with site of palpable 
abnormality. 
No abnormal collection identified 
.
CT ABDOMEN&PELVIS W/O CONTRAST Study Date of ___ 5:42 ___ 
IMPRESSION:  
1. Hemosiderosis.  
2. Mural thickening and edema of the duodenum, jejunal and ileal 
loops with relative sparing of the terminal ileum and the colon. 
Differential would include graft-versus-host disease and less 
likely differentials include infection or inflammatory 
disorders. 
3. Splenomegaly. 
4. Small volume ascites. 
.
UNILAT UP EXT VEINS US LEFT Study Date of ___ 2:29 ___ 
IMPRESSION:   
Occlusive clot in the deep veins of the left arm extending from 
the subclavian vein into the left basilic vein where PICC line 
is placed. 
.
UNILAT UP EXT VEINS US RIGHT Study Date of ___ 9:48 ___ 
IMPRESSION: No evidence of left upper extremity DVT. Limited 
evaluation of 
basilic vein. 

___ 12:00AM BLOOD WBC-1.8* RBC-2.75* Hgb-9.7* Hct-27.4* 
MCV-100* MCH-35.4* MCHC-35.5* RDW-21.1* Plt Ct-38*
___ 12:00AM BLOOD WBC-2.4* RBC-2.69* Hgb-9.6* Hct-26.4* 
MCV-98 MCH-35.7* MCHC-36.5* RDW-21.8* Plt Ct-42*
___ 12:00AM BLOOD Neuts-54 Bands-2 ___ Monos-10 Eos-0 
Baso-0 Atyps-4* Metas-2* Myelos-3*
___ 12:00AM BLOOD Neuts-70 Bands-1 Lymphs-11* Monos-10 
Eos-0 Baso-0 ___ Metas-5* Myelos-3* NRBC-3*
___ 12:00AM BLOOD Neuts-59 Bands-1 Lymphs-17* Monos-16* 
Eos-0 Baso-0 Atyps-4* Metas-1* Myelos-1* Promyel-1* NRBC-4*
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL 
Macrocy-1+ Microcy-NORMAL Polychr-1+
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ 
Macrocy-3+ Microcy-1+ Polychr-1+ Spheroc-1+ Ovalocy-1+ Tear 
___
___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-2+ 
Macrocy-2+ Microcy-1+ Polychr-NORMAL Tear ___ 
___
___ 12:00AM BLOOD Plt Ct-38*
___ 12:00AM BLOOD ___ PTT-23.3 ___
___ 12:00AM BLOOD Plt Smr-VERY LOW Plt Ct-42*
___ 12:00AM BLOOD ___ PTT-23.8 ___
___ 12:00AM BLOOD Plt Ct-54*
___ 12:00AM BLOOD ___ ___
___ 12:00AM BLOOD ___ ___
___ 12:00AM BLOOD ___ ___
___ 12:00AM BLOOD Glucose-101* UreaN-25* Creat-0.5 Na-132* 
K-4.6 Cl-103 HCO3-23 AnGap-11
___ 12:00AM BLOOD Glucose-186* UreaN-35* Creat-0.4 Na-135 
K-4.4 Cl-107 HCO3-23 AnGap-9
___ 12:00AM BLOOD Glucose-130* UreaN-28* Creat-0.5 Na-135 
K-4.0 Cl-104 HCO3-21* AnGap-14
___ 12:00AM BLOOD ALT-163* AST-61* LD(LDH)-407* AlkPhos-78 
TotBili-0.6
___ 12:00AM BLOOD ALT-161* AST-70* LD(___)-412* AlkPhos-71 
TotBili-0.4
___ 12:00AM BLOOD ALT-152* AST-73* AlkPhos-71 TotBili-0.5
___ 12:00AM BLOOD Calcium-7.8* Phos-3.8 Mg-1.8
___ 12:00AM BLOOD Calcium-7.5* Phos-3.3 Mg-2.1
___ 12:00AM BLOOD Calcium-8.1* Phos-4.1 Mg-2.0
___ 12:00AM BLOOD ___ Ferritn-6300* TRF-152*
___ 12:00AM BLOOD IgG-73* IgA-26* IgM-35*
___ 10:39AM BLOOD Cyclspr-134
___ 09:51AM BLOOD Cyclspr-107
___ 09:05AM BLOOD Cyclspr-142
___ 09:45AM BLOOD Cyclspr-209
___ 09:50AM BLOOD Cyclspr-129
___ 09:25AM BLOOD Cyclspr-88*
 
Brief Hospital Course:
___ year old woman with CML, s/p MRD allo SCT ___ with 
Busulfan/Cyclophosphamide. Her post-transplant course was 
complicated with GVH of the upper and lower GI tract that 
required hopitalization for IV steroids and increased 
immunosuppression. She was admitted for investigation of 
worsening LFTs. She was treated with high dose IV 
methylprednisolone, oral Mycophenolate mofetil and increasing 
cyclosporin doses. She quickly developed symptoms suggestive of 
GI GVHD with cramping ___ pain, nausea and vomiting. LFTs 
worsened during admission but she did not necessitate a liver 
biopsy due to considerable improvement in these following 
increased immunosuppression. The general picture was that of 
severe multi-organ GVHD. Her GI symptoms worsened with abdominal 
pain and profuse watery diarrhea and she had a CT scan which 
demonstrtaed confluent small bowel enteritis. At this point she 
was placed on bowel rest and administered TPN. GVHD was 
confirmed at endoscopy and biopsy where mucosa was noted to be 
friable and extensively ulcerated in keeping with severe GVHD. 
Her cyclosporin was titrated up and her symptoms improved 
although diarrhea persisted despite a considerable period of 
bowel rest on TPN. Her Hb/HCt had been slowly falling and her 
stool was found to be guaiac +ve felt likely 2o to her bowel 
inflammation. She was found to have a swollen left arm shortly 
after a PICC line was placed and there was evidence of an 
extensive LUE DVT extending to the subclavian vein. This was 
treated conservatively as anticoagulation was felt to be 
inadvisable in the setting of her continued bowel inflamation 
and guaiac +ve stools. Due to problmes of low cyclosporin levels 
her cyclosporina nd mycophenolate were changed to IV on ___. 
WBC count progressively dropped ? cause and she may need a bone 
marrow biopsy soon if her counts do not improve. She was 
continued on IV methylprednisolone mycophenolate and cyclosporin 
w/continued TPN for bowel rest. Blood glucoses high and 
titrating up insulin in TPN in addition to addingNPH low dose 
BID on ___. Gradually, diarrhea improved and pt was able to be 
transitioned slowly to PO medications. Levels of cyclosporin 
were monitored to ensure therapuetic range and absorptions. 
Slowly pt's diet was also advanced and at discharge pt was off 
TPN. Closes follow-up was planned on ___.
.
# Rising LFTs:  This was found to be liver GVHD.  Progressively 
settling following GVHD treatment. Mildly elevated on previous 
admission in week prior to current admission. She was initially 
asymptomatic although latterly developed severe diarrhea, nausea 
and vomiting. Her steroids initially oral prednisone were 
increased to IVMP 30mg bid and cyclosporin was gradually 
uptitrated. She had ___ U/S ___ which showed focal fatty 
infiltrate and nil else. Bil rose from 1.6 on ___ and 
transaminases were progressively rising. MRCP on ___ showed 
hemosiderosis of liver and spleen, thickening of duodenum and 
___ jejunum in keeping with inflammatory/infectious etiology 
and a small stone in GB. Seen by hepatology ___ and lab 
investigations for vit D,  Hep B/C/Adeno/CMV/HHV6/EBV PCRs, Hep 
A Ab, HSV Ab. These all came back -ve save vit D level which was 
low and seh was sterted on vitamin D supplementation. Put on 
bowel rest and started on TPN. Bil rose from 1.6 to 5.7 on ___ 
with improved transaminases. By repeat on ___ Bil level had 
dropped to 5.1 and by ___ Bil dropped to 2.9 with improved 
transaminases. She therefore did not go for liver bx. LFTs 
continued to trend down with high levels of immunosuppression. 
Slowly immunosuppression was titrated down and LFTs remained 
stable as diarrhea continued to improve. Transition to PO 
fluconazole resulted in rise in LFTs w/out evidence of other 
worsening GVHD symptoms so pt was restarted on home 
voriconazole. LFTs will continued to be monitored as meds are 
titrated on an outpt basis.
.
# CML: s/p allo SCT. She continues to recover from her 
transplant. Guaiac +ve stol ___ and transfused 1 unit 
___. Transfusion goal HCt >25 Plt >20. 
.
# GVHD ___ pain, nausea and  vomiting and elevated LFTs): 
Previous significant upper and lower GI GVHD. She ws found on 
this admission to again have severe GVHD in his case involving 
the small bowel and liver. On admission she was started on IV 
methylpred 30mg bid. Whilst she was asymptomatic on admission, 
she quickly developed abdominal pain, nausea and vomiting felt 
likely to be GVHD. Increased cyclosporin to 75mg bid, added 
mycophenolate 500mg bid and voriconazole 200mg bid on ___. 
Increased mycophenolate to 1g bid on ___. Cyclosporin 119 and 
increased cyclosporin to 100mg bid ___ then 125mg bid ___. As 
high level changed to 125/100 on ___. Cyclopsorin increased to 
125mg bid ___ and 150mg bid ___ due to persistently low 
levels and felt that this was likely due to poor absorption from 
the gut. SShe had suprapubic tenderness with diarrhea as of ___ 
- NOT peritonitic. Initially felt to be ? inadequately treated 
UTI (Enterobacter in UCx in week prior and Rx levo for 3 days). 
Rpt UA and UCx were -ve. Started on oral cipro ___.. Due to 
diarrhea was changed to IV cipro/metronidazole ___. MRI showed 
duodenitis/jejunitis ? infectious ? inflammatory. Supportive IV 
fluids where given and then TPN was started for nutritional 
support. High stool output. Seen by GI ___ who recommended 
stool studies which were negative. Changed Abx to IV meropenem 
___. ___ ___ showed small bowel enteritis 
encompassing most of small bowel with no dilatation. UGIE and bx 
___ showed abnormal, friable mucosa throughout approximately 
75% of the duodenum which was denuded with a shiny erythematous 
base and could be consistent with known history of GVHD. IV 
meropenem stopped ___. Awaiting CMV immunostaining. EBV 20 
copies and was repeated ___ and was not amplifyable although 
the sample was slightly hemolysed. She symptomatically improved 
although had persistent diarrhea despite bowel rest. She was 
treated with loperamide. Gradually symptoms improved and pt was 
able to be transition from IV meds to PO meds and diet advanced 
slowly while TPN continued until pt was able to tolerated PO 
diet at a sufficient level to maintain calorie needs. At time of 
d/c TPN had been stopped and pt was taking only POs.
.

# L UE DVT: Swollen L arm post PICC insertion. Had U/S and 
doppler ___ which showed edema but no hematoma or localised 
edema but repeat U/S showed Left Basilic DVT ___.  PICC was 
removed on ___. She did not receive anticoagulation given low 
Plts, guaiac +ve stool and significant ulceration on bx 
suggestive of continued significant bowel inflammation. Later pt 
had some intermittent residual swelling in the arm which was 
attibutated to mild edema because of lingering partial occlusion 
in the veins. Repeat US was negative at that time.
.
Recommend considering chelation therapy for treatment of iron 
overload. Monitor nutritional status and PO intake as well as GI 
symptoms of GVHD
 
Medications on Admission:
1. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8
hours).
2. Budesonide 3 mg Capsule, Sust. Release 24 hr Sig: One (1)
Capsule, Sust. Release 24 hr PO TID (3 times a day).
3. lorazepam 0.5 mg Tablet Sig: ___ Tablets PO DAILY (Daily).
4. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
5. nifedipine 30 mg Tablet Sustained Release Sig: Three (3)
Tablet Sustained Release PO DAILY (Daily).
6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2)
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day) as needed for constipation.
8. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day) as needed for constipation.
9. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily).
10. magnesium oxide 140 mg Capsule Sig: Two (2) Capsule PO BID
(2 times a day).
11. atovaquone 750 mg/5 mL Suspension Sig: Two (2) PO DAILY
(Daily).
12. cyclosporine modified 25 mg Capsule Sig: Two (2) Capsule PO
QAM (once a day (in the morning)).
13. cyclosporine modified 25 mg Capsule Sig: Three (3) Capsule
PO QPM (once a day (in the evening)).
 
Discharge Medications:
1. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
2. nifedipine 90 mg Tablet Sustained Release Sig: One (1) Tablet 
Sustained Release PO DAILY (Daily).  
3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
4. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
5. atovaquone 750 mg/5 mL Suspension Sig: Two (2)  PO DAILY 
(Daily).  
6. budesonide 3 mg Capsule, Sust. Release 24 hr Sig: One (1) 
Capsule, Sust. Release 24 hr PO TID (3 times a day).  
7. lorazepam 0.5 mg Tablet Sig: ___ Tablets PO once a day as 
needed for anxiety, nausea, vomitting, insomnia.  
8. ergocalciferol (vitamin D2) 50,000 unit Capsule Sig: One (1) 
Capsule PO 1X/WEEK (TH).
Disp:*30 Capsule(s)* Refills:*2*
9. mycophenolate mofetil 500 mg Tablet Sig: Two (2) Tablet PO 
BID (2 times a day).  
10. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, 
Chewable PO QID (4 times a day) as needed for gas, indigestion.  

11. prednisone 10 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).
Disp:*90 Tablet(s)* Refills:*2*
12. cyclosporine modified 25 mg Capsule Sig: Three (3) Capsule 
PO Q12H (every 12 hours).
Disp:*180 Capsule(s)* Refills:*2*
13. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours).  
14. omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.
Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*2*
15. voriconazole 200 mg Tablet Sig: One (1) Tablet PO Q12H 
(every 12 hours).
Disp:*60 Tablet(s)* Refills:*2*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
GVHD in setting of allogenic stem cell transplant for CML
diarrhea
nausea
vomitting
elevated liver function enzymes

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital because of rising liver 
function tests and concern that you were experiencing GVHD 
(rejection symptoms). You had recently been admitted for nausea, 
vomiting, and diarrhea and had responded to immunosupressive. 
You were again admitted to help manage your symptoms by placing 
you on bowel rest, giving you IV forms of your medications and 
supporting you with IV nutrition. Your symptoms gradually 
improved and your diet was able to be slowly advanced. Your 
immunosupressive meds were also titrated to help prevent future 
flairs without oversuppresion of your immune system and bone 
marrow.
.
The following changes were made to your medications:
- Please START taking ...
- Please STOP taking..
- Please CONTINUE taking ...
- Please continue to take all of your other home medications as 
prescribed
.
Please be sure to keep all follow-up appointments with your PCP 
oncologists and other healthcare providers.
.
It was a pleasure taking care of you and we wish you a speedy 
recovery.

 
Followup Instructions:
___
"
159,19940147,29892428," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
___ Complaint:
dyspnea 
 
Major Surgical or Invasive Procedure:
Endotracheal intubation
R thigh muscle biopsy
R forearm skin biopsy
Tracheostomy tube placement
 
History of Present Illness:
___ female with CAD s/p CABG, accelerated phase CML s/p 
allo SCT ___ complicated by upper and lower GI GVHD ___ 
and liver GVHD ___ presenting from OSH electively intubated 
for hypoxic and hypercarbic failure in the setting of worsening 
respiratory status. She was recently on prednisone 8mg ___ and 
developed sore throat and cough ___. Steroid dose was 
increased to 20mg with quick taper and she was started on 
levofloxacin. Despite the levofloxacin and continuation of 
atovaquone for PCP prophylaxis, she had increasing dyspnea and 
presented to ___ on ___.  
.  
Initially, concern was for cardiac cause for her dyspnea (she 
has a history of CABG in ___. TTE showed normal EF. She 
underwent cardiac catheterization that showed clean coronaries. 
She desatted to ___ and was transferred to OSH ICU for bipap, 
which was not helpful. CXR showed RLL consolidation and she was 
started on vancomycin/zosyn/azithromycin ___ is day 5). 
She has not had fevers or leukocytosis.  
.  
Additionally, she was found to have b/l ___ DVTs (found when 
accessing during cardiac cath). CT was negative for PE. She was 
initially on heparin gtt but developed thrombocytopenia with 
plts dropping from >100k on admission to 58k. IVC filter was 
placed; she was started on bivalrudin and transitioned to 
fondaparinux prior to transfer. HIT antibody returned negative.  

.  
Throughout her hospital course, she was becoming progressively 
weaker. She had been ambulating independently on admission and 
progressed to not being able to lift her legs with elevated CK 
(790's on ___, ESR, CRP. She then dessated to ___ on high 
flow NC yesterday and was slow to recover her sats. Given her 
hypoxia and overall progressive weakness, she was electively 
intubated for concern for respiratory fatigue after discussion 
with oncology here ___, Dr ___. Bronchoscopy was 
performed after pt was intubated and revealed thick mucoid 
secretions. Cultures sent. On transfer, vent settings were peep 
5, fiO2 40%, TV 400.  
.  
CXR was not revealing for cause of acute respiratory failure, 
though she does have retrocardiac consolidation on CXR from 
___, potentially related to atelectasis. She had low IgG and 
received IVIG on ___. Prednisone had initially been continued 
at 20mg, but then uptitrated to prednisone 60mg (and converted 
to solumedrol 40mg IV BID) after d/w heme-onc here for concern 
of GVHD. In addition her cyclosporine was held as well. She has 
been hemodynamically stable, though UOP noted to be dropping to 
20cc/hr on ambulance ride over.  
.  
On the floor, she has no specific complaints. Denies CP.  
.  
Review of systems:  
(+) Per HPI  
(-) Denies fever, chills, Denies shortness of breath. Denies 
chest pain, chest pressure, palpitations, or weakness. Denies 
nausea, vomiting. + diarrhea. Denies abdominal pain. Denies 
arthralgias or myalgias.  
 
Past Medical History:
ONCOLOGIC HISTORY:  
- ___: Asymptomatic abnormal CBC noted by PCP during routine  
visit  
- ___: Bone marrow biopsy showed myeloproliferative  
disorder, likely chronic myelogenous leukemia. Per patient  
report, began taking interferon three times weekly shortly  
after diagnosis.  
- ___: Started Gleevec 400 mg ___. At some point  
thereafter, her dose was increased to 600 mg ___  
- ___: Gleevec increased to 400 mg twice ___ with  
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be  

in late chronic phase CML. Stem cell transplant was  
recommended, but she did not wish to pursue this course.  
- ___: ___ held due to worsening anemia and  
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on  
Dasatinib   
- ___: First seen at ___. Bone marrow biopsy showed  
accelerated phase CML. began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by  
mucositis with biopsy of the esophagus suggesting upper GI GVHD  

which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper 
and  
lower GI tract in the setting of reducing immunosuppression  
.  
PMHx:  
- atherosclerotic coronary vascular disease  
- status post CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  
 
Social History:
___
Family History:
- father - died of MI, nil other health problems
- mother - had heart problems, DM
Four siblings
- 2 bothers had CABG
- 1 brother prostate cancer
- Her sister ___ is her donor and is well
 
Physical Exam:
Admission Physical Exam: 
General: Alert and answering questions yes/no with head nods, 
intubated, no acute distress  
HEENT: ET tube present, unable to assess OP  
Neck: supple, JVP not elevated, no LAD  
Lungs: CTA b/l in anterior fields  
CV: Regular rate and rhythm, normal S1 + S2  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Skin: R PICC in place, L dorsal forearm with scabbed areas over 
elbow that are purplish hue  
Neuro: ___ muscle strength in ___ b/l, 4+/5 muscle strength in UE 
b/l  
.
DISCHARGE EXAM:
HR 92 BP 165/85 O2 100% temp 98.3
vent settings: CPAP/PSV PEEP 5
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: cta b/l
CV:regular rate and rhythm, frequent early beats, normal S1 + 
S2, no murmurs, rubs, gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
GU: foley in place, good UOP  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema, able to lift arms to 90 degree angle, unable to lift legs 
off chair but hip extensors ___ and deltoids ___ (improved)
SKIN: bilateral hands bandaged per derm, right thigh biopsy site 
with surrounding ecchymosis but no hematoma, no errythema or 
warmth

 
Pertinent Results:
Admission Labs:

___ 01:17PM BLOOD WBC-6.8 RBC-2.54*# Hgb-8.2*# Hct-23.6*# 
MCV-93 MCH-32.4* MCHC-34.9 RDW-14.9 Plt Ct-66*#
___ 01:17PM BLOOD Neuts-90* Bands-2 Lymphs-2* Monos-2 Eos-0 
Baso-0 ___ Metas-2* Myelos-1* Promyel-1*
___ 01:17PM BLOOD Hypochr-1+ Anisocy-NORMAL Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-OCCASIONAL 
Stipple-OCCASIONAL
___ 01:17PM BLOOD ___ PTT-29.1 ___
___ 01:17PM BLOOD ___ ___
___ 03:54AM BLOOD Ret Aut-1.5
___ 01:17PM BLOOD ALT-102* AST-126* LD(___)-474* 
CK(CPK)-276* AlkPhos-225* TotBili-0.8
___ 01:17PM BLOOD Albumin-2.6* Calcium-8.9 Phos-2.9# Mg-1.9
___ 03:54AM BLOOD Calcium-8.9 Phos-2.5* Mg-2.0 Iron-160
___ 03:54AM BLOOD calTIBC-170* VitB12-818 Folate-6.5 
___ Ferritn-PND TRF-131*
___ 01:17PM BLOOD TSH-0.88
___ 04:52PM BLOOD Type-ART pO2-165* pCO2-37 pH-7.48* 
calTCO2-28 Base XS-4
___ 04:52PM BLOOD Lactate-1.3
.
DISCHARGE LABS:
___ 03:56AM BLOOD WBC-5.6 RBC-2.75* Hgb-9.4* Hct-27.2* 
MCV-99* MCH-34.1* MCHC-34.6 RDW-21.7* Plt ___
___ 03:56AM BLOOD ___ PTT-99.1* ___
___ 03:56AM BLOOD ACA IgG-PND ACA IgM-PND
___ 03:56AM BLOOD Glucose-121* UreaN-22* Creat-0.3* Na-137 
K-4.5 Cl-105 HCO3-26 AnGap-11
___ 04:45AM BLOOD CK(CPK)-103
___ 03:50AM BLOOD ALT-53* AST-42* LD(LDH)-439* AlkPhos-142* 
TotBili-0.7
___ 03:56AM BLOOD Calcium-8.3* Phos-2.9 Mg-2.2
___ 03:56AM BLOOD ___
___ 09:20AM BLOOD Cyclspr-43*
.
Micro:
   Blood Culture, Routine (Final ___:    NO GROWTH. 
MRSA SCREEN (Final ___:    No MRSA isolated. 
CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
  Respiratory Viral Antigen Screen (Final ___: 
      Negative for Respiratory Viral Antigen. 
      Specimen screened for: Adeno, Parainfluenza 1, 2, 3, 
Influenza A, B,
      and RSV by immunofluorescence. 
___ 8:24 pm SPUTUM      Source: Endotracheal. 
   GRAM STAIN (Final ___: 
      <10 PMNs and <10 epithelial cells/100X field. 
      NO MICROORGANISMS SEEN. 
      QUALITY OF SPECIMEN CANNOT BE ASSESSED. 
   RESPIRATORY CULTURE (Final ___:    NO GROWTH. 
   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. 
   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. 
   ACID FAST CULTURE (Final ___:    NO MYCOBACTERIA 
ISOLATED. 
CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
___ 6:46 pm BRONCHIAL WASHINGS
   GRAM STAIN (Final ___: 
      2+   ___ per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 
   RESPIRATORY CULTURE (Final ___: 
      10,000-100,000 ORGANISMS/ML. Commensal Respiratory Flora. 
   LEGIONELLA CULTURE (Final ___: 
      NO LEGIONELLA ISOLATED. 
      PAECILOMYCES SPECIES.    RARE GROWTH. 
   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. 
   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. 
   ACID FAST CULTURE (Preliminary): 
SKIN biopsy pending at ___ of discharge
.
Imaging:

IMPRESSION: 
 CT ABD & PELVIS W/O CONTRAST Study Date of ___ 5:43 ___ 
1. No evidence of retroperitoneal hematoma. 
2. Left lower lobe consolidation with adjacent small left 
nonhemorrhagic 
pleural effusion. This finding is concerning for infection in 
the appropriate clinical setting. 
3. Increased attenuation of the liver, compatible with 
hemosiderosis, 
unchanged. 
4. Cholelithiasis without evidence of cholecystitis. 
5. Extensive calcified atherosclerotic disease of the aorta and 
its branches without associated aneurysmal changes. 
6. Right thigh lipoma is partially imaged. 
.
EMG:
IMPRESSION: 
Abnormal study. There is electrophysiologic evidence for a 
myopathy with 
denervating (""inflammatory"") features, most severely affecting 
the lower 
extremities. The findings are not suggestive of an acquired 
demyelinating 
polyneuropathy, such as Guillain- ___ syndrome. 
.
ECHO ___: The left atrium is normal in size. No atrial 
septal defect is seen by 2D or color Doppler. The estimated 
right atrial pressure is ___ mmHg. Left ventricular wall 
thickness, cavity size and regional/global systolic function are 
normal (LVEF >55%). A mid-cavitary gradient is identified. There 
is no ventricular septal defect. Right ventricular chamber size 
and free wall motion are normal. The diameters of aorta at the 
sinus, ascending and arch levels are normal. The aortic valve 
leaflets (3) appear structurally normal with good leaflet 
excursion and no aortic stenosis or aortic regurgitation. The 
mitral valve appears structurally normal with trivial mitral 
regurgitation. There is no mitral valve prolapse. The pulmonary 
artery systolic pressure could not be determined. There is no 
pericardial effusion. 
Compared with the prior study (images reviewed) of ___, no 
change. 
.
CHEST CT: report pending at time of discharge
. 
PATHOLOGY:
Muscle biopsy, r4 rectus femoris muscle:
Inflammatory myopathy, see note.
Note: Section showed myofibers with prominent inflammatory 
infiltrate composed of foamy macrophages, lymphocytes, and 
plasma cells.  Degenerative and regenerative fibers are seen.  
In some areas, myofibers are replaced by adipose and connective 
tissue, consistent with a subacute clinical picture. CD3 labeled 
prominent T cell infiltrate with numerous CB8 positive cytotoxic 
and scattered CD4 positive helper cells, while CD20 labeled B 
lymphocytes are rare in perivascular zones. CD68 highlighted 
abundant macrophages, some involved in myophagocytosis. The 
findings would be consistent with GVH myositis in the clinical 
context of CML status post alloSCT and history of GI and liver 
GVH disease. GVH myositis is indistinguishable histologically 
from sporatic polymyositis. Further studies including 
biochemical panel will be reported as an addendum.
.
R forearm: pending at time of discharge

 
Brief Hospital Course:
___ female with CAD s/p CABG, accelerated phase CML s/p 
allo SCT ___ complicated by upper and lower GI GVHD ___ 
and liver GVHD ___ presenting from OSH electively intubated 
for hypoxic and hypercarbic failure in the setting of myopathy. 
.
# Hypercarbic hypoxic respiratory failure: Pt was initially 
electively intubated given diffuse myopathy affecting 
respiratory muscles. Pt was managed on endotracheal intubation 
for 11 days before being trached on ___. Her ___ NIF has 
remained (-14)-(-18). During trials on trach collar, she has 
maintained her oxygen saturation and respiratory rate, however 
her blood pressure elevates and she reports subjective feelings 
of dyspnea and fatigue. Goal now for weaning her from the vent 
is treatment of her diffuse myositis to improve respiratory 
failure in the long term with gentle weaning to trach collar.
.
# Motor weakness: Based on muscle biopsy, inflammation is 
consistent with GVHD.  Muscle biopsy shows impressive 
inflammation despite having been on steriods prior to biopsy. 
Muscle strength appeared to initially improve on steroids, 
though now has been stable x 1 week. Following muscle biopsy, 
she was started on cyclosporine 25mg IV BID and received 1 dose 
of IVIG. She has had minimal improvement in her strength and is 
aware that this will be a prolonged recovery process.
.
# Mold on BAL: Sparse growth seen on bronchial aspirate from 
___. Given clinical improvement and radiological improvement 
on CT scan ___, we do not feel that this is likely a pathogenic 
organism. We do recommend repeat CT chest in ___ weeks for 
continued monitoring. 
.
# depression: Ms ___ has started to appear overwhelmed and 
frustrated by her current condition and long term recovery that 
is necessary. We have deferred starting an SSRI but this should 
be reconsidered outside of an acute hospitalization.
.
# Pancytopenia: Developed in setting of starting cyclosporine. 
Her CBC has been stable and she has not required any recent 
transfusions. Threshold for transfusion would be platelets <10, 
hct <25
.
# bilateral hand bullae: First noticed on ___. Dermatology was 
consulted and felt that her purpura was due to trauma and her 
coagulopathy.  The bullae were probably the result of hemorrhage 
into thin skin. They were drained and per derm, continued with 
light pressure dressings to prevent re-accumulation.
.
# Hypertension: Pt has history of hypertension and had been 
managed at home on amlodipine 5mg, and metoprolol succinate 
300mg ___. These were initially held on presentation, but 
resumed as she improved clinically. She has been stable on 
amlodipine 5mg ___, metoprolol tartrate 100mg q6hr, and 
captopril 12.5mg TID. She has been noted to get hypertensive to 
170s when on trach collar. We would expect this to resolve as 
she becomes more comfortable on the trach collar and her 
strength improves. It would be possible to up titrate her 
captopril if she requires.
.
# DVT: Pt has bilateral DVT, however in setting of diffuse 
ecchymoses and hematomas, heparin drip was held. Pt had CTA at 
outside hospital to r/o PE and had an IVC filter placed.  She 
was placed on compression stockings to avoid further 
complications of thrombophlebitis.
.
# Elevated LFTs: LFT have been stably elevated during this 
hospitalization, likely secondary to her known GVHD.
.
# elevated PTT: Unclear etiology since patient has been off 
heparin drip for 1 week now. She is still getting heparin SQ TID 
and suspect that given decreased muscle mass, she may be 
supratheraputic from SQ heparin alone. Further work up is 
pending, including ___, anti-cardiolipin antibody, and 
anti-lupus antibody.
.
CHRONIC ISSUES:
.
# CML s/p allogeneic stem cell tx: Pt was continued on acyclovir 
and atovaquone for prophylaxis. She had been on budesonide, 
however this has been held recent as it cannot be given through 
her dobhoff. She has been started on cyclosporin and IVIG for 
diffuse myositis.
.
# CAD: s/p CABG in ___. Continued home medications. Repeat ECHO 
here showed no wall motion abnormalities. She also had cardiac 
catheterization at outside hospital for workup of initial 
presenting dyspnea which revealed clean coronary arteries.
.
TRANSITIONAL ISSUES:
Pt is full code.
.
She will require repeat IVIG either ___ or ___ per 
rheumatology recs.
.
She should have repeat CT chest in ___ weeks for follow up on 
interval change in L infiltrate.
.
We have decreased her heparin SQ to BID given persistently 
elevated PTT. This should be re-evaluated if remains elevated 
and further work-up would be warranted.
.
We have resumed home blood pressure medications. If necessary, 
her captopril could be up titrated.
.
Patient and her husband are aware that she will have a prolonged 
recovery period. She has expressed some thoughts of depression 
and would likely benefit from an SSRI.
.
Tube feds currently Beneprotein, 21 gm/day, Goal rate: 40 ml/hr, 
Residual Check: q4h Hold feeding for residual >= : 200 ml
.
Pt has not been getting her budesonide as it clogs her dobhoff. 
This should be discussed with hem/onc at her follow up visit.
 
Medications on Admission:
ACYCLOVIR - 400 mg Tablet - 1 Tablet(s) by mouth twice a day
AMLODIPINE - 5 mg Tablet - 1 Tablet(s) by mouth ___
ATOVAQUONE [MEPRON] - 750 mg/5 mL Suspension - 10 ml ___
BUDESONIDE [ENTOCORT EC] - 3 mg BID
CYCLOSPORINE MODIFIED [NEORAL] -  25mg BID
ERGOCALCIFEROL (VITAMIN D2) - 50,000 unit Capsule - 1 Capsule(s)
by mouth 1X/WEEK (TH)
LORAZEPAM - 0.5 mg-1mg ___ PRN
METOPROLOL SUCCINATE - 300 mg ___
OMEPRAZOLE - 20 mg ___
PREDNISONE TAPER 8mg ___
DOCUSATE SODIUM [COLACE] 100mg ___
MAGNESIUM OXIDE-MG AA CHELATE [MG-PLUS-PROTEIN] 133 mg ___
SENNOSIDES [SENNA] -  8.6 mg BID  

 
Discharge Medications:
1. acyclovir 400 mg Tablet Sig: One (1) Tablet ___ Q12H (every 12 
hours).  
2. atovaquone 750 mg/5 mL Suspension Sig: 1500 (1500) mg ___ 
___.  
3. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet ___ Q6H 
(every 6 hours).  
4. captopril 12.5 mg Tablet Sig: One (1) Tablet ___ TID (3 times 
a day).  
5. lidocaine HCl 2 % Solution Sig: Twenty (20) ML Mucous 
membrane TID (3 times a day) as needed for mouth discomfort.  
6. alum-mag hydroxide-simeth 200-200-20 mg/5 mL Suspension Sig: 
___ MLs ___ QID (4 times a day) as needed for heart burn.  
7. amlodipine 5 mg Tablet Sig: One (1) Tablet ___.  

8. acetaminophen 650 mg/20.3 mL Solution Sig: Six Hundred Fifty 
(650) mg ___ Q6H (every 6 hours) as needed for pain, fever.  
9. trazodone 50 mg Tablet Sig: 0.5 Tablet ___ HS (at bedtime).  
10. lansoprazole 30 mg Tablet,Rapid Dissolve, ___ Sig: One (1) 
Tablet,Rapid Dissolve, ___ ___.  
11. nystatin 100,000 unit/mL Suspension Sig: Five (5) ML ___ QID 
(4 times a day) as needed for thrush.  
12. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable 
Sig: One (1) Tablet, Chewable ___ TID (3 times a day).  
13. cholecalciferol (vitamin D3) 400 unit Tablet Sig: One (1) 
Tablet ___ BID (2 times a day).  
14. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
Four (4) Puff Inhalation Q4H (every 4 hours) as needed for 
wheeze.  
15. ipratropium bromide 17 mcg/Actuation HFA Aerosol Inhaler 
Sig: Two (2) Puff Inhalation Q4H (every 4 hours) as needed for 
PRN: wheeze.  
16. fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff 
Inhalation BID (2 times a day).  
17. diazepam 2 mg Tablet Sig: One (1) Tablet ___ at bedtime as 
needed for insomnia for 1 doses.  
18. heparin (porcine) 5,000 unit/mL Cartridge Sig: 5000 (5000) 
units Injection BID (2 times a day).  
19. Lorazepam 0.5-1 mg IV Q6H:PRN anxiety 
20. methylprednisolone sodium succ 40 mg Recon Soln Sig: Thirty 
(30) mg Injection Q12H (every 12 hours).  
21. cyclosporine 250 mg/5 mL Solution Sig: ___ (25) mg 
Intravenous Q12H (every 12 hours).  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Graft versus host disease myositis affecting respiratory muscles

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms ___,

It was a pleasure taking care of you at ___ 
___. You were admitted for difficulty breathing and 
had a breathing tube placed to help. This was transitioned to a 
tracheostomy. You had a muscle biopsy done to determine what 
caused your weakness. It looks like your graft versus host 
disease caused damage to your muscle and affected your 
respiratory muscles. You were started on a new medicine called 
cyclosporin and got 1 dose of IVIG to treat the muscle weakness. 
You were also continued on steroids. There was some concern for 
a pneumonia, though this looks like it has resolved on your most 
recent CT scan. Your feeding tube was left in place for you to 
get adequate nutrition until your muscle strength improves.

We will send a complete list of your medications to the ___. 
 
Followup Instructions:
___
"
160,19940147,25969058," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___.
 
Chief Complaint:
diarrhea
 
Major Surgical or Invasive Procedure:
Upper endoscopy (EGD)
Colonoscopy
 
History of Present Illness:
Ms. ___ is a ___ year old woman with accelerated CML s/p 
allo-transplant ___ complicated by GVHD of the GI/liver/muscle 
who has a trach due to respiratory failure from myositis related 
to GVHD who presented to her outpatient hematologist today with 
worsening diarrhea and was sent to the emergency room.  She 
reports that stool output varies throughout the day but has been 
worsening in the past several days.  She denies fevers, chills 
or night sweats.  She feels hungry currently but has no 
abdominal pain.
.
In the emergency department, initial vitals: 98.6 96 135/75 24 
100% 6L.  Blood and urine cultures were sent.  Stool was sent 
for C. Diff.  Labs were notable for slightly elevated LFTs 
compared to her baseline. 
.
Review of systems:
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denied cough, shortness of breath. + secretions. 
Denied chest pain or tightness, palpitations. Denied nausea, 
vomiting, abdominal pain. No recent change in bowel or bladder 
habits. No dysuria. Denied arthralgias or myalgias. 

 
Past Medical History:
ONCOLOGIC HISTORY:  
- ___: Asymptomatic abnormal CBC noted by PCP during routine 
visit  
- ___: Bone marrow biopsy showed myeloproliferative 
disorder, likely chronic myelogenous leukemia. Per patient 
report, began taking interferon three times weekly shortly after 
diagnosis.  
- ___: Started Gleevec 400 mg daily. At some point 
thereafter, her dose was increased to 600 mg daily  
- ___: Gleevec increased to 400 mg twice daily with 
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be 
in late chronic phase CML. Stem cell transplant was recommended, 
but she did not wish to pursue this course.  
- ___: ___ held due to worsening anemia and 
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on 
Dasatinib   
- ___: First seen at ___. Bone marrow biopsy showed 
accelerated phase CML. began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by  
mucositis with biopsy of the esophagus suggesting upper GI GVHD 
which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper 
and lower GI tract in the setting of reducing immunosuppression 
- course complicated by myositis due to GVHD requiring 
intubation, received IVIG on ___
.
.
PAST MEDICAL HISTORY: 
- atherosclerotic coronary vascular disease  
- status post CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  

 
Social History:
___
Family History:
- father - died of MI, no other health problems
- mother - had heart problems, DM
Four siblings
- 2 bothers had CABG
- 1 brother prostate cancer
- Her sister ___ is her donor and is well 

 
Physical Exam:
ADMISSION PHYSICAL EXAM: 
T 98.5 BP 153/70 HR 118, RR 22 93% 10L TM
GENERAL: appears fatigued, pale, no acute distress.  Tach masck 
in place.
HEENT: No scleral icterus. PERRLA/EOMI. MM dry. OP clear.  Neck 
Supple, No LAD.
CARDIAC: RR. Normal S1, S2. No m/r/g. 
LUNGS: CTA B, good air movement bilaterally.
ABDOMEN: NABS. Soft, NT, ND.  No HSM
EXTREMITIES: Diffuse bruising/ecchymosis of the right axilla 
extending down left flank.  Hands with black eschars on dorsal 
surfaces bilaterally. 
.
DISCHARGE PHYSICAL EXAM:
T 97.2 BP 116/70 P 81 RR 20 SaO2 99% RA
GENERAL: elderly F in NAD, lying in bed 
HEENT: No scleral icterus. PERRLA/EOMI. MM dry. OP clear.  Neck 
Supple, No LAD.
CARDIAC: RR. Normal S1, S2. No m/r/g. 
LUNGS: CTA B, good air movement bilaterally.
ABDOMEN: Normoactive bowel sounds. Soft, NT, ND.  No HSM.
EXTREMITIES: 1+ pitting edema in LLE. Pulses 2+ bilaterally. 
NEURO: strength ___ in RLE flexors, ___ in LLE flexors. Strength 
___ in LLE and RLE extensors. Sensation grossly intact 
bilaterally.  
SKIN: Hands with black eschars on dorsal surfaces bilaterally. 
Diffuse bruising on skin. 
 
Pertinent Results:
ADMISSION LABS:
WBC-8.0 RBC-3.40* Hgb-11.5* Hct-34.0* MCV-100* MCH-33.8* 
MCHC-33.7 RDW-20.0* Plt ___
Neuts-74* Bands-1 Lymphs-9* Monos-14* Eos-0 Baso-0 Atyps-0 
Metas-2* Myelos-0 NRBC-1*
Glucose-93 UreaN-26* Creat-0.3* Na-136 K-4.6 Cl-101 HCO3-24 
AnGap-16
Calcium-8.8 Phos-4.1 Mg-2.0
ALT-113* AST-51* AlkPhos-228* TotBili-0.8 BLOOD Lipase-21
.
DISCHARGE LABS:
WBC-3.1* RBC-2.70* Hgb-9.3* Hct-28.6* MCV-106* MCH-34.5* 
MCHC-32.4 RDW-18.8* Plt ___
Neuts-63 Bands-0 Lymphs-13* Monos-13* Eos-0 Baso-0 Atyps-0 
Metas-11* Myelos-0
Glucose-114* UreaN-20 Creat-0.4 Na-138 K-4.0 Cl-105 HCO3-29 
AnGap-8
ALT-72* AST-59* AlkPhos-178* TotBili-0.5
Calcium-8.2* Phos-2.2* Mg-1.7
.
Urine Tests:
___ 06:50PM URINE Color-Yellow Appear-Clear Sp ___
___ 06:50PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
.
MICROBIOLOGY: 
Stool culture (___): NEGATIVE
Stool O&P (___): NEGATIVE
Stool C. diff toxin A/B (___): NEGATIVE
Blood cultures (___): NEGATIVE
CMV PCR (___): NEGATIVE
Stool C. diff toxin A/B (___): POSITIVE
.
COLONOSCOPY (___): Distal ileum and colon appeared normal with 
the exception of two whitish 9 mm ""nodules/plaques"" in the 
cecum. Random biopsies were taken from the distal ileum, 
ascending colon, transverse colon, recto-sigmoid to assess for 
GVHD. Separately the two cecal nodules which readily came off 
completely with biopsy forceps, were submitted as ""cecal 
nodules"". Cold forceps biopsies were performed for histology at 
the ileum, ascending colon, transverse colon, recto-sigmoid 
colon, cecal nodules. 
.
EGD (___): Normal exam. Biopsies were taken from the ___ 
portion of the duodenum to assess for evidence of GVHD. Cold 
forceps biopsies were performed for histology. 
.
CT CHEST WITHOUT CONTRAST (___):
1. Diffuse narrowing of the airways without associated air 
trapping or 
peribronchial inflammation may represent early changes related 
to 
bronchiolitis obliterans. No air trapping or evidence of 
infection. 
2. Right approach PICC terminates within the right atrium. 
3. Diffusely increased attenuation of the liver most compatible 
with iron 
deposition. 
4. Pericardial calcification likely the residual of prior 
pericarditis. 
5. 3.0 fluid collection within the right breast is smaller since 
___, likely related to a seroma or resolving hematoma, for 
which clinical correlation is recommended. 
6. Diffusely atrophied chest wall musculature. 
.

 
Brief Hospital Course:
Ms. ___ is a ___ year old woman with a history of 
accelerated CML s/p allo-MRD SCT ___ complicated by GVHD of 
the liver, gut, myositis necessitating intubation due to 
respiratory muscle weakness.  She presented with worsening 
blood-streaked diarrhea and elevated LFTs, with hospitalization 
complicated by multiple DVTs and resulting BRBPR caused by 
heparin gtt, with BRBPR, and recurrent C. diff infection.
.
#. DIARRHEA: ___ GVHD and recurrent C diff. Patient has been 
having blood-streaked diarrhea since admission likely secondary 
to GVHD, which progressed to BRBPR with clots after starting 
heparin gtt for DVTs (see below). Heparin was discontinued, but 
patient with continued diarrhea. On ___ C. diff toxin was 
found positive. Pt has had multiple episodes of C diff in past, 
and prophylactic PO vanco had been discontinued on ___. She 
was started on IV flagyl on ___ for her positive C diff), then 
switched to vanco 500mg PO q6hrs per GI recs (used for recurrent 
c diff: 250-500mg PO q6hrs x14 days, then taper). Diarrhea 
progressively improved after this. Patient also has chronic gut 
and liver GVHD. She had EGD and colonoscopy on ___, which 
showed 2 whitish cecal plaques/nodules with biopsy showing focal 
active ileitis, rare apoptotic crypt cells in 
ileum/ascending/transverse colon consistent with (but not 
specific for) GVHD. Also had ileocecal valve nodules composed of 
""predominantly fibrinopurulent exudate consistent with ulcer and 
a very minute strip of surface epithelium"". EGD/colonoscopy 
biopsies were found negative for AFB, fungi, CMV, viruses. For 
her C diff, patient is discharged on Vancomycin 500mg PO q6 
hours for 14 days (first day = ___, last day = ___. After 
this, she should restart suppressive therapy: vancomycin 250mg 
q6 hours chronically. For her GVHD, she is discharged on 
prednisone 30mg by mouth daily, and cyclosporine 50mg by mouth 
twice daily. 
.
#. BRBPR: pt admitted with blood-streaked stools, found likely 
secondary to GVHD (confirmed by colonoscopy on ___. When 
heparin gtt was started for multiple ___ DVTs, patient developed 
frank BRBPR with clots. This resolved after discontinuing 
heparin gtt; patient guaiac negative afterward. She was started 
on enoxaparin 40mg BID for DVT prophylaxis with no ensuing 
complications.   
.
#. ELEVATED LFTs: Patient has known GVHD of the liver.  LFTs on 
admission showed elevated AST, ALT and Alk Phosph, found likely 
___s voriconazole, which she is taking for h/o 
paelomyces (___). Her cyclosporine was uptitrated from 25 
BID to 50mg qAM and 75mg qPM. When cyclosporine was decreased to 
50BID, her LFTs rose again (AST 59, ALT 72, Alk Phosph 178). 
**Cyclosporine was increased/decreased/not changed....***
.
#. GVHD: manifested as gut, liver, and muscle GVHD. During 
hospitalization her cyclosporine was increased from 25mg BID to 
50mg BID as it was felt that her diarrhea on presentation was 
from GVHD. Her prednisone was decreased to 30mg by mouth daily. 
Due to her muscle GVHD (diagnosed by rheumatology), patient is 
extremely weak in her ___ flexor muscles. She will continue 
physical therapy at rehab. She was also incidentally found to 
have diffuse airway narrowing consistent with possible early 
bronchiolitis obliterans on chest CT on ___, although no 
clinical signs/symptoms and currently appropriately treated with 
steroids and cyclosporine. 
.
# MULTIPLE ___ DVTs: patient had left ___ swelling during 
hospitalization. ___ on ___ showed multiple BLE DVTs 
involving common femoral, superficial femoral, popliteal and 
posterior tibial and peroneal veins on L>R. ___ swelling L>R. Pt 
started on heparin gtt overnight ___, with a goal PTT of 
60-80. She also has an IVC filter in place. Unfortunately, she 
then had BRBPR overnight with a supratherapeutic PTT (150).  The 
heparin gtt was held. She was started on enoxaparin 40mg BID for 
DVT prophylaxis, without further guaiac positive stools.  
.
# DYSPHAGIA, REDUCED VOCAL CORD MOBILITY: patient has h/o 
dysphagia secondary to muscle GVHD. She had repeat swallow study 
on ___ which showed no aspiration, also noted reduced right 
vocal cord mobility for which she should have outpatient ENT 
followup with Dr. ___ # ___. Swallow eval 
recs were soft solids, nectar thickened liquids, pills crushed 
in puree.
.
#. PAECILOMYCES ON BRONCHIOALVEOLAR LAVAGE: pt found to have 
paecilomyces growth on BAL on ___ (her last 
hospitalization) in Legionella bottle. She was discharged at 
that time on voriconazole with plan to follow up in 2 weeks. 
Voriconazole was continued throughout hospitalization. She will 
need outpatient ID follow-up in ___. 
___ with repeat chest CT prior to appointment, where it will be 
determined whether or not to continue Voriconazole. Beta glucan 
was rechecked and found to be 52 (down from 92 on ___.  
.
# CML s/p MRD AlloSCT: pt is s/p allogeneic SCT on ___. She 
is currently in remission, with no evidence of leukemia at this 
time. Her course has been complicated by GVHD. During 
hospitalization her acyclovir and atovaquone prophylaxis were 
continued. 
.
# MACROCYTIC ANEMIA: normal B12, folate, TSH. Likely anemia of 
chronic disease. B12 and folate supplementation were continued 
during hospitalization. 
.
# TRACHEOSTOMY: pt has h/o tracheostomy after intubation on last 
hospitalization due to respiratory muscle weakness from GVHD. 
Trach was decannulated on ___ by IP without incident. 
Patient was not dyspneic throughout hospitalization. 
.
# HYPERTENSION: home metoprolol and captopril were continued. 
Amlodipine was decreased from 10mg daily to 5mg daily. 

==================================
 
Medications on Admission:
MEDICATIONS, per rehab records:
Trazodone 50 mg PO qHS
Vancomycin 250 mg PO q6H
Jevity 1.2 cal 50 ml/hr
Water 120 ml q6H
Voriconazole 200mg PO q12
Combivent inhalation 3 ml q4H PRN
Nystatin 5ml PO QID
Amlodipine 10 mg daily
Atovaquone 1500 mg PO q12H
Colestyramine 1 packet q12
Acyclovir 400 mg PO q12
Calcium Carbonate 500 mg PO q8H
Alumina/magnesia/simethicone 30 ml PO q6H PRN
Cyclosproine 25 mg PO q12H
Lansoprazole 30 mg PO daily
Acetaminophen 650 mg PO q6H PRN
Fluticasone 2 puffs BID
Prednisone 30 mg PO BID
Metoprolol 100 mg PO q6H
Captopril 12.5 mg PO q8H
Diazeptam 2 mg PO qHS PRN
Lorazepam 1 mg IV q6H PRN
Cholecalciferol 400 units PO q12H
Heparin 5000 units SC q12
Lidocaine 2% 10ml PO q8H PRN
.
DIFFERENCES FROM PRIOR D/C SUMMARY:
- Atovaquone is listed as daily on d/c summary
- PO vanc is not on d/c summary
- immunosuppression was IV solumedrol 30 mg BID and IV 
cyclosporine
 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnoses: 
1. GVHD of gut, liver and muscle
2. C. difficile diarrhea

Secondary diagnosis: 
1. Accelerated CML 
GVHD of gut, liver and muscle

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure participating in your care at ___ 
___. You were admitted to the hospital for 
increasing diarrhea and elevations in your liver enzymes. We did 
some tests, which showed that this was probably not due to an 
infection. You also had an upper and lower endoscopy which 
showed signs of GVHD. We will continued to treat this with 
cyclosporin and prednisone. In addition, you had a recurrence of 
diarrhea caused by C. difficile (which you have had several 
times in the past). We are treating this with an antibiotic 
called vancomycin. 

Please attend the follow-up appointments listed below with your 
oncologist Dr. ___ the voice specialist Dr. ___. 

We made the following changes to your medications:
1. STARTED enoxaparin 400mg subcutaneous twice daily
2. STARTED alendronate sodium 5mg by mouth daily
3. STARTED ipratropium bromide MDI 2 puffs every 4 hours as 
needed for wheezing/shortness of breath
4. STARTED clonazepam 1mg by mouth at bedtime as needed for 
insomnia
5. INCREASED vancomycin to 500mg by mouth every 6 hours 
6. INCREASED cyclosporin to 50mg by mouth twice daily
7. DECREASED prednisone to 30mg by mouth once daily
8. DECREASED atovaquone to 1500mg by mouth once daily
9. DECREASED amlodipine to 5mg by mouth once daily
10. DECREASED cholecalciferol to 400 units by mouth once daily
11. STOPPED trazodone
12. STOPPED Jevity (tube feeds)
13. STOPPED Combivent
14. STOPPED cholestyramine
15. STOPPED aluminum/magnesium/simethicone
16. STOPPED diazepam
17. STOPPED lorazepam
18. STOPPED heparin subcutaneous injections
19. STOPPED lidocaine 2% 
20. STOPPED fluticasone
 
Followup Instructions:
___
"
161,19940147,27257780," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
Shortness of Breath
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
This is a ___ y/o F with a past medical history of CML status 
post autologous stem cell transplant in ___ complicated by 
graft versus host disease of the skin, GI tract and liver, 
recent episode of respiratory failure requiring intubation in 
___, on Voriconazole for Paecilomyces recovered 
from BAL specimen, now admitted for further evaluation of 
shortness of breath.

The patient was last seen in ___ clinic on 
___ and complained of a two day history of sore throat 
followed by a cough, congestion, and rhinorrhea.  She had 
yellowish-green sputum at that time.  A decision was made to 
treat her with a five day course of Azithromycin.  Her 
Prednisone was also increased from 30mg ___ to 40mg ___ for 
two days and then decreased to 30mg ___.  The patient says she 
did not feel much improvement on Azithromycin.  She started to 
experience increased dyspnea on exertion and became concerned.  
She denies fevers, chills, nausea, vomiting, diarrhea, chest 
pain, or new rash.  She has had a decrease in appetite and 
cough.

The patient as seen again on ___ in ___ 
clinic where she underwent Respiratory viral screen.  She had 
one set of blood cultures drawn and was given a dose of 
levofloxacin in clinic.  Due to ongoing shortness of breath, the 
she was admitted for further work up.    

The patient thinks her husband had the ""sniffles"" and a cough a 
few weeks ago.  

 
Past Medical History:
ONCOLOGIC HISTORY:  
- ___: Bone marrow biopsy showed myeloproliferative  
disorder, likely chronic myelogenous leukemia. Per patient  
report, began taking interferon three times weekly shortly  
after diagnosis.  
- ___: Started ___ 400 mg ___. At some point  
thereafter, her dose was increased to 600 mg ___  
- ___: ___ increased to 400 mg twice ___ with  
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be  

in late chronic phase CML. Stem cell transplant was  
recommended, but she did not wish to pursue this course.  
- ___: Gleevec held due to worsening anemia and  
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on  
Dasatinib  
- ___: First seen at ___. Bone marrow biopsy showed  
accelerated phase CML. began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by  
mucositis with biopsy of the esophagus suggesting upper GI GVHD  

which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper 
and
lower GI tract in the setting of reducing immunosuppression  
  
PMHx:  
- atherosclerotic coronary vascular disease  
- status post CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  

 
Social History:
___
Family History:
Father - died of MI, no other health problems
Mother - had heart problems, DM

 
Physical Exam:
admission exam 
Vitals - T: 96 BP: 141/92 HR: 97 RR: 18 02 sat: 94% 2L 
GENERAL: NAD  
SKIN: warm and well perfused, multiple healing skin lesion on 
both arm 
HEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, 
slight proptosis, patent nares, MMM, good dentition, nontender 
supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no mrg  
LUNG: CTA at apices of lungs, with diffuse rhonchi in mid and 
lower back R>L
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
M/S: moving all extremities well, no cyanosis, clubbing or 
edema, no obvious deformities  
PULSES: 1+ DP pulses bilaterally  
NEURO: CN II-XII intact, ___ strength in the lower extremities
. 
discharge exam 
VS: 96.0 131/68 (127/68-136/67) 83 (79-95) 18 99% RA
GEN: comfortable in NAD 
HEENT: AT/NC, anicteric sclera, MMM
CARDIAC: RRR, S1/S2, no mrg  
LUNG: scattered crackles throughout worse on right than left
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding
M/S: moving all extremities well, no cyanosis, clubbing or edema
PULSES: 1+ DP pulses bilaterally  
NEURO: awake, A&Ox3. 
SKIN: warm and well perfused

 
Pertinent Results:
admission labs: 
___ 02:00PM BLOOD WBC-9.3# RBC-3.95* Hgb-14.0 Hct-39.9 
MCV-101* MCH-35.5* MCHC-35.2* RDW-17.0* Plt ___
___ 02:00PM BLOOD Neuts-89.0* Lymphs-6.5* Monos-4.0 Eos-0.1 
Baso-0.5
___ 02:00PM BLOOD ___
___ 02:00PM BLOOD UreaN-40* Creat-1.0 Na-137 K-5.4* Cl-104
___ 02:00PM BLOOD ALT-151* AST-122* LD(LDH)-503* 
CK(CPK)-136 AlkPhos-218* TotBili-0.4
.
discharge labs
___ 06:50AM BLOOD WBC-6.9# RBC-3.51* Hgb-11.7* Hct-36.0 
MCV-103* MCH-33.4* MCHC-32.6 RDW-16.7* Plt ___
___ 06:50AM BLOOD Neuts-75* Bands-0 Lymphs-10* Monos-4 
Eos-0 Baso-0 ___ Metas-8* Myelos-3* NRBC-1*
___ 06:50AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ 
Macrocy-3+ Microcy-OCCASIONAL Polychr-1+ Schisto-1+ Tear Dr-1+
___ 06:50AM BLOOD ___ PTT-28.8 ___
___ 06:50AM BLOOD Glucose-100 UreaN-20 Creat-0.6 Na-142 
K-4.1 Cl-110* HCO3-19* AnGap-17
___ 06:50AM BLOOD ALT-53* AST-39 AlkPhos-107* TotBili-0.4
___ 06:50AM BLOOD Calcium-8.1* Phos-2.3* Mg-1.7
. 
micro
   Respiratory Viral Antigen Screen (Final ___: 
      Positive for Respiratory viral antigens. 
      Specimen screened for: Adeno, Parainfluenza 1, 2, 3, 
Influenza A, B,
      and RSV by immunofluorescence. 
      Refer to Respiratory Virus Identification for further 
information. 

   Respiratory Virus Identification (Final ___: 
      POSITIVE FOR RESPIRATORY SYNCYTIAL VIRUS (RSV). 
         Viral antigen identified by immunofluorescence. 
         Reported to and read back by ___ 11:17AM 
___. 
.
blood culture - no growth
urine legionella - negative
sputum ___
   GRAM STAIN (Final ___: 
      >25 PMNs and <10 epithelial cells/100X field. 
      1+    (<1 per 1000X FIELD):   MULTIPLE ORGANISMS 
CONSISTENT WITH     
                                    OROPHARYNGEAL FLORA. 
   RESPIRATORY CULTURE (Final ___: 
      SPARSE GROWTH Commensal Respiratory Flora. 
   Immunoflourescent test for Pneumocystis jirovecii (carinii) 
(Final
      ___:    NEGATIVE for Pneumocystis jirovecii 
(carinii).. 
   FUNGAL CULTURE (Preliminary): 
      PENICILLIUM SPECIES. 
.
studies:
CT chest ___
IMPRESSION:
1. Multifocal pneumonia, worst at the right upper lobe.
2. Cholelithiasis.
.
RUQ ultrasound
1. No evidence of biliary obstruction.
2. Coarsened liver, reflecting underlying diffuse disease such 
as GVHD. Other
forms of liver disease cannot be excluded. Unchanged 
subcentimeter left
hepatic cyst.
3. Punctate gallstone, without acute cholecystitis.
 
Brief Hospital Course:
___ year old woman with a history of CML s/p allo stem cell 
transplant in ___ complicated by GVHD and pulmonary 
Paecilomyces infection who presented with several days of new 
cough found to be RSV positive.  
.
# Dyspnea - Patient presented with SOB which worsened despite 
treatment with azithromycin. CT chest showed evidence of 
multifocal pneumonia. She was initially started on levofloxacin 
and vancomycin. The infectious disease team was consulted. 
Respiratory viral screen returned positive for RSV. Patient was 
treated with Palivizumab. Antibiotics were discontinued. 
Respiratory symptoms improved. Patient was discharged with plans 
to treat cough and nasal congestion symptomatically and follow 
up with her hematologist/oncologist and infectious disease 
specialist as scheduled. 
.
# GVHD: continued Azathioprine, cyclosporine, prednisone. Her 
prednisone dose was increased to 40 mg during the week of 
admission. It was tapered down to 30 mg ___ at time of 
discharge. 
.
# History of Paecilomyces Pulmonary Infection: Patient's 
voriconazole was changed to posaconazole given concern that it 
may be contributing to elevated LFTs. 
.
# History of DVT: Patient on Coumadin. INR fluctuated likely in 
the setting of many medication changes. Patient was discharged 
with alternating doses of 5 mg and 2.5 mg ___. She has plans 
to have her INR checked on ___ at her PCP's office.  
.
# Hypertension: continued home dose Metoprolol, Captopril, and 
amlodipine
.
# History of Clostridium difficile colitis: continued oral 
Vancomycin at prophylactic dosing
.
# Infection Prophylaxis - Continued Bactrim and acyclovir
.
Transitional Issues: 
- no labs pending at time of discharge
- patient's INR will need close monitoring and Coumadin dose 
will likely need further adjustment 
- patient full code on this admission

 
Medications on Admission:
Medications: RECONCILED
Acyclovir 400mg BID
amlodipine 5mg ___
Azathioprine 100mg ___
Azithromycin 250mg ___ (switched to levo in clinic)
Captopril 12.5mg TID
Cyclosporine 50mg BID
Lansoprazole 30mg ___
Metoprolol 100mg TID
Oxycodone 5mg ___ q 6 prn pain
Prednisone 30mg ___
SS Bactrim ___
Oral Vancomycin 250mg BID
Voriconazole 200mg BID
Coumadin 2.5mg ___ (I increased since subtherapeutic)
calcium carbonate 500mgTID
magnesium 133mg BID  

 
Discharge Medications:
1. posaconazole 200 mg/5 mL (40 mg/mL) Suspension Sig: Four 
Hundred (400) mg ___ Q12 () for 1 months.
Disp:*QS QS* Refills:*0*
2. acyclovir 400 mg Tablet Sig: One (1) Tablet ___ Q12H (every 12 
hours).  
3. amlodipine 5 mg Tablet Sig: One (1) Tablet ___.  

4. azathioprine 50 mg Tablet Sig: Two (2) Tablet ___ QPM (once a 
day (in the evening)).  
5. captopril 12.5 mg Tablet Sig: One (1) Tablet ___ TID (3 times 
a day).  
6. cyclosporine modified 25 mg Capsule Sig: Two (2) Capsule ___ 
Q12H (every 12 hours).  
7. lansoprazole 30 mg Tablet,Rapid Dissolve, ___ Sig: One (1) 
Tablet,Rapid Dissolve, ___ ___.  
8. oxycodone 5 mg Tablet Sig: ___ Tablets ___ Q6H (every 6 hours) 
as needed for pain.  
9. prednisone 10 mg Tablet Sig: Three (3) Tablet ___ 
(___).  
10. sulfamethoxazole-trimethoprim 400-80 mg Tablet Sig: One (1) 
Tablet ___.  
11. metoprolol succinate 100 mg Tablet Extended Release 24 hr 
Sig: Three (3) Tablet Extended Release 24 hr ___ once a day.  
12. vancomycin 250 mg Capsule Sig: One (1) Capsule ___ BID (2 
times a day).  
13. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable 
Sig: One (1) Tablet, Chewable ___ TID (3 times a day).  
14. warfarin 2.5 mg Tablet Sig: ___ Tablets ___ once a day: 
please take as directed. alternate 5 mg with 2.5 mg ___ .  
15. magnesium oxide-Mg AA chelate 133 mg Tablet Sig: One (1) 
Tablet ___ twice a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
primary diagnosis: Respiratory syncytial virus (RSV)
secondary diagnoses: chronic myelogenous leukemia, deep venous 
thrombosis, graft versus host disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 
.
It was a pleasure caring for you while you were admitted to 
___. You were admitted because you were having shortness of 
breath that was not improving with azithromycin. You had a 
number of studies done which showed a viral infection called 
RSV. You were evaluated by the infectious disease team and 
treated with Palivizumab for your illness and clinically 
improved. 
.
The following changes have been made to your medication regimen. 

Please START taking
- posaconazole 
. 
Please STOP taking
- voriconazole
. 
Please CHANGE 
- prednisone to 30 mg ___
- coumadin to be alternating doses of 5 mg or 2.5 mg ___ 
.
Please have your INR checked on ___ at your PCP's office. 

. 
Please take the rest of your medications as prescribed and 
follow up with your doctors as ___. 
 
Followup Instructions:
___
"
162,19940147,23121049," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
Diarrhea for 1 month
 
Major Surgical or Invasive Procedure:
Lumbar puncture
Colonscopy
Renal Biopsy

 
History of Present Illness:
___ y/o F with hx of accelerated phase CML s/p sibling allo D0 
___ c/b upper and lower GI GVHD ___, liver GVHD in 
setting of reducing immunosuppression ___, GVHD related 
myopathy resulting in weakness and respiratory failure ___, 
hx of multifocal pna with paecilomyces on bronch who was sent in 
from clinic for worsening pancytopenia in setting of ponatinib 
therapy and chronic diarhea. Pt has been feeling increasingly 
fatigued over last several weeks with persistent loose 
non-bloody stools, ranging from ___/ day. She has had no 
appetite and estimates loosing close to 15 pounds over last few 
weeks. Has had persistent nausea with no emesis. Also promotes 
increasing SOB with exertion and muscle weakness. Associated 
with lightheadedness when standing but no cp or palpitations. 
Symptoms had initially improved following prbc 2 weeks ago. Pt 
also promotes increasing cough this morning and some sputum 
production. Denies any sf/chills/sweats. Also promotes painful 
lesion on left lateral tongue which has been present for last 
few weeks. She denies any muscle pain and CK normal at outpt 
appointment. No calf tenderness. 

 
Past Medical History:
ONCOLOGIC HISTORY:  
- ___: Bone marrow biopsy showed myeloproliferative  
disorder, likely chronic myelogenous leukemia. Per patient  
report, began taking interferon three times weekly shortly  
after diagnosis.  
- ___: Started Gleevec 400 mg daily. At some point  
thereafter, her dose was increased to 600 mg daily  
- ___: Gleevec increased to 400 mg twice daily with  
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be  

in late chronic phase CML. Stem cell transplant was  
recommended, but she did not wish to pursue this course.  
- ___: Gleevec held due to worsening anemia and  
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on  
Dasatinib  
- ___: First seen at ___. Bone marrow biopsy showed  
accelerated phase CML. began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by  
mucositis with biopsy of the esophagus suggesting upper GI GVHD  

which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper 
and
lower GI tract in the setting of reducing immunosuppression  
  
PMHx:  
- atherosclerotic coronary vascular disease  
- status post CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  

 
Social History:
___
Family History:
Father - died of MI, no other health problems
Mother - had heart problems, DM

 
Physical Exam:
Admission:
GENERAL - ill appearing female w/ alopecia
HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, dry mucous 
membranes with large amphthous ulcer on left lateral tongue 
surface and smaller on on posterior gum. 
NECK - supple, no thyromegaly, no JVD, no carotid bruits  
LUNGS - Lungs are clear to ausculatation bilaterally, moving air 
well and symmetrically, resp unlabored, no accessory muscle use. 
Dry, flaking skin over R latetal chest wall. 
HEART - PMI non-displaced, RRR, ___ systolic flow murmur, 
rubs or gallops  
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no 
rebound/guarding  
EXTREMITIES - many ecchymosis over extremities, dry scaling skin 
over back, 2+ peripheral pulses (radials, DPs)  
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout, DTRs 2+ and 
symmetric  

Discharge:
VS: 98.3  130/85  85 18 98%RA
General: chronically ill appearing, very pleasant woman, NAD, 
alopecia
LINES: Picc in place, c/d/i
Skin: multiple ecchymoses over body, skin peeling along back and 
upper thighs bilaterally, skin very tight appearing on upper and 
lower extremities b/l
HEENT: NCAT, MMM, sclera anicteric
lungs: CTA b/l, no wheezes, rhonchi, crackles noted
CV: RRR S1 S2
Abdomen: soft, nontender, nondistended, +BS
extremities: trace pedal edema b/l
Neuro: alert and oriented, moving all extremities spontaneously  


 
Pertinent Results:
Admission:

___ 01:55PM BLOOD WBC-1.5* RBC-3.35*# Hgb-9.2*# Hct-28.3*# 
MCV-85 MCH-27.6 MCHC-32.6 RDW-18.1* Plt Ct-63*
___ 01:55PM BLOOD Neuts-82.0* Lymphs-13.1* Monos-4.2 
Eos-0.6 Baso-0.1
___ 01:55PM BLOOD UreaN-43* Creat-2.5* Na-135 K-5.0 Cl-105 
HCO3-16* AnGap-19
___ 01:55PM BLOOD ALT-16 AST-17 LD(LDH)-527* CK(CPK)-38 
AlkPhos-229* Amylase-64 TotBili-0.4

Troponins:
___ 12:10AM BLOOD CK-MB-5 cTropnT-0.21*
___ 10:30AM BLOOD CK-MB-5 cTropnT-0.24*
___ 03:39PM BLOOD cTropnT-0.23*
___ 12:08PM BLOOD CK-MB-4 cTropnT-0.21*

Other Labs:
___ 05:00PM BLOOD VitB12-1063* Ferritn-5306*
___ 03:28AM BLOOD Cryoglb-NO CRYOGLO
___ 05:00PM BLOOD IgG-82* IgA-11* IgM-4*
___ 12:40AM BLOOD C3-105 C4-37
___ 02:58AM BLOOD WBC-7.2 RBC-3.01* Hgb-9.6* Hct-27.7* 
MCV-92 MCH-31.8 MCHC-34.6 RDW-22.1* Plt ___
___ 04:21AM BLOOD WBC-6.1 RBC-2.65* Hgb-8.5* Hct-24.4* 
MCV-92 MCH-32.2* MCHC-34.9 RDW-22.0* Plt Ct-86*
___ 05:22AM BLOOD WBC-2.3* RBC-2.57* Hgb-7.7* Hct-22.9* 
MCV-89 MCH-30.0 MCHC-33.5 RDW-21.3* Plt Ct-90*
___ 12:19AM BLOOD WBC-4.9 RBC-2.84* Hgb-8.5* Hct-25.5* 
MCV-90 MCH-30.0 MCHC-33.5 RDW-21.9* Plt ___
___ 07:20AM BLOOD Glucose-93 UreaN-31* Creat-2.2* Na-133 
K-3.9 Cl-108 HCO3-13* AnGap-16
___ 04:21AM BLOOD Glucose-91 UreaN-58* Creat-2.0* Na-137 
K-3.9 Cl-109* HCO3-20* AnGap-12
___ 02:01AM BLOOD ALT-25 AST-43* LD(LDH)-661* AlkPhos-232* 
TotBili-0.3
___:21AM BLOOD ALT-35 AST-27 LD(LDH)-460* AlkPhos-170* 
TotBili-0.4
___ 11:06AM BLOOD 25VitD-34
___ 11:06AM BLOOD IgG-302*

Graft Chimerism Study: 100% donor

ASPERGILLUS GALACTOMANNAN ANTIGEN Neg 
B-GLUCAN Neg
HERPES 6 DNA PCR, QUANTITATIVE Neg
PARVOVIRUS B19 DNA Neg 
HERPES 6 DNA PCR, QUANTITATIVE Neg 
EBV PCR, QUANTITATIVE, WHOLE BLOOD Neg 
COPPER 61  
ZINC 51 
HERPES SIMPLEX VIRUS 1 AND 2 (IGG) Neg 
ADENOVIRUS PCR Neg

CSF:
___ 03:06PM CEREBROSPINAL FLUID (CSF) WBC-2 RBC-1* Polys-87 
___ ___ 03:06PM CEREBROSPINAL FLUID (CSF) TotProt-18 Glucose-74
___ 05:00PM BLOOD ZINC-Test      

Bone Marrow Bx 
HYPOCELLULAR BONE MARROW WITH TRILINEAGE HEMATOPOIESIS AND 
DECREASED MEGAKARYOCYTES.  NO MORPHOLOGIC EVIDENCE OF 
TRANSFORMATION OR HEMOPHAGOCYTIC SYNDROME ARE SEEN.  SEE NOTE.

Note: The findings overall suggest marrow suppression, perhaps 
related to TKIs, rather than hemophagocytic syndrome, i.e. there 
are only occasional hemophagocytic macrophages present, with 
hemosiderin-laden macrophages predominating, and no overt marrow 
""damage"" seen. 

Colon Bx:
Random colon, mucosal biopsies:
Colonic mucosa with focal crypt atrophy and dropout with rare 
basal crypt epithelial cell apoptoses consistent with graft 
versus host disease in the appropriate clinical setting; no 
viral cytopathic effect seen; see note.
Note: Given rare neutrophilic crypt abscesses, a concomitant 
acute infectious process cannot entirely be excluded. 
Immunostain for cytomegalovirus is in progress and will be 
reported in an addendum.
ADDENDUM #1: 
Immunostain for cytomegalovirus is negative with satisfactory 
controls.
ADDENDUM #2:
Immunostain for herpes simplex viruses 1 and 2 is negative with 
satisfactory controls.

Renal Bx:
KIDNEY (LEFT), CORE BIOPSY:

1.THROMBOTIC MICROANGIOPATHY, SEE NOTE.2.SEVERE INTERSTITIAL 
FIBROSIS AND TUBULAR ATROPHY.
Note: The biopsy shows striking acute and chronic thrombotic 
microangiopathy involving arterioles and glomeruli.  The biopsy 
also shows advanced scarring of the tubulointerstitial 
compartment (70-80% of the cortical area).

Imaging:
CT abd/pelvis ___
 
IMPRESSION: 
  
1.No wall thickening or pneumatosis concerning for colitis.    
  
2.Small amount of non-hemorrhagic intraperitoneal fluid. 

MRI C spine ___
IMPRESSION:  No cord compression or abnormal enhancement within 
the spinal canal.  Mild-to-moderate degenerative changes. 

MRI Head ___
IMPRESSION:  No acute infarcts, mass effect, hydrocephalus or 
abnormal 
enhancement.  Mild changes of small vessel disease.  Mucosal 
thickening left maxillary sinus and soft tissue changes in 
bilateral mastoids.

Renal US:
IMPRESSION: 
  
1. No evidence of hydronephrosis, stones, or focal renal 
lesions. 
2. Ascites. 

CT Chest ___
IMPRESSION: 
  
1.  Scattered small ground-glass and ___ opacities in 
the upper lobes could represent atypical infection, as 
suspected, or inflammation. 
  
2.  4 mm right upper lobe nodule is new since ___ 
and likely also infectious or inflammatory; this may be 
reassessed for resolution on follow-up imaging. 
  
3.  Hyperdense liver and spleen, similar to prior, likely due to 

hemosiderosis.  
  

Right lower extremity venous ultrasound ___:
Partial thrombus in the proximal right superficial femoral vein 
is relatively unchanged compared to the prior examination 
without evidence of DVT progression.   

 
Brief Hospital Course:
Ms. ___ is ___ with accelerated CML s/p allo transplant 
___ complicated by GVHD, pneumonia, myositis, and DVTs who 
initially presented with fatigue, diarrhea, pancytopenia in the 
setting of Cellcept and Ponatinib therapy.

# Diarrhea: Patient presented with 4 weeks of watery diarrhea 
with ___ bowel movements daily and poor appetite. Symptoms were 
most likely secondary to cellcept toxcity or ponatinib toxicity. 
Colon biopsy results were consisted with shallow crypts that are 
typically seen with GVHD or cellcept toxicity. While GVHD is a 
possible etiolgy, chronic GVHD is much less likely to present 
with acute diarrhea. An extensive infectious work up including 
norovirus, CMV, cdiff, adenovirus, parvovirus, HHV6, and O&P 
were negative. Ms. ___ improved with decreased cellcept 
dosing. She was transitioned from 1000mg BID to ___ BID at 
time of discharge. She continues to have ___ loose bowel 
movements daily. However, she continues to trend in a positive 
direction at the time of discharge. She did require 2 weeks of 
TPN but is now tolerating a PO diet at the time of discharge.

# Pancytopenia: Pt was noted to have progressive pancytopenia on 
outpatient labs over weeks preceeding admission. Pancytopenia is 
thought to be secondary to ponatinib toxicity as all cell lines 
improved after holding drug. Ms. ___ has experienced 
pancytopenia on previous TKI treatments as well. She was also 
transitioned from bactrim to atovaquone for PCP ___. A 
bone morrow biopsy was hypocellular but without concern for 
recurrent CML. A Graft chimerism study notable for 100% donor. 
Pt did also have HSV oral lesion and there may have been a 
component of HSV marrow suppression as her counts also improved 
with acyclovir therapy. Ponatinib is held at the time of 
discharge.

# Nephrotic syndrome:  The patient presented with acute on 
chronic CKD with creatinine around 2 this admission. Her 
creatinine has been gradually uptrending over the last year. It 
was never worked up and thought to be secondary to TKI therapy. 
She was found to have 4+ proteinuria this admission with low 
serum albumin and elevated triglycerides. A  renal biopsy was 
notable for acute on chronic microangiopathic disease, 
glomerular sclerosing and fibrosis of kidney. Etiology of 
changes remains unclear but differential is broad including 
effects of TKI treatment. There was no hydro or obtruction on 
renal us. Complement levels were normal and no serum 
cyroglobins. She was started on losartan 100mg daily and 
lisinopril 5mg for proteinuria. Pt was also started on aggresive 
IV diuresis for anasarca with improvement in fluid status. She 
will be discharged on 40mg PO Lasix with goal of maintaining 
within 2kg of her discharge weight, which was 143.6 lbs. 
Creatinine was stable around 2 at time of discharge. 

#Dyspnea: Patient promoted dyspnea during admission but never 
developed hypoxia. Symptoms were initially thought to be 
secondary to pulmonary edema and did improve with initial 
diuresis. However, symptoms did not completely resolve. A CT 
Chest was notable for some scattered ground glass opacities and 
a 4 mm right upper lobe nodule. PFTS show mixed obstructive and 
restrictive physiology. Fungal work up unrevealing. Pulmonology 
recommended a course of azithromycin for atypical pneumonia with 
follow up CT scan in 1 month. Dyspnea continued to improve at 
time of discharge following course of azithromycin. She was also 
started on pulmonary prophylaxis with FAM: daily fluticasone, 
azithromycin 3x/wk, monteleukast every other day.

#R lower extremity pain: Pt noted to have partial DVT of right 
superficial femoral vein which is unchanged from prev study in 
___ and most likely represents remnent from previous distal 
DVT which were treated with 6 months of anticoagulation. 
Vascular surg evaluated vascular appearing lesion on right lower 
extreity and are uncertain regarding etiology. ___ be secondary 
to smaller superficial thrombi in smaller leg veins. Recommend 
continued warm compresses, compression,and elevation of leg. 
Further anticoagulation at prophylactic dosing should be 
discussed as an outpatient once platlets are stable.

# Seizure like activity: Pt has 3 episodes of right neck 
twitching and mental status changes on ___ which appeared 
seizure like to staff. There was no tongue biting or generalized 
activity. An MRI Head was normal and LP without concern for 
bacterial infection. Viral cultures were all negative from CSF. 
An EEG was notable for encephalopathy without epileptical 
discharges. Pt experienced no further concerning neurologic 
changes following ___.

# HSV:Pt promoted oral pain on admission and was found to have 
several ulcerative lesions. An oral swab of lesions was positive 
for HSV. Symptoms and ulcers improved on acyclovir. She will 
continue prophylactic dosing as an outpatient.

#CML: Ms. ___ is status ___ allogenic transplant in ___ 
with recurrent disease in late ___. Disease has currently been 
well controlled on ponatinib with BCR-ABL PCR .09. However,has 
now been discontinued as drug toxicity outweighing benefits of 
treatment. As noted above, repeat bone marrow bx this admission 
without concern for recurrent disease. Chimerism study showed 
100% donor.

# GVHD: Has had GI  and skin involvement in past in addition to 
myositis. Has been well controlled on current MMF and prednisone 
dosing. While there was initial concern for GVHD as etiology to 
current presentation, it is uncommon to have diarrhea with 
chronic GVHD. Cellcept and prednisone doses were decreased this 
admission. She will need to closely monitor with recent decrease 
in immunosuppresion. 

#HTN: Ms. ___ had poorly controlled hypertension this 
admission. Most likely related to pregressive kidney disease. 
She was started on losartan, which was uptitrated to 100mg with 
good BP control by discharge.

#Hypogammablobulinemia: Likely ___ nephrotic syndrome and 
protein wasting. At admission, IgG level was 82 and she received 
an IVIg transfusion at 0.4g/kg. On ___, she received a second 
IVIg transfusion at the same dose for an IGg level of 300. 
During the second transfusion, she had some mild upper back pain 
and chills, which resolved with slowing the infusion.
 
=
=
=
=
=
=
=
=
=
=
=
=
=
=
=
=
=
================================================================
TRANSITIONAL ISSUES:

Please draw CBC w/ diff 2x/wk and fax results to patient's 
oncologist, Dr. ___: Fax: ___.

Patient received IVIg on ___. She may experience a severe 
headache within the first 72 hours after infusion, which can be 
treated with Tylenol.

Patient is being discharged on 40mg PO Lasix daily. This dose 
should be titrated to maintain her weight within 2kg of her 
weight upon arrival at ___.

Patient needs repeat chest CT 1 month after discharge to look 
for resolution of changes seen on CT during this admission.

Patient should arrange an appointment with a nephrologist close 
to her home in ___ within the next ___ months. If such 
arrangements cannot be made through the rehab facility; she 
should contact the ___ clinic at ___ and 
schedule an appointment with Dr. ___.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 300 mg PO DAILY 
hold for HR <60, SBP < 100 
2. PredniSONE 25 mg PO DAILY 
3. Amlodipine 5 mg PO DAILY 
4. Mycophenolate Mofetil 1000 mg PO BID 
5. OxycoDONE (Immediate Release)  ___ mg PO Q6H:PRN pain 
hold for rr <10 
6. Nystatin Oral Suspension 5 mL PO QID 
7. Omeprazole 20 mg PO DAILY 
8. Calcium Carbonate 500 mg PO BID 
9. Aspirin 81 mg PO DAILY 
10. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
11. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 

 
Discharge Medications:
1. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 
2. PredniSONE 20 mg PO DAILY 
3. OxycoDONE (Immediate Release)  ___ mg PO Q6H:PRN pain 
4. Omeprazole 20 mg PO DAILY 
5. Nystatin Oral Suspension 5 mL PO QID 
6. Mycophenolate Mofetil 250 mg PO BID 
7. Calcium Carbonate 500 mg PO BID 
8. Metoprolol Succinate XL 300 mg PO DAILY 
9. Aspirin 81 mg PO DAILY 
10. Acyclovir 400 mg PO Q8H 
11. Aquaphor Ointment 1 Appl TP BID 
12. Atovaquone Suspension 1500 mg PO DAILY 
13. Losartan Potassium 100 mg PO DAILY 
14. Allopurinol ___ mg PO DAILY 
15. Azithromycin 250 mg PO 3X/WEEK (___) 
16. Fluticasone Propionate 110mcg 4 PUFF IH BID 
17. Furosemide 40 mg PO DAILY 
18. Guaifenesin ___ mL PO Q6H:PRN cough 
19. Montelukast Sodium 10 mg PO EVERY OTHER DAY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
Mycophenolate Mofetil colitis
CML status post allogenic stem cell transplant
Graft versus host disease
Pancytopenia
Nephrotic syndrome
Hypogammablobulinemia
Hypertension
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).
 
Discharge Instructions:
Dear ___,

It was a pleasure taking care of ___ at ___. 
___ came in for several weeks of watery diarrhea which we 
believe is due to cellcept toxicity. We decreased your dose of 
cellcept with improvement of your symptoms. ___ were also found 
to have a condition called pancytopenia, which means low number 
of blood cells. We believe your CML medication ponatinib caused 
this and your blood counts improved when we discontinued this 
medication. 

___ were also found to have worsening kidney function this 
admission. The cause of your kidney problem is unclear but may 
also be due to the drug ponatinib. ___ were placed on losartan, 
which will help the kidney function better. ___ will continue to 
follow up with Dr. ___ as an outpatient.
 
Followup Instructions:
___
"
163,19940147,24246297," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
diarrhea, nausea, weight loss
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ y/o F with hx of accelerated phase CML s/p sibling allo D0 
___ c/b upper and lower GI GVHD ___, liver GVHD in 
setting of reducing immunosuppression ___, GVHD related 
myopathy resulting in weakness and respiratory failure ___, 
hx of multifocal pna with paecilomyces on bronch who was sent in 

from clinic for diarrhea x 5 days.  Diarrhea started on ___, 
worst on ___ with 10 watery stools.  Has improved in last 
several days, had 2 loose stools day prior to admission and 1 
loose stool morning of admission.  Patient notes night prior to 
start of diarrhea she went to a housewarming party where she ate 
chili.  She is usually very strict in terms of what she eats and 
visitors to her house.  She reports no other consumers of the 
chili got sick.  She notes that she usually has 2 soft bowel 
movements per day.  She denies blood in the stool and melanotic 
stools.  She also notes worsening nausea and decreased PO intake 
over the past ___ weeks but denies vomiting.  She reports weight 
loss of 5 pounds over the past 4 weeks.  Two weeks ago decreased 
her prednisone from 20mg daily to alternating 15mg and 20mg 
daily.  Denies sick contacts and recent travel history.  Denies 
fevers/chills, vomiting, hematochezia, melena, cough, abdominal 
pain.   

 
Past Medical History:
- ___: Bone marrow biopsy showed myeloproliferative 
disorder, likely chronic myelogenous leukemia. Per patient 
report, began taking interferon three times weekly shortly after 
diagnosis.  
- ___: Started Gleevec 400 mg daily. At some point 
thereafter, her dose was increased to 600 mg daily  
- ___: Gleevec increased to 400 mg twice daily with 
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be 
in late chronic phase CML. Stem cell transplant was recommended, 
but she did not wish to pursue this course.  
- ___: Gleevec held due to worsening anemia and 
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on 
Dasatinib  
- ___: First seen at ___. Bone marrow biopsy showed 
accelerated phase CML, began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by 
mucositis with biopsy of the esophagus suggesting upper GI GVHD 
which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper 
and lower GI tract in the setting of reducing immunosuppression  

- ___ Started on ponatinib 45 mg PO due to evidence of 
disease
- ___ admitted to the hospital for fatigue and diarrhea, 
renal biopsy showed microangiopathic disease, glomerular 
sclerosing and fibrosis of kidney and GI biopsy showed shallow 
crypts that are 
typically seen with GVHD or cellcept toxicity.  Her ponatinib 
was discontinued and prendisone and Cellcept doses were 
decreased.

PMHx:  
- atherosclerotic coronary vascular disease  
- status post CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  
 
Social History:
___
Family History:
Father - died of MI, no other health problems
Mother - had heart problems, DM
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
VITALS - T 97.5, BP 161/89, HR 73, RR 18, O2 sat 100%RA
GENERAL - well-appearing female w/ alopecia in no acute distress
HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, dry mucous 
membranes w/o ulcers 
NECK - supple, no thyromegaly, no JVD, no carotid bruits  
LUNGS - Lungs are clear to ausculatation bilaterally, moving air 

well and symmetrically, resp unlabored, no accessory muscle use. 
. 
HEART - RRR, normal S1/S2, ___ systolic flow murmur 
ABDOMEN - soft, non-distended, non-tender, +BS, no masses or 
HSM, no 
rebound/guarding  
EXTREMITIES - ecchymosis over extremities, hyperpigmented skin 
on dorsal bilateral hands, 2+ peripheral pulses (radials, DPs)  
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 

___ throughout 

DISCHARGE PHYSICAL EXAM:
VITALS - Tm 98.9 Tc98.6 BP 143/79 HR 85 RR 18 100%RA
GENERAL - Ill-appearing female w/ alopecia in no acute distress
HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, dry mucous 
membranes w/o ulcers 
NECK - supple, no thyromegaly, no JVD, no carotid bruits  
LUNGS - Lungs are clear to ausculatation bilaterally, moving air 

well and symmetrically, resp unlabored, no accessory muscle use 
HEART - RRR, normal S1/S2, ___ systolic flow murmur 
ABDOMEN - soft, non-distended, non-tender, +BS, no masses or 
HSM, no 
rebound/guarding  
EXTREMITIES - ecchymosis over extremities, hyperpigmented skin 
on dorsal bilateral hands, 2+ peripheral pulses (radials, DPs)  
NEURO - awake, A&Ox3, CNs II-XII intact, muscle strength 
___ throughout 
 
Pertinent Results:
___ LABS:
___ 11:30AM BLOOD WBC-13.2* RBC-2.78* Hgb-8.6* Hct-26.4* 
MCV-95 MCH-30.9 MCHC-32.6 RDW-17.3* Plt ___
___ 11:30AM BLOOD Neuts-86* Bands-0 Lymphs-3* Monos-6 Eos-0 
Baso-0 ___ Metas-4* Myelos-1*
___ 06:45PM BLOOD Ret Man-1.8*
___ 11:30AM BLOOD UreaN-66* Creat-2.6* Na-135 K-4.7 Cl-104 
HCO3-14* AnGap-22*
___ 11:30AM BLOOD ALT-14 AST-18 LD(LDH)-226 AlkPhos-123* 
TotBili-0.4
___ 11:30AM BLOOD TotProt-5.8* Albumin-3.8 Globuln-2.0 
Calcium-9.4 Phos-4.3 Mg-1.6

INTERVAL LABS:
___ 06:35AM BLOOD Hapto-303*
___ 06:40AM BLOOD Ferritn-4423*
___ 11:30AM BLOOD IgG-514*
___ 06:40AM BLOOD Cortsol-7.7

DISHCARGE LABS:
___ 06:25AM BLOOD WBC-4.5 RBC-2.94* Hgb-8.9* Hct-26.7* 
MCV-91 MCH-30.3 MCHC-33.3 RDW-16.8* Plt ___
___ 06:25AM BLOOD Neuts-86* Bands-1 Lymphs-2* Monos-7 Eos-1 
Baso-0 ___ Metas-3* Myelos-0 NRBC-2*
___ 06:25AM BLOOD Glucose-89 UreaN-31* Creat-2.0* Na-138 
K-3.8 Cl-104 HCO3-22 AnGap-16
___ 06:25AM BLOOD ALT-8 AST-21 LD(LDH)-281* AlkPhos-136* 
TotBili-0.4
___ 06:25AM BLOOD Calcium-8.7 Phos-2.1* Mg-1.6

MICRO:
___ respiratory viral screen/culture negative 
___ aspergillus galacomannan negative
___ B-glucan negative
___ HHV6 negative
___ EBV negative
___ Mycoplasma negative
___ BK Virus negative
___ stool cultures negative
___ CMV PCR negative
___ BCR/ABL gene rearrangement 2.013

IMAGING:
EGD ___ Normal
Flex Sig ___ Normal

Renal US ___
Tiny echogenic focus noted in the left kidney, perhaps a small 
AML or a calcified lesion unlikely to be of clinical 
consequence, but otherwise normal renal ultrasound. 

CT Sinus ___
Mucosal thickening in the maxillary sinuses, worse on the left.  
Opacification of the right sphenoid sinus.  Small polyps in the 
right posterior middle nasal turbinate and right pharynx.  The 
ostiomeatal units are patent. 

Gastric Empyting Study ___
IMPRESSION: Rapid gastric emptying. Note that the patient did 
not consume the full standard meal, making these findings 
difficult to interpret. 
 
Brief Hospital Course:
___ y/o F with hx of accelerated phase CML s/p sibling allo D0 
___ presenting with diarrhea x 4 days and nausea/decreased 
PO intake w/ weight loss over the past 1 month.  

# CML
CML s/p sibling allo D0 ___ complicated by GVHD.  No longer 
on TKI given multiple side effects.  Previous chimerism and 
BCR-ABL gene rearrangement study shows no residual disease 
however repeat test showed increased level of BCR-ABL gene.  
Here mycophenylate was stoooped to increase graft versus. 
leukemia effect.  We continued her current prednisone regiemtn 
15mg alternating with 20mg.  Her acyclovir and atovaquone were 
continued. 

# Nausea/Weight Loss
History of 1 month of worsening nausea and decreased PO intake 
correlated with 5 pound weight loss.  Concern for upper GI GVHD 
given decrease in steroids and nausea.  EGD and flex sig 
negative for signs of GVHD.  Her gastric empyting study was 
inconclusive.  Her symptoms improved with zyprexa and zofran.  
She was able to tolerate a diet at time of discharge and her 
symptoms were well-controlled.
 
# Sinus Congestion
Concern for sinus infection given symptoms and immunocompromised 
state.  CT sinus shows mucosal thickening w/o bone involvement.  
She was started on levofloxacin for a total of 14 days of 
treatment.  Her symptoms were imporved with afrin, flonase, and 
saline irrigation.  She will follow-up in ___ clinic in 1 month.

# Diarrhea
Presents with diarrhea x4 days and overnight had more non-bloody 
watery diearrhea.  Most likely secondary to viral or bacterial 
gastroenteritis.  However could be due to GVHD and recent 
decrease in prednisone dosing. Also could be medication side 
effects from mycophenylate.  On previous admission, had diarrhea 
and her mycophenylate dose was decreasd with improvement in his 
symptoms.  Her TKI was also disconinued during this admission.  
Diarrhea has been improving and flex sig was without signs of 
GVHD.  Stool studies were negative for infection.  On discharge 
her diarrhea had resolved.
 
# Non-Anion Gap Metabolic Acidosis 
Elevated bicarb w/ hypercholemia most likely due to combination 
of chronic kidney diease, diarrhea, and NS fluids.  We started 
oral bicarb replacement and her serum bicarb level normalized at 
time of discharge.

# Acute on Chronic Renal Failure
Elevated Cr to 2.6 from baseline 1.9-2.3 likely pre-renal 
etiology secondary to diarrhea and poor PO intake.  Also could 
possibly be due to renal GVHD.  Improved with fluids to 1.8.

# HTN
Her lasix, losartan, metoprolol, and amlodipine were continued.

# CAD
We continued here ASA 81.

Transitional Issues:
- Please follow-up pending Respiratory viral culture, HHV6, EBV, 
B-glucan, and aspergillus galactomannan
- If possible please coordinate upcoming ENT appointment on 
___ with next oncology appointment with Dr. ___

 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. PredniSONE 20 mg PO DAYS (___) 
2. PredniSONE 15 mg PO DAYS (___) 
3. Losartan Potassium 100 mg PO DAILY 
4. Acyclovir 400 mg PO Q8H 
5. Atovaquone Suspension 1500 mg PO DAILY 
6. Metoprolol Succinate XL 300 mg PO DAILY 
7. Amlodipine 5 mg PO DAILY 
8. Mycophenolate Mofetil 250 mg PO BID 
9. Furosemide 20 mg PO DAILY 
10. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
11. Omeprazole 20 mg PO DAILY 
12. Calcium Carbonate 500 mg PO BID 
13. magnesium oxide-Mg AA chelate 133 mg Oral BID 
14. Aspirin 81 mg PO DAILY 
15. albuterol sulfate 90 mcg/actuation Inhalation 1 puff daily 
TID prn SOB, wheezing 
16. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
 
Discharge Medications:
1. Acyclovir 400 mg PO Q8H 
2. Amlodipine 5 mg PO DAILY 
3. Aspirin 81 mg PO DAILY 
4. Atovaquone Suspension 1500 mg PO DAILY 
5. Calcium Carbonate 500 mg PO BID 
6. Furosemide 20 mg PO DAILY 
7. Metoprolol Succinate XL 300 mg PO DAILY 
8. Omeprazole 20 mg PO DAILY 
9. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
10. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
11. albuterol sulfate 90 mcg/actuation Inhalation 1 puff daily 
TID prn SOB, wheezing 
12. magnesium oxide-Mg AA chelate 133 mg Oral BID 
13. Levofloxacin 750 mg PO Q48H Duration: 5 Doses 
Please take the next dose in the evening on ___.   
RX *levofloxacin 750 mg Take 1 tablet by mouth every 48 hours 
Disp #*5 Tablet Refills:*0
14. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
RX *fluticasone 50 mcg Take 2 sprays nasally in both nostirls 
once daily Disp #*1 Bottle Refills:*0
15. Losartan Potassium 100 mg PO DAILY 
16. PredniSONE 15 mg PO DAYS (___) 
17. PredniSONE 20 mg PO DAYS (___) 
18. OLANZapine (Disintegrating Tablet) 5 mg PO QHS Duration: 5 
Days 
RX *olanzapine 5 mg Take 1 tablet,disintegrating(s) by mouth 
every night Disp #*5 Tablet Refills:*0
19. Ondansetron 4 mg PO Q8H:PRN nausea 
RX *ondansetron HCl 4 mg Take tablet by mouth every 8 hours Disp 
#*15 Tablet Refills:*0
 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis: Viral Gastroenteritis, Sinusitis, Acute on 
Chronic Renal Failure
Secondary Diagnosis: Accelerated Phase CML 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital because of diarrhea, nausea, 
and weight loss.  You had a upper GI scope and sigmoidoscopy 
that were normal.  You had a biopsy of your stomach that was 
normal and had no signs of graft versus host disease.  You had a 
CT of your sinuses that showed inflammation, please continue to 
take your antibiotics and follow-up with ENT.  You had an 
ultrasound of your kidneys that was normal.  Your mycophenylate 
was stopped.  Please continue taking your prednisone as before, 
alternating between 15mg and 20mg.  Your diarrhea and nausea 
were improved when you left the hospital.

All the best,
Your ___ Team
 
Followup Instructions:
___
"
164,19940147,20655019," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
Presyncope
 
Major Surgical or Invasive Procedure:
Intubation - ___
Muscle Biopsy - ___

 
History of Present Illness:
___ y/o F with history of accelerated phase CML s/p sibling allo 
D0 ___ complicated upper and lower GI GVHD ___, liver 
GVHD in setting of reducing immunosuppression ___, GVHD 
related myopathy resulting in weakness and respiratory failure 
___, history of multifocal pneumonia with paecilomyces on 
bronch, sent in from clinic for presyncope.  She woke up at 4 am 
with dry heaves, and over the course of the day of admission has 
experienced lightheadedness, failure to thrive and a presyncopal 
episode. She went to clinic, where she was given IV fluids, and 
was reportedly found to be orthostatic.  Labs showed troponin of 
1.07, CK-MB of 11. Creatinine was 2.3, bicarbonate 20.  
Hematocrit was 27.0.

Patient was recently admitted in ___ for nausea, diarrhea, 
poor PO intake and weight loss.   She had a flexible 
sigmoidoscopy and EGD with biopsy negative for GVHD.  Diarrhea 
resolved and stool cultures were negative.  Her ___ resolved w/ 
IVF. CT sinus had inflammation, and patient was given a course 
of levofloxacin for possible sinusitis.  Gastric emptying study 
was inconclusive. BCR/ABL gene rearrangment elevated from 
previous undected level to 2.013%, mycophenylate was stopped.  

Currently, patient is feeling well.  She endorses no chest pain, 
now or at the time of her symptoms.  She occasionally feels 
short of breath on exertion, but not at rest.  During her 
lightheaded episodes, she sometimes feels short of breath.  
There is no abdominal pain.  She is not currently nauseous.  
There is no palpitations.  She is currently not dizzy.

Review of Systems:  
(+) Per HPI.  
Denies fever, chills, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, cough, chest pain, 
abdominal pain, vomiting, diarrhea, constipation, BRBPR, melena, 
hematochezia, dysuria, hematuria.  
 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
- ___: Bone marrow biopsy showed myeloproliferative 
disorder, likely chronic myelogenous leukemia. Per patient 
report, began taking interferon three times weekly shortly after 
diagnosis.  
- ___: Started Gleevec 400 mg daily. At some point 
thereafter, her dose was increased to 600 mg daily  
- ___: Gleevec increased to 400 mg twice daily with 
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be 
in late chronic phase CML. Stem cell transplant was recommended, 
but she did not wish to pursue this course.  
- ___: Gleevec held due to worsening anemia and 
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on 
Dasatinib  
- ___: First seen at ___. Bone marrow biopsy showed 
accelerated phase CML, began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +___. Transplant complicated by 
mucositis with biopsy of the esophagus suggesting upper GI GVHD 
which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper  
and lower GI tract in the setting of reducing immunosuppression  

- ___ Started on ponatinib 45 mg PO due to evidence of 
disease  
- ___ admitted to the hospital for fatigue and diarrhea, 
renal biopsy showed microangiopathic disease, glomerular 
sclerosing and fibrosis of kidney and GI biopsy showed shallow 
crypts that are  
typically seen with GVHD or cellcept toxicity. Her ponatinib was 
discontinued and prendisone and Cellcept doses were decreased.  
- ___ admitted for nausea, diarrhea, poor PO intake and 
weight loss. Had flex sig and EGD with biopsy negative for GVHD. 
Diarrhea resolved, stool cultures negative. ___ resolved w/ IVF. 
CT sinus had inflammation, given course of levofloxacin. Gastric 
emptying study inconclusive. BCR/ABL gene rearrangment elevated 
from previous undected level to 2.013%, mycophenylate was 
stopped.  

PAST MEDICAL/SURGICAL HISTORY:  
- CAD s/p CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  
 
Social History:
___
Family History:
Father - died of MI, no other health problems  
Mother - had heart problems, DM  
No family history of cancer or blood disorders.  

 
Physical Exam:
ADMISSION PHYSICAL EXAM
VITALS - T 97.8, BP 92/55, HR 80, RR 18, O2 sat 99%RA  
GENERAL - ill-appearing female w/ alopecia in no acute distress  

HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, dry mucous  
membranes w/o ulcers  
NECK - supple, no thyromegaly, no JVD, no carotid bruits  
LUNGS - Lungs are clear to ausculatation bilaterally, moving air 
 
well and symmetrically, resp unlabored, no accessory muscle use. 
 
HEART - RRR, normal S1/S2, ___ systolic flow murmur  
ABDOMEN - soft, non-distended, non-tender, +BS, no masses or 
HSM, no rebound/guarding, ecchymoses over abdomen  
EXTREMITIES - ecchymosis over extremities, hyperpigmented skin 
on dorsal bilateral hands, 2+ peripheral pulses (radials, DPs)  
NEURO - non-focal
PSYCH - appropriate

DISCHARGE PHYSICAL EXAM
VITALS - TMax 98.7, TCurr 98.0, BP 121/63, HR 83, RR 20, Sat 99% 
on RA
GENERAL - chronically ill appearing female in no acute distress  

HEENT - NC/AT, PERRL, MMM, oropharynx clear without ulcers or 
lesions  
NECK - supple, no thyromegaly, no JVD, no carotid bruits  
LUNGS - Decreased breath sounds diffusely, otherwise no wheezes, 
rales, rhonci, or egophany   
HEART - RRR, normal S1/S2, stable ___ systolic decrescendo 
murmur heard best at RUSB
ABDOMEN - soft, non-distended, non-tender, +BS, no masses or 
HSM, no rebound/guarding
EXTREMITIES - trace to 1+ ___ edema (L>R), ecchymosis over 
extremities, hyperpigmented skin on dorsal bilateral hands, 2+ 
peripheral pulses (radials, DPs), superficial 3-4cm laceration 
on right posterior upper extremity near olecranon that is 
healing well
NEURO - non-focal
PSYCH - appropriate

 
Pertinent Results:
ADMISSION LABS
--------------
___ 12:10PM BLOOD WBC-9.0# RBC-3.02* Hgb-9.1* Hct-27.2* 
MCV-90 MCH-30.2 MCHC-33.5 RDW-16.7* Plt ___
___ 12:10PM BLOOD Neuts-85* Bands-2 Lymphs-4* Monos-9 Eos-0 
Baso-0 ___ Myelos-0
___ 12:10PM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL 
Ovalocy-OCCASIONAL Tear Dr-OCCASIONAL
___ 08:00PM BLOOD ___ PTT-25.2 ___
___ 12:10PM BLOOD UreaN-36* Creat-2.3* Na-135 K-4.6 Cl-100 
HCO3-20* AnGap-20
___ 12:10PM BLOOD ALT-13 AST-26 LD(LDH)-347* CK(CPK)-281* 
AlkPhos-117* TotBili-0.4
___ 12:10PM BLOOD CK-MB-11* MB Indx-3.9 cTropnT-1.07*
___ 12:10PM BLOOD TotProt-5.1* Albumin-3.0* Globuln-2.1 
Calcium-8.6 Phos-3.3 Mg-1.3*

HOSPITAL COURSE
--------------
___ 06:30AM BLOOD WBC-2.9*# RBC-2.13*# Hgb-6.4*# Hct-19.3*# 
MCV-91 MCH-29.8 MCHC-32.9 RDW-16.9* Plt ___
___ 12:45AM BLOOD WBC-3.3* RBC-2.52* Hgb-7.4* Hct-23.1* 
MCV-92 MCH-29.3 MCHC-32.0 RDW-16.0* Plt ___
___ 05:50AM BLOOD WBC-2.8* RBC-3.02* Hgb-9.0* Hct-28.3* 
MCV-94 MCH-29.7 MCHC-31.7 RDW-15.6* Plt ___
___ 06:00AM BLOOD WBC-4.7# RBC-3.48* Hgb-10.3* Hct-32.5* 
MCV-93 MCH-29.7 MCHC-31.8 RDW-15.7* Plt ___
___ 06:25AM BLOOD WBC-4.3 RBC-3.19* Hgb-9.4* Hct-30.0* 
MCV-94 MCH-29.5 MCHC-31.4 RDW-15.8* Plt ___
___ 08:00AM BLOOD WBC-4.3 RBC-2.98* Hgb-8.9* Hct-28.1* 
MCV-94 MCH-29.8 MCHC-31.7 RDW-15.9* Plt Ct-92*
___ 06:15AM BLOOD WBC-4.0 RBC-2.84* Hgb-8.3* Hct-27.0* 
MCV-95 MCH-29.1 MCHC-30.6* RDW-15.8* Plt Ct-95*
___ 06:50AM BLOOD WBC-3.5* RBC-2.65* Hgb-7.6* Hct-24.4* 
MCV-92 MCH-28.7 MCHC-31.2 RDW-16.1* Plt Ct-93*
___ 05:55AM BLOOD WBC-4.1 RBC-2.71* Hgb-8.1* Hct-25.7* 
MCV-95 MCH-29.7 MCHC-31.4 RDW-16.3* Plt Ct-87*
___ 12:45AM BLOOD Neuts-83* Bands-1 Lymphs-5* Monos-3 Eos-0 
Baso-0 ___ Metas-4* Myelos-4*
___ 05:50AM BLOOD Neuts-81* Bands-1 Lymphs-6* Monos-5 Eos-1 
Baso-0 Atyps-1* Metas-3* Myelos-2*
___ 06:00AM BLOOD Neuts-82* Bands-0 Lymphs-5* Monos-3 Eos-0 
Baso-0 ___ Metas-4* Myelos-4* Promyel-2*
___ 06:25AM BLOOD Neuts-78* Bands-11* Lymphs-4* Monos-4 
Eos-0 Baso-0 ___ Metas-3* Myelos-0 NRBC-1*
___ 08:00AM BLOOD Neuts-82* Bands-2 ___ Monos-11 Eos-1 
Baso-0 ___ Metas-2* Myelos-2*
___ 06:15AM BLOOD Neuts-88* Bands-5 ___ Monos-3 Eos-0 
Baso-0 ___ Metas-2* Myelos-2* NRBC-1*
___ 06:50AM BLOOD Neuts-85* Bands-4 Lymphs-4* Monos-4 Eos-0 
Baso-0 ___ Metas-1* Myelos-2*
___ 05:55AM BLOOD Neuts-84* Bands-0 Lymphs-11* Monos-5 
Eos-0 Baso-0 ___ Myelos-0
___ 12:45AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-NORMAL Polychr-1+ Ovalocy-1+ Schisto-1+ Tear 
Dr-1+
___ 05:50AM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-NORMAL Macrocy-2+ Microcy-NORMAL Polychr-NORMAL
___ 06:00AM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 06:25AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 08:00AM BLOOD Hypochr-2+ Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-NORMAL Polychr-NORMAL Ovalocy-1+
___ 06:15AM BLOOD Hypochr-NORMAL Anisocy-OCCASIONAL 
Poiklo-OCCASIONAL Macrocy-OCCASIONAL Microcy-NORMAL 
Polychr-NORMAL Tear Dr-OCCASIONAL
___ 06:50AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-OCCASIONAL 
Macrocy-1+ Microcy-NORMAL Polychr-NORMAL Tear Dr-OCCASIONAL
___ 05:55AM BLOOD Hypochr-1+ Anisocy-NORMAL Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 12:45AM BLOOD ___ PTT-26.4 ___
___ 05:50AM BLOOD ___ PTT-29.8 ___
___ 06:05AM BLOOD ___ PTT-26.3 ___
___ 06:30AM BLOOD Glucose-92 UreaN-36* Creat-2.3* Na-135 
K-3.7 Cl-104 HCO3-21* AnGap-14
___ 12:45AM BLOOD Glucose-122* UreaN-38* Creat-2.3* Na-139 
K-4.0 Cl-107 HCO3-24 AnGap-12
___ 05:50AM BLOOD Glucose-89 UreaN-37* Creat-2.0* Na-137 
K-3.7 Cl-106 HCO3-22 AnGap-13
___ 06:00AM BLOOD Glucose-84 UreaN-35* Creat-1.9* Na-136 
K-3.7 Cl-103 HCO3-21* AnGap-16
___ 06:25AM BLOOD Glucose-85 UreaN-35* Creat-1.8* Na-135 
K-3.7 Cl-106 HCO3-20* AnGap-13
___ 08:00AM BLOOD Glucose-84 UreaN-32* Creat-1.9* Na-134 
K-3.9 Cl-105 HCO3-21* AnGap-12
___ 06:15AM BLOOD Glucose-99 UreaN-33* Creat-1.9* Na-133 
K-4.4 Cl-104 HCO3-18* AnGap-15
___ 06:50AM BLOOD Glucose-93 UreaN-36* Creat-1.6* Na-137 
K-4.0 Cl-105 HCO3-20* AnGap-16
___ 05:55AM BLOOD Glucose-92 UreaN-41* Creat-1.9* Na-138 
K-4.2 Cl-107 HCO3-22 AnGap-13
___ 12:45AM BLOOD ALT-13 AST-20 LD(LDH)-202 AlkPhos-89 
TotBili-0.2
___ 05:50AM BLOOD ALT-15 AST-20 LD(___)-211 AlkPhos-110* 
TotBili-0.2
___ 06:00AM BLOOD ALT-16 AST-30 LD(___)-236 AlkPhos-200* 
TotBili-0.3
___ 06:25AM BLOOD ALT-13 AST-30 LD(___)-284* AlkPhos-182* 
TotBili-0.2
___ 08:00AM BLOOD ALT-13 AST-26 LD(___)-205 CK(CPK)-138 
AlkPhos-210* TotBili-0.2
___ 06:15AM BLOOD ALT-9 AST-30 LD(___)-290* AlkPhos-172* 
TotBili-0.3
___ 06:50AM BLOOD ALT-16 AST-25 LD(___)-245 AlkPhos-166* 
TotBili-0.2
___ 12:10PM BLOOD CK-MB-11* MB Indx-3.9 cTropnT-1.07*
___ 08:00PM BLOOD CK-MB-11* MB Indx-6.1* cTropnT-0.89*
___ 06:30AM BLOOD CK-MB-9 cTropnT-0.90*
___ 12:45PM BLOOD CK-MB-12* cTropnT-0.91*
___ 06:30AM BLOOD Folate-5.5 Hapto-264*
___ 12:45AM BLOOD %HbA1c-5.6 eAG-114
___ 12:45AM BLOOD Triglyc-349* HDL-33 CHOL/HD-6.6 
LDLcalc-114
___ 06:30AM BLOOD TSH-3.3
___ 06:30AM BLOOD IgG-398*
___ 06:05AM BLOOD WBC-4.8 RBC-2.74* Hgb-8.4* Hct-26.3* 
MCV-96 MCH-30.5 MCHC-31.9 RDW-17.0* Plt ___
___ 06:05AM BLOOD Neuts-91.6* Lymphs-3.3* Monos-3.6 Eos-1.0 
Baso-0.4
___ 06:05AM BLOOD Glucose-83 UreaN-50* Creat-2.1* Na-139 
K-4.7 Cl-105 HCO3-24 AnGap-15
___ 06:05AM BLOOD ALT-23 AST-42* LD(LDH)-214 AlkPhos-169* 
TotBili-0.3
___ 06:05AM BLOOD Calcium-8.9 Phos-5.6* Mg-1.7
___ 08:50AM BLOOD WBC-4.2 RBC-2.54* Hgb-7.7* Hct-24.5* 
MCV-96 MCH-30.2 MCHC-31.4 RDW-17.1* Plt ___
___ 06:25AM BLOOD WBC-4.2 RBC-2.53* Hgb-7.8* Hct-23.8* 
MCV-94 MCH-31.0 MCHC-33.0 RDW-17.1* Plt ___
___ 06:25AM BLOOD WBC-7.8# RBC-3.15* Hgb-9.4* Hct-29.6* 
MCV-94 MCH-29.9 MCHC-31.8 RDW-17.2* Plt ___
___ 02:33AM BLOOD WBC-6.3 RBC-2.67* Hgb-7.8* Hct-25.2* 
MCV-94 MCH-29.1 MCHC-30.9* RDW-17.5* Plt ___
___ 02:37AM BLOOD WBC-7.7 RBC-3.04* Hgb-8.9* Hct-28.5* 
MCV-94 MCH-29.2 MCHC-31.1 RDW-18.2* Plt ___
___ 12:02AM BLOOD WBC-10.0 RBC-3.32* Hgb-9.8* Hct-30.7* 
MCV-93 MCH-29.7 MCHC-32.0 RDW-18.3* Plt ___
___ 02:50AM BLOOD WBC-10.7 RBC-3.46* Hgb-10.0* Hct-31.4* 
MCV-91 MCH-29.0 MCHC-31.9 RDW-18.3* Plt ___
___ 02:55AM BLOOD WBC-9.9 RBC-3.23* Hgb-9.6* Hct-28.8* 
MCV-89 MCH-29.6 MCHC-33.2 RDW-18.5* Plt ___
___ 12:00AM BLOOD WBC-8.9 RBC-3.20* Hgb-9.3* Hct-29.6* 
MCV-93 MCH-29.1 MCHC-31.4 RDW-18.5* Plt ___
___ 12:20AM BLOOD WBC-5.9 RBC-2.88* Hgb-8.6* Hct-26.0* 
MCV-90 MCH-30.0 MCHC-33.1 RDW-18.4* Plt ___
___ 12:00AM BLOOD WBC-4.7 RBC-2.51* Hgb-7.4* Hct-23.2* 
MCV-93 MCH-29.7 MCHC-32.0 RDW-18.5* Plt Ct-98*
___ 12:09AM BLOOD WBC-4.0 RBC-2.37* Hgb-7.1* Hct-21.4* 
MCV-90 MCH-30.2 MCHC-33.4 RDW-18.4* Plt Ct-92*
___ 12:06PM BLOOD Hct-23.7*
___ 12:00AM BLOOD WBC-4.7 RBC-2.51* Hgb-7.4* Hct-23.2* 
MCV-93 MCH-29.7 MCHC-32.0 RDW-18.5* Plt Ct-98*
___ 12:00AM BLOOD WBC-5.8 RBC-2.57* Hgb-7.4* Hct-24.0* 
MCV-93 MCH-29.0 MCHC-31.1 RDW-18.5* Plt ___
___ 02:37AM BLOOD Neuts-96* Bands-0 ___ Monos-1* Eos-0 
Baso-0 Atyps-1* Metas-2* Myelos-0
___ 02:55AM BLOOD Neuts-90* Bands-1 Lymphs-3* Monos-2 Eos-1 
Baso-0 ___ Metas-2* Myelos-1* NRBC-1*
___ 12:00AM BLOOD Neuts-86* Bands-1 Lymphs-2* Monos-1* 
Eos-3 Baso-0 ___ Metas-5* Myelos-2*
___ 12:09AM BLOOD Neuts-93* Bands-0 Lymphs-4* Monos-3 Eos-0 
Baso-0 ___ Myelos-0
___ 12:20AM BLOOD Neuts-89.3* Lymphs-3.9* Monos-5.7 Eos-0.9 
Baso-0.3
___ 12:00AM BLOOD Neuts-90.7* Lymphs-5.0* Monos-3.2 Eos-0.8 
Baso-0.3
___ 06:25AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL 
Macrocy-NORMAL Microcy-1+ Polychr-NORMAL
___ 02:50AM BLOOD Hypochr-1+ Anisocy-2+ Poiklo-1+ 
Macrocy-1+ Microcy-1+ Polychr-1+ Spheroc-1+ Ovalocy-1+ 
Schisto-1+ Tear Dr-1+
___ 02:55AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 12:00AM BLOOD Hypochr-2+ Anisocy-1+ Poiklo-1+ 
Macrocy-1+ Microcy-NORMAL Polychr-1+ Ovalocy-1+ Schisto-1+ Tear 
Dr-1+
___ 08:55PM BLOOD ___ PTT-27.5 ___
___ 02:33AM BLOOD ___ PTT-26.8 ___
___ 12:00AM BLOOD ___ PTT-30.9 ___
___ 12:06PM BLOOD ___ PTT-36.8* ___
___ 06:25AM BLOOD Glucose-86 UreaN-69* Creat-2.3* Na-145 
K-4.3 Cl-109* HCO3-22 AnGap-18
___ 06:27PM BLOOD Glucose-174* UreaN-74* Creat-2.8* Na-142 
K-5.6* Cl-107 HCO3-20* AnGap-21*
___ 02:33AM BLOOD Glucose-100 UreaN-77* Creat-2.9* Na-140 
K-5.4* Cl-106 HCO3-22 AnGap-17
___ 02:37AM BLOOD Glucose-105* UreaN-81* Creat-2.9* Na-142 
K-5.3* Cl-107 HCO3-19* AnGap-21*
___ 12:02AM BLOOD Glucose-122* UreaN-89* Creat-3.0* Na-143 
K-4.9 Cl-108 HCO3-20* AnGap-20
___ 02:50AM BLOOD Glucose-103* UreaN-82* Creat-2.7* Na-143 
K-4.3 Cl-109* HCO3-21* AnGap-17
___ 02:55AM BLOOD Glucose-93 UreaN-76* Creat-2.5* Na-143 
K-4.0 Cl-107 HCO3-23 AnGap-17
___ 12:00AM BLOOD Glucose-114* UreaN-64* Creat-2.4* Na-141 
K-3.5 Cl-103 HCO3-24 AnGap-18
___ 12:09AM BLOOD Glucose-110* UreaN-58* Creat-2.1* Na-139 
K-3.7 Cl-104 HCO3-25 AnGap-14
___ 12:00AM BLOOD Glucose-50* UreaN-50* Creat-2.0* Na-145 
K-3.8 Cl-109* HCO3-25 AnGap-15
___ 12:20AM BLOOD Glucose-108* UreaN-46* Creat-1.8* Na-138 
K-3.3 Cl-105 HCO3-25 AnGap-11
___ 12:00AM BLOOD Glucose-103* UreaN-44* Creat-1.9* Na-137 
K-4.5 Cl-106 HCO3-23 AnGap-13
___ 06:30AM BLOOD ALT-26 AST-38 LD(LDH)-239 CK(CPK)-208* 
AlkPhos-184* TotBili-0.3
___ 06:25AM BLOOD ALT-27 AST-44* LD(LDH)-270* CK(CPK)-143 
AlkPhos-171* TotBili-0.4
___ 06:25AM BLOOD ALT-213* AST-198* LD(LDH)-414* 
CK(CPK)-137 AlkPhos-351* TotBili-0.5
___ 02:33AM BLOOD ALT-189* AST-126* LD(LDH)-344* 
CK(CPK)-112 AlkPhos-243* TotBili-0.4
___ 12:02AM BLOOD ALT-187* AST-111* AlkPhos-343* 
TotBili-0.7
___ 11:48AM BLOOD ALT-115* AST-76* LD(___)-477* 
AlkPhos-392* TotBili-0.7
___ 12:00AM BLOOD ALT-63* AST-41* LD(___)-449* CK(CPK)-131 
AlkPhos-299* TotBili-0.7
___ 12:00AM BLOOD ALT-41* AST-43* LD(___)-428* CK(CPK)-235* 
AlkPhos-263* TotBili-0.4
___ 12:20AM BLOOD ALT-23 AST-36 LD(___)-332* AlkPhos-196* 
TotBili-0.4
___ 12:09AM BLOOD ALT-31 AST-54* LD(___)-319* AlkPhos-199* 
TotBili-0.4
___ 12:20AM BLOOD ALT-27 AST-35 LD(___)-310* AlkPhos-182* 
TotBili-0.5
___ 12:00AM BLOOD ALT-26 AST-29 LD(LDH)-302* AlkPhos-184* 
TotBili-0.4
___ 06:25AM BLOOD CK-MB-12* MB Indx-8.8 cTropnT-0.93*
___ 06:27PM BLOOD CK-MB-12* cTropnT-1.08*
___ 02:33AM BLOOD CK-MB-10 MB Indx-8.9* cTropnT-0.99*
___ 04:26PM BLOOD CK-MB-9 cTropnT-0.97*
___ 02:37AM BLOOD CK-MB-9
___ 02:55AM BLOOD cTropnT-0.94*
___ 06:30AM BLOOD Calcium-9.1 Phos-5.4* Mg-1.9
___ 06:27PM BLOOD Calcium-8.7 Phos-6.1*# Mg-2.0
___ 02:37AM BLOOD Calcium-8.9 Phos-7.0* Mg-2.2
___ 02:50AM BLOOD Albumin-3.1* Calcium-9.0 Phos-4.4# Mg-2.2 
UricAcd-15.2*
___ 11:48AM BLOOD UricAcd-14.7*
___ 06:10PM BLOOD Albumin-2.9* Calcium-8.6 Phos-4.2 Mg-2.0 
UricAcd-14.2*
___ 11:00PM BLOOD UricAcd-7.8*
___ 02:55AM BLOOD Albumin-3.0* Calcium-8.9 Phos-4.3 Mg-2.0 
UricAcd-4.2
___ 12:00AM BLOOD Calcium-8.8 Phos-4.4 Mg-1.8 UricAcd-0.1*
___ 12:20AM BLOOD Calcium-8.1* Phos-5.4* Mg-2.1
___ 12:20AM BLOOD Calcium-8.3* Phos-3.9 Mg-2.2
___ 11:20AM BLOOD UricAcd-7.5*
___ 11:33AM BLOOD Type-ART pO2-174* pCO2-34* pH-7.36 
calTCO2-20* Base XS--5
___ 09:12PM BLOOD ___ pO2-40* pCO2-42 pH-7.34* 
calTCO2-24 Base XS--2 Comment-PERIPHERAL
___ 08:30AM BLOOD Type-ART pO2-225* pCO2-33* pH-7.43 
calTCO2-23 Base XS-0 Intubat-INTUBATED
___ 11:33AM BLOOD Lactate-3.0*
___ 07:06PM BLOOD Lactate-1.1
___ 08:30AM BLOOD Lactate-1.0

DISCHARGE LABS
--------------
___ 06:25AM BLOOD WBC-5.1 RBC-2.77* Hgb-8.6* Hct-25.7* 
MCV-93 MCH-31.1 MCHC-33.5 RDW-18.0* Plt ___
___ 06:25AM BLOOD Neuts-90.3* Lymphs-3.9* Monos-3.4 Eos-2.2 
Baso-0.2
___ 06:25AM BLOOD Glucose-85 UreaN-41* Creat-1.8* Na-141 
K-3.9 Cl-108 HCO3-21* AnGap-16
___ 06:25AM BLOOD ALT-25 AST-30 LD(LDH)-279* AlkPhos-162* 
TotBili-0.4
___ 06:25AM BLOOD Calcium-8.8 Phos-4.0 Mg-2.3

MICRO
-----
___ HHV6 PCR Negative
___ Parvovirus B19 PCR Negative
___ EBV PCR ___ CMV PCR negative
___ BCR/ABL gene rearrangement 2.821

IMAGING
-------
TTE ___
IMPRESSION: Hyperdynamic left ventricular systolic function. No 
clinically significant valvular regurgitation or stenosis. 
Indeterminate pulmonary artery systolic pressure. Suggestion of 
pulmonary artery diastolic hypertension.  Compared with the 
prior study (images reviewed) of ___, the left ventricular 
systolic function is now hyperdynamic (LVEF previously 55-60%). 

Pharmacological Stress MIBI ___
INTERPRETATION: Left ventricular cavity size is normal.  Rest 
and stress perfusion images reveal uniform tracer uptake 
throughout the left ventricular myocardium.  Gated images reveal 
normal wall motion. Septal wall motion compatible with prior 
CABG.  The calculated left ventricular ejection fraction is 65% 
post stress.
IMPRESSION: Normal myocardial perfusion study.

CT Abdomen/Pelvis ___
IMPRESSION:
1. No evidence of PTLD.  
2. Soft tissue nodules in the left lower quadrant most likely 
represent the sequela of subcutaneous injections.

CT Chest ___
IMPRESSION:
1. As compared to ___, no lung nodules have newly 
appeared.  The
pre-existing lung nodules, including the minimal ground-glass 
nodules in the upper lobe, are all constant, unsuspicious in 
morphology.  If the patient is not at high risk for cancer, the 
lesions do not require further followup, given that their 
dimension is below 4 mm.
2.  Status post CABG, no lymphadenopathy, no pleural effusions.

CXR ___
ET tube is in a standard position.  NG tube tip is out of view 
below the 
diaphragm.  Cardiomegaly is stable.  Increasing opacities in the 
right 
perihilar region and right lower lobe are worrisome for 
worsening pneumonia.  Component of pulmonary edema is stable.  
Left lower lobe pneumonia is stable.  There is no pneumothorax 
or large pleural effusion.  There are low lung volumes with 
stable widened mediastinum  due to engorgement of vessels. 

CXR ___:
The patient is currently not intubated.  The right internal 
jugular line tip is at the right atrium and should be pulled 
back approximately 3 cm.  Heart size and mediastinum are stable. 
 Lungs are essentially clear.  No pleural effusion or 
pneumothorax is appreciated, although cannot be entirely 
excluded. 

Muscle Biopsy ___:  Final Report Pending

CT Chest Without Contrast ___:  Newly appeared massive 
bilateral opacities, predominantly ground-glass in attenuation, 
with subtle areas of consolidation.  Accompanying airways 
disease and small pleural effusions with atelectasis. 

EMG ___:  Abnormal study. There is electrophysiologic 
evidence for a moderate, generalized myopathic process with 
denervating features. In addition, the data are suggestive of a 
moderate, generalized, axonal, sensorimotor polyneuropathy. 
Based on the limited repetitive stimulation studies performed, 
there is no evidence for a disorder of neuromuscular junction 
transmission, including myasthenia ___. Compared to the 
previous study dated ___, there has been an improvement 
in motor response amplitudes and worsening in sensory response 
amplitudes.  

 

 
Brief Hospital Course:
BRIEF HOSPITAL COURSE:  

Ms. ___ is a ___ y/o F with history of accelerated phase CML 
s/p sibling allo transplant on ___ complicated by upper and 
lower GI GVHD ___, liver GVHD in setting of reducing 
immunosuppression ___, GVHD related myopathy resulting in 
weakness and respiratory failure ___ who presented for 
presyncope. Her lightheadedness improved significantly with IV 
fluids and she had no further episodes of presyncope. She had 
elevated creatinine above baseline that resolved with IV fluids. 
She was found to have an elevated troponin that trended down 
thought to be likely due to demand ischemia in the setting of 
anemia in addition to poor clearance in the setting of acute on 
chronic kidney injury. Her BCR-ABL load was elevated compared to 
prior levels and her prednisone immunosuppression was decreased 
to improve control of her CML. She was also found to have an 
elevated EBV viral load with concern for PTLD/lymphoma and had a 
CT Torso which showed no evidence of PTLD. She received 1 dose 
of rituximab on ___ and tolerated well.

On reduction of the pt.'s prednisone, she developed severe 
myalgias and respiratory distress thought to be ___ muscle 
weakness, hypervolemia, and flash pulmonary edema with BPs in 
220s/110s. She was transferred to the ICU, required intubation, 
and was diuresed.  She was extubated and her respiratory status 
returned to baseline. She was found to have both a new 
consolidation on CXR evaluated by both the pulmonary service and 
infectious disease service who both recommended a course of 
antibiosis for HCAP. She also had an elevated troponin during 
this episode. Cardiology evaluated pt and determined her to have 
an NSTEMI in the setting of elevated troponin and new focal wall 
motion abnormality on echocardiogram. She continued to have 
myalgias and had a muscle biopsy and EMG to better assess the 
cause of her myalgias. ___ results indicate no signs of 
active GVHD or GVHD myasthenia ___. Final results are 
pending. She remained hemodynamically stable and was discharged 
to rehab on her admission dose of prednisone.
 
ACTIVE ISSUES

# Acute Myalgias and Muscle Weakness:  On admission, pt. reports 
diffuse muscle weakness and myalgias.  Following reduction of 
prednisone from alternating 15mg/20mg daily, pt. had significant 
worsening of symptoms.  CK was mildly elevated.  For concern of 
worsening symptoms ___ to ongoing levofloxacin (has been 
associated with increased risk of tenosynovitis in pt.'s on 
chronic steroids), this medication was discontinued.  An EMG was 
done showing no evidence of GVHD induced myasthenia ___.  
___ muscle biopsy performed on ___ of the left biceps 
femoris biopsy returned negative for any evidence of 
inflammation.  The most likely etiology of the patient's 
symptoms were thought to be ___ profound deconditioning with a 
possible component of steroid induced myopathic fibroatrophy 
given ongoing steroids over the last ___ years.  GVHD less likely 
given no evidence of myositis on ___ path, although pt.'s 
physical exam is somewhat consistent with chronic GVHD. 

# Respiratory Failure:  Following reduction of patient's 
steroids, pt. developed profound muscle weakness.  In this 
setting, she became hypoxic and later hypertensive with BPs in 
220s/110s.  She had a presumed episode of flash pulmonary edema 
which resulted in her transfer to the ICU and subsequent 
intubation.  Pt. was diuresed significantly and extubated 
without issue.  She was thought to be volume overloaded 
secondary to initial resuscitation following her pre-syncopal 
presentation.  Pt. continued to respond well to diuresis and was 
transferred back to the medical floor.

# Hospital Acquired Pneumonia:  Pt. had a new consolidation on 
CXR on this admission.  Started on HCAP coverage with 
vanc/meropenem.  The patient initially responded well and was 
d/c'ed off vanc.  Given concern for worsening pneumonia and 
respiratory distress, pulmonary was consulted for possible 
bronchoscopy.  ___ then recommended cardiology evaluation given 
ongoing elevated troponin and question of ischemic changes seen 
on TTE and EKG.  ID also saw pt. and recommended continuation of 
levofloxacin for total of 5 day course for atypical coverage and 
meropenem for total of 8 day course.  For concern that 
levofloxacin was contributing to pt.'s myalgias/ tendonitis, pt. 
was discontinued 1 day earlier than completion of full course.  
At time of discharge, pt. had ongoing improving cough.  She had 
a repeat CXR (___) negative for consolidation or pulmonary 
edema.  

# NSTEMI:  In the setting of episode of flash pulmonary edema, 
pt. had an elevated troponin.  Cardiology evaluated the patient 
who recommended a repeat TTE which revealed showed decrease in 
EF to 40% and akinesis of the anteroseptal wall.  Given her 
known CAD, this was thought to most likely be related to either 
a type 1 primary coronary event or type 2 demand ischemia in the 
setting of recent hypertensive emergency and flash pulmonary 
edema.  Given that pt. was a poor cath candidate with ongoing 
acute on chronic kidney injury, will proceed with medical 
optimization at this time.  As such, pt. was discharged on ASA 
81mg Daily, metoprolol and amlodipine for afterload reduction.  
A statin was held at this time given ongoing myalgias.  Her 
losartan was held for resolving acute on chronic kidney injury.  


# Admission Troponin elevation:  Pt. had admission Troponin peak 
at 1.07, CK-MB 11. Patient did not have chest pain at this time, 
but did report dizziness and dyspnea which may be her anginal 
equivalent. ECG on admission was not suggestive of ischemia.  
Pt. evaluated for ACS but noted to have downtrending trops in 
setting of resolving anemia and resolving acute on chronic 
kidney injury.  Initial TTE showed hyperdynamic function 
consistent with her volume depleted status.  In the setting of 
known CAD, pt. also had a persantine stress MIBI which was 
negative for evidence of malperfusion/ischemia.  Likely cause of 
admission troponin elevation was thought to be due to demand 
ischemia in the setting of anemia in addition to poor clearance 
in the setting of acute on chronic kidney injury.  

# Poor appetite:  Patient not taking good PO at home. Signs of 
anasarca on exam with diffuse dependent edema.  Pt. states that 
she is eating more on this hospitalization compared to any other 
time recently.  Denies nausea/vomiting, abdominal symptoms, 
diarrhea.  Pt. was started on marinol for appetite stimulation 
but developed excess sedation.  This medication was 
discontinued. 

# Anemia:  On admission, pt. found to have Hct drop from 27 to 
19.  She received fluids in clinic of unknown quantity.  No 
history of bleeding.  Anemia work-up was negative for hemolysis 
with normal TSH level.  Pt. did have a retic count which was low 
given the level of anemia consistent with decreased production 
likely ___ pt's CML.  Her Hct remained stable after initial 
transfusion throughout the remainder of admission.

# Presyncope/lightheadedness:  Pt. presented with orthostatic 
hypotension in the setting of poor PO intake and ongoing 
antihypertensive/diuretic therapy making hypovolemia the most 
likely etiology. Given troponin elevation, considered cardiac 
etiology however stress MIBI negative.  Her lightheadedness 
resolved after giving IV fluids.  Her home furosemide and 
amlodipine were discontinued.  The patient was discharged on a 
reduced hypertensive regimen as described in transitional 
issues. 

# Acute on chronic kidney injury:  On admission, pt. was found 
to have creatinine elevated to 2.6 from baseline of 1.5 to 2.0.  
Likely pre-renal given hypovolemia with orthostasis.  She 
received IV fluids and her creatinine returned to baseline.  Pt. 
then had second episode of acute on chronic kidney injury ___ 
poor forward flow in the setting of flash pulmonary edema and 
NSTEMI.  Her renal function returned to baseline with diuresis.  
She was noted to have an elevated uric acid at this time which 
dramatically decreased following one dose of rasburicase. 

# CML
Accelerated phase CML s/p sibling allo D0 ___ now relapsed 
CML.  BCR-ABL returned slightly elevated compared to prior.  We 
continued prophylaxis on home acyclovir, atovaquone, fluconazole 
at renal dosing.  Her prednisone was attempted to be reduced to 
15mg daily to improve control of CML with evidence of increasing 
BCR-ABL.  The pt. did not tolerate this as above.  She has a 
repeat BCR ABL and kinase domain mutation pending.  TKI should 
be considered as an outpatient.

# Elevated EBV Viral Load
EBV was elevated on last admission and more elevated on this 
admission.  HHV6/Parvo B19 negative.  For concern of 
PTLD/lymphoma, pt. was evaluated with CT Torso which showed no 
evidence of PTLD.  Pt. given 1 dose of rituximab on ___ and 
tolerated it well.  

# Sinusitis 
Pt. received course of levofloxacin with resolution of symptoms.

CHRONIC ISSUES
# Hypertension:  Stable.  Continued altered regimen as described 
above.

# Hyperlipidemia
Stable.  Not currently on therapy at this time

# Coronary artery disease 
Stable.  Will continue home aspirin and antihypertensives as 
above.

TRANSITIONAL ISSUES:

1. Heme/Onc Follow-Up: Pt. requires follow-up with Dr. ___ on 
___ and ___. 

2. NSTEMI Follow-Up: Pt. requires follow-up with cardiology in 
___ weeks from discharge. She also should have a repeat TTE 
shortly prior to this visit. She has an appt. with cardiology on 
___.

3. Lab Work: Pt. does have chronic anemia and thrombocytopenia 
secondary to her CML. Pt. should receive labs every other day 
(CBC with diff, Chem 10, ALT, AST, Alk Phos, TBili, LDH, ___, 
PTT, INR) while at rehab. Lab results should be faxed to Dr. 
___ office at ___.

4. Hypertension Regimen: Pt. presented with orthostasis thought 
to be ___ both poor PO intake and strict blood pressure control. 
She also had an NSTEMI while hospitalized. Pt. was discontinued 
off of her daily losartan for ongoing renal dysfunction. 
Metoprolol XL was reduced to 250mg Daily from 300mg Daily. She 
was continued on amlodipine 5mg PO Daily. Furosemide was 
continued at 20mg PO Daily. Pt's standing weight at discharge 
was 139 lbs. Pt's medications should be titrated appropriately 
to HR and BP. Her losartan should also be restarted if possible 
if close monitoring is available, in place of amlodipine if 
amlodipine if not needed for blood pressure control.

5. Immunosuppression and steroid taper: Pt. was unable to 
tolerate prednisone taper as she had significant exacerbation of 
myopathy and muscle weakness. As such, she was continued on her 
admission dose of alternating daily doses of prednisone 
15mg/20mg. If attempting to reduce prednisone in future, please 
reduce on slow taper, consider ___ / week as tolerated and 
closely monitor symptoms. 

6. Poor Nutrition: Pt. has mild anasarca likely in part due to 
poor nutrition partially caused by decreased appetite and 
nausea. Pt. was started on dronabinol to improve these symptoms, 
however she became sedated. This medication was not continued at 
discharge. She was continued on furosemide prn for management of 
fluid volume.

7. Tyrosine Kinase Inhibitor: Given increase CML disease 
activity, possible use of TKI should be discussed with Dr. 
___. Ponatinib has been associated with increased incidence 
of cardiac events and should be avoided in this pt. with known 
CAD and now recent NSTEMI. Desatinib may be a better option but 
was not initiated at time of discharge. Consider slow 
uptitration of dosage starting at 20mg as pt. tolerates.

8. Levofloxacin: Pt. was discontinued off of levofloxacin as 
this medication was associated with worsening myalgias in this 
pt. Please avoid fluoroquinolone class if possible as this seems 
to worsen her myalgias. There also is a high risk of 
tenosynovitis with these abx. in pt.'s on chronic steroids. 

9. Statin: Given pt's known CAD and NSTEMI on this admission, 
pt. would benefit from a statin. Pt. was not initiated on this 
hospitalization given myalgias.

10. Steroids and Osteopenia: Pt. had a bone scan in ___ 
revealing osteopenia. Given her chronic steroid use, please 
consider every ___ month bone scans.

11. Access Issues: Vascular access and lab draws have been a 
challenge as an inpatient. Additionally, pt. has coagulopathy 
likely ___ chronic steroid use resulting in diffuse ecchymosis 
from minimal skin injury. Given upcoming treatments and likely 
multiple hospitalizations, pt. may benefit from Port vs. PICC 
placement.

12. Pulm Follow-Up: Pt. was evaluated by the pulmonary consult 
team who recommended repeat chest CT 4 weeks from ___ to 
evaluate for resolution of pneumonia. If pt. has new symptoms, 
chest CT should be considered prior to this time. If resolution, 
no pulmonary follow-up is necessary. This can be coordinated 
with Dr. ___. 

13. Pending Labs: Pt. has BCR ABL and Domain Kinase mutation lab 
pending. This should be follow-up by Dr. ___.

14. Uric Acid: Pt. had elevated uric acid level on admission. We 
did not start allopurinol at this time given resolving kidney 
dysfunction. Consider starting allopurinol as an outpatient.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 400 mg PO Q8H 
2. Amlodipine 5 mg PO DAILY 
3. Aspirin 81 mg PO DAILY 
4. Atovaquone Suspension 1500 mg PO DAILY 
5. Calcium Carbonate 500 mg PO BID 
6. Furosemide 20 mg PO DAILY 
7. Metoprolol Succinate XL 300 mg PO DAILY 
8. Omeprazole 20 mg PO DAILY 
9. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
10. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
11. albuterol sulfate 90 mcg/actuation Inhalation 1 puff TID prn 
SOB, wheezing 
12. magnesium oxide-Mg AA chelate 133 mg Oral BID 
13. PredniSONE 15 mg PO 3X/WEEK (___) 
14. PredniSONE 20 mg PO 4X/WEEK (___) 
15. Losartan Potassium 100 mg PO DAILY 
16. Levofloxacin 750 mg PO Q48H 
 
Discharge Medications:
1. albuterol sulfate 90 mcg/actuation Inhalation 1 puff TID prn 
SOB, wheezing 
2. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
3. Multivitamins W/minerals 1 TAB PO DAILY 
4. Magnesium Oxide 400 mg PO BID 
5. Fluconazole 200 mg PO Q24H 
6. PredniSONE 15 mg PO 3X/WEEK (___) 
7. PredniSONE 20 mg PO 4X/WEEK (___) 
8. Amlodipine 5 mg PO DAILY 
9. Aspirin 81 mg PO DAILY 
10. Atovaquone Suspension 1500 mg PO DAILY 
11. Calcium Carbonate 500 mg PO BID 
12. Furosemide 20 mg PO DAILY 
13. Acyclovir 400 mg PO Q12H 
14. Metoprolol Succinate XL 250 mg PO DAILY 
15. Benzonatate 100 mg PO TID:PRN Cough 
16. Guaifenesin ___ mL PO Q6H:PRN cough 
17. Heparin 5000 UNIT SC TID 
18. Miconazole Powder 2% 1 Appl TP TID:PRN Breast Discomfort 
19. Pantoprazole 40 mg PO Q12H 
20. Vitamin E 400 UNIT PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis: 
1.  Accelerated Phase CML
2.  Acute on Chronic Renal Failure 
3.  Pre-syncope
4.  Sinusitis
5.  Anasarca
6.  NSTEMI
7.  Hospital Acquired Pneumonia

Secondary Diagnosis:
1.  Multi-System Graph Versus Host Disease
2.  Hypertension
3.  Hyperlipidemia
4.  Coronary Artery Disease
5.  Anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at the ___ 
___.  You were admitted to the hospital 
because you felt as though you were going to faint and were not 
eating or drinking well.  You received fluids through your IV 
and your lightheadedness improved.  You also had worsening 
kidney function likely due initially to poor oral intake and 
later to heart dysfunction.  Your heart enzymes were found to be 
elevated both on admission and during your hospitalization.  The 
ultrasound of your heart initially was normal as well as a 
stress test.  A repeat ultrasound did show some wall damage 
indicating that you most likely had a small heart attack.  
Additionally, your EBV virus level was high.  You received one 
dose of rituximab to treat the EBV virus.

You prednisone dose was decreased to help improve control of 
your CML.  However, you developed worsening muscle pain and 
required help breathing with an airway tube in the Intensive 
Care Unit.  We removed excess fluid which improved your 
breathing.  You were also found to have a pneumonia at this time 
which was treated with antibiotics.  We obtained a muscle biopsy 
and an EMG to better assess your muscle pain.  These tests are 
currently pending.  Your condition improved and you were 
discharged with close follow-up.

All the best,

Your ___ Team    
 
Followup Instructions:
___
"
165,19940147,22171768," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
lab abnormalities ___, hyperkalemia, hyperuricemia)
 
Major Surgical or Invasive Procedure:
None 

 
History of Present Illness:
___ with CML s/p sibling allo D0 ___, complicated by GI 
GVHD, liver GVHD, GVHD related myopathy, who presented from ___ 
clinic for lab abnormalities including hyperkalemia (5.4), 
elevated uric acid (11.5) and acute renal failure (2.3). 

Per report, she had a few day history of poor oral intake with 
suspected dehydration. They did not give IV fluid due to a 
history of recent ?NSTEMI and sysolic CHF with EF of 40%.

Of note, her history is extensive and discharge summary from 
___ reviewed.

Currently, she reports: feeling okay. She notes a cough which 
has improved from discharge. No sputum production. She has 
continued chronic weakness and myalgias upon standing. She 
doesn't note recent bleeding. She states her legs often swell up 
(""they come and go""). She denies any calf pain or worsening 
shortness of breath. She notes okay PO intake (per her report, 
other history indicates poor PO intake). She notes she vomiting 
2 days ago but has not since had nausea or vomiting. No diarrhea 
or constipation.

 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
- ___: Bone marrow biopsy showed myeloproliferative 
disorder, likely chronic myelogenous leukemia. Per patient 
report, began taking interferon three times weekly shortly after 
diagnosis.  
- ___: Started Gleevec 400 mg daily. At some point 
thereafter, her dose was increased to 600 mg daily  
- ___: Gleevec increased to 400 mg twice daily with 
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be 
in late chronic phase CML. Stem cell transplant was recommended, 
but she did not wish to pursue this course.  
- ___: Gleevec held due to worsening anemia and 
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on 
Dasatinib  
- ___: First seen at ___. Bone marrow biopsy showed 
accelerated phase CML, began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by 
mucositis with biopsy of the esophagus suggesting upper GI GVHD 
which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper  
and lower GI tract in the setting of reducing immunosuppression  

- ___ Started on ponatinib 45 mg PO due to evidence of 
disease  
- ___ admitted to the hospital for fatigue and diarrhea, 
renal biopsy showed microangiopathic disease, glomerular 
sclerosing and fibrosis of kidney and GI biopsy showed shallow 
crypts that are  
typically seen with GVHD or cellcept toxicity. Her ponatinib was 
discontinued and prendisone and Cellcept doses were decreased.  
- ___ admitted for nausea, diarrhea, poor PO intake and 
weight loss. Had flex sig and EGD with biopsy negative for GVHD. 
Diarrhea resolved, stool cultures negative. ___ resolved w/ IVF. 
CT sinus had inflammation, given course of levofloxacin. Gastric 
emptying study inconclusive. BCR/ABL gene rearrangment elevated 
from previous undected level to 2.013%, mycophenylate was 
stopped.  

PAST MEDICAL/SURGICAL HISTORY:  
- CAD s/p CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___  
 
Social History:
___
Family History:
Father - died of MI, no other health problems  
Mother - had heart problems, DM  
No family history of cancer or blood disorders.  

 
Physical Exam:
PHYSICAL EXAM ON ADMISSION:
VITALS: 98.1, 158/80, 82, 18, 99% RA
General: No apparent distress, appears chronically ill
HEENT: OP without lesions, ?moon fascies
CV: rr, nl rate, flow murmur - systolic 
Lungs: CTAB anterior and lateral exam
Abdomen: soft, nontender, nondistended
Skin: thin, multiple ecchymoses, no active bleeding
GU: no foley
Ext: bilateral lower extremity edema, L>R ___ to waist 
Neuro: diffuse weakness, CN grossly intact
Psych: pleasant

PHYSICAL EXAM ON DISCHARGE:
Vitals: 98.5 118/66 90 20 96% 
Gen: NAD, A&Ox3, appropriate affect, coughs during the interview
Skin: multiple bruises on Lt face, anterior chest and neck line 
- overall improving and decrease in size. significant bruising 
in the ___. Overall improving.  
Lungs: CTAB, no w/c/r
CV: RRR, +S1/S2
Abd: soft, NT, ND, +BSx4, large echymosis in the lower abd ___ 
heparin SC - stable 
Ext: 2+ edema up to knees Lt>Rt, improved significantly, 4cm 
laceration in the Lt anterior thigh (from muscle biopsy), 
dressing c/i/d 
Neuro: antigravity in all extremities, CNII-XII itnact 

 
Pertinent Results:
LABS ON ADMISSION:
___ 10:00PM   GLUCOSE-99 UREA N-50* CREAT-2.2* SODIUM-138 
POTASSIUM-5.3* CHLORIDE-106 TOTAL CO2-23 ANION GAP-14
___ 10:00PM   ALT(SGPT)-20 AST(SGOT)-25 LD(LDH)-268* ALK 
PHOS-132* TOT BILI-0.4
___ 10:00PM   CK-MB-12* cTropnT-0.98*
___ 10:00PM   ALBUMIN-3.0* CALCIUM-8.8 PHOSPHATE-4.9* 
MAGNESIUM-1.8 URIC ACID-11.3*
___ 10:00PM   WBC-4.6 RBC-2.54* HGB-7.5* HCT-23* MCV-93 
MCH-29.6 MCHC-31.7 RDW-18.3*
___ 10:00PM   NEUTS-92* BANDS-0 LYMPHS-4* MONOS-3 EOS-1 
BASOS-0 ___ MYELOS-0
___ 10:00PM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-OCCASIONAL 
MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-OCCASIONAL
___ 10:00PM   PLT SMR-LOW PLT COUNT-116*
___ 10:00PM   ___ PTT-26.3 ___
___ 10:00PM   ___
___ 01:15PM   GLUCOSE-118*
___ 01:15PM   UREA N-51* CREAT-2.3* SODIUM-136 
POTASSIUM-5.4* CHLORIDE-103 TOTAL CO2-22 ANION GAP-16
___ 01:15PM   estGFR-Using this
___ 01:15PM   ALT(SGPT)-25 AST(SGOT)-31 LD(LDH)-334* ALK 
PHOS-164* TOT BILI-0.5
___ 01:15PM   TOT PROT-5.5* ALBUMIN-3.4* GLOBULIN-2.1 
CALCIUM-9.4 PHOSPHATE-4.5 MAGNESIUM-1.8 URIC ACID-11.3*
___ 01:15PM   WBC-9.1# RBC-3.13* HGB-9.6* HCT-29.0* MCV-93 
MCH-30.6 MCHC-33.0 RDW-17.9*
___ 01:15PM   NEUTS-92.8* LYMPHS-2.6* MONOS-2.1 EOS-2.0 
BASOS-0.6
___ 01:15PM   PLT COUNT-148*

RELEVANT LABS:
___ 12:15AM BLOOD ___
___ 12:23AM BLOOD Hapto-163
___ 12:23AM BLOOD IgG-455*
___ 12:23AM BLOOD ___
___ 04:39AM BLOOD FacVIII-264*
___ 04:39AM BLOOD VWF AG-281* VWF ___
___ 05:11AM BLOOD ACA IgG-2.2 ACA IgM-4.9
___ 12:23AM BLOOD Hapto-163
___ 12:23AM BLOOD IgG-455*

MICROBIOLOGY:
B-GLUCAN on ___: >500
B-GLUCAN on ___: <31
Galactomannan: not detected 
BLOOD CULTURES ___ X2: NO GROWTH
CMV VIRAL LOAD: NONE DETECTED 

IMAGING:
___ ___:
1.  Left common femoral and proximal left femoral vein partially 
occlusive thrombus has decreased in size compared to the 
___ study.  
2.  The previously-seen clot in the proximal right femoral vein 
has resolved.  There is no DVT in the right lower extremity. 

___ ___:
1.  No significant overall change in chronic appearing thrombus 
within the left common femoral vein and upper portions of both 
the superficial and profunda femoris veins.  
2.  Apparent duplication along the midportion of the superficial 
femoral vein versus a prominent collateral vein, with partially 
occlusive thrombus in the deeper of the two vessels, this vessel 
was not well visualized on the prior study.   

CT-CHEST ___:
1.  The ground-glass opacities described in ___ have 
resolved.   
There are no signs of active infection.   
2. Parenchymal scarring at the lung bases is unchanged since 
___.  
3.  Severe coronary artery disease, aortic valve calcification, 
aortic annulus calcification, pericardial calcification with 
mild cardiomegaly are unchanged since ___. 
4.  Stable mild osteopenia. 

TTE ___:
Left ventricular wall thicknesses and cavity size are normal. 
There is mild regional left ventricular systolic dysfunction 
with mild hypokinesis of the basal to mid septum. The remaining 
segments contract normally. Overall left ventricular systolic 
function is normal (LVEF>55%). Right ventricular chamber size 
and free wall motion are normal. The aortic valve leaflets are 
mildly thickened (?#). No aortic stenosis or regurgitation are 
seen. The mitral valve leaflets are mildly thickened. There is 
no mitral valve prolapse. Trivial mitral regurgitation is seen. 
There is no pericardial effusion. 

US of nodule in Lt lower medial leg ___: Superficial hematoma 
of the left medial calf. 

V/Q scan ___: 
Matched defect in the posterior segment of the left upper lobe 
and 
posterior-basal segment of the left lower lobe, with no 
correlate seen on chest CT. Low likelihood of pulmonary 
embolism.  

CT chest ___:
1.  All lung nodules are stable since ___, not 
concerning for malignancy.  There are no signs of active 
infection. 
2.  Stable severe coronary, aortic valve, aortic annulus and 
pericardial calcification with mild enlargement of the left 
ventricle. 

CT sinuses ___:
Continued mild mucosal thickening of the maxillary sinuses, left 
greater than right.  Decreased opacification of the right 
sphenoid sinus from ___. 

DISCHARGE LABS:
___ 11:00PM BLOOD WBC-5.4# RBC-3.11*# Hgb-9.5*# Hct-29.0*# 
MCV-93 MCH-30.7 MCHC-32.9 RDW-18.6* Plt ___
___ 11:00PM BLOOD Neuts-86.2* Lymphs-7.4* Monos-2.7 Eos-0.8 
Baso-0.3
___ 05:11AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-2+ 
Macrocy-2+ Microcy-1+ Polychr-NORMAL Ovalocy-2+ 
Schisto-OCCASIONAL
___ 11:00PM BLOOD ___ PTT-32.9 ___
___ 12:23AM BLOOD ___
___ 11:00PM BLOOD Glucose-100 UreaN-36* Creat-2.2* Na-135 
K-4.9 Cl-100 HCO3-22 AnGap-18
___ 12:00AM BLOOD ALT-23 AST-20 LD(LDH)-244 AlkPhos-218* 
TotBili-0.4
___ 11:00PM BLOOD Calcium-9.1 Phos-4.5 Mg-2.___ with CML s/p sibling allo D0 ___, complicated by GI 
GVHD, liver GVHD, GVHD related myopathy, who presented from ___ 
clinic for lab abnormalities including hyperkalemia (5.4), 
elevated uric acid (11.5) and acute renal failure (2.3) and was 
found to have a DVT in left ___.  

#DVT in Lt ___: Based on ___ done on ___, DVT seems to be 
chronic and decreasing in size. Based on repeat ___ on ___, 
there is evidence of a new DVT in Lt superficial femoral vein 
that was not visualized on previous study. On presentation, pt 
had scute worsening of ___ edema, prompting us to do further 
imaging. Pt was initially started on heparin gtt with goal PTT 
50-80. However, given high risk of bleeding and current severe 
bruising, we transitioned to heparin SC 12500U BID. We will 
discharge pt on heparin SC 12500U BID for ___ months in 
discretion of outpatient oncologist, Dr. ___. 
- continue heparin SC 12500U BID for ___ months
- hold aspirin 81mg 

#chronic kidney failure: Cr 2.2 on discharge; baseline 1.5-2.0. 
Creatinine ranged 1.8-2.3 during hospitalization. Most likely 
prerenal in the setting of poor po intake; however, elevated 
uric acid may be contributing as well. 
. Throughout hospitalization, she received 1L of fluid and only 
upon admission. We encouraged oral intake and pt was compliant 
with plan. Given history of chronic kidney diseae and 
microangiopathic injury, small daily changes in the Cr are not 
clinically significant. ___ on presentation most likely prerenal 
given improvement with hydration. Based on renal biopsy done in 
___, there is thrombotic microangiopathic injury and severe 
intersitial fibrosis and tubular atrophy. These changes may be 
due to TKI. We held lasix and discontinued it on discharge. 
Resuming lasix will be in discretion of PCP ___ Dr. ___. 
Please encourage oral intake. Please renally dose all 
medications and monitor pt's I/O's and weight. If Cr. rises, pt 
can be given IVF conservatively since new TTE showed EF 55%.  

#CML: Progression of pt's CML was not addressed during this 
hospitalization. This will be assessed as outpatient with Dr. 
___. Last BCR/AML checked on ___ and increasing. Pt p/w 
hyperuricemia and thrombocytopenia, which may be indicating 
changes in leukemia and rapid cell turn over. We tapered 
prednisone by 1mg every other day and stopped at 10mg daily. 
This is the dose we recommend on discharge. Changes can be made 
in discretion of Dr. ___. 

#Hyperuricemia: Urice acid on presentation 11.4. Pt was treated 
with one dose of rasburicase 6mg IV and was further placed on 
allopurinol ___ daily. However, repeat urice acid on ___ was 
8.7. Given that pt has CKD and is already on optimal dose of 
allopurinol ___ daily. We added Febuxostat 40 mg PO daily on 
___ and recommend continuing allopurinol for one week after 
discharge, last dose on ___. 
The exact cause of elevated uric acid is unknown. It may be due 
to rapid cell turnover and changes in CML. Pt will be follow up 
with Dr. ___ further assessment. We recommend checking 
uric acid level in one week. Elevated uric acid may be 
contributing to poor kidney function. 

#Thrombocytopenia: Plt count fluctuated through hospital course. 
This (in addition to hyperuricemia) may present rapid cell 
turnover and changes in leukemia. We discontinued aspirin on 
discharge and held it throughout hospitalization. We recommend 
monitoring plt count as outpatient. 

#Myopathy: Muscle biopsy official report showed no evidence of 
myositit but abnormal muscle fibers. Exact etiology is unclear 
but GVHD and possibly steroids likely. We tapered steroids and 
discharged pt on prednisone 10mg daily.  

#Cough: Most likely viral and post-infectious. Improving but 
intermittent in nature. It has been going on for a few weeks and 
since last admission. CT chest/sinuses negative for any acute 
infectious processes. CT-chest (done twice on ___ and ___ 
showed improvement of opacities observed in ___. Pulmonary 
was consulted and concluded no indication for bronchoscopy given 
improvement in imaging. They concluded post-infectious cough as 
most likely etiology and recommended atroven neb. Given the 
setting of new DVT, there was concern for PE. Pt was tachycardic 
but no dyspnea or pleuritic chest pain. V/Q was negative for PE 
on ___. B-glucan was positive on ___ but repeat on ___ was 
negative. Galactomannan was negative. 

#CAD s/p CABG: History of NSTEMI on last admission is 
questionable since pt only had a trop leak but no EKG changes or 
chest pain. TTE done on ___ showed improved EF 55% (compared to 
40% on last admission). Trops are elevated but seem to be 
chronic and due to CKD. EKG with no acute ischemic changes. We 
held ASA during hospitalization and discontinued on discharge 
since pt is on heparin, she presented with severe bruising, and 
she continued have thrombocytopenia. 

#Hypertension: We continued metoprolol 250mg and amlodipine 5mg. 


 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. albuterol sulfate 90 mcg/actuation Inhalation 1 puff TID prn 
SOB, wheezing 
2. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
3. Multivitamins W/minerals 1 TAB PO DAILY 
4. Magnesium Oxide 400 mg PO BID 
5. Fluconazole 200 mg PO Q24H 
6. PredniSONE 15 mg PO 3X/WEEK (___) 
7. PredniSONE 20 mg PO 4X/WEEK (___) 
8. Amlodipine 5 mg PO DAILY 
9. Aspirin 81 mg PO DAILY 
10. Atovaquone Suspension 1500 mg PO DAILY 
11. Calcium Carbonate 500 mg PO BID 
12. Furosemide 20 mg PO DAILY 
13. Acyclovir 400 mg PO Q12H 
14. Metoprolol Succinate XL 250 mg PO DAILY 
15. Benzonatate 100 mg PO TID:PRN Cough 
16. Guaifenesin ___ mL PO Q6H:PRN cough 
17. Heparin 5000 UNIT SC TID 
18. Miconazole Powder 2% 1 Appl TP TID:PRN Breast Discomfort 
19. Pantoprazole 40 mg PO Q12H 
20. Vitamin E 400 UNIT PO DAILY 

 
Discharge Medications:
1. Acyclovir 400 mg PO Q12H 
2. Amlodipine 5 mg PO DAILY 
3. Atovaquone Suspension 1500 mg PO DAILY 
4. Benzonatate 100 mg PO TID:PRN Cough 
5. Calcium Carbonate 500 mg PO BID 
6. Fluconazole 200 mg PO Q24H 
7. Heparin 12,500 UNIT SC BID 
8. Metoprolol Succinate XL 250 mg PO DAILY 
9. Miconazole Powder 2% 1 Appl TP TID:PRN Breast Discomfort 
10. Multivitamins W/minerals 1 TAB PO DAILY 
11. Pantoprazole 40 mg PO Q12H 
12. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
13. Magnesium Oxide 400 mg PO BID 
14. Guaifenesin ___ mL PO Q6H:PRN cough 
15. albuterol sulfate 90 mcg/actuation Inhalation 1 puff TID prn 
SOB, wheezing 
16. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 
pls hold for lethargy or RR<12. 
17. PredniSONE 10 mg PO DAILY 
18. Allopurinol ___ mg PO DAILY 
Discontinue taking this medication on ___.  
19. Febuxostat 40 mg PO DAILY 
20. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN cough 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
ACUTE DIAGNOSES:
1. Acute Kidney Injury
2. DVT
3. Hyperuricemia 

CHRONIC DIAGNOSES: 
1. CML
2. Coronary artery disease 
3. Hypertension 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you here at the ___ 
___. 

You presented to us with laboratory abnormalities most likely 
due to acute kidney injury and dehydration. We treated you with 
IV fluids and following adequate hydration, these laboratory 
abnormalities resolved and your kidney function improved. In 
addition, your uric acid was very high on admission and you were 
given medications to lower the level since it can cause damage 
to your kidneys. You are being discharged on new medications, 
called allopurinol and febuxostat to maintain low uric acid 
levels. Allopurinol will be discontinued in one week, ___. It 
is important to mention that given your history of chronic 
kidney disease, small daily changes in your kidney function are 
not of clinical significance and can be managed by IV fluids. We 
encourage you to drink plenty of water everyday. 

You were also found to have a blood clot in your left leg. You 
are being treated with heparin injections twice a day. We also 
lowered your steroid dosage gradually and stopped at prednisone 
10mg daily. 

Please take your medications as instructed. Please attend all 
your follow up appointments. Please follow up with Dr. ___ in 
clinic on ___ as scheduled. 
 
Followup Instructions:
___
"
166,19276983,27596021," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROSURGERY
 
Allergies: 
Hydromorphone
 
Attending: ___.
 
Chief Complaint:
Low Back Pain
 
Major Surgical or Invasive Procedure:
L4-5,L5S1 Posterior Laminectomy Interbody Fusion with pedicle 
screws and bone marrow aspirate

 
History of Present Illness:
___ who had an MVA in ___ and soon after began to 
experience low back and right lower extremity pain.  She had 
been seen by a pain specialist who tried multiple modalities 
with epidural steroid injections being the only modality which 
provided her any relief.  MRI imaging of the spine showed large 
central disc protrusion at L4-5.  She was reffered to Dr. ___ 
___ neurosurgical evaluation. through discussion between Dr. 
___ the patient it was decided that posterior lumbar 
interbody fusion of L4-5 would be beneficial. She presented 
electively on ___ for the procedure.
 
Past Medical History:
COPD, Emphysema, degenerative lumbar spondylosis
 
Social History:
___
Family History:
NC
 
Physical Exam:
wdwn
a and o x3
ht rrr
lungs cta
ext no cce
neuro motor full, ___ intact

upon discharge:
neuro intact, wound cdi
MAE's x 4
 
Pertinent Results:
___ 12:05PM   HGB-10.5* calcHCT-32

Lumbar Films Post-OP:

FINDINGS: The patient is status post posterior lumbar fusion 
procedures with interbody fusion device is present at the L4-L5 
and L5-S1 levels. Pedicle screws traverse the L4, L5, and S1 
levels. 

Two lumbar radiographs obtained intraoperatively demonstrate one 
probe at L4 level. The second film demonstrates pedicle screws 
placed at L4, L5 and S1 with interbody fusion device. Please 
refer to operative note for full 
details.
 
Brief Hospital Course:
___ who presented electively on ___ for a posterior lumbar 
interbody fusion L4-5 with pedicle screws and bone marrow 
aspirate with Dr. ___.  She was taken to the OR and the 
procedure was completed without complications. She was 
transferred to the PACU post-operatively and then the floor when 
stable.  She had JP drain placed intra-op that was monitored and 
removed POD#2. her hematocrit was followed post operatively and 
iron supplement was initiated but then dipped down to 21 on 
___ and she was transfused with 2u PRBC. Post transfusion 
hematocrit was 26.6. Her diet and activity were advanced.  Her 
incision was clean and dry.  She was evaluated by ___ and 
recommended for rehab. Her foley was discharged on POD 3 and she 
voided without difficulty.

She went to Rehab via ambulance on ___
 
Medications on Admission:
albuterol,flexeril, valium, imitrex, percocet, trazadone, 
estradiol
 
Discharge Medications:
1. Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
2. Diphenhydramine HCl 50 mg/mL Solution Sig: One (1)  Injection 
Q6H (every 6 hours) as needed for itching,.  
3. Ondansetron HCl (PF) 4 mg/2 mL Solution Sig: One (1)  
Injection Q8H (every 8 hours) as needed for nausea.  
4. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) 
ML PO Q6H (every 6 hours) as needed for no BM>2d.  
5. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a 
day).  
6. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1)  
Injection TID (3 times a day).  
7. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) 
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for 
constipation.  
8. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours).  
9. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).  
10. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical 
QID (4 times a day) as needed for Itchiness.  
11. Cyclobenzaprine 10 mg Tablet Sig: One (1) Tablet PO TID (3 
times a day) as needed for Spasm.  
12. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).  
13. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
14. Magnesium Citrate 1.745 g/30mL Solution Sig: Three Hundred 
(300) ML PO ONCE MR1 (Once and may repeat 1 time) as needed for 
constipatino for 1 doses.  
15. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) 
Tablet, Delayed Release (E.C.) PO BID (2 times a day) as needed 
for constipation.  
16. Oxycodone 5 mg Tablet Sig: ___ Tablets PO Q2H (every 2 
hours) as needed for Pain for 10 days.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
degenerative lumbar spondylosis
post op blood loss amemia requiring transfusion

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
        Do not smoke
        Keep wound clean / No tub baths or pools until seen in 
follow up / begin daily showers ___
        You have steri-strips in place  keep dry x 72 hours.  
Do not pull them off. They will fall off on their own or be 
taken off in the office
        No pulling up, lifting> 10 lbs., excessive bending or 
twisting for two weeks.
        Limit your use of stairs to ___ times per day
        Have a family member check your incision daily for 
signs of infection
        Take pain medication as instructed; you may find it 
best if taken in the a.m. when you wake if you experience muscle 
stiffness and before bed for sleeping discomfort
        Do not take any anti-inflammatory medications such as 
Motrin, Advil, aspirin, Ibuprofen etc. for 3 months.
        Increase your intake of fluids and fiber as pain 
medicine (narcotics) can cause constipation

Patient discharged to Northeast Rehab in ___
 
Followup Instructions:
___
"
167,19276983,26000421," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Hydromorphone
 
Attending: ___.
 
Chief Complaint:
Chronic Obstructive Pulmonary Disease
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old Female with gold stage 4 COPD, admitted from 
pulmonary clinic with concern for COPD exacerbation. PFTs were 
noted as worse than baseline, and Dr. ___ that she would 
need aggressive steroids. Dyspnea seems to be slightly worse per 
the patient, but not acutely so. She initially received IV 
steroids and Zithromax. Also underwent CTA chest to rule out PE.

In addition she notes long standing moderate frank hematochezia 
due to known hemorrhoids. She reports her stools are often 
grape-jelly like.

___ F w/ hx of COPD presenting for dyspnea. Pt went to 
pulmonary clinic today and found to have PFTs suggesting severe 
obstruction with FEV1 0.63L, 21% predicted, FVC 43% predicted. 
Pt states dyspnea has been getting worse. Denies any fevers. 
Appears very anxious on exam and unable to get clear history. Pt 
states she has tried nebulizers before and makes her ""bounce off 
the walls.""  
 In the ED, initial VS were 98.2 91/57 99 24 99%RA  
 Exam notable for extremely anxious. Appears dyspneic. Little 
air movement on auscultation. Guaiac negative in ED.  
 Labs showed  
 7.0>9.6/32.7<449  
 bland chem7  
 proBNP 75  
 troponin <0.01  
 CTA showed:  
 1. Limited by respiratory motion. No evidence of pulmonary 
embolism or aortic abnormality.  
 2. 1.9 cm paramediastinal fatty attenuation lesion likely 
represents a lipoma or hamartoma.  
 Patient was given:  
 lorazepam 1mg PO  
 methylprednisolone 40mg IV  
 Azithromycin 500mg IV  
 ketorolac 30mg IV  
 
 Decision was made to admit to medicine for further management.  

 Transfer VS were 98.6 88 119/77 18 100% NC  
 On arrival to the floor, patient reports...  
 REVIEW OF SYSTEMS:  
 (+) per HPI  
 (-) Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, shortness 
of breath, chest pain, abdominal pain, nausea, vomiting, 
diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, 
hematuria.  
 All other 10-system review negative in detail.  

 
Past Medical History:
-hemorrhoids  
 -h/o pancreatitis  
 -constipation  
 -HFrEF - states had EF 40% at ___  
 -chronic dry eyes  
 -GERD  
 -s/p TAH complicated by abscess and two subsequent SBO  
 -chronic lower back pain s/p L4-5 and L5-1 posterior lumbar 
fusion.  

 
Social History:
___
Family History:
Mother - died from ___  
 Father - asbestos/lung cancer, died from MI age ___  

 
Physical Exam:
ADMIT PHYSICAL
==============
VS: 98.1 ___ 20 100%2LNC  
 GENERAL: Alert, tachypneic, anxious, pursed lip breathing  
 HEENT: NCAT, MMM, no  
 NECK: no elevated JVP  
 CARDIAC: Normal s1 and s2. No murmurs appreciated. No 
accentuated  
 second heart sound or RV heave.  
 LUNG: Symmetric expansion of the chest with markedly diminished 
 
 breath sounds throughout, no wheezes or rhonchi  
 ABDOMEN: soft, nontender, nondistended  
 EXTREMITIES: No edema. No cyanosis. No clubbing.  
 PULSES: radial 2+ bilaterally  
 NEURO: A&Ox3, anxious  
 SKIN: no rashes or lesions  

DISCHARGE PHYSICAL
==================
Vitals: 98.4, 115/64, 77, 20, 95 RA 
General: Anxious appearing female, speaking in full sentences, 
intermittently taking deep breaths  
HEENT: No scleral icterus, no conjunctival pallor.  OP clear 
with MMM.  
Lymph: No cervical, submandibular, supraclavicular LAD.  
CV: s1 s2, RRR, no MRG.  
Lungs: Decreased breath sounds throughout, otherwise CTABL.  
Abdomen: NABS, soft, NTND, no HSM.    
Ext: WWP, 2+ pulses throughout. No ___.  
Neuro: AOx3, grossly non-focal. 
 
Pertinent Results:
ADMIT LABS
==========
___ 08:20PM BLOOD WBC-7.0 RBC-3.87* Hgb-9.6*# Hct-32.7* 
MCV-85# MCH-24.8*# MCHC-29.4* RDW-17.1* RDWSD-52.9* Plt ___
___ 08:20PM BLOOD Neuts-30.4* Lymphs-53.1* Monos-14.8* 
Eos-0.6* Baso-0.4 NRBC-0.3* Im ___ AbsNeut-2.12 
AbsLymp-3.70 AbsMono-1.03* AbsEos-0.04 AbsBaso-0.03
___ 08:20PM BLOOD Plt ___
___ 11:10PM BLOOD ___ PTT-23.7* ___
___ 08:20PM BLOOD Glucose-77 UreaN-30* Creat-0.8 Na-138 
K-5.1 Cl-100 HCO3-26 AnGap-17
___ 08:20PM BLOOD calTIBC-555* Ferritn-9.1* TRF-427*

PERTINENT LABS
==============
___ 06:30AM BLOOD Ret Aut-1.8 Abs Ret-0.05
___ 06:30AM BLOOD ALT-10 AST-10 LD(LDH)-151 AlkPhos-65 
TotBili-<0.2
___ 06:30AM BLOOD Lipase-43
___ 08:20PM BLOOD cTropnT-<0.01
___ 08:20PM BLOOD proBNP-75
___ 08:20PM BLOOD calTIBC-555* Ferritn-9.1* TRF-427*
___ 06:00AM BLOOD Hapto-276*
___ 06:30AM BLOOD VitB12-334
___ 11:13PM BLOOD ___ pO2-45* pCO2-45 pH-7.35 
calTCO2-26 Base XS-0

MICRO
=====
NONE

IMAGING/STUDIES
===============
CTA CHEST ___
Limited by respiratory motion.  No evidence of pulmonary 
embolism to the 
segmental level or aortic abnormality. 

TTE ___
The left atrium is normal in size. Left ventricular wall 
thicknesses and cavity size are normal. Due to suboptimal 
technical quality, a focal wall motion abnormality cannot be 
fully excluded. Overall left ventricular systolic function is 
low normal (LVEF 50-55%). The right ventricular free wall is 
hypertrophied. with borderline normal free wall function. There 
is abnormal septal motion/position (there is an intermittent 
septal bounce that is nonspecific. Can be seen in constrictive 
pericarditis, but there is no other clear evidence for this 
including reduced e' velocities). The number of aortic valve 
leaflets cannot be determined. There is no aortic valve 
stenosis. No aortic regurgitation is seen. The mitral valve 
leaflets are mildly thickened. There is borderline pulmonary 
artery systolic hypertension. There is an anterior space which 
most likely represents a prominent fat pad. 
IMPRESSION: Suboptimal image quality. Low normal global 
biventricular systolic function. Couldnt assess RV size well 
but may be mildly dilated. Borderline pulmonary hypertension. 
Compared with the prior study (images reviewed) of ___ 
global biventricular systolic function is less vigorous. 
Pulmonary pressures are lower but could be underestimated due to 
limited interrogation angles with poor image quality (patient 
could not roll over for the technologist).  

CT ABD/PELV ___
FINDINGS:    
LOWER CHEST: Visualized lung fields are within normal limits. 
There is no 
evidence of pleural or pericardial effusion.   
ABDOMEN:  
HEPATOBILIARY: The liver demonstrates homogenous attenuation 
throughout.  
There is no evidence of focal lesions.  There is no evidence of 
intrahepatic or extrahepatic biliary dilatation.  The 
gallbladder is within normal limits.   
PANCREAS: The pancreas has normal attenuation throughout, 
without evidence of focal lesions or pancreatic ductal 
dilatation.  There is no peripancreatic stranding.   
SPLEEN: The spleen shows normal size and attenuation throughout, 
without 
evidence of focal lesions.   
ADRENALS: The right and left adrenal glands are normal in size 
and shape.   
URINARY: The kidneys are of normal and symmetric size with 
normal nephrogram.  There is no evidence of focal renal lesions 
or hydronephrosis.  There is no perinephric abnormality.   
GASTROINTESTINAL: The stomach is unremarkable.  Small bowel 
loops demonstrate normal caliber, wall thickness, and 
enhancement throughout.  The colon and rectum are within normal 
limits.   
PELVIS: The urinary bladder and distal ureters are unremarkable. 
 There is no free fluid in the pelvis.   
REPRODUCTIVE ORGANS: The visualized reproductive organs are 
unremarkable.  
LYMPH NODES: There is no retroperitoneal or mesenteric 
lymphadenopathy.  There 
is no pelvic or inguinal lymphadenopathy.   
VASCULAR: There is no abdominal aortic aneurysm.  Mild 
atherosclerotic disease 
is noted.   
BONES: There is no evidence of worrisome osseous lesions or 
acute fracture.  
Fixation hardware noted from L4-S1.   
SOFT TISSUES: The abdominal and pelvic wall is within normal 
limits.   
IMPRESSION:    
No imaging findings to explain the patient's hematocrit drop. 

DISCHARGE LABS
==============
___ 09:08AM BLOOD WBC-7.2 RBC-3.45* Hgb-8.7* Hct-29.3* 
MCV-85 MCH-25.2* MCHC-29.7* RDW-17.4* RDWSD-54.2* Plt ___
___ 09:08AM BLOOD Plt ___
___ 09:08AM BLOOD Glucose-85 UreaN-22* Creat-0.7 Na-143 
K-4.1 Cl-99 HCO___ AnGap-16
___ 09:08AM BLOOD Calcium-9.4 Phos-4.2 Mg-3.2*
 
Brief Hospital Course:
___ with hx of Gold Stage IV COPD, hemorrhoidal bleeding, GERD, 
and HFrEF (EF 40%) who presents from pulmonary clinic in setting 
of severe COPD, FEV1/FVC 32% (FEV1 21% predicted), new anemia of 
unclear etiology. She was treated with steroids and discharged 
on a steroid taper. There was concern initially for COPD 
exacerbation but further history revealed she was near her 
baseline respiratory function. Her respiratory function was 
concerning for her home safety and after ___ evaluation, the 
decision was made to discharge her to rehabilitation ___. 
During her hospitalization, she was found to have anemia 
(baseline Hgb from ___ of 12, down to 9 on admission and 
stable at 8). Given significant change from baseline, concern 
for active blood loss anemia. Stool guaiac x 3 negative, CT A/P 
without evidence of acute bleed/retroperitoneal bleed. Likely, 
anemia secondary to hemorrhoid bleeding per history but Hgb 
remained stable throughout remainder of hospitalization and was 
stable at 8.7 on discharge. 

# Acute on chronic anemia - Hemoglobin of 7.9 ___ (stably low 
on subsequent repeats ___ was concerning given 
history of severe hemorrhoids and also upper GI symptoms 
(epigastric pain and nausea)/history of acute pancreatitis 
(lipase normal).  This may all have been ___ hemorrhoidal 
bleeding, though initial rectal guaiac NEG.  Upper GI source 
considered (may be hidden somewhat ___ severe constipation), 
especially in setting of complaints of epigastric pain and 
ongoing steroid treatment for COPD.  No signs of RP bleed on 
physical exam, abdominal exam benign.  CT Abd/pelv ___ with NO 
sign of intraabdominal bleed.  Hemolysis labs unremarkable.  
Iron studies consistent with Fe deficiency (Fe 45, Ferritin 9.1, 
Fe sat ~8%), started PO supplemental iron.  Reticulocyte index 
<2% suggesting marrow suppression, furthermore WBC count quite 
low despite treatment with high dose steroids.  Patient with 
history of multiple SBOs, ?malabsorption, B12 equivocal at 334, 
together with Fe deficiency may have caused a normocytic 
anemia/cytopenias.  Started B12 supplementation at time of 
discharge.  After giving aggressive bowel regimen ___, patient 
had several BMs, the last of which this AM was mixed with red 
blood, most likely bleeding internal hemorrhoids.  Given that Hb 
was stable (8.4->8.7), patient cleared for discharge with close 
outpatient follow-up with her PCP to monitor CBC.        
- Pantoprazole 40mg BID
- Supplemental Iron
- Supplemental B12
- Continue bowel regimen as outpatient to prevent constipation 
leading to increased straining/worsening hemorrhoids 

# COPD - Gold Stage IV - Patient seen by ___ pulmonologist Dr. 
___, with whom primary team was in close contact.  Patient 
tried all standard treatments in past, much difficulties with 
different nebulizers ('jitteriness' and 'laryngitis').  Not 
using home O2, though it was prescribed.  Patient stated that 
she feels comfortable while still/in bed, dyspnea only with 
exertion.  O2 sats remained in high ___, no signs of acute CO2 
retention (pCO2 45 on VBG ___. Patient received duonebs 
q6h, intermittently refused due to 'laryngitis.'  Patient 
initially received IV methylpred and azithromycin on admission.  
Transitioned patient promptly to PO steroids, short taper esp in 
setting of ongoing anemia/upper GI complaints (will complete 
___.  d/c'd azithromycin ___.  Given Dr. ___, 
reached out to palliative care for support, they saw patient 
___ (discussed the possibility of starting methadone in future 
to help with respiratory symptoms, did not start the day of 
discharge).  SW also saw patient.  Patient seen by ___ ___, 
suggested outpatient rehab.  Social situation at home very 
difficult, patient lives home alone with little support.  Of 
note, PE initially considered as another explanation for ongoing 
SOB, though patient had good sats, no pleuritic chest pain, CTA 
chest NEG ___.

# Chronic heart failure with reduced ejection fraction - EF40% 
reportedly from ___ (___ ___.  Likely ___ 
cor pulmonale, unlikely acute exacerbation as BNP 75.  TTE ___, 
poor image quality, normal LV size and fxn, EF 50-55%, RV 
hypertrophy, improved pulm art HTN, less vigorous global 
biventricular fxn.  

# Chronic back pain ___ MVA s/p lumbar/sacral spinal fusion 
surgery.
- PRN acetaminophen
- PRN tramadol 
- Lidocaine patch

# Depression/Anxiety
- Continued diazepam 10mg q8h 

# Chronic Constipation
- Senna, Colace
- Miralx, bisacodyl PRN
- Biscodyl PR PRN

# GERD
- Protonix as above

===================
TRANSITIONAL ISSUES
- Steroid taper as follows: 
--- Prednisone 30 mg ___
--- Prednisone 20 mg ___
--- Prednisone 10 mg ___
- Started on Fe supplementation for low Fe. Started on bowel 
regimen to prevent constipation on this regimen 
- Started on B12 for level 334 in setting of normocytic anemia
- Consider further work up for low reticulocyte count and 
low-normal WBC during this admission.  
- Please repeat CBC in 1 week (___) to ensure stable. Hgb 
8.7 on discharge 
- Patient seen by palliative care, discussed possible methadone 
1mg ___ for dyspnea, did not start on day of discharge. Can 
consider if worsening dyspnea. 

DNR/DNI
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 10 mg PO QPM 
2. Diazepam 10 mg PO Q8H:PRN anxiety 
3. Daliresp (roflumilast) 500 mcg oral DAILY 
4. Restasis 1 drop Other BID 
5. FLUoxetine 20 mg PO DAILY 
6. Pantoprazole 40 mg PO Q24H 
7. Acetaminophen ___ mg PO Q6H:PRN Pain - Mild 
8. Ipratropium Bromide Neb 1 NEB IH Q6H 
9. Sumatriptan Succinate 50 mg PO ONCE MR1 
10. Vitamin D 5000 UNIT PO DAILY 

 
Discharge Medications:
1.  Cyanocobalamin 1000 mcg PO DAILY  
2.  Docusate Sodium 100 mg PO BID  
3.  Ferrous Sulfate 325 mg PO DAILY  
4.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN sob  
5.  Polyethylene Glycol 17 g PO DAILY  
6.  PredniSONE 30 mg PO DAILY Duration: 1 Dose 
30 mg ___ 20 mg ___ 10 mg ___ 
This is dose # 3 of 5 tapered doses 
7.  PredniSONE 20 mg PO DAILY Duration: 1 Dose 
This is dose # 4 of 5 tapered doses 
8.  PredniSONE 10 mg PO DAILY Duration: 1 Dose 
This is dose # 5 of 5 tapered doses 
9.  Senna 8.6 mg PO BID  
10.  Pantoprazole 40 mg PO Q12H  
11.  Acetaminophen ___ mg PO Q6H:PRN Pain - Mild  
12.  Atorvastatin 10 mg PO QPM  
13.  Diazepam 10 mg PO Q8H:PRN anxiety 
RX *diazepam 10 mg 1 tablet by mouth every eight (8) hours Disp 
#*9 Tablet Refills:*0 
14.  FLUoxetine 20 mg PO DAILY  
15.  Ipratropium Bromide Neb 1 NEB IH Q6H  
16.  Restasis 1 drop Other BID  
17.  Vitamin D 5000 UNIT PO DAILY  
18. HELD- Daliresp (roflumilast) 500 mcg oral DAILY  This 
medication was held. You stated you were no longer taking it. Do 
not restart Daliresp until speaking with your pulmonologist 
19. HELD- Sumatriptan Succinate 50 mg PO ONCE MR1  This 
medication was held. Do not restart Sumatriptan Succinate until 
speaking with your primary care physician 
20.Outpatient Lab Work
D64.9
Please check CBC on ___
Please fax results to Dr. ___  
Phone: ___ 
Fax: ___ 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY
Chronic obstructive pulmonary disease
Anemia 

SECONDARY
Chronic lower back pain 
Hemorrhoids 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you at ___. You were admitted for 
concern about your lung function. You were treated with 
steroids. During your hospitalization, you were found to have 
low blood counts which was concerning for bleeding but imaging 
testing and other lab work did not show evidence of an acute 
bleed. You were found to be iron deficient and should continue 
your iron supplementation.

Please continue your medications and follow up with your 
physicians as below.

Wishing you well,

Your ___ Care Team 
 
Followup Instructions:
___
"
168,19940147,23739599," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cefepime / Aztreonam
 
Attending: ___
 
Chief Complaint:
hyperkalemia, hyperuricemia, hypercalcemia, ___ on CKD and 
pancytopenia
 
Major Surgical or Invasive Procedure:
Tunnelled RIJ triple lumen central line placement ___ 
 
History of Present Illness:
___ with CML s/p sibling allo D0 ___, complicated by chronic 
GVHD with gut, liver, muscle involvement presenting from ___ 
clinic with hyperkalemia (5.2), hyperuricemia (9.5 from 8.7 on 
last admission), hypercalcemia (10.7 from 8s-9s), ___ on CKD (Cr 
2.9 from 2.2) and pancytopenia. 

Patient was found to have abnormal lab values as above and 
hypovolemia with Hct of 22 on visit to ___ clinic today. PIV was 
placed, 500cc IVF given, and 1 unit pRBC ordered prior to 
admission.

She had recent admission ending ___ for hypovolemia and acute 
kidney injury leading to hyperkalemia and hyperuricemia.

On admission, vital signs T 98.2 HR 105 BP 135/80 RR 18 SaO2 
99%RA Wt 127.7lb. Patient states that she has had poor PO intake 
as of late. Patient states that she has been more fatigued 
recently and has had cough for ___ weeks. She notes intermittent 
sputum production which tends to be greenish in the AM and 
whitish in the ___. She also notes rash on back and abdomen which 
she believes is due to detergent from rehab facility or drug 
reaction. She states that pain in legs and arms has decreased. 
She denies any change in urine frequency or character. 

She denies chest pain, SOB, palpitations, abd pain, new nausea, 
vomiting, diarrhea, change in bowel habits, fevers/chills. She 
states that she feels the same as she did after last admission.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
From discharge summary ___, confirmed with patient  
- ___: Bone marrow biopsy showed myeloproliferative 
disorder, likely chronic myelogenous leukemia. Per patient 
report, began taking interferon three times weekly shortly after 

diagnosis.  
- ___: Started Gleevec 400 mg daily. At some point 
thereafter, her dose was increased to 600 mg daily  
- ___: ___ increased to 400 mg twice daily with 
hydroxyurea and allopurinol  
- ___: Seen at ___, found to be 
in late chronic phase CML. Stem cell transplant was recommended, 

but she did not wish to pursue this course.  
- ___: Gleevec held due to worsening anemia and 
thrombocytosis. Started on Nilotinib  
- ___: Nilotinib held due to QTC prolongation, started on 
Dasatinib  
- ___: First seen at ___. Bone marrow biopsy showed 
accelerated phase CML, began induction chemo with 7+3.  
- ___: Admission for MRD SCT  
- ___: Discharged on day +32. Transplant complicated by 
mucositis with biopsy of the esophagus suggesting upper GI GVHD 
which was treated with steroids.  
- ___ colonoscopy showing lower GI GVHD  
- ___ readmitted with recurrent aGVHD of the liver upper  
and lower GI tract in the setting of reducing immunosuppression  

- ___ Started on ponatinib 45 mg PO due to evidence of 
disease  
- ___ admitted to the hospital for fatigue and diarrhea, 
renal biopsy showed microangiopathic disease, glomerular 
sclerosing and fibrosis of kidney and GI biopsy showed shallow 
crypts that are  
typically seen with GVHD or cellcept toxicity. Her ponatinib was 

discontinued and prendisone and Cellcept doses were decreased.  
- ___ admitted for nausea, diarrhea, poor PO intake and 
weight loss. Had flex sig and EGD with biopsy negative for GVHD. 

Diarrhea resolved, stool cultures negative. ___ resolved w/ IVF. 

CT sinus had inflammation, given course of levofloxacin. Gastric 

emptying study inconclusive. BCR/ABL gene rearrangment elevated 
from previous undetected level to 2.013%, mycophenylate was 
stopped.  
-___ admitted for hypovolemia, acute kidney injury leading 
to hyperkalemia, hyperuricemia, and found to have DVT. ___ and 
electrolyte abnormalities resolved with IVF, patient was started 
on 1 week allopurinol in addition to febuxostat, and treated 
with SQH for ___ months for superficial femoral vein DVT. 
Discharged on lower dose of steroids (10mg prednisone daily).  

PAST MEDICAL/SURGICAL HISTORY:  
From discharge summary ___, confirmed with patient  
- CAD s/p CABG in ___  
- hypertension  
- hyperlipidemia  
- Right ankle surgery in ___  
- Total abdominal hysterectomy in ___  
- Appendectomy at age ___ 
 
Social History:
___
Family History:
Father - died of MI, no other health problems  
Mother - had heart problems, DM  
No family history of cancer or blood disorders.  

 
Physical Exam:
ADMISSION EXAM:
VITALS  T 98.2 HR 105 BP 135/80 RR 18 SaO2 99%RA Wt 127.7lb
General: Well appearing woman lying in bed, friendly and 
interactive in NAD
HEENT: Little hair on head, moon facies, mildly pigmented sclera 
with no icterus or conjunctival injection, oropharynx clear, dry 
mucous membranes
Neck: No cervical LAD  
CV: Hyperdynamic precordium, early systolic murmur heard best at 
LUSB, RRR, no r/g  
Lungs: Clear to auscultation bilaterally
Abdomen: Soft, nontender, nondistended, normal bowel sounds
Ext: ___ edema in LLE, no edema in RLE, warm and well perfused  

Neuro: CN2-12 intact, motor and sensory exam grossly intact
Skin: Blanching erythematous maculopapular rash present on back 
of head, back of legs, lower abdomen, and especially on back. 
Pethechiae present on bilateral ___. Diffuse ecchymoses on upper 
and lower extremities bilaterally as well as abdomen.  

DISCHARGE EXAM:
Deceased 
 
Pertinent Results:
ADMISSION LABS:

___ 11:40AM BLOOD WBC-2.5*# RBC-2.35* Hgb-7.5* Hct-22.8* 
MCV-97 MCH-32.1* MCHC-33.1 RDW-21.2* Plt Ct-61*#
___ 11:40AM BLOOD Neuts-68 Bands-5 Lymphs-11* Monos-4 Eos-4 
Baso-0 Atyps-1* Metas-2* Myelos-1* NRBC-1* Other-4*
___ 11:40AM BLOOD ___ PTT-68.2* ___
___ 11:40AM BLOOD UreaN-45* Creat-2.9* Na-135 K-5.2* Cl-108 
HCO3-19* AnGap-13
___ 11:40AM BLOOD Glucose-126*
___ 11:40AM BLOOD ALT-13 AST-16 LD(LDH)-287* AlkPhos-285* 
TotBili-0.4
___ 11:40AM BLOOD TotProt-4.9* Albumin-3.1* Globuln-1.8* 
Calcium-10.7* Phos-4.2 Mg-1.8 UricAcd-9.5*
___ 04:31AM URINE Color-Yellow Appear-Clear Sp ___
___ 04:31AM URINE Blood-TR Nitrite-NEG Protein-30 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-LG
___ 04:31AM URINE RBC-4* WBC-35* Bacteri-FEW Yeast-NONE 
Epi-1 TransE-<1
___ 04:31AM URINE Hours-RANDOM UreaN-454 Creat-71 Na-80 
K-28 Cl-65
___ 04:31AM URINE Osmolal-406
___ 06:05AM BLOOD PTH-6*
___ 06:05AM BLOOD Ret Aut-3.2

DISCHARGE LABS:

___ 12:12AM BLOOD WBC-1.3* RBC-2.50* Hgb-7.7* Hct-22.8* 
MCV-91 MCH-30.8 MCHC-33.8 RDW-16.8* Plt Ct-15*
___ 12:12AM BLOOD Neuts-0* Bands-0 Lymphs-46* Monos-2 Eos-0 
Baso-0 ___ Myelos-0 Blasts-52*
___ 12:12AM BLOOD Glucose-105* UreaN-64* Creat-2.5* Na-143 
K-5.0 Cl-109* HCO3-22 AnGap-17
___ 12:12AM BLOOD Calcium-8.4 Phos-5.7*# Mg-2.4

PERTINENT LABS:

___ 06:50AM BLOOD Vanco-36.5*
___ 05:39AM BLOOD Vanco-28.9*
___ 12:00AM BLOOD 25VitD-46
___ 12:22AM BLOOD Albumin-2.6* Calcium-10.6* Phos-3.6 
Mg-2.1 UricAcd-10.2*
___ 02:00PM BLOOD UricAcd-1.5*
___ 02:00PM BLOOD UricAcd-1.8*
___ 12:00AM BLOOD Albumin-2.5* Calcium-10.2 Phos-3.7 Mg-2.0 
UricAcd-1.1*
___ 12:00AM BLOOD Albumin-2.6* Calcium-10.5* Phos-4.2 
Mg-2.6 UricAcd-2.0*
___ 12:00AM BLOOD Albumin-2.5* Calcium-10.9* Phos-4.1 
Mg-2.1 UricAcd-3.4
___ 02:54PM BLOOD Calcium-10.7* Phos-3.9 Mg-1.9 UricAcd-4.3
___ 12:00AM BLOOD Albumin-2.6* Calcium-10.8* Phos-4.0 
Mg-2.3 UricAcd-6.5*
___ 12:10AM BLOOD Calcium-9.7 Phos-3.7 Mg-2.0 UricAcd-7.8*
___ 12:30AM BLOOD Albumin-2.5* Calcium-9.3 Phos-3.6 Mg-2.5 
UricAcd-8.6*
___ 01:00AM BLOOD Calcium-8.8 Phos-3.4 Mg-2.2 UricAcd-9.6*
___ 12:00AM BLOOD ___
___ 06:10AM BLOOD Ret Aut-1.8
___ 12:00AM BLOOD ___
___ 12:10AM BLOOD ___ PTT-29.8 ___
___ 12:00AM BLOOD Neuts-70 Bands-5 Lymphs-8* Monos-4 Eos-3 
Baso-0 ___ Metas-2* Myelos-1* Blasts-7*
___ 12:22AM BLOOD Neuts-65 Bands-6* Lymphs-12* Monos-2 
Eos-3 Baso-0 ___ Metas-3* Myelos-0 Blasts-9*
___ 12:00AM BLOOD Neuts-69 Bands-1 Lymphs-17* Monos-0 Eos-0 
Baso-0 ___ Metas-2* Myelos-0 Blasts-11*
___ 12:00AM BLOOD Neuts-53 Bands-0 ___ Monos-1* Eos-1 
Baso-0 ___ Metas-1* Myelos-0 Blasts-15*
___ 12:00AM BLOOD Neuts-40* Bands-1 ___ Monos-0 Eos-0 
Baso-0 ___ Myelos-1* Blasts-28*
___ 12:27AM BLOOD Neuts-38* Bands-1 ___ Monos-2 Eos-3 
Baso-0 Atyps-1* ___ Myelos-0 Blasts-22*
___ 12:00AM BLOOD Neuts-17* Bands-0 ___ Monos-1* 
Eos-2 Baso-0 ___ Myelos-0 Blasts-53*
___ 12:30AM BLOOD Neuts-5* Bands-0 ___ Monos-0 Eos-5* 
Baso-0 Atyps-1* ___ Myelos-0 Blasts-52*
___ 01:00AM BLOOD Neuts-2* Bands-0 ___ Monos-2 Eos-9* 
Baso-0 ___ Myelos-0 Blasts-65*
___ 12:09AM BLOOD Neuts-5* Bands-0 ___ Monos-0 Eos-2 
Baso-0 ___ Myelos-0 Blasts-64*
___ 06:05AM BLOOD WBC-1.8* RBC-2.41* Hgb-7.6* Hct-22.7* 
MCV-94 MCH-31.7 MCHC-33.6 RDW-21.5* Plt Ct-52*
___ 06:10AM BLOOD WBC-1.7* RBC-2.32* Hgb-7.0* Hct-22.3* 
MCV-96 MCH-30.2 MCHC-31.5 RDW-21.4* Plt Ct-40*
___ 12:00AM BLOOD WBC-1.6* RBC-2.16* Hgb-6.7* Hct-20.6* 
MCV-96 MCH-31.0 MCHC-32.4 RDW-21.3* Plt Ct-36*
___ 12:22AM BLOOD WBC-2.4* RBC-2.56* Hgb-7.9* Hct-23.8* 
MCV-93 MCH-30.7 MCHC-32.9 RDW-20.0* Plt Ct-37*
___ 12:00AM BLOOD WBC-1.7* RBC-2.23* Hgb-7.0* Hct-21.0* 
MCV-94 MCH-31.3 MCHC-33.2 RDW-20.4* Plt Ct-31*
___ 12:00AM BLOOD WBC-1.9* RBC-2.49* Hgb-7.8* Hct-23.4* 
MCV-94 MCH-31.3 MCHC-33.3 RDW-19.3* Plt Ct-28*
___ 12:00AM BLOOD WBC-1.6* RBC-2.34* Hgb-7.2* Hct-22.0* 
MCV-94 MCH-30.9 MCHC-32.9 RDW-19.2* Plt Ct-24*
___ 12:27AM BLOOD WBC-1.9* RBC-2.32* Hgb-7.2* Hct-21.6* 
MCV-93 MCH-31.2 MCHC-33.6 RDW-19.1* Plt Ct-20*
___ 12:00AM BLOOD WBC-1.2* RBC-2.03* Hgb-6.4* Hct-18.8* 
MCV-93 MCH-31.5 MCHC-34.0 RDW-18.9* Plt Ct-17*
___ 12:10AM BLOOD WBC-1.8* RBC-2.34* Hgb-7.2* Hct-21.4* 
MCV-91 MCH-30.7 MCHC-33.7 RDW-18.2* Plt Ct-15*
___ 12:30AM BLOOD WBC-1.0* RBC-2.14* Hgb-6.6* Hct-19.3* 
MCV-90 MCH-30.7 MCHC-34.0 RDW-18.1* Plt Ct-11*
___ 01:00AM BLOOD WBC-1.9*# RBC-2.52* Hgb-7.7* Hct-23.2* 
MCV-92 MCH-30.7 MCHC-33.3 RDW-17.7* Plt Ct-12*
___ 12:09AM BLOOD WBC-1.6* RBC-2.32* Hgb-7.0* Hct-20.9* 
MCV-90 MCH-30.0 MCHC-33.3 RDW-17.6* Plt Ct-9*

MICRO:
___ CMV VL Not detected
___ RRV panel and cx negative
___ Ucx <10K org
___ Ucx 
  KLEBSIELLA PNEUMONIAE.    >100,000 ORGANISMS/ML.. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 
      CITROBACTER FREUNDII COMPLEX.    >100,000 ORGANISMS/ML.. 
         This organism may develop resistance to third 
generation
         cephalosporins during prolonged therapy. Therefore, 
isolates that
         are initially susceptible may become resistant within 
three to
         four days after initiation of therapy.  For serious 
infections,
         repeat culture and sensitivity testing may therefore be 
warranted
         if third generation cephalosporins were used. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             KLEBSIELLA PNEUMONIAE
                             |          CITROBACTER FREUNDII 
COMPLEX
                             |          |   
AMPICILLIN/SULBACTAM--     8 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S      <=1 S
CEFTAZIDIME-----------   <=1 S      <=1 S
CEFTRIAXONE-----------   <=1 S      <=1 S
CIPROFLOXACIN---------<=0.25 S   <=0.25 S
GENTAMICIN------------   <=1 S      <=1 S
MEROPENEM-------------<=0.25 S   <=0.25 S
NITROFURANTOIN--------    32 S     <=16 S
PIPERACILLIN/TAZO-----   <=4 S      <=4 S
TOBRAMYCIN------------   <=1 S      <=1 S
TRIMETHOPRIM/SULFA----   <=1 S      <=1 S

___ Bcx x23 no growth

___ CMV VL not detectable

IMAGING:
___ CT CHEST W/O CON
IMPRESSION: 
1.  New small foci of ground-glass opacities in the upper lobes, 
larger on the 
left, are worrisome for infection. 
2.  Stable splenomegaly. 
3.  Dense coronary calcifications. 
4.  New small left effusion. 
5.  Stable enlargement of the main pulmonary arteries suggesting 
pulmonary 
hypertension. 

___ LLE DUPLEX U/S
IMPRESSION: 
  
Chronic, non-occlusive thrombus of the left proximal superficial 
femoral vein, 
unchanged since ___.   

___ CXR (PORT)
REASON FOR EXAMINATION:  Evaluation of the patient with CML 
transformation into AML and blast crisis with persistent cough. 
Portable AP radiograph of the chest was reviewed in comparison 
to ___. 
The right central venous line tip is at the cavoatrial 
junction/proximal right atrium.  Heart size and mediastinum are 
stable.  There is new left 
retrocardiac opacity, not seen on the prior study, concerning 
for left lower lobe pneumonia associated with small amount of 
pleural effusion.  No pneumothorax is seen. 

___ TTE
The left atrium is mildly dilated. There is mild symmetric left 
ventricular hypertrophy with normal cavity size. There is mild 
to moderate regional left ventricular systolic dysfunction with 
near-akinesis of the septum, and hypokinesis of the basal-mid 
anterior wall. No masses or thrombi are seen in the left 
ventricle. There is no ventricular septal defect. Right 
ventricular chamber size and free wall motion are normal. The 
aortic valve leaflets (3) are mildly thickened. The mitral valve 
leaflets are mildly thickened. Mild (1+) mitral regurgitation is 
seen. The tricuspid valve leaflets are mildly thickened. The 
estimated pulmonary artery systolic pressure is normal. There is 
no pericardial effusion. There is an anterior space which most 
likely represents a prominent fat pad. 

IMPRESSION: Regional left ventricular systolic dysfunction 
consistent with LAD ischemia/infarction. Mild mitral 
regurgitation. 

Compared with the prior study (images reviewed) of ___ and 
___, the function of the septum and anterior wall are 
similar (septal function was described as mildly hypokinetic on 
the most recent study but it was severely hypokinetic then 
also). The function of the mid to distal inferior wall has 
improved. Mild mitral regurgitation is seen.  

PATHOLOGY:
___ IMMUNOPHENOTYPING
Increased number of blasts. In a context of patient's known CML, 
this is concerning for acute blast crisis.  Correlation with 
clinical findings and morphology (see separate report 
___ is recommended.  Flow cytometry immunophenotyping 
may not detect all abnormal populations due to topography, 
sampling or artifacts of sample preparation

___ Bone marrow bx
 Chronic Myelogeneous leukemia - Blast phase (CML-BP), see note.
Note: This represents acute myelegenous transformation of the 
patient's
previously diagnosed CML; ie., CML-BP. CD34 and CD117 are 
increased and
highlight blasts occupying estimated 70-80% of the overall 
cellularity.
 CD20 highlights rare B cells.  CD3 stains interstitial T 
lymphocytes.
CD42 is present in the megakaryocytes, which do not appear 
increased.
TdT is negative.  MP0 is not expressed in blasts.  Glycophorin
highlights erythroid precursors, but is negative in the blasts.

___ Skin bx
PATHOLOGIC DIAGNOSIS:

Skin, left mid back; punch biopsy:

 - Mild spongiosis with dyskeratosis, patchy interface 
inflammation and
focal intra-epidermal eosinophils,  with superficial 
perivascular
mononuclear cell infiltrate and dermal eosinophils (see 
comment).
 - No fungal organisms identified on a PAS stain.
 - Multiple tissue levels examined.

Comment:  The histologic differential diagnosis includes both a
hypersensitivity reaction and graft versus host disease. The 
presence
of eosinophils is compatible with the clinical suspicion of a 
drug
eruption, although they do not exclude graft versus host 
disease.
Clinical correlation is recommended.

 

 

 
Brief Hospital Course:
___ with CML s/p sibling allo D0 ___, complicated by chronic 
GVHD with gut, liver, muscle involvement presenting from ___ 
clinic with hyperkalemia, hyperuricemia, hypercalcemia, ___ on 
CKD and pancytopenia, now with conversion to AML.
 
#CML/AML: BCR/ABL trended up from 0 to 2 to 5 to 104 to 162. 
Presented with hyperuricemia and pancytopenia likely due to 
conversion to AML and rapid cell turn over. No evidence of 
bleeding. Hemolysis unlikely with normal coag studies and Tbili. 
 Retic count 1.8 with retic index 0.88% showed poor red cell 
production. CMV/EBV/HHV6 negative. BM bx shows conversion to AML 
with as much as 65% blasts on smear with absolute blast count as 
high as 1200 and 0% neutrophils. Treated with 12 days of 
nilotinib with no improvement. Given continued decline and poor 
prognosis, transitioned to comfort measures only after which she 
expired. 

#Cough/HCAP: Patient had intermittently productive cough for ___ 
weeks with negative workup on last admission including CXR, CT 
Chest, V/Q scan, rapid resp viral panel. Clear lung exam, 
negative CXR at rehab prior to admission. RRV panel and cx, 
beta-glucan, galactomannan negative. BNP >40K so volume overload 
potentially played a partial role especially given LVEF 40-45% 
on TTE. PE unlikely as patient not hypoxic, no evidence of right 
heart strain on EKG, no evidence of infarct on CT Chest; 
regardless, anticoagulation held in setting of thrombocytopenia 
and no hemodynamic compromise. CT showed ?infectious process, in 
the setting of worsening cough/resp status portable CXR showed 
likely LLL PNA. On ___ patient met ___ SIRS criteria 
(tachycardic, tachypneic, low WBC) so cx drawn and started on 
empiric vanc/meropenem. Received benzonatate, codeine, 
guaifenesin-dextromethorphan as well as levalbuterol/ipratropium 
nebs prn for symptomatic relief. With continued worsening 
respiratory status patient started on morphine for SOB O2 
supplementation prn. Given prognosis, she was transitioned to 
comfort measures only with withdrawal of abx, scopalamine patch, 
and morphine gtt, on which she expired. 

#Hypercalcemia: Baseline high 8s-9s, on admission 10.7. Unclear 
etiology, given elevated alk phos in the setting of CKD could 
have increased bony release of calcium though increased bone 
turnover would likely cause a higher phosphate level. PTH 6 
which rules out hyperparathyroidism and makes hypercalcemia in 
the setting of worsening CML more likely especially with Vit D 
wnl but PTHrP elevated. Received IVF, furosemide, ___ dose 
pamidronate ___ and calcitonin ___ while calcium 
carbonate/Vit D held and calcium downtrended to 8.4.

#UTI: Found to have citrobacter/klebsiella UTI on culture taken 
after patient began to appear septic with ___ SIRS signs. 
Infection was covered by meropenem rx'ed for putative PNA. Foley 
catheter was left in place for comfort and abx discontinued when 
patient transitioned to comfort measures only. 

#CHF: Patient has known CHF likely of ischemic nature given CAD, 
found to have persistent LVEF 40-45% on TTE ___. Increased 
volume with IVF for hypercalcemia tx led to increasing dyspnea 
treated with oxygen supplementation, which improved after 
diuresis and PNA tx as above. At this point, IVF held as calcium 
dropped and for comfort reasons. 
 
#DVT in LLE: Left superficial femoral vein DVT found on last 
admission, discharged on SQ heparin for tx. Previously presented 
with acute worsening of LLE edema but now reduced compared to 
prior admission. LLE U/S shows unchanged partially occlusive 
clot of proximal superficial femoral vein. Anticoagulation held 
given thrombocytopenia, IVC filter placement held given 
stability of clot and goals of care. 

#Hyperuricemia: Uric acid on presentation 9.5. Pt treated on 
last admission with rasburicase and started on allopurinol and 
febuxostat. Discharged with uric acid 8.7. Febuxostat held on 
this admission due to drug rash. Elevated uric acid possibly due 
to worsening renal function in the setting of hypovolemia but 
given rising BCR-ABL and known CML->AML progression likely due 
to rapid cell turnover. Elevated uric acid unlikely to be 
contributing to poor kidney function given no urate crystals on 
urine sediment. Treated with rasburicase x1, uric acid dropped 
to but rose to 9.6 over several days. Allopurinol discontinued 
after patient transitioned to comfort measures only. 

#CKD: Baseline Cr 1.5-2.0 due to thrombotic microangiopathic 
injury with severe interstitial fibrosis and tubular atrophy 
possibly related to TKI shown on renal biopsy ___. Cr 2.2 on 
last discharge, presented with Cr 2.9. Most likely prerenal in 
the setting of poor po intake and hypovolemia; elevated uric 
acid unlikely to be causing renal damage after improvement with 
fluids and no urate crystals. Cr worsened to 2.5 after several 
doses of IV lasix. Urine output decreased ___. Further 
diuresis held, no further IVF or intervention to improve kidney 
function after transition to comfort care only. 

#GVHD: Known skin, gut, liver, muscle involvement. Aldolase 
mildly elevated consistent with known muscle disease but 
improved from ___. Rash likely drug related over acute GVHD 
per derm bx. Continued on prednisone 10mg then transitioned to 
4mg IV solumedrol BID given inability to tolerate PO prior to 
discontinuation of steroids given goals of care. 

#CAD s/p CABG: History of ?NSTEMI in past, ___ TTE with 
preserved EF 55%. ASA held due to thrombocytopenia. 

#Nutrition: Patient's weight has fallen from 141 to 127 lbs 
since ___, likely ___ poor PO intake. Copper level wnl, 
B6 low. Supplemented with ensure while taking PO prior to 
transition to comfort care.  

#Hypertension: 
-Stable on metoprolol and amlodipine until transition to comfort 
care at which point both rx dc'ed. 

Patient sadly died overnight ___ with her family 
present after comfort care for about 3 days. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 400 mg PO Q12H 
2. Amlodipine 5 mg PO DAILY 
3. Atovaquone Suspension 1500 mg PO DAILY 
4. Benzonatate 100 mg PO TID:PRN Cough 
5. Calcium Carbonate 500 mg PO BID 
6. Fluconazole 200 mg PO Q24H 
7. Heparin 12,500 UNIT SC BID 
8. Metoprolol Succinate XL 250 mg PO DAILY 
9. Multivitamins W/minerals 1 TAB PO DAILY 
10. Vitamin D 50,000 UNIT PO 1X/WEEK (WE) 
11. Magnesium Oxide 400 mg PO BID 
12. Guaifenesin ___ mL PO Q6H:PRN cough 
13. albuterol sulfate 90 mcg/actuation Inhalation 1 puff TID prn 
SOB, wheezing 
14. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 
15. PredniSONE 10 mg PO DAILY 
16. Allopurinol ___ mg PO DAILY 
17. Febuxostat 40 mg PO DAILY 
18. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN cough 
19. Omeprazole 20 mg PO DAILY 

 
Discharge Medications:
Deceased 
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Primary: Chronic myelogenous leukemia conversion to acute 
myelogenous leukemia with blast crisis, health-care associated 
pneumonia

Secondary: Chronic graft-versus-host disease, acute on chronic 
kidney injury, deep venous thrombosis of left lower extremity, 
klebsiella and citrobacter urinary tract infection
 
Discharge Condition:
Deceased 
 
Discharge Instructions:
Deceased 
 
Followup Instructions:
___
"
169,19157730,28675196," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Acrylic Acid
 
Attending: ___.
 
Chief Complaint:
Band Prolapse/Band Intolerance
 
Major Surgical or Invasive Procedure:
Laparoscopic Band and Port Removal
 
History of Present Illness:
The patient is several years out for laparoscopic adjustable 
band with ___ pound weight loss. She is progressively having 
intolerance to band where she overeats or eats inappropriate 
foods and then vomits.  On swallow study, noted the band was 
prolapsed, and the decision to proceed with band removal.  The 
patient understands the risks including weight regain, but 
believes that her maladaptive eating puts her at additional 
risk.

 
Past Medical History:
Morbid obesity, HTN, DM2, Dyslipidemia, anemia of chronic 
disease
OSA, Pulmonary Hypertension,
Chronic Back Pain Chronic knee pain,
Cholecystitis, history of HEP A, 
Fibroid Uterus
 
Social History:
Denies past or present tobacco use.
Denies EtOH

 
Physical Exam:
99.7 81 122/74 18 99% RA
GEN: Well appearing, NAD
CV: no MRG, RRR, 
Pulm: CTAB
Abd: soft, appropriately tender, not distended, multiple lap 
incisions
Inc: Clean, dry, intact, no fluctuance, no erythema
Ext: WWP
 
Brief Hospital Course:
The patient presented to the hospital on ___ complaining of 
dysphagia, and abdominal pain. A UGI revealed gastric band 
prolapse. Pt was evaluated by anaesthesia and taken to the 
operating room where a laparoscopic adjustable gastric band and 
port removal was performed. There were no adverse events in the 
operating room; please see the operative note for details. Pt 
was extubated, taken to the PACU until stable, then transferred 
to the ward for observation.
 
Neuro: The patient was alert and oriented throughout the 
hospitalization; pain was well controlled with IV dilaudid PCA 
which was advanced to Roxicet
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: She was initially NPO, but after successfully 
demonstrating no constriction, and no leak on an UGI, she was 
advanced to a bariatric stage 1 diet, which was advanced 
sequentially to stage 3, and well tolerated. Patient's intake 
and output were closely monitored.
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay; she was encouraged to get 
up and ambulate as early as possible.
 
At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a stage 3 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
albuterol sulfate HFA 90 mcg/actuation 2 puffs inhaled every 
four (4) hours as 
atenolol 25 mg tablet. 1 Tablet(s) by mouth daily
Symbicort 80 mcg-4.5
mcg/actuation HFA Aerosol Inhaler. 2 puffs inhaled once a day
ciclopirox 0.77 % Topical Cream. Apply affected
areas both feet twice a day as directed.
Advair Diskus 100 mcg-50 mcg/dose 
Lasix 40 mg tablet
INSULIN LISPRO PROTAM & LISPRO [HUMALOG MIX ___ KWIKPEN] -
Humalog Mix ___ KwikPen 100 unit/mL (75-25) Sub-Q Pen. 35 
units
lisinopril 40 mg tablet
Singulair 10 mg tablet
aspirin 81 mg tablet
Calcium 600 with Vitamin D3 600 mg 
Vitamin D 2,000 unit
docusate sodium 100 mg capsule. 1 Capsule(s) by
loratadine 10 mg tablet. 1 Tablet(s) by mouth once a
day
MAGNESIUM OXIDE
MULTIVITAMIN
 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN HEADACHE 
2. Fluticasone-Salmeterol Diskus (100/50) 2 INH IH BID 
3. Insulin SC 
      Sliding Scale

Fingerstick q6h
Insulin SC Sliding Scale using REG Insulin
4. OxycoDONE-Acetaminophen Elixir ___ mL PO Q4H:PRN PAIN 
RX *oxycodone-acetaminophen [Roxicet] 5 mg-325 mg/5 mL ___ tsp 
by mouth Q4-6H Disp #*250 Milliliter Refills:*0
5. Docusate Sodium (Liquid) 100 mg PO BID 
RX *docusate sodium 50 mg/5 mL 2 tsp by mouth twice a day Disp 
#*200 Milliliter Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Band Prolapse
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Your band was removed, but that does not mean you have to 
abandon your efforts to improve your health.  Take this 
opportunity and incorporate what you have learned from your 
health care team.  Continue being active on a regular basis and 
follow these healthful guidelines (not diet!) for life long 
benefits.

In the hospital, you will be on a stage 3 diet for healing.  
This diet includes all liquid, high protein, low sugar and low 
fat supplements.  When you are discharged home, you may advance 
your diet as tolerated.  Below are some helpful tips to continue 


your journey of eating well and healthy living.

 

1.Keep an eye on calories.

2.Always eat at a table.  Avoid eating while driving, standing, 


sitting on the sofa, or lying in bed.  

3.Eat slowly.  Continue to take 30 minutes to eat a meal and 
chew your foods thoroughly. 

4.Surround yourself with healthy foods. Clean out your cabinets 


of any trigger or unsafe foods.

5.Keep a food journal or track your intake on-line.  Record 
what you eat, portion sizes, and the time you eat.  You may want 


to include your mood and hunger level, as well.

6.Avoid skipping meals.  Always eat at regular times to avoid 
overeating later in the day.

7.Listen to your body.  Eat when you are physically hungry and 
stop when you are full.

8.Be active.  Engage in at least ___ minutes of physical 
activity most (if not all) days of the week. 

9.Regularly check your weight.  Give yourself an acceptable 
range (i.e. 5 pounds).  This prevents slip ups from becoming 
bigger problems down the road.

10. Make small changes.  Set small, reasonable goals to keep on 


track. 

11. Reward yourself.  Treat yourself when you reach goals with 
a non-food treat (i.e. pedicure, movie). 

12. Ask for support. Call the ___ nutrition clinic for 
follow-up at ___. Join Weight Watchers, talk to friends 


and family or contact a local dietitian. 

13. Drink plenty of fluids. Stay hydrated.

Fluids & Diet
Fluid intake is extremely important the first month of your 
recovery. You must also take in enough liquids
to prevent dehydration. Dehydration can cause nausea, fatigue, 
lightheadedness and dark urine.  We recommend you track what you 


drink and eat each day. 
Most Frequent Problems

Discomfort
Abdominal soreness below your ribs on the left side is the most 
common site of tenderness after waking up. Despite this 
discomfort, it is very important that you get out of bed and 
take short walks.

Dehydration
Your most important job after surgery is drinking enough fluid. 
Dehydration is the most common reason to return to the hospital 
after surgery. Your goal is to drink 8 cups (64 oz) of fluid a 
day. You may not be able to drink this much fluid at first, but 
come as close as you can. Refer to your nutrition
packet for more details.

Wound Drainage & Infection
It is important to care for your incisions to prevent infection. 


You will have small fiber tapes on your wounds. This should keep 


your wound dry and closed. Leave them on until they fall off by 
themselves. Do not put band aids, ointments, lotions or powder 
on your incisions. You may get your incisions wet but
avoid scrubbing them. Pat them dry. It is not unusual for an 
incision to drain a little bloody fluid after you
go home. If you have some drainage, dab the wounds with diluted 
hydrogen peroxide (hydrogen
peroxide mixed half and half with water) and then cover with a 
dry gauze. Doing this twice a day will
speed your recovery.
Infections are uncommon and rarely serious after a laparoscopic 
operation. An infection will be red, warm,
firm, and tender. The infected fluid will look more like pus 
than like blood. If you notice this please call the
nurse at the Bariatric ___ Program to discuss your symptoms

 
Followup Instructions:
___
"
170,19157730,23131105," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Acrylic Acid / lisinopril
 
Attending: ___.
 
Chief Complaint:
Chest Pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
 ___ with DM, HTN, ___ edema who presents with episode of chest 
pain. Patient experienced episode of ""chest pressure"" yesterday 
when she was lifting 2 bags of salt. Chest pressure was 
nonradiating and was accompanied with lightheadedness, SOB,  and 
feelings of anxiety. The CP began subsiding by itself and was 
further relieved when paramedics gave patient SL NTG and O2. 
Also received ASA 325 on scene. Patient reported that BP when 
paramedics arrived was 220/110. Patient has had brief episodes 
of chest pain recently associated with stress, but states 
current episode was different lasting longer at 15 minutes. Of 
note patient has also had some muscle straining on left side and 
currently states she continues to have this muscle pain.  

Patient denies any fevers, chills, nausea, vommiting. She had 
chronic DOE with no changes recently. She sleep on ___ pillows 
with no recent changes. No recent illnesses.  No recent trauma. 
Reports she has not been taking any medications except atenolol 
and furosemide as prescribed because of angioedema/tongue 
swelling to lisinopril in ___.
 
At present patient is comfortable and asymptomatic.

ED Course (labs, imaging, interventions, consults): 
initial vitals: 98.8 64 141/72 20 98% 
- Labs were significant for negative troponins x2. Patient was 
given ASA and BB, nebulizer treatment, and total of 30 po 
prednisone.

Patient was supposed to have stress in am on ___ but could 
not go secondary to wheezing and SOB. 

 
Past Medical History:
1. CARDIAC RISK FACTORS: +Diabetes,+Hypertension  
2. CARDIAC HISTORY:  
-CABG:  none
-PERCUTANEOUS CORONARY INTERVENTIONS:none  
-PACING/ICD:  none
3. OTHER PAST MEDICAL HISTORY:  
Morbid obesity, anemia of chronic disease
OSA not using CPAP, Pulmonary Hypertension,
Chronic Back Pain Chronic knee pain,
Cholecystitis s/p cholecystectomy, history of HEP A?, asthma, 
Fibroid Uterus
 
Social History:
___
Family History:
NO early cardiac disease. Negative for CAD
 
Physical Exam:
ADMISSION:
VS: T=98.5 BP=135/60 HR= 64 RR= 18 O2 sat= 94 RA
Weight : 120.1 kg admission 
GENERAL:NAD. Oriented x3. Mood, affect appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI.  
NECK: Supple with JVP flat.   
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or 
S4.  
LUNGS:  Resp were unlabored, no accessory muscle use. CTAB, no 
crackles, wheezes or rhonchi. Reproducible Left chest pain on 
palpation at left lower ribcage.  
ABDOMEN: Obese. Soft, NTND.   
EXTREMITIES: Trace pedal edema   
PULSES:  
Right: Carotid 2+  DP 2+ ___ 2+  
Left: Carotid 2+ DP 2+ ___ 2+ 

DISCHARGE:
VS: T=98.2 BP=132-135/54-60 HR= ___ RR= 18 O2 sat= 94 RA
Weight : 120.4 --< admission 120.1 kg admission 
GENERAL:NAD. Oriented x3. Mood, affect appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI.  
NECK: Supple with JVP flat.   
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or 
S4.  
LUNGS:  Resp were unlabored, no accessory muscle use. CTAB, no 
crackles, wheezes or rhonchi. 
ABDOMEN: Obese. Soft, NTND.   
EXTREMITIES: No pedal edema   
PULSES:  
Right: Carotid 2+  DP 2+ ___ 2+  
Left: Carotid 2+ DP 2+ ___ 2+  
 
Pertinent Results:
___ 11:25PM URINE  HOURS-RANDOM
___ 11:25PM URINE  GR HOLD-HOLD
___ 11:25PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 11:25PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR 
GLUCOSE-TR KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-6.0 LEUK-NEG
___ 11:25PM URINE  RBC-0 WBC-2 BACTERIA-MOD YEAST-NONE 
EPI-2
___ 11:25PM URINE  MUCOUS-OCC
___ 08:05PM   GLUCOSE-218* UREA N-13 CREAT-0.6 SODIUM-143 
POTASSIUM-3.6 CHLORIDE-101 TOTAL CO2-29 ANION GAP-17
___ 08:05PM   estGFR-Using this
___ 08:05PM   cTropnT-<0.01
___ 08:05PM   WBC-9.3 RBC-4.75 HGB-12.1 HCT-39.2 MCV-83 
MCH-25.4* MCHC-30.8* RDW-12.8
___ 08:05PM   NEUTS-64.6 ___ MONOS-3.2 EOS-2.4 
BASOS-0.6
___ 08:05PM   PLT COUNT-304

CXR ___
The heart size is normal.  Mediastinal and hilar contours are 
unchanged. 
Pulmonary vascularity is normal.  Except for subsegmental 
atelectasis in the lingula, lungs are clear.  No pleural 
effusion or pneumothorax is present. Clips are seen in the right 
upper quadrant of the abdomen.  No acute osseous abnormalities 
are identified.
 
IMPRESSION:
No acute cardiopulmonary process.

STRESS ECHO ___
The patient exercised for 9 minutes and 0 seconds according to a 
Gervino treadmill protocol ___ METS) reaching a peak heart rate 
of 102 bpm and a peak blood pressure of 170/80 mmHg. The test 
was stopped because of fatigue. This level of exercise 
represents a poor exercise tolerance for age. The exercise ECG 
was uninterpretable due to resting ST-T wave changes (see 
exercise report for details). There is resting systolic 
hypertension. The blood pressure response to stress was blunted. 
There was a blunted heart rate response to stress [beta 
blockade].

Resting images were acquired at a heart rate of 56 bpm and a 
blood pressure of 162/90 mmHg. These demonstrated normal 
regional and global left ventricular systolic function. Right 
ventricular free wall motion is normal. There is no pericardial 
effusion. Doppler demonstrated mild mitral regurgitation with no 
aortic stenosis, aortic regurgitation or significant resting 
LVOT gradient. There is borderline pulmonary artery systolic 
hypertension. Echo images were acquired within 43 seconds after 
peak stress at heart rates of 92 - 80 bpm. These demonstrated 
appropriate augmentation of all left ventricular segments. There 
was augmentation of right ventricular free wall motion.

IMPRESSION: Poor functional exercise capacity. Uninterpretable 
ECG changes in the absence of 2D echocardiographic evidence of 
inducible ischemia to achieved low workload. Mild mitral 
regurgitation at rest. 

___ STRESS
This ___ y.o. IDDM woman with h/o HTN was referred to 
the lab for evaluation of chest pain and dyspnea. The patient 
exercised 
for 9.0 minutes of a Gervino protocol (~ ___ METS), representing 
a poor 
exercise tolerance for her age. The test was stopped due to 
fatigue. 
At minute 7 of exercise, the patient noted ___ non-progressive 
left 
sided chest heaviness. This discomfort improved with deep 
inspiration 
and resolving quickly in recovery by minute 1.25. At peak 
exercise, 
there was non-specific T wave normalization was noted. The T 
waves 
returned to baseline in recovery. The rhythm was sinus with 
rare, 
isolated apbs, frequent, polymorphic vpbs, and several 
ventricular 
couplets throughout the study. Baseline systolic hypertension 
with an 
initial drop in systolic blood pressure during exercise. 
Appropriate increase in blood pressure response to exercise as 
it 
continued but the overall response was blunted. Blunted heart 
rate 
response to exercise in the presence of beta blocker therapy. 
  
IMPRESSION: Poor exercise capacity. Atypical anginal type 
symptoms with 
uninterpretable ECG changes to achieved low workload. Resting 
systolic hypertension with abnormal blood pressure and blunted 
heart 
rate response to exercise. Echo report sent separately. 

 
 
Brief Hospital Course:
___ with DM, HTN, ___ edema presented to ED with Chest Pain. 
Chest pain was exertional in nature and raised concern for 
unstable angina. Initial troponins x2 in ED were negative. EKG 
with no acute ischemic changes. Chest pain may have been 
muscular in origin or associated with anxiety at the time, given 
patient's known history of panic attacks. Given patient's risk 
factors she underwent a stress test on ___ which showed 
nonspecific ECG changes in the absence of 2D echo evidence of 
inducible ischemia. ___ hospital course is summarized by 
problems below:

#Chest Pain: Patient presents with exertional chest pain that 
raised concern for unstable angina. Initial troponins x 2 
negative along with no EKG changes.Third troponin also returned 
negative. Stress was done on ___ which showed nonspecific 
ECG changes in the absence of 2D echo evidence of inducible 
ischemia.LVEF greater than 60%. Reached METS of 4.8 on stress. 
Patient was medically treated on aspirin 81. Home atenolol was 
discontinued and patient was started on losartan 25 daily during 
this hospitalization. PCP was notified prior to discharge and 
will monitor blood pressure on discharge. 

#HTN:SBP in th 130's. HTN was controlled with home dose of lasix 
and losaratan 25 daily. Atenolol was discontinued.

# DM: Hg A1C was 8.6 on ___. Patient's oral hypoglycemics 
were held during hospitalization. Blood sugars were controlled 
with ISS.

#OSA- Patient with history of OSA, not using CPAP. Oxygen 
saturations were apporpriately monitored with vitals.

#Asthma-  Patient was wheezing on presentation to the ED and was 
treated with nebulizers and po prednisone. No further episodes 
of wheezing. Continued albuterol and symbicort.

Patient was full code during this hospitalization.
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 
2. Atenolol 25 mg PO DAILY 
hold for sbp less than 90 or hr less than 55 
3. Symbicort *NF* (budesonide-formoterol) 80-4.5 mcg/actuation 
Inhalation daily 
2 puffs once a day 
4. Furosemide 40 mg PO DAILY 
5. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 
Do Not Crush 
6. Aspirin 81 mg PO DAILY 
7. Docusate Sodium 100 mg PO BID 
8. biotin *NF* unknown  Oral daily 
9. multivitamin *NF* unknown  Oral daily 
10. HumaLOG *NF* (insulin lispro) 50   Subcutaneous q am 
11. HumaLOG *NF* (insulin lispro) 45  Subcutaneous qpm 
12. Vitamin D ___ UNIT PO DAILY 
13. Calcium Carbonate 500 mg PO DAILY 

 
Discharge Medications:
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 
2. Aspirin 81 mg PO DAILY 
3. Calcium Carbonate 500 mg PO DAILY 
4. Docusate Sodium 100 mg PO BID 
5. Furosemide 40 mg PO DAILY 
6. Vitamin D ___ UNIT PO DAILY 
7. Losartan Potassium 25 mg PO DAILY 
RX *losartan 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
8. HumaLOG *NF* (insulin lispro) 50   Subcutaneous q am 
9. HumaLOG *NF* (insulin lispro) 45 45 SUBCUTANEOUS QPM 
10. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 
Do Not Crush 
11. multivitamin *NF* 1 pill ORAL DAILY 
12. Symbicort *NF* (budesonide-formoterol) 80-4.5 mcg/actuation 
Inhalation daily 
2 puffs once a day 
13. biotin *NF* 1 vitamin ORAL DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary: Chest Pain
Secondary: Diabetes, Hypertension  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,
It was a pleasure caring for you during your most recent 
hospitalization. You were admitted for chest pain. You underwent 
a cardiac stress test which showed was normal. Your blood 
pressure medication was changed- atenolol was stopped and you 
were started on losartan.

Please take all of your medications as prescribed and followup 
with your physician ___.
 
Followup Instructions:
___
"
171,19157730,25369427," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Acrylic Acid / lisinopril
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
___ has class III morbid obesity with weight of 282.1 pounds
as of ___ with her initial screen weight of 282.9 pounds on
___, height 62 inches and BMI of 51.6.  ___ was 
initially
evaluated in our Program ___ and ___ and was deemed
an appropriate candidate to undergo laparoscopic adjustable
gastric band procedure with Dr. ___ on ___.  Her 
high
pre-op weight was 295.9 pounds at height of 62.75 inches and BMI
of 52.9.  Her lowest weight with the lap band that she achieved
was 249.3 pounds on ___ and BMI of 44.5 represented 15.7%
total and 30% excess weight loss.  She then began to develop
issues with the lap band and an upper GI series noted slippage
and therefore the lap band and port was removed by Dr. ___ on
___.  She has subsequently gained significant weight to a
high weight of 303.5 pounds on ___.  She now wants the 
sleeve
gastrectomy procedure and she feels it would be the best option
to reduce her many co-morbid conditions such as diabetes and
obstructive sleep apnea.  She has tried in her previous weight
loss efforts Weight Watchers several times, prescription weight
loss medication Redux (now off market), Slim-Fast,
over-the-counter dietary supplement Dexatrim, ___. counseling.  She stated that her lowest adult weight was
104 pounds at the age of ___ and her highest weight prior to lap
band procedure was 296 pounds.  She weighed 253 pounds ___ years
ago, 271 pounds ___ years ago and 290 pounds one year ago.  She 
had
stated that she has been struggling with weight for the past ___
years and cites as factors contributing to her excess weight
large portions, grazing, late night eating, emotional eating
monthly, convenience eating, too many carbohydrates and 
saturated
fats including pasta, fatty foods and soda.  She is currently 
not
exercising secondary to physical limitations although she is
trying to increase her steps daily.  She denied history of 
eating
disorders - no anorexia, bulimia, diuretic or laxative abuse and
she denied binge eating.  She does have depression/anxiety and 
is
currently not seeing a therapist, she has not been hospitalized
for mental health issues and she is on psychotropic medication
(lorazepam for anxiety).

 
Past Medical History:
1. CARDIAC RISK FACTORS: +Diabetes,+Hypertension  
2. CARDIAC HISTORY:  
-CABG:  none
-PERCUTANEOUS CORONARY INTERVENTIONS:none  
-PACING/ICD:  none
3. OTHER PAST MEDICAL HISTORY:  
Morbid obesity, anemia of chronic disease
OSA not using CPAP, Pulmonary Hypertension,
Chronic Back Pain Chronic knee pain,
Cholecystitis s/p cholecystectomy, history of HEP A?, asthma, 
Fibroid Uterus
 
Social History:
___
Family History:
NO early cardiac disease. Negative for CAD
 
Physical Exam:
ADMISSION PHYSICAL EXAM 
=======================
Physical Exam:
Vitals:  T98.7, HR ___, RR ___, 95-98% on 3L NC
GEN: NAD, A&Ox3
CV: Regular rate
PULM: Breathing comfortably, no respiratory distress
ABD: soft, non-distended.  Surgical dressings clean, dry, in
tact.  
EXTR: WWP

DISCHARGE PHYSICAL EXAM 
=======================
___ 0354 Temp: 97.6 PO BP: 126/59 L Lying HR: 76 RR: 18 O2
sat: 92% O2 delivery: Cpap 
GEN: NAD, A&Ox3
CV: Regular rate
PULM: Breathing comfortably, no respiratory distress
ABD: soft, minimally tender, minimal fullness noted to
epigastrium.  Incision sites well coapted, no areas of
dehiscence, no drainage or erythema noted, no clinical signs of
infection. 
EXTR: WWP
 
Pertinent Results:
ADMISSION LABS 
==============
___ 10:35AM BLOOD Hct-37.9
___ 03:24PM BLOOD Glucose-307* UreaN-16 Creat-0.6 Na-140 
K-4.5 Cl-99 HCO3-26 AnGap-15
___ 03:24PM BLOOD Calcium-8.9 Phos-4.9* Mg-1.6
___ 10:35AM BLOOD %HbA1c-8.6* eAG-200*

PERTINENT RESULTS 
=================
UGI SGL CONTRAST W/ KUB Study Date of ___ 9:22 AM 
IMPRESSION:  
No evidence of leak or obstruction. 

PATHOLOGY ___
PATHOLOGIC DIAGNOSIS:
Stomach, sleeve gastrectomy:
-Portion of stomach (gross examination only).
CLINICAL HISTORY: Morbid obesity.
GROSS DESCRIPTION:
The specimen is received without fixative labeled with the 
patient's name and submitted as ""gastric sleeve"" is a 20.5 x 4.2 
x 3.2 cm intact gastric sleeve. The serosal surface is tan-pink, 
focally hemorrhagic with a staple line present which measures 
20.5 cm. The gastric sleeve is opened to reveal a wall thickness 
averaging 0.2 cm. The mucosa is tan-pink with the usual rugal 
fold polyps orlesions are noted. The specimen is gross only and 
no sections are submitted.

DISCHARGE LABS 
==============
___ 11:10AM BLOOD Hct-39.6
 
Brief Hospital Course:
Patient Summary 
===============
___ female hx severe obesity (BMI 52) and weight related comorbid 
illness (diabetes,hypertension, sleep apnea) now s/p sleeve 
gastrectomy ___ (___), healing on trajectory, doing well 
post operatively.  

Acute Issues 
============
1. S/p sleeve gastrectomy ___ ___

Chronic Issues Pertinent to Admission
=====================================
1.  DMII - Requires ___ follow up:  ___ Dr. ___ 8:30 am
2.  GERD - Prescribed Famotidine 

Transitional Issues 
===================
1.  DMII - ___ recommendations made while in house.  ISS 
changed, and 25mg evening Lantus added on.  Patient had one 
incident of hypoglycemia to BS 69, and evening Lantus was 
removed.  Given metabolic changes post gastric sleeve, will 
likely require adjustments to home diabetes medications.  Per 
___ recommendations, discharged home with Metformin 500mg BID 
and FSBG BID, no insulin.  
2.  B/l ___ Edema - Lasix held post-operatively.  Assess at PCP 
follow up ___. 
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Losartan Potassium 100 mg PO DAILY 
2. omega-3-dha-epa-dpa-fish oil 1,050-1,200 mg oral ASDIR 
3. Ipratropium-Albuterol Neb 1 NEB NEB ASDIR 
4. LORazepam 1 mg PO ASDIR 
5. Metoprolol Succinate XL 25 mg PO DAILY 
6. MetFORMIN (Glucophage) 1500 mg PO DAILY 
7. amLODIPine 10 mg PO DAILY 
8. Atorvastatin 10 mg PO QPM 
9. exenatide microspheres 2 mg/0.65 mL subcutaneous 1X/WEEK 
10. insulin regular hum U-500 conc 500 unit/mL subcutaneous 
ASDIR 
11. Furosemide 40 mg PO DAILY 
12. Multivitamins 1 TAB PO DAILY 
13. budesonide-formoterol 160-4.5 mcg/actuation inhalation BID 
14. Aspirin 81 mg PO DAILY 
15. albuterol sulfate 90 mcg/actuation inhalation ASDIR 
16. biotin 1 mg oral ASDIR 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild/Fever 
RX *acetaminophen 650 mg/20.3 mL 20 mL by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  Famotidine 20 mg PO BID 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
3.  MetFORMIN (Glucophage) 500 mg PO BID 
RX *metformin 500 mg 1 tablet(s) by mouth twice a day Disp #*20 
Tablet Refills:*0 
4.  Metoprolol Tartrate 12.5 mg PO BID  
5.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mL by mouth Every four hours 
Refills:*0 
6.  albuterol sulfate 90 mcg/actuation inhalation ASDIR  
7.  amLODIPine 10 mg PO DAILY  
8.  Aspirin 81 mg PO DAILY  
9.  Atorvastatin 10 mg PO QPM  
10.  biotin 1 mg oral ASDIR  
11.  budesonide-formoterol 160-4.5 mcg/actuation inhalation BID  

12.  Ipratropium-Albuterol Neb 1 NEB NEB ASDIR  
13.  Losartan Potassium 100 mg PO DAILY  
14.  Multivitamins 1 TAB PO DAILY  
15.  omega-3-dha-epa-dpa-fish oil 1,050-1,200 mg oral ASDIR  
16. HELD- exenatide microspheres 2 mg/0.65 mL subcutaneous 
1X/WEEK  This medication was held. Do not restart exenatide 
microspheres until ___ follow up
17. HELD- Furosemide 40 mg PO DAILY  This medication was held. 
Do not restart Furosemide until follow up 
18. HELD- insulin regular hum U-500 conc 500 unit/mL 
subcutaneous ASDIR  This medication was held. Do not restart 
insulin regular hum U-500 conc until ___ Follow Up. 
19. HELD- LORazepam 1 mg PO ASDIR  This medication was held. Do 
not restart LORazepam until no longer taking opioid pain 
medications

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.  
 Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination.  
 Medication Instructions:  
 Please refer to the medication list provided with your 
discharge paperwork for detailed instruction regarding your home 
and newly prescribed medications.  
 Some of the new medications you will be taking include:  
 1. Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication. This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.  
 2. Constipation: This is a common side effect of opioid pain 
medication. If you experience constipation, please reduce or 
eliminate opioid pain medication. You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern. Please stop taking this medication if you develop loose 
stools. Please do not begin taking laxatives including until you 
have discussed it with your nurse or surgeon.  
 3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.  
 4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.  
 5. Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.  
 Activity:  
 You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
 You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.  
 Wound Care:  
 You may remove any remaining gauze from over your incisions. 
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.  
 You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry. Avoid tub baths or 
swimming until cleared by your surgeon.  
 If there is clear drainage from your incisions, cover with 
clean, dry gauze.  
 Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites.  
 Avoid direct sun exposure to the incision area for up to 24 
months.  
 Do not use any ointments on the incision unless you were told 
otherwise.  
 
Followup Instructions:
___
"
172,19345921,24924415," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Allergies/ADRs on File
 
Attending: ___.
 
Chief Complaint:
Shortness of breath, palpitations
 
Major Surgical or Invasive Procedure:
Cardiac catheterization ___
TTE ___ 
Bone marrow biopsy on ___

 
History of Present Illness:
Mr. ___ is a ___ male without medical care 
for several years, no known past medical history, who initially 
presented to ___ on ___ with SOB and palpitations. 

In the ED at ___ he was found to be in afib with RVR to 
150s and respiratory distress. He was initially on BiPAP and 
weaned to ___.  CXR showed bialteral infiltrates concerning for 
pulmonary edema. Troponin was mildly elevated to 0.16, BNP was 
1066. An EKG showed lateral STD and cardiology was consulted. He 
was initially given ASA but heparin gtt was not started due to 
concern for AAA (See below). He was initially treated with 
diltiazem gtt and admitted to the ICU. An echo was obtained due 
to pulmonary edema and orthopnea and revealed a LVEF 35%, 
mild-mod global hypokinesis of inferior wall and septum, mod AI, 
mod AS, mod MR, mod TR, and mod pulmonary HTN. There was also 
moderate dilation of the aortic root and ascending aorta. No 
significant pericardial effusion was seen.  

The patient's labs were also notable for a marked leukocytosis 
with L-shift including 2% blasts. Due to concern for infection a 
CTA chest with CT abdomen and pelvis with contrast was obtained 
to rule out infectious source and PE. There was no PE or 
evidence of infection but a 6cm infrarenal AAA with possible 
evidence of impending rupture was seen. Dr. ___ at ___ 
reviewed the images urgently and felt no evidence of imminent 
rupture but transfer was initiated. 

While in the ICU he was switched from diltiazem to esmolol gtt 
and diuresed with IV Lasix with improvement in his orthopnea. 
The CTA had also been notable for bilateral pleural effusions 
and infiltrates consistent with pulmonary edema. 

On arrival to ___ the patient reports feeling improved without 
any pain or discomfort. He relays the following history: He last 
had a physical ___ years ago as part of being a ___ 
___. He has no known medical history. At baseline he has no 
functional limitation with walking on flat ground and can walk 
up at lest 2 flights of stairs without needing to stop for air. 
He has no orthopnea, PND, leg swelling, palpitations, or chest 
pain at baseline. He had no fevers, chills, URI symptoms, n/v/d 
prior to this presentation. 

He has smoked 1ppd for at least ___ years, 2 ppd for the last 
year, and quit 3 weeks ago. He previously drank 5 mixed drinks 
per week but cut back to 3 mixed drinks per week 6 months ago 
with no history of alcohol withdrawal. No recreational drugs, no 
new sexual contacts and no history of STDs. 

 
Past Medical History:
Prior to admission, did not have any diagnoses medical 
conditions.
CHF 
afib with RVR 
AAA 
Leukocytosis with left shift
 
Social History:
___
Family History:
""thoracic aneurisym"" and ""aortic aneurisym"" in his father 
HTN - father 
CHF - mother
 
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
======================  
VITALS: Reviewed in metavision  
GENERAL: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
NECK: supple, JVP mildly elevated
LUNGS: bibasilar crackles, fair air movement, no wheezing, 
comfortable lying relatively flat  
CV: irregular and fast rate. 
ABD: soft, non-tender, non-distended, bowel sounds present
EXT: Warm, well perfused, 2+ DP pulses, no clubbing, cyanosis or 
edema  
SKIN: warm
NEURO:  grossly normal, AAx3 

DISCHARGE PHYSICAL EXAM
=======================
Vitals:  
___ ___ Temp: 97.7 PO BP: 120/75 R Sitting HR: 84 RR: 17 
O2
sat: 97% O2 delivery: Ra 
I/O= net +415 cc in past 24 hrs
Weight:  74.4 kg 
GENERAL: Thin middle aged male. NAD. Appropriately interactive.
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no
pallor or cyanosis of the oral mucosa. 
NECK: JVP not elevated.   
CARDIAC: Irregular rhythm. Normal S1, S2. Systolic murmur
appreciated RUSB.
LUNGS: Resp were unlabored, no accessory muscle use. Soft
crackles L base.
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: Warm, well perfused. Distal pulses palpable and
symmetric 

 
Pertinent Results:
ADMISSION LABS
===============
___ 02:19PM BLOOD WBC-44.3* RBC-4.07* Hgb-11.4* Hct-35.3* 
MCV-87 MCH-28.0 MCHC-32.3 RDW-18.0* RDWSD-55.0* Plt ___
___ 02:19PM BLOOD Neuts-79* Bands-0 Lymphs-5* Monos-2* 
Eos-0 Baso-0 ___ Metas-6* Myelos-4* Promyel-2* Blasts-2* 
Other-0 AbsNeut-35.00* AbsLymp-2.22 AbsMono-0.89* AbsEos-0.00* 
AbsBaso-0.00*
___ 02:19PM BLOOD ___ PTT-27.2 ___
___ 10:29PM BLOOD ___ 02:19PM BLOOD Ret Aut-3.0* Abs Ret-0.12*
___ 02:19PM BLOOD Glucose-102* UreaN-35* Creat-1.6* Na-141 
K-4.2 Cl-104 HCO3-21* AnGap-16
___ 02:19PM BLOOD ALT-31 AST-25 LD(LDH)-251* AlkPhos-189* 
TotBili-0.4
___ 02:19PM BLOOD CK-MB-10 cTropnT-0.18*
___ 02:19PM BLOOD Albumin-3.4* Calcium-9.2 Phos-4.4 Mg-2.1 
UricAcd-8.4* Iron-71
___ 02:19PM BLOOD calTIBC-308 Ferritn-120 TRF-237
___ 04:44AM BLOOD %HbA1c-5.6 eAG-114

PERTINENT INTERVAL LABS
=======================
___ 06:15AM BLOOD Digoxin-0.8
___ 07:00AM BLOOD ___
___ 11:38AM BLOOD Glucose-95 UreaN-34* Creat-1.6* Na-142 
K-4.3 Cl-105 HCO3-21* AnGap-16

DISCHARGE LABS
==============
___ 07:00AM BLOOD WBC-36.0* RBC-4.19* Hgb-11.8* Hct-37.2* 
MCV-89 MCH-28.2 MCHC-31.7* RDW-18.6* RDWSD-58.8* Plt ___
___ 07:00AM BLOOD Neuts-70 Bands-3 Lymphs-8* Monos-2* Eos-5 
Baso-2* ___ Metas-3* Myelos-5* Blasts-2* AbsNeut-26.28* 
AbsLymp-2.88 AbsMono-0.72 AbsEos-1.80* AbsBaso-0.72*
___ 07:00AM BLOOD Hypochr-1+* Anisocy-1+* Poiklo-1+* 
Macrocy-1+* Microcy-OCCASIONAL Polychr-OCCASIONAL 
Spheroc-OCCASIONAL Burr-OCCASIONAL
___ 07:00AM BLOOD Glucose-86 UreaN-19 Creat-1.1 Na-142 
K-4.1 Cl-102 HCO___ AnGap-14
___ 07:00AM BLOOD Digoxin-0.7

IMAGING, STUDIES
=================
+Coronary angiogram ___
Coronary Description
The coronary circulation is right dominant.
LM: The Left Main, arising from the left cusp, is a large 
caliber vessel. This vessel bifurcates into the
Left Anterior Descending and Left Circumflex systems.
LAD: The Left Anterior Descending artery, which arises from the 
LM, is a large caliber vessel. There is
a 50% stenosis in the proximal segment.
The Septal Perforator, arising from the proximal segment, is a 
small caliber vessel.
The Diagonal, arising from the proximal segment, is a medium 
caliber vessel.
Cx: The Circumflex artery, which arises from the LM, is a large 
caliber vessel. There is a 90% stenosis
in the mid segment of the AV groove branch of the LCx
The Obtuse Marginal, arising from the proximal segment, is a 
medium caliber vessel.
RCA: The Right Coronary Artery, arising from the right cusp, is 
a large caliber vessel. There is a 50%
stenosis in the proximal segment.
The Right Posterior Descending Artery, arising from the distal 
segment, is a medium caliber vessel.
The Right Posterolateral Artery, arising from the distal 
segment, is a medium caliber vessel.
Findings
 Three vessel coronary artery disease. Moderate LAD and RCA 
disease with most significant
diseases noted in the medium caliber AV groove segment of the 
LCx

___
CONCLUSION:
The left atrial volume index is SEVERELY increased. The right 
atrium is mildly enlarged. The estimated right atrial pressure 
is ___ mmHg. There is mild symmetric left ventricular 
hypertrophy with a borderline increased/dilated cavity. There is 
normal regional left ventricular systolic function. Overall left 
ventricular systolic function is mildly depressed. There is 
beat-to-beat variability in the left
ventricular contractility due to the irregular rhythm. The 
visually estimated left ventricular ejection fraction is 45-50%. 
Left ventricular cardiac index is normal (>2.5 L/min/m2). (-10.4 
%; normal less
than -20%) There is no resting left ventricular outflow tract 
gradient. Mildly dilated right ventricular
cavity with normal free wall motion. The aortic sinus diameter 
is normal for gender with normal
ascending aorta diameter for gender. The aortic arch diameter is 
normal with a mildly dilated descending
aorta. The abdominal aorta is severely dilated. The aortic valve 
leaflets (3) are moderately thickened.
There is moderate aortic valve stenosis (valve area 1.0-1.5 
cm2). However, dimensionless index is 0.26
when using the same beat that exhibits highest peak velocity 
through the aortic valve. There is mild to
moderate [___] aortic regurgitation. The mitral valve leaflets 
are mildly thickened with no mitral valve
prolapse. Torn mitral valve chordae are seen. There is mild [1+] 
mitral regurgitation. The tricuspid valve
leaflets are mildly thickened. There is mild [1+] tricuspid 
regurgitation. There is mild pulmonary artery
systolic hypertension. There is no pericardial effusion.
IMPRESSION: 1) Mild regional LV systolic dysfunction suggesting 
CAD in LCX territory. Global
longitudinal strain is moderately depressed. 2) Moderate aortic 
stenosis by aortic valve area
however the dimensionless index borders to severe aortic 
stenosis repeat evaluation of aortic
stenosis severity in sinus rhythm may bring clarity about true 
severity of aortic stenosis. 3) The
patient has significant mitral annular calcification and 
thickening of the mitral valve leaflets with
reverbaration artifact in the left atrium however a small 
echogenicity on the posterior mitral
annulus cannot be excluded. If clinically indicated a TEE may 
improve visualization.

+TEE ___
CONCLUSION:
There is moderate/severe spontaneous echo contrast in the body 
of the left atrium and in the left atrial appendage. A probable 
xx cm left atrial appendage thrombus is seen. The left atial 
appendage ejection
velocity is very depressed. No spontaneous echo contrast is seen 
in the body of the right atrium or right atrial appendage. There 
is no evidence for an atrial septal defect by 2D/color Doppler. 
There are simple atheroma in the aortic arch with complex (>4mm, 
non-mobile) atheroma in the descending aorta to 35cm from the 
incisors. The aortic valve leaflets (3) are moderately 
thickened. No masses or vegetations are seen on the
aortic valve. No abscess is seen. There is trace aortic 
regurgitation. The mitral valve leaflets are moderately 
thickened. No masses or vegetations are seen on the mitral 
valve. No abscess is seen. There is mild to
moderate [___] mitral regurgitation. The tricuspid valve 
leaflets appear structurally normal. No mass/ vegetation are 
seen on the tricuspid valve. No abscess is seen. There is mild 
[1+] tricuspid regurgitation.
IMPRESSION: Moderate to severe spontaneous echo contrast with 
probable formation of sludge/thrombus in the left atrial 
appendage. Mild to moderate mitral regurgitation. Complex 
atheroma in the descending aorta.

+CTA Torso ___
Wet Read by ___ on WED ___ 5:29 ___  
1. Infrarenal abdominal aortic aneurysm measuring up to 6.6 x 
6.4 cm in 
greatest axial ___ (3:152). 
2. Fusiform dilatation of bilateral common iliac arteries. 
3. Mild bibasilar interlobular septal thickening and right upper 
lobe 
ground-glass opacity are improved from the prior study likely 
representing 
interval approval in volume overload. 
4. Enlarged mediastinal and hilar lymph nodes are likely 
reactive. 
5. Multiple sub solid pulmonary nodules measuring less than 6 mm 
for which 
follow-up with chest CT in ___ months is recommended. 
6. Accessory upper pole renal arteries are noted bilaterally. 
7. Diverticulosis. 
8. Final read pending 3D reformations. 

 
Brief Hospital Course:
========
SUMMARY
========
Mr. ___ is a ___ male without medical care 
for several years, no known past medical history, who initially 
presented to ___ on ___ with SOB and palpitations, 
found to have heart failure (acute, unclear if chronic 
component), afib with RVR, leukocytosis with left shift, and 
infrarenal 6cm AAA. 

====================
ACUTE MEDICAL ISSUES
====================
#6cm infrarenal AAA: CT read at outside hospital raised 
concerning for evidence of hemorrhage into wall and weakening of 
wall concerning for impending rupture. However, per review by 
Dr. ___ ___ vascular surgery team there was no 
radiographic evidence of rupture and emergent surgery was not 
indicated. Vascular surgery team saw him in house and 
recommended optimization of cardiac problems before proceeding 
with an elective AAA repair. To further evaluate the AAA, we 
obtained a dedicated CTA abdomen. Vascular surgery reviewed 
imaging and appears amenable to physician modified ___. He 
was asymptomatic from the AAA standpoint. 

From a cardiology standpoint, we would like to treat with 
uninterrupted anticoagulation for at least 4 weeks at which time 
we will repeat TEE to assess atrial thrombus. If thrombus has 
resolved, consider for cardioversion pending repeat assessment 
of EF at that time. If has cardioversion, would need to be 
followed by another 4 weeks of uninterrupted anticoagulation. 

# HFrEF, acute: Initial Outside hospital TTE showed LVEF 35% 
with inferior WMA, moderate MR/TR, moderate AI and AS while 
patient was in atrial fibrillation. On repeat at ___ while in 
afib with improved rate control showed LVEF 45-50%. He reported 
no functional limitations at home prior to this incident without 
PND, or orthopnea. He underwent a cardiac cath on ___ which 
showed coronary disease (99% stenosis of distal LCx) though not 
significant enough to explain his degree of cardiomyopathy. 
Suspect cardiomyopathy is tachycardia-mediated and may improve 
with cardioversion. Should plan for cardioversion if repeat TEE 
in 4 weeks shows resolution of atrial thrombus and persistent 
reduced EF while in atrial fibrillation. Will discharge on every 
other day dosing of lasix 20 mg. 

# NSTEMI: Presented with lateral STDs on EKG on admission, mild 
troponinemia which has not been rising. Suspect this represents 
a type II NSTEMI secondary to demand ischemia, however could 
have had a missed event several days prior to admission. Cardiac 
cath did show significant a 99% stenosis of distal LCx which was 
not revascularized as did not seem to be supplying significant 
portion of myocardium and given need for surgery in near future 
did not want to commit patient to ___ year of uninterrupted DAPT. 
Optimized medication regimen with ASA, statin, and beta blocker.

# A. fib w/ RVR: Unclear trigger, but suspect may have been 
missed ischemic event as above. Patient was initially held off 
of anticoagulation due to possible need for surgery but once 
deemed stable was started on apixaban 5mg BID (CHADs2-VASc score 
is 4). Patient was initially started on an esmolol gtt but 
eventually transitioned to PO metoprolol succinate 200mg QAM and 
100mg QPM and PO digoxin 0.125mg daily with good control of 
rates. Patient had a TEE in anticipation of cardioversion but 
discovered a left atrial thrombus so cardioversion was aborted. 
Patient will need to remain on uninterrupted for 4 weeks and 
have a repeat TEE at that time to assess for resolution of 
atrial thrombus.  Should also assess ejection fraction at that 
time and if still compromised, consider cardioversion for 
possible tachycardia mediated cardiomyopathy.

# Leukocytosis: Patient presented with leukocytosis in the range 
of ___ with no clear evidence of infection clinically or on 
imaging. In ___ he had had a WBC of 18 on outside labs which he 
brought in for our review. Heme/onc reviewed smear which 
contained signficant left shift and circulating blast count of 
2%. No dysplastic features seen. He was initially given ATRA on 
___ due to concern for APML. However,given the absence of a 
significant number of circulating blasts in the periphery this 
was felt to be unlikely. ___ was sent for BCR/ABL PCR and was 
negative.  This effectively excludes a diagnosis of chronic 
myelogenous leukemia.  Per heme/onc, given low blast count and 
leukocytosis on previous testing, very unlikely to be an acute 
leukemia.  On ___, patient underwent bone marrow biopsy.  
Results pending.  Patient has a follow-up appointment with the 
oncology team on ___ to review results of bone marrow biopsy.
  
# ___: Unknown baseline, Cr 1.8 on admission downtrended to 1.1 
on discharge.  Likely cardiorenal in the setting of heart 
failure exacerbation on admission.  Patient was given IV 
diuresis with improvement in creatinine.  Patient likely has 
mild CKD although do not have baseline to compare to.

# s/p Tobacco use disorder: had quit prior to admission. 

====================
TRANSITIONAL ISSUES
====================
[] Atrial fibrillation and left atrial thrombus: Rate is well 
controlled at discharge on metoprolol and digoxin.  Patient 
should remain on Eliquis 5 mg twice daily uninterrupted and 
should have repeat TEE in 4 weeks to reassess left atrial 
thrombus.  If ejection fraction still compromised at that time 
please consider cardioversion for potential tachycardia induced 
cardiomyopathy.
[] Should have repeat digoxin level drawn on ___ to make sure 
at therapeutic level given possible interaction with statin.
[] Please check BMP 1 week after discharge and if creatinine 
stable consider starting an ACE inhibitor to optimize heart 
failure treatment.
[] On CT torso patient was noted to have several sub-solid 
pulmonary nodules measuring less than 6 mm for which follow-up 
with CT chest in ___ months as recommended by radiology.
[] Bone marrow biopsy results are pending at time of discharge.  
Patient will follow-up appointment with hematology to review 
results as outpatient.  Please ensure patient is aware of 
appointment and any hematology recommendations.
[] Patient will be discharged on Lasix 20 mg every other day.  
Patient advised to check his weight daily and notify his 
physician if weight increases by more than 3 pounds in 1 day.  
If weight continues to increase will likely need to uptitrate 
diuretic and increased frequency.
 
# DISCHARGE WEIGHT: 74.4 kg (164.02 lb)
# DISCHARGE CREATININE: 1.1 
# Communication: HCP: Wife ___ ___  
# Code: Full, confirmed
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. This patient is not taking any preadmission medications

 
Discharge Medications:
1.  Apixaban 5 mg PO BID  
2.  Aspirin 81 mg PO DAILY  
3.  Digoxin 0.125 mg PO DAILY  
4.  Metoprolol Succinate XL 200 mg PO DAILY  
5.  Metoprolol Succinate XL 100 mg PO QHS  
6.  Pravastatin 80 mg PO QPM  
7. Furosemide 20 mg QOD
8.Outpatient Lab Work
ICD 10: N17.9
LAB TEST: Basic metabolic profile, CBC with differential
DATE: ___
PLEASE FAX RESULTS TO: ___ ATTN: Dr. ___ AND 
___ ATTN: Drs. ___ and ___
8.Outpatient Lab Work
ICD 10:  ___
LAB TEST: Digoxin serum level
DATE: ___
PLEASE FAX RESULTS TO: ___ ATTN: Dr. ___

 
___ Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
Atrial fibrillation with rapid ventricular response

SECONDARY DIAGNOSES:
Infrenal abdominal aortic aneurysm
Heart failure, mildly reduced ejection fraction
Left atrial thrombus
Leukocytosis
Acute kidney injury

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
 Dear Mr. ___,
  
It was a pleasure taking care of you at the ___ 
___!  

WHY WAS I IN THE HOSPITAL?  
==========================   
- You were admitted because your heart rate was very fast and 
you were short of breath.

WHAT HAPPENED IN THE HOSPITAL?  
==============================  
- You were transferred to ___ due to concern about an enlarged 
blood vessel in your abdomen (AAA).
- Vascular surgery reviewed your imaging and will plan on 
surgery when your heart rate is stabilized and they can 
interrupt your anticoagulation.
- You were diagnosed with atrial fibrillation. Your heart rate 
was controlled with medications (metoprolol and digoxin). 
- You were also started on a blood thinner (apixaban AKA 
ELiquis) for stroke prevention. 
- You were found to have a blood clot in your heart, which means 
your anticoagulation needs to be uninterrupted for 4 weeks.   
- You underwent a bone marrow biopsy on ___ and you tolerated 
the procedure well. 

WHAT SHOULD I DO WHEN I GO HOME?  
================================  
- Please take all your medications as prescribed.
- Please arrange to establish with a primary care doctor within 
1 week of discharge.
- Please go to your follow up appointments as scheduled below 
with cardiology, hematology, and vascular surgery.
- Please refrain from showering for 24 hours after your bone 
marrow biopsy.
- You will need to remain on anticoagulation (eliquis) 
uninterrupted for at least the next 4 weeks. After 4 weeks, you 
should undergo another transesophageal echocardiogram to 
reassess the clot. If it has resolved, then you should discuss 
with your Cardiologist about cardioversion.
- Your surgeon will be in coordination with your Cardiologist to 
decide the safest timing of surgery.
- Weigh yourself when you get home and every morning. If your 
weight changes more than 2 lbs. within 24 hours, call your 
physician for management of your heart failure medications.

Thank you for allowing us to be involved in your care, we wish 
you all the best!
  
Your ___ Team  
 
Followup Instructions:
___
"
